PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	di Martino, S; Amoreo, CA; Nuvoli, B; Galati, R; Strano, S; Facciolo, F; Alessandrini, G; Pass, HI; Ciliberto, G; Blandino, G; De Maria, R; Cioce, M				di Martino, Simona; Amoreo, Carla Azzurra; Nuvoli, Barbara; Galati, Rossella; Strano, Sabrina; Facciolo, Francesco; Alessandrini, Gabriele; Pass, Harvey I.; Ciliberto, Gennaro; Blandino, Giovanni; De Maria, Ruggero; Cioce, Mario			HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome	ONCOGENE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; CELL LUNG-CANCER; POTENT ANTITUMOR-ACTIVITY; ADVANCED SOLID TUMORS; IN-VITRO; SENESCENT CELLS; STEM-CELLS; INTRATUMORAL HETEROGENEITY; ACQUIRED-RESISTANCE; DRUG-RESISTANCE	Adaptive resistance to therapy is a hallmark of cancer progression. To date, it is not entirely clear how microenvironmental stimuli would mediate emergence of therapy-resistant cell subpopulations, although a rearrangement of the cancer cell secretome following therapy-induced stress can be pivotal for such a process. Here, by using the highly chemoresistant malignant pleural mesothelioma (MPM) as an experimental model, we unveiled a key contribution of the chaperone HSP90 at assisting a chemotherapy-instigated Senescence-Associated-Secretory-Phenotype (SASP). Thus, administration of a clinical trial grade, HSP90, inhibitor blunted the release of several cytokines by the chemotherapy-treated MPM cells, including interleukin (IL)-8. Reduction of IL-8 levels hampered the FAK-AKT signaling and inhibited 3D growth and migration. This correlated with downregulation of key EMT and chemoresistance genes and affected the survival of chemoresistant ALDH(bright) cell subpopulations. Altogether, inhibition of HSP90 provoked a switch from a pro-tumorigenic SASP to a pro-apoptotic senescence status, thus resulting in chemosensitizing effects. In mouse xenografts treated with firstline agents, inhibiting HSP90 blunted FAK activation and reduced the expression of ALDH1A3 and the levels of circulating human IL-8, these latter strongly correlating with the effect on tumor growth. We validated the above findings in primary mesothelioma cultures, a more clinically relevant model. We unveiled here a key contribution of the chaperone HSP90 at assisting the secretory stress in chemotherapy-treated cells, which may warrant further investigation in combinatorial therapeutic settings.	[di Martino, Simona; Blandino, Giovanni; Cioce, Mario] Regina Elena Inst Canc Res, Oncogen & Epigenet Unit, Rome, Italy; [Amoreo, Carla Azzurra] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy; [Nuvoli, Barbara; Galati, Rossella] Regina Elena Inst Canc Res, Preclin Models & New Therapeut Agents Unit, Rome, Italy; [Strano, Sabrina] Regina Elena Inst Canc Res, Mol Chemoprevent Unit, Rome, Italy; [Facciolo, Francesco; Alessandrini, Gabriele] Regina Elena Inst Canc Res, Dept Thorac Surg, Rome, Italy; [Pass, Harvey I.] NYU, Sch Med, Dept Cardiothorac Surg, New York, NY USA; [Ciliberto, Gennaro; De Maria, Ruggero] Regina Elena Inst Canc Res, Sci Direct, Rome, Italy; [De Maria, Ruggero] Catholic Univ, Inst Gen Pathol, Rome, Italy; [De Maria, Ruggero] Gemelli Polyclin, Rome, Italy; [Strano, Sabrina; Blandino, Giovanni] McMaster Univ, Dept Oncol, Hamilton, ON, Canada	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; New York University; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; McMaster University	Cioce, M (corresponding author), Regina Elena Inst Canc Res, Oncogen & Epigenet Unit, Rome, Italy.; De Maria, R (corresponding author), Regina Elena Inst Canc Res, Sci Direct, Rome, Italy.; De Maria, R (corresponding author), Catholic Univ, Inst Gen Pathol, Rome, Italy.; De Maria, R (corresponding author), Gemelli Polyclin, Rome, Italy.	demariaruggero@gmail.com; mariocioce@gmail.com	AMOREO, CARLA AZZURRA/K-5375-2018; Galati, Rossella Maria/H-8867-2017; De Maria, Ruggero/S-6385-2019; Cioce, Mario/R-9734-2017; di Martino, Simona SdM/K-9304-2016; Ciliberto, Gennaro/J-4131-2017; Galati, Rossella/ABH-6437-2020; Strano, Sabrina/K-9654-2016	AMOREO, CARLA AZZURRA/0000-0003-3817-1967; Galati, Rossella Maria/0000-0003-2646-8384; De Maria, Ruggero/0000-0003-2255-0583; Cioce, Mario/0000-0001-8129-6664; di Martino, Simona SdM/0000-0003-4533-3776; Ciliberto, Gennaro/0000-0003-2851-8605; Galati, Rossella/0000-0003-2646-8384; strano, sabrina/0000-0002-6341-4230; Alessandrini, Gabriele/0000-0002-4380-7627; Facciolo, Francesco/0000-0002-7137-8946; Pass, Harvey/0000-0003-3222-3471	Fundacio' La Marato' de TV3 [432/C/2013]; AIRC; Marie Curie Actions-People-COFUND fellowship; Italian Ministry of Health (Progetto Nazionale Amianto)	Fundacio' La Marato' de TV3; AIRC(Fondazione AIRC per la ricerca sul cancro); Marie Curie Actions-People-COFUND fellowship; Italian Ministry of Health (Progetto Nazionale Amianto)	The funding for this study was provided by the Fundacio' La Marato' de TV3 (grant 432/C/2013) to RDM. M.C. was supported by an AIRC and Marie Curie Actions-People-COFUND fellowship. We thankfully acknowledge the support of the Italian Ministry of Health (Progetto Nazionale Amianto) to R.D.M. We thankfully acknowledge the helpful advice of Dr. Paola Nistico, Dr. Maria Lucia Dell' Anna, and Dr. Valeria Catena (Regina Elena National Cancer Institute, Rome, Italy).	Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Aird Katherine M, 2013, Methods Mol Biol, V965, P185, DOI 10.1007/978-1-62703-239-1_12; Alimbetov D, 2016, BIOGERONTOLOGY, V17, P305, DOI 10.1007/s10522-015-9610-z; Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Basu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052188; Benoy IH, 2004, CLIN CANCER RES, V10, P7157, DOI 10.1158/1078-0432.CCR-04-0812; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Busacca S, 2016, ONCOGENE, V35, P1483, DOI 10.1038/onc.2015.213; Cahu J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.183; Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001; Canino C, 2012, ONCOGENE, V31, P3148, DOI 10.1038/onc.2011.485; Canino C, 2016, METHODS MOL BIOL, V1379, P139, DOI 10.1007/978-1-4939-3191-0_13; Canino C, 2015, ONCOTARGET, V6, P12637, DOI 10.18632/oncotarget.3703; Carbone M, 2012, J CELL PHYSIOL, V227, P44, DOI 10.1002/jcp.22724; Chatterjee S, 2017, MOL CANCER THER, V16, P793, DOI 10.1158/1535-7163.MCT-16-0677; Chernova T, 2016, CELL DEATH DIFFER, V23, P1152, DOI 10.1038/cdd.2015.165; Cioce M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.136; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Corpet A, 2014, CHROMOSOMA, V123, P423, DOI 10.1007/s00412-014-0469-6; Cortes-Dericks L, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-304; Cortes-Dericks L, 2010, INT J ONCOL, V37, P437, DOI 10.3892/ijo_00000692; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Galffy G, 1999, CANCER RES, V59, P367; Galffy G, 1999, ONCOL RES, V11, P187; Garon EB, 2013, MOL CANCER THER, V12, P890, DOI 10.1158/1535-7163.MCT-12-0998; Genovese G, 2017, NATURE, V542, P362, DOI 10.1038/nature21064; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Gomez-Casal R, 2015, CANCERS, V7, P876, DOI 10.3390/cancers7020814; He SQ, 2014, INVEST NEW DRUG, V32, P577, DOI 10.1007/s10637-014-0095-4; Hillegass JM, 2010, ANN NY ACAD SCI, V1203, P7, DOI 10.1111/j.1749-6632.2010.05554.x; Jones SF, 2015, INVEST NEW DRUG, V33, P1100, DOI 10.1007/s10637-015-0282-y; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kim KL, 2005, AM J RESP CELL MOL, V33, P541, DOI 10.1165/rcmb.2004-0355OC; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Lai CH, 2014, ONCOGENE, V33, P4867, DOI 10.1038/onc.2013.439; Liu X, 2016, ANTI-CANCER DRUG, V27, P417, DOI 10.1097/CAD.0000000000000347; Lundgren K, 2009, MOL CANCER THER, V8, P921, DOI 10.1158/1535-7163.MCT-08-0758; Marcato P, 2011, CELL CYCLE, V10, P1378, DOI 10.4161/cc.10.9.15486; Mathias RA, 2009, J PROTEOME RES, V8, P2827, DOI 10.1021/pr8010974; Mujoomdar AA, 2010, J THORAC CARDIOV SUR, V140, P352, DOI 10.1016/j.jtcvs.2009.11.072; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Obenauf AC, 2015, NATURE, V520, P368, DOI 10.1038/nature14336; Ohanna M, 2011, GENE DEV, V25, P1245, DOI 10.1101/gad.625811; Ohanna M, 2013, ONCOTARGET, V4, P2212, DOI 10.18632/oncotarget.1143; Ohkubo S, 2015, MOL CANCER THER, V14, P14, DOI 10.1158/1535-7163.MCT-14-0219; Park SY, 2014, EUR J CANCER, V50, P341, DOI 10.1016/j.ejca.2013.09.021; Patel S, 2014, ADV EXP MED BIOL, V806, P409, DOI 10.1007/978-3-319-06068-2_20; Piper PW, 2011, PHARMACEUTICALS, V4, P1400, DOI 10.3390/ph4111400; Pribluda A, 2015, CLIN CANCER RES, V21, P2916, DOI 10.1158/1078-0432.CCR-14-1213; Sarker D, 2015, CLIN CANCER RES, V21, P77, DOI 10.1158/1078-0432.CCR-14-0947; Saunders NA, 2012, EMBO MOL MED, V4, P675, DOI 10.1002/emmm.201101131; Shapiro IM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008639; Shimamura T, 2012, CLIN CANCER RES, V18, P4973, DOI 10.1158/1078-0432.CCR-11-2967; Shimizu T, 2016, CANCER CHEMOTH PHARM, V77, P997, DOI 10.1007/s00280-016-3010-1; Singh JK, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3436; Socinski MA, 2013, CLIN CANCER RES, V19, P3068, DOI 10.1158/1078-0432.CCR-12-3381; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Thakur MK, 2016, INVEST NEW DRUG, V34, P112, DOI 10.1007/s10637-015-0307-6; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wang Y, 2011, CYTOKINE, V56, P365, DOI 10.1016/j.cyto.2011.06.005; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755	65	16	17	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	10					1369	1385		10.1038/s41388-017-0044-8	http://dx.doi.org/10.1038/s41388-017-0044-8			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ0RI	29311642				2022-12-26	WOS:000427279300008
J	Hua, SN; Lei, L; Deng, L; Weng, X; Liu, CD; Qi, XL; Wang, S; Zhang, DY; Zou, XJ; Cao, CH; Liu, L; Wu, DH				Hua, Shengni; Lei, Ling; Deng, Ling; Weng, Xie; Liu, Chengdong; Qi, Xiaolong; Wang, Shuang; Zhang, Dongyan; Zou, Xuejing; Cao, Chuanhui; Liu, Li; Wu, Dehua			miR-139-5p inhibits aerobic glycolysis, cell proliferation, migration, and invasion in hepatocellular carcinoma via a reciprocal regulatory interaction with ETS1	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR ETS1; TUMOR-SUPPRESSOR; DIFFERENTIAL EXPRESSION; GASTRIC-CANCER; PROTOONCOGENE; METASTASIS; MICRORNAS; HYPOXIA; NETWORK	Cancer cells have metabolic features that allow them to preferentially metabolize glucose through aerobic glycolysis, providing them with a progression advantage. However, microRNA (miRNA) regulation of aerobic glycolysis in cancer cells has not been extensively investigated. We addressed this in the present study by examining the regulation of miR-139-5p on aerobic glycolysis of hepatocellular carcinoma (HCC) using clinical specimens, HCC cells, and a mouse xenograft model. We found that overexpressing miR-139-5p restrained aerobic glycolysis, suppressing proliferation, migration, and invasion in HCC cells. miR-139-5p regulated hexokinase 1 (HK1) and 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) expression by directly targeting the transcription factor ETS1, which bound to the promoters of the HK1 and PFKFB3 genes. miR-139-5p-induced aerobic glycolysis, proliferation, migration, and invasion were reversed by ETS1 overexpression, while ETS1 silencing induced the expression of miR-139-5p via a post-transcriptional regulation mode involving Drosha. miR-139-5p expression was reduced in HCC compared to para-carcinoma tissue, which was confirmed in The Cancer Genome Atlas and GSE54751 HCC cohorts. Notably, the lower expression of mir-139 was correlated with worse prognosis. These outcomes indicate that reciprocal regulatory interactions between miR-139-5p and ETS1 modulate aerobic glycolysis, proliferation, and metastasis in HCC cells, suggesting new targets for HCC treatment.	[Hua, Shengni; Lei, Ling; Deng, Ling; Liu, Chengdong; Zhang, Dongyan; Cao, Chuanhui; Wu, Dehua] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China; [Weng, Xie; Zou, Xuejing; Liu, Li] Southern Med Univ, Nanfang Hosp, Hepatol Unit, Guangzhou, Guangdong, Peoples R China; [Weng, Xie; Zou, Xuejing; Liu, Li] Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Qi, Xiaolong] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China; [Wang, Shuang] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Wu, DH (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China.; Liu, L (corresponding author), Southern Med Univ, Nanfang Hosp, Hepatol Unit, Guangzhou, Guangdong, Peoples R China.; Liu, L (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China.	liuli.fimmu@gmail.com; wudehua.gd@gmail.com	hua, shengni/HDN-5084-2022	Liu, Li/0000-0002-5265-4159; Zou, Xuejing/0000-0001-6360-204X; Wu, De-Hua/0000-0003-0560-0016	Nation's Nature Science Foundation of China [81472711, 91540111, 81672756, 81401180, 81372283]; Guangdong Province Nature Science Foundation [2014A030311013]	Nation's Nature Science Foundation of China; Guangdong Province Nature Science Foundation	This work was supported by Nation's Nature Science Foundation of China (Grant nos. 81472711, 91540111, 81672756, 81401180, and 81372283) and the Guangdong Province Nature Science Foundation (Grant no. 2014A030311013).	Adam M, 2003, EUR UROL, V44, P329, DOI 10.1016/S0302-2838(03)00262-8; Au SLK, 2012, HEPATOLOGY, V56, P622, DOI 10.1002/hep.25679; Bao W, 2011, GASTROENTEROLOGY, V141, P2076, DOI 10.1053/j.gastro.2011.08.050; Chabre O, 2013, ENDOCR-RELAT CANCER, V20, P579, DOI 10.1530/ERC-13-0051; Corbetta S, 2010, ENDOCR-RELAT CANCER, V17, P135, DOI 10.1677/ERC-09-0134; Dittmer J, 2015, SEMIN CANCER BIOL, V35, P20, DOI 10.1016/j.semcancer.2015.09.010; Dong Z, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004299; Emmrich S, 2016, ONCOGENE, V35, P1822, DOI 10.1038/onc.2015.247; Endig J, 2016, CANCER CELL, V30, P308, DOI 10.1016/j.ccell.2016.06.009; Findlay VJ, 2013, ADV CANCER RES, V119, P1, DOI 10.1016/B978-0-12-407190-2.00001-0; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Guo WJ, 2015, HEPATOLOGY, V62, P1132, DOI 10.1002/hep.27929; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Haakensen VD, 2016, INT J CANCER, V139, P1117, DOI 10.1002/ijc.30142; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He GF, 2015, NUCLEIC ACIDS RES, V43, P4322, DOI 10.1093/nar/gkv267; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hiroki E, 2010, CANCER SCI, V101, P241, DOI 10.1111/j.1349-7006.2009.01385.x; Hu J, 2016, CANCER CELL, V29, P49, DOI 10.1016/j.ccell.2015.12.005; Huang Y, 2012, NUCLEIC ACIDS RES, V40, P10478, DOI 10.1093/nar/gks789; Li L, 2017, CANCER LETT, V400, P89, DOI 10.1016/j.canlet.2017.04.034; Li QG, 2016, SCI REP-UK, V6, DOI 10.1038/srep27157; Liu L, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.20; Ma XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6212; Nie HZ, 2015, HEPATOLOGY, V62, P1145, DOI 10.1002/hep.27940; Nucera S, 2016, CANCER CELL, V29, P905, DOI 10.1016/j.ccell.2016.05.007; Pichiorri F, 2016, CANCER CELL, V30, P349, DOI 10.1016/j.ccell.2016.07.007; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Rupaimoole R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6202; Shen J, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0105-1; Shen K, 2014, FEBS J, V281, P3609, DOI 10.1111/febs.12880; Tsoulfas G, 2011, J GASTROENTEROL, V46, P249, DOI 10.1007/s00535-010-0302-9; Wang CD, 2015, J BIOL CHEM, V290, P21925, DOI 10.1074/jbc.M115.644864; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wong CCL, 2011, GASTROENTEROLOGY, V140, P322, DOI 10.1053/j.gastro.2010.10.006; Xu K, 2016, ONCOTARGET, V7, P75118, DOI 10.18632/oncotarget.12611; Zeng S, 2017, CANCER LETT, V390, P67, DOI 10.1016/j.canlet.2016.12.042; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhao J, 2008, HEPATOLOGY, V48, P265, DOI 10.1002/hep.22280	42	84	86	4	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	12					1624	1636		10.1038/s41388-017-0057-3	http://dx.doi.org/10.1038/s41388-017-0057-3			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GA8YC	29335523				2022-12-26	WOS:000428626700006
J	Welcker, D; Jain, M; Khurshid, S; Jokic, M; Hohne, M; Schmitt, A; Frommolt, P; Niessen, CM; Spiro, J; Persigehl, T; Wittersheim, M; Buttner, R; Fanciulli, M; Schermer, B; Reinhardt, HC; Benzing, T; Hopker, K				Welcker, Daniela; Jain, Manaswita; Khurshid, Safiya; Jokic, Mladen; Hoehne, Martin; Schmitt, Anna; Frommolt, Peter; Niessen, Carien M.; Spiro, Judith; Persigehl, Thorsten; Wittersheim, Maike; Buettner, Reinhard; Fanciulli, Maurizio; Schermer, Bernhard; Reinhardt, Hans Christian; Benzing, Thomas; Hoepker, Katja			AATF suppresses apoptosis, promotes proliferation and is critical for Kras-driven lung cancer	ONCOGENE			English	Article							DNA-DAMAGE RESPONSE; CELL-CYCLE; RAS ONCOGENES; P53 TRANSCRIPTION; CHK2 KINASES; CHECKPOINT; CHE-1; ATM; PATHWAY; GROWTH	A fundamental principle in malignant tranformation is the ability of cancer cells to escape the naturally occurring cellintrinsic responses to DNA damage. Tumors progress despite the accumulation of DNA lesions. However, the underlying mechanisms of this tolerance to genotoxic stress are still poorly characterized. Here, we show that replication stress occurs in Kras-driven murine lung adenocarcinomas, as well as in proliferating murine embryonic and adult tissues. We identify the transcriptional regulator AATF/CHE-1 as a key molecule to sustain proliferative tissues and tumor progression in parts by inhibiting p53-driven apoptosis in vivo. In an autochthonous Kras-driven lung adenocarcinoma model, deletion of Aatf delayed lung cancer formation predominantly in a p53-dependent manner. Moreover, targeting Aatf in existing tumors through a dual recombinase strategy caused a halt in tumor progression. Taken together, these data suggest that AATF may serve as a drug target to treat KRAS-driven malignancies.	[Welcker, Daniela; Jain, Manaswita; Khurshid, Safiya; Hoehne, Martin; Schmitt, Anna; Schermer, Bernhard; Benzing, Thomas; Hoepker, Katja] Univ Cologne, Dept Internal Med 2, Cologne, Germany; [Welcker, Daniela; Jain, Manaswita; Khurshid, Safiya; Jokic, Mladen; Hoehne, Martin; Frommolt, Peter; Niessen, Carien M.; Schermer, Bernhard; Reinhardt, Hans Christian; Benzing, Thomas; Hoepker, Katja] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany; [Khurshid, Safiya] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Jokic, Mladen; Reinhardt, Hans Christian] Univ Cologne, Dept Internal Med 1, Cologne, Germany; [Jokic, Mladen; Hoehne, Martin; Niessen, Carien M.; Schermer, Bernhard; Reinhardt, Hans Christian; Benzing, Thomas] Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany; [Hoehne, Martin; Schermer, Bernhard; Benzing, Thomas] Univ Cologne, Syst Biol Ageing Cologne Sybacol, Cologne, Germany; [Niessen, Carien M.] Univ Cologne, Dept Dermatol, Cologne, Germany; [Spiro, Judith; Persigehl, Thorsten] Univ Cologne, Dept Radiol, Cologne, Germany; [Wittersheim, Maike; Buettner, Reinhard] Univ Cologne, Dept Pathol, Cologne, Germany; [Fanciulli, Maurizio] Regina Elena Inst Canc Res, Translat Res Area, SAFU Lab, Dept Res Adv Diagnost & Technol Innovat, Rome, Italy	University of Cologne; University of Cologne; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Benzing, T (corresponding author), Univ Cologne, Dept Internal Med 2, Cologne, Germany.; Reinhardt, HC; Benzing, T (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany.; Reinhardt, HC (corresponding author), Univ Cologne, Dept Internal Med 1, Cologne, Germany.; Reinhardt, HC; Benzing, T (corresponding author), Univ Cologne, Ctr Mol Med Cologne, Cologne, Germany.; Benzing, T (corresponding author), Univ Cologne, Syst Biol Ageing Cologne Sybacol, Cologne, Germany.	christian.reinhardt@uk-koeln.de; thomas.benzing@uk-koeln.de	Benzing, Thomas/X-5476-2019; Schermer, Bernhard/E-9972-2014; fanciulli, maurizio/ABH-6745-2020; Frommolt, Peter/L-9656-2016	Schermer, Bernhard/0000-0002-5194-9000; Frommolt, Peter/0000-0002-1966-8014; Khurshid, Safiya/0000-0003-1620-3091; Niessen, Carien M./0000-0002-4892-9391; Hohne, Martin/0000-0001-8698-5389; Jain, Manaswita/0000-0002-5107-7505	Volkswagenstiftung; Deutsche Forschungsgemeinschaft [KFO-286, SFB-829, SCHE1562/2, BE2212]; Bundesministerium fur Bildung und Forschung; German federal state North Rhine Westphalia (NRW) as part of the EFRE initiative [LS-1-1-030a]; Else Kroner-Fresenius Stiftung [EKFS-2014-A06]; Deutsche Krebshilfe [111724]; University of Cologne (Koln Fortune Program); Cologne Cardiovascular Research Center (Graduate Program); Cologne Graduate School of Ageing Research; CECAD Research Center Cologne Maternity Leave Fellowship	Volkswagenstiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); German federal state North Rhine Westphalia (NRW) as part of the EFRE initiative; Else Kroner-Fresenius Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); University of Cologne (Koln Fortune Program); Cologne Cardiovascular Research Center (Graduate Program); Cologne Graduate School of Ageing Research; CECAD Research Center Cologne Maternity Leave Fellowship	This work was supported by Volkswagenstiftung (Lichtenberg Program to HCR), Deutsche Forschungsgemeinschaft (KFO-286 to HCR, SFB-829 to HCR, CN and TB, SCHE1562/2 to BS, BE2212 to TB), Bundesministerium fur Bildung und Forschung (SMOOSE to HCR, SYBACOL to TB), German federal state North Rhine Westphalia (NRW) as part of the EFRE initiative (grant LS-1-1-030a to HCR), Else Kroner-Fresenius Stiftung (EKFS-2014-A06 to HCR), Deutsche Krebshilfe (111724, HCR), University of Cologne (Koln Fortune Program to KH), Cologne Cardiovascular Research Center (Graduate Program to MJ), Cologne Graduate School of Ageing Research (to SK), CECAD Research Center Cologne Maternity Leave Fellowship to DW.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Ahuja AK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10660; Bacalini MG, 2012, EXP HEMATOL, V40, P197, DOI 10.1016/j.exphem.2011.11.005; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Bruno T, 2008, CELL DEATH DIFFER, V15, P515, DOI 10.1038/sj.cdd.4402284; Bruno T, 2002, CANCER CELL, V2, P387, DOI 10.1016/S1535-6108(02)00182-4; Bruno T, 2006, CANCER CELL, V10, P473, DOI 10.1016/j.ccr.2006.10.012; Bruno T, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00034; Bruno T, 2010, CANCER CELL, V18, P122, DOI 10.1016/j.ccr.2010.05.027; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; De Nicola F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.381; Desantis A, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.117; Desantis A, 2015, EMBO J, V34, P1214, DOI 10.15252/embj.201489920; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dietlein F, 2015, CELL, V162, P146, DOI 10.1016/j.cell.2015.05.053; Dobbelstein M, 2015, NAT REV DRUG DISCOV, V14, P405, DOI 10.1038/nrd4553; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Durkin M.E., 2013, BIOPROTOC, V3, pE908, DOI DOI 10.21769/BioProtoc.908; Fanciulli M, 2000, FASEB J, V14, P904, DOI 10.1096/fasebj.14.7.904; Fikaris AJ, 2006, J BIOL CHEM, V281, P34759, DOI 10.1074/jbc.M606737200; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Grabocka E, 2015, CLIN CANCER RES, V21, P1243, DOI 10.1158/1078-0432.CCR-14-0650; Guo Q, 2004, J BIOL CHEM, V279, P4596, DOI 10.1074/jbc.M309811200; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hopker K, 2012, CELL CYCLE, V11, P4122, DOI 10.4161/cc.21997; Hopker K, 2012, EMBO J, V31, P3961, DOI 10.1038/emboj.2012.236; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jiang H, 2009, GENE DEV, V23, P1895, DOI 10.1101/gad.1815309; Jokic M, 2016, MOL CANCER RES, V14, P1110, DOI 10.1158/1541-7786.MCR-16-0094; Justilien V, 2017, CANCER CELL, V31, P256, DOI 10.1016/j.ccell.2016.12.010; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kaul D, 2007, INDIAN J BIOCHEM BIO, V44, P276; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Marino S, 2000, GENE DEV, V14, P994; Maya-Mendoza A, 2015, MOL ONCOL, V9, P601, DOI 10.1016/j.molonc.2014.11.001; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ogrunc M, 2014, CELL DEATH DIFFER, V21, P998, DOI 10.1038/cdd.2014.16; Ollion J, 2013, BIOINFORMATICS, V29, P1840, DOI 10.1093/bioinformatics/btt276; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Raman M, 2007, EMBO J, V26, P2005, DOI 10.1038/sj.emboj.7601668; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Reinhardt HC, 2010, MOL CELL, V40, P34, DOI 10.1016/j.molcel.2010.09.018; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmitt A, 2017, CANCER RES, V77, P3040, DOI 10.1158/0008-5472.CAN-16-3398; Schonhuber N, 2014, NAT MED, V20, P1340, DOI 10.1038/nm.3646; Seidel D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006802; Shaltiel IA, 2015, J CELL SCI, V128, P607, DOI 10.1242/jcs.163766; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Thomas T, 2000, DEV BIOL, V227, P324, DOI 10.1006/dbio.2000.9915; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tubbs A, 2017, CELL; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Xie J, 2004, NEUROBIOL DIS, V16, P150, DOI 10.1016/j.nbd.2004.02.003	65	19	20	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	11					1503	1518		10.1038/s41388-017-0054-6	http://dx.doi.org/10.1038/s41388-017-0054-6			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ3AZ	29321668				2022-12-26	WOS:000427459500008
J	Frouin, J; Languillaume, A; Mas, J; Mieulet, D; Boisnard, A; Labeyrie, A; Bettembourg, M; Bureau, C; Lorenzini, E; Portefaix, M; Turquay, P; Vernet, A; Perin, C; Ahmadi, N; Courtois, B				Frouin, Julien; Languillaume, Antoine; Mas, Justine; Mieulet, Delphine; Boisnard, Arnaud; Labeyrie, Axel; Bettembourg, Mathilde; Bureau, Charlotte; Lorenzini, Eve; Portefaix, Muriel; Turquay, Patricia; Vernet, Aurore; Perin, Christophe; Ahmadi, Nourollah; Courtois, Brigitte			Tolerance to mild salinity stress in japonica rice: A genome-wide association mapping study highlights calcium signaling and metabolism genes	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; SALT-TOLERANCE; SOIL-SALINITY; NACL STRESS; GENOTYPES; ARCHITECTURE; HOMEOSTASIS; RESISTANCE; POPULATION; VARIETIES	Salinity tolerance is an important quality for European rice grown in river deltas. We evaluated the salinity tolerance of a panel of 235 temperate japonica rice accessions genotyped with 30,000 SNP markers. The panel was exposed to mild salt stress (50 mM NaCI; conductivity of 6 dS m(-1)) at the seedling stage. Eight different root and shoot growth parameters were measured for both the control and stressed treatments. The Na+ and K+ mass fractions of the stressed plants were measured using atomic absorption spectroscopy. The salt treatment affected plant growth, particularly the shoot parameters. The panel showed a wide range of Na+/K+ ratio and the temperate accessions were distributed over an increasing axis, from the most resistant to the most susceptible checks. We conducted a genome-wide association study on indices of stress response and ion mass fractions in the leaves using a classical mixed model controlling structure and kinship. A total of 27 QTLs validated by sub sampling were identified. For indices of stress responses, we also used another model that focused on marker x treatment interactions and detected 50 QTLs, three of which were also identified using the classical method. We compared the positions of the significant QTLs to those of approximately 300 genes that play a role in rice salt tolerance. The positions of several QTLs were close to those of genes involved in calcium signaling and metabolism, while other QTLs were close to those of kinases. These results reveal the salinity tolerance of accessions with a temperate japonica background. Although the detected QTLs must be confirmed by other approaches, the number of associations linked to candidate genes involved in calcium-mediated ion homeostasis highlights pathways to explore in priority to understand the salinity tolerance of temperate rice.	[Frouin, Julien; Languillaume, Antoine; Mas, Justine; Mieulet, Delphine; Labeyrie, Axel; Bettembourg, Mathilde; Bureau, Charlotte; Lorenzini, Eve; Turquay, Patricia; Vernet, Aurore; Perin, Christophe; Ahmadi, Nourollah; Courtois, Brigitte] Ctr Cooperat Int Rech Agron Dev, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France; [Boisnard, Arnaud] Ctr Francais Riz, Arles, France; [Portefaix, Muriel] INRA, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France	CIRAD; INRAE	Courtois, B (corresponding author), Ctr Cooperat Int Rech Agron Dev, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France.	brigitte.courtois@cirad.fr	; COURTOIS, Brigitte/A-4004-2009	MIEULET, Delphine/0000-0001-6220-0372; COURTOIS, Brigitte/0000-0003-2118-7102; AHMADI, Nourollah/0000-0003-0072-6285	French Agence Nationale de la Recherche [ANR-14-JFAC-0005-01]	French Agence Nationale de la Recherche(French National Research Agency (ANR))	This research was conducted in the framework of the FACCE-JPI project GreenRice (Sustainable and environmental friendly rice cultivation systems in Europe) and was funded by French Agence Nationale de la Recherche (ANR-14-JFAC-0005-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Z, 2001, J AGRON CROP SCI, V187, P25, DOI 10.1046/j.1439-037X.2001.00500.x; Addinsoft, 2011, XLSTAT VERSION 2011; Ahmadi N, 2011, THEOR APPL GENET, V123, P881, DOI 10.1007/s00122-011-1634-4; Al-Tamimi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13342; Almeida DM, 2017, GENET MOL BIOL, V40, P326, DOI [10.1590/1678-4685-gmb-2016-0106, 10.1590/1678-4685-GMB-2016-0106]; [Anonymous], 2014, R LANG ENV STAT COMP; Bettembourg M, 2017, RICE, V10, DOI 10.1186/s12284-017-0184-z; Bian Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1068; Bimpong IK, 2016, PLANT SCI, V242, P288, DOI 10.1016/j.plantsci.2015.09.020; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Burnham K. P., 1998, MODEL SELECTION INFE; Butler D., 2007, ANAL MIXED MODELS S; Campbell MT, 2015, PLANT PHYSIOL, V168, P1476, DOI 10.1104/pp.15.00450; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Courtois B, 2012, CROP SCI, V52, P1663, DOI 10.2135/cropsci2011.11.0588; Daliakopoulos IN, 2016, SCI TOTAL ENVIRON, V573, P727, DOI 10.1016/j.scitotenv.2016.08.177; Platten JD, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-32; De Leon TB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00374; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Fukuda A, 2011, PLANTA, V233, P175, DOI 10.1007/s00425-010-1289-4; Garcia A, 1997, PLANT CELL ENVIRON, V20, P1167, DOI 10.1046/j.1365-3040.1997.d01-146.x; Garcia AB, 1997, PLANT PHYSIOL, V115, P159, DOI 10.1104/pp.115.1.159; Gimhani DR, 2016, MOL GENET GENOMICS, V291, P2081, DOI 10.1007/s00438-016-1241-9; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Grattan S. R., 2002, California Agriculture, V56, P189, DOI 10.3733/ca.v056n06p189; Gregorio G. B., 2013, SABRAO Journal of Breeding and Genetics, V45, P31; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Horie T, 2012, RICE, V5, DOI 10.1186/1939-8433-5-11; Ismail AM, 2007, PLANT MOL BIOL, V65, P547, DOI 10.1007/s11103-007-9215-2; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kim SG, 2010, GENOMICS, V95, P56, DOI 10.1016/j.ygeno.2009.09.003; Kraft P, 2009, STAT SCI, V24, P561, DOI 10.1214/09-STS290; Kumar K, 2013, RICE, V6, DOI 10.1186/1939-8433-6-27; Kumar V, 2015, DNA RES, V22, P133, DOI 10.1093/dnares/dsu046; Lafarge T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171254; Lampayan RM, 2015, FIELD CROP RES, V170, P95, DOI 10.1016/j.fcr.2014.10.013; Lekakis E, 2015, AGRONOMY-BASEL, V5, P35, DOI 10.3390/agronomy5010035; Linquist BA, 2015, GLOBAL CHANGE BIOL, V21, P407, DOI 10.1111/gcb.12701; Liu YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004037; Maas E. V., 1977, Journal of the Irrigation and Drainage Division, American Society of Civil Engineers, V103, P115; Meijon M, 2014, NAT GENET, V46, P77, DOI 10.1038/ng.2824; Moradi F., 2003, INDIAN J PLANT PHYSI, V8, P105; Negrao S, 2017, ANN BOT-LONDON, V119, P1, DOI 10.1093/aob/mcw191; Negrao S, 2013, PLANT BIOTECHNOL J, V11, P87, DOI 10.1111/pbi.12010; Phung NTP, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0747-y; Norton GJ, 2008, GENOMICS, V92, P344, DOI 10.1016/j.ygeno.2008.07.002; Nutan KK, 2017, FUNCT INTEGR GENOMIC, V17, P69, DOI 10.1007/s10142-016-0529-5; Obata T, 2007, PLANT PHYSIOL, V144, P1978, DOI 10.1104/pp.107.101154; Olesen JE, 2011, EUR J AGRON, V34, P96, DOI 10.1016/j.eja.2010.11.003; Panagea IS, 2016, SOLID EARTH, V7, P177, DOI 10.5194/se-7-177-2016; Pires IS, 2015, PHYSIOL PLANTARUM, V155, P43, DOI 10.1111/ppl.12356; Pittman JK, 2016, RICE, V9, DOI 10.1186/s12284-016-0075-8; Platten JD, 2006, TRENDS PLANT SCI, V11, P372, DOI 10.1016/j.tplants.2006.06.001; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Price AH, 2013, FOOD ENERGY SECUR, V2, P120, DOI 10.1002/fes3.29; Punyawaew K, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0574-8; Ranathunge K, 2003, PLANTA, V217, P193, DOI 10.1007/s00425-003-0984-9; Rellosa MC, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-7; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thomson MJ, 2010, RICE, V3, P148, DOI 10.1007/s12284-010-9053-8; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Yamada N, 2014, PROTOPLASMA, V251, P1067, DOI 10.1007/s00709-014-0615-2; Yano K, 2016, NAT GENET, V48, P927, DOI 10.1038/ng.3596; YEO AR, 1986, AUST J PLANT PHYSIOL, V13, P161, DOI 10.1071/PP9860161; Yoshida S., 1976, LAB MANUAL PHYSL STU; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zeng LH, 2003, EUPHYTICA, V129, P281, DOI 10.1023/A:1022248522536; Zheng HL, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0342-1; Zheng HL, 2015, EUPHYTICA, V201, P109, DOI 10.1007/s10681-014-1192-3	77	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190964	10.1371/journal.pone.0190964	http://dx.doi.org/10.1371/journal.pone.0190964			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342194	Green Published, Green Submitted, gold			2022-12-26	WOS:000422653800039
J	Vialet, A; Modesto-Mata, M; Martinon-Torres, M; de Pinillos, MM; de Castro, JM				Vialet, Amellie; Modesto-Mata, Mario; Martinon-Torres, Maria; Martinez de Pinillos, Marina; Bermudez de Castro, Jose-Maria			A reassessment of the Montmaurin-La Niche mandible (Haute Garonne, France) in the context of European Pleistocene human evolution	PLOS ONE			English	Article							HOMO-ERECTUS; TAXONOMIC AFFINITIES; EAST RUDOLF; GENUS HOMO; ATAPUERCA; NEANDERTHAL; HOMINID; CAVE; SIMA; SPAIN	We here present a comparative study of the Montmaurin-LN Middle Pleistocene mandible (Haute-Garonne, France). This mandible, of which its right and left molar series are preserved in situ, was found in La Niche cave (Montmaurin's karst system) in 1949, and was first attributed to the `Mindel-Riss' interglacial (= MIS 9 to 11) based on its geological context. Later studies based on geological and faunal evidence have attributed the Montmaurin-LN mandible to MIS 7. Following a detailed morphological and metric comparative study of the mandible in the 1970s, it was interpreted in the light of a still limited fossil record and the prevailing paradigm back then. Waiting for geochronological studies in the forthcoming years, here we review the main morphological and metrical features of this mandible and its molars, which have been reassessed in the framework of a remarkably enlarged Pleistocene fossil record since the mandible was first described, and our current, more in-depth understanding of human evolution in Europe. Using a selection of mandibular features with potential taxonomic signal we have found that the Montmaurin-LN mandible shares only a few derived traits with Neandertals. Our analyses reveal that this mandible is more closely related to the ancient specimens from the African and Eurasian Early and Middle Pleistocene, particularly due to the presence of primitive features of the Homo clade. In contrast, the external morphology of the molars is clearly similar to that of Neandertals. The results are assessed in the light of the present competing hypotheses used to explain the European hominin fossil record.	[Vialet, Amellie] UPVD, Museum Natl Hist Nat, UMR7194, Ctr Europeen Rech Prehist Tautavel, Paris, France; [Modesto-Mata, Mario; Martinon-Torres, Maria; Martinez de Pinillos, Marina; Bermudez de Castro, Jose-Maria] Ctr Nacl Invest Evoluc Humana CENIEH, Paseo Sierra Atapuerca 3, Burgos, Spain; [Modesto-Mata, Mario] Equipo Primeros Pobladores Extremadura EPPEX, Casa Cultura Rodriguez Monino, Caceres, Spain; [Martinon-Torres, Maria; Martinez de Pinillos, Marina; Bermudez de Castro, Jose-Maria] UCL, Dept Anthropol, London, England; [Martinon-Torres, Maria] Univ Burgos, LEH, Dept Ciencias Hist & Geog, Hosp Rey S-N, Burgos, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); University of London; University College London; Universidad de Burgos	de Castro, JM (corresponding author), Ctr Nacl Invest Evoluc Humana CENIEH, Paseo Sierra Atapuerca 3, Burgos, Spain.; de Castro, JM (corresponding author), UCL, Dept Anthropol, London, England.	josemaria.bermudezdecastro@cenieh.es	Martínez de Pinillos, Marina/D-9631-2018; de Pinillos, Marina Martínez/N-7595-2019	Martínez de Pinillos, Marina/0000-0002-8035-337X; de Pinillos, Marina Martínez/0000-0002-8035-337X; Bermudez de Castro, Jose Maria/0000-0003-1314-3273	Ministerio de Economia y Competitividad (MINECO) [CGL2015-65387-C3-1, CGL2015-65387-C3-P]; Leakey Foundation; Junta de Castilla y Leon [BOCYL-D-02102014-10, BOCYL-D-20052013-14]; European Social Funds	Ministerio de Economia y Competitividad (MINECO); Leakey Foundation; Junta de Castilla y Leon(Junta de Castilla y Leon); European Social Funds(European Social Fund (ESF))	This study was part of the Ministerio de Economia y Competitividad (MINECO), project CGL2015-65387-C3-1, 3-P to Jose Maria Bermudez de Castro, and the Leakey Foundation through the personal support of Gordon Getty and Dub Crook to one of the authors (MMT). MMM and MMP have a predoctoral contract of the Junta de Castilla y Leon, (BOCYL-D-02102014-10 and BOCYL-D-20052013-14, respectively, co-financed by the European Social Funds.	AGUIRRE E, 1977, J HUM EVOL, V6, P681, DOI 10.1016/S0047-2484(77)80094-8; Aguirre E., 1976, ZEPHYRUS, V26, P489; Agusti J, 2009, J HUM EVOL, V57, P815, DOI 10.1016/j.jhevol.2009.06.005; Alcazar de Velasco Almudena, 2011, Boletin de la Real Sociedad Espanola de Historia Natural Seccion Geologica, V105, P99; Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; Arsuaga JL, 1997, J HUM EVOL, V33, P219, DOI 10.1006/jhev.1997.0133; Ascenzi A, 1996, J HUM EVOL, V31, P409, DOI 10.1006/jhev.1996.0069; Bailey SE, 2011, AM J PHYS ANTHROPOL, V145, P505, DOI 10.1002/ajpa.21468; Bailey Shara E., 2002, Anatomical Record, V269, P148, DOI 10.1002/ar.10116; de Castro JMB, 2016, QUATERNARY SCI REV, V153, P51, DOI 10.1016/j.quascirev.2016.10.010; de Castro JMB, 2015, AM J PHYS ANTHROPOL, V156, P102, DOI 10.1002/ajpa.22631; BILLY G, 1977, ANTHROPOLOGIE, V81, P411; BILLY G, 1977, ANTHROPOLOGIE, V81, P273; Blain HA, 2009, J HUM EVOL, V56, P55, DOI 10.1016/j.jhevol.2008.08.020; Boule M, 1902, ANTHROPOLOGIE, V13, P305; Brothwell D.R., 1963, DENT ANTHR; CAMMAS R, 1986, CR ACAD SCI II, V302, P609; Carbonell E, 2005, P NATL ACAD SCI USA, V102, P5674, DOI 10.1073/pnas.0501841102; CARBONELL E, 1995, SCIENCE, V269, P826, DOI 10.1126/science.7638598; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Carrion JS, 2011, QUATERNARY SCI REV, V30, P1281, DOI 10.1016/j.quascirev.2011.04.003; Chang CH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7037; Compton T, 2015, J QUATERNARY SCI, V30, P713, DOI 10.1002/jqs.2811; Condemi S., 1991, CIRCEO 1 NEANDERTHAL, P339; Condemi Silvana, 1991, Rivista di Antropologia, V69, P27; Cook J., 1982, YEARB PHYS ANTHROPOL, V25, P19, DOI DOI 10.1002/AJPA.1330250504; Cregut-Bonnoure E, 2010, PREHISTOIRES MEDITER, V1, P3; Cuenca-Bescos G, 2011, J HUM EVOL, V60, P481, DOI 10.1016/j.jhevol.2010.04.002; Daura J, 2017, P NATL ACAD SCI USA, V114, P3397, DOI 10.1073/pnas.1619040114; DAY MH, 1973, AM J PHYS ANTHROPOL, V39, P341, DOI 10.1002/ajpa.1330390303; de Castro JMB, 2003, J ARCHAEOL SCI, V30, P1421, DOI 10.1016/S0305-4403(03)00036-0; de Lumley MA, 2015, ANTHROPOLOGIE, V119, P303, DOI 10.1016/j.anthro.2015.06.001; Dean D, 1998, J HUM EVOL, V34, P485, DOI 10.1006/jhev.1998.0214; deCastro JMB, 1997, SCIENCE, V276, P1392; Dennell RW, 2011, QUATERNARY SCI REV, V30, P1511, DOI 10.1016/j.quascirev.2009.11.027; Finlayson C, 2007, TRENDS ECOL EVOL, V22, P213, DOI 10.1016/j.tree.2007.02.001; FRANCISCUS RG, 1995, J HUM EVOL, V28, P577, DOI 10.1006/jhev.1995.1043; Gabounia L, 2002, CR PALEVOL, V1, P243, DOI 10.1016/S1631-0683(02)00032-5; GABUNIA L, 1995, NATURE, V373, P509, DOI 10.1038/373509a0; Gaillard C., 1982, GALLIA PREHIST, V25, P79; HEIM JL, 1976, ARCH I PALEONTOLOGIE, V35; Herisson D, 2016, QUATERN INT, V411, P233, DOI 10.1016/j.quaint.2016.02.049; HERSHKOVITZ I, 1995, AM J PHYS ANTHROPOL, V96, P215, DOI 10.1002/ajpa.1330960302; HOWELL FC, 1960, CURR ANTHROPOL, V1, P195, DOI 10.1086/200100; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Hublin JJ, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P295; Hughes JK, 2007, J HUM EVOL, V53, P465, DOI 10.1016/j.jhevol.2006.12.011; Irish J.D., 1993, THESIS; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P709, DOI 10.1002/ajpa.10425; Kaifu Y, 2005, AM J PHYS ANTHROPOL, V128, P497, DOI 10.1002/ajpa.10427; Leakey LBS, 1969, P PREHIST SOC, V25, P48; Leakey R.E., 1978, KOOBI FORA RES PROJE, P86; LEAKEY REF, 1973, AM J PHYS ANTHROPOL, V39, P355, DOI 10.1002/ajpa.1330390304; Lefevre J, 1973, B MEM SOC ANTHRO PAR, V10, P301, DOI [10.3406/bmsap.1973.2076, DOI 10.3406/BMSAP.1973.2076]; Leroy SAG, 2011, QUATERNARY SCI REV, V30, P1448, DOI 10.1016/j.quascirev.2010.01.017; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Liu W, 2010, P NATL ACAD SCI USA, V107, P19201, DOI 10.1073/pnas.1014386107; Lumley M.-A. de, 2015, ANTHROPOLOGIE, V119, P303, DOI DOI 10.1016/PANTHR0.2015.06.001; MacDonald K, 2012, QUATERN INT, V271, P84, DOI 10.1016/j.quaint.2011.10.009; Manzi G, 2004, EVOL ANTHROPOL, V13, P11, DOI 10.1002/evan.10127; Manzi G, 2001, P NATL ACAD SCI USA, V98, P10011, DOI 10.1073/pnas.151259998; Manzi G, 2010, J HUM EVOL, V59, P580, DOI 10.1016/j.jhevol.2010.06.010; de Castro JMB, 2013, QUATERN INT, V295, P102, DOI 10.1016/j.quaint.2012.02.036; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; Meroc L, 1948, GALLIA, V6, P409; Meroc L, 1963, B SOC GEOL FRANCE, V5, P508; Meroc L, 1947, GALLIA, VV, P193; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; Mounier A, 2009, J HUM EVOL, V56, P219, DOI 10.1016/j.jhevol.2008.12.006; Nicholson E, 2006, AM J PHYS ANTHROPOL, V131, P368, DOI 10.1002/ajpa.20425; Rak Y, 2002, AM J PHYS ANTHROPOL, V119, P199, DOI 10.1002/ajpa.10131; RAK Y, 1986, J HUM EVOL, V15, P151, DOI 10.1016/S0047-2484(86)80042-2; RAK Y, 1994, J HUM EVOL, V26, P313, DOI 10.1006/jhev.1994.1019; Renault-Miskovsky J, 1988, QUATERNAIRE, V9, P185; Rightmire G.P., 1990, EVOLUTION HOMOERECTU; Roksandic M, 2011, J HUM EVOL, V61, P186, DOI 10.1016/j.jhevol.2011.03.003; Rosas A, 1998, AM J PHYS ANTHROPOL, V107, P145, DOI 10.1002/(SICI)1096-8644(199810)107:2<145::AID-AJPA2>3.3.CO;2-8; Rosas A, 1997, J HUM EVOL, V33, P319, DOI 10.1006/jhev.1997.0138; Rosas A, 2007, VERTEBR PALEOBIOL PA, P37; ROSAS A, 1987, J HUM EVOL, V16, P417, DOI 10.1016/0047-2484(87)90070-4; Rosas A, 1999, J HUM EVOL, V37, P567, DOI 10.1006/jhev.1999.0340; Rosas A, 2001, AM J PHYS ANTHROPOL, V114, P74, DOI 10.1002/1096-8644(200101)114:1<74::AID-AJPA1007>3.3.CO;2-L; Rosas A, 1998, GEOBIOS-LYON, V31, P687, DOI 10.1016/S0016-6995(98)80055-7; ROSAS A, 1995, J HUM EVOL, V28, P533, DOI 10.1006/jhev.1995.1041; Rosas A, 1991, ANTHROPOLOGIE, V4, P89; Saint-Perier R, 1922, ANTHROPOLOGIE, V32, P193; SAUSSE F, 1975, ANTHROPOLOGIE, V79, P81; SCHRENK F, 1993, NATURE, V365, P833, DOI 10.1038/365833a0; Schwartz JH, 2000, J HUM EVOL, V38, P367, DOI 10.1006/jhev.1999.0339; Scott G.R., 1997, ANTHR MODERN HUMAN T, DOI 10.1017/CBO9781316529843; Serra-Joulin D, 2002, PREHISTOIRES MEDITER, V10-11, P5; Shea JJ, 2008, QUATERNARY SCI REV, V27, P2253, DOI 10.1016/j.quascirev.2008.08.015; SNEATH PHA, 1995, SYST BIOL, V44, P281, DOI 10.2307/2413593; Stringer C.B., 1984, P51; Stringer CB, 1999, J HUM EVOL, V37, P873, DOI 10.1006/jhev.1999.0367; Suwa G, 2007, ANTHROPOL SCI, V115, P133, DOI 10.1537/ase.061203; Tavoso A., 1982, 1ER C PAL HUM NIC, P96; Tobias P.V, 1991, O GORGE, V4; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; TRINKAUS E, 1987, J HUM EVOL, V16, P429, DOI 10.1016/0047-2484(87)90071-6; TRINKAUS E, 1993, RIV ANTROPOL, V71, P259; Trinkaus E., 1983, SHANIDAR NEANDERTHAL; Trinkaus E, 2006, CURR ANTHROPOL, V47, P597, DOI 10.1086/504165; Turner II C. G., 1991, ADV DENT ANTHR, P13; VALLOIS H, 1956, AM J PHYS ANTHROPOL, V14, P319, DOI 10.1002/ajpa.1330140224; VALLOIS H, 1955, CR HEBD ACAD SCI, V240, P1577; Wagner GA, 2010, P NATL ACAD SCI USA, V107, P19726, DOI 10.1073/pnas.1012722107; Walker Alan, 1993, P63; Weaver TD, 2009, P NATL ACAD SCI USA, V106, P16028, DOI 10.1073/pnas.0903864106; Weidenreich F., 1936, Palaeontologia Sinica, VD7, P1; WHITE TD, 1981, S AFR J SCI, V77, P445; Wolpoff MH, 2005, AM J PHYS ANTHROPOL, V128, P245, DOI 10.1002/ajpa.10432; WOLPOFF MH, 1979, AM J PHYS ANTHROPOL, V50, P67, DOI 10.1002/ajpa.1330500110; Wood B., 1991, HOMINID CRANIAL REMA, V4; WOOD BA, 1986, AM J PHYS ANTHROPOL, V69, P117, DOI 10.1002/ajpa.1330690113; Wu L, 2017, AM J PHYS ANTHR; Wu XJ, 2014, CR PALEVOL, V13, P333, DOI 10.1016/j.crpv.2013.10.002	117	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0189714	10.1371/journal.pone.0189714	http://dx.doi.org/10.1371/journal.pone.0189714			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29337994	Green Submitted, Green Published, gold			2022-12-26	WOS:000422652700003
J	Fernandez-Arias, C; Arias, CF; Zhang, M; Herrero, MA; Acosta, FJ; Tsuji, M				Fernandez-Arias, Cristina; Arias, Clemente F.; Zhang, Min; Herrero, Miguel A.; Acosta, Francisco J.; Tsuji, Moriya			Modeling the effect of boost timing in murine irradiated sporozoite prime-boost vaccines	PLOS ONE			English	Article							T-CELL MEMORY; PREERYTHROCYTIC MALARIA VACCINES; PLASMODIUM-BERGHEI; IMMUNE-RESPONSES; VIRAL-INFECTIONS; DNA VACCINE; CD8(+); IMMUNIZATION; PROTECTION; ANTIGEN	Vaccination with radiation-attenuated sporozoites has been shown to induce CD8+ T cell-mediated protection against pre-erythrocytic stages of malaria. Empirical evidence suggests that successive inoculations often improve the efficacy of this type of vaccines. An initial dose (prime) triggers a specific cellular response, and subsequent inoculations (boost) amplify this response to create a robust CD8+ T cell memory. In this work we propose a model to analyze the effect of T cell dynamics on the performance of prime-boost vaccines. This model suggests that boost doses and timings should be selected according to the T cell response elicited by priming. Specifically, boosting during late stages of clonal contraction would maximize T cell memory production for vaccines using lower doses of irradiated sporozoites. In contrast, single-dose inoculations would be indicated for higher vaccine doses. Experimental data have been obtained that support theoretical predictions of the model.	[Fernandez-Arias, Cristina; Tsuji, Moriya] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, HIV & Malaria Vaccine Program, 1230 York Ave, New York, NY 10021 USA; [Arias, Clemente F.] GISC, Madrid, Spain; [Arias, Clemente F.; Herrero, Miguel A.] Univ Complutense Madrid, Dept Matemat Aplicada, Madrid, Spain; [Zhang, Min] NYU, Dept Pathol, New York, NY 10003 USA; [Acosta, Francisco J.] Univ Complutense Madrid, Dept Ecol, Madrid, Spain	Rockefeller University; Complutense University of Madrid; New York University; Complutense University of Madrid	Arias, CF (corresponding author), GISC, Madrid, Spain.; Arias, CF (corresponding author), Univ Complutense Madrid, Dept Matemat Aplicada, Madrid, Spain.	tifar@ucm.es	Fernandez-Arias, Cristina/D-1618-2018	Tsuji, Moriya/0000-0001-8587-277X	NIH [AI070258, AI102891]; MINECO [MTM2014-53156-P]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070258, R56AI070258, R01AI102891] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MINECO(Spanish Government); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MT has been partially supported by NIH AI070258 and AI102891 Grants. CFA and MAH have been partially supported by MINECO Grant MTM2014-53156-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arama C, 2014, J INTERN MED, V275, P456, DOI 10.1111/joim.12223; Arias CF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09949-w; Arias CF, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150016; Bijker EM, 2015, VACCINE, V33, P7462, DOI 10.1016/j.vaccine.2015.09.095; Boyman O, 2007, CURR OPIN IMMUNOL, V19, P320, DOI 10.1016/j.coi.2007.04.015; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Butler NS, 2012, TRENDS IMMUNOL, V33, P247, DOI 10.1016/j.it.2012.02.001; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; Daubenberger CA, 2012, EXPERT REV VACCINES, V11, P31, DOI [10.1586/erv.11.161, 10.1586/ERV.11.161]; de Souza AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154521; Doll KL, 2014, IMMUNOL RES, V59, P166, DOI 10.1007/s12026-014-8525-0; Draper SJ, 2015, VACCINE, V33, P7433, DOI 10.1016/j.vaccine.2015.09.093; Estcourt MJ, 2005, EUR J IMMUNOL, V35, P2532, DOI 10.1002/eji.200535184; Estcourt MJ, 2002, INT IMMUNOL, V14, P31, DOI 10.1093/intimm/14.1.31; Fernandez-Arias C, 2017, VIRAL VECTOR VACCINE, P157; Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011; Flesch IEA, 2010, J IMMUNOL, V184, P45, DOI 10.4049/jimmunol.0900999; Fooksman DR, 2010, ANNU REV IMMUNOL, V28, P79, DOI 10.1146/annurev-immunol-030409-101308; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; Gwadz R W, 1979, Bull World Health Organ, V57 Suppl 1, P165; HERRINGTON D, 1991, AM J TROP MED HYG, V45, P539, DOI 10.4269/ajtmh.1991.45.539; Hill AVS, 2006, NAT REV IMMUNOL, V6, P21, DOI 10.1038/nri1746; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 2015, AM J PREV MED, V49, pS319, DOI 10.1016/j.amepre.2015.09.011; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Iglesias MC, 2012, IMMUNOLOGIC MEMORY T, P61; Kalia V, 2010, ADV EXP MED BIOL, V684, P79; Kardani K, 2016, VACCINE, V34, P413, DOI 10.1016/j.vaccine.2015.11.062; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Ledgerwood JE, 2013, J INFECT DIS, V208, P418, DOI 10.1093/infdis/jit180; Leignadier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013740; Li XM, 2016, VACCINE, V34, P4501, DOI 10.1016/j.vaccine.2016.08.006; Li XM, 2015, J IMMUNOL, V195, P2710, DOI 10.4049/jimmunol.1403017; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; Martin MD, 2012, J IMMUNOL, V188, P1255, DOI 10.4049/jimmunol.1101579; Mauduit M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007717; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Minigo G, 2007, TRENDS PARASITOL, V23, P341, DOI 10.1016/j.pt.2007.06.006; Miyahira Y, 1998, P NATL ACAD SCI USA, V95, P3954, DOI 10.1073/pnas.95.7.3954; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Murphy SC, 2013, P NATL ACAD SCI USA, V110, P6055, DOI 10.1073/pnas.1303834110; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Padte NN, 2011, CLIN IMMUNOL, V140, P142, DOI 10.1016/j.clim.2010.11.009; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; Prlic M, 2007, CURR OPIN IMMUNOL, V19, P315, DOI 10.1016/j.coi.2007.04.010; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Reyes-Sandoval A, 2007, IMMUNOLOGY, V121, P158, DOI 10.1111/j.1365-2567.2006.02552.x; Richie TL, 2015, VACCINE, V33, P7452, DOI 10.1016/j.vaccine.2015.09.096; Riley EM, 2013, NAT MED, V19, P168, DOI 10.1038/nm.3083; Robinson HL, 2005, NAT MED, V11, pS25, DOI 10.1038/nm1212; Rodrigues EG, 1998, VACCINE, V16, P1812, DOI 10.1016/S0264-410X(98)00181-9; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; Rodriguez A, 2009, VACCINE, V27, P6226, DOI 10.1016/j.vaccine.2009.07.106; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Sanchez GI, 2001, INFECT IMMUN, V69, P3897, DOI 10.1128/IAI.69.6.3897-3905.2001; Sano G, 2001, J EXP MED, V194, P173, DOI 10.1084/jem.194.2.173; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; Schmidt NW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000998; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Sedegah M, 2004, GENE THER, V11, P448, DOI 10.1038/sj.gt.3302139; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Selin LK, 1999, IMMUNITY, V11, P733, DOI 10.1016/S1074-7613(00)80147-8; Sette A, 2003, CURR OPIN IMMUNOL, V15, P461, DOI 10.1016/S0952-7915(03)00083-9; Silvie O, 2002, PARASITE IMMUNOL, V24, P221, DOI 10.1046/j.1365-3024.2002.00450.x; Tse SW, 2013, GENES IMMUN, V14, P302, DOI 10.1038/gene.2013.20; Vaughan AM, 2013, VACCINATION USING RA, P549; Vaughan AM, 2012, CURR OPIN IMMUNOL, V24, P324, DOI 10.1016/j.coi.2012.03.009; Vezys V, 2009, NATURE, V457, P196, DOI 10.1038/nature07486; WEISS WR, 1992, J IMMUNOL, V149, P2103; WEISS WR, 1988, P NATL ACAD SCI USA, V85, P573, DOI 10.1073/pnas.85.2.573; Woodberry T, 2003, J IMMUNOL, V170, P2599, DOI 10.4049/jimmunol.170.5.2599; World Health Organization, 2015, MALARIA; Yang ZY, 2003, J VIROL, V77, P799, DOI 10.1128/JVI.77.1.799-803.2003; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	80	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190940	10.1371/journal.pone.0190940	http://dx.doi.org/10.1371/journal.pone.0190940			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329308	Green Published, gold, Green Submitted			2022-12-26	WOS:000419954100028
J	Lundwall, RA; Sgro, JF; Fanger, J				Lundwall, Rebecca A.; Sgro, Jordan F.; Fanger, Julia			Response time scores on a reflexive attention task predict a child's inattention score from a parent report	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; SYMPTOMS; RATINGS; SELF; PSYCHOPATHOLOGY; CONVERGENT; MOVEMENTS; SIMULATOR; VALIDITY; ADHD	Compared to sustained attention, only a small proportion of studies examine reflexive attention as a component of everyday attention. Understanding the significance of reflexive attention to everyday attention may inform better treatments for attentional disorders. Children from a general population (recruited when they were from 9-16 years old) completed an exogenously-cued task measuring the extent to which attention is captured by peripheral cue-target conditions. Parents completed a questionnaire reporting their child's day-to-day attention. A general linear model indicated that parent-rated inattention predicted the increase in response time over baseline when a bright cue preceded the target (whether it was valid or invalid) but not when a dim cue preceded the target. More attentive children had more pronounced response time increases from baseline. Our findings suggest a link between a basic measure of cognition (response time difference scores) and parent observations. The findings have implications for increased understanding of the role of reflexive attention in the everyday attention of children.	[Lundwall, Rebecca A.; Sgro, Jordan F.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Fanger, Julia] Brigham Young Univ, Sociol Dept, Provo, UT 84602 USA; [Sgro, Jordan F.] Univ Utah, Psychiat, Salt Lake City, UT USA; [Fanger, Julia] Univ Maryland, Sch Social Work, 525 W Redwood St, Baltimore, MD 21201 USA	Brigham Young University; Brigham Young University; Utah System of Higher Education; University of Utah; University System of Maryland; University of Maryland Baltimore	Lundwall, RA (corresponding author), Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.	Rebecca_lundwall@byu.edu	Lundwall, Rebecca/K-2506-2013	Lundwall, Rebecca/0000-0003-4036-9091	Social Sciences Research Institute at Rice University; Lynette S. Autrey Fund; National Institute of Child Health and Human Development [P30 HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER	Social Sciences Research Institute at Rice University; Lynette S. Autrey Fund; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The research was supported in part by grants from the Social Sciences Research Institute (https://ssri.rice.edu/) at Rice University (Dissertation Improvement Grant to RAL and Seed Money Grant to JLD) and by the Lynette S. Autrey Fund (https://sites.utexas.edu/creees/2016/10/06/funding-opportunity-lynette-s-autrey-visiting-scholars-rice-university/ to JLD). Infrastructure support was provided by the Waisman Center (University of Wisconsin-Madison) via a core grant from National Institute of Child Health and Human Development (P30 HD03352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antin TMJ, 2015, FIELD METHOD, V27, P211, DOI 10.1177/1525822X14549926; Armstrong J.M., 2003, MANUAL MACARTHUR HLT; Beane M, 2004, PROG NEUROBIOL, V74, P167, DOI 10.1016/j.pneurobio.2004.09.001; Burghy CA, 2012, NAT NEUROSCI, V15, P1736, DOI 10.1038/nn.3257; Chen Chung-Yao, 2002, Chang Gung Med J, V25, P514; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cox SM, 2016, J AUTISM DEV DISORD, V46, P1379, DOI 10.1007/s10803-015-2677-1; DeSilva HR, 1938, BRAKE SERVICE, V8, P8; Dogru S., 2015, ED RES REV, V10, P733, DOI DOI 10.5897/ERR2015.2080; Durbin CE, 2012, PSYCHOL ASSESSMENT, V24, P647, DOI 10.1037/a0026607; ENNS JT, 1989, J EXP CHILD PSYCHOL, V48, P171, DOI 10.1016/0022-0965(89)90001-5; Essex MJ, 2002, J AM ACAD CHILD PSY, V41, P588, DOI 10.1097/00004583-200205000-00017; Fishman DP, 2013, PROQUEST INFORMATION; Fogarty GJ, 2014, BRIT J EDUC PSYCHOL, V84, P281, DOI 10.1111/bjep.12024; Henderickx D, 2010, PSYCHOL RES-PSYCH FO, V74, P239, DOI 10.1007/s00426-009-0251-1; HIGGINS AT, 1984, CHILD DEV, V55, P1799; Hsieh YH, 2003, CHINESE J PSYCHOL, V45, P227; Hupp JM, 2015, INFANT CHILD DEV, V24, P44, DOI 10.1002/icd.1874; Kean M, 2003, BRIT J PSYCHOL, V94, P373, DOI 10.1348/000712603767876280; Krause B, 2013, DEV COGN NEUROS-NETH, V6, P176, DOI 10.1016/j.dcn.2013.04.001; Krauzlis RJ, 2013, ANNU REV NEUROSCI, V36, P165, DOI 10.1146/annurev-neuro-062012-170249; Lemery-Chalfant K, 2008, INFANT CHILD DEV, V17, P365, DOI 10.1002/icd.581; Lemery-Chalfant K, 2006, TWIN RES HUM GENET, V9, P1030, DOI 10.1375/183242706779462363; Lim CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046692; Lundwall RA, 2017, DEVELOPMENTAL SCI, V20, DOI 10.1111/desc.12371; Maoz H, 2014, J AM ACAD CHILD PSY, V53, P1111, DOI 10.1016/j.jaac.2014.07.005; McDonald S, 1999, NEUROPSYCHOLOGIA, V37, P345, DOI 10.1016/S0028-3932(98)00078-5; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; Muller JM, 2011, EUR CHILD ADOLES PSY, V20, P241, DOI 10.1007/s00787-011-0168-2; Nigg JT, 1997, NEUROPSYCHOLOGIA, V35, P165, DOI 10.1016/S0028-3932(96)00070-X; Nilsen HK, 2011, EUR J PAIN, V15, P409, DOI 10.1016/j.ejpain.2010.09.008; Niv Y, 2015, J NEUROSCI, V35, P8145, DOI 10.1523/JNEUROSCI.2978-14.2015; Pastor P.N., 2008, VITAL HLTH STAT, V10, P1; Patros CHG, 2016, CLIN PSYCHOL REV, V43, P162, DOI 10.1016/j.cpr.2015.11.001; PEARSON DA, 1990, CHILD DEV, V61, P1779, DOI 10.1111/j.1467-8624.1990.tb03565.x; Polner B, 2015, EUR ARCH PSY CLIN N, V265, P689, DOI 10.1007/s00406-014-0531-7; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, J NEUROSCI, V4, P1863; Posner MI, 2016, Q J EXP PSYCHOL, V69, P1864, DOI 10.1080/17470218.2014.937446; Pratt J, 2001, PSYCHON B REV, V8, P489, DOI 10.3758/BF03196183; Searle AK, 2013, EARLY EDUC DEV, V24, P1112, DOI 10.1080/10409289.2013.764223; Swineford LB, 2015, PSYCHOL ASSESSMENT, V27, P1364, DOI 10.1037/pas0000116; Teye AC, 2015, CHILD YOUTH CARE FOR, V44, P853, DOI 10.1007/s10566-015-9310-5; TSAL Y, 1983, J EXP PSYCHOL HUMAN, V9, P523, DOI 10.1037/0096-1523.9.4.523; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Wilens TE, 2007, BIOCHEM PHARMACOL, V74, P1212, DOI 10.1016/j.bcp.2007.07.002; Wilson KR, 2011, REHABIL PSYCHOL, V56, P100, DOI 10.1037/a0023446; Yoo Wonsuk, 2014, Int J Appl Sci Technol, V4, P9	48	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190724	10.1371/journal.pone.0190724	http://dx.doi.org/10.1371/journal.pone.0190724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BY	29329307	gold, Green Published, Green Submitted			2022-12-26	WOS:000419954100021
J	Sienkiewicz, W; Dudek, A; Czaja, K; Janeczek, M; Chroszcz, A; Kaleczyc, J				Sienkiewicz, Waldemar; Dudek, Agnieszka; Czaja, Krzysztof; Janeczek, Maciej; Chroszcz, Aleksander; Kaleczyc, Jerzy			Efficacy of lateral-versus medial-approach hip joint capsule denervation as surgical treatments of the hip joint pain; a neuronal tract tracing study in the sheep	PLOS ONE			English	Article							SENSORY INNERVATION; OSTEOARTHRITIS YEAR; NERVE-FIBERS; CANINE; DOGS; LOCALIZATION; DYSPLASIA	Objective To evaluate efficacy of denervation of the of the hip joint capsule (HJC), as a treatment of hip joint pain. Specifically, we tested the hypothesis that HJC denervation will significantly reduce the number of sensory neurons innervating the capsule. Study design Denervation of the HJC from a medial or lateral approach was followed by retrograde tracing of sensory neurons innervating the capsule. Animals Twenty adult male sheep (30-40 kg of body weight; Polish merino breed) were used in the study. Methods The hip joint was denervated from medial (n = 5) or lateral (n = 5) surgical approaches. Immediately after denervation, the retrograde neural tract tracer Fast Blue (FB) was injected into the HJC. An additional ten animals(n = 5 for medial and n = 5 for lateral approach) received the same treatment without HJC denervation to provide the appropriate controls. Results Results of the study revealed that the vast majority of retrogradely labelled sensory neurons innervating the HJC originate from fifth lumbar to second sacral dorsal root ganglia. Both the medial and the lateral denervations significantly reduced the number of sensory neurons innervating the HJC (39.2% and 69.0% reduction respectively). Conclusions These results show that denervation of the HJC is an effective surgical procedure for reduction of the sensory neuronal input to the HJC. Moreover, the lateral approach was found to be significantly more effective for reducing sensory innervation as compared to the medial one.	[Sienkiewicz, Waldemar; Dudek, Agnieszka; Kaleczyc, Jerzy] Univ Warmia & Mazury, Fac Vet Med, Dept Anim Anat, Olsztyn, Poland; [Czaja, Krzysztof] Univ Georgia, Coll Vet Med, Vet Biosci & Diagnost Imaging, Athens, GA USA; [Janeczek, Maciej; Chroszcz, Aleksander] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Anim Anat, Wroclaw, Poland	University of Warmia & Mazury; University System of Georgia; University of Georgia; Wroclaw University of Environmental & Life Sciences	Sienkiewicz, W (corresponding author), Univ Warmia & Mazury, Fac Vet Med, Dept Anim Anat, Olsztyn, Poland.; Czaja, K (corresponding author), Univ Georgia, Coll Vet Med, Vet Biosci & Diagnost Imaging, Athens, GA USA.	sienio@uwm.edu.pl; czajak@uga.edu	Janeczek, Maciej/B-6049-2014	Janeczek, Maciej/0000-0003-4357-2271; Chroszcz, Aleksander/0000-0001-9079-549X; Czaja, Krzysztof/0000-0002-7165-4218	National Science Centre [N N308 593240]; KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal-Safe Food", Ministry of Science and Higher Education [05-1/KNOW2/2015]	National Science Centre(National Science Centre, Poland); KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal-Safe Food", Ministry of Science and Higher Education	Research project supported by the National Science Centre, grant no: N N308 593240. Publication process supported by KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal-Safe Food", decision of Ministry of Science and Higher Education No. 05-1/KNOW2/2015.	Anderson A, 2011, J SMALL ANIM PRACT, V52, P182, DOI 10.1111/j.1748-5827.2011.01049.x; BALLINARI U, 1995, SCHWEIZ ARCH TIERH, V137, P251; Birnbaum K, 1997, SURG RADIOL ANAT, V19, P371, DOI 10.1007/BF01628504; Collard F, 2010, REV MED VET-TOULOUSE, V161, P277; Davis AM, 2013, OSTEOARTHR CARTILAGE, V21, P1414, DOI 10.1016/j.joca.2013.08.013; Dee R, 1969, Ann R Coll Surg Engl, V45, P357; Dudek A, 2013, ANAT HISTOL EMBRYOL, V42, P403, DOI 10.1111/ahe.12028; Ferrigno CRA, 2007, PESQUI VET BRASIL, V27, P61, DOI 10.1590/S0100-736X2007000200001; Flugsrud GB, 2010, CHRISTIANIA KJOBENHA, V130, P2136, DOI DOI 10.4045/TIDSSKR.09.1054; Forster KE, 2012, VET SURG, V41, P545, DOI 10.1111/j.1532-950X.2012.01015.x; Fransen M, 2014, COCHRANE DATABASE SY, V22; Gao F, 2015, EVID-BASED COMPL ALT, V2015, P1; GARDNER E, 1948, ANAT REC, V101, P353, DOI 10.1002/ar.1091010309; Gasse H, 1996, KLEINTIERPRAXIS, V41, P883; Giebels F, 2017, TIERAERZTL PRAX K H, V45, P77, DOI 10.15654/TPK-160366; Harasen G, 2004, CAN VET J, V45, P163; Hassan EA, 2016, AM J VET RES, V77, P1200, DOI 10.2460/ajvr.77.11.1200; Hodges D L, 1987, Orthop Rev, V16, P109; Huang CH, 2013, ANAT HISTOL EMBRYOL, V42, P425, DOI 10.1111/ahe.12033; Kinzel S, 1997, PRAKT TIERARZT, V78, P26; Kinzel S, 2002, BERL MUNCH TIERARZTL, V115, P53; Kinzel S, 1998, TIERARZTL PRAX K H, V26, P330; KuKanich B, 2012, VET ANAESTH ANALG, V39, P69, DOI 10.1111/j.1467-2995.2011.00675.x; Lementowski Peter W, 2008, Am J Orthop (Belle Mead NJ), V37, P148; Lincoln JD, 2007, P 34 ANN C VOS, V54; Lister SA, 2009, VET COMP ORTHOPAED, V22, P137, DOI 10.3415/VCOT-08-02-0024; Martini L, 2001, COMPARATIVE MED, V51, P292; Nakajima T, 2008, J BONE JOINT SURG BR, V90B, P254, DOI 10.1302/0301-620X.90B2.19808; Novikova L, 1997, J NEUROSCI METH, V74, P9, DOI 10.1016/S0165-0270(97)02227-9; Patricelli AJ, 2002, VET SURG, V31, P435, DOI 10.1053/jvet.2002.34766; Pupek-Musialik Danuta, 2010, Chir Narzadow Ruchu Ortop Pol, V75, P236; RANKIN JS, 1976, J AM VET MED ASSOC, V169, P614; REMEDIOS AM, 1995, CAN VET J, V36, P503; Rocha Leandro Branco, 2013, Ciênc. anim. bras., V14, P120, DOI 10.5216/cab.v14i1.3528; SANDER STEN, 1962, ACTA CHIR SCAND, V124, P106; Saxler G, 2005, Z ORTHOP GRENZGEB, V143, P424, DOI 10.1055/s-2005-836832; Saxler G, 2007, EUR J PAIN, V11, P67, DOI 10.1016/j.ejpain.2005.12.011; Schmaedecke A, 2008, VET COMP ORTHOPAED, V21, P413, DOI 10.3415/VCOT-07-10-0098; Sharma L, 2016, OSTEOARTHR CARTILAGE, V24, P36, DOI 10.1016/j.joca.2015.07.026; Souza ANA, 2016, VET COMP ORTHOPAED, V29, P108, DOI 10.3415/VCOT-15-01-0017; Staszyk C, 2002, KLEINTIERPRAXIS, V47, P11; Warnock JJ, 2003, VET SURG, V32, P285, DOI 10.1053/jvet.2003.50034; WERTHEIMER LG, 1952, J BONE JOINT SURG AM, V34-A, P477, DOI 10.2106/00004623-195234020-00016; Zaharia C, 1975, Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir, V24, P437	44	0	0	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190052	10.1371/journal.pone.0190052	http://dx.doi.org/10.1371/journal.pone.0190052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329303	Green Submitted, Green Published, gold			2022-12-26	WOS:000419954100011
J	Tohyama, T; Saku, K; Kawada, T; Kishi, T; Yoshida, K; Nishikawa, T; Mannoji, H; Kamada, K; Sunagawa, K; Tsutsui, H				Tohyama, Takeshi; Saku, Keita; Kawada, Toru; Kishi, Takuya; Yoshida, Keimei; Nishikawa, Takuya; Mannoji, Hiroshi; Kamada, Kazuhiro; Sunagawa, Kenji; Tsutsui, Hiroyuki			Impact of lipopolysaccharide-induced acute inflammation on baroreflex-controlled sympathetic arterial pressure regulation	PLOS ONE			English	Article							VENOUS RETURN CURVES; CAROTID-SINUS; BARORECEPTOR REGIONS; NERVOUS-SYSTEM; SEPTIC SHOCK; TREATED RATS; ENDOTOXIN; REFLEX; TACHYCARDIA; ACTIVATION	Background Lipopolysaccharide (LPS) induces acute inflammation, activates sympathetic nerve activity (SNA) and alters hemodynamics. Since the arterial baroreflex is a negative feedback system to stabilize arterial pressure (AP), examining the arterial baroreflex function is a prerequisite to understanding complex hemodynamics under LPS challenge. We investigated the impact of LPS-induced acute inflammation on SNA and AP regulation by performing barore-flex open-loop analysis. Methods Ten anesthetized Sprague-Dawley rats were used. Acute inflammation was induced by an intravenous injection of LPS (60 mu g/kg). We isolated the carotid sinuses from the systemic circulation and controlled carotid sinus pressure (CSP) by a servo-controlled piston pump. We matched CSP to AP to establish the baroreflex closed-loop condition, whereas we decoupled CSP from AP to establish the baroreflex open-loop condition and changed CSP stepwise to evaluate the baroreflex open-loop function. We recorded splanchnic SNA and hemodynamic parameters under baroreflex open- and closed-loop conditions at baseline and at 60 and 120 min after LPS injection. Results In the baroreflex closed-loop condition, SNA continued to increase after LPS injection, reaching three-fold the baseline value at 120 min (baseline: 94.7 +/- 3.6 vs. 120 min: 283.9 +/- 31.9 a.u.). In contrast, AP increased initially (until 75 min), then declined to the baseline level. In the baroreflex open-loop condition, LPS reset the neural arc (CSP-SNA relationship) upward to higher SNA, while shifted the peripheral arc (SNA-AP relationship) downward at 120 min after the injection. As a result, the operating point determined by the intersection between function curves of neural arc and peripheral arc showed marked sympatho-excitation without substantial changes in AP. Conclusions LPS-induced acute inflammation markedly increased SNA via resetting of the baroreflex neural arc, and suppressed the peripheral arc. The balance between the augmented neural arc and suppressed peripheral arc determines SNA and hemodynamics in LPS-induced acute inflammation.	[Tohyama, Takeshi; Yoshida, Keimei; Nishikawa, Takuya; Mannoji, Hiroshi; Kamada, Kazuhiro; Tsutsui, Hiroyuki] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka, Japan; [Saku, Keita; Kishi, Takuya] Kyushu Univ, Ctr Disrupt Cardiovasc Med, Dept Adv Risk Stratificat Cardiovasc Dis, Fukuoka, Japan; [Kawada, Toru] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Dynam, Osaka, Japan; [Sunagawa, Kenji] Kyushu Univ, Ctr Disrupt Cardiovasc Med, Dept Therapeut Regulat Cardiovasc Homeostasis, Fukuoka, Japan	Kyushu University; Kyushu University; National Cerebral & Cardiovascular Center - Japan; Kyushu University	Saku, K (corresponding author), Kyushu Univ, Ctr Disrupt Cardiovasc Med, Dept Adv Risk Stratificat Cardiovasc Dis, Fukuoka, Japan.	saku@cardiol.med.kyushu-u.ac.jp	Saku, Keita/AAE-8639-2021	Saku, Keita/0000-0001-9404-7069; Nishikawa, Takuya/0000-0002-4951-7831	Research and development of supportive device technology for medicine using ICT; AMED-SENTAN; Development of Advanced Measurement and Analysis Systems; Japan Society for the Promotion of Science [15K19383]; Actelion Academia Prize 2015	Research and development of supportive device technology for medicine using ICT; AMED-SENTAN; Development of Advanced Measurement and Analysis Systems; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Actelion Academia Prize 2015	This work was supported by following funds. 1. Research and development of supportive device technology for medicine using ICT, http://www.amed.go.jp/koubo/020120150520_kettei.html. 2. AMED-SENTAN; Development of Advanced Measurement and Analysis Systems, http://www.amed.go.jp/koubo/020120160204_kettei.html. 3. Grant-in-Aid for Young Scientists (B) (15K19383) from the Japan Society for the Promotion of Science, http://www.jsps.go.jp/j-grantsinaid/. 4. Actelion Academia Prize 2015, https://www1.actelion.co.jp/jp/activity/academia/index.page?. The fund at the top is received by Kenji Sunagawa, and the others are received by Keita Saku. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Aydemir M, 2010, LUPUS, V19, P255, DOI 10.1177/0961203309351540; BEASLEY D, 1990, AM J PHYSIOL, V259, pR38, DOI 10.1152/ajpregu.1990.259.1.R38; Brassard P, 2016, CRIT CARE MED, V44, P755, DOI 10.1097/CCM.0000000000001486; David M, 2010, CARDIOVASCULAR PHYSL; Di Giantomasso D, 2003, CHEST, V124, P1053, DOI 10.1378/chest.124.3.1053; Forfia PR, 1998, AM J PHYSIOL-HEART C, V274, pH193, DOI 10.1152/ajpheart.1998.274.1.H193; GOEHLER LE, 1995, NEUROSCI LETT, V185, P163, DOI 10.1016/0304-3940(95)11251-Q; GREENE AS, 1986, AM J PHYSIOL, V251, pH288, DOI 10.1152/ajpheart.1986.251.2.H288; GUYTON AC, 1955, PHYSIOL REV, V35, P123, DOI 10.1152/physrev.1955.35.1.123; Helwig BG, 2008, AUTON NEUROSCI-BASIC, V141, P104, DOI 10.1016/j.autneu.2008.04.008; Kawada T, 2016, LIFE SCI, V149, P72, DOI 10.1016/j.lfs.2016.02.051; Kawada T, 2016, J PHYSIOL SCI, V66, P15, DOI 10.1007/s12576-015-0412-5; Kenney MJ, 2014, COMPR PHYSIOL, V4, P1177, DOI 10.1002/cphy.c130051; KENT BB, 1972, CARDIOLOGY, V57, P295, DOI 10.1159/000169528; Martelli D, 2014, J PHYSIOL-LONDON, V592, P1677, DOI 10.1113/jphysiol.2013.268573; Masson GS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122850; MitoloChieppa D, 1996, EUR J PHARMACOL, V309, P175, DOI 10.1016/0014-2999(96)00347-0; Nooteboom A, 2000, MEDIAT INFLAMM, V9, P235, DOI 10.1080/09629350020025755; Parratt JR, 1998, J ANTIMICROB CHEMOTH, V41, P31, DOI 10.1093/jac/41.suppl_1.31; Pavlov VA, 2004, CELL MOL LIFE SCI, V61, P2322, DOI 10.1007/s00018-004-4102-3; Radaelli A, 2013, SHOCK, V39, P204, DOI 10.1097/SHK.0b013e3182767daf; Ramchandra R, 2009, AM J PHYSIOL-REG I, V297, pR1247, DOI 10.1152/ajpregu.00437.2009; Rogausch H, 2000, ANN NY ACAD SCI, V917, P165; Saku K, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12136; Sato T, 1999, AM J PHYSIOL-HEART C, V276, pH2251, DOI 10.1152/ajpheart.1999.276.6.H2251; Sato T, 1999, AM J PHYSIOL-HEART C, V276, pH326, DOI 10.1152/ajpheart.1999.276.1.H326; SHOUKAS AA, 1991, AM J PHYSIOL, V260, pH300, DOI 10.1152/ajpheart.1991.260.1.H300; Takayama K, 2005, NAT MED, V11, P562, DOI 10.1038/nm1231; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Van Linthout Sophie, 2017, Curr Heart Fail Rep, V14, P251, DOI 10.1007/s11897-017-0337-9; Vayssettes-Courchay C, 2005, AUTON NEUROSCI-BASIC, V120, P35, DOI 10.1016/j.autneu.2005.03.002; ZHOU ZZ, 1991, AM J PHYSIOL, V260, pR739, DOI 10.1152/ajpregu.1991.260.4.R739; Zorn-Pauly K, 2007, SHOCK, V28, P655, DOI 10.1097/shk.0b013e31812386bf	34	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190830	10.1371/journal.pone.0190830	http://dx.doi.org/10.1371/journal.pone.0190830			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329321	Green Submitted, Green Published, gold			2022-12-26	WOS:000419954100023
J	Berg, F; Almeland, OW; Skadal, J; Slotte, A; Andersson, L; Folkvord, A				Berg, Florian; Almeland, Oda W.; Skadal, Julie; Slotte, Aril; Andersson, Leif; Folkvord, Arild			Genetic factors have a major effect on growth, number of vertebrae and otolith shape in Atlantic herring (Clupea harengus)	PLOS ONE			English	Article							COD GADUS-MORHUA; LIFE-HISTORY; MARINE FISH; BALTIC SEA; NORTH-SEA; STOCK DISCRIMINATION; LOCAL ADAPTATION; KING MACKEREL; L.; POPULATIONS	Atlantic herring, Clupea harengus, have complex population structures. Mixing of populations is known, but the extent of connectivity is still unclear. Phenotypic plasticity results in divergent phenotypes in response to environmental factors. A marked salinity gradient occurs from Atlantic Ocean (salinity 35) into the Baltic Sea (salinity range 2-12). Herring from both habitats display phenotypic and genetic variability. To explore how genetic factors and salinity influence phenotypic traits like growth, number of vertebrae and otolith shape an experimental population consisting of Atlantic purebreds and Atlantic/Baltic F1 hybrids were incubated and co-reared at two different salinities, 16 and 35, for three years. The F1-generation was repeatedly sampled to evaluate temporal variation. A von Bertalanffy growth model indicated that reared Atlantic purebreds had a higher maximum length (26.2 cm) than Atlantic/Baltic hybrids (24.8 cm) at salinity 35, but not at salinity 16 (25.0 and 24.8 cm, respectively). In contrast, Atlantic/Baltic hybrids achieved larger size-at-age than the wild caught Baltic parental group. Mean vertebral counts and otolith aspect ratios were higher for reared Atlantic purebreds than Atlantic/Baltic hybrids, consistent with the differences between parental groups. There were no significant differences in vertebral counts and otolith aspect ratios between herring with the same genotype but raised in different salinities. A Canonical Analysis of Principal Coordinates was applied to analyze the variation in wavelet coefficients that described otolith shape. The first discriminating axis identified the differences between Atlantic purebreds and Atlantic/Baltic hybrids, while the second axis represented salinity differences. Assigning otoliths based on genetic groups (Atlantic purebreds vs. Atlantic/Baltic hybrids) yielded higher classification success (similar to 90%) than based on salinities (16 vs. 35; similar to 60%). Our results demonstrate that otolith shape and vertebral counts have a significant genetic component and are therefore useful for studies on population dynamics and connectivity.	[Berg, Florian; Almeland, Oda W.; Skadal, Julie; Folkvord, Arild] Univ Bergen, Dept Biol, Bergen, Norway; [Berg, Florian; Slotte, Aril; Folkvord, Arild] Inst Marine Res, Bergen, Norway; [Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Andersson, Leif] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA	University of Bergen; Institute of Marine Research - Norway; Uppsala University; Swedish University of Agricultural Sciences; Texas A&M University System; Texas A&M University College Station	Berg, F (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.; Berg, F (corresponding author), Inst Marine Res, Bergen, Norway.	florian.berg@uib.no	Folkvord, Arild/A-5311-2012; Berg, Florian/M-9678-2014	Folkvord, Arild/0000-0002-4763-0590; Berg, Florian/0000-0003-1543-8112	Knut and Alice Wallenberg foundation; Research Council Norway [254774]	Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Research Council Norway(Research Council of Norway)	This work was funded by a grant from the Knut and Alice Wallenberg foundation (https://kawwallenberg.org) to LA and the Research Council Norway (www.forskrugsradet.no) project 254774 (GENSINC) to AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Barrett RDH, 2011, NAT REV GENET, V12, P767, DOI 10.1038/nrg3015; Barrio AM, 2016, ELIFE, V5, DOI 10.7554/eLife.12081; Begg GA, 2001, FISH B-NOAA, V99, P1; Bekkevold D, 2005, EVOLUTION, V59, P2656; Berg F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187374; Berg F, 2017, FISH RES, V194, P68, DOI 10.1016/j.fishres.2017.05.009; Berg PR, 2015, GENOME BIOL EVOL, V7, P1644, DOI 10.1093/gbe/evv093; BIRD JL, 1986, CAN J FISH AQUAT SCI, V43, P1228, DOI 10.1139/f86-152; Blaxter JHS., 1956, MAR RES, V5, P1; Boeuf G, 2001, COMP BIOCHEM PHYS C, V130, P411, DOI 10.1016/S1532-0456(01)00268-X; Brophy D, 2002, ICES J MAR SCI, V59, P1305, DOI 10.1006/jmsc.2002.1304; Brophy D, 2016, MAR FRESHWATER RES, V67, P1023, DOI 10.1071/MF15086; Burke N, 2008, FISH RES, V91, P133, DOI 10.1016/j.fishres.2007.11.013; Cadrin S. X., 2014, STOCK IDENTIFICATION; CAMPANA SE, 1993, CAN J FISH AQUAT SCI, V50, P1062, DOI 10.1139/f93-123; Cardinale M, 2004, CAN J FISH AQUAT SCI, V61, P158, DOI 10.1139/F03-151; CHEN KY, 2017, METHODS ECOLOGY EVOL, P20832; Clausen LAW, 2007, ICES J MAR SCI, V64, P377, DOI 10.1093/icesjms/fsl036; Clausen LAW, 2015, J FISH BIOL, V86, P228, DOI 10.1111/jfb.12571; Conover DO, 2009, EVOL APPL, V2, P276, DOI 10.1111/j.1752-4571.2009.00079.x; Conover DO, 2009, ANN NY ACAD SCI, V1168, P100, DOI 10.1111/j.1749-6632.2009.04575.x; DAHLE G, 1990, FISH RES, V9, P131, DOI 10.1016/0165-7836(90)90060-9; de Villemereuil P, 2016, HEREDITY, V116, P249, DOI 10.1038/hdy.2015.93; DeFaveri J, 2013, EVOLUTION, V67, P2530, DOI 10.1111/evo.12097; DeVries DA, 2002, FISH RES, V57, P51, DOI 10.1016/S0165-7836(01)00332-0; DQWG, 2016, SAN ANTONIO REPORT; Erlandsson J, 2017, FISH RES, V189, P1, DOI 10.1016/j.fishres.2017.01.001; Fjelldal PG, 2013, J ANAT, V222, P615, DOI 10.1111/joa.12049; Folkvord A, 2004, SARSIA, V89, P297, DOI 10.1080/00364820410002532; Folkvord A, 2009, ICES J MAR SCI, V66, P1702, DOI 10.1093/icesjms/fsp072; GEISSER S, 1975, J AM STAT ASSOC, V70, P320, DOI 10.2307/2285815; Godiksen JA, 2015, PLOS ONE, V10; Grabowski TB, 2009, ENVIRON BIOL FISH, V86, P361, DOI 10.1007/s10641-009-9534-z; Grohsler T, 2013, ICES J MAR SCI, V70, P1108, DOI 10.1093/icesjms/fst064; HULME TJ, 1995, ICES J MAR SCI, V52, P775, DOI 10.1006/jmsc.1995.0074; Hussy K, 2008, J EXP MAR BIOL ECOL, V364, P35, DOI 10.1016/j.jembe.2008.06.026; Hussy K, 2016, FISH RES, V174, P210, DOI 10.1016/j.fishres.2015.10.010; Hutchings JA, 2007, P ROY SOC B-BIOL SCI, V274, P1693, DOI 10.1098/rspb.2007.0263; ILES TD, 1982, SCIENCE, V215, P627, DOI 10.1126/science.215.4533.627; Imsland AK, 2001, AQUACULTURE, V198, P353, DOI 10.1016/S0044-8486(01)00507-5; Jensen LF, 2008, P ROY SOC B-BIOL SCI, V275, P2859, DOI 10.1098/rspb.2008.0870; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Lamichhaney S, 2012, P NATL ACAD SCI USA, V109, P19345, DOI 10.1073/pnas.1216128109; Libungan LA, 2015, J FISH BIOL, V86, P1377, DOI 10.1111/jfb.12647; Libungan LA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121102; Lindsey C.C., 1988, P197; Lleonart J, 2000, J THEOR BIOL, V205, P85, DOI 10.1006/jtbi.2000.2043; Loken S, 1996, SARSIA, V80, P293; Marcil J, 2006, P ROY SOC B-BIOL SCI, V273, P217, DOI 10.1098/rspb.2005.3306; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Momigliano P, 2017, P NATL ACAD SCI USA, V114, P6074, DOI 10.1073/pnas.1615109114; Morrongiello JR, 2015, ECOL MONOGR, V85, P93, DOI 10.1890/13-2355.1; Reimchen TE, 2016, CAN J ZOOL, V94, P1, DOI 10.1139/cjz-2015-0193; RYMAN N, 1984, HEREDITY, V53, P687, DOI 10.1038/hdy.1984.127; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Shepard KE, 2010, MAR COAST FISH, V2, P195, DOI 10.1577/C09-014.1; Simoneau M, 2000, CAN J ZOOL, V78, P1597, DOI 10.1139/cjz-78-9-1597; Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443; Swain DP, 1999, FISH RES, V43, P113, DOI 10.1016/S0165-7836(99)00069-7; TANING AV, 1952, BIOL REV, V27, P169, DOI 10.1111/j.1469-185X.1952.tb01392.x; Teacher AGF, 2013, EVOL APPL, V6, P549, DOI 10.1111/eva.12042; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; von Bertalanffy L, 1934, ROUX ARCH DEV BIOL, V131, P613, DOI 10.1007/BF00650112; WERNER RG, 1980, CAN J FISH AQUAT SCI, V37, P1063, DOI 10.1139/f80-138	66	31	32	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190995	10.1371/journal.pone.0190995	http://dx.doi.org/10.1371/journal.pone.0190995			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324892	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400090
J	Ledogar, JA; Luk, THY; Perry, JMG; Neaux, D; Wroe, S				Ledogar, Justin A.; Luk, Theodora H. Y.; Perry, Jonathan M. G.; Neaux, Dimitri; Wroe, Stephen			Biting mechanics and niche separation in a specialized clade of primate seed predators	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; VIVO BONE STRAIN; DIETARY ADAPTATIONS; MASTICATORY SYSTEM; ENAMEL THICKNESS; FEEDING ECOLOGY; NATIONAL-PARK; BEARDED SAKI; STRESS-DISTRIBUTION; CRANIAL MORPHOLOGY	We analyzed feeding biomechanics in pitheciine monkeys (Pithecia, Chiropotes, Cacajao), a clade that specializes on hard-husked unripe fruit (sclerocarpy) and resistant seeds (seed predation). We tested the hypothesis that pitheciine crania are well-suited to generate and withstand forceful canine and molar biting, with the prediction that they generate bite forces more efficiently and better resist masticatory strains than the closely-related Callicebus, which does not specialize on unripe fruits and/or seeds. We also tested the hypothesis that Callicebus-Pithecia-Chiropotes-Cacajao represent a morphocline of increasing sclerocarpic specialization with respect to biting leverage and craniofacial strength, consistent with anterior dental morphology. We found that pitheciines have higher biting leverage than Callicebus and are generally more resistant to masticatory strain. However, Cacajao was found to experience high strain magnitudes in some facial regions. We therefore found limited support for the morphocline hypothesis, at least with respect to the mechanical performance metrics examined here. Biting leverage in Cacajao was nearly identical (or slightly less than) in Chiropotes and strain magnitudes during canine biting were more likely to follow a Cacajao- Chiropotes-Pithecia trend of increasing strength, in contrast to the proposed morphocline. These results could indicate that bite force efficiency and derived anterior teeth were selected for in pitheciines at the expense of increased strain magnitudes. However, our results for Cacajao potentially reflect reduced feeding competition offered by allopatry with other pitheciines, which allows Cacajao species to choose from a wider variety of fruits at various stages of ripeness, leading to reduction in the selection for robust facial features. We also found that feeding biomechanics in sympatric Pithecia and Chiropotes are consistent with data on food structural properties and observations of dietary niche separation, with the former being well-suited for the regular molar crushing of hard seeds and the latter better adapted for breaching hard fruits.	[Ledogar, Justin A.; Luk, Theodora H. Y.; Neaux, Dimitri; Wroe, Stephen] Univ New England, Sch Environm & Rural Sci, Zool Div, Armidale, NSW, Australia; [Perry, Jonathan M. G.] Johns Hopkins Univ, Ctr Funct Anat & Evolut, Baltimore, MD USA	University of New England; Johns Hopkins University	Ledogar, JA (corresponding author), Univ New England, Sch Environm & Rural Sci, Zool Div, Armidale, NSW, Australia.	JLedogar@gmail.com	Neaux, Dimitri/V-2606-2019	Wroe, Stephen/0000-0002-6365-5915; Neaux, Dimitri/0000-0001-9465-220X; Ledogar, Justin/0000-0002-3882-9354	American Association of Physical Anthropology Professional Development Grant; SUNY Albany Dissertation Research Fellowship; SUNY Albany GSEU Professional Development Grant; Australian Research Council [140102659]	American Association of Physical Anthropology Professional Development Grant; SUNY Albany Dissertation Research Fellowship; SUNY Albany GSEU Professional Development Grant; Australian Research Council(Australian Research Council)	This research was funded by an American Association of Physical Anthropology Professional Development Grant (JAL), a SUNY Albany Dissertation Research Fellowship (JAL), a SUNY Albany GSEU Professional Development Grant (JAL), and the Australian Research Council (www.arc.gov.au) Discovery Project grant #140102659 (SW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D.C., 2017, GEOMORPH SOFTWARE GE; ANAPOL F, 1994, AM J PHYS ANTHROPOL, V94, P239, DOI 10.1002/ajpa.1330940208; Anapol Fred, 2008, P201, DOI 10.1007/978-0-387-76585-3_10; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Anton SC, 1996, INT J PRIMATOL, V17, P401, DOI 10.1007/BF02736629; AYRES JM, 1989, J HUM EVOL, V18, P697, DOI 10.1016/0047-2484(89)90101-2; Ayres JMC, 1986, THESIS; Baab KL, 2014, EVOLUTION, V68, P1450, DOI 10.1111/evo.12361; Baab KL, 2007, THESIS; Barnett AA, 2005, INT J PRIMATOL, V26, P949, DOI 10.1007/s10764-005-5331-5; Barnett AA, 1997, FOLIA PRIMATOL, V68, P223, DOI 10.1159/000157249; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Boubli JP, 1999, INT J PRIMATOL, V20, P719, DOI 10.1023/A:1020704819367; BOUVIER M, 1986, INT J PRIMATOL, V7, P551, DOI 10.1007/BF02736661; Bowler M, 2009, AM J PRIMATOL, V71, P976, DOI 10.1002/ajp.20740; Byrne H, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0142-4; CACHEL SM, 1979, AM J PHYS ANTHROPOL, V50, P1, DOI 10.1002/ajpa.1330500102; Carter K, 2015, J DENT RES, V94, P886, DOI 10.1177/0022034515581644; Chalk J, 2016, AM J PHYS ANTHROPOL, V159, P199, DOI 10.1002/ajpa.22865; Curtis N, 2011, ANAT REC, V294, P1178, DOI 10.1002/ar.21415; Daegling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023095; DEMES B, 1988, J HUM EVOL, V17, P657, DOI 10.1016/0047-2484(88)90023-1; Dominy NJ, 2008, EVOL BIOL, V35, P159, DOI 10.1007/s11692-008-9026-7; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Dumont ER, 2011, P ROY SOC B-BIOL SCI, V278, P3654, DOI 10.1098/rspb.2011.0528; Dumont ER, 2011, J ANAT, V218, P151, DOI 10.1111/j.1469-7580.2010.01247.x; Dunham NT, 2016, AM J PHYS ANTHROPOL, V161, P343, DOI 10.1002/ajpa.23036; EISENBERG NA, 1965, ANAT RECORD, V152, P185, DOI 10.1002/ar.1091520209; Endo B., 1966, J FS U TOKYO, V3, P1; Finotelo LFM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-189; Fleagle J.G., 1984, P105; FONTAINE R, 1981, ECOLOGY BEHAVIOR NEO, V1, P443; Ford S.M., 1986, P73; Glowacka H, 2017, AM J PRIMATOL, P79; GREAVES WS, 1978, J ZOOL, V184, P271, DOI 10.1111/j.1469-7998.1978.tb03282.x; Grosse IR, 2007, ANAT REC, V290, P1069, DOI 10.1002/ar.20568; Gunz P, 2013, HYSTRIX, V24, P103, DOI 10.4404/hystrix-24.1-6292; Hartstone-Rose A, 2015, AM J PHYS ANTHROPOL, V157, P513, DOI 10.1002/ajpa.22726; HERSHKOVITZ P, 1987, AM J PRIMATOL, V12, P387, DOI 10.1002/ajp.1350120402; Heymann EW, 2010, INT J PRIMATOL, V31, P751, DOI 10.1007/s10764-010-9425-3; Holmes DC, 1996, J PROSTHET DENT, V75, P140, DOI 10.1016/S0022-3913(96)90090-6; Hylander WL, 1997, AM J PHYS ANTHROPOL, V102, P203, DOI 10.1002/(SICI)1096-8644(199702)102:2<203::AID-AJPA5>3.0.CO;2-Z; HYLANDER WL, 1991, AM J PHYS ANTHROPOL, V86, P1, DOI 10.1002/ajpa.1330860102; JANSON CH, 1988, BEHAVIOUR, V105, P53, DOI 10.1163/156853988X00449; Kamilar JM, 2011, AM J PHYS ANTHROPOL, V144, P131, DOI 10.1002/ajpa.21380; KAY RF, 1990, J HUM EVOL, V19, P175, DOI 10.1016/0047-2484(90)90016-5; KAY RF, 1977, J HUM EVOL, V6, P19, DOI 10.1016/S0047-2484(77)80040-7; KINZEY WG, 1993, INT J PRIMATOL, V14, P207, DOI 10.1007/BF02192632; KINZEY WG, 1990, AM J PHYS ANTHROPOL, V81, P5, DOI 10.1002/ajpa.1330810103; KINZEY WG, 1992, AM J PHYS ANTHROPOL, V88, P499, DOI 10.1002/ajpa.1330880406; Kinzey WG, ECOLOGY BEHAV NEOTRO, V1; KO CC, 1992, J PROSTHET DENT, V68, P421, DOI 10.1016/0022-3913(92)90404-X; Koyabu DB, 2010, AM J PHYS ANTHROPOL, V142, P137, DOI 10.1002/ajpa.21213; Lambert JE, 2004, AM J PHYS ANTHROPOL, V125, P363, DOI 10.1002/ajpa.10403; Ledogar JA, 2016, NAT COMMUN, P7; Ledogar JA, 2009, THESIS; Ledogar JA, 2017, ANAT REC, V300, P171, DOI 10.1002/ar.23492; Ledogar JA, 2016, PEERJ, V4, DOI 10.7717/peerj.2242; Ledogar JA, 2013, AM J PHYS ANTHROPOL, V150, P107, DOI 10.1002/ajpa.22181; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; Lucas P., 2004, DENT FUNCTIONAL MORP; Lucas PW, 2012, INT J PRIMATOL, V33, P598, DOI 10.1007/s10764-011-9540-9; Lucas PW, COLOBINE MONKEYS THE; Lucas PW, FOOD ACQUISITION PRO; Magne P, 2007, DENT MATER, V23, P539, DOI 10.1016/j.dental.2006.03.013; Marce-Nogue J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08161-0; Martin LB, 2003, J HUM EVOL, V45, P351, DOI 10.1016/j.jhevol.2003.08.005; McGraw WS, 2014, AM J PHYS ANTHROPOL, V154, P413, DOI 10.1002/ajpa.22525; MITTERMEIER RA, 1981, FOLIA PRIMATOL, V36, P1, DOI 10.1159/000156007; Murphy RA, 1998, PHYSIOLOGY; Norconk MA, 2004, INT J PRIMATOL, V25, P1, DOI 10.1023/B:IJOP.0000014642.68751.ed; Norconk MA, 2016, AM J PRIMATOL, V78, P507, DOI 10.1002/ajp.22396; Norconk MA, 2011, ANAT REC, V294, P2092, DOI 10.1002/ar.21506; Norconk Marilyn A., 2009, P279, DOI 10.1007/978-0-387-78705-3_11; Palacios E, 1997, INT J PRIMATOL, V18, P503, DOI 10.1023/A:1026307121583; Panagiotopoulou O, 2017, ZOOLOGY, V124, P13, DOI 10.1016/j.zool.2017.08.010; Perelman P, 2011, PLOS GENET, P7; Perry J. M. G, 2011, ANAT RES INT, V2011; Perry JMG, 2015, AM J PHYS ANTHROPOL, V158, P646, DOI 10.1002/ajpa.22811; Perry JMG, 2015, AM J PHYS ANTHROPOL, V158, P92, DOI 10.1002/ajpa.22779; Perry JMG, 2010, AMEGHINIANA, V47, P355, DOI 10.5710/AMGH.v47i3.9; PETERS CR, 1987, AM J PHYS ANTHROPOL, V73, P333, DOI 10.1002/ajpa.1330730306; Prado FB, 2016, ANAT REC, V299, P1753, DOI 10.1002/ar.23486; Rak Y., 1983, AUSTRALOPITHECINE FA, DOI [10.1016/B978-0-12-576280-9.50006-7, DOI 10.1016/B978-0-12-576280-9.50006-7]; ROSENBERGER AL, 1992, AM J PHYS ANTHROPOL, V88, P525, DOI 10.1002/ajpa.1330880408; Ross CF, 2014, EVOL ANTHROPOL, V23, P105, DOI 10.1002/evan.21410; Ross CF, 2012, INT J PRIMATOL, V33, P632, DOI 10.1007/s10764-012-9599-y; Ross CF, 2011, J ANAT, V218, P112, DOI 10.1111/j.1469-7580.2010.01322.x; Ross CF, 2005, ANAT REC PART A, V283A, P288, DOI 10.1002/ar.a.20170; Ross CF, 2001, AM J PHYS ANTHROPOL, V116, P108, DOI 10.1002/ajpa.1106; RUBIN C, 1983, J DENT RES, V62, P82, DOI 10.1177/00220345830620021701; Santana SE, 2010, FUNCT ECOL, V24, P776, DOI 10.1111/j.1365-2435.2010.01703.x; Schneider H, 2001, CHROMOSOMA, V109, P515, DOI 10.1007/s004120000106; Schrago CG, 2013, J EVOLUTION BIOL, V26, P2438, DOI 10.1111/jeb.12237; Shaffer CA, 2013, AM J PRIMATOL, V75, P568, DOI 10.1002/ajp.22134; Slice DE, 2005, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/0-387-27614-9_1; Smith AL, 2015, ANAT REC, V298, P122, DOI 10.1002/ar.23074; Smith AL, 2015, ANAT REC, V298, P145, DOI 10.1002/ar.23073; Spencer MA, 2003, AM J PHYS ANTHROPOL, V122, P325, DOI 10.1002/ajpa.10288; SPENCER MA, 1993, AM J PHYS ANTHROPOL, V91, P1, DOI 10.1002/ajpa.1330910102; Spencer MA, 1999, AM J PHYS ANTHROPOL, V108, P483, DOI 10.1002/(SICI)1096-8644(199904)108:4<483::AID-AJPA7>3.0.CO;2-L; Springer MS, 2012, PLOS ONE, P7; Starck D., 1933, Gegenbaurs Morphologisches Jahrbuch, V72, P212; Strait DS, 2013, AM J PHYS ANTHROPOL, V151, P339, DOI 10.1002/ajpa.22285; Strait DS, 2010, ANAT REC, V293, P583, DOI 10.1002/ar.21122; Strait DS, 2009, P NATL ACAD SCI USA, V106, P2124, DOI 10.1073/pnas.0808730106; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Taylor AB, 2015, AM J PHYS ANTHROPOL, V158, P242, DOI 10.1002/ajpa.22782; van Roosmalen M.G.M., 1981, P419; VANROOSMALEN MGM, 1988, AM J PRIMATOL, V14, P11, DOI 10.1002/ajp.1350140103; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; von Dornum M, 1999, MOL PHYLOGENET EVOL, V11, P459, DOI 10.1006/mpev.1998.0582; White TD, 2011, HUMAN OSTEOLOGY, V3rd; Wood SA, 2011, J BIOMECH, V44, P1831, DOI 10.1016/j.jbiomech.2011.03.022; Wright BW, 2012, AM J PHYS ANTHROPOL, V148, P262, DOI 10.1002/ajpa.22081; Wright BW, 2005, J HUM EVOL, V48, P473, DOI 10.1016/j.jhevol.2005.01.006; Wroe S, 2010, P ROY SOC B-BIOL SCI, V277, P3579, DOI 10.1098/rspb.2010.0509; Yamashita N, 2009, AM J PHYS ANTHROPOL, V139, P368, DOI 10.1002/ajpa.20992	118	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190689	10.1371/journal.pone.0190689	http://dx.doi.org/10.1371/journal.pone.0190689			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BJ	29324822	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400048
J	Mangini, G; Gadaleta, A; Colasuonno, P; Marcotuli, I; Signorile, AM; Simeone, R; De Vita, P; Mastrangelo, AM; Laido, G; Pecchioni, N; Blanco, A				Mangini, Giacomo; Gadaleta, Agata; Colasuonno, Pasqualina; Marcotuli, Ilaria; Signorile, Antonio M.; Simeone, Rosanna; De Vita, Pasquale; Mastrangelo, Anna M.; Laido, Giovanni; Pecchioni, Nicola; Blanco, Antonio			Genetic dissection of the relationships between grain yield components by genome-wide association mapping in a collection of tetraploid wheats	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; TRITICUM-AESTIVUM L.; BREAD WHEAT; SPRING WHEAT; PHYSIOLOGICAL TRAITS; USE EFFICIENCY; KERNEL NUMBER; WINTER-WHEAT; CROP PLANTS; WEIGHT	Increasing grain yield potential in wheat has been a major target of most breeding programs. Genetic advance has been frequently hindered by negative correlations among yield components that have been often observed in segregant populations and germplasm collections. A tetraploid wheat collection was evaluated in seven environments and genotyped with a 90K SNP assay to identify major and stable quantitative trait loci (QTL) for grain yield per spike (GYS), kernel number per spike (KNS) and thousand-kernel weight (TKW), and to analyse the genetic relationships between the yield components at QTL level. The genome-wide association analysis detected eight, eleven and ten QTL for KNS, TKW and GYS, respectively, significant in at least three environments or two environments and the mean across environments. Most of the QTL for TKW and KNS were found located in different marker intervals, indicating that they are genetically controlled independently by each other. Out of eight KNS QTL, three were associated to significant increases of GYS, while the increased grain number of five additional QTL was completely or partially compensated by decreases in grain weight, thus producing no or reduced effects on GYS. Similarly, four consistent and five suggestive TKW QTL resulted in visible increase of GYS, while seven additional QTL were associated to reduced effects in grain number and no effects on GYS. Our results showed that QTL analysis for detecting TKW or KNS alleles useful for improving grain yield potential should consider the pleiotropic effects of the QTL or the association to other QTLs.	[Mangini, Giacomo; Signorile, Antonio M.; Simeone, Rosanna; Blanco, Antonio] Univ Aldo Moro, Genet & Plant Breeding Sect, Dept Soil Plant & Food Sci, Bari, Italy; [Gadaleta, Agata; Colasuonno, Pasqualina; Marcotuli, Ilaria] Univ Aldo Moro, Res Unit Genet & Plant Biotechnol, Dept Agr & Environm Sci, Bari, Italy; [De Vita, Pasquale; Mastrangelo, Anna M.; Laido, Giovanni; Pecchioni, Nicola] Council Agr Res & Econ, Cereal Res Ctr, Foggia, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Gadaleta, A (corresponding author), Univ Aldo Moro, Res Unit Genet & Plant Biotechnol, Dept Agr & Environm Sci, Bari, Italy.	agata.gadaleta@uniba.it	Gadaleta, Agata/H-2627-2012; Pecchioni, Nicola/E-5389-2015	Gadaleta, Agata/0000-0002-6312-249X; Pecchioni, Nicola/0000-0003-1704-2541; Mangini, Giacomo/0000-0002-6600-2178; De Vita, Pasquale/0000-0002-9573-0510; Mastrangelo, Anna Maria/0000-0002-3618-0301	MIUR, Italy [PON-01_01145-ISCOCEM]	MIUR, Italy(Ministry of Education, Universities and Research (MIUR))	This research was supported by grants from MIUR, Italy, projects 'PON-01_01145-ISCOCEM' to AG.; This research was supported by grants from MIUR, Italy, projects 'PON-01_01145-ISCOCEM'.	Acreche MM, 2009, FIELD CROP RES, V110, P98, DOI 10.1016/j.fcr.2008.07.006; ADAMS MW, 1967, CROP SCI, V7, P505, DOI 10.2135/cropsci1967.0011183X000700050030x; Aisawi KAB, 2015, CROP SCI, V55, P1749, DOI 10.2135/cropsci2014.09.0601; Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Araus JL, 2008, CRIT REV PLANT SCI, V27, P377, DOI 10.1080/07352680802467736; Blanco A, 2012, MOL BREEDING, V30, P79, DOI 10.1007/s11032-011-9600-z; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Calderini DF, 1999, WHEAT ECOLOGY PHYSL, P503; Colasuonno P, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3395-6; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Cui F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04028-6; Cui F, 2014, THEOR APPL GENET, V127, P659, DOI 10.1007/s00122-013-2249-8; Cuthbert JL, 2008, THEOR APPL GENET, V117, P595, DOI 10.1007/s00122-008-0804-5; De Vita P, 2007, EUR J AGRON, V26, P39, DOI 10.1016/j.eja.2006.08.009; Deng SM, 2011, THEOR APPL GENET, V122, P281, DOI 10.1007/s00122-010-1443-1; FISCHER RA, 1986, AUST J PLANT PHYSIOL, V13, P767, DOI 10.1071/PP9860767; Foulkes MJ, 2011, J EXP BOT, V62, P469, DOI 10.1093/jxb/erq300; Foulkes MJ, 2009, CROP PHYSIOLOGY: APPLICATIONS FOR GENETIC IMPROVEMENT AND AGRONOMY, P355, DOI 10.1016/B978-0-12-374431-9.00015-3; Gao FM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01099; Gegas VC, 2010, PLANT CELL, V22, P1046, DOI 10.1105/tpc.110.074153; GenStat, 2020, GENSTAT WINDOWS, V9th ed.; Giancaspro A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01381; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Guo ZF, 2017, NEW PHYTOL, V214, P257, DOI 10.1111/nph.14342; Gupta PK, 2014, ADV GENET, V85, P109, DOI 10.1016/B978-0-12-800271-1.00002-0; Gupta PK, 2017, AGRONOMY-BASEL, V7, DOI 10.3390/agronomy7010005; Hanif M, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-015-0425-z; Hou J, 2014, PLANT PHYSIOL, V164, P1918, DOI 10.1104/pp.113.232454; Hu MJ, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0449-z; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang YL, 2015, THEOR APPL GENET, V128, P2437, DOI 10.1007/s00122-015-2598-6; Jia HY, 2013, THEOR APPL GENET, V126, P2123, DOI 10.1007/s00122-013-2123-8; Jiang YM, 2015, THEOR APPL GENET, V128, P131, DOI 10.1007/s00122-014-2417-5; JOSEPH KDSM, 1985, AGRON J, V77, P211, DOI 10.2134/agronj1985.00021962007700020009x; Kuchel H, 2007, THEOR APPL GENET, V115, P1029, DOI 10.1007/s00122-007-0629-7; LANDER ES, 1989, GENETICS, V121, P185; Lloveras J, 2004, AGRON J, V96, P1258, DOI 10.2134/agronj2004.1258; Lopes MS, 2012, CROP SCI, V52, P1123, DOI 10.2135/cropsci2011.09.0467; Ma DY, 2012, MOL BREEDING, V29, P43, DOI 10.1007/s11032-010-9524-z; Ma L, 2016, PLANT BIOTECHNOL J, V14, P1269, DOI 10.1111/pbi.12492; Ma M, 2015, PLANT J, V83, P312, DOI 10.1111/tpj.12896; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Maccaferri M, 2015, PLANT BIOTECHNOL J, V13, P648, DOI 10.1111/pbi.12288; Maphosa L, 2014, THEOR APPL GENET, V127, P1607, DOI 10.1007/s00122-014-2322-y; Marcotuli I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152590; Marcotuli I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132787; McIntyre CL, 2010, THEOR APPL GENET, V120, P527, DOI 10.1007/s00122-009-1173-4; Mir RR, 2012, MOL BREEDING, V29, P963, DOI 10.1007/s11032-011-9693-4; Miralles DJ, 1995, PLANT BREEDING, V114, P392, DOI 10.1111/j.1439-0523.1995.tb00818.x; Morgounov A, 2010, FIELD CROP RES, V117, P101, DOI 10.1016/j.fcr.2010.02.001; Nadolska-Orczyk A, 2017, THEOR APPL GENET, V130, P1081, DOI 10.1007/s00122-017-2880-x; Parry MAJ, 2011, J EXP BOT, V62, P453, DOI 10.1093/jxb/erq304; Peltonen-Sainio P, 2009, FIELD CROP RES, V110, P85, DOI 10.1016/j.fcr.2008.07.007; PERRY MW, 1989, AUST J AGR RES, V40, P457, DOI 10.1071/AR9890457c; Quarrie SA, 2006, J EXP BOT, V57, P2627, DOI 10.1093/jxb/erl026; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Rafalski JA, 2010, CURR OPIN PLANT BIOL, V13, P174, DOI 10.1016/j.pbi.2009.12.004; Reynolds M, 2012, PLANT CELL ENVIRON, V35, P1799, DOI 10.1111/j.1365-3040.2012.02588.x; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Roeder MIS, 2008, FUNCT INTEGR GENOMIC, V8, P79, DOI 10.1007/s10142-007-0053-8; Sadras VO, 2011, CROP PASTURE SCI, V62, P533, DOI 10.1071/CP11060; Sayre KD, 1997, CROP SCI, V37, P36, DOI 10.2135/cropsci1997.0011183X003700010006x; SHARP PJ, 1988, THEOR APPL GENET, V75, P286, DOI 10.1007/BF00303966; Shearman VJ, 2005, CROP SCI, V45, P175; Slafer G.A., 1996, P CIMMYT INT S GEN Y, P101; Snape JW, 2007, EUPHYTICA, V154, P401, DOI 10.1007/s10681-006-9208-2; Su JY, 2009, PLANT SCI, V176, P824, DOI 10.1016/j.plantsci.2009.03.006; Sun XC, 2010, THEOR APPL GENET, V120, P1041, DOI 10.1007/s00122-009-1232-x; Tian ZW, 2011, FIELD CROP RES, V124, P417, DOI 10.1016/j.fcr.2011.07.012; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; WADDINGTON SR, 1986, CROP SCI, V26, P698, DOI 10.2135/cropsci1986.0011183X002600040012x; Wang JS, 2011, EUPHYTICA, V177, P277, DOI 10.1007/s10681-010-0267-z; Wang LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029432; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wu XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031249; Xiao YG, 2012, CROP SCI, V52, P44, DOI 10.2135/cropsci2011.05.0246; Yao J, 2009, GENETICA, V137, P67, DOI 10.1007/s10709-009-9351-5; Zanke CD, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00644; Zhang H, 2016, CROP J, V4, P220, DOI 10.1016/j.cj.2016.01.007; Zhang HX, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1887-3; Zhang JJ, 2013, MOL BREEDING, V32, P771, DOI 10.1007/s11032-013-9905-1; Zheng J, 2014, J EXP BOT, V65, P5351, DOI 10.1093/jxb/eru306; Zheng TC, 2011, FIELD CROP RES, V122, P225, DOI 10.1016/j.fcr.2011.03.015	83	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190162	10.1371/journal.pone.0190162	http://dx.doi.org/10.1371/journal.pone.0190162			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324803	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400022
J	Mendel, JR; Baig, SA; Hall, MG; Jeong, M; Byron, MJ; Morgan, JC; Noar, SM; Ribisl, KM; Brewer, NT				Mendel, Jennifer R.; Baig, Sabeeh A.; Hall, Marissa G.; Jeong, Michelle; Byron, M. Justin; Morgan, Jennifer C.; Noar, Seth M.; Ribisl, Kurt M.; Brewer, Noel T.			Brand switching and toxic chemicals in cigarette smoke: A national study	PLOS ONE			English	Article							TOBACCO CONSTITUENTS; PERCEPTIONS; BELIEFS; ADULTS; HEALTH; ADOLESCENTS; GENDER; LIGHT	Introduction US law requires disclosure of quantities of toxic chemicals (constituents) in cigarette smoke by brand and sub-brand. This information may drive smokers to switch to cigarettes with lower chemical quantities, under the misperception that doing so can reduce health risk. We sought to understand past brand-switching behavior and whether learning about specific chemicals in cigarette smoke increases susceptibility to brand switching. Methods Participants were US adult smokers surveyed by phone (n = 1,151, probability sample) and online (n = 1,561, convenience sample). Surveys assessed whether smokers had ever switched cigarette brands or styles to reduce health risk and about likelihood of switching if the smoker learned their brand had more of a specific chemical than other cigarettes. Chemicals presented were nicotine, carbon monoxide, lead, formaldehyde, arsenic, and ammonia. Results Past brand switching to reduce health risk was common among smokers (43% in phone survey, 28% in online survey). Smokers who were female, over 25, and current "light" cigarette users were more likely to have switched brands to reduce health risks (all p < .05). Overall, 61-92% of smokers were susceptible to brand switching based on information about particular chemicals. In both samples, lead, formaldehyde, arsenic, and ammonia led to more susceptibility to switch than nicotine (all p < .05). Conclusions Many US smokers have switched brands or styles to reduce health risks. The majority said they might or would definitely switch brands if they learned their cigarettes had more of a toxic chemical than other brands. Brand switching is a probable unintended consequence of communications that show differences in smoke chemicals between brands.	[Mendel, Jennifer R.; Hall, Marissa G.; Jeong, Michelle; Byron, M. Justin; Noar, Seth M.; Ribisl, Kurt M.; Brewer, Noel T.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Baig, Sabeeh A.; Hall, Marissa G.; Jeong, Michelle; Byron, M. Justin; Morgan, Jennifer C.; Ribisl, Kurt M.; Brewer, Noel T.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27599 USA; [Noar, Seth M.] Univ N Carolina, Sch Media & Journalism, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Brewer, NT (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Brewer, NT (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27599 USA.	ntb@unc.edu	Brewer, Noel T/C-4375-2008; Ribisl, Kurt M/C-4867-2015; Noar, Seth/AAT-9402-2021	Brewer, Noel T/0000-0003-2241-7002; Ribisl, Kurt M/0000-0003-3318-8524; Mendel Sheldon, Jennifer/0000-0002-2499-2871; Jeong, Michelle/0000-0001-5767-7766	National Cancer Institute [P50CA180907]; FDA Center for Tobacco Products (CTP); National Cancer Institute of the National Institutes of Health [T32-CA057726]; NATIONAL CANCER INSTITUTE [P50CA180907] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FDA Center for Tobacco Products (CTP)(United States Department of Health & Human Services); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by grant number P50CA180907 from the National Cancer Institute and FDA Center for Tobacco Products (CTP) (http://www.cancer.gov/). T32-CA057726 from the National Cancer Institute of the National Institutes of Health (http://www.cancer.gov/) supported Marissa Hall's time writing the paper. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration.	Administration D., 2012, FED REGISTER, V77, P20034; Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; [Anonymous], 2001, SMOKING AND TOBACCO, V13; Baig SA, DOES TELLING PEOPLE; BENOWITZ NL, 1989, NEW ENGL J MED, V320, P1619, DOI 10.1056/NEJM198906153202409; Berman ML, 2017, FOOD DRUG LAW J, V72, P386; Boynton MH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3151-5; Brewer NT, 2016, TOB CONTROL; Byron MJ, 2016, TOB CONTROL, V25, P517, DOI 10.1136/tobaccocontrol-2015-052560; Byron MJ, TOBACCO REGULATORY S; Cohen JB, 1996, AM J PUBLIC HEALTH, V86, P18, DOI 10.2105/AJPH.86.1.18; Cornelius ME, 2015, TOB CONTROL, V24, P609, DOI 10.1136/tobaccocontrol-2014-051765; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Crawford MA, 2002, TOB CONTROL, V11, P14, DOI 10.1136/tc.11.1.14; Czoli CD, 2014, J ADOLESCENT HEALTH, V54, P33, DOI 10.1016/j.jadohealth.2013.07.016; Federal Trade Commission, 2000, FEDERAL TRADE COMMIS; Gilpin Elizabeth A, 2002, Nicotine Tob Res, V4 Suppl 2, pS147; Giovino GA, 1996, ATTITUDES KNOWLEDGE; Hall MG, 2014, NICOTINE TOB RES, V16, P343, DOI 10.1093/ntr/ntt158; International Agency for Research on Cancer, 2004, IARC MON EV CARC RIS, P53; Kelly KJ, 2014, J HEALTH COMMUN, V19, P1064, DOI 10.1080/10810730.2013.872720; Kozlowski LT, 1998, AM J PREV MED, V15, P9, DOI 10.1016/S0749-3797(98)00004-X; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; McDaniel PA, 2007, TOB CONTROL, V16, DOI 10.1136/tc.2006.019638; Moracco KE, 2016, NICOTINE TOB RES, V18, P1566, DOI 10.1093/ntr/ntv281; Morgan JC, 2017, J BEHAV MED, V40, P553, DOI 10.1007/s10865-017-9823-5; Rodgman A, 2013, THE CHEMICAL COMPONE; Shiffman S, 2001, TOB CONTROL, V10, pI17; Tindle HA, 2009, TOB CONTROL, V18, P485, DOI 10.1136/tc.2008.029314; U.S. Department of Health and Human Services, 2014, THE HEALTH CONSEQUEN; VERBRUGGE LM, 1985, J HEALTH SOC BEHAV, V26, P156, DOI 10.2307/2136750; Willis GB, 2004, COGNITIVE INTERVIEWI	32	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0189928	10.1371/journal.pone.0189928	http://dx.doi.org/10.1371/journal.pone.0189928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BJ	29324749	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400015
J	Peyrounette, M; Davit, Y; Quintard, M; Lorthois, S				Peyrounette, Myriam; Davit, Yohan; Quintard, Michel; Lorthois, Sylvie			Multiscale modelling of blood flow in cerebral microcirculation: Details at capillary scale control accuracy at the level of the cortex	PLOS ONE			English	Article							NUMERICAL RESERVOIR SIMULATION; WELL-BLOCK PRESSURES; MICROVASCULAR NETWORKS; 2-PHOTON MICROSCOPY; VASCULAR NETWORK; VOLUME; VESSELS; HOMOGENIZATION; HEMODYNAMICS; VISCOSITY	Aging or cerebral diseases may induce architectural modifications in human brain microvascular networks, such as capillary rarefaction. Such modifications limit blood and oxygen supply to the cortex, possibly resulting in energy failure and neuronal death. Modelling is key in understanding how these architectural modifications affect blood flow and mass transfers in such complex networks. However, the huge number of vessels in the human brain D tens of billions D prevents any modelling approach with an explicit architectural representation down to the scale of the capillaries. Here, we introduce a hybrid approach to model blood flow at larger scale in the brain microcirculation, based on its multiscale architecture. The capillary bed, which is a space-filling network, is treated as a porous medium and modelled using a homogenized continuum approach. The larger arteriolar and venular trees, which cannot be homogenized because of their fractal-like nature, are treated as a network of interconnected tubes with a detailed representation of their spatial organization. The main contribution of this work is to devise a proper coupling model at the interface between these two components. This model is based on analytical approximations of the pressure field that capture the strong pressure gradients building up in the capillaries connected to arterioles or venules. We evaluate the accuracy of this model for both very simple architectures with one arteriole and/or one venule and for more complex ones, with anatomically realistic tree-like vessels displaying a large number of coupling sites. We show that the hybrid model is very accurate in describing blood flow at large scales and further yields a significant computational gain by comparison with a classical network approach. It is therefore an important step towards large scale simulations of cerebral blood flow and lays the groundwork for introducing additional levels of complexity in the future.	[Peyrounette, Myriam; Davit, Yohan; Quintard, Michel; Lorthois, Sylvie] Univ Toulouse, CNRS, IMFT, Toulouse, France; [Lorthois, Sylvie] Cornell Univ, Nancy E & Peter C Meinig Sch Biomed Engn, Ithaca, NY 14850 USA; [Peyrounette, Myriam; Davit, Yohan; Quintard, Michel; Lorthois, Sylvie] Allee Prof Camille Soule, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Cornell University	Lorthois, S (corresponding author), Univ Toulouse, CNRS, IMFT, Toulouse, France.; Lorthois, S (corresponding author), Cornell Univ, Nancy E & Peter C Meinig Sch Biomed Engn, Ithaca, NY 14850 USA.; Lorthois, S (corresponding author), Allee Prof Camille Soule, Toulouse, France.	sylvie.lorthois@imft.fr	Quintard, Michel/R-1654-2019	Quintard, Michel/0000-0002-6150-7011; Lorthois, Sylvie/0000-0002-0711-3695	European Research Council under the European Unions Seventh Framework Programme (FP7)/ ERC grant [615102]; Institut National Polytechnique de Toulouse; Ecole Doctorale MEGeP, Toulouse; CALMIP [2016-P1541]	European Research Council under the European Unions Seventh Framework Programme (FP7)/ ERC grant(European Research Council (ERC)); Institut National Polytechnique de Toulouse; Ecole Doctorale MEGeP, Toulouse; CALMIP(Region Occitanie)	The research leading to these results has received funding from the European Research Council under the European Unions Seventh Framework Programme (FP7/2007-2013)/ ERC grant agreement no 615102. (https://erc.europa.eu/). MP was the recipient of a doctoral fellowship from Institut National Polytechnique de Toulouse (http://www.inp-toulouse.fr/) and an international mobility grant from Ecole Doctorale MEGeP, Toulouse (www.ed-megep.fr/). This work was performed using HPC resources from CALMIP (Grant 2016-P1541). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Part of this work has been done while SL was the Mary Upson Visiting Professor, Meining School of Biomedical Engineering, Cornell University. The authors gratefully acknowledge F. Cassot and F. Lauwers for sharing anatomical data, N. Nishimura and C. Schaffer for useful discussions, and F.Y. Houdroge for her participation in preliminary work on this subject. They also gratefully thank A. Smith, V. Doyeux and F. Zami-Pierre for having critically reviewed this paper. They thank the COSINUS department of IMFT for help on computational aspects. This work was performed using HPC resources from CALMIP (Grant 2016-P1541).	Agaev GS, 1996, IMPROVED TECHNIQUE C, P355; Balaji Pavan, 2007, 2007 IEEE INT PAR DI, P1; Balay S., 2016, PETSC WEB PAGE; Bear J., 1972, DYNAMICS FLUIDS PORO; Bertolino A, 2007, FOSE 2007: FUTURE OF SOFTWARE ENGINEERING, P85, DOI 10.1109/FOSE.2007.25; Blinder P, 2013, NAT NEUROSCI, V16, P889, DOI 10.1038/nn.3426; Boas DA, 2008, NEUROIMAGE, V40, P1116, DOI 10.1016/j.neuroimage.2007.12.061; Cassot F, 2006, MICROCIRCULATION, V13, P1, DOI 10.1080/10739680500383407; Chen W-K, 1997, GRAPH THEORY ITS ENG, V5; Chen ZX, 2009, INT J NUMER ANAL MOD, V6, P375; Davit Y, 2013, ADV WATER RESOUR, V62, P178, DOI 10.1016/j.advwatres.2013.09.006; Ding Y, 1995, SPE RESERV EVAL ENG, V1, P303; Dumkwu FA, 2012, J PETROL SCI ENG, V82-83, P174, DOI 10.1016/j.petrol.2011.12.005; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; El-Bouri WK, 2015, J THEOR BIOL, V380, P40, DOI 10.1016/j.jtbi.2015.05.011; Erbertseder K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031966; Errico C, 2015, NATURE, V527, P499, DOI 10.1038/nature16066; Eymard R, 2000, HDBK NUM AN, V7, P713; Fahraeus R, 1931, AM J PHYSIOL, V96, P562, DOI 10.1152/ajplegacy.1931.96.3.562; Fung Y.C., 1981, BIOMECHANICS MECH PR; FUNG YC, 1971, ANNU REV FLUID MECH, V3, P189, DOI 10.1146/annurev.fl.03.010171.001201; Gagnon L, 2015, J NEUROSCI, V35, P3663, DOI 10.1523/JNEUROSCI.3555-14.2015; Gessel GM, 2007, NEW METHOD TREATING; Gould IG, 2015, MICROCIRCULATION, V22, P1, DOI 10.1111/micc.12156; Gould IG, 2017, J CEREBR BLOOD F MET, V37, P52, DOI 10.1177/0271678X16671146; Hirsch S, 2012, J CEREBR BLOOD F MET, V32, P952, DOI 10.1038/jcbfm.2012.39; HOFMAN MA, 1988, BRAIN BEHAV EVOLUT, V32, P17, DOI 10.1159/000116529; Hyde ER, 2014, ANN BIOMED ENG, V42, P797, DOI 10.1007/s10439-013-0951-y; Iturria-Medina Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11934; Jenny P, 2009, J COMPUT PHYS, V228, P687, DOI 10.1016/j.jcp.2008.09.026; KIANI MF, 1991, BIORHEOLOGY, V28, P65; Lauwers F, 2008, NEUROIMAGE, V39, P936, DOI 10.1016/j.neuroimage.2007.09.024; Linninger AA, 2013, ANN BIOMED ENG, V41, P2264, DOI 10.1007/s10439-013-0828-0; Lorthois S, 2011, NEUROIMAGE, V54, P2840, DOI 10.1016/j.neuroimage.2010.10.040; Lorthois S, 2011, NEUROIMAGE, V54, P1031, DOI 10.1016/j.neuroimage.2010.09.032; Lorthois S, 2010, J THEOR BIOL, V262, P614, DOI 10.1016/j.jtbi.2009.10.037; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Obrist D, 2010, PHILOS T R SOC A, V368, P2897, DOI 10.1098/rsta.2010.0045; Park CS, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0078; PEACEMAN DW, 1983, SOC PETROL ENG J, V23, P531, DOI 10.2118/10528-PA; PEACEMAN DW, 1978, SOC PETROL ENG J, V18, P183, DOI 10.2118/6893-PA; Perdikaris P, 2016, PHYS FLUIDS, V28, DOI 10.1063/1.4941315; Piechnik SK, 2008, NEUROIMAGE, V39, P107, DOI 10.1016/j.neuroimage.2007.08.022; PRIES AR, 1990, CIRC RES, V67, P826, DOI 10.1161/01.RES.67.4.826; Pries AR, 1996, CARDIOVASC RES, V32, P654, DOI 10.1016/S0008-6363(96)00065-X; PRIES AR, 1995, AM J PHYSIOL-HEART C, V269, pH1713, DOI 10.1152/ajpheart.1995.269.5.H1713; Quintard M, 2000, HANDBOOK OF POROUS MEDIA, P1, DOI 10.1201/9780824741501.pt1; Reichold J, 2009, J CEREBR BLOOD F MET, V29, P1429, DOI 10.1038/jcbfm.2009.58; Sakadzic S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6734; Santisakultarm TP, 2012, AM J PHYSIOL-HEART C, V302, pH1367, DOI 10.1152/ajpheart.00417.2011; Shih AY, 2015, MICROCIRCULATION, V22, P204, DOI 10.1111/micc.12195; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Smith AF, 2014, ANN BIOMED ENG, V42, P1966, DOI 10.1007/s10439-014-1028-2; Tsai PS, 2009, J NEUROSCI, V29, P14553, DOI 10.1523/JNEUROSCI.3287-09.2009; Versteeg H. K., 2007, INTRO COMPUTATIONAL; Walshaw C, 2000, PARALLEL COMPUT, V26, P1635, DOI 10.1016/S0167-8191(00)00046-6; Waters SL, 2011, PROG BIOPHYS MOL BIO, V104, P49, DOI 10.1016/j.pbiomolbio.2010.10.001; WHITAKER S, 1986, TRANSPORT POROUS MED, V1, P3, DOI 10.1007/BF01036523	59	53	53	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0189474	10.1371/journal.pone.0189474	http://dx.doi.org/10.1371/journal.pone.0189474			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324784	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000419952400008
J	Reboucas, R; da Silva, HR; Sole, M				Reboucas, Raoni; da Silva, Helio Ricardo; Sole, Mirco			Frog size on continental islands of the coast of Rio de Janeiro and the generality of the Island Rule	PLOS ONE			English	Article							ATLANTIC RAIN-FOREST; BODY-SIZE; SOUTHEASTERN BRAZIL; AMPHIBIA ANURA; HYLIDAE; EVOLUTION; MAMMALS; POPULATIONS; DIVERSITY; ECOLOGY	Island Rule postulated that individuals on islands tend to dwarfism when individuals from mainland populations are large and to gigantism when mainland populations present small individuals. There has been much discussion about this rule, but only few studies were carried out aiming to reveal this pattern for anurans. Our study focused on measuring the size of individuals on islands and to find a possible pattern of size modification for insular anurans. Individuals were collected on continental islands, measured and compared to mainland populations. We selected four species with different natural history aspects during these analyses. Island parameters were compared to size of individuals in order to find an explanation to size modification. Three of the four species presented size shifting on islands. Ololygon trapicheiroi and Adenomera marmorata showed dwarfism, Boana albomarginata showed gigantism and in Thoropa miliaris there was no evident size modification. Allometric analysis also revealed differential modification, which might be a result of different selective pressures on islands in respect of mainland populations. Regression model explained most of the size modification in B. albomarginata, but not for the other species. Our results indicate that previous assumptions, usually proposed for mammals from older islands, do not fit to the anurans studied here. We support the assumption that size modification on islands are population-specific. Hence, in B. albomarginata some factor associated to competition, living area and isolation time might likely be responsible for gigantism on islands.	[Reboucas, Raoni] Univ Fed Espirito Santo, Programa Posgrad Ciencias Biol Biol Anim, Ave Fernando Ferrari, Vitoria, Espirito Santo, Brazil; [Reboucas, Raoni; da Silva, Helio Ricardo] Univ Fed Rural Rio de Janeiro, Lab Herpetol, Seropedica Rio De Janeiro, Brazil; [Reboucas, Raoni; Sole, Mirco] Universidade Estadual Santa Cruz, Dept Ciencias Biol, Rodovia Jorge Amado, Salobrinho, Ilheus Bahia, Brazil	Universidade Federal do Espirito Santo; Universidade Federal Rural do Rio de Janeiro (UFRRJ)	Reboucas, R (corresponding author), Univ Fed Espirito Santo, Programa Posgrad Ciencias Biol Biol Anim, Ave Fernando Ferrari, Vitoria, Espirito Santo, Brazil.; Reboucas, R (corresponding author), Univ Fed Rural Rio de Janeiro, Lab Herpetol, Seropedica Rio De Janeiro, Brazil.; Reboucas, R (corresponding author), Universidade Estadual Santa Cruz, Dept Ciencias Biol, Rodovia Jorge Amado, Salobrinho, Ilheus Bahia, Brazil.	raonisreboucas@gmail.com	Rebouças, Raoni RR/I-8451-2017; Rebouças, Raoni/F-5149-2015; Solé, Mirco/A-9722-2008	Rebouças, Raoni RR/0000-0002-7141-9031; Rebouças, Raoni/0000-0002-7141-9031; Solé, Mirco/0000-0001-7881-6227; Silva, Helio/0000-0002-1819-8110				Almeida Antonio De Padua, 2002, Herpetological Review, V33, P197; Almeida FC, 2005, GENET MOL BIOL, V28, P693, DOI 10.1590/S1415-47572005000500008; Almeida-Gomes M, 2007, HERPETOL J, V17, P81; Belo W.C., 2002, REV BRAS GEOFIS, V20, P5, DOI [10.1590/S0102-261X2002000100001, DOI 10.1590/S0102-261X2002000100001]; Benton MJ, 2010, PALAEOGEOGR PALAEOCL, V293, P438, DOI 10.1016/j.palaeo.2010.01.026; Bittencourt-Silva Gabriela Bueno, 2013, Check List, V9, P225; Bittencourt-Silva GB, 2014, PLOS ONE, P9; Brasil, 2016, BAIAS ILH GRAND SEP; Brasileiro CA, 2007, J HERPETOL, V41, P271, DOI 10.1670/0022-1511(2007)41[271:ANISOS]2.0.CO;2; Brasileiro CA, 2007, ZOOTAXA, P47, DOI 10.11646/zootaxa.1391.3; Castellano S, 1998, J HERPETOL, V32, P540, DOI 10.2307/1565208; Luna MC, 2012, J MORPHOL, V273, P712, DOI 10.1002/jmor.20016; COCROFT RB, 1988, P BIOL SOC WASH, V101, P209; da Silva Helio Ricardo, 2008, Biota Neotropica, V8, P167; FOSTER JB, 1964, NATURE, V202, P234, DOI 10.1038/202234a0; Frost D.R., 2017, AMPHIBIAN SPECIES WO; Giasson LOM, 2006, J HERPETOL, V40, P171, DOI 10.1670/205-05A.1; Giasson Luis O.M., 2007, South American Journal of Herpetology, V2, P157, DOI 10.2994/1808-9798(2007)2[157:MCARBO]2.0.CO;2; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; Heyer W.R., 1994, MEASURING MONITORING; Itescu Y, 2014, GLOBAL ECOL BIOGEOGR, V23, P689, DOI 10.1111/geb.12149; Lomolino MV, 2012, J BIOGEOGR, V39, P842, DOI 10.1111/j.1365-2699.2011.02656.x; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; Losos JB, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P1; Mageski M, 2015, ZOOLOGIA-CURITIBA, V32, P329, DOI 10.1590/S1984-46702015000500001; Mathys BA, 2009, J BIOGEOGR, V36, P2204, DOI 10.1111/j.1365-2699.2009.02169.x; Meiri S, 2004, AM NAT, V163, P469, DOI 10.1086/382229; Meiri S, 2008, P ROY SOC B-BIOL SCI, V275, P141, DOI 10.1098/rspb.2007.1056; Meiri S, 2006, J BIOGEOGR, V33, P1571, DOI 10.1111/j.1365-2699.2006.01523.x; Meiri S, 2011, J BIOGEOGR, V38, P89, DOI 10.1111/j.1365-2699.2010.02390.x; Montesinos R, 2012, BIOTROPICA, V44, P506, DOI 10.1111/j.1744-7429.2011.00835.x; Palmer M, 2002, ACTA OECOL, V23, P103, DOI 10.1016/S1146-609X(02)01140-2; Phillips BL, 2004, P NATL ACAD SCI USA, V101, P17150, DOI 10.1073/pnas.0406440101; R Core Team, 2013, R LANG ENV STAT COMP; Raia P, 2006, EVOLUTION, V60, P1731; Reboucas R, 2017, ACTA ZOOLOGICA, V98, P1; Rico M, 2004, AMPHIBIA-REPTILIA, V25, P277, DOI 10.1163/1568538041975143; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; SUGUIO K, 1988, EPISODES, V11, P203, DOI 10.18814/epiiugs/1988/v11i3/008; Suguio K, 2005, QUATERNARIO BRASIL, P114; Van Valen L, 1973, EVOL THEORY, V49, P31, DOI DOI 10.1007/S13398-014-0173-7.2; Watson DM, 2002, J BIOGEOGR, V29, P823, DOI 10.1046/j.1365-2699.2002.00726.x; Wu ZJ, 2006, J ANIM ECOL, V75, P1071, DOI 10.1111/j.1365-2656.2006.01126.x; Yom-Tov Y, 1999, J BIOGEOGR, V26, P947, DOI 10.1046/j.1365-2699.1999.00338.x	45	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190153	10.1371/journal.pone.0190153	http://dx.doi.org/10.1371/journal.pone.0190153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324790	gold, Green Submitted, Green Published			2022-12-26	WOS:000419952400020
J	Shi, TT; Yang, XX; Zhou, HP; Xi, JJ; Sun, JJ; Ke, YL; Zhang, JK; Shao, YD; Jiang, XJ; Pan, XW; Liu, SR; Zhuang, RX				Shi, Tingting; Yang, Xingxin; Zhou, Hongping; Xi, Jianjun; Sun, Jingjing; Ke, Yunling; Zhang, Jiankang; Shao, Yidan; Jiang, Xiaojie; Pan, Xuwang; Liu, Shourong; Zhuang, Rangxiao			Activated carbon N-acetylcysteine microcapsule protects against nonalcoholic fatty liver disease in young rats via activating telomerase and inhibiting apoptosis	PLOS ONE			English	Article							STEATOHEPATITIS; PROGRESSION; COMPLEX; CARCINOMA; BIOMARKER; FIBROSIS; INJURY; MICE	Non-alcoholic fatty liver disease (NAFLD) is becoming one of the world's most common chronic liver diseases in childhood, yet no therapy is available that has been approved by the food and drug administration (FDA). Previous studies have reported that telomere and telomerase are involved the development and progression of NAFLD. This study was designed to investigate the potential beneficial effects of activated carbon N-acetylcysteine (ACNAC) microcapsules on the development of NAFLD in young rats as well as the underlying mechanism(s) involved. Three-week old male Sprague Dawley rats were given high-fat diet (HFD) with/without ACNAC treatment for 7 consecutive weeks. Liver pathologies were determined by hematoxylin and eosin (H&E) and Oil Red O staining, as well as by changes in biochemical parameters of plasma alanine transaminase (ALT) and aspartate transaminase (AST) levels, respectively. Glucose homeostasis was evaluated by the glucose tolerance test and the liver telomere length and activity were measured by real time PCR and telomeric repeat amplification protocol (TRAP). Western blot analysis was performed to determine the expression level of Bcl-2, Bax and Caspase-3. Our results demonstrated that ACNAC supplementation improved liver pathologies of rats that received long-term HFD feeding. ACNAC supplementation prevented HFD-induced telomere shortening and improved telomerase activity. Moreover, in comparison to HFD-fed rats, ACNAC supplementation markedly increased the expression of Bcl-2, but significantly decreased the expression of Bax and Caspase-3 in juvenile rats. Together, these results indicate that ACNAC may be a promising choice for preventing and treating NAFLD among children.	[Shi, Tingting; Xi, Jianjun; Sun, Jingjing; Ke, Yunling; Zhang, Jiankang; Shao, Yidan; Jiang, Xiaojie; Pan, Xuwang; Liu, Shourong; Zhuang, Rangxiao] Zhejiang Chinese Med Univ, Dept Pharmaceut Preparat, Hangzhou Xixi Hosp, Hangzhou, Zhejiang, Peoples R China; [Yang, Xingxin] Yunnan Univ Tradit Chinese Med, Coll Pharmaceut Sci, Kunming, Yunnan, Peoples R China; [Zhou, Hongping] Hangzhou Childrens Hosp, Dept Pharm, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Yunnan University of Chinese Medicine	Liu, SR; Zhuang, RX (corresponding author), Zhejiang Chinese Med Univ, Dept Pharmaceut Preparat, Hangzhou Xixi Hosp, Hangzhou, Zhejiang, Peoples R China.	liushourong85463990@sina.com; zhuangrangxiao@sina.com			Hangzhou science and technology development projects [20130633609, 20140633629, 20142013A60]	Hangzhou science and technology development projects	This work was supported by Hangzhou science and technology development projects (20130633609, 20140633629,20142013A60) (http://www.hzst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisi A, 2009, J PEDIATR-US, V155, P469, DOI 10.1016/j.jpeds.2009.06.014; Allegra A, 2017, LEUKEMIA RES, V56, P60, DOI 10.1016/j.leukres.2017.02.002; Angulo P, 2007, ALIMENT PHARM THER, V25, P883, DOI 10.1111/j.1365-2036.2007.03246.x; Aravinthan A, 2013, J HEPATOL, V58, P549, DOI 10.1016/j.jhep.2012.10.031; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Bekaert S, 2005, ANTICANCER RES, V25, P3011; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Cai ZB, 2017, EXPT THERAP IN PRESS; Cai ZB, 2015, INT J CLIN EXP PATHO, V8, P8655; Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; Cao MB, 2016, AM J TRANSL RES, V8, P2325; Cao ZG, 2003, CLIN J CLIN PHARM TH, V8, P245; Carulli L, 2014, WORLD J GASTROENTERO, V20, P6287, DOI 10.3748/wjg.v20.i20.6287; Ceng J, 2012, CHIN J GASTROENTEROL, V21, P173; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Donati B, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030383; Dongiovanni P, 2016, METABOLISM, V65, P1026, DOI 10.1016/j.metabol.2015.08.018; Duan RL, 2011, ACTA PHARMACOL SIN, V32, P108, DOI 10.1038/aps.2010.192; Fan XF, 2010, CHIN J INTEGR MED, V16, P119, DOI 10.1007/s11655-010-0119-7; [方红英 Fang Hongying], 2015, [中国临床药理学与治疗学, Chinese Journal of Clinical Pharmacology and Therapeutics], V20, P976; Fang HY, 2016, CHINA PHARM, V27, P955; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Fu YF, 2002, ACTA BIOCH BIOPH SIN, V34, P389; Harper N, 2003, J BIOL CHEM, V278, P25534, DOI 10.1074/jbc.M303399200; He BH, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-017-0215-y; [贾凌 Jia Ling], 2014, [中华实验和临床病毒学杂志, Chinese Journal of Experimental and Clinical Virology], V28, P4; Jian-gao Fan, 2010, Zhonghua Gan Zang Bing Za Zhi, V18, P163; Kang PT, 2014, BIOCHEM PHARMACOL, V89, P490, DOI 10.1016/j.bcp.2014.03.012; Lechel A, 2004, J HEPATOL, V41, P491, DOI 10.1016/j.jhep.2004.06.010; Li L, 2010, CHIN J INTEGR MED, V16, P23, DOI 10.1007/s11655-010-0023-1; Li Q, 2010, INT J MOL SCI, V11, P4580, DOI 10.3390/ijms11114580; Liu XL, 2017, J MOL MED HLTH, V33, P641; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; Nobili V, 2013, J HEPATOL, V58, P1218, DOI 10.1016/j.jhep.2012.12.003; Pfeiffer V, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010405; Pusceddu I, 2015, CLIN CHEM LAB MED, V53, P1661, DOI 10.1515/cclm-2014-1184; Qu Qia-lian, 2006, Zhonghua Zhongliu Zazhi, V28, P257; Raza H, 2014, HAMDAN MED J, V2014, P1; Schattenberg JM, 2006, LIVER INT, V26, P904, DOI 10.1111/j.1478-3231.2006.01324.x; Shen Y, 2016, J CELL BIOL, V215, P719, DOI 10.1083/jcb.201605046; Skvarc DR, 2017, NEUROSCI BIOBEHAV R, V78, P44, DOI 10.1016/j.neubiorev.2017.04.013; Sunami Y, 2014, PROG MOL BIOL TRANSL, V125, P159, DOI 10.1016/B978-0-12-397898-1.00007-4; Wang FG, 2013, STRAIT PHARM J, V25, P15; Wang FG, 2014, EXP THER MED, V8, P1939, DOI 10.3892/etm.2014.2019; [王福根 Wang Fugen], 2012, [中国医药工业杂志, Chinese Journal of Pharmaceuticals], V43, P572; Wang H.W., 2014, WORLD CHIN J DIG, V22, P429, DOI [10.11569/wcjd.v22.i3.429, DOI 10.11569/wcjd.v22.i20.2881, DOI 10.11569/WCJD.V22.I3.429]; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Yang Z, 2010, J NANOSCI NANOTECHNO, V10, P8603, DOI 10.1166/jnn.2010.2492; Yu CH, 2012, J HEPATOL, V56, P241, DOI 10.1016/j.jhep.2011.05.027; Zhan YT, 2006, J CLIN HEPATOL, V9, P101; Zhang XY, 2015, J HENAN MED COLL, V27, P419; Zhao X, 2014, SHANDONG MED J, V54, P25; Zhou HP, 2017, EXP THER MED, V14, P4737, DOI 10.3892/etm.2017.5128	55	9	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0189856	10.1371/journal.pone.0189856	http://dx.doi.org/10.1371/journal.pone.0189856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324774	Green Submitted, Green Published, gold			2022-12-26	WOS:000419952400013
J	Garabedian, C; Clermont-Hama, Y; Sharma, D; Aubry, E; Butruille, L; Deruelle, P; Storme, L; De Jonckheere, J; Houfflin-Debarge, V				Garabedian, C.; Clermont-Hama, Y.; Sharma, D.; Aubry, E.; Butruille, L.; Deruelle, P.; Storme, L.; De Jonckheere, J.; Houfflin-Debarge, V.			Correlation of a new index reflecting the fluctuation of parasympathetic tone and fetal acidosis in an experimental study in a sheep model	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; SPECTRAL-ANALYSIS; NEAR-TERM; CIRCULATORY RESPONSES; ASPHYXIA; LABOR; HYPOXIA; CARDIOTOCOGRAPHY; CHEMOREFLEX; GUIDELINES	The autonomic nervous system plays a leading role in the control of fetal homeostasis. Fetal heart rate variability (HRV) analysis is a reflection of its activity. We developed a new index (the Fetal Stress Index, FSI) reflecting parasympathetic tone. The objective of this study was to evaluate this index as a predictor of fetal acid-base status. This was an experimental study on chronically instrumented fetal lambs (n = 11, surgery at 128 +/-2 days gestational age, term = 145 days). The model was based on 75% occlusion of the umbilical cord for a maximum of 120 minutes or until an arterial pH <= 7.20 was reached. Hemodynamic, gaso-metric and FSI parameters were recorded throughout the experimentation. We studied the FSI during the 10 minutes prior to pH samplings and compared values for pH>7.20 and pH <= 7.20. In order to analyze the FSI evolution during the 10 minutes periods, we analyzed the minimum, maximum and mean values of the FSI (respectively FSImin, FSImax and FSImean) over the periods. 11 experimentations were performed. During occlusion, the heart rate dropped with an increase in blood pressure (respectively 160(155-182) vs 106(101-120) bpm and 42(41-45) vs 58(55-62) mmHg after occlusion). The FSImin was 38.6 (35.2-43.3) in the group pH>7.20 and was higher in the group pH less than 7.20 (46.5 (43.3-52.0), p = 0.012). The correlation of FSImin was significant for arterial pH (coefficient of -0.671; p = 0.004) and for base excess (coefficient of -0.632; p = 0.009). The correlations were not significant for the other parameters. In conclusion, our new index seems well correlated with the fetal acid-base status. Other studies must be carried out in a situation close to the physiology of labor by sequential occlusion of the cord.	[Garabedian, C.; Clermont-Hama, Y.; Sharma, D.; Aubry, E.; Butruille, L.; Deruelle, P.; Storme, L.; De Jonckheere, J.; Houfflin-Debarge, V.] Univ Lille, EA Perinatal Environm & Hlth 4489, Lille, France; [Garabedian, C.; Clermont-Hama, Y.; Deruelle, P.; Houfflin-Debarge, V.] CHU Lille, Dept Obstet, Lille, France; [Sharma, D.; Aubry, E.] CHU Lille, Dept Pediat Surg, Lille, France; [Storme, L.] CHU Lille, Dept Neonatol, Lille, France; [De Jonckheere, J.] CHU Lille, CIC IT 1403, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Garabedian, C (corresponding author), Univ Lille, EA Perinatal Environm & Hlth 4489, Lille, France.; Garabedian, C (corresponding author), CHU Lille, Dept Obstet, Lille, France.	charles.garabedian@chru-lille.fr		BUTRUILLE, Laura/0000-0001-5760-1489; Garabedian, Charles/0000-0003-2105-9784				Akselrod S, 2000, PHYSIOL MEAS, V21, P319, DOI 10.1088/0967-3334/21/2/311; Amaya KE, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.09.084; Aubry E, 2013, J PEDIATR SURG, V48, P481, DOI 10.1016/j.jpedsurg.2012.08.024; Ayres-De-Campos D, 2015, INT J GYNECOL OBSTET, V131, P13, DOI 10.1016/j.ijgo.2015.06.020; Belfort MA, 2015, NEW ENGL J MED, V373, P632, DOI 10.1056/NEJMoa1500600; Bennet L, 2005, J APPL PHYSIOL, V99, P1477, DOI 10.1152/japplphysiol.00431.2005; Bennet L, 1998, PEDIATR RES, V44, P951, DOI 10.1203/00006450-199812000-00022; Blackwell SC, 2011, AM J OBSTET GYNECOL, V204, P371, DOI 10.1016/j.ajog.2011.02.073; Booth LC, 2009, AM J PHYSIOL-REG I, V296, pR603, DOI 10.1152/ajpregu.90624.2008; Butruille L, 2016, J CLIN MONIT COMPUT; Carbonne B, 2016, BEST PRACT RES CL OB, V30, P62, DOI 10.1016/j.bpobgyn.2015.05.006; Casati D, 2014, EXP PHYSIOL, V99, P466, DOI 10.1113/expphysiol.2013.076539; Castillo-Melendez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077377; Chandraharan E, 2016, BJOG-INT J OBSTET GY, V123, P1770, DOI 10.1111/1471-0528.13980; Chung DY, 2001, INT J GYNECOL OBSTET, V73, P109, DOI 10.1016/S0020-7292(01)00348-4; Clark SL, 2016, AM J OBSTET GYNECOL; De Jonckheere J, 2005, P ANN INT IEEE EMBS, P6739, DOI 10.1109/IEMBS.2005.1616051; Durosier LD, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00038; Everett TR, 2015, SEMIN FETAL NEONAT M, V20, P138, DOI 10.1016/j.siny.2015.03.011; Frasch MG, 2009, REPROD SCI, V16, P509, DOI 10.1177/1933719108327597; Frasch MG, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.022; Galinsky R, 2016, AM J PHYSL REGUL INT; Garabedian C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180653; Garabedian C, 2016, GYNECOL OBSTET INVES; Houfflin-Debarge V, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.049; Jensen A, 1995, REPROD FERT DEVELOP, V7, P1351, DOI 10.1071/RD9951351; Jensen A, 1999, EUR J OBSTET GYN R B, V84, P155, DOI 10.1016/S0301-2115(98)00325-X; Koome ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077480; Lear CA, 2016, J PHYSIOL-LONDON, V594, P4711, DOI 10.1113/JP271205; Pinas A, 2016, BEST PRACT RES CL OB, V30, P33, DOI 10.1016/j.bpobgyn.2015.03.022; Prout AP, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.020; Siira SM, 2013, EARLY HUM DEV, V89, P739, DOI 10.1016/j.earlhumdev.2013.05.007; Siira SM, 2005, BJOG-INT J OBSTET GY, V112, P418, DOI 10.1111/j.1471-0528.2004.00454.x; Van Laar JOEH, 2008, ACTA OBSTET GYN SCAN, V87, P300, DOI 10.1080/00016340801898950; van Laar JOEH, 2011, EARLY HUM DEV, V87, P259, DOI 10.1016/j.earlhumdev.2011.01.028; van Laar JOEH, 2010, BJOG-INT J OBSTET GY, V117, P429, DOI 10.1111/j.1471-0528.2009.02456.x; Visser GH, 2015, INT J GYNECOL OBSTET, V131, P25, DOI 10.1016/j.ijgo.2015.06.021; Yawno T, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00296; Zarate MA, 2016, PHYSL REP, V4	39	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190463	10.1371/journal.pone.0190463	http://dx.doi.org/10.1371/journal.pone.0190463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320537	gold, Green Published, Green Submitted			2022-12-26	WOS:000419689600051
J	Kiani, B; Faivre, D; Klumpp, S				Kiani, Bahareh; Faivre, Damien; Klumpp, Stefan			Self-organization and stability of magnetosome chains - A simulation study	PLOS ONE			English	Article							MAGNETOTACTIC BACTERIA; CELL BIOLOGY; GENETICS; MAMK	Magnetotactic bacteria orient in magnetic fields with the help of their magnetosome chain, a linear structure of membrane enclosed magnetic nanoparticles (magnetosomes) anchored to a cytoskeletal filament. Here, we use simulations to study the assembly and the stability of magnetosome chains. We introduce a computational model describing the attachment of the magnetosomes to the filament and their magnetic interactions. We show that the filamentous backbone is crucial for the robust assembly of the magnetic particles into a linear chain, which in turn is key for the functionality of the chain in cellular orientation and magnetically directed swimming. In addition, we simulate the response to an external magnetic field that is rotated away from the axis of the filament, an experimental method used to probe the mechanical stability of the chain. The competition between alignment along the filament and alignment with the external fields leads to the rupture of a chain if the applied field exceeeds a threshold value. These observations are in agreement with previous experiments at the population level. Beyond that, our simulations provide a detailed picture of chain rupture at the single cell level, which is found to happen through two abrupt events, which both depend on the field strength and orientation. The re-formation of the chain structure after such rupture is found to be strongly sped up in the presence of a magnetic field parallel to the filament, an observation that may also be of interest for the design of self-healing materials. Our simulations underline the dynamic nature of the magnetosome chain. More generally, they show the rich complexity of self-assembly in systems with competing driving forces for alignment.	[Kiani, Bahareh; Klumpp, Stefan] Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Sci Pk Golm, D-14424 Potsdam, Germany; [Kiani, Bahareh; Faivre, Damien] Max Planck Inst Colloids & Interfaces, Dept Biomat, Sci Pk Golm, D-14424 Potsdam, Germany; [Klumpp, Stefan] Georg August Univ Goettingen, Inst Nonlinear Dynam, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society; University of Gottingen	Kiani, B; Klumpp, S (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Theory & Biosyst, Sci Pk Golm, D-14424 Potsdam, Germany.; Kiani, B (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, Sci Pk Golm, D-14424 Potsdam, Germany.; Klumpp, S (corresponding author), Georg August Univ Goettingen, Inst Nonlinear Dynam, D-37077 Gottingen, Germany.	bahareh.kiani@mpikg.mpg.de; stefan.klumpp@phys.uni-goettingen.de	faivre, damien/D-3713-2009; Klumpp, Stefan/C-2966-2008; Klumpp, Stefan/AAC-3936-2019	faivre, damien/0000-0001-6191-3389; Klumpp, Stefan/0000-0003-0584-2146; Klumpp, Stefan/0000-0003-0584-2146				Bazylinski DA, 2009, BIOMINERALIZATION AS; BERTSIMAS D, 1993, STAT SCI, V8, P10, DOI 10.1214/ss/1177011077; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Binder K, 1988, MONTE CARLO SIMULATI, V80; Blakemore R P, 1982, ANN REV MICROBIOLOGY, V36; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Faivre D, 2010, BIOPHYS J, V99, P1268, DOI 10.1016/j.bpj.2010.05.034; Ghaisari S, 2017, BIOPHYS J, V113, P637, DOI 10.1016/j.bpj.2017.06.031; Huang SL, 2016, SOFT MATTER, V12, P228, DOI 10.1039/c5sm01814e; Jensen J, 2000, MOL MICROBIOLOGY, V37; Jogler C, 2009, ANNU REV MICROBIOL, V63, P501, DOI 10.1146/annurev.micro.62.081307.162908; Kantorovich SS, 2015, PHYS CHEM CHEM PHYS, V17, P16601, DOI 10.1039/c5cp01558h; Kiani B, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/4/043007; Kornig A, 2014, NANO LETT, V14, P4653, DOI 10.1021/nl5017267; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; MARINARI E, 1992, EUROPHYS LETT, V19, P451, DOI 10.1209/0295-5075/19/6/002; Nimpf S, 2017, EMBO J, V36, P1643, DOI 10.15252/embj.201797177; Nora A, 2003, CELL, V115; Philipse AP, 2002, LANGMUIR, V18, P9977, DOI 10.1021/la0205811; Richardi J, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4811290; Rovigatti L, 2012, SOFT MATTER, V8, P6310, DOI 10.1039/c2sm25192b; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; Schuler D, 2008, FEMS MICROBIOL REV, V32, P654, DOI 10.1111/j.1574-6976.2008.00116.x; Sneppen K., 2005, PHYS MOL BIOL; Sreekumari A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042315; STOLZ JF, 1986, NATURE, V321, P849, DOI 10.1038/321849a0; Toro-Nahuelpan M, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0290-1; van den Fusinita E, 2001, NATURE, V413; Wei A, 2011, J MATER CHEM, V21, P16686, DOI [10.1039/c1jm11916h, 10.1039/c1jm1j916h]	30	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190265	10.1371/journal.pone.0190265	http://dx.doi.org/10.1371/journal.pone.0190265			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315342	Green Submitted, Green Published, gold			2022-12-26	WOS:000419655900009
J	Faraz, M; Herdenberg, C; Holmlund, C; Henriksson, R; Hedman, H				Faraz, Mahmood; Herdenberg, Carl; Holmlund, Camilla; Henriksson, Roger; Hedman, Hakan			A protein interaction network centered on leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) regulates growth factor receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SQUAMOUS-CELL CARCINOMA; NEGATIVE REGULATOR; TYROSINE KINASES; TUMOR-SUPPRESSOR; BREAST-CANCER; EXPRESSION; GENE; GLIOBLASTOMA; HOMEOSTASIS; ACTIVATION	Leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) is a tumor suppressor and a negative regulator of several receptor tyrosine kinases. The molecular mechanisms by which LRIG1 mediates its tumor suppressor effects and regulates receptor tyrosine kinases remain incompletely understood. Here, we performed a yeast two-hybrid screen to identify novel LRIG1-interacting proteins and mined data from the Bio-Plex (biophysical interactions of ORFeome-based complexes) protein interaction data repository. The putative LRIG1 interactors identified in the screen were functionally evaluated using a triple co-transfection system in which HEK293 cells were co-transfected with platelet-derived growth factor receptor alpha, LRIG1, and shRNAs against the identified LRIG1 interactors. The effects of the shRNAs on the ability of LRIG1 to down-regulate platelet-derived growth factor receptor alpha expression were evaluated. On the basis of these results, we present an LRIG1 protein interaction network with many newly identified components. The network contains the apparently functionally important LRIG1-interacting proteins RAB4A, PON2, GAL3ST1, ZBTB16, LRIG2, CNPY3, HLA-DRA, GML, CNPY4, LRRC40, and LRIG3, together with GLRX3, PTPRK, and other proteins. In silico analyses of The Cancer Genome Atlas data sets revealed consistent correlations between the expression of the transcripts encoding LRIG1 and its interactors ZBTB16 and PTPRK and inverse correlations between the transcripts encoding LRIG1 and GLRX3. We further studied the LRIG1 function-promoting paraoxonase PON2 and found that it co-localized with LRIG1 in LRIG1-transfected cells. The proposed LRIG1 protein interaction network will provide leads for future studies aiming to understand the molecular functions of LRIG1 and the regulation of growth factor signaling.	[Faraz, Mahmood; Herdenberg, Carl; Holmlund, Camilla; Henriksson, Roger; Hedman, Hakan] Umea Univ, Oncol Res Lab, Dept Radiat Sci, SE-90187 Umea, Sweden	Umea University	Hedman, H (corresponding author), Umea Univ, Oncol Res Lab, Dept Radiat Sci, SE-90187 Umea, Sweden.	hakan.hedman@umu.se	Hedman, Håkan/F-9495-2012; Henriksson, Roger/AAI-8608-2020; Faraz, Mahmood/W-2796-2018	Herdenberg, Carl/0000-0001-8849-6810; Faraz, Mahmood/0000-0002-1965-6048	Kempe Foundations; Swedish Cancer Society; Cancer Research Foundation in Northern Sweden; Umea University; Vasterbotten County Council	Kempe Foundations; Swedish Cancer Society(Swedish Cancer Society); Cancer Research Foundation in Northern Sweden; Umea University; Vasterbotten County Council	This work was supported by grants from the Kempe Foundations, the Swedish Cancer Society, and the Cancer Research Foundation in Northern Sweden and through the regional agreement between Umea University and Vasterbotten County Council on cooperation in the fields of medicine, odontology, and health. The authors declare that they have no conflicts of interest with the contents of this article.	Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Alsina FC, 2016, EMBO REP, V17, P601, DOI 10.15252/embr.201541218; Devarajan A, 2011, ANTIOXID REDOX SIGN, V14, P341, DOI 10.1089/ars.2010.3430; ERIKSSON A, 1992, EMBO J, V11, P543, DOI 10.1002/j.1460-2075.1992.tb05085.x; Frittoli E, 2014, J CELL BIOL, V206, P307, DOI 10.1083/jcb.201403127; Gietz RD, 2001, BIOTECHNIQUES, V30, P816, DOI 10.2144/01304rv02; Gumienny TL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000963; Guo DS, 2004, GENOMICS, V84, P157, DOI 10.1016/j.ygeno.2004.01.013; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Hagmann H, 2014, FASEB J, V28, P1769, DOI 10.1096/fj.13-240309; Hedman H, 2002, ACTA ONCOL, V41, P352, DOI 10.1080/028418602760169398; Hirate Y, 2006, CURR BIOL, V16, P421, DOI 10.1016/j.cub.2006.01.055; Holmlund C, 2004, GENE, V332, P35, DOI 10.1016/j.gene.2004.02.002; Honke K, 1997, J BIOL CHEM, V272, P4864, DOI 10.1074/jbc.272.8.4864; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Johansson M, 2013, NEURO-ONCOLOGY, V15, P1200, DOI 10.1093/neuonc/not054; Kinnersley B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9559; Kolonin MG, 2000, METHOD ENZYMOL, V328, P26, DOI 10.1016/S0076-6879(00)28388-2; Krig SR, 2011, MOL CANCER RES, V9, P1406, DOI 10.1158/1541-7786.MCR-11-0227; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Kvarnbrink S, 2015, ACTA ONCOL, V54, P1113, DOI 10.3109/0284186X.2015.1021427; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Liu TM, 2016, STEM CELLS, V34, P277, DOI 10.1002/stem.2270; Lu L, 2013, J PATHOL, V229, P608, DOI 10.1002/path.4148; Matsui T, 2011, P NATL ACAD SCI USA, V108, P9881, DOI 10.1073/pnas.1017248108; Meabon JS, 2016, MOL CELL NEUROSCI, V70, P1, DOI 10.1016/j.mcn.2015.11.002; Melin BS, 2017, NAT GENET, V49, P789, DOI 10.1038/ng.3823; Nagarajan A, 2017, MOL CELL, V67, P685, DOI 10.1016/j.molcel.2017.07.014; Neirinckx V, 2017, BBA-REV CANCER, V1868, P109, DOI 10.1016/j.bbcan.2017.02.007; Nilsson J, 2003, CELL TISSUE RES, V312, P65, DOI 10.1007/s00441-003-0697-1; Nilsson J, 2001, BIOCHEM BIOPH RES CO, V284, P1155, DOI 10.1006/bbrc.2001.5092; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Rafidi H, 2013, J BIOL CHEM, V288, P21593, DOI 10.1074/jbc.M113.486050; Rao DD, 2009, ADV DRUG DELIVER REV, V61, P746, DOI 10.1016/j.addr.2009.04.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rondahl V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073635; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serebriiskii IG, 2000, ANAL BIOCHEM, V285, P1, DOI 10.1006/abio.2000.4672; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Sjodin A, 2003, J INVEST DERMATOL, V121, P428, DOI 10.1046/j.1523-1747.2003.12374.x; Suzuki Y, 2002, FEBS LETT, V521, P67, DOI 10.1016/S0014-5793(02)02824-7; Tanemura A, 2005, DERMATOL SURG, V31, P423, DOI 10.1097/00042728-200504000-00008; Tarcic G, 2009, CURR BIOL, V19, P1788, DOI 10.1016/j.cub.2009.09.048; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Thompson PA, 2014, CANCER RES, V74, P2928, DOI 10.1158/0008-5472.CAN-13-2112; van Erp S, 2015, DEV CELL, V35, P537, DOI 10.1016/j.devcel.2015.11.008; Wan CH, 2015, NATURE, V525, P339, DOI 10.1038/nature14877; Wandinger-Ness A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a022616; Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Xu YR, 2005, J BIOL CHEM, V280, P42694, DOI 10.1074/jbc.M507722200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yi W, 2011, EXP CELL RES, V317, P504, DOI 10.1016/j.yexcr.2010.11.005; Yokdang N, 2016, ONCOGENE, V35, P2932, DOI 10.1038/onc.2015.345; Zhang T, 2015, ELIFE, V4, DOI 10.7554/eLife.06734	61	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3421	3435		10.1074/jbc.M117.807487	http://dx.doi.org/10.1074/jbc.M117.807487			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29317492	Green Published, hybrid			2022-12-26	WOS:000426562800032
J	Zhang, ML; Huang, NN; Yang, XS; Luo, JY; Yan, S; Xiao, FZ; Chen, WP; Gao, XY; Zhao, K; Zhou, HK; Li, ZQ; Ming, L; Xie, B; Zhang, N				Zhang, Maolei; Huang, Nunu; Yang, Xuesong; Luo, Jingyan; Yan, Sheng; Xiao, Feizhe; Chen, Wenping; Gao, Xinya; Zhao, Kun; Zhou, Huangkai; Li, Ziqiang; Ming, Liu; Xie, Bo; Zhang, Nu			A novel protein encoded by the circular form of the SHPRH gene suppresses glioma tumorigenesis	ONCOGENE			English	Article							CELL NUCLEAR ANTIGEN; RNAS; TRANSLATION; DATABASE; INITIATION; CIRCRNAS; CANCER	Circular RNAs (circRNAs) are recognized as functional non-coding transcripts in eukaryotic cells. Recent evidence has indicated that even though circRNAs are generally expressed at low levels, they may be involved in many physiological or pathological processes, such as gene regulation, tissue development and carcinogenesis. Although the 'microRNA sponge' function is well characterized, most circRNAs do not contain perfect trapping sites for microRNAs, which suggests the possibility that circRNAs have functions that have not yet been defined. In this study, we show that a circRNA containing an open reading frame (ORF) driven by the internal ribosome entry site (IRES) can translate a functional protein. The circular form of the SNF2 histone linker PHD RING helicase (SHPRH) gene encodes a novel protein that we termed SHPRH-146aa. Circular SHPRH (circ-SHPRH) uses overlapping genetic codes to generate a 'UGA' stop codon, which results in the translation of the 17 kDa SHPRH-146aa. Both circ-SHPRH and SHPRH-146aa are abundantly expressed in normal human brains and are down-regulated in glioblastoma. The overexpression of SHPRH-146aa in U251 and U373 glioblastoma cells reduces their malignant behavior and tumorigenicity in vitro and in vivo. Mechanistically, SHPRH-146aa protects full-length SHPRH from degradation by the ubiquitin proteasome. Stabilized SHPRH sequentially ubiquitinates proliferating cell nuclear antigen (PCNA) as an E3 ligase, leading to inhibited cell proliferation and tumorigenicity. Our findings provide a novel perspective regarding circRNA function in physiological and pathological processes. Specifically, SHPRH-146aa generated from overlapping genetic codes of circ-SHPRH is a tumor suppressor in human glioblastoma.	[Zhang, Maolei; Huang, Nunu; Yang, Xuesong; Yan, Sheng; Chen, Wenping; Gao, Xinya; Zhao, Kun; Zhou, Huangkai; Zhang, Nu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Zhang, Maolei; Huang, Nunu; Yang, Xuesong; Yan, Sheng; Chen, Wenping; Gao, Xinya; Zhao, Kun; Zhou, Huangkai; Zhang, Nu] Guangdong Prov Key Lab Pituitary Tumors, Guangzhou, Guangdong, Peoples R China; [Luo, Jingyan] Forevergen Biosci Ctr, Guangzhou, Guangdong, Peoples R China; [Xiao, Feizhe] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Sci Res Sect, Guangzhou, Guangdong, Peoples R China; [Li, Ziqiang; Ming, Liu] Guangzhou Geneseed Antiaging Res Inst, Guangzhou, Guangdong, Peoples R China; [Xie, Bo] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Pharmacol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhang, N (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China.; Zhang, N (corresponding author), Guangdong Prov Key Lab Pituitary Tumors, Guangzhou, Guangdong, Peoples R China.	zhangnu2@mail.sysu.edu.cn		Li, Ziqiang/0000-0001-6301-3595	National Key Research and Development Program of China [2016YFA0503000]; National Natural Science Foundation of China [81370072, 81572477]; Science and Technology Project of Guangdong Province [S2013050014535, 2014A030313183, 2016A050502017]; Guangzhou Science and Technology Program [201704020068]; China Postdoctoral Science Foundation [2016M592579]; Innovative Funds for Small and Medium-Sized Enterprises of Guangdong Province [2016A010119103]; Pearl River S&T Nova Program of Guangzhou [201710010178]; U.S. National Cancer Institute [R01CA157933, R01CA172233]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Guangdong Province; Guangzhou Science and Technology Program; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Innovative Funds for Small and Medium-Sized Enterprises of Guangdong Province; Pearl River S&T Nova Program of Guangzhou; U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Key Research and Development Program of China (2016YFA0503000), the National Natural Science Foundation of China (81370072 and 81572477), the Science and Technology Project of Guangdong Province (S2013050014535, 2014A030313183, 2016A050502017), Guangzhou Science and Technology Program (201704020068), project funded by China Postdoctoral Science Foundation (2016M592579), Innovative Funds for Small and Medium-Sized Enterprises of Guangdong Province (2016A010119103), Pearl River S&T Nova Program of Guangzhou (201710010178) and the U.S. National Cancer Institute (grants R01CA157933 and R01CA172233).	AbouHaidar MG, 2014, P NATL ACAD SCI USA, V111, P14542, DOI 10.1073/pnas.1402814111; CHEN CY, 1995, SCIENCE, V268, P415, DOI 10.1126/science.7536344; Chen J, 2017, CANCER LETT, V388, P208, DOI 10.1016/j.canlet.2016.12.006; Chen XP, 2016, SCI REP-UK, V6, DOI 10.1038/srep34985; Du WW, 2016, NUCLEIC ACIDS RES, V44, P2846, DOI 10.1093/nar/gkw027; Glazar P, 2014, RNA, V20, P1666, DOI 10.1261/rna.043687.113; Guarnerio J, 2016, CELL, V165, P289, DOI 10.1016/j.cell.2016.03.020; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; Lopez-Lastra M, 2005, BIOL RES, V38, P121, DOI 10.4067/S0716-97602005000200003; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mokrejs M, 2006, NUCLEIC ACIDS RES, V34, pD125, DOI 10.1093/nar/gkj081; Motegi A, 2006, J CELL BIOL, V175, P703, DOI 10.1083/jcb.200606145; Pamudurti NR, 2017, MOL CELL, V66, P9, DOI 10.1016/j.molcel.2017.02.021; Qin ML, 2016, CANCER BIOMARK, V16, P161, DOI 10.3233/CBM-150552; Song XF, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw075; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Unk I, 2006, P NATL ACAD SCI USA, V103, P18107, DOI 10.1073/pnas.0608595103; Yang Y, 2017, CELL RES, V27, P626, DOI 10.1038/cr.2017.31; You XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/nn.3975; Zeman MK, 2014, J CELL BIOL, V206, P183, DOI 10.1083/jcb.201311063	25	394	422	8	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	13					1805	1814		10.1038/s41388-017-0019-9	http://dx.doi.org/10.1038/s41388-017-0019-9			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GA9AE	29343848				2022-12-26	WOS:000428632600009
J	Kuhaudomlarp, S; Patron, NJ; Henrissat, B; Rejzek, M; Saalbach, G; Field, RA				Kuhaudomlarp, Sakonwan; Patron, Nicola J.; Henrissat, Bernard; Rejzek, Martin; Saalbach, Gerhard; Field, Robert A.			Identification of Euglena gracilis beta-1,3-glucan phosphorylase and establishment of a new glycoside hydrolase (GH) family GH149	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYSACCHARIDE UTILIZATION LOCI; LAMINARIBIOSE PHOSPHORYLASE; CELLOBIOSE PHOSPHORYLASE; CELLODEXTRIN PHOSPHORYLASE; ENZYMATIC-SYNTHESIS; CRYSTAL-STRUCTURE; IN-VITRO; CARBOHYDRATE; PURIFICATION; SPECIFICITY	Glycoside phosphorylases (EC 2.4.x.x) carry out the reversible phosphorolysis of glucan polymers, producing the corresponding sugar 1-phosphate and a shortened glycan chain. beta-1,3-Glucan phosphorylase activities have been reported in the photosynthetic euglenozoan Euglena gracilis, but the cognate protein sequences have not been identified to date. Continuing our efforts to understand the glycobiology of E. gracilis, we identified a candidate phosphorylase sequence, designated EgP1, by proteomic analysis of an enriched cellular protein lysate. We expressed recombinant EgP1 in Escherichia coli and characterized it in vitro as a beta-1,3-glucan phosphorylase. BLASTP identified several hundred EgP1 orthologs, most of which were from Gram-negative bacteria and had 37-91% sequence identity to EgP1. We heterologously expressed a bacterial metagenomic sequence, Pro_7066 in E. coli and confirmed it as a beta-1,3-glucan phosphorylase, albeit with kinetics parameters distinct from those of EgP1. EgP1, Pro_7066, and their orthologs are classified as a new glycoside hydrolase (GH) family, designated GH149. Comparisons between GH94, EgP1, and Pro_7066 sequences revealed conservation of key amino acids required for the phosphorylase activity, suggesting a phosphorylase mechanism that is conserved between GH94 and GH149. We found bacterial GH149 genes in gene clusters containing sugar transporter and several other GH family genes, suggesting that bacterial GH149 proteins have roles in the degradation of complex carbohydrates. The Bacteroidetes GH149 genes located to previously identified polysaccharide utilization loci, implicated in the degradation of complex carbohydrates. In summary, we have identified a eukaryotic and a bacterial beta-1,3-glucan phosphorylase and uncovered a new family of phosphorylases that we name GH149.	[Kuhaudomlarp, Sakonwan; Rejzek, Martin; Saalbach, Gerhard; Field, Robert A.] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Patron, Nicola J.] Earlham Inst, Norwich Res Pk, Norwich NR4 7UZ, Norfolk, England; [Henrissat, Bernard] Aix Marseille Univ, Architecture & Fonct Macromol Biol, 163 Ave Luminy, F-13288 Marseille, France; [Henrissat, Bernard] CNRS, UMR 7257, 163 Ave Luminy, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 23218, Saudi Arabia	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University	Field, RA (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	rob.field@jic.ac.uk	Patron, Nicola J/D-8778-2014; Kuhaudomlarp, Sakonwan/AAO-1251-2021; Henrissat, Bernard/J-2475-2012	Patron, Nicola J/0000-0002-8389-1851; Henrissat, Bernard/0000-0002-3434-8588; Field, Rob/0000-0001-8574-0275; Kuhaudomlarp, Sakonwan/0000-0003-4415-3781	BBSRC Institute Strategic Program on Understanding and Exploiting Metabolism (MET) [BB/J004561/1]; BBSRC; EPSRC; InnovateUK: IBCatalyst [BB/M02903411]; John Innes Foundation; Royal Thai Government Scholarship program; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0618, BB/L014130/1, BB/M029026/1, BBS/E/T/000PR9819, BB/N005082/1, BBS/E/J/000PR9790] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/N033167/1] Funding Source: researchfish; BBSRC [BBS/E/J/000PR9790, BB/N005082/1, BBS/E/T/000PR9819, BBS/E/J/000C0618, BB/L014130/1, BB/M029026/1] Funding Source: UKRI; EPSRC [EP/N033167/1] Funding Source: UKRI	BBSRC Institute Strategic Program on Understanding and Exploiting Metabolism (MET)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); InnovateUK: IBCatalyst(UK Research & Innovation (UKRI)Innovate UK); John Innes Foundation; Royal Thai Government Scholarship program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the BBSRC Institute Strategic Program on Understanding and Exploiting Metabolism (MET) (Grant BB/J004561/1); the BBSRC, EPSRC, and InnovateUK: IBCatalyst (Grant BB/M02903411); the John Innes Foundation; and the Royal Thai Government Scholarship program. The authors declare that they have no conflicts of interest with the contents of this article.	ALBRECHT GJ, 1971, PHYTOCHEMISTRY, V10, P1293, DOI 10.1016/S0031-9422(00)84330-7; Bacic A, 2009, CHEMISTRY, BIOCHEMISTRY, AND BIOLOGY OF (1-->3)-BETA-GLUCANS AND RELATED POLYSACCHARIDES, P1; Barsanti L, 2001, J APPL PHYCOL, V13, P59, DOI 10.1023/A:1008105416065; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bianchetti CM, 2011, ACTA CRYSTALLOGR F, V67, P1345, DOI 10.1107/S1744309111032660; Buller C. S., 1990, US patent, Patent No. [4,908,310, 4908310]; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chiku K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114882; Conners SB, 2005, J BACTERIOL, V187, P7267, DOI 10.1128/JB.187.21.7267-7282.2005; Cruz IN, 2013, CHEM SCI, V4, P3442, DOI [10.1039/c3sc50826a, 10.1039/C3SC50826A]; De Groeve MRM, 2010, ANAL BIOCHEM, V401, P162, DOI 10.1016/j.ab.2010.02.028; Fushinobu S., 2011, Journal of Applied Glycoscience, V58, P91, DOI 10.5458/jag.jag.JAG-2010_022; GOLDEMBE.SH, 1966, J BIOL CHEM, V241, P45; Grondin JM, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00860-16; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Hidaka M, 2006, BIOCHEM J, V398, P37, DOI 10.1042/BJ20060274; Hoffmeister M, 2005, J BIOL CHEM, V280, P4329, DOI 10.1074/jbc.M411010200; Hrmova M, 2002, J BIOL CHEM, V277, P30102, DOI 10.1074/jbc.M203971200; Ivanova IM, 2017, CARBOHYD RES, V438, P26, DOI 10.1016/j.carres.2016.11.017; JAGODZINSKI PP, 1994, VIROLOGY, V202, P735, DOI 10.1006/viro.1994.1395; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; KITAOKA M, 1993, ARCH BIOCHEM BIOPHYS, V304, P508, DOI 10.1006/abbi.1993.1383; Kitaoka M, 2015, APPL MICROBIOL BIOT, V99, P8377, DOI 10.1007/s00253-015-6927-0; Kitaoka M, 2012, BIOSCI BIOTECH BIOCH, V76, P343, DOI 10.1271/bbb.110772; Krnacova K, 2012, J MOL EVOL, V75, P119, DOI 10.1007/s00239-012-9523-2; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MANNERS DJ, 1967, ARCH BIOCHEM BIOPHYS, V121, P443, DOI 10.1016/0003-9861(67)90099-9; Marechal L. R., 1963, BIOCHEM BIOPH RES CO, V13, P2; MARECHAL LR, 1967, BIOCHIM BIOPHYS ACTA, V146, P417, DOI 10.1016/0005-2744(67)90226-4; Muller C, 2017, APPL BIOCHEM BIOTECH, V182, P197, DOI 10.1007/s12010-016-2320-4; Nam YW, 2015, J BIOL CHEM, V290, P18281, DOI 10.1074/jbc.M115.664664; Nihira T, 2013, J BIOL CHEM, V288, P27366, DOI 10.1074/jbc.M113.469080; Nihira T, 2012, CARBOHYD RES, V361, P49, DOI 10.1016/j.carres.2012.08.006; Noinaj N, 2010, ANNU REV MICROBIOL, V64, P43, DOI 10.1146/annurev.micro.112408.134247; O'Neill E., 2017, BIOL BASEL, V6, pE45, DOI DOI 10.3390/BI0L0GY6040045; O'Neill E. C., 2015, PERSPECTIVES SCI, V6, P84, DOI DOI 10.1016/J.PISC.2015.07.002; O'Neill EC, 2017, CARBOHYD RES, V451, P118, DOI 10.1016/j.carres.2017.07.005; O'Neill EC, 2015, MOL BIOSYST, V11, P2808, DOI 10.1039/c5mb00319a; O'Neill EC, 2015, CARBOHYD RES, V403, P23, DOI 10.1016/j.carres.2014.06.010; O'Neill EC, 2014, CHEM SCI, V5, P341, DOI 10.1039/c3sc51829a; Ogawa Y, 2014, INT J BIOL MACROMOL, V64, P415, DOI 10.1016/j.ijbiomac.2013.12.027; Pergolizzi G, 2017, PROTEIN PEPTIDE LETT, V24, P696, DOI 10.2174/0929866524666170811125109; Rejzek M, 2017, METHOD ENZYMOL, V597, P209, DOI 10.1016/bs.mie.2017.06.005; Sawano T, 2013, FEBS J, V280, P4463, DOI 10.1111/febs.12408; Shibakami M, 2015, CARBOHYD POLYM, V119, P1, DOI 10.1016/j.carbpol.2014.11.036; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Takeda T, 2015, PHYTOCHEMISTRY, V116, P21, DOI 10.1016/j.phytochem.2015.05.010; Terrapon N, 2018, NUCLEIC ACIDS RES, V46, pD677, DOI 10.1093/nar/gkx1022; Terrapon N, 2015, BIOINFORMATICS, V31, P647, DOI 10.1093/bioinformatics/btu716; Trindade MI, 2003, APPL ENVIRON MICROB, V69, P24, DOI 10.1128/AEM.69.1.24-32.2003; Trouvelot S, 2008, MOL PLANT MICROBE IN, V21, P232, DOI 10.1094/MPMI-21-2-0232; Van Hoorebeke A, 2010, ACTA CRYSTALLOGR F, V66, P346, DOI 10.1107/S1744309110002642; Watanabe T, 2013, FOOD FUNCT, V4, P1685, DOI 10.1039/c3fo60256g; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu Y.Q., 2017, SCI REP, V7; Yamamoto Y, 2013, BIOSCI BIOTECH BIOCH, V77, P1949, DOI 10.1271/bbb.130411; Yoshida Y, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2540-6; Zheng W, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.161107	60	26	27	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2865	2876		10.1074/jbc.RA117.000936	http://dx.doi.org/10.1074/jbc.RA117.000936			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29317507	Green Published, hybrid			2022-12-26	WOS:000426051900021
J	Iimori, S; Naito, S; Noda, Y; Sato, H; Nomura, N; Sohara, E; Okado, T; Sasaki, S; Uchida, S; Rai, T				Iimori, Soichiro; Naito, Shotaro; Noda, Yumi; Sato, Hidehiko; Nomura, Naohiro; Sohara, Eisei; Okado, Tomokazu; Sasaki, Sei; Uchida, Shinichi; Rai, Tatemitsu			Prognosis of chronic kidney disease with normal-range proteinuria: The CKD-ROUTE study	PLOS ONE			English	Article							RISK; OUTCOMES; PROGRESSION; MICROALBUMINURIA; ALBUMINURIA; MORTALITY; MODERATE	Background Although lower estimated glomerular filtration rate (eGFR) and higher proteinuria are high risks for mortality and kidney outcomes, the prognosis of chronic kidney disease (CKD) in patients with normal-range proteinuria remains unclear. Methods In this prospective cohort study, 1138 newly visiting stage G2-G5 CKD patients were stratified into normal-range and abnormal-range proteinuria groups. Study endpoints were CKD progression (>50% eGFR loss or initiation of dialysis), cardiovascular events, and all-cause death. Results In total, 927 patients who were followed for >6 months were included in the analysis. The mean age was 67 years, and 70.2% were male. During a median follow-up of 35 months, CKD progression, cardiovascular events, and mortality were observed in 223, 110, and 55 patients, respectively. Patients with normal-range proteinuria had a significantly lower risk for CKD progression (hazard ratio, 0.20; 95% confidence interval, 0.10-0.38) than those with abnormal-proteinuria by multivariate Cox proportional hazard analysis. We also analyzed patients with normal-range proteinuria (n = 351). Nephrosclerosis was the most frequent cause of CKD among all patients with normal-range proteinuria (59.7%). During a median follow-up of 36 months, CKD progression, cardiovascular events, and mortality were observed in 10, 28, and 18 patients, respectively. The Kaplan +/- Meyer analysis demonstrated that the risks of CKD progression and cardiovascular events were not significantly different among CKD stages, whereas the risk of death was significantly higher in patients with advanced-stage CKD. Multivariate Cox proportional hazard analysis showed that the risk of three endpoints did not significantly differ among CKD stages. Conclusion Newly visiting CKD patients with normal-range proteinuria, who tend to be overlooked during health checkups did not exhibit a decrease in kidney function even in advanced CKD stages under specialized nephrology care.	[Iimori, Soichiro; Naito, Shotaro; Noda, Yumi; Sato, Hidehiko; Nomura, Naohiro; Sohara, Eisei; Okado, Tomokazu; Sasaki, Sei; Uchida, Shinichi; Rai, Tatemitsu] Tokyo Med & Dent Univ, Dept Nephrol, Bunkyo Ku, Tokyo, Japan; [Noda, Yumi; Sato, Hidehiko] Nitobe Mem Nakano Gen Hosp, Dept Nephrol, Nakano Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Rai, T (corresponding author), Tokyo Med & Dent Univ, Dept Nephrol, Bunkyo Ku, Tokyo, Japan.	trai.kid@tmd.ac.jp	Rai, Tatemitsu/K-7165-2019					Atkins RC, 2005, AM J KIDNEY DIS, V45, P281, DOI 10.1053/j.ajkd.2004.10.019; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Chan MR, 2007, AM J MED, V120, P1063, DOI 10.1016/j.amjmed.2007.04.024; Cravedi P, 2012, NAT REV NEPHROL, V8, P301, DOI 10.1038/nrneph.2012.42; De Nicola L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172241; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Iimori S, 2015, NEPHROLOGY, V20, P601, DOI 10.1111/nep.12493; Iimori S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-152; Imai E, 2010, CLIN EXP NEPHROL, V14, P558, DOI 10.1007/s10157-010-0328-6; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Japanese Soc Nephrology, 2014, CLIN EXP NEPHROL, V18, P346, DOI 10.1007/s10157-014-0949-2; Jones C, 2006, NEPHROL DIAL TRANSPL, V21, P2133, DOI 10.1093/ndt/gfl198; Keane WF, 2006, CLIN J AM SOC NEPHRO, V1, P761, DOI 10.2215/CJN.01381005; Levin A, 2008, AM J KIDNEY DIS, V52, P661, DOI 10.1053/j.ajkd.2008.06.023; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mottl AK, 2013, J DIABETES COMPLICAT, V27, P123, DOI 10.1016/j.jdiacomp.2012.09.010; Obi Y, 2010, CLIN J AM SOC NEPHRO, V5, P1558, DOI 10.2215/CJN.08061109; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Roscioni SS, 2014, KIDNEY INT, V86, P40, DOI 10.1038/ki.2013.490; Smart NA, 2011, AM J MED, V124, P1073, DOI 10.1016/j.amjmed.2011.04.026; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Titze S, 2015, NEPHROL DIAL TRANSPL, V30, P441, DOI 10.1093/ndt/gfu294	25	12	13	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190493	10.1371/journal.pone.0190493	http://dx.doi.org/10.1371/journal.pone.0190493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342207	Green Published, gold, Green Submitted			2022-12-26	WOS:000422653800023
J	Chen, WT; Lin, GB; Lin, SH; Lu, CH; Hsieh, CH; Ma, BL; Chao, CY				Chen, Wei-Ting; Lin, Guan-Bo; Lin, Shu-Hui; Lu, Chueh-Hsuan; Hsieh, Chih-Hsiung; Ma, Bo-Lun; Chao, Chih-Yu			Static magnetic field enhances the anticancer efficacy of capsaicin on HepG2 cells via capsaicin receptor TRPV1	PLOS ONE			English	Article							BCL-2 FAMILY PROTEINS; ION-CHANNEL; VANILLOID RECEPTOR; INDUCED APOPTOSIS; EXPOSURE; CANCER; ANTAGONIST; ACTIVATION; TUMORIGENESIS; INVOLVEMENT	Static magnetic field (SMF) has shown some possibilities for cancer therapies. In particular, the combinational effect between SMF and anti-cancer drugs has drawn scientists' attentions in recent years. However, the underlying mechanism for the drug-specific synergistic effect is far from being understood. Besides, the drugs used are all conventional chemotherapy drugs, which may cause unpleasant side effects. In this study, our results demonstrate for the first time that SMF could enhance the anti-cancer effect of natural compound, capsaicin, on HepG2 cancer cells through the mitochondria-dependent apoptosis pathway. We found that the synergistic effect could be due to that SMF increased the binding efficiency of capsaicin for the TRPV1 channel. These findings may provide a support to develop an application of SMF for cancer therapy. The present study offers the first trial in combining SMF with natural compound on anti-cancer treatment, which provides additional insight into the interaction between SMF and anti-cancer drugs and opens the door for the development of new strategies in fighting cancer with minimum cytotoxicity and side effects.	[Chen, Wei-Ting; Lin, Guan-Bo; Lu, Chueh-Hsuan; Hsieh, Chih-Hsiung; Chao, Chih-Yu] Natl Taiwan Univ, Dept Phys, Lab Med Phys & Biomed Engn, Taipei, Taiwan; [Chen, Wei-Ting; Lin, Guan-Bo; Lin, Shu-Hui; Lu, Chueh-Hsuan; Hsieh, Chih-Hsiung; Ma, Bo-Lun; Chao, Chih-Yu] Natl Taiwan Univ, Biomed & Mol Imaging Ctr, Coll Med, Taipei, Taiwan; [Ma, Bo-Lun; Chao, Chih-Yu] Natl Taiwan Univ, Inst Appl Phys, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Chao, CY (corresponding author), Natl Taiwan Univ, Dept Phys, Lab Med Phys & Biomed Engn, Taipei, Taiwan.; Chao, CY (corresponding author), Natl Taiwan Univ, Biomed & Mol Imaging Ctr, Coll Med, Taipei, Taiwan.; Chao, CY (corresponding author), Natl Taiwan Univ, Inst Appl Phys, Taipei, Taiwan.	cychao@phys.ntu.edu.tw	Hsieh, Chih-Hsiung/GMX-1452-2022; Hsieh, Chih-Hsiung/AFI-4085-2022		Ministry of Science and Technology of the Republic of China [MOST 105-2112-M-002-006-MY3]; Ministry of Education of the Republic of China [NTU-ICRP-103R7560-2]; National Taiwan University	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education of the Republic of China(Ministry of Education, Taiwan); National Taiwan University(National Taiwan University)	This work was supported by grants from Ministry of Science and Technology (MOST 105-2112-M-002-006-MY3; C.Y. Chao) and Ministry of Education (NTU-ICRP-103R7560-2; C.Y. Chao) of the Republic of China. One of authors (CYC) acknowledges the National Taiwan University for financial supports on this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Technology Commons in College of Life Science, National Taiwan University for use of flow cytometry system. One of authors (CYC) acknowledges the National Taiwan University for financial supports on this work.	Amantini C, 2007, J NEUROCHEM, V102, P977, DOI 10.1111/j.1471-4159.2007.04582.x; Brito R, 2014, CELLS-BASEL, V3, P517, DOI 10.3390/cells3020517; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHARD PS, 1995, NEUROSCIENCE, V65, P1099, DOI 10.1016/0306-4522(94)00548-J; Chionna A, 2005, BIOELECTROMAGNETICS, V26, P275, DOI 10.1002/bem.20081; Clark R, 2016, ANTICANCER RES, V36, P837; Darre L, 2015, MOL PHARMACEUT, V12, P4454, DOI 10.1021/acs.molpharmaceut.5b00641; Dejean LM, 2006, BBA-MOL BASIS DIS, V1762, P191, DOI 10.1016/j.bbadis.2005.07.002; Del Seppia C, 2003, BEHAV BRAIN RES, V144, P1, DOI 10.1016/S0166-4328(03)00042-1; Ding YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166303; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Fang EF, 2012, APOPTOSIS, V17, P377, DOI 10.1007/s10495-011-0684-z; Gellrich D, 2014, CANCER LETT, V343, P107, DOI 10.1016/j.canlet.2013.09.021; Gunthorpe MJ, 2007, J PHARMACOL EXP THER, V321, P1183, DOI 10.1124/jpet.106.116657; Holland C, 2014, BRIT J CLIN PHARMACO, V77, P777, DOI 10.1111/bcp.12219; Hong ZF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121538; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Huang SP, 2009, ANTICANCER RES, V29, P165; Jing D, 2010, BIOELECTROMAGNETICS, V31, P640, DOI 10.1002/bem.20592; Kanai S, 2012, ADV BIOSCI BIOTECHNO, V3, P511; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Knudson CM, 2001, CANCER RES, V61, P659; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liu Y, 2011, TUMORI, V97, P386, DOI 10.1700/912.10039; Lundbaek JA, 2005, MOL PHARMACOL, V68, P680, DOI 10.1124/mol.105.013573; Luo Y, 2016, BIOELECTROCHEMISTRY, V109, P31, DOI 10.1016/j.bioelechem.2016.01.001; Manson MM, 2003, TRENDS MOL MED, V9, P11, DOI 10.1016/S1471-4914(02)00002-3; Markov MS, 2007, ELECTROMAGN BIOL MED, V26, P1, DOI 10.1080/15368370600925342; Meng J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02655; Okano H, 2005, BIOELECTROMAGNETICS, V26, P469, DOI 10.1002/bem.20115; Perlman H, 1999, CELL DEATH DIFFER, V6, P48, DOI 10.1038/sj.cdd.4400453; Pinter M, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000042; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Ramos-Torres A, 2016, ONCOTARGET, V7, P1569, DOI 10.18632/oncotarget.6415; Rosen AD, 2003, CELL BIOCHEM BIOPHYS, V39, P163, DOI 10.1385/CBB:39:2:163; Salakou S, 2007, IN VIVO, V21, P123; Sandor K, 2007, LIFE SCI, V81, P97, DOI 10.1016/j.lfs.2007.04.029; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Sisken Betty F., 2007, Environmentalist, V27, P477, DOI 10.1007/s10669-007-9117-5; Strelczyk D, 2009, CANCER BIOL THER, V8, P1756, DOI 10.4161/cbt.8.18.9294; SZALLASI A, 1990, LIFE SCI, V47, P1399, DOI 10.1016/0024-3205(90)90518-V; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Tofani S, 2002, BIOELECTROMAGNETICS, V23, P230, DOI 10.1002/bem.10010; Vergallo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113530; Vergallo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072374; Zhang K, 2014, BIOELECTROMAGNETICS, V35, P437, DOI 10.1002/bem.21863; Zheng L, 2016, MOL MED REP, V13, P881, DOI 10.3892/mmr.2015.4623	47	17	19	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191078	10.1371/journal.pone.0191078	http://dx.doi.org/10.1371/journal.pone.0191078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338036	Green Published, Green Submitted, gold			2022-12-26	WOS:000422652700030
J	Badano, I; Sanabria, DJ; Totem, ME; Rubinstein, S; Gili, JA; Liotta, DJ; Picconi, MA; Campos, RH; Schurr, TG				Badano, Ines; Sanabria, Daiana J.; Totem, Maria E.; Rubinstein, Samara; Gili, Juan A.; Liotta, Domingo J.; Picconi, Maria A.; Campos, Rodolfo H.; Schurr, Theodore G.			Mitochondrial DNAancestry, HPV infection and the risk of cervical cancer in a multiethnic population of northeastern Argentina	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; RACIAL DISPARITIES; EMBEDDED TISSUES; GENETIC ANCESTRY; BREAST-CANCER; DNA VARIATION; BUENOS-AIRES; CLASSIFICATION; EXTRACTION; ADMIXTURE	Background Misiones Province in northeastern Argentina is considered to be a region with a high prevalence of HPV infection and a high mortality rate due to cervical cancer. The reasons for this epidemiological trend are not completely understood. To gain insight into this problem, we explored the relationship between mitochondrial DNA (mtDNA) ancestry, HPV infection, and development of cervical lesions/cancer in women from the city of Posadas in Misiones Province. Methods Two hundred and sixty-one women, including 92 cases of patients diagnosed with cervical lesions and 169 controls, were analyzed. mtDNA ancestry was assessed through HVS1 sequencing, while the detection and typing of HPV infection was conducted through nested multiplex PCR analysis. Multivariate logistic regression was conducted with the resulting data to estimate the odds ratios (ORs) adjusted by socio-demographic variables. Results The study participants showed 68.6% Amerindian, 26.1 % European and 5.3% African mtDNA ancestry, respectively. Multiple regression analysis showed that women with African mtDNAs were three times more likely to develop a cervical lesion than those with Native American or European mtDNAs [OR of 3.8 (1.2-11.5) for ancestry and OR of 3.5 (1.0-12.0) for L haplogroups], although the associated p values were not significant when tested under more complex multivariate models. HPV infection and the development of cervical lesions/cancer were significant for all tested models, with the highest OR values for HPV16 [OR of 24.2 (9.3-62.7)] and HPV-58 [OR of 19.0 (2.4-147.7)]. Conclusion HPV infection remains a central risk factor for cervical cancer in the Posadas population. The potential role of African mtDNA ancestry opens a new avenue for future medical association studies in multiethnic populations, and will require further confirmation in large-scale studies.	[Badano, Ines; Sanabria, Daiana J.; Totem, Maria E.; Liotta, Domingo J.] Univ Nacl Misiones, Fac Ciencias Exactas Quim & Nat, Lab Biol Mol Aplicada, Misiones, Argentina; [Badano, Ines; Sanabria, Daiana J.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Rubinstein, Samara; Schurr, Theodore G.] Univ Penn, Dept Anthropol, Lab Mol Anthropol, Philadelphia, PA 19104 USA; [Gili, Juan A.] Consejo Nacl Invest Cient & Tecn, Direcc Invest CEMIC, Lab Epidemiol Genet, Buenos Aires, DF, Argentina; [Picconi, Maria A.] INEI ANLIS Dr Carlos G Malbran, Serv Virus Oncogen, Dept Virol, Buenos Aires, DF, Argentina; [Campos, Rodolfo H.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Pennsylvania; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Badano, I (corresponding author), Univ Nacl Misiones, Fac Ciencias Exactas Quim & Nat, Lab Biol Mol Aplicada, Misiones, Argentina.; Badano, I (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	inesbadano@gmail.com	Gili, Juan Antonio/P-2970-2016	Gili, Juan Antonio/0000-0001-7924-0776; Sanabria, Daiana/0000-0002-6908-9387	Agenda Nacional de Promotion Cientffica y Tecnologica, Argentina [PICT- 2012 - 0761]; Comite Ejecutivo de Desarrollo e Innovation Tecnologica, Gobiernode Misiones, Argentina [31/12]; Ministerio de Salud de la Nation (MSAL) Argentina-Comision National Salud Investiga-Becas "Carrillo-Onativia" [699/13]; CONICET Argentina [4838/13, 3993/12]; Codon-Code Aligner License Grant-USA	Agenda Nacional de Promotion Cientffica y Tecnologica, Argentina; Comite Ejecutivo de Desarrollo e Innovation Tecnologica, Gobiernode Misiones, Argentina; Ministerio de Salud de la Nation (MSAL) Argentina-Comision National Salud Investiga-Becas "Carrillo-Onativia"; CONICET Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Codon-Code Aligner License Grant-USA	This work was supported by the Agenda Nacional de Promotion Cientffica y Tecnologica, Argentina (Grant number PICT- 2012 - 0761); the Comite Ejecutivo de Desarrollo e Innovation Tecnologica, Gobiernode Misiones, Argentina (Becas CEDIT - Res. 31/12 to DJS); the Ministerio de Salud de la Nacion (MSAL) Argentina-Comision National Salud Investiga - Becas "Carrillo - Onativia" (Res. 699/13 to DJS); and CONICET Argentina (Res. 4838/13 to DJS and Res. Resolucion D No 3993/12 to IB) and Codon-Code Aligner License Grant-USA (2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Altuna ME, 2006, HUM BIOL, V78, P635, DOI 10.1353/hub.2007.0000; Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Arrossi S, 2008, PROYECTO MEJORAMIENT; Avena S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034695; Badano I, 2013, INT J IMMUNOGENET, V40, P216, DOI 10.1111/iji.12002; Badano I, 2011, REV ARGENT MICROBIOL, V43, P263, DOI 10.1590/S0325-75412011000400005; Badano I, 2012, J CLIN VIROL, V53, P54, DOI 10.1016/j.jcv.2011.09.030; Bartolome L., 2007, COLONOS APOSTOLES ES; BERNARD HU, 1994, J INFECT DIS, V170, P1077, DOI 10.1093/infdis/170.5.1077; Bonilla C, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0171-8; Bruni L., 2016, SUMMARY REPORT; Cardena MMSG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062005; Catelli ML, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-77; Chan PKS, 2001, J CLIN PATHOL, V54, P401, DOI 10.1136/jcp.54.5.401; Conley AB, 2017, G3-GENES GENOM GENET, V7, P3435, DOI 10.1534/g3.117.1118; Corach D, 2010, ANN HUM GENET, V74, P65, DOI 10.1111/j.1469-1809.2009.00556.x; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P290, DOI 10.3322/caac.21340; Fang H, BMC CANC, V10, P421; Fejerman L, 2005, AM J PHYS ANTHROPOL, V128, P164, DOI 10.1002/ajpa.20083; Guardado-Estrada M, 2012, J HUM GENET, V57, P269, DOI 10.1038/jhg.2012.17; Hildesheim A, 2002, VIRUS RES, V89, P229, DOI 10.1016/S0168-1702(02)00191-0; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1; Instituto Nacional de Estadisticas y Censos, 2010, CENS NAC REP ARG; Instituto Provincial de Estadistica y Censos, 2015, GRAN ATL MIS; Kabekkodu SP, 2014, MITOCHONDRION, V16, P73, DOI 10.1016/j.mito.2013.07.001; Klemba A, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-73; Lagheden C, 2016, J CLIN VIROL, V80, P36, DOI 10.1016/j.jcv.2016.04.016; Lamborghini E, 2017, ESTUDIOS AFROLATINOA; Li YY, 2016, J OBSTET GYNAECOL RE, V42, P325, DOI 10.1111/jog.12879; Lopera EA, 2014, INFECT GENET EVOL, V28, P339, DOI 10.1016/j.meegid.2014.10.014; Madeleine MM, 2008, CANCER RES, V68, P3532, DOI 10.1158/0008-5472.CAN-07-6471; Marignac VLM, 2004, HUM BIOL, V76, P543, DOI 10.1353/hub.2004.0058; Movva S, 2008, CANCER-AM CANCER SOC, V112, P1264, DOI 10.1002/cncr.23310; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Rauh-Hain JA, 2013, CANCER-AM CANCER SOC, V119, P3644, DOI 10.1002/cncr.28261; Rosa A, 2011, J ANTHROPOL SCI, V89, P25, DOI 10.4436/jass.89006; Ruiz JM, 2013, AM J PUBLIC HEALTH, V103, pE52, DOI 10.2105/AJPH.2012.301103; Sala A, 2010, HUM BIOL, V82, P433, DOI 10.3378/027.082.0406; Salas A, 2008, J HUM GENET, V53, P662, DOI 10.1007/s10038-008-0297-8; Salas A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-659; Salas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008347; Sans M, 2000, HUM BIOL, V72, P155; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; Sheppard CS, 2016, INT J CANCER, V138, P2622, DOI 10.1002/ijc.29996; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Steinau M, 2011, J MOL DIAGN, V13, P377, DOI 10.1016/j.jmoldx.2011.03.007; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1993, AM J HUM GENET, V53, P563; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; van Oven M, 2015, FORENS SCI INT-GEN S, V5, pE392, DOI 10.1016/j.fsigss.2015.09.155; Viens LJ, 2016, MMWR-MORBID MORTAL W, V65, P661, DOI 10.15585/mmwr.mm6526a1; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001; Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW58, DOI 10.1093/nar/gkw233; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297	58	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190966	10.1371/journal.pone.0190966	http://dx.doi.org/10.1371/journal.pone.0190966			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BY	29329337	Green Published, Green Submitted, gold			2022-12-26	WOS:000419954100030
J	Chuang, MC; Yang, YH; Tsai, YH; Hsieh, MJ; Lin, YC; Lin, CK; Chen, PC; Yang, TM				Chuang, Min-Chun; Yang, Yao-Hsu; Tsai, Ying-Huang; Hsieh, Meng-Jer; Lin, Yu-Ching; Lin, Chin-Kuo; Chen, Pau-Chung; Yang, Tsung-Ming			Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study	PLOS ONE			English	Article							MORTALITY; NSCLC; RISK; COMBINATION; APOPTOSIS; IMPACT; GROWTH	Objective To evaluate the effects of metformin use on the survival of inoperable non-small cell lung cancer (NSCLC) patients with diabetes using the Taiwanese National Health Insurance Research Database. Research design and methods In total, 7,620 patients were eligible in this study, among them, 3,578 patients were metformin users and 4,042 were non-users. Propensity score matching was used to reduce possible confounding factors. In total, 4,182 patients (2,091 matched pairs) were included in the matched cohort. Cox proportional hazard model with time-dependent covariate were also applied to evaluate the association between metformin use and overall survival (OS). Results A total of 3,578 patients were metformin users at the time of diagnosis of NSCLC. Cox proportional hazard model with time-dependent covariate revealed that metformin use was associated with a significantly longer OS (HR: 0.85, 95.0% Cl: 0.80-0.90). The survival benefit of metformin use was maintained after propensity score matching at a ratio of 1:1 (HR: 0.90, 95.0% Cl: 0.84-0.97). Conclusions Metformin use is associated with longer OS in inoperable NSCLC patients with diabetes, suggesting a potential anti-tumorigenic effect for metformin. Further research is needed to investigate the actual role of metformin in the treatment of NSCLC patients with diabetes.	[Chuang, Min-Chun; Hsieh, Meng-Jer; Lin, Yu-Ching; Lin, Chin-Kuo; Yang, Tsung-Ming] Chiayi Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Chiayi, Taiwan; [Chuang, Min-Chun] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Yang, Yao-Hsu] Chiayi Chang Gung Mem Hosp, Dept Tradit Chinese Med, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Mem Hosp, Hlth Informat & Epidemiol Lab, Chiayi, Taiwan; [Yang, Yao-Hsu] Chang Gung Univ, Coll Med, Sch Tradit Chinese Med, Taoyuan, Taiwan; [Tsai, Ying-Huang] Chang Gung Mem Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Kaohsiung Med Ctr, Kaohsiung, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ Hosp, Dept Environm & Occupat Med, Taipei, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Coll Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Yang, TM (corresponding author), Chiayi Chang Gung Mem Hosp, Dept Pulm & Crit Care Med, Chiayi, Taiwan.	n120633@cgmh.org.tw	楊, 曜旭/A-3450-2019; Chen, Pau-Chung/H-5686-2011	楊, 曜旭/0000-0002-8080-0504; Chen, Pau-Chung/0000-0002-6242-5974; Chuang, Min-Chun/0000-0002-2817-2790; Hsieh, Meng-Jer/0000-0002-2077-0470; Lin, Chin-Kuo/0000-0002-5940-3715	Chiayi Chang Gung Memorial Hospital, Taiwan [CORPG6D0162, CLRPG6G0041]	Chiayi Chang Gung Memorial Hospital, Taiwan	This study was supported by a grant from Chiayi Chang Gung Memorial Hospital, Taiwan (CORPG6D0162) and (CLRPG6G0041) to YHY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2015, J THORAC DIS, V7, P346, DOI 10.3978/j.issn.2072-1439.2014.12.32; Algire C, 2008, ENDOCR-RELAT CANCER, V15, P833, DOI 10.1677/ERC-08-0038; Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Ashinuma H, 2012, ONCOL REP, V28, P8, DOI 10.3892/or.2012.1763; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Brule S.Y., 2015, ONCOL EXCH, V14, P12; Chen HY, 2015, CANCER LETT, V369, P97, DOI 10.1016/j.canlet.2015.08.024; Chen HL, 2014, J DIABETES COMPLICAT, V28, P612, DOI 10.1016/j.jdiacomp.2014.05.011; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Gaga M, 2013, EUR RESPIR J, V42, P1183, DOI 10.1183/09031936.00145813; He XX, 2011, ANN ONCOL, V22, P2640, DOI 10.1093/annonc/mdr020; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kourelis TV, 2012, MED ONCOL, V29, P1314, DOI 10.1007/s12032-011-9846-7; Lin JJ, 2015, AM J RESP CRIT CARE, V191, P448, DOI 10.1164/rccm.201407-1395OC; Luo JH, 2016, BRIT J CANCER, V115, P76, DOI 10.1038/bjc.2016.141; Mazzone PJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-410; Mc Menamin UC, 2016, LUNG CANCER, V94, P35, DOI 10.1016/j.lungcan.2016.01.012; Morgillo F, 2013, CLIN CANCER RES, V19, P3508, DOI 10.1158/1078-0432.CCR-12-2777; National Comprehensive Cancer Network, 2015, THE NCCN CLINICAL PR; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Pollak M, 2014, NAT MED, V20, P591, DOI 10.1038/nm.3596; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Saxena A, 2015, ONCOLOGIST, V20, P934, DOI 10.1634/theoncologist.2015-0064; Sayed Rana, 2015, Asian Pac J Cancer Prev, V16, P6621; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Skinner HD, 2013, CANCER MED-US, V2, P99, DOI 10.1002/cam4.54; Stevens RJ, 2012, DIABETOLOGIA, V55, P2593, DOI 10.1007/s00125-012-2653-7; Storozhuk Y, 2013, BRIT J CANCER, V108, P2021, DOI 10.1038/bjc.2013.187; Tan BX, 2011, CANCER-AM CANCER SOC, V117, P5103, DOI 10.1002/cncr.26151; Teixeira SF, 2013, J BRAS PNEUMOL, V39, P644, DOI 10.1590/S1806-37132013000600002; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Tsilidis KK, 2014, DIABETES CARE, V37, P2522, DOI 10.2337/dc14-0584; Wink KCJ, 2016, RADIOTHER ONCOL, V118, P453, DOI 10.1016/j.radonc.2016.01.012; Wu N, 2011, NEOPLASMA, V58, P482, DOI 10.4149/neo_2011_06_482; Xu H, 2015, ONCOLOGIST, V20, P1236, DOI 10.1634/theoncologist.2015-0096; Xu H, 2015, J AM MED INFORM ASSN, V22, P179, DOI 10.1136/amiajnl-2014-002649; Zhang PP, 2013, CANCER EPIDEMIOL, V37, P207, DOI 10.1016/j.canep.2012.12.009	39	19	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191129	10.1371/journal.pone.0191129	http://dx.doi.org/10.1371/journal.pone.0191129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329345	Green Published, Green Submitted, gold			2022-12-26	WOS:000419954100040
J	Mohri, S; Takahashi, H; Sakai, M; Takahashi, S; Waki, N; Aizawa, K; Suganuma, H; Ara, T; Matsumura, Y; Shibata, D; Goto, T; Kawada, T				Mohri, Shinsuke; Takahashi, Haruya; Sakai, Maiko; Takahashi, Shingo; Waki, Naoko; Aizawa, Koichi; Suganuma, Hiroyuki; Ara, Takeshi; Matsumura, Yasuki; Shibata, Daisuke; Goto, Tsuyoshi; Kawada, Teruo			Wide-range screening of anti-inflammatory compounds in tomato using LC-MS and elucidating the mechanism of their functions	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; INFLAMMATORY CHANGES; METABOLIC SYNDROME; LIPID-METABOLISM; FATTY-ACID; PPAR-ALPHA; OBESITY; MACROPHAGES	Obesity-induced chronic inflammation is a key factor in type 2 diabetes. A vicious cycle involving pro-inflammatory mediators between adipocytes and macrophages is a common cause of chronic inflammation in the adipose tissue. Tomato is one of the most popular vegetables and is associated with a reduced risk of diabetes. However, the molecular mechanism underlying the effect of tomato on diabetes is unclear. In this study, we focused on anti-inflammatory compounds in tomato. We found that the extract of tomato reduced plasma glucose and inflammatory markers in mice. We screened anti-inflammatory fractions in tomato using lipopolysaccharide-stimulated RAW264.7 macrophages, and active compounds were estimated by liquid chromatography-mass spectrometry over a wide range. Surprisingly, a large number of compounds including oxylipin and coumarin derivatives were estimated as anti-inflammatory compounds. Especially, 9-oxo-octadecadienoic acid and daphnetin suppressed pro-inflammatory cytokines in RAW264.7 macrophages inhibiting mitogen-activated protein kinase phosphorylation and inhibitor of kappa B a protein degradation. These findings suggest that tomato containing diverse anti-inflammatory compounds ameliorates chronic inflammation in obese adipose tissue.	[Mohri, Shinsuke; Takahashi, Haruya; Sakai, Maiko; Goto, Tsuyoshi; Kawada, Teruo] Kyoto Univ, Grad Sch Agr, Lab Mol Funct Food, Uji, Kyoto, Japan; [Takahashi, Haruya; Waki, Naoko; Ara, Takeshi; Shibata, Daisuke] Kyoto Univ, Grad Sch Agr, KAGOME Tomato Discoveries Lab, Kyoto, Japan; [Takahashi, Shingo; Waki, Naoko; Aizawa, Koichi; Suganuma, Hiroyuki] KAGOME Co Ltd, Innovat Div, Nasushiobara, Tochigi, Japan; [Matsumura, Yasuki] Kyoto Univ, Grad Sch Agr, Lab Qual Anal & Assessment, Uji, Kyoto, Japan; [Shibata, Daisuke] Kazusa DNA Res Inst, Kisarazu, Chiba, Japan; [Goto, Tsuyoshi; Kawada, Teruo] Kyoto Univ, Res Unit Physiol Chem, Kyoto, Japan	Kyoto University; Kyoto University; Kagome Co., Ltd.; Kyoto University; Kazusa DNA Research Institute; Kyoto University	Kawada, T (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Mol Funct Food, Uji, Kyoto, Japan.; Kawada, T (corresponding author), Kyoto Univ, Res Unit Physiol Chem, Kyoto, Japan.	fat@kais.kyoto-u.ac.jp	Goto, Tsuyoshi/AAY-2344-2020	Goto, Tsuyoshi/0000-0003-1283-147X; Ara, Takeshi/0000-0003-1754-2837; Takahashi, Shingo/0000-0002-0182-2589; Suganuma, Hiroyuki/0000-0001-6596-9881	KAGOME CO., LTD	KAGOME CO., LTD	This study was funded by KAGOME CO., LTD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Benzler J, 2015, DIABETES, V64, P2015, DOI 10.2337/db14-0093; Blum Arnon, 2005, Eur J Intern Med, V16, P402, DOI 10.1016/j.ejim.2005.02.017; Bogna GG, 2014, NUTR J, V13, P17, DOI DOI 10.1186/1475-2891-13-17; Canene-Adams K, 2005, J NUTR, V135, P1226, DOI 10.1093/jn/135.5.1226; Chinetti G, 2000, INFLAMM RES, V49, P497, DOI 10.1007/s000110050622; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Engeli S, 2007, J CLIN ENDOCR METAB, V92, P2706, DOI 10.1210/jc.2007-0234; Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6; Fenni S, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601083; Ghavipour M, 2013, BRIT J NUTR, V109, P2031, DOI 10.1017/S0007114512004278; Gouranton E, 2011, J NUTR BIOCHEM, V22, P642, DOI 10.1016/j.jnutbio.2010.04.016; Granger DL, 1996, METHOD ENZYMOL, V268, P142; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Iijima Y, 2008, PLANT J, V54, P949, DOI 10.1111/j.1365-313X.2008.03434.x; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kang MS, 2008, BIOCHEM BIOPH RES CO, V369, P333, DOI 10.1016/j.bbrc.2008.02.002; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kim YI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031317; Kim YI, 2011, MOL NUTR FOOD RES, V55, P585, DOI 10.1002/mnfr.201000264; Kim Y, 2014, FOOD FUNCT, V5, P2371, DOI 10.1039/c4fo00351a; Kuo JM, 2006, J AGR FOOD CHEM, V54, P3151, DOI 10.1021/jf060022q; Lazarus SA, 2004, JAMA-J AM MED ASSOC, V292, P805, DOI 10.1001/jama.292.7.805; Li Y, 2016, OBESITY, V24, P2351, DOI 10.1002/oby.21611; Li YF, 2015, NUTRITION, V31, P691, DOI 10.1016/j.nut.2014.11.008; Lin CH, 2016, DRUG DES DEV THER, V10, P3591, DOI 10.2147/DDDT.S114879; Mariutto M, 2014, PLANT MOL BIOL, V84, P455, DOI 10.1007/s11103-013-0144-y; Luvizotto RDM, 2013, BRIT J NUTR, V110, P1803, DOI 10.1017/S0007114513001256; Miller CW, 1996, P NATL ACAD SCI USA, V93, P9443, DOI 10.1073/pnas.93.18.9443; Miranda PJ, 2005, AM HEART J, V149, P33, DOI 10.1016/j.ahj.2004.07.013; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Palozza P, 2010, CURR MED CHEM, V17, P2547, DOI 10.2174/092986710791556041; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pulvera ZM, 2006, BIOSCI BIOTECH BIOCH, V70, P2598, DOI 10.1271/bbb.60121; Ravi R, 1998, CANCER RES, V58, P4531; Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0; Roepstorff C, 2005, AM J PHYSIOL-ENDOC M, V288, pE133, DOI 10.1152/ajpendo.00379.2004; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Takahashi H, 2015, LIPIDS, V50, P1083, DOI 10.1007/s11745-015-4071-3; Takahashi H, 2015, J LIPID RES, V56, P254, DOI 10.1194/jlr.M052464; Takahashi H, 2014, BIOSCI BIOTECH BIOCH, V78, P1761, DOI 10.1080/09168451.2014.930330; Tsuchiya K, 2007, ENDOCRINOLOGY, V148, P4548, DOI 10.1210/en.2006-1371; TUGWOOD JD, 1992, EMBO J, V11, P433, DOI 10.1002/j.1460-2075.1992.tb05072.x; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wensveen FM, 2015, EUR J IMMUNOL, V45, P2446, DOI 10.1002/eji.201545502; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang EB, 1999, BIOCHEM BIOPH RES CO, V260, P682, DOI 10.1006/bbrc.1999.0958; Yu WW, 2014, INT IMMUNOPHARMACOL, V21, P1, DOI 10.1016/j.intimp.2014.04.005	53	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191203	10.1371/journal.pone.0191203	http://dx.doi.org/10.1371/journal.pone.0191203			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329333	Green Published, gold, Green Submitted			2022-12-26	WOS:000419954100048
J	Fuentes, S; Carrasco, J; Hatto, A; Navarro, J; Armario, A; Monsonet, M; Ortiz, J; Nadal, R				Fuentes, Silvia; Carrasco, Javier; Hatto, Abigail; Navarro, Juan; Armario, Antonio; Monsonet, Manel; Ortiz, Jordi; Nadal, Roser			Sex-dependent impact of early-life stress and adult immobilization in the attribution of incentive salience in rats	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS SHELL; SIGN-TRACKING; MATERNAL SEPARATION; TYROSINE-HYDROXYLASE; INDIVIDUAL VARIATION; GENDER-DIFFERENCES; SINGLE EXPOSURE; REWARD CUES; CHOLINERGIC CONTROL; DOPAMINE SYSTEM	Early life stress (ELS) induces long-term effects in later functioning and interacts with further exposure to other stressors in adulthood to shape our responsiveness to reward-related cues. The attribution of incentive salience to food-related cues may be modulated by previous and current exposures to stressors in a sex-dependent manner. We hypothesized from human data that exposure to a traumatic (severe) adult stressor will decrease the attribution of incentive salience to reward-associated cues, especially in females, because these effects are modulated by previous ELS. To study these factors in Long-Evans rats, we used as an ELS model of restriction of nesting material and concurrently evaluated maternal care. In adulthood, the offspring of both sexes were exposed to acute immobilization (IMO), and several days after, a Pavlovian conditioning procedure was used to assess the incentive salience of food-related cues. Some rats developed more attraction to the cue predictive of reward (sign-tracking) and others were attracted to the location of the reward itself, the food-magazine (goal-tracking). Several dopaminergic markers were evaluated by in situ hybridization. The results showed that ELS increased maternal care and decreased body weight gain (only in females). Regarding incentive salience, in absolute control animals, females presented slightly greater sign-tracking behavior than males. Non-ELS male rats exposed to IMO showed a bias towards goal-tracking, whereas in females, IMO produced a bias towards sign-tracking. Animals of both sexes not exposed to IMO displayed an intermediate phenotype. ELS in IMO-treated females was able to reduce sign-tracking and decrease tyrosine hydroxylase expression in the ventral tegmental area and dopamine D1 receptor expression in the accumbens shell. Although the predicted greater decrease in females in sign-tracking after IMO exposure was not corroborated by the data, the results highlight the idea that sex is an important factor in the study of the long-term impact of early and adult stressors.	[Fuentes, Silvia; Carrasco, Javier; Hatto, Abigail; Navarro, Juan; Armario, Antonio; Monsonet, Manel; Ortiz, Jordi; Nadal, Roser] Univ Autonoma Barcelona, Inst Neurociencies, Barcelona, Spain; [Fuentes, Silvia; Monsonet, Manel; Nadal, Roser] Univ Autonoma Barcelona, Sch Psychol, Psychobiol Unit, Barcelona, Spain; [Hatto, Abigail; Armario, Antonio] Univ Autonoma Barcelona, Sch Biosci, Anim Physiol Unit, Barcelona, Spain; [Navarro, Juan; Ortiz, Jordi] Univ Autonoma Barcelona, Sch Med, Biochem Unit, Barcelona, Spain; [Armario, Antonio; Ortiz, Jordi; Nadal, Roser] Inst Salud Carlos III, CIBERSAM, Barcelona, Spain; [Monsonet, Manel] Univ Autonoma Barcelona, Personal Assessment & Psychol Treatment Unit, Sch Psychol, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Autonomous University of Barcelona	Nadal, R (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Barcelona, Spain.; Nadal, R (corresponding author), Univ Autonoma Barcelona, Sch Psychol, Psychobiol Unit, Barcelona, Spain.; Nadal, R (corresponding author), Inst Salud Carlos III, CIBERSAM, Barcelona, Spain.	roser.nadal@uab.es	Nadal, Roser/C-7977-2011; Armario, Antonio/C-9267-2011; Monsonet, manel/AAZ-3152-2021; Ortiz, Jordi/E-9018-2011; Carrasco, Javier/C-9732-2011	Nadal, Roser/0000-0001-8972-2525; Armario, Antonio/0000-0001-9524-3635; Monsonet, manel/0000-0003-1898-3212; Ortiz, Jordi/0000-0002-9748-2290; Carrasco, Javier/0000-0001-6436-0863; Fuentes, Silvia/0000-0002-8352-1068	Plan Nacional sobre drogas [2011/021]; Ministerio de Economia y Competitividad [SAF2014-53876-R]; Ministerio de Sanidad, Servicios Sociales e Igualdad [RD12/0028/0014]; Generalitat de Catalunya [SGR2014-1020, 2015 FEDER7S-201U16-0019]; ICREA Academia award (Generalitat de Catalunya)	Plan Nacional sobre drogas; Ministerio de Economia y Competitividad(Spanish Government); Ministerio de Sanidad, Servicios Sociales e Igualdad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); ICREA Academia award (Generalitat de Catalunya)(ICREA)	We have received funding from the following Institutions: Plan Nacional sobre drogas (award number: 2011/021) to RN; Ministerio de Economia y Competitividad (award number: SAF2014-53876-R) to AA and RN; Ministerio de Sanidad, Servicios Sociales e Igualdad (award number: RD12/0028/0014) to AA; Generalitat de Catalunya (award number: SGR2014-1020) to AA; ICREA Academia award (Generalitat de Catalunya) to RN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Universitat Autanoma de Barcelona received funding from the Generalitat de Catalunya (2015 FEDER7S-201U16-0019) for the construction of the Animal Facility.	Abellan C, 2008, PSYCHONEUROENDOCRINO, V33, P1139; Agrawal A, 2012, ARCH GEN PSYCHIAT, V69, P732, DOI 10.1001/archgenpsychiatry.2011.2273; Andero R, 2012, HIPPOCAMPUS, V22, P399, DOI 10.1002/hipo.20906; Andero R, 2011, AM J PSYCHIAT, V168, P163, DOI 10.1176/appi.ajp.2010.10030326; Anderson SM, 2003, PSYCHOPHARMACOLOGY, V168, P132, DOI 10.1007/s00213-002-1298-5; Armario A, 2008, NEUROSCI BIOBEHAV R, V32, P1121, DOI 10.1016/j.neubiorev.2008.04.003; Bachtell RK, 2005, PSYCHOPHARMACOLOGY, V183, P41, DOI 10.1007/s00213-005-0133-1; Bayer TA, 1999, J PSYCHIATR RES, V33, P543, DOI 10.1016/S0022-3956(99)00039-4; Becker JB, 2007, J NEUROSCI, V27, P11851, DOI 10.1523/JNEUROSCI.3565-07.2007; Beckmann JS, 2012, BEHAV BRAIN RES, V226, P331, DOI 10.1016/j.bbr.2011.09.021; Beckmann JS, 2011, BEHAV BRAIN RES, V216, P159, DOI 10.1016/j.bbr.2010.07.022; Belda X, 2008, HORM BEHAV, V54, P654, DOI 10.1016/j.yhbeh.2008.07.003; Belda X, 2016, SCI REP-UK, V6, DOI 10.1038/srep31244; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Bock J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00011; Bossert JM, 2007, J NEUROSCI, V27, P12655, DOI 10.1523/JNEUROSCI.3926-07.2007; Braw Y, 2009, PHYSIOL BEHAV, V96, P209, DOI 10.1016/j.physbeh.2008.10.002; Buwalda B, 2013, NEUROSCIENCE, V249, P258, DOI 10.1016/j.neuroscience.2012.12.050; Campus P, 2016, PSYCHOPHARMACOLOGY, V233, P1157, DOI 10.1007/s00213-015-4192-7; Lopez JC, 2015, NEUROPSYCHOPHARMACOL, V40, P2096, DOI 10.1038/npp.2015.68; Carmassi C, 2014, J AFFECT DISORDERS, V160, P55, DOI 10.1016/j.jad.2014.02.028; Carragher N, 2016, J AFFECT DISORDERS, V190, P56, DOI 10.1016/j.jad.2015.09.071; Carroll ME, 2010, HORM BEHAV, V58, P44, DOI 10.1016/j.yhbeh.2009.10.001; Chaudhri N, 2009, PSYCHOPHARMACOLOGY, V207, P303, DOI 10.1007/s00213-009-1657-6; Chocyk A, 2011, NEUROSCIENCE, V182, P43, DOI 10.1016/j.neuroscience.2011.03.008; Claessens SEF, 2011, PSYCHOPHARMACOLOGY, V214, P141, DOI 10.1007/s00213-010-2118-y; Cohen H, 2011, DIS MARKERS, V30, P141, DOI [10.1155/2011/734372, 10.3233/DMA-2011-0778]; D'Cunha TM, 2017, NEUROPSYCHOPHARMACOL, V42, P1136, DOI 10.1038/npp.2016.250; Danna CL, 2010, PHARMACOL BIOCHEM BE, V96, P40, DOI 10.1016/j.pbb.2010.04.004; Dickson PE, 2015, BEHAV BRAIN RES, V292, P305, DOI 10.1016/j.bbr.2015.05.039; DiFeliceantonio AG, 2016, EUR J NEUROSCI, V43, P1203, DOI 10.1111/ejn.13220; Dillon DG, 2014, DEPRESS ANXIETY, V31, P233, DOI 10.1002/da.22202; Dillon DG, 2009, BIOL PSYCHIAT, V66, P206, DOI 10.1016/j.biopsych.2009.02.019; Dimitsantos E, 2007, PHYSIOL BEHAV, V92, P708, DOI 10.1016/j.physbeh.2007.05.066; Fitzpatrick CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075042; Flagel SB, 2007, PSYCHOPHARMACOLOGY, V191, P599, DOI 10.1007/s00213-006-0535-8; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Fuentes S, 2014, HORM BEHAV, V66, P475, DOI 10.1016/j.yhbeh.2014.07.003; Fuentes S, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00056; Gagliano H, 2014, HORM BEHAV, V66, P793, DOI 10.1016/j.yhbeh.2014.11.002; Gao J, 2013, J PSYCHOPHARMACOL, V27, P181, DOI 10.1177/0269881112466181; Garofalo S, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00163; Gillies GE, 2014, NEUROSCIENCE, V282, P69, DOI 10.1016/j.neuroscience.2014.05.033; Goel N, 2009, J NEUROENDOCRINOL, V21, P415, DOI 10.1111/j.1365-2826.2009.01843.x; Gore BB, 2013, J NEUROSCI, V33, P8640, DOI 10.1523/JNEUROSCI.5532-12.2013; Hammerslag LR, 2014, DEV PSYCHOBIOL, V56, P611, DOI 10.1002/dev.21127; Hanson JL, 2016, SOC COGN AFFECT NEUR, V11, P405, DOI 10.1093/scan/nsv124; Holmes NM, 2010, NEUROSCI BIOBEHAV R, V34, P1277, DOI 10.1016/j.neubiorev.2010.03.007; Ivy AS, 2008, NEUROSCIENCE, V154, P1132, DOI 10.1016/j.neuroscience.2008.04.019; Kearns DN, 2006, BEHAV BRAIN RES, V169, P193, DOI 10.1016/j.bbr.2006.01.005; King CP, 2016, PSYCHOPHARMACOLOGY, V233, P2593, DOI 10.1007/s00213-016-4306-x; Laurent V, 2014, J NEUROSCI, V34, P1358, DOI 10.1523/JNEUROSCI.4592-13.2014; Lex A, 2008, LEARN MEMORY, V15, P483, DOI 10.1101/lm.978708; Lomanowska AM, 2011, BEHAV BRAIN RES, V220, P91, DOI 10.1016/j.bbr.2011.01.033; Lovic V, 2011, BEHAV BRAIN RES, V223, P255, DOI 10.1016/j.bbr.2011.04.006; Mahler SV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015475; Marin-Blasco I, 2017, CEREB CORTEX; Marmendal M, 2004, DEV PSYCHOBIOL, V45, P140, DOI 10.1002/dev.20027; Marquez C, 2002, BRAIN RES, V926, P181, DOI 10.1016/S0006-8993(01)03112-2; Maynard TM, 2001, SCHIZOPHRENIA BULL, V27, P457, DOI 10.1093/oxfordjournals.schbul.a006887; McClory AJ, 2014, ALCOHOL, V48, P755, DOI 10.1016/j.alcohol.2014.05.006; McCulloch C. E., 2008, GEN LINEAR MIXED MOD; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; Meyer PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038987; Milian MJ, 2014, EUR NEUROPSYCHOPHARM, V24, P645, DOI 10.1016/j.euroneuro.2014.03.008; Molet J, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2015.200; Molet J, 2014, DEV PSYCHOBIOL, V56, P1675, DOI 10.1002/dev.21230; Moore CL, 1997, DEV PSYCHOBIOL, V30, P301; Morrow JD, 2015, BEHAV BRAIN RES, V276, P59, DOI 10.1016/j.bbr.2014.04.002; Morrow JD, 2011, BEHAV BRAIN RES, V220, P238, DOI 10.1016/j.bbr.2011.02.013; Naeem M, 2016, BEHAV NEUROSCI, V130, P376, DOI 10.1037/bne0000154; Nasser HM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00289; Nawijn L, 2015, NEUROSCI BIOBEHAV R, V51, P189, DOI 10.1016/j.neubiorev.2015.01.019; Nemeroff CB, 2006, J PSYCHIATR RES, V40, P1, DOI 10.1016/j.jpsychires.2005.07.005; Ons S, 2010, EUR J NEUROSCI, V31, P2043, DOI 10.1111/j.1460-9568.2010.07242.x; Own LS, 2013, HORM BEHAV, V63, P411, DOI 10.1016/j.yhbeh.2012.11.010; Paolone G, 2013, J NEUROSCI, V33, P8321, DOI 10.1523/JNEUROSCI.0709-13.2013; Pastor-Ciurana J, 2014, BEHAV BRAIN RES, V265, P155, DOI 10.1016/j.bbr.2014.02.028; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pitchers KK, 2015, BEHAV BRAIN RES, V278, P462, DOI 10.1016/j.bbr.2014.10.036; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Robinson TE, 2014, NEUROPHARMACOLOGY, V76, P450, DOI 10.1016/j.neuropharm.2013.05.040; Saddoris MP, 2015, J NEUROSCI, V35, P11572, DOI 10.1523/JNEUROSCI.2344-15.2015; Salamone JD, 2016, CURR TOP BEHAV NEURO, V27, P231, DOI 10.1007/7854_2015_383; Santarelli S, 2017, PSYCHONEUROENDOCRINO, V78, P213, DOI 10.1016/j.psyneuen.2017.01.021; Sanz-Garcia A, 2016, HIPPOCAMPUS, V26, P1179, DOI 10.1002/hipo.22599; Saunders BT, 2013, NEUROSCI BIOBEHAV R, V37, P1955, DOI 10.1016/j.neubiorev.2013.02.008; Saunders BT, 2012, EUR J NEUROSCI, V36, P2521, DOI 10.1111/j.1460-9568.2012.08217.x; Schmidt EF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-07-j0003.2001; Schmidt MV, 2011, PSYCHONEUROENDOCRINO, V36, P330, DOI 10.1016/j.psyneuen.2010.07.001; Schultz W, 2016, NAT REV NEUROSCI, V17, P183, DOI 10.1038/nrn.2015.26; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Singer BF, 2016, EUR J NEUROSCI, V43, P662, DOI 10.1111/ejn.13134; Taylor SE, 2010, P NATL ACAD SCI USA, V107, P8507, DOI 10.1073/pnas.1003890107; Teicher MH, 2013, AM J PSYCHIAT, V170, P1114, DOI 10.1176/appi.ajp.2013.12070957; Tomie A, 2008, BRAIN RES REV, V58, P121, DOI 10.1016/j.brainresrev.2007.12.003; Torres C, 2016, NEUROSCIENCE, V332, P13, DOI 10.1016/j.neuroscience.2016.06.041; TRULSON ME, 1987, BRAIN RES BULL, V19, P39, DOI 10.1016/0361-9230(87)90163-8; Versace F, 2016, SOC COGN AFFECT NEUR, V11, P604, DOI 10.1093/scan/nsv143; Wei L, 2010, HORM BEHAV, V57, P396, DOI 10.1016/j.yhbeh.2010.01.007; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; Zalosnik MI, 2014, STRESS, V17, P445, DOI 10.3109/10253890.2014.936005	102	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190044	10.1371/journal.pone.0190044	http://dx.doi.org/10.1371/journal.pone.0190044			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324797	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400016
J	More, S; Yang, XY; Zhu, ZY; Bamunuarachchi, G; Guo, YJ; Huang, CQ; Bailey, K; Metcalf, JP; Liu, L				More, Sunil; Yang, Xiaoyun; Zhu, Zhengyu; Bamunuarachchi, Gayan; Guo, Yujie; Huang, Chaoqun; Bailey, Keith; Metcalf, Jordan P.; Liu, Lin			Regulation of influenza virus replication by Wnt/beta-catenin signaling	PLOS ONE			English	Article							A VIRUS; BETA-CATENIN; TRANS-DIFFERENTIATION; NS1 PROTEIN; PATHWAY; CELLS; ACTIVATION; INTERFERON; INFECTION; KINASE	Wnt/beta-catenin signaling is an essential pathway in cell cycle control. Dysregulation of the Wnt/beta-catenin signaling pathway during viral infection has been reported. In this study, we examined the effect of modulating Wnt/beta-catenin signaling during influenza virus infection. The activation of the Wnt/beta-catenin pathway by Wnt3a increased influenza virus mRNA and virus production in in vitro in mouse lung epithelial E10 cells and mRNA expresson of influenza virus genes in vivo in the lungs of mice infected with influenza virus A/Puerto Rico/8/34. However, the inhibition of Wnt/beta-catenin signaling by iCRT14 reduced virus titer and viral gene expression in human lung epithelial A549 cells and viral replication in primary mouse alveolar epithelial cells infected with different influenza virus strains. Knockdown of beta-catenin also reduced viral protein expression and virus production. iCRT14 acts at the early stage of virus replication. Treatment with iCRT14 inhibited the expression of the viral genes (vRNA, cRNA and mRNA) evaluated in this study. The intraperitoneal administration of iCRT14 reduced viral load, improved clinical signs, and partially protected mice from influenza virus infection.	[More, Sunil; Yang, Xiaoyun; Zhu, Zhengyu; Bamunuarachchi, Gayan; Guo, Yujie; Huang, Chaoqun; Liu, Lin] Oklahoma State Univ, Dept Physiol Sci, Lundberg Kienlen Lung Biol & Toxicol Lab, Stillwater, OK 74078 USA; [More, Sunil; Yang, Xiaoyun; Zhu, Zhengyu; Bamunuarachchi, Gayan; Guo, Yujie; Huang, Chaoqun; Metcalf, Jordan P.; Liu, Lin] Oklahoma Ctr Resp & Infect Dis, Stillwater, OK 74078 USA; [Bailey, Keith] Oklahoma State Univ, Dept Vet Pathobiol, Stillwater, OK 74078 USA; [Bailey, Keith] Oklahoma Anim Dis Diagnost Lab, Stillwater, OK USA; [Metcalf, Jordan P.] Univ Oklahoma, Dept Med, Hlth Sci Ctr, Pulm & Crit Care Div, Oklahoma City, OK USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; University of Oklahoma System; University of Oklahoma Health Sciences Center	Liu, L (corresponding author), Oklahoma State Univ, Dept Physiol Sci, Lundberg Kienlen Lung Biol & Toxicol Lab, Stillwater, OK 74078 USA.; Liu, L (corresponding author), Oklahoma Ctr Resp & Infect Dis, Stillwater, OK 74078 USA.	lin.liu@okstate.edu		Liu, Lin/0000-0002-4811-4897	NIH [AI121591, HL116876, HL135152, GM103648, AI062629]; Oklahoma Center for the Advancement of Science Technology; Oklahoma Center for Adult Stem Cell Research; Lundberg-Kienlen endowment fund; Center of Veterinary Health Sciences, Oklahoma State University; Merit Review Program of the Department of Veterans Affairs; Flight Attendant Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116876, R01HL135152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121591, U19AI062629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103648] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science Technology; Oklahoma Center for Adult Stem Cell Research; Lundberg-Kienlen endowment fund; Center of Veterinary Health Sciences, Oklahoma State University; Merit Review Program of the Department of Veterans Affairs(US Department of Veterans Affairs); Flight Attendant Medical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	L.L. is supported by NIH grants AI121591, HL116876, HL135152 and GM103648, the Oklahoma Center for the Advancement of Science & Technology, the Oklahoma Center for Adult Stem Cell Research, the Lundberg-Kienlen endowment fund and seed grants from the Center of Veterinary Health Sciences, Oklahoma State University. J.P.M. is supported by NIH grants AI062629 and GM103648, the Merit Review Program of the Department of Veterans Affairs, and the Flight Attendant Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeffner F, 2012, AM J RESP CELL MOL, V47, P543, DOI 10.1165/rcmb.2012-0112OC; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Arias-Romero LE, 2013, CANCER RES, V73, P3671, DOI 10.1158/0008-5472.CAN-12-4453; Baril M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003416; Bhaskaran M, 2007, J BIOL CHEM, V282, P3968, DOI 10.1074/jbc.M609060200; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Cawood R, 2007, CELL CYCLE, V6, P863, DOI 10.4161/cc.6.7.4032; Dandekar S, 2014, BRIT J HAEMATOL, V167, P87, DOI 10.1111/bjh.13011; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; Govorkova EA, 2010, VIRUSES-BASEL, V2, P1510, DOI 10.3390/v2081510; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; HAYDEN FG, 1992, CURR TOP MICROBIOL, V176, P119; Hillesheim A, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-29; Hopkins K, 2013, CELL CYCLE, V12, P3711, DOI 10.4161/cc.26878; Juang YT, 1998, P NATL ACAD SCI USA, V95, P9837, DOI 10.1073/pnas.95.17.9837; Kelso JK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-81; Kumar A, 2008, J VIROL, V82, P2813, DOI 10.1128/JVI.02498-07; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Kumar N, 2011, ANTIMICROB AGENTS CH, V55, P5553, DOI 10.1128/AAC.00725-11; Lamb RA, 2003, LIPPINCOTT RAVEN, P1487; Liu J, 2011, ARCH VIROL, V156, P1013, DOI 10.1007/s00705-011-0943-x; LU Y, 1995, VIROLOGY, V214, P222, DOI 10.1006/viro.1995.9937; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; Ma B, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00378; Mishra A, 2016, J IMMUNOL, V197, P2828, DOI 10.4049/jimmunol.1501041; Narasipura SD, 2012, J VIROL, V86, P1911, DOI 10.1128/JVI.06266-11; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Nimmerjahn F, 2004, J GEN VIROL, V85, P2347, DOI 10.1099/vir.0.79958-0; Noah DL, 2013, AM J PHYSIOL-LUNG C, V305, pL108, DOI 10.1152/ajplung.00105.2013; Perwitasari O, 2014, J VIROL, V88, P10228, DOI 10.1128/JVI.01774-14; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; REED L. J., 1938, AMER JOUR HYG, V27, P493; Samji Tasleem, 2009, Yale Journal of Biology and Medicine, V82, P153; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shirey KA, 2013, NATURE, V497, P498, DOI 10.1038/nature12118; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Street A, 2005, J VIROL, V79, P5006, DOI 10.1128/JVI.79.8.5006-5016.2005; Tanaka M, 2014, J CLIN INVEST, V124, P3061, DOI 10.1172/JCI72399; Wang Y, 2013, NUCLEIC ACIDS RES, V41, P3833, DOI 10.1093/nar/gks1460; Watanabe T, 2014, CELL HOST MICROBE, V16, P795, DOI 10.1016/j.chom.2014.11.002; Weiser K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077865; WRAY SK, 1985, ANTIVIR RES, V5, P29, DOI 10.1016/0166-3542(85)90012-9; Wurzer WJ, 2004, J BIOL CHEM, V279, P30931, DOI 10.1074/jbc.M403258200	48	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191010	10.1371/journal.pone.0191010	http://dx.doi.org/10.1371/journal.pone.0191010			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324866	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400091
J	Shahzad, MMK; Felder, M; Ludwig, K; Van Gelder, HR; Anderson, ML; Kim, J; Cook, ME; Kapur, AK; Patankar, MS				Shahzad, Mian M. K.; Felder, Mildred; Ludwig, Kai; Van Gelder, Hannah R.; Anderson, Matthew L.; Kim, Jong; Cook, Mark E.; Kapur, Arvinder K.; Patankar, Manish S.			Trans10, cis12 conjugated linoleic acid inhibits proliferation and migration of ovarian cancer cells by inducing ER stress, autophagy, and modulation of Src	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; COLON; APOPTOSIS; ISOMERS; KINASE; EXPRESSION; BREAST; DEPHOSPHORYLATION; ANTICARCINOGENS; DERIVATIVES	The goal of this study was to investigate the anti-cancer effects of Trans10, cis12 conjugated linoleic acid (t10, c12 CLA). MTT assays and QCM T chemotaxis 96-wells were used to test the effect of t10, c12 CLA on the proliferation and migration and invasion of cancer cells. qPCR and Western Blotting were used to determine the expression of specific factors. RNA sequencing was conducted using the Illumina platform and apoptosis was measured using a flow cytometry assay. t10, c12 CLA (IC50, 7 mu M) inhibited proliferation of ovarian cancer cell lines SKOV-3 and A2780. c9, t11 CLA did not attenuate the proliferation of these cells. Transcription of 165 genes was significantly repressed and 28 genes were elevated. Genes related to ER stress, ATF4, CHOP, and GADD34 were overexpressed whereas EDEM2 and Hsp90, genes required for proteasomal degradation of misfolded proteins, were downregulated upon treatment. While apoptosis was not detected, t10, c12 CLA treatment led to 9-fold increase in autophagolysosomes and higher levels of LC3-II. G1 cell cycle arrest in treated cells was correlated with phosphorylation of GSK3 beta and loss of beta-catenin. microRNA miR184 and miR215 were upregulated. miR184 likely contributed to G1 arrest by downregulating E2F1. miR215 upregulation was correlated with increased expression of p27/Kip-1. t10, c12 CLA-mediated inhibition of invasion and migration correlated with decreased expression of PTP1b and decreased Src activation by inhibiting phosphorylation at Tyr 416. Due to its ability to inhibit proliferation and migration, t10, c12 CLA should be considered for treatment of ovarian cancer.	[Shahzad, Mian M. K.; Felder, Mildred; Ludwig, Kai; Van Gelder, Hannah R.; Kapur, Arvinder K.; Patankar, Manish S.] Univ Wisconsin, Dept Obstet & Gynecol, Div Gynecol Oncol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Shahzad, Mian M. K.] H Lee Moffitt Canc Ctr & Res Inst, Dept Obstet & Gynecol, Tampa, FL USA; [Anderson, Matthew L.; Kim, Jong] Baylor Coll Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Cook, Mark E.] Univ Wisconsin Sch Madison, Dept Anim Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; H Lee Moffitt Cancer Center & Research Institute; Baylor College of Medicine	Kapur, AK; Patankar, MS (corresponding author), Univ Wisconsin, Dept Obstet & Gynecol, Div Gynecol Oncol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	akapur@wisc.edu; patankar@wisc.edu	Anderson, Matthew/C-4755-2019	Anderson, Matthew/0000-0002-2081-4672; Ludwig, Kai/0000-0001-9867-9346; Patankar, Manish/0000-0002-8205-6432	Department of Obstetrics and Gynecology at UW-Madison; NCI (T32 training grant) [CA 009614]; Cancer Prevention and Research Institute of Texas [RP11035]; Partnership for Baylor College of Medicine; Ovarian Cancer Research Fund; Young Texans Against Cancer; Cancer Fighters of Houston; Alkek Foundation; NATIONAL CANCER INSTITUTE [T32CA009614, T32CA009206] Funding Source: NIH RePORTER	Department of Obstetrics and Gynecology at UW-Madison; NCI (T32 training grant); Cancer Prevention and Research Institute of Texas; Partnership for Baylor College of Medicine; Ovarian Cancer Research Fund; Young Texans Against Cancer; Cancer Fighters of Houston; Alkek Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by an intramural grant from the Department of Obstetrics and Gynecology (MS, AK, and MSP) at UW-Madison, and a grant from the NCI (T32 training grant CA 009614) to MS. Additional support was provided by RP11035 from the Cancer Prevention and Research Institute of Texas (MLA), Partnership for Baylor College of Medicine (MLA), Ovarian Cancer Research Fund (MLA), Young Texans Against Cancer (MLA), Cancer Fighters of Houston (MLA) and the Alkek Foundation (MLA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Bilal Hafeez for providing helpful discussions. Author contributions: M.M.S., A. K.K., and M.S.P. designed the study. M.M.S., A.K.K., K.L., and H.R.V.G. performed all experiments, analyzed data, and helped prepare the manuscript. M.L.A., J.K. prepared small RNA sequencing libraries and performed small RNA sequencing. M.F. helped with flow cytometry and cell culture assays, K.L. and H.R.V.G helped with MTT assays,. M.E.C. provided expert and essential advice on CLA biochemistry and the CLA literature and M.S.P. designed and edited the manuscript. This research was supported by an intramural grants from the Department of Obstetrics and Gynecology (MS, AK, and MSP) at UW-Madison, and a grant from the NCI (T32 training grant CA 009614) to MS. Additional support was provided by RP11035 from the Cancer Prevention and Research Institute of Texas (MLA), Partnership for Baylor College of Medicine (MLA), Ovarian Cancer Research Fund (MLA), Young Texans Against Cancer (MLA), Cancer Fighters of Houston (MLA) and the Alkek Foundation (MLA).	Beppu F, 2006, J NUTR BIOCHEM, V17, P830, DOI 10.1016/j.jnutbio.2006.01.007; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Boni V, 2010, MOL CANCER THER, V9, P2265, DOI 10.1158/1535-7163.MCT-10-0061; Cho HJ, 2006, J NUTR, V136, P893, DOI 10.1093/jn/136.4.893; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; Degner SC, 2006, J NUTR, V136, P421, DOI 10.1093/jn/136.2.421; Flowers M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005342; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Gildea JJ, 2000, BIOTECHNIQUES, V29, P81, DOI 10.2144/00291st02; Gubbels JAA, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-8; HA YL, 1987, CARCINOGENESIS, V8, P1881, DOI 10.1093/carcin/8.12.1881; Halder J, 2005, CLIN CANCER RES, V11, P8829, DOI 10.1158/1078-0432.CCR-05-1728; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hsu YC, 2011, CELL SIGNAL, V23, P2013, DOI 10.1016/j.cellsig.2011.07.015; Ip C, 2002, NUTR CANCER, V43, P52, DOI 10.1207/S15327914NC431_6; Ip MM, 2007, CARCINOGENESIS, V28, P1269, DOI 10.1093/carcin/bgm018; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; Jones LJ, 2001, J IMMUNOL METHODS, V254, P85, DOI 10.1016/S0022-1759(01)00404-5; Kelley NS, 2007, J NUTR, V137, P2599, DOI 10.1093/jn/137.12.2599; Kuniyasu H, 2006, INT J CANCER, V118, P571, DOI 10.1002/ijc.21368; Lau DSY, 2010, NUTR CANCER, V62, P116, DOI 10.1080/01635580903191536; Lim DY, 2005, J CELL PHYSIOL, V205, P107, DOI 10.1002/jcp.20380; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053178; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; Miller A, 2001, LIPIDS, V36, P1161, DOI 10.1007/s11745-001-0827-0; Mosley EE, 2006, J NUTR, V136, P2297, DOI 10.1093/jn/136.9.2297; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Ou LH, 2008, J LIPID RES, V49, P985, DOI 10.1194/jlr.M700465-JLR200; PARIZA MW, 1990, MED ONCOL TUMOR PHAR, V7, P169; QIN XQ, 1995, MOL CELL BIOL, V15, P742; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Shahzad MMK, 2011, NEOPLASIA, V13, P309, DOI 10.1593/neo.101372; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Soel SM, 2007, J NUTR BIOCHEM, V18, P650, DOI 10.1016/j.jnutbio.2006.10.011; Wang LS, 2006, ANTICANCER RES, V26, P889; Yamasaki M, 2002, CANCER LETT, V188, P171, DOI 10.1016/S0304-3835(02)00459-7	41	12	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0189524	10.1371/journal.pone.0189524	http://dx.doi.org/10.1371/journal.pone.0189524			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324748	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400009
J	Shin, JH; Roh, D; Lee, DH; Kim, SW; Kim, SW; Cho, JH; Kim, BG; Kim, BY				Shin, Ji-Hyeon; Roh, Daeyoung; Lee, Dong-Hee; Kim, Soo Whan; Kim, Sung Won; Cho, Jin Hee; Kim, Byung-Guk; Kim, Boo-Young			Allergic rhinitis and rhinosinusitis synergistically compromise the mental health and health-related quality of life of Korean adults: A nationwide population-based survey	PLOS ONE			English	Article							RISK-FACTORS; SYMPTOMS; PREVALENCE; SEVERITY; DISEASE; ASTHMA; IMPACT; ASSOCIATION; DEPRESSION; CYTOKINES	Background Allergic rhinitis (AR) and rhinosinusitis (RS) negatively impact psychological well-being and health-related quality of life (HRQoL). However, few population-based studies have investigated the effects of these conditions on mental health and HRQoL. Purpose To explore independent associations of AR and/or RS with mental health and HRQoL using data from the 2013-2015 Korea National Health and Nutrition Examination Survey (KNHANES). Methods The KNHANES is a nationwide cross-sectional survey of the non-institutionalized population of Korea. A total of 15,441 adults completed the clinical examination and the health questionnaire. We divided all participants into four groups: AR-/RS-, AR-/RS+, AR+/RS-, and AR+/RS+. Logistic regression analyses were performed after adjustment for sociodemographic characteristics, general health behaviors, and other comorbidities. Results The AR+/RS+ group contained the highest proportion of subjects with perceived stress and depressed mood. Subjects with AR+/RS+ also had more frequent problems in terms of pain/discomfort and anxiety/depression. After adjusting for all confounders, the odds ratios (ORs) were 2.96 (p = 0.009) for depressed mood and 3.17 (p = 0.013) for suicidal ideation in the AR+/RS+ group compared with in the AR-/RS- group. The AR+/RS- group reported more perceived stress (OR, 1.56, p = 0.003) and depression (OR, 1.72, p = 0.024) compared with the AR-/RS- group. In terms of the ORs for HRQoL, the AR+/RS+ group reported more problems in terms of self-care (OR, 3.73, p = 0.038) and more pain/discomfort (OR 2.19, p = 0.006) compared with the AR-/RS- group. Conclusions In the Korean population, AR and RS exerted a synergistic negative impact on mental health and HRQoL, especially suicidal ideation. Most patients seek help from clinicians for impaired HRQoL. Therefore, clinicians should consider the underlying mental health and HRQoL of patients with AR and/or RS, as these may be impaired by their conditions.	[Shin, Ji-Hyeon; Lee, Dong-Hee; Kim, Soo Whan; Kim, Sung Won; Cho, Jin Hee; Kim, Byung-Guk; Kim, Boo-Young] Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Roh, Daeyoung] Hallym Univ, Chuncheon Sacred Heart Hosp, Dept Psychiat, Coll Med, Chuncheon Si, Gangwon Do, South Korea; [Roh, Daeyoung] Hallym Univ, Mind Neuromodulat Lab, Coll Med, Chuncheon Si, Gangwon Do, South Korea	Catholic University of Korea; Hallym University; Hallym University	Lee, DH (corresponding author), Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	leedh0814@catholic.ac.kr		Roh, Daeyoung/0000-0001-7242-9496; Shin, Ji-Hyeon/0000-0003-0934-8700; Lee, Darrall/0000-0002-6990-4441; Lee, Dong-Hee/0000-0002-0401-1183				Ahn JC, 2016, JAMA OTOLARYNGOL, V142, P162, DOI 10.1001/jamaoto.2015.3142; American Psychiatric Association, 2013, DIAGNOSTIC AND STATI; An SY, 2015, ASIAN PAC J ALLERGY, V33, P143, DOI [10.12932/AP0554.33.2.2015, 10.12932/ap0554.33.2.2015]; Beeckmans N, 2016, MANUAL THER, V26, P77, DOI 10.1016/j.math.2016.07.011; Bhattacharyya N, 2012, AM J RHINOL ALLERGY, V26, P120, DOI 10.2500/ajra.2012.26.3752; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Brozek JL, 2017, J ALLERGY CLIN IMMUN; Caulley L, 2015, J ALLERGY CLIN IMMUN, V136, P1517, DOI 10.1016/j.jaci.2015.08.037; Chapurin N, 2017, OTOLARYNG HEAD NECK, V156, P751, DOI 10.1177/0194599817691476; Christensen RAG, 2016, CLIN OBES, V6, P389, DOI 10.1111/cob.12164; Cox DR, 2016, INT FORUM ALLERGY RH, V6, P308, DOI 10.1002/alr.21664; Crump R Trafford, 2017, Int Forum Allergy Rhinol, V7, P480, DOI 10.1002/alr.21917; Erskine SE, 2017, RHINOLOGY, V55, P113, DOI [10.4193/Rhino16.111, 10.4193/Rhin16.111]; EuroQol, 1990, HLTH POLICY, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9; Feng CH, 2012, AM J RHINOL ALLERGY, V26, P187, DOI 10.2500/ajra.2012.26.3762; Fokkens Wytske J, 2012, Rhinol Suppl, V23, P1; Fu QL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126881; Gananca L, 2016, PSYCHONEUROENDOCRINO, V63, P296, DOI 10.1016/j.psyneuen.2015.10.008; Georgalas C, 2014, ALLERGY, V69, P828, DOI 10.1111/all.12413; Gray ST, 2017, CLIN OTOLARYNGOL; Guyatt GH, 2007, MAYO CLIN PROC, V82, P1229, DOI 10.4065/82.10.1229; Han YY, 2016, J ALLERGY CLIN IMMUN, V137, P1460, DOI 10.1016/j.jaci.2015.12.1307; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hoehle LP, 2016, RHINOLOGY, V54, P316, DOI [10.4193/Rhin16.211, 10.4193/Rhino16.211]; Illum L, 2004, J PHARM PHARMACOL, V56, P3, DOI 10.1211/0022357022539; Jaruvongvanich V, 2016, ALLERGOL INT, V65, P199, DOI 10.1016/j.alit.2015.11.006; Joo YH, 2015, AM J RHINOL ALLERGY, V29, P268, DOI 10.2500/ajra.2015.29.4194; Katotomichelakis M, 2014, INT J PSYCHIAT MED, V48, P83, DOI 10.2190/PM.48.2.a; Kim DH, 2016, CLIN EXP OTORHINOLAR, V9, P150, DOI 10.21053/ceo.2015.01053; Kim DH, 2016, ALLERGY ASTHMA IMMUN, V8, P49, DOI 10.4168/aair.2016.8.1.49; Kim JH, 2016, RHINOLOGY, V54, P329, DOI [10.4193/Rhin15.157, 10.4193/Rhino15.157]; Kim SH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173075; Kim YS, 2011, AM J RHINOL ALLERGY, V25, pE117, DOI 10.2500/ajra.2011.25.3630; Ko Y, 2006, CURR MED RES OPIN, V22, P2065, DOI 10.1185/030079906X132622; Koinis-Mitchell D, 2012, J ALLERGY CLIN IMMUN, V130, P1275, DOI 10.1016/j.jaci.2012.06.026; Krouse HJ, 2002, OTOLARYNG HEAD NECK, V126, P607, DOI 10.1067/mhn.2002.125300; Lichtblau N, 2013, INT REV PSYCHIATR, V25, P592, DOI 10.3109/09540261.2013.813442; Lin SY, 2012, INT FORUM ALLERGY RH, V2, P51, DOI 10.1002/alr.20102; Lin XJ, 2013, TZU CHI MED J, V25, P8, DOI 10.1016/j.tcmj.2012.09.002; Maspero J, 2012, CLIN EXP ALLERGY, V42, P1684, DOI 10.1111/j.1365-2222.2012.04025.x; Miller AH, 2013, DEPRESS ANXIETY, V30, P297, DOI 10.1002/da.22084; Min JY, 2017, J ALLERGY CLIN IMMUN, V140, P1562, DOI 10.1016/j.jaci.2017.05.032; Murdaugh C, 1997, MED CARE, V35, pNS41, DOI 10.1097/00005650-199711001-00005; Nathan RA, 2007, ALLERGY ASTHMA PROC, V28, P3, DOI 10.2500/aap.2007.28.2934; OECD, 2013, HLTH GLANC 2013 OECD, DOI [10.1787/health_glance-2013-49-en, DOI 10.1787/HEALTH_GLANCE-2013-49-EN]; Olowosusi OZ, 2015, EUR ARCH OTO-RHINO-L, V272, P2341, DOI 10.1007/s00405-014-3348-0; Pardeshi CV, 2013, EXPERT OPIN DRUG DEL, V10, P957, DOI 10.1517/17425247.2013.790887; Philpott C, 2016, RHINOLOGY, V54, P134, DOI [10.4193/Rhin15.272, 10.4193/Rhino15.272]; Rhee CS, 2014, AM J RHINOL ALLERGY, V28, pE107, DOI 10.2500/ajra.2014.28.4040; Rosati MG, 2016, AM J RHINOL ALLERGY, V30, P44, DOI 10.2500/ajra.2016.30.4252; Schatz M, 2007, ALLERGY, V62, P9, DOI 10.1111/j.1398-9995.2007.01548.x; Shi JB, 2015, ALLERGY, V70, P533, DOI 10.1111/all.12577; Smith KA, 2015, LARYNGOSCOPE, V125, P1547, DOI 10.1002/lary.25180; Smith MP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161461; Soler ZM, 2015, INT FORUM ALLERGY RH, V5, P1010, DOI 10.1002/alr.21581; Szeinbach Sheryl L, 2007, Prim Care Respir J, V16, P98, DOI 10.3132/pcrj.2007.00015; Testa MA, 1996, NEW ENGL J MED, V334, P835, DOI 10.1056/NEJM199603283341306; Tomassen P, 2016, J ALLERGY CLIN IMMUN, V137, P1449, DOI 10.1016/j.jaci.2015.12.1324; Trikojat K, 2017, BRAIN BEHAV IMMUN, V65, P202, DOI 10.1016/j.bbi.2017.05.005	60	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191115	10.1371/journal.pone.0191115	http://dx.doi.org/10.1371/journal.pone.0191115			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BJ	29324857	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400117
J	Stoltze, U; Skytte, AB; Roed, H; Hasle, H; Ejlertsen, B; Hansen, TV; Schmiegelow, K; Gerdes, AM; Wadt, K				Stoltze, Ulrik; Skytte, Anne-Bine; Roed, Henriette; Hasle, Henrik; Ejlertsen, Bent; Hansen, Thomas van Overeem; Schmiegelow, Kjeld; Gerdes, Anne-Marie; Wadt, Karin			Clinical characteristics and registry-validated extended pedigrees of germline TP53 mutation carriers in Denmark	PLOS ONE			English	Article							LI-FRAUMENI SYNDROME; ONSET BREAST-CANCER; IMAGING SURVEILLANCE; INDIVIDUALS; FAMILIES; BRCA2; TUMOR	Introduction TP53 mutation carrier (Li-Fraumeni Syndrome, LFS) cohort studies often suffer from lack of extensive pedigree exploration. Methods We performed a nation-wide exploration of TP53 mutation carrier families identified through all clinical genetics departments in Denmark. Pedigrees were expanded and verified using unique national person identification, cancer, cause of death, pathology, and church registries. Results We identified 30 confirmed, six obligate and 14 assumed carriers in 15 families harboring 14 different mutations, including five novel and three de novo germline mutations. All but two (96%) developed cancer by age 54 years [mean debut age; 29.1 y., median 33.0 y., n = 26 (17F, 9M), range 1-54 y]]. Cancer was the primary cause of all deaths [average age at death; 34.5 years]. Two tumors were identified through registry data alone. Two independent families harbored novel c. 80delC mutations shown to be related through an ancestor born in 1907. This exhaustive national collection yielded markedly fewer TP53 mutation carriers than the 300-1,100 expected based on estimated background population frequencies. Conclusion Germline TP53 mutations in Denmark are likely to be drastically underdiagnosed despite their severe phenotype. Following recent advances in surveillance options of LFS patients, lack of pre-symptomatic testing may lead to the mismanagement of some individuals.	[Stoltze, Ulrik; Gerdes, Anne-Marie; Wadt, Karin] Rigshosp, Clin Genet Dept, Copenhagen, Denmark; [Stoltze, Ulrik; Schmiegelow, Kjeld] Rigshosp, Pediat Oncol Lab, Copenhagen, Denmark; [Skytte, Anne-Bine] Aarhus Univ Hosp, Clin Genet Dept, Aarhus, Denmark; [Roed, Henriette] Odense Univ Hosp, Clin Genet Dept, Odensen, Denmark; [Hasle, Henrik] Aarhus Univ Hosp, Pediat & Adolescent Med, Aarhus, Denmark; [Ejlertsen, Bent] Rigshosp, Finsen Ctr, Oncol Clin, Copenhagen, Denmark; [Hansen, Thomas van Overeem] Rigshosp, Ctr Genom Med, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University; University of Southern Denmark; Odense University Hospital; Aarhus University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen	Stoltze, U (corresponding author), Rigshosp, Clin Genet Dept, Copenhagen, Denmark.; Stoltze, U (corresponding author), Rigshosp, Pediat Oncol Lab, Copenhagen, Denmark.	ulrik.kristoffer.stoltze@regionh.dk	Hansen, Thomas v. O./J-9361-2014; Hansen, Thomas/GWZ-2858-2022	Hansen, Thomas v. O./0000-0003-4635-2653; Skytte, Anne-Bine/0000-0002-0067-9557; Gerdes, Anne-Marie/0000-0002-0328-3320; Hasle, Henrik/0000-0003-3976-9231	Kraeftens Bekaempelse [A8697, 2015-6]; The Danish Cancer Society [R136-A8693] Funding Source: researchfish	Kraeftens Bekaempelse; The Danish Cancer Society(Danish Cancer Society)	This work was supported by a project funding from Kraeftens Bekaempelse, A8697, (https://www.cancer.dk/) awarded to US and Bornecancerfonden, 2015-6, (https:// boernecancerfonden.dk/) awarded to KS; 3) Rigshospitalet (DK), awarded to AMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariffin H, 2014, P NATL ACAD SCI USA, V111, P15497, DOI 10.1073/pnas.1417322111; Bougeard G, 2015, J CLIN ONCOL, V33, P2345, DOI 10.1200/JCO.2014.59.5728; Custodio G, 2013, J CLIN ONCOL, V31, P2619, DOI 10.1200/JCO.2012.46.3711; de Andrade M, 2001, GENET EPIDEMIOL, V20, P258, DOI 10.1002/1098-2272(200102)20:2<258::AID-GEPI8>3.0.CO;2-N; Gonzalez KD, 2009, J MED GENET, V46, P689, DOI 10.1136/jmg.2008.058958; Gonzalez KD, 2009, J CLIN ONCOL, V27, P1250, DOI 10.1200/JCO.2008.16.6959; Hettmer S, 2014, CANCER-AM CANCER SOC, V120, P1068, DOI 10.1002/cncr.28507; Holmfeldt L, 2013, NAT GENET, V45, P242, DOI 10.1038/ng.2532; Jonson L, 2016, BREAST CANCER RES TR, V155, P215, DOI 10.1007/s10549-015-3674-y; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kratz CP, 2017, CLIN CANCER RES, V23, pE38, DOI 10.1158/1078-0432.CCR-17-0408; Lalloo F, 2006, EUR J CANCER, V42, P1143, DOI 10.1016/j.ejca.2005.11.032; Lalloo F, 2003, LANCET, V361, P1101, DOI 10.1016/S0140-6736(03)12856-5; Lammens C, 2009, FAM CANCER, V8, P457, DOI 10.1007/s10689-009-9265-5; Magnusson S, 2012, PEDIATR BLOOD CANCER, V59, P846, DOI 10.1002/pbc.24223; Malkin D, 2011, CANCER, V2, P475, DOI [10.1177/1947601911413466, DOI 10.1177/1947601911413466]; Melhem-Bertrandt A, 2012, CANCER-AM CANCER SOC, V118, P908, DOI 10.1002/cncr.26377; Patrier-Sallebert S, 2015, J MED GENET, V52, P145, DOI 10.1136/jmedgenet-2014-102853; Simpson Joe Leigh, 2005, J Natl Cancer Inst Monogr, P87; Stecher CW, 2008, PEDIATR BLOOD CANCER, V50, P701, DOI 10.1002/pbc.21074; Villani A, 2016, LANCET ONCOL, V17, P1295, DOI 10.1016/S1470-2045(16)30249-2; Villani A, 2011, LANCET ONCOL, V12, P559, DOI 10.1016/S1470-2045(11)70119-X; Warner E, 2011, J CLIN ONCOL, V29, P1664, DOI 10.1200/JCO.2009.27.0835; Weitzel JN, 2007, JAMA-J AM MED ASSOC, V297, P2587, DOI 10.1001/jama.297.23.2587; Zhang JH, 2015, NEW ENGL J MED, V373, P2336, DOI 10.1056/NEJMoa1508054; Zhou X, 2016, NAT GENET, V48, P4, DOI 10.1038/ng.3466	26	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190050	10.1371/journal.pone.0190050	http://dx.doi.org/10.1371/journal.pone.0190050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324801	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400017
J	Xu, R; Jiang, YF; Zhang, YH; Yang, X				Xu, Rong; Jiang, Yong-fang; Zhang, Yong-hong; Yang, Xu			The optimal threshold of serum ceruloplasmin in the diagnosis of Wilson's disease: A large hospital-based study	PLOS ONE			English	Article							PENICILLAMINE CHALLENGE; CHILDREN ANALYSIS; LIVER-DISEASE; 3 DECADES; REEVALUATION; SPECIFICITY; SENSITIVITY; ACCURACY; PROTEIN; UPDATE	Background and aims A ceruloplasmin (CP) concentration <200 mg/L is conventionally considered as one of the major diagnostic criteria for Wilson's disease (WD). However, the diagnostic accuracy of this threshold has never been investigated in a sufficiently large group of patients. This study aims to present the results of serum CP measurements in various patients and to identify the optimal cutoff value of CP for the diagnosis of WD. Materials and methods We identified patients whose CP levels were evaluated from January 1, 2016 to December 31, 2016 using a laboratory information database. Data related to CP measurement were retrieved. We carefully reviewed patients' electronic medical records to correct errors and to obtain other necessary data. Data related to WD were retrieved from a special document containing medical records of patients with WD, which were created, modified, and maintained by authors. Results CP level was determined in 4048 patients (WD, 297; non-WD, 3751). The mean serum CP level in patients with WD was 50.6 +/- 44.2 mg/L, which was significantly lower than that in non-WD patients (293.2 +/- 117.3 mg/L, p<0.001). Only 1.0% of patients with WD had CP >= 200 mg/L. The sensitivity and specificity of CP for the diagnosis of WD were 99.0 and 80.9%, respectively, for the conventional cutoff value <200 mg/L and 95.6 and 95.5%, respectively, for the cutoff value <150 mg/L; the latter provided a higher diagnostic accuracy for WD. 53.0% of patients with liver failure, 37.7% of patients with nephrotic syndrome, and 23.0% of patients age 1 to 6 months had serum CP <200 mg/L. Patients who were pregnant and those with malignant tumors, and infectious and inflammatory diseases had significantly higher mean serum CP levels. Conclusion The optimal cutoff value of CP for the diagnosis of WD in China is 150 mg/L, with a sensitivity of 95.6% and specificity of 95.5%, thereby providing the highest diagnostic accuracy for WD.	[Xu, Rong] Cent S Univ, Xiangya Hosp 2, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China; [Jiang, Yong-fang; Zhang, Yong-hong; Yang, Xu] Cent S Univ, Xiangya Hosp 2, Dept Infect Dis, Liver Dis Res Ctr, Changsha, Hunan, Peoples R China	Central South University; Central South University	Yang, X (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Infect Dis, Liver Dis Res Ctr, Changsha, Hunan, Peoples R China.	yangxu1023@csu.edu.cn						Bielli P, 2002, CELL MOL LIFE SCI, V59, P1413, DOI 10.1007/s00018-002-8519-2; BREWER GJ, 1992, MEDICINE, V71, P139, DOI 10.1097/00005792-199205000-00004; COX DW, 1966, J LAB CLIN MED, V68, P893; DACOSTA CM, 1992, HEPATOLOGY, V15, P609, DOI 10.1002/hep.1840150410; El-Karaksy Hanaa, 2011, Arab J Gastroenterol, V12, P125, DOI 10.1016/j.ajg.2011.07.007; Feng Li, 2016, Sichuan Da Xue Xue Bao Yi Xue Ban, V47, P128; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; Gheorghe Liana, 2004, Rom J Gastroenterol, V13, P179; GITLIN JD, 1988, J BIOL CHEM, V263, P6281; Gow PJ, 2000, GUT, V46, P415, DOI 10.1136/gut.46.3.415; Gray LW, 2009, BIOCHEM J, V419, P237, DOI 10.1042/BJ20081983; He Gang, 2007, Zhonghua Gan Zang Bing Za Zhi, V15, P712; HOLMBERG CG, 1948, ACTA CHEM SCAND, V2, P550, DOI 10.3891/acta.chem.scand.02-0550; Jund J, 2005, MED DECIS MAKING, V25, P406, DOI 10.1177/0272989X05276855; Kim JA, 2015, PEDIATR GASTROENTERO, V18, P187, DOI 10.5223/pghn.2015.18.3.187; Lee BH, 2011, LIVER INT, V31, P833, DOI 10.1111/j.1478-3231.2011.02503.x; Leeflang MMG, 2008, CLIN CHEM, V54, P729, DOI 10.1373/clinchem.2007.096032; Linder MC, 2016, METALLOMICS, V8, P887, DOI 10.1039/c6mt00103c; Liu Y, 2015, ANAL BIOCHEM, V483, P7, DOI 10.1016/j.ab.2015.04.022; MACKIEWICZ A, 1988, BIOCHEM J, V253, P851, DOI 10.1042/bj2530851; MAINERO A, 1992, CLIN INVEST MED, V15, P295; Mak CM, 2008, CLIN CHEM, V54, P1356, DOI 10.1373/clinchem.2008.103432; Manolaki N, 2009, J PEDIATR GASTR NUTR, V48, P72, DOI 10.1097/MPG.0b013e31817d80b8; Merle U, 2007, GUT, V56, P115, DOI 10.1136/gut.2005.087262; MIDDLETON RB, 1993, ARCH BIOCHEM BIOPHYS, V302, P362, DOI 10.1006/abbi.1993.1224; Muller T, 2007, J HEPATOL, V47, P270, DOI 10.1016/j.jhep.2007.03.011; Nicastro E, 2010, HEPATOLOGY, V52, P1948, DOI 10.1002/hep.23910; PERMAN JA, 1979, J PEDIATR-US, V94, P564, DOI 10.1016/S0022-3476(79)80011-6; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; Rukunuzzaman M, 2015, PEDIATR GASTROENTERO, V18, P121, DOI 10.5223/pghn.2015.18.2.121; SCHEINBERG IH, 1952, SCIENCE, V116, P484, DOI 10.1126/science.116.3018.484; Scheinberg IH., 1984, WILSONS DIS; Sox HC, 1988, MED DECISION MAKING; Steindl P, 1997, GASTROENTEROLOGY, V113, P212, DOI 10.1016/S0016-5085(97)70097-0; Taly AB, 2007, MEDICINE, V86, P112, DOI 10.1097/MD.0b013e318045a00e; WALSHE JM, 1989, Q J MED, V70, P253; Walshe JM, 2005, MOVEMENT DISORD, V20, P1658, DOI 10.1002/mds.20628; Yang X, 2016, HEPATOLOGY, V64, P1382, DOI 10.1002/hep.28565; Yang X, 2015, HEPATOLOGY, V62, P1731, DOI 10.1002/hep.27932; Yang Xu, 2005, Zhonghua Nei Ke Za Zhi, V44, P13	40	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190887	10.1371/journal.pone.0190887	http://dx.doi.org/10.1371/journal.pone.0190887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324775	Green Submitted, gold, Green Published			2022-12-26	WOS:000419952400067
J	Gonzalez, C; Leon, C; Paz, A; Lopez, M; Molina, G; Toro, D; Ortiz, M; Cordovez, JM; Atencia, MC; Aguilera, G; Tovar, C				Gonzalez, Camila; Leon, Cielo; Paz, Andrea; Lopez, Marla; Molina, Gisell; Toro, Diana; Ortiz, Mario; Manuel Cordovez, Juan; Claudia Atencia, Maria; Aguilera, Germaan; Tovar, Catalina			Diversity patterns, Leishmania DNA detection, and bloodmeal identification of Phlebotominae sand flies in villages in northern Colombia	PLOS ONE			English	Article							AMERICAN CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; DIPTERA PSYCHODIDAE; LUTZOMYIA-LONGIPALPIS; VALENCIA CORDOBA; BREEDING SITES; ENDEMIC FOCUS; TRANSMISSION; ECOLOGY; VECTOR	Leishmaniases are neglected tropical diseases exhibiting complex transmission cycles due to the number of parasite species circulating, sand fly species acting as vectors and infected mammals, including humans, which are defined in the New World as accidental hosts. However, current transmission scenarios are changing, and the disease is no longer exclusively related to forested areas but urban transmission foci occur, involving some species of domestic animals as suspected reservoirs. The aim of this study was to determine the transmission cycles in urban environments by evaluating sand fly diversity, detection of Leishmania DNA, and bloodmeal sources through intra and peridomestic collections. The study was carried out in Colombia, in 13 municipalities of Cordoba department, implementing a methodology that could be further used for the evaluation of vector-borne diseases in villages or towns. Our sampling design included 24 houses randomly selected in each of 15 villages distributed in 13 municipalities, which were sampled in two seasons in 2015 and 2016. Sand flies were collected using CDC light traps placed in intra and peridomestic habitats. In addition to the morphological identification, molecular identification through DNA barcodes was also performed. A total of 19,743 sand flies were collected and 13,848 of them (10,268 females and 3,580 males) were used in molecular procedures. Circulation of two known parasite species-Leishmania infantum and Leishmania panamensis was confirmed. Blood source analyses showed that sand flies fed on humans, particularly in the case of the known L. infantum vector, P. evansi; further analyses are advised to evaluate the reservoirs involved in parasite transmission. Our sampling design allowed us to evaluate potential transmission cycles on a department scale, by defining suspected vector species, parasite species present in different municipalities and feeding habits.	[Gonzalez, Camila; Leon, Cielo; Paz, Andrea; Lopez, Marla; Molina, Gisell; Toro, Diana; Ortiz, Mario; Aguilera, Germaan] Univ Los Andes, Dept Ciencias Biol, CIMPAT, Ctr Invest Microbiol & Parasitol Trop, Bogota, Colombia; [Manuel Cordovez, Juan] Univ Los Andes, Fac Ingn, Dept Ingn Biomed, Grp Biol Matemat,BIOMAC, Bogota, Colombia; [Claudia Atencia, Maria] Univ Sinu, Fac Ciencias Salud, Cordoba, Colombia; [Tovar, Catalina] Univ Sinu, Fac Ciencias Salud, Grp Enfermedades Trop & Resistencia Bacteriana, Cordoba, Colombia; [Paz, Andrea] CUNY City Coll, Dept Biol, New York, NY USA; [Paz, Andrea] CUNY, Grad Ctr, Dept Biol, New York, NY USA	Universidad de los Andes (Colombia); Universidad de los Andes (Colombia); City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Gonzalez, C (corresponding author), Univ Los Andes, Dept Ciencias Biol, CIMPAT, Ctr Invest Microbiol & Parasitol Trop, Bogota, Colombia.	c.gonzalez2592@uniandes.edu.co	González, Camila/AAW-9144-2021; Paz, Andrea/W-1068-2019	Paz, Andrea/0000-0001-6484-1210; Gonzalez, Camila/0000-0001-8089-4056	GOBERNACION DE CORDOBA, SISTEMA GENERAL DE REGALIAS (SGR) Colombia [754/2013]	GOBERNACION DE CORDOBA, SISTEMA GENERAL DE REGALIAS (SGR) Colombia	Funded by GOBERNACION DE CORDOBA, SISTEMA GENERAL DE REGALIAS (SGR) Colombia. Grant number 754/2013. https://vmv.sgr.gov.co/.	Abbasi I, 2009, VECTOR-BORNE ZOONOT, V9, P79, DOI 10.1089/vbz.2008.0064; Acosta L, 2015, REV INST MED TROP SP, V57, P175, DOI 10.1590/S0036-46652015000200013; Akhoundi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004349; Alexander B, 2002, EMERG INFECT DIS, V8, P1480, DOI 10.3201/eid0812.010485; Ashford RW, 1996, CLIN DERMATOL, V14, P523, DOI 10.1016/0738-081X(96)00041-7; Azpurua J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000627; Barreto M, 2000, MEM I OSWALDO CRUZ, V95, P633, DOI 10.1590/S0074-02762000000500009; Bejarano Eduar Elias, 2003, Biomedica, V23, P341; Bejarano EE, 2002, MEM I OSWALDO CRUZ, V97, P645, DOI 10.1590/S0074-02762002000500010; CHRISTENSEN HA, 1983, J MED ENTOMOL, V20, P463, DOI 10.1093/jmedent/20.5.463; Cochero Suljey, 2007, Rev Cubana Med Trop, V59, P0; Gutierrez MAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085496; Contreras M. Y. Lopez, 2013, THESIS; Cortes LA, 2008, BIOMEDICA, P433; Cotton JA, 2017, TRENDS PARASITOL, V33, P341, DOI 10.1016/j.pt.2017.02.002; Ramirez JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep28266; Duque P, 2004, NEOTROP ENTOMOL, V33, P255, DOI 10.1590/S1519-566X2004000200018; El Tai NO, 2000, T ROY SOC TROP MED H, V94, P575, DOI 10.1016/S0035-9203(00)90093-2; Feliciangeli MD, 2004, MED VET ENTOMOL, V18, P71, DOI 10.1111/j.0269-283X.2004.0487.x; Feliciangeli MD, 1998, MED VET ENTOMOL, V12, P121, DOI 10.1046/j.1365-2915.1998.00072.x; FERRO C, 1995, J MED ENTOMOL, V32, P618, DOI 10.1093/jmedent/32.5.618; Ferro C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139391; Ferro C, 2011, AM J TROP MED HYG, V85, P847, DOI 10.4269/ajtmh.2011.10-0560; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Galati EAB, 2005, APOSTILA BIOECOLOGIA; González Camila, 2006, Biomed., V26, P64; Gonzalez C, 2014, ACTA TROP, V129, P83, DOI 10.1016/j.actatropica.2013.08.014; Gonzalez M, 2009, ACTA OTORRINOLAR ESP, V60, P298, DOI 10.1016/j.otorri.2009.01.006; Harhay MO, 2011, TRENDS PARASITOL, V27, P403, DOI 10.1016/j.pt.2011.04.001; Hernandez C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0501-y; Vivero RJ, 2017, J VECTOR DIS, V54, P87; Vivero RJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0711-y; Le Pape P., 1992, THESIS; Molaei G, 2008, J MED ENTOMOL, V45, P1143, DOI 10.1603/0022-2585(2008)45[1143:HPOPMV]2.0.CO;2; Montoya-Lerma J, 2003, ACTA TROP, V85, P19, DOI 10.1016/S0001-706X(02)00189-4; Montoya-Lerma J, 1999, FLEBOTOMOS DIPTERA P; MontoyaLerma J, 1996, B ENTOMOL RES, V86, P43, DOI 10.1017/S0007485300052184; MORRISON AC, 1993, AM J TROP MED HYG, V49, P68, DOI 10.4269/ajtmh.1993.49.68; Paternina LE, 2016, ACTA TROP, V153, P86, DOI 10.1016/j.actatropica.2015.10.005; Rodriguez N, 1999, T ROY SOC TROP MED H, V93, P47, DOI 10.1016/S0035-9203(99)90176-1; Romero-Ricardo L, 2016, ACTA TROP, V159, P125, DOI 10.1016/j.actatropica.2016.03.017; Rotureau B, 2006, AM J TROP MED HYG, V74, P81, DOI 10.4269/ajtmh.2006.74.81; Sandoval C. M., 1998, Biomedica, V18, P161; Sant'Anna MRV, 2008, ACTA TROP, V107, P230, DOI 10.1016/j.actatropica.2008.06.003; Santamaría Erika, 2006, Biomed., V26, P82; Schmidt KA, 2001, ECOLOGY, V82, P609, DOI 10.1890/0012-9658(2001)082[0609:BATDEI]2.0.CO;2; Travi B, 2002, MEM I OSWALDO CRUZ, V97, P887, DOI 10.1590/S0074-02762002000600025; TRAVI BL, 1994, AM J TROP MED HYG, V50, P557, DOI 10.4269/ajtmh.1994.50.557; Travi BL, 2002, J MED ENTOMOL, V39, P451, DOI 10.1603/0022-2585-39.3.451; Velez I D, 2001, Cad Saude Publica, V17, P171, DOI 10.1590/S0102-311X2001000100018; Vergel C, 2006, J INFECT DIS, V194, P503, DOI 10.1086/505583; Vieira VP, 2012, AM J TROP MED HYG, V87, P1089, DOI 10.4269/ajtmh.2012.12-0470; WHO, FACT SHEET; Patino-Londono SY, 2017, SALUD COLECT, V13, P123, DOI 10.18294/sc.2017.1079; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1	55	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190686	10.1371/journal.pone.0190686	http://dx.doi.org/10.1371/journal.pone.0190686			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320544	gold, Green Published, Green Submitted			2022-12-26	WOS:000419689600061
J	Inoue, A; Furukawa, A; Yamamoto, H; Ohta, S; Linh, NDH; Syerikjan, T; Kaida, S; Yamaguchi, T; Murata, S; Obata, T; Tani, M; Murata, K				Inoue, Akitoshi; Furukawa, Akira; Yamamoto, Hiroshi; Ohta, Shinichi; Nguyen Dai Hung Linh; Syerikjan, Tulyeubai; Kaida, Sachiko; Yamaguchi, Tsuyoshi; Murata, Satoshi; Obata, Toru; Tani, Masaji; Murata, Kiyoshi			Acceleration of small bowel motility after oral administration of dai-kenchu-to (TJ-100) assessed by cine magnetic resonance imaging	PLOS ONE			English	Article							STIMULATES COLONIC MOTILITY; INTRAABDOMINAL ADHESIONS; HERBAL MEDICINE; CROHNS-DISEASE; HUMAN PLASMA; DAIKENCHUTO; MRI; PERISTALSIS; MECHANISMS; SYSTEM	Dai-kenchu-to (TJ-100) is an herbal medicine used to shorten the duration of intestinal transit by accelerating intestinal movement. However, intestinal movement in itself has not been evaluated in healthy volunteers using radiography, fluoroscopy, and radioisotopes because of exposure to ionizing radiation. The purpose of this study was to evaluate the effect of TJ100 on intestinal motility using cinematic magnetic resonance imaging (cine MRI) with a steady-state free precession sequence. Ten healthy male volunteers received 5 g of either TJ-100 or lactose without disclosure of the identity of the substance. Each volunteer underwent two MRI examinations after taking the substances (TJ-100 and lactose) on separate days. They drank 1200 mL of tap water and underwent cine MRI after 10 min. A steadystate free precession sequence was used for imaging, which was performed thrice at 0, 10, 20, 30, 40, and 50 min. The bowel contraction frequency and distention score were assessed. Wilcoxon signed-rank test was used, and differences were considered significant at a P-value < 0.05. The bowel contraction frequency tended to be greater in the TJ-100 group and was significantly different in the ileum at 20 (TJ-100, 8.95 +/- 2.88; lactose, 4.80 +/- 2.92; P < 0.05) and 50 min (TJ-100, 9.45 +/- 4.49; lactose, 4.45 +/- 2.65; P < 0.05) between the groups. No significant differences were observed in the bowel distention scores. Cine MRI demonstrated that TJ-100 activated intestinal motility without dependence on ileum distention.	[Inoue, Akitoshi; Ohta, Shinichi; Murata, Kiyoshi] Shiga Univ Med Sci, Dept Radiol, Otsu, Shiga, Japan; [Furukawa, Akira; Nguyen Dai Hung Linh; Syerikjan, Tulyeubai] Tokyo Metropolitan Univ, Dept Radiol Sci, Arakawa, Tokyo, Japan; [Yamamoto, Hiroshi; Kaida, Sachiko; Yamaguchi, Tsuyoshi; Murata, Satoshi; Obata, Toru; Tani, Masaji] Shiga Univ Med Sci, Dept Surg, Otsu, Shiga, Japan	Shiga University of Medical Science; Tokyo Metropolitan University; Shiga University of Medical Science	Inoue, A (corresponding author), Shiga Univ Med Sci, Dept Radiol, Otsu, Shiga, Japan.	akino@belle.shiga-med.ac.jp	Inoue, Akitoshi/AAV-1760-2020	Inoue, Akitoshi/0000-0002-8610-2571				Buhmann-Kirchhoff S, 2008, EUR RADIOL, V18, P1215, DOI 10.1007/s00330-008-0881-5; Epithelial transient receptor potential ankyrin 1 (TRPA1), 2013, AM J PHYSIOL-GASTR L, V304, pG428; Froehlich JM, 2010, EUR RADIOL, V20, P1945, DOI 10.1007/s00330-010-1759-x; Ghobrial PM, 2014, ACAD RADIOL, V21, P86, DOI 10.1016/j.acra.2013.09.024; Girometti R, 2008, ACAD RADIOL, V15, P153, DOI 10.1016/j.acra.2007.08.010; Hahnemann ML, 2015, J MAGN RESON IMAGING, V41, P354, DOI 10.1002/jmri.24557; Hayakawa Terumasa, 1999, Journal of Smooth Muscle Research, V35, P55; Hayakawa Terumasa, 1999, Journal of Smooth Muscle Research, V35, P47; Iwabu J, 2010, DRUG METAB DISPOS, V38, P2040, DOI 10.1124/dmd.110.033589; Kawahara H, 2009, SURG TODAY, V39, P175, DOI 10.1007/s00595-008-3810-y; Kikuchi D, 2013, TOHOKU J EXP MED, V230, P197, DOI 10.1620/tjem.230.197; Kitazume Y, 2007, J COMPUT ASSIST TOMO, V31, P876, DOI 10.1097/rct.0b013e31804b1a26; Kito Yoshihiko, 2006, Journal of Smooth Muscle Research, V42, P189, DOI 10.1540/jsmr.42.189; Kono T, 2008, J SURG RES, V150, P78, DOI 10.1016/j.jss.2008.02.057; Kuehle Christiane A, 2006, AJR Am J Roentgenol, V187, pW375, DOI 10.2214/AJR.05.1079; Lang RA, 2008, SURG ENDOSC, V22, P2455, DOI 10.1007/s00464-008-9763-9; Lienemann A, 2000, RADIOLOGY, V217, P421, DOI 10.1148/radiology.217.2.r00oc23421; Manabe N, 2010, AM J PHYSIOL-GASTR L, V298, pG970, DOI 10.1152/ajpgi.00043.2010; Menys A, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140330; Menys A, 2013, RADIOLOGY, V269, P442, DOI 10.1148/radiol.13130151; Munekage M, 2011, DRUG METAB DISPOS, V39, P1784, DOI 10.1124/dmd.111.040097; Nagano T, 1999, BIOL PHARM BULL, V22, P1131, DOI 10.1248/bpb.22.1131; Neunlist M, 2014, J PHYSIOL-LONDON, V592, P2959, DOI 10.1113/jphysiol.2014.272948; Numata T, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/231258; Ohkubo H, 2013, AM J GASTROENTEROL, V108, P1130, DOI 10.1038/ajg.2013.57; Okada K, 2015, HEPATO-GASTROENTEROL, V62, P466, DOI 10.5754/hge14897; Psichas A, 2015, J CLIN INVEST, V125, P908, DOI 10.1172/JCI76309; Satoh K, 2001, BIOL PHARM BULL, V24, P1122, DOI 10.1248/bpb.24.1122; Satoh K, 2001, DIGEST DIS SCI, V46, P250, DOI 10.1023/A:1005636412287; Shibata C, 1999, SURGERY, V126, P918; Takahara T, 2011, JPN J RADIOL, V29, P11, DOI 10.1007/s11604-010-0508-z; Trung VN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065739; Wakamiya M, 2011, J MAGN RESON IMAGING, V33, P1235, DOI 10.1002/jmri.22529	33	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0191044	10.1371/journal.pone.0191044	http://dx.doi.org/10.1371/journal.pone.0191044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320574	Green Published, Green Submitted, gold			2022-12-26	WOS:000419689600084
J	Jeong, HS; Lee, SR; Kim, JE; Lyoo, IK; Yoon, S; Namgung, E; Chang, KT; Kim, BS; Yang, S; Im, JJ; Jeon, S; Kang, I; Ma, J; Chung, YA; Lim, SM				Jeong, Hyeonseok S.; Lee, Sang-Rae; Kim, Jieun E.; Lyoo, In Kyoon; Yoon, Sujung; Namgung, Eun; Chang, Kyu-Tae; Kim, Bom Sahn; Yang, Sejung; Im, Jooyeon J.; Jeon, Saerom; Kang, Ilhyang; Ma, Jiyoung; Chung, Yong-An; Lim, Soo Mee			Brain structural changes in cynomolgus monkeys administered with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A longitudinal voxel-based morphometry and diffusion tensor imaging study	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; PARKINSONS-DISEASE; GRAY-MATTER; MICROGLIAL ACTIVATION; BEHAVIORAL RECOVERY; ALZHEIMERS-DISEASE; PATHWAY LOSS; MPTP MODEL; IN-VIVO; PRIMATE	In animal models of Parkinson's disease (PD), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is one of the most widely used agents that damages the nigrostriatal dopaminergic pathway. However, brain structural changes in response to MPTP remain unclear. This study aimed to investigate in vivo longitudinal changes in gray matter (GM) volume and white matter (WM) microstructure in primate models administered with MPTP. In six cynomolgus monkeys, high-resolution magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) scans were acquired 7 times over 32 weeks, and assessments of motor symptoms were conducted over 15 months, before and after the MPTP injection. Changes in GM volume and WM microstructure were estimated on a voxel-by-voxel basis. Mixed-effects regression models were used to examine the trajectories of these structural changes. GM volume initially increased after the MPTP injection and gradually decreased in the striatum, midbrain, and other dopaminergic areas. The cerebellar volume temporarily decreased and returned to its baseline level. The rate of midbrain volume increase was positively correlated with the increase rate of motor symptom severity (Spearman rho = 0.93, p = 0.008). Mean, axial, and radial diffusivity in the striatum and frontal areas demonstrated initial increases and subsequent decreases. The current multi-modal imaging study of MPTP-administered monkeys revealed widespread and dynamic structural changes not only in the nigrostriatal pathway but also in other cortical, subcortical, and cerebellar areas. Our findings may suggest the need to further investigate the roles of inflammatory reactions and glial activation as potential underlying mechanisms of these structural changes.	[Jeong, Hyeonseok S.; Im, Jooyeon J.; Chung, Yong-An] Catholic Univ Korea, Incheon St Marys Hosp, Dept Radiol, Coll Med, Seoul, South Korea; [Lee, Sang-Rae; Chang, Kyu-Tae] Korean Res Inst Biosci & Biotechnol, Natl Primate Res Ctr, Ochang, South Korea; [Kim, Jieun E.; Lyoo, In Kyoon; Yoon, Sujung; Namgung, Eun; Im, Jooyeon J.; Jeon, Saerom; Kang, Ilhyang; Ma, Jiyoung] Ewha Womans Univ, Ewha Brain Inst, Seoul, South Korea; [Kim, Jieun E.; Lyoo, In Kyoon; Yoon, Sujung; Namgung, Eun; Jeon, Saerom; Kang, Ilhyang; Lim, Soo Mee] Ewha Womans Univ, Dept Brain & Cognit Sci, Seoul, South Korea; [Lyoo, In Kyoon] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea; [Kim, Bom Sahn] Ewha Womans Univ, Dept Nucl Med, Mokdong Hosp, Seoul, South Korea; [Yang, Sejung] Ewha Womans Univ, Inst Convergence Med, Med Ctr, Seoul, South Korea; [Im, Jooyeon J.; Ma, Jiyoung] Seoul Natl Univ, Coll Nat Sci, Interdisciplinary Program Neurosci, Seoul, South Korea; [Lim, Soo Mee] Ewha Womans Univ, Dept Radiol, Mokdong Hosp, Seoul, South Korea	Catholic University of Korea; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Ewha Womans University; Ewha Womans University; Ewha Womans University; Ewha Womans University; Ewha Womans University; Seoul National University (SNU); Ewha Womans University	Lim, SM (corresponding author), Ewha Womans Univ, Dept Brain & Cognit Sci, Seoul, South Korea.; Lim, SM (corresponding author), Ewha Womans Univ, Dept Radiol, Mokdong Hosp, Seoul, South Korea.	soomee@ewha.ac.kr		Ma, Jiyoung/0000-0002-1276-9330	Bio & Medical Technology Development Program [NRF-2012M3A9B6055362, NRF-2012M3A9B6055379]; National Research Foundation - Ministry of Science and ICT [2015M3C7A1028373, 2015R1A2A2A04003443]; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program [KGM4241743]	Bio & Medical Technology Development Program; National Research Foundation - Ministry of Science and ICT; Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	This research was supported by the Bio & Medical Technology Development Program (NRF-2012M3A9B6055362 and NRF-2012M3A9B6055379, B.S.K.), Brain Research Program (2015M3C7A1028373, I.K.L.), and a grant (2015R1A2A2A04003443, S.M.L.) through the National Research Foundation funded by the Ministry of Science and ICT, as well as the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program (KGM4241743, S.R.L.). The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Alexander GE, 2008, J NEUROSCI, V28, P2710, DOI 10.1523/JNEUROSCI.1852-07.2008; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barraud Q, 2009, EXP NEUROL, V219, P574, DOI 10.1016/j.expneurol.2009.07.019; Beaudoin-Gobert M, 2015, BRAIN, V138, P2632, DOI 10.1093/brain/awv183; Boulet S, 2008, J NEUROSCI, V28, P9575, DOI 10.1523/JNEUROSCI.3465-08.2008; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Brown CA, 2012, EXP NEUROL, V236, P190, DOI 10.1016/j.expneurol.2012.04.025; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Czlonkowska A, 1996, NEURODEGENERATION, V5, P137, DOI 10.1006/neur.1996.0020; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Davison AC, 1997, BOOTSTRAP METHODS TH; Dehmer T, 2000, J NEUROCHEM, V74, P2213, DOI 10.1046/j.1471-4159.2000.0742213.x; Gispert JD, 2016, ALZHEIMERS DEMENT, V12, P1259, DOI 10.1016/j.jalz.2016.06.005; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Durand E, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00042; EIDELBERG E, 1986, NEUROSCIENCE, V18, P817, DOI 10.1016/0306-4522(86)90102-8; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; HEIKKILA RE, 1989, MOL CHEM NEUROPATHOL, V10, P171, DOI 10.1007/BF03159727; HERKENHAM M, 1991, NEUROSCIENCE, V40, P133, DOI 10.1016/0306-4522(91)90180-V; Hikishima K, 2015, NEUROSCIENCE, V300, P585, DOI 10.1016/j.neuroscience.2015.05.041; Hikishima K, 2015, RADIOLOGY, V275, P430, DOI 10.1148/radiol.14140601; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Jeong HS, 2016, INT J IMAG SYST TECH, V26, P124, DOI 10.1002/ima.22167; Joglar B, 2009, J NEUROCHEM, V109, P656, DOI 10.1111/j.1471-4159.2009.05999.x; Kinoshita Y, 1999, ENVIRON RES, V80, P348, DOI 10.1006/enrs.1998.3935; KURLAN R, 1991, ANN NEUROL, V29, P677, DOI 10.1002/ana.410290618; Liberatore GT, 1999, NAT MED, V5, P1403; McLaren DG, 2009, NEUROIMAGE, V45, P52, DOI 10.1016/j.neuroimage.2008.10.058; Melchitzky DS, 2000, NEUROPSYCHOPHARMACOL, V22, P466, DOI 10.1016/S0893-133X(99)00139-6; MILETICH RS, 1994, ANN NEUROL, V35, P689, DOI 10.1002/ana.410350609; MITCHELL IJ, 1985, NEUROSCI LETT, V61, P195, DOI 10.1016/0304-3940(85)90424-0; Okubo G, 2016, J MAGN RESON IMAGING, V43, P55, DOI 10.1002/jmri.24960; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Park SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056034; Podell M, 2003, EXP NEUROL, V179, P159, DOI 10.1016/S0014-4886(02)00015-8; Rakshi JS, 1999, BRAIN, V122, P1637, DOI 10.1093/brain/122.9.1637; ROSE S, 1989, NEUROSCI LETT, V101, P305, DOI 10.1016/0304-3940(89)90550-8; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Takagi Y, 2005, J CLIN INVEST, V115, P102, DOI 10.1172/JCI200521137; Takahashi M, 2000, RADIOLOGY, V216, P881, DOI 10.1148/radiology.216.3.r00se41881; UEKI A, 1989, NEUROPHARMACOLOGY, V28, P1089, DOI 10.1016/0028-3908(89)90122-6; VIGNOLA C, 1994, NEURODEGENERATION, V3, P25; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360; Yeo HG, 2015, J ALZHEIMERS DIS, V46, P989, DOI 10.3233/JAD-143222; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0189804	10.1371/journal.pone.0189804	http://dx.doi.org/10.1371/journal.pone.0189804			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320500	Green Published, gold			2022-12-26	WOS:000419689600017
J	Muhammad, N; Nadeem, S; Mustafa, MT				Muhammad, Noor; Nadeem, Sohail; Mustafa, M. T.			Analysis of ferrite nanoparticles in the flow of ferromagnetic nanofluid	PLOS ONE			English	Article							CATTANEO-CHRISTOV HEAT; STAGNATION POINT FLOW; BOUNDARY-LAYER-FLOW; STRETCHING SHEET; METALLIC NANOPARTICLES; BLOOD-FLOW; FLUID; TEMPERATURE; DIPOLE; IMPACT	Theoretical analysis has been carried out to establish the heat transport phenomenon of six different ferromagnetic MnZnFe2O4-C2H6O2 (manganese zinc ferrite-ethylene glycol), NiZnFe2O4-C2H6O2 (Nickel zinc ferrite-ethylene glycol), Fe2O4-C2H6O2 (magnetite ferrite-ethylene glycol), NiZnFe2O4-H2O (Nickel zinc ferrite-water), MnZnFe2O4-H2O (manganese zinc ferrite-water), and Fe2O4-H2O (magnetite ferrite-water) nanofluids containing manganese zinc ferrite, Nickel zinc ferrite, and magnetite ferrite nanoparticles dispersed in a base fluid of ethylene glycol and water mixture. The performance of convective heat transfer is elevated in boundary layer flow region via nanoparticles. Magnetic dipole in presence of ferrites nanoparticles plays a vital role in controlling the thermal and momentum boundary layers. In perspective of this, the impacts of magnetic dipole on the nano boundary layer, steady, and laminar flow of incompressible ferromagnetic nanofluids are analyzed in the present study. Flow is caused by linear stretching of the surface. Fourier's law of heat conduction is used in the evaluation of heat flux. Impacts of emerging parameters on the magneto-thermomechanical coupling are analyzed numerically. Further, it is evident that Newtonian heating has increasing behavior on the rate of heat transfer in the boundary layer. Comparison with available results for specific cases show an excellent agreement.	[Muhammad, Noor; Nadeem, Sohail] Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan; [Mustafa, M. T.] Qatar Univ, Dept Math Stat & Phys, Doha 2713, Qatar	Quaid I Azam University; Qatar University	Muhammad, N (corresponding author), Quaid I Azam Univ 45320, Dept Math, Islamabad 44000, Pakistan.	noor@math.qau.edu.pk	Nadeem, Sohail/I-5248-2013; Akbar, Noreen Sher/ABA-2946-2021; Nadeem, Sohail/AAA-1202-2019; Muhammad, Dr. Noor/X-3486-2018	Nadeem, Sohail/0000-0002-1052-011X; Akbar, Noreen Sher/0000-0003-4530-5978; Nadeem, Sohail/0000-0002-1052-011X; Muhammad, Noor/0000-0003-1029-6389	Qatar University Doha, Qatar	Qatar University Doha, Qatar	Authors would like to acknowledge and express their gratitude to the Qatar University Doha 2713, Qatar, for providing the financial support to publish this article.	Afrand M, 2016, EXP THERM FLUID SCI, V77, P38, DOI 10.1016/j.expthermflusci.2016.04.007; Ahmed A, 2017, RESULTS PHYS, V7, P677, DOI 10.1016/j.rinp.2017.01.015; Ahmed A, 2016, J MOL LIQ, V216, P615, DOI 10.1016/j.molliq.2016.01.059; Andersson HI, 1998, ACTA MECH, V128, P39, DOI 10.1007/BF01463158; [Anonymous], [No title captured]; BAILEY RL, 1983, J MAGN MAGN MATER, V39, P178, DOI 10.1016/0304-8853(83)90428-6; Choi SUS., 1995, ASME PUBLICATIONS FE, P99; Eastman JA, 2001, APPL PHYS LETT, V78, P718, DOI 10.1063/1.1341218; Eringen A.C., 1990, ELECTRODYNAMICS CONT, DOI DOI 10.1007/978-1-4612-3226-1; Farooq M, 2016, J MOL LIQ, V221, P1097, DOI 10.1016/j.molliq.2016.06.077; Gireesha BJ, 2014, J NANOFLUIDS, V3, P267, DOI 10.1166/jon.2014.1101; Hayat T, 2016, INT J HEAT MASS TRAN, V99, P702, DOI 10.1016/j.ijheatmasstransfer.2016.04.016; Hayat T, 2016, J MOL LIQ, V220, P49, DOI 10.1016/j.molliq.2016.04.032; Javidi M, 2015, INT J HYPERTHER, V31, P33, DOI 10.3109/02656736.2014.988661; Khan AU, 2016, J MOL LIQ, V224, P1210, DOI 10.1016/j.molliq.2016.10.102; Liao S., 2003, PERTURBATION INTRO H, DOI 10.1201/9780203491164; Liao S., 2012, HOMOTOPY ANAL METHOD; Majeed A, 2016, J MOL LIQ, V223, P528, DOI 10.1016/j.molliq.2016.07.145; MEE CD, 1950, P PHYS SOC LOND A, V63, P922, DOI 10.1088/0370-1298/63/8/122; Mehmood R, 2017, J TAIWAN INST CHEM E, V74, P49, DOI 10.1016/j.jtice.2017.02.001; Muhammad N, 2017, RESULTS PHYS, V7, P862, DOI 10.1016/j.rinp.2016.12.028; Muhammad N, 2017, EUR PHYS J PLUS, V132, DOI 10.1140/epjp/i2017-11650-2; Muhammad N, 2017, RESULTS PHYS, V7, P854, DOI 10.1016/j.rinp.2016.12.027; Nadeem S, 2016, J MOL LIQ, V224, P423, DOI 10.1016/j.molliq.2016.10.006; Nadeem S, 2015, PHYS LETT A, V379, P542, DOI 10.1016/j.physleta.2014.12.013; Nadeem S, 2017, RESULTS PHYS, V7, P2607, DOI 10.1016/j.rinp.2017.06.017; Nadeem S, 2017, RESULTS PHYS, V7, P2361, DOI 10.1016/j.rinp.2017.06.007; Nadeem S, 2017, J MOL LIQ, V237, P180, DOI 10.1016/j.molliq.2017.04.080; Neuringer JL., 1966, INT J NON LINEAR MEC, V1, P123; Rashid I, 2017, PHYSICA E, V89, P33, DOI 10.1016/j.physe.2017.01.029; Rashidi MM, 2016, INT J HEAT MASS TRAN, V98, P616, DOI 10.1016/j.ijheatmasstransfer.2016.03.006; ROSENSWEIG RE, 1987, ANNU REV FLUID MECH, V19, P437, DOI 10.1146/annurev.fl.19.010187.002253; Sadaf H, 2017, J BIONIC ENG, V14, P182, DOI 10.1016/S1672-6529(16)60389-X; Salahuddin T, 2017, EUR PHYS J PLUS, V132, DOI 10.1140/epjp/i2017-11477-9; Voit W, 2001, MAT RES SOC S P, V676; Waqas M, 2017, CHINESE J PHYS, V55, P729, DOI 10.1016/j.cjph.2017.02.003; Xu XQ, 2017, HEAT TRANSF-ASIAN RE, V46, P1281, DOI 10.1002/htj.21273; Zeeshan A, 2016, ALEX ENG J, V55, P2171, DOI 10.1016/j.aej.2016.06.014	38	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0188460	10.1371/journal.pone.0188460	http://dx.doi.org/10.1371/journal.pone.0188460			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320488	Green Published, gold, Green Submitted			2022-12-26	WOS:000419689600001
J	Pan, BL; Loke, SS				Pan, Bo-Lin; Loke, Song-Seng			Chronic kidney disease associated with decreased bone mineral density, uric acid and metabolic syndrome	PLOS ONE			English	Article							RENAL-DISEASE; CREATININE CLEARANCE; POPULATION; OSTEOPOROSIS; MODERATE; ADULTS; WOMEN; RISK; CKD; HYPERURICEMIA	Objective The relationship between decreased bone mineral density (BMD) and chronic kidney disease (CKD) is controversial. The associations among metabolic syndrome (MetS), serum uric acid and CKD are also unclear. We aimed to investigate the relationship between decreased BMD, MetS, serum uric acid and CKD in a general population. Methods A total of 802 subjects who visited a medical center in Southern Taiwan and underwent a BMD measured by dual-energy X-ray absorptiometry (DEXA) during a health examination were enrolled in this retrospective cross-sectional study. Either osteopenia or osteoporosis was defined as decreased BMD. CKD was defined as the estimated glomerular filtration rate (eGFR) of less than 60 mL/min/1.73m(2). Simple and multivariate logistic regression analyses were used to investigate the association between variables, decreased BMD and CKD. Results Of the 802 subjects with a mean age of 54.4 +/- 10.2 years, the prevalence of decreased BMD was 62.9%, and CKD was 3.7%. Simple logistic analysis showed that sex (OR 3.50, 95% CI 1.21-10.12, p = 0.021), age (OR 1.14, 95% CI 1.07-1.21, p < 0.001), BMI (OR 1.11, 95% CI 1.01-1.22, p = 0.028), waist circumference (OR 1.06, 95% CI 1.02-1.10, p = 0.002), SBP (OR 1.03, 95% CI 1.01-1.04, p = 0.003), DBP (OR 1.03, 95% CI 1.001.06, p = 0.030), HDL-C (OR 0.97, 95% CI 0.94-1.00, p = 0.026), uric acid (OR 1.84, 95% CI 1.49-2.27, p < 0.001), metabolic syndrome (OR 2.68, 95% CI 1.29-5.67, p = 0.009), and decreased BMD (OR 3.998, 95% CI 1.38-11.57, p = 0.011) were significantly associated with CKD. Multivariate analysis showed that age (OR 1.05, 95% CI 1.03-1.07, p < 0.001), decreased BMD (OR 0.64, 95% CI 0.45-0.91, p = 0.013), and uric acid (OR 1.40, 95% CI 1.24-1.59, p < 0.001) were significantly independently associated with CKD. Conclusions Decreased BMD, uric acid and MetS were significantly associated with CKD.. Further large and prospective cohort studies are necessary to investigate whether management of osteoporosis, hyperuricemia, or MetS might prevent the progression of CKD.	[Pan, Bo-Lin; Loke, Song-Seng] Kaohsiung Chang Gung Mem Hosp, Dept Family Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital	Loke, SS (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Family Med, Kaohsiung, Taiwan.	loke@adm.cgmh.org.tw						Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bacchetta J, 2010, J BONE MINER RES, V25, P849, DOI 10.1359/jbmr.090831; Borghi C, 2015, J HYPERTENS, V33, P1729, DOI 10.1097/HJH.0000000000000701; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Chen J, 2007, NEPHROL DIAL TRANSPL, V22, P1100, DOI 10.1093/ndt/gfl759; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Dai HJ, 2016, KIDNEY BLOOD PRESS R, V41, P413, DOI 10.1159/000443443; Hsu CY, 2002, KIDNEY INT, V61, P1814, DOI 10.1046/j.1523-1755.2002.00306.x; Hui WS, 2010, EUR J EPIDEMIOL, V25, P375, DOI 10.1007/s10654-010-9459-z; Hwang SJ, 2010, NEPHROLOGY, V15, P3, DOI 10.1111/j.1440-1797.2010.01304.x; Jamal SA, 2013, J CLIN DENSITOM, V16, P64, DOI 10.1016/j.jocd.2012.11.012; Jassal SK, 2007, J BONE MINER RES, V22, P203, DOI 10.1359/JBMR.061014; Jorgetti V, 2014, KIDNEY INT, V85, P1283, DOI 10.1038/ki.2013.443; Kaji H, 2010, J CLIN ENDOCR METAB, V95, P4635, DOI 10.1210/jc.2010-0099; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Kidney Dis Improving Global, 2017, KIDNEY INT SUPPL, V7, P1, DOI 10.1016/j.kisu.2017.04.001; Kohagura K, 2013, HYPERTENS RES, V36, P43, DOI 10.1038/hr.2012.135; Kong XL, 2015, INT UROL NEPHROL, V47, P1547, DOI 10.1007/s11255-015-1082-1; Lee CC, 2011, CLIN NEPHROL, V75, P141, DOI 10.5414/CNP75141; LEMANN J, 1966, J CLIN INVEST, V45, P1608, DOI 10.1172/JCI105467; Levin A, 2007, KIDNEY INT, V71, P31, DOI 10.1038/sj.ki.5002009; Lin WY, 2008, ANN RHEUM DIS, V67, P432, DOI 10.1136/ard.2007.073601; Lindberg JS, 1999, SEMIN NEPHROL, V19, P115; Locatelli F, 2006, J AM SOC NEPHROL, V17, pS81, DOI 10.1681/ASN.2005121332; Madero M, 2009, AM J KIDNEY DIS, V53, P796, DOI 10.1053/j.ajkd.2008.12.021; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Mende C, 2015, ADV THER, V32, P1177, DOI 10.1007/s12325-015-0272-7; Miller PD, 2012, ENDOCRIN METAB CLIN, V41, P613, DOI 10.1016/j.ecl.2012.05.005; Myong JP, 2013, J KOREAN MED SCI, V28, P569, DOI 10.3346/jkms.2013.28.4.569; Ninomiya T, 2006, AM J KIDNEY DIS, V48, P383, DOI 10.1053/j.ajkd.2006.06.003; Viazzi F, 2014, NUTR METAB CARDIOVAS, V24, P921, DOI 10.1016/j.numecd.2014.01.018; Viazzi F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176058; Wolf M, 2012, KIDNEY INT, V82, P737, DOI 10.1038/ki.2012.176; YENDT ER, 1993, J BONE MINER RES, V8, P1045; YENDT ER, 1991, J BONE MINER RES, V6, P1043	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190985	10.1371/journal.pone.0190985	http://dx.doi.org/10.1371/journal.pone.0190985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320555	Green Published, Green Submitted, gold			2022-12-26	WOS:000419689600077
J	Carvalho, SB; Moreira, AS; Gomes, J; Carrondo, MJT; Thornton, DJ; Alves, PM; Costa, J; Peixoto, C				Carvalho, Sofia B.; Moreira, Ana Sofia; Gomes, Joana; Carrondo, Manuel J. T.; Thornton, David J.; Alves, Paula M.; Costa, Julia; Peixoto, Cristina			A detection and quantification label-free tool to speed up downstream processing of model mucins	PLOS ONE			English	Article							BOVINE SUBMAXILLARY MUCIN; HYDROPHOBIC SURFACE; RECEPTOR-BINDING; CANCER; MUC5B; OLIGOSACCHARIDES; VIRUSES; ASSAY; BSM	Mucins are high-molecular weight glycoproteins (0.25 +/- 20 MDa) containing one or more domains that are heavily O-glycosylated. Their implications as targets for cancer treatment have increased the interest in these glycoproteins, mainly in the fields of vaccines and antibodies. However, mucins present high heterogeneity, posing challenges that affect purification processes and quality control analysis. In that sense, it is necessary to develop and improve downstream processes and analytical methods to characterize these products. Here a tool based on biolayer interferometry analysis to improve mucin's detection and quantification in a fast, simple and label free-way is presented. Taking advantage of lectin recognition of mucins' carbohydrate structures, several lectins were evaluated and immobilized on streptavidin biosensors. Different assay conditions were optimized and the most suitable lectin, Aleuria aurantia lectin (AAL), was selected. Bovine Submaxillary Gland and human MUC5B mucins were used as proof of concept and were successfully detected and quantified at different stages of purification. High sensitivity levels were achieved with LOD and LOQ of 3.8 mu g mL(-1) and 11.7 mu g mL(-1) for BSM, and 0.2 mu g mL(-1) and 0.6 mu g mL(-1) for MUC5B. AAL binding specificity was also confirmed with fucose competition assays. Our method represents an advance on mucins detection and quantification since the existing methods present several disadvantages for process development. Hereafter, it can be applied to the optimization of new or already established downstream processes for mucins' purification.	[Carvalho, Sofia B.; Moreira, Ana Sofia; Gomes, Joana; Carrondo, Manuel J. T.; Alves, Paula M.; Peixoto, Cristina] Inst Biol Expt Tecnol, Oeiras, Portugal; [Carvalho, Sofia B.; Gomes, Joana; Alves, Paula M.; Costa, Julia; Peixoto, Cristina] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal; [Carrondo, Manuel J. T.] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, Monte De Caparica, Portugal; [Thornton, David J.] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England	Universidade Nova de Lisboa; Universidade Nova de Lisboa; University of Manchester	Peixoto, C (corresponding author), Inst Biol Expt Tecnol, Oeiras, Portugal.; Peixoto, C (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal.	peixoto@ibet.pt	Costa, Júlia C/B-7131-2008; Alves, Paula M/C-1070-2008; Peixoto, Cristina/K-8945-2014	Costa, Júlia C/0000-0001-7782-6319; Alves, Paula M/0000-0003-1445-3556; Moreira, Ana Sofia/0000-0003-4448-6375; Peixoto, Cristina/0000-0002-0995-6637; Carrondo, Manuel/0000-0002-4550-4574; Thornton, David/0000-0001-7148-1970	iNNOVATE PROJECT [ERA-IB-2/0007/2013]; GlioEx [Euronanomed 2 ERA-NET ENMed/0001/2013]; Fundacao para a Ciencia e a Tecnologia, Portugal; iNOVA4Health Research Unit [LISBOA-01-0145-FEDER-007344]; Fundacao para a Ciencia e Tecnologia / Ministerio da Ciencia e do Ensino Superior; FEDER under the PT Partnership Agreement; FCT [SFRH/BD/52302/2013]	iNNOVATE PROJECT; GlioEx; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); iNOVA4Health Research Unit; Fundacao para a Ciencia e Tecnologia / Ministerio da Ciencia e do Ensino Superior(Portuguese Foundation for Science and Technology); FEDER under the PT Partnership Agreement; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors acknowledge funding from: iNNOVATE PROJECT (ERA-IB-2/0007/2013); GlioEx (Euronanomed 2 ERA-NET ENMed/0001/2013), Fundacao para a Ciencia e a Tecnologia, Portugal, http://www.fct.pt; iNOVA4Health Research Unit (LISBOA-01-0145-FEDER-007344), which is cofunded by Fundacao para a Ciencia e Tecnologia / Ministerio da Ciencia e do Ensino Superior, through national funds, and by FEDER under the PT2020 Partnership Agreement, http://www.inova4health.com. S.C. acknowledges FCT for PhD fellowship SFRH/BD/52302/2013 within the scope of the PhD program Molecular Biosciences.	[Anonymous], 2000, METHODS MOL BIOL, V125; Armbruster David A, 2008, Clin Biochem Rev, V29 Suppl 1, pS49; Bergstrom K, 2016, GASTROENTEROLOGY, V151, P152, DOI 10.1053/j.gastro.2016.03.039; Carvalho SB, 2017, BIOTECHNOL J, P1; Concepcion J, 2009, COMB CHEM HIGH T SCR, V12, P791, DOI 10.2174/138620709789104915; Crusat M, 2013, VIROLOGY, V447, P326, DOI 10.1016/j.virol.2013.08.010; Cummings R.D., 2009, ANTIBODIES LECTINS G; Davies JR, 2012, METHODS MOL BIOL, V842, P27, DOI 10.1007/978-1-61779-513-8_2; Do T, 2008, PROTEIN EXPRES PURIF, V60, P147, DOI 10.1016/j.pep.2008.04.009; Gaidzik N, 2013, CHEM SOC REV, V42, P4421, DOI 10.1039/c3cs35470a; Gomes J, 2015, EXTRACELLULAR VESICL, P1741; Harrop CA, 2012, METHODS MOL BIOL, V842, P49, DOI 10.1007/978-1-61779-513-8_3; Kirkham S, 2002, BIOCHEM J, V361, P537, DOI 10.1042/0264-6021:3610537; Lakshmanan I, 2015, J THORAC ONCOL, V10, P19, DOI 10.1097/JTO.0000000000000404; Lee CS, 2013, ANALYST, V138, P3522, DOI 10.1039/c3an36258b; Li JA, 2011, J PHARMACEUT BIOMED, V54, P286, DOI 10.1016/j.jpba.2010.08.022; Livraghi-Butrico A, 2016, MUCOSAL IMMUNOL; Lundin M, 2009, J COLLOID INTERF SCI, V336, P30, DOI 10.1016/j.jcis.2009.03.061; Madsen JB, 2015, LANGMUIR, V31, P8303, DOI 10.1021/acs.langmuir.5b01281; Madsen JB, 2014, PREP BIOCHEM BIOTECH, P37; MANTLE M, 1978, Biochemical Society Transactions, V6, P607; Nikogeorgos N, 2014, COLLOID SURFACE B, V122, P760, DOI 10.1016/j.colsurfb.2014.08.017; Perez-Vilar J, 2004, GLYCOBIOLOGY, V14, P325, DOI 10.1093/glycob/cwh041; Ramachandran P, 2006, IDENTIFICATION N LIN; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; SAVAGE AV, 1991, BIOCHEM J, V279, P95, DOI 10.1042/bj2790095; Schomig VJ, 2016, RSC ADV, V6, P44932, DOI 10.1039/c6ra07424c; Shrivastava A., 2011, CHRONICLES YOUNG SCI, V2, P21, DOI [DOI 10.4103/2229-5186.79345, 10.4103/2229-5186.79345]; Silva MLS, 2014, BIOSENS BIOELECTRON, V57, P254, DOI 10.1016/j.bios.2014.02.006; Singh RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109265; Singh RS, 2015, CHARACTERIZATION MIT, P1938; Spurr-Michaud S, 2007, EXP EYE RES, V84, P939, DOI 10.1016/j.exer.2007.01.018; Thomsson KA, 2002, GLYCOBIOLOGY, V12, P1, DOI 10.1093/glycob/12.1.1; Thornton David J, 2004, Proc Am Thorac Soc, V1, P54, DOI 10.1513/pats.2306016; Tobias R., 2013, BIOMOLECULAR BINDING; Vachieri SG, 2014, NATURE, V511, P475, DOI 10.1038/nature13443; Vicente T, 2011, BIOTECHNOL ADV, V29, P869, DOI 10.1016/j.biotechadv.2011.07.004; WU AM, 1994, MOL CELL BIOCHEM, V137, P39, DOI 10.1007/BF00926038; Zappone B, 2015, LANGMUIR, V31, P4524, DOI 10.1021/acs.langmuir.5b00548; Zhang SY, 2014, ANALYST, V139, P439, DOI 10.1039/c3an01835k; Zhou J, 2017, SITE SPECIFIC FUCOSY	41	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190974	10.1371/journal.pone.0190974	http://dx.doi.org/10.1371/journal.pone.0190974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315346	Green Published, Green Submitted, gold			2022-12-26	WOS:000419655900036
J	Duffee, L; Columbano, N; Scanu, A; Melosu, V; Careddu, GM; Sotgiu, G; Driessen, B				Duffee, Lauren; Columbano, Nicolo; Scanu, Antonio; Melosu, Valentino; Careddu, Giovanni Mario; Sotgiu, Giovanni; Driessen, Bernd			MAC-sparing effect of nitrous oxide in sevoflurane anesthetized sheep and its reversal with systemic atipamezole administration	PLOS ONE			English	Article							MINIMUM ALVEOLAR CONCENTRATION; ANTINOCICEPTIVE RESPONSE; ISOFLURANE ANESTHESIA; HALOTHANE; REQUIREMENT; DOGS; MEDETOMIDINE; DESFLURANE; ACTIVATION; REDUCTION	Introduction Nitrous oxide (N2O) is an anesthetic gas with antinociceptive properties and reduces the minimum alveolar concentration (MAC) for volatile anesthetic agents, potentially through mechanisms involving central alpha(2)-adrenoceptors. We hypothesized that 70% N2O in the inspired gas will significantly reduce the MAC of sevoflurane (MACSEVO) in sheep, and that this effect can be reversed by systemic atipamezole. Materials and methods Animals were initially anesthetized with SEVO in oxygen (O-2) and exposed to an electrical current as supramaximal noxious stimulus in order to determine MACSEVO (in duplicates). Thereafter, 70% N2O was added to the inspired gas and the MAC re-determined in the presence of N2O (MACSN). A subgroup of sheep were anesthetized a second time with SEVO/N2O for re-determination of MACSN, after which atipamezole (0.2 mg kg(-1), IV) was administered for MACSNA determinations. Sheep were anesthetized a third time, initially with only SEVO/O-2 to re-determine MACSEVO, after which atipamezole (0.2 mg kg(-1), IV) was administered for determination of MACSA. Results MACSEVO was 2.7 (0.3)% [mean (standard deviation)]. Addition of (NO)-O-2 resulted in a 37% reduction of MACSEVO to MACSN of 1.7 (0.2)% (p < 0.0001). Atipamezole reversed this effect, producing a MACSNA of 3.1 (0.7)%, which did not differ from MACSEVO (p = 0.12). MACSEVO did not differ from MACSA (p = 0.69). Cardiorespiratory variables were not different among experimental groups except a lower ETCO2 in animals exposed to SEVO/N2O. Conclusions N2O produces significant MACSEVO-reduction in sheep; this effect is completely reversed by IV atipamezole confirming the involvement of alpha(2)-adrenoreceptors in the MAC-sparing action of N2O.	[Duffee, Lauren; Driessen, Bernd] Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Kennett Sq, PA 19348 USA; [Columbano, Nicolo; Scanu, Antonio; Melosu, Valentino; Careddu, Giovanni Mario] Univ Sassari, Dipartimento Med Vet, Sassari, Sardegna, Italy; [Columbano, Nicolo; Careddu, Giovanni Mario] Univ Sassari, CRCC, Sassari, Sardegna, Italy; [Sotgiu, Giovanni] Univ Sassari, Dipartimento Sci Biomed, Sassari, Sardegna, Italy; [Driessen, Bernd] Narkovet Consulting LLC, Chadds Ford, PA USA	University of Pennsylvania; University of Sassari; University of Sassari; University of Sassari	Duffee, L (corresponding author), Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Kennett Sq, PA 19348 USA.	lduffee@upenn.edu	COLUMBANO, Nicolo'/AAK-6378-2020; columbano, nicolò/Y-8050-2018; Sotgiu, Giovanni/N-1032-2017	COLUMBANO, Nicolo'/0000-0003-2201-8773; columbano, nicolò/0000-0003-2201-8773; Sotgiu, Giovanni/0000-0002-1600-4474; Driessen, Bernd/0000-0001-5522-6072	Centro di Ricerca di Chirurgia Comparata (CRCC), Universita degli Studi di Sassari; Department of Clinical Studies-VHUP, School of Veterinary Medicine, University of Pennsylvania; Central Administration of the University of Sassari, Italy	Centro di Ricerca di Chirurgia Comparata (CRCC), Universita degli Studi di Sassari; Department of Clinical Studies-VHUP, School of Veterinary Medicine, University of Pennsylvania; Central Administration of the University of Sassari, Italy	This work was supported by the Centro di Ricerca di Chirurgia Comparata (CRCC), Universita degli Studi di Sassari and a contribution of the Fondazione Banco di Sardegna as well as the Regione Autonoma della Sardegna. Some essential equipment was acquired through unrestricted Department of Clinical Studies-New Bolton Center, School of Veterinary Medicine, University of Pennsylvania. Lauren Duffee received a travel grant from the Department of Clinical Studies-VHUP, School of Veterinary Medicine, University of Pennsylvania. Prof. B. Driessen was awarded a competitive, 14-day all inclusive Visiting Professorship grant from the Central Administration of the University of Sassari, Italy. The funder provided support in the form of salaries for authors N.C., A.S., V.M., and G.M.C., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Dr. Bernd Driessen is the founder and current managing partner of Narkovet Consultung, LLC., however the company had neither funded the study nor had any other interest (i.e. financial, patent, or other commercial interest) in the study.	Acevedo-Arcique CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106620; BLOOR BC, 1982, ANESTH ANALG, V61, P741; Dixon WJ, 1983, INTRO STAT ANAL, P428; EWING KK, 1993, AM J VET RES, V54, P294; GHOURI AF, 1991, ANESTH ANALG, V72, P377; Guo TZ, 1996, ANESTHESIOLOGY, V85, P846, DOI 10.1097/00000542-199610000-00020; Guo TZ, 1999, ANESTHESIOLOGY, V90, P470, DOI 10.1097/00000542-199902000-00022; Hikasa Y, 1998, CAN J VET RES, V62, P299; HORNBEIN TF, 1982, ANESTH ANALG, V61, P553; Jevtovic-Todorovic V, 1998, NAT MED, V4; Lukasik VM, 1997, VET SURG, V27, P168; Nishimori CT, 2007, ARQ BRAS MED VET ZOO, V59, P97, DOI 10.1590/S0102-09352007000100017; Niu B, 2017, ANAESTHESIA, V72, P570, DOI 10.1111/anae.13843; Okutomi T, 2009, J ANESTH, V23, P392, DOI 10.1007/s00540-009-0763-2; Ranheim B, 2000, J VET PHARMACOL THER, V23, P401, DOI 10.1046/j.1365-2885.2000.00282.x; RUSSELL GB, 1992, ANESTH ANALG, V75, P995; SAIDMAN LJ, 1964, ANESTHESIOLOGY, V25, P302, DOI 10.1097/00000542-196405000-00007; Sanders RD, 2008, ANESTHESIOLOGY, V109, P707, DOI 10.1097/ALN.0b013e3181870a17; Sawamura S, 2000, J NEUROSCI, V20, P9242; Steffey E. P., 2015, VET ANAESTH ANALG, V3, P297; STEFFEY EP, 1974, J APPL PHYSIOL, V36, P530, DOI 10.1152/jappl.1974.36.5.530; STEVENS WC, 1975, ANESTHESIOLOGY, V42, P197, DOI 10.1097/00000542-197502000-00014; Voulgaris DA, 2013, CAN J VET RES, V77, P131; WEISKOPF RB, 1984, ANESTH ANALG, V63, P529; YLIHANKALA A, 1993, BRIT J ANAESTH, V70, P54, DOI 10.1093/bja/70.1.54	25	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190167	10.1371/journal.pone.0190167	http://dx.doi.org/10.1371/journal.pone.0190167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315308	Green Published, gold, Green Submitted			2022-12-26	WOS:000419655900007
J	Unkovic, N; Dimkic, I; Stupar, M; Stankovic, S; Vukojevic, J; Grbic, ML				Unkovic, Nikola; Dimkic, Ivica; Stupar, Milos; Stankovic, Slavisa; Vukojevic, Jelena; Grbic, Milica Ljaljevic			Biodegradative potential of fungal isolates from sacral ambient: In vitro study as risk assessment implication for the conservation of wall paintings	PLOS ONE			English	Article							ASPERGILLUS-NIGER; CULTURAL-HERITAGE; HETEROTROPHIC MICROORGANISMS; BEARING MINERALS; MURAL PAINTINGS; AIR ENVIRONMENT; AGAR PLATES; BIODETERIORATION; DETERIORATION; DIVERSITY	The principal purpose of the study was to evaluate in vitro the potential ability of fungal isolates obtained from the painted layer of frescoes and surrounding air to induce symptoms of fresco deterioration, associated with their growth and metabolism, so that the risk of such deterioration can be precisely assessed and appropriate conservation treatments formulated. Biodegradative properties of the tested microfungi were qualitatively characterized through the use of a set of special agar plates: CaCO(3)d glucose agar (calcite dissolution), casein nutrient agar (casein hydrolysis), Czapek-Dox minimal medium (pigment secretion); and Czapek-Dox minimal broth (acid and alkali production). Most of the tested isolates (71.05%) demonstrated at least one of the degradative properties, with Penicillium bilaiae as the most potent, since it tested positive in all four. The remaining isolates (28.95%) showed no deterioration capabilities and were hence considered unlikely to partake in the complex process of fungal deterioration of murals via the tested mechanisms. The obtained results clearly indicate that utilization of fast and simple plate assays can provide insight into the biodegradative potential of deteriogenic fungi and allow for their separation from allochthonous transients, a prerequisite for precise assessment of the amount of risk posed by a thriving mycobiota to mural paintings.	[Unkovic, Nikola; Stupar, Milos; Vukojevic, Jelena; Grbic, Milica Ljaljevic] Univ Belgrade, Dept Algol Mycol & Lichenol, Inst Bot, Belgrade, Serbia; [Unkovic, Nikola; Dimkic, Ivica; Stupar, Milos; Stankovic, Slavisa; Vukojevic, Jelena; Grbic, Milica Ljaljevic] Univ Belgrade, Fac Biol, Bot Garden Jevremovac, Belgrade, Serbia; [Dimkic, Ivica; Stankovic, Slavisa] Univ Belgrade, Dept Microbiol, Inst Bot, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade	Unkovic, N (corresponding author), Univ Belgrade, Dept Algol Mycol & Lichenol, Inst Bot, Belgrade, Serbia.; Unkovic, N (corresponding author), Univ Belgrade, Fac Biol, Bot Garden Jevremovac, Belgrade, Serbia.	unkovicn@bio.bg.ac.rs	Dimkic, Ivica/GWR-2445-2022; Stanković, Slaviša/S-6273-2018; Dimkić, Ivica/AAE-1508-2019	Stanković, Slaviša/0000-0003-0527-8741; Dimkic, Ivica/0000-0002-0425-5938	Ministarstvo Prosvete, Nauke i Tehnoloskog Razvoja [173032]	Ministarstvo Prosvete, Nauke i Tehnoloskog Razvoja	The work was supported by Ministarstvo Prosvete, Nauke i Tehnoloskog Razvoja #173032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Azeem AM, 2016, PLANT BIOSYST, V150, P420, DOI 10.1080/11263504.2014.984791; Adeyemi AO, 2005, BIOMETALS, V18, P269, DOI 10.1007/s10534-005-1539-2; Albertano P, 1999, MICROB ECOL, V38, P244, DOI 10.1007/s002489900174; Allsopp D., 2004, INTRO BIODETERIORATI; Berthelin J., 1983, Microbial geochemistry, P223; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Borrego S, 2010, INT BIODETER BIODEGR, V64, P139, DOI 10.1016/j.ibiod.2009.12.005; BREWER D, 1968, CAN J MICROBIOL, V14, P861, DOI 10.1139/m68-145; Ciferri O, 1999, APPL ENVIRON MICROB, V65, P879; CUNNINGHAM JE, 1992, APPL ENVIRON MICROB, V58, P1451, DOI 10.1128/AEM.58.5.1451-1458.1992; Dakal Tikam Chand, 2012, Environmental Sciences Europe, V24, P1, DOI 10.1186/2190-4715-24-36; DELATORRE MA, 1991, SCI TOTAL ENVIRON, V107, P159, DOI 10.1016/0048-9697(91)90257-F; DELATORRE MA, 1994, MICROB ECOL, V27, P177, DOI 10.1007/BF00165816; DELATORRE MA, 1993, BIOGEOCHEMISTRY, V19, P129, DOI 10.1007/BF00000875; Dornieden T, 2000, INT BIODETER BIODEGR, V46, P261, DOI 10.1016/S0964-8305(00)00107-4; Ettenauer JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103844; Florian M.L.E., 2002, FUNGAL FACTS SOLVING; Gadd GM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.275; Gadd GM, 2010, MICROBIOL-SGM, V156, P609, DOI 10.1099/mic.0.037143-0; GARG KL, 1995, SCI TOTAL ENVIRON, V167, P255, DOI 10.1016/0048-9697(95)04587-Q; Gorbushina AA, 2004, INT BIODETER BIODEGR, V53, P13, DOI 10.1016/j.ibiod.2003.07.003; Rojas TI, 2012, GRANA, V51, P44, DOI 10.1080/00173134.2011.643920; JONES B, 1987, CAN J EARTH SCI, V24, P903, DOI 10.1139/e87-088; Karbowska-Berent J., 2003, ART BIOL CONSERVATIO, P266; KARPOVICHTATE N, 1991, INT BIODETERIOR, V27, P281, DOI 10.1016/0265-3036(91)90057-X; Medic M., 2002, START SLIKARSKI PRIR; Molitoris HP, 2000, FUNGAL DIVERS, V5, P55; Ortega-Morales BO, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00201; Pangallo D, 2012, WORLD J MICROB BIOT, V28, P2015, DOI 10.1007/s11274-012-1004-7; Pangallo D, 2009, CAN J MICROBIOL, V55, P277, DOI [10.1139/W08-136, 10.1139/w08-136]; Pepe O, 2010, MICROBIOL RES, V165, P21, DOI 10.1016/j.micres.2008.03.005; Petersen K., 1995, P 3 INT C BIOD CULT, P371; Petersen K, 1992, INT S CONS REST CULT, P263; Pinar G, 2009, INT BIODETER BIODEGR, V63, P851, DOI 10.1016/j.ibiod.2009.02.004; Ranalli G, 2005, J APPL MICROBIOL, V98, P73, DOI 10.1111/j.1365-2672.2004.02429.x; Rosado T, 2015, MICROSC MICROANAL, V21, P78, DOI 10.1017/S1431927614013439; Saran S, 2007, J BIOCHEM BIOPH METH, V70, P697, DOI 10.1016/j.jbbm.2007.03.005; Savkovic Z, 2016, INT BIODETER BIODEGR, V115, P212, DOI 10.1016/j.ibiod.2016.08.027; Sayer JA, 1997, FEMS MICROBIOL LETT, V154, P29, DOI 10.1016/S0378-1097(97)00296-6; Sayer JA, 2001, MYCOL RES, V105, P1261, DOI 10.1016/S0953-7562(08)61998-X; SCHRICKX JM, 1995, ANAL BIOCHEM, V231, P175, DOI 10.1006/abio.1995.1518; Shivani D., 2015, INT J CURR MICROBIOL, V4, P122; SIMONART P, 1960, NATURE, V186, P78, DOI 10.1038/186078a0; Sterflinger K, 2000, GEOMICROBIOL J, V17, P97, DOI 10.1080/01490450050023791; Sterflinger K, 2013, APPL MICROBIOL BIOT, V97, P9637, DOI 10.1007/s00253-013-5283-1; Sterflinger Katja, 2010, Fungal Biology Reviews, V24, P47, DOI 10.1016/j.fbr.2010.03.003; Unkovic N, 2017, MICRON, V100, P1, DOI 10.1016/j.micron.2017.04.004; Unkovic N, 2016, INDOOR BUILT ENVIRON, V25, P826, DOI 10.1177/1420326X15587178; Unkovic N, 2016, MICROSC MICROANAL, V22, P410, DOI 10.1017/S1431927616000544; Urzi C, 1998, INT BIODETER BIODEGR, V42, P45, DOI 10.1016/S0964-8305(98)00045-6; Vermelho AB, 1996, MEM I OSWALDO CRUZ, V91, P755, DOI 10.1590/S0074-02761996000600020; Warscheid T, 2000, INT BIODETER BIODEGR, V46, P343, DOI 10.1016/S0964-8305(00)00109-8; Zhu TT, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00004; Zikic R., 2014, P SEM WORKSH LIM HIS, P105; Znad H, 2004, PROCESS BIOCHEM, V39, P1341, DOI 10.1016/S0032-9592(03)00270-X	55	28	28	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2018	13	1							e0190922	10.1371/journal.pone.0190922	http://dx.doi.org/10.1371/journal.pone.0190922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS0GW	29309432	gold, Green Published, Green Submitted			2022-12-26	WOS:000419453100019
J	Liao, Y; Du, W				Liao, Yang; Du, Wei			An Rb family-independent E2F3 transcription factor variant impairs STAT5 signaling and mammary gland remodeling during pregnancy in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAVEOLIN-1 GENE-EXPRESSION; INCOMPLETE PENETRANCE; CELL-PROLIFERATION; EPITHELIAL-CELLS; IN-VIVO; CANCER; TUMORIGENESIS; DIFFERENTIATION; PROLACTIN; RETINOBLASTOMA	E2F transcription factors are regulated by binding to the retinoblastoma (Rb) tumor suppressor family of proteins. Previously, we reported an E2F(LQ) mutation that disrupts the binding with Rb proteins without affecting the transcriptional activity of E2F. We also showed that mouse embryonic fibroblasts with an E2F3(LQ) mutation exhibit increased E2F activity and more rapid cell proliferation. In this report, we analyzed E2F3(LQ) mice to further characterize the in vivo consequences of Rb family-independent E2F3 activity. We found that homozygous E2F3(LQ) mice were viable and had no obvious developmental defects or tumor growth. Our results also indicated that E2F3(LQ) cells largely retain normal control of cell proliferation in vivo. However, female E2F3(LQ) mice had partial nursing defects. Examination of the E2F3(LQ) mammary glands revealed increased caveolin-1 (CAV1) expression, reduced prolactin receptor/Stat5 signaling, and impaired pregnancy-induced cell proliferation and differentiation. Of note, ChIP experiments disclosed that E2F3 binds the CAV1 promoter. Furthermore, E2F3 overexpression induced CAV1 expression, and CRISPR/CAS9-mediated E2F3 knockout reduced CAV1 levels and also increased prolactin receptor-induced Stat5 signaling in mammary epithelial cells. Our results suggest that the Rb family-independent E2F3(LQ) variant inhibits pregnancy-induced mammary gland cell proliferation and differentiation by up-regulating CAV1 expression and inhibiting Stat5 signaling.	[Liao, Yang; Du, Wei] Univ Chicago, Ben May Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA	University of Chicago	Du, W (corresponding author), Univ Chicago, Ben May Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	wei@uchicago.edu		Du, Wei/0000-0003-3962-370X	University of Chicago Women's Board; NIGMS, National Institutes of Health [R01 GM120046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120046] Funding Source: NIH RePORTER	University of Chicago Women's Board; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the University of Chicago Women's Board and NIGMS, National Institutes of Health Grant R01 GM120046 (to W.D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Bist A, 2000, BIOCHEMISTRY-US, V39, P1966, DOI 10.1021/bi991721h; Brisken C, 1999, DEV BIOL, V210, P96, DOI 10.1006/dbio.1999.9271; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Cecchini MJ, 2014, MOL CELL BIOL, V34, P2029, DOI 10.1128/MCB.01589-13; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Cocolakis E, 2008, J BIOL CHEM, V283, P1293, DOI 10.1074/jbc.M707492200; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; Du W, 2000, DEVELOPMENT, V127, P367; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Feber A, 2004, ONCOGENE, V23, P1627, DOI 10.1038/sj.onc.1207274; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Forster N, 2014, DEV CELL, V28, P147, DOI 10.1016/j.devcel.2013.11.019; Foster CS, 2004, ONCOGENE, V23, P5871, DOI 10.1038/sj.onc.1207800; Francis SM, 2009, MOL CELL BIOL, V29, P4455, DOI 10.1128/MCB.00473-09; Gallego MI, 2001, DEV BIOL, V229, P163, DOI 10.1006/dbio.2000.9961; Gordon GM, 2013, J CELL SCI, V126, P2004, DOI 10.1242/jcs.121301; Gordon GM, 2011, PROTEIN CELL, V2, P864, DOI 10.1007/s13238-011-1117-z; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Herrera RE, 1996, MOL CELL BIOL, V16, P2402; Humbert PO, 2000, GENE DEV, V14, P690; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; KRATZKE RA, 1994, ONCOGENE, V9, P1321; Law YN, 2012, J MED IMAG HEALTH IN, V2, P352, DOI 10.1166/jmihi.2012.1109; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee EY, 2002, CANCER CELL, V2, P463, DOI 10.1016/S1535-6108(02)00207-6; Li BH, 2010, CANCER CELL, V17, P469, DOI 10.1016/j.ccr.2010.03.019; Liao Y, 2017, FEBS OPEN BIO, V7, P1611, DOI 10.1002/2211-5463.12306; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Otterson GA, 1997, P NATL ACAD SCI USA, V94, P12036, DOI 10.1073/pnas.94.22.12036; Park DS, 2002, MOL BIOL CELL, V13, P3416, DOI 10.1091/mbc.02-05-0071; Park DS, 2001, J BIOL CHEM, V276, P48389, DOI 10.1074/jbc.M108210200; Pogoriler J, 2006, DEVELOPMENT, V133, P3929, DOI 10.1242/dev.02556; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; SHAN B, 1994, MOL CELL BIOL, V14, P299, DOI 10.1128/MCB.14.1.299; Shillingford JM, 2003, J HISTOCHEM CYTOCHEM, V51, P555, DOI 10.1177/002215540305100501; Sloan EK, 2009, AM J PATHOL, V174, P2035, DOI 10.2353/ajpath.2009.080924; Sun HF, 2011, P NATL ACAD SCI USA, V108, P704, DOI 10.1073/pnas.1015027108; Teglund S, 1998, CELL, V93, P841, DOI 10.1016/S0092-8674(00)81444-0; Tonko-Geymayer S, 2002, MOL ENDOCRINOL, V16, P1680, DOI 10.1210/me.16.7.1680; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tsai KY, 1998, MOL CELL, V2, P293, DOI 10.1016/S1097-2765(00)80274-9; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Weng L, 2003, EMBO J, V22, P3865, DOI 10.1093/emboj/cdg373; Williams TM, 2006, AM J PATHOL, V169, P1784, DOI 10.2353/ajpath.2006.060590; Williams TM, 2003, MOL BIOL CELL, V14, P1027, DOI 10.1091/mbc.E02-08-0503; Williams TM, 2004, J BIOL CHEM, V279, P51630, DOI 10.1074/jbc.M409214200; Yamasaki L, 1998, NAT GENET, V18, P360, DOI 10.1038/ng0498-360; Zhang TY, 2015, DEV BIOL, V407, P246, DOI 10.1016/j.ydbio.2015.09.011; Ziebold U, 2003, MOL CELL BIOL, V23, P6542, DOI 10.1128/MCB.23.18.6542-6552.2003; Ziebold U, 2001, GENE DEV, V15, P386, DOI 10.1101/gad.858801	56	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3156	3167		10.1074/jbc.RA117.000583	http://dx.doi.org/10.1074/jbc.RA117.000583			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29330306	hybrid, Green Published			2022-12-26	WOS:000426562800011
J	van Mastrigt, E; Zweekhorst, S; Bol, B; Tibboel, J; van Rosmalen, J; Samsom, JN; Kroon, AA; de Jongste, JC; Reiss, IKM; Post, M; Pijnenburg, MW				van Mastrigt, Esther; Zweekhorst, Salome; Bol, Bas; Tibboel, Jeroen; van Rosmalen, Joost; Samsom, Janneke N.; Kroon, Andre A.; de Jongste, Johan C.; Reiss, Irwin K. M.; Post, Martin; Pijnenburg, Marielle W.			Ceramides in tracheal aspirates of preterm infants: Marker for bronchopulmonary dysplasia	PLOS ONE			English	Article							INDUCED APOPTOSIS; CIGARETTE-SMOKE; LUNG; SPHINGOLIPIDS; INFLAMMATION; STRESS; SPHINGOSINE-1-PHOSPHATE; HYPEROXIA	Background In an experimental mouse model we showed that ceramides play a role in the pathogenesis of bronchopulmonary dysplasia (BPD) and are a potential target for therapeutic intervention. We investigated whether ceramides are detectable in tracheal aspirates (TAs) of preterm infants and differ between infants with or without BPD. Methods Infants born <= 32 weeks of gestational age in need of mechanical ventilation in the first week of life were included. TAs were obtained directly after intubation and at day 1, 3, 5, 7, and 14. Ceramide concentrations were measured by tandem mass spectrometry. At 36 weeks postmenstrual age BPD was defined as having had >= 28 days supplemental oxygen. Results 122 infants were included, of which 14 died and 41 developed BPD. All infants showed an increase in ceramides after the first day of intubation. The ceramide profile differed significantly between preterm infants who did and did not develop BPD. However, the ceramide profile had no additional predictive value for BPD development over GA at birth, birth weight and total days of mechanical ventilation. Conclusions Ceramides are measurable in TAs of preterm born infants and may be an early marker for BPD development.	[van Mastrigt, Esther; Zweekhorst, Salome; de Jongste, Johan C.; Pijnenburg, Marielle W.] Erasmus MC, Sophia Childrens Hosp, Div Pediat Pulmonol, Rotterdam, Netherlands; [van Mastrigt, Esther; Bol, Bas; Kroon, Andre A.; Reiss, Irwin K. M.] Erasmus MC, Sophia Childrens Hosp, Div Neonatol, Rotterdam, Netherlands; [Tibboel, Jeroen; Post, Martin] Hosp Sick Children, Program Physiol & Expt Med, Toronto, ON, Canada; [van Rosmalen, Joost] Erasmus MC, Dept Biostat, Rotterdam, Netherlands; [Samsom, Janneke N.] Erasmus MC, Lab Pediat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Pijnenburg, MW (corresponding author), Erasmus MC, Sophia Childrens Hosp, Div Pediat Pulmonol, Rotterdam, Netherlands.	m.pijnenburg@erasmusmc.nl			Stichting Sophia Wetenschappelijk Onderzoek [S13-24]	Stichting Sophia Wetenschappelijk Onderzoek	Funding from the Stichting Sophia Wetenschappelijk Onderzoek, abbreviated as SSWO, number S13-24. However, we declare that the funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Becker KA, 2010, BIOCHEM BIOPH RES CO, V403, P368, DOI 10.1016/j.bbrc.2010.11.038; Becker KA, 2010, AM J RESP CELL MOL, V42, P716, DOI 10.1165/rcmb.2009-0174OC; Bose CL, 2008, ARCH DIS CHILD-FETAL, V93, P1455, DOI 10.1136/adc.2007.121327; Boucherat O, 2007, PLOS MED, V4, P1205, DOI 10.1371/journal.pmed.0040237; D'Angio CT, 2002, BIOL NEONATE, V82, P145, DOI 10.1159/000063608; De Brauwer EIGB, 2000, ANAL QUANT CYTOL, V22, P416; De Brauwer EIGB, 2002, ANAL QUANT CYTOL, V24, P337; Dechecchi MC, 2011, AM J RESP CELL MOL, V45, P825, DOI 10.1165/rcmb.2010-0457OC; Dieperink HI, 2006, PEDIATR RES, V59, P185, DOI 10.1203/01.pdr.0000196371.85945.3a; Gortner L, 2011, NEONATOLOGY, V99, P112, DOI 10.1159/000313024; Gough A, 2012, CHEST, V141, P1554, DOI 10.1378/chest.11-1306; Hammad SM, 2012, J LIPIDS, V2012, DOI 10.1155/2012/180705; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hartmann D, 2012, INT J BIOCHEM CELL B, V44, P620, DOI 10.1016/j.biocel.2011.12.019; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kroon AA, 2013, AM J PHYSIOL-LUNG C, V305, pL795, DOI 10.1152/ajplung.00048.2013; Kunzmann S, 2011, AM J RESP CELL MOL, V45, P969, DOI 10.1165/rcmb.2010-0519OC; Levy BD, 2013, NEW ENGL J MED, V369, P976, DOI 10.1056/NEJMcibr1306864; Levy M, 2009, AM J PHYSIOL-LUNG C, V297, pL125, DOI 10.1152/ajplung.00031.2009; Mathew B, 2011, FASEB J, V25, P3388, DOI 10.1096/fj.11-183970; Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465; May M, 2004, EUR RESPIR J, V23, P113, DOI 10.1183/09031936.03.00038403; Onland W, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-207; Ono Jennie G, 2015, Mol Cell Pediatr, V2, P13, DOI 10.1186/s40348-015-0025-3; Payne SG, 2002, FEBS LETT, V531, P54, DOI 10.1016/S0014-5793(02)03480-4; Rook D, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-65; Sawicka E, 2003, J IMMUNOL, V171, P6206, DOI 10.4049/jimmunol.171.11.6206; Schweitzer KS, 2011, AM J PHYSIOL-LUNG C, V301, pL836, DOI 10.1152/ajplung.00385.2010; Snoek KG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155136; Tibboel J, 2014, CHEST, V145, P120, DOI 10.1378/chest.13-0967; Tibboel J, 2013, EUR RESPIR J, V42, P776, DOI 10.1183/09031936.00092212; Verbeke G, 2000, LINEAR MIXED MODELS; Walsh MC, 2004, PEDIATRICS, V114, P1305, DOI 10.1542/peds.2004-0204; Yang Yang, 2011, Ther Adv Respir Dis, V5, P325, DOI 10.1177/1753465811406772	35	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0185969	10.1371/journal.pone.0185969	http://dx.doi.org/10.1371/journal.pone.0185969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346372	gold, Green Published, Green Submitted			2022-12-26	WOS:000422749500001
J	Bhende, M; Raman, R; Jain, M; Shah, PK; Sharma, T; Gopal, L; Bhende, PS; Srinivasan, S; Jambulingam, M				Bhende, Muna; Raman, Rajiv; Jain, Mukesh; Shah, Pratik K.; Sharma, Tarun; Gopal, Lingam; Bhende, Pramod S.; Srinivasan, Sangeetha; Jambulingam, Malathi		Sankara Nethralaya Vitreoretinal S	Incidence, microbiology, and outcomes of endophthalmitis after 111,876 pars plana vitrectomies at a single, tertiary eye care hospital	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; 25-GAUGE; 20-GAUGE; MANAGEMENT; NATIONWIDE; ORGANISMS; DIAGNOSIS; 23-GAUGE	Purpose To describe the incidence, risk factors, clinical presentation, causative organisms, and outcomes in patients with endophthalmitis following pars plana vitrectomy (20G and minimally invasive vitrectomy surgery (MIVS). Methods Of 111,876 vitrectomies (70,585 20-G 41,291 MIVS) performed, 45 cases developed acute onset, postoperative endophthalmitis. Results The rate of culture positive and culture negative endophthalmitis was 0.021% (2.1/10,000 surgeries) and 0.019% (1.9/10,000 surgeries) overall, 0.031% (3.1/10,000 surgeries) and 0.025% (2.5/10,000 surgeries) in 20G, and 0.005% (0.5/10,000 surgeries) and 0.007% (0.7/10,000 surgeries) in the MIVS group respectively. Potential predisposing factors were as follows: diabetes, 46.7%; vitrectomy for vascular retinopathies, 44.4%; and vitrectomy combined with anterior segment surgeries, 35.5%. The culture proven rates were 53.3% overall, 55.0% for 20G and 40.0% for MIVS. The most common organism was Pseudomonas aeruginosa for 20G. Klebsiella and Staphylococcus aureus were isolated in the two culture positive cases in MIVS group. The follow-up period for the patients with endophthalmitis was 586.14 +/- 825.15 days. Seven were lost to follow up beyond one week. Of the remaining 38, 13 (34.2%) cases had a favorable visual outcome (i.e., best-corrected visual acuity [BCVA] > 5/200) and 24 (63.2%) had unfavorable visual outcome (BCVA < 5/200). Group with culture test results negative had significantly better outcomes (P < 0.05) as compared to those with positive. Conclusions MIVS does not increase the risk of endophthalmitis. Outcomes are poor despite appropriate treatment, particularly in cases with culture results positive.	[Bhende, Muna; Raman, Rajiv; Jain, Mukesh; Shah, Pratik K.; Sharma, Tarun; Gopal, Lingam; Bhende, Pramod S.; Srinivasan, Sangeetha] Sankara Nethralaya, Shri Bhagwan Mahavir Vitreoretinal Serv, Madras, Tamil Nadu, India; [Jambulingam, Malathi] Sankara Nethralaya, Vis Res Fdn, L&T Microbiol Res Ctr, Madras, Tamil Nadu, India		Bhende, M (corresponding author), Sankara Nethralaya, Shri Bhagwan Mahavir Vitreoretinal Serv, Madras, Tamil Nadu, India.	drmuna@snmail.org	Ratra, Dhanashree/AAE-2517-2020; Raman, Rajiv/A-7234-2009	Ratra, Dhanashree/0000-0001-5687-6384; Raman, Rajiv/0000-0001-5842-0233; Khetan, Vikas/0000-0003-4396-9877; Bhende, Muna/0000-0002-9251-170X				Anand A R, 2000, Indian J Ophthalmol, V48, P123; Anand AR, 2001, OPHTHALMOLOGY, V108, P326, DOI 10.1016/S0161-6420(00)00517-0; [Anonymous], 1995, Arch Ophthalmol, V113, P1479; Chen JK, 2009, EYE, V23, P780, DOI 10.1038/eye.2008.160; Chiang A, 2011, RETINA-J RET VIT DIS, V31, P1513, DOI 10.1097/IAE.0b013e3182209290; Chiquet C, 2007, J CATARACT REFR SURG, V33, P635, DOI 10.1016/j.jcrs.2006.12.017; COHEN SM, 1995, OPHTHALMOLOGY, V102, P705, DOI 10.1016/S0161-6420(95)30965-7; Czajka MP, 2016, ACTA OPHTHALMOL, V94, P829, DOI 10.1111/aos.13121; Dave VP, 2016, ASIA-PAC J OPHTHALMO, V5, P192, DOI 10.1097/APO.0000000000000192; Eifrig CWG, 2004, AM J OPHTHALMOL, V138, P799, DOI 10.1016/j.ajo.2004.06.035; Fujii GY, 2002, OPHTHALMOLOGY, V109, P1807, DOI 10.1016/S0161-6420(02)01179-X; Gupta Amit, 2003, Indian Journal of Ophthalmology, V51, P139; Gupta OP, 2008, AM J OPHTHALMOL, V146, P193, DOI 10.1016/j.ajo.2008.04.010; Gupta OP, 2007, OPHTHAL SURG LAS IM, V38, P270, DOI 10.3928/15428877-20070701-01; Jambulingam M, 2010, INDIAN J OPHTHALMOL, V58, P297, DOI 10.4103/0301-4738.64132; Joondeph BC, 2005, RETINA-J RET VIT DIS, V25, P587, DOI 10.1097/00006982-200507000-00008; Kunimoto DY, 2007, OPHTHALMOLOGY, V114, P2133, DOI 10.1016/j.ophtha.2007.08.009; Lisboa T, 2010, CRIT CARE MED, V38, pS656, DOI 10.1097/CCM.0b013e3181f2453a; Oshima Y, 2010, AM J OPHTHALMOL, V150, P716, DOI 10.1016/j.ajo.2010.06.002; Park JC, 2014, BRIT J OPHTHALMOL, V98, P1080, DOI 10.1136/bjophthalmol-2013-304486; Park JC, 2014, BRIT J OPHTHALMOL, V98, P529, DOI 10.1136/bjophthalmol-2013-304485; Scott IU, 2008, RETINA-J RET VIT DIS, V28, P138, DOI 10.1097/IAE.0b013e31815e9313; Scott IU, 2011, GRAEF ARCH CLIN EXP, V249, P377, DOI 10.1007/s00417-010-1505-8; Sharma S, 2014, INDIAN J MED RES, V139, P91; Shimada H, 2008, OPHTHALMOLOGY, V115, P2215, DOI 10.1016/j.ophtha.2008.07.015; Therese KL, 1998, BRIT J OPHTHALMOL, V82, P1078, DOI 10.1136/bjo.82.9.1078; Turhan V, 2013, J INFECT DEV COUNTR, V7, P707, DOI 10.3855/jidc.2967; Wu L, 2011, RETINA-J RET VIT DIS, V31, P673, DOI 10.1097/IAE.0b013e318203c183	28	23	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191173	10.1371/journal.pone.0191173	http://dx.doi.org/10.1371/journal.pone.0191173			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338030	Green Published, gold, Green Submitted			2022-12-26	WOS:000422652700037
J	Muraduzzaman, AKM; Khan, MH; Parveen, R; Sultana, S; Alam, AN; Akram, A; Rahman, M; Shirin, T				Muraduzzaman, A. K. M.; Khan, Manjur Hossain; Parveen, Rezina; Sultana, Sharmin; Alam, Ahmed Nawsher; Akram, Arifa; Rahman, Mahmudur; Shirin, Tahmina			Event based surveillance of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Bangladesh among pilgrims and travelers from the Middle East: An update for the period 2013-2016	PLOS ONE			English	Article							INFECTION	Introduction Every year around 150,000 pilgrims from Bangladesh perform Umrah and Hajj. Emergence and continuous reporting of MERS-CoV infection in Saudi Arabia emphasize the need for surveillance of MERS-CoV in returning pilgrims or travelers from the Middle East and capacity building of health care providers for disease containment. The Institute of Epidemiology, Disease Control & Research (IEDCR) under the Bangladesh Ministry of Health and Family welfare (MoHFW), is responsible for MERS-CoV screening of pilgrims/travelers returning from the Middle East with respiratory illness as part of its outbreak investigation and surveillance activities. Methods Bangladeshi travelers/pilgrims who returned from the Middle East and presented with fever and respiratory symptoms were studied over the period from October 2013 to June 2016. Patients with respiratory symptoms that fulfilled the WHO MERS-CoV case algorithm were tested for MERS-CoV and other respiratory tract viruses. Beside surveillance, case recognition training was conducted at multiple levels of health care facilities across the country in support of early detection and containment of the disease. Results Eighty one suspected cases tested by real time PCR resulted in zero detection of MERSCoV infection. Viral etiology detected in 29.6% of the cases was predominantly influenza A (H 1N 1 and H3N2), and influenza B infection (22%). Peak testing occurred mostly following the annual Hajj season. Conclusions Respiratory tract infections in travelers/pilgrims returning to Bangladesh from the Middle East are mainly due to influenza A and influenza B. Though MERS-CoV was not detected in the 81 patients tested, continuous screening and surveillance are essential for early detection of MERS-CoV infection and other respiratory pathogens to prevent transmissions in hospital settings and within communities. Awareness building among healthcare providers will help identify suspected cases.	[Muraduzzaman, A. K. M.; Khan, Manjur Hossain; Sultana, Sharmin; Alam, Ahmed Nawsher; Akram, Arifa; Shirin, Tahmina] IEDCR, Dept Virol, Dhaka, Bangladesh; [Parveen, Rezina] Dhaka Dent Coll, Dept Pathol & Microbiol, Dhaka, Bangladesh; [Rahman, Mahmudur] IEDCR, Dhaka, Bangladesh		Shirin, T (corresponding author), IEDCR, Dept Virol, Dhaka, Bangladesh.	tahmina.shirin14@gmail.com	Akram, Arifa/ADI-4706-2022; sultana, sharmin/HHZ-7068-2022	Akram, Arifa/0000-0001-8829-9817; Shirin, Tahmina/0000-0002-5061-3783				Al-Hajjar S, 1998, ANN TROP PAEDIATR, V18, P87, DOI 10.1080/02724936.1998.11747933; Al-Tawfiq JA, 2013, SAUDI MED J, V34, P991; Alzeer AH, 2009, ANN THORAC MED, V4, P50, DOI 10.4103/1817-1737.49412; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P435; Arabi Y, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1490-9; Assiri A, N ENGL J MED, V369, P407; Atabani SF, 2016, INT J INFECT DIS; CDC, 2014, CDC LAB TEST MIDDL E; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gautret P, 2016, INT J INFECT DIS; Gautret P, 2014, EMERG INFECT DIS, V20, P728, DOI 10.3201/eid2004.131708; Gautret P, 2013, TRAVEL MED INFECT DI, V11, P95, DOI 10.1016/j.tmaid.2013.03.003; Hashem AM, 2016, ANN THORAC MED, V11, P161, DOI 10.4103/1817-1737.180022; Korea Centers for Disease Control and Prevention, 2016, Osong Public Health Res Perspect, V7, P138, DOI 10.1016/j.phrp.2016.03.002; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Lu XY, 2014, J CLIN MICROBIOL, V52, P67, DOI 10.1128/JCM.02533-13; Mackay IM, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0439-5; [MaMWR MMWR], 2014, 1 CONF CAS MIDDL E R; Memish ZA, 2014, J INFECT DIS; Memish ZA, N ENGL J MED, V368, P2487; Memish ZA, B WHO, V91, P899; Pavli A, 2014, TRAVEL MED INFECT DI, V12, P602, DOI 10.1016/j.tmaid.2014.10.006; Puzelli S., 2013, EURO SURVEILL, V18; Sridhar S, 2015, TRAVEL MED INFECT DI, V13, P106, DOI 10.1016/j.tmaid.2014.11.006; The WHO MERS-CoV Research Group, 2013, PLOS CURR, V5; Van Boheemen S, MBIO, V3; WHO (World Health Organization), 2012, GUID REG TRANSP INF; World Health Organization, 2016, WHO MERS COV GLOB SU; World Health Organization, 2016, WHOMERSRA161; World Health Organization (WHO), 2019, MIDDLE E RESP SYNDRO; Zaki A.M., N ENGL J MED, V367, P1814	31	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0189914	10.1371/journal.pone.0189914	http://dx.doi.org/10.1371/journal.pone.0189914			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29337997	Green Published, Green Submitted, gold			2022-12-26	WOS:000422652700005
J	Dell'Isola, A; Steultjens, M				Dell'Isola, A.; Steultjens, M.			Classification of patients with knee osteoarthritis in clinical phenotypes: Data from the osteoarthritis initiative	PLOS ONE			English	Article							RISK-FACTORS; PAIN SEVERITY; OLDER-ADULTS; FOLLOW-UP; IDENTIFICATION; PROGRESSION; OVERWEIGHT; OUTCOMES; MARKERS; COHORT	Objectives The existence of phenotypes has been hypothesized to explain the large heterogeneity characterizing the knee osteoarthritis. In a previous systematic review of the literature, six main phenotypes were identified: Minimal Joint Disease (MJD), Malaligned Biomechanical (MB), Chronic Pain (CP), Inflammatory (I), Metabolic Syndrome (MS) and Bone and Cartilage Metabolism (BCM). The purpose of this study was to classify a sample of individuals with knee osteoarthritis (KOA) into pre-defined groups characterized by specific variables that can be linked to different disease mechanisms, and compare these phenotypes for demographic and health outcomes. Methods 599 patients were selected from the OAI database FNIH at 24 months' time to conduct the study. For each phenotype, cut offs of key variables were identified matching the results from previous studies in the field and the data available for the sample. The selection process consisted of 3 steps. At the end of each step, the subjects classified were excluded from the further classification stages. Patients meeting the criteria for more than one phenotype were classified separately into a 'complex KOA' group. Results Phenotype allocation (including complex KOA) was successful for 84% of cases with an overlap of 20%. Disease duration was shorter in the MJD while the CP phenotype included a larger number of Women (81 %). A significant effect of phenotypes on WOMAC pain (F = 16.736 p <0.001) and WOMAC physical function (F = 14.676, p < 0.001) was identified after controlling for disease duration. Conclusion This study signifies the feasibility of a classification of KOA subjects in distinct phenotypes based on subgroup-specific characteristics.	[Dell'Isola, A.; Steultjens, M.] Glasgow Caledonian Univ, Inst Appl Hlth Res, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland	Glasgow Caledonian University	Dell'Isola, A; Steultjens, M (corresponding author), Glasgow Caledonian Univ, Inst Appl Hlth Res, Sch Hlth & Life Sci, Glasgow, Lanark, Scotland.	andrea.dellIsola@gcu.ac.uk; Martijn.steultjens@gcu.ac.uk	Dell'Isola, Andrea/Y-6165-2019	Dell'Isola, Andrea/0000-0002-0319-458X	European Union's Seventh Framework Programme (FP7) [607510]; National Institutes of Health, a branch of the Department of Health and Human Services [N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, N01-AR-2-2262]; OAI Study Investigators; Merck Research Laboratories; Novartis Pharmaceuticals Corporation; GlaxoSmithKline; Pfizer, Inc.; Foundation for the National Institutes of Health; NIH	European Union's Seventh Framework Programme (FP7); National Institutes of Health, a branch of the Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OAI Study Investigators; Merck Research Laboratories(Merck & Company); Novartis Pharmaceuticals Corporation(Novartis); GlaxoSmithKline(GlaxoSmithKline); Pfizer, Inc.(Pfizer); Foundation for the National Institutes of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7-PE0PLE-2013-ITN) under grant agreement no 607510. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The OAI is a public-private partnership comprised of five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Merck Research Laboratories; Novartis Pharmaceuticals Corporation, GlaxoSmithKline; and Pfizer, Inc. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This manuscript was prepared using an OAI public use data set and does not necessarily reflect the opinions orviews of the OAI investigators, the NIH, or the private funding partners. The funders of the OAI dataset had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Andriacchi TP, 2015, ANN BIOMED ENG, V43, P376, DOI 10.1007/s10439-014-1117-2; Angst F, 2001, ARTHRIT RHEUM-ARTHR, V45, P384, DOI 10.1002/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0; Bae WC, 2010, CARTILAGE, V1, P10, DOI 10.1177/1947603509354991; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Berry PA, 2010, J RHEUMATOL, V37, P1252, DOI 10.3899/jrheum.091055; Carlesso LC, 2016, ARTHRITIS CARE RES H; Courties A, 2015, OSTEOARTHR CARTILAGE, V23, P1955, DOI 10.1016/j.joca.2015.05.016; Cruz-Almeida Y, 2013, ARTHRIT CARE RES, V65, P1786, DOI 10.1002/acr.22070; Dahaghin S, 2007, ANN RHEUM DIS, V66, P916, DOI 10.1136/ard.2005.045724; Dekker J, 2009, CURR OPIN RHEUMATOL, V21, P520, DOI 10.1097/BOR.0b013e32832e6eaa; Dell'Isola A, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1286-2; Dell'Isola A, 2017, OSTEOARTHR CARTIL; Driban JB, 2010, CLIN RHEUMATOL, V29, P123, DOI 10.1007/s10067-009-1301-1; Eckstein F, 2012, NAT REV RHEUMATOL, V8, P622, DOI 10.1038/nrrheum.2012.113; Felson DT, 2010, OSTEOARTHR CARTILAGE, V18, P601, DOI 10.1016/j.joca.2010.01.007; Heinegard D, 2011, NAT REV RHEUMATOL, V7, P50, DOI 10.1038/nrrheum.2010.198; Holla JFM, 2014, ANN RHEUM DIS, V73, P1369, DOI 10.1136/annrheumdis-2012-202984; Hunter DJ, 2011, OSTEOARTHR CARTILAGE, V19, P990, DOI 10.1016/j.joca.2011.05.004; Hussain SM, 2014, SEMIN ARTHRITIS RHEU, V43, P429, DOI 10.1016/j.semarthrit.2013.07.013; Karsdal MA, 2015, OSTEOARTHR CARTILAGE, V23, P550, DOI 10.1016/j.joca.2014.12.024; Karsdal MA, 2014, OSTEOARTHR CARTILAGE, V22, P7, DOI 10.1016/j.joca.2013.10.018; Karsdal MA, 2016, DIS MODIFYING TREATM, P2013; King CD, 2013, OSTEOARTHR CARTILAGE, V21, P1243, DOI 10.1016/j.joca.2013.05.015; Knoop J, 2011, ARTHRIT CARE RES, V63, P1535, DOI 10.1002/acr.20571; Lewinsohn PM, 1997, PSYCHOL AGING, V12, P277, DOI 10.1037/0882-7974.12.2.277; McCabe PS, 2016, ARTHRITIS RHEUMATOL; Messier SP, 2013, JAMA-J AM MED ASSOC, V310, P1263, DOI 10.1001/jama.2013.277669; Murphy SL, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3449; Neogi T, 2015, ANN RHEUM DIS, V74, P682, DOI 10.1136/annrheumdis-2013-204191; Otterness IG, 2000, OSTEOARTHR CARTILAGE, V8, P180, DOI 10.1053/joca.1999.0288; Riddle DL, 2016, OSTEOARTHR CARTILAGE, V24, P2100, DOI 10.1016/j.joca.2016.06.021; Roemer FW, 2012, ARTHRITIS RHEUM-US, V64, P429, DOI 10.1002/art.33344; Sharma L, 2010, ANN RHEUM DIS, V69, P1940, DOI 10.1136/ard.2010.129742; Sowers M, 2002, OSTEOARTHR CARTILAGE, V10, P595, DOI 10.1053/joca.2002.0800; van der Esch M, 2015, OSTEOARTHR CARTILAGE, V23, P544, DOI 10.1016/j.joca.2015.01.006; van Spil WE, 2012, OSTEOARTHR CARTILAGE, V20, P745, DOI 10.1016/j.joca.2012.04.004; Waarsing JH, 2015, DISTINCT SUBTYPES KN, P1; Yoshimura N, 2012, OSTEOARTHR CARTILAGE, V20, P1217, DOI 10.1016/j.joca.2012.06.006	38	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191045	10.1371/journal.pone.0191045	http://dx.doi.org/10.1371/journal.pone.0191045			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329325	Green Published, gold, Green Submitted			2022-12-26	WOS:000419954100034
J	Eide, I; Westad, F				Eide, Ingvar; Westad, Frank			Automated multivariate analysis of multi-sensor data submitted online: Real-time environmental monitoring	PLOS ONE			English	Article							SEDIMENTS; SYSTEM; METAL	A pilot study demonstrating real-time environmental monitoring with automated multivariate analysis of multi-sensor data submitted online has been performed at the cabled LoVe Ocean Observatory located at 258 m depth 20 km off the coast of Lofoten-Vesteralen, Norway. The major purpose was efficient monitoring of many variables simultaneously and early detection of changes and time-trends in the overall response pattern before changes were evident in individual variables. The pilot study was performed with 12 sensors from May 16 to August 31, 2015. The sensors provided data for chlorophyll, turbidity, conductivity, temperature (three sensors), salinity (calculated from temperature and conductivity), biomass at three different depth intervals (5-50, 50-120,120-250 m), and current speed measured in two directions (east and north) using two sensors covering different depths with overlap. A total of 88 variables were monitored, 78 from the two current speed sensors. The time-resolution varied, thus the data had to be aligned to a common time resolution. After alignment, the data were interpreted using principal component analysis (PCA). Initially, a calibration model was established using data from May 16 to July 31. The data on current speed from two sensors were subject to two separate PCA models and the score vectors from these two models were combined with the other 10 variables in a multi-block PCA model. The observations from August were projected on the calibration model consecutively one at a time and the result was visualized in a score plot. Automated PCA of multi-sensor data submitted online is illustrated with an attached time-lapse video covering the relative short time period used in the pilot study. Methods for statistical validation, and warning and alarm limits are described. Redundant sensors enable sensor diagnostics and quality assurance. In a future perspective, the concept may be used in integrated environmental monitoring.	[Eide, Ingvar] Statoil ASA, Res Ctr, Trondheim, Norway; [Westad, Frank] CAMO Software AS, Oslo, Norway	Equinor	Eide, I (corresponding author), Statoil ASA, Res Ctr, Trondheim, Norway.	ieide1950@gmail.com			Statoil ASA	Statoil ASA	The work was financed by Statoil ASA who also established the cabled LoVe Ocean Observatory. The data from the LoVe Ocean Observatory are open, and the intention and a prerequisite have been to publish the work in peer reviewed scientific journals. The funder provided support in the form of salaries for the first author [IE] who is an employee in Statoil ASA. The second author (FW) who is an employee in Camo Software AS was contracted by Statoil ASA. However, Statoil ASA did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alvarez-Guerra M, 2010, J CHEMOMETR, V24, P379, DOI 10.1002/cem.1264; Bagley PM, 2015, SEAFLOOR OBSERVATORI, P325; Derot J, 2015, CONT SHELF RES, V109, P210, DOI 10.1016/j.csr.2015.09.015; Eide I, 2017, INTEGR ENVIRON ASSES, V13, P387, DOI 10.1002/ieam.1840; Eide I, 2011, WATER AIR SOIL POLL, V218, P387, DOI 10.1007/s11270-010-0653-0; Godo OR, 2014, MAR POLLUT BULL, V84, P236, DOI 10.1016/j.marpolbul.2014.05.007; Godo OR, 2014, MAR TECHNOL SOC J, V48, P24, DOI 10.4031/MTSJ.48.2.2; Jackson J.E., 2004, USERS GUIDE PRINCIPA; Jalon-Rojas I, 2016, LIMNOL OCEANOGR-METH, V14, P381, DOI 10.1002/lom3.10097; Johannesson KA, 1983, FAO FISH TECH PAP; LEWIS EL, 1981, DEEP-SEA RES, V28, P307, DOI 10.1016/0198-0149(81)90002-9; Lin YC, 2013, MAR POLLUT BULL, V76, P266, DOI 10.1016/j.marpolbul.2013.08.027; MacLennan DN, 2002, ICES J MAR SCI, V59, P365, DOI 10.1006/jmsc.2001.1158; Munoz I, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4970-z; Navarro G, 2012, SENSORS-BASEL, V12, P1398, DOI 10.3390/s120201398; Neff JM, 2005, INTEGR ENVIRON ASSES, V1, P22, DOI 10.1897/IEAM_2004a-016.1; Nilssen I, 2015, MAR POLLUT BULL, V96, P374, DOI 10.1016/j.marpolbul.2015.04.045; NOMIKOS P, 1995, TECHNOMETRICS, V37, P41, DOI 10.2307/1269152; Rodriguez-Ortega MJ, 2009, MAR POLLUT BULL, V58, P64, DOI 10.1016/j.marpolbul.2008.09.006; Tunnicliffe V., 2003, OCEANOGRAPHY, V16, P53, DOI DOI 10.5670/0CEAN0G.2003.08; Westad F, 2015, ANAL CHIM ACTA, V893, P14, DOI 10.1016/j.aca.2015.06.056	21	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0189443	10.1371/journal.pone.0189443	http://dx.doi.org/10.1371/journal.pone.0189443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329297	Green Published, gold, Green Submitted			2022-12-26	WOS:000419954100007
J	Barakat, DJ; Suresh, R; Barberi, T; Pienta, KJ; Simons, BW; Friedman, AD				Barakat, David J.; Suresh, Rahul; Barberi, Theresa; Pienta, Kenneth J.; Simons, Brian W.; Friedman, Alan D.			Absence of myeloid Klf4 reduces prostate cancer growth with pro-atherosclerotic activation of tumor myeloid cells and infiltration of CD8 T cells	PLOS ONE			English	Article							MONOCYTE DIFFERENTIATION; MACROPHAGE POLARIZATION; TRANSCRIPTION FACTOR; INFLUENZA INFECTION; MIGRATION; MICE; IMMUNE; PU.1; HETERODIMERS; INFLAMMATION	The microenvironment of prostate cancer often includes abundant tumor-associated macrophages (TAMs), with their acquisition of an M2 phenotype correlating with local aggressiveness and metastasis. Tumor-derived M-CSF contributes to TAM M2 polarization, and M-CSF receptor inhibition slows prostate cancer growth in model systems. As additional cytokines can direct TAM M2 polarization, targeting downstream transcription factors could avoid resistance. Klf4 and C/EBP beta each contribute to monocyte development, and reduced expression of macrophage Klf4 or C/EBP beta favors their adoption of a pro-inflammatory M1 state. We find that a Hi-Myc C57BL/6 prostate cancer line grows more slowly in syngeneic Klf4(f/f); Lys-Cre compared with Klf4(f/f) mice when inoculated subcutaneously, but grows equally rapidly in C/EBP beta(f/f); Lys-Cre and C/EBP beta(f/f) hosts. In the absence of myeloid Klf4, TAMs have reduced expression of surface mannose receptor and Fizz1 mRNA, both M2 markers. Global gene expression analysis further revealed activation of pro-inflammatory, pro-atherosclerotic pathways. Analysis of tumor-infiltrating lymphocytes (TILs) demonstrated markedly increased activated CD8 T cell numbers, and CD8 T cell depletion obviated the inhibitory effect of myeloid Klf4 deletion on prostate cancer growth. These findings suggest that reducing expression or activity of	[Barakat, David J.; Suresh, Rahul; Barberi, Theresa; Pienta, Kenneth J.; Friedman, Alan D.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21218 USA; [Pienta, Kenneth J.; Simons, Brian W.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Friedman, AD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21218 USA.	afriedm2@jhmi.edu	Suresh, Rahul/W-6333-2019	Friedman, Alan/0000-0002-5615-7061; Barakat, David/0000-0001-7057-178X	Department of Defense (DOD) [PC150202]; CDMRP.army.mil,; National Institutes of Health [T32 CA60441, P30 CA006973]; Oncology enter core services; Giant Food Children's Cancer Research Fund	Department of Defense (DOD)(United States Department of Defense); CDMRP.army.mil,; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oncology enter core services; Giant Food Children's Cancer Research Fund	This work was supported by Department of Defense (DOD) grant PC150202, CDMRP.army.mil, and National Institutes of Health grants T32 CA60441 and P30 CA006973, www.nih.gov. The DOD grant includes funds designated for Dr. Friedman's laboratory and personnel support. The P30 grant provides Oncology enter core services. The T32 grant is a training grant which helps fund Drs. Barakat and Barberi's salaries. The Giant Food Children's Cancer Research Fund, no grant number, www.giantfood.com. Giant foods makes an annual charitable donation to our Pediatric Oncology division and the monies are used in part for maintaining laboratory equipment.	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Andreasen SO, 2003, J IMMUNOL, V171, P2804, DOI 10.4049/jimmunol.171.6.2804; Cai DH, 2008, ONCOGENE, V27, P2772, DOI 10.1038/sj.onc.1210940; Comito G, 2014, ONCOGENE, V33, P2423, DOI 10.1038/onc.2013.191; Comperat E, 2012, ANAL QUANT CYTOL HIS, V32, P39; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Escamilla J, 2015, CANCER RES, V75, P950, DOI 10.1158/0008-5472.CAN-14-0992; Feinberg MW, 2007, EMBO J, V26, P4138, DOI 10.1038/sj.emboj.7601824; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Gewaltig J, 2008, HUM PATHOL, V39, P1756, DOI 10.1016/j.humpath.2008.04.018; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; HANSSON GK, 1989, AM J PATHOL, V135, P169; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hong S, 2011, J LEUKOCYTE BIOL, V90, P643, DOI 10.1189/jlb.0111043; Hume DA, 2011, J LEUKOCYTE BIOL, V89, P525, DOI 10.1189/jlb.0810472; Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; Langley SR, 2017, J CLIN INVEST, V127, P1546, DOI 10.1172/JCI86924; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; Nonomura N, 2011, BJU INT, V107, P1918, DOI 10.1111/j.1464-410X.2010.09804.x; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Overstreet MG, 2013, NAT IMMUNOL, V14, P949, DOI 10.1038/ni.2682; Quail DF, 2016, SCIENCE, V352, DOI 10.1126/science.aad3018; Ray SJ, 2004, IMMUNITY, V20, P167, DOI 10.1016/S1074-7613(04)00021-4; Richter M, 2007, J IMMUNOL, V178, P4506, DOI 10.4049/jimmunol.178.7.4506; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Sharma N, 2012, ARTERIOSCL THROM VAS, V32, P2836, DOI 10.1161/ATVBAHA.112.300471; SHEKHONIN BV, 1987, ATHEROSCLEROSIS, V67, P9, DOI 10.1016/0021-9150(87)90259-0; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Simons BW, 2015, J PATHOL, V235, P478, DOI 10.1002/path.4472; Tang S, 2012, CANCER RES, V72, P1975, DOI 10.1158/0008-5472.CAN-11-2499; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tugal D, 2013, ARTERIOSCL THROM VAS, V33, P1135, DOI 10.1161/ATVBAHA.113.301453; Zhou GJ, 2012, J CLIN INVEST, V122, P4727, DOI 10.1172/JCI66056	42	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191188	10.1371/journal.pone.0191188	http://dx.doi.org/10.1371/journal.pone.0191188			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324844	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400130
J	Irigoyen, AJ; Rojo, I; Calo, A; Trobbiani, G; Sanchez-Carnero, N; Garcia-Charton, JA				Irigoyen, Alejo J.; Rojo, Irene; Calo, Antonio; Trobbiani, Gaston; Sanchez-Carnero, Noela; Garcia-Charton, Jose A.			The "Tracked Roaming Transect" and distance sampling methods increase the efficiency of underwater visual censuses	PLOS ONE			English	Article							REEF FISH ASSEMBLAGE; HABITAT STRUCTURE; ABUNDANCE; DIVERSITY; DENSITY; COUNTS; COMMUNITIES; POPULATIONS; PRESSURE; IMPACT	Underwater visual census (UVC) is the most common approach for estimating diversity, abundance and size of reef fishes in shallow and clear waters. Abundance estimation through UVC is particularly problematic in species occurring at low densities and/or highly aggregated because of their high variability at both spatial and temporal scales. The statistical power of experiments involving UVC techniques may be increased by augmenting the number of replicates or the area surveyed. In this work we present and test the efficiency of an UVC method based on diver towed GPS, the Tracked Roaming Transect (TRT), designed to maximize transect length (and thus the surveyed area) with respect to diving time invested in monitoring, as compared to Conventional Strip Transects (CST). Additionally, we analyze the effect of increasing transect width and length on the precision of density estimates by comparing TRT vs. CST methods using different fixed widths of 6 and 20 m (FW3 and FW10, respectively) and the Distance Sampling (DS) method, in which perpendicular distance of each fish or group of fishes to the transect line is estimated by divers up to 20 m from the transect line. The TRT was 74% more time and cost efficient than the CST (all transect widths considered together) and, for a given time, the use of TRT and/or increasing the transect width increased the precision of density estimates. In addition, since with the DS method distances of fishes to the transect line have to be estimated, and not measured directly as in terrestrial environments, errors in estimations of perpendicular distances can seriously affect DS density estimations. To assess the occurrence of distance estimation errors and their dependence on the observer's experience, a field experiment using wooden fish models was performed. We tested the precision and accuracy of density estimators based on fixed widths and the DS method. The accuracy of the estimates was measured comparing the actual total abundance with those estimated by divers using FW3, FW10, and DS estimators. Density estimates differed by 13% (range 0.1-31%) from the actual values (average = 13.09%; median = 14.16%). Based on our results we encourage the use of the Tracked Roaming Transect with Distance Sampling (TRT+DS) method for improving density estimates of species occurring at low densities and/or highly aggregated, as well as for exploratory rapid-assessment surveys in which divers could gather spatial ecological and ecosystem information on large areas during UVC.	[Irigoyen, Alejo J.; Trobbiani, Gaston; Sanchez-Carnero, Noela] Consejo Nacl Invest Cient & Tecn CCT CENPAT CONICE, Ctr Estudio Sistemas Marinos CESIMAR, Blvd Brown, Puerto Madryn, Chubut, Argentina; [Rojo, Irene; Garcia-Charton, Jose A.] Univ Murcia, Dept Ecol & Hidrol, Campus Espinardo, Murcia, Spain; [Calo, Antonio] Univ Cote dAzur, CNRS, FRE ECOMERS 3729, Parc Valrose, Nice, France	University of Murcia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Irigoyen, AJ (corresponding author), Consejo Nacl Invest Cient & Tecn CCT CENPAT CONICE, Ctr Estudio Sistemas Marinos CESIMAR, Blvd Brown, Puerto Madryn, Chubut, Argentina.	alejo@cenpat-conicet.gob.ar	Moreno, Irene Rojo/R-9803-2019; Calò, Antonio/ABB-2995-2020; Calò, Antonio/ABH-4727-2020; García-Charton, José Antonio/E-2793-2010	Calò, Antonio/0000-0001-6703-6751; García-Charton, José Antonio/0000-0002-5973-9913; Rojo, Irene/0000-0002-9007-3101; Trobbiani, Gaston Andres/0000-0001-7793-7553; Sanchez-Carnero, Noela/0000-0001-5940-0517	project from Argentina: IRSES-RECOMPRA (FP7-People-Marie Curie Actions-IRSES) [295213]; project from Spain: IRSES-RECOMPRA (FP7-People-Marie Curie Actions-IRSES) [295213]; Monitoring of the Cabo de Palos - Islas Hormigas marine reserve (Regional Fisheries and Aquaculture Service, Autonomous Community of the Region of Murcia); REDEMED [MINECO CGL2013-49039-R]; ABHACO2DE [Fundacion Seneca 19516/PI/14]; Agenda Nacional de Promocion de Ciencia y Tecnica [PICT 2012-0297]	project from Argentina: IRSES-RECOMPRA (FP7-People-Marie Curie Actions-IRSES); project from Spain: IRSES-RECOMPRA (FP7-People-Marie Curie Actions-IRSES); Monitoring of the Cabo de Palos - Islas Hormigas marine reserve (Regional Fisheries and Aquaculture Service, Autonomous Community of the Region of Murcia); REDEMED; ABHACO2DE; Agenda Nacional de Promocion de Ciencia y Tecnica	Field activities and data acquisition were accomplished in the course and funded by the following projects from Argentina and Spain: IRSES-RECOMPRA (FP7-People-Marie Curie Actions-IRSES-Contract no 295213), Monitoring of the Cabo de Palos - Islas Hormigas marine reserve (Regional Fisheries and Aquaculture Service, Autonomous Community of the Region of Murcia), REDEMED (MINECO CGL2013-49039-R), ABHACO2DE (Fundacion Seneca 19516/PI/14) and Agenda Nacional de Promocion de Ciencia y Tecnica (PICT 2012-0297).	Anderson AB, 2014, MAR ECOL PROG SER, V514, P207, DOI 10.3354/meps11032; [Anonymous], ESTUDIOS SEGUIMIENTO; Beck HJ, 2014, B MAR SCI, V90, P705, DOI 10.5343/bms.2013.1055; Bernard ATF, 2013, J EXP MAR BIOL ECOL, V443, P75, DOI 10.1016/j.jembe.2013.02.039; Bohnsack J.A., 1986, NOAA Technical Report NMFS, V41, P1; BORTONE S A, 1991, Northeast Gulf Science, V12, P17; Bozec YM, 2011, MAR BIOL, V158, P969, DOI 10.1007/s00227-011-1623-9; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Buckland S., 2004, ADV DISTANCE SAMPLIN; Buckland S.T., 2001, pi; BURNHAM KP, 1980, WILDLIFE MONOGR, P7; Cappo M., 2007, CUTTINGEDGE TECHNOLO, V1, P101; Cheal AJ, 1997, MAR ECOL PROG SER, V158, P241, DOI 10.3354/meps158241; Colin PL, 2013, ESTUAR COAST SHELF S, V123, P1, DOI 10.1016/j.ecss.2011.10.011; Colin PL, 2005, 7 IND REEF FISH C, P16; Colton MA, 2010, MAR ECOL PROG SER, V400, P19, DOI 10.3354/meps08377; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Garcia-Charton JA, 1998, MAR ECOL-P S Z N I, V19, P111; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; Garcia-Charton JA, 2001, MAR BIOL, V138, P917, DOI 10.1007/s002270000524; Goetze JS, 2017, ECOL APPL, V27, P1178, DOI 10.1002/eap.1511; Hill JJ, 2004, METHODS ECOLOGICAL M; Hodgson G., 2004, REEF CHECK INSTRUCTI; Irigoyen AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061072; Ivarez-Berastegui D, 2014, J NAT CONSERV, V22, P1; Katsanevakis S, 2012, AQUAT BIOL, V16, P31, DOI 10.3354/ab00426; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Kulbicki M, 1999, AQUAT LIVING RESOUR, V12, P315, DOI 10.1016/S0990-7440(99)00116-3; Kulbicki M, 2007, J EXP MAR BIOL ECOL, V353, P145, DOI 10.1016/j.jembe.2007.02.021; Kulbicki M, 2010, J EXP MAR BIOL ECOL, V387, P15, DOI 10.1016/j.jembe.2010.03.003; Labrosse P, UNDERWATER VISUAL FI; Lloret J, 2008, FISH RES, V94, P84, DOI 10.1016/j.fishres.2008.07.002; Loiseau N, 2016, ECOL INDIC, V60, P815, DOI 10.1016/j.ecolind.2015.08.019; Louisy P., PECES MARINOS EUROPA; Lynch T, 2015, BIOL CONSERV, V191, P700, DOI 10.1016/j.biocon.2015.08.009; MacNeill MA, 2008, MAR ECOL PROG SER, V367, P249, DOI 10.3354/meps07580; Marino A, 2012, WILDLIFE RES, V39, P503, DOI 10.1071/WR11174; McClanahan TR, 2007, MAR ECOL PROG SER, V340, P221, DOI 10.3354/meps340221; NOLAN RS, 1980, EVALUATION TRANSECT; Polunin N. V. C., 2009, DEV INDICATORS MPA E; Rizzari JR, 2014, MAR BIOL, V161, P2847, DOI 10.1007/s00227-014-2550-3; Sadovy Y, 2003, REV FISH BIOL FISHER, V13, P327, DOI 10.1023/B:RFBF.0000033122.90679.97; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Schmitt EF, 2002, CORAL REEFS, V21, P216, DOI 10.1007/s00338-002-0216-y; Schories D, 2012, ENVIRON MONIT ASSESS, V184, P2359, DOI 10.1007/s10661-011-2122-7; Siwiec T., 2008, DIVING SCI 2008, P159; Stobart B, 2007, J EXP MAR BIOL ECOL, V345, P158, DOI 10.1016/j.jembe.2007.02.009; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Thompson AA, 2002, MAR ECOL PROG SER, V232, P247, DOI 10.3354/meps232247; THRESHER RE, 1986, ENVIRON BIOL FISH, V17, P93, DOI 10.1007/BF00001740; Usseglio Paolo, 2015, P270; Ward-Paige C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011722, 10.1371/journal.pone.0011968]; Williams ID, 2006, MAR ECOL PROG SER, V310, P185, DOI 10.3354/meps310185; Willis TJ, 2003, MAR ECOL PROG SER, V257, P209, DOI 10.3354/meps257209; Willis TJ, 2001, J FISH BIOL, V59, P1408, DOI 10.1006/jfbi.2001.1721; Zeller DC, 2002, CORAL REEFS, V21, P183, DOI 10.1007/s00338-002-0231-z	57	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190990	10.1371/journal.pone.0190990	http://dx.doi.org/10.1371/journal.pone.0190990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324887	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400087
J	Ramesh, S; Govindarajulu, M; Lynd, T; Briggs, G; Adamek, D; Jones, E; Heiner, J; Majrashi, M; Moore, T; Amin, R; Suppiramaniam, V; Dhanasekaran, M				Ramesh, Sindhu; Govindarajulu, Manoj; Lynd, Tyler; Briggs, Gwyneth; Adamek, Danielle; Jones, Ellery; Heiner, Jake; Majrashi, Mohammed; Moore, Timothy; Amin, Rajesh; Suppiramaniam, Vishnu; Dhanasekaran, Muralikrishnan			SIRT3 activator Honokiol attenuates beta-Amyloid by modulating amyloidogenic pathway	PLOS ONE			English	Article							BRAIN INSULIN-RESISTANCE; TRANSGENIC MOUSE MODEL; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; PRECURSOR PROTEIN; MITOCHONDRIAL DYSFUNCTION; DEGRADING ENZYME; CALORIE RESTRICTION; SECRETASE CLEAVAGE; SWEDISH MUTATION	Honokiol (poly-phenolic lignan from Magnolia grandiflora) is a Sirtuin-3 (SIRT3) activator which exhibit antioxidant activity and augment mitochondrial functions in several experimental models. Modern evidence suggests the critical role of SIRT3 in the progression of several metabolic and neurodegenerative diseases. Amyloid beta (A beta), the precursor to extracellular senile plaques, accumulates in the brains of patients with Alzheimer's disease (AD) and is related to the development of cognitive impairment and neuronal cell death. A beta is generated from amyloid-beta precursor protein (APP) through sequential cleavages, first by beta-secretase and then by gamma-secretase. Drugs modulating this pathway are believed to be one of the most promising strategies for AD treatment. In the present study, we found that Honokiol significantly enhanced SIRT3 expression, reduced reactive oxygen species generation and lipid peroxidation, enhanced antioxidant activities, and mitochondrial function thereby reducing A beta and sAPP beta levels in Chinese Hamster Ovarian (CHO) cells (carrying the amyloid precursor protein-APP and Presenilin PS1 mutation). Mechanistic studies revealed that Honokiol affects neither protein levels of APP nor alpha-secretase activity. In contrast, Honokiol increased the expression of AMPK, CREB, and PGC-1 alpha, thereby inhibiting beta-secretase activity leading to reduced A beta levels. These results suggest that Honokiol is an activator of SIRT3 capable of improving antioxidant activity, mitochondrial energy regulation, while decreasing A beta, thereby indicating it to be a lead compound for AD drug development.	[Ramesh, Sindhu; Govindarajulu, Manoj; Lynd, Tyler; Briggs, Gwyneth; Adamek, Danielle; Jones, Ellery; Heiner, Jake; Majrashi, Mohammed; Moore, Timothy; Amin, Rajesh; Suppiramaniam, Vishnu; Dhanasekaran, Muralikrishnan] Auburn Univ, Harrison Sch Pharm, Dept Drug Discovery & Dev, Auburn, AL 36849 USA	Auburn University System; Auburn University	Dhanasekaran, M (corresponding author), Auburn Univ, Harrison Sch Pharm, Dept Drug Discovery & Dev, Auburn, AL 36849 USA.	dhanamu@aubum.edu	Govindarajulu, Manoj Yogish/ABB-7883-2021; Majrashi, Mohammed/AAM-4998-2020	Govindarajulu, Manoj Yogish/0000-0003-4739-648X; Majrashi, Mohammed/0000-0001-5752-7389				Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Ahuja M, 2017, LIFE SCI, V177, P49, DOI 10.1016/j.lfs.2017.03.004; Akagi M, 2015, J PHARMACOL SCI, V127, P155, DOI 10.1016/j.jphs.2014.12.015; Anekonda TS, 2005, BRAIN RES REV, V50, P361, DOI 10.1016/j.brainresrev.2005.09.001; Atanasov AG, 2013, BIOCH BIOPHYS ACTA; Austin S, 2012, J CELL SCI, V125, P4963, DOI 10.1242/jcs.113662; Beers RF, 2017, SPECTROPHOTOMETRIC M; Calvo-Ochoa E, 2015, DIABETES-METAB RES, V31, P1, DOI 10.1002/dmrr.2531; Castellani R, 2002, J NEUROSCI RES, V70, P357, DOI 10.1002/jnr.10389; Chen ZC, 2013, PROG NEUROBIOL, V108, P21, DOI 10.1016/j.pneurobio.2013.06.004; Choi IS, 2011, J ALZHEIMERS DIS, V27, P127, DOI 10.3233/JAD-2011-110545; Craft S, 2006, ALZ DIS ASSOC DIS, V20, P298, DOI 10.1097/01.wad.0000213866.86934.7e; de la Monte SM, 2002, CELL MOL LIFE SCI, V59, P882, DOI 10.1007/s00018-002-8475-x; de la Monte SM, 2014, BIOCHEM PHARMACOL, V88, P548, DOI 10.1016/j.bcp.2013.12.012; de la Monte SM, 2012, CURR ALZHEIMER RES, V9, P35; de la Monte SM, 2012, DRUGS, V72, P49, DOI 10.2165/11597760-000000000-00000; Deng J, 2012, J NEUROCHEM, V120, P732, DOI 10.1111/j.1471-4159.2011.07629.x; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Gemma C, 2007, BRAIN AGING MODELS M; Grasso G, 2014, INT J MOL SCI, V15, P16787, DOI 10.3390/ijms150916787; Guo CY, 2013, NEURAL REGEN RES, V8, P2003, DOI 10.3969/j.issn.1673-5374.2013.21.009; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hahn S, 2011, J NEUROCHEM, V116, P385, DOI 10.1111/j.1471-4159.2010.07118.x; Hallows William C, 2008, Biochem J, V411, pe11, DOI 10.1042/BJ20080336; Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hoi CP, 2010, PHYTOTHER RES, V24, P1538, DOI 10.1002/ptr.3178; Hoyer S, 2000, ANN NY ACAD SCI, V920, P256; Hoyer S, 1999, ANN NY ACAD SCI, V893, P301, DOI 10.1111/j.1749-6632.1999.tb07842.x; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Katsouri L, 2016, P NATL ACAD SCI USA, V113, P12292, DOI 10.1073/pnas.1606171113; Katsouri L, 2011, J ALZHEIMERS DIS, V25, P151, DOI 10.3233/JAD-2011-101356; Keller JN, 2004, INT J BIOCHEM CELL B, V36, P2376, DOI 10.1016/j.biocel.2004.05.003; Kim SH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014731, 10.1371/journal.pone.0026214]; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Kumar A, 2015, PHARMACOL REP, V67, P195, DOI 10.1016/j.pharep.2014.09.004; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Leuner K, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00044; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Lin CL, 2016, EXP NEUROL, V275, P84, DOI 10.1016/j.expneurol.2015.10.009; Ling Y, 2003, INT J BIOCHEM CELL B, V35, P1505, DOI 10.1016/S1357-2725(03)00133-X; Luchsinger JA, 2004, NEUROLOGY, V63, P1187, DOI 10.1212/01.WNL.0000140292.04932.87; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006; Mouli S, 2015, AM J PHYSL D, V309; Mungarro-Menchaca X, 2002, J NEUROSCI RES, V68, P89, DOI 10.1002/jnr.10193; Muralikrishnan D, 1998, FASEB J, V12, P905, DOI 10.1096/fasebj.12.10.905; Musiek ES, 2015, NAT NEUROSCI, V18, P800, DOI 10.1038/nn.4018; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Obregon D, 2012, SOLUBLE AMYLOID PREC; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Pappolla MA, 1998, AM J PATHOL, V152, P871; Picone P, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/780179; Pillai VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7656; Pope S, 2008, BBA-BIOENERGETICS, V1777, P794, DOI 10.1016/j.bbabio.2008.03.011; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Qin WP, 2009, ARCH NEUROL-CHICAGO, V66, P352, DOI 10.1001/archneurol.2008.588; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; RAMSAY RR, 1986, BIOCHEM BIOPH RES CO, V135, P269, DOI 10.1016/0006-291X(86)90972-1; Schrijvers EMC, 2010, NEUROLOGY, V75, P1982, DOI 10.1212/WNL.0b013e3181ffe4f6; Schuh Artur F, 2011, ISRN Neurol, V2011, P306905, DOI 10.5402/2011/306905; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Shin J, 2010, BMB REP, V43, P704, DOI [10.3858/BMBRep.2010.43.10.704, 10.5483/BMBRep.2010.43.10.704]; Smith IF, 2004, J NEUROCHEM, V88, P869, DOI 10.1016/j.1471-4159.2003.02212.x; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Swerdlow RH, 2014, BBA-MOL BASIS DIS, V1842, P1219, DOI 10.1016/j.bbadis.2013.09.010; Talbot K, 2014, ALZHEIMERS DEMENT, V10, pS12, DOI 10.1016/j.jalz.2013.12.007; Tamagno E, 2007, J NEUROCHEM; Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456; Thomson MJ, 1997, J BIOL CHEM, V272, P7759, DOI 10.1074/jbc.272.12.7759; Thrash B, 2010, NEUROCHEM RES, V35, P171, DOI 10.1007/s11064-009-0042-5; Tolppanen AM, 2012, J ALZHEIMERS DIS, V32, P531, DOI 10.3233/JAD-2012-120802; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; van der Heide LP, 2005, J NEUROCHEM, V94, P1158, DOI 10.1111/j.1471-4159.2005.03269.x; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Wharton D.C., 1967, CYTOCHROME OXIDASE B, P245, DOI [10.1016/0076-6879(67)10048-7, DOI 10.1016/0076-6879(67)10048-7]; Williamson R, 2012, BIOCHEM PHARMACOL, V84, P737, DOI 10.1016/j.bcp.2012.05.007; WILLS ED, 1965, BIOCHIM BIOPHYS ACTA, V98, P238, DOI 10.1016/0005-2760(65)90118-9; Woodbury A, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00130; Xian Y.-F., 2016, NEUROCHEMISTRY INT; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yang TT, 2015, J NEURAL TRANSM, V122, P1381, DOI 10.1007/s00702-015-1413-5; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045; Zheng H, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-27	95	48	49	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190350	10.1371/journal.pone.0190350	http://dx.doi.org/10.1371/journal.pone.0190350			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324783	Green Submitted, Green Published, gold			2022-12-26	WOS:000419952400031
J	Tewawong, N; Marathe, BM; Poovorawan, Y; Vongpunsawad, S; Webby, RJ; Govorkova, EA				Tewawong, Nipaporn; Marathe, Bindumadhav M.; Poovorawan, Yong; Vongpunsawad, Sompong; Webby, Richard J.; Govorkova, Elena A.			Neuraminidase inhibitor susceptibility and neuraminidase enzyme kinetics of human influenza A and B viruses circulating in Thailand in 2010-2015	PLOS ONE			English	Article							ACTIVE-SITE; 8 PLASMIDS; RESISTANCE; HEMAGGLUTININ; FITNESS; ASSAY	Amino acid substitutions within or near the active site of the viral neuraminidase (NA) may affect influenza virus fitness. In influenza A(H3N2) and B viruses circulating in Thailand between 2010 and 2015, we identified several NA substitutions that were previously reported to be associated with reduced inhibition by NA inhibitors (NAIs). To study the effect of these substitutions on the enzymatic properties of NA and on virus characteristics, we generated recombinant influenza viruses possessing either a wild type (WT) NA or an NA with a single I222V, S331G, or S331R substitution [in influenza A(H3N2) viruses] or a single D342S, A395T, A395V, or A395D NA substitution (in influenza B viruses). We generated recombinant (7: 1) influenza A and B viruses on the genetic background of A/Puerto Rico/8/1934 (A/PR/8, H1N1) or B/Yamanashi/166/1998 (B/YAM) viruses, respectively. In contrast to the expected phenotypes, all the recombinant influenza A(H3N2) and B viruses carrying putative NA resistance substitutions were susceptible to NAIs. The K-m and V-max for the NAs of A/PR8-S331G and A/PR8-S331R viruses were higher than for the NA of WT virus, and the corresponding values for the B/YAM-D342S virus were lower than for the NA of WT virus. Although there was initial variation in the kinetics of influenza A and B viruses' replication in MDCK cells, their titers were comparable to each other and to WT viruses at later time points. All introduced substitutions were stable except for B/YAM-D342S and B/YAM-A395V which reverted to WT sequences after three passages. Our data suggest that inferring susceptibility to NAIs based on sequence information alone should be cautioned. The impact of NA substitution on NAI resistance, viral growth, and enzymatic properties is viral context dependent and should be empirically determined.	[Tewawong, Nipaporn; Poovorawan, Yong; Vongpunsawad, Sompong] Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Clin Virol, Bangkok, Thailand; [Marathe, Bindumadhav M.; Webby, Richard J.; Govorkova, Elena A.] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA	Chulalongkorn University; St Jude Children's Research Hospital	Govorkova, EA (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	elena.govorkova@stjude.org	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022; Webby, Richard J/N-5657-2018	Tewawong, Nipaporn/0000-0003-1098-3701; Govorkova, Elena/0000-0001-9067-5682; vongpunsawad, sompong/0000-0001-7520-8728	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Centers of Excellence for Influenza Research and Surveillance (CEIRS) [HHSN272201400006C]; American Lebanese Syrian Associated Charities (ALSAC); National Science and Technology Development Agency [P-15-50004]; Center of Excellence in Clinical Virology of Chulalongkorn University [GCE 59-009-30-005]; Chulalongkorn University	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Centers of Excellence for Influenza Research and Surveillance (CEIRS); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); National Science and Technology Development Agency; Center of Excellence in Clinical Virology of Chulalongkorn University; Chulalongkorn University(Chulalongkorn University)	This work was supported by the following funding sources: The National Institute of Allergy and Infectious Diseases, National Institutes of Health, Centers of Excellence for Influenza Research and Surveillance (CEIRS) contract no. HHSN272201400006C to Richard J. Webby, the American Lebanese Syrian Associated Charities (ALSAC), The Research Chair Grant from the National Science and Technology Development Agency (P-15-50004) to Yong Poovorawan, and The Center of Excellence in Clinical Virology of Chulalongkorn University (GCE 59-009-30-005) to Yong Poovorawan. Nipaporn Tewawong received the Overseas Research Experience Scholarship for Graduate Students of Chulalongkorn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baz M, 2006, CLIN INFECT DIS, V43, P1555, DOI 10.1086/508777; BURMEISTER WP, 1992, EMBO J, V11, P49, DOI 10.1002/j.1460-2075.1992.tb05026.x; Burnham AJ, 2014, ANTIMICROB AGENTS CH, V58, P2718, DOI 10.1128/AAC.02628-13; Burnham AJ, 2013, ANTIVIR RES, V100, P520, DOI 10.1016/j.antiviral.2013.08.023; Centers for Disease Control and Prevention, INFLUENZA ANTIVIRAL; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; COLMAN PM, 1993, J VIROL, V67, P2972, DOI 10.1128/JVI.67.6.2972-2980.1993; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Govorkova EA, 2013, INFLUENZA OTHER RESP, V7, P50, DOI 10.1111/irv.12044; Gubareva LV, 2002, ANTIVIR RES, V53, P47, DOI 10.1016/S0166-3542(01)00192-9; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2002, P NATL ACAD SCI USA, V99, P11411, DOI 10.1073/pnas.172393399; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hurt AC, 2016, ANTIVIR RES, V132, P178, DOI 10.1016/j.antiviral.2016.06.001; Leang SK, 2014, INFLUENZA OTHER RESP, V8, P135, DOI 10.1111/irv.12187; Leang SK, 2013, ANTIVIR RES, V97, P206, DOI 10.1016/j.antiviral.2012.12.016; Li WF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-183; Little K, 2015, EURO SURVEILL, V20; Marathe BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071401; McKimm-Breschkin JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066105; Nguyen HT, 2012, ANTIVIR THER, V17, P159, DOI 10.3851/IMP2067; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; REED L. J., 1938, AMER JOUR HYG, V27, P493; Simon P, 2011, J CLIN MICROBIOL, V49, P715, DOI 10.1128/JCM.01732-10; Tewawong N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175655; The WHO GISRS Antiviral Susceptibility Expert Working Group (AVWG), SUMM BEUR AM AC SUB; Tu V, 2017, ANTIVIR RES, V137, P6, DOI 10.1016/j.antiviral.2016.11.007; WHO, 2012, WKLY EPIDEMIOL REC, V87, P369; Yen HL, 2006, J VIROL, V80, P8787, DOI 10.1128/JVI.00477-06	31	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190877	10.1371/journal.pone.0190877	http://dx.doi.org/10.1371/journal.pone.0190877			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324781	Green Submitted, Green Published, gold			2022-12-26	WOS:000419952400066
J	Franz, J; Grunebaum, J; Schafer, M; Mulac, D; Rehfeldt, F; Langer, K; Kramer, A; Riethmuller, C				Franz, Jonas; Gruenebaum, Jonas; Schaefer, Marcus; Mulac, Dennis; Rehfeldt, Florian; Langer, Klaus; Kramer, Armin; Riethmueller, Christoph			Rhombic organization of microvilli domains found in a cell model of the human intestine	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; SCANNING ELECTRON-MICROSCOPY; BRUSH-BORDER; IN-VITRO; SUCRASE-ISOMALTASE; EPITHELIAL-CELLS; DRUG ABSORPTION; CACO-2 ASSAY; MEMBRANE; LOCALIZATION	Symmetry is rarely found on cellular surfaces. An exception is the brush border of microvilli, which are essential for the proper function of transport epithelia. In a healthy intestine, they appear densely packed as a 2D-hexagonal lattice. For in vitro testing of intestinal transport the cell line Caco-2 has been established. As reported by electron microscopy, their microvilli arrange primarily in clusters developing secondly into a 2D-hexagonal lattice. Here, atomic force microscopy (AFM) was employed under aqueous buffer conditions on Caco-2 cells, which were cultivated on permeable filter membranes for optimum differentiation. For analysis, the exact position of each microvillus was detected by computer vision; subsequent Fourier transformation yielded the type of 2D-lattice. It was confirmed, that Caco-2 cells can build a hexagonal lattice of microvilli and form clusters. Moreover, a second type of arrangement was discovered, namely a rhombic lattice, which appeared at sub-maximal densities of microvilli with (29 +/- 4) microvilli/mu m(2). Altogether, the findings indicate the existence of a yet undescribed pattern in cellular organization.	[Franz, Jonas] Georg August Univ, Fac Phys, Gottingen, Germany; [Franz, Jonas] Max Planck Inst Dynam & Self Org, Theoret Neurophys, Gottingen, Germany; [Gruenebaum, Jonas; Mulac, Dennis; Langer, Klaus] Univ Munster, Inst Pharmaceut Technol & Biopharm, Munster, Germany; [Schaefer, Marcus] NanoAnalyt GmbH, Ctr Nanotechnol, Munster, Germany; [Rehfeldt, Florian] Georg August Univ, Inst Phys Biophys 3, Gottingen, Germany; [Kramer, Armin; Riethmueller, Christoph] Serend Ip GmbH, Ctr Nanotechnol, Munster, Germany	University of Gottingen; Max Planck Society; University of Munster; University of Gottingen	Riethmuller, C (corresponding author), Serend Ip GmbH, Ctr Nanotechnol, Munster, Germany.	info@nanostic.org	Rehfeldt, Florian/A-1078-2007	Rehfeldt, Florian/0000-0001-9086-3835; Franz, Jonas/0000-0001-7523-6622; Langer, Klaus/0000-0002-0203-7478	German Bundesministerium fur Bildung fur Forschung (BMBF) [FKZ 13N11390, 01DJ13022A]; Open Access Publication Funds of the Gottingen University; Serend-ip GmbH / nanoAnalytics GmbH	German Bundesministerium fur Bildung fur Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Open Access Publication Funds of the Gottingen University; Serend-ip GmbH / nanoAnalytics GmbH	he authors acknowledge the German Bundesministerium fur Bildung fur Forschung (BMBF - https://www.bmbf.de/en/research-funding-1411.html) for funding (FKZ 13N11390 to KL and 01DJ13022A to CR) and by the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Serend-ip GmbH / nanoAnalytics GmbH provided support in the form of salaries for authors [CR, AK / MS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.; The authors acknowledge support by the Open Access Publication Funds of the Gottingen University.	Artursson P, 1997, PHARMACEUT RES, V14, P1655, DOI 10.1023/A:1012155124489; Benard H., 1901, J PHYS THEOR APPL, V10, P254, DOI [10.1051/jphystap:0190100100025400, DOI 10.1051/JPHYSTAP:0190100100025400]; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Braet F, 1996, J MICROSC-OXFORD, V181, P10, DOI 10.1046/j.1365-2818.1996.72348.x; Brown JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009406; Crawley SW, 2014, J CELL BIOL, V207, P441, DOI 10.1083/jcb.201407015; Crawley SW, 2014, CELL, V157, P433, DOI 10.1016/j.cell.2014.01.067; Ferrary E, 1999, J CELL BIOL, V146, P819, DOI 10.1083/jcb.146.4.819; FRANSEN JAM, 1985, EUR J CELL BIOL, V38, P6; Frederix PLTM, 2009, BIOPHYS J, V96, P329, DOI 10.1016/j.bpj.2008.09.046; Gershanik T, 2000, INT J PHARM, V211, P29, DOI 10.1016/S0378-5173(00)00591-3; Greif D, 2010, ULTRAMICROSCOPY, V110, P1290, DOI 10.1016/j.ultramic.2010.06.004; GUSNARD D, 1977, J MICROSC-OXFORD, V110, P51, DOI 10.1111/j.1365-2818.1977.tb00012.x; Hecht E, 2011, ANAL BIOANAL CHEM, V399, P2369, DOI 10.1007/s00216-010-4407-z; HIROKAWA N, 1983, CELL, V32, P953, DOI 10.1016/0092-8674(83)90080-6; HIROKAWA N, 1982, J CELL BIOL, V94, P425, DOI 10.1083/jcb.94.2.425; HIROKAWA N, 1981, J CELL BIOL, V91, P399, DOI 10.1083/jcb.91.2.399; HOH JH, 1994, J CELL SCI, V107, P1105; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Kim SJ, 2008, ULTRAMICROSCOPY, V108, P1148, DOI 10.1016/j.ultramic.2008.04.081; Kucki M, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0280-7; McConnell RE, 2011, AM J PHYSIOL-GASTR L, V300, pG914, DOI 10.1152/ajpgi.00005.2011; Mirijanian DT, 2008, P NATL ACAD SCI USA, V105, P1204, DOI 10.1073/pnas.0707500105; MULLER DJ, 1995, BIOPHYS J, V68, P1681, DOI 10.1016/S0006-3495(95)80345-0; Neuhaus W, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00352; NISHI Y, 1978, J CELL BIOL, V79, P516, DOI 10.1083/jcb.79.2.516; Ouwendijk J, 1996, J CLIN INVEST, V97, P633, DOI 10.1172/JCI118459; Ouyang Q, 1993, CHAOS, V3, P707, DOI 10.1063/1.165931; PALAY SL, 1959, J BIOPHYS BIOCHEM CY, V5, P363, DOI 10.1083/jcb.5.3.363; PETERSON MD, 1993, J CELL SCI, V105, P445; Poole K, 2004, FEBS LETT, V565, P53, DOI 10.1016/j.febslet.2004.03.095; Press B, 2008, CURR DRUG METAB, V9, P893, DOI 10.2174/138920008786485119; Riethmuller C, 2008, BIOPHYS J, V94, P671, DOI 10.1529/biophysj.107.104893; Riethmueller C, 2007, ULTRAMICROSCOPY, V107, P895, DOI 10.1016/j.ultramic.2007.04.007; Rubas W, 1996, PHARMACEUT RES, V13, P23, DOI 10.1023/A:1016060729594; Scheuring S, 2002, EUR BIOPHYS J BIOPHY, V31, P172, DOI 10.1007/s00249-001-0197-8; Skolnik S, 2010, J PHARM SCI-US, V99, P3246, DOI 10.1002/jps.22080; SWINDALE NV, 1980, PROC R SOC SER B-BIO, V208, P243, DOI 10.1098/rspb.1980.0051; Swindale NV, 1982, P ROY SOC LOND B BIO, P215; Thoelking G, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/26/265102; Tran DT, 2013, J BIOL CHEM, V288, P6921, DOI 10.1074/jbc.R112.418558; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572; Tyska MJ, 2004, J CELL BIOL, V165, P395, DOI 10.1083/jcb.200310031; US Department of Health and Human Services FaDA Center for Drug Evaluation and Research (CDER)., WAIV IN VIV BIOAV BI; Volkmann N, 2001, J CELL BIOL, V153, P947, DOI 10.1083/jcb.153.5.947; Wolf F, 2005, PHYS REV LETT, P95; Zhang LX, 2013, CANCER IMMUNOL IMMUN, V62, P423, DOI 10.1007/s00262-012-1325-2	47	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0189970	10.1371/journal.pone.0189970	http://dx.doi.org/10.1371/journal.pone.0189970			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320535	Green Published, Green Submitted, gold			2022-12-26	WOS:000419689600025
J	Navarro-Lozano, A; Sanchez-Domene, D; Rossa-Feres, DC; Bosch, J; Sawaya, RJ				Navarro-Lozano, Alba; Sanchez-Domene, David; Rossa-Feres, Denise C.; Bosch, Jaime; Sawaya, Ricardo J.			Are oral deformities in tadpoles accurate indicators of anuran chytridiomycosis?	PLOS ONE			English	Article							UV-B RADIATION; BATRACHOCHYTRIUM-DENDROBATIDIS; POPULATION DECLINES; MOUTHPART DEPIGMENTATION; INTRODUCED FISHES; CENTRAL SPAIN; RANA-MUSCOSA; CALIFORNIA; MORTALITY; MOUNTAIN	We evaluated the use of oral deformities as reliable proxies for determining Batrachochytrium dendrobatidis (Bd) infection in tadpoles of six anuran species of the Atlantic Forest in southeastern Brazil. We examined oral discs of 2156 tadpoles of six species of anurans collected in 2016: Aplastodiscus albosignatus, Boana albopunctata, Boana faber, Scinax hayii, Crossodactylus caramaschii, and Physalaemus cuvieri. Three oral deformities were recognized: lack of keratinization only in upper and/or lower jaw sheaths, lack of keratinization only in upper or lower tooth rows, and both deformities together. A subsample composed of all the individuals possessing oral deformities (N = 195) plus randomly selected individuals without oral deformities (N = 184) were tested for Bd via qPCR. Oral deformities were observed in all six species, but only five were infected with Bd. Since we found that dekeratinization of tooth rows was not associated with the presence of Bd in any of the studied species we used a new proxy (jaw sheaths dekeratinization with or without dekeratinization in tooth rows: JSD-proxy) for Bd detection. Our results showed a nonrandom relationship between Bd infection and JSD-proxy in three species of the family Hylidae. However, the use of JSD-proxy for Bd detection in these species resulted in up to 30.8% false positives and up to 29.3% false negatives. The use of the JSD-proxy in species for which no relationship was found reached 100% of false positives. We conclude that the use of oral dekeratinization as a generalized proxy for Bd detection in tadpoles should not be used as a single diagnosis technique.	[Navarro-Lozano, Alba; Rossa-Feres, Denise C.] Univ Estadual Paulista, Dep Zool & Bot, Sao Jose Rio Do Preto, SP, Brazil; [Sanchez-Domene, David] Univ Estadual Paulista, Inst Pesquisa Bioenergia, Rio Claro, SP, Brazil; [Bosch, Jaime] CSIC, Museo Nacl Ciencias Nat, Madrid, Spain; [Sawaya, Ricardo J.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Bernardo Do Campo, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Navarro-Lozano, A (corresponding author), Univ Estadual Paulista, Dep Zool & Bot, Sao Jose Rio Do Preto, SP, Brazil.	alba.navarro.lozano@gmail.com	Rossa-Feres, Denise C/B-7903-2012; Bosch, Jaime/H-3042-2011	Bosch, Jaime/0000-0002-0099-7934; Sawaya, Ricardo/0000-0003-1897-1836; Sanchez Domene, David/0000-0002-7530-6886	Asociacion Universitaria Iberoamericana de Postgrado; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [1518162]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [303522/2013-5, 563075/2010-4, 304929/2015-8]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2010/52321-7, 2014/23677-9]; Fundacion BBVA	Asociacion Universitaria Iberoamericana de Postgrado; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacion BBVA(BBVA Foundation)	ANL thanks Asociacion Universitaria Iberoamericana de Postgrado for doctoral fellowship (www.auip.org); DSD thanks Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior for doctoral fellowship (#1518162) (www.capes.gov.br); DCRF thanks Conselho Nacional de Desenvolvimento Cientifico e Tecnologico for the research fellowship (303522/2013-5) and (563075/2010-4) (www.cnpq.br), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (#2010/52321-7) (www.fapesp.br); JB thanks Fundacion BBVA (www.fbbva.es); RJS thanks Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (#2014/23677-9), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (304929/2015-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altig R, 2007, HERPETOL CONSERV BIO, V2, P1; Bailey J, 2010, LABOUR HIST-AUST, P1; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; BERGER L, 1999, DECLINES DISAPPEARAN; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; BLAUSTEIN AR, 1994, P NATL ACAD SCI USA, V91, P1791, DOI 10.1073/pnas.91.5.1791; Blaustein AR, 1997, P NATL ACAD SCI USA, V94, P13735, DOI 10.1073/pnas.94.25.13735; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; BRADFORD DF, 1989, COPEIA, P775, DOI 10.2307/1445515; BRADFORD DF, 1993, CONSERV BIOL, V7, P882, DOI 10.1046/j.1523-1739.1993.740882.x; CAREY C, 1993, CONSERV BIOL, V7, P355, DOI 10.1046/j.1523-1739.1993.07020355.x; Carvalho T, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2254; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; Drake DL, 2007, COPEIA, P449, DOI 10.1643/0045-8511(2007)7[449:OOODIL]2.0.CO;2; Fellers GM, 2001, COPEIA, P945, DOI 10.1643/0045-8511(2001)001[0945:OCITMY]2.0.CO;2; Fisher RN, 1996, CONSERV BIOL, V10, P1387, DOI 10.1046/j.1523-1739.1996.10051387.x; Garcia RJF, 2005, PAISAGEM AMBIENTE EN, V20, P131; Gosner K. L., 1960, Herpetologica, V16, P183; HARTE J, 1989, CONSERV BIOL, V3, P149, DOI 10.1111/j.1523-1739.1989.tb00067.x; HEYER WR, 1988, BIOTROPICA, V20, P230, DOI 10.2307/2388238; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; KIESECKER JM, 1995, P NATL ACAD SCI USA, V92, P11049, DOI 10.1073/pnas.92.24.11049; Knapp RA, 2006, COPEIA, P188, DOI 10.1643/0045-8511(2006)6[188:TMDAAA]2.0.CO;2; Laurance WF, 1996, BIOL CONSERV, V77, P203, DOI 10.1016/0006-3207(95)00142-5; Lips KR, 1999, CONSERV BIOL, V13, P117, DOI 10.1046/j.1523-1739.1999.97185.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lizana M, 1998, CONSERV BIOL, V12, P703, DOI 10.1046/j.1523-1739.1998.97187.x; MALAGOLI L. R., 2013, THESIS; Marantelli Gerry, 2004, Pacific Conservation Biology, V10, P173; McDiarmid R. W., 1999, TADPOLES BIOL ANURAN; Nichols DK, 2001, J WILDLIFE DIS, V37, P1; Padgett-Flohr GE, 2007, J WILDLIFE DIS, V43, P690, DOI 10.7589/0090-3558-43.4.690; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Rachowicz Lara J., 2002, Herpetological Review, V33, P263; Relyea RA, 2005, ECOLOGY, V86, P1723, DOI 10.1890/04-1920; Rosa GM, 2017, SCI REP-UK, V7, DOI 10.1038/srep43260; Rowe CL, 1998, COPEIA, P244, DOI 10.2307/1447729; Skerratt LF, 2007, ECOHEALTH; Sutherland MAB, 2009, J HERPETOL, V43, P165; van Steenis W., 2021, IUCN RED LIST THREAT, pe.T149165436A149165446, DOI [10.2305/IUCN.UK.2021-3.RLTS.T149165436A149165446.en, DOI 10.2305/IUCN.UK.2021-1.RLTS.T49254712A49256721]; Vieira CA, 2013, BRAZ J BIOL, V73, P195, DOI 10.1590/S1519-69842013000100021	42	11	11	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190955	10.1371/journal.pone.0190955	http://dx.doi.org/10.1371/journal.pone.0190955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320551	Green Published, gold, Green Submitted			2022-12-26	WOS:000419689600075
J	Bucsics, T; Schoder, M; Diermayr, M; Feldner-Busztin, M; Goeschl, N; Bauer, D; Schwabl, P; Mandorfer, M; Angermayr, B; Cejna, M; Ferlitsch, A; Sieghart, W; Trauner, M; Peck-Radosavljevic, M; Karner, J; Karnel, F; Reiberger, T				Bucsics, Theresa; Schoder, Maria; Diermayr, Magdalena; Feldner-Busztin, Maria; Goeschl, Nicolas; Bauer, David; Schwabl, Philipp; Mandorfer, Mattias; Angermayr, Bernhard; Cejna, Manfred; Ferlitsch, Arnulf; Sieghart, Wolfgang; Trauner, Michael; Peck-Radosavljevic, Markus; Karner, Josef; Karnel, Franz; Reiberger, Thomas			Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience	PLOS ONE			English	Article							POLYTETRAFLUOROETHYLENE-COVERED STENT; PORTAL-HYPERTENSION; HEPATIC-ENCEPHALOPATHY; CONSENSUS WORKSHOP; ADVANCED CIRRHOSIS; CONTROLLED-TRIAL; LIVER-DISEASES; COMPETING RISK; BARE STENTS; THERAPY	Background and aims Transjugular intrahepatic portosystemic shunts (TIPS) are used in patients with cirrhosis for the prevention of variceal rebleeding. Methods We retrospectively evaluated re-bleeding rate, patency, mortality, and transplant-free survival (TFS) in cirrhotic patients receiving TIPS implantation for variceal bleeding between 1994-2014. Results 286 patients received TIPS (n = 119 bare metal stents, n = 167 polytetrafluorethylene (PTFE)-covered stents) for prevention of variceal re-bleeding. Mean age was 55.1 years, median MELD was 11.8, and the main etiology of cirrhosis was alcoholic liver disease (70%). Median follow-up was 821 days. 67 patients (23%) experienced at least one rebleeding event. Patients with PTFE-TIPS were at significantly lower risk for variceal rebleeding than patients with bare metal stents (14% vs. 37%, OR: 0.259; p<0.001) and had less need for stent revision (21% vs. 37%; p = 0.024). Patients with PTFE stent grafts showed lower mortality than patients with bare stents after 1 year (19% vs. 31%, p = 0.020) and 2 years (29% vs. 40%; p = 0.041) after TIPS implantation. Occurrence of hepatic encephalopathy after TIPS was similar between groups (20% vs. 24%, p = 0.449). Conclusions PTFE-TIPS were more effective at preventing variceal re-bleeding than bare metal stents due to better patency. Since this tended to translate in improved survival, only covered stents should be implemented for bleeding prophylaxis when TIPS is indicated.	[Bucsics, Theresa; Diermayr, Magdalena; Feldner-Busztin, Maria; Goeschl, Nicolas; Bauer, David; Schwabl, Philipp; Mandorfer, Mattias; Angermayr, Bernhard; Ferlitsch, Arnulf; Sieghart, Wolfgang; Trauner, Michael; Peck-Radosavljevic, Markus; Reiberger, Thomas] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria; [Bucsics, Theresa; Diermayr, Magdalena; Feldner-Busztin, Maria; Goeschl, Nicolas; Bauer, David; Schwabl, Philipp; Mandorfer, Mattias; Ferlitsch, Arnulf; Sieghart, Wolfgang; Peck-Radosavljevic, Markus; Reiberger, Thomas] Med Univ Vienna, Vienna Hepat Hemodynam Lab, Vienna, Austria; [Schoder, Maria] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Cejna, Manfred] Landeskrankenhaus, Dept Radiol, Feldkirch, Austria; [Karner, Josef] Kaiser Franz Josef Spital, Dept Surg, Vienna, Austria; [Karnel, Franz] Kaiser Franz Josef Spital, Dept Radiol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Kaiser-Franz-Josef Hospital; Kaiser-Franz-Josef Hospital	Reiberger, T (corresponding author), Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria.; Reiberger, T (corresponding author), Med Univ Vienna, Vienna Hepat Hemodynam Lab, Vienna, Austria.	thomas.reiberger@meduniwien.ac.at	Reiberger, Thomas/H-7613-2019; Mandorfer, Mattias/H-7603-2019	Reiberger, Thomas/0000-0002-4590-3583; Mandorfer, Mattias/0000-0003-2330-0017; Mullner-Bucsics, Theresa/0000-0003-3901-4111; Schwabl, Philipp/0000-0002-7183-8076; Bauer, David JM/0000-0002-9363-8518; Trauner, Michael/0000-0002-1275-6425				Angeloni S, 2004, AM J GASTROENTEROL, V99, P280, DOI 10.1111/j.1572-0241.2004.04056.x; Angermayr B, 2003, HEPATOLOGY, V38, P1043, DOI 10.1053/jhep.2003.50423; Bai Ming, 2014, World J Gastrointest Pharmacol Ther, V5, P97, DOI 10.4292/wjgpt.v5.i2.97; Barrio J, 2005, EUR J RADIOL, V55, P120, DOI 10.1016/j.ejrad.2004.10.007; Berzigotti A, 2013, EXPERT REV GASTROENT, V7, P141, DOI [10.1586/EGH.12.83, 10.1586/egh.12.83]; Bosch J, 2008, HEPATOLOGY, V47, P1604, DOI 10.1002/hep.22216; Boyer TD, 2005, HEPATOLOGY, V41, P386, DOI 10.1002/hep.20559; Bureau C, 2004, GASTROENTEROLOGY, V126, P469, DOI 10.1053/j.gastro.2003.11.016; Bureau C, 2007, LIVER INT, V27, P742, DOI 10.1111/j.1478-3231.2007.01522.x; Burroughs AK, 2002, SCAND J GASTROENTERO, V37, P249, DOI 10.1080/003655202317284138; Casadaban LC, 2014, SEMIN INTERVENT RAD, V31, P227, DOI 10.1055/s-0034-1382789; Conejo I, 2017, CLIN GASTROENTEROL H; de Franchis R, 2005, J HEPATOL, V43, P167, DOI 10.1016/j.jhep.2005.05.009; de Franchis R, 2015, J HEPATOL, V63, P743, DOI 10.1016/j.jhep.2015.05.022; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Garcia-Pagan JC, 2012, J HEPATOL, V57, P458, DOI 10.1016/j.jhep.2012.03.007; Garcia-Tsao G, 2017, HEPATOLOGY, V65, P310, DOI 10.1002/hep.28906; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; HASKAL ZJ, 1994, AM J ROENTGENOL, V163, P439, DOI 10.2214/ajr.163.2.8037046; Holster IL, 2016, HEPATOLOGY, V63, P581, DOI 10.1002/hep.28318; Huang QA, 2010, J CLIN ULTRASOUND, V38, P353, DOI 10.1002/jcu.20709; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Lin L, 2017, ONCOTARGET; Luo XF, 2015, RADIOLOGY, V276, P286, DOI 10.1148/radiol.15141252; Mandorfer M, 2017, DIGEST LIVER DIS, V49, P3, DOI 10.1016/j.dld.2016.09.013; Masson S, 2008, QJM-INT J MED, V101, P493, DOI 10.1093/qjmed/hcn037; Peck-Radosavljevic M, 2013, WIEN KLIN WOCHENSCHR, V125, P200, DOI 10.1007/s00508-013-0337-z; Perarnau JM, 2014, J HEPATOL, V60, P962, DOI 10.1016/j.jhep.2014.01.015; RICHTER GM, 1992, BAILLIERE CLIN GASTR, V6, P403, DOI 10.1016/0950-3528(92)90011-3; Riggio O, 2008, AM J GASTROENTEROL, V103, P2738, DOI 10.1111/j.1572-0241.2008.02102.x; Ripoll C, 2012, SCAND J GASTROENTERO, V47, P204, DOI 10.3109/00365521.2011.645500; Sauerbruch T, 2015, GASTROENTEROLOGY, V149, P660, DOI 10.1053/j.gastro.2015.05.011; Schulman AR, 2017, GASTROINTEST ENDOSC, V85, P243, DOI 10.1016/j.gie.2016.07.041; Silva-junior G, 2017, GASTROENTEROLOGY; Stanley AJ, 1998, QJM-MON J ASSOC PHYS, V91, P19, DOI 10.1093/qjmed/91.1.19; Wang Q, 2017, J HEPATOL	37	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0189414	10.1371/journal.pone.0189414	http://dx.doi.org/10.1371/journal.pone.0189414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315304	Green Submitted, gold, Green Published			2022-12-26	WOS:000419655900003
J	Obermeier, A; Schneider, J; Harrasser, N; Tubel, J; Muhlhofer, H; Pforringer, D; von Deimling, C; Foehr, P; Kiefel, B; Kramer, C; Stemberger, A; Schieker, M; Burgkart, R; von Eisenhart-Rothe, R				Obermeier, Andreas; Schneider, Jochen; Harrasser, Norbert; Tuebel, Jutta; Muehlhofer, Heinrich; Pfoerringer, Dominik; von Deimling, Constantin; Foehr, Peter; Kiefel, Barbara; Kraemer, Christina; Stemberger, Axel; Schieker, Matthias; Burgkart, Rainer; von Eisenhart-Rothe, Ruediger			Viable adhered Staphylococcus aureus highly reduced on novel antimicrobial sutures using chlorhexidine and octenidine to avoid surgical site infection (SSI)	PLOS ONE			English	Article							TRICLOSAN-COATED SUTURES; EVIDENCE-BASED ARGUMENT; BACTERIAL ADHERENCE; PREVENTION; METAANALYSIS; RESISTANCE; BIOFILMS; SURGERY; TECHNOLOGY; EFFICACY	Background Surgical sutures can promote migration of bacteria and thus start infections. Antiseptic coating of sutures may inhibit proliferation of adhered bacteria and avoid such complications. Objectives This study investigated the inhibition of viable adhering bacteria on novel antimicrobially coated surgical sutures using chlorhexidine or octenidine, a critical factor for proliferation at the onset of local infections. The medical need, a rapid eradication of bacteria in wounds, can be fulfilled by a high antimicrobial efficacy during the first days after wound closure. Methods As a pretesting on antibacterial efficacy against relevant bacterial pathogens a zone of inhibition assay was conducted with middle ranged concentrated suture coatings (22 mu g/cm). For further investigation of adhering bacteria in detail the most clinically relevant Staphylococcus aureus (ATCC (R) 49230 (TM)) was used. Absorbable braided sutures were coated with chlorhexidine-laurate, chlorhexidine-palmitate, octenidine-laurate, and octenidine-palmitate. Each coating type resulted in 11, 22, or 33 mu g/cm drug content on sutures. Scanning electron microscopy (SEM) was performed once to inspect the coating quality and twice to investigate if bacteria have colonized on sutures. Adhesion experiments were assessed by exposing coated sutures to S. aureus suspensions for 3 h at 37 degrees C. Subsequently, sutures were sonicated and the number of viable bacteria released from the suture surface was determined. Furthermore, the number of viable planktonic bacteria was measured in suspensions containing antimicrobial sutures. Commercially available sutures without drugs (Vicryl (R), PGA Resorba (R), and Gunze PGA), as well as triclosan-containing Vicryl (R) Plus were used as control groups. Results Zone of inhibition assay documented a multispecies efficacy of novel coated sutures against tested bacterial strains, comparable to most relevant S. aureus over 48 hours. SEM pictures demonstrated uniform layers on coated sutures with higher roughness for palmitate coatings and sustaining integrity of coated sutures. Adherent S. aureus were found via SEM on all types of investigated sutures. The novel antimicrobial sutures showed significantly less viable adhered S. aureus bacteria (up to 6.1 log) compared to Vicryl (R) Plus (0.5 log). Within 11 mu g/cm drug-containing sutures, octenidine-palmitate (OL11) showed the highest number of viable adhered S. aureus (0.5 log), similar to Vicryl (R) Plus. Chlorhexidine-laurate (CL11) showed the lowest number of S. aureus on sutures (1.7 log), a 1.2 log greater reduction. In addition, planktonic S. aureus in suspensions were highly inhibited by CL11 (0.9 log) represents a 0.6 log greater reduction compared to Vicryl (R) Plus (0.3 log). Conclusions Novel antimicrobial sutures can potentially limit surgical site infections caused by multiple pathogenic bacterial species. Therefore, a potential inhibition of multispecies biofilm formation is assumed. In detail tested with S. aureus, the chlorhexidine-laurate coating (CL11) best meets the medical requirements for a fast bacterial eradication. This suture coating shows the lowest survival rate of adhering as well as planktonic bacteria, a high drug release during the first-clinically most relevant-48 hours, as well as biocompatibility. Thus, CL11 coatings should be recommended for prophylactic antimicrobial sutures as an optimal surgical supplement to reduce wound infections. However, animal and clinical investigations are important to prove safety and efficacy for future applications.	[Obermeier, Andreas; Harrasser, Norbert; Tuebel, Jutta; Muehlhofer, Heinrich; von Deimling, Constantin; Foehr, Peter; Kiefel, Barbara; Kraemer, Christina; Stemberger, Axel; Burgkart, Rainer; von Eisenhart-Rothe, Ruediger] Tech Univ Munich, Klinikum Rechts Isar, Klin Orthopad & Sportorthopad, Munich, Germany; [Schneider, Jochen] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, Munich, Germany; [Pfoerringer, Dominik] Tech Univ Munich, Klinikum Rechts Isar, Klin & Poliklin Unfallchirurg, Munich, Germany; [Schieker, Matthias] Klinikum Univ Munchen, Klin Chirurg Expt Chirurg & Regenerat Med, Munich, Germany	Technical University of Munich; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technical University of Munich; University of Munich	Obermeier, A (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Klin Orthopad & Sportorthopad, Munich, Germany.	aobermeier@tum.de	Pförringer, PD Dr. med. Dominik/AAI-2368-2019; Schieker, Matthias/AGZ-2030-2022; Schieker, Matthias/J-6511-2015; Obermeier, Andreas/B-3020-2016	Pförringer, PD Dr. med. Dominik/0000-0002-0682-8293; Schieker, Matthias/0000-0002-1230-3653; Schieker, Matthias/0000-0002-1230-3653; Obermeier, Andreas/0000-0002-1774-5194; Foehr, Peter/0000-0003-1042-546X; Schneider, Jochen/0000-0002-0300-0159; Tuebel, Jutta/0000-0001-5033-2191	Heraeus Medical GmbH, Wehrheim, Germany; German Research Foundation (DFG); Technical University of Munich (TUM); Klinikum rechts der Isar, Technische Universitat Munchen [8895117_HeraeusCoating]	Heraeus Medical GmbH, Wehrheim, Germany; German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM); Klinikum rechts der Isar, Technische Universitat Munchen	This study was partially funded by the Heraeus Medical GmbH, Wehrheim, Germany (www.heraeus.com). At the Klinikum rechts der Isar, Technische Universitat Munchen the external funding number was 8895117_HeraeusCoating. The funder had no role in study design, data collection and interpretation, nor the decision to submit the work for publication. Additionally, this work was supported by the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program (www.ub.tum.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2007, CLIN INFECT DIS, V45, pS137, DOI 10.1086/519255; Al-Doori Z, 2007, J ANTIMICROB CHEMOTH, V59, P1280, DOI 10.1093/jac/dkm092; Amalaradjou MAR, 2014, PATHOGENS, V3, P404, DOI 10.3390/pathogens3020404; Baracs J, 2011, SURG INFECT, V12, P483, DOI 10.1089/sur.2011.001; Barnett Todd E, 2007, AORN J, V86, P249, DOI 10.1016/j.aorn.2007.03.012; Bedoux G, 2012, ENVIRON SCI POLLUT R, V19, P1044, DOI 10.1007/s11356-011-0632-z; Bratzler DW, 2005, AM J SURG, V189, P395, DOI 10.1016/j.amjsurg.2005.01.015; Chang WK, 2012, ANN SURG, V255, P854, DOI 10.1097/SLA.0b013e31824e7005; Cooney CM, 2010, ENVIRON HEALTH PERSP, V118, pA242, DOI 10.1289/ehp.118-a242; COOPER GL, 1988, J CLIN MICROBIOL, V26, P8, DOI 10.1128/JCM.26.1.8-12.1988; Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Edmiston CE, 2006, J AM COLL SURGEONS, V203, P481, DOI 10.1016/j.jamcollsurg.2006.06.026; Edmiston CE, 2014, SURGERY, V155, P362, DOI 10.1016/j.surg.2013.11.002; Edmiston CE, 2013, SURGERY, V154, P89, DOI 10.1016/j.surg.2013.03.008; ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573; Portillo ME, 2013, J CLIN MICROBIOL, V51, P591, DOI 10.1128/JCM.02482-12; Fischer Elizabeth R, 2012, Curr Protoc Microbiol, VChapter 2, DOI 10.1002/9780471729259.mc02b02s25; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Fujita T, 2010, SURGERY, V147, P464, DOI 10.1016/j.surg.2009.04.019; Geiger Dieter, 2005, Surg Infect (Larchmt), V6, P377, DOI 10.1089/sur.2005.6.377; Gollwitzer H, 2003, J ANTIMICROB CHEMOTH, V51, P585, DOI 10.1093/jac/dkg105; Gomez-Alonso A, 2007, J INFECTION, V54, P82, DOI 10.1016/j.jinf.2006.01.008; Greener M., 2011, OCTENIDINE ANTIMICRO, V7; Henry-Stanley MJ, 2010, SURG INFECT, V11, P433, DOI 10.1089/sur.2010.006; Hidalgo E, 2001, TOXICOL IN VITRO, V15, P271, DOI 10.1016/S0887-2333(01)00020-0; Hranjec T, 2010, SURG INFECT, V11, P289, DOI 10.1089/sur.2010.021; Hubner NO, 2010, SKIN PHARMACOL PHYS, V23, P28, DOI 10.1159/000318265; Hubner NO, 2010, SKIN PHARMACOL PHYS, V23, P244, DOI 10.1159/000314699; James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x; Justinger C, 2011, LANGENBECK ARCH SURG, V396, P845, DOI 10.1007/s00423-011-0786-7; Kathju S, 2009, SURG INFECT, V10, P457, DOI 10.1089/sur.2008.062; KATZ S, 1981, ANN SURG, V194, P35, DOI 10.1097/00000658-198107000-00007; Kouyos RD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0566; Leaper DJ, 2010, BRIT J SURG, V97, P1601, DOI 10.1002/bjs.7275; Leaper D, 2011, INT WOUND J, V8, P556, DOI 10.1111/j.1742-481X.2011.00841.x; Ming Xintian, 2007, Surg Infect (Larchmt), V8, P201, DOI 10.1089/sur.2006.005; Ming XT, 2008, SURG INFECT, V9, P451, DOI 10.1089/sur.2007.061; Mingmalairak, 2011, SCI MICROBIAL PATHOG, V313, P23; Monsen T, 2009, J CLIN MICROBIOL, V47, P2496, DOI 10.1128/JCM.02316-08; Mueller G, 2008, J ANTIMICROB CHEMOTH, V61, P1281, DOI 10.1093/jac/dkn125; Obermeier A, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0523-4; Obermeier A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101426; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Owens CD, 2008, J HOSP INFECT, V70, P3, DOI 10.1016/S0195-6701(08)60017-1; Perez-Kohler B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142768; Pillai CKS, 2010, J BIOMATER APPL, V25, P291, DOI 10.1177/0885328210384890; Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Stone J, 2010, PEDIATR NEUROSURG, V46, P19, DOI 10.1159/000314053; Syed AK, 2014, MBIO, V5, DOI 10.1128/mBio.01015-13; Wang ZX, 2013, BRIT J SURG, V100, P465, DOI 10.1002/bjs.9062; Yazdankhah SP, 2006, MICROB DRUG RESIST, V12, P83, DOI 10.1089/mdr.2006.12.83; Zhukovskii VA, 2008, FIBRE CHEM+, V40, P208, DOI 10.1007/s10692-008-9039-0; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181	55	20	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190912	10.1371/journal.pone.0190912	http://dx.doi.org/10.1371/journal.pone.0190912			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315313	Green Published, gold, Green Submitted			2022-12-26	WOS:000419655900032
J	Jia, WZ; Zhao, XP; Zhao, L; Yan, H; Li, JJ; Yang, H; Huang, G; Liu, JJ				Jia, Wenzhi; Zhao, Xiaoping; Zhao, Li; Yan, Hui; Li, Jiajin; Yang, Hao; Huang, Gang; Liu, Jianjun			Non-canonical roles of PFKFB3 in regulation of cell cycle through binding to CDK4	ONCOGENE			English	Article							ADVANCED BREAST-CANCER; 6-PHOSPHOFRUCTO-2-KINASE PFKFB3; DEPENDENT KINASES; DOWN-REGULATION; GLYCOLYSIS; GROWTH; INHIBITORS; ARREST; EXPRESSION; CARCINOMA	There is growing interest in studying the molecular mechanisms of crosstalk between cancer metabolism and the cell cycle. 6-phosphate fructose-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) is a well-known glycolytic activator that plays an important role in tumorigenesis. We investigated whether PFKFB3 was directly involved in oncogenic signaling networks. Mass Spectrometry showed that PFKFB3 interacts with cyclin-dependent kinase (CDK) 4, which controls the transition from G1 phase to S phase of the cell cycle. Further analysis indicated that lysine 147 was a key site for the binding of PFKBFB3 to CDK4. PFKFB3 binding resulted in the accumulation of CDK4 protein by inhibiting ubiquitin proteasome degradation mediated by the heat shock protein 90-Cdc37-CDK4 complex. The proteasome-dependent degradation of CDK4 was accelerated by disrupting the interaction of PFKFB3 with CDK4 by mutating lysine (147) to alanine. Blocking PFKFB3-CDK4 interaction improved the therapeutic effect of FDA-approved CDK4 inhibitor palbociclib on breast cancer. These findings suggest that PFKFB3 is a hub for coordinating cell cycle and glucose metabolism. Combined targeting of PFKFB3 and CDK4 may be new strategy for breast cancer treatment.	[Jia, Wenzhi; Zhao, Xiaoping; Zhao, Li; Yan, Hui; Li, Jiajin; Yang, Hao; Huang, Gang; Liu, Jianjun] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Nucl Med, Shanghai, Peoples R China; [Huang, Gang] Shanghai Univ Med & Hlth Sci, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai University of Medicine & Health Sciences	Huang, G; Liu, JJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Nucl Med, Shanghai, Peoples R China.; Huang, G (corresponding author), Shanghai Univ Med & Hlth Sci, Shanghai, Peoples R China.	huang2802@163.com; ljjsh@133sh.com		Li, Jiajin/0000-0003-1300-6025	National Natural Science Foundation of China [81471687, 81530053, 81372195, 81471685, 81572719, 81601520]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by research grants from National Natural Science Foundation of China (No. 81471687, 81530053, 81372195, 81471685, 81572719, 81601520).	Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Atsumi T, 2002, CANCER RES, V62, P5881; Braden WA, 2008, ONCOGENE, V27, P7083, DOI 10.1038/onc.2008.319; Calvo MN, 2006, FEBS LETT, V580, P3308, DOI 10.1016/j.febslet.2006.04.093; Cavalier MC, 2012, PROTEINS, V80, P1143, DOI 10.1002/prot.24015; Cen L, 2012, NEURO-ONCOLOGY, V14, P870, DOI 10.1093/neuonc/nos114; Chesney J, 1999, P NATL ACAD SCI USA, V96, P3047, DOI 10.1073/pnas.96.6.3047; Cieslar-Pobuda A, 2015, ONCOTARGET, V6, P29753, DOI 10.18632/oncotarget.4995; Clem BF, 2013, MOL CANCER THER, V12, P1461, DOI 10.1158/1535-7163.MCT-13-0097; Dai MO, 2016, SCI REP-UK, V6, DOI 10.1038/srep35383; Dimco G, 2010, CELL CYCLE, V9, P4638, DOI 10.4161/cc.9.23.13955; Domenech E, 2015, NAT CELL BIOL, V17, P1304, DOI 10.1038/ncb3231; Enzo E, 2015, EMBO J, V34, P1349, DOI 10.15252/embj.201490379; Erez A, 2015, NAT REV CANCER, V15, P440, DOI 10.1038/nrc3949; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Finn RS, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0661-5; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Gillam MP, 2015, ONCOGENE, V34, P932, DOI 10.1038/onc.2014.3; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Heilmann AM, 2014, CANCER RES, V74, P3947, DOI 10.1158/0008-5472.CAN-13-2923; Imbert-Fernandez Y, 2014, J BIOL CHEM, V289, P9440, DOI 10.1074/jbc.M113.529990; Jia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097448; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Katsumi Y, 2011, BIOCHEM BIOPH RES CO, V413, P62, DOI 10.1016/j.bbrc.2011.08.047; Klarer AC, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-2; Konecny GE, 2011, CLIN CANCER RES, V17, P1591, DOI 10.1158/1078-0432.CCR-10-2307; Li HM, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-016-0481-1; Li TY, 2014, CELL PHYSIOL BIOCHEM, V34, P1351, DOI 10.1159/000366342; Lu J, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0194-5; Lu YZ, 2014, J CLIN INVEST, V124, P1672, DOI 10.1172/JCI63139; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Mao CQ, 2014, MOL THER, V22, P964, DOI 10.1038/mt.2014.18; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; O'Leary B, 2016, NAT REV CLIN ONCOL, V13, P417, DOI 10.1038/nrclinonc.2016.26; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Perez M, 2015, ONCOTARGET, V6, P40557, DOI 10.18632/oncotarget.5829; Reid MA, 2016, GENE DEV, V30, P1837, DOI 10.1101/gad.287235.116; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Roberts PJ, 2012, JNCI-J NATL CANCER I, V104, P476, DOI 10.1093/jnci/djs002; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Shi H, 2009, CANCER SCI, V100, P1585, DOI 10.1111/j.1349-7006.2009.01223.x; Smith JR, 2009, ONCOGENE, V28, P157, DOI 10.1038/onc.2008.380; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; Verba KA, 2016, SCIENCE, V352, P1542, DOI 10.1126/science.aaf5023; Wang HM, 2002, EMBO J, V21, P930, DOI 10.1093/emboj/21.5.930; Wu AB, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-38; Yalcin A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.292; Yalcin A, 2009, J BIOL CHEM, V284, P24223, DOI 10.1074/jbc.M109.016816; Yamamoto T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4480; Yang C, 2017, ONCOGENE, V36, P2255, DOI 10.1038/onc.2016.379; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang Y, 2014, ONCOL REP, V31, P2759, DOI 10.3892/or.2014.3127; Young RJ, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12228; Zhong ZJ, 2010, CANCER RES, V70, P2105, DOI 10.1158/0008-5472.CAN-08-1108; Zhu Z, 2016, ONCOGENE, V35, P1399, DOI 10.1038/onc.2015.197	59	32	32	3	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	13					1685	1698		10.1038/s41388-017-0072-4	http://dx.doi.org/10.1038/s41388-017-0072-4			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GA9AE	29335521				2022-12-26	WOS:000428632600001
J	Benetti, E; Mastrocola, R; Chiazza, F; Nigro, D; D'Antona, G; Bordano, V; Fantozzi, R; Aragno, M; Collino, M; Minetto, MA				Benetti, Elisa; Mastrocola, Raffaella; Chiazza, Fausto; Nigro, Debora; D'Antona, Giuseppe; Bordano, Valentina; Fantozzi, Roberto; Aragno, Manuela; Collino, Massimo; Minetto, Marco Alessandro			Effects of vitamin D on insulin resistance and myosteatosis in diet-induced obese mice	PLOS ONE			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; SERUM 25-HYDROXYVITAMIN D; SKELETAL-MUSCLE; D SUPPLEMENTATION; TNF-ALPHA; GLUCOSE-HOMEOSTASIS; HEPATIC STEATOSIS; HYPOVITAMINOSIS-D; ACTIVATION	Epidemiological studies pointed out to a strong association between vitamin D deficiency and type 2 diabetes prevalence. However, the role of vitamin D supplementation in the skeletal muscle, a tissue that play a crucial role in the maintenance of glucose homeostasis, has been scarcely investigated so far. On this basis, this study aimed to evaluate the effect of vitamin D supplementation in a murine model of diet-induced insulin resistance with particular attention to the effects evoked on the skeletal muscle. Male C57BU6J mice (n = 40) were fed with a control or a High Fat-High Sugar (HFHS) diet for 4 months. Subsets of animals were treated for 2 months with vitamin D (7 mu g.kg-1, i.p. three times/week). HFHS diet induced body weight increase, hyperglycemia and impaired glucose tolerance. HFHS animals showed an impaired insulin signaling and a marked fat accumulation in the skeletal muscle. Vitamin D reduced body weight and improved systemic glucose tolerance. In addition, vitamin D restored the impaired muscle insulin signaling and reverted myosteatosis evoked by the diet. These effects were associated to decreased activation of NF-kappa B and lower levels of TNF-alpha. Consistently, a significantly decreased activation of the SCAP/SREBP lipogenic pathway and lower levels of CML protein adducts and RAGE expression were observed in skeletal muscle of animals treated with vitamin D. Collectively, these data indicate that vitamin D-induced selective inhibition of signaling pathways (including NF-kappa B, SCAP/SREBP and CMURAGE cascades) within the skeletal muscle significantly contributed to the beneficial effects of vitamin D supplementation against diet-induced metabolic derangements.	[Benetti, Elisa; Chiazza, Fausto; Bordano, Valentina; Fantozzi, Roberto; Collino, Massimo] Univ Turin, Dipartimento Sci & Tecnol Farmaco, Turin, Italy; [Mastrocola, Raffaella; Nigro, Debora; Aragno, Manuela] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [D'Antona, Giuseppe] Univ Pavia, Dept Publ Hlth Mol & Forens Med, Pavia, Italy; [D'Antona, Giuseppe] Univ Pavia, Sport Med Ctr Voghera, Pavia, Italy; [Minetto, Marco Alessandro] Univ Turin, Dept Med Sci, Div Endocrinol Diabetol & Metab, Turin, Italy; [Minetto, Marco Alessandro] Univ Turin, Dept Surg Sci, Div Phys Med & Rehabil, Turin, Italy	University of Turin; University of Turin; University of Pavia; University of Pavia; University of Turin; University of Turin	Benetti, E (corresponding author), Univ Turin, Dipartimento Sci & Tecnol Farmaco, Turin, Italy.	elisa.benetti@unito.it	Chiazza, Fausto/I-5559-2015; Collino, Massimo/AAK-8532-2020	Collino, Massimo/0000-0001-8782-3496; ARAGNO, Manuela/0000-0002-0453-5235; Chiazza, Fausto/0000-0001-7273-0051	University of Turin	University of Turin	This work was supported and funded by the University of Turin (Ricerca Locale 2015) to Elisa Benetti.	Alemzadeh R, 2008, METABOLISM, V57, P183, DOI 10.1016/j.metabol.2007.08.023; Alkharfy KM, 2013, METAB SYNDR RELAT D, V11, P283, DOI 10.1089/met.2012.0068; Alkharfy KM, 2013, BASIC CLIN PHARMACOL, V112, P42, DOI 10.1111/j.1742-7843.2012.00936.x; Benetti E, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/509502; Benetti E, 2016, J PHARMACOL EXP THER, V359, P45, DOI 10.1124/jpet.116.235069; Chen SC, 2016, J BONE MINER RES, V31, P585, DOI 10.1002/jbmr.2729; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254; Collino M, 2014, BRIT J PHARMACOL, V171, P5802, DOI 10.1111/bph.12888; Collino M, 2013, BIOCHEM PHARMACOL, V85, P257, DOI 10.1016/j.bcp.2012.10.014; Crescenzo R, 2013, EUR J NUTR, V52, P537, DOI 10.1007/s00394-012-0356-y; De Stefanis D, 2017, EUR J NUTR, V56, P363, DOI 10.1007/s00394-015-1086-8; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; Earthman CP, 2012, INT J OBESITY, V36, P387, DOI 10.1038/ijo.2011.119; Endo M, 2007, EXP BIOL MED, V232, P614; Gagnon C, 2011, DIABETES CARE, V34, P1133, DOI 10.2337/dc10-2167; Girgis CM, 2014, ENDOCRINOLOGY, V155, P3227, DOI 10.1210/en.2014-1016; Girgis CM, 2013, ENDOCR REV, V34, P33, DOI 10.1210/er.2012-1012; Grubler MR, 2016, DIABETES OBES METAB, V18, P1006, DOI 10.1111/dom.12709; Hamrick MW, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00069; Harant H, 1998, FEBS LETT, V436, P329, DOI 10.1016/S0014-5793(98)01153-3; Haroon NN, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0130-9; Hassan-Smith ZK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170665; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Jorde R, 2010, EUR J NUTR, V49, P401, DOI 10.1007/s00394-010-0098-7; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kaur P, 2015, CLIN ENDOCRINOL, V83, P327, DOI 10.1111/cen.12836; Leung PS, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030147; Li JF, 1997, J BIOL CHEM, V272, P16498, DOI 10.1074/jbc.272.26.16498; Liu LN, 2016, EXP THER MED, V11, P2284, DOI 10.3892/etm.2016.3242; Manna P, 2012, J BIOL CHEM, V287, P42324, DOI 10.1074/jbc.M112.407833; Mastrocola R, 2016, FREE RADICAL BIO MED, V91, P224, DOI 10.1016/j.freeradbiomed.2015.12.022; Mastrocola R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119587; Mastrocola R, 2013, AM J PHYSIOL-GASTR L, V305, pG398, DOI 10.1152/ajpgi.00450.2012; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meerza D, 2012, J DIABETES COMPLICAT, V26, P363, DOI 10.1016/j.jdiacomp.2012.05.013; Miljkovic I, 2010, CURR OPIN CLIN NUTR, V13, P260, DOI 10.1097/MCO.0b013e328337d826; Mishima Y, 2001, DIABETES RES CLIN PR, V52, P119, DOI 10.1016/S0168-8227(00)00247-3; Mostafa DK, 2016, EUR J PHARMACOL, V792, P38, DOI 10.1016/j.ejphar.2016.10.031; Muscogiuri G, 2017, ARCH TOXICOL, V91, P97, DOI 10.1007/s00204-016-1804-x; Muscogiuri G, 2014, EUR J ENDOCRINOL, V171, pR101, DOI 10.1530/EJE-14-0158; Nameni G, 2017, J MOL NEUROSCI, V61, P247, DOI 10.1007/s12031-016-0864-y; Osati S, 2016, DIABETES METAB SYND, V10, pS7, DOI 10.1016/j.dsx.2016.01.007; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; Schwabe RF, 2002, AM J PHYSIOL-GASTR L, V283, pG204, DOI 10.1152/ajpgi.00016.2002; Scragg R, 2004, DIABETES CARE, V27, P2813, DOI 10.2337/diacare.27.12.2813; Sisley SR, 2016, DIABETES, V65, P2732, DOI 10.2337/db16-0309; Song BJ, 2013, LIVER INT, V33, P653, DOI 10.1111/liv.12147; Song YQ, 2013, DIABETES CARE, V36, P1422, DOI 10.2337/dc12-0962; Stio M, 2007, J STEROID BIOCHEM, V103, P51, DOI 10.1016/j.jsbmb.2006.07.008; Takada Y, 2004, J BIOL CHEM, V279, P39541, DOI 10.1074/jbc.M403449200; Trinko JR, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0122-15.2016; Tukaj S, 2012, ACTA BIOCHIM POL, V59, P395; Tzotzas T, 2010, J CLIN ENDOCR METAB, V95, P4251, DOI 10.1210/jc.2010-0757; Yin Y, 2012, EUR J CLIN INVEST, V42, P1189, DOI 10.1111/j.1365-2362.2012.02706.x; YU XP, 1995, P NATL ACAD SCI USA, V92, P10990, DOI 10.1073/pnas.92.24.10990; Zhou QG, 2008, DIABETES-METAB RES, V24, P459, DOI 10.1002/dmrr.873	61	46	48	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0189707	10.1371/journal.pone.0189707	http://dx.doi.org/10.1371/journal.pone.0189707			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342166	Green Published, Green Submitted, gold			2022-12-26	WOS:000422653800010
J	Depue, SM; Neilson, MM; Lusk, JL; Mafi, G; Norwood, FB; Ramanathan, R; VanOverbeke, D				Depue, Sandra Molly; Neilson, Morgan Marie; Lusk, Jayson L.; Mafi, Gretchen; Norwood, F. Bailey; Ramanathan, Ranjith; VanOverbeke, Deborah			Preference evaluation of ground beef by untrained subjects with three levels of finely textured beef	PLOS ONE			English	Article							CONSUMER SENSORY ACCEPTANCE; CHOICE EXPERIMENTS; QUALITY; PALATABILITY; TENDERNESS; ATTRIBUTES; RATINGS; STEAKS; SHEAR; PANEL	After receiving bad publicity in 2012 and being removed from many ground beef products, finely textured beef (referred to as 'pink slime' by some) is making a comeback. Some of its proponents argue that consumers prefer ground beef containing finely textured beef, but no objective scientific party has tested this claim that is the purpose of the present study. Over 200 untrained subjects participated in a sensory analysis in which they tasted one ground beef sample with no finely textured beef, another with 15% finely textured beef (by weight), and another with more than 15%. Beef with 15% finely textured beef has an improved juiciness (p < 0.01) and tenderness (p < 0.01) quality. However, subjects rate the flavor-liking and overall likeability the same regardless of the finely textured beef content. Moreover, when the three beef types are consumed as part of a slider (small hamburger), subjects are indifferent to the level of finely textured beef.	[Depue, Sandra Molly; Lusk, Jayson L.; Norwood, F. Bailey] Oklahoma State Univ, Dept Agr Econ, Stillwater, OK 74078 USA; [Neilson, Morgan Marie; Mafi, Gretchen; Ramanathan, Ranjith; VanOverbeke, Deborah] Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Norwood, FB (corresponding author), Oklahoma State Univ, Dept Agr Econ, Stillwater, OK 74078 USA.	bailey.norwood@okstate.edu	Ramanathan, Ranjith/AAW-3071-2021	VanOverbeke, Deborah/0000-0001-8791-382X	USDA National Institute of Food and Agriculture, Hatch grant [OKLO 2851]; Oklahoma Agricultural Experiment Station	USDA National Institute of Food and Agriculture, Hatch grant; Oklahoma Agricultural Experiment Station	Funding was provided by the USDA National Institute of Food and Agriculture, Hatch grant number OKLO 2851, and by the Oklahoma Agricultural Experiment Station. Support does not constitute an endorsement of the views expressed in the paper by the USDA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2014, BUS SOC REV, V119, P221, DOI 10.1111/basr.12031; Anderson EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160424; Barrena R, 2009, FOOD QUAL PREFER, V20, P144, DOI 10.1016/j.foodqual.2008.08.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonny SP, 2017, ANIMAL, V11, P8; Brewer S, 2007, J SENSORY FOOD QUALI, V73, P2008; Calhoun CM, 1999, J FOOD SCI, V64, P76, DOI 10.1111/j.1365-2621.1999.tb09864.x; Cargill, 2016, WHAT IS FIN TEXT BEE; Dominguez-Torreiro M, 2014, FOOD QUAL PREFER, V35, P15, DOI 10.1016/j.foodqual.2014.01.006; Greene JL., 2012, LEAN FINELY TEXTURED, P7; Hamling AE, 2008, J ANIM SCI, V86, P967, DOI 10.2527/jas.2007-0346; Hamling AE, 2007, MP9091 U NEBR; HAMM REINER, 1960, ADVANCES IN FOOD RES, V10, P355; Johansson L, 1999, FOOD QUAL PREFER, V10, P289, DOI 10.1016/S0950-3293(99)00022-1; Kerth CR, 2015, MEAT SCI, V104, P30, DOI 10.1016/j.meatsci.2015.01.014; Killinger KM, 2004, J ANIM SCI, V82, P3302; KRINSKY I, 1986, REV ECON STAT, V68, P715, DOI 10.2307/1924536; Lagerkvist CJ, 2014, FOOD QUAL PREFER, V34, P50, DOI 10.1016/j.foodqual.2013.12.009; Lazarus D, 2014, LOS ANGELES TIMES; Legako JF, 2016, MEAT SCI, V112, P77, DOI 10.1016/j.meatsci.2015.10.018; Lusk JL, 2004, AM J AGR ECON, V86, P467, DOI 10.1111/j.0092-5853.2004.00592.x; Marsh JM, 2003, TECHNOLOGICAL CHANGE; Moon CT, 2012, INCORPORATION LEAN F; Morales R, 2013, FOOD QUAL PREFER, V29, P166, DOI 10.1016/j.foodqual.2013.02.006; Napolitano F, 2010, FOOD QUAL PREFER, V21, P207, DOI 10.1016/j.foodqual.2009.08.007; Parsons AN, 2011, J FOOD SCI, V76, pS84, DOI 10.1111/j.1750-3841.2010.01903.x; Platter WJ, 2003, J ANIM SCI, V81, P2741; Pruitt JR, 2012, ASSESSING IMPACT LFT; Sitz BM, 2005, J ANIM SCI, V83, P2863; Thomas H.A., 2012, SENSORY EVALUATION P; Van Laack R. L. J. M., 1997, J MUSCLE FOODS, V8, P287; Voges KL, 2007, MEAT SCI, V77, P357, DOI 10.1016/j.meatsci.2007.03.024; Watson R, 2008, AUST J EXP AGR, V48, P1360, DOI 10.1071/EA07176; Wheeler TL, 1999, J ANIM SCI, V77, P3219; Yadavalli A, 2014, FOOD POLICY, V49, P219, DOI 10.1016/j.foodpol.2014.08.002; Yan KS, 2015, J EXP PSYCHOL HUMAN, V41, P590, DOI 10.1037/xhp0000044; Zimoch J, 1997, FOOD QUAL PREFER, V8, P203, DOI 10.1016/S0950-3293(96)00049-3	37	2	2	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190680	10.1371/journal.pone.0190680	http://dx.doi.org/10.1371/journal.pone.0190680			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8II	29342174	Green Published, gold, Green Submitted			2022-12-26	WOS:000422653800031
J	Neska-Matuszewska, M; Bladowska, J; Sasiadek, M; Zimny, A				Neska-Matuszewska, Malgorzata; Bladowska, Joanna; Sasiadek, Marek; Zimny, Anna			Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach	PLOS ONE			English	Article							HIGH-GRADE GLIOMAS; BRAIN-TUMORS; SOLITARY METASTASES; LESIONS; COEFFICIENT; PERCENTAGE; VALUES; EDEMA	Introduction In conventional MR examinations glioblastomas multiforme (GBMs), metastases and primary CNS lymphomas (PCNSLs) may show very similar appearance. The aim of the study was to evaluate usefulness of multiparametric T2*DSC perfusion and diffusion MR imaging in the preoperative differentiation of these tumors. Material and methods Seventy four solitary enhancing tumors (27 GBMs, 30 metastases, 17 PCNSLs) were enrolled in the study. Parameters of cerebral blood volume (rCBV), peak height (rPH), percentage of signal recovery (rPSR) and apparent diffusion coefficient (ADC) were assessed from the tumor core and the peritumoral non-enhancing T2-hyperintense zone. Results Within the tumor core there were no differences in perfusion and diffusion parameters between GBMs and metastases. Compared to GBMs and metastases, PCNSLs showed significantly lower rCBV and rPH, ADC as well as higher rPSR values. Max rCBV with a cutoff value of 2.18 demonstrated the highest accuracy of 0.98 in differentiating PCNSLs from other tumors. To distinguish GBMs from metastases analysis of the peritumoral zone was performed showing significantly higher rCBV, rPH and lower ADC values in GBMs with the highest accuracy of 0.94 found for max rCBV at a cut-off value of 0.98. Conclusions Max rCBV seems to be the most important parameter to differentiate GBMs, metastases and PCNSLs. Analysis of max rCBV within the tumor core enables to distinguish hypoperfused PCNSLs from hyperperfused GBMs and metastases while evaluation of max rCBV within the peritumoral zone is helpful to distinguish GBMs showing peritumoral infiltration from metastases surrounded by pure edema.	[Neska-Matuszewska, Malgorzata; Bladowska, Joanna; Sasiadek, Marek; Zimny, Anna] Wroclaw Med Univ, Dept Gen & Intervent Radiol & Neuroradiol, Wroclaw, Poland	Wroclaw Medical University	Neska-Matuszewska, M (corresponding author), Wroclaw Med Univ, Dept Gen & Intervent Radiol & Neuroradiol, Wroclaw, Poland.	neskamatuszewska@gmail.com		Sasiadek, Marek/0000-0003-3627-118X	Wroclaw Medical University grant [ST-868]	Wroclaw Medical University grant	Source of financial support: Wroclaw Medical University grant No ST-868, responsible author: Anna Zimny. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONEN HJ, 1994, RADIOLOGY, V191, P41, DOI 10.1148/radiology.191.1.8134596; Blasel S, 2010, ACTA NEUROCHIR, V152, P1893, DOI 10.1007/s00701-010-0774-7; Calli C, 2006, EUR J RADIOL, V58, P394, DOI 10.1016/j.ejrad.2005.12.032; Cha S, 2007, AM J NEURORADIOL, V28, P1078, DOI 10.3174/ajnr.A0484; Cha S, 2006, AM J NEURORADIOL, V27, P475; Chiang IC, 2004, NEURORADIOLOGY, V46, P619, DOI 10.1007/s00234-004-1246-7; Cho SK, 2002, KOREAN J RADIOL, V3, P171, DOI 10.3348/kjr.2002.3.3.171; Essig M, 2013, AM J ROENTGENOL, V201, pW495, DOI 10.2214/AJR.12.9544; Guo AC, 2002, RADIOLOGY, V224, P177, DOI 10.1148/radiol.2241010637; Hartmann M, 2003, NEUROSCI LETT, V338, P119, DOI 10.1016/S0304-3940(02)01367-8; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Kono K, 2001, AM J NEURORADIOL, V22, P1081; Krabbe K, 1997, NEURORADIOLOGY, V39, P483, DOI 10.1007/s002340050450; Kremer S, 2002, J NEURORADIOLOGY, V29, P105; Law M, 2002, RADIOLOGY, V222, P715, DOI 10.1148/radiol.2223010558; Lee EJ, 2011, AM J ROENTGENOL, V196, P71, DOI 10.2214/AJR.10.4752; Lemercier P, 2014, AM J ROENTGENOL, V203, P163, DOI 10.2214/AJR.13.11186; Liao WH, 2009, ACTA RADIOL, V50, P217, DOI 10.1080/02841850802616752; Lupo JM, 2005, AM J NEURORADIOL, V26, P1446; Mangla R, 2011, AM J NEURORADIOL, V32, P1004, DOI 10.3174/ajnr.A2441; Neska-Matuszewska M, 2015, POL J RADIOL, V80, P31, DOI 10.12659/PJR.892106; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Pasricha S, 2011, INDIAN J CANCER, V48, P199, DOI 10.4103/0019-509X.82890; Pavlisa G, 2009, CLIN IMAG, V33, P96, DOI 10.1016/j.clinimag.2008.06.035; Rizzo L, 2009, RADIOL MED, V114, P645, DOI 10.1007/s11547-009-0401-y; ROSEN BR, 1990, MAGNET RESON MED, V14, P249, DOI 10.1002/mrm.1910140211; Sperduto PW, 2010, INT J RADIAT ONCOL, V77, P655, DOI 10.1016/j.ijrobp.2009.08.025; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Svolos P, 2013, MAGN RESON IMAGING, V31, P1567, DOI 10.1016/j.mri.2013.06.010; Toh CH, 2013, AM J NEURORADIOL, V34, P1145, DOI 10.3174/ajnr.A3383; Tsougos I, 2012, CANCER IMAGING, V12, P423, DOI 10.1102/1470-7330.2012.0038; Wetzel SG, 2002, RADIOLOGY, V224, P797, DOI 10.1148/radiol.2243011014; Zhao JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123694	33	46	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191341	10.1371/journal.pone.0191341	http://dx.doi.org/10.1371/journal.pone.0191341			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342201	Green Published, gold, Green Submitted			2022-12-26	WOS:000422653800064
J	Jimenez-Lopez, D; Aguilar-Henonin, L; Gonzalez-Prieto, JM; Aguilar-Hernandez, V; Guzman, P				Jimenez-Lopez, Domingo; Aguilar-Henonin, Laura; Manuel Gonzalez-Prieto, Juan; Aguilar-Hernandez, Victor; Guzman, Plinio			CTLs, a new class of RING-H2 ubiquitin ligases uncovered by YEELL, a motif close to the RING domain that is present across eukaryotes	PLOS ONE			English	Article							FINGER DOMAIN; EXPRESSION; FAMILY; GENES; PROTEIN; ARKADIA; EVOLUTION; INSIGHTS; SYSTEM; PLANTS	RING ubiquitin E3 ligases enclose a RING domain for ubiquitin ligase activity and associated domains and/or conserved motifs outside the RING domain that collectively facilitate their classification and usually reveal some of key information related to mechanism of action. Here we describe a new family of E3 ligases that encodes a RING-H2 domain related in sequence to the ATL and BTL RING-H2 domains. This family, named CTL, encodes a motif designed as YEELL that expands 21 amino acids next to the RING-H2 domain that is present across most eukaryotic lineages. E3 ubiquitin ligase BIG BROTHER is a plant CTL that regulates organ size, and SUMO-targeted ubiquitin E3 ligase RNF111/ARKADIA is a vertebrate CTL. Basal animal and vertebrate, as well as fungi species, encode a single CTL gene that constraints the number of paralogs observed in vertebrates. Conversely, as previously described in ATL and BTL families in plants, CTL genes range from a single copy in green algae and 3 to 5 copies in basal species to 9 to 35 copies in angiosperms. Our analysis describes key structural features of a novel family of E3 ubiquitin ligases as an integral component of the set of core eukaryotic genes.	[Jimenez-Lopez, Domingo; Aguilar-Henonin, Laura; Guzman, Plinio] IPN, Ctr Invest & Estudios Avanzados, Dept Ingn Genet, Unidad Irapuato, Guanajuato, Mexico; [Jimenez-Lopez, Domingo; Manuel Gonzalez-Prieto, Juan] Inst Politecn Nacl, Ctr Biotecnol Genom, Biotecnol Vegetal, Reynosa, Tamaulipas, Mexico; [Aguilar-Hernandez, Victor] CONACYT, Ctr Invest Cient Yucatan, Unidad Bioquim & Biol Mol Plantas, Merida, Yucatan, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Politecnico Nacional - Mexico; Centro de Investigacion Cientifica de Yucatan	Guzman, P (corresponding author), IPN, Ctr Invest & Estudios Avanzados, Dept Ingn Genet, Unidad Irapuato, Guanajuato, Mexico.	plino.guzman@cinvestav.mx	Aguilar-Hernández, Victor/Q-9860-2019	Aguilar-Hernández, Victor/0000-0001-7308-4047; Guzman, Plinio/0000-0001-7905-5693	Consejo Nacional de Glenda y Tecnologia (CoNaCYT)	Consejo Nacional de Glenda y Tecnologia (CoNaCYT)	This work was supported by Consejo Nacional de Glenda y Tecnologia (CoNaCYT, https://www.conacyt.gob.mx/).	Aguilar-Hernandez V, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-179; Aguilar-Hernandez V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072729; Aguilar-Hernandez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023934; Alam I, 2017, SCI REPORTS, P7; Ariani P, 2016, SCI REP-UK, V6, DOI 10.1038/srep38260; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Buetow L, 2016, NAT REV MOL CELL BIO, V17, P626, DOI 10.1038/nrm.2016.91; Buetow L, 2015, MOL CELL, V58, P297, DOI 10.1016/j.molcel.2015.02.017; Chasapis CT, 2012, PROTEINS, V80, P1484, DOI 10.1002/prot.24048; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Chung BYW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-120; Disch S, 2006, CURR BIOL, V16, P272, DOI 10.1016/j.cub.2005.12.026; Erker Y, 2013, MOL CELL BIOL, V33, P2163, DOI 10.1128/MCB.01019-12; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Gao Y, 2016, MAR GENOM, V26, P51, DOI 10.1016/j.margen.2015.12.008; Guzman P, 2014, PLANT SCI, V215, P69, DOI 10.1016/j.plantsci.2013.10.017; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Katoh S, 2003, J BIOL CHEM, V278, P15341, DOI 10.1074/jbc.M210531200; Kelly CE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001538; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Li XW, 2017, PLANT BIOTECHNOL-NAR, V34, P71, DOI 10.5511/plantbiotechnology.17.0306a; Li YZ, 2011, MOL GENET GENOMICS, V286, P81, DOI 10.1007/s00438-011-0625-0; Lim SD, 2010, PLANT MOL BIOL, V72, P369, DOI 10.1007/s11103-009-9576-9; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Parra G, 2011, NUCLEIC ACIDS RES, V39, P5328, DOI 10.1093/nar/gkr043; Poulsen SL, 2013, J CELL BIOL, V201, P797, DOI 10.1083/jcb.201212075; Robinson Richard, 2006, PLoS Biol, V4, pe304, DOI 10.1371/journal.pbio.0040304; Salinas-Mondragon RE, 1999, PLANT MOL BIOL, V40, P579, DOI 10.1023/A:1006267201855; Shaul O, 2017, INT J BIOCH CELL BIO; Sheren JE, 2013, BIOCHEM BIOPH RES CO, V440, P473, DOI 10.1016/j.bbrc.2013.08.031; Sun HY, 2014, MOL CELL BIOL, V34, P2981, DOI 10.1128/MCB.00036-14; Vierstra RD, 2012, PLANT PHYSIOL, V160, P2, DOI 10.1104/pp.112.200667; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Wright JD, 2016, NAT STRUCT MOL BIOL, V23, P45, DOI 10.1038/nsmb.3142	42	2	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190969	10.1371/journal.pone.0190969	http://dx.doi.org/10.1371/journal.pone.0190969			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324855	Green Submitted, Green Published, gold			2022-12-26	WOS:000419952400083
J	Kato, H; Isohashi, K; Shimosegawa, E; Hatazawa, J				Kato, Hiroki; Isohashi, Kayako; Shimosegawa, Eku; Hatazawa, Jun			Increase in extraction of I-123 iomazenil in patients with chronic cerebral ischemia	PLOS ONE			English	Article							BLOOD-FLOW; SPECT; BRAIN; IODINE-123-IOMAZENIL; HETEROGENEITY; CAPILLARIES; METABOLISM; TRANSPORT; O-15	Background Cerebral extraction of diffusively distributed substances like oxygen has been suggested to change according to the cerebral blood flow (CBF) and status of the microvasculature. The relationships between the cerebral extraction of diffusively distributed lipophilic tracers and the severity of cerebral ischemia has not yet been clarified. In the present study, we attempted to elucidate the association between the extraction fraction of the lipophilic tracer I-123 iomazenil (IMZ) (IMZ-EF) and the oxygen extraction fraction (OEF) derived from O-15 PET in patients with chronic steno-occlusive disease of internal carotid artery (ICA) or middle cerebral artery (MCA). Methods Seven patients with unilateral chronic severe stenosis or occlusion of the middle cerebral/internal cerebral artery were prospectively recruited for this study. All the patients underwent both O-15 PET and quantitative I-123 IMZ SPECT. Parametric images derived from the PET and SPECT scans were anatomically normalized and evaluated by automated image analysis based on the volume-of-interest template. Results The asymmetry index (AI) of IMZ-EF was shown to be significantly correlated with the AI of OEF (r = 0.562, P < 0.001) in the internal carotid artery perfusion area. Strong and significant correlation between the AI of the influx rate constant K1 of IMZ and the AI of the cerebral metabolic rate of oxygen (r = 0.552, P = 0.001) was clarified. Conclusions Our results suggested that the transportation efficiency of I-123 IMZ into the brain tissue was an indicator for evaluating severity of cerebral ischemia in patients with chronic stenoocclusive disease of ICA or MCA. Cerebral metabolic state can possibly be estimated by I123 IMZ SPECT without cyclotron.	[Kato, Hiroki; Isohashi, Kayako; Hatazawa, Jun] Osaka Univ, Dept Nucl Med & Tracer Kinet, Grad Sch Med, Suita, Osaka, Japan; [Shimosegawa, Eku] Osaka Univ, Dept Mol Imaging Med, Grad Sch Med, Suita, Osaka, Japan	Osaka University; Osaka University	Kato, H (corresponding author), Osaka Univ, Dept Nucl Med & Tracer Kinet, Grad Sch Med, Suita, Osaka, Japan.	kato-h@umin.org	Isohashi, Kayako/AAA-7379-2022	Isohashi, Kayako/0000-0002-2081-3020	Japan Society for the Promotion of Science [JP26462204]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science, grant number JP26462204 to HK (URL: https://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CRONE C, 1963, ACTA PHYSIOL SCAND, V58, P292, DOI 10.1111/j.1748-1716.1963.tb02652.x; FRACKOWIAK RSJ, 1980, J COMPUT ASSIST TOMO, V4, P727, DOI 10.1097/00004728-198012000-00001; Gupta A, 2014, AM J NEURORADIOL, V35, P250, DOI 10.3174/ajnr.A3668; HATAZAWA J, 1995, J NUCL MED, V36, P2154; HATAZAWA J, 1995, STROKE, V26, P2267, DOI 10.1161/01.STR.26.12.2267; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; LAMMERTSMA AA, 1983, J CEREBR BLOOD F MET, V3, P416, DOI 10.1038/jcbfm.1983.67; ONISHI Y, 1995, J NUCL MED, V36, P1201; Ostergaard L, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0557-x; RENKIN EM, 1959, AM J PHYSIOL, V197, P1205, DOI 10.1152/ajplegacy.1959.197.6.1205; Shimosegawa E, 1997, J NUCL MED, V38, P791; Stefanovic B, 2008, J CEREBR BLOOD F MET, V28, P961, DOI 10.1038/sj.jcbfm.9600590; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Vogel J, 1996, J CEREBR BLOOD F MET, V16, P1300, DOI 10.1097/00004647-199611000-00026	14	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190720	10.1371/journal.pone.0190720	http://dx.doi.org/10.1371/journal.pone.0190720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324813	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400052
J	Spoorenberg, SMC; Vestjens, SMT; Voorn, GP; van Moorsel, CHM; Meek, B; Zanen, P; Rijkers, GT; Bos, WJW; Grutters, JC				Spoorenberg, Simone M. C.; Vestjens, Stefan M. T.; Voorn, G. P.; van Moorsel, Coline H. M.; Meek, Bob; Zanen, Pieter; Rijkers, Ger T.; Bos, Willem Jan W.; Grutters, Jan C.		Ovidius Study Grp	Course of SP-D, YKL-40, CCL18 and CA 15-3 in adult patients hospitalised with community-acquired pneumonia and their association with disease severity and aetiology: A post-hoc analysis	PLOS ONE			English	Article							SURFACTANT PROTEIN-D; IDIOPATHIC PULMONARY-FIBROSIS; LUNG-DISEASE; SYSTEMIC-SCLEROSIS; PNEUMOCOCCAL PNEUMONIA; MATRIX PROTEIN; BREAST-CANCER; SERUM-LEVELS; T-CELLS; CHEMOKINE	Background and aim SP-D, YKL-40, CCL18 and CA 15-3 are pulmonary markers that have been extensively investigated in different chronic pulmonary diseases. However, in acute pulmonary diseases, such as community-acquired pneumonia (CAP), little is known about the course of these markers and their relationship with the aetiological agent. The aim of this study was to investigate the course of these four markers in CAP and to study influence of disease severity, aetiology and antibiotic use prior to admission on their course. Methods We included 291 adult patients hospitalised with CAP and 20 healthy controls. Measurements were performed in serum of day 0, 2, and 4, and at least 30 days after admission. Results Our most important results were: 1) At all time-points, including 30 days after admission, YKL-40 and CCL18 levels were higher in CAP patients compared to healthy controls; and 2) Patients with CAP caused by an intracellular, atypical bacterium had lower YKL-40 and especially CCL18 levels on and during admission in comparison with other or unknown CAP aetiology. Conclusions Our findings suggest that these pulmonary markers could be useful to assess CAP severity and, especially YKL-40 and CCL18 by helping predict CAP caused by atypical pathogens.	[Spoorenberg, Simone M. C.; Vestjens, Stefan M. T.; Bos, Willem Jan W.] St Antonius Hosp, Dept Internal Med, Nieuwegein, Netherlands; [Voorn, G. P.; Meek, Bob; Rijkers, Ger T.] St Antonius Hosp, Dept Med Microbiol & Immunol, Nieuwegein, Netherlands; [van Moorsel, Coline H. M.; Grutters, Jan C.] St Antonius Hosp, Dept Pulmonol, Nieuwegein, Netherlands; [van Moorsel, Coline H. M.; Zanen, Pieter; Grutters, Jan C.] Univ Med Ctr Utrecht, Div Heart & Lungs, Utrecht, Netherlands; [Rijkers, Ger T.] Roosevelt Acad, Dept Sci, Middelburg, Netherlands	St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center	Spoorenberg, SMC (corresponding author), St Antonius Hosp, Dept Internal Med, Nieuwegein, Netherlands.	simonespoorenberg@gmail.com; w.bos@antoniusziekenhuis.nl; j.grutters@antoniusziekenhuis.nl	Rijkers, Ger/AAW-6143-2020; Rijkers, Ger/R-7236-2019	Rijkers, Ger/0000-0001-6948-6123; Bos, Willem Jan W/0000-0002-5062-2567				Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Bandyopadhyay S, 2011, STAT METHODS MED RES, V20, P299, DOI 10.1177/0962280209340191; Begum M, 2012, ASIAN PAC J CANCER P, V13, P5257, DOI 10.7314/APJCP.2012.13.10.5257; Bonella P, 2011, SARCOIDOSIS VASC DIF, V28, P27; Chenivesse C, 2012, J IMMUNOL, V189, P128, DOI 10.4049/jimmunol.1003616; COONROD JD, 1977, INFECT IMMUN, V18, P14, DOI 10.1128/IAI.18.1.14-22.1977; Crouch E, 2009, BIOCHEMISTRY-US, V48, P3335, DOI 10.1021/bi8022703; Delgado C, 2014, SERUM SURFACTANT PRO; Guzel A, 2014, CLIN LAB, V60, P1091, DOI 10.7754/Clin.Lab.2013.130323; Hickling TP, 1999, EUR J IMMUNOL, V29, P3478, DOI 10.1002/(SICI)1521-4141(199911)29:11<3478::AID-IMMU3478>3.0.CO;2-W; Holmgaard DB, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-77; Kodelja V, 1998, J IMMUNOL, V160, P1411; Korthagen NM, 2011, RESP MED, V105, P106, DOI 10.1016/j.rmed.2010.09.012; Kucejko W, 2009, FOLIA HISTOCHEM CYTO, V47, P225, DOI 10.2478/v10042-009-0028-9; Leth-Larsen R, 2003, CLIN IMMUNOL, V108, P29, DOI 10.1016/S1521-6616(03)00042-1; Lock-Johansson S, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0147-5; Luzina IG, 2006, J CELL PHYSIOL, V206, P221, DOI 10.1002/jcp.20452; Meijvis SCA, 2011, LANCET, V377, P2023, DOI 10.1016/S0140-6736(11)60607-7; Menendez R, 2012, CHEST, V141, P1537, DOI 10.1378/chest.11-1446; Nakajima A, 2014, INTERNAL MED, V53, P1497, DOI 10.2169/internalmedicine.53.1785; Nordenbaek C, 2005, SCAND J RHEUMATOL, V34, P293, DOI 10.1080/03009740510018598; Nordenbaek C, 1999, J INFECT DIS, V180, P1722, DOI 10.1086/315050; Ohshimo S, 2014, RESP MED, V108, P1031, DOI 10.1016/j.rmed.2014.04.009; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; Pfister R, 2014, CRIT CARE, V18, DOI 10.1186/cc13760; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Prassel A, 2009, AM J RESP CRIT CARE, V179, P717, DOI 10.1164/rccm.200808-1201OC; Remmelts HHF, 2012, J INFECTION, V65, P25, DOI 10.1016/j.jinf.2012.03.008; Ricci A, 2009, SARCOIDOSIS VASC DIF, V26, P54; Schleimer Robert P, 2004, Proc Am Thorac Soc, V1, P222, DOI 10.1513/pats.200402-018MS; Schupp J, 2014, EUR RESPIR J, V43, P1530, DOI 10.1183/09031936.00131713; Sin DD, 2011, AM J RESP CRIT CARE, V183, P1187, DOI 10.1164/rccm.201008-1220OC; Spoorenberg SM, 2016, RESPIROLOGY; Tiev KP, 2011, EUR RESPIR J, V38, P1355, DOI 10.1183/09031936.00004711; Tyrrell C, 2012, EXP LUNG RES, V38, P266, DOI 10.3109/01902148.2012.683321; Volck B, 1998, P ASSOC AM PHYSICIAN, V110, P351; Wang X, 2014, SCAND J CLIN LAB INV, V74, P74, DOI 10.3109/00365513.2013.859726; Willemsen AECAB, 2014, INT J CANCER, V135, P1007, DOI 10.1002/ijc.28714; Zhou Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007096	39	5	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190575	10.1371/journal.pone.0190575	http://dx.doi.org/10.1371/journal.pone.0190575			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324810	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400040
J	Wojczulanis-Jakubas, K; Araya-Salas, M; Jakubas, D				Wojczulanis-Jakubas, Katarzyna; Araya-Salas, Marcelo; Jakubas, Dariusz			Seabird parents provision their chick in a coordinated manner	PLOS ONE			English	Article							AUK ALLE-ALLE; FORAGING STRATEGIES; CONFLICT; CARE; SEX; NEGOTIATION; DOVEKIES; TRIPS	Pair collaborative behavior may play an important role in avian reproduction. However, evidence for this mainly comes from certain ecological groups (e.g. passerines). We studied the coordination of parents in foraging and its effect on food provisioning rate and chick growth in a small seabird, the Dovekie (Little auk, Alle alle). The species exhibits a dual foraging strategy, where provisioning adults make foraging trips of short (mean similar to 2 h; to provide food for the chick) and long duration (mean similar to 13 h; mainly for adults self-maintenance, although the food is also brought to the chick). We expected that offspring would benefit if parents coordinate their foraging patterns: one making short trips in the time when the other performing the long one. We examined this hypothesis using Monte Carlo randomization tests on field data collected during observations of individually marked birds. We found that parents did indeed adjust provisioning, making their long and short trips in an alternating pattern with respect to each other. Furthermore, we found that a higher level of coordination is associated with a lower variability in the duration of inter-feeding intervals, although this does not affect chick growth. Nevertheless, our results provide compelling evidence on the coordinated behavior of breeding partners.	[Wojczulanis-Jakubas, Katarzyna; Jakubas, Dariusz] Univ Gdansk, Fac Biol, Dept Vertebrate Ecol & Zool, Gdansk, Poland; [Araya-Salas, Marcelo] New Mexico State Univ, Las Cruses, NM USA; [Araya-Salas, Marcelo] Cornell Univ, Lab Ornithol, Ithaca, NY USA	Fahrenheit Universities; University of Gdansk; Cornell University	Wojczulanis-Jakubas, K (corresponding author), Univ Gdansk, Fac Biol, Dept Vertebrate Ecol & Zool, Gdansk, Poland.	biokwj@univ.gda.pl	Jakubas, Dariusz/N-3680-2019; Wojczulanis-Jakubas, Katarzyna/AAO-4126-2021; Jakubas, Dariusz/L-9660-2015; Araya-Salas, Marcelo/G-8840-2011	Jakubas, Dariusz/0000-0002-1879-4342; Wojczulanis-Jakubas, Katarzyna/0000-0001-6230-0509; Jakubas, Dariusz/0000-0002-1879-4342; Araya-Salas, Marcelo/0000-0003-3594-619X	Norway through the Norwegian Financial Mechanism [PNRF-234-AI-1/07]; Polish Ministry of Science and Higher Education [Iuventus Plus 0638/IP1/2013/72]; National Science Centre, Poland [2017/25/B/NZ8/01417]	Norway through the Norwegian Financial Mechanism; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre, Poland(National Science Centre, Poland)	This work was supported by Norway through the Norwegian Financial Mechanism (grant number: ALKEKONGE, PNRF-234-AI-1/07), the Polish Ministry of Science and Higher Education (grant number: Iuventus Plus 0638/IP1/2013/72 to KWJ), and National Science Centre, Poland (no: 2017/25/B/NZ8/01417 to KWJ).	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bebbington K, 2016, BEHAV ECOL, V27, P652, DOI 10.1093/beheco/arv198; Black J.M., 1996, PARTNERSHIPS BIRDS S; Bried J., 2001, CRC MARINE BIOL SERI, P263, DOI [10.1201/9781420036305.ch9, DOI 10.1201/9781420036305.CH9]; CHAURAND T, 1994, J ANIM ECOL, V63, P275, DOI 10.2307/5546; Congdon BC, 2005, MAR ECOL PROG SER, V301, P293, DOI 10.3354/meps301293; Dewey M., 2016, METAP METAANALYSIS S; FITZHUGH HA, 1976, J ANIM SCI, V42, P1036, DOI 10.2527/jas1976.4241036x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; GABRIELSEN GW, 1991, AUK, V108, P71; Good P., 2013, PERMUTATION TESTS PR; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hamer KC, 1999, J AVIAN BIOL, V30, P309, DOI 10.2307/3677357; Hammer K, 2001, BIOL MARINE BIRDS, P217; Harding AMA, 2004, IBIS, V146, P642, DOI 10.1111/j.1474-919x.2004.00297.x; Houston A.I., 1985, P471; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Jakubas D, 2007, WATERBIRDS, V30, P92, DOI 10.1675/1524-4695(2007)030[0092:PTSODB]2.0.CO;2; Jakubas D, 2014, J AVIAN BIOL, V45, P551, DOI 10.1111/jav.00303; Jakubas D, 2013, MAR ECOL PROG SER, V489, P263, DOI 10.3354/meps10414; Jakubas D, 2011, MAR ECOL PROG SER, V432, P277, DOI 10.3354/meps09082; Johnstone RA, 2006, BEHAV ECOL, V17, P818, DOI 10.1093/beheco/arl009; Johnstone RA, 2014, BEHAV ECOL, V25, P216, DOI 10.1093/beheco/art109; Keslinka LK, 2015, THESIS; Kidawa D, 2015, MAR BIOL RES, V11, P349, DOI 10.1080/17451000.2014.940974; Kidawa D, 2014, POLAR BIOL, V37, P641, DOI 10.1007/s00300-014-1464-3; Krebs EA, 1999, ANIM BEHAV, V57, P753, DOI 10.1006/anbe.1998.1029; Kwasniewski S, 2010, PROG OCEANOGR, V87, P72, DOI 10.1016/j.pocean.2010.06.004; Lessells CM, 2012, EVOLUTION OF PARENTAL CARE, P150; Lessells CM, 2012, P ROY SOC B-BIOL SCI, V279, P1506, DOI 10.1098/rspb.2011.1690; LINDEN M, 1989, TRENDS ECOL EVOL, V4, P367, DOI 10.1016/0169-5347(89)90101-8; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; Mariette MM, 2015, AM NAT, V185, P270, DOI 10.1086/679441; Mariette MM, 2012, J AVIAN BIOL, V43, P131, DOI 10.1111/j.1600-048X.2012.05555.x; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; McNamara JM, 1999, NATURE, V401, P368, DOI 10.1038/43869; McNamara JM, 2003, BEHAV ECOL, V14, P301, DOI 10.1093/beheco/14.3.301; OWENS IPF, 1994, P ROY SOC B-BIOL SCI, V257, P1, DOI 10.1098/rspb.1994.0086; R Core Team, 2021, R LANGUAGE ENV STAT; Raihani NJ, 2010, J ANIM ECOL, V79, P44, DOI 10.1111/j.1365-2656.2009.01606.x; Robert C, 2009, INTRO MONTE CARLO ME; Roughgarden J, 2012, PHILOS T R SOC B, V367, P2294, DOI 10.1098/rstb.2011.0282; Saraux C, 2011, ECOLOGY, V92, P1909, DOI 10.1890/11-0407.1; SCHAFFNER FC, 1990, ECOLOGY, V71, P375, DOI 10.2307/1940275; Shen SF, 2010, BIOL LETTERS, V6, P318, DOI 10.1098/rsbl.2009.0909; Steen H, 2007, POLAR RES, V26, P118, DOI 10.1111/j.1751-8369.2007.00022.x; Stempniewicz L, 2001, J BIRDS W PALEARCTIC, V3, P175; Stouffer SA, 1949, AM SOLDIER ADJUSTMEN, V1; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; van Rooij EP, 2013, PEERJ, V1, DOI 10.7717/peerj.232; Welcker J, 2012, BEHAV ECOL, V23, P1372, DOI 10.1093/beheco/ars131; Welcker J, 2009, J AVIAN BIOL, V40, P388, DOI 10.1111/j.1600-048X.2008.04620.x; Wojczulanis-Jakubas K, 2012, AUK, V129, P632, DOI 10.1525/auk.2012.12095; Wojczulanis-Jakubas K, 2012, J ORNITHOL, V153, P793, DOI 10.1007/s10336-011-0796-9; Wojczulanis-Jakubas K, 2010, POLAR RES, V29, P22, DOI 10.1111/j.1751-8369.2009.00145.x; Wojczulanis-Jakubas K, 2009, ORNIS FENNICA, V86, P140; ZACH R, 1988, AUK, V105, P208, DOI 10.1093/auk/105.1.208	57	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0189969	10.1371/journal.pone.0189969	http://dx.doi.org/10.1371/journal.pone.0189969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320525	gold, Green Published, Green Submitted			2022-12-26	WOS:000419689600024
J	Jacinto, MJ; Trabuco, JRC; Vu, BV; Garvey, G; Khodadady, M; Azevedo, AM; Aires-Barros, MR; Chang, L; Kourentzi, K; Litvinov, D; Willson, RC				Jacinto, Maria Joao; Trabuco, Joao R. C.; Vu, Binh V.; Garvey, Gavin; Khodadady, Mohammad; Azevedo, Ana M.; Aires-Barros, Maria Raquel; Chang, Long; Kourentzi, Katerina; Litvinov, Dmitri; Willson, Richard C.			Enhancement of lateral flow assay performance by electromagnetic relocation of reporter particles	PLOS ONE			English	Article							BACILLUS-ANTHRACIS SPORES; RAPID DETECTION; NANOPARTICLES; IMMUNOASSAY; LABELS; SENSORS; SYSTEM	Lateral flow assays (LFAs) are a widely-used point-of care diagnostic format, but suffer from limited analytical sensitivity, especially when read by eye. It has recently been reported that LFA performance can be improved by using magnetic reporter particles and an external magnetic field applied at the test line. The mechanism of sensitivity/performance enhancement was suggested to be concentration/retardation of reporter particles at the test line. Here we demonstrate an additional mechanism of particle relocation where reporter particles from the lower depths of the translucent LFA strip relocate to more-visible locations nearer to the top surface, producing a more visible signal. With a magnetic field we observed an improvement in sensitivity of human chorionic gonadotropin (hCG) detection from 1.25 ng/mL to 0.31 ng/mL. We also observed an increase of the color intensity per particle in test lines when the magnetic field was present.	[Jacinto, Maria Joao; Trabuco, Joao R. C.; Azevedo, Ana M.; Aires-Barros, Maria Raquel] Univ Lisbon, Inst Super Tecn, IBB, Dept Bioengn, Lisbon, Portugal; [Jacinto, Maria Joao; Trabuco, Joao R. C.; Vu, Binh V.; Garvey, Gavin; Kourentzi, Katerina; Litvinov, Dmitri; Willson, Richard C.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77004 USA; [Khodadady, Mohammad; Chang, Long; Litvinov, Dmitri] Univ Houston, Ctr Integrated Bio & Nano Syst, Houston, TX 77004 USA; [Azevedo, Ana M.; Aires-Barros, Maria Raquel] Univ Lisbon, Inst Super Tecn, Dept Bioengn, Lisbon, Portugal; [Chang, Long; Litvinov, Dmitri] Univ Houston, Dept Elect & Comp Engn, Houston, TX 77004 USA; [Willson, Richard C.] Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA; [Willson, Richard C.] Tecnol Monterrey, Ctr Biotecnol FEMSA, Dept Biotecnol Ingn Alimentos, Monterrey, Nuevo Leon, Mexico	Universidade de Lisboa; Instituto Superior Tecnico; University of Houston System; University of Houston; University of Houston System; University of Houston; Universidade de Lisboa; Instituto Superior Tecnico; University of Houston System; University of Houston; University of Houston System; University of Houston; Tecnologico de Monterrey	Willson, RC (corresponding author), Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77004 USA.; Willson, RC (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77004 USA.; Willson, RC (corresponding author), Tecnol Monterrey, Ctr Biotecnol FEMSA, Dept Biotecnol Ingn Alimentos, Monterrey, Nuevo Leon, Mexico.	willson@uh.edu	Willson, richard/AAD-4832-2019; Khodadadi, Mohammad/O-4070-2019; Aires-Barros, Maria Raquel M.S./E-6021-2010; Azevedo, Ana/A-2985-2011	Khodadadi, Mohammad/0000-0002-4604-8726; Aires-Barros, Maria Raquel M.S./0000-0002-1813-4280; Azevedo, Ana/0000-0001-5659-466X; Cardoso Jacinto, Maria Joao/0000-0001-6260-3198	National Institute of Allergy and Infectious Diseases, National Institutes of Health [1R21AI111120-01A1]; National Science Foundation [CBET-1511789]; Cancer Prevention & Research Institute of Texas [RP150343]; Fundacao para Ciencia e Tecnologia (FCT) [PD/BD/105883/2014, SFRH/BD/91099/2012, IF/00048/2014/CP1214/CT0010]; FCT [UID/BIO/04565/2013]	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); Cancer Prevention & Research Institute of Texas; Fundacao para Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	RCW and DL gratefully acknowledge support from National Institute of Allergy and Infectious Diseases, National Institutes of Health, http://www.niaid.nih.gov, (Grant 1R21AI111120-01A1), National Science Foundation, www.nsf.gov, (Grant CBET-1511789) and Cancer Prevention & Research Institute of Texas, www.cprit.state.tx.us, (Grant RP150343). MJJ, JRCT and AMA acknowledge Fundacao para Ciencia e Tecnologia (FCT), http://www.fct.pt, for the PhD grants PD/BD/105883/2014 and SFRH/BD/91099/2012, and research contract under the program Investigador FCT 2014 (IF/00048/2014/CP1214/CT0010), respectively. The Institute for Bioengineering and Biosciences also acknowledges FCT for funding through the research contract (UID/BIO/04565/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari M, 2015, ANAL CHEM, V87, P11660, DOI 10.1021/acs.analchem.5b00702; Adhikari M, 2013, ANALYST, V138, P5584, DOI 10.1039/c3an00891f; Bruls DM, 2009, LAB CHIP, V9, P3504, DOI 10.1039/b913960e; Carpenter CR, 2007, United States of America patent, Patent No. [2007/0020699 A1, 20070020699]; Dittmer WU, 2008, J IMMUNOL METHODS, V338, P40, DOI 10.1016/j.jim.2008.07.001; Dittmer WU, 2010, CLIN CHIM ACTA, V411, P868, DOI 10.1016/j.cca.2010.03.001; Feistel C, 2006, United States of America Patent, Patent No. [6,713,271 B1, 6713271]; Granade TC, 2010, CLIN VACCINE IMMUNOL, V17, P1034, DOI 10.1128/CVI.00029-10; Hagstrom AEV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126571; Handali S, 2010, CLIN VACCINE IMMUNOL, V17, P631, DOI 10.1128/CVI.00511-09; Liu CY, 2011, ANAL CHEM, V83, P6778, DOI 10.1021/ac201462d; Marquina C, 2012, J MAGN MAGN MATER, V324, P3495, DOI 10.1016/j.jmmm.2012.02.074; Moghadam BY, 2015, ANAL CHEM, V87, P1009, DOI 10.1021/ac504552r; Morozov VN, 2006, ANAL CHIM ACTA, V564, P40, DOI 10.1016/j.aca.2005.09.068; Orlov AV, 2016, BIOSENS BIOELECTRON, V79, P423, DOI 10.1016/j.bios.2015.12.049; Pamme N, 2004, ANAL CHEM, V76, P7250, DOI 10.1021/ac049183o; Paterson AS, 2014, ANAL CHEM, V86, P9481, DOI 10.1021/ac5012624; Peyman SA, 2009, LAB CHIP, V9, P3110, DOI 10.1039/b904724g; Posthuma-Trumpie GA, 2012, ANAL BIOANAL CHEM, V402, P593, DOI 10.1007/s00216-011-5340-5; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; Ren W, 2016, CHEM COMMUN, V52, P4930, DOI 10.1039/c5cc10240e; Rivas L, 2014, LAB CHIP, V14, P4406, DOI 10.1039/c4lc00972j; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tang D, 2009, BIOSENS BIOELECTRON, V25, P514, DOI 10.1016/j.bios.2009.07.030; Taton K, 2009, J MAGN MAGN MATER, V321, P1679, DOI 10.1016/j.jmmm.2009.02.113; Wang DB, 2015, BIOSENS BIOELECTRON, V67, P608, DOI 10.1016/j.bios.2014.09.067; Wang DB, 2013, BIOSENS BIOELECTRON, V42, P661, DOI 10.1016/j.bios.2012.10.088; Wang YY, 2009, MAT SCI ENG C-BIO S, V29, P714, DOI 10.1016/j.msec.2009.01.011; WOLFE CAC, 1995, ANAL BIOCHEM, V231, P123, DOI 10.1006/abio.1995.1511; Workman S, 2009, J VIROL METHODS, V160, P14, DOI 10.1016/j.jviromet.2009.04.003; Xu QF, 2009, MAT SCI ENG C-BIO S, V29, P702, DOI 10.1016/j.msec.2009.01.009	31	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2018	13	1							e0186782	10.1371/journal.pone.0186782	http://dx.doi.org/10.1371/journal.pone.0186782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS0GW	29309424	Green Published, gold, Green Submitted			2022-12-26	WOS:000419453100002
J	Almasi, S; Kennedy, BE; El-Aghil, M; Sterea, AM; Gujar, S; Partida-Sanchez, S; El Hiani, Y				Almasi, Shekoufeh; Kennedy, Barry E.; El-Aghil, Mariam; Sterea, Andra M.; Gujar, Shashi; Partida-Sanchez, Santiago; El Hiani, Yassine			TRPM2 channel-mediated regulation of autophagy maintains mitochondrial function and promotes gastric cancer cell survival via the JNK-signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; ADP-RIBOSE; ION-CHANNEL; CA2+ INFLUX; ANTISENSE TRANSCRIPTION; INSULIN-SECRETION; FLUFENAMIC ACID; TUMOR-GROWTH; APOPTOSIS; DEATH	A lack of effective treatment is one of the main factors contributing to gastric cancer-related death. Discovering effective targets and understanding their underlying anti-cancer mechanism are key to achieving the best response to treatment and to limiting side effects. Although recent studies have shown that the cation channel transient receptor potential melastatin-2 (TRPM2) is crucial for cancer cell survival, the exact mechanism remains unclear, limiting its therapeutic potential. Here, using molecular and functional assays, we investigated the role of TRPM2 in survival of gastric cancer cells. Our results indicated that TRPM2 knockdown in AGS and MKN-45 cells decreases cell proliferation and enhances apoptosis. We also observed that the TRPM2 knockdown impairs mitochondrial metabolism, indicated by a decrease in basal and maximal mitochondrial oxygen consumption rates and ATP production. These mitochondrial defects coincided with a decrease in autophagy and mitophagy,indicated by reduced levels of autophagy- and mitophagy-associated proteins (i.e. ATGs, LC3A/B II, and BNIP3). Moreover, we found that TRPM2 modulates autophagy through a c-Jun N-terminal kinase (JNK)-dependent and mechanistic target of rapamycin-independent pathway. We conclude that in the absence of TRPM2, down-regulation of the JNK-signaling pathway impairs autophagy, ultimately causing the accumulation of damaged mitochondria and death of gastric cancer cells. Of note, by inhibiting cell proliferation and promoting apoptosis, the TRPM2 down-regulation enhanced the efficacy of paclitaxel and doxorubicin in gastric cancer cells. Collectively, we provide compelling evidence that TRPM2 inhibition may benefit therapeutic approaches for managing gastric cancer.	[Almasi, Shekoufeh] Dalhousie Univ, Biophys Fac Life Sci, Dept Biol, Halifax, NS, Canada; [Kennedy, Barry E.; Gujar, Shashi] Dalhousie Univ, Biophys Fac Life Sci, Dept Pathol, Halifax, NS, Canada; [El-Aghil, Mariam; Gujar, Shashi] Dalhousie Univ, Biophys Fac Life Sci, Dept Microbiol & Immunol, Halifax, NS, Canada; [Sterea, Andra M.; El Hiani, Yassine] Dalhousie Univ, Biophys Fac Life Sci, Dept Physiol, Halifax, NS, Canada; [Gujar, Shashi] IWK Hlth Ctr, Ctr Innovat & Collaborat Hlth Serv Res, Qual & Syst Performance, Halifax, NS B3H 4R2, Canada; [Partida-Sanchez, Santiago] Ohio State Univ, Nationwide Childrens Hosp, Res Inst, Ctr Microbial Pathogenesis, Columbus, OH 43205 USA; [Partida-Sanchez, Santiago] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43205 USA	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	El Hiani, Y (corresponding author), Dalhousie Univ, Biophys Fac Life Sci, Dept Physiol, Halifax, NS, Canada.	yassine.elhiani@dal.ca	Almasi, Shekoufeh/AAN-2109-2021; Partida-Sanchez, Santiago/B-7523-2008	Almasi, Shekoufeh/0000-0002-3631-5931; Partida-Sanchez, Santiago/0000-0003-2996-9440; El Hiani, Yassine/0000-0002-1251-5066; Gujar, Shashi/0000-0002-5427-0829	Department of Physiology and Biophysics, Dalhousie University; Nova Scotia Graduate Scholarship; Beatrice Hunter Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI120013] Funding Source: NIH RePORTER	Department of Physiology and Biophysics, Dalhousie University; Nova Scotia Graduate Scholarship; Beatrice Hunter Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by start-up funds (to Y. E. H.) from the Department of Physiology and Biophysics, Dalhousie University. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Nova Scotia Graduate Scholarship.; Supported by the trainee awards from the Beatrice Hunter Cancer Research Institute.	Akpinar H, 2016, SCI REP-UK, V6, DOI 10.1038/srep37196; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Aoki M, 2017, CURR TOP MICROBIOL, V407, P153, DOI 10.1007/82_2017_6; Bao L, 2016, J BIOL CHEM, V291, P24449, DOI 10.1074/jbc.M116.747147; Becchetti A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00312; Beceiro S, 2017, MUCOSAL IMMUNOL, V10, P493, DOI 10.1038/mi.2016.60; Bencze M, 2015, EUR J PHARMACOL, V765, P533, DOI 10.1016/j.ejphar.2015.09.014; Bhardwaj R, 2000, PDA J PHARM SCI TECH, V54, P233; Blake SD, 2017, TRANSL CANCER RES, V6, pS342, DOI 10.21037/tcr.2017.03.11; Bost F, 1999, MOL CELL BIOL, V19, P1938; Brenkman HJF, 2016, WORLD J GASTROENTERO, V22, P4041, DOI 10.3748/wjg.v22.i15.4041; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; BRUGNARA C, 1995, J PHARMACOL EXP THER, V273, P266; Brugnara C, 1995, Ann N Y Acad Sci, V763, P262, DOI 10.1111/j.1749-6632.1995.tb32411.x; Byun JY, 2009, CARCINOGENESIS, V30, P1880, DOI 10.1093/carcin/bgp235; Cao QH, 2016, AM J TRANSL RES, V8, P3831; Chaanine AH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.5; Chadderton A, 2000, BREAST CANCER RES TR, V59, P231, DOI 10.1023/A:1006344200094; Chandel NS, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-8; Chang L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.415; Chattopadhyay E, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00043; Chen HY, 2011, CANCER PREV RES, V4, P973, DOI 10.1158/1940-6207.CAPR-10-0387; Chen JQ, 2009, BBA-MOL CELL RES, V1793, P1540, DOI 10.1016/j.bbamcr.2009.06.001; Chen SJ, 2014, J BIOL CHEM, V289, P36284, DOI 10.1074/jbc.M114.620922; Chen SJ, 2013, AM J PHYSIOL-CELL PH, V304, pC548, DOI 10.1152/ajpcell.00069.2012; Chung MK, 2015, NEUROSCIENCE, V297, P160, DOI 10.1016/j.neuroscience.2015.03.067; de Mestier L, 2016, DIGEST LIVER DIS, V48, P984, DOI 10.1016/j.dld.2016.04.010; Dello Sbarba P, 2015, ONCOTARGET, V6, P36924, DOI 10.18632/oncotarget.6244; Dong YQ, 2015, TUMOR BIOL, V36, P1477, DOI 10.1007/s13277-014-2631-4; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fock KM, 2014, ALIMENT PHARM THER, V40, P250, DOI 10.1111/apt.12814; Ge J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110293; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Gonzalez CA, 2013, HELICOBACTER, V18, P34, DOI 10.1111/hel.12082; Ham HY, 2012, TOXICOL APPL PHARM, V258, P82, DOI 10.1016/j.taap.2011.10.010; Hamamoto Y, 2015, MOL CLIN ONCOL, V3, P539, DOI 10.3892/mco.2015.510; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; He W, 2014, ONCOGENE, V33, P3004, DOI 10.1038/onc.2013.256; He YJ, 2016, ONCOTARGET, V7, P54537, DOI 10.18632/oncotarget.10402; Hopkins MM, 2015, INT J ONCOL, V46, P2267, DOI 10.3892/ijo.2015.2919; Huang Changzhou, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P39; Jeong HJ, 2017, BIOCHEM BIOPH RES CO, V485, P301, DOI 10.1016/j.bbrc.2017.02.087; Jiang LH, 2010, EXPERT OPIN THER TAR, V14, P973, DOI 10.1517/14728222.2010.510135; Jiang Q, 2017, ANTIOXID REDOX SIGN, V27, P1297, DOI 10.1089/ars.2016.6873; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kamm Gretel B, 2017, Temperature (Austin), V4, P21, DOI 10.1080/23328940.2016.1258445; Kashio M, 2017, CHANNELS, V11, P426, DOI 10.1080/19336950.2017.1344801; Klages N, 2000, MOL THER, V2, P170, DOI 10.1006/mthe.2000.0103; Koh DW, 2015, ONCOL REP, V34, P1589, DOI 10.3892/or.2015.4131; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Lange I, 2008, CELL CALCIUM, V44, P604, DOI 10.1016/j.ceca.2008.05.001; Lastraioli E, 2015, BBA-BIOMEMBRANES, V1848, P2685, DOI 10.1016/j.bbamem.2014.12.016; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Liu AJ, 2013, CHEM-BIOL INTERACT, V205, P20, DOI 10.1016/j.cbi.2013.06.004; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Liu J, 2014, ONCOL REP, V32, P567, DOI 10.3892/or.2014.3239; Liu L, 2011, LEUKEMIA, V25, P23, DOI 10.1038/leu.2010.225; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Menges M, 2009, J CANCER RES CLIN, V135, P29, DOI 10.1007/s00432-008-0425-z; Miller BA, 2014, J BIOL CHEM, V289, P7615, DOI 10.1074/jbc.M113.533851; Mortadza SAS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00407; Mortadza SS, 2017, SCI REP-UK, V7, DOI 10.1038/srep45032; Nakajo A, 2007, GASTRIC CANCER, V10, P58, DOI 10.1007/s10120-006-0394-3; Orfanelli U, 2015, ONCOGENE, V34, P2094, DOI 10.1038/onc.2014.144; Orfanelli U, 2008, CELL RES, V18, P1128, DOI 10.1038/cr.2008.296; Ouadid-Ahidouch H, 2013, TRENDS MOL MED, V19, P117, DOI 10.1016/j.molmed.2012.11.004; Partida-Sanchez S, 2007, J IMMUNOL, V179, P7827, DOI 10.4049/jimmunol.179.11.7827; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Perraud AL, 2003, J BIOL CHEM, V278, P1794, DOI 10.1074/jbc.M205601200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Potapova O, 2000, MOL CELL BIOL, V20, P1713, DOI 10.1128/MCB.20.5.1713-1722.2000; Potapova O, 2002, CANCER RES, V62, P3257; Prevarskaya N, 2007, BBA-MOL BASIS DIS, V1772, P937, DOI 10.1016/j.bbadis.2007.05.006; Rae MG, 2012, NEUROCHEM INT, V60, P543, DOI 10.1016/j.neuint.2012.02.014; Rodrigues T, 2016, CHEM SOC REV, V45, P6130, DOI 10.1039/c5cs00916b; Rogalinska M, 2016, MINI-REV MED CHEM, V16, P524, DOI 10.2174/1389557515666151016124331; Sakamoto J, 2009, GASTRIC CANCER, V12, P69, DOI 10.1007/s10120-009-0505-z; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Santoni Giorgio, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P54; Shimizu S, 2010, ONCOGENE, V29, P2070, DOI 10.1038/onc.2009.487; Shulman K, 2012, ONCOL LETT, V3, P1154, DOI 10.3892/ol.2012.617; Starkus JG, 2010, J PHYSIOL-LONDON, V588, P1227, DOI 10.1113/jphysiol.2010.187476; Strohecker AM, 2014, CANCER DISCOV, V4, P766, DOI 10.1158/2159-8290.CD-14-0196; Strohecker AM, 2014, AUTOPHAGY, V10, P384, DOI 10.4161/auto.27320; Strohecker AM, 2013, CANCER DISCOV, V3, P1272, DOI 10.1158/2159-8290.CD-13-0397; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Tan CH, 2016, NATURE, V536, P460, DOI 10.1038/nature19074; Uchida K, 2011, ISLETS, V3, P209, DOI 10.4161/isl.3.4.16130; Uchida K, 2011, DIABETES, V60, P119, DOI 10.2337/db10-0276; Veldhoen RA, 2013, ONCOGENE, V32, P736, DOI 10.1038/onc.2012.92; Venerito M, 2014, HELICOBACTER, V19, P32, DOI 10.1111/hel.12164; Wang M, 2012, AUTOPHAGY, V8, P1273, DOI 10.4161/auto.20917; Wang Q, 2017, BBA-MOL CELL RES, V1864, P957, DOI 10.1016/j.bbamcr.2016.12.014; Wang Q, 2016, AUTOPHAGY, V12, P1340, DOI 10.1080/15548627.2016.1187365; Wang YY, 2014, DRUG DES DEV THER, V8, P1965, DOI 10.2147/DDDT.S64989; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wulff H, 2001, J BIOL CHEM, V276, P32040, DOI 10.1074/jbc.M105231200; Wyrsch P, 2012, MOL CELL BIOL, V32, P3541, DOI 10.1128/MCB.00437-12; Xia HHX, 2006, CANCER LETT, V241, P268, DOI 10.1016/j.canlet.2005.10.031; Xu P, 2011, GENE DEV, V25, P310, DOI 10.1101/gad.1984311; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yang W, 2010, J BIOL CHEM, V285, P30411, DOI 10.1074/jbc.M110.139774; Yazgan Y, 2017, MOL NEUROBIOL, V54, P7620, DOI 10.1007/s12035-016-0232-5; Yosida M, 2014, DIABETES, V63, P3394, DOI 10.2337/db13-1868; Zhao HF, 2015, INT J ONCOL, V47, P429, DOI 10.3892/ijo.2015.3052; Zhao LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep38471; Zhong LM, 2017, J VIROL, V91, DOI 10.1128/JVI.00001-17; Zhou YY, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140141; Zoli W, 2005, BREAST CANCER RES, V7, pR681, DOI 10.1186/bcr1274	114	64	65	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3637	3650		10.1074/jbc.M117.817635	http://dx.doi.org/10.1074/jbc.M117.817635			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29343514	Green Published, hybrid			2022-12-26	WOS:000427030200018
J	Thompson, JL; Zhao, Y; Stathopulos, PB; Grossfield, A; Shuttleworth, TJ				Thompson, Jill L.; Zhao, Yue; Stathopulos, Peter B.; Grossfield, Alan; Shuttleworth, Trevor J.			Phosphorylation-mediated structural changes within the SOAR domain of stromal interaction molecule 1 enable specific activation of distinct Orai channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAC CHANNELS; ARC CHANNEL; STIM1; STORE; CA2+; DYNAMICS; GLYCINE; ALANINE; ENTRY	Low-conductance, highly calcium-selective channels formed by the Orai proteins exist as store-operated CRAG channels and store-independent, arachidonic acid activated ARC channels. Both are activated by stromal interaction molecule 1 (STIM1), but CRAG channels are activated by STIM1 located in the endoplasmic reticulum membrane, whereas ARC channels are activated by the minor plasma membrane associated pool of STIM1. Critically, maximally activated CRAG channel and ARC channel currents are completely additive within the same cell, and their selective activation results in their ability to each induce distinct cellular responses. We have previously shown that specific ARC channel activation requires a PIG'S-mediated phosphorylation of a single threonine residue (Thr(389)) within the cytoplasmic region of STIM1. Here, examination of the molecular basis of this phosphorylation-dependent activation revealed that phosphorylation of the Thr(389) residue induces a significant structural change in the STIM1-Orai activating region (SOAR) that interacts with the Orai proteins, and it is this change that determines the selective activation of the store-independent ARC channels versus the store-operated CRAG channels. In conclusion, our findings reveal the structural changes underlying the selective activation of STIM1-induced CRAG or ARC channels that determine the specific stimulation of these two functionally distinct Ca2+ entry pathways.	[Thompson, Jill L.; Shuttleworth, Trevor J.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Grossfield, Alan] Univ Rochester, Med Ctr, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Zhao, Yue; Stathopulos, Peter B.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada	University of Rochester; University of Rochester; Western University (University of Western Ontario)	Shuttleworth, TJ (corresponding author), Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA.	trevor_shuttleworth@URMC.rochester.edu		Stathopulos, Peter B./0000-0002-0536-6656	NIGMS, National Institutes of Health [GM040457]; Natural Sciences and Engineering Research Council [250225]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040457] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant GM040457 (to T.J.S.) and Natural Sciences and Engineering Research Council Grant 250225 (to P.B.S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Calloway N, 2010, BIOCHEMISTRY-US, V49, P1067, DOI 10.1021/bi901936q; Covington ED, 2010, MOL BIOL CELL, V21, P1897, DOI 10.1091/mbc.E10-02-0145; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Derler I, 2016, AM J PHYSIOL-CELL PH, V310, pC643, DOI 10.1152/ajpcell.00007.2016; Espinoza-Fonseca LM, 2014, MOL BIOSYST, V10, P2693, DOI 10.1039/c4mb00364k; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Korzeniowski MK, 2017, J CELL SCI, V130, P2821, DOI 10.1242/jcs.205583; Korzeniowski MK, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001122; Li YS, 2008, ARCH BIOCHEM BIOPHYS, V478, P110, DOI 10.1016/j.abb.2008.07.002; Lopez-Llano J, 2006, PROTEINS, V64, P769, DOI 10.1002/prot.21041; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mignen O, 2005, J PHYSIOL-LONDON, V564, P791, DOI 10.1113/jphysiol.2005.085704; Mignen O, 2003, J BIOL CHEM, V278, P10174, DOI 10.1074/jbc.M212536200; Monera OD, 1995, J PEPT SCI, V1, P319, DOI 10.1002/psc.310010507; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; Romo TD, 2014, J COMPUT CHEM, V35, P2305, DOI 10.1002/jcc.23753; SERRANO L, 1992, NATURE, V356, P453, DOI 10.1038/356453a0; Shuttleworth TJ, 1996, J BIOL CHEM, V271, P21720, DOI 10.1074/jbc.271.36.21720; Stathopulos PB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3963; Thompson JL, 2015, J PHYSIOL-LONDON, V593, P559, DOI 10.1113/jphysiol.2014.284182; Thompson JL, 2013, J PHYSIOL-LONDON, V591, P3507, DOI 10.1113/jphysiol.2013.256784; Thompson JL, 2012, CHANNELS, V6, P370, DOI 10.4161/chan.21947; Thompson JL, 2011, J PHYSIOL-LONDON, V589, P5057, DOI 10.1113/jphysiol.2011.214437; Tien MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080635; Wang XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4183; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Yang X, 2012, P NATL ACAD SCI USA, V109, P5657, DOI 10.1073/pnas.1118947109; Yeung-Yam-Wah V, 2010, CELL CALCIUM, V47, P77, DOI 10.1016/j.ceca.2009.11.007; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou YD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9395; Zhou YB, 2013, NAT STRUCT MOL BIOL, V20, P973, DOI 10.1038/nsmb.2625; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107	44	7	7	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3145	3155		10.1074/jbc.M117.819078	http://dx.doi.org/10.1074/jbc.M117.819078			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29326165	Green Published, hybrid			2022-12-26	WOS:000426562800010
J	Morath, I; Jung, C; Leveque, R; Chen, LF; Toillon, RA; Warth, A; Orian-Rousseau, V				Morath, Iris; Jung, Christian; Leveque, Romain; Chen Linfeng; Toillon, Robert-Alain; Warth, Arne; Orian-Rousseau, Veronique			Differential recruitment of CD44 isoforms by ErbB ligands reveals an involvement of CD44 in breast cancer	ONCOGENE			English	Article							GROWTH-FACTOR; SIGNALING PLATFORM; EGF RECEPTOR; C-MET; EXPRESSION; CYTOSKELETON; EZRIN; METASTASIS; ACTIVATION; PROTEINS	Members of the CD44 family of transmembrane glycoproteins control cell signaling pathways from numerous cell surface receptors, including receptor tyrosine kinases (RTKs). The decisive factor (ligand, RTKs or both) that controls the recruitment of specific CD44 isoforms is still unknown. We investigated this question by using the EGFR signaling pathway, in which one receptor can be activated by a broad range of ligands. By means of siRNA-mediated downregulation of CD44 expression and blocking experiments, we identified CD44v6 as a co-receptor for EGF- and ER-induced ErbB1 activation and for NRG1-induced ErbB3 and ErbB4 activation. In contrast, TGFa is independent of all CD44 isoforms, even though it addresses the same receptor pairs as EGF. Moreover, the heparin-sulfated CD44v3 isoform is required for HB-EGF-induced EGFR signaling. These data suggest that specific CD44 isoforms are recruited in a ligand-dependent manner as co-receptors in the EGFR signaling pathways and that the specificity is determined by the ligand and not by the receptors themselves. The in vivo relevance of this interplay between CD44 isoforms and EGFR ligands is underlined by the decreased metastatic spreading of mammary carcinomas in mice treated with a CD44v6-specific peptide. Most importantly, we found a clear correlation between the presence of CD44v6/ErbB1 complexes in breast cancer patients and lymph node metastases.	[Morath, Iris; Jung, Christian; Orian-Rousseau, Veronique] Karlsruhe Inst Technol, Inst Toxicol & Genet, Karlsruhe, Germany; [Leveque, Romain; Toillon, Robert-Alain] Univ Lille, INSERM, U908, CPAC, Lille, France; [Chen Linfeng] Dana Farber Canc Inst, Boston, MA 02115 USA; [Warth, Arne] Univ Hosp Heidelberg, Inst Pathol, Heidelberg, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Harvard University; Dana-Farber Cancer Institute; Ruprecht Karls University Heidelberg	Orian-Rousseau, V (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, Karlsruhe, Germany.	veronique.orian-rousseau@kit.edu	Jung, Christian/AAN-4537-2021; Toillon, Robert-Alain/Q-2286-2018; Orian-Rousseau, Veronique/H-5735-2013	Jung, Christian/0000-0001-8325-250X; Toillon, Robert-Alain/0000-0001-5483-2118; Orian-Rousseau, Veronique/0000-0003-2939-9257	Mildred Scheel Foundation	Mildred Scheel Foundation(Deutsche Krebshilfe)	The authors are very thankful to Selma Huber and the animal facility of the Institute of Toxicology and Genetics for their excellent work and help with the animal experiments. This work was supported by a grant from Mildred Scheel Foundation.	ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; Bennett R, 2001, J HISTOCHEM CYTOCHEM, V49, P67, DOI 10.1177/002215540104900107; Bourguignon LYW, 1997, J BIOL CHEM, V272, P27913, DOI 10.1074/jbc.272.44.27913; Bourguignon LYW, 2001, J MAMMARY GLAND BIOL, V6, P287, DOI 10.1023/A:1011371523994; Bruce B, 2007, CLIN EXP METASTAS, V24, P69, DOI 10.1007/s10585-006-9050-x; COOK PW, 1991, MOL CELL BIOL, V11, P2547, DOI 10.1128/MCB.11.5.2547; Diaz LK, 2005, CLIN CANCER RES, V11, P3309, DOI 10.1158/1078-0432.CCR-04-2184; Ellis IR, 2007, EXP CELL RES, V313, P732, DOI 10.1016/j.yexcr.2006.11.016; Foekens JA, 1999, INT J CANCER, V84, P209, DOI 10.1002/(SICI)1097-0215(19990621)84:3<209::AID-IJC2>3.0.CO;2-9; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ilangumaran S, 1999, LEUKEMIA LYMPHOMA, V35, P455, DOI 10.1080/10428199909169610; Kivisaari AK, 2010, BRIT J DERMATOL, V163, P726, DOI 10.1111/j.1365-2133.2010.09924.x; Konig H, 1996, EMBO J, V15, P4030, DOI 10.1002/j.1460-2075.1996.tb00776.x; Konstantinovsky S, 2012, CLIN EXP METASTAS, V29, P527, DOI 10.1007/s10585-012-9468-2; Lynch CC, 2007, CANCER RES, V67, P6760, DOI 10.1158/0008-5472.CAN-07-0026; Matsuo I, 2013, CURR OPIN GENET DEV, V23, P399, DOI 10.1016/j.gde.2013.02.004; Matzke A, 2005, CANCER RES, V65, P6105, DOI 10.1158/0008-5472.CAN-05-0207; Matzke-Ogi A, 2016, GASTROENTEROLOGY, V150, P513, DOI 10.1053/j.gastro.2015.10.020; Minuti G, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.06.22; Misra S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00201; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Olaku V, 2011, MOL BIOL CELL, V22, P2777, DOI 10.1091/mbc.E11-02-0134; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; Orian-Rousseau W, 2007, MOL BIOL CELL, V18, P76, DOI 10.1091/mbc.E06-08-0674; Orian-Rousseau V, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00154; Orian-Rousseau V, 2014, ADV CANCER RES, V123, P231, DOI 10.1016/B978-0-12-800092-2.00009-5; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Orian-Rousseau V, 2008, ADV CANCER RES, V101, P63, DOI 10.1016/S0065-230X(08)00404-1; Pochampalli MR, 2007, ONCOGENE, V26, P1693, DOI 10.1038/sj.onc.1209976; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Raymond E, 2000, DRUGS, V60, P15, DOI 10.2165/00003495-200060001-00002; Rodig SJ, 2010, CURR OPIN INVEST DR, V11, P1477; Rowinsky E, 2000, DRUGS, V60, P41; Sherman L, 1998, GENE DEV, V12, P1058, DOI 10.1101/gad.12.7.1058; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Tremmel M, 2009, BLOOD, V114, P5236, DOI 10.1182/blood-2009-04-219204; Tsatas D, 2002, J CLIN NEUROSCI, V9, P282, DOI 10.1054/jocn.2001.1063; Volz Y, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150093; Wan X, 2009, ONCOGENE, V28, P3401, DOI 10.1038/onc.2009.206; Wu WKK, 2009, ANTICANCER RES, V29, P229; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702	48	27	27	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	11					1472	1484		10.1038/s41388-017-0030-1	http://dx.doi.org/10.1038/s41388-017-0030-1			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ3AZ	29321661				2022-12-26	WOS:000427459500006
J	Anuja, P; Venugopalan, V; Darakhshan, N; Awadh, P; Wilson, V; Manoj, G; Manish, M; Vivek, L				Anuja, Patil; Venugopalan, Vishnu; Darakhshan, Naheed; Awadh, Pandit; Wilson, Vinny; Manoj, Goyal; Manish, Modi; Vivek, Lal			Rapidly progressive dementia: An eight year (2008-2016) retrospective study	PLOS ONE			English	Article							SUBACUTE SCLEROSING-PANENCEPHALITIS; CREUTZFELDT-JAKOB-DISEASE; YOUNG-ONSET DEMENTIA; DIAGNOSTIC-CRITERIA; INTERNATIONAL WORKSHOP; GUIDELINES	Background and purpose Rapidly progressive dementia (RPD) is an emergency in cognitive neurology, defined as cognitive impairment affecting the daily living activities developed over less than 1 year. This study investigated the profile of patients with rapidly progressive dementia at first presentation. Methods Retrospective case analysis was done in 187 patients with rapidly progressive dementia who presented to the Postgraduate Institute of Medical Education and Research, Chandigarh, India from January 2008 to August 2016. Patients were divided into three groups: (1) Reversible (treatable) secondary dementia group, (2) Prion dementia group (sporadic Creutzfeldt-Jakob disease), (3) Non-prion Neurodegenerative and vascular dementias (primary neurodegenerative and vascular dementia). Cases presenting with delirium secondary to metabolic, drug induced or septic causes and those with signs of meningitis were excluded. Results Secondary reversible causes formed the most common cause for RPD with immune mediated encephalitides, neoplastic and infectious disorders as the leading causes. The patients in this series had an younger onset of RPD. Infections presenting with RPD accounted for the most common cause in our series (39%) with SSPE (41%) as the leading cause followed by neurosyphilis (17.9%) and progressive multifocal leukoencephalopathy (15.3%). Immune mediated dementias formed the second most common (18.1%) etiologic cause for RPD. The neurodegenerative dementias were third common cause for RPD in our series. Neoplastic disorders and immune mediated presented early (< 6 months) while neurodegenerative disorders presented later (> 6 months). Conclusions Rapidly progressive dementia is an emergency in cognitive neurology with potentially treatable or reversible causes that should be sought for diligently.	[Anuja, Patil; Darakhshan, Naheed; Wilson, Vinny; Manoj, Goyal; Manish, Modi; Vivek, Lal] Postgrad Inst Med Educ & Res, Dept Neurol, Sect 12, Chandigarh, India; [Venugopalan, Vishnu; Awadh, Pandit] All India Inst Med Sci, Dept Neurol, New Delhi, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; All India Institute of Medical Sciences (AIIMS) New Delhi	Venugopalan, V (corresponding author), All India Inst Med Sci, Dept Neurol, New Delhi, India.	vishnuvy16@yahoo.com	Vishnu, Venugopalan Y/Q-1382-2019	Vishnu, Venugopalan Y/0000-0002-3654-8137; Modi, Manish/0000-0002-5494-3704				CALABRESE LH, 1988, MEDICINE, V67, P20, DOI 10.1097/00005792-198801000-00002; Chakor RT, 2013, J PAK MED ASSOC, V63, P921; Chitravas N, 2011, ANN NEUROL, V70, P437, DOI 10.1002/ana.22454; Degnan AJ, 2014, AM J NEURORADIOL, V35, P418, DOI 10.3174/ajnr.A3454; Dugbartey AT, 1998, ARCH INTERN MED, V158, P1413, DOI 10.1001/archinte.158.13.1413; DYKEN PR, 1985, NEUROL CLIN, V3, P179, DOI 10.1016/S0733-8619(18)31062-4; Geschwind Michael D, 2016, Continuum (Minneap Minn), V22, P510, DOI 10.1212/CON.0000000000000319; Geschwind Michael D, 2010, Continuum (Minneap Minn), V16, P31, DOI 10.1212/01.CON.0000368211.79211.4c; GILBERSTADT SJ, 1980, ARCH INTERN MED, V140, P519, DOI 10.1001/archinte.140.4.519; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Grau-Rivera O, 2015, NEURODEGENER DIS, V15, P350, DOI 10.1159/000439251; Graus F, 2016, LANCET NEUROL, V15, P391, DOI 10.1016/S1474-4422(15)00401-9; Kelley BJ, 2008, ARCH NEUROL-CHICAGO, V65, P1502, DOI 10.1001/archneur.65.11.1502; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; McKeon Andrew, 2010, Continuum (Minneap Minn), V16, P80, DOI 10.1212/01.CON.0000368213.63964.34; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Neto AS, 2017, ALZ DIS ASSOC DIS, V31, P239, DOI 10.1097/WAD.0000000000000170; Papageorgiou SG, 2009, ALZ DIS ASSOC DIS, V23, P337, DOI 10.1097/WAD.0b013e31819e099b; Paterson Ross W, 2012, Neurol Clin Pract, V2, P187; Poser S, 1999, BRAIN, V122, P2345, DOI 10.1093/brain/122.12.2345; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Sala I, 2012, ALZ DIS ASSOC DIS, V26, P267, DOI 10.1097/WAD.0b013e3182368ed4; Singer C, 1997, MOVEMENT DISORD, V12, P342, DOI 10.1002/mds.870120313; Tagliapietra M, 2013, J ALZHEIMERS DIS, V34, P231, DOI 10.3233/JAD-121873; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191	26	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0189832	10.1371/journal.pone.0189832	http://dx.doi.org/10.1371/journal.pone.0189832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346380	Green Submitted, gold, Green Published			2022-12-26	WOS:000422749500006
J	Harada, S; Hirayama, A; Chan, Q; Kurihara, A; Fukai, K; Iida, M; Kato, S; Sugiyama, D; Kuwabara, K; Takeuchi, A; Akiyama, M; Okamura, T; Ebbels, TMD; Elliott, P; Tomita, M; Sato, A; Suzuki, C; Sugimoto, M; Soga, T; Takebayashi, T				Harada, Sei; Hirayama, Akiyoshi; Chan, Queenie; Kurihara, Ayako; Fukai, Kota; Iida, Miho; Kato, Suzuka; Sugiyama, Daisuke; Kuwabara, Kazuyo; Takeuchi, Ayano; Akiyama, Miki; Okamura, Tomonori; Ebbels, Timothy M. D.; Elliott, Paul; Tomita, Masaru; Sato, Asako; Suzuki, Chizuru; Sugimoto, Masahiro; Soga, Tomoyoshi; Takebayashi, Toru			Reliability of plasma polar metabolite concentrations in a large-scale cohort study using capillary electrophoresis-mass spectrometry	PLOS ONE			English	Article							HUMAN BLOOD METABOLITES; PROFILING REVEALS; WIDE ASSOCIATION; SERUM METABOLOME; BIOMARKERS; CANCER; RISK; URINE; IDENTIFICATION; MULTICENTER	Background Cohort studies with metabolomics data are becoming more widespread, however, large-scale studies involving 10,000s of participants are still limited, especially in Asian populations. Therefore, we started the Tsuruoka Metabolomics Cohort Study enrolling 11,002 community-dwelling adults in Japan, and using capillary electrophoresis-mass spectrometry (CE-MS) and liquid chromatography-mass spectrometry. The CE-MS method is highly amenable to absolute quantification of polar metabolites, however, its reliability for large-scale measurement is unclear. The aim of this study is to examine reproducibility and validity of large-scale CE-MS measurements. In addition, the study presents absolute concentrations of polar metabolites in human plasma, which can be used in future as reference ranges in a Japanese population. Methods Metabolomic profiling of 8,413 fasting plasma samples were completed using CE-MS, and 94 polar metabolites were structurally identified and quantified. Quality control (QC) samples were injected every ten samples and assessed throughout the analysis. Inter-and intra-batch coefficients of variation of QC and participant samples, and technical intraclass correlation coefficients were estimated. Passing-Bablok regression of plasma concentrations by CE-MS on serum concentrations by standard clinical chemistry assays was conducted for creatinine and uric acid. Results and conclusions In QC samples, coefficient of variation was less than 20% for 64 metabolites, and less than 30% for 80 metabolites out of the 94 metabolites. Inter-batch coefficient of variation was less than 20% for 81 metabolites. Estimated technical intraclass correlation coefficient was above 0.75 for 67 metabolites. The slope of Passing-Bablok regression was estimated as 0.97 (95% confidence interval: 0.95, 0.98) for creatinine and 0.95 (0.92, 0.96) for uric acid. Compared to published data from other large cohort measurement platforms, reproducibility of metabolites common to the platforms was similar to or better than in the other studies. These results show that our CE-MS platform is suitable for conducting large-scale epidemiological studies.	[Harada, Sei; Kurihara, Ayako; Fukai, Kota; Iida, Miho; Kato, Suzuka; Sugiyama, Daisuke; Kuwabara, Kazuyo; Takeuchi, Ayano; Okamura, Tomonori; Takebayashi, Toru] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Harada, Sei; Hirayama, Akiyoshi; Kurihara, Ayako; Akiyama, Miki; Tomita, Masaru; Sato, Asako; Suzuki, Chizuru; Sugimoto, Masahiro; Soga, Tomoyoshi; Takebayashi, Toru] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Harada, Sei; Chan, Queenie; Elliott, Paul] Imperial Coll London, Fac Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Chan, Queenie; Ebbels, Timothy M. D.; Elliott, Paul] Imperial Coll London, MRC PHE Ctr Environm & Hlth, London, England; [Iida, Miho] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo, Japan; [Akiyama, Miki; Tomita, Masaru; Soga, Tomoyoshi] Keio Univ, Fac Environm & Informat Studies, Fujisawa, Kanagawa, Japan; [Ebbels, Timothy M. D.] Imperial Coll London, Dept Surg & Canc, Computat & Syst Med, London, England	Keio University; Keio University; Imperial College London; Imperial College London; Keio University; Keio University; Imperial College London	Harada, S (corresponding author), Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan.; Harada, S (corresponding author), Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.; Harada, S (corresponding author), Imperial Coll London, Fac Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England.	seiharada@keio.jp	Takeuchi, Ayano/C-3130-2019; Fukai, Kota/P-9046-2017; Takebayashi, Toru/AAB-9356-2019; Takebayashi, Toru/K-7526-2013; Ebbels, Tim/ABB-2627-2021; Okamura, Tomonori/L-1693-2013; Chan, Queenie/C-5017-2011; Harada, Sei/ABA-5975-2020	Takeuchi, Ayano/0000-0002-0908-1850; Fukai, Kota/0000-0002-8319-8467; Takebayashi, Toru/0000-0002-8268-8026; Takebayashi, Toru/0000-0002-8268-8026; Ebbels, Tim/0000-0002-3372-8423; Okamura, Tomonori/0000-0003-0488-0351; Chan, Queenie/0000-0001-9278-230X; Harada, Sei/0000-0003-2666-4932; Sugimoto, Masahiro/0000-0003-3316-2543; Elliott, Paul/0000-0002-7511-5684	Yamagata Prefectural Government; city of Tsuruoka; Public Health England [MR/L01341X/1]; Medical Research Council; NIHR Health Protection Research Unit in Health Impact of Environmental Hazards [HPRU-2012-10141]; Japan Society for the Promotion of Science [JP24390168, JP15H04778, 25670303, JP15K19231]; MRC [MR/L01341X/1] Funding Source: UKRI; Medical Research Council [MR/L01341X/1, HDR-2002] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10136] Funding Source: researchfish; Grants-in-Aid for Scientific Research [15K21364] Funding Source: KAKEN	Yamagata Prefectural Government; city of Tsuruoka; Public Health England; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Health Protection Research Unit in Health Impact of Environmental Hazards; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by research funds from the Yamagata Prefectural Government (http://www.pref.yamagata.jp/) and the city of Tsuruoka (https://www.city.tsuruoka.lg.jp/), Medical Research Council and Public Health England (https://www.mrc.ac.uk/, grant number MR/L01341X/1) and NIHR Health Protection Research Unit in Health Impact of Environmental Hazards (http://hieh.hpru.nihr.ac.uk/, grant number HPRU-2012-10141), and by the Grant-in-Aid for Scientific Research (B) (grant numbers JP24390168, JP15H04778), Grant-in-Aid for Challenging Exploratory Research (grant number 25670303), and Grant-in-Aid for Young Scientists (B) (grant number JP15K19231) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage EG, 2014, J PHARMACEUT BIOMED, V87, P1, DOI 10.1016/j.jpba.2013.08.041; Athersuch TJ, 2015, MUTAGENESIS, V30, P755, DOI 10.1093/mutage/gev060; Boizard F, 2016, SCI REP-UK, V6, DOI 10.1038/srep34453; Brunius C, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1124-4; Chan Q, 2017, HYPERTENS RES, V40, P336, DOI 10.1038/hr.2016.164; Cheng SS, 2012, CIRCULATION, V125, P2222, DOI 10.1161/CIRCULATIONAHA.111.067827; DiBattista A, 2017, ANAL CHEM, V89, P8112, DOI 10.1021/acs.analchem.7b01727; Dunn WB, 2015, METABOLOMICS, V11, P9, DOI 10.1007/s11306-014-0707-1; Dunn WB, 2012, BIOANALYSIS, V4, P2249, DOI [10.4155/BIO.12.204, 10.4155/bio.12.204]; Elliott P, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5680; Fischer K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001606; FOSSATI P, 1980, CLIN CHEM, V26, P227; Frantzi M, 2016, CLIN CANCER RES, V22, P4077, DOI 10.1158/1078-0432.CCR-15-2715; Fukai K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164877; Guertin KA, 2014, AM J CLIN NUTR, V100, P208, DOI 10.3945/ajcn.113.078758; Harada S, 2016, ENVIRON HEALTH PREV, V21, P18, DOI 10.1007/s12199-015-0494-y; Hirayama A, 2015, ELECTROPHORESIS, V36, P2148, DOI 10.1002/elps.201400600; Hirayama A, 2012, ANAL BIOANAL CHEM, V404, P3101, DOI 10.1007/s00216-012-6412-x; Hirayama A, 2012, ANALYST, V137, P5026, DOI 10.1039/c2an35492f; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Iida M, 2016, MENOPAUSE, V23, P749, DOI 10.1097/GME.0000000000000630; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Karaman I, 2016, J PROTEOME RES, V15, P4188, DOI 10.1021/acs.jproteome.6b00125; Kuligowski J, 2014, TALANTA, V130, P442, DOI 10.1016/j.talanta.2014.07.031; Long T, 2017, NAT GENET, V49, P568, DOI 10.1038/ng.3809; Macedo AN, 2017, ACS CENTRAL SCI, V3, P904, DOI 10.1021/acscentsci.7b00299; Mondul AM, 2015, INT J CANCER, V137, P2124, DOI 10.1002/ijc.29576; Peake Michael, 2006, Clin Biochem Rev, V27, P173; Ramautar R, 2017, ELECTROPHORESIS, V38, P190, DOI 10.1002/elps.201600370; Ramautar R, 2009, ELECTROPHORESIS, V30, P276, DOI 10.1002/elps.200800512; Rhee EP, 2013, CELL METAB, V18, P130, DOI 10.1016/j.cmet.2013.06.013; Sampson JN, 2013, CANCER EPIDEM BIOMAR, V22, P631, DOI 10.1158/1055-9965.EPI-12-1109; Sekula P, 2016, J AM SOC NEPHROL, V27, P1175, DOI 10.1681/ASN.2014111099; Shah SH, 2012, CIRCULATION, V126, P1110, DOI 10.1161/CIRCULATIONAHA.111.060368; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Sugimoto M, 2010, ELECTROPHORESIS, V31, P2311, DOI 10.1002/elps.200900584; Sugimoto M, 2010, METABOLOMICS, V6, P78, DOI 10.1007/s11306-009-0178-y; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; TANGANELLI E, 1982, CLIN CHEM, V28, P1461; Townsend MK, 2013, CLIN CHEM, V59, P1657, DOI 10.1373/clinchem.2012.199133; US FDA, 2011, GUID IND BIOAN METH; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wehrens R, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1015-8; White Emily, 2011, IARC Sci Publ, P143; Xu T, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-60; Yamamoto Y, 2013, CLIN CHEM LAB MED, V51, P1663, DOI 10.1515/cclm-2012-0413; Yu B, 2016, AM J EPIDEMIOL, V183, P650, DOI 10.1093/aje/kwv213; Yu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021230	51	36	36	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191230	10.1371/journal.pone.0191230	http://dx.doi.org/10.1371/journal.pone.0191230			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346414	Green Published, gold			2022-12-26	WOS:000422749500038
J	Boddaert, J; Bielen, K; Jongers, B; Manocha, E; Yperzeele, L; Cras, P; Pirici, D; Kumar-Singh, S				Boddaert, Jan; Bielen, Kenny; Jongers, Bart's; Manocha, Ekta; Yperzeele, Laetitia; Cras, Patrick; Pirici, Daniel; Kumar-Singh, Samir			CD8 signaling in microglia/macrophage polarization in a rat model of cerebral ischemia	PLOS ONE			English	Article							NF-KAPPA-B; FOCAL ISCHEMIA; MACROPHAGE ACTIVATION; STROKE; INJURY; MICROGLIA; BRAIN; INFLAMMATION; MICE; MTOR	Classical or M1 activity of microglia/macrophages has been described in several neurode-generative and brain inflammatory conditions and has also been linked to expansion of ischemic injury in post-stroke brain. While different pathways of M1 polarization have been suggested to occur in the post-stroke brain, the precise underlying mechanisms remain undefined. Using a transient middle cerebral artery occlusion (MCAO) rat model, we showed a progressive M2 to M1 polarization in the perilesional brain region with M1 cells becoming one of the dominant subsets by day 4 post-stroke. Comparing key receptors involved in M1 polarization (CD8, IFNyR, Clec4, FcyR, TLR3 and TLR4) and their signal transducers (Syk, Stat1, Irf3, and Traf6) at the day 4 time point, we showed a strong upregulation of CD8 along with SYK transducer in dissected perilesional brain tissue. We further showed that CD8 expression in the post-stroke brain was associated with activated (CD68+) macrophages and that progressive accumulation of CD8+CD68+ cells in the post-stroke brain coincided with increased iNOS (M1 marker) and reduced Arg1 (M2 marker) expression on these cells. In vitro ligand-based stimulation of the CD8 receptor caused increased iNOS expression and an enhanced capacity to phagocytose E. coll particles; and interestingly, CD8 stimulation was also able to repolarize IL4-treated M2 cells to an M1 phenotype. Our data suggest that increased CD8 signaling in the post-stroke brain is primarily associated with microglia/macrophages and can independently drive M1 polarization, and that modulation of CD8 signaling could be a potential target to limit secondary post-stroke brain damage.	[Boddaert, Jan; Bielen, Kenny; Jongers, Bart's; Manocha, Ekta; Kumar-Singh, Samir] Fac Med & Hlth Sci, Mol Pathol Grp, Cell Biol & Histol, Antwerp, Belgium; [Yperzeele, Laetitia; Cras, Patrick] Univ Ziekenhuis Antwerpen, Dept Neurol, Edegem, Belgium; [Cras, Patrick; Kumar-Singh, Samir] Fac Med & Hlth Sci, Translat Neurosci, Antwerp, Belgium; [Pirici, Daniel] Univ Med & Pharm Craiova, Dept Res Methodol, Craiova, Romania	University of Antwerp; University of Medicine & Pharmacy of Craiova	Kumar-Singh, S (corresponding author), Fac Med & Hlth Sci, Mol Pathol Grp, Cell Biol & Histol, Antwerp, Belgium.; Kumar-Singh, S (corresponding author), Fac Med & Hlth Sci, Translat Neurosci, Antwerp, Belgium.	samir.kumarsingh@uantwerpen.be	Yperzeele, Laetitia/AAQ-7742-2020; Kumar-Singh, Samir/G-6280-2012	Yperzeele, Laetitia/0000-0002-5503-5724; Kumar-Singh, Samir/0000-0001-9466-6732	BOF grant from the University of Antwerp [BOF/NOI/LP/DOCPR025813, BOF/NOI-FFP130265, GOA-s30729]; Romanian National Authority for Scientific Research and Innovation - CNCS - UEFISCDI [PN-II-RU-TE-2014-4-0582]; Flemish Fund for Scientific Research/Flemish Institute for Science and technology [IWT-SB111664, FWO- SB151525]	BOF grant from the University of Antwerp; Romanian National Authority for Scientific Research and Innovation - CNCS - UEFISCDI; Flemish Fund for Scientific Research/Flemish Institute for Science and technology	This work was supported by a BOF grant from the University of Antwerp (BOF/NOI/LP/DOCPR025813; BOF/NOI-FFP130265; GOA-s30729) and a project granted by the Romanian National Authority for Scientific Research and Innovation - CNCS - UEFISCDI (project number PN-II-RU-TE-2014-4-0582). KB (IWT-SB111664) and BsJ (FWO- SB151525) are doctoral fellows of the Flemish Fund for Scientific Research/Flemish Institute for Science and technology.; The authors would like to thank Tom K Raju for his assistance in experimental procedures and the Biomedical Microscopic Imaging core facility of the University of Antwerp for equipment and technical support. This work was supported by a BOF grant from the University of Antwerp (B0F/NOI/LP/DOCPRO25813; BOF/NOI-FFP130265; GOA-s30729) and a project granted by the Romanian National Authority for Scientific Research and Innovation-CNCS-UEFISCDI (project number PN-II-RU-TE-2014-4-0582). KB (IWT-SB111664) and BsJ (FWO-SB151525) are doctoral fellows of the Flemish Fund for Scientific Research/Flemish Institute for Science and technology. All authors read, edited, and approved the final draft.	Araki E, 2001, STROKE, V32, P2370, DOI 10.1161/hs1001.096057; Baba T, 2006, BLOOD, V107, P2004, DOI 10.1182/blood-2005-06-2345; Bielen K, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00274; Bielen K, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.03.72; Carnevale J, 2013, LEUKEMIA, V27, P2118, DOI 10.1038/leu.2013.89; CHAO CC, 1992, J IMMUNOL, V149, P2736; Chernykh ER, 2015, CELL TRANSPLANTATION; Clausen BH, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-46; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; Denes A, 2007, J CEREBR BLOOD F MET, V27, P1941, DOI 10.1038/sj.jcbfm.9600495; Desestret V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067063; Frieler RA, 2011, STROKE, V42, P179, DOI 10.1161/STROKEAHA.110.598441; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gibbings DJ, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-12; Gliem M, 2016, BBA-MOL BASIS DIS, V1862, P329, DOI 10.1016/j.bbadis.2015.11.004; Han ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105711; Harari OA, 2010, ANN NY ACAD SCI, V1207, P32, DOI 10.1111/j.1749-6632.2010.05735.x; Hill JK, 1999, BRAIN RES, V820, P45, DOI 10.1016/S0006-8993(98)01140-8; Hirji N, 1997, J IMMUNOL, V158, P1833; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Hu XY, 2002, NAT IMMUNOL, V3, P859, DOI 10.1038/ni828; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jander S, 1998, EUR J NEUROSCI, V10, P680, DOI 10.1046/j.1460-9568.1998.00078.x; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Lan X, 2016, BRAIN BEHAV IMMUNITY; Li T, 2013, BRAIN, V136, P3578, DOI 10.1093/brain/awt287; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166; Mosser David M, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1402s83; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Pirici D, 2009, J HISTOCHEM CYTOCHEM, V57, P567, DOI 10.1369/jhc.2009.953240; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Ritzel RM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0329-1; Schmidt A, 2017, STROKE, V48, P1061, DOI 10.1161/STROKEAHA.116.015577; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroeter M, 2001, ACTA NEUROPATHOL, V101, P440; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sladojevic N, 2014, NEUROBIOL DIS, V67, P57, DOI 10.1016/j.nbd.2014.03.010; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Wang-Fischer Y., 2008, MANUAL STROKE MODELS; Wattananit S, 2016, J NEUROSCI, V36, P4182, DOI 10.1523/JNEUROSCI.4317-15.2016; Xie LK, 2014, J IMMUNOL, V192, P6009, DOI 10.4049/jimmunol.1303492; Xu Y, 2012, NEUROSCIENCE, V218, P35, DOI 10.1016/j.neuroscience.2012.05.036; Yang JJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00061; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027; Zheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063967	50	31	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0186937	10.1371/journal.pone.0186937	http://dx.doi.org/10.1371/journal.pone.0186937			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342151	Green Submitted, Green Published, gold			2022-12-26	WOS:000422653800003
J	Li, Z; Coffey, L; Garfin, J; Miller, ND; White, MR; Spalding, EP; de Leon, N; Kaeppler, SM; Schnable, PS; Springer, NM; Hirsch, CN				Li, Zhi; Coffey, Lisa; Garfin, Jacob; Miller, Nathan D.; White, Michael R.; Spalding, Edgar P.; de Leon, Natalia; Kaeppler, Shawn M.; Schnable, Patrick S.; Springer, Nathan M.; Hirsch, Candice N.			Genotype-by-environment interactions affecting heterosis in maize	PLOS ONE			English	Article							SINGLE-CROSS PERFORMANCE; GENE-EXPRESSION; YIELD STABILITY; HYBRID VIGOR; ARABIDOPSIS; PREDICTION; MANIFESTATION; GENOME; NETWORKS; INBREDS	The environment can influence heterosis, the phenomena in which the offspring of two inbred parents exhibits phenotypic performance beyond the inbred parents for specific traits. In this study we measured 25 traits in a set of 47 maize hybrids and their inbred parents grown in 16 different environments with varying levels of average productivity. By quantifying 25 vegetative and reproductive traits across the life cycle we were able to analyze interactions between the environment and multiple distinct instances of heterosis. The magnitude and rank among hybrids for better -parent heterosis (BPH) varied for the different traits and environments. Across the traits, a higher within plot variance was observed for inbred lines compared to hybrids. However, for most traits, variance across environments was not significantly different for inbred lines compared to hybrids. Further, for many traits the correlations of BPH to hybrid performance and BPH to better parent performance were of comparable magnitude. These results indicate that inbred lines and hybrids show similar trends in environmental response and both are contributing to observed genotype -by -environment interactions for heterosis. This study highlights the degree of heterosis is not an inherent trait of a specific hybrid, but varies depending on the trait measured and the environment where that trait is measured. Studies that attempt to correlate molecular processes with heterosis are hindered by the fact that heterosis is not a consistent attribute of a specific hybrid.	[Li, Zhi; Garfin, Jacob; Hirsch, Candice N.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA; [Coffey, Lisa; Schnable, Patrick S.] Iowa State Univ, Dept Agron, Ames, IA USA; [Miller, Nathan D.; Spalding, Edgar P.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [White, Michael R.; de Leon, Natalia; Kaeppler, Shawn M.] Univ Wisconsin, Dept Agron, Madison, WI 53706 USA; [Springer, Nathan M.] Univ Minnesota, Dept Plant & Microbial Biol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; Iowa State University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities	Hirsch, CN (corresponding author), Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA.	cnhirsch@umn.edu	Spalding, Edgar P/GWC-1811-2022; Spalding, Edgar P/A-9034-2008; Spalding, Edgar P/ABF-3253-2021	Spalding, Edgar P/0000-0002-6890-4765; Spalding, Edgar P/0000-0002-6890-4765; Li, Zhi/0000-0002-6572-7935; Schnable, Patrick/0000-0001-9169-5204; Garfin, Jacob/0000-0002-4120-2376	Minnesota Corn Research and Promotion Council [4108-16SP]; Minnesota Agricultural Experiment Station [13-014]; Iowa Corn Growers; Iowa State University's Plant Sciences Institute	Minnesota Corn Research and Promotion Council; Minnesota Agricultural Experiment Station; Iowa Corn Growers; Iowa State University's Plant Sciences Institute	This work was supported in part by the Minnesota Corn Research and Promotion Council (Project Number 4108-16SP) to CNH, the Minnesota Agricultural Experiment Station (Project 13-014) to CNH, the Iowa Corn Growers to PSS, and Iowa State University's Plant Sciences Institute to PSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD R. W., 1964, CROP SCI, V4, P503; Bernardo R, 1996, CROP SCI, V36, P50, DOI [10.2135/cropsci1996.0011183X003600040009x, 10.2135/cropsci1996.0011183X003600040007x]; BERNARDO R, 1994, CROP SCI, V34, P20, DOI 10.2135/cropsci1994.0011183X003400010003x; Chairi F, 2016, AGR WATER MANAGE, V164, P100, DOI 10.1016/j.agwat.2015.08.005; Cole CB, 2009, CROP SCI, V49, P1577, DOI 10.2135/cropsci2008.08.0450; Crow JF, 1998, GENETICS, V148, P923; Dahal D, 2012, PLANT J, V72, P70, DOI 10.1111/j.1365-313X.2012.05056.x; de Abreu ELF, 2017, PLANT J; Duvick DN, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P19; EAST E.M., 1908, CONN AGR EXP STN REP, P419; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fasoula DA, 2005, MAYDICA, V50, P49; Flint-Garcia SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007433; Frisch M, 2010, THEOR APPL GENET, V120, P441, DOI 10.1007/s00122-009-1204-1; GRIFFING B, 1971, GENETICS, V68, P443; Groszmann M, 2015, P NATL ACAD SCI USA, V112, pE6397, DOI 10.1073/pnas.1519926112; Groszmann M, 2011, P NATL ACAD SCI USA, V108, P2617, DOI 10.1073/pnas.1019217108; Henderson C. R, 1984, APPL LINEAR MODELS A; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Hirsch CN, 2014, PLANT CELL, V26, P121, DOI 10.1105/tpc.113.119982; Hoecker N, 2006, THEOR APPL GENET, V112, P421, DOI 10.1007/s00122-005-0139-4; Janick J, 1998, CSSA SPEC PUBL, P45; Kaeppler S, 2012, ISRN BOT, DOI [10.5402/2012/682824, DOI 10.5402/2012/682824]; Melchinger AE, 1998, CSSA SPEC PUBL, P29; Meyer RC, 2004, PLANT PHYSIOL, V134, P1813, DOI 10.1104/pp.103.033001; Meyer RC, 2012, PLANT J, V71, P669, DOI 10.1111/j.1365-313X.2012.05021.x; Meyer RC, 2010, THEOR APPL GENET, V120, P227, DOI 10.1007/s00122-009-1074-6; Meyer S, 2007, PLANT MOL BIOL, V63, P381, DOI 10.1007/s11103-006-9095-x; Miller M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8453; Miller ND, 2017, PLANT J, V89, P169, DOI 10.1111/tpj.13320; Munaro EM, 2011, FIELD CROP RES, V124, P441, DOI 10.1016/j.fcr.2011.08.001; Munaro EM, 2011, HETEROTIC RESPONSE G, V51; Paschold A, 2010, THEOR APPL GENET, V120, P383, DOI 10.1007/s00122-009-1082-6; Pordes R, 2007, J PHYS CONF SER, V78, DOI 10.1088/1742-6596/78/1/012057; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Romay MC, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r55; SAS Institute, 2002, SAS SYST WIND VERS 9; Schnable PS, 2013, ANNU REV PLANT BIOL, V64, P71, DOI 10.1146/annurev-arplant-042110-103827; SCHNELL FW, 1986, PLANT BREEDING, V97, P30, DOI 10.1111/j.1439-0523.1986.tb01298.x; Scholten S., 2013, DIAGNOSTICS PLANT BR, P265; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shull G., 1909, AM BREEDERS ASS REPO, V5, P51, DOI 10.1093/jhered/os-5.1.51; SHULL G.H., 1908, J HERED, V4, P296; Thain D, 2005, CONCURR COMP-PRACT E, V17, P323, DOI 10.1002/cpe.938; Thiemann A, 2009, CHINESE SCI BULL, V54, P2363, DOI 10.1007/s11434-009-0326-9; Troyer AF, 2009, CROP SCI, V49, P1969, DOI 10.2135/cropsci2009.04.0170; Troyer AF, 2006, CROP SCI, V46, P528, DOI 10.2135/cropsci2005.0065; Zhang L, 2014, J EXP BOT, V65, P5989, DOI 10.1093/jxb/eru337	49	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191321	10.1371/journal.pone.0191321	http://dx.doi.org/10.1371/journal.pone.0191321			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342221	Green Submitted, Green Published, gold			2022-12-26	WOS:000422653800061
J	Reeves, LE; Krysko, KL; Avery, ML; Gillett-Kaufman, JL; Kawahara, AY; Connelly, CR; Kaufman, PE				Reeves, Lawrence E.; Krysko, Kenneth L.; Avery, Michael L.; Gillett-Kaufman, Jennifer L.; Kawahara, Akito Y.; Connelly, C. Roxanne; Kaufman, Phillip E.			Interactions between the invasive Burmese python, Python bivittatus Kuhl, and the local mosquito community in Florida, USA	PLOS ONE			English	Article							HOST-FEEDING PATTERNS; EQUINE ENCEPHALITIS-VIRUS; ERRATICUS DIPTERA-CULICIDAE; EVERGLADES NATIONAL-PARK; MOLURUS-BIVITTATUS; BLOOD MEALS; HEPATOZOON APICOMPLEXA; PLASMODIUM-FLORIDENSE; CULEX; INFECTION	The Burmese python, Python bivittatus Kuhl, is a well-established invasive species in the greater Everglades ecosystem of southern Florida, USA. Most research on its ecological impacts focuses on its role as a predator and its trophic interactions with native vertebrate species, particularly mammals. Beyond predation, there is little known about the ecological interactions between P. bivittatus and native faunal communities. It is likely that established populations of P. bivittatus in southern Florida serve as hosts for native mosquito communities. To test this concept, we used mitochondrial cytochrome c oxidase subunit I DNA bar-coding to determine the hosts of blood fed mosquitoes collected at a research facility in northern Florida where captive P. bivittatus and Argentine black and white tegu, Salvator merianae (Dume A ril and Bibron), are maintained in outdoor enclosures, accessible to local mosquitoes. We recovered python DNA from the blood meals of three species of Culex mosquitoes: Culex erraticus (Dyar and Knab), Culex quinquefasciatus Say, and Culex pilosus (Dyar and Knab). Culex erraticus conclusively (P = 0.001; Fisher's Exact Test) took more blood meals from P. bivittatus than from any other available host. While the majority of mosquito blood meals in our sample were derived from P. bivittatus, only one was derived from S. merianae. These results demonstrate that local mosquitoes will feed on invasive P. bivittatus, a recently introduced host. If these interactions also occur in southern Florida, P. bivittatus may be involved in the transmission networks of mosquito-vectored pathogens. Our results also illustrate the potential of detecting the presence of P. bivittatus in the field through screening mosquito blood meals for their DNA.	[Reeves, Lawrence E.; Gillett-Kaufman, Jennifer L.; Kaufman, Phillip E.] Univ Florida, Inst Food & Agr Sci, Entomol & Nematol Dept, Gainesville, FL 32611 USA; [Krysko, Kenneth L.] Univ Florida, Florida Museum Nat Hist, Div Herpetol, Gainesville, FL 32611 USA; [Avery, Michael L.] Natl Wildlife Res Ctr, USDA, Gainesville, FL USA; [Kawahara, Akito Y.] Univ Florida, Florida Museum Nat Hist, McGuire Ctr Lepidoptera & Biodivers, Gainesville, FL 32611 USA; [Connelly, C. Roxanne] Univ Florida, Inst Food & Agr Sci, Florida Med Entomol Lab, Vero Beach, FL 32962 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Department of Agriculture (USDA); State University System of Florida; University of Florida; State University System of Florida; University of Florida	Reeves, LE (corresponding author), Univ Florida, Inst Food & Agr Sci, Entomol & Nematol Dept, Gainesville, FL 32611 USA.	lereeves@ufl.edu		Gillett-Kaufman, Jennifer/0000-0001-8116-0249; Reeves, Lawrence/0000-0003-3968-8124; Kaufman, Phillip/0000-0001-6159-8358	National Science Foundation [00107251]; United States Department of Agriculture, National Wildlife Research Center; University of Florida Open Access Publishing Fund	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture, National Wildlife Research Center; University of Florida Open Access Publishing Fund	This material is based upon work supported by the National Science Foundation (http://www.nsf.gov) Graduate Research Fellowship under Grant No. 00107251 to LER. Additional support for this study was provided by the United States Department of Agriculture, National Wildlife Research Center (http://www.usda.gov). Publication of this article was funded in part by the University of Florida Open Access Publishing Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffenberg K, 2010, ZOOTAXA, P1; Bataille A, 2012, INFECT GENET EVOL, V12, P1831, DOI 10.1016/j.meegid.2012.07.019; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bingham AM, 2016, J MED ENTOMOL, V53, P473, DOI 10.1093/jme/tjv195; Bingham AM, 2014, AM J TROP MED HYG, V91, P685, DOI 10.4269/ajtmh.14-0081; Bingham AM, 2012, AM J TROP MED HYG, V87, P1140, DOI 10.4269/ajtmh.2012.12-0257; Blosser EM, 2016, ACTA TROP, V164, P352, DOI 10.1016/j.actatropica.2016.10.001; Boback SM, 2016, BIOINVASIONS REC, V5, P197, DOI 10.3391/bir.2016.5.4.02; Brault AC, 2004, P NATL ACAD SCI USA, V101, P11344, DOI 10.1073/pnas.0402905101; Burkett-Cadena ND, 2008, AM J TROP MED HYG, V79, P809, DOI 10.4269/ajtmh.2008.79.809; Burkett-Cadena ND, 2011, J AM MOSQUITO CONTR, V27, P153, DOI 10.2987/10-6076.1; Coffey LL, 2006, EMERG INFECT DIS, V12, P1873; Coffey LL, 2004, EMERG INFECT DIS, V10, P2182, DOI 10.3201/eid1012.040442; COLEMAN PH, 1969, AM J EPIDEMIOL, V89, P217, DOI 10.1093/oxfordjournals.aje.a120931; Cronk QCB, 1995, PLANT INVADERS THREA; Cupp EW, 2004, AM J TROP MED HYG, V71, P272, DOI 10.4269/ajtmh.2004.71.272; Dahlin CR, 2016, ONE HEALTH, V2, P136, DOI 10.1016/j.onehlt.2016.09.003; Darsie RF, 2000, KEYS ADULT FEMALES F; Detinova TS, 1962, B WORLD HEALTH ORGAN, V47, P48; Dobson A, 2006, PLOS MED, V3, P714, DOI 10.1371/journal.pmed.0030231; Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096; Dorcas ME, 2012, P NATL ACAD SCI USA, V109, P2418, DOI 10.1073/pnas.1115226109; Dove CJ, 2011, WILSON J ORNITHOL, V123, P126, DOI 10.1676/10-092.1; EDMAN JD, 1974, J MED ENTOMOL, V11, P95, DOI 10.1093/jmedent/11.1.95; EDMAN JD, 1972, J MED ENTOMOL, V9, P429, DOI 10.1093/jmedent/9.5.429; EDMAN JD, 1979, J MED ENTOMOL, V15, P521, DOI 10.1093/jmedent/15.5-6.521; Engeman R, 2011, CURR ZOOL, V57, P599, DOI 10.1093/czoolo/57.5.599; Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993; FIELDS BN, 1969, AM J EPIDEMIOL, V89, P222, DOI 10.1093/oxfordjournals.aje.a120932; Fonseca DM, 2000, MOL ECOL, V9, P1803, DOI 10.1046/j.1365-294x.2000.01070.x; GEBHARDT LP, 1964, NEW ENGL J MED, V271, P172, DOI 10.1056/NEJM196407232710402; Graham SP, 2012, AM J TROP MED HYG, V86, P540, DOI 10.4269/ajtmh.2012.11-0283; Greene Daniel U., 2007, Herpetological Review, V38, P355; Guedes DRD, 2016, 073197 BIORXIVORG; Hardin Scott, 2007, P43; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HENDERSON BE, 1969, AM J EPIDEMIOL, V89, P227, DOI 10.1093/oxfordjournals.aje.a120933; Holbrook Joshua, 2011, Florida Scientist, V74, P17; Hoyer IJ, 2017, BIOL LETTERS, V13, DOI 10.1098/rsbl.2017.0353; Hunter ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121655; Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Kelly DW, 2009, ECOLOGY, V90, P2047, DOI 10.1890/08-1085.1; KLEIN TA, 1987, J AM MOSQUITO CONTR, V3, P165; Krysko Kenneth L., 2016, IRCF Reptiles & Amphibians, V23, P110; Martinez-de la Puente J, 2015, PARASITOL RES, V114, P1607, DOI 10.1007/s00436-015-4343-0; McCleery RA, 2015, P ROY SOC LOND B BIO, V282, P2015, DOI DOI 10.1098/RSPB.2015.0120); McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Mendenhall IH, 2012, J MED ENTOMOL, V49, P1092, DOI 10.1603/ME11260; Meshaka Walter E. Jr., 2000, Florida Scientist, V63, P84; Molaei G, 2007, AM J TROP MED HYG, V77, P73; Nagy Zoltan T, 2012, PLoS One, V7, pe34506, DOI 10.1371/journal.pone.0034506; Paperna I, 2004, PARASITE, V11, P175, DOI 10.1051/parasite/2004112175; Perkins SL, 2007, J HERPETOL, V41, P750, DOI 10.1670/07-052.1; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reeves LE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1791-z; Rodrigues SCG, 2006, J AM MOSQUITO CONTR, V22, P557, DOI 10.2987/8756-971X(2006)22[557:BMIFMC]2.0.CO;2; Savage HM, 2008, J MED ENTOMOL, V45, P276, DOI 10.1603/0022-2585(2008)45[276:HHHAPA]2.0.CO;2; Savage HM, 2007, VECTOR-BORNE ZOONOT, V7, P365, DOI 10.1089/vbz.2006.0602; Simberloff Daniel, 1997, P3; Smith TG, 1996, J PARASITOL, V82, P565, DOI 10.2307/3283781; Snow Ray W., 2007, Herpetological Bulletin, P5; Snow RW, BIOL BOAS PYTHONS; Steinman A, 2006, VECTOR-BORNE ZOONOT, V6, P361, DOI 10.1089/vbz.2006.6.361; Telford SR, 2001, J PARASITOL, V87, P890, DOI 10.2307/3285149; TEMPELIS CH, 1975, J MED ENTOMOL, V11, P635, DOI 10.1093/jmedent/11.6.635; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Unlu I, 2010, J MED ENTOMOL, V47, P625, DOI 10.1603/ME09087; Viana LA, 2010, J MED ENTOMOL, V47, P670, DOI 10.1603/ME09260; Walters TM, 2016, J HERPETOL, V50, P50, DOI 10.1670/14-098; White G, 2011, AM J TROP MED HYG, V85, P421, DOI 10.4269/ajtmh.2011.11-0006; Willson JD, 2017, J APPL ECOL, V54, P1251, DOI 10.1111/1365-2664.12844; Willson JD, 2011, BIOL INVASIONS, V13, P1493, DOI 10.1007/s10530-010-9908-3; WORK TH, 1964, SCIENCE, V145, P270, DOI 10.1126/science.145.3629.270	79	9	9	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190633	10.1371/journal.pone.0190633	http://dx.doi.org/10.1371/journal.pone.0190633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342169	gold, Green Published			2022-12-26	WOS:000422653800028
J	Dreyer-Andersen, N; Almeida, AS; Jensen, P; Kamand, M; Okarmus, J; Rosenberg, T; Friis, SD; Serrano, AM; Blaabjerg, M; Kristensen, BW; Skrydstrup, T; Gramsbergen, JB; Vieira, HLA; Meyer, M				Dreyer-Andersen, Nanna; Almeida, Ana Sofia; Jensen, Pia; Kamand, Morad; Okarmus, Justyna; Rosenberg, Tine; Friis, Stig During; Serrano, Alberto Martinez; Blaabjerg, Morten; Kristensen, Bjarne Winther; Skrydstrup, Troels; Gramsbergen, Jan Bert; Vieira, Helena L. A.; Meyer, Morten			Intermittent, low dose carbon monoxide exposure enhances survival and dopaminergic differentiation of human neural stem cells	PLOS ONE			English	Article							HEME OXYGENASE 1; FETAL NIGRAL TRANSPLANTATION; ENDOTHELIAL GROWTH-FACTOR; PARKINSONS-DISEASE; NEURONAL DIFFERENTIATION; INFLAMMATORY RESPONSE; MOLECULE-2 CORM-2; PROLIFERATION; ACTIVATION; PROTECTION	Exploratory studies using human fetal tissue have suggested that intrastriatal transplantation of dopaminergic neurons may become a future treatment for patients with Parkinson's disease. However, the use of human fetal tissue is compromised by ethical, regulatory and practical concerns. Human stem cells constitute an alternative source of cells for transplantation in Parkinson's disease, but efficient protocols for controlled dopaminergic differentiation need to be developed. Short-term, low-level carbon monoxide (CO) exposure has been shown to affect signaling in several tissues, resulting in both protection and generation of reactive oxygen species. The present study investigated the effect of CO produced by a novel CO-releasing molecule on dopaminergic differentiation of human neural stem cells. Short-term exposure to 25 ppm CO at days 0 and 4 significantly increased the relative content of beta-tubulin III-immunoreactive immature neurons and tyrosine hydroxylase expressing catecholaminergic neurons, as assessed 6 days after differentiation. Also the number of microtubule associated protein 2-positive mature neurons had increased significantly. Moreover, the content of apoptotic cells (Caspase3) was reduced, whereas the expression of a cell proliferation marker (Ki67) was left unchanged. Increased expression of hypoxia inducible factor-l alpha and production of reactive oxygen species (ROS) in cultures exposed to CO may suggest a mechanism involving mitochondrial alterations and generation of ROS. In conclusion, the present procedure using controlled, short-term CO exposure allows efficient dopaminergic differentiation of human neural stem cells at low cost and may as such be useful for derivation of cells for experimental studies and future development of donor cells for transplantation in Parkinson's disease.	[Dreyer-Andersen, Nanna; Jensen, Pia; Kamand, Morad; Okarmus, Justyna; Gramsbergen, Jan Bert; Meyer, Morten] Univ Southern Denmark, Inst Mol Med, Dept Neurobiol Res, Odense, Denmark; [Almeida, Ana Sofia; Vieira, Helena L. A.] IBET, Oeiras, Portugal; [Almeida, Ana Sofia] Inst Tecnol Quim & Biol, Oeiras, Portugal; [Almeida, Ana Sofia; Vieira, Helena L. A.] Univ Nova Lisboa, Fac Ciencia Med, NOVA Med Sch, CEDOC, Lisbon, Portugal; [Rosenberg, Tine; Kristensen, Bjarne Winther] Odense Univ Hosp, Dept Pathol, Odense, Denmark; [Rosenberg, Tine; Kristensen, Bjarne Winther] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Friis, Stig During; Skrydstrup, Troels] Aarhus Univ, Dept Chem, Ctr Insoluble Prot Struct InSPIN, Aarhus, Denmark; [Serrano, Alberto Martinez] Univ Autonoma Madrid, Dept Mol Biol, CSIC, Campus Cantoblanco, Madrid, Spain; [Serrano, Alberto Martinez] Univ Autonoma Madrid, Ctr Mol Biol Severo Ochoa, CSIC, Campus Cantoblanco, Madrid, Spain; [Blaabjerg, Morten; Meyer, Morten] Zealand Univ Hosp, Dept Neurol, Roskilde, Denmark	University of Southern Denmark; Universidade Nova de Lisboa; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Aarhus University; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Meyer, M (corresponding author), Univ Southern Denmark, Inst Mol Med, Dept Neurobiol Res, Odense, Denmark.; Meyer, M (corresponding author), Zealand Univ Hosp, Dept Neurol, Roskilde, Denmark.	mmeyer@health.sdu.dk	Kristensen, Bjarne Winther/AAX-5491-2020; Kristensen, Bjarne Winther/A-6690-2012; Vieira, Helena/AAZ-9562-2021	Kristensen, Bjarne Winther/0000-0002-6352-0826; Kristensen, Bjarne Winther/0000-0002-6352-0826; Blaabjerg, Morten/0000-0001-6007-1861; Friis, Stig/0000-0003-4330-5173; Vieira, Helena/0000-0001-9415-3742; Rosenberg, Tine/0000-0002-7874-5526	Lundbeck Foundation; Danish Parkinson Association; Danish National Research Foundation [DNRF118]	Lundbeck Foundation(Lundbeckfonden); Danish Parkinson Association; Danish National Research Foundation(Danmarks Grundforskningsfond)	This research was supported by the Lundbeck Foundation (MM, NDA), the Danish Parkinson Association (MM), I MK Almene Fond (MM), and the Danish National Research Foundation (TS, SF; grant no. DNRF118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154781; Almeida AS, 2012, J BIOL CHEM, V287, P10761, DOI 10.1074/jbc.M111.306738; Bani-Hani MG, 2006, J PHARMACOL EXP THER, V318, P1315, DOI 10.1124/jpet.106.104729; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P3784, DOI 10.1167/iovs.09-4894; Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3; Brookes PS, 2002, FREE RADICAL BIO MED, V33, P755, DOI 10.1016/S0891-5849(02)00901-2; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Brundin P, 2000, BRAIN, V123, P1380, DOI 10.1093/brain/123.7.1380; Butterfield DA, 2012, INT J NEUROPSYCHOPH, V15, P981, DOI 10.1017/S1461145711001118; Caumartin Y, 2011, KIDNEY INT, V79, P1080, DOI 10.1038/ki.2010.542; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen ZY, 2007, J BIOL CHEM, V282, P25875, DOI 10.1074/jbc.M701988200; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; Choi YK, 2016, NAT MED, V22, P1335, DOI 10.1038/nm.4188; Choi YK, 2010, J BIOL CHEM, V285, P32116, DOI 10.1074/jbc.M110.131284; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Cochen V, 2003, MOVEMENT DISORD, V18, P928, DOI 10.1002/mds.10463; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Eells JB, 2001, J NEUROSCI RES, V64, P322, DOI 10.1002/jnr.1082; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Fagone P, 2011, CLIN EXP IMMUNOL, V163, P368, DOI 10.1111/j.1365-2249.2010.04303.x; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Freed CR, 1990, NEW ENGL J MED, V344, P710; Friis SD, 2011, J AM CHEM SOC, V133, P18114, DOI 10.1021/ja208652n; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Garcia-Gallego S, 2014, ANGEW CHEM INT EDIT, V53, P9712, DOI 10.1002/anie.201311225; Gomez-Nicola D, 2008, GLIA, V56, P494, DOI 10.1002/glia.20628; Gomez-Nicola D, 2011, MOL BIOL CELL, V22, P1960, DOI 10.1091/mbc.E11-01-0053; Gramsbergen JB, 2002, BRAIN RES, V935, P47, DOI 10.1016/S0006-8993(02)02451-4; Hagell P, 1999, BRAIN, V122, P1121, DOI 10.1093/brain/122.6.1121; Hashemi SB, 2008, EUR J APPL PHYSIOL, V104, P95, DOI 10.1007/s00421-008-0776-9; Hauser RA, 1999, ARCH NEUROL-CHICAGO, V56, P179, DOI 10.1001/archneur.56.2.179; Hervera A, 2013, PSYCHOPHARMACOLOGY, V228, P463, DOI 10.1007/s00213-013-3053-5; Hoffrogge R, 2006, PROTEOMICS, V6, P1833, DOI 10.1002/pmic.200500556; Huang LE, 1999, J BIOL CHEM, V274, P9038, DOI 10.1074/jbc.274.13.9038; Huang YS, 2009, BRAIN RES, V1304, P38, DOI 10.1016/j.brainres.2009.09.009; Hung SY, 2008, MOL PHARMACOL, V74, P1564, DOI 10.1124/mol.108.048611; Jensen P, 2007, J NEUROSCI RES, V85, P1884, DOI 10.1002/jnr.21327; Jiang XH, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-132; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Kim JY, 2003, J NEUROCHEM, V85, P1443, DOI 10.1046/j.1471-4159.2003.01780.x; Kim SJ, 2010, J ENDODONT, V36, P1326, DOI 10.1016/j.joen.2010.04.011; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; Krabbe C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096465; Krabbe C, 2009, J NEUROCHEM, V110, P1908, DOI 10.1111/j.1471-4159.2009.06281.x; Larsen TR, 2008, EUR J NEUROSCI, V28, P569, DOI 10.1111/j.1460-9568.2008.06354.x; Leffler CW, 2011, AM J PHYSIOL-HEART C, V301, pH1, DOI 10.1152/ajpheart.00230.2011; Lin HH, 2011, J BIOL CHEM, V286, P3829, DOI 10.1074/jbc.M110.168831; Lindvall O, 2011, NEUROTHERAPEUTICS, V8, P539, DOI 10.1007/s13311-011-0069-6; Liste I, 2007, CELL DEATH DIFFER, V14, P1880, DOI 10.1038/sj.cdd.4402205; Masini E, 2008, FASEB J, V22, P3380, DOI 10.1096/fj.08-107110; Mendez I, 2000, J NEUROSURG, V92, P863, DOI 10.3171/jns.2000.92.5.0863; Meyer AK, 2010, J NEUROL SCI, V289, P93, DOI 10.1016/j.jns.2009.08.024; Morita T, 1997, J BIOL CHEM, V272, P32804, DOI 10.1074/jbc.272.52.32804; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Motterlini R, 2004, FASEB J; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Nakao A, 2003, AM J PATHOL, V163, P1587, DOI 10.1016/S0002-9440(10)63515-8; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Opii W, 2008, NEUROBIOL AGING, V29, P51, DOI 10.1016/j.neurobiolaging.2006.09.012; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Parfenova H, 2003, J CEREBR BLOOD F MET, V23, P190, DOI 10.1097/01.WCB.000004823561824.C4; Parfenova H, 2012, J CEREBR BLOOD F MET, V32, P1024, DOI 10.1038/jcbfm.2012.13; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Petrache I, 2000, AM J PHYSIOL-LUNG C, V278, pL312, DOI 10.1152/ajplung.2000.278.2.L312; Queiroga CSF, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/749845; Queiroga CSF, 2015, BRIT J PHARMACOL, V172, P1533, DOI 10.1111/bph.12729; Queiroga CSF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042632; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rodriguez-Oroz MC, 2009, LANCET NEUROL, V8, P1128, DOI 10.1016/S1474-4422(09)70293-5; Ryan MJ, 2006, PHARMACOL RES, V54, P24, DOI 10.1016/j.phrs.2006.01.012; Ryter SW, 2013, KOREAN J INTERN MED, V28, P123, DOI 10.3904/kjim.2013.28.2.123; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Schallner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060672; Song RP, 2004, J IMMUNOL, V172, P1220, DOI 10.4049/jimmunol.172.2.1220; Soni H, 2011, TOXICOL APPL PHARM, V253, P70, DOI 10.1016/j.taap.2011.03.013; Soni H, 2010, VASC PHARMACOL, V53, P68, DOI 10.1016/j.vph.2010.04.002; Stein AB, 2012, J MOL CELL CARDIOL, V52, P228, DOI 10.1016/j.yjmcc.2011.11.005; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Studer L, 2000, J NEUROSCI, V20, P7377; Sutherland BA, 2009, NEUROSCI RES, V65, P326, DOI 10.1016/j.neures.2009.08.007; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; Vieira HLA, 2008, J NEUROCHEM, V107, P375, DOI 10.1111/j.1471-4159.2008.05610.x; Vieira HLA, 2011, PROG NEUROBIOL, V93, P444, DOI 10.1016/j.pneurobio.2011.01.007; Villa A, 2009, EXP CELL RES, V315, P1860, DOI 10.1016/j.yexcr.2009.03.011; Wang B, 2011, STROKE, V42, P2605, DOI 10.1161/STROKEAHA.110.607101; Wang N, 2007, J CELL BIOCHEM, V100, P1548, DOI 10.1002/jcb.21139; Winkler C, 2005, TRENDS NEUROSCI, V28, P86, DOI 10.1016/j.tins.2004.12.006; Yabluchanskiy A, 2012, CRIT CARE MED, V40, P544, DOI 10.1097/CCM.0b013e31822f0d64; Yu S, 2006, NEUROSCIENCE, V141, P817, DOI 10.1016/j.neuroscience.2006.02.080; Zeynalov E, 2009, NEUROBIOL DIS, V35, P264, DOI 10.1016/j.nbd.2009.05.010; Zimmermann A, 2007, AM J PHYSIOL-HEART C, V293, pH2501, DOI 10.1152/ajpheart.00354.2007	97	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191207	10.1371/journal.pone.0191207	http://dx.doi.org/10.1371/journal.pone.0191207			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338033	gold, Green Published, Green Submitted			2022-12-26	WOS:000422652700040
J	Mason, JS; Wileman, T; Chapman, T				Mason, Janet S.; Wileman, Tom; Chapman, Tracey			Lifespan extension without fertility reduction following dietary addition of the autophagy activator Torinl in Drosophila melanogaster	PLOS ONE			English	Article							MTOR INHIBITORS; FRUIT-FLY; RAPAMYCIN; SPERMIDINE; LONGEVITY; FEMALE; RESTRICTION; RESVERATROL; TARGET; MALES	Autophagy is a highly conserved mechanism for cellular repair that becomes progressively down-regulated during normal ageing. Hence, manipulations that activate autophagy could increase lifespan. Previous reports show that manipulations to the autophagy pathway can result in longevity extension in yeast, flies, worms and mammals. Under standard nutrition, autophagy is inhibited by the nutrient sensing kinase Target of Rapamycin (TOR). Therefore, manipulations of TOR that increase autophagy may offer a mechanism for extending lifespan. Ideally, such manipulations should be specific and minimise off-target effects, and it is important to discover additional methods for 'clean' lifespan manipulation. Here we report an initial study into the effect of up-regulating autophagy on lifespan and fertility in Drosophila melanogasterby dietary addition of Torin1. Activation of autophagy using this selective TOR inhibitor was associated with significantly increased lifespan in both sexes. Torinl induced a dose-dependent increase in lifespan in once-mated females. There was no evidence of a trade-off between longevity and fecundity or fertility. Torin1-fed females exhibited significantly elevated fecundity, but also elevated egg infertility, resulting in no net change in overall fertility. This supports the idea that lifespan can be extended without tradeoffs in fertility and suggest that Torin1 may be a useful tool with which to pursue anti-ageing research.	[Mason, Janet S.; Chapman, Tracey] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich, Norfolk, England; [Wileman, Tom] Univ East Anglia, Norwich Med Sch, Norwich Res Pk, Norwich, Norfolk, England	University of East Anglia; University of East Anglia	Chapman, T (corresponding author), Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich, Norfolk, England.	tracey.chapman@uea.ac.uk	Chapman, Tracey/E-5100-2011		Research into Ageing and Age UK (RIA) [363]; NERC [NE/K004697/1]; Natural Environment Research Council [NE/K004697/1] Funding Source: researchfish	Research into Ageing and Age UK (RIA); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by Research into Ageing and Age UK (RIA:363 PhD studentship to JSM, TW, Dylan R Edwards and TC) and the NERC (NE/K004697/1 to TC).	Agarwal B, 2011, ANN NY ACAD SCI, V1215, P138, DOI 10.1111/j.1749-6632.2010.05850.x; Albert V, 2015, CURR OPIN CELL BIOL, V33, P55, DOI 10.1016/j.ceb.2014.12.001; Bauer MA, 2013, CELL CYCLE, V12, P346, DOI 10.4161/cc.23199; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Carey JR, 2008, AGING CELL, V7, P470, DOI 10.1111/j.1474-9726.2008.00389.x; Carr TD, 2015, CARCINOGENESIS, V36, P487, DOI 10.1093/carcin/bgv012; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; De Loof A, 2011, J INSECT PHYSIOL, V57, P1, DOI 10.1016/j.jinsphys.2010.08.018; Dean JM, OECOLOGIA, P385; Dou XW, 2017, AGING CELL, V16, P825, DOI 10.1111/acel.12617; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Evans DS, 2011, AGEING RES REV, V10, P225, DOI 10.1016/j.arr.2010.04.001; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Galluzzi L, 2017, M S-MED SCI, V33, P246, DOI 10.1051/medsci/20173303010; Gelino S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006135; Gonzalez A, 2017, EMBO J, V36, P397, DOI 10.15252/embj.201696010; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hands SL, 2009, AGING-US, V1, P586, DOI 10.18632/aging.100070; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hsieh PN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00899-5; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Laplante M, 2011, COLD SPRING HARB PER, P1; Leontieva OV, 2016, AGING-US, V8, P3535, DOI 10.18632/aging.101155; Liu QS, 2012, J BIOL CHEM, V287, P9742, DOI 10.1074/jbc.M111.304485; Liu QS, 2011, J MED CHEM, V54, P1473, DOI 10.1021/jm101520v; Magwere T, 2004, J GERONTOL A-BIOL, V59, P3; Mehrpour M, 2010, AM J PHYSIOL-CELL PH, V298, pC776, DOI 10.1152/ajpcell.00507.2009; Minnerly J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006764; Minois N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.139; Moorman NJ, 2010, J VIROL, V84, P5260, DOI 10.1128/JVI.02733-09; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Morselli E, 2009, AGING-US, V1, P961, DOI 10.18632/aging.100110; OLIVER B, 1990, GENETICS, V125, P535; PARTRIDGE L, 1986, J INSECT PHYSIOL, V32, P925, DOI 10.1016/0022-1910(86)90140-X; PARTRIDGE L, 1990, J INSECT PHYSIOL, V36, P419, DOI 10.1016/0022-1910(90)90059-O; PARTRIDGE L, 1985, J INSECT PHYSIOL, V31, P393, DOI 10.1016/0022-1910(85)90084-8; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Piper MDW, 2005, EXP GERONTOL, V40, P857, DOI 10.1016/j.exger.2005.06.013; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; SPSS, 2009, PASW STAT WIND; Team RC, 2015, R LANG ENV STAT COMP; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vogel KR, 2016, J INHERIT METAB DIS, V39, P877, DOI 10.1007/s10545-016-9959-4; Wang T, 2009, J CELL BIOL, V186, P703, DOI 10.1083/jcb.200904090; Yang S, 2015, AGING CELL, V14, P1024, DOI 10.1111/acel.12371; ZWAAN BJ, 1991, HEREDITY, V66, P29, DOI 10.1038/hdy.1991.4	50	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190105	10.1371/journal.pone.0190105	http://dx.doi.org/10.1371/journal.pone.0190105			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329306	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000419954100012
J	Chauhan, AS; Prinja, S; Ghoshal, S; Verma, R; Oinam, AS				Chauhan, Akashdeep Singh; Prinja, Shankar; Ghoshal, Sushmita; Verma, Roshan; Oinam, Arun S.			Cost of treatment for head and neck cancer in India	PLOS ONE			English	Article							MODULATED RADIATION-THERAPY; AVAILABILITY; BURDEN	There are no published data on the cost of cancer treatment for guiding reimbursement decisions in India. The present study was designed to estimate the cost of treating head and neck cancer (HNC) with the aim of determining package rates. The present study was undertaken in the Departments of Radiotherapy and Otolaryngology of a large tertiary care hospital in North India. Economic health system costs incurred were assessed using a bottom-up methodology. Data on all resources-capital or recurrent, incurred on the delivery of HNC treatment were collected from April 2014 to March 2015. Following the cost-of-illness approach, patients were interviewed to elicit out-of-pocket (OOP) expenditure. A total of INR 40,993,017 (USD 0.67 million) was spent on radiotherapy care for treating HNC during 1 year. Salaries constituted the major component (42.6%) of this cost, followed by equipment/furniture (29%), space rent (20.7%), overheads and consumables (7.7%). In addition, INR 47,191 (USD 773) per HNC patient was spent on the surgery. Furthermore, patients spent an average amount ranging from INR 12,575 (USD 206) to INR 65,257 (USD 1069) on the different treatment therapies. In terms of package rates, cobalt radiotherapy alone was the cheapest (INR 38,714, USD 634), while intensity modulated radiotherapy (IMRT) was most expensive (INR 192,914, USD 3161). The estimates from the present study could be used for developing package rates under various publicly financed health insurance schemes as well as for the planning for creation of new cancer centres.	[Chauhan, Akashdeep Singh; Prinja, Shankar] Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Ghoshal, Sushmita; Oinam, Arun S.] Postgrad Inst Med Educ & Res, Dept Radiotherapy, Chandigarh, India; [Verma, Roshan] Postgrad Inst Med Educ & Res, Dept Otolaryngol, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Prinja, S (corresponding author), Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.	shankarprinja@gmail.com		Chauhan, Akashdeep Singh/0000-0001-6791-2221				Bang A, 2011, HIGH LEVEL EXPERT GR; Chapko MK, 2009, HEALTH ECON, V18, P1188, DOI 10.1002/hec.1422; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Ezzell GA, 2003, MED PHYS, V30, P2089, DOI 10.1118/1.1591194; Ferlay J., 2015, IARC CANCERBASE; Government of India Ministry of Health and Family Welfare National Programme For Prevention and Control of Cancer, DIAB CARD DIS STROK; Government of India Ministry of Health and Fanily Welfare Directorate General of Health Services Central Bureau of Health Intelligence, 2013, HLTH HLTH PROF; Government of India Ministry of Health and Fanily Welfare Directorate General of Health Services Central Bureau of Health Intelligence, 2009, HLTH HLTH PROF; Government of Punjab Department of Health and Family Welfare, MUKH MANTR PUNJ CANC; Kotwani A, 2007, INDIAN J MED RES, V125, P645; Kouloulias V, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/401261; Mahal A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071853; Mallath MK, 2014, LANCET ONCOL, V15, pE205, DOI 10.1016/S1470-2045(14)70115-9; Marta GN, 2014, RADIOTHER ONCOL, V110, P9, DOI 10.1016/j.radonc.2013.11.010; Mohanti BK., 2011, ESTIMATING EC BURDEN; Mondal S., 2010, CATASTROPHIC OUT OF; Murthy NS, 2008, ASIAN PAC J CANCER P, V9, P671; Prinja S, 2017, PHARMACOECONOMICS OP; Prinja S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160986; Prinja S, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070673; Prinja S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091781; Purdy JA, 1999, PRACTICAL GUIDE 3 D; Rice D P, 2000, Inj Prev, V6, P177, DOI 10.1136/ip.6.3.177; Richman BD, CONCENTRATION HLTH C; Sangwan A, 2017, COST TRAUMA CARE SEC; Sheets NC, 2014, AM J CLIN ONCOL-CANC, V37, P539, DOI 10.1097/COC.0b013e318282a850; Smith BD, 2011, JNCI-J NATL CANCER I, V103, P798, DOI 10.1093/jnci/djr100; Torrance GW, 1987, METHODS EC EVALUATIO; Van Dyk J, 1999, MODERN TECHNOLOGY RA; WHO, 2003, MAKING CHOICES HLTH	30	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191132	10.1371/journal.pone.0191132	http://dx.doi.org/10.1371/journal.pone.0191132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324861	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400119
J	Jung, YS; Park, CH; Kim, NH; Park, JH; Park, DI; Sohn, CI				Jung, Yoon Suk; Park, Chan Hyuk; Kim, Nam Hee; Park, Jung Ho; Park, Dong Il; Sohn, Chong Il			Clinical risk stratification model for advanced colorectal neoplasia in persons with negative fecal immunochemical test results	PLOS ONE			English	Article							CANCER INCIDENCE; COLONOSCOPY; ATHEROSCLEROSIS; SIGMOIDOSCOPY; POPULATION; INDEX; ASIA	Objectives The fecal immunochemical test (FIT) has low sensitivity for detecting advanced colorectal neoplasia (ACRN); thus, a considerable portion of FIT-negative persons may have ACRN. We aimed to develop a risk-scoring model for predicting ACRN in FIT-negative persons. Materials and methods We reviewed the records of participants aged >= 40 years who underwent a colonoscopy and FIT during a health check-up. We developed a risk-scoring model for predicting ACRN in FIT-negative persons. Results Of 11,873 FIT-negative participants, 255 (2.1%) had ACRN. On the basis of the multivariable logistic regression model, point scores were assigned as follows among FIT-negative persons: age (per year from 40 years old), 1 point; current smoker, 10 points; overweight, 5 points; obese, 7 points; hypertension, 6 points; old cerebrovascular attack (CVA), 15 points. Although the proportion of ACRN in FIT-negative persons increased as risk scores increased (from 0.6% in the group with 0-4 points to 8.1% in the group with 35-39 points), it was significantly lower than that in FIT-positive persons (14.9%). However, there was no statistical difference between the proportion of ACRN in FIT-negative persons with >= 40 points and in FIT-positive persons (10.5% vs. 14.9%, P = 0.321). Conclusions FIT-negative persons may need to undergo screening colonoscopy if they clinically have a high risk of ACRN. The scoring model based on age, smoking habits, overweight or obesity, hypertension, and old CVA may be useful in selecting and prioritizing FIT-negative persons for screening colonoscopy.	[Jung, Yoon Suk; Park, Jung Ho; Park, Dong Il; Sohn, Chong Il] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Gastroenterol,Dept Internal Med, Seoul, South Korea; [Park, Chan Hyuk] Hanyang Univ, Coll Med, Guri Hosp, Dept Internal Med, Guri, South Korea; [Kim, Nam Hee] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Prevent HealthCare, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Hanyang University; Sungkyunkwan University (SKKU); Samsung Medical Center	Park, CH (corresponding author), Hanyang Univ, Coll Med, Guri Hosp, Dept Internal Med, Guri, South Korea.	yesable7@gmail.com	Park, Chan Hyuk/I-1794-2016; Jung, Yoon Suk/AAB-7998-2022	Park, Chan Hyuk/0000-0003-3824-3481; Jung, Yoon Suk/0000-0002-1963-7170	National Research Foundation of Korea(NRF) [NRF-2017R1C1B5015928]	National Research Foundation of Korea(NRF)(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea(NRF), grant NRF-2017R1C1B5015928 (htrps://www.nrf.re.kr/eng/main). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Carroll MRR, 2014, CLIN BIOCHEM, V47, P921, DOI 10.1016/j.clinbiochem.2014.04.019; de Wijkerslooth TR, 2012, AM J GASTROENTEROL, V107, P1570, DOI 10.1038/ajg.2012.249; Erichsen R, 2013, CANCER EPIDEM BIOMAR, V22, P1994, DOI 10.1158/1055-9965.EPI-13-0444; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fraser CG, 2012, JNCI-J NATL CANCER I, V104, P810, DOI 10.1093/jnci/djs190; Graser A, 2009, GUT, V58, P241, DOI 10.1136/gut.2008.156448; Hsu WC, 2015, DIABETES CARE, V38, P150, DOI 10.2337/dc14-2391; Hull M, 2010, DIGESTION, V81, P16, DOI 10.1159/000222789; Kim DH, 2015, J CLIN GASTROENTEROL, V49, P41, DOI 10.1097/MCG.0000000000000102; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Lin JS, 2016, JAMA-J AM MED ASSOC, V315, P2576, DOI 10.1001/jama.2016.3332; Lin OS, 2014, INTEST RES, V12, P268, DOI 10.5217/ir.2014.12.4.268; Moons KGM, 2002, J CLIN EPIDEMIOL, V55, P1054, DOI 10.1016/S0895-4356(02)00453-5; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Ng SC, 2013, BRIT MED BULL, V105, P29, DOI 10.1093/bmb/lds040; Park CH, 2015, DIGEST DIS SCI, V60, P38, DOI 10.1007/s10620-014-3288-y; Prizment AE, 2011, CANCER EPIDEM BIOMAR, V20, P297, DOI 10.1158/1055-9965.EPI-10-1146; Rodu B, 2009, PUBLIC HEALTH, V123, P598, DOI 10.1016/j.puhe.2009.07.014; Schroy PC, 2015, AM J GASTROENTEROL, V110, P1062, DOI 10.1038/ajg.2015.146; Soweid AM, 2010, ENDOSCOPY, V42, P633, DOI 10.1055/s-0029-1244236; Watanabe Y, 2005, J EPIDEMIOL, V15, pS168, DOI 10.2188/jea.15.S168; Wildman RP, 2004, AM J CLIN NUTR, V80, P1129, DOI 10.1093/ajcn/80.5.1129; Wong MCS, 2015, CLIN GASTROENTEROL H, V13, P1472, DOI 10.1016/j.cgh.2015.02.021; Yeoh KG, 2011, GUT, V60, P1236, DOI 10.1136/gut.2010.221168	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191125	10.1371/journal.pone.0191125	http://dx.doi.org/10.1371/journal.pone.0191125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324874	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400118
J	Chiang, S; Vankov, ER; Yeh, HJ; Guindani, M; Vannucci, M; Haneef, Z; Stern, JM				Chiang, Sharon; Vankov, Emilian R.; Yeh, Hsiang J.; Guindani, Michele; Vannucci, Marina; Haneef, Zulfi; Stern, John M.			Temporal and spectral characteristics of dynamic functional connectivity between resting-state networks reveal information beyond static connectivity	PLOS ONE			English	Article							HIPPOCAMPAL NETWORKS; MOTION CORRECTION; BRAIN; MEMORY; FMRI; ANTICORRELATIONS; SCHIZOPHRENIA; ORGANIZATION; ACTIVATION; REGRESSION	Estimation of functional connectivity (FC) has become an increasingly powerful tool for investigating healthy and abnormal brain function. Static connectivity, in particular, has played a large part in guiding conclusions from the majority of resting-state functional MRI studies. However, accumulating evidence points to the presence of temporal fluctuations in FC, leading to increasing interest in estimating FC as a dynamic quantity. One central issue that has arisen in this new view of connectivity is the dramatic increase in complexity caused by dynamic functional connectivity (dFC) estimation. To computationally handle this increased complexity, a limited set of dFC properties, primarily the mean and variance, have generally been considered. Additionally, it remains unclear how to integrate the increased information from dFC into pattern recognition techniques for subject-level prediction. In this study, we propose an approach to address these two issues based on a large number of previously unexplored temporal and spectral features of dynamic functional connectivity. A Generalized Autoregressive Conditional Heteroskedasticity (GARCH) model is used to estimate time-varying patterns of functional connectivity between resting-state networks. Time-frequency analysis is then performed on dFC estimates, and a large number of previously unexplored temporal and spectral features drawn from signal processing literature are extracted for dFC estimates. We apply the investigated features to two neurologic populations of interest, healthy controls and patients with temporal lobe epilepsy, and show that the proposed approach leads to substantial increases in predictive performance compared to both traditional estimates of static connectivity as well as current approaches to dFC. Variable importance is assessed and shows that there are several quantities that can be extracted from dFC signal which are more informative than the traditional mean or variance of dFC. This work illuminates many previously unexplored facets of the dynamic properties of functional connectivity between resting-state networks, and provides a platform for dynamic functional connectivity analysis that facilitates its usage as an investigative measure for healthy as well as abnormal brain function.	[Chiang, Sharon; Vankov, Emilian R.; Vannucci, Marina] Rice Univ, Dept Stat, Houston, TX 77251 USA; [Chiang, Sharon] Baylor Coll Med, Sch Med, Houston, TX 77030 USA; [Vankov, Emilian R.] Rice Univ, Baker Inst Publ Policy, Houston, TX 77251 USA; [Yeh, Hsiang J.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Guindani, Michele] Uniers Calif Irvine, Dept Stat, Irvine, CA USA; [Haneef, Zulfi] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Haneef, Zulfi] Michael E DeBakey VA Med Ctr, Neurol Care Line, Houston, TX USA	Rice University; Baylor College of Medicine; Rice University; University of California System; University of California Los Angeles; Baylor College of Medicine; Baylor College of Medicine	Chiang, S (corresponding author), Rice Univ, Dept Stat, Houston, TX 77251 USA.; Chiang, S (corresponding author), Baylor Coll Med, Sch Med, Houston, TX 77030 USA.	schiang@bcm.edu	Vannucci, Marina/I-8439-2014; Guindani, Michele/F-1301-2017	Vannucci, Marina/0000-0002-7360-5321; Guindani, Michele/0000-0002-6363-9907; Chiang, Sharon/0000-0002-4548-4550; Stern, John/0000-0002-3549-1642	National Library of Medicine Training Fellowship in Biomedical Informatics, Gulf Coast Consortia for Quantitative Biomedical Sciences [2T15-LM007093-21]; National Institute of Health [5T32-CA096520-07]; NSF [SES-1659921, SES-1659925]; Epilepsy Foundation of America [244976]; Baylor College of Medicine Computational and Integrative Biomedical Research Center (CIBR) Seed Grant Awards; Baylor College of Medicine Junior Faculty Seed Funding Program; NIH-NINDS [NS044936]; Leff Family Foundation; NATIONAL CANCER INSTITUTE [T32CA096520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS044936] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007093] Funding Source: NIH RePORTER	National Library of Medicine Training Fellowship in Biomedical Informatics, Gulf Coast Consortia for Quantitative Biomedical Sciences; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Epilepsy Foundation of America; Baylor College of Medicine Computational and Integrative Biomedical Research Center (CIBR) Seed Grant Awards; Baylor College of Medicine Junior Faculty Seed Funding Program; NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Leff Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Funding/support provided by (1) the National Library of Medicine Training Fellowship in Biomedical Informatics, Gulf Coast Consortia for Quantitative Biomedical Sciences (Grant #2T15-LM007093-21) (SC); (2) the National Institute of Health (Grant #5T32-CA096520-07) (SC); (3) NSF SES-1659921 (MG, MV); (4) NSF SES-1659925 (MG, MV); (5) The Epilepsy Foundation of America (award ID 244976) (ZH); (6) Baylor College of Medicine Computational and Integrative Biomedical Research Center (CIBR) Seed Grant Awards (ZH); (7) Baylor College of Medicine Junior Faculty Seed Funding Program Grant (ZH); (8) NIH-NINDS K23 Grant NS044936 (JMS); (9) The Leff Family Foundation (JMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding/support for this research was provided by (1) the National Library of Medicine Training Fellowship in Biomedical Informatics, Gulf Coast Consortia for Quantitative Biomedical Sciences (Grant #2T15-LM007093-21) (SC); (2) the National Institute of Health (Grant #5T32-CA096520-07) (SC); (3) the National Science Foundation (NSF SES-1659921, NSF SES-1659925) (MG, MV); (4) The Epilepsy Foundation of America (award ID 244976)(ZH); (5) Baylor College of Medicine Computational and Integrative Biomedical Research Center (CIBR) Seed Grant Awards (ZH); (6) Baylor College of Medicine Junior Faculty Seed Funding Program Grant (ZH); (7) NIH-NINDS K23 Grant NS044936 (JMS); (8) The Leff Family Foundation (JMS). We want to thank the three referees whose insightful comments have led to a much improved version of the paper.	Alessio A, 2006, EPILEPSY BEHAV, V8, P593, DOI 10.1016/j.yebeh.2006.01.007; Allen EA, 2018, BRAIN TOPOGR, V31, P101, DOI 10.1007/s10548-017-0546-2; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bell B, 2011, NAT REV NEUROL, V7, P154, DOI 10.1038/nrneurol.2011.3; Benjamini Y, 2005, J AM STAT ASSOC, V100, P71, DOI 10.1198/016214504000001907; Boubela RN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00168; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Chang EF, 2015, J NEUROSURG, V122, P250, DOI 10.3171/2014.10.JNS132647; Chiang S, 2017, NEUROL INDIA, V65, P25; Chiang S, 2016, NEUROIMAGE, V125, P601, DOI 10.1016/j.neuroimage.2015.10.070; Chiang S, 2014, CLIN NEUROPHYSIOL, V125, P1295, DOI 10.1016/j.clinph.2014.04.004; Constable RT, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00039; de Campos BM, 2016, HUM BRAIN MAPP, V37, P3137, DOI 10.1002/hbm.23231; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; DiCiccio TJ, 1996, STAT SCI, V11, P189; Engle R, 2002, J BUS ECON STAT, V20, P339, DOI 10.1198/073500102288618487; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gonzalez-Castillo J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00138; Gotman J, 1997, ELECTROEN CLIN NEURO, V103, P356, DOI 10.1016/S0013-4694(97)00003-9; Haneef Z, 2014, EPILEPSIA, V55, P137, DOI 10.1111/epi.12476; Hindriks R, 2016, NEUROIMAGE, V127, P242, DOI 10.1016/j.neuroimage.2015.11.055; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Kaiser RH, 2016, NEUROPSYCHOPHARMACOL, V41, P1822, DOI 10.1038/npp.2015.352; Kang J, 2011, NEUROIMAGE, V56, P1222, DOI 10.1016/j.neuroimage.2011.03.033; Keller JB, 2015, CORTEX, V64, P271, DOI 10.1016/j.cortex.2014.12.001; Kudela M, 2017, NEUROIMAGE, V149, P165, DOI 10.1016/j.neuroimage.2017.01.056; Lindquist MA, 2014, NEUROIMAGE, V101, P531, DOI 10.1016/j.neuroimage.2014.06.052; Ma S, 2014, NEUROIMAGE, V90, P196, DOI 10.1016/j.neuroimage.2013.12.063; McCormick C, 2014, NEUROIMAGE-CLIN, V5, P188, DOI 10.1016/j.nicl.2014.05.008; McIntosh AR, 2000, NEURAL NETWORKS, V13, P861, DOI 10.1016/S0893-6080(00)00059-9; Meda SA, 2012, BIOL PSYCHIAT, V71, P881, DOI 10.1016/j.biopsych.2012.01.025; Milner B, 1972, Clin Neurosurg, V19, P421; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Qin J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00418; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Schultz DH, 2016, J NEUROSCI, V36, P8551, DOI 10.1523/JNEUROSCI.0358-16.2016; Shen K, 2015, P NATL ACAD SCI USA, V112, P6473, DOI 10.1073/pnas.1503436112; Shen K, 2015, J NEUROSCI, V35, P5579, DOI 10.1523/JNEUROSCI.4903-14.2015; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stern JM, 2011, CLIN NEUROPHYSIOL, V122, P1382, DOI 10.1016/j.clinph.2010.12.049; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Tzanetakis G, 2002, IEEE T SPEECH AUDI P, V10, P293, DOI 10.1109/TSA.2002.800560; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Van Oort E, 2012, RESTING STATE NETWOR; Vannest J, 2008, EPILEPSY BEHAV, V12, P410, DOI 10.1016/j.yebeh.2007.11.012; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Vlooswijk MCG, 2010, LANCET NEUROL, V9, P1018, DOI 10.1016/S1474-4422(10)70180-0; Voets NL, 2014, J NEUROSCI, V34, P4920, DOI 10.1523/JNEUROSCI.4281-13.2014; Warnick R, J AM STAT A IN PRESS; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Xiang HD, 2009, CEREB CORTEX; Yaesoubi M, 2015, NEUROIMAGE, V120, P133, DOI 10.1016/j.neuroimage.2015.07.002; Zalesky A, 2014, P NATL ACAD SCI USA, V111, P10341, DOI 10.1073/pnas.1400181111; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang AH, 2008, INT CONF BIOMED, P435; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2	72	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190220	10.1371/journal.pone.0190220	http://dx.doi.org/10.1371/journal.pone.0190220			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320526	gold, Green Published			2022-12-26	WOS:000419689600039
J	Orellana, A; Gonzalez, VG; Lopez, R; Pascual-Guiral, S; Lozoya, E; Diaz, J; Casals, D; Barrena, A; Paris, S; Andres, M; Segarra, V; Vilella, D; Malhotra, R; Eastwood, P; Planaguma, A; Miralpeix, M; Nueda, A				Orellana, Adelina; Gonzalez, Vicente Garcia; Lopez, Rosa; Pascual-Guiral, Sonia; Lozoya, Estrella; Diaz, Julia; Casals, Daniel; Barrena, Antolin; Paris, Stephane; Andres, Miriam; Segarra, Victor; Vilella, Dolors; Malhotra, Rajneesh; Eastwood, Paul; Planaguma, Anna; Miralpeix, Montserrat; Nueda, Arsenio			Application of a phenotypic drug discovery strategy to identify biological and chemical starting points for inhibition of TSLP production in lung epithelial cells	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; NF-KAPPA-B; SYK KINASE INHIBITORS; IN-VITRO; POTENT; EXPRESSION; IDENTIFICATION; INFLAMMATION; MODULATORS; MEDICINES	Thymic stromal lymphopoietin (TSLP) is a cytokine released by human lung epithelium in response to external insult. Considered as a master switch in T helper 2 lymphocyte (Th2) mediated responses, TSLP is believed to play a key role in allergic diseases including asthma. The aim of this study was to use a phenotypic approach to identify new biological and chemical starting points for inhibition of TSLP production in human bronchial epithelial cells (NHBE), with the objective of reducing Th2-mediated airway inflammation. To this end, a phenotypic screen was performed using poly I:C / IL-4 stimulated NHBE cells interrogated with a 44,974 compound library. As a result, 85 hits which downregulated TSLP protein and mRNA levels were identified and a representative subset of 7 hits was selected for further characterization. These molecules inhibited the activity of several members of the MAPK, PI3K and tyrosine kinase families and some of them have been reported as modulators of cellular phenotypic endpoints like cell-cell contacts, microtubule polymerization and caspase activation. Characterization of the biological profile of the hits suggested that mTOR could be a key activity involved in the regulation of TSLP production in NHBE cells. Among other targeted kinases, inhibition of p38 MAPK and JAK kinases showed different degrees of correlation with TSLP downregulation, while Syk kinase did not seem to be related. Overall, inhibition of TSLP production by the selected hits, rather than resulting from inhibition of single isolated targets, appeared to be due to a combination of activities with different levels of relevance. Finally, a hit expansion exercise yielded additional active compounds that could be amenable to further optimization, providing an opportunity to dissociate TSLP inhibition from other non-desired activities. This study illustrates the potential of phenotypic drug discovery to complement target based approaches by providing new chemistry and biology leads.	[Orellana, Adelina; Gonzalez, Vicente Garcia; Lopez, Rosa; Pascual-Guiral, Sonia; Lozoya, Estrella; Diaz, Julia; Casals, Daniel; Barrena, Antolin; Paris, Stephane; Andres, Miriam; Segarra, Victor; Vilella, Dolors; Malhotra, Rajneesh; Eastwood, Paul; Planaguma, Anna; Miralpeix, Montserrat; Nueda, Arsenio] Almirall SA, Almirall R&D Ctr, Barcelona, Spain; [Orellana, Adelina] Inst Catala Neurociencies Aplicades, Neurosci Res Ctr & Memory Clin Fundacio ACE, Barcelona, Spain; [Gonzalez, Vicente Garcia; Lopez, Rosa; Pascual-Guiral, Sonia] Univ Autonoma Barcelona, Fac Med, Inst Neurociencies, Dept Bioquim, Barcelona, Spain; [Lozoya, Estrella; Diaz, Julia; Casals, Daniel; Barrena, Antolin; Paris, Stephane; Andres, Miriam; Segarra, Victor; Vilella, Dolors; Malhotra, Rajneesh] AstraZeneca Gothenburg, RIA IMED Biotech Unit, Immun Dept, Molndal, Sweden; [Eastwood, Paul; Planaguma, Anna; Miralpeix, Montserrat] Galapagos NV, Therapeut Area Drug Discovery, Mechelen, Belgium	Almirall; Autonomous University of Barcelona; University of Barcelona; AstraZeneca; Galapagos NV	Nueda, A (corresponding author), Almirall SA, Almirall R&D Ctr, Barcelona, Spain.	arsenio.nueda@almirall.com		Pascual Guiral, Sonia/0000-0001-5791-3095; Nueda, Arsenio/0000-0001-8373-500X; Orellana, Adelina/0000-0002-0204-1944	Almirall, S.A.	Almirall, S.A.(Almirall)	This study was funded by Almirall, S.A. who also provided support in the form of salaries to all authors. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the authors is detailed in the "author contributions" section.	Almirall Lab, 2008, 1, 7-naphthyridine derivatives as P38 map kinase inhibitors, Patent No. [WO2008017461, 2008017461, WO2008017461A1]; Bauer S, 2009, Patent No. [WO2009145856A1, 2009145856]; Berg EL, 2010, J PHARMACOL TOX MET, V61, P3, DOI 10.1016/j.vascn.2009.10.001; Brandelius A, 2013, BRIT J PHARMACOL, V168, P363, DOI 10.1111/j.1476-5381.2012.02131.x; Brownjohn PW, 2017, STEM CELL REP, V8, P870, DOI 10.1016/j.stemcr.2017.02.006; Butcher EC, 2005, NAT REV DRUG DISCOV, V4, P461, DOI 10.1038/nrd1754; Castillo M, 2012, BIOORG MED CHEM LETT, V22, P5419, DOI 10.1016/j.bmcl.2012.07.045; Cereijido M, 2012, AM J PHYSIOL-CELL PH, V302, pC473, DOI 10.1152/ajpcell.00083.2011; Chen Y, 2015, ALLERGOL IMMUNOPATH, V43, P584, DOI 10.1016/j.aller.2015.01.008; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Cully M, 2014, NAT REV DRUG DISCOV, V13, P717, DOI 10.1038/nrd4457; DEBRABANDER MJ, 1976, CANCER RES, V36, P905; EASTWOOD PR, 2009, Patent No. 2009124692; Eder J, 2014, NAT REV DRUG DISCOV, V13, P577, DOI 10.1038/nrd4336; Erra M, 2017, ACS MED CHEM LETT, V8, P118, DOI 10.1021/acsmedchemlett.6b00438; Forns P, 2012, BIOORG MED CHEM LETT, V22, P2784, DOI 10.1016/j.bmcl.2012.02.087; Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960; Gras D, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02399-2016; Haasen D, 2017, ASSAY DRUG DEV TECHN, V15, P239, DOI 10.1089/adt.2017.796; Han H, 2012, MUCOSAL IMMUNOL, V5, P342, DOI 10.1038/mi.2012.14; Han HW, 2017, IMMUNOL REV, V278, P116, DOI 10.1111/imr.12546; Harada M, 2009, AM J RESP CELL MOL, V40, P368, DOI 10.1165/rcmb.2008-0041OC; Jariwala SP, 2011, CLIN EXP ALLERGY, V41, P1515, DOI 10.1111/j.1365-2222.2011.03797.x; Jiang H, 2010, AM J PHYSIOL-LUNG C, V298, pL660, DOI 10.1152/ajplung.00394.2009; Jones LH, 2017, NAT REV DRUG DISCOV, V16, P285, DOI 10.1038/nrd.2016.244; Kamal A, 2015, ORG BIOMOL CHEM, V13, P3416, DOI 10.1039/c4ob02449d; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Lee JA, 2013, J BIOMOL SCREEN, V18, P1143, DOI 10.1177/1087057113506118; Lelievre LG, 2001, CELL MOL BIOL, V47, P265; Li J, 2013, CELL REP, V5, P1650, DOI 10.1016/j.celrep.2013.11.037; Lumeras W, 2011, J MED CHEM, V54, P7899, DOI 10.1021/jm200975u; MATHEWS WR, 1991, HYPERTENSION, V17, P930, DOI 10.1161/01.HYP.17.6.930; Meyer DM, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-41; Miller SC, 2010, BIOCHEM PHARMACOL, V79, P1272, DOI 10.1016/j.bcp.2009.12.021; Moffat JG, 2017, NAT REV DRUG DISCOV, V16, P531, DOI 10.1038/nrd.2017.111; Park H, 2012, CHEMMEDCHEM, V7, P53, DOI 10.1002/cmdc.201100410; Remez N, 2016, CHEM RES TOXICOL, V29, P637, DOI 10.1021/acs.chemrestox.5b00470; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Sedrani R, 1998, TRANSPLANT P, V30, P2192, DOI 10.1016/S0041-1345(98)00587-9; Seshasayee D, 2007, J CLIN INVEST, V117, P3868, DOI 10.1172/JCI33559; Shah F, 2017, CELL CHEM BIOL, V24, P858, DOI 10.1016/j.chembiol.2017.06.003; Shikotra A, 2012, J ALLERGY CLIN IMMUN, V129, P104, DOI 10.1016/j.jaci.2011.08.031; Shor B, 2008, CANCER RES, V68, P2934, DOI 10.1158/0008-5472.CAN-07-6487; Sirisoma N, 2008, J MED CHEM, V51, P4771, DOI 10.1021/jm8003653; Stewart Ceri E, 2012, J Allergy (Cairo), V2012, P943982, DOI 10.1155/2012/943982; Swinney DC, 2013, J BIOMOL SCREEN, V18, P1186, DOI 10.1177/1087057113501199; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tsilingiri K, 2017, CELL MOL GASTROENTER, V3, P174, DOI 10.1016/j.jcmgh.2017.01.005; Vincent F, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1201; Wagner JE, 2016, CELL STEM CELL, V18, P144, DOI 10.1016/j.stem.2015.10.004; Wassermann AM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00164; Wawer MJ, 2014, P NATL ACAD SCI USA, V111, P10911, DOI 10.1073/pnas.1410933111; Yamaguchi T, 2007, CANCER SCI, V98, P1809, DOI 10.1111/j.1349-7006.2007.00604.x; Yao F, 2015, TUMOR BIOL, V36, P7873, DOI 10.1007/s13277-015-3362-x; Zhang YL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04826-y; Ziegler SF, 2006, NAT IMMUNOL, V7, P709, DOI 10.1038/ni1360; Ziegler SF, 2013, ADV PHARMACOL, V66, P129, DOI 10.1016/B978-0-12-404717-4.00004-4	60	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0189247	10.1371/journal.pone.0189247	http://dx.doi.org/10.1371/journal.pone.0189247			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320511	Green Submitted, gold, Green Published			2022-12-26	WOS:000419689600007
J	Srivastava, P; Sarma, A; Chaturvedi, CM				Srivastava, Pallavi; Sarma, Asitikantha; Chaturvedi, Chandra Mohini			Targeting DNA repair with PNKP inhibition sensitizes radioresistant prostate cancer cells to high LET radiation	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; CARBON-ION; POLYNUCLEOTIDE KINASE/PHOSPHATASE; IN-VITRO; RADIOSENSITIZATION; RADIOTHERAPY; IRRADIATION; EXPRESSION; APOPTOSIS; THERAPY	High linear energy transfer (LET) radiation or heavy ion such as carbon ion radiation is used as a method for advanced radiotherapy in the treatment of cancer. It has many advantages over the conventional photon based radiotherapy using Co-60 gamma or high energy X-rays from a Linear Accelerator. However, charged particle therapy is very costly. One way to reduce the cost as well as irradiation effects on normal cells is to reduce the dose of radiation by enhancing the radiation sensitivity through the use of a radiomodulator. PNKP (polynucleotide kinase/phosphatase) is an enzyme which plays important role in the non-homologous end joining (NHEJ) DNA repair pathway. It is expected that inhibition of PNKP activity may enhance the efficacy of the charged particle irradiation in the radioresistant prostate cancer cell line PC-3. To test this hypothesis, we investigated cellular radiosensitivity by clonogenic cell survival assay in PC-3 cells. (12)Carbon ion beam of62 MeVenergy (equivalent 5.16 MeV/nucleon) and with an entrance LET of 287 kev/mu m was used for the present study. Apoptotic parameters such as nuclear fragmentation and caspase-3 activity were measured by DAPI staining, nuclear ladder assay and colorimetric caspase-3method. Cell cycle arrest was determined by FACS analysis. Cell death was enhanced when carbon ion irradiation is combined with PNKPi (PNKP inhibitor) to treat cells as compared to that seen for PNKPi untreated cells. A low concentration (10 mu M) of PNKPi effectively radiosensitized the PC-3 cells in terms of reduction of dose in achieving the same survival fraction. PC-3 cells underwent significant apoptosis and cell cycle arrest too was enhanced at G2/M phase when carbon ion irradiation was combined with PNKPi treatment. Our findings suggest that combined treatment of carbon ion irradiation and PNKP inhibition could enhance cellular radiosensitivity in a radioresistant prostate cancer cell line PC-3. The synergistic effect of PNKPi and carbon ion irradiation could be used as a promising method for carbonion therapy in radioresistant cells.	[Srivastava, Pallavi; Chaturvedi, Chandra Mohini] Banaras Hindu Univ, Dept Zool, Varanasi, Uttar Pradesh, India; [Sarma, Asitikantha] Inter Univ Accelerator Ctr, Radiat Biol Lab, New Delhi, India	Banaras Hindu University (BHU); Inter-University Accelerator Centre	Chaturvedi, CM (corresponding author), Banaras Hindu Univ, Dept Zool, Varanasi, Uttar Pradesh, India.	cmcbhu@gmail.com		Chaturvedi, Chandra Mohini/0000-0001-7788-6557	Inter University Accelerator Centre, New Delhi [UFR 56310]	Inter University Accelerator Centre, New Delhi	This work was supported by the Inter University Accelerator Centre, New Delhi Grant No. UFR 56310 (http://www.iuac.res.in/) to Dr. Chandra Mohini Chaturvedi and a Junior Research Fellowship to Pallavi Srivastava. The funders helped in preparation of manuscript.	Allen C, 2012, MUTAT RES, V711, P150; An J, 2007, ONCOGENE, V26, P652, DOI 10.1038/sj.onc.1209830; Bala M., 2012, RAD INDUCED RADIORES; Barazzuol L, 2015, INT J RADIAT BIOL, V91, P90, DOI 10.3109/09553002.2014.946111; Bartek J, 2013, CANCER DISCOV, V3, P1222, DOI 10.1158/2159-8290.CD-13-0679; Brenner DJ, 2008, SEMIN RADIAT ONCOL, V18, P234, DOI 10.1016/j.semradonc.2008.04.004; Cartwright IM, 2015, ONCOL LETT, V9, P1621, DOI 10.3892/ol.2015.2974; Chang L, 2015, CRIT REV ONCOL HEMAT, V96, P507, DOI 10.1016/j.critrevonc.2015.07.005; Coquelle N, 2011, P NATL ACAD SCI USA, V108, P21022, DOI 10.1073/pnas.1112036108; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; Davidson D, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00005; Ezekwudo D, 2008, CANCER LETT, V270, P277, DOI 10.1016/j.canlet.2008.05.022; Freschauf GK, 2010, J BIOL CHEM, V285, P2351, DOI 10.1074/jbc.M109.055764; Freschauf GK, 2009, CANCER RES, V69, P7739, DOI 10.1158/0008-5472.CAN-09-1805; Fukumura A, 2009, RADIAT PROT DOSIM, V137, P149, DOI 10.1093/rpd/ncp188; Ghorai A, 2016, RADIAT ONCOL, V11, DOI 10.1186/s13014-016-0703-x; Ghorai A, 2015, APOPTOSIS, V20, P562, DOI 10.1007/s10495-015-1107-3; Gu JL, 2014, EUR J CANCER, V50, P1184, DOI 10.1016/j.ejca.2013.12.027; Guogyte Kamile, 2017, Genome Integr, V8, P1, DOI 10.4103/2041-9414.198907; Hamada N, 2010, J RADIAT RES, V51, P365, DOI 10.1269/jrr.09137; Hanot M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044367; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hirai T, 2012, CANCER SCI, V103, P1045, DOI 10.1111/j.1349-7006.2012.02268.x; Hur JM, 2010, TOXICOL RES-GER, V26, P109, DOI 10.5487/TR.2010.26.2.109; Ishikawa H, 2012, INT J UROL, V19, P296, DOI 10.1111/j.1442-2042.2012.02961.x; Jiegler JF, STOPPING RANGES IONS; Kelley MR, 2014, FUTURE ONCOL, V10, P1215, DOI 10.2217/fon.14.60; Kim BM, 2015, INT J MOL SCI, V16, P26880, DOI 10.3390/ijms161125991; Kothari A, 2015, RADIAT MEAS, V76, P17, DOI 10.1016/j.radmeas.2015.03.011; KRAFTWEYRATHER W, 1989, NUCL INSTRUM METH A, V282, P22, DOI 10.1016/0168-9002(89)90104-6; Kramer M, 2006, PHYS MED BIOL, V51, P1959, DOI 10.1088/0031-9155/51/8/001; Lee Y, 2017, MOL CANCER THER, V16, P16, DOI 10.1158/1535-7163.MCT-16-0573; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li Xue-Song, 2008, Zhonghua Wai Ke Za Zhi, V46, P768; Liu X, 2016, INT J NANOMED, V11, P3517, DOI 10.2147/IJN.S105348; Liu YJ, 2017, CELL PHYSIOL BIOCHEM, V41, P1605, DOI 10.1159/000470896; Ma HY, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0536-z; Mori E, 2009, J RADIAT RES, V50, P37, DOI 10.1269/jrr.08075; SCHNEIDER M, 1994, RADIAT ENVIRON BIOPH, V33, P111, DOI 10.1007/BF01219335; Schroeter H, 2001, BIOCHEM J, V358, P547, DOI 10.1042/0264-6021:3580547; Shioyama Y, 2015, INT J UROL, V22, P33, DOI 10.1111/iju.12640; Shuji K., 2014, YAKUGAKUZASSHI, V134, P743; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; STENERLOW B, 1994, INT J RADIAT BIOL, V65, P631, DOI 10.1080/09553009414550741; Suetens A, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00087; Suetens A, 2015, J RADIAT RES, V56, P11, DOI 10.1093/jrr/rru070; TAUCHERSCHOLZ G, 1995, RADIAT ENVIRON BIOPH, V34, P101, DOI 10.1007/BF01275214; Wang J, 2017, RADIAT RES, V188, P105, DOI 10.1667/RR14708.1; Yu T, 2016, ONCOTARGET, V7, P79075, DOI 10.18632/oncotarget.12597; Zereshkian A, 2014, NUCL MED BIOL, V41, P377, DOI 10.1016/j.nucmedbio.2014.02.003	50	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190516	10.1371/journal.pone.0190516	http://dx.doi.org/10.1371/journal.pone.0190516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320576	Green Published, gold, Green Submitted			2022-12-26	WOS:000419689600055
J	Vidal, B; Cascao, R; Finnila, MAJ; Lopes, IP; Saarakkala, S; Zioupos, P; Canhao, H; Fonseca, JE				Vidal, Bruno; Cascao, Rita; Finnila, Mikko A. J.; Lopes, Ines P.; Saarakkala, Simo; Zioupos, Peter; Canhao, Helena; Fonseca, Joao E.			Early arthritis induces disturbances at bone nanostructural level reflected in decreased tissue hardness in an animal model of arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; MECHANICAL-PROPERTIES; SUBCHONDRAL BONE; DOUBLE-BLIND; RECEPTOR; OSTEOARTHRITIS; ACTIVATION; EXPRESSION; OSTEOCYTES; ANTIBODY	Introduction Arthritis induces joint erosions and skeletal bone fragility. Objectives The main goal of this work was to analyze the early arthritis induced events at bone architecture and mechanical properties at tissue level. Methods Eighty-eight Wistar rats were randomly housed in experimental groups, as follows: adjuvant induced arthritis (AIA) (N = 47) and a control healthy group (N = 41). Rats were monitored during 22 days for the inflammatory score, ankle perimeter and body weight and sacrificed at different time points (11 and 22 days post disease induction). Bone samples were collected for histology, micro computed tomography (micro-CT), 3-point bending and nanoindentation. Blood samples were also collected for bone turnover markers and systemic cytokine quantification. Results At bone tissue level, measured by nanoindentation, there was a reduction of hardness in the arthritic group, associated with an increase of the ratio of bone concentric to parallel lamellae and of the area of the osteocyte lacuna. In addition, increased bone turnover and changes in the microstructure and mechanical properties were observed in arthritic animals, since the early phase of arthritis, when compared with healthy controls. Conclusion We have shown in an AIA rat model that arthritis induces very early changes at bone turnover, structural degradation and mechanical weakness. Bone tissue level is also affected since the early phase of arthritis, characterized by decreased tissue hardness associated with changes in bone lamella organization and osteocyte lacuna surface. These observations highlight the pertinence of immediate control of inflammation in the initial stages of arthritis.	[Vidal, Bruno; Cascao, Rita; Lopes, Ines P.; Fonseca, Joao E.] Univ Lisbon, Inst Mol Med, Fac Med, Lisbon, Portugal; [Finnila, Mikko A. J.; Saarakkala, Simo] Univ Oulu, Fac Med, Res Unit Med Imaging Phys & Technol, Oulu, Finland; [Finnila, Mikko A. J.] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Saarakkala, Simo] Oulu Univ, Med Res Ctr Oulo, Oulu, Finland; [Saarakkala, Simo] Oulu Univ Hosp, Dept Diagnost Radiol, Oulu, Finland; [Zioupos, Peter] Cranfield Univ, Def Acad UK, Cranfield Forens Inst, Biomech Lab, Shrivenham, England; [Canhao, Helena] Nova Univ, Med Sch, CEDOC, EpiDoC Unit, Lisbon, Portugal; [Fonseca, Joao E.] Hosp Santa Maria, Lisbon Acad Med Ctr, Ctr Hospt Lisboa Norte, EPE,Rheumatol Dept, Lisbon, Portugal	Universidade de Lisboa; University of Oulu; University of Eastern Finland; University of Oulu; University of Oulu; Cranfield University; Universidade Nova de Lisboa; Universidade de Lisboa; Hospital Santa Maria	Vidal, B (corresponding author), Univ Lisbon, Inst Mol Med, Fac Med, Lisbon, Portugal.	vidal.bmc@gmail.com	Finnila, Mikko/X-6492-2019; ZIOUPOS, PETER/S-4342-2019; Saarakkala, Simo/F-5839-2013; Canhao, Helena/C-9611-2018	ZIOUPOS, PETER/0000-0002-0123-2706; Saarakkala, Simo/0000-0003-2850-5484; Canhao, Helena/0000-0003-1894-4870; Finnila, Mikko/0000-0002-3348-5759	ECTS/AMGEN Bone Biology Fellowship; ECTS/AMGEN BONE BIOLOGY	ECTS/AMGEN Bone Biology Fellowship; ECTS/AMGEN BONE BIOLOGY	This work was supported by ECTS/AMGEN Bone Biology Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge ECTS/AMGEN BONE BIOLOGY for funding this project.	Bailey AJ, 2004, BIORHEOLOGY, V41, P349; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Caetano-Lopes J, 2009, AUTOIMMUN REV, V8, P250, DOI 10.1016/j.autrev.2008.07.038; Caetano-Lopes J, 2014, CLIN REV ALLERG IMMU, V47, P38, DOI 10.1007/s12016-013-8366-y; Caetano-Lopes J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2908; Cascao R, 2012, AUTOIMMUN REV, V11, P856, DOI 10.1016/j.autrev.2012.02.022; Cascao R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3168; Choy EHS, 2002, ARTHRITIS RHEUM-US, V46, P3143, DOI 10.1002/art.10623; Cortet B, 1998, J RHEUMATOL, V25, P2339; Dall'Ara E, 2011, J BIOMECH, V44, P1593, DOI 10.1016/j.jbiomech.2010.12.022; Eric-Jan JA K, 2000, CLIN EXPT RHEUMATOLO; Fonseca JE, 2009, AUTOIMMUN REV, V8, P538, DOI 10.1016/j.autrev.2009.01.012; Fonseca JE, 2005, CLIN EXP RHEUMATOL, V23, P185; Gibofsky Allan, 2012, Am J Manag Care, V18, pS295; Haugeberg G, 2002, ARTHRITIS RHEUM-US, V46, P1720, DOI 10.1002/art.10408; Herlin M, 2013, TOXICOL APPL PHARM, V273, P219, DOI 10.1016/j.taap.2013.09.002; Jaiprakash A, 2012, INT J BIOL SCI, V8, P406, DOI 10.7150/ijbs.4221; Lin YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062926; Lisa R, 2006, VIVO MODELS INFLAMMA; Maeshima K, 2012, ARTHRITIS RHEUM-US, V64, P1790, DOI 10.1002/art.34329; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Moura RA, 2011, RHEUMATOLOGY, V50, P278, DOI 10.1093/rheumatology/keq338; Nishimoto N, 2004, ARTHRITIS RHEUM-US, V50, P1761, DOI 10.1002/art.20303; Oliver W.C., 1992, IMPROVED TECHNIQUE D; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Siebuhr AS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-195; Taylor AF, 2007, AM J PHYSIOL-CELL PH, V292, pC545, DOI 10.1152/ajpcell.00611.2005; Ugural A. C., 1995, ADV STRENGTH APPL EL, Vthird; Vidal B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117100; YELIN E, 1995, ARTHRITIS RHEUM, V38, P1351, DOI 10.1002/art.1780381002; Zhang R, 2015, BONE, V76, P76, DOI 10.1016/j.bone.2015.03.022	32	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190920	10.1371/journal.pone.0190920	http://dx.doi.org/10.1371/journal.pone.0190920			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315314	Green Published, gold			2022-12-26	WOS:000419655900033
J	Itoh, G; Ishii, H; Kato, H; Nagano, Y; Hayashi, H; Funasaki, H				Itoh, Gento; Ishii, Hideyuki; Kato, Haruyasu; Nagano, Yasuharu; Hayashi, Hiroteru; Funasaki, Hiroki			Risk assessment of the onset of Osgood-Schlatter disease using kinetic analysis of various motions in sports	PLOS ONE			English	Article							OVERUSE INJURIES; KNEE	Background Some studies have listed motions that may cause Osgood-Schlatter disease, but none have quantitatively assessed the load on the tibial tubercle by such motions. Purposes To quantitatively identify the load on the tibial tubercle through a biomechanical approach using various motions that may cause Osgood-Schlatter disease, and to compare the load between different motions. Methods Eight healthy male subjects were included. They conducted 4 types of kicks with a soccer ball, 2 types of runs, 2 types of squats, 2 types of jump landings, 2 types of stops, 1 type of turn, and 1 type of cutting motion. The angular impulse was calculated for knee extension moments >= 1.0 Nm/kg, >= 1.5 Nm/kg, >= 2.0 Nm/kg, and >= 2.5 Nm/kg. After analysis of variance, the post-hoc test was used to perform pairwise comparisons between all groups. Results/Conclusions The motion with the highest mean angular impulse of knee extension moment >= 1.0 Nm/kg was the single-leg landing after a jump, and that with the second highest mean was the cutting motion. At >= 1.5 Nm/kg, >= 2.0 Nm/kg, and >= 2.5 Nm/kg, the cutting motion was the highest, followed by the jump with a single-leg landing. They have a large load, and are associated with a higher risk of developing Osgood-Schlatter disease. The mean angular impulse of the 2 types of runs was small at all the indicators.	[Itoh, Gento] Rikkyo Univ, Grad Sch Community & Human Serv, Saitama, Japan; [Ishii, Hideyuki; Kato, Haruyasu] Rikkyo Univ, Dept Sport & Wellness, Saitama, Japan; [Nagano, Yasuharu] Japan Womens Coll Phys Educ, Dept Sports Wellness Sci, Tokyo, Japan; [Hayashi, Hiroteru; Funasaki, Hiroki] Jikei Univ, Sch Med, Dept Sports & Wellness Clin, Tokyo, Japan	Rikkyo University; Rikkyo University; Jikei University	Itoh, G (corresponding author), Rikkyo Univ, Grad Sch Community & Human Serv, Saitama, Japan.	gento.itoh@gmail.com	Nagano, Yasuharu/AAH-7814-2019	Nagano, Yasuharu/0000-0001-6964-2245	Rikkyo University Special Fund for Research [23]	Rikkyo University Special Fund for Research	This work was supported by the Rikkyo University Special Fund for Research, Grant number: 23 (http://www3.rikkyo.ac.jp/research/initiative/aid/interior/SFR/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are deeply grateful to eight participants. This research was supported by Grants in-Aid from Rikkyo University Special Fund for Research, 2016 (Rikkyo SFR, Grant number: 23). We would like to thank Editage (www.editage.jp) for English language editing.	Ae M., 1992, BIOMECHANISM, V11, P23; Ben Kibler W, 2000, CLIN SPORT MED, V19, P781, DOI 10.1016/S0278-5919(05)70237-4; Blankstein A, 2001, ARCH ORTHOP TRAUM SU, V121, P536, DOI 10.1007/s004020100285; Bloom OJ, 2004, J FAM PRACTICE, V53, P153; Chang GH, 2013, CLIN IMAG, V37, P836, DOI 10.1016/j.clinimag.2013.04.002; DAMBROSIA RD, 1975, CLIN ORTHOP RELAT R, P206; de Lucena GL, 2011, AM J SPORT MED, V39, P415, DOI 10.1177/0363546510383835; EHRENBORG G, 1962, Acta Chir Scand Suppl, VSuppl 288, P1; Fotiadou A. N., 2011, SPORTS INJURIES CHIL; Gerbino PG, 2006, OPER TECHN SPORT MED, V14, P203, DOI 10.1053/j.otsm.2006.04.003; Gerrard D F, 1993, Br J Sports Med, V27, P14; GRASS AL, 1978, JAMA-J AM MED ASSOC, V240, P212, DOI 10.1001/jama.1978.03290030030008; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Hirano A, 2002, SKELETAL RADIOL, V31, P334, DOI 10.1007/s00256-002-0486-z; Hoffman DF, 2001, PRINCIPLES PRACTICE; KRIDELBAUGH WW, 1948, AM J SURG, V75, P553, DOI 10.1016/0002-9610(48)90366-3; KUJALA UM, 1985, AM J SPORT MED, V13, P236, DOI 10.1177/036354658501300404; Launay F, 2015, ORTHOP TRAUMATOL-SUR, V101, pS139, DOI 10.1016/j.otsr.2014.06.030; LEVINE J, 1981, CLIN ORTHOP RELAT R, P126; Micheli LJ, 1995, SPORTS MED BIBLE PRE; OGDEN JA, 1976, CLIN ORTHOP RELAT R, P180; Osgood RE, 1903, BOSTON MED SURG J, V148, P0114, DOI 10.1056/NEJM190301291480502; Plagenhoef S., 1971, PATTERNS HUMAN MOTIO; ROSENBERG ZS, 1992, RADIOLOGY, V185, P853, DOI 10.1148/radiology.185.3.1438775; Sanna G, 2008, CLIN BIOMECH, V23, P946, DOI 10.1016/j.clinbiomech.2008.03.065; SCHLATTER C, 1903, BRUNS BEITR KLIN CHI, V38, P874; Soren A, 1968, Am J Orthop Surg, V10, P70; Wall EJ, 1998, PHYSICIAN SPORTSMED, V26, P29, DOI 10.3810/psm.1998.03.802; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd	29	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2018	13	1							e0190503	10.1371/journal.pone.0190503	http://dx.doi.org/10.1371/journal.pone.0190503			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS0GW	29309422	Green Published, Green Submitted, gold			2022-12-26	WOS:000419453100010
J	Ha, J; Xu, Y; Kawano, T; Hendon, T; Baki, L; Garai, S; Papapetropoulos, A; Thakur, GA; Plant, LD; Logothetis, DE				Ha, Junghoon; Xu, Yu; Kawano, Takeharu; Hendon, Tyler; Baki, Lia; Garai, Sumanta; Papapetropoulos, Andreas; Thakur, Ganesh A.; Plant, Leigh D.; Logothetis, Diomedes E.			Hydrogen sulfide inhibits Kir2 and Kir3 channels by decreasing sensitivity to the phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; K-ATP CHANNELS; RECTIFYING POTASSIUM CHANNELS; G-PROTEINS; H2S; PHOSPHOINOSITIDES; CARDIOPROTECTION; SULFHYDRATION; ACTIVATION; MECHANISM	Inwardly rectifying potassium (Kir) channels establish and regulate the resting membrane potential of excitable cells in the heart, brain, and other peripheral tissues. Phosphatidylinositol 4,5-bisphosphate (PIP2) is a key direct activator of ion channels, including Kir channels. The gasotransmitter carbon monoxide has been shown to regulate Kir channel activity by altering channel-PIP2 interactions. Here, we tested in two cellular models the effects and mechanism of action of another gasotransmitter, hydrogen sulfide (H2S), thought to play a key role in cellular responses under ischemic conditions. Direct administration of sodium hydrogen sulfide as an exogenous H2S source and expression of cystathionine gamma-lyase, a key enzyme that produces endogenous H2S in specific brain tissues, resulted in comparable current inhibition of several Kir2 and Kir3 channels. This effect resulted from changes in channel-gating kinetics rather than in conductance or cell-surface localization. The extent of H2S regulation depended on the strength of the channel-PIP2 interactions. H2S regulation was attenuated when channel-PIP2 interactions were strengthened and was increased when channel-PIP2 interactions were weakened by depleting PIP2 levels. These H2S effects required specific cytoplasmic cysteine residues in Kir3.2 channels. Mutation of these residues abolished H2S inhibition, and reintroduction of specific cysteine residues back into the background of the cytoplasmic cysteine-lacking mutant rescued H2S inhibition. Molecular dynamics simulation experiments provided mechanistic insights into how potential sulfhydration of specific cysteine residues could lead to changes in channel-PIP2 interactions and channel gating.	[Ha, Junghoon; Hendon, Tyler; Logothetis, Diomedes E.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Xu, Yu; Kawano, Takeharu; Baki, Lia; Garai, Sumanta; Thakur, Ganesh A.; Plant, Leigh D.; Logothetis, Diomedes E.] Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm, Bouve Coll Hlth Sci, Boston, MA 02115 USA; [Papapetropoulos, Andreas] Univ Athens, Fac Pharm, Lab Pharmacol, Athens 15771, Greece; [Papapetropoulos, Andreas] Acad Athens, Biomed Res Fdn, Ctr Clin Expt Surg & Translat Res, Athens 11527, Greece	Virginia Commonwealth University; Northeastern University; National & Kapodistrian University of Athens; Academy of Athens	Logothetis, DE (corresponding author), Northeastern Univ, Bouve Coll Hlth Sci, Dept Pharmaceut Sci, 805 Columbus Ave,428 ISEC, Boston, MA 02120 USA.	d.logothetis@northeastern.edu	Andreas, Papapetropoulos/AAJ-3089-2020; Garai, Sumanta/S-6193-2019; Xu, Yu/AAM-8492-2021	Garai, Sumanta/0000-0003-4071-8490	National Institutes of Health [R01 HL059949-19]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R01 HL059949-19. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adney SK, 2015, J NEUROSCI, V35, P14397, DOI 10.1523/JNEUROSCI.1415-15.2015; Austgen JR, 2011, J NEUROPHYSIOL, V106, P1822, DOI 10.1152/jn.00463.2011; Bian JS, 2006, J PHARMACOL EXP THER, V316, P670, DOI 10.1124/jpet.105.092023; Bodhinathan K, 2013, P NATL ACAD SCI USA, V110, P18309, DOI 10.1073/pnas.1311406110; Chen L, 2002, P NATL ACAD SCI USA, V99, P8430, DOI 10.1073/pnas.122682899; Das A, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0500-y; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Feng XM, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-4; Gade AR, 2013, MOL PHARMACOL, V83, P294, DOI 10.1124/mol.112.081596; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Johansen D, 2006, BASIC RES CARDIOL, V101, P53, DOI 10.1007/s00395-005-0569-9; Karschin C, 1996, J NEUROSCI, V16, P3559; Khademullah CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064495; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Kuksis M, 2015, J NEUROPHYSIOL, V114, P1641, DOI 10.1152/jn.00252.2015; Logothetis DE, 2015, INT REV NEUROBIOL, V123, P1, DOI 10.1016/bs.irn.2015.05.013; Luo Y, 2014, CNS NEUROSCI THER, V20, P411, DOI 10.1111/cns.12228; McCune CD, 2016, ACS CENTRAL SCI, V2, P242, DOI 10.1021/acscentsci.6b00019; Mustafa AK, 2011, CIRC RES, V109, P1259, DOI 10.1161/CIRCRESAHA.111.240242; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Paul BD, 2015, TRENDS BIOCHEM SCI, V40, P687, DOI 10.1016/j.tibs.2015.08.007; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Pietri R, 2011, ANTIOXID REDOX SIGN, V15, P393, DOI 10.1089/ars.2010.3698; Plant LD, 2016, ELIFE, V5, DOI 10.7554/eLife.20054; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Rohacs T, 2002, METHOD ENZYMOL, V345, P71; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Salloum FN, 2015, PHARMACOL THERAPEUT, V152, P11, DOI 10.1016/j.pharmthera.2015.04.004; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wei HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050641; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang DH, 2014, ANGEW CHEM INT EDIT, V53, P575, DOI 10.1002/anie.201305876; Zhang M, 2014, NAT CHEM BIOL, V10, P753, DOI [10.1038/NCHEMBIO.1592, 10.1038/nchembio.1592]; Zhang Z, 2007, CAN J PHYSIOL PHARM, V85, P1248, DOI 10.1139/Y07-120	40	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3546	3561		10.1074/jbc.RA117.001679	http://dx.doi.org/10.1074/jbc.RA117.001679			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29317494	Green Published, hybrid			2022-12-26	WOS:000427030200008
J	Martinez-Ordonez, A; Seoane, S; Cabezas, P; Eiro, N; Sendon-Lago, J; Macia, M; Garcia-Caballero, T; Gonzalez, LO; Sanchez, L; Vizoso, F; Perez-Fernandez, R				Martinez-Ordonez, Anxo; Seoane, Samuel; Cabezas, Pablo; Eiro, Noemi; Sendon-Lago, Juan; Macia, Manuel; Garcia-Caballero, Tomas; Gonzalez, Luis O.; Sanchez, Laura; Vizoso, Francisco; Perez-Fernandez, Roman			Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis	ONCOGENE			English	Article							CHEMOKINE RECEPTOR CXCR4; PREDICTS POOR-PROGNOSIS; TRANSCRIPTION FACTOR; TUMOR-GROWTH; CXCR4/CXCL12 AXIS; CELL-MIGRATION; EXPRESSION; PIT-1; CXCL12/CXCR4; MICROENVIRONMENT	Development of human tumors is driven by accumulation of alterations in tumor suppressor genes and oncogenes in cells. The POU1F1 transcription factor (also known Pit-1) is expressed in the mammary gland and its overexpression induces profound phenotypic changes in proteins involved in breast cancer progression. Patients with breast cancer and elevated expression of Pit-1 show a positive correlation with the occurrence of distant metastasis and poor overall survival. However, some mediators of Pit-1 actions are still unknown. Here, we show that CXCR4 chemokine receptor and its ligand CXCL12 play a critical role in the pro-tumoral process induced by Pit-1. We found that Pit-1 increases mRNA and protein in both CXCR4 and CXCL12. Knock-down of CXCR4 reduces tumor growth and spread of Pit-1 overexpressing cells in a zebrafish xenograft model. Furthermore, we described for the first time pro-angiogenic effects of Pit-1 through the CXCL12-CXCR4 axis, and that extravasation of Pit-1 overexpressing breast cancer cells is strongly reduced in CXCL12-deprived target tissues. Finally, in breast cancer patients, expression of Pit-1 in primary tumors was found to be positively correlated with CXCR4 and CXCL12, with specific metastasis in liver and lung, and with clinical outcome. Our results suggest that Pit-1-CXCL12-CXCR4 axis could be involved in chemotaxis guidance during the metastatic process, and may represent prognostic and/or therapeutic targets in breast tumors.	[Martinez-Ordonez, Anxo; Seoane, Samuel; Sendon-Lago, Juan; Perez-Fernandez, Roman] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Dept Physiol, Santiago De Compostela, Spain; [Cabezas, Pablo; Sanchez, Laura] Univ Santiago de Compostela, Dept Genet, Campus Lugo, Lugo, Spain; [Eiro, Noemi; Gonzalez, Luis O.; Vizoso, Francisco] Hosp Fdn Jove, Res Unit, Gijon, Spain; [Macia, Manuel] Univ Santiago de Compostela, Dept Obstet & Gynecol, Santiago De Compostela, Spain; [Garcia-Caballero, Tomas] Univ Santiago de Compostela, Dept Morphol Sci, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Perez-Fernandez, R (corresponding author), Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Dept Physiol, Santiago De Compostela, Spain.	roman.perez.fernandez@usc.es	Sainz, Pablo Cabezas/AAB-5798-2019; Perez-Fernandez, Roman/L-6342-2014; Sánchez, Laura/L-2411-2014; Gómez, ACUIGEN/ABD-5337-2020; Lago, Juan José Sendón/L-1227-2014; Eiro, Noemi/C-9510-2018; Seoane Ruzo, Samuel/H-6299-2015	Perez-Fernandez, Roman/0000-0002-5894-0615; Sánchez, Laura/0000-0001-7927-5303; Lago, Juan José Sendón/0000-0001-8360-0033; Eiro, Noemi/0000-0001-5840-4807; Garcia-Caballero, Tomas/0000-0002-7938-1437; Cabezas Sainz, Pablo/0000-0002-7158-4459; Seoane Ruzo, Samuel/0000-0002-9178-0887	Ministerio de Economia y Competividad (MINECO/FEDER) [SAF2015-69221-R]; Conselleria de Cultura, Educacion e Ordenacion Universitaria [GPC2014/001]; Ministerio de Educacion [FPU14/00548]; BioBank Complejo Hospitalario Universitario de Santiago (CHUS) [PT17/0015/0002]	Ministerio de Economia y Competividad (MINECO/FEDER); Conselleria de Cultura, Educacion e Ordenacion Universitaria; Ministerio de Educacion; BioBank Complejo Hospitalario Universitario de Santiago (CHUS)	This study was supported by Ministerio de Economia y Competividad (SAF2015-69221-R, MINECO/FEDER), and Conselleria de Cultura, Educacion e Ordenacion Universitaria (GPC2014/001) to RP-F, and Ministerio de Educacion, FPU14/00548 to AM-O. We want to particularly acknowledge the patients and the BioBank Complejo Hospitalario Universitario de Santiago (CHUS) (PT17/0015/0002), integrated in the Spanish National Biobanks Network for its collaboration, to P. Penas for providing biological samples, and to M. Fraile for help us with histological analyses.	Bachelder RE, 2002, CANCER RES, V62, P7203; Ben-Batalla I, 2010, J CLIN INVEST, V120, P4289, DOI 10.1172/JCI42015; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Chen HW, 2013, CURR MOL MED, V13, P410; Deshane J, 2007, J EXP MED, V204, P605, DOI 10.1084/jem.20061609; DeVries ME, 2006, J IMMUNOL, V176, P401, DOI 10.4049/jimmunol.176.1.401; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Eiro N, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.992222; Gao ZC, 2016, MED SCI MONITOR, V22, P4121, DOI 10.12659/MSM.896107; Gil M, 2013, P NATL ACAD SCI USA, V110, pE1291, DOI 10.1073/pnas.1220580110; Gil-Puig C, 2005, EUR J ENDOCRINOL, V153, P335, DOI 10.1530/eje.1.01962; Gil-Puig C, 2002, J ENDOCRINOL, V173, P161, DOI 10.1677/joe.0.1730161; Guo F, 2016, ONCOGENE, V35, P816, DOI 10.1038/onc.2015.139; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hassan S, 2011, INT J CANCER, V129, P225, DOI 10.1002/ijc.25665; Huang EH, 2009, J SURG RES, V155, P231, DOI 10.1016/j.jss.2008.06.044; Kim J, 2006, ANN SURG, V244, P113, DOI 10.1097/01.sla.0000217690.65909.9c; Kryczek I, 2005, CANCER RES, V65, P465; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; LEFEVRE C, 1987, EMBO J, V6, P971, DOI 10.1002/j.1460-2075.1987.tb04847.x; Lefort S, 2017, ONCOGENE, V36, P1211, DOI 10.1038/onc.2016.284; Liang Z, 2007, BIOCHEM BIOPH RES CO, V359, P716, DOI 10.1016/j.bbrc.2007.05.182; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nica G, 2004, MOL ENDOCRINOL, V18, P1196, DOI 10.1210/me.2003-0377; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Palevitch O, 2010, GEN COMP ENDOCR, V165, P262, DOI 10.1016/j.ygcen.2009.07.001; Peixoto P, 2008, NUCLEIC ACIDS RES, V36, P3341, DOI 10.1093/nar/gkn208; Salvucci O, 2002, BLOOD, V99, P2703, DOI 10.1182/blood.V99.8.2703; Scala S, 2015, CLIN CANCER RES, V21, P4278, DOI 10.1158/1078-0432.CCR-14-0914; Sendon-Lago J, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0505-8; Seoane S, 2006, MOL ENDOCRINOL, V20, P735, DOI 10.1210/me.2005-0253; Seoane S, 2015, ONCOTARGET, V6, P14456, DOI 10.18632/oncotarget.3894; Tiveron MC, 2008, CURR OPIN NEUROBIOL, V18, P237, DOI 10.1016/j.conb.2008.06.004; Tulotta C, 2016, DIS MODEL MECH, V9, P141, DOI 10.1242/dmm.023275; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Xu C, 2015, DRUG DES DEV THER, V9, P4953, DOI 10.2147/DDDT.S84932; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	43	43	45	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	11					1430	1444		10.1038/s41388-017-0036-8	http://dx.doi.org/10.1038/s41388-017-0036-8			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ3AZ	29321662				2022-12-26	WOS:000427459500003
J	Narayanaswamy, VP; Giatpaiboon, SA; Uhrig, J; Orwin, P; Wiesmann, W; Baker, SM; Townsend, SM				Narayanaswamy, Vidya P.; Giatpaiboon, Scott A.; Uhrig, John; Orwin, Paul; Wiesmann, William; Baker, Shenda M.; Townsend, Stacy M.			In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus	PLOS ONE			English	Article							LEVEL MUPIROCIN RESISTANCE; ANTIBIOTIC-RESISTANCE; BETA-LACTAMS; VANCOMYCIN; EPIDEMIOLOGY; INFECTIONS; CEFTAROLINE; COMBINATION; FITNESS; SUSCEPTIBILITY	The incidence of multidrug-resistant (MDR) organisms, including methicillin-resistant Staphylococcus aureus (MRSA), is a serious threat to public health. Progress in developing new therapeutics is being outpaced by antibiotic resistance development, and alternative agents that rapidly permeabilize bacteria hold tremendous potential for treating MDR infections. A new class of glycopolymers includes polycationic poly-N (acetyl, arginyl) glucosamine (PAAG) is under development as an alternative to traditional antibiotic strategies to treat MRSA infections. This study demonstrates the antibacterial activity of PAAG against clinical isolates of methicillin and mupirocin-resistant Staphylococcus aureus. Multidrug-resistant S. aureus was rapidly killed by PAAG, which completely eradicated 88% (15/17) of all tested strains (6-log reduction in CFU) in <= 12-hours at doses that are non-toxic to mammalian cells. PAAG also sensitized all the clinical MRSA strains (17/17) to oxacillin as demonstrated by the observed reduction in the oxacillin MIC to below the antibiotic resistance breakpoint. The effect of PAAG and standard antibiotics including vancomycin, oxacillin, mupirocin and bacitracin on MRSA permeability was studied by measuring propidium iodide (PI) uptake by bacterial cells. Antimicrobial resistance studies showed that S. aureus developed resistance to PAAG at a rate slower than to mupirocin but similar to bacitracin. PAAG was observed to resensitize drug-resistant S. aureus strains sampled from passage 13 and 20 of the multi-passage resistance study, reducing MICs of mupirocin and bacitracin below their clinical sensitivity breakpoints. This class of bacterial permeabilizing glycopolymers may provide a new tool in the battle against multidrug-resistant bacteria.	[Narayanaswamy, Vidya P.; Giatpaiboon, Scott A.; Wiesmann, William; Baker, Shenda M.; Townsend, Stacy M.] Synedgen Inc, Claremont, CA 91711 USA; [Uhrig, John] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Orwin, Paul] Calif State Univ San Bernardino, San Bernardino, CA 92407 USA; [Townsend, Stacy M.] Mol Sci Inst, San Jose, CA USA	Medical College of Wisconsin; California State University System; California State University San Bernardino	Narayanaswamy, VP (corresponding author), Synedgen Inc, Claremont, CA 91711 USA.	vn@synedgen.com		Uhrig, John/0000-0001-7630-0921; Narayanaswamy, Vidya/0000-0002-9165-5672; Baker, Shenda/0000-0002-9985-473X	Synedgen Inc.	Synedgen Inc.	The funders, through Synedgen Inc., provided support in the form of salaries for authors SMT, VPN, SG, SMB, and WPW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersson DI, 2011, FEMS MICROBIOL REV, V35, P901, DOI 10.1111/j.1574-6976.2011.00289.x; [Anonymous], 2016, ANT RES; [Anonymous], EXCERPTA MED CURR CL; Aritaka N, 2001, ANTIMICROB AGENTS CH, V45, P1292, DOI 10.1128/AAC.45.4.1292-1294.2001; Barber KE, 2015, J ANTIMICROB CHEMOTH, V70, P311, DOI 10.1093/jac/dku322; BARR JG, 1990, EUR J CLIN MICROBIOL, V9, P804, DOI 10.1007/BF01967378; Baxter RM, 2013, J BIOMED MATER RES A, V101, P340, DOI 10.1002/jbm.a.34328; Bayer AS, 2000, INFECT IMMUN, V68, P3548, DOI 10.1128/IAI.68.6.3548-3553.2000; Besier S, 2005, ANTIMICROB AGENTS CH, V49, P1426, DOI 10.1128/AAC.49.4.1426-1431.2005; Burkatovskaya M, 2006, BIOMATERIALS, V27, P4157, DOI 10.1016/j.biomaterials.2006.03.028; Centers for Disease Control and Prevention, BIGG THREATS; Claudia S, 2015, PLOS ONE, V10; Climo MW, 1999, ANTIMICROB AGENTS CH, V43, P1747, DOI 10.1128/AAC.43.7.1747; Dasenbrook EC, 2010, JAMA-J AM MED ASSOC, V303, P2386, DOI 10.1001/jama.2010.791; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Dawson RM, 2011, INT J ANTIMICROB AG, V37, P432, DOI 10.1016/j.ijantimicag.2011.01.007; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Doring G, 2012, J CYST FIBROS, V11, P461, DOI 10.1016/j.jcf.2012.10.004; Domaracki BE, 1998, EUR J CLIN MICROBIOL, V17, P143; dosSantos KRN, 1996, INFECT CONT HOSP EP, V17, P813; Drago L, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-111; Eliopoulos G.M., 1991, ANTIBIOTICS LAB MED, V3rd Edn, P432; Farrell DJ, 2011, ANTIMICROB AGENTS CH, V55, P1177, DOI 10.1128/AAC.01285-10; Fischer TH, 2007, J BIOMED MATER RES A, V80A, P167, DOI 10.1002/jbm.a.30877; Frank PT, ANTIBIOTIC THERAPY M, V24, P249; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Gisby J, 2000, ANTIMICROB AGENTS CH, V44, P255, DOI 10.1128/AAC.44.2.255-260.2000; Han LL, 2007, J CLIN MICROBIOL, V45, P1350, DOI 10.1128/JCM.02274-06; Ho TT, 2012, J ANTIMICROB CHEMOTH, V67, P1267, DOI 10.1093/jac/dks006; Hurdle JG, 2004, ANTIMICROB AGENTS CH, V48, P4366, DOI 10.1128/AAC.48.11.4366-4376.2004; Jain R, 2014, PHARMACOTHERAPY, V34, P758, DOI 10.1002/phar.1435; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; Kollef MH, 2007, CLIN INFECT DIS, V45, pS191, DOI 10.1086/519470; Kubicek-Sutherland JZ, 2017, J ANTIMICROB CHEMOTH, V72, P115, DOI 10.1093/jac/dkw381; Kumar A, 2010, CRIT CARE MED, V38, P1773, DOI 10.1097/CCM.0b013e3181eb3ccd; Liu C, 2008, CLIN INFECT DIS, V46, P1637, DOI 10.1086/587893; Maddin S, 1987, CONT DERMATOL    JUN, P32; MCRIPLEY RJ, 1976, ANTIMICROB AGENTS CH, V10, P38, DOI 10.1128/AAC.10.1.38; Meletiadis J, 2010, ANTIMICROB AGENTS CH, V54, P602, DOI 10.1128/AAC.00999-09; Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260; Mishra NN, IN VITRO CROSS RESIS; Mohamed MF, 2016, SCI REP-UK, V6, DOI 10.1038/srep29707; Narayanaswamy VP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179776; National Committee for Clinical Laboratory Standards, 2013, M100S23 CLSI; Nawrocki KL, 2014, ANTIBIOTICS-BASEL, V3, P461, DOI 10.3390/antibiotics3040461; Nilsson AI, 2006, P NATL ACAD SCI USA, V103, P6976, DOI 10.1073/pnas.0602171103; Noble L, 1999, INT J PHARM, V192, P173, DOI 10.1016/S0378-5173(99)00306-3; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Pulido MR, 2013, J ANTIMICROB CHEMOTH, V68, P2710, DOI 10.1093/jac/dkt253; Reddy C. M., 2012, WORLD J SCI TECHNOLO, V2, P6; Rimawi RH, 2013, J CLIN PHARM THER, V38, P330, DOI 10.1111/jcpt.12062; Seah C, 2012, ANTIMICROB AGENTS CH, V56, P1916, DOI 10.1128/AAC.05325-11; Svetitsky S, 2009, ANTIMICROB AGENTS CH, V53, P4069, DOI 10.1128/AAC.00341-09; Tabuchi F, 2017, J ANTIBIOT, V70, P771, DOI 10.1038/ja.2017.7; Tang H, 2010, ACTA BIOMATER, V6, P2562, DOI 10.1016/j.actbio.2010.01.002; Thangamani S, 2016, SCI REP-UK, V6, DOI 10.1038/srep22571; VANBLITTERSWIJK WJ, 1987, BIOCHEMISTRY-US, V26, P1746, DOI 10.1021/bi00380a038; Vasquez JE, 2000, INFECT CONT HOSP EP, V21, P459, DOI 10.1086/501788; Wertheim HFL, 2004, ANN INTERN MED, V140, P419, DOI 10.7326/0003-4819-140-6-200403160-00007; Yam FK, 2014, AM J HEALTH-SYST PH, V71, P1457, DOI 10.2146/ajhp130474	61	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191522	10.1371/journal.pone.0191522	http://dx.doi.org/10.1371/journal.pone.0191522			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342216	Green Submitted, gold, Green Published			2022-12-26	WOS:000422653800070
J	Legras, R; Gaudric, A; Woog, K				Legras, Richard; Gaudric, Alain; Woog, Kelly			Distribution of cone density, spacing and arrangement in adult healthy retinas with adaptive optics flood illumination	PLOS ONE			English	Article							PHOTORECEPTOR PACKING DENSITY; AXIAL LENGTH; ECCENTRICITY; VARIABILITY; TOPOGRAPHY; IMAGES; EYE	The aim of this article is to analyse cone density, spacing and arrangement using an adaptive optics flood illumination retina camera (rtx1 (TM)) on a healthy population. Cone density, cone spacing and packing arrangements were measured on the right retinas of 109 subjects at 2 degrees, 3 degrees, 4 degrees, 5 degrees and 6 degrees of eccentricity along 4 meridians. The effects of eccentricity, meridian, axial length, spherical equivalent, gender and age were evaluated. Cone density decreased on average from 28 884 +/- 3 692 cones/mm(2), at 2 degrees of eccentricity, to 15 843 +/- 1 598 cones/mm(2) at 6 degrees. A strong inter-individual variation, especially at 2, was observed. No important difference of cone density was observed between the nasal and temporal meridians or between the superior and inferior meridians. However, the horizontal and vertical meridians differed by around 14%(T-test, p<0.0001). Cone density, expressed in units of area, decreased as a function of axial length (r(2) = 0.60), but remained constant (r(2) = 0.05) when cone density is expressed in terms of visual angle supporting the hypothesis that the retina is stretched during the elongation of the eyeball. Gender did not modify the cone distribution. Cone density was slightly modified by age but only at 2 degrees. The older group showed a smaller density (7%). Cone spacing increased from 6,49 +/- 0,42 pm to 8,72 +/- 0,45 pm respectively between 2 degrees and 6 degrees of eccentricity. The mosaic of the retina is mainly triangularly arranged (i.e. cells with 5 to 7 neighbors) from 2 degrees to 6 degrees. Around half of the cells had 6 degrees neighbors.	[Legras, Richard; Woog, Kelly] Univ Paris Saclay, Univ Paris Sud, CNRS, Lab Aime Cotton,ENS Paris Saclay, Orsay, France; [Gaudric, Alain] Univ Paris Diderot, Hop Lariboisiere, AP HP, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Legras, R (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, Lab Aime Cotton,ENS Paris Saclay, Orsay, France.	richard.legras@u-psud.fr	LEGRAS, Richard/ABE-3424-2021	Gaudric, Alain/0000-0002-2486-4722; Legras, Richard/0000-0002-1430-3649	Initiative Doctorale Interdisciplinaire grant	Initiative Doctorale Interdisciplinaire grant	This project was founded by the Conseil General de l'Essonne (Action de Soutien a la Technologie eta la Recherche en Essonne) and by Imagine Eyes, Orsay, France. This research was supported by an Initiative Doctorale Interdisciplinaire grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altpeter E, 2000, VISION RES, V40, P1539, DOI 10.1016/S0042-6989(00)00059-6; Chui TYP, 2008, INVEST OPHTH VIS SCI, V49, P4679, DOI 10.1167/iovs.08-2135; Chui TYP, 2008, J OPT SOC AM A, V25, P3021, DOI 10.1364/JOSAA.25.003021; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; da Costa BLSA, 2000, VISION RES, V40, P2395, DOI 10.1016/S0042-6989(00)00104-8; Dabir S, 2014, EYE, V28, P1488, DOI 10.1038/eye.2014.229; Dabir S, 2015, INDIAN J OPHTHALMOL, V63, P423, DOI 10.4103/0301-4738.159876; DEBERG M, 2000, COMPUTATIONAL GEOMET; Feng S, 2015, INVEST OPHTH VIS SCI, V56, P5751, DOI 10.1167/iovs.15-16954; Garnier MB, 2014, CLIN EXP OPHTHALMOL, V42, P833, DOI 10.1111/ceo.12356; Garrioch R, 2012, OPTOMETRY VISION SCI, V89, P632, DOI 10.1097/OPX.0b013e3182540562; Guez J.-E., 1995, VISION RES S, V35, pS80; Jacob J, 2017, OSLI RETINA, V48, P45, DOI 10.3928/23258160-20161219-06; Kitaguchi Y, 2007, JPN J OPHTHALMOL, V51, P456, DOI 10.1007/s10384-007-0477-7; KUAN DT, 1985, IEEE T PATTERN ANAL, V7, P165, DOI 10.1109/TPAMI.1985.4767641; Li KY, 2007, J OPT SOC AM A, V24, P1358, DOI 10.1364/JOSAA.24.001358; Li KY, 2010, INVEST OPHTH VIS SCI, V51, P6858, DOI 10.1167/iovs.10-5499; Lindeberg T., 1994, SCALE SPACE THEORY C; Lombardo M, 2011, OPHTALMOLOGY; Lombardo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107402; Lombardo M, 2013, RETINA-J RET VIT DIS, V33, P1640, DOI 10.1097/IAE.0b013e3182807642; Lombardo M, 2013, OPHTHAL PHYSL OPT, V33, P516, DOI 10.1111/opo.12053; Lombardo M, 2012, J CATARACT REFR SURG, V38, P1147, DOI 10.1016/j.jcrs.2012.02.033; Muthiah MN, 2014, BRIT J OPHTHALMOL, V98, P1073, DOI 10.1136/bjophthalmol-2013-304615; Obata R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091873; Osterberg G., 1935, ACTA OPHTHALMOL, V6, P11; PandaJonas S, 1995, OPHTHALMOLOGY, V102, P1853, DOI 10.1016/S0161-6420(95)30784-1; Park SP, 2013, EXP EYE RES, V108, P1, DOI 10.1016/j.exer.2012.12.011; Rees AL, 2005, INT C SER, V1282, P694, DOI DOI 10.1016/JICS.2005.05.172; Song HX, 2011, INVEST OPHTH VIS SCI, V52, P7376, DOI 10.1167/iovs.11-7199; Supriya D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/968672; Talcott KE, 2011, INVEST OPHTH VIS SCI, V52, P2219, DOI 10.1167/iovs.10-6479; Viard C, 2011, PROC SPIE, V7885, DOI 10.1117/12.874766; Wells-Gray EM, 2016, EYE, V30, P1135, DOI 10.1038/eye.2016.107; Wilkinson MO, 2016, J VISION, V16, DOI 10.1167/16.2.1; Zhang TJ, 2015, AM J OPHTHALMOL, V160, P290, DOI 10.1016/j.ajo.2015.04.034	38	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191141	10.1371/journal.pone.0191141	http://dx.doi.org/10.1371/journal.pone.0191141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338027	Green Published, Green Submitted, gold			2022-12-26	WOS:000422652700032
J	Eyring, KR; Pedersen, BS; Maclean, KN; Stabler, SP; Yang, IV; Schwartz, DA				Eyring, Kenneth R.; Pedersen, Brent S.; Maclean, Kenneth N.; Stabler, Sally P.; Yang, Ivana V.; Schwartz, David A.			Methylene-tetrahydrofolate reductase contributes to allergic airway disease	PLOS ONE			English	Article							NUCLEOTIDE-RELEASING PROTEIN; DNA METHYLATION; CELL FUNCTION; TRANSCRIPTION FACTORS; C677T POLYMORPHISM; T-CELLS; ASTHMA; EXPRESSION; FOLATE; EXPOSURE	Rationale Environmental exposures strongly influence the development and progression of asthma. We have previously demonstrated that mice exposed to a diet enriched with methyl donors during vulnerable periods of fetal development can enhance the heritable risk of allergic airway disease through epigenetic changes. There is conflicting evidence on the role of folate (one of the primary methyl donors) in modifying allergic airway disease. Objectives We hypothesized that blocking folate metabolism through the loss of methylene-tetrahydrofolate reductase (Mthfr) activity would reduce the allergic airway disease phenotype through epigenetic mechanisms. Methods Allergic airway disease was induced in C57BL/6 and C57BL/6(Mthfr-/-) mice through house dust mite (HDM) exposure. Airway inflammation and airway hyperresponsiveness (AHR) were measured between the two groups. Gene expression and methylation profiles were generated for whole lung tissue. Disease and molecular outcomes were evaluated in C57BL/6 and C57BL/6(Mthfr-/-) mice supplemented with betaine. Measurements and main results Loss of Mthfr alters single carbon metabolite levels in the lung and serum including elevated homocysteine and cystathionine and reduced methionine. HDM-treated C57BL/6(Mthfr-/-) mice demonstrated significantly less airway hyperreactivity (AHR) compared to HDM-treated C57BL/6 mice. Furthermore, HDM-treated C57BL/6(Mthfr-/-) mice compared to HDM-treated C57BL/6 mice have reduced whole lung lavage (WLL) cellularity, eosinophilia, and II-4/II-5 cytokine concentrations. Betaine supplementation reversed parts of the HDM-induced allergic airway disease that are modified by Mthfr loss. 737 genes are differentially expressed and 146 regions are differentially methylated in lung tissue from HDM-treated C57BL/6(Mthfr-/-) mice and HDM-treated C57BL/6 mice. Additionally, analysis of methylation/expression relationships identified 503 significant correlations. Conclusion Collectively, these findings indicate that the loss of folate as a methyl donor is a modifier of allergic airway disease, and that epigenetic and expression changes correlate with this modification. Further investigation into the mechanisms that drive this observation is warranted.	[Eyring, Kenneth R.; Pedersen, Brent S.; Stabler, Sally P.; Yang, Ivana V.; Schwartz, David A.] Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA; [Maclean, Kenneth N.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA; [Schwartz, David A.] Univ Colorado, Sch Med, Dept Immunol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Schwartz, DA (corresponding author), Univ Colorado, Sch Med, Dept Med, Aurora, CO 80045 USA.; Schwartz, DA (corresponding author), Univ Colorado, Sch Med, Dept Immunol, Aurora, CO 80045 USA.	david.schwartz@ucdenver.edu	Yang, Ivana V/P-3059-2018	Yang, Ivana V/0000-0002-1018-489X; Eyring, Kenneth/0000-0003-4163-5435	National Institute of Health, National Institute of Environmental Health Sciences [P01-ES18181]; National Institute of Health, National Heart, Lung, and Blood Institute [R01-HL101251]	National Institute of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Health, National Institute of Environmental Health Sciences, P01-ES18181 (http://www.niehs.nih.gov/) to DA and the National Institute of Health, National Heart, Lung, and Blood Institute, R01-HL101251 (http://www.nhibi.nih.gov/) to DA and IVY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allis CD, 2007, EPIGENETICS, Vx; Amarasekera M, 2014, FASEB J, V28, P4068, DOI 10.1096/fj.13-249029; Bandyopadhyay S, 2014, MOL CELL BIOL, V34, P233, DOI 10.1128/MCB.00902-13; Bousquet J, 2003, ALLERGY, V58, P265, DOI 10.1034/j.1398-9995.2003.02005.x; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Burney P, 2002, THORAX, V57, P36; de Launoit Y, 1998, ONCOGENE, V16, P2065, DOI 10.1038/sj.onc.1201726; Delaney C, 2012, J NUTR, V142, P1329, DOI 10.3945/jn.111.155903; DeWan AT, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-95; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Dunstan JA, 2003, J ALLERGY CLIN IMMUN, V112, P1178, DOI 10.1016/j.jaci.2003.09.009; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; Fitzsimon N, 2007, Ir Med J, V100, P27; Fodil-Cornu N, 2009, GENES IMMUN, V10, P662, DOI 10.1038/gene.2009.50; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Hancock DB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000623; Harb H, 2016, CURR OPIN PEDIATR, V28, P754, DOI 10.1097/MOP.0000000000000424; Harb H, 2015, INT ARCH ALLERGY IMM, V168, P173, DOI 10.1159/000442158; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Kabesch Michael, 2016, Mol Cell Pediatr, V3, P31, DOI 10.1186/s40348-016-0056-4; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kit BK, 2012, PEDIATRICS, V129, P62, DOI 10.1542/peds.2011-1513; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Knock E, 2008, J NUTR, V138, P653, DOI 10.1093/jn/138.4.653; Kwon NH, 2008, J CLIN IMMUNOL, V28, P139, DOI 10.1007/s10875-007-9148-1; Li LX, 2002, MOL IMMUNOL, V38, P1283, DOI 10.1016/S0161-5890(02)00076-7; Maclean KN, 2012, MOL GENET METAB, V105, P395, DOI 10.1016/j.ymgme.2011.11.190; MARTINEZ FD, 1995, J ALLERGY CLIN IMMUN, V96, P652, DOI 10.1016/S0091-6749(95)70264-4; Meadows DN, 2014, HUM MUTAT, V35, P594, DOI 10.1002/humu.22533; Mehta AK, 2010, IMMUNOBIOLOGY, V215, P527, DOI 10.1016/j.imbio.2009.09.004; Patel SR, 2012, MOL CELL, V45, P185, DOI 10.1016/j.molcel.2011.11.007; Pedersen BS, 2014, ARXIV, P1; Pham D, 2014, J ALLERGY CLIN IMMUN, V134, P204, DOI 10.1016/j.jaci.2013.12.021; SAMET JM, 1991, ENVIRON HEALTH PERSP, V95, P71, DOI 10.2307/3431109; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Shin HJ, 2005, J IMMUNOL, V175, P7143, DOI 10.4049/jimmunol.175.11.7143; Smith M, 2008, J ALLERGY CLIN IMMUN, V121, P1460, DOI 10.1016/j.jaci.2008.03.025; Sofer T, 2013, BIOINFORMATICS, V29, P2884, DOI 10.1093/bioinformatics/btt498; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Stevens Richard L, 2005, Novartis Found Symp, V271, P54; Stevens RL, 2005, NOVART FDN SYMP, V271, P77; Stevens RL, 2005, NOVART FDN SYMP, V271, P95; TANG MLK, 1994, LANCET, V344, P983, DOI 10.1016/S0140-6736(94)91641-1; Thuesen BH, 2010, BRIT J NUTR, V103, P1195, DOI 10.1017/S0007114509992947; Thuesen BH, 2009, CLIN RESPIR J, V3, P102, DOI 10.1111/j.1752-699X.2009.00128.x; Toniutto P, 2008, LIVER INT, V28, P257, DOI 10.1111/j.1478-3231.2007.01591.x; van der Valk RJP, 2013, ALLERGY, V68, P788, DOI 10.1111/all.12146; Vuillermin PJ, 2009, ALLERGY, V64, P348, DOI 10.1111/j.1398-9995.2009.01970.x; WAINFAN E, 1989, CANCER RES, V49, P4094; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Williams CL, 2013, J IMMUNOL, V191, P678, DOI 10.4049/jimmunol.1203360; WILSON MJ, 1984, BIOCHEM J, V218, P987, DOI 10.1042/bj2180987; Yerkovich ST, 2007, PEDIATR RES, V62, P547, DOI 10.1203/PDR.0b013e3181568105; Zhu MH, 2012, J BIOL CHEM, V287, P8135, DOI 10.1074/jbc.M111.320580; Zou Chao-chun, 2003, Zhonghua Jiehe He Huxi Zazhi, V26, P161	55	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190916	10.1371/journal.pone.0190916	http://dx.doi.org/10.1371/journal.pone.0190916			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329322	Green Submitted, Green Published, gold			2022-12-26	WOS:000419954100027
J	Ting, JP; Tung, F; Antonysamy, S; Wasserman, S; Jones, SB; Zhang, FF; Espada, A; Broughton, H; Chalmers, MJ; Woodman, ME; Bina, HA; Dodge, JA; Benach, J; Zhang, AP; Groshong, C; Manglicmot, D; Russell, M; Afshar, S				Ting, Joey P.; Tung, Frances; Antonysamy, Stephen; Wasserman, Stephen; Jones, Spencer B.; Zhang, Feiyu F.; Espada, Alfonso; Broughton, Howard; Chalmers, Michael J.; Woodman, Michael E.; Bina, Holly A.; Dodge, Jeffrey A.; Benach, Jordi; Zhang, Aiping; Groshong, Christopher; Manglicmot, Danalyn; Russell, Marijane; Afshar, Sepideh			Utilization of peptide phage display to investigate hotspots on IL-17 A and what it means for drug discovery	PLOS ONE			English	Article								To date, IL-17A antibodies remain the only therapeutic approach to correct the abnormal activation of the IL-17A/IL-17R signaling complex. Why is it that despite the remarkable success of IL-17 antibodies, there is no small molecule antagonist of IL-17A in the clinic? Here we offer a unique approach to address this question. In order to understand the interaction of IL-17A with its receptor, we combined peptide discovery using phage display with HDX, crystallography, and functional assays to map and characterize hot regions that contribute to most of the energetics of the IL-17A/IL-17R interaction. These functional maps are proposed to serve as a guide to aid in the development of small molecules that bind to IL-17A and block its interaction with IL-17RA.	[Ting, Joey P.; Afshar, Sepideh] Eli Lilly Biotechnol Ctr, Dept Prot Engn, San Diego, CA 92121 USA; [Tung, Frances; Antonysamy, Stephen; Zhang, Feiyu F.; Zhang, Aiping; Groshong, Christopher; Manglicmot, Danalyn; Russell, Marijane] Eli Lilly & Co, Dept Struct Biol, Lilly Biotechnol Ctr, Discovery Chem Res & Technol, San Diego, CA USA; [Wasserman, Stephen; Benach, Jordi] Eli Lilly & Co, Adv Photon Source, Dept Struct Biol, Discovery Chem Res & Technol, Argonne, IL USA; [Jones, Spencer B.; Chalmers, Michael J.; Woodman, Michael E.; Bina, Holly A.; Dodge, Jeffrey A.] Lilly Res Labs, Indianapolis, IN USA; [Espada, Alfonso; Broughton, Howard] Ctr Invest Lilly, Alcobendas, Spain	Eli Lilly; Eli Lilly; Eli Lilly; United States Department of Energy (DOE); Argonne National Laboratory; Eli Lilly	Afshar, S (corresponding author), Eli Lilly Biotechnol Ctr, Dept Prot Engn, San Diego, CA 92121 USA.	s.afshar@lilly.com		Chalmers, Michael/0000-0002-2139-6089	Eli Lilly Company	Eli Lilly Company(Eli Lilly)	This research was funded by Eli Lilly & Company. The funder provided support in the form of salaries for authors [JPT, FT, SA, SW, SBJ, FFZ, AE, HB, MJC, HAB, MW, JAD, JB, AZ, CG, DM, MR, & SA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar S, 2016, INVENTORPHAGE DISPLA; [Anonymous], 2013, OA ARTHRITIS; [Anonymous], 2013, ACR ANN M; Atwell S, 1997, SCIENCE, V278, P1125, DOI 10.1126/science.278.5340.1125; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Campa M, 2016, DERMATOLOGY THER, V6, P1, DOI 10.1007/s13555-015-0092-3; Cummins DJ, 2016, ANAL CHEM, V88, P6607, DOI 10.1021/acs.analchem.6b01650; Duncan E, 2016, NAT REV DRUG DISCOV, V15, P533; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espada A, 2016, J MED CHEM, V59, P2255, DOI 10.1021/acs.jmedchem.5b01693; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Huang KPRenhua, 2011, AMINO ACIDS PEPTIDES; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Liu L, 2016, J INFLAMM RES, V9, P39, DOI [10.2147/JIR.S100940, 10.3993/jfbim00203]; Liu SP, 2016, SCI REP-UK, V6, DOI 10.1038/srep30859; Liu SP, 2016, SCI REP-UK, V6, DOI 10.1038/srep26071; Liu SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2880; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Pascal SW Bruce D., 2013, J AM SOC MASS SPECTO, V23, P1; Pelletier J, 2001, CURR OPIN BIOTECH, V12, P340, DOI 10.1016/S0958-1669(00)00225-1; SACHDEV S., 2000, METHOD ENZYMOL, V328, P333; Sachdev S., 2004, J MOL BIOL, V338, P299, DOI DOI 10.HTTPS://D0I.0RG/10.1016/J.JMB.2004.02.050; Saltzberg DJ, 2017, J PHYS CHEM B, V121, P3493, DOI 10.1021/acs.jpcb.6b09358; Sarah LG, 2014, NAT REV IMMUNOL, V14, P585; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wu H., 2003, SIMULTANEOUS HUMANIZ	30	13	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190850	10.1371/journal.pone.0190850	http://dx.doi.org/10.1371/journal.pone.0190850			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329326	Green Published, Green Submitted, gold			2022-12-26	WOS:000419954100025
J	Heijne, M; van der Goot, JA; Fijten, H; van der Giessen, JW; Kuijt, E; Maassen, CBM; van Roon, A; Wit, B; Koets, AP; Roest, HIJ				Heijne, Marloes; van der Goot, Jeanet A.; Fijten, Helmi; van der Giessen, Joke W.; Kuijt, Eric; Maassen, Catharina B. M.; van Roon, Annika; Wit, Ben; Koets, Ad P.; Roest, Hendrik I. J.			A cross sectional study on Dutch layer farms to investigate the prevalence and potential risk factors for different Chlamydia species	PLOS ONE			English	Article							PSITTACI INFECTIONS; C. GALLINACEA; PATHOLOGY; SAMPLES; CATTLE; DNA	In poultry several Chlamydia species have been detected, but Chlamydia psittaci and Chlamydia gallinacea appear to be most prevalent and important. Chlamydia psittaci is a well-known zoonosis and is considered to be a pathogen of poultry. Chlamydia gallinacea has been described more recently. Its avian pathogenicity and zoonotic potential have to be further elucidated. Within the Netherlands no data were available on the presence of Chlamydia on poultry farms. As part of a surveillance programme for zoonotic pathogens in farm animals, we investigated pooled faecal samples from 151 randomly selected layer farms. On a voluntary base, 69 farmers, family members or farm workers from these 151 farms submitted a throat swab. All samples were tested with a generic 23S Chlamydiaceae PCR followed by a species specific PCR for C. avium, C. gallinacea and C. psittaci. C. avium and psittaci DNA was not detected at any of the farms. At 71 farms the positive result could be confirmed as C. gallinacea. Variables significantly associated with the presence of C. gallinacea in a final multivariable model were 'ge of hens,' 'use of bedding material' and 'the presence of horses.' The presence of C. gallinacea was associated with neither clinical signs, varying from respiratory symptoms, nasal and ocular discharges to diarrhoea, nor with a higher mortality rate the day before the visit. All throat swabs from farmers, family members or farm workers tested negative for Chlamydia DNA, giving no further indication for possible bird-to-human (or human-to-bird) transmission.	[Heijne, Marloes; van der Goot, Jeanet A.; van der Giessen, Joke W.; Koets, Ad P.; Roest, Hendrik I. J.] Wageningen Biovet Res, Dept Bacteriol & Epidemiol, Lelystad, Netherlands; [Fijten, Helmi; Kuijt, Eric] Wageningen Biovet Res, Dept Infect Biol, Lelystad, Netherlands; [van der Giessen, Joke W.; Maassen, Catharina B. M.; van Roon, Annika] Natl Inst Publ Hlth & Environm RIVM, Ctr Zoonoses & Environm Microbiol, Bilthoven, Netherlands; [Wit, Ben] Food & Consumer Prod Safety Author NVWA, Consumer & Safety Div, Utrecht, Netherlands; [Koets, Ad P.] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands	Wageningen University & Research; Wageningen University & Research; Netherlands National Institute for Public Health & the Environment; Utrecht University	Heijne, M (corresponding author), Wageningen Biovet Res, Dept Bacteriol & Epidemiol, Lelystad, Netherlands.	marloes.heijne@wur.nl	Heijne, Marloes/ABC-1819-2021	Heijne, Marloes/0000-0002-6314-1869	Food and Consumer Product Safety Authority (NVWA); public-private-partnership: "1H4F-Chlamydia and respiratory problems in poultry" [TKI-AF-14212]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000063, Z01DC000063] Funding Source: NIH RePORTER	Food and Consumer Product Safety Authority (NVWA); public-private-partnership: "1H4F-Chlamydia and respiratory problems in poultry"; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was partly financed by the Food and Consumer Product Safety Authority (NVWA) and partly as a public-private-partnership: "1H4F-Chlamydia and respiratory problems in poultry" (TKI-AF-14212, http://www.1health4food.nl/nl/show/Chlamydia-en-respiratoire-problemen-in-pluimvee-.htm).	Andersen AA, 1996, J VET DIAGN INVEST, V8, P448, DOI 10.1177/104063879600800407; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; Freidl GS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174796; Guo WN, 2016, SCI REP-UK, V6, DOI 10.1038/srep19638; Hewinson RG, 1997, VET MICROBIOL, V54, P155, DOI 10.1016/S0378-1135(96)01268-0; Hulin V, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv005; Kaleta EF, 2003, AVIAN PATHOL, V32, P435, DOI 10.1080/03079450310001593613; Lagae S, 2014, J MED MICROBIOL, V63, P399, DOI 10.1099/jmm.0.064675-0; Laroucau K, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.24.21155; Laroucau K, 2009, INFECT GENET EVOL, V9, P1240, DOI 10.1016/j.meegid.2009.08.005; Li J, 2016, VET MICROBIOL, V193, P93, DOI 10.1016/j.vetmic.2016.08.008; Pantchev A, 2010, COMP IMMUNOL MICROB, V33, P473, DOI 10.1016/j.cimid.2009.08.002; Pantchev A, 2009, VET J, V181, P145, DOI 10.1016/j.tvjl.2008.02.025; Reinhold P, 2011, VET J, V189, P257, DOI 10.1016/j.tvjl.2010.09.003; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Sachse K, 2015, CURR CLIN MICROBIOL, V2, P10, DOI 10.1007/s40588-014-0010-y; Sachse K, 2014, SYST APPL MICROBIOL, V37, P79, DOI 10.1016/j.syapm.2013.12.004; Salisch H, 1996, WORLD POULTRY SCI J, V52, P279, DOI 10.1079/WPS19960021; Smit LAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038843; SUWA T, 1990, JPN J VET SCI, V52, P275; Yin LZ, 2013, VET MICROBIOL, V162, P740, DOI 10.1016/j.vetmic.2012.09.026; Zocevic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058741	22	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190774	10.1371/journal.pone.0190774	http://dx.doi.org/10.1371/journal.pone.0190774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324884	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400056
J	Saliba, W; Rennert, HS; Gronich, N; Gruber, SB; Rennert, G				Saliba, Walid; Rennert, Hedy S.; Gronich, Naomi; Gruber, Stephen B.; Rennert, Gad			Association of atrial fibrillation and cancer: Analysis from two large population-based case-control studies	PLOS ONE			English	Article							COLORECTAL-CANCER; NATRIURETIC-PEPTIDE; BREAST-CANCER; CHA(2)DS(2)-VASC SCORES; RISK-FACTOR; METAANALYSIS; PERFORMANCE; PREVENTION; PREDICTION; CHADS(2)	Background An association between atrial fibrillation (AF) and risk of cancer has been suggested in several studies, including prospective cohort studies. However, the magnitude and the temporal nature of this association remain unclear. Methods Data from two large prospective population-based case-control studies, the Molecular Epidemiology of Colorectal Cancer (MECC, n = 8,383) and the Breast Cancer in Northern Israel Study (BCINIS, n = 11,608), were used to better understand the nature and temporality of a possible association between cancer diagnosis and AF events before and after cancer diagnosis. A case-control study approach was employed to study prior AF as a risk factor for cancer, and a cohort study approach was employed to study incident cancer as a risk factor for AF. Results AF was associated with a significant reduced odds of cancer as reflected in the case-control approach, with an adjusted OR = 0.77 (95% CI, 0.65-0.91), while cancer was not found to be significantly associated with elevated risk of AF in the cohort approach, with an adjusted HR = 1.10 (0.98-1.23). The immediate period (90 days) after an AF event was associated with a 1.85 times increased risk of cancer, and the immediate period after the diagnosis of cancer was associated with a 3.4 fold increased risk of AF. These findings probably reflect both the effect of acute transient conditions associated with new cancer diagnosis and detection bias. Similar results were identified with colorectal and breast cancer cases. Conclusions Atrial fibrillation of longer than 90 days duration is associated with reduced odds of new cancer diagnosis. The results of this study suggest that an association observed in prior research may be due to instances related to cancer diagnosis and detection bias rather than a causal relationship. However, there may be bias in the sampling and residual confounding that distort the associations.	[Saliba, Walid; Rennert, Hedy S.; Gronich, Naomi; Rennert, Gad] Lady Davis Carmel Med Ctr, Dept Community Med & Epidemiol, Haifa, Israel; [Saliba, Walid; Rennert, Hedy S.; Gronich, Naomi; Rennert, Gad] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Saliba, Walid; Rennert, Hedy S.; Gronich, Naomi; Rennert, Gad] Clalit Natl Canc Control Ctr, Haifa, Israel; [Gruber, Stephen B.] Univ Southern Calif, USC Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Gruber, Stephen B.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA	Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Southern California; University of Southern California	Saliba, W (corresponding author), Lady Davis Carmel Med Ctr, Dept Community Med & Epidemiol, Haifa, Israel.; Saliba, W (corresponding author), Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel.; Saliba, W (corresponding author), Clalit Natl Canc Control Ctr, Haifa, Israel.	saliba_wa@clalit.org.il		Rennert, Gad/0000-0002-8512-068X	National Institute of Health [R01 CA81488]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded in part by the National Institute of Health R01 CA81488 to SG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Conen D, 2016, JAMA CARDIOL, V1, P389, DOI 10.1001/jamacardio.2016.0280; Emilsson L, 2017, ALIMENT PHARM THER, V45, P193, DOI 10.1111/apt.13857; Erichsen R, 2012, INTERN EMERG MED, V7, P431, DOI 10.1007/s11739-011-0701-9; Farmakis D, 2014, J AM COLL CARDIOL, V63, P945, DOI 10.1016/j.jacc.2013.11.026; Ford AC, 2008, GUT, V57, P1545, DOI 10.1136/gut.2008.159723; Gronich N, 2015, DIABETES CARE, V38, P1657, DOI 10.2337/dc14-2515; Guzzetti S, 2002, AM J MED, V112, P587, DOI 10.1016/S0002-9343(02)01029-X; Guzzetti S, 2008, INTERN EMERG MED, V3, P227, DOI 10.1007/s11739-008-0124-4; Guzzetti Stefano, 2003, Recenti Progressi in Medicina, V94, P260; Haim M, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001486; Inadomi JM, 2017, NEW ENGL J MED, V376, P149, DOI 10.1056/NEJMcp1512286; Kershenbaum A, 2013, EUR J CANCER, V49, P923, DOI 10.1016/j.ejca.2012.09.020; Kershenbaum A, 2010, DIS COLON RECTUM, V53, P224, DOI 10.1007/DCR.0b013e3181b9d89e; Levin ER, 1998, NEW ENGL J MED, V339, P321; Link MS, 2016, CIRCULATION, V134, P339, DOI 10.1161/CIRCULATIONAHA.116.021727; Lip GYH, 2006, HEART, V92, P155, DOI 10.1136/hrt.2005.066944; Lobo RA., 2016, NAT REV ENDOCRINOL; Moslehi JJ, 2016, NEW ENGL J MED, V375, P1457, DOI 10.1056/NEJMra1100265; Nojiri T, 2015, P NATL ACAD SCI USA, V112, P4086, DOI 10.1073/pnas.1417273112; O'Neal WT, 2015, AM J CARDIOL, V115, P1090, DOI 10.1016/j.amjcard.2015.01.540; Ostenfeld EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102861; Poynter JN, 2005, NEW ENGL J MED, V352, P2184, DOI 10.1056/NEJMoa043792; Rennert G, 2010, J CLIN ONCOL, V28, P3577, DOI 10.1200/JCO.2010.28.1113; Rennert G, 2009, J CLIN ONCOL, V27, P4542, DOI 10.1200/JCO.2009.22.0764; Rossi A, 2000, J AM COLL CARDIOL, V35, P1256, DOI 10.1016/S0735-1097(00)00515-5; Saliba W, 2016, J THROMB HAEMOST, V14, P1155, DOI 10.1111/jth.13324; Saliba W, 2016, AM J MED, V129, P843, DOI 10.1016/j.amjmed.2016.02.029; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Serafino A, 2012, BBA-MOL BASIS DIS, V1822, P1004, DOI 10.1016/j.bbadis.2012.02.016; Veronesi U, 2007, J NATL CANCER I, V99, P727, DOI 10.1093/jnci/djk154; Vesely DL, 2016, ANTICANCER RES, V36, P5693, DOI 10.21873/anticanres.11152; Vesely DL, 2009, J INVEST MED, V57, P22, DOI 10.2310/JIM.0b013e3181948b25; Wilkins MR, 1997, LANCET, V349, P1307, DOI 10.1016/S0140-6736(96)07424-7	34	17	18	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190324	10.1371/journal.pone.0190324	http://dx.doi.org/10.1371/journal.pone.0190324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324747	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400029
J	Brauge, T; Faille, C; Sadovskaya, I; Charbit, A; Benezech, T; Shen, Y; Loessner, MJ; Bautista, JR; Midelet-Bourdin, G				Brauge, Thomas; Faille, Christine; Sadovskaya, Irina; Charbit, Alain; Benezech, Thierry; Shen, Yang; Loessner, Martin J.; Bautista, Jean Romain; Midelet-Bourdin, Graziella			The absence of N-acetylglucosamine in wall teichoic acids of Listeria monocytogenes modifies biofilm architecture and tolerance to rinsing and cleaning procedures	PLOS ONE			English	Article							STAINLESS-STEEL; PHYSICOCHEMICAL PROPERTIES; NONCULTURABLE STATE; CONTACT SURFACES; BACILLUS SPORES; FORM BIOFILMS; ADHESION; ABILITY; GROWTH; WATER	The wall teichoic acid (WTA) is the major carbohydrate found within the extracellular matrix of the Listeria monocytogenes biofilm. We first addressed the frequency of spontaneous mutations in two genes (lmo2549 and lmo2550) responsible for the GlcNAcylation in 93 serotype 1/2a strains that were mainly isolated from seafood industries. We studied the impact of mutations in lmo2549 or lmo2550 genes on biofilm formation by using one mutant carrying a natural mutation inactivating the lmo2550 gene (DSS 1130 BFA2 strain) and two EGD-e mutants that lack respective genes by in-frame deletion of lmo2549 or lmo2550 using splicing-by-overlap-extension PCR, followed by allelic exchange mutagenesis. The lmo2550 gene mutation, occurring in around 50% isolates, caused a decrease in bacterial adhesion to stainless steel compared to wild-type EGD-e strain during the adhesion step. On the other hand, bacterial population weren't significantly different after 24h-biofilm formation. The biofilm architecture was different between the wild-type strain and the two mutants inactivated for lmo2549 or lmo2550 genes respectively with the presence of bacterial microcolonies for mutants which were not observed in the wild-type EGD-e strain biofilm. These differences might account for the stronger hydrophilic surface exhibited by the mutant cells. Upon a water flow or to a cleaning procedure at a shear stress of 0.16 Pa, the mutant biofilms showed the higher detachment rate compared to wild-type strain. Meanwhile, an increase in the amount of residual viable but non-culturable population on stainless steel was recorded in two mutants. Our data suggests that the GlcNAc residue of WTA played a role in adhesion and biofilm formation of Listeria monocyctogenes.	[Brauge, Thomas; Bautista, Jean Romain; Midelet-Bourdin, Graziella] ANSES, Lab Food Safety, Boulogne, France; [Faille, Christine; Benezech, Thierry] Univ Lille 1, CNRS, INRA, UMR UMET, Villeneuve Dascq, France; [Sadovskaya, Irina] Univ Littoral Cote dOpale, Inst Charles Violette EA 7394, USC Anses, Boulogne, France; [Charbit, Alain] CNRS, INSERM, U1151, UMR 8253, Paris, France; [Shen, Yang; Loessner, Martin J.] Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Zurich, Switzerland	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Securite Aliments; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Lille - ISITE; Universite de Lille; Universite du Littoral-Cote-d'Opale; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Swiss Federal Institutes of Technology Domain; ETH Zurich	Midelet-Bourdin, G (corresponding author), ANSES, Lab Food Safety, Boulogne, France.	graziella.bourdin@anses.fr	Brauge, Thomas/AAC-2916-2021; Loessner, Martin J/B-4316-2012; Shen, Yang/X-2665-2018	Brauge, Thomas/0000-0002-7649-3919; Loessner, Martin J/0000-0002-8162-2631; Shen, Yang/0000-0003-4278-1477; Bautista Angeli, Jean-Romain/0000-0002-0235-8909; Graziella, MIDELET/0000-0001-5336-0323; charbit, alain/0000-0001-5243-4861	Region Haut de France	Region Haut de France	This work was a part of T.Brauge's PhD thesis financially supported by Region Haut de France	Ainsworth S, 2014, MBIO, V5, DOI 10.1128/mBio.00880-14; Alonso AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113696; Autret N, 2001, INFECT IMMUN, V69, P2054, DOI 10.1128/IAI.69.4.2054-2065.2001; Besnard V, 2000, FOOD MICROBIOL, V17, P697, DOI 10.1006/fmic.2000.0366; Bos R, 1999, COLLOID SURFACE B, V14, P169, DOI 10.1016/S0927-7765(99)00034-X; Brauge T, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnv229; Briandet R, 1999, APPL ENVIRON MICROB, V65, P5328; Brown S, 2012, P NATL ACAD SCI USA, V109, P18909, DOI 10.1073/pnas.1209126109; Carpentier B, 2011, INT J FOOD MICROBIOL, V145, P1, DOI 10.1016/j.ijfoodmicro.2011.01.005; CDC, 2014, CDC NAT HLTH REP LEA CDC NAT HLTH REP LEA; Chae MS, 2001, FOOD MICROBIOL, V18, P103, DOI 10.1006/fmic.2000.0374; Chavant P, 2002, APPL ENVIRON MICROB, V68, P728, DOI 10.1128/AEM.68.2.728-737.2002; Combrouse T, 2013, J APPL MICROBIOL, V114, P1120, DOI 10.1111/jam.12127; Currie A, 2015, FOODBORNE PATHOG DIS, V12, P645, DOI 10.1089/fpd.2015.1939; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; De Noordhout C Maertens, 2014, LANCET INFECT DIS; Duffy LL, 2009, FOODBORNE PATHOG DIS, V6, P631, DOI 10.1089/fpd.2008.0250; Eugster MR, 2012, J BACTERIOL, V194, P6498, DOI 10.1128/JB.00808-12; Eugster MR, 2011, MOL MICROBIOL, V81, P1419, DOI 10.1111/j.1365-2958.2011.07774.x; Faille C, 2013, FOOD MICROBIOL, V33, P149, DOI 10.1016/j.fm.2012.09.010; Faille C, 2014, BIOFOULING, V30, P845, DOI 10.1080/08927014.2014.939073; Faille C, 2010, INT J FOOD MICROBIOL, V143, P125, DOI 10.1016/j.ijfoodmicro.2010.07.038; Giao MS, 2008, APPL ENVIRON MICROB, V74, P5898, DOI 10.1128/AEM.00827-08; Giao MS, 2014, MICROB ECOL, V67, P603, DOI 10.1007/s00248-013-0364-3; Glaser P, 2001, SCIENCE, V294, P849; Guenther Susanne, 2011, Bacteriophage, V1, P94; Hebraud M, 2000, FEMS MICROBIOL LETT, V190, P29, DOI 10.1016/S0378-1097(00)00310-4; KRYSINSKI EP, 1992, J FOOD PROTECT, V55, P246, DOI 10.4315/0362-028X-55.4.246; LERICHE V, 1995, J FOOD PROTECT, V58, P1186, DOI 10.4315/0362-028X-58.11.1186; Moretro T, 2017, INT J FOOD MICROBIOL, V241, P215, DOI 10.1016/j.ijfoodmicro.2016.10.025; Mullapudi S, 2008, APPL ENVIRON MICROB, V74, P1464, DOI 10.1128/AEM.02426-07; Nogva HK, 2000, APPL ENVIRON MICROB, V66, P4266, DOI 10.1128/AEM.66.10.4266-4271.2000; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Overney A, 2016, INT J FOOD MICROBIOL, V238, P7, DOI 10.1016/j.ijfoodmicro.2016.08.034; Piercey MJ, 2016, INT J FOOD MICROBIOL, V223, P63, DOI 10.1016/j.ijfoodmicro.2016.02.009; Promadej N, 1999, J BACTERIOL, V181, P418, DOI 10.1128/JB.181.2.418-425.1999; Ramamurthy T, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00103; Renier S, 2011, ENVIRON MICROBIOL, V13, P835, DOI 10.1111/j.1462-2920.2010.02378.x; Signoretto C, 2004, APPL ENVIRON MICROB, V70, P6892, DOI 10.1128/AEM.70.11.6892-6896.2004; Silva S, 2008, J FOOD PROTECT, V71, P1379, DOI 10.4315/0362-028X-71.7.1379; Spears PA, 2016, MOL MICROBIOL, V101, P714, DOI 10.1111/mmi.13353; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; UCHIKAWA KI, 1986, J BIOCHEM-TOKYO, V99, P315, DOI 10.1093/oxfordjournals.jbchem.a135486	43	19	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190879	10.1371/journal.pone.0190879	http://dx.doi.org/10.1371/journal.pone.0190879			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320565	Green Published, Green Submitted, gold			2022-12-26	WOS:000419689600071
J	Plummer, SL; Corrigan, F; Thornton, E; Woenig, JA; Vink, R; Cappai, R; Van Den Heuvel, C				Plummer, Stephanie L.; Corrigan, Frances; Thornton, Emma; Woenig, Joshua A.; Vink, Robert; Cappai, Roberto; Van Den Heuvel, Corinna			The amyloid precursor protein derivative, APP96-110, is efficacious following intravenous administration after traumatic brain injury	PLOS ONE			English	Article							DIFFUSE AXONAL INJURY; ALZHEIMERS-DISEASE; NEURITE OUTGROWTH; HEAD-INJURY; BETA-APP; RATS; PATHOPHYSIOLOGY; OPPORTUNITIES; THERAPIES; KNOCKOUT	Following traumatic brain injury (TBI) neurological damage is ongoing through a complex cascade of primary and secondary injury events in the ensuing minutes, days and weeks. The delayed nature of secondary injury provides a valuable window of opportunity to limit the consequences with a timely treatment. Recently, the amyloid precursor protein (APP) and its derivative APP96-110 have shown encouraging neuroprotective activity following TBI following an intracerebroventricular administration. Nevertheless, its broader clinical utility would be enhanced by an intravenous (IV) administration. This study assessed the efficacy of IV APP96-110, where a dose-response for a single dose of 0.005mg/kg +/- 0.5mg/ kg APP96-110 at either 30 minutes or 5 hours following moderate-severe diffuse impactacceleration injury was performed. Male Sprague-Dawley rats were assessed daily for 3 or 7 days on the rotarod to examine motor outcome, with a separate cohort of animals utilised for immunohistochemistry analysis 3 days post-TBI to assess axonal injury and neuroinflammation. Animals treated with 0.05mg/kg or 0.5mg/kg APP96-110 after 30 minutes demonstrated significant improvements in motor outcome. This was accompanied by a reduction in axonal injury and neuroinflammation in the corpus callosum at 3 days post-TBI, whereas 0.005mg/kg had no effect. In contrast, treatment with 0.005m/kg or 0.5mg/kg APP96-110 at 5 hours post-TBI demonstrated significant improvements in motor outcome over 3 days, which was accompanied by a reduction in axonal injury in the corpus callosum. This demonstrates that APP96-110 remains efficacious for up to 5 hours post-TBI when administered IV, and supports its development as a novel therapeutic compound following TBI.	[Plummer, Stephanie L.; Corrigan, Frances; Thornton, Emma; Woenig, Joshua A.; Van Den Heuvel, Corinna] Univ Adelaide, Translat Neuropathol Lab, Adelaide, SA, Australia; [Vink, Robert] Univ South Australia, Div Hlth Sci, Adelaide, SA, Australia; [Cappai, Roberto] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia	University of Adelaide; University of South Australia; University of Melbourne	Plummer, SL (corresponding author), Univ Adelaide, Translat Neuropathol Lab, Adelaide, SA, Australia.	Stephanie.plummer@adelaide.edu.au	Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Corrigan, Frances/0000-0001-6150-8893; Plummer, Stephanie/0000-0002-9582-1703	National Health and Medical Research Council (NHMRC) of Australia; National Health and Medical Research Council of Australia	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this project was sought through the National Health and Medical Research Council (NHMRC) of Australia to Corinna Van Den Heuvel. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; This study was funded by a grant from the National Health and Medical Research Council of Australia. We thank Jim Manavis for expert technical assistance.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Andrew RJ, 2016, J BIOL CHEM, V291, P19235, DOI 10.1074/jbc.R116.746032; Badan I, 2004, EUR J NEUROSCI, V19, P2270, DOI 10.1111/j.0953-816X.2004.03323.x; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bayer TA, 1999, MOL PSYCHIATR, V4, P524, DOI 10.1038/sj.mp.4000552; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Clarris HJ, 1997, J NEUROCHEM, V68, P1164; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; Corrigan F, 2011, BRAIN RES, V1378, P137, DOI 10.1016/j.brainres.2010.12.077; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GREENBERG SM, 1995, NEUROSCI LETT, V198, P52, DOI 10.1016/0304-3940(95)11944-R; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Habgood MD, 2007, EUR J NEUROSCI, V25, P231, DOI 10.1111/j.1460-9568.2006.05275.x; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Kobayashi S, 2010, NEUROCHEM INT, V56, P387, DOI 10.1016/j.neuint.2009.11.005; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MAXWELL WL, 1993, ACTA NEUROPATHOL, V86, P136, DOI 10.1007/BF00334880; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; NARINDRASORASAK S, 1991, J BIOL CHEM, V266, P12878; Plummer S, 2016, AGING DIS, V7, P163, DOI 10.14336/AD.2015.0907; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; SMALL DH, 1994, J NEUROSCI, V14, P2117; SMALL DH, 1992, J NEUROSCI, V12, P4143; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Vink R, 2002, EXPERT OPIN INV DRUG, V11, P1375, DOI 10.1517/13543784.11.10.1375; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215; WILLIAMSON TG, 1995, J NEUROCHEM, V65, P2201; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15	43	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190449	10.1371/journal.pone.0190449	http://dx.doi.org/10.1371/journal.pone.0190449			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320530	Green Published, gold, Green Accepted			2022-12-26	WOS:000419689600050
J	Lim, LK; Yap, SL; Bradley, DA				Lim, Lian-Kuang; Yap, Seong-Ling; Bradley, D. A.			Time-resolved characteristics of deuteron-beam generated by plasma focus discharge	PLOS ONE			English	Article							ION-BEAM; NEUTRON-PRODUCTION; ENERGY-SPECTRUM; TRACK DETECTORS; THIN-FILMS; X-RAY; DEVICE; EMISSION; IRRADIATION; CR-39	The plasma focus device discussed herein is a Z-pinch pulsed-plasma arrangement. In this, the plasma is heated and compressed into a cylindrical column, producing a typical density of > 10(25) particles/m(3) and a temperature of (1 +/- 3) x 10(7)degrees C. The plasma focus has been widely investigated as a radiation source, including as ion-beams, electron-beams and as a source of x-ray and neutron production, providing considerable scope for use in a variety of technological situations. Thus said, the nature of the radiation emission depends on the dynamics of the plasma pinch. In this study of the characteristics of deuteron-beam emission, in terms of energy, fluence and angular distribution were analyzed. The 2.7 kJ plasma focus discharge has been made to operate at a pressure of less than 1 mbar rather than at its more conventional operating pressure of a few mbar. Faraday cup were used to determine deuteron-beam energy and deuteron-beam fluence per shot while CR-39 solid-state nuclear track detectors were employed in studying the angular distribution of deuteron emission. Beam energy and deuteron-beam fluence per shot have been found to be pressure dependent. The largest value of average deuteron energy measured for present conditions was found to be (52 +/- 7) keV, while the deuteron-beam fluence per shot was of the order of 10(15) ions/m(2) when operated at a pressure of 0.2 mbar. The deuteron-beam emission is in the forward direction and is observed to be highly anisotropic.	[Lim, Lian-Kuang; Yap, Seong-Ling] Univ Malaya, Fac Sci, Plasma Technol Res Ctr, Phys Dept, Kuala Lumpur, Malaysia; [Bradley, D. A.] Sunway Univ, Inst Healthcare Dev, Subang Jaya, Selangor, Malaysia; [Bradley, D. A.] Univ Surrey, Fac Engn & Phys Sci, Dept Phys, Guildford, Surrey, England	Universiti Malaya; Sunway University; University of Surrey	Yap, SL (corresponding author), Univ Malaya, Fac Sci, Plasma Technol Res Ctr, Phys Dept, Kuala Lumpur, Malaysia.	yapsl@um.edu.my	Yap, Seong Ling/B-3930-2009; KUANG, LIM LIAN/AAF-9557-2019; Yap, Seong Shan/F-4963-2010	KUANG, LIM LIAN/0000-0002-0183-3253; Yap, Seong Shan/0000-0001-6005-5212	Ministry of Higher Education Fundamental Research Grant Scheme [FP013-2014A]; University of Malaya PPP research grant [PG010-2015B]; University of Malaya [PG010-2015B]	Ministry of Higher Education Fundamental Research Grant Scheme; University of Malaya PPP research grant; University of Malaya(Universiti Malaya)	The authors acknowledge the grant support from Ministry of Higher Education Fundamental Research Grant Scheme (FP013-2014A) and University of Malaya PPP research grant (PG010-2015B).	Ayash S, 2016, J FUSION ENERG, P1; BERNSTEIN MJ, 1970, PHYS FLUIDS, V13, P2858, DOI 10.1063/1.1692871; Bhuyan H, 2005, J PHYS D APPL PHYS, V38, P1164, DOI 10.1088/0022-3727/38/8/011; BOSTICK WH, 1993, NUCL FUSION, V33, P413, DOI 10.1088/0029-5515/33/3/I04; Damideh V, 2017, PHYS PLASMAS, V24, DOI 10.1063/1.4985309; Etaati GR, 2010, J FUSION ENERG, P1; Ghareshabani E, 2016, J FUSION ENERG, P1; Gribkov VA, 2003, J PHYS D APPL PHYS, V36, P1817, DOI 10.1088/0022-3727/36/15/312; GULLICKSON RL, 1978, J APPL PHYS, V49, P1099, DOI 10.1063/1.325045; Habibi M, 2016, J FUSION ENERG, P1; Kelly H, 1996, PLASMA PHYS CONTR F, V38, P1931, DOI 10.1088/0741-3335/38/11/005; LEE JH, 1971, PHYS FLUIDS, V14, P2217, DOI 10.1063/1.1693313; Lee S, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4811650; Lerner EJ, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.3694746; Lim LK, 2014, AIP CONF PROC, V1588, P181, DOI 10.1063/1.4866940; Lim LK, 2013, J FUSION ENERG, V32, P287, DOI 10.1007/s10894-012-9566-9; Lin JJ, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/13/135213; Malinowski K, 2005, RADIAT MEAS, V40, P371, DOI 10.1016/j.radmeas.2005.01.015; MATHER JW, 1965, PHYS FLUIDS, V8, P366, DOI 10.1063/1.1761231; Mejia FC, 1997, J PHYS D APPL PHYS, V30, P1499, DOI 10.1088/0022-3727/30/10/017; MEMBREY F, 1993, NUCL TRACKS RAD MEAS, V21, P417, DOI 10.1016/0969-8078(93)90240-5; Mohanty SR, 2005, JPN J APPL PHYS 1, V44, P5199, DOI 10.1143/JJAP.44.5199; MOO SP, 1991, IEEE T PLASMA SCI, V19, P515, DOI 10.1109/27.87231; MOZER A, 1982, J APPL PHYS, V53, P2959, DOI 10.1063/1.331033; Namini SE, 2010, J FUSION ENERG, V29, P471, DOI 10.1007/s10894-010-9308-9; Nayak BB, 2001, SURF COAT TECH, V145, P8, DOI 10.1016/S0257-8972(01)01285-3; Neog NK, 2007, PHYS LETT A, V361, P377, DOI 10.1016/j.physleta.2006.10.082; Ngoi SK, 2012, J FUSION ENERG, V31, P96, DOI 10.1007/s10894-011-9435-y; Pan ZY, 2009, APPL PHYS A-MATER, V96, P1027, DOI 10.1007/s00339-009-5138-x; Pouzo JO, 2003, IEEE T PLASMA SCI, V31, P1237, DOI 10.1109/TPS.2003.821475; Rawat RS, 2003, SURF COAT TECH, V173, P276, DOI 10.1016/S0257-8972(03)00628-5; Roshan MV, 2010, PLASMA PHYS CONTR F, V52, DOI 10.1088/0741-3335/52/8/085007; Roshan MV, 2009, PHYS LETT A, V373, P3771, DOI 10.1016/j.physleta.2009.08.025; Sadiq M, 2006, PHYS LETT A, V352, P150, DOI 10.1016/j.physleta.2005.11.058; Sadowski M, 2000, NUKLEONIKA, V45, P179; Skladnik-Sadowska E, 2001, RADIAT MEAS, V34, P337, DOI 10.1016/S1350-4487(01)00179-2; Skladnik-Sadowska E, 2001, RADIAT MEAS, V34, P315, DOI 10.1016/S1350-4487(01)00175-5; Szydlowski A, 2004, VACUUM, V76, P357, DOI 10.1016/j.vacuum.2004.07.040; Takao K, 2001, JPN J APPL PHYS 1, V40, P1013, DOI 10.1143/JJAP.40.1013; YAMAMOTO T, 1984, JPN J APPL PHYS 1, V23, P242, DOI 10.1143/JJAP.23.242; Yap SL, 2005, JPN J APPL PHYS 1, V44, P8125, DOI 10.1143/JJAP.44.8125; Zakaullah M, 1998, PLASMA SOURCES SCI T, V7, P206, DOI 10.1088/0963-0252/7/2/015; Zakaullah M, 2000, J FUSION ENERG, V19, P143, DOI 10.1023/A:1013970229271; Zhang T, 2006, J PHYS D APPL PHYS, V39, P2212, DOI 10.1088/0022-3727/39/10/033	44	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2018	13	1							e0188009	10.1371/journal.pone.0188009	http://dx.doi.org/10.1371/journal.pone.0188009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS0GW	29309425	Green Published, Green Submitted, gold			2022-12-26	WOS:000419453100003
J	Gautam, M; Bhattacharya, I; Rai, U; Majumdar, SS				Gautam, Mukesh; Bhattacharya, Indrashis; Rai, Umesh; Majumdar, Subeer S.			Hormone induced differential transcriptome analysis of Sertoli cells during postnatal maturation of rat testes	PLOS ONE			English	Article							GERM-CELL; GENE-EXPRESSION; ANDROGEN RECEPTOR; MOUSE TESTIS; JUNCTION DYNAMICS; MONONUCLEAR-CELLS; MESSENGER-RNA; FSH; IDENTIFICATION; CYTOKINES	Sertoli cells (Sc) are unique somatic cells of testis that are the target of both FSH and testosterone (T) and regulate spermatogenesis. Although Sc of neonatal rat testes are exposed to high levels of FSH and T, robust differentiation of spermatogonial cells becomes conspicuous only after 11-days of postnatal age. We have demonstrated earlier that a developmental switch in terms of hormonal responsiveness occurs in rat Sc at around 12 days of postnatal age during the rapid transition of spermatogonia A to B. Therefore, such "functional maturation" of Sc, during pubertal development becomes prerequisite for the onset of spermatogenesis. However, a conspicuous difference in robust hormone (both T and FSH) induced gene expression during the different phases of Sc maturation restricts our understanding about molecular events necessary for the spermatogenic onset and maintenance. Here, using microarray technology, we for the first time have compared the differential transcriptional profile of Sc isolated and cultured from immature (5 days old), maturing (12 days old) and mature (60 days old) rat testes. Our data revealed that immature Sc express genes involved in cellular growth, metabolism, chemokines, cell division, MAPK and Wnt pathways, while mature Sc are more specialized expressing genes involved in glucose metabolism, phagocytosis, insulin signaling and cytoskeleton structuring. Taken together, this differential transcriptome data provide an important resource to reveal the molecular network of Sc maturation which is necessary to govern male germ cell differentiation, hence, will improve our current understanding of the etiology of some forms of idiopathic male infertility.	[Gautam, Mukesh; Rai, Umesh] Univ Delhi, Dept Zool, Delhi, India; [Bhattacharya, Indrashis; Majumdar, Subeer S.] Natl Inst Immunol, Cellular Endocrinol Lab, New Delhi, India; [Majumdar, Subeer S.] Natl Inst Anim Biotechnol, Hyderabad, Andhra Pradesh, India; [Gautam, Mukesh] Northwestern Univ, Ken & Ruth Davee Dept Neurol, Chicago, IL 60611 USA; [Bhattacharya, Indrashis] Hemvati Nandan Bahuguna Garhwal Univ, Dept Zool, Garhwal, Uttarakhand, India	University of Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Department of Biotechnology (DBT) India; National Institute of Animal Biotechnology (NIAB); Northwestern University; Hemwati Nandan Bahuguna Garhwal University	Majumdar, SS (corresponding author), Natl Inst Immunol, Cellular Endocrinol Lab, New Delhi, India.; Majumdar, SS (corresponding author), Natl Inst Anim Biotechnol, Hyderabad, Andhra Pradesh, India.	subeer@nii.ac.in	Gautam, Mukesh/AAB-9208-2020	Gautam, Mukesh/0000-0002-6595-3051; Majumdar, Subeer/0000-0003-1724-7483	Indian Council of Medical Research [5/10/FR/8/2010-RHN]; Tata Innovation Award [BT/HRD/35/01/01/2010]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Tata Innovation Award	Funded by Indian Council of Medical Research. Grant number: 5/10/FR/8/2010-RHN. Tata Innovation Award.Grant number: BT/HRD/35/01/01/2010. SSM received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2009, J MOL ENDOCRINOL, V42, P291, DOI 10.1677/JME-08-0107; Anderson R, 1999, DEVELOPMENT, V126, P1655; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bhattacharya I, 2017, CELL TISSUE RES, V368, P389, DOI 10.1007/s00441-016-2410-1; Bhattacharya I, 2012, AM J PHYSIOL-ENDOC M, V303, pE886, DOI 10.1152/ajpendo.00293.2012; Boyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029764; Chalmel F, 2015, REPRODUCTION, V150, pR149, DOI 10.1530/REP-15-0073; Com E, 2014, J PROTEOMICS, V107, P128, DOI 10.1016/j.jprot.2014.04.013; Crepieux P, 2001, ONCOGENE, V20, P4696, DOI 10.1038/sj.onc.1204632; DeFalco T, 2009, ANNU REV CELL DEV BI, V25, P457, DOI 10.1146/annurev.cellbio.042308.13350; Denolet E, 2006, MOL ENDOCRINOL, V20, P321, DOI 10.1210/me.2005-0113; Dickinson RJ, 2006, J CELL SCI, V119, P4607, DOI 10.1242/jcs.03266; Eacker SM, 2007, MOL ENDOCRINOL, V21, P895, DOI 10.1210/me.2006-0113; Ewen K, 2010, BIOL REPROD, V83, P1005, DOI 10.1095/biolreprod.110.086801; Fujimoto T, 1998, J ELECTRON MICROSC, V47, P451, DOI 10.1093/oxfordjournals.jmicro.a023616; GALDIERI M, 1983, EXP CELL RES, V145, P191, DOI 10.1016/S0014-4827(83)80020-2; Gassei K, 2017, BIOL REPROD, V96, P707, DOI 10.1095/biolreprod.116.142828; Gautam M, 2016, ANDROLOGY-US, V4, P509, DOI 10.1111/andr.12161; Gautam M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058276; Gilbert DC, 2009, J PATHOL, V217, P94, DOI 10.1002/path.2436; Gondos B, 1993, SERTOLI CELL, P115; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Guraya SS., 1998, CELLULAR MOL BIOL GO, V346, P1998; Hedger MP, 2003, J REPROD IMMUNOL, V58, P1, DOI 10.1016/S0165-0378(02)00060-8; Hermans-Borgmeyer I, 1999, MOL BRAIN RES, V65, P216, DOI 10.1016/S0169-328X(99)00022-4; Hoeben E, 1996, ENDOCRINOLOGY, V137, P514, DOI 10.1210/en.137.2.514; Hoeben E, 1997, MOL CELL ENDOCRINOL, V132, P149, DOI 10.1016/S0303-7207(97)00132-9; Iida H, 2005, MOL REPROD DEV, V71, P178, DOI 10.1002/mrd.20294; Itman C, 2006, REPRODUCTION, V132, P233, DOI 10.1530/rep.1.01075; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jacobsen L, 2001, J BIOL CHEM, V276, P22788, DOI 10.1074/jbc.M100857200; Jeays-Ward K, 2004, DEV BIOL, V276, P431, DOI 10.1016/j.ydbio.2004.08.049; JEGOU B, 1983, INT J ANDROL, V6, P249, DOI 10.1111/j.1365-2605.1983.tb00539.x; JEGOU B, 1993, INT REV CYTOL, V147, P25, DOI 10.1016/S0074-7696(08)60766-4; Jiang X, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/489095; Kaitu'u-Lino TJ, 2007, REPRODUCTION, V133, P1169, DOI 10.1530/REP-06-0385; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Li CY, 2007, DEVELOPMENT, V134, P167, DOI 10.1242/dev.02701; LINGWOOD CA, 1994, MOL REPROD DEV, V37, P462, DOI 10.1002/mrd.1080370414; Lui WY, 2003, BIOL REPROD, V68, P2189, DOI 10.1095/biolreprod.102.011379; Lui WY, 2003, BIOL REPROD, V68, P1087, DOI 10.1095/biolreprod.102.010371; Majumdar SS, 2013, PROG BIOPHYS MOL BIO, V113, P409, DOI 10.1016/j.pbiomolbio.2013.01.002; Majumdar SS, 2012, HUM REPROD, V27, P2515, DOI 10.1093/humrep/des184; Malkov M, 1998, BIOL REPROD, V59, P84, DOI 10.1095/biolreprod59.1.84; Mandal K, 2017, DNA RES, V24, P143, DOI 10.1093/dnares/dsw057; Masters JR, 2007, NAT PROTOC, V2, P2276, DOI 10.1038/nprot.2007.319; Mastroianni L., 1994, P 4 ORG ROUND TABL C, Vviii; MATSUMOTO AM, 1990, AM J OBSTET GYNECOL, V163, P1743, DOI 10.1016/0002-9378(90)91439-J; McLean DJ, 2002, MOL ENDOCRINOL, V16, P2780, DOI 10.1210/me.2002-0059; Miller TL, 2002, IMMUNOLOGY, V105, P101, DOI 10.1046/j.0019-2805.2001.01352.x; Mithraprabhu S, 2010, BIOL REPROD, V82, P980, DOI 10.1095/biolreprod.109.079855; Mruk DD, 2015, ENDOCR REV, V36, P681, DOI [10.1210/er.2015-1127, 10.1210/er.2014-1101]; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; O'Shaughnessy PJ, 2007, ENDOCRINOLOGY, V148, P2914, DOI 10.1210/en.2006-1412; O'Shaughnessy PJ, 2014, SEMIN CELL DEV BIOL, V29, P55, DOI 10.1016/j.semcdb.2014.02.010; O'Shaughnessy PJ, 2003, BIOL REPROD, V69, P797, DOI 10.1095/biolreprod.103.016899; Oatley MJ, 2011, BIOL REPROD, V84, P639, DOI 10.1095/biolreprod.110.087320; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Petersen C, 2002, MOL CELL ENDOCRINOL, V186, P37, DOI 10.1016/S0303-7207(01)00680-3; Plant TM, 2016, J ENDOCRINOL, V226, pT41; Primig M, 2012, BBA-MOL BASIS DIS, V1822, P1880, DOI 10.1016/j.bbadis.2012.05.018; Rato L, 2012, NAT REV UROL, V9, P330, DOI 10.1038/nrurol.2012.77; Rato L, 2010, J MEMBRANE BIOL, V236, P215, DOI 10.1007/s00232-010-9294-x; Robinson LLL, 2003, J CLIN ENDOCR METAB, V88, P3943, DOI 10.1210/jc.2003-030196; Sadate-Ngatchou PI, 2004, MOL ENDOCRINOL, V18, P2805, DOI 10.1210/me.2003-0203; Sarkar H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151150; Sarret P, 2003, J COMP NEUROL, V461, P483, DOI 10.1002/cne.10708; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Setchell B P, 1975, Curr Top Mol Endocrinol, V2, P223; Sharpe Richard M., 1994, P1363; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tassi E, 1991, JBIOLCHEM, V274, P33287; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Thompson IR, 2014, MOL CELL ENDOCRINOL, V385, P28, DOI 10.1016/j.mce.2013.09.012; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Wang SW, 1997, BIOCHEM BIOPH RES CO, V236, P502, DOI 10.1006/bbrc.1997.6995; Warr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019572; WEISS L, 1963, EXP CELL RES, V30, P509, DOI 10.1016/0014-4827(63)90327-6; Willems A, 2010, INT J ANDROL, V33, P507, DOI 10.1111/j.1365-2605.2009.00964.x; Wong EWP, 2013, FASEB J, V27, P464, DOI 10.1096/fj.12-212514; Yang S, 2004, GENOME RES, V14, P517, DOI 10.1101/gr.1984404; Yeh JR, 2011, J CELL SCI, V124, P2357, DOI 10.1242/jcs.080903; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977; Zhang JD, 2011, DEVELOPMENT, V138, P3159, DOI 10.1242/dev.062380; Zhao SY, 2004, GENOME RES, V14, P1851, DOI 10.1101/gr.2663304; Zhou Q, 2005, BIOL REPROD, V72, P1010, DOI 10.1095/biolreprod.104.035915; Zimmermann C, 2015, MOL ENDOCRINOL, V29, P627, DOI 10.1210/me.2014-1356	91	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191201	10.1371/journal.pone.0191201	http://dx.doi.org/10.1371/journal.pone.0191201			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342173	Green Submitted, Green Published, gold			2022-12-26	WOS:000422653800051
J	Hultman, I; Haeggblom, L; Rognmo, I; Edqvist, JJ; Blomberg, E; Ali, R; Phillips, L; Sandstedt, B; Kogner, P; Fard, SS; Ahrlund-Richter, L				Hultman, Isabell; Haeggblom, Linnea; Rognmo, Ingvild; Edqvist, Josefin Jansson; Blomberg, Evelina; Ali, Rouknuddin; Phillips, Lottie; Sandstedt, Bengt; Kogner, Per; Fard, Shahrzad Shirazi; Ahrlund-Richter, Lars			Doxorubicin-provoked increase of mitotic activity and concomitant drain of G0-pool in therapy-resistant BE(2)-C neuroblastoma	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CANCER-CELLS; TUMOR MICROENVIRONMENT; EXPERIMENTAL TERATOMA; DRUG-RESISTANCE; DNA-DAMAGE; IN-VITRO; GROWTH; MYCN; HETEROGENEITY	In this study chemotherapy response in neuroblastoma (NB) was assessed for the first time in a transplantation model comprising non-malignant human embryonic microenvironment of pluripotent stem cell teratoma (PSCT) derived from diploid bona fide hESC. Two NB cell lines with known high-risk phenotypes; the multi-resistant BE(2)-C and the drug sensitive IMR-32, were transplanted to the PSCT model and the tumour growth was exposed to single or repeated treatments with doxorubicin, and thereafter evaluated for cell death, apoptosis, and proliferation. Dose dependent cytotoxic effects were observed, this way corroborating the experimental platform for this type of analysis. Notably, analysis of doxorubicin-resilient BE(2)-C growth in the PSCT model revealed an unexpected 1,5 fold increase in Ki67-index (p<0.05), indicating that non-cycling (GO) cells entered the cell cycle following the doxorubicin exposure. Support for this notion was obtained also in vitro. A pharmacologically relevant dose (1 mu M) resulted in a marked accumulation of Ki67 positive BE(2)-C cells (p<0.0001), as well as a >3-fold increase in active cell cycle (i.e. cells positive staining for PH3 together with incorporation of EdU) (p<0.01). Considering the clinical challenge for treating high-risk NB, the discovery of a therapy-provoked growth stimulating effect in the multi-resistant and p53-mutated BE(2)-C cell line, but not in the drug-sensitive p53wt IMR-32 cell line, warrants further studies concerning generality and clinical significance of this new observation.	[Hultman, Isabell; Rognmo, Ingvild; Edqvist, Josefin Jansson; Blomberg, Evelina; Ali, Rouknuddin; Phillips, Lottie; Sandstedt, Bengt; Kogner, Per; Fard, Shahrzad Shirazi; Ahrlund-Richter, Lars] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Haeggblom, Linnea] Karolinska Inst, Dept Oncol & Pathol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Fard, SS (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	shahrzad.shirazifard@ki.se	Phillips, Lottie/AAV-7902-2021	Kogner, Per/0000-0002-2202-9694	Cancer Research Foundations of Radiumhemmet [121262, 141393]; Swedish Childhood Cancer Foundation [2015-0168]; Robert Lundbergs minnesstiftelse; Stiftelsen Anna Brita och Bo Castegrens Minne	Cancer Research Foundations of Radiumhemmet; Swedish Childhood Cancer Foundation(European Commission); Robert Lundbergs minnesstiftelse; Stiftelsen Anna Brita och Bo Castegrens Minne	This work was supported by the Cancer Research Foundations of Radiumhemmet (Dnr 121262 and 141393) to LAR, The Swedish Childhood Cancer Foundation (Dnr 2015-0168) to LAR, Robert Lundbergs minnesstiftelse to IH, and Stiftelsen Anna Brita och Bo Castegrens Minne to SSF and LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083651; [Anonymous], 2011, CHAR HUM PLUR STEM C; BECKWITH JB, 1963, AM J PATHOL, V43, P1089; Bell E, 2006, CELL CYCLE, V5, P2639, DOI 10.4161/cc.5.22.3443; Braekeveldt N, 2015, INT J CANCER, V136, pE252, DOI 10.1002/ijc.29217; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burgos-Ojeda D, 2013, CANCER RES, V73, P3555, DOI 10.1158/0008-5472.CAN-12-2845; Calcagno AM, 2010, JNCI-J NATL CANCER I, V102, P1637, DOI 10.1093/jnci/djq361; Castedo M, 2006, ANN NY ACAD SCI, V1090, P35, DOI 10.1196/annals.1378.004; Choi SY, 2012, INT J ONCOL, V40, P277, DOI 10.3892/ijo.2011.1184; Das Thakur M, 2014, J PATHOL, V232, P103, DOI 10.1002/path.4285; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Eckerle I, 2009, CANCER LETT, V285, P99, DOI 10.1016/j.canlet.2009.05.007; ELBADRY OM, 1991, J CLIN INVEST, V87, P648, DOI 10.1172/JCI115042; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; GERDES J, 1984, J IMMUNOL, V133, P1710; Gertow K, 2004, STEM CELLS DEV, V13, P421, DOI 10.1089/scd.2004.13.421; Gertow K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027741; Hopkins-Donaldson S, 2002, ONCOGENE, V21, P6132, DOI 10.1038/sj.onc.1205879; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Hultman I, 2014, SEMIN CANCER BIOL, V29, P75, DOI 10.1016/j.semcancer.2014.08.005; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Jamil S, 2013, INT J ONCOL, V43, P831, DOI 10.3892/ijo.2013.2014; Jamil S, 2014, INT J CANCER, V134, P1630, DOI 10.1002/ijc.28498; Junttila MR, 2013, NATURE, V501, P346, DOI 10.1038/nature12626; Katz E, 2009, CLIN CANCER RES, V15, P70, DOI 10.1158/1078-0432.CCR-08-1233; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Kurtova AV, 2015, NATURE, V517, P209, DOI 10.1038/nature14034; Morton CL, 2009, CANC DRUG DISCOVERY, P195; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Normand G, 2005, J BIOL CHEM, V280, P7118, DOI 10.1074/jbc.M412330200; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Pession A, 2005, CURR CANCER DRUG TAR, V5, P273, DOI 10.2174/1568009054064606; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Scotting PJ, 2005, NAT REV CANCER, V5, P481, DOI 10.1038/nrc1633; Shen H, 2008, CANCER RES, V68, P8260, DOI 10.1158/0008-5472.CAN-08-1901; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; STUDEBAKER GA, 1985, J SPEECH HEAR RES, V28, P455, DOI 10.1044/jshr.2803.455; TEICHER BA, 1989, CANCER RES, V49, P5994; Teitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019133; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Tzukerman M, 2006, CANCER RES, V66, P3792, DOI 10.1158/0008-5472.CAN-05-3467; Tzukerman M, 2003, P NATL ACAD SCI USA, V100, P13507, DOI 10.1073/pnas.2235551100; Westermann F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r150; Wickstrom M, 2007, MOL CANCER THER, V6, P2409, DOI 10.1158/1535-7163.MCT-07-0156; Zheng X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.264	51	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190970	10.1371/journal.pone.0190970	http://dx.doi.org/10.1371/journal.pone.0190970			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342186	Green Published, gold, Green Submitted			2022-12-26	WOS:000422653800040
J	Piotrowska, A; Syguda, A; Wyrwas, B; Chrzanowski, L; Luckenbach, T; Heipieper, HJ				Piotrowska, Aleksandra; Syguda, Anna; Wyrwas, Bogdan; Chrzanowski, Lukasz; Luckenbach, Till; Heipieper, Hermann J.			Effects of ammonium-based ionic liquids and 2,4-dichlorophenol on the phospholipid fatty acid composition of zebrafish embryos	PLOS ONE			English	Article							TOXICITY; MODEL; FISH; MECHANISMS; 2,4-D	Ionic liquids consisting of a combination of herbicidal anions with a quaternary ammonium cation act as efficient herbicides, which are under consideration to be used in the agriculture. In the present study, we used embryos of the zebrafish (Danio rerio) as a model to assess the toxic potential of ammonium-based ionic liquids for aquatic organisms. As we assumed interference of the partially hydrophobic ionic liquid cation with lipids, we investigated the adaptation response in the lipid composition of the zebrafish embryos, triggered by the ionic compound. Therefore, the impact of ammonium-based ionic liquids with different lengths of the alkyl chain ([C-6,C-6,C-1,C1N][Br], [C-8,C-8,C-1,C1N][Br]) on the phospholipid fatty acid (PLFA) profile of zebrafish embryos up to 72 hours post fertilization (hpf) was examined. Furthermore, the changes in the unsaturation index (UI) of PLFAs, as the sum parameter of membrane fluidity in eukaryotic cells, were presented. The PLFA's UI in the zebrafish embryos upon exposure to quaternary ammonium salts was compared to the UI of the embryos upon exposure to nonionic 2,4-dichlorophenol, which has a similar hydrophobicity but is structurally different to [C-8,C-8,C-1,C-1 Nl][Br]. It was shown that for ammonium-based ionic liquid precursors non-specific mode of action occurs and the toxic effect on lipid composition of zebrafish embryos can be well predicted based on chemical properties, like hydrophobicity. Furthermore, the changes in PLFAs, expressed by the UI, can be useful to study toxic effects of organic contamination. However, for zebrafish embryos, after ionic liquids and 2,4-DCP exposure, the changes were observed at high lethal concentrations, which caused the incidence of lethality of 30 and 50% of a group of test animals.	[Piotrowska, Aleksandra; Heipieper, Hermann J.] UFZ Helmholtz Ctr Environm Res, Dept Environm Biotechnol, Leipzig, Germany; [Piotrowska, Aleksandra; Syguda, Anna; Wyrwas, Bogdan; Chrzanowski, Lukasz] Poznan Univ Tech, Fac Chem Technol, Poznan, Poland; [Luckenbach, Till] UFZ Helmholtz Ctr Environm Res, Dept Bioanalyt Ecotoxicol, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Poznan University of Technology; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Heipieper, HJ (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Environm Biotechnol, Leipzig, Germany.	hermann.heipieper@ufz.de	Chrzanowski, Lukasz/M-3439-2014; Luckenbach, Till/G-6482-2015; Heipieper, Hermann/D-1864-2010; Wyrwas, Bogdan/B-3116-2016	Luckenbach, Till/0000-0001-6204-1033; Heipieper, Hermann/0000-0002-3723-9600; Wyrwas, Bogdan/0000-0002-4791-5318; Syguda, Anna/0000-0003-0145-7478; Chrzanowski, Lukasz/0000-0002-2171-4913	National Science Centre in Poland [DEC-2011/03/B/NZ9/00731]; "Chemicals in the Environment" (CITE) within the research program of the UFZ-Helmholtz Centre for Environmental Research [POF II-U45]	National Science Centre in Poland(National Science Centre, Poland); "Chemicals in the Environment" (CITE) within the research program of the UFZ-Helmholtz Centre for Environmental Research	This work was funded by the National Science Centre in Poland conferred on the basis of the decision DEC-2011/03/B/NZ9/00731.; This work is part of the research topic "Chemicals in the Environment" (CITE) within the research program of the UFZ-Helmholtz Centre for Environmental Research (POF II-U45). This work was performed within the doctoral thesis of Aleksandra Piotrowska at the University of Technology in Poznan, Poland. This work was funded by the National Science Centre in Poland conferred on the basis of the decision DEC-2011/03/B/NZ9/00731.	Armitage JM, 2017, ENVIRON TOXICOL CHEM, V36, P882, DOI 10.1002/etc.3680; Belanger SE, 2013, ENVIRON TOXICOL CHEM, V32, P1768, DOI 10.1002/etc.2244; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cojocaru OA, 2013, GREEN CHEM, V15, P2110, DOI 10.1039/c3gc37143c; COUTURE P, 1995, J MEMBRANE BIOL, V148, P27; Goldsmith P, 2004, CURR OPIN PHARMACOL, V4, P504, DOI 10.1016/j.coph.2004.04.005; Hachicho N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134755; HAZEL JR, 1984, AM J PHYSIOL, V246, pR460, DOI 10.1152/ajpregu.1984.246.4.R460; Kaszycki P, 2013, APPL MICROBIOL BIOT, V97, P5555, DOI 10.1007/s00253-013-4796-y; Kluver N, 2016, CHEMOSPHERE, V164, P164, DOI 10.1016/j.chemosphere.2016.08.079; KROES J, 1972, BIOCHIM BIOPHYS ACTA, V274, P71, DOI 10.1016/0005-2736(72)90281-7; Lam PKS, 2003, MAR POLLUT BULL, V46, P182, DOI 10.1016/S0025-326X(02)00449-6; Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006; MORRISON WR, 1964, J LIPID RES, V5, P600; Nagel R, 2002, ALTEX-ALTERN TIEREXP, V19, P38; OECD, 2013, OECD TEST NO 236 FIS; Padmini E, 2010, REV ENVIRON CONTAM T, V206, P1, DOI 10.1007/978-1-4419-6260-7_1; Pelster Bernd, 2008, P91; Pernak J, 2012, TETRAHEDRON, V68, P4267, DOI 10.1016/j.tet.2012.03.065; Pernak J, 2011, TETRAHEDRON, V67, P4838, DOI 10.1016/j.tet.2011.05.016; Piotrowska A, 2017, CHEMOSPHERE, V167, P114, DOI 10.1016/j.chemosphere.2016.09.140; Pirro V, 2016, MOL BIOSYST, V12, P2069, DOI 10.1039/c6mb00168h; Praczyk T, 2012, WEED SCI, V60, P189, DOI 10.1614/WS-D-11-00171.1; Scholz S, 2008, ENVIRON SCI POLLUT R, V15, P394, DOI 10.1007/s11356-008-0018-z; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Strahle U, 2012, REPROD TOXICOL, V33, P128, DOI 10.1016/j.reprotox.2011.06.121; VAN WEZEL A, 1995, CRIT REV TOXICOL, V25, P255, DOI 10.3109/10408449509089890; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE	30	13	13	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190779	10.1371/journal.pone.0190779	http://dx.doi.org/10.1371/journal.pone.0190779			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342167	Green Submitted, Green Published, gold			2022-12-26	WOS:000422653800033
J	Takematsu, E; Noguchi, K; Kuroda, K; Ikoma, T; Niinomi, M; Matsushita, N				Takematsu, Eri; Noguchi, Kimihiro; Kuroda, Kensuke; Ikoma, Toshiyuki; Niinomi, Mitsuo; Matsushita, Nobuhiro			In vivo osteoconductivity of surface modified Ti-29Nb-13Ta-4.6Zr alloy with low dissolution of toxic trace elements	PLOS ONE			English	Article							TITANIUM; VITRO; BIOACTIVITY	Simulated Body Fluid (SBF) has served as a useful standard to check the bioactivity of implant materials for years. However, it is not perfectly able to imitate human serum; sometimes disparities between the SBF test and animal test were confirmed. Therefore, to ensure the reliability of the results of the SBF test obtained from our previous study, an animal study was performed to check osteoconductivity of surface modified implant materials. Three types of solution processes, hydrothermal (H), electrochemical (E), and hydrothermal-electrochemical (HE), were performed on the Ti-29Nb-13Ta-4.6Zr alloy (TNTZ) to improve its bioactivity, and their bioactivities were measured in vivo using bone-implant contacts (BICs). BICs of the HE-and H-treated samples were significantly higher than that of the control. Metal ion diffusion towards the bone was also evaluated to examine the adverse effect of metal ions. No metal ion diffusion was observed, indicating the safety of our solution processed implant materials.	[Takematsu, Eri] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Noguchi, Kimihiro] Western Washington Univ, Dept Math, Bellingham, WA 98225 USA; [Kuroda, Kensuke; Niinomi, Mitsuo] Nagoya Univ, Inst Mat & Syst Sustainabil, Nagoya, Aichi, Japan; [Ikoma, Toshiyuki; Matsushita, Nobuhiro] Tokyo Inst Technol, Sch Mat & Chem Technol, Dept Mat Sci & Engn, Meguro Ku, Tokyo, Japan; [Niinomi, Mitsuo] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi, Japan; [Niinomi, Mitsuo] Osaka Univ, Grad Sch Engn, Dept Mat & Mfg Sci, Suita, Osaka, Japan	University of Texas System; University of Texas Austin; Western Washington University; Nagoya University; Tokyo Institute of Technology; Tohoku University; Osaka University	Matsushita, N (corresponding author), Tokyo Inst Technol, Sch Mat & Chem Technol, Dept Mat Sci & Engn, Meguro Ku, Tokyo, Japan.	matsushita.n.ab@m.titech.ac.jp	Niinomi, Mitsuo/HGE-6839-2022; Ikoma, Toshiyuki/E-4288-2012; Kuroda, Kensuke/P-4037-2019; Kuroda, Kensuke/I-6069-2014	Ikoma, Toshiyuki/0000-0003-3154-1777; Kuroda, Kensuke/0000-0002-9848-7528; Kuroda, Kensuke/0000-0002-9848-7528	Collaboration Research Project of Advanced Materials Development and Integration of Novel Structured Metallic and Inorganic Materials - MEXT as well as the collaborative research of the Institute for Materials Research at Tohoku University	Collaboration Research Project of Advanced Materials Development and Integration of Novel Structured Metallic and Inorganic Materials - MEXT as well as the collaborative research of the Institute for Materials Research at Tohoku University	This research was funded by a grant from the Collaboration Research Project of Advanced Materials Development and Integration of Novel Structured Metallic and Inorganic Materials supported by MEXT as well as the collaborative research of the Institute for Materials Research at Tohoku University (http://www.msl.titech.ac.jp/english/member/six_institutes.html; http://www.imr.tohoku.ac.jp/en/).	Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008; DAVIES L, 1993, J AM STAT ASSOC, V88, P782, DOI 10.2307/2290763; Fukuda A, 2011, ACTA BIOMATER, V7, P1379, DOI 10.1016/j.actbio.2010.09.026; GABRIEL KR, 1969, ANN MATH STAT, V40, P224, DOI 10.1214/aoms/1177697819; Sanchez AG, 2013, J MATER SCI-MATER M, V24, P161, DOI 10.1007/s10856-012-4770-8; Hamadouche M, 2000, J BIOMED MATER RES, V52, P422, DOI 10.1002/1097-4636(200011)52:2<422::AID-JBM24>3.3.CO;2-G; HASSELBLAD V, 1995, PSYCHOL BULL, V117, P167, DOI 10.1037/0033-2909.117.1.167; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017; Konietschke F, 2015, J STAT SOFTW, V64; Konietschke F, 2012, ELECTRON J STAT, V6, P738, DOI 10.1214/12-EJS691; Milosev I, 2000, BIOMATERIALS, V21, P2103, DOI 10.1016/S0142-9612(00)00145-9; Mine Y, 2010, J PROSTHODONT RES, V54, P1, DOI 10.1016/j.jpor.2009.07.003; Mizutani M., 2005, DIGITAL REPOSITORY I; Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970; Ozcan M, 2012, MATERIALS, V5, P1528, DOI 10.3390/ma5091528; Park SK, 2009, CRYST GROWTH DES, V9, P3615, DOI 10.1021/cg9003593; Strehle MA, 2004, PHYS CHEM CHEM PHYS, V6, P5232, DOI 10.1039/b406524g; Taira M, 2006, DENT MATER J, V25, P726, DOI 10.4012/dmj.25.726; Takematsu E, 2016, J MECH BEHAV BIOMED, V61, P174, DOI 10.1016/j.jmbbm.2015.12.046; Takematsu E, 2016, MAT SCI ENG C-MATER, V62, P662, DOI 10.1016/j.msec.2016.01.041; TONDEVOLD E, 1982, ACTA ORTHOP SCAND, V53, P7, DOI 10.3109/17453678208992171; Xin RL, 2005, BIOMATERIALS, V26, P6477, DOI 10.1016/j.biomaterials.2005.04.028; Yamamoto D., 2013, J BIOMATER NANOBIOTE, V04, P45, DOI DOI 10.4236/JBNB.2013.41007; Zadpoor AA, 2014, MAT SCI ENG C-MATER, V35, P134, DOI 10.1016/j.msec.2013.10.026	25	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0189967	10.1371/journal.pone.0189967	http://dx.doi.org/10.1371/journal.pone.0189967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342150	Green Published, Green Submitted, gold			2022-12-26	WOS:000422653800013
J	Alpert, NM; Guehl, N; Ptaszek, L; Pelletier-Galarneau, M; Ruskin, J; Mansour, MC; Wooten, D; Ma, C; Takahashi, K; Zhou, Y; Shoup, TM; Normandin, MD; El Fakhri, G				Alpert, Nathaniel M.; Guehl, Nicolas; Ptaszek, Leon; Pelletier-Galarneau, Matthieu; Ruskin, Jeremy; Mansour, Moussa C.; Wooten, Dustin; Ma, Chao; Takahashi, Kazue; Zhou, Yun; Shoup, Timothy M.; Normandin, Marc D.; El Fakhri, Georges			Quantitative in vivo mapping of myocardial mitochondrial membrane potential	PLOS ONE			English	Article							GRAPHICAL ANALYSIS; LIPOPHILIC CATION; VOLTAGE SENSOR; ION CHANNELS; PET TRACER; BINDING; CELLS; TETRAPHENYLPHOSPHONIUM; PHOSPHORYLATION; QUANTIFICATION	Background Mitochondrial membrane potential (Delta psi(m)) arises from normal function of the electron transport chain. Maintenance of Delta psi(m) within a narrow range is essential for mitochondrial function. Methods for in vivo measurement of Delta psi(m) do not exist. We use F-18-labeled tetraphenylphosphonium (F-18-TPP+) to measure and map the total membrane potential, Delta psi(T), as the sum of Delta psi(m) and cellular (Delta psi(c)) electrical potentials. Methods Eight pigs, five controls and three with a scar-like injury, were studied. Pigs were studied with a dynamic PET scanning protocol to measure F-18-TPP+ volume of distribution, V-T. Fractional extracellular space (f(Ecs)) was measured in 3 pigs. We derived equations expressing Delta psi(T) as a function of V-T and the volume-fractions of mitochondria and fEcs. Seventeen segment polar maps and parametric images of Delta psi(T) were calculated in millivolts (mV). Results In controls, mean segmental Delta psi(T) = -129.4 +/- 1.4 mV (SEM). In pigs with segmental tissue injury, Delta psi(T) was clearly separated from control segments but variable, in the range -100 to 0 mV. The quality of Delta psi(T) maps was excellent, with low noise and good resolution. Measurements of Delta psi(T) in the left ventricle of pigs agree with previous in in-vitro measurements. Conclusions We have analyzed the factors affecting the uptake of voltage sensing tracers and developed a minimally invasive method for mapping Delta psi(T) in left ventricular myocardium of pigs. Delta psi(T) is computed in absolute units, allowing for visual and statistical comparison of individual values with normative data. These studies demonstrate the first in vivo application of quantitative mapping of total tissue membrane potential, Delta psi(T).	[Alpert, Nathaniel M.; Guehl, Nicolas; Pelletier-Galarneau, Matthieu; Wooten, Dustin; Ma, Chao; Takahashi, Kazue; Shoup, Timothy M.; Normandin, Marc D.; El Fakhri, Georges] Harvard Med Sch, Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Boston, MA 02114 USA; [Ptaszek, Leon; Ruskin, Jeremy; Mansour, Moussa C.] Harvard Med Sch, Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Boston, MA 02114 USA; [Zhou, Yun] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Johns Hopkins University	Alpert, NM (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Boston, MA 02114 USA.	alpert@pet.mgh.harvard.edu	Normandin, Marc D/C-6728-2015; Pelletier-Galarneau, Matthieu/L-7818-2019	Normandin, Marc D/0000-0003-1645-523X; 	United States National Institutes of Health [R01HL110241, R01HL137230]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL137230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB022544] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by two grants from the United States National Institutes of Health: R01HL110241 (GEF) and R01HL137230 (GEF), https://www.nhibi.nih.gov. These grants were awarded as part of the standard peer review process for new grants. The study design and analysis are solely the work of the study authors, meaning that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIUCHI T, 1989, CHEM PHARM BULL, V37, P3333; Bandula S, 2013, RADIOLOGY, V269, P395, DOI 10.1148/radiol.13130130; BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S; Bockris JOM, 2012, MODERN ELECTROCHEMIS; Brown DA, 2010, CARDIOVASC RES, V88, P241, DOI 10.1093/cvr/cvq231; Bruce A., 2002, MOL BIOL CELL, V4th ed.; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103; De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954; DEMURA M, 1987, BIOCHIM BIOPHYS ACTA, V894, P355, DOI 10.1016/0005-2728(87)90113-7; Gerencser AA, 2012, J PHYSIOL-LONDON, V590, P2845, DOI 10.1113/jphysiol.2012.228387; Gurm GS, 2012, JACC-CARDIOVASC IMAG, V5, P285, DOI 10.1016/j.jcmg.2011.11.017; Ho CY, 2012, CIRCULATION CARDIOVA, V6, P415; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; KAUPPINEN R, 1983, BIOCHIM BIOPHYS ACTA, V725, P131, DOI 10.1016/0005-2728(83)90232-3; KAUPPINEN RA, 1984, AM J PHYSIOL, V247, pH508, DOI 10.1152/ajpheart.1984.247.4.H508; Kawamoto A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117091; Kim DY, 2015, J NUCL MED, V56, P1581, DOI 10.2967/jnumed.115.156794; Kim DY, 2012, J NUCL MED, V53, DOI 10.2967/jnumed.111.102657; Labajova A, 2006, ANAL BIOCHEM, V353, P37, DOI 10.1016/j.ab.2006.03.032; LANOUE KF, 1986, J BIOL CHEM, V261, P298; LICHTSTEIN D, 1979, P NATL ACAD SCI USA, V76, P650, DOI 10.1073/pnas.76.2.650; Liu SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138716; Logan A, 2016, CELL METAB, V23, P379, DOI 10.1016/j.cmet.2015.11.014; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; lwai S, 2013, ELECTROPHYSIOLOGY CA, P261; Madar I, 2007, EUR J NUCL MED MOL I, V34, P2057, DOI 10.1007/s00259-007-0500-8; Madar I, 2009, J NUCL MED, V50, P774, DOI 10.2967/jnumed.108.061283; Min JJ, 2004, J NUCL MED, V45, P636; Moreno AnJ, 2015, CURRENT PROTOCOLS TO, V25; Nernst W, 1889, Z PHYS CHEM, V4, P129, DOI 10.1515/zpch- 1889-0412.; Nernst W, 1907, EXPT THEORETICAL APP; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; O'Rourke B, 2005, PHYSIOLOGY, V20, P303, DOI 10.1152/physiol.00020.2005; O'Rourke B, 2016, NAT REV CARDIOL, V13, P386, DOI 10.1038/nrcardio.2016.95; Pfeffer G, 2013, ANN MED, V45, P4, DOI 10.3109/07853890.2011.605389; Pohanka M, 2014, CURR MED CHEM, V21, P356; Rich P, 2003, NATURE, V421, P583, DOI 10.1038/421583a; RITCHIE RJ, 1984, PROG BIOPHYS MOL BIO, V43, P1, DOI 10.1016/0079-6107(84)90002-6; ROTTENBERG H, 1984, J MEMBRANE BIOL, V81, P127, DOI 10.1007/BF01868977; Rutledge C, 2013, EXPERT REV CARDIOVAS, V11, P799, DOI 10.1586/14779072.2013.811969; Sado DM, 2012, HEART; Schelbert EB, J CARDIOVASCULAR MAG, V13, P16; SELDINGER SI, 1953, ACTA RADIOL, V39, P368, DOI 10.3109/00016925309136722; Shoup TM, 2011, MOL IMAGING BIOL, V13, P511, DOI 10.1007/s11307-010-0349-2; Slifstein M, 2000, J NUCL MED, V41, P2083; SUMMERHAYES IC, 1982, P NATL ACAD SCI-BIOL, V79, P5292, DOI 10.1073/pnas.79.17.5292; Varga J, 2002, J CEREBR BLOOD F MET, V22, P240, DOI 10.1097/00004647-200202000-00012; WAN B, 1993, AM J PHYSIOL, V265, pH453, DOI 10.1152/ajpheart.1993.265.2.H453; WHALLEY DW, 1995, PACE, V18, P1556, DOI 10.1111/j.1540-8159.1995.tb06742.x; Wong TC, 2012, EUROPEAN HEART J; Zhou Y, 2009, NEUROIMAGE, V44, P661, DOI 10.1016/j.neuroimage.2008.09.021	53	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190968	10.1371/journal.pone.0190968	http://dx.doi.org/10.1371/journal.pone.0190968			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338024	Green Published, Green Submitted, gold			2022-12-26	WOS:000422652700025
J	Sunde, RA				Sunde, Roger A.			Selenium regulation of selenoprotein enzyme activity and transcripts in a pilot study with Founder strains from the Collaborative Cross	PLOS ONE			English	Article							MESSENGER-RNA LEVELS; GLUTATHIONE-PEROXIDASE-ACTIVITY; THIOREDOXIN REDUCTASE-ACTIVITY; DIETARY SELENIUM; RAT-LIVER; SELENOCYSTEINE INCORPORATION; DEPENDENT PARAMETERS; POPULATION; DEFICIENCY; TISSUES	Rodents and humans have 24-25 selenoproteins, and these proteins contain the 21st amino acid, selenocysteine, incorporated co-translationally into the peptide backbone in a series of reactions dependent on at least 6 unique gene products. In selenium (Se) deficiency, there is differential regulation of selenoprotein expression, whereby levels of some selenoproteins and their transcripts decrease dramatically in Se deficiency, but other selenoprotein transcripts are spared this decrease; the underlying mechanism, however, is not fully understood. To begin explore the genetic basis for this variation in regulation by Se status in a pilot study, we fed Se-deficient or Se-adequate diets (0.005 or 0.2 mu g Se/g, respectively) for eight weeks to the eight Founder strains of the Collaborative Cross. We found rather uniform expression of selenoenzyme activity for glutathione peroxidase (Gpx) 3 in plasma, Gpx1 in red blood cells, and Gpx1, Gpx4, and thioredoxin reductase in liver. In Founder mice, Se deficiency decreased each of these activities to a similar extent. Regulation of selenoprotein transcript expression by Se status was also globally retained intact, with dramatic down-regulation of Gpxl, Selenow, and Selenoh transcripts in all 8 strains of Founder mice. These results indicate that differential regulation of selenoprotein expression by Se status is an essential aspect of Se metabolism and selenoprotein function. A few lone differences in Se regulation were observed for individual selenoproteins in this pilot study, but these differences did not single-out one strain or one selenoprotein that consistently had unique Se regulation of selenoprotein expression. These differences should be affirmed in larger studies; use of the Diversity Outbred and Collaborative Cross strains may help to better define the functions of these selenoproteins.	[Sunde, Roger A.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sunde, RA (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	sunde@nutrisci.wisc.edu			Wisconsin Alumni Foundation Selenium Nutrition Research Fund [12046295]	Wisconsin Alumni Foundation Selenium Nutrition Research Fund	This Research was supported by the Wisconsin Alumni Foundation (http://www.uwalumni.com) Selenium Nutrition Research Fund (No. 12046295). There was no additional external funding received for this study.	Attie AD, 2017, CURR OPIN ENDOCRINOL, V24, P83, DOI 10.1097/MED.0000000000000321; Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; BEHNE D, 1988, BIOCHIM BIOPHYS ACTA, V966, P12, DOI 10.1016/0304-4165(88)90123-7; BEHNE D, 1990, BIOCHIM BIOPHYS ACTA, V1033, P219, DOI 10.1016/0304-4165(90)90124-F; BERMANO G, 1995, BIOCHEM J, V311, P425, DOI 10.1042/bj3110425; BERRY MJ, 1991, NATURE, V349, P438, DOI 10.1038/349438a0; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Carlson BA, 2007, J BIOL CHEM, V282, P32591, DOI 10.1074/jbc.M707036200; Chick JM, 2016, NATURE, V534, P500, DOI 10.1038/nature18270; Church RJ, 2015, FOOD CHEM TOXICOL, V76, P19, DOI 10.1016/j.fct.2014.11.008; Churchill GA, 2012, MAMM GENOME, V23, P713, DOI 10.1007/s00335-012-9414-2; Fradejas-Villar N, 2017, NUCLEIC ACIDS RES, V45, P4094, DOI 10.1093/nar/gkw1255; Gladyshev VN, 2016, J BIOL CHEM, V291, P24036, DOI 10.1074/jbc.M116.756155; Hadley KB, 2001, J NUTR BIOCHEM, V12, P693, DOI 10.1016/S0955-2863(01)00189-9; HAFEMAN DG, 1974, J NUTR, V104, P580, DOI 10.1093/jn/104.5.580; Hatfield D.L., 2016, SELENIUM ITS MOL BIO, Vfourth; HILL KE, 1992, BIOCHEM BIOPH RES CO, V185, P260, DOI 10.1016/S0006-291X(05)80984-2; Hill KE, 1997, ANAL BIOCHEM, V253, P123, DOI 10.1006/abio.1997.2373; Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639; Kohrle J, 1996, ACTA MED AUST, V23, P17; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013; LAWRENCE RA, 1974, EXP EYE RES, V18, P563, DOI 10.1016/0014-4835(74)90062-1; LEI XG, 1995, J NUTR, V125, P1438; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maurer S, 1998, Z ERNAHRUNGSWISS, V37, P110; Munger SC, 2014, GENETICS, V198, P59, DOI 10.1534/genetics.114.165886; National Research Council, 1995, NUTR REQ LAB AN; Odet F, 2015, G3-GENES GENOM GENET, V5, P2671, DOI 10.1534/g3.115.020172; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raines AM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-26; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; SAEDI MS, 1988, BIOCHEM BIOPH RES CO, V153, P855, DOI 10.1016/S0006-291X(88)81174-4; Srivastava A, 2017, GENETICS, V206, P537, DOI 10.1534/genetics.116.198838; Steel R.G., 1980, PRINCIPLES PROCEDURE, P481; Sun XL, 2001, MOL BIOL CELL, V12, P1009, DOI 10.1091/mbc.12.4.1009; SUNDE RA, 1987, J BIOL CHEM, V262, P933; Sunde RA, 2005, J NUTR, V135, P2144, DOI 10.1093/jn/135.9.2144; Sunde RA, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P137, DOI 10.1007/978-1-4614-1025-6_11; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Thompson KM, 1998, J NUTR, V128, P1289, DOI 10.1093/jn/128.8.1289; THOMPSON KM, 1995, J NUTR, V125, P864; Weiss SL, 1996, J NUTR, V126, P2260, DOI 10.1093/jn/126.9.2260; Weiss SL, 1997, J NUTR BIOCHEM, V8, P85, DOI 10.1016/S0955-2863(96)00178-7; Wen W, 1998, J BIOL CHEM, V273, P28533, DOI 10.1074/jbc.273.43.28533	47	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191449	10.1371/journal.pone.0191449	http://dx.doi.org/10.1371/journal.pone.0191449			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338053	Green Submitted, Green Published, gold			2022-12-26	WOS:000422652700053
J	Capdevila, P; Linares, C; Aspillaga, E; Riera, JL; Hereu, B				Capdevila, Pol; Linares, Cristina; Aspillaga, Eneko; Lluis Riera, Joan; Hereu, Bernet			Effective dispersal and density-dependence in mesophotic macroalgal forests: Insights from the Mediterranean species Cystoseira zosteroides	PLOS ONE			English	Article							LONG-TERM DECLINE; SPORE DISPERSAL; SEED DISPERSAL; PROPAGULE DISPERSAL; ASCOPHYLLUM-NODOSUM; PHAEOPHYCEAE POPULATIONS; SETTLEMENT DENSITY; PLANT DISPERSAL; LIFE-HISTORIES; RECRUITMENT	Dispersal and recruitment are fundamental processes for population recovery following disturbances in sessile species. While both processes are well understood for many terrestrial species, they still remain poorly resolved for some macroalgal species. Here we experimentally investigated the effective dispersal and recruit survival of a mesophotic Mediterranean fucoid, Cystoseira zosteroides. In three isolated populations, four sets of settlement collectors were placed at increasing distances (from 0 to 10 m) and different orientations (North, South, East and West). We observed that effective dispersal was restricted to populations' vicinity, with an average of 6.43 m and not further than 13.33 m, following a Weibull distribution. During their first year of life, survival was up to 50%, but it was lower underneath the adult canopy, suggesting a negative density-dependence. To put our results in a broader context we compared the effective dispersal of other fucoid and kelp species reported in the literature, which confirmed the low dispersal ability of brown algae, in particular for fucoids, with an effective dispersal of few meters. Given the importance of recruitment for the persistence and recovery of populations after disturbances, these results underline the vulnerability of C. zosteroides and other fucoid species to escalating threats.	[Capdevila, Pol; Linares, Cristina; Aspillaga, Eneko; Lluis Riera, Joan; Hereu, Bernet] Univ Barcelona, Fac Biol, Dept Biol Evolut Ecol & Ciencies Ambientals, Barcelona, Spain	University of Barcelona	Capdevila, P (corresponding author), Univ Barcelona, Fac Biol, Dept Biol Evolut Ecol & Ciencies Ambientals, Barcelona, Spain.	pcapdevila.pc@gmail.com	Hereu, Bernat/K-9150-2015; Linares, Cristina/A-5244-2018; Aspillaga, Eneko/AAH-8613-2019; Capdevila, Pol/J-7730-2016	Hereu, Bernat/0000-0001-6247-7638; Linares, Cristina/0000-0003-3855-2743; Aspillaga, Eneko/0000-0002-8888-8731; Capdevila, Pol/0000-0002-2842-4302; Riera Rey, Joan Lluis/0000-0002-2810-2581	Spanish MINECO [CGL2012-32194]; European Union's Horizon research and innovation program [689518]; FI-DRG grant from the Secretaria d'Universitats i Recercafrom the Economy and Knowledge Department of the Generalitat de Catalunya to Pol Capdevila; Ramon y Cajal research contract [RyC-2011-08134]; Generalitat de Catalunya [2014SGR1297]	Spanish MINECO(Spanish Government); European Union's Horizon research and innovation program; FI-DRG grant from the Secretaria d'Universitats i Recercafrom the Economy and Knowledge Department of the Generalitat de Catalunya to Pol Capdevila; Ramon y Cajal research contract(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	Funding was provided by the Spanish MINECO (CGL2012-32194) and the European Union's Horizon 2020 research and innovation program under grant agreement No 689518 (MERCES). Support for this work was provided by an FI-DRG grant from the Secretaria d'Universitats i Recercafrom the Economy and Knowledge Department of the Generalitat de Catalunya to Pol Capdevila and by a Ramon y Cajal research contract (RyC-2011-08134) to Cristina Linares. The authors are part of the Marine Biodiversity Conservation research group (2014SGR1297,www.medrecover.org) from Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BALLESTEROS E, 1990, Scientia Marina, V54, P217; Ballesteros E, 2009, ESTUAR COAST SHELF S, V82, P477, DOI 10.1016/j.ecss.2009.02.013; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bolker B, 2016, DEV CORE TEAM BBMLE, P1; Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; Bullock JM, 2017, J ECOL, V105, P6, DOI 10.1111/1365-2745.12666; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; Buonomo R, 2016, MOL ECOL; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Campbell AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084106; Capdevila P, 2015, MAR BIOL, V162, P1165, DOI 10.1007/s00227-015-2658-0; Capdevila P, 2016, J ECOL, V104, P1799, DOI 10.1111/1365-2745.12625; Carr MH, 2003, ECOL APPL, V13, pS90; Cervin G, 2005, MAR ECOL PROG SER, V305, P31, DOI 10.3354/meps305031; CHAPMAN ARO, 1995, PHYCOLOGIA, V34, P1, DOI 10.2216/i0031-8884-34-1-1.1; Cheminee A, 2013, J EXP MAR BIOL ECOL, V442, P70, DOI 10.1016/j.jembe.2013.02.003; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Clark JS, 1999, AM J BOT, V86, P1, DOI 10.2307/2656950; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; Coleman MA, 2011, J ECOL, V99, P1026, DOI 10.1111/j.1365-2745.2011.01822.x; Coulson SJ, 2001, J APPL ECOL, V38, P204, DOI 10.1046/j.1365-2664.2001.00585.x; Dayton PK, 1973, POSTELSIA PALMAEFORM, V54, P433; DEYSHER L, 1981, J EXP MAR BIOL ECOL, V56, P179, DOI 10.1016/0022-0981(81)90188-X; Doropoulos C, 2016, ECOL MONOGR, V86, P20, DOI 10.1890/15-0668.1; Dudgeon S, 2005, OIKOS, V109, P405, DOI 10.1111/j.0030-1299.2005.13782.x; Dudgeon S, 2001, FUNCT ECOL, V15, P595, DOI 10.1046/j.0269-8463.2001.00559.x; Durrant HMS, 2014, CONSERV BIOL, V28, P438, DOI 10.1111/cobi.12203; Engelen AH, 2001, MAR BIOL, V139, P267; Forbis TA, 2004, AM J BOT, V91, P1147, DOI 10.3732/ajb.91.7.1147; FREDRIKSEN S, 1995, SARSIA, V80, P47, DOI 10.1080/00364827.1995.10413579; Gaylord B, 2002, ECOLOGY, V83, P1239, DOI 10.1890/0012-9658(2002)083[1239:APBMOM]2.0.CO;2; Gaylord B, 2006, ECOL MONOGR, V76, P481, DOI 10.1890/0012-9615(2006)076[0481:MSDICE]2.0.CO;2; Giaccone G, 1973, CISTOSEIRE VEGETAZIO; Giaccone G, 1973, RAPPORTS COMMUNICATI, V22, P49; Gianni Fabrizio, 2014, Advances in Oceanography and Limnology, V4, P83, DOI 10.1080/19475721.2013.845604; Hereu B, 2008, EUR J PHYCOL, V43, P263, DOI 10.1080/09670260801930330; Hernandez-Carmona G, 2000, BOT MAR, V43, P273, DOI 10.1515/BOT.2000.029; Hirsch BT, 2012, METHODS ECOL EVOL, V3, P595, DOI 10.1111/j.2041-210X.2011.00183.x; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Irving AD, 2009, MAR BIOL, V156, P1223, DOI 10.1007/s00227-009-1164-7; Jenkins SR, 2004, J MAR BIOL ASSOC UK, V84, P327, DOI 10.1017/S0025315404009221h; Kang YH, 2016, J APPL PHYCOL, V28, P1859, DOI 10.1007/s10811-015-0689-z; KENDRICK GA, 1994, MAR ECOL PROG SER, V103, P129, DOI 10.3354/meps103129; KENDRICK GA, 1995, J EXP MAR BIOL ECOL, V192, P273, DOI 10.1016/0022-0981(95)00076-4; KENDRICK GA, 1991, MAR ECOL PROG SER, V79, P133, DOI 10.3354/meps079133; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Kinlan BP, 2005, DIVERS DISTRIB, V11, P139, DOI 10.1111/j.1366-9516.2005.00158.x; Krumhansl KA, 2016, P NATL ACAD SCI USA, V113, P13785, DOI 10.1073/pnas.1606102113; Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428; Lloret F, 2012, GLOBAL CHANGE BIOL, V18, P797, DOI 10.1111/j.1365-2486.2011.02624.x; Mangialajo L, 2012, J EXP MAR BIOL ECOL, V412, P72, DOI 10.1016/j.jembe.2011.10.031; Mineur F, 2015, J SEA RES, V98, P91, DOI 10.1016/j.seares.2014.11.004; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Navarro L, 2011, ESTUAR COAST SHELF S, V95, P52, DOI 10.1016/j.ecss.2011.08.002; NORTON TA, 1992, BRIT PHYCOL J, V27, P293, DOI 10.1080/00071619200650271; Paine RT, 2017, ECOLOGY, V98, P1560, DOI 10.1002/ecy.1798; Parada GM, 2016, BOT MAR, V59, P283, DOI 10.1515/bot-2016-0034; Pearson GA, 1996, MAR ECOL PROG SER, V143, P211, DOI 10.3354/meps143211; R Core Team, 2021, R LANGUAGE ENV STAT; REED DC, 1988, ECOL MONOGR, V58, P321, DOI 10.2307/1942543; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; Schiel DR, 2012, J EXP MAR BIOL ECOL, V434, P25, DOI 10.1016/j.jembe.2012.07.023; Shanks AL, 2003, ECOL APPL, V13, pS159; Skarpaas O, 2004, J ECOL, V92, P747, DOI 10.1111/j.0022-0477.2004.00915.x; Steen H, 2004, MAR BIOL, V144, P61, DOI 10.1007/s00227-003-1175-8; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Stevens CL, 2008, J MARINE SYST, V74, P96, DOI 10.1016/j.jmarsys.2007.11.006; Susini ML, 2007, PHYCOLOGIA, V46, P605, DOI 10.2216/06-100.1; Taylor D, 2010, LIMNOL OCEANOGR, V55, P66, DOI 10.4319/lo.2010.55.1.0066; Tegner MJ, 1997, MAR ECOL PROG SER, V146, P117, DOI 10.3354/meps146117; Thibaut T, 2005, MAR POLLUT BULL, V50, P1472, DOI 10.1016/j.marpolbul.2005.06.014; Thibaut T, 2015, MEDITERR MAR SCI, V16, P206, DOI 10.12681/mms.1032; Tufto J, 1997, THEOR POPUL BIOL, V52, P16, DOI 10.1006/tpbi.1997.1306; Underwood AJ, 1999, J EXP MAR BIOL ECOL, V232, P125, DOI 10.1016/S0022-0981(98)00105-1; VADAS RL, 1992, BRIT PHYCOL J, V27, P331, DOI 10.1080/00071619200650291; Wernberg T, 2016, SCIENCE, V353, P169, DOI 10.1126/science.aad8745; Wernberg T, 2010, ECOL LETT, V13, P685, DOI 10.1111/j.1461-0248.2010.01466.x; Wright JT, 2001, ECOLOGY, V82, P2200, DOI 10.1890/0012-9658(2001)082[2200:EOVRAP]2.0.CO;2	81	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191346	10.1371/journal.pone.0191346	http://dx.doi.org/10.1371/journal.pone.0191346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329336	Green Published, Green Submitted, gold			2022-12-26	WOS:000419954100060
J	Arnold, TE; Kenney, WF; Curtis, JH; Bianchi, TS; Brenner, M				Arnold, T. E.; Kenney, W. F.; Curtis, J. H.; Bianchi, T. S.; Brenner, M.			Sediment biomarkers elucidate the Holocene ontogeny of a shallow lake	PLOS ONE			English	Article							STABLE-ISOTOPE DELTA-C-13; ORGANIC-MATTER; VEGETATION HISTORY; CARBON; FLORIDA; CLIMATE; BURIAL; RECORD; RECONSTRUCTIONS; GEOCHEMISTRY	We carried out geochemical analyses on a sediment core from Lake Harris, Florida (USA) to identify sources of organic matter to the sediment throughout the Holocene, and relate changes in those sources to shifts in past climate and environmental conditions. We hypothesized that the sources of organic matter changed in response to regional hydrologic shifts following de-glaciation, and to human population expansion in the state during the 20th century. Hydroclimate shifts in Florida were related to: 1) a steady rise in relative sea level and the fresh water table that began in the early Holocene, 2) wetland formation and expansion ca. 5,000 cal yrs BP, and 3) the onset of the modern El Nino (ENSO) cycle similar to 3,000 cal yrs BP. Stratigraphic changes in sediment variables from Lake Harris reflect each of these hydroclimate periods. Early in the Holocene, Lake Harris was a marsh-like system in a relatively dry, open-prairie environment. Organic sediments deposited at that time were derived largely from terrestrial sources, as inferred from high TOC/TN ratios, a dominance of longer-chain of n-alkanes (n-C29-31), relatively negative organic carbon isotope values (delta C-13(TOC)), and low biogenic silica concentrations. In the middle Holocene, a positive shift in delta C-13(TOC) coincided with the onset of wetter conditions in Florida. Submerged macrophyte biomarkers (n-C21-23) dominated, and during that period bulk organic carbon isotope values were most similar to delta C-13 values of mid-chain-length n-alkanes. In the late Holocene, delta C-13(TOC) values declined, CaCO3 levels decreased to trace amounts, organic carbon concentrations increased and diatom biogenic silica concentrations increased from 10 to 120 mg g(-1). Around 2,900 cal yrs BP, the effects of ENSO intensified and many Florida lakes deepened to their current limnetic state. Concentrations of algal and cyanobacterial biomarkers in the Lake Harris core increased by orders of magnitude after about AD 1940, in response to human-induced eutrophication, an inference supported by values of delta N-15 that fluctuate around zero.	[Arnold, T. E.; Curtis, J. H.; Bianchi, T. S.; Brenner, M.] Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA; [Kenney, W. F.; Brenner, M.] Univ Florida, Land Use & Environm Change Inst, Gainesville, FL USA; [Arnold, T. E.] Univ Pittsburgh, Dept Geol & Planetary Sci, Pittsburgh, PA 15260 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Arnold, TE (corresponding author), Univ Florida, Dept Geol Sci, Gainesville, FL 32611 USA.; Arnold, TE (corresponding author), Univ Pittsburgh, Dept Geol & Planetary Sci, Pittsburgh, PA 15260 USA.	tarnold@ufl.edu	Bianchi, Thomas S/L-4060-2014	Bianchi, Thomas S/0000-0002-3068-2933	Water Institute; Land Use and Environmental Change Institute at the University of Florida	Water Institute; Land Use and Environmental Change Institute at the University of Florida	We received funding from the Water Institute and the Land Use and Environmental Change Institute at the University of Florida.; We thank the Water Institute and the Land Use and Environmental Change Institute at the University of Florida for funding this project, and Gianna Browne for sample preparations. We thank Dr. Andrea Dutton for valuable comments on the manuscript.	ALLER RC, 1994, CHEM GEOL, V114, P331, DOI 10.1016/0009-2541(94)90062-0; Bianchi T.S., 2011, CHEM BIOMARKERS AQUA; Bianchi TS, 2002, MAR CHEM, V77, P211, DOI 10.1016/S0304-4203(01)00088-3; Brenner M, 1999, J PALEOLIMNOL, V22, P205, DOI 10.1023/A:1008078222806; Brenner M, 2006, J PALEOLIMNOL, V35, P129, DOI 10.1007/s10933-005-7881-0; BROECKER W. S., 2006, EOS T, V87, P27, DOI DOI 10.1029/2006EO030002; Castaneda IS, 2011, QUATERNARY SCI REV, V30, P2851, DOI 10.1016/j.quascirev.2011.07.009; Cloern JE, 2002, LIMNOL OCEANOGR, V47, P713, DOI 10.4319/lo.2002.47.3.0713; CRANWELL PA, 1983, PROG LIPID RES, V21, P271, DOI 10.1016/0163-7827(82)90012-1; Dean WE, 1998, GEOLOGY, V26, P535, DOI 10.1130/0091-7613(1998)026<0535:MASOCB>2.3.CO;2; Diefendorf AF, 2017, ORG GEOCHEM, V103, P1, DOI 10.1016/j.orggeochem.2016.10.016; Dolman Andrew M, 2012, PLoS One, V7, pe38757, DOI 10.1371/journal.pone.0038757; Donar C, 2009, NOVA HEDWIGIA, P57; Donders TH, 2005, P NATL ACAD SCI USA, V102, P10904, DOI 10.1073/pnas.0505015102; Donders TH, 2008, QUATERNARY SCI REV, V27, P571, DOI 10.1016/j.quascirev.2007.11.010; Donders TH, 2014, QUATERNARY SCI REV, V103, P170, DOI 10.1016/j.quascirev.2014.09.011; EADIE BJ, 1984, J GREAT LAKES RES, V10, P307, DOI 10.1016/S0380-1330(84)71844-2; EGLINTON G, 1967, SCIENCE, V156, P1322, DOI 10.1126/science.156.3780.1322; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Ficken KJ, 2000, ORG GEOCHEM, V31, P745, DOI 10.1016/S0146-6380(00)00081-4; Filley TR, 2001, ORG GEOCHEM, V32, P1153, DOI 10.1016/S0146-6380(01)00063-8; FLETT RJ, 1980, CAN J FISH AQUAT SCI, V37, P494, DOI 10.1139/f80-064; Fulton JM, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004196; Fulton RS, 2008, LAKE RESERV MANAGE, V24, P139, DOI 10.1080/07438140809354057; Galman V, 2008, LIMNOL OCEANOGR, V53, P1076, DOI 10.4319/lo.2008.53.3.1076; Garcin Y, 2014, GEOCHIM COSMOCHIM AC, V142, P482, DOI 10.1016/j.gca.2014.07.004; Gu BH, 2006, LIMNOL OCEANOGR, V51, P2837, DOI 10.4319/lo.2006.51.6.2837; HAN J, 1969, P NATL ACAD SCI USA, V64, P436, DOI 10.1073/pnas.64.2.436; Huang YS, 2006, PALAEOGEOGR PALAEOCL, V237, P428, DOI 10.1016/j.palaeo.2005.12.014; Kenney WF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147331; Kenney WF, 2016, ECOL INDIC, V60, P963, DOI 10.1016/j.ecolind.2015.08.046; Kenney WF, 2010, J PALEOLIMNOL, V44, P1039, DOI 10.1007/s10933-010-9472-y; Meyers P.A., 1994, CHEM GEOL, V144, P289, DOI DOI 10.1016/0009-2541(94)90059-0; MEYERS PA, 1993, ORG GEOCHEM, V20, P867, DOI 10.1016/0146-6380(93)90100-P; Meyers PA, 1997, ORG GEOCHEM, V27, P213, DOI 10.1016/S0146-6380(97)00049-1; Meyers PA, 2003, ORG GEOCHEM, V34, P261, DOI 10.1016/S0146-6380(02)00168-7; MOOK WG, 1974, EARTH PLANET SC LETT, V22, P169, DOI 10.1016/0012-821X(74)90078-8; Nichols J.E., 2011, MIRES PEAT, V7, P1; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Polissar PJ, 2014, GEOCHIM COSMOCHIM AC, V129, P146, DOI 10.1016/j.gca.2013.12.021; Quillen A. K., 2009, DIATOM BASED PALEOLI; Quillen AK, 2013, J PALEOLIMNOL, V49, P15, DOI 10.1007/s10933-011-9558-1; Riedinger-Whitmore MA, 2005, LAKE RESERV MANAGE, V21, P423, DOI 10.1080/07438140509354447; Schelske CL, 2005, AMBIO, V34, P192, DOI 10.1639/0044-7447(2005)034[0192:ABRTHA]2.0.CO;2; Silliman JE, 1996, ORG GEOCHEM, V24, P463, DOI 10.1016/0146-6380(96)00041-1; Tornqvist TE, 2004, GEOL SOC AM BULL, V116, P1026, DOI 10.1130/B2525478.1; Torres IC, 2012, J PALEOLIMNOL, V47, P693, DOI 10.1007/s10933-012-9593-6; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Waters MN, 2016, ECOSYSTEMS, V19, P426, DOI 10.1007/s10021-015-9943-0; WATTS WA, 1975, GEOLOGY, V3, P344, DOI 10.1130/0091-7613(1975)3<344:ALQROV>2.0.CO;2; WATTS WA, 1980, SCIENCE, V210, P325, DOI 10.1126/science.210.4467.325; WATTS WA, 1994, PALAEOGEOGR PALAEOCL, V109, P163, DOI 10.1016/0031-0182(94)90174-0; WATTS WA, 1971, ECOLOGY, V52, P676, DOI 10.2307/1934159; Willard DA, 2011, CLIMATIC CHANGE, V107, P59, DOI 10.1007/s10584-011-0078-9	55	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191073	10.1371/journal.pone.0191073	http://dx.doi.org/10.1371/journal.pone.0191073			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324791	Green Submitted, Green Published, gold			2022-12-26	WOS:000419952400103
J	Ho, CH; Liang, FW; Wang, JJ; Chio, CC; Kuo, JR				Ho, Chung-Han; Liang, Fu-Wen; Wang, Jhi-Joung; Chio, Chung-Ching; Kuo, Jinn-Rung			Impact of grouping complications on mortality in traumatic brain injury: A nationwide population-based study	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; ACUTE MYOCARDIAL-INFARCTION; ARTIFICIAL NEURAL-NETWORK; IN-HOSPITAL MORTALITY; RISK-FACTORS; SLEEP DISORDERS; ISCHEMIC-STROKE; TAIWAN; CARE; EPIDEMIOLOGY	Traumatic brain injury (TBI) is an important health issue with high mortality. Various complications of physiological and cognitive impairment may result in disability or death after TBI. Grouping of these complications could be treated as integrated post-TBI syndromes. To improve risk estimation, grouping TBI complications should be investigated, to better predict TBI mortality. This study aimed to estimate mortality risk based on grouping of complications among TBI patients. Taiwan's National Health Insurance Research Database was used in this study. TBI was defined according to the International Classification of Diseases, Ninth Revision, Clinical Modification codes: 801-804 and 850-854. The association rule data mining method was used to analyze coexisting complications after TBI. The mortality risk of post-TBI complication sets with the potential risk factors was estimated using Cox regression. A total 139,254 TBI patients were enrolled in this study. Intracerebral hemorrhage was the most common complication among TBI patients. After frequent item set mining, the most common post-TBI grouping of complications comprised pneumonia caused by acute respiratory failure (ARF) and urinary tract infection, with mortality risk 1.55 (95% C. I.: 1.51-1.60), compared with those without the selected combinations. TBI patients with the combined combinations have high mortality risk, especially those aged < 20 years with septicemia, pneumonia, and ARF (HR: 4.95, 95% C. I.: 3.55-6.88). We used post-TBI complication sets to estimate mortality risk among TBI patients. According to the combinations determined by mining, especially the combination of septicemia with pneumonia and ARF, TBI patients have a 1.73-fold increased mortality risk, after controlling for potential demographic and clinical confounders. TBI patients aged<20 years with each combination of complications also have increased mortality risk. These results could provide physicians and caregivers with important information to increase their awareness about sequences of clinical syndromes among TBI patients, to prevent possible deaths among these patients.	[Ho, Chung-Han; Wang, Jhi-Joung; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp Hlth Care Adm, Tainan, Taiwan; [Liang, Fu-Wen] Natl Cheng Kung Univ, Coll Med, Res Ctr Hlth Data, Tainan, Taiwan; [Liang, Fu-Wen] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan, Taiwan; [Chio, Chung-Ching; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science; National Cheng Kung University; National Cheng Kung University; Chi Mei Hospital; Southern Taiwan University of Science & Technology	Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan.; Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan.; Kuo, JR (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan.	kuojinnrung@gmail.com		Ho, Chung-Han/0000-0001-5925-8477; Liang, Fu-Wen/0000-0002-3396-037X	Ministry of Science and Technology (MOST), Executive Yuan, Taiwan [MOST 104-2314-6-384-006]	Ministry of Science and Technology (MOST), Executive Yuan, Taiwan	This study was supported by grants (MOST 104-2314-6-384-006) from the Ministry of Science and Technology (MOST), Executive Yuan, Taiwan to author CHH, JRK and JJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaranta H, 1946, WIEN MED WOCHENSCHR, V150, P444; Arabi Y, 2002, INT J QUAL HEALTH C, V14, P403, DOI 10.1093/intqhc/14.5.403; Calderon-Larranaga A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X659295; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen TJ, 2003, CLIN THER, V25, P2453, DOI 10.1016/S0149-2918(03)80287-4; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng T-M, 2009, TAIWANS NATL HLTH IN, P171; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; DuGoff EH, 2014, MED CARE, V52, P688, DOI 10.1097/MLR.0000000000000166; Eftekhar Behzad, 2005, BMC Med Inform Decis Mak, V5, P3; Faul M, 2010, TRAUMATIC BRAIN INJU, V2, P1; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Hamele M, 2016, J NEUROTRAUM, V33, P832, DOI 10.1089/neu.2015.4004; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P287, DOI 10.1016/j.apmr.2011.08.041; Howle AA, 2011, BRAIN IMPAIR, V12, P179; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hung L-C, 2016, J EPIDEMIOLOGY; Jawad I, 2012, POPULATION, V2, P4; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Jovanovic B, 2015, INT J INFECT DIS, V38, P46, DOI 10.1016/j.ijid.2015.07.005; Launey Y, 2014, CRITICAL CARE, V18, P1; Liao JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084941; Liesemer K, 2014, PEDIAT CRITICAL CARE; Lockey DJ, 1999, ANAESTHESIA, V54, P1097, DOI 10.1046/j.1365-2044.1999.00754.x; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pasquier N, 1999, LECT NOTES COMPUT SC, V1540, P398; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Piatetsky-Shapiro G., 1991, Knowledge discovery in databases, P229; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rothen HU, 2007, INTENS CARE MED, V33, P1329, DOI 10.1007/s00134-007-0690-3; Rughani AI, 2010, J NEUROSURG, V113, P585, DOI 10.3171/2009.11.JNS09857; Sanchez-Olmedo J, 2005, TRANSPLANTATION P; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; Shi HY, 2013, J NEUROSURG, V118, P746, DOI 10.3171/2013.1.JNS121130; Shultz SR, 2016, NEUROSCIENCE BIOBEHA; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thompson HJ, 2008, CRIT CARE MED, V36, P282, DOI 10.1097/01.CCM.0000297884.86058.8A; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Tu CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014824; van Oostrom SH, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-61; Venturi L, 2009, J NEUROTRAUM, V26, P1547, DOI [10.1089/neu.2008.0723, 10.1089/neu.2008-0723]; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Wang LL, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-016-0580-x; Webster JB, 2001, ARCH PHYS MED REHAB, V82, P316, DOI 10.1053/apmr.2001.20840; Wee HY, 2016, J CLIN PSYCHIAT, V77, P505, DOI 10.4088/JCP.14m09749; Weissman C, 2000, INTENS CARE MED, V26, P1319, DOI 10.1007/s001340000612; Wu MP, 2014, STROKE, V45, P1349, DOI 10.1161/STROKEAHA.113.003675; Yasseen B, 2008, BRAIN INJURY, V22, P752, DOI 10.1080/02699050802320132	59	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e190683	10.1371/journal.pone.0190683	http://dx.doi.org/10.1371/journal.pone.0190683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BJ	29324771	Green Submitted, Green Published, gold			2022-12-26	WOS:000419952400047
J	Li, XM; Liu, J; Pan, FF; Shi, DD; Wen, ZG; Yang, PL				Li, Xiu-Mei; Liu, Jing; Pan, Fang-Fang; Shi, Dong-Dong; Wen, Zhi-Guo; Yang, Pei-Long			Quercetin and aconitine synergistically induces the human cervical carcinoma HeLa cell apoptosis via endoplasmic reticulum (ER) stress pathway	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; P-GLYCOPROTEIN; IRE1 PATHWAY; TOXICITY; PROLIFERATION; GENE	Up till now, studies have not been conducted on how the combination of Quercetin (Q), Aconitine (A) and apoptosis induction affects human cervical carcinoma HeLa cells. The result of our findings shows that the combination of Q and A (QA) is capable of synergistically inhibiting the proliferation of HeLa cells in a number of concentrations. QA synergistically inhibits the proliferation of MDR1 gene in the HeLa cells. It is concluded based on our result that QA induces apoptosis and ER stress just as QA-induced ER stress pathway may mediate apoptosis by upregulating mRNA expression levels of eIF2 alpha, ATF4, IRE1, XBP1, ATF6, PERK and CHOP in the HeLa cells. The up-regulating of mRNA expression level of GRP78 and activation of UPR are a molecular basis of QA-induced ER stress.	[Li, Xiu-Mei; Liu, Jing; Shi, Dong-Dong; Wen, Zhi-Guo; Yang, Pei-Long] Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing, Peoples R China; [Li, Xiu-Mei; Liu, Jing; Shi, Dong-Dong; Wen, Zhi-Guo; Yang, Pei-Long] Chinese Acad Agr Sci, Feed Res Inst, Natl Engn Res Ctr Biol Feed, Beijing, Peoples R China; [Pan, Fang-Fang] Tianjin Univ Sci & Technol, Coll Biotechnol, Tianjin Key Lab Ind Microbiol, Key Lab Ind Fermentat Microbiol,Minist Educ, Tianjin, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Tianjin University Science & Technology	Li, XM; Yang, PL (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Minist Agr, Key Lab Feed Biotechnol, Beijing, Peoples R China.; Li, XM; Yang, PL (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Natl Engn Res Ctr Biol Feed, Beijing, Peoples R China.	lixiumei@caas.cn; yangpeilong@caas.cn	li, xiu/GXV-1745-2022		National Key Research and Development Program of China [2017YFD0400300]; Agricultural Science and Technology Innovation Program [CAAS-XTCX2016011-04-3]	National Key Research and Development Program of China; Agricultural Science and Technology Innovation Program	Our work was financially supported by the National Key Research and Development Program of China (2017YFD0400300) and the Agricultural Science and Technology Innovation Program (CAAS-XTCX2016011-04-3).	Barros GP, 2012, INT J GEOPHYS, V2012, DOI [10.1155/2012/459497, 10.5402/2012/137289]; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Chan TYK, 2012, FORENSIC SCI INT, V222, P1, DOI 10.1016/j.forsciint.2012.02.026; Chan TYK, 2009, CLIN TOXICOL, V47, P279, DOI 10.1080/15563650902904407; Chen JQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085161, 10.1371/journal.pone.0101277]; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Coley HM, 2010, METHODS MOL BIOL, V596, P341, DOI 10.1007/978-1-60761-416-6_15; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Deng HD, 2016, AGING-US, V8, P3552, DOI 10.18632/aging.101150; Dudek J, 2009, CELL MOL LIFE SCI, V66, P1556, DOI 10.1007/s00018-009-8745-y; Efferth T, 2008, MOL CANCER THER, V7, P152, DOI 10.1158/1535-7163.MCT-07-0073; Faitova J, 2006, CELL MOL BIOL LETT, V11, P488, DOI 10.2478/s11658-006-0040-4; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gallay C, 2017, INT J WOMENS HEALTH, V9, P455, DOI 10.2147/IJWH.S136351; Gautam S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079352; Guo HR, 2016, ONCOTARGET, V7, P17508, DOI 10.18632/oncotarget.7919; Guo WK, 2014, INT J MOL SCI, V15, P484, DOI 10.3390/ijms15010484; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hardy B, 2010, J MOL MED, V88, P1157, DOI 10.1007/s00109-010-0657-7; Haze K, 2001, BIOCHEM J, V355, P19, DOI 10.1042/0264-6021:3550019; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hseu YC, 2014, J ETHNOPHARMACOL, V153, P499, DOI 10.1016/j.jep.2014.03.012; Jiang CY, 2012, TOXICOL LETT, V211, P325, DOI 10.1016/j.toxlet.2012.04.009; Ke LJ, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-1155-1; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Li-Weber M, 2013, CANCER LETT, V332, P304, DOI 10.1016/j.canlet.2010.07.015; Liu HL, 2014, TOXICOL LETT, V224, P341, DOI 10.1016/j.toxlet.2013.11.001; Liu L, 2015, BIOL TRACE ELEM RES, V164, P64, DOI 10.1007/s12011-014-0192-4; Liu Y, 2014, CANCER SCI, V105, P520, DOI 10.1111/cas.12395; Meng GM, 2015, INT J ONCOL, V46, P1007, DOI 10.3892/ijo.2015.2814; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; Rieger Aja M, 2011, J Vis Exp, DOI 10.3791/2597; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shang HS, 2016, ONCOL REP, V36, P2207, DOI 10.3892/or.2016.5002; Smith HO, 2000, GYNECOL ONCOL, V78, P97, DOI 10.1006/gyno.2000.5826; Sreejith PS, 2015, J ETHNOPHARMACOL, V172, P38, DOI 10.1016/j.jep.2015.05.051; Susuki S, 2009, J BIOL CHEM, V284, P8312, DOI 10.1074/jbc.M809354200; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang NB, 2017, BIOMED PHARMACOTHER, V90, P368, DOI 10.1016/j.biopha.2017.03.083; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Xiang T, 2014, J HUAZHONG U SCI-MED, V34, P740, DOI 10.1007/s11596-014-1345-6; Xiong ZY, 2015, INT J MOL SCI, V16, P21153, DOI 10.3390/ijms160921153; Yang Yang, 2009, Wuhan Daxue Xuebao (Yixue Ban), V30, P334; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang SX, 2014, EXP EYE RES, V125, P30, DOI 10.1016/j.exer.2014.04.015	50	24	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191062	10.1371/journal.pone.0191062	http://dx.doi.org/10.1371/journal.pone.0191062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324796	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400102
J	Carimo, AA; Gudo, ES; Maueia, C; Mabunda, N; Chambal, L; Vubil, A; Flora, A; Antunes, F; Bhatt, N				Carimo, Awa Abdul; Gudo, Eduardo Samo; Maueia, Cremildo; Mabunda, Nedio; Chambal, Lucia; Vubil, Adolfo; Flora, Ana; Antunes, Francisco; Bhatt, Nilesh			First report of occult hepatitis B infection among ART naive HIV seropositive individuals in Maputo, Mozambique	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS COINFECTION; CORE ANTIGEN; POSITIVE PATIENTS; BLOOD-DONORS; PREVALENCE; AFRICA; RISK; REACTIVATION; ANTIBODIES; PATIENT	Background The prevalence of hepatitis B virus (HBV) infection and human immunodeficiency virus (HIV) infection in Mozambique is one of the highest in the world, though in spite of this the prevalence of occult hepatitis B infection (OBI) is unknown. Objectives This study was conducted with the aim to investigate the prevalence of OBI and frequency of isolated hepatitis B core antibody (anti-HBc alone) among antiretroviral (ART) naive HIV-positive patients in Mozambique. Methods A cross-sectional study was conducted in two health facilities within Maputo city. All ART-naive HIV seropositive patients attending outpatient clinics between June and October 2012 were consecutively enrolled. Blood samples were drawn from each participant and used for serological measurement of HBV surface antigen (HBsAg), antibodies against HBV surface antigen (anti-HBs) and antibodies against core antigen (anti-HBc) using ELISA. Quantification of HBV DNA was performed by real time PCR. A questionnaire was used to obtain demographics and clinical data. Results Of the 518 ART-naive HIV-positive subjects enrolled in the study, 90.9% (471/518) were HBsAg negative. Among HBsAg negative, 45.2% (213/471) had isolated anti-HBc antibodies, and the frequency of OBI among patients with anti-HBc alone was 8.3% (17/206). OBI was not correlated either with CD4(+) T cells count or transaminases levels. A total of 11.8% of patients with OBI presented elevated HBV DNA level. Frequency of individuals with APRI score > 2 and FIB-4 score > 3.25 was higher in patients with OBI as compared not exposed, immune and anti-HBc alone patients. Conclusion Our data demonstrate for the first time that OBI is prevalent among HIV patients in Mozambique, and will be missed using the commonly available serological assays that measures HBsAg.	[Carimo, Awa Abdul; Chambal, Lucia] Maputo Cent Hosp, Internal Med Dept, Maputo, Mozambique; [Gudo, Eduardo Samo; Maueia, Cremildo; Mabunda, Nedio; Vubil, Adolfo; Flora, Ana; Bhatt, Nilesh] Minist Hlth, Inst Nacl Saude, Maputo, Mozambique; [Antunes, Francisco] Univ Lisbon, Fac Med, Inst Saude Ambiental ISAMB, Lisbon, Portugal	Universidade de Lisboa	Carimo, AA (corresponding author), Maputo Cent Hosp, Internal Med Dept, Maputo, Mozambique.	awacarimo83@gmail.com		Maueia, Cremildo Gomes/0000-0002-1511-6175	Ministry of Health of Mozambique; Ministry of Health of Mozambique and Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina (AIDFM), Lisbon, Portugal	Ministry of Health of Mozambique; Ministry of Health of Mozambique and Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina (AIDFM), Lisbon, Portugal	This work was supported by Ministry of Health of Mozambique, which participated in study design, data collection and analysis, and the decision to publish and the preparation of the manuscript. The funds were received by NB and ESG. Associagao para Investigapo e Desenvolvimento da Faculdade de Medicina, Lisbon, Portugal who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It was a part of the master thesis in emerging infectious diseases scholarship.; This study was supported by funds from Ministry of Health of Mozambique and Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina (AIDFM), Lisbon, Portugal.	Allain JP, 2004, TRANSFUS CLIN BIOL, V11, P18, DOI 10.1016/j.tracli.2003.11.007; Altfeld M, 1998, J HEPATOL, V29, P306, DOI 10.1016/S0168-8278(98)80017-2; BOS P, 1995, E AFR MED J, V72, P113; Brechot C, 2001, HEPATOLOGY, V34, P194, DOI 10.1053/jhep.2001.25172; Burnett RJ, 2005, LIVER INT, V25, P201, DOI 10.1111/j.1478-3231.2005.01054.x; Chadwick D, 2014, HIV MED, V15, P189, DOI 10.1111/hiv.12093; Chambal LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181836; Chamorro AJ, 2005, EUR J CLIN MICROBIOL, V24, P492, DOI 10.1007/s10096-005-1355-1; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Cunha L, 2007, J MED VIROL, V79, P1832, DOI 10.1002/jmv.21010; Filippini P, 2006, AIDS, V20, P1253, DOI 10.1097/01.aids.0000232232.41877.2a; Grob P, 2000, J MED VIROL, V62, P450, DOI 10.1002/1096-9071(200012)62:4&lt;450::AID-JMV9&gt;3.0.CO;2-Y; Gudo ES, 2009, TRANSFUSION, V49, P1146, DOI 10.1111/j.1537-2995.2009.02100.x; Hofer M, 1998, EUR J CLIN MICROBIOL, V17, P6, DOI 10.1007/BF01584356; Hu KQ, 2002, J VIRAL HEPATITIS, V9, P243, DOI 10.1046/j.1365-2893.2002.00344.x; INS IaM, 2010, INQ NAC SIDA MOC INS; INS IaM, 2017, INQ IND IM MAL HIV S; Kwak MS, 2014, WORLD J HEPATOL, V6, P860, DOI 10.4254/wjh.v6.i12.860; LAZIZI Y, 1988, J INFECT DIS, V158, P666, DOI 10.1093/infdis/158.3.666; Lo Re V, 2007, JAIDS-J ACQ IMM DEF, V44, P315, DOI 10.1097/QAI.0b013e31802ea499; Lurie Y, 2015, WORLD J GASTROENTERO, V21, P11567, DOI 10.3748/wjg.v21.i41.11567; Mphahlele MJ, 2006, J CLIN VIROL, V35, P14, DOI 10.1016/j.jcv.2005.04.003; Neau D, 2005, CLIN INFECT DIS, V40, P750, DOI 10.1086/427882; Nebbia G, 2007, J MED VIROL, V79, P1464, DOI 10.1002/jmv.20954; Nunez M, 2002, AIDS, V16, P2099, DOI 10.1097/00002030-200210180-00024; Ozaslan E, 2009, WORLD J GASTROENTERO, V15, P4986, DOI 10.3748/wjg.15.4986; Phung BC, 2014, WORLD J GASTROENTERO, V20, P17360, DOI 10.3748/wjg.v20.i46.17360; Puoti M, 2006, J HEPATOL, V44, pS65, DOI 10.1016/j.jhep.2005.11.015; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Sagnelli E, 2014, WORLD J HEPATOL, V6, P384, DOI 10.4254/wjh.v6.i6.384; Said ZNA, 2011, WORLD J GASTROENTERO, V17, P1927, DOI 10.3748/wjg.v17.i15.1927; Shire NJ, 2004, JAIDS-J ACQ IMM DEF, V36, P869, DOI 10.1097/00126334-200407010-00015; Stokx J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-141; Sun HY, 2010, J VIRAL HEPATITIS, V17, P578, DOI 10.1111/j.1365-2893.2009.01212.x; Viegas EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121452; Wandeler G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152043; WHO, 2015, WHO GUID PREV CAR TR	37	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190775	10.1371/journal.pone.0190775	http://dx.doi.org/10.1371/journal.pone.0190775			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320552	Green Published, gold, Green Submitted			2022-12-26	WOS:000419689600064
J	Gil-Cayuela, C; Ortega, A; Tarazon, EA; Martinez-Dolz, L; Cinca, J; Gonzalez-Juanatey, JR; Lago, F; Rosello-Lleti, E; Rivera, M; Portoles, M				Gil-Cayuela, Carolina; Ortega, Ana; Tarazon, Estefania A.; Martinez-Dolz, Luis; Cinca, Juan; Ramon Gonzalez-Juanatey, Jose; Lago, Francisca; Rosello-Lleti, Esther; Rivera, Miguel; Portoles, Manuel			Myocardium of patients with dilated cardiomyopathy presents altered expression of genes involved in thyroid hormone biosynthesis	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; SUBCLINICAL HYPOTHYROIDISM; REPLACEMENT THERAPY; IODIDE TRANSPORT; CARDIAC-FUNCTION; TASK-FORCE; RAT-HEART; DYSFUNCTION; INDUCTION; HEMODYNAMICS	Background The association between dilated cardiomyopathy (DCM) and low thyroid hormone (TH) levels has been previously described. In these patients abnormal thyroid function is significantly related to impaired left ventricular (LV) function and increased risk of death. Although TH was originally thought to be produced exclusively by the thyroid gland, we recently reported TH biosynthesis in the human ischemic heart. Objectives Based on these findings, we evaluated whether the genes required for TH production are also altered in patients with DCM. Methods Twenty-three LV tissue samples were obtained from patients with DCM (n = 13) undergoing heart transplantation and control donors (n = 10), and used for RNA sequencing analysis. The number of LV DCM samples was increased to 23 to determine total T4 and T3 tissue levels by ELISA. Results We found that all components of TH biosynthesis are expressed in human dilated heart tissue. Expression of genes encoding thyroperoxidase (-2.57-fold, P < 0.05) and dual oxidase 2 (2.64-fold, P < 0.01), the main enzymatic system of TH production, was significantlyaltered in patients with DCM and significantly associated with LV remodeling parameters. Thyroxine (T4) cardiac tissue levels were significantly increased (P < 0.01), whilst triiodothyronine (T3) levels were significantly diminished (P < 0.05) in the patients. Conclusions Expression of TH biosynthesis machinery in the heart and total tissue levels of T4 and T3, are altered in patients with DCM. Given the relevance of TH in cardiac pathology, our results provide a basis for new gene-based therapeutic strategies for treating DCM.	[Gil-Cayuela, Carolina; Ortega, Ana; Tarazon, Estefania A.; Rosello-Lleti, Esther; Rivera, Miguel; Portoles, Manuel] La Fe Univ Hosp IIS La Fe, Hlth Res Inst, Cardiocirculatory Unit, Valencia, Spain; [Gil-Cayuela, Carolina; Ortega, Ana; Tarazon, Estefania A.; Martinez-Dolz, Luis; Cinca, Juan; Ramon Gonzalez-Juanatey, Jose; Lago, Francisca; Rosello-Lleti, Esther; Rivera, Miguel; Portoles, Manuel] Ctr Biomed Res Network Cardiovasc Dis CIBERCV, Madrid, Spain; [Martinez-Dolz, Luis] La Fe Univ Hosp, Cardiol Dept, Heart Failure & Transplantat Unit, Valencia, Spain; [Cinca, Juan] Santa Creu & St Pau Hosp, Cardiol Serv, Barcelona, Spain; [Ramon Gonzalez-Juanatey, Jose; Lago, Francisca] Univ Clin Hosp, Cellular & Mol Cardiol Res Unit, Dept Cardiol, Santiago De Compostela, Spain; [Ramon Gonzalez-Juanatey, Jose; Lago, Francisca] Univ Clin Hosp, Inst Biomed Res, Santiago De Compostela, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Rosello-Lleti, E; Rivera, M; Portoles, M (corresponding author), La Fe Univ Hosp IIS La Fe, Hlth Res Inst, Cardiocirculatory Unit, Valencia, Spain.; Rosello-Lleti, E; Rivera, M; Portoles, M (corresponding author), Ctr Biomed Res Network Cardiovasc Dis CIBERCV, Madrid, Spain.	esther_rosello_lleti@hotmail.com; miguelrivera492@gmail.com; portoles_man@gva.es	Roselló Lletí, Esther/ABG-8503-2020; Ortega, Ana/AAG-5941-2020; Tarazón, Estefanía/D-6950-2017; PORTOLES, MANUEL/B-4789-2009; Ortega, Ana AO/D-3027-2017; Dolz, Luis Martinez/X-4627-2018	Roselló Lletí, Esther/0000-0003-2627-6104; Ortega, Ana/0000-0002-9763-0505; Tarazón, Estefanía/0000-0003-3466-2558; PORTOLES, MANUEL/0000-0002-4415-7160; Ortega, Ana AO/0000-0002-9763-0505; Dolz, Luis Martinez/0000-0001-5145-8191; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	National Institute of Health "Fondo de Investigaciones Sanitarias del Institute de Salud Carlos III" Madrid, Spain [PI13/00100, PI14/01506]; CIBERCV [CB16/11/00261]; European Regional Development Fund (FEDER); Thematic Networks for Co-Operative Research in Health (RETICS), Madrid, Spain [12/0042/0003]	National Institute of Health "Fondo de Investigaciones Sanitarias del Institute de Salud Carlos III" Madrid, Spain; CIBERCV; European Regional Development Fund (FEDER)(European Commission); Thematic Networks for Co-Operative Research in Health (RETICS), Madrid, Spain	This work was supported by the National Institute of Health "Fondo de Investigaciones Sanitarias del Institute de Salud Carlos III" Madrid, Spain [PI13/00100 to Miguel Rivera, PI14/01506 to Esther Rosello-Lleti] and CIBERCV [CB16/11/00261 to Miguel Rivera]; European Regional Development Fund (FEDER), and Thematic Networks for Co-Operative Research in Health (RETICS), Madrid, Spain [12/0042/0003 to Miguel Rivera]. Gil-Cayuela, C. and Rosello-Lleti, E., received a salary from CIBERCV [CB16/11/00261]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Pimentel CRA, 2010, INT J CARDIOL, V145, P52, DOI 10.1016/j.ijcard.2009.04.001; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Biondi B, 2002, THYROID, V12, P505, DOI 10.1089/105072502760143890; Biondi B, 2012, EUR J ENDOCRINOL, V167, P609, DOI 10.1530/EJE-12-0627; Cangul H, 2013, CLIN ENDOCRINOL, V79, P275, DOI 10.1111/cen.12127; CARRASCO N, 1993, BIOCHIM BIOPHYS ACTA, V1154, P65, DOI 10.1016/0304-4157(93)90017-I; Cortes R, 2007, J CARD FAIL, V13, P549, DOI 10.1016/j.cardfail.2007.04.007; Fazio S, 2004, RECENT PROG HORM RES, V59, P31, DOI 10.1210/rp.59.1.31; Gerard AC, 2003, J CLIN ENDOCR METAB, V88, P4977, DOI 10.1210/jc.2003-030586; Gerdes AM, 2010, CIRCULATION, V122, P385, DOI 10.1161/CIRCULATIONAHA.109.917922; Gil-Cayuela C, 2017, INT J CARDIOL; Ginabreda MGP, 2008, EUR J ENDOCRINOL, V158, P223, DOI 10.1530/EJE-07-0602; Grais IM, 2014, AM J MED, V127, P691, DOI 10.1016/j.amjmed.2014.03.009; Iervasi G, 2013, INTERN EMERG MED, V8, pS71, DOI 10.1007/s11739-013-0911-4; Kahaly GJ, 2000, THYROID, V10, P665, DOI 10.1089/10507250050137743; Khalife WI, 2005, AM J PHYSIOL-HEART C, V289, pH2409, DOI 10.1152/ajpheart.00483.2005; Kinugawa K, 2001, CIRCULATION, V103, P1089, DOI 10.1161/01.CIR.103.8.1089; Li XP, 2014, J CARD FAIL, V20, P506, DOI 10.1016/j.cardfail.2014.05.002; LIU Z, 1990, J MOL CELL CARDIOL, V22, P1339, DOI 10.1016/0022-2828(90)90979-C; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macrae Duncan J, 2007, Proc Am Thorac Soc, V4, P176, DOI 10.1513/pats.200701-011GC; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Meischl C, 2008, AM J PHYSIOL-CELL PH, V294, pC1227, DOI 10.1152/ajpcell.00328.2007; Mitchell JE, 2013, JACC-HEART FAIL, V1, P48, DOI 10.1016/j.jchf.2012.10.004; Naderi N, 2015, RES CARDIOVASC MED, V4; OBREGON MJ, 1981, ENDOCRINOLOGY, V109, P908, DOI 10.1210/endo-109-3-908; Ojamaa K, 2000, ENDOCRINOLOGY, V141, P2139, DOI 10.1210/en.141.6.2139; Ortega A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160168; Nicola JP, 2011, J CLIN ENDOCR METAB, V96, pE1100, DOI 10.1210/jc.2011-0349; Pantos C, 2008, BASIC RES CARDIOL, V103, P308, DOI 10.1007/s00395-008-0697-0; Pantos C, 2009, BASIC RES CARDIOL, V104, P69, DOI 10.1007/s00395-008-0758-4; Pingitore A, 2008, J CLIN ENDOCR METAB, V93, P1351, DOI 10.1210/jc.2007-2210; Pol CJ, 2011, ENDOCRINOLOGY, V152, P669, DOI 10.1210/en.2010-0431; Rhee CM, 2013, J CLIN ENDOCR METAB, V98, P2326, DOI 10.1210/jc.2013-1039; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Riou C, 1999, ENDOCRINOLOGY, V140, P1990, DOI 10.1210/en.140.5.1990; Ripoli A, 2005, J AM COLL CARDIOL, V45, P439, DOI 10.1016/j.jacc.2004.10.044; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Wassen FWJS, 2002, ENDOCRINOLOGY, V143, P2812, DOI 10.1210/en.143.7.2812; Wassner AJ, 2017, THYROID, V27, P732, DOI 10.1089/thy.2016.0570; YAO JL, 1992, CIRC RES, V71, P831, DOI 10.1161/01.RES.71.4.831	41	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190987	10.1371/journal.pone.0190987	http://dx.doi.org/10.1371/journal.pone.0190987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320567	Green Submitted, Green Published, gold			2022-12-26	WOS:000419689600078
J	Bivigou-Mboumba, B; Amougou-Atsama, M; Zoa-Assoumou, S; Kamdem, HM; Nzengui-Nzengui, GF; Ndojyi-Mbiguino, A; Njouom, R; Francois-Souquiere, S				Bivigou-Mboumba, Berthold; Amougou-Atsama, Marie; Zoa-Assoumou, Samira; Kamdem, Herve M'boyis; Nzengui-Nzengui, Guy Francis; Ndojyi-Mbiguino, Angelique; Njouom, Richard; Francois-Souquiere, Sandrine			Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; GENETIC-VARIABILITY; DELTA-VIRUS; IDENTIFICATION; COINFECTION; GENOTYPES; SUPPRESSION; DIVERSITY; CANCERS; AFRICA	In Gabon, a central African country, human immunodeficiency virus (HIV) and hepatitis B virus (HBV) are endemic. In a recent study, conducted in a semi- urban area (Franceville, Gabon), HBV infection was found to be more prevalent among HIV infected individuals. This study aims to investigate the prevalence and genetic diversity of hepatitis B virus infection among HIV infected individuals, predominantly under antiretroviral therapy, living in fully urbanized area: Libreville, capital of Gabon. Serological and molecular tests were performed to detect HBV infection among patients living with HIV/AIDS (PLHA). We used Monolisa HBsAg ULTRA, Anti-HBc Plus and Anti-HBs Plus EIA kits for serological analyses. HBV DNA viral load (HBV DNA VL) was determined by real time PCR and molecular characterization of HBV strains was performed by sequencing and phylogenetic analysis of partial HBV surface and core genes. At all, 70.2% of patients were under antiretroviral therapy. The prevalence of HBsAg was 8.8% (43/487). Detectable HBV DNA was found in 69.7% (30/43) of HBsAg positive patients and in 17.5% (24/137) HBsAg negative patients. HBV DNA VL was significantly higher among patient with CD4 cell counts less than 200 cells/ mm(3) than those with CD4 cell counts greater than 500 cells/mm(3) (p = 0.008). We confirmed the presence of HBV sub-genotypes QS-A3 (40%), and A4 (20%) and HBV-E genotype (40%). The percentage of resistance to Lamivudine was high (40%) and varied according to the M204V/I motif. Occult hepatitis B infection (OBI) was found in patients with isolated HBcAb and among patients who had completed their HBsAg seroconversion. We detected HBV DNA for one patient without any HBV serological marker. This study provides a new landmark for the comprehension of HBV infection in PLHA in urban areas. OBI enhances HBV DNA prevalence and should be investigated in all HBsAg negative individuals.	[Bivigou-Mboumba, Berthold; Francois-Souquiere, Sandrine] Ctr Int Rech Med CIRMF, UMR VIH MIA, Libreville, Gabon; [Bivigou-Mboumba, Berthold; Zoa-Assoumou, Samira; Kamdem, Herve M'boyis; Nzengui-Nzengui, Guy Francis; Ndojyi-Mbiguino, Angelique; Francois-Souquiere, Sandrine] Univ Sci Sante, Lab Reference IST SIDA, Lab Bacteriol Virol, Owendo, Gabon; [Amougou-Atsama, Marie; Njouom, Richard] Ctr Pasteur Cameroun, Serv Virol, Yaounde, Cameroon	Centre Pasteur du Cameroun	Bivigou-Mboumba, B (corresponding author), Ctr Int Rech Med CIRMF, UMR VIH MIA, Libreville, Gabon.; Bivigou-Mboumba, B (corresponding author), Univ Sci Sante, Lab Reference IST SIDA, Lab Bacteriol Virol, Owendo, Gabon.	bivigou.berthold@gmail.com			Gabonese Government, Total Gabon; French Foreign Ministry	Gabonese Government, Total Gabon; French Foreign Ministry	We are indebted to all patients who participated to this study. We also especially thank the clinicians. We thank Dr Katharine Abernethy for reading manuscript. We thank Miss Leonie NGOUANGA for the blood samplings and Miss Falone Larissa AKOMBI for technical help. The Centre International de Recherches Medicales de Franceville (CIRMF) is funded by the Gabonese Government, Total Gabon and the French Foreign Ministry.	Amougou MA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1992-2; Anastasiou OE, 2017, J CLIN VIROL, V93, P46, DOI 10.1016/j.jcv.2017.06.001; Anderson M, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw140; Aoudjane S, 2014, CLIN INFECT DIS, V59, P1618, DOI 10.1093/cid/ciu630; Avettand-Fenoel V, 2006, J CLIN MICROBIOL, V44, P2250, DOI 10.1128/JCM.00234-06; Barth RE, 2010, INT J INFECT DIS, V14, pE1024, DOI 10.1016/j.ijid.2010.06.013; Bell TG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-62; Bertherat E, 1999, SEX TRANSM INFECT, V75, P271, DOI 10.1136/sti.75.4.271; Bian T, 2013, J VIROL, V87, P12196, DOI 10.1128/JVI.02127-13; Bivigou-Mboumba B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143869; Chen M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150512; Christine Larsen, 2005, B EPIDEMIOLOGIQE HEB; Desire N, 2011, Pathol Biol (Paris), V59, pe13, DOI 10.1016/j.patbio.2010.07.005; Francois-Souquiere S, 2016, INFECT GENET EVOL, V39, P12, DOI 10.1016/j.meegid.2015.12.021; Gachara G, 2017, AIDS RES THER, V14, DOI 10.1186/s12981-017-0136-0; Geretti AM, 2010, J CLIN MICROBIOL, V48, P3223, DOI 10.1128/JCM.02231-09; Hafkin JS, 2014, J VIRAL HEPATITIS, V21, P288, DOI 10.1111/jvh.12142; Hann HW, 2008, HEPATOL INT, V2, P244, DOI 10.1007/s12072-008-9045-6; Honge BL, 2016, J MED VIROL, V88, P1653, DOI 10.1002/jmv.24455; Honge BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099971; Hu XL, 2000, P NATL ACAD SCI USA, V97, P1661, DOI 10.1073/pnas.97.4.1661; Huang YS, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0169228, 10.1371/journal.pone.0]; Kfutwah AKW, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-62; Kouanfack C, 2012, ANTIVIR THER, V17, P321, DOI 10.3851/IMP1911; Kramvis A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947; Krarup HB, 2008, SCAND J GASTROENTERO, V43, P334, DOI 10.1080/00365520701712198; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lam L, 2004, CD4 T LYMPHOCYTES CD; Lim L, 2017, LIVER INT, V37, P827, DOI 10.1111/liv.13331; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Ma Q, 2012, J MED VIROL, V84, P198, DOI 10.1002/jmv.23183; Makuwa M, 2008, J CLIN MICROBIOL, V46, P754, DOI 10.1128/JCM.02142-07; Makuwa M, 2006, J MED VIROL, V78, P1175, DOI 10.1002/jmv.20678; Makuwa M, 2009, J CLIN MICROBIOL, V47, P2265, DOI 10.1128/JCM.02012-08; Menendez-Arias L, 2014, CURR OPIN VIROL, V8, P1, DOI 10.1016/j.coviro.2014.04.005; Modi AA, 2007, AIDS REV, V9, P25; Noubiap JJN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137375; Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0; Osborn Melissa, 2011, Infect Drug Resist, V4, P55, DOI 10.2147/IDR.S4188; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Parvez MK, 2015, WORLD J HEPATOL, V7, P121, DOI 10.4254/wjh.v7.i1.121; Petty LA, 2014, INFECT DIS CLIN N AM, V28, P477, DOI 10.1016/j.idc.2014.05.005; Pourkarim MR, 2014, WORLD J GASTROENTERO, V20, P7152, DOI 10.3748/wjg.v20.i23.7152; Ruggiero Giuseppe, 2016, Infez Med, V24, P278; Ryan K, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx195; Scheiblauer H, 2010, VOX SANG, V98, P403, DOI 10.1111/j.1423-0410.2009.01272.x; Tong YQ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004618; Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016/S1473-3099(02)00345-6; Urone N, 2015, INFECT GENET EVOL, V33, P281, DOI 10.1016/j.meegid.2015.05.016	49	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190592	10.1371/journal.pone.0190592	http://dx.doi.org/10.1371/journal.pone.0190592			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315352	Green Published, gold, Green Submitted			2022-12-26	WOS:000419655900015
J	Gong, L; Huang, YT; Wong, CH; Chao, WC; Wu, ZY; Wei, CL; Liu, PY				Gong, Liang; Huang, Yao-Ting; Wong, Chee-Hong; Chao, Wen-Cheng; Wu, Zong-Yen; Wei, Chia-Lin; Liu, Po-Yu			Culture-independent analysis of liver abscess using nanopore sequencing	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; IDENTIFICATION; PATHOGENS; BACTERIA; DISEASE; TAIWAN; TRENDS; MODEL; ABC	The identification of microbial species has depended predominantly upon culture-based techniques. However, the difficulty with which types of organisms are cultured implies that the grown species may be overrepresented by both cultivation and plate counts. In recent years, culture-independent analysis using high-throughput sequencing has been advocated for use as a point-of-care diagnostic tool. Although it offers a rapid and unbiased survey to characterize the pathogens in clinical specimens, its accuracy is reduced by the high level of contamination of human DNA. In this paper, we propose using a culture-independent analysis for a Klebsiella pneumoniae clinical strain within a liver abscess using nanopore sequencing. Owing to the highly-contaminated cell population within a liver abscess, we managed to reduce the confounding effects of human DNA through the use of DNase and differential centrifugation. Genomic DNA was sequenced through the use of Nanopore Min-ION sequencer and analyzed using a suite of bioinformatics approaches. K. pneumoniae was successfully identified along with antibiotic-resistant genes. Our results indicate that, by integrating real-time nanopore sequencing and bioinformatics software, real-time pathogen identification in a liver abscess can be achieved.	[Gong, Liang; Wong, Chee-Hong; Wei, Chia-Lin; Liu, Po-Yu] Jackson Lab Genom Med, Genome Technol, Farmington, CT USA; [Huang, Yao-Ting] Natl Chung Cheng Univ, Dept Comp Sci & Informat Engn, Chiayi, Taiwan; [Chao, Wen-Cheng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Wu, Zong-Yen] Natl Chung Hsing Univ, Dept Vet Med, Taichung, Taiwan; [Wei, Chia-Lin] Univ Connecticut, Inst Syst Gen, Mansfield, CT USA; [Wei, Chia-Lin] China Med Univ, Taichung, Taiwan; [Liu, Po-Yu] Taichung Vet Gen Hosp, Div Infect Dis, Dept Internal Med, Taichung, Taiwan; [Liu, Po-Yu] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan	Jackson Laboratory; National Chung Cheng University; Taichung Veterans General Hospital; National Chung Hsing University; University of Connecticut; China Medical University Taiwan; Taichung Veterans General Hospital; National Chung Hsing University	Wei, CL; Liu, PY (corresponding author), Jackson Lab Genom Med, Genome Technol, Farmington, CT USA.; Wei, CL (corresponding author), Univ Connecticut, Inst Syst Gen, Mansfield, CT USA.; Wei, CL (corresponding author), China Med Univ, Taichung, Taiwan.; Liu, PY (corresponding author), Taichung Vet Gen Hosp, Div Infect Dis, Dept Internal Med, Taichung, Taiwan.; Liu, PY (corresponding author), Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.	Chia-lin.Wei@jax.org; pyliu@vghtc.gov.tw	LIU, PO-YU/AHB-4861-2022; Gong, Liang/CAG-5950-2022	Wong, Chee Hong/0000-0003-4546-4979; Liu, Po-Yu/0000-0001-8006-4917; Huang, Yao-Ting/0000-0001-9253-2394	Ministry of Science and Technology (MOST) [103-2923-E-194-001-MY3, 104-2221-E-194-048-MY2]; Taichung Veterans General Hospital in Taiwan [TCVGH-1073901B, TCVGH-NCHU1067611]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Taichung Veterans General Hospital in Taiwan	This work was supported in part by the Ministry of Science and Technology (MOST) with grant numbers 103-2923-E-194-001-MY3 and 104-2221-E-194-048-MY2 to YTH and this was supported by grants from Taichung Veterans General Hospital in Taiwan (TCVGH-1073901B and TCVGH-NCHU1067611) to PYL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anstey JR, 2010, MED J AUSTRALIA, V193, P543, DOI 10.5694/j.1326-5377.2010.tb04042.x; Braiteh F, 2007, INT J INFECT DIS, V11, P16, DOI 10.1016/j.ijid.2005.10.006; Gevers D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002779; Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Jumbe N, 2003, J CLIN INVEST, V112, P275, DOI 10.1172/JCI200316814; Juul S, 2015, BIORXIV; Kirn TJ, 2013, CLIN MICROBIOL INFEC, V19, P513, DOI 10.1111/1469-0691.12180; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Koser CU, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002824; Kujiraoka M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00685; Li H, 2017, ARXIV E PRINTS, P1708; Liao CH, 2009, CLIN MICROBIOL INFEC, V15, P1119, DOI 10.1111/j.1469-0691.2009.02720.x; Mavilia MG, 2016, J CLIN TRANSL HEPATO, V4, P158, DOI 10.14218/JCTH.2016.00004; Meddings L, 2010, AM J GASTROENTEROL, V105, P117, DOI 10.1038/ajg.2009.614; Moore R, 2013, INFECTION, V41, P681, DOI 10.1007/s15010-013-0408-0; Perlin MH, 2014, ADV GENET, V85, P201, DOI 10.1016/B978-0-12-800271-1.00004-4; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Schmidt K, 2017, J ANTIMICROB CHEMOTH, V72, P104, DOI 10.1093/jac/dkw397; Shon AS, 2013, VIRULENCE, V4, P107, DOI 10.4161/viru.22718; Siu LK, 2012, LANCET INFECT DIS, V12, P881, DOI 10.1016/S1473-3099(12)70205-0; Theodoulou FL, 2015, BIOCHEM SOC T, V43, P1033, DOI 10.1042/BST20150139; Tsai FC, 2008, EMERG INFECT DIS, V14, P1592, DOI 10.3201/eid1410.071254; van Duin D, 2016, INFECT DIS CLIN N AM, V30, P377, DOI 10.1016/j.idc.2016.02.004; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Yeh KM, 2007, J CLIN MICROBIOL, V45, P466, DOI 10.1128/JCM.01150-06; Ziha-Zarifi I, 1999, ANTIMICROB AGENTS CH, V43, P287, DOI 10.1128/AAC.43.2.287	28	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190853	10.1371/journal.pone.0190853	http://dx.doi.org/10.1371/journal.pone.0190853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315344	Green Published, gold, Green Submitted			2022-12-26	WOS:000419655900027
J	Macdonald, SS; Patel, A; Larmour, VLC; Morgan-Lang, C; Hallam, SJ; Mark, BL; Withers, SG				Macdonald, Spencer S.; Patel, Ankoor; Larmour, Veronica L. C.; Morgan-Lang, Connor; Hallam, Steven J.; Mark, Brian L.; Withers, Stephen G.			Structural and mechanistic analysis of a beta-glycoside phosphorylase identified by screening a metagenomic library	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINIDASE; PURIFICATION; GLUCOSIDASE; CELLOBIOSE; EXPRESSION; EXTRACTS; GENOMICS; ENZYMES; CLONING; ACID	Glycoside phosphorylases have considerable potential as catalysts for the assembly of useful glycans for products ranging from functional foods and prebiotics to novel materials. However, the substrate diversity of currently identified phosphorylases is relatively small, limiting their practical applications. To address this limitation, we developed a high-throughput screening approach using the activated substrate 2,4-dinitrophenyl beta-D-glucoside (DNPGlc) and inorganic phosphate for identifying glycoside phosphorylase activity and used it to screen a large insert metagenomic library. The initial screen, based on release of 2,4-dinitrophenyl from DNPGlc in the presence of phosphate, identified the gene bglP, encoding a retaining beta-glycoside phosphorylase from the CAZy GH3 family. Kinetic and mechanistic analysis of the gene product, BglP, confirmed a double displacement ping-pong mechanism involving a covalent glycosyl-enzyme intermediate. X-ray crystallographic analysis provided insights into the phosphate-binding mode and identified a key glutamine residue in the active site important for substrate recognition. Substituting this glutamine for a serine swapped the substrate specificity from glucoside to N-acetylglucosaminide. In summary, we present a high-throughput screening approach for identifying beta-glycoside phosphorylases, which was robust, simple to implement, and useful in identifying active clones within a metagenomics library. Implementation	[Macdonald, Spencer S.; Withers, Stephen G.] Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada; [Macdonald, Spencer S.; Withers, Stephen G.] Univ British Columbia, Dept Biochem, Vancouver, BC V6T 1Z1, Canada; [Hallam, Steven J.] Univ British Columbia, Peter Wall Inst Adv Studies, Vancouver, BC V6T 1Z1, Canada; [Patel, Ankoor; Larmour, Veronica L. C.; Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Hallam, Steven J.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Hallam, Steven J.; Withers, Stephen G.] Univ British Columbia, ECOSCOPE Training Program, Vancouver, BC V6T 1Z3, Canada; [Macdonald, Spencer S.; Hallam, Steven J.; Withers, Stephen G.] Univ British Columbia, Genome Sci & Technol Program, Vancouver, BC V6T 1Z4, Canada; [Morgan-Lang, Connor] Univ British Columbia, Grad Program Bioinformat, Vancouver, BC V6T 1Z4, Canada; [Withers, Stephen G.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of Manitoba; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Withers, SG (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca	Morgan-Lang, Connor/P-5309-2014	Morgan-Lang, Connor/0000-0002-6714-0898; Macdonald, Spencer/0000-0001-9879-5507	Ecosystem Services, Commercialization Platforms, and Entrepreneurship (ECOSCOPE) through Natural Sciences and Engineering Research Council of Canada CREATE; Research Manitoba; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-05310]; Canada Council for the Arts; Killam Foundation	Ecosystem Services, Commercialization Platforms, and Entrepreneurship (ECOSCOPE) through Natural Sciences and Engineering Research Council of Canada CREATE; Research Manitoba; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Council for the Arts; Killam Foundation	Supported by Ecosystem Services, Commercialization Platforms, and Entrepreneurship (ECOSCOPE), funded through Natural Sciences and Engineering Research Council of Canada CREATE.; Holds a studentship award from Research Manitoba.; Supported by Discovery Grants from Natural Sciences and Engineering Research Council of Canada and grants from the Canada Foundation for Innovation.; Supported by Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2015-05310.; Recipient of salary support from the Canada Council for the Arts and the Killam Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bacik JP, 2012, CHEM BIOL, V19, P1471, DOI 10.1016/j.chembiol.2012.09.016; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berini F, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx211; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchholz K, 2008, CARBOHYD RES, V343, P1966, DOI 10.1016/j.carres.2008.02.007; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Cori GT, 1938, J BIOL CHEM, V123, P375; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; de Kok S, 2011, METAB ENG, V13, P518, DOI 10.1016/j.ymben.2011.06.001; Ducatti DRB, 2016, CARBOHYD RES, V435, P106, DOI 10.1016/j.carres.2016.09.015; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gabor EM, 2004, ENVIRON MICROBIOL, V6, P879, DOI 10.1111/j.1462-2920.2004.00640.x; Gaida SM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8045; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KITAOKA M, 1992, BIOSCI BIOTECH BIOCH, V56, P652, DOI 10.1271/bbb.56.652; Kitaoka M, 2002, TRENDS GLYCOSCI GLYC, V14, P35, DOI 10.4052/tigg.14.35; Kitaoka M, 2015, APPL MICROBIOL BIOT, V99, P8377, DOI 10.1007/s00253-015-6927-0; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Konwar KM, 2015, BIOINFORMATICS, V31, P3345, DOI 10.1093/bioinformatics/btv361; Kumar V, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-015-2005-0; Ladeveze S, 2013, J BIOL CHEM, V288, P32370, DOI 10.1074/jbc.M113.483628; Lairson LL, 2007, CHEM COMMUN, P365, DOI 10.1039/b614636h; Li DH, 2015, BIOINFORMATICS, V31, P1674, DOI 10.1093/bioinformatics/btv033; Li H, 2013, EURASIP J WIREL COMM, V2013, P1, DOI DOI 10.4236/C0CA2013.71001; Litzinger S, 2010, J BIOL CHEM, V285, P35675, DOI 10.1074/jbc.M110.131037; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luley-Goedl C, 2010, BIOTECHNOL J, V5, P1324, DOI 10.1002/biot.201000217; Macdonald SS, 2015, J BIOL CHEM, V290, P4887, DOI 10.1074/jbc.M114.621110; Mayer C, 2006, FEBS J, V273, P2929, DOI 10.1111/j.1742-4658.2006.05308.x; Mazzella LJ, 1996, J AM CHEM SOC, V118, P2111, DOI 10.1021/ja953537z; Mewis K, 2013, J BIOTECHNOL, V167, P462, DOI 10.1016/j.jbiotec.2013.07.015; Moure A, 2006, PROCESS BIOCHEM, V41, P1913, DOI 10.1016/j.procbio.2006.05.011; Nakai H, 2013, CURR OPIN CHEM BIOL, V17, P301, DOI 10.1016/j.cbpa.2013.01.006; Nyyssonen M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00282; O'Neill EC, 2015, CARBOHYD RES, V403, P23, DOI 10.1016/j.carres.2014.06.010; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Palcic MM, 2011, CURR OPIN CHEM BIOL, V15, P226, DOI 10.1016/j.cbpa.2010.11.022; PEARCE PJ, 1968, CAN J CHEMISTRY, V46, P241, DOI 10.1139/v68-038; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; SHETH K, 1969, J BIOL CHEM, V244, P457; SIH CJ, 1957, SCIENCE, V126, P1116, DOI 10.1126/science.126.3283.1116; Sun WC, 1998, BIOORG MED CHEM LETT, V8, P3107, DOI 10.1016/S0960-894X(98)00578-2; Treangen Todd J, 2011, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1108s33; Ulusu NN, 2015, J MOL EVOL, V80, P251, DOI 10.1007/s00239-015-9681-0; Valdes A., 2016, MATER SCI FORUM, V842, P182, DOI DOI 10.4028/www.scientific.net/MSF.842.182; Vocadlo DJ, 2000, METH MOL B, V146, P203, DOI 10.1385/1-59259-045-4:203; Vocadlo DJ, 2000, BIOCHEMISTRY-US, V39, P117, DOI 10.1021/bi991958d; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Warren RL, 2008, GENOME RES, V18, P1798, DOI 10.1101/gr.080358.108; WITHERS SG, 1988, J BIOL CHEM, V263, P7929; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zhang YHP, 2005, P NATL ACAD SCI USA, V102, P7321, DOI 10.1073/pnas.0408734102; Zhang YHP, 2004, APPL ENVIRON MICROB, V70, P1563, DOI 10.1128/AEM.70.3.1563-1569.2004	63	16	16	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3451	3467		10.1074/jbc.RA117.000948	http://dx.doi.org/10.1074/jbc.RA117.000948			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29317495	Green Published, hybrid			2022-12-26	WOS:000426562800034
J	Ting, YT; Petersen, J; Ramarathinam, SH; Scally, SW; Loh, KL; Thomas, R; Suri, A; Baker, DG; Purcell, AW; Reid, HH; Rossjohn, J				Ting, Yi Tian; Petersen, Jan; Ramarathinam, Sri H.; Scally, Stephen W.; Loh, Khai L.; Thomas, Ranjeny; Suri, Anish; Baker, Daniel G.; Purcell, Anthony W.; Reid, Hugh H.; Rossjohn, Jamie			The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; MOLECULAR-BASIS; CELIAC-DISEASE; ANTIGEN; MHC; ASSOCIATION; IDENTIFICATION; VIMENTIN; EPITOPES; CELLS	The HLA-DRB1 locus is strongly associated with rheumatoid arthritis (RA) susceptibility, whereupon citrullinated self-peptides bind to HLA-DR molecules bearing the shared epitope (SE) amino acid motif. However, the differing propensity for citrullinated/non-citrullinated self-peptides to bind given HLA-DR allomorphs remains unclear. Here, we used a fluorescence polarization assay to determine a hierarchy of binding affinities of 34 self-peptides implicated in RA against three HLA-DRB1 allomorphs (HLA-DRB1*04:01/*04:04/*04:05) each possessing the SE motif. For all three HLA-DRB1 allomorphs, we observed a strong correlation between binding affinity and citrullination at P4 of the bound peptide ligand. A differing hierarchy of peptide-binding affinities across the three HLA-DRB1 allomorphs was attributable to the beta-chain polymorphisms that resided outside the SE motif and were consistent with sequences of naturally presented peptide ligands. Structural determination of eight HLA-DR4-self-epitope complexes revealed strict conformational convergence of the P4-Cit and surrounding HLA beta-chain residues. Polymorphic residues that form part of the P1 and P9 pockets of the HLA-DR molecules provided a structural basis for the preferential binding of the citrullinated self-peptides to the HLA-DR4 allomorphs. Collectively, we provide a molecular basis for the interplay between citrullination of self-antigens and HLA polymorphisms that shape peptide-HLADR4 binding affinities in RA.	[Ting, Yi Tian; Petersen, Jan; Ramarathinam, Sri H.; Scally, Stephen W.; Loh, Khai L.; Purcell, Anthony W.; Reid, Hugh H.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Ting, Yi Tian; Petersen, Jan; Ramarathinam, Sri H.; Scally, Stephen W.; Loh, Khai L.; Purcell, Anthony W.; Reid, Hugh H.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Petersen, Jan; Reid, Hugh H.; Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia; [Thomas, Ranjeny] Univ Queensland, Diamantina Inst, Translat Res Inst, Princess Alexandra Hosp, Brisbane, Qld 4102, Australia; [Suri, Anish] Pharmaceut Co Johnson & Johnson, Janssen Res & Dev, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Baker, Daniel G.] Janssen Res & Dev LLC, Spring House, PA 19002 USA; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [Scally, Stephen W.] Hosp Sick Children, Program Mol Med, Toronto, ON M5G 1X8, Canada	Monash University; Monash University; Monash University; University of Queensland; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Cardiff University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Reid, HH; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.; Reid, HH; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Reid, HH; Rossjohn, J (corresponding author), Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	hugh.reid@monash.edu; Jamie.rossjohn@monash.edu	Rossjohn, Jamie/F-9032-2013; Ramarathinam, Sri H/G-2278-2012; Thomas, Ranjeny/B-4504-2013; Purcell, Anthony/AAH-1942-2019	Rossjohn, Jamie/0000-0002-2020-7522; Ramarathinam, Sri H/0000-0002-2787-1282; Thomas, Ranjeny/0000-0002-0518-8386; Purcell, Anthony/0000-0003-0532-8331; Loh, Khai Lee/0000-0002-2211-2404; Ting, Yi Tian/0000-0001-7718-8396; Scally, Stephen/0000-0002-4264-7772	National Health and Medical Research Council; ARC	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council)	Supported by National Health and Medical Research Council research fellowships.; Supported by an ARC Laureate Fellowship.	Adams EJ, 2013, ANNU REV IMMUNOL, V31, P529, DOI 10.1146/annurev-immunol-032712-095912; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson KM, 2016, ARTHRITIS RHEUMATOL, V68, P1627, DOI 10.1002/art.39636; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Biswas S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056246; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Dudek NL, 2016, METHODS MOL BIOL, V1394, P189, DOI 10.1007/978-1-4939-3341-9_14; Dudek NL, 2012, DIABETES, V61, P3018, DOI 10.2337/db11-1333; El-Gabalawy Hani, 2009, Best Pract Res Clin Rheumatol, V23, P49, DOI 10.1016/j.berh.2008.11.004; Feitsma AL, 2010, ARTHRITIS RHEUM-US, V62, P117, DOI 10.1002/art.25059; Foulquier C, 2007, ARTHRITIS RHEUM-US, V56, P3541, DOI 10.1002/art.22983; Friede T, 1996, BBA-MOL BASIS DIS, V1316, P85, DOI 10.1016/0925-4439(96)00010-5; Fugger L, 2000, ARTHRITIS RES, V2, P208, DOI 10.1186/ar89; Gerstner C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00494; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Hardy MY, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.58; Henderson KN, 2007, IMMUNITY, V27, P23, DOI 10.1016/j.immuni.2007.05.015; Hill JA, 2003, J IMMUNOL, V171, P538, DOI 10.4049/jimmunol.171.2.538; Hill JA, 2008, J EXP MED, V205, P967, DOI 10.1084/jem.20072051; Illing PT, 2012, NATURE, V486, P554, DOI 10.1038/nature11147; James EA, 2014, ARTHRITIS RHEUMATOL, V66, P1712, DOI 10.1002/art.38637; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Kinloch A, 2005, ARTHRITIS RES THER, V7, pR1421, DOI 10.1186/ar1845; KINOUCHI R, 1994, IMMUNOGENETICS, V40, P376, DOI 10.1007/BF01246679; Koning F, 2015, NAT REV RHEUMATOL, V11, P450, DOI 10.1038/nrrheum.2015.59; Law SC, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3848; Malmstrom V, 2017, NAT REV IMMUNOL, V17, P60, DOI 10.1038/nri.2016.124; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Pang SS, 2010, NATURE, V467, P844, DOI 10.1038/nature09448; Patil NS, 2001, J IMMUNOL, V167, P7157, DOI 10.4049/jimmunol.167.12.7157; Petersen J, 2009, J MOL MED, V87, P1045, DOI 10.1007/s00109-009-0526-4; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Scally SW, 2017, ANN RHEUM DIS, V76, P1915, DOI 10.1136/annrheumdis-2017-211300; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Sidney J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177140; Snir O, 2011, ARTHRITIS RHEUM-US, V63, P2873, DOI 10.1002/art.30445; Snir O, 2010, ARTHRITIS RHEUM-US, V62, P44, DOI 10.1002/art.25036; Sohn DH, 2015, ARTHRITIS RHEUMATOL, V67, P2877, DOI 10.1002/art.39283; Trouw LA, 2017, NAT REV RHEUMATOL, V13, P331, DOI 10.1038/nrrheum.2017.15; Tye-Din JA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001012; van Beers JJBC, 2013, ARTHRITIS RHEUM-US, V65, P69, DOI 10.1002/art.37720; van Beers JJBC, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3744; Van Steendam K, 2011, RHEUMATOLOGY, V50, P830, DOI 10.1093/rheumatology/keq419; von Delwig A, 2010, ARTHRITIS RHEUM-US, V62, P143, DOI 10.1002/art.25064; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yin L, 2014, CURR PROTOC IMMUNOL, V106, P5	52	51	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3236	3251		10.1074/jbc.RA117.001013	http://dx.doi.org/10.1074/jbc.RA117.001013			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29317506	Green Published, hybrid			2022-12-26	WOS:000426562800017
J	Khalis, M; Charbotel, B; Chajes, V; Rinaldi, S; Moskal, A; Biessy, C; Dossus, L; Huybrechts, I; Fort, E; Mellas, N; Elfakir, S; Charaka, H; Nejjari, C; Romieu, I; El Rhazi, K				Khalis, Mohamed; Charbotel, Barbara; Chajes, Veronique; Rinaldi, Sabina; Moskal, Aurelie; Biessy, Carine; Dossus, Laure; Huybrechts, Inge; Fort, Emmanuel; Mellas, Nawfel; Elfakir, Samira; Charaka, Hafida; Nejjari, Chakib; Romieu, Isabelle; El Rhazi, Karima			Menstrual and reproductive factors and risk of breast cancer: A case-control study in the Fez region, Morocco	PLOS ONE			English	Article							COLLABORATIVE REANALYSIS; ORAL-CONTRACEPTIVES; WOMEN; AGE; ASSOCIATION; METAANALYSIS; MENOPAUSE; MENARCHE; ABORTION; PARITY	Background Breast cancer is the most common cancer in women worldwide. In the Moroccan context, the role of well-known reproductive factors in breast cancer remains poorly documented. The aim of this study was to explore the relationship between menstrual and reproductive factors and breast cancer risk in Moroccan women in the Fez region. Methods A case control study was conducted at the Hassan ll University Hospital of Fez between January 2014 and April 2015. A total of 237 cases of breast cancer and 237 age-matched controls were included. Information on sociodemographic characteristics, menstrual and reproductive history, family history of breast cancer, and lifestyle factors was obtained through a structured questionnaire. Conditional logistic regression models were used to estimate odds ratios and 95% confidence intervals for breast cancer by menstrual and reproductive factors adjusted for potential confounders. Results Early menarche (OR = 1.60, 95% CI: 1.08-2.38) and nulliparity (OR = 3.77, 95% CI: 1.987.30) were significantly related to an increased risk of breast cancer, whereas an early age at first full-term pregnancy was associated with a decreased risk of breast cancer (OR = 0.41, 95% CI: 0.25-0.65). Conclusion The results of this study confirm the role of established reproductive factors for breast cancer in Moroccan women. It identified some susceptible groups at high risk of breast cancer. Preventive interventions and screening should focus on these groups as a priority. These results should be confirmed in a larger, multicenter study.	[Khalis, Mohamed; Elfakir, Samira; Charaka, Hafida; Nejjari, Chakib; El Rhazi, Karima] Fac Med & Pharm, Dept Epidemiol, Fes, Morocco; [Khalis, Mohamed; Charbotel, Barbara; Fort, Emmanuel] Univ Claude Bernard Lyon1, Ifsttar, UMRESTTE, UMR T 9405, Lyon, France; [Khalis, Mohamed; Elfakir, Samira; Charaka, Hafida; El Rhazi, Karima] Sidi Mohamed Ben Abdellah Univ, Fes, Morocco; [Chajes, Veronique; Rinaldi, Sabina; Moskal, Aurelie; Biessy, Carine; Dossus, Laure; Huybrechts, Inge; Romieu, Isabelle] Int Agcy Res Canc, Sect Nutr & Metab, Lyon, France; [Mellas, Nawfel] Hassan II Univ Hosp Fez, Dept Oncol, Fes, Morocco; [Nejjari, Chakib] Mohammed VI Univ Hlth Sci, Casablanca, Morocco	Hassan II University Hospital Center of Fez; Mohammed First University of Oujda; Mohammed VI University Hospital Center of Oujda; Sidi Mohamed Ben Abdellah University of Fez; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Gustave-Eiffel; Sidi Mohamed Ben Abdellah University of Fez; World Health Organization; International Agency for Research on Cancer (IARC); Hassan II University Hospital Center of Fez; Mohammed VI University of Health Sciences (UM6SS)	Khalis, M (corresponding author), Fac Med & Pharm, Dept Epidemiol, Fes, Morocco.; Khalis, M (corresponding author), Univ Claude Bernard Lyon1, Ifsttar, UMRESTTE, UMR T 9405, Lyon, France.; Khalis, M (corresponding author), Sidi Mohamed Ben Abdellah Univ, Fes, Morocco.	khalis.mohamed79@gmail.com	Khalis, Mohamed/AAM-5446-2020; Charbotel, Barbara/C-2936-2016; Fort, Emmanuel/Q-4570-2019; Dossus, Laure/AAW-9097-2021	Charbotel, Barbara/0000-0001-8805-6225; Fort, Emmanuel/0000-0003-1419-9914; Dossus, Laure/0000-0003-2716-5748; Chajes, Veronique/0000-0003-1297-3064; moskal, aurelie/0000-0003-4127-4334				Awatef M, 2010, CANCER CAUSE CONTROL, V21, P393, DOI 10.1007/s10552-009-9471-3; Beral V, 2004, LANCET, V363, P1007, DOI 10.1016/S0140-6736(04)15835-2; Beral V, 2012, LANCET ONCOL, V13, P1141, DOI 10.1016/S1470-2045(12)70425-4; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Bouchbika Z, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.31.2791; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Chie WC, 2000, AM J EPIDEMIOL, V151, P715, DOI 10.1093/oxfordjournals.aje.a010266; Clavel-Chapelon F, 2002, BREAST CANCER RES TR, V72, P107, DOI 10.1023/A:1014891216621; Clavel-Chapelon F, 2002, CANCER CAUSE CONTROL, V13, P831, DOI 10.1023/A:1020684821837; Corbex M, 2014, EUR J CANCER, V50, P1808, DOI 10.1016/j.ejca.2014.03.016; Coughlin SS, 2015, J ENV HLTH SCI, V1; DeSantis CE, 2015, CANCER EPIDEM BIOMAR, V24, P1495, DOI 10.1158/1055-9965.EPI-15-0535; EASTON DF, 1994, LANCET, V344, P761, DOI 10.1016/S0140-6736(94)92256-X; Ebrahimi M, 2002, BREAST CANCER RES, V4, DOI 10.1186/bcr454; Ewertz M, 1990, INT J CANCER, P46; Ferlay J, 2010, BREAST CANCER EPIDEMIOLOGY, P1, DOI 10.1007/978-1-4419-0685-4_1; Gao YT, 2000, INT J CANCER, V87, P295, DOI 10.1002/1097-0215(20000715)87:2<295::AID-IJC23>3.0.CO;2-7; Gray J, 2009, INT J OCCUP ENV HEAL, V15, P43; Guo J, 2015, CANCER CAUSE CONTROL, V26, P811, DOI 10.1007/s10552-015-0536-1; HSIEH CC, 1990, INT J CANCER, V46, P796, DOI 10.1002/ijc.2910460508; Huang YB, 2014, CANCER CAUSE CONTROL, V25, P227, DOI 10.1007/s10552-013-0325-7; Huo D, 2008, BRIT J CANCER, V98, P992, DOI 10.1038/sj.bjc.6604275; Kawai M, 2010, CANCER CAUSE CONTROL, V21, P135, DOI 10.1007/s10552-009-9443-7; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Khalis M, 2016, ASIAN PAC J CANCER P, V01, P17; Laamiri FZ, 2015, OPEN J OBSTET GYNECO, V5, P79, DOI [10.4236/ojog.2015.52011, DOI 10.4236/OJOG.2015.52011]; Lalla Salma Foundation Prevention Detection and Treatment of Cancers, 2017, REG GREAT CAS 2008 2; Lambe M, 1996, BREAST CANCER RES TR, V38, P305, DOI 10.1007/BF01806150; LAVECCHIA C, 1992, ANN ONCOL, V3, P625, DOI 10.1093/oxfordjournals.annonc.a058288; Lee E, 2008, CANCER EPIDEM BIOMAR, V17, P3170, DOI 10.1158/1055-9965.EPI-08-0396; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Loukid Mohamed, 2007, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V19, P65; MacMahon B, 2006, INT J CANCER, V118, P2373, DOI 10.1002/ijc.21404; Magnusson CM, 1999, INT J CANCER, V80, P231, DOI 10.1002/(SICI)1097-0215(19990118)80:2<231::AID-IJC11>3.3.CO;2-I; Martinez ME, 2013, CANCER EPIDEM BIOMAR, V22, P1853, DOI 10.1158/1055-9965.EPI-13-0560; Msolly A, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0480-4; NAGATA C, 1995, JPN J CANCER RES, V86, P910, DOI 10.1111/j.1349-7006.1995.tb03000.x; Oran B, 2004, MED ONCOL, V21, P31, DOI 10.1385/MO:21:1:31; Palmer JR, 2011, CANCER EPIDEM BIOMAR, V20, P1883, DOI 10.1158/1055-9965.EPI-11-0465; Parsa P, 2009, ASIAN PAC J CANCER P, V10, P545; Redondo CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040543; Rosenberg L, 2009, AM J EPIDEMIOL, V169, P473, DOI 10.1093/aje/kwn360; Russo J, 2005, BREAST CANCER RES, V7, P131, DOI 10.1186/bcr1029; Tryggvadottir L, 2001, AM J EPIDEMIOL, V154, P37, DOI 10.1093/aje/154.1.37; Turkoz FP, 2013, BREAST, V22, P344, DOI 10.1016/j.breast.2012.08.005; World Health Organization, GLOB PHYS ACT QUEST; Xu YL, 2012, ARCH MED SCI, V8, P303, DOI 10.5114/aoms.2012.28558; Zhou Y, 2015, BREASTFEED MED, V10, P175, DOI 10.1089/bfm.2014.0141	50	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191333	10.1371/journal.pone.0191333	http://dx.doi.org/10.1371/journal.pone.0191333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338058	Green Published, Green Submitted, gold			2022-12-26	WOS:000422652700050
J	Marcussen, M; Sonderkaer, M; Bodker, JS; Andersen, M; Nielsen, S; Vesteghem, C; Christiansen, I; Bergmann, OJ; Bogsted, M; Dybkaer, K; Vyberg, M; Johnsen, HE				Marcussen, Mette; Sonderkaer, Mads; Bodker, Julie Stove; Andersen, Maria; Nielsen, Soren; Vesteghem, Charles; Christiansen, Ilse; Bergmann, Olav Jonas; Bogsted, Martin; Dybkear, Karen; Vyberg, Mogens; Johnsen, Hans Erik			Oral mucosa tissue gene expression profiling before, during, and after radiation therapy for tonsil squamous cell carcinoma	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; NECK-CANCER; RECEIVING RADIOTHERAPY; HEAD; CHEMOTHERAPY; MECHANISMS; OUTCOMES; DAHANCA; BLOOD	Background Radiation-therapy (RT) induces mucositis, a clinically challenging condition with limited prophylactic interventions and no predictive tests. In this pilot study, we applied global gene-expression analysis on serial human oral mucosa tissue and blood cells from patients with tonsil squamous cell cancer (TSCC) to identify genes involved in mucositis pathogenesis. Methods and findings Eight patients with TSCC each provided consecutive buccal biopsies and blood cells before, after 7 days of RT treatment, and 20 days following RT. We monitored clinical mucositis and performed gene-expression analysis on tissue samples. We obtained control tissue from nine healthy individuals. After RT, expression was upregulated in apoptosis inducer and inhibitor genes, EDA2R and MDM2, and in POLH, a DNA-repair polymerase. Expression was downregulated in six members of the histone cluster family, e.g., HIST1H3B. Gene expression related to proliferation and differentiation was altered, including MKI67 (downregulated), which encodes the Ki-67-proliferation marker, and KRT16 (upregulated), which encodes keratin16. These alterations were not associated with the clinical mucositis grade. However, the expression of LY6G6C, which encodes a surface immunoregulatory protein, was upregulated before treatment in three cases of clinical none/mild mucositis, but not in four cases of ulcerative mucositis. Conclusion RT caused molecular changes related to apoptosis, DNA-damage, DNA-repair, and proliferation without a correlation to the severity of clinical mucositis. LY6G6C may be a potential protective biomarker for ulcerative mucositis. Based on these results, our study model of consecutive human biopsies will be useful in designing a prospective clinical validation trial to characterize molecular mucositis and identify predictive biomarkers.	[Marcussen, Mette; Bogsted, Martin; Dybkear, Karen; Vyberg, Mogens; Johnsen, Hans Erik] Aalborg Univ, Dept Clin Med, Aalborg, Denmark; [Sonderkaer, Mads; Bodker, Julie Stove; Vesteghem, Charles; Bogsted, Martin; Dybkear, Karen; Vyberg, Mogens; Johnsen, Hans Erik] Aalborg Univ Hosp, Clin Canc Res Ctr, Aalborg, Denmark; [Bodker, Julie Stove; Vesteghem, Charles; Christiansen, Ilse; Bogsted, Martin; Dybkear, Karen; Vyberg, Mogens; Johnsen, Hans Erik] Aalborg Univ Hosp, Dept Haematol, Aalborg, Denmark; [Andersen, Maria] Aalborg Univ Hosp, Dept Oncol, Aalborg, Denmark; [Nielsen, Soren] Aalborg Univ Hosp, Inst Pathol, Aalborg, Denmark; [Bergmann, Olav Jonas] Aarhus Univ, Fac Hlth Sci, Sch Dent, Aarhus, Denmark	Aalborg University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aarhus University	Marcussen, M (corresponding author), Aalborg Univ, Dept Clin Med, Aalborg, Denmark.	mette.marcussen@rn.dk		Sonderkaer, Mads/0000-0002-9309-7459; Bogsted, Martin/0000-0001-9192-1814; marcussen, mette/0000-0003-0795-2293; Vesteghem, Charles/0000-0003-2301-9081; Dybkaer, Karen/0000-0003-2488-435X	Det Obelske Familiefond [25042]	Det Obelske Familiefond	Grant no 25042 recived from Det Obelske Familiefond (http://obel.com/) to Mette Marcussen. The funders has no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abendstein H, 2005, LARYNGOSCOPE, V115, P2183, DOI 10.1097/01.MLG.0000181507.69620.14; Acauan MD, 2015, ARCH ORAL BIOL, V60, P1802, DOI 10.1016/j.archoralbio.2015.09.014; Alisoltani A, 2014, PLOSONE; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhide SA, 2012, RADIOTHER ONCOL, V103, P88, DOI 10.1016/j.radonc.2011.12.027; Bonan PRF, 2007, ORAL DIS, V13, P170, DOI 10.1111/j.1601-0825.2006.01254.x; Bonan PRF, 2006, ORAL SURG ORAL MED O, V101, P207, DOI 10.1016/j.tripleo.2005.03.033; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dorr W, 2002, INT J RADIAT ONCOL, V52, P911, DOI 10.1016/S0360-3016(01)02721-3; Elad S, 2016, SUPPORT CARE CANCER, V24, P4825, DOI 10.1007/s00520-016-3337-5; Elting LS, 2007, INT J RADIAT ONCOL, V68, P1110, DOI 10.1016/j.ijrobp.2007.01.053; Gagliardi F, 2017, CRIT REV ONCOL HEMAT, V109, P63, DOI 10.1016/j.critrevonc.2016.11.013; Garnaes E, 2015, INT J CANCER, V136, P2196, DOI 10.1002/ijc.29254; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gregoire V, 2010, ANN ONCOL, V21, pv184, DOI 10.1093/annonc/mdq185; Gregoire V, 2014, RADIOTHER ONCOL, V110, P172, DOI 10.1016/j.radonc.2013.10.010; Handschel J, 2001, EUR J ORAL SCI, V109, P95, DOI 10.1034/j.1600-0722.2001.00975.x; Handschel J, 2001, J PATHOL, V193, P242; Kabacik S, 2011, INT J RADIAT BIOL, V87, P115, DOI 10.3109/09553002.2010.519424; Kennedy WR, 2016, EUR ARCH OTO-RHINO-L, V273, P2117, DOI 10.1007/s00405-016-4027-0; Kouloulias V, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/401261; Lalla RV, 2014, CANCER-AM CANCER SOC, V120, P1453, DOI 10.1002/cncr.28592; Lee MLT, 2002, STAT MED, V21, P3543, DOI 10.1002/sim.1335; Li ML, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-5; Manikantan K, 2009, CANCER TREAT REV, V35, P639, DOI 10.1016/j.ctrv.2009.04.010; Marcussen M, 2017, SYSTEMATIC IN PRESS; Marcussen M, 2017, PLOS ONE; Mortensen HR, 2012, RADIOTHER ONCOL, V103, P69, DOI 10.1016/j.radonc.2012.01.002; Murphy BA, 2009, J PAIN SYMPTOM MANAG, V38, P522, DOI 10.1016/j.jpainsymman.2008.12.004; Nag S, 2013, J BIOMED RES, V27, P254, DOI 10.7555/JBR.27.20130030; Prott FJ, 2002, INT J RADIAT ONCOL, V54, P203, DOI 10.1016/S0360-3016(02)02867-5; Quinn B, 2007, EUR J ONCOL NURS, V11, pS10, DOI 10.1016/S1462-3889(07)70003-0; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sonis S, 2007, ORAL ONCOL, V43, P289, DOI 10.1016/j.oraloncology.2006.03.014; Sonis ST, 2002, CELL PROLIFERAT, V35, P93, DOI 10.1046/j.1365-2184.35.s1.10.x; Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162; Sonis ST., 2013, AM SOC CLIN ONCOL ED, DOI [10.1200/EdBook_AM.2013.33.e236, DOI 10.1200/EDBOOK_AM.2013.33.E236]; Su C, 2004, EMBO J, V23, P1133, DOI 10.1038/sj.emboj.7600120; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanikawa C, 2009, ONCOGENE, V28, P3081, DOI 10.1038/onc.2009.154; TCHAKAROV L, 1990, FEBS LETT, V268, P209, DOI 10.1016/0014-5793(90)81010-L; Trotti A, 2003, RADIOTHER ONCOL, V66, P253, DOI 10.1016/S0167-8140(02)00404-8; Tudor D, 2004, J INVEST DERM SYMP P, V9, P208, DOI 10.1111/j.1087-0024.2004.09310.x; Xanthinaki A, 2008, SUPPORT CARE CANCER, V16, P1025, DOI 10.1007/s00520-007-0379-8; Yeoh ASJ, 2005, INT J RADIAT ONCOL, V63, P1295, DOI 10.1016/j.ijrobp.2005.04.041	48	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190709	10.1371/journal.pone.0190709	http://dx.doi.org/10.1371/journal.pone.0190709			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338018	Green Published, gold, Green Submitted			2022-12-26	WOS:000422652700017
J	Pont, I; Calatayud-Pascual, A; Lopez-Castellano, A; Albelda, EP; Garcia-Espana, E; Marti-Bonmat, L; Frias, JC; Albelda, MT				Pont, Isabel; Calatayud-Pascual, Aracely; Lopez-Castellano, Alicia; Albelda, Elena P.; Garcia-Espana, Enrique; Marti-Bonmat, Luis; Frias, Juan C.; Teresa Albelda, M.			Anti-angiogenic drug loaded liposomes: Nanotherapy for early atherosclerotic lesions in mice	PLOS ONE			English	Article							METHIONINE AMINOPEPTIDASE; CARDIOVASCULAR-DISEASE; SCAVENGER RECEPTOR; CONTRAST AGENTS; IN-VIVO; FUMAGILLIN; MACROPHAGE; NANOPARTICLES; NEOVASCULARIZATION; TNP-470	Fumagillin-loaded liposomes were injected into ApoE-KO mice. The animals were divided into several groups to test the efficacy of this anti-angiogenic drug for early treatment of atherosclerotic lesions. Statistical analysis of the lesions revealed a decrease in the lesion size after 5 weeks of treatment.	[Pont, Isabel; Garcia-Espana, Enrique] Univ Valencia, Inst Ciencia Mol, Valencia, Spain; [Calatayud-Pascual, Aracely; Lopez-Castellano, Alicia] Univ Cardenal Herrera CEU, CEU Univ, Dept Fisiol Farmacol & Toxicol, Alfara Del Patriarca, Spain; [Albelda, Elena P.] Hosp Lluis Alcanyis, Dept Anestesiol, Valencia, Spain; [Marti-Bonmat, Luis; Frias, Juan C.; Teresa Albelda, M.] Hosp Univ Polite cnico LaFe, Grp Invest Biomed Imagen, Valencia, Spain; [Frias, Juan C.] Univ Cardenal Herrera CEU, CEU Univ, Dept Ciencias Biomed, Alfara Del Patriarca, Spain	University of Valencia; Universidad CEU Cardenal Herrera; Universidad CEU Cardenal Herrera	Frias, JC; Albelda, MT (corresponding author), Hosp Univ Polite cnico LaFe, Grp Invest Biomed Imagen, Valencia, Spain.; Frias, JC (corresponding author), Univ Cardenal Herrera CEU, CEU Univ, Dept Ciencias Biomed, Alfara Del Patriarca, Spain.	juan.frias@uchceu.es; teresa.albelda@uv.es	Frias, Juan C/K-8003-2019; Stefanadis, Christodoulos/ABH-2232-2020; Frias, Juan/F-9778-2016; Pont Niclos, Isabel/O-8638-2016; García-España, Enrique V./F-5473-2016; Gimeno, Maria Teresa Albelda/J-5929-2012; Pascual, Maria Aracely Calatayud/AAC-3326-2020; Lopez Castellano, Alicia/F-9549-2016	Frias, Juan C/0000-0002-2948-5086; Stefanadis, Christodoulos/0000-0001-5974-6454; Frias, Juan/0000-0002-2948-5086; Pont Niclos, Isabel/0000-0001-5573-4990; García-España, Enrique V./0000-0002-4601-6505; Gimeno, Maria Teresa Albelda/0000-0002-9572-8912; Pascual, Maria Aracely Calatayud/0000-0002-6328-7622; Lopez Castellano, Alicia/0000-0003-0601-1440	Spanish MINECO; ISCIII; FEDER [CSD2010-000652010, CP13/00216]; Unidad de Excelencia Maria de Maeztu [MDM-2015-0538]; Fundacio Gent per Gent	Spanish MINECO(Spanish Government); ISCIII(Instituto de Salud Carlos III); FEDER(European Commission); Unidad de Excelencia Maria de Maeztu(Spanish Government); Fundacio Gent per Gent	financial support by the Spanish MINECO, ISCIII, FEDER (Projects Consolider-I ngenio CSD2010-000652010 (EGE) and Project CP13/00216 (MTA), and " Unidad de Excelencia Maria de Maeztu" MDM-2015-0538) and Fundacio Gent per Gent (JCF).	Amirbekian V, 2007, P NATL ACAD SCI USA, V104, P961, DOI 10.1073/pnas.0606281104; BRACKETT JM, 1988, J AGR FOOD CHEM, V36, P762, DOI 10.1021/jf00082a022; Briley-Saebo KC, 2009, J PHYS CHEM B, V113, P6283, DOI 10.1021/jp8108286; Deveza L, 2012, THERANOSTICS, V2, P801, DOI 10.7150/thno.4419; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; Gianolio E, 2007, CHEM-EUR J, V13, P5785, DOI 10.1002/chem.200601277; Gonzalez-Navarro H, 2010, J AM COLL CARDIOL, V55, P2258, DOI 10.1016/j.jacc.2010.01.026; Griffith EC, 1998, P NATL ACAD SCI USA, V95, P15183, DOI 10.1073/pnas.95.26.15183; IBM Corp, IBM SPSS STAT WIND V; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Katsi VK, 2014, ANTIANGIO DRUG DISC, V2, P268; Kilarski WW, 2012, ANGIOGENESIS, V15, P643, DOI 10.1007/s10456-012-9287-8; Kruger EA, 2000, EXPERT OPIN INV DRUG, V9, P1383, DOI 10.1517/13543784.9.6.1383; Lipinski MJ, 2006, J NUCL CARDIOL, V13, P699, DOI 10.1016/j.nuclcard.2006.07.004; Lipinski MJ, 2006, MAGN RESON MED, V56, P601, DOI 10.1002/mrm.20995; Lipinski MJ, 2009, JACC-CARDIOVASC IMAG, V2, P637, DOI 10.1016/j.jcmg.2008.08.009; Lobatto ME, 2010, MOL PHARMACEUT, V7, P2020, DOI 10.1021/mp100309y; Moulton KS, 1999, CIRCULATION, V99, P1726, DOI 10.1161/01.CIR.99.13.1726; Pant S, 2013, BIOCH BASIS THERAPEU, P209; Park YM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.38; Patel A, 2014, ANAT PHYSL, V4, P147; Sanz J, 2008, NATURE, V451, P953, DOI 10.1038/nature06803; Sin N, 1997, P NATL ACAD SCI USA, V94, P6099, DOI 10.1073/pnas.94.12.6099; Tang J, 2012, CURR CARDIOVASC IMAG, V5, P19, DOI 10.1007/s12410-011-9120-6; Albelda MT, 2014, CHEM SOC REV, V43, P2858, DOI 10.1039/c3cs60410a; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; Winter PM, 2008, JACC-CARDIOVASC IMAG, V1, P624, DOI 10.1016/j.jcmg.2008.06.003; Zhou HF, 2014, ACS NANO, V8, P7305, DOI 10.1021/nn502372n; Zhou HF, 2012, BIOMATERIALS, V33, P8632, DOI 10.1016/j.biomaterials.2012.08.005	29	7	7	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190540	10.1371/journal.pone.0190540	http://dx.doi.org/10.1371/journal.pone.0190540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338009	Green Published, Green Submitted, gold			2022-12-26	WOS:000422652700014
J	Yang, XZ; Li, H; Yang, YC; Wang, YQ; Mo, YL; Zhang, RM; Zhang, Y; Ma, JX; Wei, CH; Zhang, X				Yang, Xiaozhen; Li, Hao; Yang, Yongchao; Wang, Yongqi; Mo, Yanling; Zhang, Ruimin; Zhang, Yong; Ma, Jianxiang; Wei, Chunhua; Zhang, Xian			Identification and expression analyses of WRKY genes reveal their involvement in growth and abiotic stress response in watermelon (Citrullus lanatus)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; DIFFERENTIAL EXPRESSION; FUNCTIONAL-ANALYSIS; DISEASE RESISTANCE; SALICYLIC-ACID; ARABIDOPSIS; PLANT; TOLERANCE; SUPERFAMILY; GENOME	Despite identification of WRKY family genes in numerous plant species, a little is known about WRKY genes in watermelon, one of the most economically important fruit crops around the world. Here, we identified a total of 63 putative WRKY genes in watermelon and classified them into three major groups (I-III) and five subgroups (lla-lle) in group II. The structure analysis indicated that CIWRKYs with different WRKY domains or motifs may play different roles by regulating respective target genes. The expressions of CIWRKYs in different tissues indicate that they are involved in various tissue growth and development. Furthermore, the diverse responses of CIWRKYs to drought, salt, or cold stress suggest that they positively or negatively affect plant tolerance to various abiotic stresses. In addition, the altered expression patterns of CIWRKYs in response to phytohormones such as, ABA, SA, MeJA, and ETH, imply the occurrence of complex cross-talks between CIWRKYs and plant hormone signals in regulating plant physiological and biological processes. Taken together, our findings provide valuable clues to further explore the function and regulatory mechanisms of CIWRKY genes in watermelon growth, development, and adaption to environmental stresses.	[Yang, Xiaozhen; Li, Hao; Yang, Yongchao; Wang, Yongqi; Zhang, Ruimin; Zhang, Yong; Ma, Jianxiang; Wei, Chunhua; Zhang, Xian] Northwest A&F Univ, Coll Hort, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China; [Yang, Yongchao] Wenshan Acad Agr Sci, Wenshan, Peoples R China; [Wang, Yongqi] Hanzhong City Agrotechnol Extens Ctr, Hanzhong, Peoples R China; [Mo, Yanling] Yangtze Normal Univ, Fuling, Peoples R China	Northwest A&F University - China; Yangtze Normal University	Wei, CH; Zhang, X (corresponding author), Northwest A&F Univ, Coll Hort, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China.	xjwend020405@163.com; zhangxian098@126.com			Earmarked Fund for Modern Agro-industry Technology Research System of China [CARS-25]; Science and Technological of Shaanxi Province [2015KTTSNY03-04]; Scientific Startup Foundation for Doctors of Northwest AF University [Z109021604]; Basal Research Foundation of Northwest AF University [Z109021612]; Key Project of Shaanxi Province [2017ZDXM-NY-025]	Earmarked Fund for Modern Agro-industry Technology Research System of China; Science and Technological of Shaanxi Province; Scientific Startup Foundation for Doctors of Northwest AF University; Basal Research Foundation of Northwest AF University; Key Project of Shaanxi Province	The present study was financially supported by grants from the Earmarked Fund for Modern Agro-industry Technology Research System of China (CARS-25), the Science and Technological of Shaanxi Province (2015KTTSNY03-04), the Scientific Startup Foundation for Doctors of Northwest A&F University (Z109021604), the Basal Research Foundation of Northwest A&F University (Z109021612) and the Key Project of Shaanxi Province (2017ZDXM-NY-025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato A, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01979; Balazadeh S, 2008, PLANT BIOLOGY, V10, P63, DOI 10.1111/j.1438-8677.2008.00088.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chen JN, 2017, PLANT CELL, V29, P1425, DOI 10.1105/tpc.17.00364; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Cheng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep39000; Cho SM, 2012, BIOL PLANTARUM, V56, P560, DOI 10.1007/s10535-012-0070-x; Ciolkowski I, 2008, PLANT MOL BIOL, V68, P81, DOI 10.1007/s11103-008-9353-1; Ding ZJ, 2015, PLANT J, V84, P56, DOI 10.1111/tpj.12958; Ding ZJ, 2014, PLANT J, V79, P13, DOI 10.1111/tpj.12538; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Gao QM, 2011, PLANT PHYSIOL, V155, P464, DOI 10.1104/pp.110.166876; Gu YZ, 2017, J EXP BOT, V68, P2717, DOI 10.1093/jxb/erx147; Guo CL, 2014, J EXP BOT, V65, P1513, DOI 10.1093/jxb/eru007; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; He HS, 2012, PLANT CELL REP, V31, P1199, DOI 10.1007/s00299-012-1241-0; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Huang XS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2233-6; ISHIGURO S, 1994, MOL GEN GENET, V244, P563, DOI 10.1007/BF00282746; Jaffar MA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050693; Jiang JJ, 2017, J INTEGR PLANT BIOL, V59, P86, DOI 10.1111/jipb.12513; Jiang YJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00145; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Jing-Hua Y, 2008, SCI HORTIC-AMSTERDAM, V118, P200, DOI 10.1016/j.scienta.2008.06.015; Karanja BK, 2017, PLANT CELL REP, V36, P1757, DOI 10.1007/s00299-017-2190-4; Kazan K, 2015, TRENDS PLANT SCI, V20, P219, DOI 10.1016/j.tplants.2015.02.001; Khan MIR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00462; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Kozik EU, 2014, HORTSCIENCE, V49, P240, DOI 10.21273/HORTSCI.49.3.240; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00295; Li J, 2013, NEW PHYTOL, V200, P455, DOI 10.1111/nph.12378; Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2; Li W, 2016, MOL PLANT, V9, P1492, DOI 10.1016/j.molp.2016.08.003; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo DL, 2017, J AGR FOOD CHEM, V65, P3627, DOI 10.1021/acs.jafc.7b00915; Lv XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30574; Mo YL, 2016, PLANT GROWTH REGUL, V79, P229, DOI 10.1007/s10725-015-0128-9; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Phukan UJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00760; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Singh AK, 2017, NEW PHYTOL, V215, P1115, DOI 10.1111/nph.14663; Song H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00534; Song QM, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0681-4; van Verk MC, 2008, PLANT PHYSIOL, V146, P1983, DOI 10.1104/pp.107.112789; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wang Z, 2014, MOL PLANT PATHOL, V15, P677, DOI 10.1111/mpp.12123; Wei KF, 2012, DNA RES, V19, P153, DOI 10.1093/dnares/dsr048; Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Yan HR, 2014, PLANT CELL PHYSIOL, V55, P2060, DOI 10.1093/pcp/pcu133; Yang BY, 2014, INDIAN J BIOCHEM BIO, V51, P302; Yang J, 2017, J PLANT GROWTH REGUL, V36, P590, DOI 10.1007/s00344-017-9670-1; Yang Y, 2016, J EXP BOT, V67, P4727, DOI 10.1093/jxb/erw252; Zhang H, 2017, 2017 4TH INTERNATIONAL CONFERENCE ON TRANSPORTATION INFORMATION AND SAFETY (ICTIS), P1, DOI 10.1109/ICTIS.2017.8047712; Zhang J, 2008, CELL RES, V18, P508, DOI 10.1038/cr.2007.104; Zhang M, 2016, ACTA HORTIC, V1110, P49, DOI 10.17660/ActaHortic.2016.1110.8; Zhang Y, 2016, PLANT PHYSIOL BIOCH, V108, P478, DOI 10.1016/j.plaphy.2016.08.013; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x	68	36	41	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191308	10.1371/journal.pone.0191308	http://dx.doi.org/10.1371/journal.pone.0191308			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338040	gold, Green Published, Green Submitted			2022-12-26	WOS:000422652700049
J	Torres, SMF; Furrow, E; Souza, CP; Granick, JL; de Jong, EP; Griffin, TJ; Wang, X				Torres, Sheila M. F.; Furrow, Eva; Souza, Clarissa P.; Granick, Jennifer L.; de Jong, Ebbing P.; Griffin, Timothy J.; Wang, Xiong			Salivary proteomics of healthy dogs: An in depth catalog	PLOS ONE			English	Article							FREE-FLOW ELECTROPHORESIS; PEPTIDOGLYCAN RECOGNITION PROTEINS; 2-DIMENSIONAL GEL-ELECTROPHORESIS; ANTIMICROBIAL PEPTIDES; LIQUID-CHROMATOGRAPHY; QUANTITATIVE-ANALYSIS; STREPTOCOCCUS-MUTANS; PAROTID-SALIVA; MUCIN; IDENTIFICATION	Objective To provide an in-depth catalog of the salivary proteome and endogenous peptidome of healthy dogs, evaluate proteins and peptides with antimicrobial properties, and compare the most common salivary proteins and peptides between different breed phylogeny groups. Methods 36 healthy dogs without evidence of periodontal disease representing four breed phylogeny groups, based upon single nucleotide polymorphism haplotypes (ancient, herding/sight-hound, and two miscellaneous groups). Saliva collected from dogs was pooled by phylogeny group and analyzed using nanoscale liquid chromatography-tandem mass spectrometry. Resulting tandem mass spectra were compared to databases for identification of endogenous peptides and inferred proteins. Results 2,491 proteins and endogenous peptides were found in the saliva of healthy dogs with no periodontal disease. All dog phylogeny groups' saliva was rich in proteins and peptides with antimicrobial functions. The ancient breeds group was distinct in that it contained unique proteins and was missing many proteins and peptides present in the other groups. Conclusions and clinical relevance Using a sophisticated nanoscale liquid chromatography-tandem mass spectrometry, we were able to identify 10-fold more salivary proteins than previously reported in dogs. Seven of the top 10 most abundant proteins or peptides serve immune functions and many more with various antimicrobial mechanisms were found. This is the most comprehensive analysis of healthy canine saliva to date, and will provide the groundwork forfuture studies analyzing salivary proteins and endogenous peptides in diseasestates.	[Torres, Sheila M. F.; Furrow, Eva; Souza, Clarissa P.; Granick, Jennifer L.] Univ Minnesota, Coll Vet Med, Vet Clin Sci Dept, St Paul, MN 55108 USA; [Souza, Clarissa P.] Colorado State Univ, Coll Vet Med, Clin Sci Dept, Ft Collins, CO 80523 USA; [de Jong, Ebbing P.; Griffin, Timothy J.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [de Jong, Ebbing P.] SUNY Upstate Med Univ, Dept Biochem & Mol Biochem, Syracuse, NY 13210 USA; [Wang, Xiong] Univ Minnesota, Dept Vet Biomed Sci, St Paul, MN 55108 USA; [Wang, Xiong] Minnesota Dept Hlth, St Paul, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Colorado State University; University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Minnesota Department of Health (MHD)	Torres, SMF (corresponding author), Univ Minnesota, Coll Vet Med, Vet Clin Sci Dept, St Paul, MN 55108 USA.	torre009@umn.edu	Furrow, Eva/W-9963-2018	Granick, Jennifer/0000-0001-8330-3848; Griffin, Timothy/0000-0001-6801-2559; Torres, Sheila/0000-0002-9004-9304; Furrow, Eva/0000-0002-7339-2354	Office of the Director, National Institute of Health (NIH) [K010D019912]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019912] Funding Source: NIH RePORTER	Office of the Director, National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was self-funded by the corresponding author. Partial funding for E.F. was provided by the Office of the Director, National Institute of Health (NIH) under award number K010D019912. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tarawneh SK, 2011, OMICS, V15, P353, DOI 10.1089/omi.2010.0134; Alterman A, 2012, ARCH ORAL BIOL, V57, P663, DOI 10.1016/j.archoralbio.2011.12.008; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Ang CS, 2011, J PROTEOME RES, V10, P5059, DOI 10.1021/pr200516d; Asano Masatake, 2011, J Oral Sci, V53, P147; Bingle L, 2009, HISTOCHEM CELL BIOL, V132, P339, DOI 10.1007/s00418-009-0610-4; Cabras T, 2009, J PROTEOME RES, V8, P4126, DOI 10.1021/pr900212u; Camisasca DR, 2017, J PROTEOMICS, V151, P43, DOI 10.1016/j.jprot.2016.07.029; Cargile BJ, 2004, ELECTROPHORESIS, V25, P936, DOI 10.1002/elps.200305722; Castagnola M, 2011, TRENDS BIOTECHNOL, V29, P409, DOI 10.1016/j.tibtech.2011.04.002; Cho HR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181765; Csosz E, 2017, J PROTEOMICS, V153, P30, DOI 10.1016/j.jprot.2016.08.009; Culp DJ, 2015, J BIOL CHEM, V290, P2993, DOI 10.1074/jbc.M114.597906; da Costa JP, 2015, APPL MICROBIOL BIOT, V99, P2023, DOI 10.1007/s00253-015-6375-x; de Sousa-Pereira P, 2015, PROTEOMICS, V15, P1598, DOI 10.1002/pmic.201400083; de Sousa-Pereira P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109050; de Sousa-Pereira P, 2013, ARCH ORAL BIOL, V58, P451, DOI 10.1016/j.archoralbio.2012.12.011; den Hertog AL, 2005, BIOCHEM J, V388, P689, DOI 10.1042/BJ20042099; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; ERICSON D, 1984, INFECT IMMUN, V46, P526, DOI 10.1128/IAI.46.2.526-530.1984; Ghafouri B, 2003, PROTEOMICS, V3, P1003, DOI 10.1002/pmic.200300426; Gonzalez-Begne M, 2011, J PROTEOME RES, V10, P5031, DOI 10.1021/pr200505t; Gorr SU, 2009, PERIODONTOL 2000, V51, P152, DOI 10.1111/j.1600-0757.2009.00310.x; Groenink J, 1996, ANTON LEEUW INT J G, V70, P79, DOI 10.1007/BF00393572; Guo T, 2006, J PROTEOME RES, V5, P1469, DOI 10.1021/pr060065m; Gutierrez AM, 2011, VET J, V187, P356, DOI 10.1016/j.tvjl.2009.12.020; Hardt M, 2005, BIOCHEMISTRY-US, V44, P2885, DOI 10.1021/bi048176r; Hardt M, 2005, ANAL CHEM, V77, P4947, DOI 10.1021/ac050161r; Hebert AS, 2014, MOL CELL PROTEOMICS, V13, P339, DOI 10.1074/mcp.M113.034769; Hekman JP, 2012, APPL ANIM BEHAV SCI, V141, P149, DOI 10.1016/j.applanim.2012.08.007; Heo SM, 2013, INFECT IMMUN, V81, P1364, DOI 10.1128/IAI.00825-12; Hirtz C, 2005, J PHYSIOL BIOCHEM, V61, P469, DOI 10.1007/BF03168453; Hornshoj H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-30; Hu S, 2005, PROTEOMICS, V5, P1714, DOI 10.1002/pmic.200401037; Jacobs R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160546; Jehmlich N, 2013, J PERIODONTAL RES, V48, P392, DOI 10.1111/jre.12025; Ji S, 2007, J PERIODONTAL RES, V42, P410, DOI 10.1111/j.1600-0765.2006.00962.x; Katsiougiannis S, 2016, RHEUM DIS CLIN N AM, V42, P449, DOI 10.1016/j.rdc.2016.03.004; Khurshid Z, 2016, SAUDI PHARM J, V24, P515, DOI 10.1016/j.jsps.2015.02.015; Kobayashi K, 2002, GUT, V51, P169, DOI 10.1136/gut.51.2.169; Lamy E, 2011, J ANIM PHYSIOL AN N, V95, P304, DOI 10.1111/j.1439-0396.2010.01055.x; Lamy E, 2009, PHYSIOL BEHAV, V98, P393, DOI 10.1016/j.physbeh.2009.07.002; Lamy E, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-65; Leonard BC, 2012, J INNATE IMMUN, V4, P248, DOI 10.1159/000334566; Lima DP, 2010, INT J INFECT DIS, V14, pE184, DOI 10.1016/j.ijid.2009.04.022; Loseva OI, 1998, ELECTROPHORESIS, V19, P1127, DOI 10.1002/elps.1150190712; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; Manconi B, 2013, J PROTEOMICS, V91, P536, DOI 10.1016/j.jprot.2013.08.009; MCNEELY TB, 1995, J CLIN INVEST, V96, P456, DOI 10.1172/JCI118056; Messana I, 2008, J SEP SCI, V31, P1948, DOI 10.1002/jssc.200800100; Messana I, 2015, J PROTEOME RES, V14, P1666, DOI 10.1021/pr501270x; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Moritz RL, 2004, ANAL CHEM, V76, P4811, DOI 10.1021/ac049717l; Moshier A, 1996, CURR MICROBIOL, V33, P200, DOI 10.1007/s002849900100; Mostowy S, 2015, NAT REV IMMUNOL, V15, P559, DOI 10.1038/nri3877; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Ostrander EA, 2005, GENOME RES, V15, P1706, DOI 10.1101/gr.3736605; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Podzimek S, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/9179632; Quintana M, 2009, J PROTEOMICS, V72, P822, DOI 10.1016/j.jprot.2009.05.004; REDDY MS, 1993, CRIT REV ORAL BIOL M, V4, P315, DOI 10.1177/10454411930040030901; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Santoro D, 2011, VET DERMATOL, V22, P61, DOI 10.1111/j.1365-3164.2010.00911.x; SCANNAPIECO FA, 1994, CRIT REV ORAL BIOL M, V5, P203, DOI 10.1177/10454411940050030201; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501; Simpson AJ, 1999, FEBS LETT, V452, P309, DOI 10.1016/S0014-5793(99)00670-5; Sivadasan P, 2015, J PROTEOMICS, V127, P89, DOI 10.1016/j.jprot.2015.05.039; Vitorino R, 2004, PROTEOMICS, V4, P1109, DOI 10.1002/pmic.200300638; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wang QH, 2015, CLIN CHIM ACTA, V438, P214, DOI 10.1016/j.cca.2014.08.037; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Wilmarth PA, 2004, J PROTEOME RES, V3, P1017, DOI 10.1021/pr049911o; Wingate KV, 2009, VET DERMATOL, V20, P19, DOI 10.1111/j.1365-3164.2008.00707.x; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xie HW, 2005, MOL CELL PROTEOMICS, V4, P1826, DOI 10.1074/mcp.D500008-MCP200; Yao Y, 2003, J BIOL CHEM, V278, P5300, DOI 10.1074/jbc.M206333200; Zhang Y, 2016, PERIODONTOL 2000, V70, P38, DOI 10.1111/prd.12099	78	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191307	10.1371/journal.pone.0191307	http://dx.doi.org/10.1371/journal.pone.0191307			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329347	Green Submitted, gold, Green Published			2022-12-26	WOS:000419954100057
J	Restani, P; Di Lorenzo, C; Garcia-Alvarez, A; Frigerio, G; Colombo, F; Maggi, FM; Mila-Villarroel, R; Serra-Majem, L				Restani, Patrizia; Di Lorenzo, Chiara; Garcia-Alvarez, Alicia; Frigerio, Gianfranco; Colombo, Francesca; Maggi, Franco M.; Mila-Villarroel, Raimon; Serra-Majem, Lluis			The PlantLIBRA consumer survey: Findings on the use of plant food supplements in Italy	PLOS ONE			English	Article							HERBAL SUPPLEMENTS; HEALTH; PATTERNS	Background Food supplements, and in particular those containing botanicals (plant food supplements, PFS), have in recent decades been of great interest both to consumers and to food/pharmaceutical industries. Objectives The aim of this paper is to examine replies by Italian consumers to the PlantLIBRA consumers' survey in order to: 1) assess the behaviour of an Italian population with respect to the use of PFS, and to compare it with that of other 5 countries involved in the whole survey; 2) identify different habits in the 4 Italian cities selected according to their geographical distribution; 3) collect independent information on the actual intake of PFS and consumers' behaviour. Subjects/setting 397 Italian consumers enrolled, 187 males (49.5%) and 191 female (50.5%). The distribution of subjects among the 4 cities included was: Milan 99; Venice 90; Rome 96 and Catania 96. Results The interest in PFS in Italy is high, the prevalence of "regular" consumers being 22.7%. Some differences were observed between the 4 cities involved: the pattern of use during the year was specific to each city; consumers in Milan reported reasons to use PFS significantly different from those in the whole Italian sample and did not indicate supermarkets as an important place of purchase; respondents from Rome and Catania more frequently used family doctors and pharmacists as a source of recommendation. Some significant difference among cities, sex and age groups were observed when the most frequently used botanicals were ranked. Conclusions The results provide new insights on the socio-economic characteristics and lifestyle of Italian PFS consumers, on their reasons for and pattern of use, and on their behaviour and expectations. The value of this information is not restricted to the specific country (Italy) but allows for a more general evaluation of the pattern of use, according to habits and geographical area.	[Restani, Patrizia; Di Lorenzo, Chiara; Frigerio, Gianfranco; Colombo, Francesca; Maggi, Franco M.] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Garcia-Alvarez, Alicia; Mila-Villarroel, Raimon; Serra-Majem, Lluis] Univ Barcelona, Fdn Invest Nutr, Barcelona Sci Pk, Barcelona, Spain; [Serra-Majem, Lluis] Inst Salud Carlos III, Ciber Obn Fisiopatol Obesidad & Nutr, Madrid, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Inst Biomed & Hlth Res Las Palmas, Las Palmas Gran Canaria, Spain	University of Milan; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Las Palmas de Gran Canaria	Restani, P (corresponding author), Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy.	patrizia.restani@unimi.it	Frigerio, Gianfranco/GSN-3033-2022; Garcia-Alvarez, Alicia/AAV-9762-2020; Serra-Majem, Lluis/I-6708-2019; Frigerio, Gianfranco/AAX-6091-2021; Milà Villarroel, Raimon/AGR-2823-2022	Frigerio, Gianfranco/0000-0002-3538-1443; Serra-Majem, Lluis/0000-0002-9658-9061; Colombo, Francesca/0000-0002-8099-0192	European Community's Seventh framework Programme [245199]	European Community's Seventh framework Programme	The research leading to these results has received funding from the European Communitys Seventh framework Programme (FP/2007-2013) under grant agreement no 245199. It has been carried out within the PlantLiBRA project. This report does not necessarily reflect the Commissions views or the future policy on this area. The European Commission had no direct say in the project methods or outcome beyond providing funding for material and personnel, and did not directly contribute to the writing of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardia A, 2007, MAYO CLIN PROC, V82, P561, DOI 10.4065/82.5.561; Block G, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-30; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; European Advisory Service (EAS), 2007, SANCO2006E4018; Garcia-Alvarez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092265; Giammarioli S, 2013, PUBLIC HEALTH NUTR, V16, P1768, DOI 10.1017/S1368980012004314; Harrison RA, 2004, INT J VITAM NUTR RES, V74, P183, DOI 10.1024/0300-9831.74.3.183; Kelly JP, 2005, ARCH INTERN MED, V165, P281, DOI 10.1001/archinte.165.3.281; Larranaga-Guetaria A, 2012, AGRO FOOD IND HI TEC, V23, P20; Messerer M, 2001, J INTERN MED, V250, P160, DOI 10.1046/j.1365-2796.2001.00872.x; Restani P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150089; Rietjens IMCM, 2008, TOXICOL LETT, V180, P131, DOI 10.1016/j.toxlet.2008.05.024; Ritchie MR, 2007, P NUTR SOC, V66, P479, DOI 10.1017/S0029665107005794; Rock CL, 2007, AM J CLIN NUTR, V85, p277S, DOI 10.1093/ajcn/85.1.277S; Rovira MA, 2013, J NUTR EDUC BEHAV, V45, P386, DOI 10.1016/j.jneb.2012.03.007; Schilter B, 2003, FOOD CHEM TOXICOL, V41, P1625, DOI 10.1016/S0278-6915(03)00221-7; Silano V, 2011, FOOD FUNCT, V2, P710, DOI 10.1039/c1fo10105f; Touvier M, 2009, EUR J CLIN NUTR, V63, P39, DOI 10.1038/sj.ejcn.1602907; Wu CH, 2011, CLIN THER, V33, P1749, DOI 10.1016/j.clinthera.2011.09.024	19	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190915	10.1371/journal.pone.0190915	http://dx.doi.org/10.1371/journal.pone.0190915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324831	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400072
J	Sukkarieh-Haraty, O; Egede, LE; Kharma, JA; Bassil, M				Sukkarieh-Haraty, Ola; Egede, Leonard E.; Kharma, Joelle Abi; Bassil, Maya			Psychometric properties of the Arabic version of the 12-item diabetes fatalism scale	PLOS ONE			English	Article							SELF-MANAGEMENT; POPULATION; BEHAVIORS; OUTCOMES; ILLNESS; ADULTS; HEALTH	Background There are widespread fatalistic beliefs in Arab countries, especially among individuals with diabetes. However, there is no tool to assess diabetes fatalism in this population. This study describes the processes used to create an Arabic version of the Diabetes Fatalism Scale (DFS) and examine its psychometric properties. Methods A descriptive correlational design was used with a convenience sample of Lebanese adults (N = 274) with type 2 diabetes recruited from a major hospital in Beirut, Lebanon and by snowball sampling. The 12-item Diabetes Fatalism Scale-Arabic (12-item DFS-Ar) was back-translated from the original version, pilot tested on 22 adults with type 2 diabetes and then administered to 274 patients to assess the validity and reliability of the scale. Confirmatory factor analysis (CFA) was used to test the hypothesized factor structure. Cronbach's alpha was used to test for reliability. Results CFA supported the existence of the three factor hypothesis of the original DFS scale. The five items measuring "emotional distress" loaded under Factor 1, the four items measuring "spiritual coping" loaded under factor 2 and the last three items measuring "perceived self-efficacy" of the original scale loaded under Factor 3 (p < 0.001 for all three subscales). Goodness of fit indices confirmed adequateness of the CFA model (CFI = 0.97, TLI = 0.96, RMSEA = 0.067 and pclose = 0.05). The 12-item DFS-Ar showed good reliability (Cronbach's alpha of 0.86) and significantly predicted HbA1c (beta = 0.20, p < 0.01). After adjusting for the demographic characteristics and the number of diabetes comorbid conditions, the 12-item DFS-Ar score was independently associated with HbA1c in a multivariable model (beta = 0.16, p < 0.05). Conclusions The 12-item DFS-Ar demonstrated good psychometric properties that are comparable to the original scale. It is a valid and reliable measure of diabetes fatalism. Further testing with larger and non-Lebanese Arabic population is needed.	[Sukkarieh-Haraty, Ola] Lebanese Amer Univ, Alice Ramez Chagoury Sch Nursing, Byblos, Lebanon; [Egede, Leonard E.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Kharma, Joelle Abi; Bassil, Maya] Lebanese Amer Univ, Sch Arts & Sci, Dept Nat Sci, Beirut, Lebanon	Lebanese American University; Medical College of Wisconsin; Lebanese American University	Sukkarieh-Haraty, O (corresponding author), Lebanese Amer Univ, Alice Ramez Chagoury Sch Nursing, Byblos, Lebanon.	ola.sukkarieh@lau.edu.lb	Bassil, Maya/AAG-2846-2019	Bassil, Maya/0000-0001-9996-1300; Sukkarieh, Ola/0000-0001-9971-1563	Lebanese American University	Lebanese American University	The study was funded by the Lebanese American University to OS-H. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Lebanese American University Medical Center-Risk Hospital (LAUMC-RH) for enabling access to the patients. The authors would like to extend their appreciation to Nutrition students at the Lebanese American University for their valuable contribution. The study was funded by the Lebanese American University.	Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS6, DOI 10.2337/dc16-S004; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Costanian C, 2014, DIABETES RES CLIN PR, V105, P408, DOI 10.1016/j.diabres.2014.06.005; Egede LE, 2003, DIABETES EDUCATOR, V29, P105, DOI 10.1177/014572170302900115; Egede LE, 2010, DIABETES EDUCATOR, V36, P276, DOI 10.1177/0145721710361389; Egede LE, 2010, J GEN INTERN MED, V25, P61, DOI 10.1007/s11606-009-1168-5; Esparza OA, 2015, CURR PSYCHOL, V34, P597, DOI 10.1007/s12144-014-9272-z; Franklin MD, 2007, AM J HEALTH BEHAV, V31, P563, DOI 10.5993/AJHB.31.6.1; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Nabolsi MM, 2011, SCAND J CARING SCI, V25, P716, DOI 10.1111/j.1471-6712.2011.00882.x; Osborn CY, 2010, DIABETES TECHNOL THE, V12, P913, DOI 10.1089/dia.2010.0058; Osborn CY, 2010, PATIENT EDUC COUNS, V79, P49, DOI 10.1016/j.pec.2009.07.016; Patel NR, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0269-y; Powe BD, 1997, J RELIG HEALTH, V36, P135, DOI 10.1023/A:1027440520268; Sukkarieh-Haraty O, 2015, HOLIST NURS PRACT, V29, P37, DOI 10.1097/HNP.0000000000000060; Sun J, 2005, MEAS EVAL COUNS DEV, V37, P240, DOI 10.1080/07481756.2005.11909764; Valerio MA, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0242-z; Walker RJ, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-82; Walker RJ, 2012, GEN HOSP PSYCHIAT, V34, P598, DOI 10.1016/j.genhosppsych.2012.07.005	19	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190719	10.1371/journal.pone.0190719	http://dx.doi.org/10.1371/journal.pone.0190719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BJ	29324827	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400051
J	Tsutsui, MH; Kobayashi, K; Miyashita, T				Tsutsui, Masaru H.; Kobayashi, Kazuhiko; Miyashita, Tadashi			Temporal trends in arthropod abundances after the transition to organic farming in paddy fields	PLOS ONE			English	Article							BIODIVERSITY; RICE; MANAGEMENT; CONVERSION; IMPACTS; PEST	Organic farming aims to reduce the effect on the ecosystem and enhance biodiversity in agricultural areas, but the long-term effectiveness of its application is unclear. Assessments have rarely included various taxonomic groups with different ecological and economic roles. In paddy fields with different numbers of years elapsed since the transition from conventional to organic farming, we investigated changes in the abundance of insect pests, generalist predators, and species of conservation concern. The abundance of various arthropods exhibited diverse trends with respect to years elapsed since the transition to organic farming. Larval lepidopterans, Tetragnatha spiders, and some planthoppers and stink bugs showed non-linear increases over time, eventually reaching saturation, such as the abundance increasing for several years and then becoming stable after 10 years. This pattern can be explained by the effects of residual pesticides, the lag time of soil mineralization, and dispersal limitation. A damselfly (Ischnura asiatica) did not show a particular trend over time, probably due to its rapid immigration from source habitats. Unexpectedly, both planthoppers and some leafhoppers exhibited gradual decreases over time. As their abundances were negatively related to the abundance of Tetragnatha spiders, increased predation by natural enemies might gradually decrease these insect populations. These results suggest that the consideration of time-dependent responses of organisms is essential for the evaluation of the costs and benefits of organic farming, and such evaluations could provide a basis for guidelines regarding the length of time for organic farming to restore biodiversity or the economic subsidy needed to compensate for pest damage.	[Tsutsui, Masaru H.; Miyashita, Tadashi] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Biodivers Sci, Tokyo, Japan; [Kobayashi, Kazuhiko] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Sustainable Agr, Tokyo, Japan	University of Tokyo; University of Tokyo	Miyashita, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Biodivers Sci, Tokyo, Japan.	tmiya@es.a.u-tokyo.ac.jp	Kobayashi, Kazuhiko/AAN-7096-2020		Japan Society for the Promotion of Science [26310304]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science Grant-in Aid for Scientific Research (http://www.jsps.go.jp/english/index.html), Grant Number (B) 26310304. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFRC/ NIAES/ NIAS (Agriculture Forestry and Fisheries Research Council National Institute for AgroEnvironmental Sciences and National Institute of Agrobiological Sciences), 2012, IND AN FUNCT AGR SUR, p[65, 56]; Amano T, 2011, ECOL LETT, V14, P1263, DOI 10.1111/j.1461-0248.2011.01699.x; Andersson G. K. S., 2010, Aspects of Applied Biology, P381; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Blaxter K., 1995, DEARTH PLENTY 2 AGR; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Concepcion ED, 2012, J APPL ECOL, V49, P695, DOI 10.1111/j.1365-2664.2012.02131.x; Cross WF, 2005, LIMNOL OCEANOGR, V50, P1730, DOI 10.4319/lo.2005.50.6.1730; DRINKWATER LE, 1995, ECOL APPL, V5, P1098, DOI 10.2307/2269357; FAO, 2013, FAO STAT YB, P123; Fasola Mauro, 1997, P210; Garibaldi LA, 2017, TRENDS ECOL EVOL, V32, P68, DOI 10.1016/j.tree.2016.10.001; GILLESPIE RG, 1987, ANIM BEHAV, V35, P675, DOI 10.1016/S0003-3472(87)80103-3; Hayasaka D, 2012, ECOTOX ENVIRON SAFE, V80, P355, DOI 10.1016/j.ecoenv.2012.04.004; Hidaka Kazumasa, 1998, Japanese Journal of Ecology (Tokyo), V48, P167; Hokazono S, 2012, J CLEAN PROD, V28, P101, DOI 10.1016/j.jclepro.2011.12.005; Hyvonen T, 2007, BIOL CONSERV, V137, P382, DOI 10.1016/j.biocon.2007.02.021; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Jonason D, 2013, BASIC APPL ECOL, V14, P515, DOI [10.1016/j.baae.2013.07.002, 10.1016/j.baae.2013.07.003]; Jonason D, 2011, J APPL ECOL, V48, P543, DOI 10.1111/j.1365-2664.2011.01989.x; Kadoya T, 2009, BIOL CONSERV, V142, P1899, DOI 10.1016/j.biocon.2009.02.033; Katayama N, 2015, AGR SYST, V132, P73, DOI 10.1016/j.agsy.2014.09.001; Kiritani K, 2007, GLOBAL CHANGE BIOL, V13, P1586, DOI 10.1111/j.1365-2486.2007.01397.x; KIRITANI K, 1972, Researches on Population Ecology (Tokyo), V13, P187, DOI 10.1007/BF02521977; Kiritani Keizi, 2000, Integrated Pest Management Reviews, V5, P175, DOI 10.1023/A:1011315214598; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Kobayashi T, 2011, BASIC APPL ECOL, V12, P532, DOI 10.1016/j.baae.2011.07.007; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Lundkvist A, 2008, EUR J AGRON, V28, P570, DOI 10.1016/j.eja.2008.01.001; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Manhoudt AGE, 2007, AGR ECOSYST ENVIRON, V119, P353, DOI 10.1016/j.agee.2006.08.004; Martini EA, 2004, FIELD CROP RES, V86, P255, DOI 10.1016/j.fcr.2003.09.002; Ministry of the Environment Government of Japan, REG WITHH STAND AGR; Miyashita T, 2014, ECOL RES MONOGR, P29, DOI 10.1007/978-4-431-54783-9_2; Nandi S, 2012, J LIMNOL, V71, P320, DOI 10.4081/jlimnol.2012.e34; Natuhara Y, 2013, ECOL ENG, V56, P97, DOI 10.1016/j.ecoleng.2012.04.026; R Core Team, 2016, R FDN STAT COMP; Sato M, 2008, ODONATOLOGICA, V37, P131; Takada MB, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-418; Tanaka A, 2012, FIELD CROP RES, V137, P251, DOI 10.1016/j.fcr.2012.09.005; Taylor ME, 2009, AGR ECOSYST ENVIRON, V130, P9, DOI 10.1016/j.agee.2008.11.004; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tsutsui MH, 2016, APPL ENTOMOL ZOOL, V51, P631, DOI 10.1007/s13355-016-0440-5; Usio N, 2014, SOCIAL ECOLGICAL RES; Wakasugi K, 2002, T JAP SOC IRRIG DRAI, V219, p127 ; Wang S, 2012, WORLD J MICROB BIOT, V28, P493, DOI 10.1007/s11274-011-0840-1; Washitani I., 2001, GLOBAL ENV RES, V5, P119; WILLER H, 2009, WORLD ORGANIC AGR ST; Yoshioka A, 2014, J INSECT SCI, V14, DOI 10.1673/031.014.110	49	8	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190946	10.1371/journal.pone.0190946	http://dx.doi.org/10.1371/journal.pone.0190946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324809	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400079
J	Wang, F; Minakhina, S; Tran, H; Changela, N; Kramer, J; Steward, R				Wang, Fei; Minakhina, Svetlana; Tran, Hiep; Changela, Neha; Kramer, Joseph; Steward, Ruth			Tet protein function during Drosophila development	PLOS ONE			English	Article							DNA METHYLATION; POSTNATAL-DEVELOPMENT; NEURAL DEVELOPMENT; MEDIATED FORMATION; NERVOUS-SYSTEM; MAMMALIAN DNA; STEM-CELLS; 5-HYDROXYMETHYLCYTOSINE; RNA; 5-METHYLCYTOSINE	The TET (Ten-eleven translocation) 1, 2 and 3 proteins have been shown to function as DNA hydroxymethylases in vertebrates and their requirements have been documented extensively. Recently, the Tet proteins have been shown to also hydroxylate 5-methylcytosine in RNA. 5-hydroxymethylcytosine (5hmrC) is enriched in messenger RNA but the function of this modification has yet to be elucidated. Because Cytosine methylation in DNA is barely detectable in Drosophila, it serves as an ideal model to study the biological function of 5hmrC. Here, we characterized the temporal and spatial expression and requirement of Tet throughout Drosophila development. We show that Tet is essential for viability as Tet complete loss-of-function animals die at the late pupal stage. Tet is highly expressed in neuronal tissues and at more moderate levels in somatic muscle precursors in embryos and larvae. Depletion of Tet in muscle precursors at early embryonic stages leads to defects in larval locomotion and late pupal lethality. Although Tet knock-down in neuronal tissue does not cause lethality, it is essential for neuronal function during development through its affects upon locomotion in larvae and the circadian rhythm of adult flies. Further, we report the function of Tet in ovarian morphogenesis. Together, our findings provide basic insights into the biological function of Tet in Drosophila, and may illuminate observed neuronal and muscle phenotypes observed in vertebrates.	[Wang, Fei; Minakhina, Svetlana; Tran, Hiep; Changela, Neha; Kramer, Joseph; Steward, Ruth] Rutgers State Univ, Waksman Inst, Dept Mol Biol, Piscataway, NJ 08854 USA; [Kramer, Joseph] Rutgers State Univ, Rutgers Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, New Brunswick, NJ USA; [Steward, Ruth] Canc Inst New Jersey, New Brunswick, NJ 08901 USA; [Minakhina, Svetlana] Rutgers State Univ, Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center	Steward, R (corresponding author), Rutgers State Univ, Waksman Inst, Dept Mol Biol, Piscataway, NJ 08854 USA.; Steward, R (corresponding author), Canc Inst New Jersey, New Brunswick, NJ 08901 USA.	steward@waksman.rutgers.edu	Tran, Hiep/AAW-6702-2020	Tran, Hiep/0000-0001-5312-8989	National Institutes of Health [2R01 GM089992, 1 R01 GM120405-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120405, R01GM089992] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (2R01 GM089992 and 1 R01 GM120405-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kenneth Irvine for helpful comments on the manuscript; Isaac Edery and Gabe Villegas for helping with the circadian rhythm experiments and interpretation of results, Tatyana Naryshkina for assistance with biochemical experiments, and Neha Changela for microscopy work. We also thank H. Nguyen, R. Renkawitz-Phol, Scott Selleck, Richard Cripps for fly stocks, vectors and antibodies, Le Nguyen for help with fly stocks and fly food. Stocks obtained from the Bloomington Drosophila Stock Center (NIH P400D018537) were used in this study. This work was supported by grants from the National Institutes of Health (2R01 GM089992 and 1 R01 GM120405-01).	BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; Brent J., 2009, J VIS EXP, V1108, DOI [DOI 10.3791/1108, 10.3791/1108]; Brent Jonathan, 2009, J Vis Exp, DOI 10.3791/1108; Capuano F, 2014, ANAL CHEM, V86, P3697, DOI 10.1021/ac500447w; Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Delatte B, 2016, SCIENCE, V351, P282, DOI 10.1126/science.aac5253; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dunwell TL, 2013, CELL CYCLE, V12, P3357, DOI 10.4161/cc.26540; Frye M, 2016, DEVELOPMENT, V143, P3871, DOI 10.1242/dev.136556; Frye M, 2016, NAT REV GENET, V17, P365, DOI 10.1038/nrg.2016.47; Fu LJ, 2014, J AM CHEM SOC, V136, P11582, DOI 10.1021/ja505305z; Garcia-Bellido A, 2009, GENETICS, V182, P631, DOI 10.1534/genetics.109.104083; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jin SG, 2011, NUCLEIC ACIDS RES, V39, P5015, DOI 10.1093/nar/gkr120; Kinney SM, 2011, J BIOL CHEM, V286, P24685, DOI 10.1074/jbc.M110.217083; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; LEISS D, 1988, DEVELOPMENT, V104, P525; Li T, 2015, MOL NEUROBIOL, V51, P142, DOI 10.1007/s12035-014-8734-5; Louis M, 2008, J VIS EXP; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Nicholson L, 2008, GENETICS, V178, P215, DOI 10.1534/genetics.107.081968; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Perrimon N, 1998, INT J DEV BIOL, V42, P243; Raddatz G, 2013, P NATL ACAD SCI USA, V110, P8627, DOI 10.1073/pnas.1306723110; Santiago M, 2014, GENOMICS, V104, P334, DOI 10.1016/j.ygeno.2014.08.018; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; XU T, 1993, DEVELOPMENT, V117, P1223; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Zeidler MP, 2004, NAT BIOTECHNOL, V22, P871, DOI 10.1038/nbt979; Zhang GL, 2015, PR INT ASIA CONF IND, P161, DOI 10.2991/978-94-6239-100-0_30; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006; Zhong X, 2017, SCI REP-UK, V7, DOI 10.1038/srep43539	47	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190367	10.1371/journal.pone.0190367	http://dx.doi.org/10.1371/journal.pone.0190367			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324752	Green Submitted, Green Published, gold			2022-12-26	WOS:000419952400032
J	Kjeld, NG; Hua, B; Karsdal, MA; Sun, S; Manon-Jensen, T				Kjeld, Nadja Gad; Hua, Baolai; Karsdal, Morten Asser; Sun, Shu; Manon-Jensen, Tina			The endothelial specific isoform of type XVIII collagen correlates to annual bleeding rate in haemophilia patients	PLOS ONE			English	Article							FACTOR-VIII ACTIVITY; SEROLOGICAL BIOMARKERS; EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANES; ARTHROPATHY; ABNORMALITIES; INFLAMMATION; DESTRUCTION; PROPHYLAXIS; ENDOSTATIN	Introduction The medical need in the haemophilic (HF) field to reduce bleeding incidents requires measurement of the annual bleeding rate (ABR) in haemophiliacs. Vascular rupture is associated with damage to the vascular endothelium causing exposure of the basement membrane. Endothelial cells and matrix impairment may be associated with joint bleeds and later development of HF arthropathy. Imbalanced extracellular matrix turnover is a central pathological feature in many diseases consequent to epithelial or endothelial cell damage. Type XVIII collagen is an essential basement membrane component, with an endothelial specific isoform. Aim To quantify the basement membrane specifically for the endothelial cells, as that may have particular relevance to endothelial cell stability and rupture in haemophiliacs. A newly developed ELISA assay detecting endothelial type XVIII collagen (COL-18N) was used to assess the clinical relevance of endothelial basement membrane turnover in patients diagnosed with HF arthropathy and correlation to ABR. Methods We developed an ELISA assay for quantification of COL-18N. Serum from 35 male HF patients was investigated using the COL-18N ELISA. Results COL-18N correlated to the ABR of haemophiliacs, r = 0.45, P<0.006. Conclusion Vascular rupture and consequent bleeding are associated with joint damage and deterioration of life quality in haemophiliacs. Quantification of ABR is an important part in efficacy assessment of different interventions, and the benchmark of these. Objective biomarkers reflecting endothelial dysfunction, vascular leaks and rupture, like the COL-18N biomarker that associate with ABR, may assist in identifying the most optimal treatment and monitoring of HF patients.	[Kjeld, Nadja Gad; Karsdal, Morten Asser; Sun, Shu; Manon-Jensen, Tina] Nord Biosci A S, Herlev Hovedgade, Herlev, Denmark; [Hua, Baolai] Chinese Acad Med Sci, PUMCH, Dept Hematol, Beijing, Peoples R China; [Hua, Baolai] Peking Union Med Coll, Beijing, Peoples R China; [Hua, Baolai] Northern Jiangsu Peoples Hosp, Dept Hematol, Yangzhou, Jiangsu, Peoples R China	Nordic Bioscience; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Manon-Jensen, T (corresponding author), Nord Biosci A S, Herlev Hovedgade, Herlev, Denmark.	tmj@nordicbio.com		Karsdal, Morten/0000-0001-5026-8740; Sun, Shu/0000-0002-2477-8904	Danish Research Foundation (Den Danske Forskningsfond) [20130067]; Danish Research Foundation (Den Danske Forskningsfond)	Danish Research Foundation (Den Danske Forskningsfond); Danish Research Foundation (Den Danske Forskningsfond)	We acknowledge the funding from the Danish Research Foundation (Den Danske Forskningsfond, grant number 20130067).; We would like to thank Kristina Kjaer Larsen for great technical assistance. We acknowledge the funding from the Danish Research Foundation (Den Danske Forskningsfond).	Aikio M, 2014, P NATL ACAD SCI USA, V111, pE3043, DOI 10.1073/pnas.1405879111; ALEDORT LM, 1994, J INTERN MED, V236, P391, DOI 10.1111/j.1365-2796.1994.tb00815.x; Aznar JA, 2000, HAEMOPHILIA, V6, P170, DOI 10.1046/j.1365-2516.2000.00397.x; Barrowcliffe TW, 2002, SEMIN THROMB HEMOST, V28, P247, DOI 10.1055/s-2002-32658; Brummel-Ziedins KE, 2009, J THROMB HAEMOST, V7, P825, DOI 10.1111/j.1538-7836.2009.03306.x; Carmeliet P, 1997, AM J PHYSIOL-HEART C, V273, pH2091, DOI 10.1152/ajpheart.1997.273.5.H2091; Elamaa H, 2003, MATRIX BIOL, V22, P427, DOI 10.1016/S0945-053X(03)00073-8; Fischer K, 2013, BLOOD, V122, P1129, DOI 10.1182/blood-2012-12-470898; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Funk MB, 2002, HAEMOPHILIA, V8, P98, DOI 10.1046/j.1365-2516.2002.00585.x; GEFTER ML, 1977, SOMAT CELL GENET, V3, P231, DOI 10.1007/BF01551818; Gringeri A, 2011, J THROMB HAEMOST, V9, P700, DOI 10.1111/j.1538-7836.2011.04214.x; Hua B, 2017, HAEMOPHILIA, V23, pE294, DOI 10.1111/hae.13196; Karsdal MA, 2013, BIOMARKERS, V18, P375, DOI 10.3109/1354750X.2013.789084; Karsdal MA, 2013, ASSAY DRUG DEV TECHN, V11, P70, DOI 10.1089/adt.2012.474; Lundin B, 2005, HAEMOPHILIA, V11, P116, DOI 10.1111/j.1365-2516.2005.01061.x; Manon-Jensen T, 2017, HAEMOPHILIA, V23, pE515, DOI 10.1111/hae.13329; Manon-Jensen T, 2016, J THROMB HAEMOST, V14, P2419, DOI 10.1111/jth.13518; Manon-Jensen T, 2016, J THROMB HAEMOST, V14, P438, DOI 10.1111/jth.13249; Marneros AG, 2005, FASEB J, V19, P716, DOI 10.1096/fj.04-2134rev; Marneros AG, 2004, EMBO J, V23, P89, DOI 10.1038/sj.emboj.7600014; Marneros AG, 2003, INVEST OPHTH VIS SCI, V44, P2367, DOI 10.1167/iovs.02-1180; Mikaelsson M, 1998, HAEMOPHILIA, V4, P646, DOI 10.1046/j.1365-2516.1998.440646.x; Mikaelsson M, 2002, SEMIN THROMB HEMOST, V28, P257, DOI 10.1055/s-2002-32659; Passos-Bueno MR, 2006, AN ACAD BRAS CIENC, V78, P123, DOI 10.1590/S0001-37652006000100012; Qvist P, 2002, BONE, V31, P57, DOI 10.1016/S8756-3282(02)00791-3; Ragni MV, 2016, HAEMOPHILIA, V22, P240, DOI 10.1111/hae.12830; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; Saarela J, 1998, AM J PATHOL, V153, P611, DOI 10.1016/S0002-9440(10)65603-9; Seppinen L, 2011, MATRIX BIOL, V30, P83, DOI 10.1016/j.matbio.2010.11.001; Tomono Y, 2002, CELL STRUCT FUNCT, V27, P9, DOI 10.1247/csf.27.9; Utriainen A, 2004, HUM MOL GENET, V13, P2089, DOI 10.1093/hmg/ddh213; van Velzen AS, 2016, THROMB HAEMOSTASIS, V115, P543, DOI 10.1160/TH15-03-0212	33	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190375	10.1371/journal.pone.0190375	http://dx.doi.org/10.1371/journal.pone.0190375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320534	Green Published, Green Submitted, gold			2022-12-26	WOS:000419689600047
J	Zenouzi, R; von der Gablentz, J; Heldmann, M; Gottlich, M; Weiler-Normann, C; Sebode, M; Ehlken, H; Hartl, J; Fellbrich, A; Siemonsen, S; Schramm, C; Munte, TF; Lohse, AW				Zenouzi, Roman; von der Gablentz, Janina; Heldmann, Marcus; Goettlich, Martin; Weiler-Normann, Christina; Sebode, Marcial; Ehlken, Hanno; Hartl, Johannes; Fellbrich, Anja; Siemonsen, Susanne; Schramm, Christoph; Muente, Thomas F.; Lohse, Ansgar W.			Patients with primary biliary cholangitis and fatigue present with depressive symptoms and selected cognitive deficits, but with normal	PLOS ONE			English	Article							QUALITY-OF-LIFE; MAGNETIZATION-TRANSFER RATIO; MULTIPLE-SCLEROSIS; PART-B; CIRRHOSIS; VALIDATION; IMPACT; TRAIL; TRANSPLANTATION	Background In primary biliary cholangitis (PBC) fatigue is a major clinical challenge of unknown etiology. By demonstrating that fatigue in PBC is associated with an impaired cognitive performance, previous studies have pointed out the possibility of brain abnormalities underlying fatigue in PBC. Whether structural brain changes are present in PBC patients with fatigue, however, is unclear. To evaluate the role of structural brain abnormalities in PBC patients severely affected from fatigue we, therefore, performed a case-control cerebral magnetic resonance imaging (cMRI) study and correlated changes of white and grey brain matter with the cognitive and attention performance. Methods 20 female patients with PBC and 20 female age-matched controls were examined in this study. The assessment of fatigue, psychological symptoms, cognitive and attention performance included clinical questionnaires, established cognition tests and a computerized test battery of attention performance. T1-weighted cMRI and diffusion tensor imaging (DTI) scans were acquired with a 3 Tesla scanner. Structural brain alterations were investigated with voxel-based morphometry (VBM) and DTI analyses. Results were correlated to the cognitive and attention performance. Results Compared to healthy controls, PBC patients had significantly higher levels of fatigue and associated psychological symptoms. Except for an impairment of verbal fluency, no cognitive or attention deficits were found in the PBC cohort. The VBM and DTI analyses revealed neither major structural brain abnormalities in the PBC cohort nor correlations with the cognitive and attention performance. Conclusions Despite the high burden of fatigue and selected cognitive deficits, the attention performance of PBC patients appears to be comparable to healthy people. As structural brain alterations do not seem to be present in PBC patients with fatigue, fatigue in PBC must be regarded as purely functional. Future studies should evaluate, whether functional brain changes underlie fatigue in PBC.	[Zenouzi, Roman; Weiler-Normann, Christina; Sebode, Marcial; Ehlken, Hanno; Hartl, Johannes; Schramm, Christoph; Lohse, Ansgar W.] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [von der Gablentz, Janina; Heldmann, Marcus; Goettlich, Martin; Fellbrich, Anja; Muente, Thomas F.] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Ehlken, Hanno] Univ Med Ctr Hamburg Eppendorf, Dept Interdisciplinary Endoscopy, Hamburg, Germany; [Siemonsen, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Zenouzi, R (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany.	r.zenouzi@uke.de		Hartl, Johannes/0000-0002-4037-9938; Gottlich, Martin/0000-0002-7668-0730	Deutsche Forschungsgemeinschaft [DFG SFB841]; YAEL Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); YAEL Foundation	This study was supported by the "Deutsche Forschungsgemeinschaft" (DFG SFB841) and the YAEL Foundation (https://yael-stiftung.de).	Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Bajaj JS, 2009, HEPATOLOGY, V50, P1175, DOI 10.1002/hep.23128; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Boissoneault J, 2015, MAGN RESON IMAGING; Burak KW, 2001, BRAIN RES, V892, P376, DOI 10.1016/S0006-8993(00)03058-4; Carbone M, 2013, J HEPATOL, V59, P490, DOI 10.1016/j.jhep.2013.04.017; CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E; DEROGATIS LR, 1976, BRIT J PSYCHIAT, V128, P280, DOI 10.1192/bjp.128.3.280; Flachenecker R, 2006, NERVENARZT, V77, P165, DOI 10.1007/s00115-005-1990-x; Forton DM, 2004, GUT, V53, P587, DOI 10.1136/gut.2003.016766; GAUDINO EA, 1995, J CLIN EXP NEUROPSYC, V17, P529, DOI 10.1080/01688639508405143; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Grover VPB, 2016, ALIMENT PHARM THER, V44, P936, DOI 10.1111/apt.13797; Hollingsworth KG, 2009, J MAGN RESON IMAGING, V29, P780, DOI 10.1002/jmri.21555; Hoppe C, 2000, CLIN NEUROPSYCHOL, V14, P38, DOI 10.1076/1385-4046(200002)14:1;1-8;FT038; Huet PM, 2000, AM J GASTROENTEROL, V95, P760; Jacoby A, 2005, GUT, V54, P1622, DOI 10.1136/gut.2005.065862; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jones DE, 2010, J HEPATOL, V53, P911, DOI 10.1016/j.jhep.2010.05.026; Jopson L, 2015, DIGEST DIS, V33, P109, DOI 10.1159/000440757; Nagels G, 2007, J CLIN NEUROSCI, V14, P33, DOI 10.1016/j.jocn.2005.10.008; Newton JL, 2006, J HEPATOL, V44, P776, DOI 10.1016/j.jhep.2005.12.012; Newton JL, 2008, HEPATOLOGY, V48, P541, DOI 10.1002/hep.22371; Newton JL, 2006, HEPATOLOGY, V44, P91, DOI 10.1002/hep.21230; Prince MI, 2000, J HEPATOL, V32, P368, DOI 10.1016/S0168-8278(00)80385-2; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Soares JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00031; Tang L, 2015, EVID-BASED COMPL ALT, V2015; Wilting J, 2016, EUR RADIOL, V26, P515, DOI 10.1007/s00330-015-3857-2; Zenouzi R, 2013, J HEPATOL, V59, P418, DOI 10.1016/j.jhep.2013.05.037	33	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190005	10.1371/journal.pone.0190005	http://dx.doi.org/10.1371/journal.pone.0190005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320524	Green Published, Green Submitted, gold			2022-12-26	WOS:000419689600028
J	van Lindert, EJ; van Bilsen, M; van der Flier, M; Kolwijck, E; Delye, H; ten Oever, J				van Lindert, Erik J.; van Bilsen, Martine; van der Flier, Michiel; Kolwijck, Eva; Delye, Hans; ten Oever, Jaap			Topical vancomycin reduces the cerebrospinal fluid shunt infection rate: A retrospective cohort study	PLOS ONE			English	Article							EXTERNAL VENTRICULAR DRAINS; VENTRICULOPERITONEAL SHUNT; CLINICAL ARTICLE; CONTROLLED-TRIAL; HYDROCEPHALUS; CHILDREN; CATHETERS; METAANALYSIS; SYSTEMS; PREVENTION	Object Despite many efforts at reduction, cerebrospinal fluid (CSF) shunt infections are a major cause of morbidity in shunt surgery, occurring in 5-15% of cases. To attempt to reduce the shunt infection rate at our institution, we added topical vancomycin (intrashunt and perishunt) to our existing shunt infection prevention protocol in 2012. Methods We performed a retrospective cohort study comparing all shunted patients in January 2010 to December 2011 without vancomycin (control group, 263 procedures) to all patients who underwent shunt surgery between April 2012 and December 2015 with vancomycin (intervention group, 499 procedures). Results The overall shunt infection rate significantly decreased from 6.8% (control group) to 3.0% (intervention group) (p = 0.023, absolute risk reduction 3.8%, relative risk reduction 56%). Multivariate logistic regression analysis confirmed that the addition of topical vancomycin showed that cases treated under a protocol of topical vancomycin were associated with a decreased shunt infection rate (odds ratio [OR] 0.49 95% CI 0.25-0.998; p = 0.049). Age < 1 year was associated with an increased risk of infection (OR) 4.41, 95% CI 2,10-9,26; p = 0.001). Time from surgery to infection was significantly prolonged in the intervention group (p = 0.001). Conclusion Adding intraoperative vancomycin to a shunt infection prevention protocol significantly reduces CSF shunt infection rate.	[van Lindert, Erik J.; van Bilsen, Martine; Delye, Hans] Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, Nijmegen, Netherlands; [van der Flier, Michiel] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, Nijmegen, Netherlands; [Kolwijck, Eva] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; [ten Oever, Jaap] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [ten Oever, Jaap] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van Lindert, EJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, Nijmegen, Netherlands.	erik.vanlindert@radboudumc.nl	Delye, H.H.K./L-4265-2015; Oever, Jaap ten/P-6617-2015; Kolwijck, E./L-4444-2015; Lindert, E.J./L-4491-2015; van der Flier, M./L-4307-2015	Oever, Jaap ten/0000-0003-2397-0125; van der Flier, M./0000-0003-1296-0159				BORGBJERG BM, 1995, ACTA NEUROCHIR, V136, P1, DOI 10.1007/BF01411427; Brown EM, 2006, NEUROSURGERY, V58, P657, DOI 10.1227/01.NEU.0000204126.54417.46; CHOUX M, 1992, J NEUROSURG, V77, P875, DOI 10.3171/jns.1992.77.6.0875; Cochrane DD, 2003, PEDIATR NEUROSURG, V38, P295, DOI 10.1159/000070413; Edwards NC, 2015, J NEUROSURG, V122, P139, DOI 10.3171/2014.9.JNS131277; James BC, 2011, HEALTH AFFAIR, V30, P1185, DOI 10.1377/hlthaff.2011.0358; James G, 2014, J NEUROSURG-PEDIATR, V13, P101, DOI 10.3171/2013.10.PEDS13189; Kandasamy J, 2011, CHILD NERV SYST, V27, P575, DOI 10.1007/s00381-010-1290-z; Kestle JRW, 2016, J NEUROSURG-PEDIATR, V17, P391, DOI 10.3171/2015.8.PEDS15253; Kestle JRW, 2011, J NEUROSURG-PEDIATR, V8, P22, DOI 10.3171/2011.4.PEDS10551; Klimo P, 2014, J NEUROSURG-PEDIATR, V14, P44, DOI 10.3171/2014.7.PEDS14326; Klimo P, 2014, J NEUROSURG-PEDIATR, V14, P53, DOI 10.3171/2014.7.PEDS14327; Klimo P, 2011, J NEUROSURG-PEDIATR, V8, P600, DOI 10.3171/2011.8.PEDS11346; Konstantelias AA, 2015, J NEUROSURG, V122, P1096, DOI 10.3171/2014.12.JNS14908; Moussa WMM, 2016, CLIN NEUROL NEUROSUR, V143, P144, DOI 10.1016/j.clineuro.2016.02.034; Parker SL, 2015, J NEUROSURG, V122, P443, DOI 10.3171/2014.10.JNS13395; Parker SL, 2011, J NEUROSURG-PEDIATR, V8, P259, DOI 10.3171/2011.6.PEDS11257; Pople I, 2012, NEUROSURGERY, V71, P6, DOI 10.1227/NEU.0b013e3182544e31; Prusseit J, 2009, PEDIATR NEUROSURG, V45, P325, DOI 10.1159/000257520; Ragel BT, 2006, J NEUROSURG, V105, P242, DOI 10.3171/jns.2006.105.2.242; Root BK, 2016, WORLD NEUROSURG, V86, P306, DOI [10.1016/j.wneu.2015.09.032, 10.1016/J.WNEU.2015.09.032]; Sarmey N, 2015, CHILD NERV SYST, V31, P541, DOI 10.1007/s00381-015-2637-2; Simon TD, 2009, J NEUROS-PEDIATR, V4, P156, DOI 10.3171/2009.3.PEDS08215; Xu H, 2016, CHILD NERV SYST, V32, P253, DOI 10.1007/s00381-015-2937-6; Zabramski JM, 2003, J NEUROSURG, V98, P725, DOI 10.3171/jns.2003.98.4.0725	25	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190249	10.1371/journal.pone.0190249	http://dx.doi.org/10.1371/journal.pone.0190249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315341	Green Published, Green Submitted, gold			2022-12-26	WOS:000419655900008
J	Ikink, GJ; Boer, M; Bakker, ERM; Vendel-Zwaagstra, A; Klijn, C; ten Hoeve, J; Jonkers, J; Wessels, LF; Hilkens, J				Ikink, Gerjon J.; Boer, Mandy; Bakker, Elvira R. M.; Vendel-Zwaagstra, Annabel; Klijn, Chris; ten Hoeve, Jelle; Jonkers, Jos; Wessels, Lodewyk F.; Hilkens, John			Insertional mutagenesis in a HER2-positive breast cancer model reveals ERAS as a driver of cancer and therapy resistance	ONCOGENE			English	Article							TRANSGENIC MAMMARY-TUMORS; EXPRESSED RAS ERAS; TRASTUZUMAB RESISTANCE; GASTRIC-CANCER; PI3K PATHWAY; NEU ONCOGENE; MICE; GENE; ACTIVATION; LAPATINIB	Personalized medicine for cancer patients requires a deep understanding of the underlying genetics that drive cancer and the subsequent identification of predictive biomarkers. To discover new genes and pathways contributing to oncogenesis and therapy resistance in HER2+ breast cancer, we performed Mouse Mammary Tumor Virus (MMTV)-induced insertional mutagenesis screens in ErbB2/cNeu-transgenic mouse models. The screens revealed 34 common integration sites (CIS) in mammary tumors of MMTV-infected mice, highlighting loci with multiple independent MMTV integrations in which potential oncogenes are activated, most of which had never been reported as MMTV CIS. The CIS most strongly associated with the ErbB2-transgenic genotype was the locus containing Eras (ES cell-expressed Ras), a constitutively active RAS-family GTPase. We show that upon expression, Eras acts as a potent oncogenic driver through hyperactivation of the PI3K/AKT pathway, in contrast to other RAS proteins that signal primarily via the MAPK/ERK pathway and require upstream activation or activating mutations to induce signaling. We additionally show that ERAS synergistically enhances HER2-induced tumorigenesis and, in this role, can functionally replace ERBB3/HER3 by acting as a more powerful activator of PI3K/AKT signaling. Although previously reported as pseudogene in humans, we observed ERAS RNA and protein expression in a substantial subset of human primary breast carcinomas. Importantly, we show that ERAS induces primary resistance to the widely used HER2-targeting drugs Trastuzumab (Herceptin) and Lapatinib (Tykerb/Tyverb) in vivo, and is involved in acquired resistance via selective upregulation during treatment in vitro, indicating that ERAS may serve as a novel clinical biomarker for PI3K/AKT pathway hyperactivation and HER2-targeted therapy resistance.	[Ikink, Gerjon J.; Boer, Mandy; Bakker, Elvira R. M.; Vendel-Zwaagstra, Annabel; Hilkens, John] Netherlands Canc Inst, Div Mol Genet, Amsterdam, Netherlands; [Klijn, Chris; Jonkers, Jos] Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands; [ten Hoeve, Jelle; Wessels, Lodewyk F.] Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Hilkens, J (corresponding author), Netherlands Canc Inst, Div Mol Genet, Amsterdam, Netherlands.	j.hilkens@nki.nl	Jonkers, Jos/AAG-3246-2019	Jonkers, Jos/0000-0002-9264-9792; Hilkens, John/0000-0002-0932-7793; Ikink, Gerjon/0000-0002-7482-9298				Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Andrechek ER, 2000, P NATL ACAD SCI USA, V97, P3444, DOI 10.1073/pnas.050408497; Andrechek ER, 2003, CANCER RES, V63, P4920; Aoyama M, 2010, INT J ONCOL, V37, P1011, DOI 10.3892/ijo_00000752; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; BOUCHARD L, 1989, CELL, V57, P931, DOI 10.1016/0092-8674(89)90331-0; Callahan R, 2008, J MAMMARY GLAND BIOL, V13, P309, DOI 10.1007/s10911-008-9092-6; Callahan R, 2012, ONCOTARGET, V3, P1320, DOI 10.18632/oncotarget.682; Chandarlapaty S, 2012, CLIN CANCER RES, V18, P6784, DOI 10.1158/1078-0432.CCR-12-1785; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Dawood S, 2010, J CLIN ONCOL, V28, P92, DOI 10.1200/JCO.2008.19.9844; Eichhorn PJA, 2008, CANCER RES, V68, P9221, DOI 10.1158/0008-5472.CAN-08-1740; Ellis MJ, 2013, CANCER DISCOV, V3, P27, DOI 10.1158/2159-8290.CD-12-0462; Engstrom MJ, 2013, BREAST CANC RES TREA, V140, P1; Esteva FJ, 2010, AM J PATHOL, V177, P1647, DOI 10.2353/ajpath.2010.090885; Gagliato DD, 2016, ONCOTARGET, V7, P64431, DOI 10.18632/oncotarget.7043; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hanker AB, 2013, P NATL ACAD SCI USA, V110, P14372, DOI 10.1073/pnas.1303204110; Hilkens J, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1376; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Ikink GJ, 2017, MOL CELL ONCOL, V4, DOI 10.1080/23723556.2017.1279722; Ikink GJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13567; Kaizaki R, 2009, ANTICANCER RES, V29, P2189; Kameda T, 2005, STEM CELLS, V23, P1535, DOI 10.1634/stemcells.2005-0054; Kim HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027425; Klijn C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062113; Knutson KL, 2004, CANCER RES, V64, P1146, DOI 10.1158/0008-5472.CAN-03-0173; Koudijs MJ, 2011, GENOME RES, V21, P2181, DOI 10.1101/gr.112763.110; Kubota E, 2011, ANTICANCER RES, V31, P3353; Kubota E, 2010, AM J PATHOL, V177, P955, DOI 10.2353/ajpath.2010.091056; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Mah W, 2010, J NEUROSCI, V30, P5559, DOI 10.1523/JNEUROSCI.4839-09.2010; Majewski IJ, 2015, J CLIN ONCOL, V33, P1334, DOI 10.1200/JCO.2014.55.2158; MIYOSHI J, 1984, NUCLEIC ACIDS RES, V12, P1821, DOI 10.1093/nar/12.4.1821; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nusse R, 1991, Curr Top Microbiol Immunol, V171, P43; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Vyazunova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113489; Wang LP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-248; Wang PY, 2008, MOL CELL NEUROSCI, V39, P83, DOI 10.1016/j.mcn.2008.05.019; Yu Y, 2014, STEM CELLS, V32, P349, DOI 10.1002/stem.1447; Zhao ZA, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150092	50	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	12					1594	1609		10.1038/s41388-017-0031-0	http://dx.doi.org/10.1038/s41388-017-0031-0			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GA8YC	29326437	hybrid, Green Published			2022-12-26	WOS:000428626700004
J	Jensen, PN; Bao, TQ; Huong, TTT; Heckbert, SR; Fitzpatrick, AL; LoGerfo, JP; Ngoc, TLV; Mokdad, AH				Jensen, Paul N.; Tran Quoc Bao; Tran Thi Thanh Huong; Heckbert, Susan R.; Fitzpatrick, Annette L.; LoGerfo, James P.; Truong Le Van Ngoc; Mokdad, Ali H.			The association of estimated salt intake with blood pressure in a Viet Nam national survey	PLOS ONE			English	Article							24-H URINARY SODIUM; POTASSIUM EXCRETION; SENSITIVITY; HEALTH; ADULTS; URBAN; INTERVENTIONS; HYPERTENSION; MIGRATION; COSTS	Objective To evaluate the association of salt consumption with blood pressure in Viet Nam, a developing country with a high level of salt consumption. Design and setting Analysis of a nationally representative sample of Vietnamese adults 25 +/- 65 years of age who were surveyed using the World Health Organization STEPwise approach to Surveillance protocol. Participants who reported acute illness, pregnancy, or current use of antihypertensive medications were excluded. Daily salt consumption was estimated from fasting mid-morning spot urine samples. Associations of salt consumption with systolic blood pressure and prevalent hypertension were assessed using adjusted linear and generalized linear models. Interaction terms were tested to assess differences by age, smoking, alcohol consumption, and rural/urban status. Results The analysis included 2,333 participants (mean age: 37 years, 46% male, 33% urban). The average estimated salt consumption was 10g/day. No associations of salt consumption with blood pressure or prevalent hypertension were observed at a national scale in men or women. The associations did not differ in subgroups defined by age, smoking, or alcohol consumption; however, associations differed between urban and rural participants (p-value for interaction of urban/rural status with salt consumption, p = 0.02), suggesting that higher salt consumption may be associated with higher systolic blood pressure in urban residents but lower systolic blood pressure in rural residents. Conclusions Although there was no evidence of an association at a national level, associations of salt consumption with blood pressure differed between urban and rural residents in Viet Nam. The reasons for this differential association are not clear, and given the large rate of rural to urban migration experienced in Viet Nam, this topic warrants further investigation.	[Jensen, Paul N.; Heckbert, Susan R.; Fitzpatrick, Annette L.; Mokdad, Ali H.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Tran Quoc Bao; Truong Le Van Ngoc] Viet Nam Minist Hlth, Dept Prevent Med, Hanoi, Vietnam; [Tran Thi Thanh Huong] Hanoi Med Univ, Dept Eth & Social Med, Hanoi, Vietnam; [Fitzpatrick, Annette L.; LoGerfo, James P.; Mokdad, Ali H.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [LoGerfo, James P.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Hanoi Medical University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Jensen, PN (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	pnjensen@uw.edu	Mokdad, Ali H./AAD-1232-2022	Mokdad, Ali H./0000-0002-4994-3339	Atlantic Philanthropies Inc.	Atlantic Philanthropies Inc.	Funding to support data collection (TQB, TTTH, TLVN) was provided by The Atlantic Philanthropies Inc.; the sponsor had no role in the study design, data analysis, writing or preparation of the article, or decision to have it submitted for publication. Study authors had no association with the funding organization. http://www.atlanticphilanthropies.org/	[Anonymous], 1988, BMJ, V297, P319; [Anonymous], 2005, ASEAN EC B, DOI DOI 10.1355/AE22-1G; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; CARVALHO JJM, 1989, HYPERTENSION, V14, P238, DOI 10.1161/01.HYP.14.3.238; Cogswell ME, 2013, AM J CLIN NUTR, V98, P1502, DOI 10.3945/ajcn.113.059436; Cuong TQ, 2007, EUR J CLIN NUTR, V61, P673, DOI 10.1038/sj.ejcn.1602563; Dans A, 2011, LANCET, V377, P680, DOI 10.1016/S0140-6736(10)61506-1; Do HTP, 2014, THESIS; Elliott P, 2013, AM J EPIDEMIOL, V177, P1196, DOI 10.1093/aje/kwt065; Do HTP, 2016, J CLIN HYPERTENS, V18, P1135, DOI 10.1111/jch.12884; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; He F. J., 2013, BMJ, V346; He FJ, 2010, PROG CARDIOVASC DIS, V52, P363, DOI 10.1016/j.pcad.2009.12.006; HE J, 1991, AM J EPIDEMIOL, V134, P1085, DOI 10.1093/oxfordjournals.aje.a116012; HOLBROOK JT, 1984, AM J CLIN NUTR, V40, P786, DOI 10.1093/ajcn/40.4.786; Huang LP, 2016, INT J EPIDEMIOL, V45, P239, DOI 10.1093/ije/dyv313; Huyen DNTN, VIETNAMS EC DEV OPPO; Ji C, 2012, REV PANAM SALUD PUBL, V32, P307, DOI 10.1590/S1020-49892012001000010; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Kotchen TA, 1998, CIRCULATION, V98, P613, DOI 10.1161/01.CIR.98.6.613; LIU K, 1984, ANN CLIN RES, V16, P49; LUFT FC, 1979, CIRCULATION, V60, P697, DOI 10.1161/01.CIR.60.3.697; Lumley T, 2006, UW BIOSTATISTICS WOR; Mann SJ, 2010, J CLIN HYPERTENS, V12, P174, DOI 10.1111/j.1751-7176.2009.00241.x; Mattson DL, 2008, AM J PHYSIOL-RENAL, V295, pF837, DOI 10.1152/ajprenal.90341.2008; MENEELY GR, 1976, AM J CARDIOL, V38, P768, DOI 10.1016/0002-9149(76)90356-8; Mente A, 2014, J HYPERTENS, V32, P1005, DOI 10.1097/HJH.0000000000000122; Mill José Geraldo, 2015, Rev. bras. epidemiol., V18, P224, DOI 10.1590/1980-5497201500060020; MILLER JZ, 1987, AM J EPIDEMIOL, V126, P822, DOI 10.1093/oxfordjournals.aje.a114719; Mohani S, 2013, PROMOTING POPULATION; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; NADIM A, 1978, INT J EPIDEMIOL, V7, P131, DOI 10.1093/ije/7.2.131; Nguyen QN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042825; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; Oh J, 2014, J KOREAN MED SCI, V29, pS109, DOI 10.3346/jkms.2014.29.S2.S109; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; POULTER N, 1984, J EPIDEMIOL COMMUN H, V38, P181, DOI 10.1136/jech.38.3.181; Rubinstein Adolfo, 2009, Cost Eff Resour Alloc, V7, P10, DOI 10.1186/1478-7547-7-10; Sanada H, 2011, CURR HYPERTENS REP, V13, P55, DOI 10.1007/s11906-010-0167-6; Sanders PW, 2009, HYPERTENSION, V53, P442, DOI 10.1161/HYPERTENSIONAHA.108.120303; Steffen PR, 2006, PSYCHOSOM MED, V68, P386, DOI 10.1097/01.psy.0000221255.48190.32; Svetkey LP, 1996, HYPERTENSION, V28, P854, DOI 10.1161/01.HYP.28.5.854; Bui TV, 2015, NICOTINE TOB RES, V17, P831, DOI 10.1093/ntr/ntu202; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; Trang Nguyen Hoang Hanh Doan, 2012, BMJ Open, V2, pe000362, DOI 10.1136/bmjopen-2011-000362; Trinh OTH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-204; United Nations Population Fund, 2011, VIETN POP HOUS CENS; Wang GJ, 2011, J HYPERTENS, V29, P1693, DOI 10.1097/HJH.0b013e328349ba18; Weinberger MH, 1996, HYPERTENSION, V27, P481, DOI 10.1161/01.HYP.27.3.481; White E, 2008, PRINCIPLES EXPOSURE, Vxi; World Health Organization, 2012, STEPWISE APPR SURV S; World Health Organization, 2016, SALT RED D FACT SHEE	54	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191437	10.1371/journal.pone.0191437	http://dx.doi.org/10.1371/journal.pone.0191437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS9PC	29346423	Green Submitted, Green Published, gold			2022-12-26	WOS:000422749500051
J	Martinez-Andrade, JM; Avalos-Borja, M; Vilchis-Nestor, AR; Sanchez-Vargas, LO; Castro-Longoria, E				Martinez-Andrade, Juan M.; Avalos-Borja, Miguel; Vilchis-Nestor, Alfredo R.; Sanchez-Vargas, Luis O.; Castro-Longoria, Ernestina			Dual function of EDTA with silver nanoparticles for root canal treatment-A novel modification	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS BIOFILMS; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL ACTIVITY; BACTERICIDAL ACTIVITY; AMPHOTERICIN-B; IN-VITRO; ANTIBACTERIAL; ACID; DENTIN; IRRIGATION	The chelating and antimicrobial capacity of a novel modification of 17% EDTA with silver nanoparticles (AgNPs) (EDTA-AgNPs) was evaluated in-vitro for root canal treatment (RCT). The EDTA-AgNPs solution was characterized by UV-Vis spectroscopy,zeta-potential and high-resolution transmission electron microscopy (HRTEM). Antimicrobial capacity was evaluated against Candida albicans and Staphylococcus aureus in planktonic and biofilm cells by broth macrodilution (24 h) and XTT assays, (1, 10 and 30 min) respectively. The chelating capacity of EDTA-AgNPs was assessed indirectly (smear layer removal) and directly (demineralizing effect) in bovine dentin at two silver concentrations, 16 and 512 mu g/ml at 1 and 10 minutes of exposure time. Smear layer removal was evaluated by atomic force microscopy (AFM) and scanning electron microscopy (SEM). The demineralizing effect was determined by atomic absorption spectroscopy (AAS), microhardness test (MH) and X-ray diffractometer (XRD). Synthesized AgNPs were quasi-spherical in shape with an average size of 13.09 +/- 8.05 nm. 17% EDTA-AgNPs was effective to inhibit C. albicans and S. aureus in planktonic and biofilm cultures. The smear layer removal and demineralizing effect were similar between 17% EDTA-AgNPs and 17% EDTA treatments. The 17% EDTA-AgNPs solution proved to be an effective antimicrobial agent, and has a similar chelating capacity to 17% EDTA alone. These in-vitro studies strongly suggest that EDTA-AgNPs could be used for effective smear layer removal, having an antimicrobial effect at the same time during RCT.	[Martinez-Andrade, Juan M.; Castro-Longoria, Ernestina] CICESE, Dept Microbiol, Ensenada, Baja California, Mexico; [Avalos-Borja, Miguel] Inst Potosino Invest Cient & Tecnol IPICyT, San Luis Potosi, San Luis Potosi, Mexico; [Vilchis-Nestor, Alfredo R.] Univ Autonoma Estado Mexico, Ctr Conjunto Invest Quim Sustentable, Toluca, Estado De Mexic, Mexico; [Vilchis-Nestor, Alfredo R.] UNAM, UAEM, Toluca, Estado De Mexic, Mexico; [Sanchez-Vargas, Luis O.] UASLP, Fac Estomatol, San Luis Potosi, San Luis Potosi, Mexico	CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Instituto Potosino Investigacion Cientifica y Tecnologica; Universidad Autonoma del Estado de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Autonoma de San Luis Potosi	Castro-Longoria, E (corresponding author), CICESE, Dept Microbiol, Ensenada, Baja California, Mexico.	ecastro@cicese.mx	VILCHIS-NESTOR, ALFREDO R/B-6776-2016; Castro-Longoria, Ernestina/GYV-4776-2022	VILCHIS-NESTOR, ALFREDO R/0000-0001-8490-0900; Martinez-Andrade, Juan Manuel/0000-0002-2166-6659	SEP-CONACyT [CB2011/169154, LN-0271911]; Consejo Nacional de Ciencia y Tecnologia (CONACyT)	SEP-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was partially funded by a SEP-CONACyT grant CB2011/169154 to EC-L and LN-0271911 to MA-B (www.conacyt.mx). We also thank Consejo Nacional de Ciencia y Tecnologia (CONACyT) for a scholarship to JMM-A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bakri AG, 2009, J APPL MICROBIOL, V107, P280, DOI 10.1111/j.1365-2672.2009.04205.x; Arias-Moliz MT, 2008, ORAL SURG ORAL MED O, V106, pE84, DOI 10.1016/j.tripleo.2008.04.002; Baumgartner JC, 2007, J ENDODONT, V33, P48, DOI 10.1016/j.joen.2006.08.007; Bian SW, 2011, LANGMUIR, V27, P6059, DOI 10.1021/la200570n; Branen JK, 2004, INT J FOOD MICROBIOL, V90, P63, DOI 10.1016/S0168-1605(03)00172-7; Calt S, J ENDOD, V28, P17; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V32; CLSI, 2008, M27A3 CLSI; Teruel JD, 2015, ARCH ORAL BIOL, V60, P768, DOI 10.1016/j.archoralbio.2015.01.014; Dunavant TR, 2006, J ENDODONT, V32, P527, DOI 10.1016/j.joen.2005.09.001; Dutner J, J ENDOD, V38, P37; El Din SN, 2016, INT J NANOMED, V11, P1749, DOI 10.2147/IJN.S102398; El-Sharif AA, 2011, CURR MICROBIOL, V62, P739, DOI 10.1007/s00284-010-9777-0; Gill AO, 2003, INT J FOOD MICROBIOL, V80, P251, DOI 10.1016/S0168-1605(02)00171-X; Gomes JE, 2010, J ENDODONT, V36, P1698, DOI 10.1016/j.joen.2010.07.007; GRAY GW, 1965, J APPL BACTERIOL, V28, P153, DOI 10.1111/j.1365-2672.1965.tb04547.x; Haapasalo M, 2014, BRIT DENT J, V216, P299, DOI 10.1038/sj.bdj.2014.204; Hansen LT, 2001, INT J FOOD MICROBIOL, V66, P149, DOI 10.1016/S0168-1605(01)00428-7; Hulsmann M, 2003, INT ENDOD J, V36, P810, DOI 10.1111/j.1365-2591.2003.00754.x; Le Ouay B, 2015, NANO TODAY, V10, P339, DOI 10.1016/j.nantod.2015.04.002; Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z; McComb D, 1975, J Endod, V1, P238, DOI 10.1016/S0099-2399(75)80226-3; Morgental RD, 2013, J ENDODONT, V39, P406, DOI 10.1016/j.joen.2012.10.028; Narayanan L Lakshmi, 2010, J Conserv Dent, V13, P233, DOI 10.4103/0972-0707.73386; Niu W, 2002, INT ENDOD J, V35, P934, DOI 10.1046/j.1365-2591.2002.00594.x; Novais JS, RSC ADV; Ordinola-Zapata R, 2012, INT ENDOD J, V45, P162, DOI 10.1111/j.1365-2591.2011.01959.x; Pan HC, 2007, TALANTA, V71, P276, DOI 10.1016/j.talanta.2006.03.057; Panacek A, 2016, COLLOID SURFACE B, V142, P392, DOI 10.1016/j.colsurfb.2016.03.007; PFALLER MA, 1995, J CLIN MICROBIOL, V33, P1104, DOI 10.1128/JCM.33.5.1104-1107.1995; Pierce CG, 2008, NAT PROTOC, V3, P1494, DOI 10.1038/nprot.2008.141; PUGH D, 1980, SABOURAUDIA, V18, P157; Raad II, 2008, INT J ANTIMICROB AG, V32, P515, DOI 10.1016/j.ijantimicag.2008.06.020; Serper A, 2002, J ENDODONT, V28, P501, DOI 10.1097/00004770-200207000-00002; Siqueira JF, 2004, ORAL SURG ORAL MED O, V97, P632, DOI 10.1016/j.tripleo.2003.12.022; Slistan-Grijalva A, 2005, PHYSICA E, V27, P104, DOI 10.1016/j.physe.2004.10.014; Sreeprasad TS, 2011, LANGMUIR, V27, P3381, DOI 10.1021/la104828e; Stuart CH, 2006, J ENDODONT, V32, P93, DOI 10.1016/j.joen.2005.10.049; Arias-Moliz MT, 2009, J ENDODONT, V35, P711, DOI 10.1016/j.joen.2009.01.018; Torabinejad M, 2003, J ENDODONT, V29, P400, DOI 10.1097/00004770-200306000-00005; Touzel RE, 2016, J HOSP INFECT, V92, P154, DOI 10.1016/j.jhin.2015.09.013; Wang CC, 2009, TALANTA, V77, P1238, DOI 10.1016/j.talanta.2008.08.035; Wang ZJ, 2013, J ENDODONT, V39, P1395, DOI 10.1016/j.joen.2013.05.007; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Xia YN, 2005, MRS BULL, V30, P338, DOI 10.1557/mrs2005.96; Xiu ZM, 2011, ENVIRON SCI TECHNOL, V45, P9003, DOI 10.1021/es201918f; Zhang HZ, 2010, J PHYS CHEM C, V114, P14876, DOI 10.1021/jp1060842	47	18	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190866	10.1371/journal.pone.0190866	http://dx.doi.org/10.1371/journal.pone.0190866			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346398	Green Published, Green Submitted, gold			2022-12-26	WOS:000422749500019
J	Pollack, TM; Duong, HT; Truong, PT; Pham, TT; Do, CD; Colby, D				Pollack, Todd M.; Duong, Hao T.; Truong, Phuong T.; Pham, Thuy T.; Do, Cuong D.; Colby, Donn			Sensitivity and specificity of two dried blood spot methods for HIV-1 viral load monitoring among patients in Hanoi, Vietnam	PLOS ONE			English	Article							SCALE-UP; SETTINGS; THERAPY	The use of dried blood spot (DBS) specimens for HIV viral load (VL) monitoring is recommended to support the roll-out of routine VL monitoring in low and middle income countries (LMICs). To better understand the use of DBS for VL monitoring, we evaluated two DBS testing methods, Roche TaqMan (R) Free Virus Evolution protocol (DBS-FVE) and Roche TaqMan (R) SPEX protocol (DBS-SPEX)) in patients receiving ART at an HIV clinic in Hanoi, Vietnam. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for each DBS testing method at the thresholds of 1000 and 5000 copies/ml compared to plasma VL. At a threshold of 1000 copies/ml, sensitivity, specificity, PPV and NPV of the DBS-SPEX method were 98.8% (95% CI: 93.3%-100%), 74.3% (95% CI: 70.8%-77.5%), 31.5% (95% CI: 25.8%-37.6%), and 99.8% (95% CI: 98.9%-100%), respectively. Increasing the VL threshold value to 5000 copies/ml improved specificity (97.9% CI: 96.6%-98.9%) and PPV (83.9% CI: 74.5%-90.9%). Using the DBS-FVE method, at the threshold of 1000 copies/ml and with a correction factor of + 0.3 log copies/ml, sensitivity was 95.1% (87.8%-98.6%) and specificity was 98.8% (97.7%-99.5%). Sensitivity decreased at the threshold of 5000 copies/ml (65.8%, 95% CI: 54.3%-76.1%). With a correction factor of + 0.7 log copies/ml, the sensitivity was 96.3% (89.6%-99.2%) and specificity was 98.2% (96.9%-99.1%) at the threshold of 1000 copies/ml. We found that the Roche DBS-FVE method, with a + 0.7 log copies/ml correction factor, performed well with sensitivity and specificity greater than 96% at a VL threshold of 1000 copies/m. These findings add to the growing body of evidence supporting the use of DBS VL testing for ART monitoring. Future research should evaluate the association between VL results by DBS and clinical outcome measures such as HIV drug resistance, morbidity, and mortality.	[Pollack, Todd M.; Duong, Hao T.; Pham, Thuy T.] Beth Israel Deaconess Med Ctr, Partnership Hlth Adv Vietnam, Hanoi, Vietnam; [Pollack, Todd M.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Truong, Phuong T.] Bach Mai Hosp, Dept Microbiol, Hanoi, Vietnam; [Pham, Thuy T.; Do, Cuong D.] Bach Mai Hosp, Dept Infect Dis, Hanoi, Vietnam; [Colby, Donn] Ctr Appl Res Men & Community Hlth, Ho Chi Minh City, Vietnam; [Colby, Donn] Thai Red Cross AIDS Res Ctr, SEARCH, Bangkok, Thailand	Harvard University; Beth Israel Deaconess Medical Center; Thai Red Cross Society	Pollack, TM (corresponding author), Beth Israel Deaconess Med Ctr, Partnership Hlth Adv Vietnam, Hanoi, Vietnam.; Pollack, TM (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA.	todd@haivn.org		Pollack, Todd/0000-0002-0011-5233; colby, donn j./0000-0003-3931-5926	Roche Molecular Systems, Inc. [974, L-18559]	Roche Molecular Systems, Inc.	This study was funded by Roche Molecular Systems, Inc. (https://molecular.roche.com) under Contract No. 974 and Contract No L-18559. Funding was received by TMP. The study sponsor participated in the study design but otherwise had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention, 2016, FREQ ASK QUEST US DR; EPP Technical Working Group M of H, 2013, VIET NAM 2013; Ferreyra C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049834; Harrigan R., 1995, JAIDS-J ACQ IMM DEF, V10, pS1 ; Inzaule S, 2016, STRINGENT HIV VIRAL, V71, P30; Johannessen A, 2009, J ANTIMICROB CHEMOTH, V64, P1126, DOI 10.1093/jac/dkp353; KROUWER J, 2002, METHOD COMP BIAS EST, V22; Lecher S, 2015, MMWR-MORBID MORTAL W, V64, P1287, DOI 10.15585/mmwr.mm6446a3; Mavedzenge SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126878; MOH, 2015, GUID HIV AIDS DIAGN; MOH, 2011, GUID HIV AIDS DIAGN; Pollack TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173534; Rangarajan S, 2016, J VIRUS ERAD, V2, P94; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Rottinghaus E, 2013, J CLIN MICROBIOL, V51, P55, DOI 10.1128/JCM.02002-12; Rutstein SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124748; Smit PW, 2014, PLOS ONE, V9; Taieb F, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw142; The U. S. President's Emergency Plan for AIDS Relief (PEPFAR), 2016, VIETN COUNTR REG OP; UNAIDS, 2016, 90 90 90 RIGHT TRACK; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2014, TECHN OP CONS IMPL H; Wu XN, 2015, J CLIN VIROL, V65, P38, DOI 10.1016/j.jcv.2015.01.022	23	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191411	10.1371/journal.pone.0191411	http://dx.doi.org/10.1371/journal.pone.0191411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346431	Green Published, Green Submitted, gold			2022-12-26	WOS:000422749500048
J	Sanscrainte, ND; Arimoto, H; Waits, CM; Li, LY; Johnson, D; Geden, C; Becnel, JJ; Estep, AS				Sanscrainte, Neil D.; Arimoto, Hanayo; Waits, Christy M.; Li, Lucy Y.; Johnson, Dana; Geden, Chris; Becnel, James J.; Estep, Alden S.			Reduction in Musca domestica fecundity by dsRNA-mediated gene knockdown	PLOS ONE			English	Article							IN-HOUSE FLIES; RNA INTERFERENCE; RESISTANCE; FLY; INSECTICIDES; EXPRESSION; DELIVERY; MUSCIDAE; INSECTS; DIPTERA	House flies (Musca domestica) are worldwide agricultural pests with estimated control costs at $375 million annually in the U.S. Non-target effects and widespread resistance challenge the efficacy of traditional chemical control. Double stranded RNA (dsRNA) has been suggested as a biopesticide for M. domestica but a phenotypic response due to the induction of the RNAi pathway has not been demonstrated in adults. In this study female house flies were injected with dsRNA targeting actin-5C or ribosomal protein (RP) transcripts RPL26 and RPS6. Ovaries showed highly reduced provisioning and clutch reductions of 94-99% in RP dsRNA treated flies but not in actin-5C or GFP treated flies. Gene expression levels were significantly and specifically reduced in dsRNA injected groups but remained unchanged in the control dsGFP treated group. Furthermore, injections with an Aedes aegypti conspecific dsRNA designed against RPS6 did not impact fecundity, demonstrating species specificity of the RNAi response. Analysis of M. domestica tissues following RPS6 dsRNA injection showed significant reduction of transcript levels in the head, thorax, and abdomen but increased expression in ovarian tissues. This study demonstrates that exogenous dsRNA is specifically effective and has potential efficacy as a highly specific biocontrol intervention in adult house flies. Further work is required to develop effective methods for delivery of dsRNA to adult flies.	[Sanscrainte, Neil D.; Li, Lucy Y.; Johnson, Dana; Geden, Chris; Becnel, James J.; Estep, Alden S.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA; [Arimoto, Hanayo] Naval Med Res Unit 3, Cairo, Egypt; [Waits, Christy M.; Estep, Alden S.] US Navy Entomol Ctr Excellence, CMAVE Detachment, Gainesville, FL USA; [Waits, Christy M.] Lovelace Resp Res Inst, Albuquerque, NM USA	United States Department of Agriculture (USDA); Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3); Lovelace Respiratory Research Institute	Sanscrainte, ND (corresponding author), USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.	neil.sanscrainte@ars.usda.gov	Geden, Christopher J/J-5413-2016	Sanscrainte, Neil/0000-0002-0891-5278; Estep, Alden/0000-0002-8281-3229	USDA; WII-141C project of the Navy and Marine Corps Public Health Center; Deployed War Fighters Protection Program	USDA(United States Department of Agriculture (USDA)); WII-141C project of the Navy and Marine Corps Public Health Center; Deployed War Fighters Protection Program	Funding was provided by the USDA, the WII-141C project of the Navy and Marine Corps Public Health Center, and the Deployed War Fighters Protection Program. The funders had no role in design or direction of the study or development of the manuscript.; The authors thank Drs. Pia Olafson and James Baum for critical review of the manuscript as well as Jessica Louton and Roxie White (USDA) for technical support. Funding was provided by the USDA, the WII-141C project of the Navy and Marine Corps Public Health Center, and the Deployed War Fighters Protection Program. The funders had no role in design or direction of the study or development of the manuscript.	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Baum JA, 2014, ADV INSECT PHYSIOL, V47, P249, DOI 10.1016/B978-0-12-800197-4.00005-1; Bobbin ML, 2016, ANNU REV PHARMACOL, V56, P103, DOI 10.1146/annurev-pharmtox-010715-103633; Burghardt G, 2005, DEV GENES EVOL, V215, P165, DOI 10.1007/s00427-004-0464-7; CHAMBERLAIN R, 1961, ANNU REV ENTOMOL, V6, P371, DOI 10.1146/annurev.en.06.010161.002103; Coy MR, 2012, J APPL ENTOMOL, V136, P741, DOI 10.1111/j.1439-0418.2012.01713.x; Estep AS, 2016, J INSECT PHYSIOL, V90, P17, DOI 10.1016/j.jinsphys.2016.05.001; Gao YF, 2015, MOL IMMUNOL, V67, P465, DOI 10.1016/j.molimm.2015.08.007; Geden C. J., 2001, P WORKSHOP LINCOLN; Ghosh A, 2015, J FOOD PROTECT, V78, P567, DOI 10.4315/0362-028X.JFP-14-429; Gordon KHJ, 2007, NAT BIOTECHNOL, V25, P1231, DOI 10.1038/nbt1107-1231; Graczyk TK, 2001, MICROBES INFECT, V3, P231, DOI 10.1016/S1286-4579(01)01371-5; HAGEDORN HH, 1972, J EXP ZOOL, V182, P367, DOI 10.1002/jez.1401820308; Hediger M, 2004, DEV GENES EVOL, V214, P29, DOI 10.1007/s00427-003-0372-2; Horn T, 2010, NUCLEIC ACIDS RES; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Kaufman PE, 2001, PEST MANAG SCI, V57, P514, DOI 10.1002/ps.319; Khan HAA, 2013, PARASITOL RES, V112, P2049, DOI 10.1007/s00436-013-3365-8; Kim M, 2010, INSECT MOL BIOL, V19, P27, DOI 10.1111/j.1365-2583.2009.00926.x; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017788; Machtinger ET, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew032; Machtinger ET, 2017, ECOLOGY CONTROL VECT, V5; Malik A, 2007, J ENVIRON SCI HEAL B, V42, P453, DOI 10.1080/03601230701316481; Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470; Palli SR, 2014, CURR OPIN INSECT SCI, V6, P1, DOI 10.1016/j.cois.2014.09.011; Puglise JM, 2016, J MED ENTOMOL, V53, P304, DOI 10.1093/jme/tjv191; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scott JG, 2017, PEST MANAG SCI, V73, P716, DOI 10.1002/ps.4328; Scott JG, 2013, PESTIC BIOCHEM PHYS, V107, P377, DOI 10.1016/j.pestbp.2013.10.006; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Tang T, 2012, J INSECT PHYSIOL, V58, P1226, DOI 10.1016/j.jinsphys.2012.06.007; Tang T, 2012, GENE, V505, P211, DOI 10.1016/j.gene.2012.06.025; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; TYNDALEBISCOE M, 1969, B ENTOMOL RES, V59, P129, DOI 10.1017/S0007485300003126; Walshe DP, 2009, INSECT MOL BIOL, V18, P11, DOI 10.1111/j.1365-2583.2008.00839.x; Wu K, 2014, EXP APPL ACAROL, V63, P171, DOI 10.1007/s10493-014-9772-4; Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x; Zhang H, 2013, INSECT SCI, V20, P15, DOI 10.1111/j.1744-7917.2012.01513.x; Zhu F, 2011, PEST MANAG SCI, V67, P175, DOI 10.1002/ps.2048; Zurek L, 2014, APPL ENVIRON MICROB, V80, P3562, DOI 10.1128/AEM.00600-14	43	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0187353	10.1371/journal.pone.0187353	http://dx.doi.org/10.1371/journal.pone.0187353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342168	gold, Green Published, Green Submitted			2022-12-26	WOS:000422653800004
J	Zhao, H; Zhao, J; Sun, XL; Chen, FJ; Han, GQ				Zhao, Hui; Zhao, Jian; Sun, Xingli; Chen, Fajin; Han, Guoqi			A strong summer phytoplankton bloom southeast of Vietnam in 2007, a transitional year from El Nino to La Nina	PLOS ONE			English	Article							LUZON STRAIT; CHINA SEA; CHLOROPHYLL; VARIABILITY; WATERS; COAST	Summer upwelling occurs frequently off the southeast Vietnam coast in the western South China Sea (SCS), where summer phytoplankton blooms generally appear during June-August. In this study, we investigate inter-annual variation of Ekman pumping and offshore transport, and its modulation on summer blooms southeast of Vietnam. The results indicate that there are low intensities of summer blooms in El Nino years, under higher sea surface temperatures (SST) and weaker winds. However, a different pattern of monthly chlorophyll a (Chl-a) blooms occurred in summer of 2007, a transitional stage from El Nino to La Nina, with weak (strong) wind and high (low) SST before (after) early July. There is a weak phytoplankton bloom before July 2007 and a strong phytoplankton bloom after July 2007. The abrupt change in the wind intensity may enhance the upwelling associated with Ekman pumping and offshore Ekman transport, bringing more high-nutrient water into the upper layer from the subsurface, and thus leading to an evident Chl-a bloom in the region.	[Zhao, Hui; Zhao, Jian; Sun, Xingli; Chen, Fajin] Guangdong Ocean Univ, Zhanjiang, Peoples R China; [Han, Guoqi] Fisheries & Oceans Canada, Northwest Atlantic Fisheries Ctr, St John, NF, Canada	Guangdong Ocean University; Fisheries & Oceans Canada	Chen, FJ (corresponding author), Guangdong Ocean Univ, Zhanjiang, Peoples R China.	fjchen04@163.com; guoqi.han@dfo-mpo.gc.ca	Han, Guoqi/T-7365-2019		National Natural Science Foundation of China [41376125, 41476066, 41006070]; International Scientific & Technological Cooperation Project of Education of Department Guangdong Province [2015KGJHZ017]; Foundation for Distinguished Young Teacher in Higher Education of Guangdong [Yq2014004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Scientific & Technological Cooperation Project of Education of Department Guangdong Province; Foundation for Distinguished Young Teacher in Higher Education of Guangdong	The present research is supported by the National Natural Science Foundation of China (grants 41376125, 41476066 and 41006070), International Scientific & Technological Cooperation Project of Education of Department Guangdong Province (2015KGJHZ017), and The Foundation for Distinguished Young Teacher in Higher Education of Guangdong (Yq2014004).	Antico PL, 2009, INT J CLIMATOL, V29, P719, DOI 10.1002/joc.1734; Babin SM, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001938; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; [陈湘雅 CHEN Xiang-ya], 2009, [南京气象学院学报, Journal of Nanjing Institute of Meteorology], V32, P71; Chen YLL, 2004, CONT SHELF RES, V24, P527, DOI 10.1016/j.csr.2003.12.006; Chen Z, 2016, J GEOPHYS RES OCEANS, V121; DICKSON ML, 1995, LIMNOL OCEANOGR, V40, P533, DOI 10.4319/lo.1995.40.3.0533; [高姗 Gao Shan], 2010, [海洋学报, Acta Oceanologica Sinica], V32, P168; Gong X, 2015, BIOGEOSCIENCES, V12, P905, DOI 10.5194/bg-12-905-2015; Halpern D, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014097; Hein H, 2013, GLOBAL PLANET CHANGE, V110, P170, DOI 10.1016/j.gloplacha.2013.09.009; Iles AC, 2012, GLOBAL CHANGE BIOL, V18, P783, DOI 10.1111/j.1365-2486.2011.02567.x; Isoguchi O, 2006, GEOPHYS RES LETT, V331, P597; Jin X, 2009, J PHYS OCEANOGR, V39, P2957, DOI 10.1175/2009JPO4205.1; Kowalewski M, 2014, PALAIOS, P277; Kuo NJ, 2004, REMOTE SENS ENVIRON, V89, P106, DOI 10.1016/j.rse.2003.10.009; Li LA, 1990, J OCEANOGRAPHY TAIWA; Lin LR, 2012, J MARINE SCI; Maritorena S, 2005, REMOTE SENS ENVIRON, V94, P429, DOI 10.1016/j.rse.2004.08.014; Ogashawara I, 2014, REMOTE SENS-BASEL, V6, P1634, DOI 10.3390/rs6021634; Picado A, 2016, INT J CLIMATOL, V36, P3280, DOI 10.1002/joc.4555; Renault L, 2012, J GEOPHYS RES-ATMOS, V117, P41; Renault L, 2016, CLIM DYNAM, V46, P273, DOI 10.1007/s00382-015-2583-4; Roy C, 2001, PROG OCEANOGR, V49, P245, DOI 10.1016/S0079-6611(01)00025-8; Santos F, 2012, CONT SHELF RES, V34, P79, DOI 10.1016/j.csr.2011.12.004; Shu Y., 2006, J GEOPHYS RES-OCEANS, V121, P1145; Signorini SR, 1999, J GEOPHYS RES-OCEANS, V104, P18367, DOI 10.1029/1999JC900134; SMITH R L, 1968, Oceanography and Marine Biology an Annual Review, V6, P11; Tang D, 2014, PUBLIC HLTH REPORTS, P1899; Tang DL, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002045; Tang DL, 2003, HARMFUL ALGAE, V2, P89, DOI 10.1016/S1568-9883(03)00021-0; Tang DL, 1999, MAR ECOL PROG SER, V191, P43, DOI 10.3354/meps191043; Voss M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025569; Wang CZ, 2013, J CLIMATE, V26, P1322, DOI 10.1175/JCLI-D-12-00107.1; Wang DX, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007465; Wang Q, 2015, J GEOPHYS RES-OCEANS, V120, P517, DOI 10.1002/2014JC009814; Ware DM, 2011, CANADIAN J FISHERIES, V48, P2296; Xie SP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001867; Zhao H., 2005, ACTA OCEANOGR, V27, P45, DOI [10.3321/j.issn:0253, DOI 10.3321/J.ISSN:0253, 10.3321/j.issn:0253-4193.2005.04.006, DOI 10.3321/J.ISSN:0253-4193.2005.04.006]; Zhao H, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003536; Zhao H, 2013, J GEOPHYS RES-BIOGEO, V118, P412, DOI 10.1002/jgrg.20041; [赵辉 ZHAO Hui], 2005, [热带海洋学报, Journal of tropical oceanography], V24, P31; Zhou W, 2010, INT J CLIMATOLOGY, V27, P157	43	12	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0189926	10.1371/journal.pone.0189926	http://dx.doi.org/10.1371/journal.pone.0189926			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342148	Green Published, gold, Green Submitted			2022-12-26	WOS:000422653800012
J	Vanzyl, EJ; Rick, KRC; Blackmore, AB; MacFarlane, EM; McKay, BC				Vanzyl, Erin J.; Rick, Kayleigh R. C.; Blackmore, Alex B.; MacFarlane, Erin M.; McKay, Bruce C.			Flow cytometric analysis identifies changes in S and M phases as novel cell cycle alterations induced by the splicing inhibitor isoginkgetin	PLOS ONE			English	Article							GENETIC-CONTROL; DIVISION CYCLE; IN-VITRO; P53; PROGRESSION; YEAST; PHOSPHORYLATION; REPLICATION; SPLICEOSOME; SUBSTANCES	The spliceosome is a large ribonucleoprotein complex that catalyzes the removal of introns from RNA polymerase II-transcribed RNAs. Spliceosome assembly occurs in a stepwise manner through specific intermediates referred to as pre-spliceosome complexes E, A, B, B* and C. It has been reported that small molecule inhibitors of the spliceosome that target the SF3B1 protein component of complex A lead to the accumulation of cells in the G(1) and G(2)/M phases of the cell cycle. Here we performed a comprehensive flow cytometry analysis of the effects of isoginkgetin (IGG), a natural compound that interferes with spliceosome assembly at a later step, complex B formation. We found that IGG slowed cell cycle progression in multiple phases of the cell cycle (G(1), S and G(2)) but not M phase. This pattern was somewhat similar to but distinguishable from changes associated with an SF3B1 inhibitor, pladienolide B (PB). Both drugs led to a significant decrease in nascent DNA synthesis in S phase, indicative of an S phase arrest. However, IGG led to a much more prominent S phase arrest than PB while PB exhibited a more pronounced G(1) arrest that decreased the proportion of cells in S phase as well. We also found that both drugs led to a comparable decrease in the proportion of cells in M phase. This work indicates that spliceosome inhibitors affect multiple phases of the cell cycle and that some of these effects vary in an agent specific manner despite the fact that they target splicing at similar stages of spliceosome assembly.	[Vanzyl, Erin J.; Rick, Kayleigh R. C.; Blackmore, Alex B.; MacFarlane, Erin M.; McKay, Bruce C.] Carleton Univ, Dept Biol, Ottawa, ON, Canada; [McKay, Bruce C.] Carleton Univ, Inst Biochem, Ottawa, ON, Canada	Carleton University; Carleton University	McKay, BC (corresponding author), Carleton Univ, Dept Biol, Ottawa, ON, Canada.; McKay, BC (corresponding author), Carleton Univ, Inst Biochem, Ottawa, ON, Canada.	bruce_mckay@carleton.ca	McKay, Bruce C/I-4081-2013	McKay, Bruce C/0000-0002-7921-1331	Natural Science and Engineering Research Council of Canada [RGPIN 2014-03645]; Carleton University from the Canadian Institutes of Health Research	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Carleton University from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported with funds from the Natural Science and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) grant number RGPIN 2014-03645 and start-up funds from Carleton University (www.carleton.ca) to B.C.M. E.J.V. is the recipient of graduate studentship from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The funders were not involved in the study design.	Abou Faycal C, 2016, CURR OPIN ONCOL, V28, P58, DOI 10.1097/CCO.0000000000000254; Ben Yehuda S, 1998, RNA, V4, P1304; Ben-Yehuda S, 2000, GENETICS, V156, P1503; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Effenberger KA, 2016, WILEY INTERDISCIP RE; Effenberger KA, 2016, INTERCHANGEABLE SF3B; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; HARTWELL LH, 1970, P NATL ACAD SCI USA, V66, P352, DOI 10.1073/pnas.66.2.352; HARTWELL LH, 1973, GENETICS, V74, P267; Hashimoto K, 2010, TOXICOL IN VITRO, V24, P208, DOI 10.1016/j.tiv.2009.09.006; Hoskins AA, 2012, TRENDS BIOCHEM SCI, V37, P179, DOI 10.1016/j.tibs.2012.02.009; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Maguire SL, 2015, J PATHOL, V235, P571, DOI 10.1002/path.4483; Matlin AJ, 2007, ADV EXP MED BIOL, V623, P14, DOI 10.1007/978-0-387-77374-2_2; Melanson BD, 2011, RNA, V17, P2222, DOI 10.1261/rna.030122.111; Mizui Y, 2004, J ANTIBIOT, V57, P188, DOI 10.7164/antibiotics.57.188; Nakajima H, 1996, J ANTIBIOT, V49, P1204; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; Pawellek A, 2014, J BIOL CHEM, V289, P34683, DOI 10.1074/jbc.M114.590976; RIEDER CL, 1992, J CELL SCI, V102, P387; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sakai Y, 2002, J ANTIBIOT, V55, P863, DOI 10.7164/antibiotics.55.863; Salton M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8103; Sato M, 2014, CANCER SCI, V105, P110, DOI 10.1111/cas.12317; SHIBATA K, 1990, EUR J BIOCHEM, V192, P87, DOI 10.1111/j.1432-1033.1990.tb19199.x; Somma MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000126; Sperling R, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1377; Stubbert LJ, 2007, CELL CYCLE, V6, P1730, DOI 10.4161/cc.6.14.4427; Stubbert LJ, 2009, CELL CYCLE, V8, P2995; Suryadinata R, 2010, BIOSCIENCE REP, V30, P243, DOI 10.1042/BSR20090171; TAMURA T, 1995, ONCOGENE, V11, P1939; Tzang BS, 1999, DNA CELL BIOL, V18, P315, DOI 10.1089/104454999315376; VAISMAN N, 1995, MOL GEN GENET, V247, P123, DOI 10.1007/BF00705642; Yip BH, 2016, CURR PHARM DESIGN, V22, P2333, DOI 10.2174/1381612822666160226132112; Yokoi A, 2011, FEBS J, V278, P4870, DOI 10.1111/j.1742-4658.2011.08387.x	36	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191178	10.1371/journal.pone.0191178	http://dx.doi.org/10.1371/journal.pone.0191178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338026	Green Submitted, Green Published, gold			2022-12-26	WOS:000422652700038
J	Joerling, J; Barth, SA; Schlez, K; Willems, H; Herbst, W; Ewers, C				Joerling, Jessica; Barth, Stefanie A.; Schlez, Karen; Willems, Hermann; Herbst, Werner; Ewers, Christa			Phylogenetic diversity, antimicrobial susceptibility and virulence gene profiles of Brachyspira hyodysenteriae isolates from pigs in Germany	PLOS ONE			English	Article							SERPULINA-HYODYSENTERIAE; LIFE-STYLE; EXPRESSION; SEQUENCE; MUTANTS; ENTEROPATHOGENICITY; INTRACELLULARIS; RESISTANCE; MUTATIONS; HAMPSONII	Swine dysentery (SD) is an economically important diarrheal disease in pigs caused by different strongly hemolytic Brachyspira (B.) species, such as B. hyodysenteriae, B. suanatina and B. hampsonii. Possible associations of epidemiologic data, such as multilocus sequence types (STs) to virulence gene profiles and antimicrobial susceptibility are rather scarce, particularly for B. hyodysenteriae isolates from Germany. In this study, B. hyodysenteriae (n = 116) isolated from diarrheic pigs between 1990 and 2016 in Germany were investigated for their STs, susceptibility to the major drugs used for treatment of SD (tiamulin and valnemulin) and genes that were previously linked with virulence and encode for hemolysins (tlyA, tlyB, tlyC, hlyA, BHWA1_RS02885, BHWA1_RS09085, BHWA1_RS04705, and BHWA1_RS02195), outer membrane proteins (OMPs) (bhlp16, bhlp17.6, bhlp29.7, bhmp39f, and bhmp39h) as well as iron acquisition factors (ftnA and bitC). Multilocus sequence typing (MLST) revealed that 79.4% of the isolates belonged to only three STs, namely ST52 (41.4%), ST8 (12.1%), and ST112 (25.9%) which have been observed in other European countries before. Another 24 isolates belonged to twelve new STs (ST113-118, ST120-123, ST131, and ST193). The temporal distribution of STs revealed the presence of new STs as well as the regular presence of ST52 over three decades (1990s - 2000s). The proportion of strains that showed resistance to both tiamulin und valnemulin (39.1%) varied considerably among the most frequent STs ranging from 0% (0/14 isolates resistant) in ST8 isolates to 46.7% (14/30), 52.1% (25/48), and 85.7% (6/7) in isolates belonging to ST112, ST52, and ST114, respectively. All hemolysin genes as well as the iron-related gene ftnA and the OMP gene bhlp29.7 were regularly present in the isolates, while the OMP genes bhlp17.6 and bhmp39h could not be detected. Sequence analysis of hemolysin genes of selected isolates revealed co-evolution of tlyB, BHWA1_RS02885, BHWA1_RS09085, and BHWA1_RS02195 with the core genome and suggested independent evolution of tlyA, tlyC, and hlyA. Our data indicate that in Germany, swine dysentery might be caused by a limited number of B. hyodysenteriae clonal groups. Major STs (ST8, ST52, and ST112) are shared with other countries in Europe suggesting a possible role of the European intra-Community trade of pigs in the dissemination of certain clones. The identification of several novel STs, some of which are single or double locus variants of ST52, may on the other hand hint towards an ongoing diversification of the pathogen in the studied area. The linkage of pleuromutilin susceptibility and sequence type of an isolate might reflect a clonal expansion of the underlying resistance mechanism, namely mutations in the ribosomal RNA genes. A linkage between single virulence-associated genes (VAGs) or even VAG patterns and the phylogenetic background of the isolates could not be established, since almost all VAGs were regularly present in the isolates.	[Joerling, Jessica; Barth, Stefanie A.; Schlez, Karen; Herbst, Werner; Ewers, Christa] Justus Liebig Univ Giessen, Inst Hyg & Infect Dis Anim, Giessen, Germany; [Barth, Stefanie A.] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Jena, Germany; [Willems, Hermann] Justus Liebig Univ Giessen, Dept Vet Clin Sci, Clin Swine, Giessen, Germany	Justus Liebig University Giessen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; Justus Liebig University Giessen	Herbst, W (corresponding author), Justus Liebig Univ Giessen, Inst Hyg & Infect Dis Anim, Giessen, Germany.	Werner.Herbst@vetmed.uni-giessen.de	Barth, Stefanie/K-7053-2019; Ewers, Christa/AAL-9186-2020	Barth, Stefanie/0000-0003-4921-5056; Ewers, Christa/0000-0001-6167-1340	Boehringer Ingelheim Vetmedica GmbH.; Akademie fur Tiergesundheit e. V.	Boehringer Ingelheim Vetmedica GmbH.(Boehringer Ingelheim); Akademie fur Tiergesundheit e. V.	This work was financially supported by Boehringer Ingelheim Vetmedica GmbH. Jessica Joerling was holder of a grant of the "Akademie fur Tiergesundheit e. V.". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achacha M, 1996, CAN J VET RES, V60, P45; Barth S, 2012, VET MICROBIOL, V155, P438, DOI 10.1016/j.vetmic.2011.09.032; Bebell LM, 2014, GLOB HEART, V9, P347, DOI 10.1016/j.gheart.2014.08.009; Bellgard MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004641; Black M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131050; Chander Y, 2012, J VET DIAGN INVEST, V24, P903, DOI 10.1177/1040638712456975; Dugourd D, 1999, J BACTERIOL, V181, P6948, DOI 10.1128/JB.181.22.6948-6957.1999; Gasparrini S, 2017, J APPL MICROBIOL, V123, P340, DOI 10.1111/jam.13492; Hampson DJ, 2015, PORCINE HEALTH MANAG, V1, DOI 10.1186/s40813-015-0002-1; Harris D. L., 1999, DIS SWINE, P579; Herbst W, 2004, BERL MUNCH TIERARZTL, V117, P493; Herbst W, 2014, VET REC, V174, DOI 10.1136/vr.102169; Hidalgo A, 2009, RES VET SCI, V87, P7, DOI 10.1016/j.rvsc.2008.10.017; Hillen S, 2014, VET MICROBIOL, V172, P223, DOI 10.1016/j.vetmic.2014.04.021; Holden J, 2006, VET MICROBIOL, V113, P109, DOI 10.1016/j.vetmic.2005.10.025; Hsu T, 2001, INFECT IMMUN, V69, P706, DOI 10.1128/IAI.69.2.706-711.2001; HYATT DR, 1994, INFECT IMMUN, V62, P2244, DOI 10.1128/IAI.62.6.2244-2248.1994; JENSEN NS, 1993, VET MICROBIOL, V36, P221, DOI 10.1016/0378-1135(93)90090-T; JONES GF, 1993, J CLIN MICROBIOL, V31, P2611, DOI 10.1128/JCM.31.10.2611-2615.1993; Kajiwara K, 2016, J VET MED SCI, V78, P517, DOI 10.1292/jvms.15-0608; Kennedy MJ, 1997, FEMS MICROBIOL LETT, V153, P119, DOI 10.1016/S0378-1097(97)00244-9; KINYON JM, 1977, INFECT IMMUN, V15, P638, DOI 10.1128/IAI.15.2.638-646.1977; Kirchgassner C, 2016, SCHWEIZ ARCH TIERH, V158, P405, DOI 10.17236/sat00066; KUNKLE RA, 1988, J CLIN MICROBIOL, V26, P2357, DOI 10.1128/JCM.26.11.2357-2360.1988; La T, 2005, VET MICROBIOL, V107, P249, DOI 10.1016/j.vetmic.2005.01.016; La T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167424; La T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160362; La T, 2014, VET RES, V45, DOI 10.1186/s13567-014-0131-6; La T, 2009, VET MICROBIOL, V138, P330, DOI 10.1016/j.vetmic.2009.03.025; La T, 2009, VET MICROBIOL, V133, P98, DOI 10.1016/j.vetmic.2008.06.003; Lee CR, 2013, INT J ENV RES PUB HE, V10, P4274, DOI 10.3390/ijerph10094274; Lobert S, 2016, TIERAERZTL PRAX G N, V44, P13, DOI 10.15653/TPG-150674; Mahu M, 2017, VET MICROBIOL, V207, P125, DOI 10.1016/j.vetmic.2017.05.022; Mahu M, 2014, VET REC, V174, DOI 10.1136/vr.101868; Mahu M, 2016, VET RES, V47, DOI 10.1186/s13567-016-0353-x; MANTEL N, 1967, CANCER RES, V27, P209; MAPOTHER ME, 1985, J CLIN MICROBIOL, V22, P161, DOI 10.1128/JCM.22.2.161-164.1985; McEwen SA, 2002, CLIN INFECT DIS, V34, pS93, DOI 10.1086/340246; Mirajkar NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107176; MUIR S, 1992, INFECT IMMUN, V60, P529, DOI 10.1128/IAI.60.2.529-535.1992; Osorio J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039082; Pringle M, 2004, MOL MICROBIOL, V54, P1295, DOI 10.1111/j.1365-2958.2004.04373.x; Pringle M, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-54; Rasback T, 2007, MICROBIOL-SGM, V153, P4074, DOI 10.1099/mic.0.2007/008540-0; Rasback T, 2007, ENVIRON MICROBIOL, V9, P983, DOI 10.1111/j.1462-2920.2006.01220.x; Rohde J, 2004, VET MICROBIOL, V102, P25, DOI 10.1016/j.vetmic.2004.03.023; Rohde J, 2014, VET MICROBIOL, V168, P432, DOI 10.1016/j.vetmic.2013.11.016; Rohde J, 2012, VET MICROBIOL, V158, P211, DOI 10.1016/j.vetmic.2012.02.008; Rugna G, 2015, VET J, V203, P115, DOI 10.1016/j.tvjl.2014.10.033; Sperling D, 2011, VET REC, V168, P215, DOI 10.1136/vr.c4247; Stanton TB, 1999, APPL ENVIRON MICROB, V65, P5028; TERHUURNE AAHM, 1994, MICROB PATHOGENESIS, V16, P269, DOI 10.1006/mpat.1994.1028; Trott Darren J., 2001, Animal Health Research Reviews, V2, P19; Wanchanthuek P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011455; Wilberts BL, 2015, J VET DIAGN INVEST, V27, P41, DOI 10.1177/1040638714563064; Witchell TD, 2006, INFECT IMMUN, V74, P3271, DOI 10.1128/IAI.02000-05	56	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190928	10.1371/journal.pone.0190928	http://dx.doi.org/10.1371/journal.pone.0190928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324785	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400075
J	Watanabe, PD; Trevizan, AR; Silva, SE; Gois, MB; Garcia, JL; Cuman, RKN; Breithaupt-Faloppa, AC; Sant'Ana, DDG; de Melo, GDN				Watanabe, Paulo da Silva; Trevizan, Aline Rosa; Silva-Filho, Saulo Euclides; Gois, Marcelo Biondaro; Garcia, Joao Luiz; Nakamura Cuman, Roberto Kenji; Breithaupt-Faloppa, Ana Cristina; Goncales Sant'Ana, Debora de Mello; Nogueira de Melo, Gessilda de Alcantara			Immunocompetent host develops mild intestinal inflammation in acute infection with Toxoplasma gondii	PLOS ONE			English	Article							ORAL INFECTION; NITRIC-OXIDE; LIFE-CYCLE; MICE; NEUTROPHILS; PREVALENCE; INDUCTION; MECHANISM; ANTIGEN; HUMANS	Toxoplasma gondii (T. gondii) is the causative agent of toxoplasmosis, common zoonosis among vertebrates and high incidence worldwide. During the infection, the parasite needs to transpose the intestinal barrier to spread throughout the body, which may be a trigger for an inflammatory reaction. This work evaluated the inflammatory alterations of early T. gondii infection in peripheral blood cells, in the mesenteric microcirculation, and small intestinal tissue by measurement of MPO (myeloperoxidase) activity and NO (nitric oxide) level in rats. Animals were randomly assigned into control group (CG) that received saline orally and groups infected with 5,000 oocysts for 6 (G6), 12 (G12), 24 (G24), 48 (G48) and 72 hours (G72). Blood samples were collected for total and differential leukocyte count. Intravital microscopy was performed in the mesentery to evaluate rolling and adhesion of leukocytes. After euthanasia, 0.5cm of the duodenum, jejunum and ileum were collected for the determination of MPO activity, NO level and PCR to identify the parasite DNA and also the mesentery were collected to perform immunohistochemistry on frozen sections to quantify adhesion molecules ICAM-1, PECAM-1 and P-Selectin. The parasite DNA was identified in all infected groups and there was an increase in leukocytes in the peripheral blood and in expression of ICAM-1 and PECAM-1 in G6 and G12, however, the expression of P-selectin was reduced in G12. Leukocytes are in rolling process during the first 12 hours and they are adhered at 24 hours post-infection. The activity of MPO increased in the duodenum at 12 hours, and NO increased in the jejunum in G72 and ileum in G24, G48 and G72. Our study demonstrated that T. gondii initiates the infection precociously (at 6 hours) leading to a systemic activation of innate immune response resulting in mild inflammation in a less susceptible experimental model.	[Watanabe, Paulo da Silva; Trevizan, Aline Rosa; Gois, Marcelo Biondaro; Goncales Sant'Ana, Debora de Mello; Nogueira de Melo, Gessilda de Alcantara] Univ Estadual Maringa, Biosci & Physiopathol Program, Maringa, Parana, Brazil; [Silva-Filho, Saulo Euclides; Nakamura Cuman, Roberto Kenji] Univ Estadual Maringa, Pharmaceut Sci Grad Program, Maringa, Parana, Brazil; [Garcia, Joao Luiz] Univ Estadual Londrina, Londrina, Parana, Brazil; [Breithaupt-Faloppa, Ana Cristina] Univ Sao Paulo, Med Sch, LIM 11, Heart Inst InCor, Sao Paulo, SP, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Londrina; Universidade de Sao Paulo	de Melo, GDN (corresponding author), Univ Estadual Maringa, Biosci & Physiopathol Program, Maringa, Parana, Brazil.	gessilda.melo@gmail.com	Gois, Marcelo Biondaro/F-9028-2016; Silva-Filho, Saulo Euclides/B-4957-2018; Garcia, Joao Luis/Y-8864-2019; Luis, João/AAE-9252-2019; Nogueira-Melo, Gessilda/ABE-8377-2020; Nogueira-Melo, Gessilda Alcantara/ABE-8317-2020; Breithaupt-Faloppa, Ana Cristina/O-9094-2017; Garcia, João Luis/X-4279-2019	Gois, Marcelo Biondaro/0000-0003-0822-8440; Silva-Filho, Saulo Euclides/0000-0002-9676-7622; Garcia, Joao Luis/0000-0002-5736-7511; Nogueira-Melo, Gessilda/0000-0001-6698-5015; Nogueira-Melo, Gessilda Alcantara/0000-0001-6698-5015; Breithaupt-Faloppa, Ana Cristina/0000-0003-0554-0674; Garcia, João Luis/0000-0003-1826-7582; da Silva Watanabe, Paulo/0000-0002-5134-233X				Almeida F, 2015, PLOS ONE, V10, P1; BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; Barragan A, 2005, CELL MICROBIOL, V7, P561, DOI 10.1111/j.1462-5822.2005.00486.x; Bliss SK, 1999, J IMMUNOL, V163, P2081; Bliss SK, 2001, INFECT IMMUN, V69, P4898, DOI 10.1128/IAI.69.8.4898-4905.2001; Bonapaz RD, 2010, PESQUI VET BRASIL, V30, P787, DOI 10.1590/S0100-736X2010000900013; Butcher BA, 2002, INFECT IMMUN, V70, P5216, DOI 10.1128/IAI.70.9.5216-5224.2002; Butcher BA, 2001, J IMMUNOL, V167, P2193, DOI 10.4049/jimmunol.167.4.2193; Cohen SB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003706; Coombes JL, 2013, P NATL ACAD SCI USA, V110, pE1913, DOI 10.1073/pnas.1220272110; Cordeiro CA, 2017, IMMUNOL LETT, V184, P84, DOI 10.1016/j.imlet.2017.02.009; Coutermarsh-Ott SL, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/9848263; Vivas LAD, 2007, ACTA CIR BRAS, V22, P229, DOI 10.1590/S0102-86502007000300012; Denkers EY, 2004, INT J PARASITOL, V34, P411, DOI 10.1016/j.ijpara.2003.11.001; Dincel GC, 2015, EXP PARASITOL, V156, P104, DOI 10.1016/j.exppara.2015.06.009; Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765; Dubey JP, 2012, PARASITOLOGY, V139, P1, DOI 10.1017/S0031182011001673; Dubey JP, 2009, INT J PARASITOL, V39, P877, DOI 10.1016/j.ijpara.2009.01.005; Dubey JP, 1998, INT J PARASITOL, V28, P1019, DOI 10.1016/S0020-7519(98)00023-X; Dubey JP, 1998, VET PARASITOL, V74, P75, DOI 10.1016/S0304-4017(97)00135-0; Dunn JD, 2007, TOXOPLASMA GONDII, p0 ; Goebel S, 2001, J CELL SCI, V114, P3495; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Gregg B, 2013, INFECT IMMUN, V81, P1635, DOI 10.1128/IAI.01126-12; Hawkins PT, 2015, BBA-MOL CELL BIOL L, V1851, P882, DOI 10.1016/j.bbalip.2014.12.006; Hill D, 2002, CLIN MICROBIOL INFEC, V8, P634, DOI 10.1046/j.1469-0691.2002.00485.x; Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100; Hoffmann U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062055; Homan WL, 2000, INT J PARASITOL, V30, P69, DOI 10.1016/S0020-7519(99)00170-8; Jung C, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/823710; Khan IA, 1997, P NATL ACAD SCI USA, V94, P13955, DOI 10.1073/pnas.94.25.13955; Leite M, 2008, REV I MED TROP, V50, P237, DOI 10.1590/S0036-46652008000400010; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Miller CM, 2009, INT J PARASITOL, V39, P23, DOI 10.1016/j.ijpara.2008.08.002; Guarda IFMS, 2015, CLINICS, V70, P508, DOI 10.6061/clinics/2015(07)08; Nacif LS, 2013, ABCD-ARQ BRAS CIR DI, V26, P293, DOI 10.1590/S0102-67202013000400008; Niehus S, 2012, IMMUNOBIOLOGY, V217, P61, DOI 10.1016/j.imbio.2011.08.001; Park S, 2015, CLIN SCI, V129, P217, DOI 10.1042/CS20140714; Rachinel N, 2004, J IMMUNOL, V173, P2725, DOI 10.4049/jimmunol.173.4.2725; de Souza JBR, 2016, VET PARASITOL, V226, P145, DOI 10.1016/j.vetpar.2016.07.015; Saleh TSF, 1999, PEPTIDES, V20, P949; Santos TR, 2009, VET PARASITOL, V161, P324, DOI 10.1016/j.vetpar.2009.01.017; Silva J.M. da, 2010, REV BRAS PARASITOL V, V19, P57, DOI [10.4322/rbpv.01901010, DOI 10.4322/RBPV.01901010]; Speer CA, 1998, PARASITOLOGY, V116, P35, DOI 10.1017/S0031182097001959; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; Trevizan AR, 2016, EXP PARASITOL, V165, P22, DOI 10.1016/j.exppara.2016.03.015; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Unno A, 2010, BIOCHEM BIOPH RES CO, V391, P477, DOI 10.1016/j.bbrc.2009.11.083; Wilson DC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000815; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Woodfin A, 2010, CURR OPIN HEMATOL, V17, P9, DOI 10.1097/MOH.0b013e3283333930	52	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190155	10.1371/journal.pone.0190155	http://dx.doi.org/10.1371/journal.pone.0190155			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324806	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400021
J	Bouwer, FL; Burgoyne, JA; Odijk, D; Honing, H; Grahn, JA				Bouwer, Fleur L.; Burgoyne, J. Ashley; Odijk, Daan; Honing, Henkjan; Grahn, Jessica A.			What makes a rhythm complex? The influence of musical training and accent type on beat perception	PLOS ONE			English	Article							METER PERCEPTION; LIKERT SCALES; SEQUENCES; RESPONSES; BRAIN; MUSICIANS; PATTERNS; POTENTIALS; REGULARITY; ATTENTION	Perception of a regular beat in music is inferred from different types of accents. For example, increases in loudness cause intensity accents, and the grouping of time intervals in a rhythm creates temporal accents. Accents are expected to occur on the beat: when accents are "missing" on the beat, the beat is more difficult to find. However, it is unclear whether accents occurring off the beat alter beat perception similarly to missing accents on the beat. Moreover, no one has examined whether intensity accents influence beat perception more or less strongly than temporal accents, nor how musical expertise affects sensitivity to each type of accent. In two experiments, we obtained ratings of difficulty in finding the beat in rhythms with either temporal or intensity accents, and which varied in the number of accents on the beat as well as the number of accents off the beat. In both experiments, the occurrence of accents on the beat facilitated beat detection more in musical experts than in musical novices. In addition, the number of accents on the beat affected beat finding more in rhythms with temporal accents than in rhythms with intensity accents. The effect of accents off the beat was much weaker than the effect of accents on the beat and appeared to depend on musical expertise, as well as on the number of accents on the beat: when many accents on the beat are missing, beat perception is quite difficult, and adding accents off the beat may not reduce beat perception further. Overall, the different types of accents were processed qualitatively differently, depending on musical expertise. Therefore, these findings indicate the importance of designing ecologically valid stimuli when testing beat perception in musical novices, who may need different types of accent information than musical experts to be able to find a beat. Furthermore, our findings stress the importance of carefully designing rhythms for social and clinical applications of beat perception, as not all listeners treat all rhythms alike.	[Bouwer, Fleur L.; Burgoyne, J. Ashley; Honing, Henkjan] Univ Amsterdam, Inst Log Language & Computat, Amsterdam, Netherlands; [Bouwer, Fleur L.; Burgoyne, J. Ashley; Honing, Henkjan] Univ Amsterdam, Amsterdam Brain & Cognit, Amsterdam, Netherlands; [Odijk, Daan] Univ Amsterdam, Inst Informat, Amsterdam, Netherlands; [Grahn, Jessica A.] Univ Western Ontario, Brain & Mind Inst, Dept Psychol, London, ON, Canada; [Bouwer, Fleur L.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam; Western University (University of Western Ontario); University of Amsterdam	Bouwer, FL (corresponding author), Univ Amsterdam, Inst Log Language & Computat, Amsterdam, Netherlands.; Bouwer, FL (corresponding author), Univ Amsterdam, Amsterdam Brain & Cognit, Amsterdam, Netherlands.; Bouwer, FL (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	info@fleurbouwer.nl	Grahn, Jessica/A-1371-2010; Honing, Henkjan/A-1362-2012	Grahn, Jessica/0000-0001-7270-2114; Bouwer, Fleur/0000-0001-7064-7481; Honing, Henkjan/0000-0001-7046-7923; Burgoyne, John Ashley/0000-0001-6854-5646	ABC Talent Grant (Amsterdam Brain and Cognition); Continuing Access to Cultural Heritage (CATCH) grant of the Netherlands Organization for Scientific Research (NWO); Distinguished Lorentz fellowship - Lorentz Center for the Sciences; Netherlands Institute for Advanced Study in the Humanities and Social Sciences (NIAS); Horizon grant of the Netherlands Organization for Scientific Research (NWO); Dutch national program COMMIT; Natural Sciences and Engineering Research Council (NSERC); James S. McDonnell Foundation	ABC Talent Grant (Amsterdam Brain and Cognition); Continuing Access to Cultural Heritage (CATCH) grant of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Distinguished Lorentz fellowship - Lorentz Center for the Sciences; Netherlands Institute for Advanced Study in the Humanities and Social Sciences (NIAS); Horizon grant of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch national program COMMIT; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); James S. McDonnell Foundation	FB is supported by an ABC Talent Grant (Amsterdam Brain and Cognition). JAB is supported by a Continuing Access to Cultural Heritage (CATCH) grant of the Netherlands Organization for Scientific Research (NWO; www.nwo.nl). HH is supported by a Distinguished Lorentz fellowship granted by the Lorentz Center for the Sciences and the Netherlands Institute for Advanced Study in the Humanities and Social Sciences (NIAS; www.nias.knaw.nl) and a Horizon grant of the Netherlands Organization for Scientific Research (NWO; www.nwo.nl). DO is supported by the Dutch national program COMMIT (www.commit-nl.nl). JAG is supported by the Natural Sciences and Engineering Research Council (NSERC; www.nserc-crsng.gc.ca) and the James S. McDonnell Foundation (www.jsmf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis D, 2009, ANN NY ACAD SCI, V1169, P74, DOI 10.1111/j.1749-6632.2009.04766.x; Bergeson TR, 2006, MUSIC PERCEPT, V23, P345, DOI 10.1525/mp.2006.23.4.345; Bolger D, 2013, ACTA PSYCHOL, V142, P238, DOI 10.1016/j.actpsy.2012.11.012; Bouwer FL, 2016, NEUROPSYCHOLOGIA; Bouwer FL, 2016, NEUROPSYCHOLOGIA, V85, P80, DOI 10.1016/j.neuropsychologia.2016.02.018; Bouwer FL, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01094; Bouwer FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097467; Brochard R, 2003, PSYCHOL SCI, V14, P362, DOI 10.1111/1467-9280.24441; Cameron DJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01003; Carifio J, 2008, MED EDUC, V42, P1150, DOI 10.1111/j.1365-2923.2008.03172.x; Chapin HL, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00224; Chen JL, 2006, NEUROIMAGE, V32, P1771, DOI 10.1016/j.neuroimage.2006.04.207; Christensen RHB., 2015, ORDINAL REGRESSION M; Drake C, 2000, MUSIC PERCEPT, V18, P1; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; Ellis RJ, 2009, J EXP PSYCHOL HUMAN, V35, P264, DOI 10.1037/a0013482; FRIEDMAN H, 1982, EDUC PSYCHOL MEAS, V42, P521, DOI 10.1177/001316448204200214; Fujioka T, 2012, J NEUROSCI, V32, P1791, DOI 10.1523/JNEUROSCI.4107-11.2012; Gardner HJ, 2007, PRESENCE-TELEOP VIRT, V16, P439, DOI 10.1162/pres.16.4.439; Geiser E, 2010, EUR J NEUROSCI, V32, P1979, DOI 10.1111/j.1460-9568.2010.07462.x; Geiser E, 2009, CORTEX, V45, P93, DOI 10.1016/j.cortex.2007.09.010; Grahn JA, 2012, PSYCHOMUSICOLOGY MUS, V22, P105, DOI [10.1037/a0031188, DOI 10.1037/A0031188]; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Grahn JA, 2013, CEREB CORTEX, V23, P913, DOI 10.1093/cercor/bhs083; Grahn JA, 2012, TOP COGN SCI, V4, P585, DOI 10.1111/j.1756-8765.2012.01213.x; Grahn JA, 2009, NEUROIMAGE, V47, P1894, DOI 10.1016/j.neuroimage.2009.04.039; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; Grube M, 2009, CORTEX, V45, P72, DOI 10.1016/j.cortex.2008.01.006; Hannon EE, 2004, J EXP PSYCHOL HUMAN, V30, P956, DOI 10.1037/0096-1523.30.5.956; Henry MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172454; Honing H, 2015, PHILOS T R SOC B, V370, P5, DOI 10.1098/rstb.2014.0088; Honing H, 2014, ADV EXP MED BIOL, V829, P305, DOI 10.1007/978-1-4939-1782-2_16; Honing H, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P369, DOI 10.1016/B978-0-12-381460-9.00009-2; Honing H, 2008, EMPIR MUSICOL REV, V3, P73, DOI 10.18061/1811/31943; Honing H, 2009, J EXP PSYCHOL HUMAN, V35, P281, DOI 10.1037/a0012732; Iversen JR, 2009, ANN NY ACAD SCI, V1169, P58, DOI 10.1111/j.1749-6632.2009.04579.x; Jackendoff R, 2006, COGNITION, V100, P33, DOI 10.1016/j.cognition.2005.11.005; Jamieson S, 2004, MED EDUC, V38, P1217, DOI 10.1111/j.1365-2929.2004.02012.x; Jones MR, 1997, CAN J EXP PSYCHOL, V51, P271, DOI 10.1037/1196-1961.51.4.271; Kung SJ, 2013, J COGNITIVE NEUROSCI, V25, P401, DOI 10.1162/jocn_a_00325; Kung SJ, 2011, EXP BRAIN RES, V210, P269, DOI 10.1007/s00221-011-2630-2; Large EW, 2008, PSYCHOLOGY OF TIME, P189, DOI 10.1016/B978-0-08046-977-5.00006-5; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Large EW, 2000, HUM MOVEMENT SCI, V19, P527, DOI 10.1016/S0167-9457(00)00026-9; Lerdahl F., 1983, GENERATIVE THEORY TO; London J., 2012, HEARING TIME; Madison G, 2011, J EXP PSYCHOL HUMAN, V37, P1578, DOI 10.1037/a0024323; Martens PA, 2011, MUSIC PERCEPT, V28, P433, DOI 10.1525/MP.2011.28.5.433; McAuley JD, 1999, AUST J PSYCHOL, V51, P176, DOI 10.1080/00049539908255355; Merchant H, 2015, PHILOS T R SOC B, V370, P91, DOI 10.1098/rstb.2014.0093; Mullensiefan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089642; Nozaradan S, 2011, J NEUROSCI, V31, P10234, DOI 10.1523/JNEUROSCI.0411-11.2011; PALMER C, 1990, J EXP PSYCHOL HUMAN, V16, P728, DOI 10.1037/0096-1523.16.4.728; Peugh JL, 2010, J SCHOOL PSYCHOL, V48, P85, DOI 10.1016/j.jsp.2009.09.002; Potter DD, 2009, CORTEX, V45, P103, DOI 10.1016/j.cortex.2008.01.004; POVEL DJ, 1981, PERCEPT PSYCHOPHYS, V30, P565, DOI 10.3758/BF03202011; POVEL DJ, 1985, MUSIC PERCEPT, V2, P411; R Core Team, 2018, R LANG ENV STAT COMP; Repp BH, 2010, ATTEN PERCEPT PSYCHO, V72, P1390, DOI 10.3758/APP.72.5.1390; Richter SH, 2010, NAT METHODS, V7, P167, DOI 10.1038/nmeth0310-167; Schwartze M, 2013, NEUROPSYCHOLOGIA, V51, P320, DOI 10.1016/j.neuropsychologia.2012.09.037; Schwartze M, 2011, BIOL PSYCHOL, V87, P146, DOI 10.1016/j.biopsycho.2011.02.021; Shmulevich I, 2000, J NEW MUSIC RES, V29, P61, DOI 10.1076/0929-8215(200003)29:01;1-P;FT061; Su YH, 2012, PSYCHOL RES-PSYCH FO, V76, P373, DOI 10.1007/s00426-011-0346-3; Tierney A, 2015, J COGNITIVE NEUROSCI, V27, P400, DOI 10.1162/jocn_a_00704; Tierney A, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00014; van der Weij B, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00824; Vuust P, 2005, NEUROIMAGE, V24, P560, DOI 10.1016/j.neuroimage.2004.08.039; Vuust P, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01111; Vuust P, 2009, CORTEX, V45, P80, DOI 10.1016/j.cortex.2008.05.014; Witek MAG, 2014, MUSIC PERCEPT, V32, P201, DOI 10.1525/MP.2014.32.2.201	71	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190322	10.1371/journal.pone.0190322	http://dx.doi.org/10.1371/journal.pone.0190322			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS3NS	29320533	gold, Green Submitted, Green Published			2022-12-26	WOS:000419689600044
J	Kayiga, H; Lester, F; Amuge, PM; Byamugisha, J; Autry, AM				Kayiga, Herbert; Lester, Felicia; Amuge, Pauline Mary; Byamugisha, Josaphat; Autry, Amy Meg			Impact of mode of delivery on pregnancy outcomes in women with premature rupture of membranes after 28 weeks of gestation in a low-resource setting: A prospective cohort study	PLOS ONE			English	Article							PRETERM; CHORIOAMNIONITIS	Background Despite the high prevalence of premature rupture of membranes (PROM) in low-resource settings, the preferred mode of delivery remains unclear. We compared the perinatal mortality in a prospective cohort of women with PROM after 28 weeks following vaginal or caesarean delivery at Mulago Hospital with the aim of adopting evidence based practice and improving patient care. Methods Between November 2015 and May 2016, 1455 women with PROM after 28 weeks of gestation and their newborns were prospectively followed from admission to discharge at Mulago Hospital. The primary outcome was perinatal mortality. Secondary neonatal outcomes included sepsis and admission to the Special Care Unit. Maternal outcomes included maternal deaths and complications. Outcomes were compared between women who had vaginal vs. caesarean delivery using multivariable logistic regression. All statistical tests were 2-sided with the level of statistical significance set at p < 0.05. Results The incidence of PROM was 12.1%. The perinatal mortality following PROM was 65 per 1000 live births. Of the 1425 women with PROM, 991 (69.5%) had vaginal delivery and 434 (30.5%) underwent Caesarean section. There was no statistical difference in perinatal mortality by the mode of delivery (vaginal vs. caesarean) in PROM (p = 0.12). The risk factors for perinatal mortality included chorioamnionitis, failure to administer corticosteroids in preterm PROM, gestational age (28 +/- 33 weeks), duration of drainage of liquor (24 +/- 48 hours), and presence of maternal complications. Caesarean delivery was associated with increased maternal postpartum infections, admission to the Special Care Unit and maternal death. Conclusion In low resource settings, vaginal delivery is the preferred mode of delivery for PROM after 28 weeks gestation. It is associated with lesser maternal and perinatal morbidity when compared to caesarean delivery.	[Kayiga, Herbert; Byamugisha, Josaphat] Makerere Univ, Coll Hlth Sci, Directorate Obstet & Gynecol, Kampala, Uganda; [Lester, Felicia; Autry, Amy Meg] Univ Calif San Francisco, Dept Obstet & Gynecol & RS, San Francisco, CA 94143 USA; [Amuge, Pauline Mary] Baylor Coll Med, San Francisco, CA USA	Makerere University; University of California System; University of California San Francisco	Kayiga, H (corresponding author), Makerere Univ, Coll Hlth Sci, Directorate Obstet & Gynecol, Kampala, Uganda.	hkayiga@gmail.com	Byamugisha, Josaphat/AAL-5776-2020	Byamugisha, Josaphat/0000-0002-3438-9662; Amuge, Pauline/0000-0001-5264-1916	NIH Research Training Grant - Fogarty International Center [R25 TW009343]; National Institute of Mental Health; National Health, Lung and Blood Institute; Office of Research on Women's Health; University of California Global Health Institute; Glocal fellowship-training program at University of California San Francisco; FOGARTY INTERNATIONAL CENTER [D43TW009343] Funding Source: NIH RePORTER	NIH Research Training Grant - Fogarty International Center; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Health, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); University of California Global Health Institute; Glocal fellowship-training program at University of California San Francisco; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This project was supported by NIH Research Training Grant #R25 TW009343 funded by the Fogarty International Center; the National Institute of Mental Health; the National Health, Lung and Blood Institute; and the Office of Research on Women's Health, as well as the University of California Global Health Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health or the University of California Global Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; With great pleasure we acknowledge Dr. Andrew Edielu for developing the study database and also for the data analysis. We are grateful to Professor Deborah Grady, Professor Abner Korn and Dr. Megan Swanson for their input in critiquing the manuscript. We are indebted to the Department of Obstetrics and Gynecology at Mulago hospital for all the support it gave us during the study period. We wish to acknowledge the Glocal fellowship-training program at University of California San Francisco for availing me the opportunity and mentorship that has enabled me conduct this study.	Caughey Aaron B, 2008, Rev Obstet Gynecol, V1, P11; Chakraborty B, 2013, INDIAN J CLIN PRACTI, V24; Cohen-Wolkowiez M, 2009, PEDIATR INFECT DIS J, V28, P1052, DOI 10.1097/INF.0b013e3181acf6bd; Eleje GU., 2010, AFR J, V1, P10; Fatemeh Tavassoli, 2010, OMAN MED J, V25, P118; GIBBS RS, 1980, AM J OBSTET GYNECOL, V136, P709, DOI 10.1016/0002-9378(80)90445-7; GILSTRAP LC, 1988, AM J OBSTET GYNECOL, V159, P579, DOI 10.1016/S0002-9378(88)80012-7; Harding JE, 2001, AM J OBSTET GYNECOL, V184, P131, DOI 10.1067/mob.2001.108331; Ibishi Vlora Ademi, 2015, Open Access Maced J Med Sci, V3, P237, DOI 10.3889/oamjms.2015.037; Mousiolis A, 2012, J MATERN-FETAL NEO M, V25, P1044, DOI 10.3109/14767058.2011.614659; Noor Shehla, 2007, J Ayub Med Coll Abbottabad, V19, P14; Okeke TC, 2014, AM J CLIN MED RES, V2, P14, DOI [10.12691/ajcmr-2-1-4, DOI 10.12691/AJCMR-2-1-4]; Pasquier JC, 2005, EUR J OBSTET GYN R B, V121, P164, DOI 10.1016/j.ejogrb.2004.12.015; Revathi V., IOSR J DENTAL MED SC, V1, P12; Rouse DJ, 2004, AM J OBSTET GYNECOL, V191, P211, DOI 10.1016/j.ajog.2004.03.003; SEO K, 1992, OBSTET GYNECOL, V79, P75; Shukla P., 2014, PRETERM PREMATURE RU; Snehamay C, 2006, J OBSTET GYN INDIA, V56, P224; Steer P, 1999, BRIT MED J, V318, P1059, DOI 10.1136/bmj.318.7190.1059; Sumera Tahir, 2002, Pakistan Journal of Medical Sciences, V18, P26; Victoria Nankabirwa, 2011, PLOS ONE, V6	21	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1								10.1371/journal.pone.0190388	http://dx.doi.org/10.1371/journal.pone.0190388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320516	gold, Green Published, Green Submitted			2022-12-26	WOS:000419689600049
J	Kang, QQ; Sun, ZL; Zou, ZY; Wang, M; Li, QY; Hu, XX; Li, N				Kang, Qianqian; Sun, Zhaolin; Zou, Zhiyuan; Wang, Ming; Li, Qiuyan; Hu, Xiaoxiang; Li, Ning			Cell-penetrating peptide-driven Cre recombination in porcine primary cells and generation of marker-free pigs	PLOS ONE			English	Article							ARGININE-RICH PEPTIDES; EMBRYONIC STEM-CELLS; NUCLEAR TRANSFER; MOLECULAR-MECHANISMS; PROTEIN TRANSDUCTION; RETROVIRAL VECTORS; MAMMALIAN-CELLS; GENE-TRANSFER; LIVING CELLS; DELIVERY	Cell-penetrating peptides (CPPs) have been increasingly used to deliver various molecules, both in vitro and in vivo. However, there are no reports of CPPs being used in porcine fetal fibroblasts (PFFs). The increased use of transgenic pigs for basic research and biomedical applications depends on the availability of technologies for efficient genetic-modification of PFFs. Here, we report that three CPPs (CPP5, TAT, and R9) can efficiently deliver active Cre recombinase protein into PFFs via an energy-dependent endocytosis pathway. The three CPP-Cre proteins can enter PFFs and subsequently perform recombination with different efficiencies. The recombination efficacy of CPP5-Cre was found to be nearly 90%. The rate-limiting step for CPP-Cre-mediated recombination was the step of endosome escape. HA2 and chloroquine were found to improve the recombination efficiency of TAT-Cre. Furthermore, we successfully obtained marker-free transgenic pigs using TAT-Cre and CPP5-Cre. We provide a framework for the development of CPP-based farm animal transgenic technologies that would be beneficial to agriculture and biomedicine.	[Kang, Qianqian; Sun, Zhaolin; Zou, Zhiyuan; Wang, Ming; Li, Qiuyan; Hu, Xiaoxiang; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Labs Agrobiotechnol, Beijing, Peoples R China	China Agricultural University	Li, QY; Hu, XX; Li, N (corresponding author), China Agr Univ, Coll Biol Sci, State Key Labs Agrobiotechnol, Beijing, Peoples R China.	liqiuyan-yuan@163.com; huxx@cau.edu.cn; ninglcau@cau.edu.cn			National Transgenic Breeding Project of China [2013ZX08006001, 2014ZX08006006]	National Transgenic Breeding Project of China	This work was supported by the National Transgenic Breeding Project of China (2013ZX08006001 and 2014ZX08006006).	Abuin A, 1996, MOL CELL BIOL, V16, P1851; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Bi YZ, 2016, SCI REPORTS, P6; Brasseur R, 2010, BBA-BIOMEMBRANES, V1798, P2177, DOI 10.1016/j.bbamem.2010.09.001; Carlson DF, 2011, TRANSGENIC RES, V20, P1125, DOI 10.1007/s11248-010-9481-7; Chugh A, 2008, FEBS J, V275, P2403, DOI 10.1111/j.1742-4658.2008.06384.x; Chugh A, 2008, J PEPT SCI, V14, P477, DOI 10.1002/psc.937; Chugh A, 2010, IUBMB LIFE, V62, P183, DOI 10.1002/iub.297; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Cozzi E, 2005, BRIT MED BULL, V75-76, P99, DOI 10.1093/bmb/ldh061; Domashenko AD, 2010, BLOOD, V116, P2676, DOI 10.1182/blood-2010-03-273441; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; EGLITIS MA, 1988, BIOTECHNIQUES, V6, P608; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Fischer PM, 2007, MED RES REV, V27, P755, DOI 10.1002/med.20093; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Garrels W, 2011, PLOS ONE, V6; Garrels W, 2016, TRANSGENIC RES, V25, P63, DOI 10.1007/s11248-015-9914-4; Gomez JA, 2010, PHARMACEUTICALS, V3, P3594, DOI 10.3390/ph3123594; Gresch O, 2004, METHODS, V33, P151, DOI 10.1016/j.ymeth.2003.11.009; HAMMER RE, 1985, NATURE, V315, P680, DOI 10.1038/315680a0; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Hirose H, 2012, MOL THER, V20, P984, DOI 10.1038/mt.2011.313; Ivics Z, 2014, NAT PROTOC, V9, P810, DOI 10.1038/nprot.2014.010; Jo DW, 2001, NAT BIOTECHNOL, V19, P929, DOI 10.1038/nbt1001-929; Koren E, 2012, TRENDS MOL MED, V18, P385, DOI 10.1016/j.molmed.2012.04.012; Kues WA, 2011, PREV VET MED, V102, P146, DOI 10.1016/j.prevetmed.2011.04.009; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; LIU CP, 1979, P NATL ACAD SCI USA, V76, P4503, DOI 10.1073/pnas.76.9.4503; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Luo YL, 2012, J INHERIT METAB DIS, V35, P695, DOI 10.1007/s10545-012-9475-0; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Mae M, 2006, CURR OPIN PHARMACOL, V6, P509, DOI 10.1016/j.coph.2006.04.004; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Nolden L, 2006, NAT METHODS, V3, P461, DOI 10.1038/NMETH884; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Schuurman HJ, 2011, CLIN TRANSPLANT, V25, pE415, DOI 10.1111/j.1399-0012.2011.01471.x; Schwarze SR, 2000, TRENDS PHARMACOL SCI, V21, P45, DOI 10.1016/S0165-6147(99)01429-7; SEGLEN PO, 1979, EUR J BIOCHEM, V95, P215, DOI 10.1111/j.1432-1033.1979.tb12956.x; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Skehel JJ, 2001, BIOCHEM SOC T, V29, P623, DOI 10.1042/BST0290623; Soukharev S, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.18.e21; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7; Wang FH, 2014, J CONTROL RELEASE, V174, P126, DOI 10.1016/j.jconrel.2013.11.020; Wei HX, 2009, J REPROD DEVELOP, V55, P99, DOI 10.1262/jrd.19167; Xu YY, 2008, GENE, V419, P70, DOI 10.1016/j.gene.2008.04.020; Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062457; Zhang YH, 2006, SCI CHINA SER C, V49, P164, DOI 10.1007/s11427-006-0164-9	62	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190690	10.1371/journal.pone.0190690	http://dx.doi.org/10.1371/journal.pone.0190690			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315333	gold, Green Submitted, Green Published			2022-12-26	WOS:000419655900019
J	Lollert, A; Stihl, C; Hotker, AM; Mengel, E; Konig, J; Laudemann, K; Gokce, S; Duber, C; Staatz, G				Lollert, Andre; Stihl, Clemens; Hoetker, Andreas M.; Mengel, Eugen; Koenig, Jochem; Laudemann, Katharina; Goekce, Seyfullah; Dueber, Christoph; Staatz, Gundula			Quantification of intramuscular fat in patients with late-onset Pompe disease by conventional magnetic resonance imaging for the long-term follow-up of enzyme replacement therapy	PLOS ONE			English	Article							MUSCLE MRI; WATER; INFILTRATION; RELIABILITY	Objective The objective of this study was to evaluate a quantitative method based on conventional T1weighted magnetic resonance (MR) imaging to assess fatty muscular degeneration in patients with late-onset Pompe disease and to compare it with semi-quantitative visual evaluation (the Mercuri score). In addition, a long-term retrospective data analysis was performed to evaluate treatment response to enzyme replacement therapy with alglucosidase alfa. Methods MR images of the lumbar spine were acquired in 41 patients diagnosed with late-onset Pompe disease from 2006 through 2015. Two independent readers retrospectively evaluated fatty degeneration of the psoas and paraspinal muscles by applying the Mercuri score. Quantitative semi-automated muscle and fat tissue separation was performed, and interobserver agreement and correlations with clinical parameters were assessed. Follow-up examinations were performed in 13 patients treated with alglucosidase alfa after a median of 39 months; in 7/13 patients, an additional follow-up examination was completed after a median of 63 months. Results Inter-observer agreement was high. Measurements derived from the quantitative method correlated well with Medical Research Council scores of muscle strength, with moderate correlations found for the 6-minute walk test, the 4-step stair climb test, and spirometry in the supine position. A significant increase in the MR-derived fat fraction of the psoas muscle was found between baseline and follow-up 1 (P = 0.016), as was a significant decrease in the performance on the 6-minute walk test (P = 0.006) and 4-step stair climb test (P = 0.034), as well as plasma creatine kinase (P = 0.016). No statistically significant difference in clinical or MR-derived parameters was found between follow-up 1 and follow-up 2. Conclusions Quantification of fatty muscle degeneration using the semi-automated method can provide a more detailed overview of disease progression than semi-quantitative Mercuri scoring. MR-derived data correlated with clinical symptoms and patient exercise capacity. After an initial worsening, the fat fraction of the psoas muscle and performance on the 6-minute walk test stayed constant during long-term follow-up under enzyme replacement therapy.	[Lollert, Andre; Stihl, Clemens; Laudemann, Katharina; Staatz, Gundula] Johannes Gutenberg Univ Mainz, Med Ctr, Sect Pediat Radiol, Dept Diagnost & Intervent Radiol, Mainz, Germany; [Hoetker, Andreas M.; Dueber, Christoph] Johannes Gutenberg Univ Mainz, Med Ctr, Dept Diagnost & Intervent Radiol, Mainz, Germany; [Mengel, Eugen; Goekce, Seyfullah] Johannes Gutenberg Univ Mainz, Med Ctr, Ctr Pediat & Adolescent Med, Villa Metab, Mainz, Germany; [Koenig, Jochem] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Med Biostat Epidemiol & Informat, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Lollert, A (corresponding author), Johannes Gutenberg Univ Mainz, Med Ctr, Sect Pediat Radiol, Dept Diagnost & Intervent Radiol, Mainz, Germany.	andre.lollert@unimedizin-mainz.de	König, Jochem/T-3500-2019	König, Jochem/0000-0003-4683-0360	Sanofi-Genzyme [LSD0136-2015]	Sanofi-Genzyme	This study was funded by Sanofi-Genzyme (grant number LSD0136-2015) to GS. The funder had no role in study design, data collection and analysis, or preparation of the manuscript.	Alejaldre A, 2012, NEUROMUSCUL DISORD, V22; Anderson LJ, 2014, J INHERIT METAB DIS, V37, P945, DOI 10.1007/s10545-014-9728-1; Andreassen CS, 2014, MOL GENET METAB, V112, P40, DOI 10.1016/j.ymgme.2014.02.015; Azzabou N, 2015, J MAGN RESON IMAGING, V41, P645, DOI 10.1002/jmri.24613; Bembi B, 2010, J INHERIT METAB DIS, V33, P727, DOI 10.1007/s10545-010-9201-8; Bennell K, 2011, ARTHRIT CARE RES, V63, pS350, DOI 10.1002/acr.20538; Boutin RD, 2015, AM J ROENTGENOL, V205, pW255, DOI 10.2214/AJR.15.14635; Carlier PG, 2015, J INHERIT METAB DIS, V38, P565, DOI 10.1007/s10545-015-9825-9; Carlier RY, 2011, NEUROMUSCULAR DISORD, V21, P791, DOI 10.1016/j.nmd.2011.06.748; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Crawford RJ, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-016-1378-z; Dlamini N, 2008, NEUROMUSCULAR DISORD, V18, P408, DOI 10.1016/j.nmd.2008.02.006; Figueroa-Bonaparte S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163493; Fortin M, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-017-0350-y; Fortin M, 2016, EUR SPINE J, V25, P1452, DOI 10.1007/s00586-016-4503-7; Fortin M, 2014, MED SCI SPORT EXER, V46, P893, DOI 10.1249/MSS.0000000000000179; Fortin M, 2012, PHYS THER, V92, P853, DOI 10.2522/ptj.20110380; Gruhn KM, 2015, MOLEC GENET METAB RE, V3, P58, DOI 10.1016/j.ymgmr.2015.03.010; Hagemans MLC, 2005, BRAIN, V128, P671, DOI 10.1093/brain/awh384; Hernando D, 2017, MAGN RESON MED, V77, P1516, DOI 10.1002/mrm.26228; Horvath JJ, 2015, MUSCLE NERVE, V51, P722, DOI 10.1002/mus.24437; Hu HH, 2012, MAGN RESON MED, V68, P378, DOI 10.1002/mrm.24369; Kassardjian CD, 2015, MUSCLE NERVE, V51, P759, DOI 10.1002/mus.24620; Lim JA, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00177; Ma JF, 2004, MAGN RESON MED, V52, P415, DOI 10.1002/mrm.20146; Medical Research Council (Great Britain), 1976, AIDS EX PER NERV SYS; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Mercuri Eugenio, 2002, Eur J Paediatr Neurol, V6, P305; Mhuiris AN, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1090-z; Ortolan P, 2015, EUR J TRANSL MYOL, V25, P121, DOI 10.4081/ejtm.2015.5014; Portney L., 2009, FDN CLIN RES, V(3rd ed.); Schoser B, 2017, J NEUROL, V264, P621, DOI 10.1007/s00415-016-8219-8; Strothotte S, 2010, J NEUROL, V257, P91, DOI 10.1007/s00415-009-5275-3; Taisne N, 2017, MUSCLE NERVE, V56, P167, DOI 10.1002/mus.25478; van der Ploeg AT, 2008, LANCET, V372, P1342, DOI 10.1016/S0140-6736(08)61555-X; van der Ploeg AT, 2012, MOL GENET METAB, V107, P456, DOI 10.1016/j.ymgme.2012.09.015; van der Ploeg AT, 2010, NEW ENGL J MED, V362, P1396, DOI 10.1056/NEJMoa0909859; Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2; Willis TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090377; Wurslin C, 2011, J MAGN RESON IMAGING, V34, P716, DOI 10.1002/jmri.22682	40	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190784	10.1371/journal.pone.0190784	http://dx.doi.org/10.1371/journal.pone.0190784			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315315	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000419655900024
J	Han, Z; Wu, H; Kim, S; Yang, XK; Li, QJ; Huang, H; Cai, HJ; Bartlett, MG; Dong, AP; Zeng, H; Brown, PJ; Yang, XJ; Arrowsmith, CH; Zhao, YM; Zheng, YG				Han, Zhen; Wu, Hong; Kim, Sunjoo; Yang, Xiangkun; Li, Qianjin; Huang, He; Cai, Houjian; Bartlett, Michael G.; Dong, Aiping; Zeng, Hong; Brown, Peter J.; Yang, Xiang-jiao; Arrowsmith, Cheryl H.; Zhao, Yingming; Zheng, Y. George			Revealing the protein propionylation activity of the histone acetyltransferase MOF (males absent on the first)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE PROPIONYLATION; MSL COMPLEX; ACETYLATION; DISEASE; BUTYRYLATION; METABOLISM; MECHANISMS; PATHOLOGY; CANCER; MODEL	Short-chain acylation of lysine residues has recently emerged as a group of reversible posttranslational modifications in mammalian cells. The diversity of acylation further broadens the landscape and complexity of the proteome. Identification of regulatory enzymes and effector proteins for lysine acylation is critical to understand functions of these novel modifications at the molecular level. Here, we report that the MYST family of lysine acetyltransferases (KATs) possesses strong propionyltransferase activity both in vitro and in cellulo. Particularly, the propionyltransferase activity of MOF, MOZ, and HBO1 is as strong as their acetyltransferase activity. Overexpression of MOF in human embryonic kidney 293T cells induced significantly increased propionylation in multiple histone and nonhistone proteins, which shows that the function of MOF goes far beyond its canonical histone H4 lysine 16 acetylation. We also resolved the X-ray co-crystal structure of MOF bound with propionyl-coenzyme A, which provides a direct structural basis for the propionyltransferase activity of the MYST KATs. Our data together define a novel function for the MYST KATs as lysine propionyltransferases and suggest much broader physiological impacts for this family of enzymes.	[Han, Zhen; Yang, Xiangkun; Li, Qianjin; Cai, Houjian; Bartlett, Michael G.; Zheng, Y. George] Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA; [Wu, Hong; Dong, Aiping; Zeng, Hong; Brown, Peter J.; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Kim, Sunjoo; Huang, He; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Yang, Xiang-jiao] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Yang, Xiang-jiao] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University System of Georgia; University of Georgia; University of Toronto; Structural Genomics Consortium; University of Chicago; McGill University; McGill University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Zheng, YG (corresponding author), Univ Georgia, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA.	yzheng@uga.edu	Cai, Houjian/AAJ-1290-2020; Han, Zhen/AAA-4764-2022; Yang, Xiangkun/I-6141-2019; Han, Zhen/GQA-7275-2022	Han, Zhen/0000-0001-7362-7080; Brown, Peter/0000-0002-8454-0367; Arrowsmith, Cheryl/0000-0002-4971-3250; Bartlett, Michael/0000-0003-0626-3234	National Science Foundation [1507741]; AbbVie [1097737]; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute; Innovative Medicines Initiative (EU/EFPIA) [115766]; Janssen; Merck Co; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust; Chinese Scholarship Council; National Institutes of Health [R01CA172495, GM105933, DK107868, GM115961]; Department of Defense [W81XWH-15-1-0507]; Nancy and Leonard Florsheim Family Foundation; NATIONAL CANCER INSTITUTE [R01CA172495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115961] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada through Ontario Genomics Institute(Genome Canada); Innovative Medicines Initiative (EU/EFPIA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Co(Merck & Company); Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Chinese Scholarship Council(China Scholarship Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Nancy and Leonard Florsheim Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Science Foundation Grant 1507741 (to Y. G. Z.). The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation,Genome Canada through Ontario Genomics Institute, Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD Grant 115766), Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and the Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by a scholarship from the Chinese Scholarship Council.; Supported by National Institutes of Health Grant R01CA172495 and Department of Defense Grant W81XWH-15-1-0507.; Supported by National Institutes of Health Grants GM105933, DK107868, and GM115961 and the Nancy and Leonard Florsheim Family Foundation.	Avvakumov Nikita, 2007, Subcell Biochem, V41, P295; Bodai L, 2012, NEURODEGENER DIS, V9, P104, DOI 10.1159/000330505; Buscaino A, 2003, MOL CELL, V11, P1265, DOI 10.1016/S1097-2765(03)00140-0; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Chen QY, 2015, AIMS BIOPHYS, V2, P555, DOI 10.3934/biophy.2015.4.555; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Chen ZW, 2014, BRIT J PHARMACOL, V171, P3196, DOI 10.1111/bph.12661; Cheng ZY, 2009, MOL CELL PROTEOMICS, V8, P45, DOI 10.1074/mcp.M800224-MCP200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao TL, 2013, ANAL BIOANAL CHEM, V405, P1361, DOI 10.1007/s00216-012-6522-5; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Han Z, 2017, ACS CHEM BIOL, V12, P1547, DOI 10.1021/acschembio.7b00114; Kim SC, 2006, J PROTEOME RES, V5, P3446, DOI 10.1021/pr0603396; Klein BJ, 2017, STRUCTURE, V25, P650, DOI 10.1016/j.str.2017.02.003; Krautkramer KA, 2016, MOL CELL, V64, P982, DOI 10.1016/j.molcel.2016.10.025; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Leemhuis H, 2008, CHEMBIOCHEM, V9, P499, DOI 10.1002/cbic.200700556; Liu XG, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.16; Marmorstein R, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018762; Marmorstein R, 2009, BBA-GENE REGUL MECH, V1789, P58, DOI 10.1016/j.bbagrm.2008.07.009; Memarzadeh S, 2011, P NATL ACAD SCI USA, V108, P7962, DOI 10.1073/pnas.1105243108; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nochi Z, 2017, J INHERIT METAB DIS, V40, P641, DOI 10.1007/s10545-017-0047-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pougovkina O, 2014, J INHERIT METAB DIS, V37, P709, DOI 10.1007/s10545-014-9684-9; Ringel AE, 2016, ACTA CRYSTALLOGR D, V72, P841, DOI 10.1107/S2059798316007907; Sabari BR, 2015, MOL CELL, V58, P203, DOI 10.1016/j.molcel.2015.02.029; Scholl-Burgi S, 2012, J INHERIT METAB DIS, V35, P65, DOI 10.1007/s10545-010-9245-9; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Sun MW, 2016, J PROTEOME RES, V15, P4696, DOI 10.1021/acs.jproteome.6b00798; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008; Woo V, 2017, CURR OPIN IMMUNOL, V44, P52, DOI 10.1016/j.coi.2016.12.001; Xie ZY, 2012, MOL CELL PROTEOMICS, V11, P100, DOI 10.1074/mcp.M111.015875; Yang C, 2012, J BIOL CHEM, V287, P34917, DOI 10.1074/jbc.M112.359356; Yang XK, 2017, ANAL CHEM, V89, P813, DOI 10.1021/acs.analchem.6b03623; Zhang K, 2009, J PROTEOME RES, V8, P900, DOI 10.1021/pr8005155; Zhou YG, 2009, NAT CELL BIOL, V11, P1010, DOI 10.1038/ncb1914	42	31	32	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3410	3420		10.1074/jbc.RA117.000529	http://dx.doi.org/10.1074/jbc.RA117.000529			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29321206	Green Published, hybrid			2022-12-26	WOS:000426562800031
J	Mayorova, TD; Smith, CL; Hammar, K; Winters, CA; Pivovarova, NB; Aronova, MA; Leapman, RD; Reese, TS				Mayorova, Tatiana D.; Smith, Carolyn L.; Hammar, Katherine; Winters, Christine A.; Pivovarova, Natalia B.; Aronova, Maria A.; Leapman, Richard D.; Reese, Thomas S.			Cells containing aragonite crystals mediate responses to gravity in Trichoplax adhaerens (Placozoa), an animal lacking neurons and synapses	PLOS ONE			English	Article							CALCIUM-SULFATE HEMIHYDRATE; ELECTRON-MICROSCOPE; STATOCYST; STATOLITHS; TRANSDUCTION; BIOMINERALIZATION; PLATYHELMINTHES; ULTRASTRUCTURE; EVOLUTIONARY; ADAPTATION	Trichoplax adhaerens has only six cell types. The function as well as the structure of crystal cells, the least numerous cell type, presented an enigma. Crystal cells are arrayed around the perimeter of the animal and each contains a birefringent crystal. Crystal cells resemble lithocytes in other animals so we looked for evidence they are gravity sensors. Confocal microscopy showed that their cup-shaped nuclei are oriented toward the edge of the animal, and that the crystal shifts downward under the influence of gravity. Some animals spontaneously lack crystal cells and these animals behaved differently upon being tilted vertically than animals with a typical number of crystal cells. EM revealed crystal cell contacts with fiber cells and epithelial cells but these contacts lacked features of synapses. EM spectroscopic analyses showed that crystals consist of the aragonite form of calcium carbonate. We thus provide behavioral evidence that Trichoplax are able to sense gravity, and that crystal cells are likely to be their gravity receptors. Moreover, because placozoans are thought to have evolved during Ediacaran or Cryogenian eras associated with aragonite seas, and their crystals are made of aragonite, they may have acquired gravity sensors during this early era.	[Mayorova, Tatiana D.; Smith, Carolyn L.; Winters, Christine A.; Pivovarova, Natalia B.; Reese, Thomas S.] NINDS, Lab Neurobiol, NIH, Bethesda, MD 20892 USA; [Mayorova, Tatiana D.] Russian Acad Sci, Koltzov Inst Dev Biol, Lab Dev Neurobiol, Moscow, Russia; [Hammar, Katherine] Marine Biol Lab, Cent Microscopy Facil, Woods Hole, MA 02543 USA; [Aronova, Maria A.; Leapman, Richard D.] Natl Inst Biomed Imaging & Bioengn, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Marine Biological Laboratory - Woods Hole; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Mayorova, TD (corresponding author), NINDS, Lab Neurobiol, NIH, Bethesda, MD 20892 USA.; Mayorova, TD (corresponding author), Russian Acad Sci, Koltzov Inst Dev Biol, Lab Dev Neurobiol, Moscow, Russia.	mayorova@wsbs-msu.ru		Mayorova, Tatiana/0000-0003-4132-0222	intramural research program of the NIH, NINDS; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002972] Funding Source: NIH RePORTER	intramural research program of the NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the intramural research program of the NIH, NINDS.	Achatz JG, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-27; Aizenberg J, 2001, NATURE, V412, P819, DOI 10.1038/35090573; Aronova MZ, 2009, J EVOL BIOCHEM PHYS+, V45, P179, DOI 10.1134/S0022093009020017; Baldwin KL, 2013, AM J BOT, V100, P126, DOI 10.3732/ajb.1200318; Becker A, 2005, DALTON T, P1545, DOI 10.1039/b416246c; Beg AA, 2008, CELL, V132, P149, DOI 10.1016/j.cell.2007.10.058; BERNER RA, 1975, GEOCHIM COSMOCHIM AC, V39, P489, DOI 10.1016/0016-7037(75)90102-7; Brandes JA, 2010, J SYNCHROTRON RADIAT, V17, P676, DOI 10.1107/S0909049510020029; BRAUN M, 1993, PROTOPLASMA, V174, P50, DOI 10.1007/BF01404042; Bru E, 1981, ZOOMORPHOLOGY, V97, P75; BUCHHOLZ K, 1995, Z NATURFORSCH C, V50, P282; Budelmann B.-U., 1988, P757; CAMPBELL RD, 1972, NATURE, V238, P49, DOI 10.1038/238049a0; DEGENS ET, 1969, MAR BIOL, V2, P105, DOI 10.1007/BF00347005; EAKIN RM, 1971, Z ZELLFORSCH MIK ANA, V112, P287; EHLERS U, 1991, HYDROBIOLOGIA, V227, P263, DOI 10.1007/BF00027611; Erwin DH, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0036; FENCHEL T, 1986, J PROTOZOOL, V33, P69, DOI 10.1111/j.1550-7408.1986.tb05560.x; FERRERO E, 1973, ZOOL SCR, V2, P5, DOI 10.1111/j.1463-6409.1973.tb00793.x; FERRERO EA, 1985, ACTA ZOOL-STOCKHOLM, V66, P75, DOI 10.1111/j.1463-6395.1985.tb00826.x; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Gal J, 2000, VISION RES, V40, P843, DOI 10.1016/S0042-6989(99)00216-3; GARVIE LAJ, 1994, AM MINERAL, V79, P411; Hader DP, 2005, ADV SPACE RES-SERIES, V36, P1182, DOI 10.1016/j.asr.2005.03.081; Hader DP, 2001, ADV SPACE RES-SERIES, V27, P861, DOI 10.1016/S0273-1177(01)00149-1; Hahn Mark E., 2017, Current Opinion in Toxicology, V2, P58, DOI 10.1016/j.cotox.2017.02.003; HANLON RT, 1989, J EXP BIOL, V141, P187; Hemmersbach R., 2006, SIGNAL TRANSDUCT, V6, P432, DOI [10.1002/sita.200600106, DOI 10.1002/SITA.200600106]; Heyland A, 2014, METHODS MOL BIOL, V1128, P45, DOI 10.1007/978-1-62703-974-1_4; Knoll AH, 2003, REV MINERAL GEOCHEM, V54, P329, DOI 10.2113/0540329; Kristan WB, 2016, CURR BIOL, V26, pR949, DOI 10.1016/j.cub.2016.05.030; Leitz G, 2009, PLANT CELL, V21, P843, DOI 10.1105/tpc.108.065052; MARMO F, 1983, CELL TISSUE RES, V233, P35; Martinez P, 2017, OXFORD RES ENCY NEUR; NAKAHARA H, 1979, ANAT REC, V193, P233, DOI 10.1002/ar.1091930205; PEARSE VB, 1994, T AM MICROSC SOC, V113, P385, DOI 10.2307/3226631; Pearse VB, 2007, INTEGR COMP BIOL, V47, P677, DOI 10.1093/icb/icm015; Pedrozo HA, 1996, HEARING RES, V102, P51, DOI 10.1016/S0378-5955(96)00147-5; Peng G., 2014, MOL PHYLOGENET EVOL; Pivovarova NB, 2013, JOVE-J VIS EXP, DOI 10.3791/50807; Porter SM, 2007, SCIENCE, V316, P1302, DOI 10.1126/science.1137284; RASSAT J, 1979, ZOOMORPHOLOGIE, V93, P59, DOI 10.1007/BF02568675; Ries JB, 2008, GEOBIOLOGY, V6, P106, DOI 10.1111/j.1472-4669.2007.00134.x; ROHDE K, 1993, AUST J ZOOL, V41, P215, DOI 10.1071/ZO9930215; RUTHMANN A, 1986, ZOOMORPHOLOGY, V106, P115, DOI 10.1007/BF00312113; Senatore A, 2017, J EXP BIOL, V220, P3381, DOI 10.1242/jeb.162396; SINGLA CL, 1975, CELL TISSUE RES, V158, P391; Smith CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136098; Smith CL, 2014, CURR BIOL, V24, P1565, DOI 10.1016/j.cub.2014.05.046; Speiser DI, 2014, J NAT HIST, V48, P2899, DOI 10.1080/00222933.2014.959572; Speiser DI, 2011, CURR BIOL, V21, P665, DOI 10.1016/j.cub.2011.03.033; Sperlagh B, 1996, SEMIN NEUROSCI, V8, P175, DOI 10.1006/smns.1996.0023; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Tamm SL, 2014, BIOL BULL-US, V227, P7, DOI 10.1086/BBLv227n1p7; Tatsumi H, 2014, PLANT BIOLOGY, V16, P18, DOI 10.1111/plb.12095; Tiemann H, 2002, J CHEM SOC DALTON, P1266, DOI 10.1039/b111524c; Tiemann H, 2006, ZOOL ANZ, V245, P13, DOI 10.1016/j.jcz.2006.03.001; Toyota M, 2013, AM J BOT, V100, P111, DOI 10.3732/ajb.1200408; Ueda T, 1999, BIOSYSTEMS, V54, P65, DOI 10.1016/S0303-2647(99)00066-0; Vinnikov YA., 1974, SENSORY RECEPTION, P272; Wood R, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0059	61	22	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190905	10.1371/journal.pone.0190905	http://dx.doi.org/10.1371/journal.pone.0190905			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342202	Green Published, gold, Green Submitted			2022-12-26	WOS:000422653800036
J	Yang, J; Du, L; Gong, W; Shi, S; Sun, J; Chen, BW				Yang, Jian; Du, Lin; Gong, Wei; Shi, Shuo; Sun, Jia; Chen, Biwu			Potential of vegetation indices combined with laser-induced fluorescence parameters for monitoring leaf nitrogen content in paddy rice	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; NONDESTRUCTIVE ESTIMATION; CANOPY REFLECTANCE; USE EFFICIENCY; GREEN PLANTS; SOIL QUALITY; CROP YIELD; PERFORMANCE; MANAGEMENT; SPECTRA	Nitrogen (N) is important for the growth of crops. Leaf nitrogen content (LNC) serves as a crucial indicator of the growth status of crops and can help determine the dose of N fertilizer. Laser-induced fluorescence (LIF) technology and the reflectance spectra of crops are widely used to detect the biochemical content of leaves. Many vegetation indices (Vls) and fluorescence parameters have been developed to estimate LNC. However, the comparison among Vls and between fluorescence parameters and Vls has been rarely studied in the estimation of LNC. In this study, the performances of several published empirical Vls and fluorescence parameters for the estimation of paddy rice LNC were analyzed using the support vector machine (SVM) algorithm. Then, the optimal Vls (TVI, MTVII, MTVI2, and MSAVI) and fluorescence parameters (F735/F460 and F685/F460), which were suitable for LNC monitoring in this study, were chosen. In addition, the combination of the Vls and fluorescence parameters was proposed as the input variables in the SVM model and used to estimate the LNC. Experimental results exhibited the promising potential of the LIF technology combined with reflectance for the accurate estimation of LNC, which provided guidance for monitoring the LNC.	[Yang, Jian; Du, Lin] China Univ Geosci, Fac Informat Engn, Wuhan, Hubei, Peoples R China; [Yang, Jian; Gong, Wei; Shi, Shuo; Sun, Jia; Chen, Biwu] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan, Hubei, Peoples R China; [Gong, Wei; Shi, Shuo] Collaborat Innovat Ctr Geospatial Technol, Wuhan, Hubei, Peoples R China	China University of Geosciences; Wuhan University	Yang, J (corresponding author), China Univ Geosci, Fac Informat Engn, Wuhan, Hubei, Peoples R China.; Yang, J (corresponding author), Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan, Hubei, Peoples R China.	wind_yang@whu.edu.cn	Yang, Jian/AAO-1667-2020		Open Fund of State Laboratory of Information Engineering in Surveying, Mapping and Remote Sensing, Wuhan University [17R05]; Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan) [CUG170661]; National Natural Science Foundation of China [41571370]; Natural Science Foundation of Hubei Province [2015CFA002]	Open Fund of State Laboratory of Information Engineering in Surveying, Mapping and Remote Sensing, Wuhan University; Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan)(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This work was supported by the Open Fund of State Laboratory of Information Engineering in Surveying, Mapping and Remote Sensing, Wuhan University (grant number 17R05 to Dr. Jian Yang), Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan) (grant number CUG170661 to Dr. Jian Yang), the National Natural Science Foundation of China (grant number 41571370 to Shuo Shi), the Natural Science Foundation of Hubei Province (grant number 2015CFA002 to Wei Gong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2003, IEEE J SEL TOP QUANT, V9, P154, DOI 10.1109/JSTQE.2003.813318; Cao Q, 2013, FIELD CROP RES, V154, P133, DOI 10.1016/j.fcr.2013.08.005; Cendrero-Mateo MP, 2016, J EXP BOT, V67, P275, DOI 10.1093/jxb/erv456; CHAPPELLE EW, 1984, APPL OPTICS, V23, P134, DOI 10.1364/AO.23.000134; CHAPPELLE EW, 1991, REMOTE SENS ENVIRON, V36, P213, DOI 10.1016/0034-4257(91)90058-E; Du L, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8060526; Ehlert D, 2009, PRECIS AGRIC, V10, P395, DOI 10.1007/s11119-009-9114-4; Eitel JUH, 2010, REMOTE SENS ENVIRON, V114, P2229, DOI 10.1016/j.rse.2010.04.025; Farkas DL, 2010, SPIE, V7568; Gaulton R, 2013, REMOTE SENS ENVIRON, V132, P32, DOI 10.1016/j.rse.2013.01.001; Gill MK, 2006, J AM WATER RESOUR AS, V42, P1033, DOI 10.1111/j.1752-1688.2006.tb04512.x; Gitelson AA, 1999, REMOTE SENS ENVIRON, V69, P296, DOI 10.1016/S0034-4257(99)00023-1; Gong W, 2012, ISPRS J PHOTOGRAMM, V69, P1, DOI 10.1016/j.isprsjprs.2012.02.001; Haboudane D, 2004, REMOTE SENS ENVIRON, V90, P337, DOI 10.1016/j.rse.2003.12.013; Huang M, 2013, FIELD CROP RES, V146, P10, DOI 10.1016/j.fcr.2013.03.007; JAMIESON PD, 1991, FIELD CROP RES, V27, P337, DOI 10.1016/0378-4290(91)90040-3; Kalaji HM, 2014, PHOTOSYNTH RES, V122, P121, DOI 10.1007/s11120-014-0024-6; Kira O, 2015, INT J APPL EARTH OBS, V38, P251, DOI 10.1016/j.jag.2015.01.003; Kumar K, 2000, ADV AGRON, V68, P197; Li F, 2008, FIELD CROP RES, V106, P77, DOI 10.1016/j.fcr.2007.11.001; Li F, 2014, EUR J AGRON, V52, P198, DOI 10.1016/j.eja.2013.09.006; Li W, 2014, REMOTE SENS LETT, V5, P693, DOI 10.1080/2150704X.2014.960608; Liang XQ, 2013, FIELD CROP RES, V146, P66, DOI 10.1016/j.fcr.2013.03.002; LICHTENTHALER HK, 1988, CRC CR REV ANAL CHEM, V19, pS29, DOI 10.1080/15476510.1988.10401466; Ma YY, 2012, IEEE J-STARS, V5, P1849, DOI 10.1109/JSTARS.2012.2206572; Malenovsky Z, 2009, J EXP BOT, V60, P2987, DOI 10.1093/jxb/erp156; Malhi SS, 2006, SOIL TILL RES, V90, P171, DOI 10.1016/j.still.2005.09.001; MCMURTREY JE, 1994, REMOTE SENS ENVIRON, V47, P36, DOI 10.1016/0034-4257(94)90125-2; Morsdorf F, 2006, REMOTE SENS ENVIRON, V104, P50, DOI 10.1016/j.rse.2006.04.019; Mulla DJ, 2013, BIOSYST ENG, V114, P358, DOI 10.1016/j.biosystemseng.2012.08.009; Nevalainen O., 2013, ISPRS ANN PHOTOGRAM, VII-5/W2, P205, DOI DOI 10.5194/ISPRSANNALS-II-5-W2-205-2013; Pacheco-Labrador J, 2014, INT J APPL EARTH OBS, V26, P105, DOI 10.1016/j.jag.2013.05.013; Pedros R, 2008, PHOTOCH PHOTOBIO SCI, V7, P498, DOI 10.1039/b719506k; Pu R, 2003, INT J REMOTE SENS, V24, P1799, DOI 10.1080/01431160210155965; SINCLAIR TR, 1989, CROP SCI, V29, P90, DOI 10.2135/cropsci1989.0011183X002900010023x; Song SL, 2011, ISPRS J PHOTOGRAMM, V66, P672, DOI 10.1016/j.isprsjprs.2011.05.002; Stroppiana D, 2009, FIELD CROP RES, V111, P119, DOI 10.1016/j.fcr.2008.11.004; Tian YC, 2011, FIELD CROP RES, V120, P299, DOI 10.1016/j.fcr.2010.11.002; Tian YC, 2014, PLANT SOIL, V376, P193, DOI 10.1007/s11104-013-1937-0; Tremblay N, 2012, AGRON SUSTAIN DEV, V32, P451, DOI 10.1007/s13593-011-0041-1; Vidakovic B, 1998, IEEE T SIGNAL PROCES, V46, P2549, DOI 10.1109/78.709544; Vijayalakshmi P, 2015, FIELD CROP RES, V179, P132, DOI 10.1016/j.fcr.2015.04.012; Wang JH, 2015, SCI REP-UK, V5, DOI 10.1038/srep08391; Wang JJ, 2015, REMOTE SENS-BASEL, V7, P5901, DOI 10.3390/rs70505901; Wu CY, 2008, AGR FOREST METEOROL, V148, P1230, DOI 10.1016/j.agrformet.2008.03.005; Yang J, 2015, PLANT SOIL ENVIRON, V61, P182, DOI 10.17221/7/2015-PSE; Yang J, 2016, SCI REP, V6, P144; Yang J, 2016, OPT EXPRESS, V24, P19354, DOI 10.1364/OE.24.019354; Yang XH, 2011, SCI CHINA LIFE SCI, V54, P272, DOI 10.1007/s11427-011-4135-4; Yl QX, 2007, ENVIRON SCI TECHNOL, V41, P6770, DOI 10.1021/es070144e; Zhao KG, 2013, REMOTE SENS ENVIRON, V132, P102, DOI 10.1016/j.rse.2012.12.026; Zhu X, 2015, ISPRS J PHOTOGRAMM, V110, P14, DOI 10.1016/j.isprsjprs.2015.10.001; Zhu Y, 2006, CAN J PLANT SCI, V86, P1037, DOI 10.4141/P05-157; Zivcak M, 2014, PLANT SOIL ENVIRON, V60, P210, DOI 10.17221/73/2014-PSE	54	15	15	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191068	10.1371/journal.pone.0191068	http://dx.doi.org/10.1371/journal.pone.0191068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342190	gold, Green Submitted, Green Published			2022-12-26	WOS:000422653800043
J	Alesina, A; Giuliano, P; Nunn, N				Alesina, Alberto; Giuliano, Paola; Nunn, Nathan			Traditional agricultural practices and the sex ratio today	PLOS ONE			English	Article							MISSING WOMEN; SON PREFERENCE; SLAVE-TRADE; INDIA; CHINA; ORIGINS; BIRTH; AFRICA; INVESTMENT; CHILDREN	We study the historical origins of cross-country differences in the male-to-female sex ratio. Our analysis focuses on the use of the plough in traditional agriculture. In societies that did not use the plough, women tended to participate in agriculture as actively as men. By contrast, in societies that used the plough, men specialized in agricultural work, due to the physical strength needed to pull the plough or control the animal that pulls it. We hypothesize that this difference caused plough-using societies to value boys more than girls. Today, this belief is reflected in male-biased sex ratios, which arise due to sex-selective abortion or infanticide, or gender-differences in access to family resources, which results in higher mortality rates for girls. Testing this hypothesis, we show that descendants of societies that traditionally practiced plough agriculture today have higher average male-to-female sex ratios. We find that this effect systematically increases in magnitude and statistical significance as one looks at older cohorts. Estimates using instrumental variables confirm our findings from multivariate OLS analysis.	[Alesina, Alberto; Nunn, Nathan] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Alesina, Alberto; Giuliano, Paola; Nunn, Nathan] NBER, Cambridge, MA 02138 USA; [Giuliano, Paola] UCLA, Anderson Sch Management, Los Angeles, CA 90095 USA	Harvard University; National Bureau of Economic Research; University of California System; University of California Los Angeles	Giuliano, P (corresponding author), NBER, Cambridge, MA 02138 USA.; Giuliano, P (corresponding author), UCLA, Anderson Sch Management, Los Angeles, CA 90095 USA.	paola.giuliano@anderson.ucla.edu	Giuliano, Paola/J-3159-2013	Nunn, Nathan/0000-0002-5101-9866; giuliano, paola/0000-0002-3809-4108				Alesina A, 2013, Q J ECON, V128, P469, DOI 10.1093/qje/qjt005; Anderson S, 2010, REV ECON STUD, V77, P1262, DOI 10.1111/j.1467-937X.2010.00609.x; [Anonymous], 2007, WOMANS ROLE EC DEV; Bahrami-Rad D, 2017, TABULATED NONSENSE T; CHAHNAZARIAN A, 1988, SOC BIOL, V35, P214; Chu JH, 2001, POPUL DEV REV, V27, P259; Conley TG, 1999, J ECONOMETRICS, V92, P1, DOI 10.1016/S0304-4076(98)00084-0; Dalton JT, 2014, ECON DEV CULT CHANGE, V62, P599, DOI 10.1086/676531; Das Gupta M, 2005, POPUL DEV REV, V31, P529; Das Gupta M, 2003, J DEV STUD, V40, P153, DOI 10.1080/00220380412331293807; DasGupta M, 1997, POP STUD-J DEMOG, V51, P307, DOI 10.1080/0032472031000150076; DASGUPTA M, 1987, POPUL DEV REV, V13, P77; DICKEMANN M, 1979, EVOLUTIONARY BIOL HU, P321; DYSON T, 1983, POPUL DEV REV, V9, P35, DOI 10.2307/1972894; Fischer G, 2002, GLOBAL AGROECOLOGICA; Freese J, 1999, AM J SOCIOL, V104, P1704, DOI 10.1086/210221; Galor O, 2016, AM ECON REV, V106, P3064, DOI 10.1257/aer.20150020; GAULIN SJC, 1991, AM J PHYS ANTHROPOL, V85, P61, DOI 10.1002/ajpa.1330850108; Green E, 2013, INT POLIT SCI REV, V34, P235, DOI 10.1177/0192512112455075; Henry C. K. Jeya, 1996, LONG TERM CONSEQUENC; HULL TH, 1990, POPUL DEV REV, V16, P63, DOI 10.2307/1972529; JAMES WH, 1987, HUM BIOL, V59, P721; Jayachandran S, 2017, AM ECON REV, V107, P2600, DOI 10.1257/aer.20151282; Jayachandran S, 2011, Q J ECON, V126, P1485, DOI 10.1093/qje/qjr029; Lazarus J, SEX RATIOS CONCEPTS; Mace R, 2005, EVOLUTION CULTURAL D; Mulder MB, 1998, HUM NATURE-INT BIOS, V9, P119, DOI 10.1007/s12110-998-1001-6; Murdock G.P., 1967, ETHNOGRAPHIC ATLAS; Nisbett Richard E., 1996, CULTURE HONOR PSYCHO; Nunn N, 2008, Q J ECON, V123, P139, DOI 10.1162/qjec.2008.123.1.139; Nunn N, 2011, AM ECON REV, V101, P3221, DOI 10.1257/aer.101.7.3221; PRYOR FL, 1985, COMP STUD SOC HIST, V27, P727, DOI 10.1017/S0010417500011749; Qian N, 2008, Q J ECON, V123, P1251, DOI 10.1162/qjec.2008.123.3.1251; Ramakrishnan S, 2011, HEART, V97, P1920, DOI 10.1136/hrt.2011.224410; Rohlfs C, 2010, J DEV ECON, V92, P82, DOI 10.1016/j.jdeveco.2008.11.005; ROSENZWEIG MR, 1982, AM ECON REV, V72, P803; SEN A, 1992, BRIT MED J, V304, P587, DOI 10.1136/bmj.304.6827.587; SEN A, 1990, NEW YORK REV BOOKS, V37, P61; SMITH MS, 1987, ETHOL SOCIOBIOL, V8, P171, DOI 10.1016/0162-3095(87)90042-2; Spolaore E, 2009, Q J ECON, V124, P469, DOI 10.1162/qjec.2009.124.2.469; Talhelm T, 2014, SCIENCE, V344, P603, DOI 10.1126/science.1246850; Teso E., J EUROPEAN IN PRESS; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Voigtlander N, 2012, Q J ECON, V127, P1339, DOI 10.1093/qje/qjs019; ZENG Y, 1993, POPUL DEV REV, V19, P283	45	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190510	10.1371/journal.pone.0190510	http://dx.doi.org/10.1371/journal.pone.0190510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29338023	Green Published, gold, Green Submitted			2022-12-26	WOS:000422652700012
J	Kuraszkiewicz, B; Chen, JJJS; Goszczynska, H; Wang, YL; Piotrkiewicz, M				Kuraszkiewicz, Bozenna; Chen, Jia-Jin Jason; Goszczynska, Hanna; Wang, Yu-Lin; Piotrkiewicz, Maria			Bilateral changes in afterhyperpolarization duration of spinal motoneurones in post-stroke patients	PLOS ONE			English	Article							STROKE SURVIVORS; DISCHARGE VARIABILITY; MOTOR UNITS; TIME-COURSE; PATTERN; DECOMPOSITION; RECOVERY	This paper extends the observations presented in the previously published work on the afterhyperpolarization (AHP) duration changes in motoneurones (MNs) on the paretic (more affected) side of 11 post-stroke patients by the same analysis on the non-paretic (less affected) side. The estimated AHP duration for patients' MNs supplying more-affected muscles was significantly longer than control values and the elongation decreased with patient age and disorder duration. For MNs supplying less-affected muscles, dependency of AHP duration on age was closer to the control data, but the scatter was substantially bigger. However, the AHP duration estimate of less-affected MNs tended to be longer than that of controls in the short time elapsed since the stroke, and shorter than controls in the long time. Our results thus suggest that the spinal MNs on both sides respond to the cerebral stroke rapidly with prolongation of AHP duration, which tends to normalize with time, in line with functional recovery. This suggestion is in concert with the published research on post-stroke changes in brain hemispheres. To our knowledge, these dependencies have never been investigated before. Since the number of our data was limited, the observed trends should be verified in a larger sample of patients and such a verification could take into account the suggestions for data analysis that we provide in this paper. Our data are in line with the earlier published research on MN firing characteristics post-stroke and support the conclusion that the MUs of the muscles at the non-paretic side are also affected and cannot be considered a suitable control for the MUs on the paretic side.	[Kuraszkiewicz, Bozenna; Goszczynska, Hanna; Piotrkiewicz, Maria] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Chen, Jia-Jin Jason] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan, Taiwan; [Wang, Yu-Lin] Chi Mei Med Ctr, Dept Rehabil, Tainan, Taiwan; [Wang, Yu-Lin] Southern Taiwan Univ Sci & Technol, Ctr Gen Educ, Tainan, Taiwan	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; National Cheng Kung University; Chi Mei Hospital; Southern Taiwan University of Science & Technology	Piotrkiewicz, M (corresponding author), Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland.	masia@ibib.waw.pl	Piotrkiewicz, Maria/A-6349-2008; Kuraszkiewicz, Bozenna/AAD-7390-2019	Piotrkiewicz, Maria/0000-0001-9340-1724; Kuraszkiewicz, Bozenna/0000-0002-0570-9655; Goszczynska, Hanna/0000-0003-1106-2672				ANDREASSEN S, 1978, MUSCLE NERVE, V1, P416, DOI 10.1002/mus.880010514; Grefkes C, 2014, LANCET NEUROL, V13, P206, DOI 10.1016/S1474-4422(13)70264-3; Holt GR, 1996, J NEUROPHYSIOL, V75, P1806, DOI 10.1152/jn.1996.75.5.1806; Hu XG, 2015, CLIN NEUROPHYSIOL, V126, P1599, DOI 10.1016/j.clinph.2014.11.005; Hultborn H, 1992, Curr Opin Neurobiol, V2, P770, DOI 10.1016/0959-4388(92)90132-5; Ivanova TD, 2014, CLIN NEUROPHYSIOL, V125, P544, DOI 10.1016/j.clinph.2013.08.017; Kuraszkiewicz B, 2012, LECT N BIOINFORMAT, V7339, P209; Liang LY, 2010, J MED BIOL ENG, V30, P17; McNeal DW, 2010, J COMP NEUROL, V518, P586, DOI 10.1002/cne.22218; McNulty PA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00518; Mierzejewska J., 2001, BIOCYBERN BIOMED ENG, V21, P53; Mlozniak D, 2015, BIOCYBERN BIOMED ENG, V35, P22, DOI 10.1016/j.bbe.2014.05.002; PERSON RS, 1972, ELECTROEN CLIN NEURO, V32, P471, DOI 10.1016/0013-4694(72)90058-2; Piotrkiewicz M, 1999, J PHYSIOLOGY-PARIS, V93, P125, DOI 10.1016/S0928-4257(99)80143-0; Piotrkiewicz M, 1999, CLIN NEUROPHYSIOL, V110, P1111, DOI 10.1016/S1388-2457(99)00051-6; Piotrkiewicz M, 2012, BIOCYBERN BIOMED ENG, V32, P43; Piotrkiewicz M, 2011, J PHYSIOL-LONDON, V589, P2745, DOI 10.1113/jphysiol.2011.204891; Powers RK, 2000, J PHYSIOL-LONDON, V528, P131, DOI 10.1111/j.1469-7793.2000.t01-1-00131.x; Sun TY, 2000, MUSCLE NERVE, V23, P1057, DOI 10.1002/1097-4598(200007)23:7<1057::AID-MUS8>3.0.CO;2-A; Suresh AK, 2014, J NEUROPHYSIOL, V112, P1447, DOI 10.1152/jn.01091.2012; Suresh NL, 2015, EXP BRAIN RES, V233, P15, DOI 10.1007/s00221-014-4061-3; Tokizane T, 1964, FUNCTIONAL DIFFERENT	22	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0189845	10.1371/journal.pone.0189845	http://dx.doi.org/10.1371/journal.pone.0189845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338007	gold, Green Published			2022-12-26	WOS:000422652700004
J	Dullaert-de Boer, M; Akkerman, OW; Vermeer, M; Hess, DLJ; Kerstjens, HAM; Anthony, RM; van der Werf, TS; van Soolingen, D; van der Zanden, AGM				Dullaert-de Boer, Maria; Akkerman, Onno W.; Vermeer, Marloes; Hess, Dorine L. J.; Kerstjens, Huib A. M.; Anthony, Richard M.; van der Werf, Tjip S.; van Soolingen, Dick; van der Zanden, Adri G. M.			Variability and cost implications of three generations of the Roche LightCycler (R) 480	PLOS ONE			English	Article							REAL-TIME PCR; YERSINIA-ENTEROCOLITICA; AMPLIFICATION; SALMONELLA; STRAINS; PRODUCT; CULTURE; SYSTEM; ASSAYS; COLI	Real time PCR has become a dominant method for the highly sensitive detection of pathogens in clinical material. Real time PCR can generate a fluorescence signal by using fluorescence labelled probes, allowing us to detect and semi quantify the amount of amplified DNA. Here we test the variability of the detection system and cost implications of three different versions of the LightCycler (R) 480 (LC480), focusing on the intensity of fluorescence and Cq in monoplex and multiplex rtPCRs. For gastro-intestinal pathogens there was no correlation between the intensity of fluorescence and the Cq value in the different LC480 types. For probes with the dyes FAM (TM), HEX (TM), Cy5 and Red610a higher fluorescence intensity was seen in LC480 type II and III compared to LC480 type I. After lowering the probe concentration for the Cy5 dye three-fold (from 0.3 mu M to 0.1 mu M) the Cq value remains the same and the intensity of fluorescence decreases. For the LC480 type II and III the difference in fluorescence intensity was much more extreme. The concentration of the different labelled probes can be lowered at least six-fold in LC480 type II and III cyclers while maintaining a fluorescence intensity as high as achieved in the LC480 type I with undiluted probe. In conclusion, the strength of the fluorescence signal of the LightCycler (R) 480 type 111 is superior to that of LightCycler (R) 480 types I and II, allowing the use of lower probe concentrations for all dyes, particularly for the dyes Red610 and Cy5. This results in a two thirds reduction in PCR probe costs. Switching to these newer machines for real-time PCR can reduce dye labelled probe consumption and thus reduce costs significantly.	[Dullaert-de Boer, Maria; Hess, Dorine L. J.; van der Zanden, Adri G. M.] Lab Med Microbiol & Publ Hlth, Hengelo, Netherlands; [Akkerman, Onno W.; Kerstjens, Huib A. M.; van der Werf, Tjip S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Groningen, Netherlands; [Vermeer, Marloes] ZGT Acad, ZGT, Almelo, Netherlands; [Anthony, Richard M.; van Soolingen, Dick] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Res Diagnost & Perinatal Screening, TB Reference Lab, Bilthoven, Netherlands; [van der Werf, Tjip S.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands	University of Groningen; Netherlands National Institute for Public Health & the Environment; University of Groningen	Dullaert-de Boer, M (corresponding author), Lab Med Microbiol & Publ Hlth, Hengelo, Netherlands.	m.deboer@labmicta.nl	Anthony, Richard/AAP-3406-2020; Kerstjens, Huib/N-4754-2017	Anthony, Richard/0000-0002-0550-5273; Kerstjens, Huib/0000-0001-7705-7927; Akkerman, Onno/0000-0001-5638-9260				Akkerman OW, 2013, J CLIN MICROBIOL, V51, P3505, DOI 10.1128/JCM.00843-13; Best EL, 2003, FEMS MICROBIOL LETT, V229, P237, DOI 10.1016/S0378-1097(03)00845-0; Brown NA, 2011, INFECT DIS REP, V3, P15, DOI 10.4081/idr.2011.e5; Brownie J, 1997, NUCLEIC ACIDS RES, V25, P3235, DOI 10.1093/nar/25.16.3235; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Buzard GS, 2012, FORENSIC SCI INT, V223, P292, DOI 10.1016/j.forsciint.2012.10.003; Chang SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054564; Exner MM, 2002, MOL CELL PROBE, V16, P351, DOI 10.1006/mcpr.2002.0433; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Ibrahim A, 1997, J CLIN MICROBIOL, V35, P1636, DOI 10.1128/JCM.35.6.1636-1638.1997; Jaramillo-Gutierrez G, 2013, J VIROL METHODS, V190, P53, DOI 10.1016/j.jviromet.2013.02.010; LEE LG, 1993, NUCLEIC ACIDS RES, V21, P3761, DOI 10.1093/nar/21.16.3761; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Malorny B, 2004, APPL ENVIRON MICROB, V70, P7046, DOI 10.1128/AEM.70.12.7046-7052.2004; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; Raymaekers M, 2009, J CLIN LAB ANAL, V23, P145, DOI 10.1002/jcla.20307; RYCHLIK W, 1995, MOL BIOTECHNOL, V3, P129, DOI 10.1007/BF02789108; Schuurman T, 2007, J MICROBIOL METH, V70, P406, DOI 10.1016/j.mimet.2007.05.016; Singh I, 2004, J MED MICROBIOL, V53, P1065, DOI 10.1099/jmm.0.45527-0; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; Thiem VD, 2004, J CLIN MICROBIOL, V42, P2031, DOI 10.1128/JCM.42.5.2031-2035.2004; Thompson PP, 2011, OPHTHALMOLOGY, V118, P1449, DOI 10.1016/j.ophtha.2010.12.004; Verweij JJ, 2007, MOL CELL PROBE, V21, P400, DOI 10.1016/j.mcp.2007.05.006; Verweij JJ, 2004, J CLIN MICROBIOL, V42, P1220, DOI 10.1128/JCM.42.3.1220-1223.2004; Wannet WJB, 2001, J CLIN MICROBIOL, V39, P4483, DOI 10.1128/JCM.39.12.4483-4486.2001; Wilkins W, 2010, ZOONOSES PUBLIC HLTH, V57, P121, DOI 10.1111/j.1863-2378.2010.01366.x	27	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190847	10.1371/journal.pone.0190847	http://dx.doi.org/10.1371/journal.pone.0190847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329324	Green Published, Green Submitted, gold			2022-12-26	WOS:000419954100024
J	Ban, MJ; Kim, WS; Park, KN; Kim, JW; Lee, SW; Hans, K; Chang, JW; Byeon, HK; Koh, YW; Park, JH				Ban, Myung Jin; Kim, Won Shik; Park, Ki Nam; Kim, Jae Wook; Lee, Seung Won; Hans, Kyungdo; Chang, Jae Won; Byeon, Hyung Kwon; Koh, Yoon Woo; Park, Jae Hong			Korean survey data reveals an association of chronic laryngitis with tinnitus in men	PLOS ONE			English	Article							GASTROESOPHAGEAL REFLUX DISEASE; METABOLIC SYNDROME; NERVE-STIMULATION; DISORDERS; INSOMNIA; APNEA; SLEEP	The association between chronic laryngitis and tinnitus is not a well- studied topic, unlike the association of these two conditions with many other disorders. Cross- sectional data of 11,347 adults (males: 4,934; females: 6,413), who completed the Korea National Health and Nutrition Examination Survey (KNHANES) from 2010 to 2012 were used to investigate this association. Lifestyle patterns, including smoking and alcohol habits, regular exercise, physical and mental health status, socioeconomic status, nutritional status, and other chronic diseases, were analyzed. Chronic laryngitis and tinnitus were diagnosed by field survey teams, which included otolaryngologists, who conducted chronic disease surveillance using a health status interview, a nutritional status questionnaire, and a physical examination. Chronic laryngitis was significantly associated with age, education beyond high school, depressed mood, voice change, metabolic syndrome, and tinnitus in men. In women, chronic laryngitis was associated with body mass index and diabetes mellitus. Chronic laryngitis in men was significantly associated with tinnitus (odds ratio 1.671, [95% confidence interval: 1.167 +/- 2.393]) after adjusting for age, body mass index, smoking status, alcohol intake, regular exercise, metabolic syndrome, education beyond high school, and depressed mood. Additionally, the prevalence of chronic laryngitis increased with increasing severity of tinnitus in men alone (P = 0.002). The study revealed a significant association between chronic laryngitis and tinnitus.	[Ban, Myung Jin; Park, Jae Hong] Soonchunhyang Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Cheonan, South Korea; [Ban, Myung Jin] Yonsei Univ, Grad Sch, Dept Med, Seoul, South Korea; [Kim, Won Shik; Byeon, Hyung Kwon; Koh, Yoon Woo] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Park, Ki Nam; Lee, Seung Won] Soonchunhyang Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Bucheon, South Korea; [Kim, Jae Wook] Soonchunhyang Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Hans, Kyungdo] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Chang, Jae Won] Chungnam Natl Univ, Coll Med, Dept Otorhinolaryngol, Daejeon, South Korea	Soonchunhyang University; Yonsei University; Yonsei University; Yonsei University Health System; Soonchunhyang University; Soonchunhyang University; Catholic University of Korea; Chungnam National University	Park, JH (corresponding author), Soonchunhyang Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Cheonan, South Korea.	entparkong@hanmail.net	Chang, Jae Won/R-3511-2019; Ban, Myung Jin/B-4619-2016	Ban, Myung Jin/0000-0003-2069-2422; Chang, Jae Won/0000-0002-6596-931X; PARK, JAE HONG/0000-0002-5409-5581; LEE, SEUNGWON/0000-0002-0468-8143	Soonchunhyang University Research Fund	Soonchunhyang University Research Fund	This work was supported by the Soonchunhyang University Research Fund. (URL: http://sanhak.sch.ac.kr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; BRADLEY LA, 1993, AM J GASTROENTEROL, V88, P11; Broekaert D, 2006, ALIMENT PHARM THER, V23, P365, DOI 10.1111/j.1365-2036.2006.02772.x; Dworkin JP, 2008, OTOLARYNG CLIN N AM, V41, P419, DOI 10.1016/j.otc.2007.11.011; Ervin R. B., 2009, NATL HLTH STAT REPOR, P1; Geocze L, 2013, BRAZ J OTORHINOLAR, V79, P106, DOI 10.5935/1808-8694.20130018; Jalali MM, 2009, MED SCI MONITOR, V15, pPI55; Joo YH, 2015, OBESITY FACTS, V8, P252, DOI 10.1159/000437004; Joo YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133180; Joo YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131247; Jung Hye-Kyung, 2010, J Neurogastroenterol Motil, V16, P22, DOI 10.5056/jnm.2010.16.1.22; Kim CS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001890; Kim Yangho, 2013, J Prev Med Public Health, V46, P96, DOI 10.3961/jpmph.2013.46.2.96; KOUFMAN JA, 1991, LARYNGOSCOPE, V101, P1; Krog NH, 2010, J PSYCHOSOM RES, V69, P289, DOI 10.1016/j.jpsychores.2010.03.008; Lee BE, 2012, WORLD J GASTROENTERO, V18, P2462, DOI 10.3748/wjg.v18.i20.2462; Lehtimaki J, 2013, ACTA OTO-LARYNGOL, V133, P378, DOI 10.3109/00016489.2012.750736; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Moller Aage R, 2016, Int J Otolaryngol, V2016, P2830157, DOI 10.1155/2016/2830157; Ohayon MM, 2003, J PSYCHIAT RES, V37, P9, DOI 10.1016/S0022-3956(02)00052-3; Okuyama M, 2017, SCAND J GASTROENTERO, V52, P44, DOI 10.1080/00365521.2016.1224383; Payne RJ, 2006, OTOLARYNG HEAD NECK, V134, P836, DOI 10.1016/j.otohns.2006.01.012; Pinto PCL, 2014, J LARYNGOL OTOL, V128, P660, DOI 10.1017/S0022215114001030; Reulbach TR, 2001, OTOLARYNG HEAD NECK, V124, P448, DOI 10.1067/mhn.2001.114256; Shaffer MJ, 2005, ANN OTO RHINOL LARYN, V114, P7, DOI 10.1177/000348940511400103; Stein DJ, 2013, ANN OTO RHINOL LARYN, V122, P771, DOI 10.1177/000348941312201207; Suganuma N, 2001, PSYCHIAT CLIN NEUROS, V55, P255, DOI 10.1046/j.1440-1819.2001.00848.x; Wallhausser-Franke E, 2013, SLEEP MED REV, V17, P65, DOI 10.1016/j.smrv.2012.04.003; WARD PH, 1982, LARYNGOSCOPE, V92, P1377; Ylikoski J, 2017, ACTA OTO-LARYNGOL, V137, P426, DOI 10.1080/00016489.2016.1269197	30	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191148	10.1371/journal.pone.0191148	http://dx.doi.org/10.1371/journal.pone.0191148			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324903	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400122
J	Turner, A; Fischer, M; Tzanopoulos, J				Turner, Anthony; Fischer, Michael; Tzanopoulos, Joseph			Sound-mapping a coniferous forest-Perspectives for biodiversity monitoring and noise mitigation	PLOS ONE			English	Article							BIRD COMMUNITIES; VEGETATION STRUCTURE; PLANTATION FORESTS; TEMPERATE FOREST; SPECIES RICHNESS; ACOUSTIC INDEXES; DIVERSITY; CONSERVATION; INDICATORS; ECOLOGY	Acoustic diversity indices have been proposed as low-cost biodiversity monitoring tools. The acoustic diversity of a soundscape can be indicative of the richness of an acoustic community and the structural/vegetation characteristics of a habitat. There is a need to apply these methods to landscapes that are ecologically and/or economically important. We investigate the relationship between the acoustic properties of a coniferous forest with stand-age and structure. We sampled a 73 point grid in part of the UK's largest man-made lowland coniferous plantation forest, covering a 320ha mosaic of different aged stands. Forest stands ranged from 0-85 years old providing an age-gradient. Short soundscape recordings were collected from each grid point on multiple mornings (between 6am-11am) to capture the dawn chorus. We repeated the study during July/August in 2014 and again in 2015. Five acoustic indices were calculated for a total of 889 two minute samples. Moderate relationships between acoustic diversity with forest stand-age and vegetation characteristics (canopy height; canopy cover) were observed. Ordinations suggest that as structural complexity and forest age increases, the higher frequency bands (4-10KHz) become more represented in the soundscape. A strong linear relationship was observed between distance to the nearest road and the ratio of anthropogenic noise to biological sounds within the soundscape. Similar acoustic patterns were observed in both years, though acoustic diversity was generally lower in 2014, which was likely due to differences in wind conditions between years. Our results suggest that developing these relatively low-cost acoustic monitoring methods to inform adaptive management of production landscapes, may lead to improved biodiversity monitoring. The methods may also prove useful for modelling road noise, landscape planning and noise mitigation.	[Turner, Anthony; Fischer, Michael; Tzanopoulos, Joseph] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Turner, Anthony; Fischer, Michael; Tzanopoulos, Joseph] Univ Kent, Kents Interdisciplinary Ctr Spatial Studies KISS, Canterbury, Kent, England	University of Kent; University of Kent	Turner, A (corresponding author), Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.; Turner, A (corresponding author), Univ Kent, Kents Interdisciplinary Ctr Spatial Studies KISS, Canterbury, Kent, England.	at417@kent.ac.uk		Turner, Anthony/0000-0001-9736-7666	GTA/PhD studentship; University of Kent 50 Year Anniversary GTA Scholarship; Durrell Institute of Conservation and Ecology; Durrell Institute of Conservation and Ecology (DICE) at the University of Kent	GTA/PhD studentship; University of Kent 50 Year Anniversary GTA Scholarship; Durrell Institute of Conservation and Ecology; Durrell Institute of Conservation and Ecology (DICE) at the University of Kent	The authors received no specific funding for the study. AT used his bursary/salary from his GTA/PhD studentship to buy equipment for the study. Due to this the authors acknowledge the University of Kent 50 Year Anniversary GTA Scholarship, which AT was supported by. They also acknowledge the Durrell Institute of Conservation and Ecology who provide a yearly small bursary to all PhD students to contribute to their studies. AT used this to purchase recording equipment for this study.; We would like to thank the Forestry Commission for allowing us to conduct this research. We are especially grateful to Neal Armour-Chelu and Nicky Russell at the Forestry Commission in Santon Downham. Funding from The Durrell Institute of Conservation and Ecology (DICE) at the University of Kent enabled this research project to be realised.	Alvarsson JJ, 2010, INT J ENV RES PUB HE, V7, P1036, DOI 10.3390/ijerph7031036; Angelstam P, 2013, AMBIO, V42, P129, DOI 10.1007/s13280-012-0368-0; Armour-Chelu N, 2014, OPEN HABITAT IMPLEME; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Bennett VJ, 2013, J WILDLIFE MANAGE, V77, P93, DOI 10.1002/jwmg.467; Boelman NT, 2007, ECOL APPL, V17, P2137, DOI 10.1890/07-0004.1; Bormpoudakis D, 2013, LANDSCAPE ECOL, V28, P495, DOI 10.1007/s10980-013-9849-1; Boudreault LE, 2015, AGR FOREST METEOROL, V201, P86, DOI 10.1016/j.agrformet.2014.10.014; Bradley BA, 2012, ECOL MODEL, V244, P57, DOI 10.1016/j.ecolmodel.2012.06.019; Brandes TS, 2005, TROPICAL ECOLOGY ASS; Buckland ST, 2005, PHILOS T R SOC B, V360, P243, DOI 10.1098/rstb.2004.1589; Calladine J, 2015, FOREST ECOL MANAG, V344, P20, DOI 10.1016/j.foreco.2015.02.017; Chiste MN, 2016, LOSERS WINNERS OPPOR, V7, P1; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; Coote L, 2013, ECOL INDIC, V32, P107, DOI 10.1016/j.ecolind.2013.03.020; Donald PF, 1997, BIRD STUDY, V44, P206, DOI 10.1080/00063659709461056; Duarte MHL, 2015, BIOL CONSERV, V191, P623, DOI 10.1016/j.biocon.2015.08.006; Dumyahn SL, 2011, LANDSCAPE ECOL, V26, P1327, DOI 10.1007/s10980-011-9635-x; Edwards DP, 2012, BIOL CONSERV, V151, P60, DOI 10.1016/j.biocon.2012.01.017; ESRI, 2014, ARCGIS DESKT VERS 10; Farina A, 2016, BIOSEMIOTICS-NETH, V9, P227, DOI 10.1007/s12304-016-9266-3; Farina A, 2014, URBAN ECOSYST, V17, P923, DOI 10.1007/s11252-014-0365-0; Farina A, 2016, BIOSYSTEMS, V147, P11, DOI 10.1016/j.biosystems.2016.05.011; Farina A, 2014, ECOL INFORM, V21, P120, DOI 10.1016/j.ecoinf.2013.10.008; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Forest Stewardship Council, 2015, FSC INT STAND FSC PR; Forestry Commission, 2011, STAND TIMB VOL CON T; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gasc A, 2013, ECOL INDIC, V25, P279, DOI 10.1016/j.ecolind.2012.10.009; Goetz S, 2007, REMOTE SENS ENVIRON, V108, P254, DOI 10.1016/j.rse.2006.11.016; Goines L, 2007, SOUTH MED J, V100, P287, DOI 10.1097/SMJ.0b013e3180318be5; Guynn DC, 2004, J FOREST, V102, P46; Han XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100380; Holt DE, 2015, BIOL CONSERV, V187, P27, DOI 10.1016/j.biocon.2015.04.004; Humphrey JW, 1999, FOREST ECOL MANAG, V113, P11, DOI 10.1016/S0378-1127(98)00413-7; Humphrey JW, 2005, FORESTRY, V78, P33, DOI 10.1093/forestry/cpi004; IBM Corp. Released, 2015, IBM SPSS STAT WINDOW; Irvine KN, 2009, LOCAL ENVIRON, V14, P155, DOI 10.1080/13549830802522061; JAMES FC, 1982, ECOLOGY, V63, P159, DOI 10.2307/1937041; Jung K, 2012, J APPL ECOL, V49, P523, DOI 10.1111/j.1365-2664.2012.02116.x; Kasten EP, 2012, ECOL INFORM, V12, P50, DOI 10.1016/j.ecoinf.2012.08.001; Kerr G., 2011, THINNING PRACTICE SI; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2011, TRENDS ECOL EVOL, V26, P474, DOI 10.1016/j.tree.2011.05.009; Krause BL, 1993, NICHE HYPOTHESIS SOU, P1; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; Leyequien E, 2007, INT J APPL EARTH OBS, V9, P1, DOI 10.1016/j.jag.2006.08.002; Li Qing, 2010, Environmental Health and Preventive Medicine, V15, P9, DOI 10.1007/s12199-008-0068-3; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Mason W., 1999, WHAT IS CONTINUOUS C; McClure CJW, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2290; Merchan CI, 2014, LANDSCAPE URBAN PLAN, V123, P1, DOI 10.1016/j.landurbplan.2013.11.006; Muller J, 2009, J APPL ECOL, V46, P897, DOI 10.1111/j.1365-2664.2009.01677.x; Noss RF, 1999, FOREST ECOL MANAG, V115, P135, DOI 10.1016/S0378-1127(98)00394-6; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; PARRIS KM, 2009, ECOL SOC, V14; Pekin BK, 2012, LANDSCAPE ECOL, V27, P1513, DOI 10.1007/s10980-012-9806-4; Pieretti N, 2011, ECOL INDIC, V11, P868, DOI 10.1016/j.ecolind.2010.11.005; Pijanowski BC, 2011, LANDSCAPE ECOL, V26, P1213, DOI 10.1007/s10980-011-9600-8; R-Core-Team, 2015, LANG ENV STAT COMP; Roberts D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S15-I1; Robinson DJ, 2002, ADV INSECT PHYSIOL, V29, P151, DOI 10.1016/S0065-2806(02)29003-7; Saadatmand V, 2013, INT J NURS STUD, V50, P895, DOI 10.1016/j.ijnurstu.2012.11.018; Shannon G, 2014, ANIM BEHAV, V94, P135, DOI 10.1016/j.anbehav.2014.06.004; Slabbekoorn H, 2003, NATURE, V424, P267, DOI 10.1038/424267a; Slabbekoorn H, 2008, MOL ECOL, V17, P72, DOI 10.1111/j.1365-294X.2007.03487.x; Spellerberg IANF, 1998, ECOLOGICAL EFFECTS R, P317; Sueur J, 2012, GLOBAL ESTIMATION AN, P99; Sueur J, 2014, ACTA ACUST UNITED AC, V100, P772, DOI 10.3813/AAA.918757; Sueur J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004065; Takahashi R, 2014, ENVIRON IMPACT ASSES, V44, P76, DOI 10.1016/j.eiar.2013.10.002; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Towsey M, 2014, ECOL INFORM, V21, P110, DOI 10.1016/j.ecoinf.2013.11.007; Towsey M, 2014, ECOL INFORM, V21, P1, DOI 10.1016/j.ecoinf.2014.02.002; Trombulak SC, 2016, REV ECOLOGICAL EFFEC, V14, P18; Villanueva-Rivera LJ, 2014, R PACKAGE SOUNDECOLO; Villanueva-Rivera LJ, 2011, LANDSCAPE ECOL, V26, P1233, DOI 10.1007/s10980-011-9636-9; Waber K, 2013, J WILDLIFE MANAGE, V77, P726, DOI 10.1002/jwmg.530; Waldon J, 2011, TROP CONSERV SCI, V4, P254, DOI 10.1177/194008291100400303; Weiss N, 2013, BIODIVERS CONSERV, V22, P2167, DOI 10.1007/s10531-012-0398-8	82	25	26	9	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0189843	10.1371/journal.pone.0189843	http://dx.doi.org/10.1371/journal.pone.0189843			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320514	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000419689600019
J	Carmalt, JL; Mortazavi, S; McOnie, RC; Allen, AL; Unniappan, S				Carmalt, James L.; Mortazavi, Sima; McOnie, Rebecca C.; Allen, Andrew L.; Unniappan, Suraj			Profiles of pro-opiomelanocortin and encoded peptides, and their processing enzymes in equine pituitary pars intermedia dysfunction	PLOS ONE			English	Article							MELANOCYTE-STIMULATING HORMONE; HEALTHY HORSES; CUSHINGS-DISEASE; CLINICAL SIGNS; CORTISOL; ACTH	Equine pituitary pars intermedia dysfunction (PPID) is characterized by hyperplasia of the pars intermedia (PI) melanotrophs of the pituitary gland (PG), and increased production of proopiomelanocortin (POMC). POMC is cleaved by prohormone convertase 1 (PC1) to produce adrenocorticotropic hormone (ACTH), and further processing of ACTH by PC2 to produce alpha-melanocyte stimulating hormone (alpha-MSH) and corticotropin-like intermediate peptide (CLIP). High plasma ACTH concentrations in horses with PPID might be related to reduced conversion of ACTH to alpha-MSH by PCs. The hypothesis of this study was that PC1 and PC2 expression in the pituitary gland are altered in PPID, resulting in an abnormal relative abundance of POMC derived proteins. The objectives of this study were to identify the partial sequences of equine POMC, PC1, and PC2 mRNAs; and to determine whether the expression of POMC, PC1, and PC2 mRNAs in whole pituitary extracts, and POMC-protein in the cavernous sinus blood of horses are altered in PPID. We confirmed (RT-PCR and sequencing) that the partial sequences obtained match the corresponding regions of predicted equine POMC, PC1 and PC2 sequences. The expression (quantification by RT-qPCR) of POMC, PC1 and PC2 mRNAs were found upregulated in the pituitary of horses with PPID. Plasma (measured using RIA/ELISA) ACTH and alpha-MSH were elevated in PPID horses. These results indicate distinct differences in gene and protein expression of POMC and its intermediates, and processing enzymes in PPID. It provides evidence to support the notion that local, pituitary-specific inadequacies in prohormone processing likely contribute to equine PPID.	[Carmalt, James L.; McOnie, Rebecca C.] Univ Saskatchewan, Dept Large Anim Clin Sci, Western Coll Vet Med, Saskatoon, SK, Canada; [Mortazavi, Sima; Unniappan, Suraj] Univ Saskatchewan, Dept Vet Biomed Sci, Lab Integrat Neuroendocrinol, Western Coll Vet Med, Saskatoon, SK, Canada; [Allen, Andrew L.] Univ Saskatchewan, Dept Vet Pathol, Western Coll Vet Med, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Carmalt, JL (corresponding author), Univ Saskatchewan, Dept Large Anim Clin Sci, Western Coll Vet Med, Saskatoon, SK, Canada.	james.carmalt@usask.ca		McOnie, Rebecca/0000-0002-6868-9735	Townsend Equine Health Research Fund; Western College of Veterinary Medicine, University of Saskatchewan	Townsend Equine Health Research Fund; Western College of Veterinary Medicine, University of Saskatchewan	This research was funded by the Townsend Equine Health Research Fund, and the Western College of Veterinary Medicine, University of Saskatchewan to SU, JLC, and ALA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additionally, there was no additional external funding received for this study.	Beech J, 2013, J AM VET MED ASSOC, V27, P73; Cordero M, 2012, DOMEST ANIM ENDOCRIN, V43, P317, DOI 10.1016/j.domaniend.2012.05.005; Couetil L, 1996, J VET INTERN MED, V10, P1, DOI 10.1111/j.1939-1676.1996.tb02016.x; ENGLER D, 1990, ENDOCRINOLOGY, V127, P1956, DOI 10.1210/endo-127-4-1956; Gehlert D R, 1988, Peptides, V9 Suppl 1, P161, DOI 10.1016/0196-9781(88)90240-9; IRVINE CHG, 1987, J ENDOCRINOL, V113, P183, DOI 10.1677/joe.0.1130183; Klein Claudia, 2011, BMC Res Notes, V4, P120, DOI 10.1186/1756-0500-4-120; Lee ZY, 2010, VET J, V185, P58, DOI 10.1016/j.tvjl.2010.04.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McFarlane D, 2005, J NEUROENDOCRINOL, V17, P73, DOI 10.1111/j.1365-2826.2005.01277.x; McFarlane D, 2006, DOMEST ANIM ENDOCRIN, V30, P276, DOI 10.1016/j.domaniend.2005.07.005; McGowan TW, 2013, EQUINE VET J, V45, P74, DOI 10.1111/j.2042-3306.2012.00578.x; MILLINGTON WR, 1988, ENDOCRINOLOGY, V123, P1598, DOI 10.1210/endo-123-3-1598; ORTH DN, 1982, ENDOCRINOLOGY, V110, P1430, DOI 10.1210/endo-110-4-1430; Saiardi A, 1998, MOL ENDOCRINOL, V12, P1133, DOI 10.1210/me.12.8.1133; Samuels ME, 2013, J CLIN ENDOCR METAB, V98, P736, DOI 10.1210/jc.2012-3199	16	7	7	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2018	13	1							e0190796	10.1371/journal.pone.0190796	http://dx.doi.org/10.1371/journal.pone.0190796			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS0GW	29309431	Green Submitted, Green Published, gold			2022-12-26	WOS:000419453100016
J	Beqollari, D; Dockstader, K; Bannister, RA				Beqollari, Donald; Dockstader, Karen; Bannister, Roger A.			A skeletal muscle L-type Ca2+ channel with a mutation in the selectivity filter (Ca(v)1.1 E1014K) conducts K+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CONCENTRATION CHANGES; DIHYDROPYRIDINE RECEPTOR; SARCOPLASMIC-RETICULUM; TRANSVERSE TUBULES; CALCIUM-CHANNELS; EXCITATION-FREQUENCY; CHARGE MOVEMENT; DYSGENIC MUSCLE; CONTRACTION; CURRENTS	A glutamate-to-lysine substitution at position 1014 within the selectivity filter of the skeletal muscle L-type Ca2+ channel (Ca(v)1.1) abolishes Ca2+ flux through the channel pore. Mice engineered to exclusively express the mutant channel display accelerated muscle fatigue, changes in muscle composition, and altered metabolism relative to wildtype littermates. By contrast, mice expressing another mutant Ca(v)1.1 channel that is impermeable to Ca2+ (Ca(v)1.1 N617D) have shown no detectable phenotypic differences from wildtype mice to date. The major biophysical difference between the Ca(v)1.1 E1014K and Ca(v)1.1 N617D mutants elucidated thus far is that the former channel conducts robust Ne+ and Cs+ currents in patch-clamp experiments, but neither of these monovalent conductances seems to be of relevance in vivo. Thus, the basis for the different phenotypes of these mutants has remained enigmatic. We now show that Cav1.1 E1014K readily conducts 1,4-dihydropyridine-sensitive K+ currents at depolarizing test potentials, whereas Ca(v)1.1 N617D does not. Our observations, coupled with a large body of work by others regarding the role of K+ accumulation in muscle fatigue, raise the possibility that the introduction of an additional K+ flux from the myoplasm into the transverse-tubule lumen accelerates the onset of fatigue and precipitates the metabolic changes observed in Ca(v)1.1 E1014K muscle. These results, highlighting an unexpected consequence of a channel mutation, may help define the complex mechanisms underlying skeletal muscle fatigue and related dysfunctions.	[Beqollari, Donald; Dockstader, Karen; Bannister, Roger A.] Univ Colorado, Sch Med, Dept Med, Div Cardiol, 12700 East 19th Ave,P15-8006,B-139, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Bannister, RA (corresponding author), Univ Colorado, Sch Med, Dept Med, Div Cardiol, 12700 East 19th Ave,P15-8006,B-139, Aurora, CO 80045 USA.	roger.bannister@ucdenver.edu			National Institutes of Health/National Center for Research Resources (NCCR) Colorado Clinical and Translational Sciences Institute (CCTSI) [UL1 RR025780]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER	National Institutes of Health/National Center for Research Resources (NCCR) Colorado Clinical and Translational Sciences Institute (CCTSI); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Acknowledgments We thank Drs. K.G. Beam, S.L. Hamilton, D. Oskar, S. Papadopoulos, and A.A. Voss for helpful discussions. We are also grateful to O. Moua for the generation of the YFP-Ca<INF>v</INF>1.1 N617D construct. Confocal images were acquired in the University of Colorado Advanced Light Microscopy Core with the expert assistance of Dr. R. Moldovan (who is funded in part by National Institutes of Health/National Center for Research Resources (NCCR) Colorado Clinical and Translational Sciences Institute (CCTSI) Grant UL1 RR025780).	ADRIAN RH, 1970, J PHYSIOL-LONDON, V208, P645, DOI 10.1113/jphysiol.1970.sp009140; ADRIAN RH, 1976, J PHYSIOL-LONDON, V254, P361, DOI 10.1113/jphysiol.1976.sp011236; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; ALMERS W, 1980, FED PROC, V39, P1527; ALMERS W, 1972, J PHYSIOL-LONDON, V225, P33, DOI 10.1113/jphysiol.1972.sp009928; ARMSTRONG CM, 1972, BIOCHIM BIOPHYS ACTA, V267, P605, DOI 10.1016/0005-2728(72)90194-6; Bannister RA, 2016, J EXP BIOL, V219, P175, DOI 10.1242/jeb.124123; Bannister RA, 2013, BIOPHYS J, V104, P1917, DOI 10.1016/j.bpj.2013.03.035; Bannister RA, 2011, CHANNELS, V5, P262, DOI 10.4161/chan.5.3.15269; Bannister RA, 2009, CHANNELS, V3, P268, DOI 10.4161/chan.3.4.9342; Bannister RA, 2009, J GEN PHYSIOL, V133, P79, DOI 10.1085/jgp.200810105; BEAM KG, 1983, J GEN PHYSIOL, V81, P513, DOI 10.1085/jgp.81.4.513; BEAN BP, 1984, P NATL ACAD SCI-BIOL, V81, P6388, DOI 10.1073/pnas.81.20.6388; Benedetti B, 2015, BIOPHYS J, V108, P1072, DOI 10.1016/j.bpj.2015.01.026; Beqollari D, 2015, PFLUG ARCH EUR J PHY, V467, P2299, DOI 10.1007/s00424-015-1700-x; BIGLANDRITCHIE B, 1979, EXP NEUROL, V64, P414, DOI 10.1016/0014-4886(79)90280-2; Dayal A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00629-x; DiFranco M, 2015, J PHYSIOL-LONDON, V593, P1213, DOI 10.1113/jphysiol.2014.283648; DiFranco M, 2012, J GEN PHYSIOL, V140, P109, DOI 10.1085/jgp.201210802; Dirksen RT, 1999, J GEN PHYSIOL, V114, P393, DOI 10.1085/jgp.114.3.393; DONALDSON PL, 1983, J GEN PHYSIOL, V82, P449, DOI 10.1085/jgp.82.4.449; Filatov GN, 2005, J GEN PHYSIOL, V126, P161, DOI 10.1085/jgp.200509337; FLUCHER BE, 1993, J CELL BIOL, V123, P1161, DOI 10.1083/jcb.123.5.1161; Fortune E, 2009, ANN BIOMED ENG, V37, P2105, DOI 10.1007/s10439-009-9756-4; FREYGANG WH, 1964, J GEN PHYSIOL, V48, P235, DOI 10.1085/jgp.48.2.235; FREYGANG WH, 1964, J GEN PHYSIOL, V47, P929, DOI 10.1085/jgp.47.5.929; Georgiou DK, 2015, J BIOL CHEM, V290, P23751, DOI 10.1074/jbc.M115.643544; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; JONES DA, 1979, EXP NEUROL, V64, P401, DOI 10.1016/0014-4886(79)90279-6; JUEL C, 1986, PFLUG ARCH EUR J PHY, V406, P458, DOI 10.1007/BF00583367; KIRSCH GE, 1977, J GEN PHYSIOL, V70, P1, DOI 10.1085/jgp.70.1.1; Lee CS, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-014-0027-1; Leuranguer V, 2003, J GEN PHYSIOL, V121, P541, DOI 10.1085/jgp.200308833; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Meza U, 2013, BIOCHEM BIOPH RES CO, V439, P270, DOI 10.1016/j.bbrc.2013.08.044; NAKAJIMA S, 1973, J PHYSIOL-LONDON, V234, P465, DOI 10.1113/jphysiol.1973.sp010355; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; PEACHEY LD, 1965, J CELL BIOL, V25, P209, DOI 10.1083/jcb.25.3.209; PETERSON BZ, 1995, J BIOL CHEM, V270, P18201, DOI 10.1074/jbc.270.31.18201; Pirkmajer S, 2016, AM J PHYSIOL-ENDOC M, V311, pE1, DOI 10.1152/ajpendo.00539.2015; Polster A, 2015, P NATL ACAD SCI USA, V112, P602, DOI 10.1073/pnas.1423113112; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; Robin G, 2015, J PHYSIOL-LONDON, V593, P4781, DOI 10.1113/JP270252; SCHNEIDER MF, 1973, NATURE, V242, P244, DOI 10.1038/242244a0; Schredelseker J, 2010, P NATL ACAD SCI USA, V107, P5658, DOI 10.1073/pnas.0912153107; Schrotter K, 2017, CELL CALCIUM, V61, P22, DOI 10.1016/j.ceca.2016.10.002; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Wallinga W, 1999, EUR BIOPHYS J BIOPHY, V28, P317, DOI 10.1007/s002490050214; WESTERBLAD H, 1990, PFLUG ARCH EUR J PHY, V415, P734, DOI 10.1007/BF02584013	50	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3126	3133		10.1074/jbc.M117.812446	http://dx.doi.org/10.1074/jbc.M117.812446			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29326166	Green Published, hybrid			2022-12-26	WOS:000426562800008
J	Nguyen, TT; Ghirlando, R; Venditti, V				Nguyen, Trang T.; Ghirlando, Rodolfo; Venditti, Vincenzo			The oligomerization state of bacterial enzyme I (EI) determines EI's allosteric stimulation or competitive inhibition by alpha-ketoglutarate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUGAR PHOSPHOTRANSFERASE SYSTEM; N-TERMINAL DOMAIN; ESCHERICHIA-COLI; SEDIMENTATION-VELOCITY; PHOSPHOCARRIER PROTEIN; SALMONELLA-TYPHIMURIUM; PHOSPHOENOLPYRUVATE; PHOSPHORYLATION; EQUILIBRIUM; HPR	The bacterial phosphotransferase system (PTS) is a signal transduction pathway that couples phosphoryl transfer to active sugar transport across the cell membrane. The PTS is initiated by phosphorylation of enzyme I (EI) by phosphoenolpyruvate (PEP). The EI phosphorylation state determines the phosphorylation states of all other PTS components and is thought to play a central role in the regulation of several metabolic pathways and to control the biology of bacterial cells at multiple levels, for example, affecting virulence and biofilm formation. Given the pivotal role of EI in bacterial metabolism, an improved understanding of the mechanisms controlling its activity could inform future strategies for bioengineering and antimicrobial design. Here, we report an enzymatic assay, based on Selective Optimized Flip Angle Short Transient (SOFAST) NMR experiments, to investigate the effect of the small-molecule metabolite alpha-ketoglutarate (alpha KG) on the kinetics of the EI-catalyzed phosphoryl transfer reaction. We show that at experimental conditions favoring the monomeric form of EI, alpha KG promotes dimerization and acts as an allosteric stimulator of the enzyme. However, when the oligomerization state of EI is shifted toward the dimeric species, alpha KG functions as a competitive inhibitor of EI. We developed a kinetic model that fully accounted for the experimental data and indicated that bacterial cells might use the observed interplay between allosteric stimulation and competitive inhibition of EI by alpha KG to respond to physiological fluctuations in the intracellular environment. We expect that the mechanism for regulating EI activity revealed here is common to several other oligomeric enzymes.	[Nguyen, Trang T.; Venditti, Vincenzo] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Venditti, Vincenzo] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Ghirlando, Rodolfo] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Iowa State University; Iowa State University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Venditti, V (corresponding author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.	venditti@iastate.edu			Roy J. Carver Charitable Trust; Iowa State University; NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007] Funding Source: NIH RePORTER	Roy J. Carver Charitable Trust; Iowa State University; NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funds from the Roy J. Carver Charitable Trust and Iowa State University (to V. V.) and by the Intramural Research Program of the NIDDK, National Institutes of Health (to R. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBE KR, 1990, J THEOR BIOL, V143, P163, DOI 10.1016/S0022-5193(05)80266-8; Cabrera R, 2011, J BIOL CHEM, V286, P5774, DOI 10.1074/jbc.M110.163162; Chauvin F, 1996, RES MICROBIOL, V147, P471, DOI 10.1016/0923-2508(96)84001-0; Clore GM, 2013, TRENDS BIOCHEM SCI, V38, P515, DOI 10.1016/j.tibs.2013.08.003; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deutscher J, 2014, MICROBIOL MOL BIOL R, V78, P231, DOI 10.1128/MMBR.00001-14; Doucette CD, 2011, NAT CHEM BIOL, V7, P894, DOI [10.1038/NCHEMBIO.685, 10.1038/nchembio.685]; Garrett DS, 1999, NAT STRUCT BIOL, V6, P166; Ghirlando R, 2013, ANAL BIOCHEM, V440, P81, DOI 10.1016/j.ab.2013.05.011; Hogema BM, 1998, MOL MICROBIOL, V30, P487, DOI 10.1046/j.1365-2958.1998.01053.x; Kee JM, 2013, NAT CHEM BIOL, V9, P416, DOI [10.1038/NCHEMBIO.1259, 10.1038/nchembio.1259]; Klumpp S, 2002, EUR J BIOCHEM, V269, P1067, DOI 10.1046/j.1432-1033.2002.02755.x; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; LAGUNAS R, 1983, EUR J BIOCHEM, V137, P479, DOI 10.1111/j.1432-1033.1983.tb07851.x; Lee CR, 2013, MOL MICROBIOL, V88, P473, DOI 10.1111/mmi.12196; MATTOO RL, 1983, CAN J BIOCHEM CELL B, V61, P29, DOI 10.1139/o83-005; Meadow ND, 2005, BIOCHEMISTRY-US, V44, P12790, DOI 10.1021/bi0502846; Patel HV, 2006, J BIOL CHEM, V281, P17570, DOI 10.1074/jbc.M508965200; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Postma P.W., 1996, ESCHERICHIA COLI SAL, P1149; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seok YJ, 1998, BIOCHEM BIOPH RES CO, V250, P381, DOI 10.1006/bbrc.1998.9323; Suh JY, 2008, J BIOL CHEM, V283, P18980, DOI 10.1074/jbc.M802211200; Takayama Y, 2011, J AM CHEM SOC, V133, P424, DOI 10.1021/ja109866w; Teplyakov A, 2006, P NATL ACAD SCI USA, V103, P16218, DOI 10.1073/pnas.0607587103; Venditti V, 2015, P NATL ACAD SCI USA, V112, P11565, DOI 10.1073/pnas.1515366112; Venditti V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6960; Venditti V, 2013, ACS CHEM BIOL, V8, P1232, DOI 10.1021/cb400027q; Venditti V, 2012, J BIOL CHEM, V287, P26989, DOI 10.1074/jbc.M112.382291; WEIGEL N, 1982, J BIOL CHEM, V257, P4499; Zhao H., 2013, Curr. Protoc. Protein Sci., DOI [10.1002/0471140864.ps2012s71, DOI 10.1002/0471140864.PS2012S71]; Zhao HY, 2011, BIOPHYS J, V100, P2309, DOI 10.1016/j.bpj.2011.03.004	34	10	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 16	2018	293	7					2631	2639		10.1074/jbc.RA117.001466	http://dx.doi.org/10.1074/jbc.RA117.001466			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FW4TU	29317499	Green Published, hybrid			2022-12-26	WOS:000425308300033
J	Loeffert, ST; Vanhems, P; Tissot, E; Dananche, C; Cassier, P; Benet, T; Perraud, M; Thibaudon, M; Gustin, MP				Loeffert, Sophie Tiphaine; Vanhems, Philippe; Tissot, Estelle; Dananche, Cedric; Cassier, Pierre; Benet, Thomas; Perraud, Michel; Thibaudon, Michel; Gustin, Marie-Paule			Evaluation of Hirst-type spore traps in outdoor Aspergillaceae monitoring during large demolition work in hospital	PLOS ONE			English	Article							FUMIGATUS	Demolition can generate fungal spore suspensions in association with various adverse health effects, such as high risk of invasive aspergillosis in immunocompromised patients. One block of Edouard Herriot Hospital was entirely demolished. The aim of the present study was to evaluate Hirst-type spore traps utility in monitoring outdoor Aspergillaceae (Aspergillus spp. + Penicillium spp.) spores in part of Edouard Herriot Hospital (Lyon, France) undergoing major demolition. Three periods were scheduled in 2015: (A) Gutting of building and asbestos removal, (B) Demolition of floors, (C) Excavation and earthwork. Outdoor Aspergillaceae fungal load was monitored by cultivable (Air Ideal (R), bioMerieux) and non-cultivable methods (Lanzoni VPPS-2000, Analyzair (R), Bologna, Italy). Differences of Aspergillaceae recorded with Hirst-type spore traps were observed between Gerland and Edouard Herriot Hospital. Differences between Aspergillaceae were recorded between day time and night time at Gerland and Edouard Herriot Hospital. Daily paired differences between Aspergillaceae recorded with non-cultivable methodology at Edouard Herriot Hospital and in an area without demolition work were significant in Period A vs Period B (p = 10-4) and Period A vs Period C (p = 10 - 4). Weak correlation of daily Aspergillaceae recorded by both methods at Edouard Herriot Hospital was significant only for Period C (r = 0.26, p = 0.048, n = 58). Meteorological parameters and type of demolition works were found to heavily influenced Aspergillaceae dispersion. Non-cultivable methodology is a promising tool for outdoor Aspergillaceae scrutiny during major demolition work in hospital, helping infection control staff to rapidly implement control measures.	[Loeffert, Sophie Tiphaine; Vanhems, Philippe; Dananche, Cedric; Gustin, Marie-Paule] Univ Lyon 1, ENS Lyon, CIRI, CNRS UMR5308,INSERM U1111,Lab Pathogenes Emergent, Lyon, France; [Vanhems, Philippe; Dananche, Cedric; Benet, Thomas] Grp Hosp Edouard Herriot, Unite Hyg Epidemiol & Prevent, Lyon, France; [Tissot, Estelle] Analyzair, Lyon, France; [Cassier, Pierre; Perraud, Michel] Grp Hosp Edouard Herriot, Lab Biol Secur Environm, Lyon, France; [Thibaudon, Michel] Reseau Natl Surveillance Aerobiol, Brussieu, France; [Gustin, Marie-Paule] Univ Lyon 1, Fac Pharm, ISPB, Dept Sante Publ, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Loeffert, ST (corresponding author), Univ Lyon 1, ENS Lyon, CIRI, CNRS UMR5308,INSERM U1111,Lab Pathogenes Emergent, Lyon, France.	sophie.loeffert01@chu-lyon.fr		Dananche, Cedric/0000-0002-0791-6391	Laboratoires ANIOS	Laboratoires ANIOS	Laboratoires ANIOS provided funding in the form of salaries to first author ST Loeffert. Laboratoires ANIOS did not have any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. Additionally, Analyzair provided funding in the form of salaries to co-author Estelle Tissot. Analyzair did not have any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. Analyzair is the society to which we rent the Hirst collector. The lab technician (Estelle Tissot) from Analyzair was responsible for the implementation and control of the Hirst collector at our hospital. The specific roles of these authors are articulated in the 'author contributions' section.	Bellanger AP, 2012, J OCCUP ENVIRON HYG, V9, pD7, DOI 10.1080/15459624.2012.636727; Boff C, 2012, AM J INFECT CONTROL, V40, P1016, DOI 10.1016/j.ajic.2012.01.029; Brenier-Pinchart MP, 2009, AM J INFECT CONTROL, V37, P631, DOI 10.1016/j.ajic.2009.03.013; Bryant R.B., 1989, AEROBIOLOGIA, V5, P123; Dananche C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177263; Elvira-Rendueles B, 2013, ANN AGR ENV MED, V20, P664; Rodriguez SF, 2011, GRANA, V50, P202, DOI 10.1080/00173134.2011.596218; Fernandez-Rodriguez S, 2014, FUNGAL ECOL, V7, P16, DOI 10.1016/j.funeco.2013.11.004; Gangneux JP, 2012, J MYCOL MED, V22, P64, DOI 10.1016/j.mycmed.2012.01.003; Grinn-Gofron A, 2008, INT J BIOMETEOROL, V52, P859, DOI 10.1007/s00484-008-0182-3; Grinn-Gofron A, 2011, AEROBIOLOGIA, V27, P67, DOI 10.1007/s10453-010-9177-8; Hameed AAA, 2012, SCI TOTAL ENVIRON, V414, P696, DOI 10.1016/j.scitotenv.2011.10.042; HIRST JM, 1952, ANN APPL BIOL, V39, P257, DOI 10.1111/j.1744-7348.1952.tb00904.x; HOLM S, 1979, SCAND J STAT, V6, P65; Lang-Yona N, 2012, ATMOS CHEM PHYS, V12, P2681, DOI 10.5194/acp-12-2681-2012; Marr KA, 2002, INFECT DIS CLIN N AM, V16, P875, DOI 10.1016/S0891-5520(02)00035-1; STREIFEL AJ, 1983, APPL ENVIRON MICROB, V46, P375, DOI 10.1128/AEM.46.2.375-378.1983; Molina RT, 2013, GRANA, V52, P59, DOI 10.1080/00173134.2012.718359; Molina RT, 2010, GRANA, V49, P134, DOI 10.1080/00173131003617390; Vonberg RP, 2006, J HOSP INFECT, V63, P246, DOI 10.1016/j.jhin.2006.02.014	20	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191135	10.1371/journal.pone.0191135	http://dx.doi.org/10.1371/journal.pone.0191135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346411	Green Published, Green Submitted, gold			2022-12-26	WOS:000422749500031
J	Roux, D; Schaefers, M; Clark, BS; Weatherholt, M; Renaud, D; Scott, D; LiPuma, JJ; Priebe, G; Gerard, C; Yoder-Himes, DR				Roux, Damien; Schaefers, Matthew; Clark, Bradley S.; Weatherholt, Molly; Renaud, Diane; Scott, David; LiPuma, John J.; Priebe, Gregory; Gerard, Craig; Yoder-Himes, Deborah R.			A putative lateral flagella of the cystic fibrosis pathogen Burkholderia dolosa regulates swimming motility and host cytokine production	PLOS ONE			English	Article							HOMOSERINE LACTONE PRODUCTION; CEPACIA COMPLEX; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; ORNIBACTIN BIOSYNTHESIS; EPITHELIAL-CELLS; POLAR FLAGELLA; GENE-CLUSTER; SP-NOV.; CENOCEPACIA	Burkholderia dolosa caused an outbreak in the cystic fibrosis clinic at Boston Children's Hospital and was associated with high mortality in these patients. This species is part of a larger complex of opportunistic pathogens known as the Burkholderia cepacia complex (Bcc). Compared to other species in the Bcc, B. dolosa is highly transmissible; thus understanding its virulence mechanisms is important for preventing future outbreaks. The genome of one of the outbreak strains, AU0158, revealed a homolog of the lafA gene encoding a putative lateral flagellin, which, in other non-Bcc species, is used for movement on solid surfaces, attachment to host cells, or movement inside host cells. Here, we analyzed the conservation of the lafA gene and protein sequences, which are distinct from those of the polar flagella, and found lafA homologs to be present in numerous beta-proteobacteria but notably absent from most other Bcc species. A lafA deletion mutant in B. dolosa showed a greater swimming motility than wild-type due to an increase in the number of polar flagella, but did not appear to contribute to biofilm formation, host cell invasion, or murine lung colonization or persistence over time. However, the lafA gene was important for cytokine production in human peripheral blood mononuclear cells, suggesting it may have a role in recognition by the human immune response.	[Clark, Bradley S.; Weatherholt, Molly; Yoder-Himes, Deborah R.] Univ Louisville, Dept Biol, Louisville, KY 40292 USA; [Roux, Damien] INSERM, IAME, UMR 1137, Paris, France; [Roux, Damien] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Roux, Damien] Louis Mourier Hosp, AP HP, Intens Care Unit, Colombes, France; [Schaefers, Matthew; Priebe, Gregory] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Div Crit Care Med, Boston, MA USA; [Schaefers, Matthew; Priebe, Gregory] Harvard Med Sch, Dept Anesthesia, Boston, MA USA; [Renaud, Diane; Scott, David] Univ Louisville, Sch Dent, Oral Immunol & Infect Dis, Louisville, KY 40292 USA; [LiPuma, John J.] Univ Michigan, Div Pediat, Ann Arbor, MI 48109 USA; [Gerard, Craig] Boston Childrens Hosp, Div Resp Dis, Boston, MA USA	University of Louisville; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Louisville; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital	Yoder-Himes, DR (corresponding author), Univ Louisville, Dept Biol, Louisville, KY 40292 USA.	deborah.yoder-himes@louisville.edu	Scott, David/GYU-8656-2022; Schaefers, Matthew/AAU-8213-2021; Roux, Damien/C-5618-2014; Roux, Damien/L-3671-2014; Priebe, Gregory/AAG-4027-2021	Schaefers, Matthew/0000-0001-7454-4180; Roux, Damien/0000-0002-6103-6416; Roux, Damien/0000-0002-6103-6416; Priebe, Gregory/0000-0001-9831-0354; Scott, David A./0000-0003-1007-2756; Yoder-Himes, Deborah/0000-0001-9576-3833	William Randolph Hearst Fund; Societe de Reanimation de Lang ue Francaise; University of Louisville [RIG50895]; Slifka Family Fund; Cystic Fibrosis Foundation [PRIEBE13I0, YODERH10F0]	William Randolph Hearst Fund; Societe de Reanimation de Lang ue Francaise; University of Louisville; Slifka Family Fund; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by the William Randolph Hearst Fund (https://www.hearstfdn.org/) and the Societe de Reanimation de Lang ue Francaise (http://www.srlf.org/en/home/) (DR), the University of Louisville (http://louisville.edu/) (DRYH; RIG50895, MW), the Slifka Family Fund (http://www.slifkafounciation.org/) (CG), and the Cystic Fibrosis Foundation (https://www.cff.org/) (CG; PRIEBE13I0, GPP; YODERH10F0, DRYH; JJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We applied the SDC approach for the sequence of authors. This work was supported by the William Randolph Hearst Fund and the Societe de Reanimation de Langue Francaise (DR), the University of Louisville (RIG50895, MW), the Slifka Family Fund (CG), and the Cystic Fibrosis Foundation (CG; PRIEBE13I0, GPP; YODERH10F0, DRYH; JJL). We also thank Maria Ericson for her assistance with the electron microscopy.	Abdulrahman BA, 2011, AUTOPHAGY, V7, P1359, DOI 10.4161/auto.7.11.17660; Agnoli K, 2012, MOL MICROBIOL, V83, P362, DOI 10.1111/j.1365-2958.2011.07937.x; Agnoli K, 2014, APPL ENVIRON MICROB, V80, P1340, DOI 10.1128/AEM.03330-13; Altarriba M, 2003, MICROB PATHOGENESIS, V34, P249, DOI 10.1016/S0882-4010(03)00047-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Araque-Calderon Y, 2008, MED SCI MONITOR, V14, pBR49; Atsumi T, 1996, J BACTERIOL, V178, P5024, DOI 10.1128/jb.178.16.5024-5026.1996; Bamford S, 2007, CELL MICROBIOL, V9, P532, DOI 10.1111/j.1462-5822.2006.00808.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Biddick R, 2003, FEMS MICROBIOL LETT, V228, P57, DOI 10.1016/S0378-1097(03)00724-9; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; Burns JL, 1996, INFECT IMMUN, V64, P4054, DOI 10.1128/IAI.64.10.4054-4059.1996; Canals R, 2006, J BACTERIOL, V188, P852, DOI 10.1128/JB.188.3.852-862.2006; Canals R, 2006, J BACTERIOL, V188, P542, DOI 10.1128/JB.188.2.542-555.2006; Caraher E, 2007, J CYST FIBROS, V6, P49, DOI 10.1016/j.jcf.2006.05.007; Choi KH, 2006, NAT PROTOC, V1, P162, DOI 10.1038/nprot.2006.25; Conway BAD, 2002, J BACTERIOL, V184, P5678, DOI 10.1128/JB.184.20.5678-5685.2002; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; De Smet B, 2015, INT J SYST EVOL MICR, V65, P2265, DOI 10.1099/ijs.0.000251; Delputte PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016827; Deng YY, 2010, APPL ENVIRON MICROB, V76, P4675, DOI 10.1128/AEM.00480-10; Deng YY, 2009, J BACTERIOL, V191, P7270, DOI 10.1128/JB.00681-09; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dong TG, 2013, P NATL ACAD SCI USA, V110, P2623, DOI 10.1073/pnas.1222783110; Duff C, 2006, MICROB PATHOGENESIS, V41, P183, DOI 10.1016/j.micpath.2006.07.005; Eberl L, 2006, INT J MED MICROBIOL, V296, P103, DOI 10.1016/j.ijmm.2006.01.035; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; French CT, 2011, P NATL ACAD SCI USA, V108, P12095, DOI 10.1073/pnas.1107183108; Gavin R, 2003, FEMS MICROBIOL LETT, V224, P77, DOI 10.1016/S0378-1097(03)00418-X; Gavin R, 2002, MOL MICROBIOL, V43, P383, DOI 10.1046/j.1365-2958.2002.02750.x; Gill JJ, 2011, J BACTERIOL, V193, P5300, DOI 10.1128/JB.05287-11; Glendinning KJ, 2004, FEMS MICROBIOL LETT, V235, P229, DOI 10.1016/j.femsle.2004.04.039; Goodman AL, 2009, CELL HOST MICROBE, V6, P279, DOI 10.1016/j.chom.2009.08.003; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GOVAN JRW, 1993, LANCET, V342, P15, DOI 10.1016/0140-6736(93)91881-L; Gutierrez MG, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00078; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Huang YJ, 2016, CLIN CHEST MED, V37, P59, DOI 10.1016/j.ccm.2015.10.003; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Hutcherson JA, 2016, MOL ORAL MICROBIOL, V31, P354, DOI 10.1111/omi.12135; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Jacchieri SG, 2003, J BACTERIOL, V185, P4243, DOI 10.1128/JB.185.14.4243-4247.2003; Jang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087623; Johnson S. L., 2015, Genome Announcements, V3, pe00159; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Kalish LA, 2006, AM J RESP CRIT CARE, V173, P421, DOI 10.1164/rccm.200503-344OC; Kim JM, 2015, J IND MICROBIOL BIOT, V42, P905, DOI 10.1007/s10295-015-1605-x; Kirov SM, 2002, J BACTERIOL, V184, P547, DOI 10.1128/JB.184.2.547-555.2002; Kopp BT, 2012, BIOCHEM BIOPH RES CO, V424, P221, DOI 10.1016/j.bbrc.2012.06.066; Lamothe J, 2007, CELL MICROBIOL, V9, P40, DOI 10.1111/j.1462-5822.2006.00766.x; Lamothe J, 2008, MICROBIOL-SGM, V154, P3825, DOI 10.1099/mic.0.2008/023200-0; Lefebre MD, 2001, MICROBIOL-SGM, V147, P97, DOI 10.1099/00221287-147-1-97; Leitao JH, 2008, EUR J CLIN MICROBIOL, V27, P1101, DOI 10.1007/s10096-008-0552-0; Lewenza S, 2001, J BACTERIOL, V183, P2212, DOI 10.1128/JB.183.7.2212-2218.2001; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lopez CM, 2009, APPL ENVIRON MICROB, V75, P6496, DOI 10.1128/AEM.01669-09; Mahenthiralingam E, 1997, J CLIN MICROBIOL, V35, P808, DOI 10.1128/JCM.35.4.808-816.1997; Malott RJ, 2009, J BACTERIOL, V191, P2447, DOI 10.1128/JB.01746-08; MCCARTER L, 1988, CELL, V54, P345, DOI 10.1016/0092-8674(88)90197-3; Merino S, 2006, FEMS MICROBIOL LETT, V263, P127, DOI 10.1111/j.1574-6968.2006.00403.x; Miller DA, 2003, J ROY SOC MED, V96, P57; O'Grady EP, 2011, J BACTERIOL, V193, P163, DOI 10.1128/JB.00852-10; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Ottemann KM, 1997, MOL MICROBIOL, V24, P1109, DOI 10.1046/j.1365-2958.1997.4281787.x; Pallen MJ, 2005, TRENDS MICROBIOL, V13, P143, DOI 10.1016/j.tim.2005.02.008; Park KS, 2005, INFECT IMMUN, V73, P5754, DOI 10.1128/IAI.73.9.5754-5761.2005; Parsons YN, 2001, FEMS MICROBIOL LETT, V203, P103, DOI 10.1111/j.1574-6968.2001.tb10827.x; Partridge JD, 2015, MBIO, V6, DOI 10.1128/mBio.02367-14; Ramphal R, 2008, J IMMUNOL, V181, P586, DOI 10.4049/jimmunol.181.1.586; Ren CP, 2005, J BACTERIOL, V187, P1430, DOI 10.1128/JB.187.4.1430-1440.2005; Roux D, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00765-16; Schaefers MM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006116; Scotet V, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-14; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurnik D, 2013, P NATL ACAD SCI USA, V110, P20747, DOI 10.1073/pnas.1221552110; Skurnik D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003582; SMITH DL, 1993, J CLIN MICROBIOL, V31, P3017, DOI 10.1128/JCM.31.11.3017-3022.1993; Sokol PA, 1999, INFECT IMMUN, V67, P4443, DOI 10.1128/IAI.67.9.4443-4455.1999; SOKOL PA, 1992, J MED MICROBIOL, V36, P184, DOI 10.1099/00222615-36-3-184; Sokol PA, 2000, INFECT IMMUN, V68, P6554, DOI 10.1128/IAI.68.12.6554-6560.2000; Song WS, 2017, SCI REP-UK, V7, DOI 10.1038/srep40878; Stewart BJ, 2003, J BACTERIOL, V185, P4508, DOI 10.1128/JB.185.15.4508-4518.2003; Tomich M, 2003, INFECT IMMUN, V71, P1405, DOI 10.1128/IAI.71.3.1405-1415.2003; Tomich M, 2002, INFECT IMMUN, V70, P1799, DOI 10.1128/IAI.70.4.1799-1806.2002; Urban TA, 2004, INFECT IMMUN, V72, P5126, DOI 10.1128/IAI.72.9.5126-5134.2004; Vandivier RW, 2009, AM J PHYSIOL-LUNG C, V297, pL677, DOI 10.1152/ajplung.00030.2009; Vanlaere E, 2008, INT J SYST EVOL MICR, V58, P1580, DOI 10.1099/ijs.0.65634-0; Verma A, 2005, INFECT IMMUN, V73, P8237, DOI 10.1128/IAI.73.12.8237-8246.2005; Vermis K, 2004, INT J SYST EVOL MICR, V54, P689, DOI 10.1099/ijs.0.02888-0; Wilhelms M, 2013, J BACTERIOL, V195, P1436, DOI 10.1128/JB.01994-12; Wilson K., 2001, CURR PROTOC MOL BIOL, V56, P2, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524; Zhang L, 2015, CELL MOL IMMUNOL, V12, P625, DOI 10.1038/cmi.2014.76	95	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0189810	10.1371/journal.pone.0189810	http://dx.doi.org/10.1371/journal.pone.0189810			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346379	Green Published, Green Submitted, gold			2022-12-26	WOS:000422749500005
J	Rezinciuc, S; Sandoval-Sierra, JV; Ruiz-Leon, Y; van West, P; Dieguez-Uribeondo, J				Rezinciuc, Svetlana; Vladimir Sandoval-Sierra, Jose; Ruiz-Leon, Yolanda; van West, Pieter; Dieguez-Uribeondo, Javier			Specialized attachment structure of the fish pathogenic oomycete Saprolegnia parasitica	PLOS ONE			English	Article							PHYTOPHTHORA-CINNAMOMI ZOOSPORES; APHANOMYCES-ASTACI; GENUS SAPROLEGNIA; IMAGE-ANALYSIS; BROWN TROUT; COMPLEX; FUNGUS; INFESTANS; ADHESION; DICLINA	The secondary cysts of the fish pathogen oomycete Saprolegnia parasitica possess bundles of long hooked hairs that are characteristic to this economically important pathogenic species. Few studies have been carried out on elucidating their specific role in the S. parasitica life cycle and the role they may have in the infection process. We show here their function by employing several strategies that focus on descriptive, developmental and predictive approaches. The strength of attachment of the secondary cysts of this pathogen was compared to other closely related species where bundles of long hooked hairs are absent. We found that the attachment of the S. parasitica cysts was around three times stronger than that of other species. The time sequence and influence of selected factors on morphology and the number of the bundles of long hooked hairs conducted by scanning electron microscopy study revealed that these are dynamic structures. They are deployed early after encystment, i.e., within 30 sec of zoospore encystment, and the length, but not the number, of the bundles steadily increased over the encystment period. We also observed that the number and length of the bundles was influenced by the type of substrate and encystment treatment applied, suggesting that these structures can adapt to different substrates (glass or fish scales) and can be modulated by different signals (i.e., protein media, 50 mM CaCl2 concentrations, carbon particles). Immunolocalization studies evidenced the presence of an adhesive extracellular matrix. The bioinformatic analyses of the S. parasitica secreted proteins showed that there is a high expression of genes encoding domains of putative proteins related to the attachment process and cell adhesion (fibronectin and thrombospondin) coinciding with the deployment stage of the bundles of long hooked hairs formation. This suggests that the bundles are structures that might contribute to the adhesion of the cysts to the host because they are composed of these adhesive proteins and/or by increasing the surface of attachment of this extracellular matrix.	[Rezinciuc, Svetlana; Vladimir Sandoval-Sierra, Jose; Dieguez-Uribeondo, Javier] CSIC, Real Jardin Bot, Dept Mycol, Madrid, Spain; [Ruiz-Leon, Yolanda] CSIC, UTAI, Real Jardin Bot, Madrid, Spain; [van West, Pieter] Univ Aberdeen, Int Ctr Aquaculture Res & Dev, Inst Med Sci, Aberdeen Oomycete Lab, Aberdeen, Scotland; [Rezinciuc, Svetlana] Royal Inst Technol KTH, AlbaNova Univ Ctr, Div Glycosci, Stockholm, Sweden	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; University of Aberdeen; Royal Institute of Technology	Dieguez-Uribeondo, J (corresponding author), CSIC, Real Jardin Bot, Dept Mycol, Madrid, Spain.	dieguez@rjb.csic.es	dieguez-uribeondo, javier/I-2178-2015; Diéguez-Uribeondo, Javier/ABF-1130-2021; Sandoval, Vladimir/GYD-5018-2022	dieguez-uribeondo, javier/0000-0002-4488-0658; Diéguez-Uribeondo, Javier/0000-0002-4488-0658; Sandoval, Vladimir/0000-0003-2007-6582; Ruiz-Leon, Yolanda/0000-0001-5872-742X; van West, Pieter/0000-0002-0767-6017	European Union [ITN-SAPRO-238550]; Ministerio de Economia y Competitividad, Spain [CGL2016-80526]; BBSRC [BB/P020224/1, BB/J018333/1, BB/M026566/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M026566/1, BB/P020224/1, BB/J018333/1] Funding Source: researchfish	European Union(European Commission); Ministerio de Economia y Competitividad, Spain; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The funding or sources of support were grants of: (1) European Union (ITN-SAPRO-238550), (2) Ministerio de Economia y Competitividad, Spain (CGL2016-80526), which supported lab-bench expenses and experiments. Moreover, Svetlana Rezinciuc and Jose V. Sandoval-Sierra were supported by fellowships from ITN-SAPRO-238550.	Andersson MG, 2002, EUKARYOT CELL, V1, P105, DOI 10.1128/EC.1.1.105-111.2002; Arnhold E., 2015, EASYNLS EASY NONLINE; BEAKES G, 1983, CAN J BOT, V61, P603, DOI 10.1139/b83-068; BEAKES G, 1983, J GEN MICROBIOL, V129, P2605; Beakes GW, 1994, SALMON SAPROLEGNIASI, P33; Bechinger C, 1999, SCIENCE, V285, P1896, DOI 10.1126/science.285.5435.1896; Brazee NJ, 2012, FUNGAL ECOL, V5, P600, DOI 10.1016/j.funeco.2012.03.002; BURR AW, 1994, PROTOPLASMA, V181, P142, DOI 10.1007/BF01666393; Carris L., 2012, PLANT HLTH INSTRUCTO, DOI [10.1094/PHI-I-2012-0426-01, DOI 10.1094/PHI-I-2012-0426-01]; CERENIUS L, 1985, EXP MYCOL, V9, P259, DOI 10.1016/0147-5975(85)90022-2; CERENIUS L, 1984, J INVERTEBR PATHOL, V43, P278, DOI 10.1016/0022-2011(84)90150-2; Deacon JW, 1998, MYCOL RES, V102, P33, DOI 10.1017/S0953756297004358; DEACON JW, 1993, MYCOL RES, V97, P1153, DOI 10.1016/S0953-7562(09)81278-1; Dieguez-Uribeondo J, 2004, FUNGAL GENET BIOL, V41, P293, DOI 10.1016/j.fgb.2003.10.012; Dieguez-Uribeondo J, 2007, FUNGAL GENET BIOL, V44, P585, DOI 10.1016/j.fgb.2007.02.010; DIEGUEZURIBEONDO J, 1994, AQUACULTURE, V120, P219, DOI 10.1016/0044-8486(94)90080-9; DIEGUEZURIBEONDO J, 1994, MYCOL RES, V98, P810, DOI 10.1016/S0953-7562(09)81060-5; DONALDSON SP, 1992, J GEN MICROBIOL, V138, P2051, DOI 10.1099/00221287-138-10-2051; Epstein L., 1997, PLANT RELATIONSHIPS, Vvol. 5, P11, DOI [10.1007/978-3-662-10370-8_2, DOI 10.1007/978-3-662-10370-8_2]; Epstein L, 2006, BIOLOGICAL ADHESIVES, P41, DOI 10.1007/978-3-540-31049-5_3; Fabritius AL, 2003, MOL PLANT MICROBE IN, V16, P926, DOI 10.1094/MPMI.2003.16.10.926; Fregeneda-Grandes JM, 2007, J FISH BIOL, V71, P510, DOI 10.1111/j.1095-8649.2007.01510.x; Grenville-Briggs LJ, 2008, PLANT CELL, V20, P720, DOI 10.1105/tpc.107.052043; GUBLER F, 1989, PROTOPLASMA, V149, P24, DOI 10.1007/BF01623979; GUBLER F, 1988, J CELL SCI, V90, P225; HARDHAM AR, 1990, CAN J MICROBIOL, V36, P183, DOI 10.1139/m90-032; Hardham AR, 2001, MYCOTA, V8, P91; Jiang RHY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003272; JONES MJ, 1990, APPL ENVIRON MICROB, V56, P3772, DOI 10.1128/AEM.56.12.3772-3778.1990; Kim KS, 2003, EUKARYOT CELL, V2, P1376, DOI 10.1128/EC.2.6.1376-1385.2003; Koya PR, 2013, OPEN J MODELLING SIM, V01, P12; KUNOH H, 1988, EXP MYCOL, V12, P325, DOI 10.1016/0147-5975(88)90024-2; Letourneau J, 2011, JOVE-J VIS EXP, V51, P1; MANTON I, 1951, J EXP BOT, V2, P321, DOI 10.1093/jxb/2.3.321; MEIER H, 1954, J EXP BOT, V5, P401, DOI 10.1093/jxb/5.3.401; Mendgen K, 1996, ANNU REV PHYTOPATHOL, V34, P367, DOI 10.1146/annurev.phyto.34.1.367; MERCURE EW, 1994, PHYSIOL MOL PLANT P, V45, P421, DOI 10.1016/S0885-5765(05)80040-2; MUELLER GJ, 1994, SALMON SAPROLEGNIASI, P163; PICKERING AD, 1979, T BRIT MYCOL SOC, V72, P427, DOI 10.1016/S0007-1536(79)80150-3; PRIETO AL, 1992, J CELL BIOL, V119, P663, DOI 10.1083/jcb.119.3.663; R Development Core Team, 2017, R LANG ENV STAT COMP; Raftoyannis Y, 2006, MICROBIOL RES, V161, P1, DOI 10.1016/j.micres.2005.04.003; Rand Thomas G., 1993, Journal of Aquatic Animal Health, V5, P240, DOI 10.1577/1548-8667(1993)005&lt;0240:COZOTF&gt;2.3.CO;2; REID B, 1995, EXP MYCOL, V19, P202, DOI 10.1006/emyc.1995.1025; Robold AV, 2005, CURR GENET, V47, P307, DOI 10.1007/s00294-004-0559-8; Saraiva M, 2014, FUNGAL BIOL-UK, V118, P621, DOI 10.1016/j.funbio.2014.01.011; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaw BD, BIOL FUNGAL CELL; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Smith A. M, 2006, BIOL ADHESIVES; SODERHALL K, 1991, AQUACULTURE, V92, P121, DOI 10.1016/0044-8486(91)90014-X; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Stueland S, 2005, J FISH DIS, V28, P445, DOI 10.1111/j.1365-2761.2005.00635.x; Takano Y, 2000, MOL PLANT MICROBE IN, V13, P374, DOI 10.1094/MPMI.2000.13.4.374; UNESTAM T, 1965, PHYSIOL PLANTARUM, V18, P483, DOI 10.1111/j.1399-3054.1965.tb06911.x; van West P, 2010, FEMS MICROBIOL LETT, V310, P127, DOI 10.1111/j.1574-6968.2010.02055.x; Sandoval-Sierra JV, 2014, FUNGAL BIOL-UK, V118, P559, DOI 10.1016/j.funbio.2013.10.005; Walker Claire A., 2007, Fungal Biology Reviews, V21, P10, DOI 10.1016/j.fbr.2007.02.001; Wawra S, 2012, P NATL ACAD SCI USA, V109, P2096, DOI 10.1073/pnas.1113775109; WOOD SE, 1988, T BRIT MYCOL SOC, V90, P63, DOI 10.1016/S0007-1536(88)80181-5; Xiang QJ, 2009, FUNGAL GENET BIOL, V46, P400, DOI 10.1016/j.fgb.2009.02.006; Yamaoka N, 1999, PHYSIOL MOL PLANT P, V54, P145, DOI 10.1006/pmpp.1998.0194; Zhang WW, 2013, PEERJ, V1, DOI 10.7717/peerj.221	63	10	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190361	10.1371/journal.pone.0190361	http://dx.doi.org/10.1371/journal.pone.0190361			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342156	Green Submitted, Green Published, gold			2022-12-26	WOS:000422653800019
J	Scurfield, A; Latimer, DC				Scurfield, Abby; Latimer, David C.			A computational study of the impact of inhomogeneous internodal lengths on conduction velocity in myelinated neurons	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; EXTENSIVE REMYELINATION; CHRONIC DEMYELINATION; MULTIPLE-SCLEROSIS; RANVIER FORMATION; MAMMALIAN NERVE; NA+ CHANNELS; FIBERS; AXONS	Age-related decreases in the conduction velocity (CV) of action potentials along myelinated axons have been linked to morphological changes in the myelin sheath. In particular, evidence suggests the presence of segmental demyelination and remyelination of axons. In remyelinated segments, the distance between adjacent nodes of Ranvier is typically shorter, and myelin sheaths are thinner. Both experimental and computational evidence indicates that shortened internodes slows CV. In this computational study, we determine the impact of progressive segmental demyelination and remyelination, modeled by shorter internodes with thinner myelin sheaths interspersed with normal ones, upon the CV. We find that CV progressively decreases as the number of remyelinated segments increases, but this decrease is greater than one would expect from an estimate of the CV based merely upon the number of short and long internodes. We trace the additional suppression of the CV to transitions between long and short internodes. Our study presents an important consideration for the precise modeling of neural circuits with remyelinated neurons.	[Scurfield, Abby; Latimer, David C.] Univ Puget Sound, Dept Phys, Tacoma, WA 98416 USA		Latimer, DC (corresponding author), Univ Puget Sound, Dept Phys, Tacoma, WA 98416 USA.	dlatimer@pugetsound.edu						ASTONJONES G, 1985, NATURE, V318, P462, DOI 10.1038/318462a0; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BLIGHT AR, 1985, NEUROSCIENCE, V15, P13, DOI 10.1016/0306-4522(85)90119-8; BOYD IA, 1979, J PHYSIOL-LONDON, V289, P277, DOI 10.1113/jphysiol.1979.sp012737; BRILL MH, 1977, J NEUROL NEUROSUR PS, V40, P769, DOI 10.1136/jnnp.40.8.769; Bruck W, 2003, J NEUROL SCI, V206, P181, DOI 10.1016/s0022-510x(02)00191-0; Dekker DMT, 2014, J COMPUT NEUROSCI, V37, P307, DOI 10.1007/s10827-014-0503-y; Devaux J, 2008, J CELL BIOL, V183, P909, DOI 10.1083/jcb.200808034; DUGANDZIJANOVAKOVIC S, 1995, J NEUROSCI, V15, P492; Duncan ID, 2009, P NATL ACAD SCI USA, V106, P6832, DOI 10.1073/pnas.0812500106; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; GLEDHILL RF, 1977, ANN NEUROL, V1, P552, DOI 10.1002/ana.410010607; GOLDMAN L, 1968, BIOPHYS J, V8, P596, DOI 10.1016/S0006-3495(68)86510-5; Gow A, 2008, NEURON GLIA BIOL, V4, P307, DOI 10.1017/S1740925X09990391; HILDEBRAND C, 1993, PROG NEUROBIOL, V40, P319, DOI 10.1016/0301-0082(93)90015-K; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hursh JB, 1939, AM J PHYSIOL, V127, P131, DOI 10.1152/ajplegacy.1939.127.1.131; Ikeda M, 2012, BRAIN BEHAV, V2, P382, DOI 10.1002/brb3.61; Keener JP, 2009, MATH PHYSL; LASCELLES RG, 1966, J NEUROL NEUROSUR PS, V29, P40, DOI 10.1136/jnnp.29.1.40; Lasiene J, 2008, J NEUROSCI, V28, P3887, DOI 10.1523/JNEUROSCI.4756-07.2008; Lasiene J, 2009, AGING CELL, V8, P201, DOI 10.1111/j.1474-9726.2009.00462.x; Liewald D, 2014, BIOL CYBERN, V108, P541, DOI 10.1007/s00422-014-0626-2; MATTHEWS MA, 1968, ANAT RECORD, V161, P337, DOI 10.1002/ar.1091610306; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; McLeod J, 1973, PATHOLOGICAL CONDUCT, V2, P248; MOORE JW, 1978, BIOPHYS J, V21, P147, DOI 10.1016/S0006-3495(78)85515-5; MORALES FR, 1987, J NEUROPHYSIOL, V58, P180, DOI 10.1152/jn.1987.58.1.180; Novakovic SD, 1996, J NEUROCYTOL, V25, P403, DOI 10.1007/BF02284811; Pajevic S, 2014, NEUROSCIENCE, V276, P135, DOI 10.1016/j.neuroscience.2013.11.007; Peters A, 2003, J COMP NEUROL, V460, P238, DOI 10.1002/cne.10639; Peters A, 2012, NEUROBIOL AGING, V33, P2357, DOI 10.1016/j.neurobiolaging.2011.11.015; Peters A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.011.2009; Powers BE, 2012, J NEUROSCI, V32, P5120, DOI 10.1523/JNEUROSCI.0002-12.2012; RITCHIE JM, 1981, NATURE, V294, P257, DOI 10.1038/294257a0; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; Sasaki M, 2006, J NEUROSCI, V26, P1803, DOI 10.1523/JNEUROSCI.3611-05.2006; Schafer DP, 2006, NEURON GLIA BIOL, V2, P69, DOI 10.1017/S1740925X06000093; SMITH KJ, 1980, J NEUROL SCI, V48, P201, DOI 10.1016/0022-510X(80)90201-4; Tasaki I, 1943, JAPANESE J MED SCI 3, V9, P189; VIZOSO AD, 1950, J ANAT, V84, P342; Wang YC, 2005, CEREB CORTEX, V15, P403, DOI 10.1093/cercor/bhh143; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; WAXMAN SG, 1972, NATURE-NEW BIOL, V238, P217, DOI 10.1038/newbio238217a0; Xi MC, 1999, NEUROSCIENCE, V92, P219, DOI 10.1016/S0306-4522(98)00754-4; Zhang H, 2011, EXP NEUROL, V230, P138, DOI 10.1016/j.expneurol.2011.04.009	48	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191106	10.1371/journal.pone.0191106	http://dx.doi.org/10.1371/journal.pone.0191106			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329312	Green Published, gold, Green Submitted			2022-12-26	WOS:000419954100038
J	Bao, XL; Zhou, YX; Wang, YL; Zhang, JJ; Lu, XY; Wang, ZG				Bao, Xueliang; Zhou, Yuxuan; Wang, Yunlong; Zhang, Jianjun; Lu, Xiaoying; Wang, Zhigong			Electrode placement on the forearm for selective stimulation of finger extension/flexion	PLOS ONE			English	Article							NEUROMUSCULAR ELECTRICAL-STIMULATION; MOTOR; STROKE; MUSCLE; SINGLE; SYSTEM; ARM	It is still challenging to achieve a complex grasp or fine finger control by using surface functional electrical stimulation (FES), which usually requires a precise electrode configuration under laboratory or clinical settings. The goals of this study are as follows: 1) to study the possibility of selectively activating individual fingers; 2) to investigate whether the current activation threshold and selective range of individual fingers are affected by two factors: changes in the electrode position and forearm rotation (pronation, neutral and supination); and 3) to explore a theoretical model for guidance of the electrode placement used for selective activation of individual fingers. A coordinate system with more than 400 grid points was established over the forearm skin surface. A searching procedure was used to traverse all grid points to identify the stimulation points for finger extension/flexion by applying monophasic stimulation pulses. Some of the stimulation points for finger extension and flexion were selected and tested in their respective two different forearm postures according to the number and the type of the activated fingers and the strength of finger action response to the electrical stimulation at the stimulation point. The activation thresholds and current ranges of the selectively activated finger at each stimulation point were determined by visual analysis. The stimulation points were divided into three groups "Low", "Medium" and "High") according to the thresholds of the 1st activated fingers. The angles produced by the selectively activated finger within selective current ranges were measured and analyzed. Selective stimulation of extension/flexion is possible for most fingers. Small changes in electrode position and forearm rotation have no significant effect on the threshold amplitude and the current range for the selective activation of most fingers (p > 0.05). The current range is the largest (more than 2 mA) for selective activation of the thumb, followed by those for the index, ring, middle and little fingers. The stimulation points in the "Low" group for all five fingers lead to noticeable finger angles at low current intensity, especially for the index, middle, and ring fingers. The slopes of the finger angle variation in the "Low" group for digits 2 similar to 4 are inversely proportional to the current intensity, whereas the slopes of the finger angle variation in other groups and in all groups for the thumb and little finger are proportional to the current intensity. It is possible to selectively activate the extension/flexion of most fingers by stimulating the forearm muscles. The physiological characteristics of each finger should be considered when placing the negative electrode for selective stimulation of individual fingers. The electrode placement used for the selective activation of individual fingers should not be confined to the location with the lowest activation threshold.	[Bao, Xueliang; Zhou, Yuxuan; Wang, Yunlong; Zhang, Jianjun; Lu, Xiaoying] Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China; [Lu, Xiaoying; Wang, Zhigong] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China; [Wang, Zhigong] Southeast Univ, Inst RF & OE ICs, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Nantong University; Southeast University - China	Lu, XY (corresponding author), Southeast Univ, State Key Lab Bioelect, Nanjing, Jiangsu, Peoples R China.; Lu, XY; Wang, ZG (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China.; Wang, ZG (corresponding author), Southeast Univ, Inst RF & OE ICs, Nanjing, Jiangsu, Peoples R China.	luxy@seu.edu.cn; zgwang@seu.edu.cn	Zhou, Yuxuan/V-6261-2019		National Natural Science Foundation of China [61534003]; Jiangsu Province Science and Technology Project of China [BE2016738]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Science and Technology Project of China	This paper was supported by the National Natural Science Foundation of China (61534003) and the Jiangsu Province Science and Technology Project of China (BE2016738).r The authors would like to thank the AJE team for providing native English editing. The authors would also like to thank the anonymous reviewers for helpful comments and suggestions. This paper was supported by the National Natural Science Foundation of China (61534003) and the Jiangsu Province Science and Technology Project of China (BE2016738).	Agur AM, 2009, GRANTOS ATLAS ANATOM; Behringer M, 2014, EUR J APPL PHYSIOL, V114, P1605, DOI 10.1007/s00421-014-2892-z; Botter A, 2011, EUR J APPL PHYSIOL, V111, P2461, DOI 10.1007/s00421-011-2093-y; Butler TJ, 2005, J PHYSIOL-LONDON, V567, P301, DOI 10.1113/jphysiol.2005.089201; Chipchase LS, 2011, ARCH PHYS MED REHAB, V92, P1423, DOI 10.1016/j.apmr.2011.01.011; Cristiano DM, 2016, J NEUROENG REHABIL, V13, P1; Doucet Barbara M., 2012, Yale Journal of Biology and Medicine, V85, P201; Glaviano NR, 2016, SPORTS HEALTH, V8, P79, DOI 10.1177/1941738115618174; Gobbo M, 2011, EUR J APPL PHYSIOL, V111, P2451, DOI 10.1007/s00421-011-2047-4; Gobbo M, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-17; Gomez-Tames JD, 2012, IEEE ENG MED BIO, P3576, DOI 10.1109/EMBC.2012.6346739; Huang ZH, 2014, NEURAL REGEN RES, V9, P2102, DOI 10.4103/1673-5374.147938; Keller T, 2006, INT FUNCT EL STIM SO; Kilgore K., 2015, IMPLANTABLE NEUROPRO; Kim Y, 2014, NEUROREHABILITATION, V34, P429, DOI 10.3233/NRE-141050; Knutson JS, 2012, J REHABIL RES DEV, V49, P1505, DOI 10.1682/JRRD.2011.09.0171; Koutsou A., 2014, BIOSYSTEMS BIOROBOTI, V4, P207, DOI [10.1007/978-3-642-38556-8_11, DOI 10.1007/978-3-642-38556-8_11]; Koutsou AD, 2013, NOVEL METHOD ANAL FO; Koutsou AD, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0165-2; Kuhn Andreas, 2008, MODELING TRANSCUTANE; Lang CE, 2004, J NEUROPHYSIOL, V92, P2802, DOI 10.1152/jn.00480.2004; Lawrence M., 2015, TRANSCUTANEOUS ELECT; Leijnse JNAL, 2008, J NEUROPHYSIOL, V100, P64, DOI 10.1152/jn.00706.2007; Loitz Jan C., 2016, Current Directions in Biomedical Engineering, V2, P391, DOI 10.1515/cdbme-2016-0087; Lyons GM, 2004, MED ENG PHYS, V26, P873, DOI 10.1016/j.medengphy.2004.08.003; Malesevic J, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0275-5; McIsaac TL, 2007, J NEUROPHYSIOL, V97, P550, DOI 10.1152/jn.01071.2006; NATHAN RH, 1990, MED BIOL ENG COMPUT, V28, P249, DOI 10.1007/BF02442681; O'Dwyer SB, 2006, MED ENG PHYS, V28, P166, DOI 10.1016/j.medengphy.2005.03.010; Popovic DB, 2009, J NEUROSCI METH, V178, P174, DOI 10.1016/j.jneumeth.2008.12.003; Popovic LZ, 2009, IEEE ENG MED BIO, P6785, DOI 10.1109/IEMBS.2009.5333983; Popovic MR, 2013, NEUROLOGICAL RES; Popovic-Maneski L, 2013, IEEE T NEUR SYS REH, V21, P648, DOI 10.1109/TNSRE.2013.2239662; Schieber MH, 2009, ADV EXP MED BIOL, V629, P559, DOI 10.1007/978-0-387-77064-2_30; Shalaby RE, 2011, DEV ELECTROMYOGRAPHY; Wang HP, 2017, INT C IEEE ENG MED B; Westerveld AJ, 2012, IEEE T NEUR SYS REH, V20, P94, DOI 10.1109/TNSRE.2011.2178749; Yin CS, 2005, AM J CHINESE MED, V33, P729, DOI 10.1142/S0192415X05003284; Zhou YX, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016004	39	6	6	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190936	10.1371/journal.pone.0190936	http://dx.doi.org/10.1371/journal.pone.0190936			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324829	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400077
J	Harrington-Kandt, R; Stylianou, E; Eddowes, LA; Lime, PJ; Stockdale, L; Pinpathomrat, N; Bull, N; Pasricha, J; Ulaszewska, M; Beglov, Y; Vaulont, S; Drakesmith, H; McShane, H				Harrington-Kandt, Rachel; Stylianou, Elena; Eddowes, Lucy A.; Lime, Pei Jin; Stockdale, Lisa; Pinpathomrat, Nawamin; Bull, Naomi; Pasricha, Janet; Ulaszewska, Marta; Beglov, Yulia; Vaulont, Sophie; Drakesmith, Hal; McShane, Helen			Hepcidin deficiency and iron deficiency do not alter tuberculosis susceptibility in a murine M. tb infection model	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; INCIDENT TUBERCULOSIS; HIV-INFECTION; FERROPORTIN; HOMEOSTASIS; EXPRESSION; GROWTH; HYPOFERREMIA; INFLAMMATION	Tuberculosis (TB), caused by the macrophage-tropic pathogen Mycobacterium tuberculosis (M.tb) is a highly prevalent infectious disease. Since an immune correlate of protection or effective vaccine have yet to be found, continued research into host-pathogen interactions is important. Previous literature reports links between host iron status and disease outcome for many infections, including TB. For some extracellular bacteria, the iron regulatory hormone hepcidin is essential for protection against infection. Here, we investigated hepcidin (encoded by Hamp1) in the context of murine M.tb infection. Female C57BL/6 mice were infected with M.tb Erdman via aerosol. Hepatic expression of iron-responsive genes was measured by qRT-PCR and bacterial burden determined in organ homogenates. We found that hepatic Hamp1 mRNA levels decreased post-infection, and correlated with a marker of BMP/SMAD signalling pathways. Next, we tested the effect of Hamp1 deletion, and low iron diets, on M.tb infection. Hamp1 knockout mice did not have a significantly altered M.tb mycobacterial load in either the lungs or spleen. Up to 10 weeks of dietary iron restriction did not robustly affect disease outcome despite causing iron deficiency anaemia. Taken together, our data indicate that unlike with many other infections, hepcidin is decreased following M.tb infection, and show that hepcidin ablation does not influence M.tb growth in vivo. Furthermore, because even severe iron deficiency did not affect M.tb mycobacterial load, we suggest that the mechanisms M.tb uses to scavenge iron from the host must be extremely efficient, and may therefore represent potential targets for drugs and vaccines.	[Harrington-Kandt, Rachel; Stylianou, Elena; Pinpathomrat, Nawamin; Bull, Naomi; Pasricha, Janet; Ulaszewska, Marta; McShane, Helen] Univ Oxford, Jenner Inst, Oxford, England; [Eddowes, Lucy A.; Lime, Pei Jin; Drakesmith, Hal] Univ Oxford, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [Beglov, Yulia] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Vaulont, Sophie] Univ Paris 05, CNRS 8104, INSERM 567, Inst Cochin, Paris, France	University of Oxford; Jenner Institute; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	McShane, H (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.; Drakesmith, H (corresponding author), Univ Oxford, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England.	alexander.drakesmith@imn.ox.ac.uk; helen.mcshane@ndm.ox.ac.uk	Vaulont, Sophie/O-6732-2017; Pinpathomrat, Nawamin/ABE-4538-2021	Pinpathomrat, Nawamin/0000-0002-0776-595X; Bull, Naomi/0000-0002-9436-8919; McShane, Helen/0000-0002-2126-5142; Lim, Pei Jin/0000-0003-4201-1210	UK Medical Research Council [MC_UU_12010/1]; Bill and Melinda Gates Foundation; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Haematology Theme at Oxford University Hospitals NHS Trust; University of Oxford; Medical Research Council [MC_UU_12010/10, MC_UU_00008/10] Funding Source: researchfish; MRC [MC_UU_12010/10] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Haematology Theme at Oxford University Hospitals NHS Trust; University of Oxford; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	HMcS is a Wellcome Trust Senior Clinical Research Fellow (095780/Z/11/Z) and a Jenner Institute Investigator. H.D. is funded supported by the UK Medical Research Council (Grant MC_UU_12010/1), the Bill and Melinda Gates Foundation and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Haematology Theme at Oxford University Hospitals NHS Trust and University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arezes J, 2015, CELL HOST MICROBE, V17, P47, DOI 10.1016/j.chom.2014.12.001; Armitage AE, 2011, BLOOD; Boelaert JR, 2007, J INFECT DIS, V195, P1745, DOI 10.1086/518040; Bonaccorsi-Riani E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136106; Chlosta S, 2006, INFECT IMMUN, V74, P3065, DOI 10.1128/IAI.74.5.3065-3067.2006; Deschemin JC, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00804; Dhople AM, 1996, MICROBIOS, V87, P77; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Fang Z, 2015, TUBERCULOSIS, V95, P123, DOI 10.1016/j.tube.2015.01.004; Fung E, 2015, BIOORG MED CHEM LETT, V25, P763, DOI 10.1016/j.bmcl.2014.12.094; Gan EK, 2011, SEMIN LIVER DIS, V31, P293, DOI 10.1055/s-0031-1286060; Gangaidzo IT, 2001, J INFECT DIS, V184, P936, DOI 10.1086/323203; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Horseman MA, 2011, INT J INFECT DIS, V15, pE157, DOI 10.1016/j.ijid.2010.11.003; Johnson EE, 2010, INFECT IMMUN, V78, P5099, DOI 10.1128/IAI.00498-10; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Kerkhoff AD, 2015, J INFECT DIS; Kim DK, 2014, NAT MED, V20, P419, DOI 10.1038/nm.3483; Kleinnijenhuis J, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/405310; LEPPER AWD, 1988, VET MICROBIOL, V16, P369, DOI 10.1016/0378-1135(88)90017-X; Lesbordes-Brion JC, 2006, BLOOD, V108, P1402, DOI 10.1182/blood-2006-02-003376; MAINOUFOWLER T, 1985, IMMUNOLOGY, V54, P325; McDermid JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-48; McDermid JM, 2009, AM J CLIN NUTR, V90, P225, DOI 10.3945/ajcn.2009.27709; Meneghetti F, 2016, CURR MED CHEM, V23, P4009, DOI 10.2174/0929867323666160607223747; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Minchella PA, 2014, INT J TUBERC LUNG D, V18, P1337, DOI 10.5588/ijtld.14.0143; Minchella PA, 2015, TUBERCULOSIS, V95, P288, DOI 10.1016/j.tube.2015.02.042; Nairz M, 2007, CELL MICROBIOL, V9, P2126, DOI 10.1111/j.1462-5822.2007.00942.x; Nairz M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00152; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nemeth E, 2009, ACTA HAEMATOL-BASEL, V122, P78, DOI 10.1159/000243791; Nguyen NB, 2006, AM J PHYSIOL-LUNG C, V291, pL417, DOI 10.1152/ajplung.00484.2005; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Peyssonnaux C, 2006, BLOOD, V107, P3727, DOI 10.1182/blood-2005-06-2259; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; Rodrigues PN, 2011, IMMUNOBIOLOGY, V216, P1127, DOI 10.1016/j.imbio.2011.04.004; Sasu BJ, 2010, BLOOD, V115, P3616, DOI 10.1182/blood-2009-09-245977; Schaible UE, 2002, J EXP MED, V196, P1507, DOI 10.1084/jem.20020897; Schlesinger LS, 1996, CURR TOP MICROBIOL, V215, P71; Sow FB, 2011, TUBERCULOSIS, V91, P314, DOI 10.1016/j.tube.2011.03.003; Stefanova D, 2017, BLOOD; Tanner R, 2017, SCI REP-UK, V7, DOI 10.1038/srep43478; Walter T, 1997, NUTR REV, V55, P111, DOI 10.1111/j.1753-4887.1997.tb06462.x; Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266; Willemetz A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00498; Young DC, 2009, J BIOL CHEM, V284, P25087, DOI 10.1074/jbc.M109.000802; Zuniga J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/193923	54	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191038	10.1371/journal.pone.0191038	http://dx.doi.org/10.1371/journal.pone.0191038			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324800	Green Published, Green Accepted, gold			2022-12-26	WOS:000419952400097
J	Martucci, MEP; Loeuille, B; Pirani, JR; Gobbo-Neto, L				Poleti Martucci, Maria Elvira; Loeuille, Benoit; Pirani, Jose Rubens; Gobbo-Neto, Leonardo			Comprehensive untargeted metabolomics of Lychnnophorinae subtribe (Asteraceae: Vernonieae) in a phylogenetic context	PLOS ONE			English	Article							HPLC-DAD-MS/MS; SESQUITERPENE LACTONES; LYCHNOPHORINAE; COMPOSITAE; LEAVES; TOOL; MS	Members of the subtribe Lychnophorinae occur mostly within the Cerrado domain of the Brazilian Central Plateau. The relationships between its 11 genera, as well as between Lychnophorinae and other subtribes belonging to the tribe Vernonieae, have recently been investigated upon a phylogeny based on molecular and morphological data. We report the use of a comprehensive untargeted metabolomics approach, combining HPLC-MS and GC-MS data, followed by multivariate analyses aiming to assess the congruence between metabolomics data and the phylogenetic hypothesis, as well as its potential as a chemotaxonomic tool. We analyzed 78 species by UHPLC-MS and GC-MS in both positive and negative ionization modes. The metabolic profiles obtained for these species were treated in MetAlign and in MSClust and the matrices generated were used in SIMCA for hierarchical cluster analyses, principal component analyses and orthogonal partial least square discriminant analysis. The results showed that metabolomic analyses are mostly congruent with the phylogenetic hypothesis especially at lower taxonomic levels (Lychnophora or Eremanthus). Our results confirm that data generated using metabolomics provide evidence for chemotaxonomical studies, especially for phylogenetic inference of the Lychnophorinae subtribe and insight into the evolution of the secondary metabolites of this group.	[Poleti Martucci, Maria Elvira; Gobbo-Neto, Leonardo] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Ribeirao Preto, SP, Brazil; [Loeuille, Benoit; Pirani, Jose Rubens] Univ Sao Paulo, Inst Biosci, Dept Bot, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Gobbo-Neto, L (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Ribeirao Preto, SP, Brazil.	gobbo@fcfrp.usp.br	Pirani, José Rubens R./G-2919-2012; Gobbo-Neto, Leonardo/AAJ-5547-2020; Poleti Martucci, Maria Elvira/X-2640-2018; Fapesp, Biota/F-8655-2017	Pirani, José Rubens R./0000-0001-7984-4457; Gobbo-Neto, Leonardo/0000-0002-0133-6142; Poleti Martucci, Maria Elvira/0000-0002-0601-8848; Fapesp, Biota/0000-0002-9887-8449	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2010/51454-3, 2012/16646-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [471615/2013-7]; Alexander von Humboldt Stiftung	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br/) (grants 2010/51454-3 J.R.P. and L.G.N. and 2012/16646-4 M.E.P.M.), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br/) (grant 471615/2013-7 - L.G.N.) and Alexander von Humboldt Stiftung (https//www.hurnboldt-foundation.de/web/home. html) L.G.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COILE NC, 1981, BRITTONIA, V33, P528, DOI 10.2307/2806758; COILE NC, 1983, CASTANEA, V48, P232; Dematteis M., 2007, BONPLANDIA, V16, P259; DUARTE A P, 1974, Revista Brasileira de Biologia, V34, P653; Gobbo-Neto L, 2008, J AGR FOOD CHEM, V56, P1193, DOI 10.1021/jf072812l; Gouvea DR, 2012, ANAL CHIM ACTA, V748, P28, DOI 10.1016/j.aca.2012.08.027; Hind D.J.N, 1993, NOTES COMPOSITAE SOF, V48, P245; Keeley SC., 2009, SYSTEMATICS EVOLUTIO, P439, DOI DOI 10.2988/08-21.1; Keles LC, 2010, QUIM NOVA, V33, P2245, DOI 10.1590/S0100-40422010001000038; Lee TS, 2013, METABOLOMICS, V9, P1301, DOI 10.1007/s11306-013-0539-4; Loeuille B, 2015, SYST BOT, V40, P286, DOI 10.1600/036364415X686576; Loeuille B, 2015, SYST BOT, V40, P299, DOI 10.1600/036364415X686585; Lommen A, 2007, ANAL CHIM ACTA, V584, P43, DOI 10.1016/j.aca.2006.11.018; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; MACLEISH NFF, 1987, ANN MO BOT GARD, V74, P265, DOI 10.2307/2399398; Martucci MEP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093149; Robinson H, 1996, RHODORA, V98, P85; ROBINSON H, 1992, P BIOL SOC WASH, V105, P640; Robinson H., 1999, SMITHSONIAN CONTR BO, V89, P1, DOI DOI 10.5479/SI.0081024X.89; Robinson H., 2007, FAMILIES GENERA VASC, P149; Sakamoto HT, 2005, J BRAZIL CHEM SOC, V16, P1396, DOI 10.1590/S0103-50532005000800016; Sandasi M, 2012, PHYTOCHEMISTRY, V84, P94, DOI 10.1016/j.phytochem.2012.08.009; Schaefer C.E.G.R., 2016, ECOLOGY CONSERVATION, P15, DOI [10.1007/978-3-319-29808-5_2, DOI 10.1007/978-3-319-29808-5_2]; SCHUH RT, 2009, BIOL SYSTEMATICS PRI; Semir J., 2011, ARNICAS ENDEMICAS SE; Semir J, 1991, REVISAO TAXONOMICA L; Tikunov YM, 2012, METABOLOMICS, V8, P714, DOI 10.1007/s11306-011-0368-2	27	14	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190104	10.1371/journal.pone.0190104	http://dx.doi.org/10.1371/journal.pone.0190104			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324799	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400019
J	Reipa, V; Atha, DH; Coskun, SH; Sims, CM; Nelson, BC				Reipa, Vytas; Atha, Donald H.; Coskun, Sanem H.; Sims, Christopher M.; Nelson, Bryant C.			Controlled potential electro-oxidation of genomic DNA	PLOS ONE			English	Article							PYROLYTIC-GRAPHITE ELECTRODE; DOPED DIAMOND ELECTRODES; AQUEOUS-SOLUTION; OXIDATION REACTIONS; HYDROXYL RADICALS; CHARGE-TRANSPORT; BASE DAMAGE; ELECTROCHEMICAL TECHNIQUES; REDUCTION POTENTIALS; MECHANISTIC ASPECTS	Exposure of mammalian cells to oxidative stress can result in DNA damage that adversely affects many cell processes. Lack of dependable DNA damage reference materials and standardized measurement methods, despite many case-control studies hampers the wider recognition of the link between oxidatively degraded DNA and disease risk. We used bulk electrolysis in an electrochemical system and gas chromatographic mass spectrometric analysis (GC/MS/MS) to control and measure, respectively, the effect of electrochemically produced reactive oxygen species on calf thymus DNA (ct-DNA). DNA was electro-oxidized for 1 h at four fixed oxidizing potentials (E = 0.5 V, 1.0 V, 1.5 V and 2 V (vs Ag/AgCl)) using a high surface area boron-doped diamond (BDD) working electrode (WE) and the resulting DNA damage in the form of oxidatively-modified DNA lesions was measured using GC/MS/MS. We have shown that there are two distinct base lesion formation modes in the explored electrode potential range, corresponding to 0.5 V < E < 1.5 V and E > 1.5 V. Amounts of all four purine lesions were close to a negative control levels up to E = 1.5 V with evidence suggesting higher levels at the lowest potential of this range (E = 0.5 V). A rapid increase in all base lesion yields was measured when ct-DNA was exposed at E = 2 V, the potential at which hydroxyl radicals were efficiently produced by the BDD electrode. The present results demonstrate that controlled potential preparative electrooxidation of double-stranded DNA can be used to purposely increase the levels of oxidatively modified DNA lesions in discrete samples. It is envisioned that these DNA samples may potentially serve as analytical control or quality assurance reference materials for the determination of oxidatively induced DNA damage.	[Reipa, Vytas; Atha, Donald H.; Coskun, Sanem H.; Sims, Christopher M.; Nelson, Bryant C.] NIST, Biosyst & Biomat Div, Mat Measurement Lab, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA	Reipa, V (corresponding author), NIST, Biosyst & Biomat Div, Mat Measurement Lab, Gaithersburg, MD 20899 USA.	vytas@nist.gov	reipa, vytas/AAF-9120-2019	reipa, vytas/0000-0001-6984-4146; Sims, Christopher/0000-0002-5623-6974	National Institute of Standards and Technology	National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA)	This work was funded by the National Institute of Standards and Technology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan O, 2012, ACS NANO, V6, P2904, DOI 10.1021/nn300261t; Atha DH, 2013, J ELECTROCHEM SOC, V160, pG3139, DOI 10.1149/2.021307jes; Baumann A, 2010, ELECTROANAL, V22, P286, DOI 10.1002/elan.200900358; Bergeron F, 2004, NUCLEIC ACIDS RES, V32, P6154, DOI 10.1093/nar/gkh950; Bergeron F, 2010, P NATL ACAD SCI USA, V107, P5528, DOI 10.1073/pnas.1000193107; Boal AK, 2005, BIOCONJUGATE CHEM, V16, P312, DOI 10.1021/bc0497362; Boon EM, 2003, BIOCONJUGATE CHEM, V14, P1140, DOI 10.1021/bc034139l; Boussicault F, 2008, CHEM REV, V108, P2622, DOI 10.1021/cr0680787; BRETT CMA, 1994, J ELECTROANAL CHEM, V366, P225, DOI 10.1016/0022-0728(93)02994-S; Brotons A, 2016, ANAL METHODS-UK, V8, P702, DOI 10.1039/c5ay02616d; Burrows CJ, 1998, CHEM REV, V98, P1109, DOI 10.1021/cr960421s; Cadet J, 1999, MUTAT RES-FUND MOL M, V424, P9, DOI 10.1016/S0027-5107(99)00004-4; Cadet J, 1999, NATO ADV SCI I A-LIF, V302, P47; Cadet J, 2008, CHIMIA, V62, P742, DOI 10.2533/chimia.2008.742; Cadet J, 2014, INT J RADIAT BIOL, V90, P423, DOI 10.3109/09553002.2013.877176; Cadet J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012559; Cahova-Kucharikova K, 2005, ANAL CHEM, V77, P2920, DOI 10.1021/ac048423x; Close DM, 2016, J PHYS CHEM A, V120, P4043, DOI 10.1021/acs.jpca.6b02653; Close DM, 2004, J PHYS CHEM A, V108, P10376, DOI 10.1021/jp046660y; Collins AR, 2000, FREE RADICAL RES, V32, P333, DOI 10.1080/10715760000300331; Comninellis C, 2008, J CHEM TECHNOL BIOT, V83, P769, DOI 10.1002/jctb.1873; Crespo-Hernandez CE, 2004, J PHYS CHEM A, V108, P6373, DOI 10.1021/jp049270k; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P677, DOI 10.1016/S0891-5849(02)00766-9; Faraggi M, 1996, J PHYS CHEM-US, V100, P14751, DOI 10.1021/jp960590g; Gasparutto D, 2000, CHEM RES TOXICOL, V13, P575, DOI 10.1021/tx000005+; Goyal RN, 2006, BIOELECTROCHEMISTRY, V69, P223, DOI 10.1016/j.bioelechem.2006.03.003; Goyal RN, 2005, B CHEM SOC JPN, V78, P1944, DOI 10.1246/bcsj.78.1944; Goyal RN, 2005, ANAL BIOANAL CHEM, V382, P1683, DOI 10.1007/s00216-005-3344-8; Goyal RN, 2005, NEW J CHEM, V29, P587, DOI 10.1039/b415452p; Goyal RN, 2005, ELECTROANAL, V17, P246, DOI 10.1002/elan.200303087; Goyal RN, 1997, BIOELECTROCH BIOENER, V43, P105, DOI 10.1016/S0302-4598(96)05182-3; Grodick MA, 2015, BIOCHEMISTRY-US, V54, P962, DOI 10.1021/bi501520w; Gupta P, 2016, RSC ADV, V6, P1722, DOI 10.1039/c5ra22682a; Halliwell B, 2007, BIOCHEM SOC T, V35, P1147, DOI 10.1042/BST0351147; Hawke LGD, 2010, EUR PHYS J E, V32, P291, DOI 10.1140/epje/i2010-10650-y; Hunt PR, 2017, J APPL TOXICOL, V37, P50, DOI 10.1002/jat.3357; Hunt PR, 2013, J APPL TOXICOL, V33, P1131, DOI 10.1002/jat.2872; Ivandini TA, 2007, TALANTA, V71, P648, DOI 10.1016/j.talanta.2006.05.009; Ivanova AV, 2015, CRIT REV ANAL CHEM, V45, P311, DOI 10.1080/10408347.2014.910443; Jaruga P, 2017, ENV TOXICOL; JOHNSTON DH, 1995, ABSTR PAP AM CHEM S, V209, P543; Joseph J, 2010, CHEM COMMUN, V46, P7872, DOI 10.1039/c0cc02118k; Kanvah S, 2005, NUCLEIC ACIDS RES, V33, P5133, DOI 10.1093/nar/gki801; Kapalka A, 2009, ELECTROCHIM ACTA, V54, P2018, DOI 10.1016/j.electacta.2008.06.045; Kielbassa C, 1997, CARCINOGENESIS, V18, P811, DOI 10.1093/carcin/18.4.811; Kubar T, 2013, PHYS STATUS SOLIDI B, V250, P2277, DOI 10.1002/pssb.201349148; MALINS DC, 1993, J TOXICOL ENV HEALTH, V40, P247, DOI 10.1080/15287399309531792; MALINS DC, 1991, CANCER RES, V51, P5430; Marselli B, 2003, J ELECTROCHEM SOC, V150, pD79, DOI 10.1149/1.1553790; Martinez-Huitle CA, 2015, CHEM REV, V115, P13362, DOI 10.1021/acs.chemrev.5b00361; Michaud PA, 2003, J APPL ELECTROCHEM, V33, P151, DOI 10.1023/A:1024084924058; Moller P, 2012, FREE RADICAL RES, V46, P541, DOI 10.3109/10715762.2011.644241; Nowicka AM, 2011, PHYS CHEM CHEM PHYS, V13, P7500, DOI 10.1039/c0cp02667k; Nunez ME, 2001, BIOCHEMISTRY-US, V40, P12465, DOI 10.1021/bi011560t; Oliveira-Brett AM, 2004, ANAL BIOCHEM, V332, P321, DOI 10.1016/j.ab.2004.06.021; Palecek E, 2012, CHEM REV, V112, P3427, DOI 10.1021/cr200303p; Petersen EJ, 2013, SMALL, V9, P205, DOI 10.1002/smll.201201217; Porsch B, 2009, BIOMACROMOLECULES, V10, P3148, DOI 10.1021/bm900768j; RAO PS, 1975, J PHYS CHEM-US, V79, P397, DOI 10.1021/j100571a021; Ravanat JL, 2016, RADIAT PHYS CHEM, V128, P92, DOI 10.1016/j.radphyschem.2016.07.007; Reddy PT, 2013, J PROTEOME RES, V12, P1049, DOI 10.1021/pr301037t; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; STEENKEN S, 1989, CHEM REV, V89, P503, DOI 10.1021/cr00093a003; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; Steenken S, 2000, J AM CHEM SOC, V122, P2373, DOI 10.1021/ja993508e; Thapa B, 2015, J PHYS CHEM A, V119, P5134, DOI 10.1021/jp5088866; VOET D, 1963, BIOPOLYMERS, V1, P193, DOI 10.1002/bip.360010302; Wagner JR, 2010, ACCOUNTS CHEM RES, V43, P564, DOI 10.1021/ar9002637; WAGNER JR, 1992, P NATL ACAD SCI USA, V89, P3380, DOI 10.1073/pnas.89.8.3380; Wang LL, 2016, J PHYS CHEM A, V120, P535, DOI 10.1021/acs.jpca.5b11021; WARDMAN P, 1989, J PHYS CHEM REF DATA, V18, P1637, DOI 10.1063/1.555843	72	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190907	10.1371/journal.pone.0190907	http://dx.doi.org/10.1371/journal.pone.0190907			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324786	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400071
J	Seyfart, T; Friedrich, N; Kische, H; Bulow, R; Wallaschofski, H; Volzke, H; Nauck, M; Keevil, BG; Haring, R				Seyfart, Tom; Friedrich, Nele; Kische, Hanna; Buelow, Robin; Wallaschofski, Henri; Voelzke, Henry; Nauck, Matthias; Keevil, Brian G.; Haring, Robin			Association of sex hormones with physical, laboratory, and imaging markers of anthropometry in men and women from the general population	PLOS ONE			English	Article							SERUM TESTOSTERONE; METABOLIC SYNDROME; REFERENCE RANGES; HEALTH; RISK; DETERMINANTS; THERAPY; PROFILE; TISSUE; LIFE	Objectives The aim of this study was to evaluate the association of sex hormones with anthropometry in a large population-based cohort, with liquid chromatography-mass spectrometry (LCMS)based sex hormone measurements and imaging markers. Study design/Main outcome measures Cross-sectional data from 957 men and women from the population-based Study of Health in Pomerania (SHIP) were used. Associations of a comprehensive panel of LCMSmeasured sex hormones with anthropometric parameters, laboratory, and imaging markers were analyzed in multivariable regression models for the full sample and stratified by sex. Sex hormone measures included total testosterone (TT), free testosterone (fT), estrone and estradiol, androstenedione (ASD), dehydroepiandrosterone sulfate (DHEAS), and sex hormone-binding globulin (SHBG). Domains of anthropometry included physical measures (body-mass-index (BMI), waist circumference, waist-to-height-ratio, waist-tohip- ratio, and hip circumference), laboratory measures of adipokines (leptin and vaspin), and magnet resonance imaging-based measures (visceral and subcutaneous adipose tissue). Results In men, inverse associations between all considered anthropometric parameters with TT were found: BMI (beta-coefficient, standard error (SE): -0.159, 0.037), waist-circumference (beta-coefficient, SE: -0.892, 0.292), subcutaneous adipose tissue (beta-coefficient, SE: -0.156, 0.023), and leptin (beta-coefficient, SE: -0.046, 0.009). In women TT (beta-coefficient, SE: 1.356, 0.615) and estrone (beta-coefficient, SE: 0.014, 0.005) were positively associated with BMI. In analyses of variance, BMI and leptin were inversely associated with TT, ASD, and DHEAS in men, but positively associated with estrone. In women, BMI and leptin were positively associated with all sex hormones. Conclusion The present population-based study confirmed and extended previously reported sex-specific associations between sex hormones and various anthropometric markers of overweight and obesity.	[Seyfart, Tom; Friedrich, Nele; Kische, Hanna; Wallaschofski, Henri; Nauck, Matthias; Haring, Robin] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Buelow, Robin] Univ Med Greifswald, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Voelzke, Henry; Nauck, Matthias] Univ Med Greifswald, German Ctr Cardiovasc Res DZHK, Greifswald, Germany; [Keevil, Brian G.] Univ Hosp South Manchester, Dept Clin Chem, Manchester, Lancs, England; [Haring, Robin] European Univ Appl Sci, Fac Appl Publ Hlth, Rostock, Germany	Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; German Centre for Cardiovascular Research; Greifswald Medical School; Wythenshawe Hospital NHS Foundation Trust	Kische, H (corresponding author), Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany.	hanna.kische@tu-dresden.de	Wilkening, Robin/J-5535-2018	Wilkening, Robin/0000-0002-8332-5016	Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania	SHIP is part of the Community Medicine Research net (CMR) of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Allen NE, 2002, CANCER CAUSE CONTROL, V13, P353, DOI 10.1023/A:1015238102830; Brand JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100409; Corona G, 2011, J SEX MED, V8, P272, DOI 10.1111/j.1743-6109.2010.01991.x; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Eriksson J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176277; Friedrich N, 2010, EXP CLIN ENDOCR DIAB, V118, P266, DOI 10.1055/s-0029-1225616; Friedrich N, 2008, J ANDROL, V29, P610, DOI 10.2164/jandrol.108.005561; GIAGULLI VA, 1994, J CLIN ENDOCR METAB, V79, P997, DOI 10.1210/jc.79.4.997; Haring R, 2013, ANDROLOGY-US, V1, P17, DOI 10.1111/j.2047-2927.2012.00002.x; Haring R, 2013, EUR J PREV CARDIOL, V20, P1061, DOI 10.1177/2047487312452965; Haring R, 2012, J CLIN ENDOCR METAB, V97, P408, DOI 10.1210/jc.2011-2134; Haring R, 2009, DIABETES, V58, P2027, DOI 10.2337/db09-0031; Hegenscheid K, 2009, ROFO-FORTSCHR RONTG, V181, P748, DOI 10.1055/s-0028-1109510; Isidori AM, 2005, CLIN ENDOCRINOL, V63, P280, DOI 10.1111/j.1365-2265.2005.02339.x; Key TJ, 2003, J NATL CANCER I, V95, P1218, DOI 10.1093/jnci/djg022; Luukkaa V, 1998, J CLIN ENDOCR METAB, V83, P3243, DOI 10.1210/jc.83.9.3243; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mensink GBM, 2013, BUNDESGESUNDHEITSBLA, V56, P786, DOI 10.1007/s00103-012-1656-3; Fernandez-Balsells MM, 2010, J CLIN ENDOCR METAB, V95, P2560, DOI 10.1210/jc.2009-2575; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Muller HP, 2011, NMR BIOMED, V24, P17, DOI 10.1002/nbm.1549; Salpeter SR, 2006, DIABETES OBES METAB, V8, P538, DOI 10.1111/j.1463-1326.2005.00545.x; SCHNEIDER G, 1979, J CLIN ENDOCR METAB, V48, P633, DOI 10.1210/jcem-48-4-633; Schwarz S, 2007, MENOPAUSE, V14, P123, DOI 10.1097/01.gme.0000227860.58097.e9; Siiteri P, 1981, INCREASED AVAILABILI; Torkler S, 2011, AGING MALE, V14, P176, DOI 10.3109/13685538.2010.529194; Vaidya D, 2012, INT J OBESITY, V36, P1578, DOI 10.1038/ijo.2012.3; Vikan T, 2009, EUR J ENDOCRINOL, V161, P435, DOI 10.1530/EJE-09-0284; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; VOLZKE H, 2007, ARZTEBLATT MECKLENBU, V17, P49; WHO, 2011, GLOBAL STATUS REPORT	33	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0189042	10.1371/journal.pone.0189042	http://dx.doi.org/10.1371/journal.pone.0189042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324787	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400004
J	Thalin, C; Lundstrom, S; Seignez, C; Daleskog, M; Lundstrom, A; Henriksson, P; Helleday, T; Phillipson, M; Wallen, H; Demers, M				Thalin, Charlotte; Lundstrom, Staffan; Seignez, Cedric; Daleskog, Maud; Lundstrom, Annika; Henriksson, Peter; Helleday, Thomas; Phillipson, Mia; Wallen, Hakan; Demers, Melanie			Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer	PLOS ONE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; CIRCULATING TUMOR-CELLS; INNATE IMMUNITY; CATHEPSIN-G; DNA TRAPS; ELASTASE; PROMOTE; NETOSIS; PLASMA; SERUM	Citrullinated histone H3 (H3Cit) is a central player in the neutrophil release of nuclear chromatin, known as neutrophil extracellular traps (NETs). NETs have been shown to elicit harmful effects on the host, and were recently proposed to promote tumor progression and spread. Here we report significant elevations of plasma H3Cit in patients with advanced cancer compared with age-matched healthy individuals. These elevations were specific to cancer patients as no increase was observed in severely ill and hospitalized patients with a higher non-malignant comorbidity. The analysis of neutrophils from cancer patients showed a higher proportion of neutrophils positive for intracellular H3Cit compared to severely ill patients. Moreover, the presence of plasma H3Cit in cancer patients strongly correlated with neutrophil activation markers neutrophil elastase (NE) and myeloperoxidase (MPO), and the inflammatory cytokines interleukin-6 and -8, known to induce NETosis. In addition, we show that high levels of circulating H3Cit strongly predicted poor clinical outcome in our cohort of cancer patients with a 2-fold increased risk for short-term mortality. Our results also corroborate the association of NE, interleukin-6 and -8 with poor clinical outcome. Taken together, our results are the first to unveil H3Cit as a potential diagnostic and prognostic blood marker associated with an exacerbated inflammatory response in patients with advanced cancer.	[Thalin, Charlotte; Daleskog, Maud; Lundstrom, Annika; Demers, Melanie] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Internal Med, Stockholm, Sweden; [Lundstrom, Staffan] Stockholms Sjukhem Fdn, Palliat Care Serv, Stockholm, Sweden; [Lundstrom, Staffan] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Seignez, Cedric; Phillipson, Mia] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Henriksson, Peter; Wallen, Hakan] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Cardiovasc Med, Stockholm, Sweden; [Helleday, Thomas] Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, Stockholm, Sweden	Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Uppsala University; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet	Demers, M (corresponding author), Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Internal Med, Stockholm, Sweden.	Melanie.demers@ki.se		Phillipson, Mia/0000-0002-2387-0266; Seignez, Cedric/0000-0002-6381-2968	Helleday Foundation; Jochnick Foundation; Swedish Research Council; Knut and Alice Wallenberg Foundation; Ragnar Soderberg Foundation; OE and Edla Johansson Foundation	Helleday Foundation; Jochnick Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ragnar Soderberg Foundation; OE and Edla Johansson Foundation	This work was supported by grants from the Helleday Foundation (CT), the Jochnick Foundation (CT), the Swedish Research Council (MP), Knut and Alice Wallenberg Foundation (MP), Ragnar Soderberg Foundation (MP), and OE and Edla Johansson Foundation (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams ST, 2013, AM J RESP CRIT CARE, V187, P160, DOI 10.1164/rccm.201206-1037OC; Alfaro C, 2016, CLIN CANCER RES, V22, P3924, DOI 10.1158/1078-0432.CCR-15-2463; Allam R, 2014, J MOL MED, V92, P465, DOI 10.1007/s00109-014-1148-z; Anzilotti C, 2010, AUTOIMMUN REV, V9, P158, DOI 10.1016/j.autrev.2009.06.002; Arelaki S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154484; Boone BA, 2015, CANCER GENE THER, V22, P326, DOI 10.1038/cgt.2015.21; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cedervall J, 2015, CANCER RES, V75, P2653, DOI 10.1158/0008-5472.CAN-14-3299; Chang XT, 2006, MOL CARCINOGEN, V45, P183, DOI 10.1002/mc.20169; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Demers M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1134073; Demers M, 2014, SEMIN THROMB HEMOST, V40, P277, DOI 10.1055/s-0034-1370765; Demers M, 2012, P NATL ACAD SCI USA, V109, P13076, DOI 10.1073/pnas.1200419109; Ekaney ML, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0543-8; Eriksson L, 2006, BASIC PRINCIPLES APP; Foekens JA, 2003, CANCER RES, V63, P337; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2011, BLOOD, V118, P3708, DOI 10.1182/blood-2011-01-332676; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gahan PB, 2010, EPMA J, V1, P503, DOI 10.1007/s13167-010-0021-6; Guglietta S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11037; Hazeldine J, 2014, AGING CELL, V13, P690, DOI 10.1111/acel.12222; Helin K, 2013, NATURE, V502, P480, DOI 10.1038/nature12751; Holdenrieder S, 2001, INT J CANCER, V95, P114, DOI 10.1002/1097-0215(20010320)95:2<114::AID-IJC1020>3.0.CO;2-Q; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Houghton AM, 2010, NAT MED, V16, P219, DOI 10.1038/nm.2084; Huang H, 2013, J IMMUNOL, V191, P2665, DOI 10.4049/jimmunol.1202733; Huang ZH, 2006, CANCER LETT, V243, P64, DOI 10.1016/j.canlet.2005.11.027; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jethwa HS, 2000, CLIN EXP IMMUNOL, V121, P544, DOI 10.1046/j.1365-2249.2000.01325.x; Jorch SK, 2017, NAT MED, V23, P279, DOI 10.1038/nm.4294; Joshi MB, 2013, FEBS LETT, V587, P2241, DOI 10.1016/j.febslet.2013.05.053; Kawabata K, 2002, EUR J PHARMACOL, V451, P1, DOI 10.1016/S0014-2999(02)02182-9; Keshari RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048111; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Leshner M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00307; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Najmeh S, 2017, INT J CANCER, V140, P2321, DOI 10.1002/ijc.30635; Neeli I, 2009, J INNATE IMMUN, V1, P194, DOI 10.1159/000206974; Park J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1711; Podaza E, 2017, CANCER IMMUNOL IMMUN, V66, P77, DOI 10.1007/s00262-016-1921-7; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Sanmamed MF, 2014, CLIN CANCER RES, V20, P5697, DOI 10.1158/1078-0432.CCR-13-3203; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Semeraro F, 2011, BLOOD, V118, P1952, DOI 10.1182/blood-2011-03-343061; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Thalin C, 2017, IMMUNOL RES, V65, P706, DOI 10.1007/s12026-017-8905-3; Thalin C, 2016, THROMB RES, V139, P56, DOI 10.1016/j.thromres.2016.01.009; Tohme S, 2016, CANCER RES, V76, P1367, DOI 10.1158/0008-5472.CAN-15-1591; Visconti L, 2014, BIOMARK MED, V8, P297, DOI 10.2217/bmm.13.122; Wang S, 2013, BBA-GENE REGUL MECH, V1829, P1126, DOI 10.1016/j.bbagrm.2013.07.003; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wu TL, 2002, CLIN CHIM ACTA, V321, P77, DOI 10.1016/S0009-8981(02)00091-8; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yang CF, 2015, INT J CLIN EXP PATHO, V8, P14075	60	105	109	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191231	10.1371/journal.pone.0191231	http://dx.doi.org/10.1371/journal.pone.0191231			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324871	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000419952400133
J	Ozturk, MC; Xu, Q; Cinar, A				Ozturk, Mustafa Cagdas; Xu, Qian; Cinar, Ali			Agent-based modeling of the interaction between CD8(+) T cells and Beta cells in type 1 diabetes	PLOS ONE			English	Article							LIFE-SPAN; ONSET; EFFECTOR; PROLIFERATION; ANGIOGENESIS; PATHOGENESIS; PROGRESSION; ACTIVATION; SIMULATION; DYNAMICS	We propose an agent-based model for the simulation of the autoimmune response in T1D. The model incorporates cell behavior from various rules derived from the current literature and is implemented on a high-performance computing system, which enables the simulation of a significant portion of the islets in the mouse pancreas. Simulation results indicate that the model is able to capture the trends that emerge during the progression of the autoimmunity. The multi-scale nature of the model enables definition of rules or equations that govern cellular or sub-cellular level phenomena and observation of the outcomes at the tissue scale. It is expected that such a model would facilitate in vivo clinical studies through rapid testing of hypotheses and planning of future experiments by providing insight into disease progression at different scales, some of which may not be obtained easily in clinical studies. Furthermore, the modular structure of the model simplifies tasks such as the addition of new cell types, and the definition or modification of different behaviors of the environment and the cells with ease.	[Ozturk, Mustafa Cagdas; Cinar, Ali] IIT, Dept Chem & Biol Engn, Chicago, IL 60616 USA; [Xu, Qian; Cinar, Ali] IIT, Dept Biomed Engn, Chicago, IL 60616 USA	Illinois Institute of Technology; Illinois Institute of Technology	Cinar, A (corresponding author), IIT, Dept Chem & Biol Engn, Chicago, IL 60616 USA.; Cinar, A (corresponding author), IIT, Dept Biomed Engn, Chicago, IL 60616 USA.	cinar@iit.edu	Cinar, Ali/I-7300-2012	Cinar, Ali/0000-0002-1607-9943	National Science Foundation [IIS-1125412]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation IIS-1125412 (https://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is partially supported by National Science Foundation (IIS-1125412).	Ajmera I, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.30; Akirav E, 2008, DIABETES, V57, P2883, DOI 10.2337/db07-1817; Alanentalo T, 2010, DIABETES, V59, P1756, DOI 10.2337/db09-1400; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Artel A, 2010, THESIS; Bailey AM, 2007, ANN BIOMED ENG, V35, P916, DOI 10.1007/s10439-007-9266-1; Berkland C, 2008, TEMPLATED ISLET CELL; Bianconi E, 2013, ANN HUM BIOL, V40, P463, DOI 10.3109/03014460.2013.807878; Bluestone JA, 2006, SEMIN IMMUNOL, V18, P77, DOI 10.1016/j.smim.2006.01.003; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Bock T, 2003, DIABETES, V52, P1716, DOI 10.2337/diabetes.52.7.1716; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Collier N, 2013, SIMUL-T SOC MOD SIM, V89, P1215, DOI 10.1177/0037549712462620; Coppieters K, 2012, J CLIN INVEST, V122, P119, DOI 10.1172/JCI59285; Dabelea D, 2009, LANCET, V373, P1999, DOI 10.1016/S0140-6736(09)60874-6; Dahlen E, 1998, J IMMUNOL, V160, P3585; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; De Blasio BF, 1999, DIABETES, V48, P1677, DOI 10.2337/diabetes.48.9.1677; Di Rosa F, 1999, J IMMUNOL, V163, P1253; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Gadhamsetty S, 2014, BIOPHYS J, V106, P1780, DOI 10.1016/j.bpj.2014.01.048; Gianani R, 2010, DIABETOLOGIA, V53, P690, DOI 10.1007/s00125-009-1642-y; Gianani R, 2011, SEMIN IMMUNOPATHOL, V33, P23, DOI 10.1007/s00281-010-0235-7; Graham Kate L, 2012, Rev Diabet Stud, V9, P148, DOI 10.1900/RDS.2012.9.148; Graham KL, 2012, EUR J IMMUNOL, V42, P1717, DOI 10.1002/eji.201242435; Graw F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000466; Harjutsalo V, 2008, LANCET, V371, P1777, DOI 10.1016/S0140-6736(08)60765-5; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Ionescu-Tirgoviste C, 2015, SCI REP-UK, V5, DOI 10.1038/srep14634; Jaberi-Douraki M, 2015, J THEOR BIOL, V375, P77, DOI 10.1016/j.jtbi.2014.05.003; Jaberi-Douraki M, 2014, PEDIATR DIABETES, V15, P162, DOI 10.1111/pedi.12148; Jaberi-Douraki M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093326; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Khadra A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014796; Khadra A, 2009, J THEOR BIOL, V256, P126, DOI 10.1016/j.jtbi.2008.09.019; Kinjyo I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7301; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Lee Y, 2006, IMMUNITY, V25, P499, DOI 10.1016/j.immuni.2006.06.016; Liu G, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-6; Magnuson AM, 2015, P NATL ACAD SCI USA, V112, P1511, DOI 10.1073/pnas.1423769112; Makino S, 1980, Jikken Dobutsu, V29, P1; Maree AFM, 2006, PHILOS T R SOC A, V364, P1267, DOI 10.1098/rsta.2006.1769; Espinosa IVM, 2010, ADV INTEL SOFT COMPU, V74, P157, DOI 10.1007/978-3-642-13214-8_21; Martinez I.V., 2012, 7 IBERIAN C INFORM S, P1; Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Murphy JT, 2016, WINT SIMUL C PROC, P2087, DOI 10.1109/WSC.2016.7822252; Oehen S, 1998, J IMMUNOL, V161, P5338; Peirce SM, 2003, MICROCIRCULATION, V10, P99, DOI 10.1038/sj.mn.7800172; Qutub AA, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-13; Schmitz I, 2003, J IMMUNOL, V171, P2930, DOI 10.4049/jimmunol.171.6.2930; Sherry NA, 2006, DIABETES, V55, P3238, DOI 10.2337/db05-1034; Shoda L, 2010, CLIN EXP IMMUNOL, V161, P250, DOI 10.1111/j.1365-2249.2010.04166.x; Simeonovic CJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00471; Sreenan S, 1999, DIABETES, V48, P989, DOI 10.2337/diabetes.48.5.989; Tang J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-14; Tang J, 2014, STEM CELLS, V32, P649, DOI 10.1002/stem.1533; Tang J, 2011, INTEGR BIOL-UK, V3, P408, DOI 10.1039/c0ib00092b; Tang J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000681; Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724; von Herrath M, 2007, NAT REV IMMUNOL, V7, P988, DOI 10.1038/nri2192; VONBOEHMER H, 1993, J EXP MED, V177, P891, DOI 10.1084/jem.177.4.891; Wedgwood KCA, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00633; Wiedemann A, 2006, P NATL ACAD SCI USA, V103, P10985, DOI 10.1073/pnas.0600651103; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	68	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190349	10.1371/journal.pone.0190349	http://dx.doi.org/10.1371/journal.pone.0190349			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320541	Green Published, Green Submitted, gold			2022-12-26	WOS:000419689600046
J	Parlato, S; Chiacchio, T; Salerno, D; Petrone, L; Castiello, L; Romagnoli, G; Canini, I; Goletti, D; Gabriele, L				Parlato, Stefania; Chiacchio, Teresa; Salerno, Debora; Petrone, Linda; Castiello, Luciano; Romagnoli, Giulia; Canini, Irene; Goletti, Delia; Gabriele, Lucia			Impaired IFN-alpha-mediated signal in dendritic cells differentiates active from latent tuberculosis	PLOS ONE			English	Article							EFFECTOR MEMORY PHENOTYPE; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSE; I INTERFERONS; T-CELLS; SUBSETS; EXPRESSION; INFECTION; TYPE-1; PERSPECTIVES	Individuals exposed to Mycobacterium tuberculosis (Mtb) may be infected and remain for the entire life in this condition defined as latent tuberculosis infection (LTBI) or develop active tuberculosis (TB). Among the multiple factors governing the outcome of the infection, dendritic cells (DCs) play a major role in dictating antibacterial immunity. However, current knowledge on the role of the diverse components of human DCs in shaping specific T-cell response during Mtb infection is limited. In this study, we performed a comparative evaluation of peripheral blood circulating DC subsets as well as of monocyte-derived Interferon-alpha DCs (IFN-DCs) from patients with active TB, subjects with LTBI and healthy donors (HD). The proportion of circulating myeloid BDCA3(+) DCs (mDC2) and plasmacytoid CD123(+) DCs (pDCs) declined significantly in active TB patients compared to HD, whereas the same subsets displayed a remarkable activation in LTBI subjects. Simultaneously, the differentiation of IFN-DCs from active TB patients resulted profoundly impaired compared to those from LTBI and HD individuals. Importantly, the altered developmental trait of IFN-DCs from active TB patients was associated with down-modulation of IFN-linked genes, marked changes in molecular signaling conveying antigen (Ag) presentation and full inability to induce Ag-specific T cell response. Thus, these data reveal an important role of IFN-alpha in determining the induction of Mtb-specific immunity.	[Parlato, Stefania; Romagnoli, Giulia; Canini, Irene; Gabriele, Lucia] Ist Super Sanita, Dept Oncol & Mol Med, Rome, Italy; [Chiacchio, Teresa; Petrone, Linda; Goletti, Delia] L Spallanzani Natl Inst Infect Dis INMI IRCCS, Dept Epidemiol & Preclin Res, Translat Res Unit, Rome, Italy; [Salerno, Debora] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [Castiello, Luciano] Fdn Cenci Bolognetti, Ist Pasteur, Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Italiano di Tecnologia - IIT; Fondazione Cenci Bolognetti	Gabriele, L (corresponding author), Ist Super Sanita, Dept Oncol & Mol Med, Rome, Italy.; Goletti, D (corresponding author), L Spallanzani Natl Inst Infect Dis INMI IRCCS, Dept Epidemiol & Preclin Res, Translat Res Unit, Rome, Italy.	delia.goletti@inmi.it; lucia.gabriele@iss.it	Petrone, Linda/K-3947-2016; Castiello, Luciano/Z-3150-2019; goletti, delia/AAM-6577-2020; Gabriele, Lucia/J-8335-2016; Salerno, Debora/AAM-9940-2021; PARLATO, STEFANIA/J-2777-2018	Petrone, Linda/0000-0002-2593-3478; Castiello, Luciano/0000-0001-7146-3158; Gabriele, Lucia/0000-0002-1483-866X; PARLATO, STEFANIA/0000-0001-6727-0900; Goletti, Delia/0000-0001-8360-4376; romagnoli, giulia/0000-0002-0621-2579; SALERNO, DEBORA/0000-0003-0504-1904	Italian Association for Research against Cancer (AIRC) [11610]; Italian Ministry of Health "Ricerca Corrente"; European Union [HEALTH-F3-2009-241642]; EC NEWTBVAC [HEALTH.F3.2009 241745]	Italian Association for Research against Cancer (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health "Ricerca Corrente"(Ministry of Health, Italy); European Union(European Commission); EC NEWTBVAC	This work was supported by the Italian Association for Research against Cancer (AIRC) grant #11610 to LG and by grants from the Italian Ministry of Health Ricerca Corrente and from the European Union, HEALTH-F3-2009-241642 and EC FP7 NEWTBVAC (contract no. HEALTH.F3.2009 241745) to DG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askenase MH, 2015, IMMUNITY, V42, P1130, DOI 10.1016/j.immuni.2015.05.011; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bhatt K, 2013, CELL IMMUNOL, V285, P69, DOI 10.1016/j.cellimm.2013.09.004; Bond E, 2012, J INVEST DERMATOL, V132, P114, DOI 10.1038/jid.2011.246; Cai QL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003751; Cantini F, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/8909834; Chiacchio T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183846; Chiacchio T, 2014, J INFECTION, V69, P533, DOI 10.1016/j.jinf.2014.06.009; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P533, DOI 10.1016/j.smim.2014.10.002; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gabriele L, 2004, BLOOD, V103, P980, DOI 10.1182/blood-2003-03-0981; Giacomini E, 2009, J LEUKOCYTE BIOL, V85, P462, DOI 10.1189/jlb.0908583; Gigante M, 2008, J IMMUNOTHER, V31, P254, DOI 10.1097/CJI.0b013e318167b023; Girardi E, 2017, INT J INFECT DIS, V56, P45, DOI 10.1016/j.ijid.2017.01.018; Goletti D, 1996, J IMMUNOL, V157, P1271; Goletti D, 2014, J RHEUMATOL, V41, P24, DOI 10.3899/jrheum.140099; Gupta V, 2010, HUM IMMUNOL, V71, P682, DOI 10.1016/j.humimm.2010.03.010; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hoshino A, 2014, PATHOG DIS, V70, P28, DOI 10.1111/2049-632X.12082; Koh VHQ, 2017, TUBERCULOSIS, V102, P34, DOI 10.1016/j.tube.2016.12.003; Kuchtey J, 2006, IMMUNOLOGY, V118, P39, DOI 10.1111/j.1365-2567.2006.02337.x; Lattanzi L, 2011, IMMUNOBIOLOGY, V216, P537, DOI 10.1016/j.imbio.2010.10.003; Lichtner M, 2006, CLIN EXP IMMUNOL, V143, P329, DOI 10.1111/j.1365-2249.2005.02994.x; Lin PL, 2015, SEMIN IMMUNOPATHOL, V37, P239, DOI 10.1007/s00281-015-0490-8; Lozza L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00324; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Mihret A, 2012, VIRULENCE, V3, P654, DOI 10.4161/viru.22586; Montoya M, 2002, BLOOD, V99, P3263, DOI 10.1182/blood.V99.9.3263; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mourik BC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00294; Ng CT, 2016, CELL, V164, P349, DOI 10.1016/j.cell.2015.12.027; O'Keeffe M, 2015, CELL MOL LIFE SCI, V72, P4309, DOI 10.1007/s00018-015-2005-0; Parlato S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072833; Parlato S, 2010, BLOOD, V115, P1554, DOI 10.1182/blood-2009-07-234468; Perera PY, 2012, MICROBES INFECT, V14, P247, DOI 10.1016/j.micinf.2011.10.006; Petruccioli E, 2016, EUR RESPIR J, V48, P1751, DOI 10.1183/13993003.01012-2016; Petruccioli E, 2016, DIAGN MICR INFEC DIS, V86, P169, DOI 10.1016/j.diagmicrobio.2016.06.007; Petruccioli E, 2015, J INFECTION, V71, P526, DOI 10.1016/j.jinf.2015.07.009; Petruccioli E, 2013, J INFECTION, V66, P475, DOI 10.1016/j.jinf.2013.02.004; Prendergast KA, 2013, TUBERCULOSIS, V93, P115, DOI 10.1016/j.tube.2012.10.008; Prezzemolo T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00180; Rizza P, 2015, CYTOKINE GROWTH F R, V26, P195, DOI 10.1016/j.cytogfr.2014.10.002; Rocca S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062751; Sakhno LV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/628635; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Santodonato L, 2003, J IMMUNOL, V170, P5195, DOI 10.4049/jimmunol.170.10.5195; Satake Y, 2017, INT J TUBERC LUNG D, V21, P523, DOI 10.5588/ijtld.16.0371; Schiavoni G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00483; Schlitzer A, 2015, SEMIN CELL DEV BIOL, V41, P9, DOI 10.1016/j.semcdb.2015.03.011; Simmons DP, 2010, J IMMUNOL, V185, P2405, DOI 10.4049/jimmunol.0904005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Travar M, 2016, ARCH IMMUNOL THER EX, V64, P19, DOI 10.1007/s00005-015-0365-7; van der Aa E, 2015, SEMIN CELL DEV BIOL, V41, P39, DOI 10.1016/j.semcdb.2014.05.016; Van Rhijn I, 2015, IMMUNOL REV, V264, P138, DOI 10.1111/imr.12253; Vermi W, 2011, J INVEST DERMATOL, V131, P426, DOI 10.1038/jid.2010.256; Xu Y, 2013, TUBERCULOSIS, V93, pS33, DOI 10.1016/S1472-9792(13)70008-8	59	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0189477	10.1371/journal.pone.0189477	http://dx.doi.org/10.1371/journal.pone.0189477			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320502	Green Published, Green Submitted, gold			2022-12-26	WOS:000419689600010
J	Tonen-Wolyec, S; Batina-Agasa, S; Muwonga, J; N'kulu, FF; Bouassa, RSM; Belec, L				Tonen-Wolyec, Serge; Batina-Agasa, Salomon; Muwonga, Jeremie; N'kulu, Franck Fwamba; Bouassa, Ralph-Sydney Mboumba; Belec, Laurent			Evaluation of the practicability and virological performance of finger-stick whole-blood HIV self-testing in French-speaking sub-Saharan Africa	PLOS ONE			English	Article							DIAGNOSTIC-TEST; ATTITUDES	Background Opportunities for HIV testing could be enhanced by offering HIV self-testing (HIVST) in populations that fear stigma and discrimination when accessing conventional HIV counselling and testing in health care facilities. Field experience with HIVST has not yet been reported in French-speaking African countries. Methods The practicability of HIVST was assessed using the prototype the Exacto (R) Test HIV (Biosynex, Strasbourg, France) self-test in 322 adults living in Kisangani and Bunia, Democratic Republic of the Congo, according to World Health Organization's recommendations. Simplified and easy-to-read leaflet was translated in French, Lingala and Swahili. Results Forty-nine percent of participants read the instructions for use in French, while 17.1% and 33.9% read the instructions in Lingala and Swahili, respectively. The instructions for use were correctly understood in 79.5% of cases. The majority (98.4%) correctly performed the HIV self-test; however, 20.8% asked for oral assistance. Most of the participants (95.3%) found that performing the self-test was easy, while 4.7% found it difficult. Overall, the results were correctly interpreted in 90.2% of cases. Among the positive, negative, and invalid self-tests, misinterpretation occurred in 6.5%, 11.2%, and 16.0% of cases, respectively (P<0.0001). The Cohen's. coefficient was 0.84. The main obstacle for HIVST was educational level, with execution and interpretation difficulties occurring among poorly educated people. The Exacto (R) Test HIV self-test showed 100.0% (95% CI; 98.8-100.0) sensitivity and 99.2% (95% CI; 97.5-99.8) specificity. Conclusions Our field observations demonstrate: (i) the need to adapt the instructions for use to the Congolese general public, including adding educational pictograms as well as instructions for use in the local vernacular language(s); (ii) frequent difficulties understanding the instructions for use in addition to frequent misinterpretation of test results; and (iii) the generally good practicability of the HIV self-test despite some limitations. Supervised use of HIVST is recommended among poorly-educated people.	[Tonen-Wolyec, Serge] Ecole Doctorale Reg Africa Cent Infectiol Trop, Franceville, Gabon; [Tonen-Wolyec, Serge] Univ Bunia, Fac Med, Bunia, DEM REP CONGO; [Tonen-Wolyec, Serge; Batina-Agasa, Salomon] Univ Kisangani, Fac Med & Pharm, Kisangani, DEM REP CONGO; [Muwonga, Jeremie] Lab Natl Reference Sida, Kinshasa, DEM REP CONGO; [N'kulu, Franck Fwamba] Programme Natl Lutte VIH SIDA & IST, Kinshasa, DEM REP CONGO; [Bouassa, Ralph-Sydney Mboumba; Belec, Laurent] Hop Europe Georges Pompidou, Lab Virol, Paris, France; [Bouassa, Ralph-Sydney Mboumba; Belec, Laurent] Univ Paris 05, Paris Sorbonne Cite, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Tonen-Wolyec, S (corresponding author), Ecole Doctorale Reg Africa Cent Infectiol Trop, Franceville, Gabon.; Tonen-Wolyec, S (corresponding author), Univ Bunia, Fac Med, Bunia, DEM REP CONGO.; Tonen-Wolyec, S (corresponding author), Univ Kisangani, Fac Med & Pharm, Kisangani, DEM REP CONGO.	wolyec@gmail.com	Tonen-Wolyec, Serge/ADM-2951-2022	Tonen-Wolyec, Serge/0000-0002-7734-7729	University of Bunia, Democratic Republic of Congo; University of Kisangani, Democratic Republic of Congo; Programme National de Lutte contre le VIH/SIDA et les Infections Sexuellement Transmissibles, Kinshasa, Democratic Republic of Congo; pharmaceutical companies	University of Bunia, Democratic Republic of Congo; University of Kisangani, Democratic Republic of Congo; Programme National de Lutte contre le VIH/SIDA et les Infections Sexuellement Transmissibles, Kinshasa, Democratic Republic of Congo; pharmaceutical companies	The study was partly sponsored by the University of Bunia, Democratic Republic of Congo, the University of Kisangani, Democratic Republic of Congo, and by the Programme National de Lutte contre le VIH/SIDA et les Infections Sexuellement Transmissibles, Kinshasa, Democratic Republic of Congo without a grant from pharmaceutical companies. No grant was received from the HIV test manufacturer.	Aghokeng AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007702; [Anonymous], 2014, ENQ DEM SANT REP DEM; Asiimwe S, 2014, AIDS BEHAV, V18, P2477, DOI 10.1007/s10461-014-0765-4; Battye R, 2000, FRENCH LANGUAGE TODA, P257; Beaulieu Q, 2017, MED MALADIES INFECT, V47, pS54; Belza MJ, 2012, SEX TRANSM INFECT, V88, P218, DOI 10.1136/sextrans-2011-050131; Brown B, 2015, GLOB PUBLIC HEALTH, V10, P354, DOI 10.1080/17441692.2014.947303; Cambiano V, 2015, J INFECT DIS, V212, P570, DOI 10.1093/infdis/jiv040; Chappelle R, 2012, FDA APPROVES 1 COUNT; Cherutich P., 2014, Retrovirology: Research and Treatment, V6, P23; Choko AT, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001873; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Johnson C, 2014, AIDS BEHAV, V18, pS391, DOI 10.1007/s10461-014-0832-x; Johnson CC, 2016, LANCET HIV, V3, pE243, DOI 10.1016/S2352-3018(16)00044-8; Kalibala S, 2014, AIDS BEHAV, V18, pS405, DOI 10.1007/s10461-014-0830-z; Kalichman SC, 2003, SEX TRANSM INFECT, V79, P442, DOI 10.1136/sti.79.6.442; Khirani D., 2016, CONCEPTION REALISATI; Klarkowski D, 2014, EXPERT REV ANTI-INFE, V12, P49, DOI 10.1586/14787210.2014.866516; Klarkowski D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081656; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Makomo MJ, 2013, SYNERGIES GRANDS LAC, P45; Makusha T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122783; Mbopi-Keou FX, 2014, J CLIN MICROBIOL, V52, P660, DOI 10.1128/JCM.02945-13; Meiberg Annemarie E, 2008, East Afr J Public Health, V5, P49; Pai NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079772; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Peck RB, 2014, AIDS BEHAV, V18, pS422, DOI 10.1007/s10461-014-0818-8; Prazuck T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146755; Shanks L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059906; Spielberg F, 2004, LANCET INFECT DIS, V4, P640, DOI 10.1016/S1473-3099(04)01150-8; Stevens DR, 2017, AIDS BEHAV; Thirumurthy H, 2016, LANCET HIV, V3, pE266, DOI 10.1016/S2352-3018(16)00041-2; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2014, 90 90 90 AMB TREATM; van Rooyen H, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19445; Vidal N, 2006, AIDS RES HUM RETROV, V22, P202, DOI 10.1089/aid.2006.22.202; [WHO WHO UNAIDS Brocher Foundation Liverpool School of Tropical Mediciine], 2013, 1 INT S SELF TEST HI; WHO, 2015, CONSOLIDATED GUIDELI; WHO, 2016, SUPPL GUID HIV SELF; World Health Organization, 1997, WKLY EPIDEMIOL REC, V72, P81; World Health Organization, 2017, MARK TECHN LANDSC 20; World Health Organization, 2012, SERV DEL APPR HIV TE; World Health Organization & Unitaid, 2016, TECHN LANDSC HIV RAP; World Health Organization (WHO), 2016, TECHN SPEC SER SUBM; World Health Organization (WHO), 2015, WHO PREQ SAMPL PROD; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	49	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0189475	10.1371/journal.pone.0189475	http://dx.doi.org/10.1371/journal.pone.0189475			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320504	Green Published, gold			2022-12-26	WOS:000419689600009
J	Yang, VK; Tai, AK; Huh, TP; Meola, DM; Juhr, CM; Robinson, NA; Hoffman, AM				Yang, Vicky K.; Tai, Albert K.; Huh, Terry P.; Meola, Dawn M.; Juhr, Christine M.; Robinson, Nicholas A.; Hoffman, Andrew M.			Dysregulation of valvular interstitial cell let-7c, miR-17, miR-20a, and miR-30d in naturally occurring canine myxomatous mitral valve disease	PLOS ONE			English	Article							CARDIOMYOCYTE APOPTOSIS; EXPRESSION; DOGS; MANAGEMENT; FIBROSIS	Canine myxomatous mitral valve disease (MMVD) resembles the early stages of myxomatous pathology seen in human non-syndromic mitral valve prolapse, a common valvular heart disease in the adult human population. Canine MMVD is seen in older subjects, suggesting age-related epigenetic dysregulation leading to derangements in valvular cell populations and matrix synthesis or degradation. We hypothesized that valvular interstitial cells (VICs) undergo disease-relevant changes in miRNA expression. In primary VIC lines from diseased and control valves, miRNA expression was profiled using RT-qPCR and next generation sequencing. VICs from diseased valves showed phenotypic changes consistent with myofibroblastic differentiation (vimentin(low+), alpha-SMA(high+)), increases in senescence markers (p21, SA-beta-gal), and decreased cell viability and proliferation potential. RT-qPCR and miRNA sequencing analyses both showed significant (p<0.05) downregulation of let-7c, miR-17, miR-20a, and miR-30d in VICs from diseased valves compared to controls. Decreased let-7c, miR-17, and miR-20a may contribute to myofibroblastic differentiation in addition to cell senescence, and decreased miR-30d may disinhibit cell apoptosis. These data support the hypothesis that epigenetic dysregulation plays an important role in age-related canine MMVD.	[Yang, Vicky K.; Huh, Terry P.; Meola, Dawn M.; Juhr, Christine M.; Hoffman, Andrew M.] Tufts Univ, Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA 01536 USA; [Tai, Albert K.] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA; [Robinson, Nicholas A.] Tufts Univ, Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA USA	Tufts University; Tufts University; Tufts University	Yang, VK (corresponding author), Tufts Univ, Cummings Sch Vet Med, Dept Clin Sci, North Grafton, MA 01536 USA.	vicky.yang@tufts.edu		Yang, Vicky/0000-0002-1281-4250	Shipley Foundation	Shipley Foundation	This work was supported by the Shipley Foundation to AMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Aupperle H, 2012, J VET CARDIOL, V14, P59, DOI 10.1016/j.jvc.2012.01.005; Aupperle H, 2009, RES VET SCI, V87, P277, DOI 10.1016/j.rvsc.2009.01.009; Barth PJ, 2005, PATHOL RES PRACT, V201, P301, DOI 10.1016/j.prp.2005.02.001; Borgarelli M, 2012, J VET CARDIOL, V14, P93, DOI 10.1016/j.jvc.2012.01.011; Brennan EP, 2013, J AM SOC NEPHROL, V24, P627, DOI 10.1681/ASN.2012060550; Chen YW, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060833; Cole WG, BIOCH J, V2984, P415; Correia ACP, 2016, J CELL SCI, V129, P569, DOI 10.1242/jcs.176248; Dakhlallah D, 2013, AM J RESP CRIT CARE, V187, P397, DOI 10.1164/rccm.201205-0888OC; Du WW, 2015, J CELL SCI, V128, P293, DOI 10.1242/jcs.158360; Frank D, 2012, J MOL CELL CARDIOL, V52, P711, DOI 10.1016/j.yjmcc.2011.12.001; Geirsson A, 2012, CIRCULATION, V126, pS189, DOI 10.1161/CIRCULATIONAHA.111.082610; Georgakilas AG, 2017, TRENDS MOL MED; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Guo YQ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003850; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; Hagler MA, 2013, CARDIOVASC RES, V99, P175, DOI 10.1093/cvr/cvt083; Han RI, 2008, AM J VET RES, V69, P763, DOI 10.2460/ajvr.69.6.763; HARPER JW, 1993, CELL, V75, P805; Hulanicka M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0205-8; IBM Corp, 2013, SPSS STAT WIND; Jiang T, 2016, MOL CELLS, V39, P345, DOI 10.14348/molcells.2016.2336; Khee SGS, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/725929; Lu CC, 2015, VET J, V204, P23, DOI 10.1016/j.tvjl.2015.02.021; Melman YF, 2015, CIRCULATION, V131, P2202, DOI 10.1161/CIRCULATIONAHA.114.013220; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Murray MJ, 2015, CANCER EPIDEM BIOMAR, V24, P350, DOI 10.1158/1055-9965.EPI-14-0669; Oyama MA, 2006, AM J VET RES, V67, P1307, DOI 10.2460/ajvr.67.8.1307; Pickering MT, 2009, ONCOGENE, V28, P140, DOI 10.1038/onc.2008.372; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Wang XH, 2015, INT J CARDIOL, V187, P365, DOI 10.1016/j.ijcard.2015.03.195; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xie H, 2016, ONCOTARGET, V7, P51473, DOI 10.18632/oncotarget.10444; Yang VK, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1350088	38	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0188617	10.1371/journal.pone.0188617	http://dx.doi.org/10.1371/journal.pone.0188617			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315310	Green Published, Green Submitted, gold			2022-12-26	WOS:000419655900001
J	Ko, CW; Counihan, D; Wu, J; Hatzoglou, M; Puchowicz, MA; Croniger, CM				Ko, Chih-Wei; Counihan, Daniel; Wu, Jing; Hatzoglou, Maria; Puchowicz, Michelle A.; Croniger, Colleen M.			Macrophages with a deletion of the phosphoenolpyruvate carboxykinase 1 (Pck1) gene have a more proinflammatory phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CITRIC-ACID CYCLE; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; ER STRESS; INFLAMMATION; OBESITY; CARBOXYKINASE; CATAPLEROSIS; EXPRESSION; SUCCINATE	Phosphoenolpyruvate carboxykinase (Pck1) is a metabolic enzyme that is integral to the gluconeogenic and glyceroneogenic pathways. However, Pck1' s role in macrophage metabolism and function is unknown. Using stable isotopomer MS analysis in a mouse model with a myeloid cell-specific Pck1 deletion, we show here that this deletion increases the proinflammatory phenotype in macrophages. Incubation of LPS-stimulated bone marrow-derived macrophages (BMDM) with [U-C-13] glucose revealed reduced C-13 labeling of citrate and malate and increased C-13 labeling of lactate in Pck1-deleted bone marrow-derived macrophages. We also found that the Pck1 deletion in the myeloid cells increases reactive oxygen species (ROS). Of note, this altered macrophage metabolism increased expression of the M1 cytokines TNF alpha, IL-1 beta, and IL-6. We therefore conclude that Pck1 contributes to M1 polarization in macrophages. Our findings provide important insights into the factors determining the macrophage inflammatory response and indicate that Pck1 activity contributes to metabolic reprogramming and polarization in macrophages.	[Ko, Chih-Wei; Counihan, Daniel; Puchowicz, Michelle A.; Croniger, Colleen M.] Case Western Reserve Univ, Dept Nutr, Sch Med, Cleveland, OH 44106 USA; [Wu, Jing; Hatzoglou, Maria] Case Western Reserve Univ, Dept Genet & Genome Sci, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Croniger, CM (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	cmc6@case.edu			National Institutes of Health [U24 DK76174]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053307, R37DK060596, U24DK076174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Case Mouse Metabolic Phenotyping Center (MMPC) was supported by National Institutes of Health Grant U24 DK76174. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Beale EG, 2007, CELL BIOCHEM BIOPHYS, V48, P89, DOI 10.1007/s12013-007-0025-6; Bederman IR, 2009, J BIOL CHEM, V284, P6101, DOI 10.1074/jbc.M808668200; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; DeSantis DA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/751374; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Freemerman AJ, 2014, J BIOL CHEM, V289, P7884, DOI 10.1074/jbc.M113.522037; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Geeraerts X, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00289; He L, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040215; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Infantino V, 2013, BIOCHEM BIOPH RES CO, V440, P105, DOI 10.1016/j.bbrc.2013.09.037; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Kombu RS, 2011, METHODS MOL BIOL, V708, P147, DOI 10.1007/978-1-61737-985-7_8; Liemburg-Apers DC, 2015, ARCH TOXICOL, V89, P1209, DOI 10.1007/s00204-015-1520-y; Meiser J, 2016, J BIOL CHEM, V291, P3932, DOI 10.1074/jbc.M115.676817; Mekahli D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004317; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Millward CA, 2010, J LIPID RES, V51, P1452, DOI 10.1194/jlr.M005363; Montal ED, 2015, MOL CELL, V60, P571, DOI 10.1016/j.molcel.2015.09.025; O'Neill LAJ, 2015, IMMUNITY, V42, P393, DOI 10.1016/j.immuni.2015.02.017; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Yang LL, 2008, J BIOL CHEM, V283, P21978, DOI 10.1074/jbc.M803454200; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	38	20	21	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3399	3409		10.1074/jbc.M117.819136	http://dx.doi.org/10.1074/jbc.M117.819136			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29317502	Green Published, hybrid			2022-12-26	WOS:000426562800030
J	Lopez-Delisle, L; Pierre-Eugene, C; Louis-Brennetot, C; Surdez, D; Raynal, V; Baulande, S; Boeva, V; Grossetete-Lalami, S; Combaret, V; Peuchmaur, M; Delattre, O; Janoueix-Lerosey, I				Lopez-Delisle, Lucille; Pierre-Eugene, Cecile; Louis-Brennetot, Caroline; Surdez, Didier; Raynal, Virginie; Baulande, Sylvain; Boeva, Valentina; Grossetete-Lalami, Sandrine; Combaret, Valerie; Peuchmaur, Michel; Delattre, Olivier; Janoueix-Lerosey, Isabelle			Activated ALK signals through the ERK-ETV5-RET pathway to drive neuroblastoma oncogenesis	ONCOGENE			English	Article							ANAPLASTIC LYMPHOMA KINASE; ETS TRANSCRIPTION FACTORS; RECEPTOR TYROSINE KINASE; INHIBITOR PF-06463922; THERAPEUTIC TARGET; UP-REGULATION; RET; MUTATIONS; CANCER; EXPRESSION	Activating mutations of the ALK receptor occur in a subset of neuroblastoma tumors. We previously demonstrated that Alk mutations cooperate with MYCN overexpression to induce neuroblastoma in mice and identified Ret as being strongly upregulated in MYCN/Alk(mu)t tumors. By a genetic approach in vivo, we now document an oncogenic cooperation between activated Ret and MYCN overexpression in neuroblastoma formation. We show that MYCN/Ret(M919T) tumors exhibit histological features and expression profiles close to MYCN/Alk(mut) tumors. We show that RET transcript levels decrease precedes RET protein levels decrease upon ALK inhibition in neuroblastoma cell lines. Etv5 was identified as a candidate transcription factor regulating Ret expression from murine MYCN/Alk(mut) tumor transcriptomic data. We demonstrate that ETV5 is regulated both at the protein and mRNA levels upon ALK activation or inhibition in neuroblastoma cell lines and that this regulation precedes RET modulation. We document that ALK activation induces ETV5 protein upregulation through stabilization in a MEK/ERK- dependent manner. We show that RNAi-mediated inhibition of ETV5 decreases RET expression. Reporter assays indicate that ETV5 is able to drive RET gene transcription. ChIP-seq analysis confirmed ETV5 binding on the RET promoter and identified an enhancer upstream of the promoter. Finally, we demonstrate that combining RET and ALK inhibitors reduces tumor growth more efficiently than each single agent in MYCN and Alk(F1178L)-driven murine neuroblastoma. Altogether, these results define the ERK-ETV5-RET pathway as a critical axis driving neuroblastoma oncogenesis downstream of activated ALK.	[Lopez-Delisle, Lucille; Pierre-Eugene, Cecile; Louis-Brennetot, Caroline; Surdez, Didier; Raynal, Virginie; Grossetete-Lalami, Sandrine; Delattre, Olivier; Janoueix-Lerosey, Isabelle] PSL Res Univ, INSERM, U830, Equipe Labellisee Ligue Canc,Inst Curie, Paris, France; [Raynal, Virginie; Baulande, Sylvain] Inst Curie Res Ctr, Inst Curie Genom Excellence ICGex, Paris, France; [Boeva, Valentina] Univ Paris 05, CNRS, UMR 8104, Inst Cochin,INSERM,U1016,UMR S1016, Paris, France; [Boeva, Valentina] PSL Res Univ, INSERM, U900, Inst Curie,Mines ParisTech, Paris, France; [Combaret, Valerie] Ctr Leon Berard, Lab Rech Translat, Lyon, France; [Peuchmaur, Michel] Hop Univ Robert Debre, AP HP, Dept Pathol, Paris, France; [Peuchmaur, Michel] Univ Diderot Paris 7, Paris Sorbonne Cite, Paris, France; [Delattre, Olivier; Janoueix-Lerosey, Isabelle] Inst Curie, SIREDO Care Innovat & Res Children Adolescents &, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Janoueix-Lerosey, I (corresponding author), PSL Res Univ, INSERM, U830, Equipe Labellisee Ligue Canc,Inst Curie, Paris, France.; Janoueix-Lerosey, I (corresponding author), Inst Curie, SIREDO Care Innovat & Res Children Adolescents &, Paris, France.	janoueix@curie.fr	Janoueix-Lerosey, Isabelle/G-1758-2018; Boeva, Valentina/C-2855-2017; Surdez, Didier/ABG-4565-2020	Janoueix-Lerosey, Isabelle/0000-0003-0434-3003; Boeva, Valentina/0000-0002-4382-7185; LOUIS, Caroline/0000-0002-4952-3828; Lopez-Delisle, Lucille/0000-0002-1964-4960; BAULANDE, Sylvain/0000-0003-3104-1684; delattre, olivier/0000-0002-8730-2276	Institut National du Cancer [PRT-K 14061]; Ligue Nationale contre le Cancer (Equipe labellisee); Association Hubert Gouin "Enfance et Cancer"; Les Bagouz a Manon, les amis de Claire; la Federation Enfants et Sante et la Societe Francaise de Lutte contre les Cancers et les Leucemies de l'Enfant et l'Adolescent; Fondation pour la Recherche Medicale [FDT20140930966]; Institut Curie-SIRIC (Site de Recherche Integree en Cancerologie) program; ATIP-Avenir program; "Who am I?" program; Agence Nationale de la Recherche ("Investissements d'Avenir" program) [ANR-10-EQPX-03, ANR-10-INBS-09-08]; Canceropole Ile-de-France; SiRIC-Curie program-SiRIC [INCa-DGOS-4654]	Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); Association Hubert Gouin "Enfance et Cancer"; Les Bagouz a Manon, les amis de Claire; la Federation Enfants et Sante et la Societe Francaise de Lutte contre les Cancers et les Leucemies de l'Enfant et l'Adolescent; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut Curie-SIRIC (Site de Recherche Integree en Cancerologie) program; ATIP-Avenir program; "Who am I?" program; Agence Nationale de la Recherche ("Investissements d'Avenir" program)(French National Research Agency (ANR)); Canceropole Ile-de-France(Region Ile-de-France); SiRIC-Curie program-SiRIC	The U830 Inserm laboratory is supported by grants from the Institut National du Cancer (PRT-K 14061), the Ligue Nationale contre le Cancer (Equipe labellisee), the Association Hubert Gouin "Enfance et Cancer", Les Bagouz a Manon, les amis de Claire, la Federation Enfants et Sante et la Societe Francaise de Lutte contre les Cancers et les Leucemies de l'Enfant et l'Adolescent. LL-D was the recipient of a fellowship of the Fondation pour la Recherche Medicale (FDT20140930966). DS is supported by the Institut Curie-SIRIC (Site de Recherche Integree en Cancerologie) program. VB is supported by the ATIP-Avenir and the "Who am I?" programs. High-throughput sequencing has been performed by the ICGex NGS platform of the Institut Curie supported by the grants ANR-10-EQPX-03 (Equipex) and ANR-10-INBS-09-08 (France Genomique Consortium) from the Agence Nationale de la Recherche ("Investissements d'Avenir" program), by the Canceropole Ile-de-France and by the SiRIC-Curie program-SiRIC Grant "INCa-DGOS-4654". We thank Jean-Luc Baert (Institut de Recherche Interdisciplinaire de Lille, Lille, France) for providing us with the pcDNA3-ETV5 plasmid and Matthias Fischer for providing the ALK status of tumors from the GSE49711 dataset. We thank D Gentien and his team from the translational department of Institut Curie for Affymetrix profiling experiments. We are grateful to the animal facilities team of the Institut Curie and especially to I Grandjean and C Jouhanneau. We thank the Experimental Pathology Department of Institut Curie for their valuable help and the SIRIC-Curie for help in image analyses. We acknowledge our colleagues F Tirode and W Richer for assistance in the analysis of Affymetrix data.	Ashoor H, 2013, BIOINFORMATICS, V29, P2979, DOI 10.1093/bioinformatics/btt524; Baert JL, 2007, ONCOGENE, V26, P415, DOI 10.1038/sj.onc.1209801; Berry T, 2012, CANCER CELL, V22, P117, DOI 10.1016/j.ccr.2012.06.001; Boeva V, 2017, NAT GENET, V49, P1408, DOI 10.1038/ng.3921; Bresler SC, 2014, CANCER CELL, V26, P682, DOI 10.1016/j.ccell.2014.09.019; Bresler SC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002950; Camidge DR, 2012, NAT REV CLIN ONCOL, V9, P268, DOI 10.1038/nrclinonc.2012.43; Cazes A, 2014, ONCOTARGET, V5, P2688, DOI 10.18632/oncotarget.1883; Chatterjee S, 2016, CELL, V167, P355, DOI 10.1016/j.cell.2016.09.005; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chi P, 2010, NATURE, V467, P849, DOI 10.1038/nature09409; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Fontanet P, 2013, J NEUROSCI, V33, P15940, DOI 10.1523/JNEUROSCI.0928-13.2013; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guan J, 2016, DIS MODEL MECH, V9, P941, DOI 10.1242/dmm.024448; Hallberg B, 2016, ANN ONCOL, V27, P4, DOI 10.1093/annonc/mdw301; Infarinato NR, 2016, CANCER DISCOV, V6, P96, DOI 10.1158/2159-8290.CD-15-1056; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Lambertz I, 2015, CLIN CANCER RES, V21, P3327, DOI 10.1158/1078-0432.CCR-14-2024; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lin S, 2006, J BIOL CHEM, V281, P16716, DOI 10.1074/jbc.M602221200; Liu YR, 2003, DEV BIOL, V261, P10, DOI 10.1016/S0012-1606(03)00359-2; Lu BC, 2009, NAT GENET, V41, P1295, DOI 10.1038/ng.476; Mano H, 2012, CANCER DISCOV, V2, P495, DOI 10.1158/2159-8290.CD-12-0009; Matthay KK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.78; Mazot P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033581; Medina-Rivera A, 2015, NUCLEIC ACIDS RES, V43, pW50, DOI 10.1093/nar/gkv362; Moog-Lutz C, 2005, J BIOL CHEM, V280, P26039, DOI 10.1074/jbc.M501972200; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Mulligan LM, 2014, NAT REV CANCER, V14, P173, DOI 10.1038/nrc3680; Oh S, 2012, BBA-REV CANCER, V1826, P1, DOI 10.1016/j.bbcan.2012.02.002; Pasini B, 1996, TRENDS GENET, V12, P138, DOI 10.1016/0168-9525(96)10012-3; Reiff T, 2011, DEVELOPMENT, V138, P4699, DOI 10.1242/dev.072157; Sasaki T, 2010, CANCER RES, V70, P10038, DOI 10.1158/0008-5472.CAN-10-2956; Schulte JH, 2011, CLIN CANCER RES, V17, P5082, DOI 10.1158/1078-0432.CCR-10-2809; Shaw AT, 2013, NAT REV CANCER, V13, P772, DOI 10.1038/nrc3612; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.3.CO;2-Z; Simon L, 2007, EXP CELL RES, V313, P3090, DOI 10.1016/j.yexcr.2007.05.002; Smith-Hicks CL, 2000, EMBO J, V19, P612, DOI 10.1093/emboj/19.4.612; Tyagi G, 2009, BIOL REPROD, V81, P258, DOI 10.1095/biolreprod.108.075200; Vitari AC, 2011, NATURE, V474, P403, DOI 10.1038/nature10005; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Wood AC, 2017, CLIN CANCER RES, V23, P2856, DOI 10.1158/1078-0432.CCR-16-1114; Zhang WQ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0694-1	49	28	31	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	11					1417	1429		10.1038/s41388-017-0039-5	http://dx.doi.org/10.1038/s41388-017-0039-5			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ3AZ	29321660	Green Published, hybrid			2022-12-26	WOS:000427459500002
J	Esmail, S; Kartner, N; Yao, YQ; Kim, JW; Reithmeier, RAF; Manolson, MF				Esmail, Sally; Kartner, Norbert; Yao, Yeqi; Kim, Joo Wan; Reithmeier, Reinhart A. F.; Manolson, Morris F.			Molecular mechanisms of cutis laxa- and distal renal tubular acidosis-causing mutations in V-ATPase a subunits, ATP6V0A2 and ATP6V0A4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; N-LINKED GLYCOSYLATION; A3; OSTEOPETROSIS; TRANSPORT; MEMBRANE; ACIDIFICATION; COMPLEXES; TOPOLOGY; ISOFORMS	The a subunit is the largest of 15 different subunits that make up the vacuolar H+-ATPase (V-ATPase) complex, where it functions in proton translocation. In mammals, this subunit has four paralogous isoforms, a1-a4, which may encode signals for targeting assembled V-ATPases to specific intracellular locations. Despite the functional importance of the a subunit, its structure remains controversial. By studying molecular mechanisms of human disease-causing missense mutations within a subunit isoforms, we may identify domains critical for V-ATPase targeting, activity and/or regulation. cDNA-encoded FLAG-tagged human wildtype ATP6V0A2 (a2) and ATP6V0A4 (a4) subunits and their mutants, a2(P405L) (causing cutis laxa), and a4(R449H) and a4(G820R) (causing renal tubular acidosis, dRTA), were transiently expressed in HEK 293 cells. N-Glycosylation was assessed using endoglycosidases, revealing that a2(P405L), a4(R449H), and a4(G820R) were fully N-glycosylated. Cycloheximide (CHX) chase assays revealed that a2(P405L) and a4(R449H) were unstable relative to wildtype. a4(R449H) was degraded predominantly in the proteasomal pathway, whereas a2(P405L) was degraded in both proteasomal and lysosomal pathways. Immunofluorescence studies disclosed retention in the endoplasmic reticulum and defective cell-surface expression of a4(R449H) and defective Golgi trafficking of a2(P405L). Co-immunoprecipitation studies revealed an increase in association of a4(R449H) with the V-0 assembly factor VMA21, and a reduced association with the V-1 sector subunit, ATP6V1B1 (B1). For a4(G820R), where stability, degradation, and trafficking were relatively unaffected, 3D molecular modeling suggested that the mutation causes dRTA by blocking the proton pathway. This study provides critical information that may assist rational drug design to manage dRTA and cutis laxa.	[Esmail, Sally; Kartner, Norbert; Yao, Yeqi; Kim, Joo Wan; Manolson, Morris F.] Univ Toronto, Fac Dent, Dent Res Inst, Toronto, ON M5G 1G6, Canada; [Reithmeier, Reinhart A. F.; Manolson, Morris F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Manolson, MF (corresponding author), Univ Toronto, Fac Dent, 124 Edward St, Toronto, ON M5G 1G6, Canada.	m.manolson@utoronto.ca	Esmail, Sally/P-1256-2019	Manolson, Morris/0000-0001-8755-5460	Canadian Institutes of Health Research [MOP-12333, PJT-148508]; Toronto Musculoskeletal Centre; Canadian Institutes of Health Research/Institute of Musculoskeletal Health and Arthritis	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Toronto Musculoskeletal Centre; Canadian Institutes of Health Research/Institute of Musculoskeletal Health and Arthritis(Canadian Institutes of Health Research (CIHR))	This work was supported in part by the Canadian Institutes of Health Research Grants MOP-12333 and PJT-148508 (to M. F. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported in part by a scholarship from the Toronto Musculoskeletal Centre.; Supported by a scholarship from the Canadian Institutes of Health Research/Institute of Musculoskeletal Health and Arthritis.	Batlle D, 2012, NEPHROL DIAL TRANSPL, V27, P3691, DOI 10.1093/ndt/gfs442; Bexiga MG, 2013, INT J MOL SCI, V14, P18670, DOI 10.3390/ijms140918670; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Bhargava A, 2012, J BIOL CHEM, V287, P26829, DOI 10.1074/jbc.M112.345702; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Esmail S, 2018, J CELL BIOCHEM, V119, P861, DOI 10.1002/jcb.26250; Esmail S, 2016, J CELL BIOCHEM, V117, P2757, DOI 10.1002/jcb.25574; Fischer B, 2012, HUM GENET, V131, P1761, DOI 10.1007/s00439-012-1197-8; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Freeze H.H., 2010, CURR PROTOC PROTEIN; Futai M, 2012, BBA-BIOENERGETICS, V1817, P1711, DOI 10.1016/j.bbabio.2012.03.015; Guevara-Coto J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S11-S4; Guillard M, 2009, BBA-MOL BASIS DIS, V1792, P903, DOI 10.1016/j.bbadis.2008.12.009; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; Hinton A, 2009, PFLUG ARCH EUR J PHY, V457, P589, DOI 10.1007/s00424-007-0382-4; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Kartner N, 2016, ADV BIOCHEM HEALTH D, V14, P407, DOI 10.1007/978-3-319-24780-9_20; Kartner N, 2013, J CELL BIOCHEM, V114, P1474, DOI 10.1002/jcb.24489; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Lemus Leticia, 2014, Cells, V3, P824, DOI 10.3390/cells3030824; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Malkus P, 2004, MOL BIOL CELL, V15, P5075, DOI 10.1091/mbc.E04-06-0514; Mazhab-Jafari MT, 2016, NATURE, V539, P118, DOI 10.1038/nature19828; Ochotny N, 2006, J BIOL CHEM, V281, P26102, DOI 10.1074/jbc.M601118200; Okiyoneda T, 2013, NAT CHEM BIOL, V9, P444, DOI [10.1038/NCHEMBIO.1253, 10.1038/nchembio.1253]; Ramachandran N, 2013, ACTA NEUROPATHOL, V125, P439, DOI 10.1007/s00401-012-1073-6; Ryan M, 2008, MOL BIOL CELL, V19, P5131, DOI 10.1091/mbc.E08-06-0629; Schep DG, 2016, P NATL ACAD SCI USA, V113, P3245, DOI 10.1073/pnas.1521990113; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Sobacchi C, 2013, NAT REV ENDOCRINOL, V9, P522, DOI 10.1038/nrendo.2013.137; Stover EH, 2002, J MED GENET, V39, P796, DOI 10.1136/jmg.39.11.796; Su Y, 2008, AM J PHYSIOL-RENAL, V295, pF950, DOI 10.1152/ajprenal.90258.2008; Sun-Wada GH, 2013, HISTOL HISTOPATHOL, V28, P805, DOI 10.14670/HH-28.805; Toei M, 2011, J BIOL CHEM, V286, P35176, DOI 10.1074/jbc.M111.273409; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Valastyan JS, 2014, DIS MODEL MECH, V7, P9, DOI 10.1242/dmm.013474; Van Durme J, 2011, BIOINFORMATICS, V27, P1711, DOI 10.1093/bioinformatics/btr254; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003	44	15	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2787	2800		10.1074/jbc.M117.818872	http://dx.doi.org/10.1074/jbc.M117.818872			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29311258	hybrid, Green Published			2022-12-26	WOS:000426051900015
J	Jobst-Schwan, T; Schmidt, JM; Schneider, R; Hoogstraten, CA; Ullmann, JFP; Schapiro, D; Majmundar, AJ; Kolb, A; Eddy, K; Shril, S; Braun, DA; Poduri, A; Hildebrandt, F				Jobst-Schwan, Tilman; Schmidt, Johanna Magdalena; Schneider, Ronen; Hoogstraten, Charlotte A.; Ullmann, Jeremy F. P.; Schapiro, David; Majmundar, Amar J.; Kolb, Amy; Eddy, Kaitlyn; Shril, Shirlee; Braun, Daniela A.; Poduri, Annapurna; Hildebrandt, Friedhelm			Acute multi-sgRNA knockdown of KEOPS complex genes reproduces the microcephaly phenotype of the stable knockout zebrafish model	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; NEXT-GENERATION; WEB TOOL; DNA; CRISPR; MUTATIONS; SCREENS; REPAIR; CHOPCHOP; LEUKEMIA	Until recently, morpholino oligonucleotides have been widely employed in zebrafish as an acute and efficient loss-of-function assay. However, off-target effects and reproducibility issues when compared to stable knockout lines have compromised their further use. Here we employed an acute CRISPR/Cas approach using multiple single guide RNAs targeting simultaneously different positions in two exemplar genes (osgep or tprkb) to increase the likelihood of generating mutations on both alleles in the injected F0 generation and to achieve a similar effect as morpholinos but with the reproducibility of stable lines. This multi single guide RNA approach resulted in median likelihoods for at least one mutation on each allele of >99% and sgRNA specific insertion/deletion profiles as revealed by deep-sequencing. Immunoblot showed a significant reduction for Osgep and Tprkb proteins. For both genes, the acute multi-sgRNA knockout recapitulated the microcephaly phenotype and reduction in survival that we observed previously in stable knockout lines, though milder in the acute multi- sgRNA knockout. Finally, we quantify the degree of mutagenesis by deep sequencing, and provide a mathematical model to quantitate the chance for a biallelic lossof- function mutation. Our findings can be generalized to acute and stable CRISPR/Cas targeting for any zebrafish gene of interest.	[Jobst-Schwan, Tilman; Schmidt, Johanna Magdalena; Schneider, Ronen; Hoogstraten, Charlotte A.; Schapiro, David; Majmundar, Amar J.; Kolb, Amy; Eddy, Kaitlyn; Shril, Shirlee; Braun, Daniela A.; Hildebrandt, Friedhelm] Harvard Med Sch, Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Ullmann, Jeremy F. P.; Poduri, Annapurna] Harvard Med Sch, Boston Childrens Hosp, Dept Neurol, Epilepsy Genet Program, Boston, MA USA; [Ullmann, Jeremy F. P.; Poduri, Annapurna] Harvard Med Sch, Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Dept Neurol, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Hildebrandt, F (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA.	friedhelm.hildebrandt@childrens.harvard.edu	Hoogstraten, Charlotte A/F-6553-2018; Jobst-Schwan, Tilman/AAF-6364-2020; Schneider, Ronen/ABD-6649-2020; Shril, Shirlee/Q-5825-2016; Ullmann, Jeremy/B-9799-2015	Hoogstraten, Charlotte A/0000-0002-6976-6026; Jobst-Schwan, Tilman/0000-0001-9802-6783; Ullmann, Jeremy/0000-0002-3073-9151	National Institutes of Health [DK076683, T32DK007726-31A1]; Howard Hughes Medical Institute; Deutsche Forschungsgemeinschaft [Jo 1324/1-1]; Harvard Stem Cell Institute Kidney Group Inter-laboratory Post-doctoral Fellowship; Translational Research Program, Boston Childrens Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Harvard Stem Cell Institute Kidney Group Inter-laboratory Post-doctoral Fellowship; Translational Research Program, Boston Childrens Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the National Institutes of Health to F.H. (DK076683, www.ncbi.nlm.nih.gov) and by the Howard Hughes Medical Institute (www.hhmi.org) to F.H. F.H. is the William E. Harmon Professor. T.J.S. is supported by a grant of the Deutsche Forschungsgemeinschaft (Jo 1324/1-1, www.dfg.de). A.M. is supported by the National Institutes of Health funded Training Grant T32DK007726-31A1 (www.ncbi.nlm.nih.gov) and the Harvard Stem Cell Institute Kidney Group Inter-laboratory Post-doctoral Fellowship (https://hsci.harvard.edu). A.P. is supported by the Translational Research Program, Boston Childrens Hospital (http://www.childrenshospital.org/research-and-innovation/research/icctr/centers-services/translational-research-program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aanes H, 2014, BRIEF FUNCT GENOMICS, V13, P95, DOI 10.1093/bfgp/elt049; Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Bentley J, 2004, NUCLEIC ACIDS RES, V32, P5249, DOI 10.1093/nar/gkh842; Braun DA, 2017, NAT GENET, V49, P1529, DOI 10.1038/ng.3933; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gebruers E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083293; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; He MD, 2015, MUTAT RES-FUND MOL M, V780, P86, DOI 10.1016/j.mrfmmm.2015.08.004; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Liang L, 2008, NUCLEIC ACIDS RES, V36, P3297, DOI 10.1093/nar/gkn184; Mattarucchi E, 2008, GENE CHROMOSOME CANC, V47, P625, DOI 10.1002/gcc.20568; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Mishima Y, 2016, MOL CELL, V61, P874, DOI 10.1016/j.molcel.2016.02.027; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Morgens DW, 2016, NAT BIOTECHNOL, V34, P634, DOI 10.1038/nbt.3567; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Peterson RT, 2011, METHOD CELL BIOL, V105, P525, DOI 10.1016/B978-0-12-381320-6.00023-0; Pfeifer J.D., 2006, MOL GENETIC TESTING; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Qi YP, 2013, GENOME RES, V23, P547, DOI 10.1101/gr.145557.112; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shah AN, 2016, METHOD CELL BIOL, V135, P89, DOI 10.1016/bs.mcb.2016.01.008; Shah AN, 2015, NAT METHODS, V12, P535, DOI 10.1038/nmeth.3360; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Stainier DYR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007000; Varshney GK, 2015, GENOME RES, V25, P1030, DOI 10.1101/gr.186379.114; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Zhang YM, 2006, DNA REPAIR, V5, P1282, DOI 10.1016/j.dnarep.2006.05.020	38	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191503	10.1371/journal.pone.0191503	http://dx.doi.org/10.1371/journal.pone.0191503			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346415	Green Published, Green Submitted, gold			2022-12-26	WOS:000422749500057
J	Cormier, N; McGlone, JJ; Leszyk, J; Hardy, DM				Cormier, Nathaly; McGlone, John J.; Leszyk, John; Hardy, Daniel M.			Immunocontraceptive target repertoire defined by systematic identification of sperm membrane alloantigens in a single species	PLOS ONE			English	Article							ZONA-PELLUCIDA; LIPID RAFTS; ANCHORED PROTEINS; BOAR SPERMATOZOA; BINDING-ACTIVITY; AUTO-ANTIGENS; FAMILY; FERTILIZATION; MOUSE; EXPRESSION	Sperm competence in animal fertilization requires the collective activities of numerous sperm-specific proteins that are typically alloimmunogenic in females. Consequently, sperm membrane alloantigens are potential targets for contraceptives that act by blocking the proteins' functions in gamete interactions. Here we used a targeted proteomics approach to identify the major alloantigens in swine sperm membranes and lipid rafts, and thereby systematically defined the repertoire of these sperm-specific proteins in a single species. Gilts with high alloantibody reactivity to proteins in sperm membranes or lipid rafts produced fewer offspring (73% decrease) than adjuvant-only or nonimmune control animals. Alloantisera recognized more than 20 potentially unique sperm membrane proteins and five sperm lipid raft proteins resolved on two-dimensional immunoblots with or without prior enrichment by anion exchange chromatography. Dominant sperm membrane alloantigens identified by mass spectrometry included the ADAMs fertilin a, fertilin 13, and cyritestin. Less abundant alloantigens included ATP synthase Fl p subunit, myo-inositol monophosphatase-1, and zymogen granule membrane glycoprotein-2. Immunodominant sperm lipid raft alloantigens included SAMP14, lymphocyte antigen 6K, and the epididymal sperm protein E12. Of the fifteen unique membrane alloantigens identified, eleven were known sperm-specific proteins with uncertain functions in fertilization, and four were not previously suspected to exist as sperm-specific isoforms. De novo sequences of tryptic peptides from sperm membrane alloantigen "M6" displayed no evident homology to known proteins, so is a newly discovered sperm-specific gene product in swine. We conclude that alloimmunizing gilts with sperm membranes or lipid rafts evokes formation of antibodies to a relatively small number of dominant alloantigens that include known and novel sperm-specific proteins with possible functions in fertilization and potential utility as targets for immunocontraception.	[Cormier, Nathaly; Hardy, Daniel M.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [McGlone, John J.] Texas Tech Univ, Dept Anim & Food Sci, Lubbock, TX 79409 USA; [Leszyk, John] Univ Massachusetts, Sch Med, Prote & Mass Spectrometry Facil, Shrewsbury, MA USA; [Leszyk, John] Univ Massachusetts, Sch Med, Dept Biochem & Pharmacol, Shrewsbury, MA USA; [Cormier, Nathaly] Univ Wisconsin, Dept Biol Sci, Whitewater, WI 53190 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; University of Massachusetts System; University of Massachusetts System; University of Wisconsin System	Hardy, DM (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.	Daniel.Hardy@TTUHSC.edu	McGlone, John/AAJ-7362-2021; Hardy, Daniel/AAP-5823-2020	Hardy, Daniel/0000-0002-7297-3093	Texas Department of Agriculture; National Institutes of Health [HD35166]	Texas Department of Agriculture; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded in part by a grant from the Texas Department of Agriculture to JJM and DMH and by grant HD35166 from the National Institutes of Health to DMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2002, J REPROD IMMUNOL, V57, P273, DOI 10.1016/S0165-0378(02)00010-4; ALEXANDER NJ, 1989, CURR OPIN IMMUNOL, V1, P1125, DOI 10.1016/0952-7915(89)90003-4; Alonso MA, 2001, J CELL SCI, V114, P3957; BABA T, 1989, BIOCHEM BIOPH RES CO, V160, P1026, DOI 10.1016/S0006-291X(89)80105-6; BABA T, 1994, J BIOL CHEM, V269, P10133; Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952; Bi M, 2003, BIOCHEM J, V375, P477, DOI 10.1042/BJ20030753; Bradley Mark P., 2002, P401, DOI 10.1016/B978-012311629-1/50016-4; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CALVETE JJ, 1993, FEBS LETT, V334, P37, DOI 10.1016/0014-5793(93)81675-P; Cho CH, 1998, SCIENCE, V281, P1857, DOI 10.1126/science.281.5384.1857; Cho C, 2012, NAT REV UROL, V9, P550, DOI 10.1038/nrurol.2012.167; Cross NL, 2004, BIOL REPROD, V71, P1367, DOI 10.1095/biolreprod.104.030502; DOSTALOVA Z, 1995, EUR J BIOCHEM, V230, P329, DOI 10.1111/j.1432-1033.1995.tb20567.x; Druce HC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027952; Ekhlasi-Hundrieser M, 2007, GENE, V392, P253, DOI 10.1016/j.gene.2007.01.002; Ensslin M, 1998, BIOL REPROD, V58, P1057, DOI 10.1095/biolreprod58.4.1057; Flesch FM, 1998, BIOL REPROD, V59, P1530, DOI 10.1095/biolreprod59.6.1530; FREUND J, 1953, J EXP MED, V97, P711, DOI 10.1084/jem.97.5.711; Fujihara Y, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.112888; Fujinoki M, 2003, J BIOCHEM, V134, P559, DOI 10.1093/jb/mvg174; FUKUOKA SI, 1992, P NATL ACAD SCI USA, V89, P1189, DOI 10.1073/pnas.89.4.1189; Gibbs GM, 2010, ENDOCRINOLOGY, V151, P2331, DOI 10.1210/en.2009-1255; GOLDBERG E, 1973, SCIENCE, V181, P458, DOI 10.1126/science.181.4098.458; GUMLEY TP, 1995, IMMUNOL CELL BIOL, V73, P277, DOI 10.1038/icb.1995.45; Haden NP, 2000, BIOL REPROD, V63, P1839, DOI 10.1095/biolreprod63.6.1839; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P143, DOI 10.1023/A:1026524820177; Hao ZL, 2002, BIOL REPROD, V66, P735, DOI 10.1095/biolreprod66.3.735; Hardy D. M., 2002, FERTILIZATION; HARDY DM, 1988, BIOL REPROD, V38, P423, DOI 10.1095/biolreprod38.2.423; Hickox JR, 2001, J BIOL CHEM, V276, P41502, DOI 10.1074/jbc.M106795200; Huang SY, 2005, PROTEOMICS, V5, P4205, DOI 10.1002/pmic.200401284; HUANG TTF, 1981, SCIENCE, V213, P1267, DOI 10.1126/science.7268435; Jonakova V, 1998, J REPROD FERTIL, V114, P25, DOI 10.1530/jrf.0.1140025; JONAKOVA V, 1991, FEBS LETT, V280, P183, DOI 10.1016/0014-5793(91)80233-S; Khalil MB, 2006, DEV BIOL, V290, P220, DOI 10.1016/j.ydbio.2005.11.030; Kim T, 2006, BIOL REPROD, V74, P744, DOI 10.1095/biolreprod.105.048892; Kirkpatrick JF, 2011, AM J REPROD IMMUNOL, V66, P40, DOI 10.1111/j.1600-0897.2011.01003.x; Lahm HW, 2000, ELECTROPHORESIS, V21, P2105, DOI 10.1002/1522-2683(20000601)21:11<2105::AID-ELPS2105>3.0.CO;2-M; Luo LL, 2016, ONCOTARGET, V7, P11165, DOI 10.18632/oncotarget.7163; Martinez-Heredia J, 2006, PROTEOMICS, V6, P4356, DOI 10.1002/pmic.200600094; Maruyama M, 2010, BIOCHEM BIOPH RES CO, V402, P75, DOI 10.1016/j.bbrc.2010.09.117; Naz RK, 2011, AM J REPROD IMMUNOL, V66, P5, DOI 10.1111/j.1600-0897.2011.01000.x; Nickels JD, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002214; Nishimura H, 2004, J BIOL CHEM, V279, P34957, DOI 10.1074/jbc.M314249200; Nishimura H, 2001, DEV BIOL, V233, P204, DOI 10.1006/dbio.2001.0166; Nixon B, 2009, J CELL PHYSIOL, V218, P122, DOI 10.1002/jcp.21575; Ohta K, 1999, BIOCHEM BIOPH RES CO, V258, P616, DOI 10.1006/bbrc.1999.0686; ORAND MG, 1981, BIOL REPROD, V25, P621, DOI 10.1095/biolreprod25.3.621; ORAND MG, 1988, DEV BIOL, V129, P231, DOI 10.1016/0012-1606(88)90177-7; PARRY RV, 1992, MOL REPROD DEV, V33, P108, DOI 10.1002/mrd.1080330115; Peddinti D, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-19; POLLACK SJ, 1994, P NATL ACAD SCI USA, V91, P5766, DOI 10.1073/pnas.91.13.5766; PRIMAKOFF P, 1983, DEV BIOL, V98, P417, DOI 10.1016/0012-1606(83)90371-8; PRIMAKOFF P, 1988, NATURE, V335, P543, DOI 10.1038/335543a0; Quill TA, 1996, J BIOL CHEM, V271, P33509, DOI 10.1074/jbc.271.52.33509; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; SALING PM, 1986, DEV BIOL, V117, P511, DOI 10.1016/0012-1606(86)90318-0; Schafer B, 2003, REPROD DOMEST ANIM, V38, P111, DOI 10.1046/j.1439-0531.2003.00403.x; Shadan S, 2004, BIOL REPROD, V71, P253, DOI 10.1095/biolreprod.103.026435; Shamsadin R, 1999, BIOL REPROD, V61, P1445, DOI 10.1095/biolreprod61.6.1445; Shetty J, 2003, J BIOL CHEM, V278, P30506, DOI 10.1074/jbc.M301713200; Sleight SB, 2005, BIOL REPROD, V73, P721, DOI 10.1095/biolreprod.105.041533; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Tanphaichitr N, 1998, MOL REPROD DEV, V49, P203, DOI 10.1002/(SICI)1098-2795(199802)49:2&lt;203::AID-MRD11&gt;3.0.CO;2-Z; Travis AJ, 2001, DEV BIOL, V240, P599, DOI 10.1006/dbio.2001.0475; Tung KSK, 2017, J CLIN INVEST, V127, P1046, DOI 10.1172/JCI89927; TUNG KSK, 1980, BIOL REPROD, V23, P877, DOI 10.1095/biolreprod23.4.877; TUNG KSK, 1981, IMMUNOL REV, V55, P217, DOI 10.1111/j.1600-065X.1981.tb00344.x; van Gestel RA, 2005, MOL HUM REPROD, V11, P583, DOI 10.1093/molehr/gah200; Vazquez-Levin MH, 2014, AM J REPROD IMMUNOL, V72, P206, DOI 10.1111/aji.12272; Verdier Y, 2002, J ANDROL, V23, P529; Wang DX, 2004, RAPID COMMUN MASS SP, V18, P96, DOI 10.1002/rcm.1289; Wheeler K, 2011, P NATL ACAD SCI USA, V108, P7511, DOI 10.1073/pnas.1017615108; WOLFSBERG TG, 1995, DEV BIOL, V169, P378, DOI 10.1006/dbio.1995.1152; Wu A, 2007, J CELL PHYSIOL, V213, P201, DOI 10.1002/jcp.21113; Yanagimachi R., 1994, P189; YANAGIMACHI R, 1981, BIOL REPROD, V24, P512, DOI 10.1095/biolreprod24.3.512; Yoshitake H, 2008, BIOCHEM BIOPH RES CO, V372, P277, DOI 10.1016/j.bbrc.2008.05.088; Yoshitake Y, 2015, CLIN CANCER RES, V21, P312, DOI 10.1158/1078-0432.CCR-14-0202	81	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190891	10.1371/journal.pone.0190891	http://dx.doi.org/10.1371/journal.pone.0190891			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342175	Green Published, gold, Green Submitted			2022-12-26	WOS:000422653800035
J	Ohyama, Y; Ito, J; Kitano, VJ; Shimada, J; Hakeda, Y				Ohyama, Yoko; Ito, Junta; Kitano, Victor J.; Shimada, Jun; Hakeda, Yoshiyuki			The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors	PLOS ONE			English	Article							NADPH OXIDASE; ANGIOTENSIN-II; PROMOTING OSTEOCLASTOGENESIS; RHEUMATOID-ARTHRITIS; RECEPTOR ACTIVATOR; ASCORBIC-ACID; HIP FRACTURE; MUSCLE-CELLS; RISK-FACTORS; IN-VITRO	Inflammatory bone diseases, including rheumatoid arthritis, periodontitis and peri-implantitis, are associated not only with the production of inflammatory cytokines but also with local oxidative status, which is defined by intracellular reactive oxygen species (ROS). Osteoclast differentiation has been reported to be related to increased intracellular ROS levels in osteoclast lineage cells. Sudachitin, which is a polymethoxyflavone derived from Citrus sudachi, possesses antioxidant properties and regulates various functions in mammalian cells. However, the effects of sudachitin on inflammatory bone destruction and osteoclastogenesis remain unknown. In calvaria inflamed by a local lipopolysaccharide (LPS) injection, inflammation -induced bone destruction and the accompanying elevated expression of osteoclastogenesis-related genes were reduced by the co-administration of sudachitin and LPS. Moreover, sudachitin inhibited osteoclast formation in cultures of isolated osteoblasts and osteoclast precursors. However, sudachitin rather increased the expression of receptor activator of NF-kappa B ligand (RANKL), which is an important molecule triggering osteoclast differentiation, and the mRNA ratio of RANKL/osteoprotegerin that is a decoy receptor for RANKL, in the isolated osteoblasts, suggesting the presence of additional target cells. When osteoclast formation was induced from osteoclast precursors derived from bone marrow cells in the presence of soluble RANKL and macrophage colony-stimulating factor, sudachitin inhibited osteoclastogenesis without influencing cell viability. Consistently, the expression of osteoclast differentiation-related molecules including c-fos, NFATcl, cathepsin K and osteoclast fusion proteins such as DC-STAMP and Atp6v0d2 was reduced by sudachitin. In addition, sudachitin decreased activation of MAPKs such as Erk and JNK and the ROS production evoked by RANKL in osteoclast lineage cells. Our findings suggest that sudachitin is a useful agent for the treatment of anti-inflammatory bone destruction.	[Ohyama, Yoko; Ito, Junta; Kitano, Victor J.; Hakeda, Yoshiyuki] Meikai Univ, Div Oral Anat, Sch Dent, Sakado, Saitama, Japan; [Ohyama, Yoko; Kitano, Victor J.; Shimada, Jun] Meikai Univ, Div Oral & Maxillofacial Surg, Sch Dent, Sakado, Saitama, Japan; [Ito, Junta] Josai Univ, Fac Pharm & Pharmaceut Sci, Dept Clin Dietet & Human Nutr, Sakado, Saitama, Japan	Meikai University; Meikai University; Josai University	Ito, J; Hakeda, Y (corresponding author), Meikai Univ, Div Oral Anat, Sch Dent, Sakado, Saitama, Japan.; Ito, J (corresponding author), Josai Univ, Fac Pharm & Pharmaceut Sci, Dept Clin Dietet & Human Nutr, Sakado, Saitama, Japan.	junta@josai.ac.jp; y-hakeda@dent.meikai.ac.jp			Japanese Ministry of Education, Science, and Sports [16H05505, 16K20677]	Japanese Ministry of Education, Science, and Sports	This study was supported by a Grant-in Aid for Scientific Research (B) (16H05505 to YH) and a Grant-in-Aid for Young Scientists (B) (16K20677 to J. I.) from the Japanese Ministry of Education, Science, and Sports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; El-Benna J, 2016, IMMUNOL REV, V273, P180, DOI 10.1111/imr.12447; Fuller K, 1998, J EXP MED, V188, P997, DOI 10.1084/jem.188.5.997; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; Goettsch C, 2013, J CLIN INVEST, V123, P4731, DOI 10.1172/JCI67603; Gummersbach C, 2009, DIFFERENTIATION, V77, P115, DOI 10.1016/j.diff.2008.09.009; Harada S, 2011, J PHARMACOL SCI, V115, P89, DOI 10.1254/jphs.10193SC; Hayashi T, 2002, J BIOL CHEM, V277, P27880, DOI 10.1074/jbc.M203836200; Hayashida C, 2014, J BIOL CHEM, V289, P11545, DOI 10.1074/jbc.M113.523811; Horcajada Marie-Noelle, 2012, Curr Mol Pharmacol, V5, P205; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V206, P89, DOI 10.1006/bbrc.1995.1013; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; JOHNELL O, 1995, J BONE MINER RES, V10, P1802, DOI 10.1002/jbmr.5650101125; Jung UJ, 2004, J NUTR, V134, P2499, DOI 10.1093/jn/134.10.2499; Kanis J, 1999, OSTEOPOROSIS INT, V9, P45, DOI 10.1007/s001980050115; Kikuta J, 2013, J CLIN INVEST, V123, P866, DOI 10.1172/JCI65054; Kim MS, 2010, J BIOL CHEM, V285, P6913, DOI 10.1074/jbc.M109.051557; Kim T, 2010, BIOCHEM BIOPH RES CO, V403, P73, DOI 10.1016/j.bbrc.2010.10.117; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Kyaw M, 2001, HYPERTENS RES, V24, P251, DOI 10.1291/hypres.24.251; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Le Nihouannen D, 2010, BONE, V46, P1336, DOI 10.1016/j.bone.2009.11.021; Lee JH, 2010, MOL PHARMACOL, V77, P17, DOI 10.1124/mol.109.057877; Lee JH, 2009, J BIOL CHEM, V284, P13725, DOI 10.1074/jbc.M806941200; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Lee YS, 2010, BIOCHEM PHARMACOL, V79, P1674, DOI 10.1016/j.bcp.2010.01.034; Liu T, 2016, J BIOCHEM, V160, P315, DOI 10.1093/jb/mvw040; Markatseli TE, 2014, CLIN EXP RHEUMATOL, V32, P415; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Matsuo K, 2000, NAT GENET, V24, P184, DOI 10.1038/72855; MATTIA CJ, 1991, BIOCHEM PHARMACOL, V42, P879, DOI 10.1016/0006-2952(91)90048-A; Mensah KA, 2010, J CELL PHYSIOL, V223, P76, DOI 10.1002/jcp.22012; Mizukami J, 2002, MOL CELL BIOL, V22, P992, DOI 10.1128/MCB.22.4.992-1000.2002; Nakagawa H, 2006, J NAT PROD, V69, P1177, DOI 10.1021/np060217s; Nakayachi M, 2015, BONE, V75, P170, DOI 10.1016/j.bone.2015.02.025; Oka Y, 2012, J PHARMACOL SCI, V118, P55, DOI 10.1254/jphs.11082FP; Romagnoli C, 2013, FEBS J, V280, P867, DOI 10.1111/febs.12075; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Sasaki H, 2009, J MED INVESTIG, V56, P33, DOI 10.2152/jmi.56.33; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Smith MR, 2012, LANCET, V379, P39, DOI 10.1016/S0140-6736(11)61226-9; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takarada T, 2007, EUR J PHARMACOL, V575, P1, DOI 10.1016/j.ejphar.2007.07.041; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Tominari T, 2012, J PHARMACOL SCI, V119, P390, DOI 10.1254/jphs.11188SC; Tsutsumi R, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-32; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Wang HD, 2016, MOL CELLS, V39, P508, DOI 10.14348/molcells.2016.2170; Weaver Connie M., 2012, Journal of Nutrition in Gerontology and Geriatrics, V31, P239, DOI 10.1080/21551197.2012.698220; Wei YZ, 2006, J BIOL CHEM, V281, P35137, DOI 10.1074/jbc.M601320200; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yanagihara N, 2014, J PHARMACOL SCI, V124, P123, DOI 10.1254/jphs.13R17CP; Yang EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086062; Yang S, 2001, J BIOL CHEM, V276, P5452, DOI 10.1074/jbc.M001004200; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Yuasa K, 2012, BIOSCI BIOTECH BIOCH, V76, P598, DOI 10.1271/bbb.110800	61	24	25	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191192	10.1371/journal.pone.0191192	http://dx.doi.org/10.1371/journal.pone.0191192			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342179	Green Submitted, Green Published, gold			2022-12-26	WOS:000422653800050
J	Emran, KM; Al-Harbi, AK				Emran, Khadijah M.; Al-Harbi, Albandaree K.			Outstanding resistance and passivation behaviour of new Fe-Co metal-metal glassy alloys in alkaline media	PLOS ONE			English	Article							CORROSION-RESISTANCE; BULK; COBALT; FILMS	The electrochemical behavior of the oxide layers on two metal-metal glassy alloys, Fe78Co9Cr10Mo2Al1 (VX9)and Fe49Co49V2 (VX50) (at.%), were studied using electrochemical techniques including electrochemical frequency modulation (EFM), electrochemical impedance spectroscopy (EIS) and cyclic polarization (CP) measurements. The morphology and composition of the alloy surfaces were investigated using X-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM) and atomic force microscopy (AFM). The corrosion rate and surface roughness of both alloys increased as the concentration of NaOH in aqueous solution was raised. The presence of some protective elements in the composition of the alloys led to the formation of a spontaneous passive layer on the alloy surface. The higher resistance values of both alloys were associated with the magnitude of the dielectric properties of the passive films formed on their surfaces. Both alloys are classified as having outstanding resistance to corrosion, which results from the formation of a passive film that acts as an efficient barrier to corrosion in alkaline solution.	[Emran, Khadijah M.; Al-Harbi, Albandaree K.] Taibah Univ, Chem Dept, Coll Sci, Al Madinah Al Monawarah, Saudi Arabia	Taibah University	Emran, KM (corresponding author), Taibah Univ, Chem Dept, Coll Sci, Al Madinah Al Monawarah, Saudi Arabia.	kabdalsamad@taibahu.edu.sa	Emran, Khadijah/AAA-3437-2021; Emran, Khadijah/AAB-4044-2022	Emran, Khadijah/0000-0003-3672-9744; 				Biesinger MC, 2011, APPL SURF SCI, V257, P2717, DOI 10.1016/j.apsusc.2010.10.051; Fontana M., 1987, CORROSION ENG; Gallant D, 2006, J PHYS CHEM B, V110, P6871, DOI 10.1021/jp056689h; Gostin PF, 2010, CORROS SCI, V52, P273, DOI 10.1016/j.corsci.2009.09.016; Guo SF, 2013, J NON-CRYST SOLIDS, V369, P29, DOI 10.1016/j.jnoncrysol.2013.02.026; INOUE A, 1995, MATER T JIM, V36, P1180, DOI 10.2320/matertrans1989.36.1180; Inoue A, 2001, MAT SCI ENG A-STRUCT, V304, P1, DOI 10.1016/S0921-5093(00)01551-3; Kim KH, 2011, CORROS SCI, V53, P3576, DOI 10.1016/j.corsci.2011.07.001; KLEMENT W, 1960, NATURE, V187, P869, DOI 10.1038/187869b0; Li G, 2010, SCI CHINA PHYS MECH, V53, P435, DOI 10.1007/s11433-010-0139-5; Moulder J. F., 1995, HDB XRAY PHOTOELECTR; OHTSUKA T, 1981, J ELECTROCHEM SOC, V128, P2522, DOI 10.1149/1.2127284; Schroeder T., 2004, J SURFACE SCI, V552, P1, DOI DOI 10.1016/J; Suryanarayana C, 2013, INT MATER REV, V58, P131, DOI 10.1179/1743280412Y.0000000007; Suryanarayana C, 2011, BULK METALLIC GLASSES, P1, DOI 10.1201/9781420085976-1; Wang HJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2786598; Wang WH, 2007, PROG MATER SCI, V52, P540, DOI 10.1016/j.pmatsci.2006.07.003; Wang WH, 2004, MAT SCI ENG R, V44, P45, DOI 10.1016/j.mser.2004.03.001; Xu T, 2015, J NON-CRYST SOLIDS, V410, P20, DOI 10.1016/j.jnoncrysol.2014.12.006; Xu T, 2015, J ALLOY COMPD, V625, P318, DOI 10.1016/j.jallcom.2014.09.166	20	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0187567	10.1371/journal.pone.0187567	http://dx.doi.org/10.1371/journal.pone.0187567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29337992	Green Published, Green Submitted, gold			2022-12-26	WOS:000422652700001
J	Ahmad, M; Suhaimi, SN; Chu, TL; Aziz, NA; Kornain, NKM; Samiulla, DS; Lo, KW; Ng, CH; Khoo, ASB				Ahmad, Munirah; Suhaimi, Shazlan-Noor; Chu, Tai-Lin; Aziz, Norazlin Abdul; Kornain, Noor-Kaslina Mohd; Samiulla, D. S.; Lo, Kwok-Wai; Ng, Chew-Hee; Khoo, Alan Soo-Beng			Ternary copper(II) complex: NCI60 screening, toxicity studies, and evaluation of efficacy in xenograft models of nasopharyngeal carcinoma	PLOS ONE			English	Article							IN-VITRO; ANTITUMOR-ACTIVITY; ANTICANCER AGENTS; DRUG-RESISTANCE; VIVO; MECHANISMS; CANCER; LIGAND; DNA; CYTOTOXICITY	Copper(II) ternary complex, [Cu(phen)(C-dmg)(H2O)]NO3 was evaluated against a panel of cell lines, tested for in vivo efficacy in nasopharyngeal carcinoma xenograft models as well as for toxicity in NOD scid gamma mice. The Cu(II) complex displayed broad spectrum cytotoxicity against multiple cancer types, including lung, colon, central nervous system, melanoma, ovarian, and prostate cancer cell lines in the NCI-60 panel. The Cu(II) complex did not cause significant induction of cytochrome P450 (CYP) 3A and 1A enzymes but moderately inhibited CYP isoforms 1A2, 2C9, 2C19, 2D6, 2B6, 2C8 and 3A4. The complex significantly inhibited tumor growth in nasopharyngeal carcinoma xenograft bearing mice models at doses which were well tolerated without causing significant or permanent toxic side effects. However, higher doses which resulted in better inhibition of tumor growth also resulted in toxicity.	[Ahmad, Munirah; Suhaimi, Shazlan-Noor; Chu, Tai-Lin; Aziz, Norazlin Abdul; Khoo, Alan Soo-Beng] Inst Med Res, Canc Res Ctr, Mol Pathol Unit, Kuala Lumpur, Malaysia; [Kornain, Noor-Kaslina Mohd] Univ Teknol MARA, Dept Pathol, Fac Med, Sungai Buloh, Selangor, Malaysia; [Samiulla, D. S.] Aurigene Discovery Technol Ltd, Bangalore, Karnataka, India; [Lo, Kwok-Wai] Chinese Univ Hong Kong, State Key Lab Oncol South China, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Lo, Kwok-Wai] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Ng, Chew-Hee] Int Med Univ, Sch Pharm, Dept Pharmaceut Chem, Kuala Lumpur, Malaysia; [Khoo, Alan Soo-Beng] Int Med Univ, Inst Res Dev & Innovat, Kuala Lumpur, Malaysia	Kementerian Kesihatan Malaysia; Universiti Teknologi MARA; Aurigene Discovery Technologies Limited; Chinese University of Hong Kong; State Key Lab Oncology South China; Chinese University of Hong Kong; International Medical University Malaysia; International Medical University Malaysia	Khoo, ASB (corresponding author), Inst Med Res, Canc Res Ctr, Mol Pathol Unit, Kuala Lumpur, Malaysia.; Ng, CH (corresponding author), Int Med Univ, Sch Pharm, Dept Pharmaceut Chem, Kuala Lumpur, Malaysia.; Khoo, ASB (corresponding author), Int Med Univ, Inst Res Dev & Innovat, Kuala Lumpur, Malaysia.	ngchewhee@imu.edu.my; alankhoo@imr.gov.my	Aziz, Norazlin Abdul/I-7743-2019; Suhaimi, Shazlan Noor/AAE-2079-2022	Abdul Aziz, Norazlin/0000-0001-8137-2399; Suhaimi, Shazlan-Noor/0000-0003-0426-0056; Lo, Kwok Wai/0000-0002-3488-6124	Ministry of Health Malaysia [JPP12-046, NMRR-13-898-17054]; Ministry of Science, Technology and Innovation eScience [02-02-SF0033, 02-02-09-SF0036]; Aurigene Discovery Technologies Limited	Ministry of Health Malaysia; Ministry of Science, Technology and Innovation eScience; Aurigene Discovery Technologies Limited	This work was supported by Ministry of Health Malaysia (JPP12-046; NMRR-13-898-17054) and Ministry of Science, Technology and Innovation eScience grants (02-02-SF0033; 02-02-09-SF0036). The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Aurigene Discovery Technologies Limited provided support in the form of salaries for author [DSS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The salaries of authors [MA, SNS, TLC, NAA, NKMK, KWL, CHN, ASBK] were through their respective institutes independent of the grants. The specific roles of these authors are articulated in the 'author contributions' section.	Allardyce CS, 2016, DALTON T, V45, P3201, DOI 10.1039/c5dt03919c; Azizah AM, 2016, MALAYSIAN NATIONAL C; Beijnen JH, 2004, LANCET ONCOL, V5, P489, DOI 10.1016/S1470-2045(04)01528-1; Bjorkhem-Bergman L, 2014, DRUG METAB PHARMACOK, V29, P352, DOI 10.2133/dmpk.DMPK-13-SH-138; BONNEY RJ, 1974, IN VITRO CELL DEV B, V9, P399; Cao S, 2014, BRIT J CANCER, V110, P1733, DOI 10.1038/bjc.2014.85; Cheung ST, 1999, INT J CANCER, V83, P121, DOI 10.1002/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F; Denoyer D, 2015, METALLOMICS, V7, P1459, DOI 10.1039/c5mt00149h; El-Naga RN, 2014, TOXICOL APPL PHARM, V274, P87, DOI 10.1016/j.taap.2013.10.031; Bravo-Gomez ME, 2012, J MEX CHEM SOC, V56, P85; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gandin V, 2015, METALLOMICS, V7, P1497, DOI 10.1039/c5mt00163c; Hambley TW, 2007, DALTON T, P4929, DOI 10.1039/b706075k; Hearn JM, 2013, ACS CHEM BIOL, V8, P1335, DOI 10.1021/cb400070a; Hoen Peter A.Chr. 't, 2000, Biochemical Pharmacology, V60, P1509; Holbeck SL, 2010, MOL CANCER THER, V9, P1451, DOI 10.1158/1535-7163.MCT-10-0106; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hu PC, 2016, RSC ADV, V6, P29963, DOI 10.1039/c6ra02571d; HUANG DP, 1980, INT J CANCER, V26, P127, DOI 10.1002/ijc.2910260202; Jia L, 2016, J INORG BIOCHEM, V159, P107, DOI 10.1016/j.jinorgbio.2016.02.033; Jiang W, 2009, 2009 IEEE PULSED POWER CONFERENCE, VOLS 1 AND 2, P1, DOI 10.1109/PPC.2009.5386209; Kelly GL, 2014, GENE DEV, V28, P58, DOI 10.1101/gad.232009.113; Khoo ASB, 2013, ADV EXP MED BIOL, V778, P1; KNOX RJ, 1986, CANCER RES, V46, P1972; Krikavova R, 2016, RSC ADV, V6, P3899, DOI 10.1039/c5ra22141b; Lee AWM, 2012, SEMIN RADIAT ONCOL, V22, P233, DOI 10.1016/j.semradonc.2012.03.008; Lu C, 2001, CHEM-BIOL INTERACT, V134, P271, DOI 10.1016/S0009-2797(01)00162-4; Ma P, 2009, J BIOMED NANOTECHNOL, V5, P151, DOI 10.1166/jbn.2009.1021; Medici S, 2015, COORDIN CHEM REV, V284, P329, DOI 10.1016/j.ccr.2014.08.002; Nagababu P, 2015, J MED CHEM, V58, P5226, DOI 10.1021/acs.jmedchem.5b00651; Ng CH, 2016, Malaysia patent, Patent No. [MY-157886-A, 157886]; Ng CH, 2014, METALLOMICS, V6, P892, DOI 10.1039/c3mt00276d; Palanimuthu D, 2013, J MED CHEM, V56, P722, DOI 10.1021/jm300938r; Pua K C, 2008, Med J Malaysia, V63 Suppl C, P59; Qin QP, 2015, METALLOMICS, V7, P1124, DOI 10.1039/c5mt00027k; Raman N, 2010, EUR J MED CHEM, V45, P5438, DOI 10.1016/j.ejmech.2010.09.004; Santini C, 2014, CHEM REV, V114, P815, DOI 10.1021/cr400135x; Sava G, 2012, DALTON T, V41, P8226, DOI 10.1039/c2dt30075c; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Silva-Platas C, 2016, J BIOENERG BIOMEMBR, V48, P43, DOI 10.1007/s10863-015-9640-x; Slator C, 2016, ACS CHEM BIOL, V11, P159, DOI 10.1021/acschembio.5b00513; Soldatow VY, 2013, TOXICOL RES-UK, V2, P23, DOI 10.1039/c2tx20051a; Spreckelmeyer S, 2014, MOLECULES, V19, P15584, DOI 10.3390/molecules191015584; Tang LL, 2016, CANCER LETT, V374, P22, DOI 10.1016/j.canlet.2016.01.040; Tao XF, 2014, RSC ADV, V4, P54026, DOI 10.1039/c4ra09160d; U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research (CDER), 2012, GUIDANCE FOR INDUSTR; Wheate NJ, 2010, DALTON T, V39, P8113, DOI 10.1039/c0dt00292e; Yom SS, 2014, CLINICAL INSIGHTS NA; Zaidi Y, 2014, METALLOMICS, V6, P1469, DOI 10.1039/c4mt00035h; Zaki M, 2016, INORG CHIM ACTA, V444, P1, DOI 10.1016/j.ica.2016.01.006	51	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191295	10.1371/journal.pone.0191295	http://dx.doi.org/10.1371/journal.pone.0191295			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329342	Green Published, Green Submitted, gold			2022-12-26	WOS:000419954100056
J	Arshad, M; Bhatti, A; John, P				Arshad, Maria; Bhatti, Attya; John, Peter			Identification and in silico analysis of functional SNPs of human TAGAP protein: A comprehensive study	PLOS ONE			English	Article							EVOLUTIONARY CONSERVATION; METHYLATION SITES; PHOSPHORYLATION; MUTATIONS; DISEASE; GENE; PREDICTION; SEQUENCE; SERVER; POLYMORPHISMS	Genetic polymorphisms in TAGAP gene have been associated with many diseases including rheumatoid arthritis, multiple sclerosis and other autoimmune disorders. Identifying functional SNPs in such disease associated genes is an uphill task hence before planning larger population study, it is better to scrutinize putative functional SNPs. In this study we used various computational approaches to identify nsSNPs which are deleterious to the structure and/or function of TAGAP protein that might be causing these diseases. Computational analysis was performed by five different in silico tools including SIFT, PROVEAN, Poly-Phen-2, PhD-SNP and SNPs&GO. The study concludes that mutations of Glycine -> Glutamic Acid at position 120, Glycine -> Tryptophan at position 141 and Valine -> Methionine at position 151 are major mutations in native TAGAP protein which might contribute to its malfunction and ultimately causing disease. The study also proposed 3D structures of native TAGAP protein and its three mutants. Future studies should consider these nsSNPs as main target mutations in various diseases involving TAGAP malfunction. This is the first comprehensive study, where TAGAP gene variants were analyzed using in silico tools hence will be of great help while considering large scale studies and also in developing precision medicines for cure of diseases related to these polymorphisms. Furthermore, animal models of various autoimmune diseases and having these mutations might be of help in exploring their precise roles.	[Arshad, Maria; Bhatti, Attya; John, Peter] Natl Univ Sci & Technol, Atta Ur Rahman Sch Appl Biosci, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan	Arshad, M; Bhatti, A (corresponding author), Natl Univ Sci & Technol, Atta Ur Rahman Sch Appl Biosci, Islamabad, Pakistan.	maria.arshad14@gmail.com; attyabhatti@asab.nust.edu.pk		Arshad, Maria/0000-0001-8262-1246				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Azad AK, 2012, INFECT IMMUN, V80, P3343, DOI 10.1128/IAI.00443-12; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bava KA, 2004, NUCLEIC ACIDS RES, V32, pD120, DOI 10.1093/nar/gkh082; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bhagwat M., 2010, CURR PROTOC BIOINFOR, P19, DOI DOI 10.1002/0471250953.BI0119S32; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Capriotti E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S6; Capriotti E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S4-S3; Carugo O, 2001, PROTEIN SCI, V10, P1470, DOI 10.1110/ps.690101; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Ciesla J, 2011, ACTA BIOCHIM POL, V58, P137; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Connelly TM, 2014, J SURG RES, V190, P457, DOI 10.1016/j.jss.2014.01.019; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Deutscher J, 2005, J MOL MICROB BIOTECH, V9, P125, DOI 10.1159/000089641; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Gallo LH, 2017, CELL CYCLE; Heim MH, 2013, J HEPATOL, V58, P564, DOI 10.1016/j.jhep.2012.10.005; Kalia N, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2543-4; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kucukkal TG, 2015, CURR OPIN STRUC BIOL, V32, P18, DOI 10.1016/j.sbi.2015.01.003; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Mao M, 2004, GENOMICS, V83, P989, DOI 10.1016/j.ygeno.2003.12.019; Marin-Martin FR, 2014, CHOLESTEROL, DOI 10.1155/2014/639751; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Naveed M., 2017, INT J COMPUT SCI INF, V15, P31; Naveed M, 2016, OPEN LIFE SCI, V11, P402, DOI 10.1515/biol-2016-0054; Naveed M, 2014, BRAZ J MICROBIOL, V45, P603, DOI 10.1590/S1517-83822014000200031; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Patel K, 2017, J CLIN ONCOL S, V35; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Petukh M, 2015, HUM MUTAT, V36, P524, DOI 10.1002/humu.22770; Puttick J, 2008, BBA-PROTEINS PROTEOM, V1784, P100, DOI 10.1016/j.bbapap.2007.07.008; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Samad FA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153999; Santana-de Anda K, 2011, AUTOIMMUN REV, V11, P98, DOI 10.1016/j.autrev.2011.08.006; Sawicka A, 2014, BBA-GENE REGUL MECH, V1839, P711, DOI 10.1016/j.bbagrm.2014.04.013; Shao JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004920; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Singh SM, 2010, P NATL ACAD SCI USA, V107, P15069, DOI 10.1073/pnas.1008818107; Sobieszczyk ME, 2011, CURR OPIN HIV AIDS, V6, P427, DOI 10.1097/COH.0b013e3283497155; Thomas R, 1999, AM J HUM GENET, V65, P39, DOI 10.1086/302460; Wen PP, 2016, BIOINFORMATICS, V32, P3107, DOI 10.1093/bioinformatics/btw377; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	62	48	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0188143	10.1371/journal.pone.0188143	http://dx.doi.org/10.1371/journal.pone.0188143			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329296	Green Submitted, gold, Green Published			2022-12-26	WOS:000419954100004
J	Yoo, Y; Park, HJ; Park, S; Cho, MJ; Cho, SJ; Lee, JY; Choi, SH; Lee, JY				Yoo, Yongjoon; Park, Hyeon-Ju; Park, Soowon; Cho, Maeng Je; Cho, Seong-Jin; Lee, Ji Yeon; Choi, Soo-Hee; Lee, Jun-Young			Interpersonal trauma moderates the relationship between personality factors and suicidality of individuals with posttraumatic stress disorder	PLOS ONE			English	Article							SOCIAL SUPPORT; MENTAL-DISORDERS; IDEATION; TRAITS; RISK; PTSD; PREVALENCE; DEPRESSION; MILITARY; EXPOSURE	Individuals with posttraumatic stress disorder (PTSD) are more prone to suicidal ideation and behavior. While those who have experienced interpersonal trauma exhibit more suicidality than those who have experienced non-interpersonal trauma, it is unclear how the traumatic effects are related to an individual's personality characteristics. This study examined the association between interpersonal trauma and personality factors with suicidality, and elucidated the moderating role of interpersonal trauma in individuals with PTSD. The study included 6,022 participants from the Korean Epidemiologic Catchment Area Study 2011. The Korean Version of Composite International Diagnostic Interview was used for the survey, including the participants' history of suicidality, the traumas they have experienced, and their PTSD symptoms. The 11-item version of the Big Five Inventory (BFI-11) was used to assess the participants' personality factors. 76 individuals were diagnosed with PTSD, while 810 had been exposed to trauma but were not diagnosed with any DSM-IV mental disorder. Among the individuals with PTSD, those who had experienced interpersonal trauma were more likely to have suicidal ideation than those who had experienced non-interpersonal trauma (p =.020; odds ratio [OR] = 3.643;95% confidence interval of OR = [1.226, 10.825]). High agreeableness and conscientiousness predicted less suicidality in those exposed to non-interpersonal trauma, while predicting more suicidality in those exposed to interpersonal trauma. Clinicians examining individuals with PTSD should pay closer attention to the trauma that they have experienced, as well as their personality factors, to provide appropriate treatment.	[Yoo, Yongjoon] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Park, Hyeon-Ju; Lee, Ji Yeon; Lee, Jun-Young] SMG SNU Boramae Med Ctr, Dept Psychiat, Seoul, South Korea; [Park, Soowon] Sejong Univ, Dept Educ, Seoul, South Korea; [Cho, Maeng Je; Choi, Soo-Hee; Lee, Jun-Young] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Cho, Seong-Jin] Gachon Med Sch, Dept Psychiat, Incheon, South Korea; [Lee, Jun-Young] Seoul Natl Univ, Neurosci Res Inst, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Sejong University; Seoul National University (SNU); Gachon University; Seoul National University (SNU)	Lee, JY (corresponding author), SMG SNU Boramae Med Ctr, Dept Psychiat, Seoul, South Korea.; Choi, SH; Lee, JY (corresponding author), Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul, South Korea.; Lee, JY (corresponding author), Seoul Natl Univ, Neurosci Res Inst, Coll Med, Seoul, South Korea.	soohchoi@snu.ac.kr; benji@snu.ac.kr	Lee, Jun-Young/N-5963-2019; Yoo, Yongjoon/P-6767-2016	Lee, Jun-Young/0000-0002-5893-3124; Yoo, Yongjoon/0000-0001-6193-5262; Park, Soowon/0000-0002-3348-940X	Korea Mental Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HM14C2624]; SNUH research fund [05-2012-0050]	Korea Mental Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; SNUH research fund	This study was supported by a grant of the Korea Mental Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HM14C2624; http://www.mhrnd.re.kr/xe/) and the SNUH research fund (05-2012-0050; http://bri.snuh.org/pub/_/singlecont/view.do). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahadi S., 1994, DEVELOPING STRUCTURE, P189; Allport G. W., 1937, PERSONALITY PSYCHOL; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Amir M, 1999, PSYCHOTHER PSYCHOSOM, V68, P76, DOI 10.1159/000012316; Ayub N, 2015, PERSONAL MENT HEALTH, V9, P308, DOI 10.1002/pmh.1301; Baxter AJ, 2013, PSYCHOL MED, V43, P897, DOI 10.1017/S003329171200147X; Bebbington PE, 2009, AM J PSYCHIAT, V166, P1135, DOI 10.1176/appi.ajp.2009.09030310; Benjet C, 2016, PSYCHOL MED, V46, P327, DOI 10.1017/S0033291715001981; Bentley KH, 2016, CLIN PSYCHOL REV, V43, P30, DOI 10.1016/j.cpr.2015.11.008; Breslau N, 2001, J CLIN PSYCHIAT, V62, P16; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brezo J, 2006, ACTA PSYCHIAT SCAND, V113, P180, DOI 10.1111/j.1600-0447.2005.00702.x; Briere J, 2015, J TRAUMA DISSOCIATIO, V16, P153, DOI 10.1080/15299732.2014.970265; Cain NM, 2013, J PERS ASSESS, V95, P640, DOI 10.1080/00223891.2013.821073; Cho MJ, 2015, PSYCHIAT INVEST, V12, P164, DOI 10.4306/pi.2015.12.2.164; Cho MJ, 2002, J KOREAN NEUROPSYCHI, V41, P123; Costa PT, 2007, REVISED NEO PERSONAL; Cougle JR, 2009, J PSYCHIATR RES, V43, P825, DOI 10.1016/j.jpsychires.2008.12.004; Davidson JRT, 2004, J NEUROPSYCH CLIN N, V16, P135, DOI 10.1176/appi.neuropsych.16.2.135; Forbes D, 2014, J CLIN PSYCHIAT, V75, P147, DOI 10.4088/JCP.13m08374; Forbes D, 2012, J CLIN PSYCHIAT, V73, P372, DOI 10.4088/JCP.10m06640; Fowler JC, 2013, J AFFECT DISORDERS, V149, P313, DOI 10.1016/j.jad.2013.01.045; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; Hirsch JK, 2011, J AM COLL HEALTH, V59, P393, DOI 10.1080/07448481.2010.515635; Hopwood CJ, 2013, J PERS DISORD, V27, P270, DOI 10.1521/pedi.2013.27.3.270; Jackson JJ, 2012, PSYCHOL SCI, V23, P270, DOI 10.1177/0956797611423545; Jaksic N, 2012, PSYCHIAT DANUB, V24, P256; Jensen-Campbell LA, 2003, J PERS, V71, P1059, DOI 10.1111/1467-6494.7106007; Jensen-Campbell LA, 2007, J RES PERS, V41, P403, DOI 10.1016/j.jrp.2006.05.001; John O.P., 1991, BIG 5 INVENTORY VERS; Kerby DS, 2003, PERS INDIV DIFFER, V35, P249, DOI 10.1016/S0191-8869(02)00174-5; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; 김선영, 2010, [Journal of Korean Society of Biological Psychiatry, 생물정신의학], V17, P15; Korean National Statistical Office, 2010, REP POP HOUS CENS 20; Kotler M, 2001, J NERV MENT DIS, V189, P162, DOI 10.1097/00005053-200103000-00004; Krysinska K, 2010, ARCH SUICIDE RES, V14, P1, DOI 10.1080/13811110903478997; Lee HS, 2012, PSYCHIAT INVEST, V9, P361, DOI 10.4306/pi.2012.9.4.361; Luthra R, 2009, J INTERPERS VIOLENCE, V24, P1919, DOI 10.1177/0886260508325494; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; McCann SJH, 2010, ARCH SUICIDE RES, V14, P368, DOI 10.1080/13811118.2010.524070; McLean CP, 2017, J AFFECT DISORDERS, V208, P392, DOI 10.1016/j.jad.2016.08.061; Min MO, 2014, DRUG ALCOHOL DEPEN, V142, P277, DOI 10.1016/j.drugalcdep.2014.06.032; Mueser KT, 1998, J CONSULT CLIN PSYCH, V66, P493, DOI 10.1037/0022-006X.66.3.493; O'Connor RC, 2014, LANCET PSYCHIAT, V1, P73, DOI 10.1016/S2215-0366(14)70222-6; Panagioti M, 2015, PSYCHIAT RES, V227, P302, DOI 10.1016/j.psychres.2015.02.019; Panagioti M, 2009, CLIN PSYCHOL REV, V29, P471, DOI 10.1016/j.cpr.2009.05.001; Piedmont RL, 1998, REVISED NEO PERSONAL, P113; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; RESNICK HS, 1993, J CONSULT CLIN PSYCH, V61, P984, DOI 10.1037/0022-006X.61.6.984; Sadock BJ, 2015, KAPLAN SADOCKS SYNOP, P763; Schumm JA, 2006, J TRAUMA STRESS, V19, P825, DOI 10.1002/jts.20159; Sharma K, 2019, J EARTHQ ENG, V23, P512, DOI 10.1080/13632469.2017.1342299; Shea MT, 1996, DSM 4 SOURCEBOOK, V2, P849; Steel Z, 2014, INT J EPIDEMIOL, V43, P476, DOI 10.1093/ije/dyu038; Stepp SD, 2008, SUICIDE LIFE-THREAT, V38, P592, DOI 10.1521/suli.2008.38.5.592; Stewart S, 2005, ADV MENT HEALTH, V4, P108, DOI 10.5172/jamh.4.2.108; Sun RCF, 2007, BRIT J GUID COUNS, V35, P299, DOI 10.1080/03069880701384452; Talbot NL, 2004, AM J GERIAT PSYCHIAT, V12, P536, DOI 10.1176/appi.ajgp.12.5.536; Voracek M, 2006, PERCEPT MOTOR SKILL, V102, P609, DOI 10.2466/PMS.102.2.609-610; WHO-WORLD HEALTH ORGANIZATION, 2002, MULT INT STUD SUIC B; Widera-Wysoczanska A, 2010, INTERPERSONAL TRAUMA, P15; Wills JL, 2016, J TRAUMA STRESS, V29, P185, DOI 10.1002/jts.22089; Woodward MJ, 2015, J ANXIETY DISORD, V35, P60, DOI 10.1016/j.janxdis.2015.09.002; Zoladz PR, 2013, NEUROSCI BIOBEHAV R, V37, P860, DOI 10.1016/j.neubiorev.2013.03.024	66	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191198	10.1371/journal.pone.0191198	http://dx.doi.org/10.1371/journal.pone.0191198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BY	29329352	Green Published, gold, Green Submitted			2022-12-26	WOS:000419954100046
J	Flanagan, AM; Flood, RD; Frisk, MG; Garza, CD; Lopez, GR; Maher, NP; Cerrato, RM				Flanagan, Alison M.; Flood, Roger D.; Frisk, Michael G.; Garza, Corey D.; Lopez, Glenn R.; Maher, Nicole P.; Cerrato, Robert M.			The relationship between observational scale and explained variance in benthic communities	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION; CLASSIFICATION; ASSEMBLAGES; ORDINATION; PATTERNS; HABITAT; MARINE; SONAR; VARIABILITY; BACKSCATTER	This study addresses the impact of spatial scale on explaining variance in benthic communities. In particular, the analysis estimated the fraction of community variation that occurred at a spatial scale smaller than the sampling interval (i.e., the geographic distance between samples). This estimate is important because it sets a limit on the amount of community variation that can be explained based on the spatial configuration of a study area and sampling design. Six benthic data sets were examined that consisted of faunal abundances, common environmental variables (water depth, grain size, and surficial percent cover), and sonar backscatter treated as a habitat proxy (categorical acoustic provinces). Redundancy analysis was coupled with spatial variograms generated by multiscale ordination to quantify the explained and residual variance at different spatial scales and within and between acoustic provinces. The amount of community variation below the sampling interval of the surveys (< 100 m) was estimated to be 36 +/- 59% of the total. Once adjusted for this small-scale variation, > 71% of the remaining variance was explained by the environmental and province variables. Furthermore, these variables effectively explained the spatial structure present in the infaunal community. Overall, no scale problems remained to compromise inferences, and unexplained infaunal community variation had no apparent spatial structure within the observational scale of the surveys (> 100 m), although small-scale gradients (< 100 m) below the observational scale may be present.	[Flanagan, Alison M.; Flood, Roger D.; Frisk, Michael G.; Lopez, Glenn R.; Cerrato, Robert M.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Garza, Corey D.] Calif State Univ Monterey Bay, Sch Nat Sci, Seaside, CA USA; [Maher, Nicole P.] Nature Conservancy, Long Isl Chapter, Cold Spring Harbor, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; California State University System; California State University Monterey Bay; Nature Conservancy	Flanagan, AM (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	alisonmflanagan@gmail.com		Flanagan, Adrienne/0000-0002-2832-1303; Garza, Corey/0000-0002-4915-7776	National Sea Grant College Program of the U.S. Department of Commerce's National Oceanic and Atmospheric Administration [R/C0-7, 53266, R/C0-6, 22915]; New York Department of Environmental Conservation "Integrating Fish Trawl, Water Quality, and Benthic Mapping Data in the Peconic Estuary" project	National Sea Grant College Program of the U.S. Department of Commerce's National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); New York Department of Environmental Conservation "Integrating Fish Trawl, Water Quality, and Benthic Mapping Data in the Peconic Estuary" project	This manuscript is a resulting product from project R/C0-7 funded under award 53266 and from project R/C0-6 funded under award 22915 from the National Sea Grant College Program of the U.S. Department of Commerce's National Oceanic and Atmospheric Administration, to the Research Foundation of the State University of New York on behalf of New York Sea Grant, and from the New York Department of Environmental Conservation "Integrating Fish Trawl, Water Quality, and Benthic Mapping Data in the Peconic Estuary" project. The statements, findings, conclusions, views, and recommendations are those of the authors and do not necessarily reflect the views of any of those organizations.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Allen T. F. H., 1982, HIERARCHY PERSPECTIV; Auster PJ, 2009, LONG ISLAND SOUND ST; Bachmaier M, 2008, PRECIS AGRIC, V9, P173, DOI 10.1007/s11119-008-9056-2; Banks HT, 2017, APPL MATH LETT, V74, P33, DOI 10.1016/j.aml.2017.05.005; Bell R.E., 2000, HUDSON RIVER E UNPUB; Benedetti-Cecchi L, 2000, OECOLOGIA, V123, P406, DOI 10.1007/s004420051028; Boldina I, 2014, J SEA RES, V85, P85, DOI 10.1016/j.seares.2013.10.006; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Borgeld JC, 1999, MAR GEOL, V154, P197, DOI 10.1016/S0025-3227(98)00113-3; Brown CJ, 2002, ESTUAR COAST SHELF S, V54, P263, DOI 10.1006/ecss.2001.0841; Brown CJ, 2008, ESTUAR COAST SHELF S, V78, P203, DOI 10.1016/j.ecss.2007.11.026; Brown CJ, 2011, ESTUAR COAST SHELF S, V92, P502, DOI 10.1016/j.ecss.2011.02.007; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cerrato R.M, 2015, 141 MAR SCI RES CTR; Cerrato RM, 2004, 134 MAR SCI RES CTR; Chapman MG, 2010, MAR ECOL PROG SER, V398, P33, DOI 10.3354/meps08328; Clarke KR, 2006, J EXP MAR BIOL ECOL, V338, P179, DOI 10.1016/j.jembe.2006.06.019; Cole RG, 2001, ENVIRON MONIT ASSESS, V69, P85, DOI 10.1023/A:1010756729485; Cole RG, 2001, NEW ZEAL J MAR FRESH, V35, P891, DOI 10.1080/00288330.2001.9517051; Cowardin LM., 2005, WATER ENCY; Cressie N., 2011, STAT SPATIO TEMPORAL; Davies CE, 2004, EUROPEAN ENV AGENCY; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Denny MW, 2004, ECOL MONOGR, V74, P513, DOI 10.1890/03-4043; Diaz RJ, 2004, J ENVIRON MANAGE, V73, P165, DOI 10.1016/j.jenvman.2004.06.004; DOMBURG P, 1994, GEODERMA, V62, P151, DOI 10.1016/0016-7061(94)90033-7; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Dray S, 2011, GEOGR ANAL, V43, P127, DOI 10.1111/j.1538-4632.2011.00811.x; Dungan JL, 2002, ECOGRAPHY, V25, P626, DOI 10.1034/j.1600-0587.2002.250510.x; Eastwood PD, 2006, CAN J FISH AQUAT SCI, V63, P1536, DOI 10.1139/F06-058; Federal Geographic Data Committee (FGDC), 2012, COAST MAR EC CLASS S; Flanagan AM, 2015, CONT SHELF RES, V109, P55, DOI 10.1016/j.csr.2015.08.023; Flanagan A.M., 2016, THESIS; FLEEGER JW, 1995, J MAR RES, V53, P609, DOI 10.1357/0022240953213070; Folk R.L., 1974, PETROLOGY SEDIMENTAR; Fonseca L, 2007, MAR GEOPHYS RES, V28, P119, DOI 10.1007/s11001-007-9019-4; Fraschetti S, 2005, MAR ECOL PROG SER, V296, P13, DOI 10.3354/meps296013; Garza C, 2008, LANDSCAPE ECOL, V23, P107, DOI 10.1007/s10980-007-9142-2; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Greene HG, 1999, OCEANOL ACTA, V22, P663, DOI 10.1016/S0399-1784(00)88957-4; Griffith DA, 2005, ANN ASSOC AM GEOGR, V95, P740, DOI 10.1111/j.1467-8306.2005.00484.x; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; JACKSON DR, 1992, J ACOUST SOC AM, V92, P962, DOI 10.1121/1.403966; Jenness JS, 2004, WILDLIFE SOC B, V32, P829, DOI 10.2193/0091-7648(2004)032[0829:CLSAFD]2.0.CO;2; Johnson DS, 2007, ESTUAR COAST, V30, P226, DOI 10.1007/BF02700166; Jongman RHG, 1995, DATA ANAL COMMUNITY; Journal AG., 1978, MINING GEOSTATISTICS; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Kostylev VE, 2001, MAR ECOL PROG SER, V219, P121, DOI 10.3354/meps219121; Kraufvelin P, 2011, MAR ECOL PROG SER, V426, P13, DOI 10.3354/meps09038; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; MANTEL N, 1967, CANCER RES, V27, P209; McGonigle C, 2009, ESTUAR COAST SHELF S, V81, P423, DOI 10.1016/j.ecss.2008.11.017; Nitsche FO, 2004, MAR GEOL, V209, P131, DOI 10.1016/j.margeo.2004.05.023; Nitsche FO, 2005, COAST SYST CONT MARG, V8, P33; O'Leary JK, 2011, CORAL REEFS, V30, P1013, DOI 10.1007/s00338-011-0789-4; Pineda J, 2010, J EXP MAR BIOL ECOL, V392, P9, DOI 10.1016/j.jembe.2010.04.008; Ramey PA, 2009, CONT SHELF RES, V29, P2222, DOI 10.1016/j.csr.2009.08.020; Rietkerk M, 2002, ECOL MODEL, V149, P1, DOI 10.1016/S0304-3800(01)00510-5; Rossi F, 2002, MAR ECOL PROG SER, V241, P29, DOI 10.3354/meps241029; Saul SE, 2013, FISH RES, V143, P12, DOI 10.1016/j.fishres.2013.01.002; Schlup BM, 2008, J VEG SCI, V19, P621, DOI 10.3170/2008-8-18421; Shumchenia EJ, 2010, CONT SHELF RES, V30, P1717, DOI 10.1016/j.csr.2010.07.007; Strayer DL, 2006, FRESHWATER BIOL, V51, P25, DOI 10.1111/j.1365-2427.2005.01472.x; Tamburello L, 2013, ECOLOGY, V94, P1102, DOI 10.1890/12-1293.1; Thrush SF, 2005, MAR ECOL PROG SER, V302, P13, DOI 10.3354/meps302013; Underwood AJ, 1996, OECOLOGIA, V107, P212, DOI 10.1007/BF00327905; Urgeles R, 2002, MAR GEOL, V184, P41, DOI 10.1016/S0025-3227(01)00303-6; Verfaillie E, 2009, ESTUAR COAST SHELF S, V83, P175, DOI 10.1016/j.ecss.2009.03.003; Wackernagel H., 1995, MULTIVARIATE GEOSTAT, V1, P74, DOI [10.1007/978-3-662-03098-1_11, DOI 10.1007/978-3-662-03098-1_11]; Wagner HH, 2005, ECOLOGY, V86, P1975, DOI 10.1890/04-0914; Wagner HH, 2004, ECOLOGY, V85, P342, DOI 10.1890/02-0738; Wagner HH, 2003, ECOLOGY, V84, P1045, DOI 10.1890/0012-9658(2003)084[1045:SCIPCI]2.0.CO;2; Wheatley M, 2009, ECOL COMPLEX, V6, P150, DOI 10.1016/j.ecocom.2008.10.011; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wu JG, 1995, Q REV BIOL, V70, P439, DOI 10.1086/419172; Zimmerman DL, 2010, CH CRC HANDB MOD STA, P29	79	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0189313	10.1371/journal.pone.0189313	http://dx.doi.org/10.1371/journal.pone.0189313			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324746	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400007
J	Lyte, M; Brown, DR				Lyte, Mark; Brown, David R.			Evidence for PMAT- and OCT-like biogenic amine transporters in a probiotic strain of Lactobacillus: Implications for interkingdom communication within the microbiota-gut-brain axis	PLOS ONE			English	Article							ESCHERICHIA-COLI; FLUORESCENT SUBSTRATE; THERAPEUTIC TARGETS; ACTIVE-TRANSPORT; ENDOCRINOLOGY; BACTERIA; NOREPINEPHRINE; SALIVARIUS; HOMOLOG; SYSTEM	The ability of prokaryotic microbes to produce and respond to neurochemicals that are more often associated with eukaryotic systems is increasingly recognized through the concept of microbial endocrinology. Most studies have described the phenomena of neurochemical production by bacteria, but there remains an incomplete understanding of the mechanisms by which microbe- or host-derived neuroactive substances can be recognized by bacteria. Based on the evolutionary origins of eukaryotic solute carrier transporters, we hypothesized that bacteria may possess an analogous uptake function for neuroactive biogenic amines. Using specific fluorescence-based assays, Lactobacillus salivarius biofilms appear to express both plasma membrane monoamine transporter (PMAT)- and organic cation transporter (OCT)-like uptake of transporter-specific fluorophores. This phenomenon is not distributed throughout the genus Lactobacillus as L. rhamnosus biofilms did not take up these fluorophores. PMAT probe uptake into L. salivarius biofilms was attenuated by the protonophore CCCP, the cation transport inhibitor decynium-22, and the natural substrates norepinephrine, serotonin and fluoxetine. These results provide the first evidence, to our knowledge, for the existence of PMAT- and OCT-like uptake systems in a bacterium. They also suggest the existence of a hitherto unrecognized mechanism by which a probiotic bacterium may interact with host signals and may provide a means to examine microbial endocrinology-based interactions in health and disease that are part of the larger microbiota-gut-brain axis.	[Lyte, Mark] Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA; [Brown, David R.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA	Iowa State University; University of Minnesota System; University of Minnesota Twin Cities	Lyte, M (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA.	mlyte@iastate.edu	Lyte, Mark/AAI-7602-2020	Lyte, Mark/0000-0001-8512-2581; Brown, David/0000-0003-3844-5454	Department of Defense, Office of Naval research [N000141512706]; Metagenics, Aliso Viejo, CA	Department of Defense, Office of Naval research(Office of Naval ResearchUnited States Department of Defense); Metagenics, Aliso Viejo, CA	This work was supported by Department of Defense, Office of Naval research grant #N000141512706 (to M.L.) and by a grant from Metagenics (www.rnetagenics.com), Aliso Viejo, CA (to M.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano Y, 2012, AM J PHYSIOL-GASTR L, V303, pG1288, DOI 10.1152/ajpgi.00341.2012; Beikmann BS, 2013, ACS CHEM NEUROSCI, V4, P161, DOI 10.1021/cn300146w; Boxberger KH, 2014, DRUG METAB DISPOS, V42, P990, DOI 10.1124/dmd.113.055095; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Chaves BD, 2017, J APPL MICROBIOL, V123, P18, DOI 10.1111/jam.13438; Duan HC, 2015, DRUG METAB DISPOS, V43, P1773, DOI 10.1124/dmd.115.064824; Forsyth CB, 2009, ALCOHOL, V43, P163, DOI 10.1016/j.alcohol.2008.12.009; Freestone PPE, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-8; Grover M, 2013, J GASTROENTEROL, V48, P177, DOI 10.1007/s00535-012-0726-5; Hata T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180745; HO LC, 1993, PARASITOL RES, V79, P614, DOI 10.1007/BF00932249; Hoglund PJ, 2011, MOL BIOL EVOL, V28, P1531, DOI 10.1093/molbev/msq350; Jorgensen S, 2008, J NEUROSCI METH, V169, P168, DOI 10.1016/j.jneumeth.2007.12.004; Salas-Jara MJ, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4030035; KABACK HR, 1986, ANNU REV BIOPHYS BIO, V15, P279; Lambert RJW, 2001, J APPL MICROBIOL, V91, P453, DOI 10.1046/j.1365-2672.2001.01428.x; Lin L, 2015, NAT REV DRUG DISCOV, V14, P543, DOI 10.1038/nrd4626; LYTE M, 1993, BIOCHEM BIOPH RES CO, V190, P447, DOI 10.1006/bbrc.1993.1068; Lyte M, 2003, LANCET, P361; Lyte M, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0021-2015; Lyte M, 2014, GUT MICROBES, V5, P381, DOI 10.4161/gmic.28682; Lyte M, 2014, ADV EXP MED BIOL, V817, P3, DOI 10.1007/978-1-4939-0897-4_1; Lyte M, 2011, BIOESSAYS, V33, P574, DOI 10.1002/bies.201100024; Lyte M, 2011, CELL TISSUE RES, V343, P23, DOI 10.1007/s00441-010-1050-0; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; Moreira CG, 2016, ADV EXP MED BIOL, V874, P247, DOI 10.1007/978-3-319-20215-0_12; Neville BA, 2010, FUTURE MICROBIOL, V5, P759, DOI 10.2217/FMB.10.35; Pakandl M, 1999, PARASITOL RES, V85, P743, DOI 10.1007/s004360050625; Pessione E, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00876; Sandrini S, 2015, J ENDOCRINOL, V225, pR21, DOI 10.1530/JOE-14-0615; SCHOMIG E, 1993, N-S ARCH PHARMACOL, V347, P379, DOI 10.1007/BF00165387; Schwartz JW, 2003, J BIOL CHEM, V278, P9768, DOI 10.1074/jbc.M209824200; Sharon G, 2016, CELL, V167, P915, DOI 10.1016/j.cell.2016.10.027; Solis E, 2012, J BIOL CHEM, V287, P8852, DOI 10.1074/jbc.M111.267757; Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107; STROBEL HJ, 1989, J BACTERIOL, V171, P280, DOI 10.1128/jb.171.1.280-284.1989; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yang Q, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00584; Yang YX, 2014, ANAL LETT, V47, P1290, DOI 10.1080/00032719.2013.871550; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; YARBROUGH JM, 1980, APPL ENVIRON MICROB, V39, P831, DOI 10.1128/AEM.39.4.831-834.1980; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	43	29	29	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191037	10.1371/journal.pone.0191037	http://dx.doi.org/10.1371/journal.pone.0191037			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324833	Green Submitted, Green Published, gold			2022-12-26	WOS:000419952400096
J	Wu, YN; Ma, WM; Liu, JK; Zhu, LJ; Cong, L; Zhai, JX; Wang, Y; Zhang, ZM				Wu, Yanan; Ma, Wenmei; Liu, Jiakai; Zhu, Lijuan; Cong, Ling; Zhai, Jiexiu; Wang, Yu; Zhang, Zhenming			Sabina chinensis and Liriodendron chinense improve air quality in Beijing, China	PLOS ONE			English	Article							DRY-DEPOSITION; PARTICULATE MATTER; FINE PARTICLES; MEXICO-CITY; FOREST; POLLUTION; PM10; WET; POLLUTANTS; CAPTURE	Urban forests have been shown to be efficient for reducing air pollutants especially for particulate matters (PMs). This study aims to reveal the PM blocking capacity of two common artificial landscape species, Sabina chinensis and Liriodendron chinense and to investigate spatial-temporal heterogeneities by estimating the vegetation collection velocity of coarse (PM10) and fine particles (PM2.5) during different seasons and heights. PM concentration and meteorological data were collected on both leeward and windward sides of trees during the daytime in both summers and winters from 2013 to 2015. Concentration and meteorological monitors were installed at three heights, bottom (1.5 m), middle (3.5 m), and top (5.5 m) of the canopy. The results showed: During daytime, the collection velocity changed and PM2.5 collection velocity was much higher than that of PM10. Furthermore, the maximum collection velocities of L. chinense and S. chinensis occurred at 14: 00 +/- 16: 00 both in summer and winter. Moreover, the collection velocity had a positive correlation with wind speed and temperature. The blocking capacities of L. chinense and S. chinensis varied from season to season, and the concentrations of particulate matter indicate the middle canopy of both species as the most effective part for TSP blocking. Furthermore, these two species are more effective blocking in PM2.5 than PM10. The blocking capacity of S. chinensis is generally better. The vegetation collection is the major process of PM removal near the ground and sedimentation was not taken into consideration near the ground.	[Wu, Yanan; Ma, Wenmei; Liu, Jiakai; Zhu, Lijuan; Cong, Ling; Zhai, Jiexiu; Wang, Yu; Zhang, Zhenming] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China	Beijing Forestry University	Zhang, ZM (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	zhenmingzhang@bjfu.edu.cn	cong, ling/GQG-9582-2022; Liu, Jiakai/L-9946-2014	Liu, Jiakai/0000-0002-3337-1962	Fundamental Research Funds for the Central Universities [2016JX05]; Forestry Public Welfare Projects Special Fund of China [201304301]; Beijing Municipal Science and Technology Project [Z141100006014031]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Forestry Public Welfare Projects Special Fund of China; Beijing Municipal Science and Technology Project	This research was supported by the Fundamental Research Funds for the Central Universities (2016JX05), Forestry Public Welfare Projects Special Fund of China (201304301), and Beijing Municipal Science and Technology Project (Z141100006014031).	Balestrini R, 2007, ATMOS ENVIRON, V41, P745, DOI 10.1016/j.atmosenv.2006.09.002; Baumgardner D, 2012, ENVIRON POLLUT, V163, P174, DOI 10.1016/j.envpol.2011.12.016; BECKETT K.P., 2000, J ARBOR, V26, P12; Beckett KP, 1998, ENVIRON POLLUT, V99, P347, DOI 10.1016/S0269-7491(98)00016-5; Beckett KP, 2000, GLOBAL CHANGE BIOL, V6, P995, DOI 10.1046/j.1365-2486.2000.00376.x; Borja-Aburto VH, 1998, ENVIRON HEALTH PERSP, V106, P849, DOI 10.2307/3434129; Cacciola RR, 2002, ALLERGY, V57, P281, DOI 10.1034/j.1398-9995.2002.1r3315.x; Carlson RW, 1977, WATER AIR SOIL POLL, V7, P545; Chai Yixin, 2002, Yingyong Shengtai Xuebao, V13, P1121; Connan O, 2013, ATMOS ENVIRON, V67, P394, DOI 10.1016/j.atmosenv.2012.11.029; DRAAIJERS GPJ, 1994, BOUND-LAY METEOROL, V69, P343, DOI 10.1007/BF00718124; Dzierzanowski K, 2011, CHALLENGES MODERN TE, V2, P60; Dzierzanowski K, 2011, INT J PHYTOREMEDIAT, V13, P1037, DOI 10.1080/15226514.2011.552929; Escobedo FJ, 2009, LANDSCAPE URBAN PLAN, V90, P102, DOI 10.1016/j.landurbplan.2008.10.021; FOWLER D, 1989, PHILOS T ROY SOC B, V324, P247, DOI 10.1098/rstb.1989.0047; Freer-Smith PH, 2005, ENVIRON POLLUT, V133, P157, DOI 10.1016/j.envpol.2004.03.031; Freer-Smith PH, 2004, WATER AIR SOIL POLL, V155, P173, DOI 10.1023/B:WATE.0000026521.99552.fd; Gao JinHui, 2007, Journal of Beijing Forestry University, V29, P94; GIORGI F, 1986, J GEOPHYS RES-ATMOS, V91, P9794, DOI 10.1029/JD091iD09p09794; Guo L, 2012, ENG APPL COMP FLUID, V6, P110, DOI 10.1080/19942060.2012.11015407; Jafary Z. A., 2007, PAK J PHYSL, P30; Khan FI, 2000, ENVIRON MONIT ASSESS, V64, P457, DOI 10.1023/A:1006278000352; Liu JK, 2016, ATMOS ENVIRON, V125, P178, DOI 10.1016/j.atmosenv.2015.11.023; Liu R. T., 2008, ENV ECOL, V17, P1879; Liu X, 2008, NO HORTICULTURE, V4, P167; Liu ZH, 2015, ENVIRON SCI POLLUT R, V22, P4753, DOI [10.1007/s11356-014-3347-0, 10.1007/s11356-014-3981-6]; Matsuda K, 2012, ATMOS ENVIRON, V54, P282, DOI 10.1016/j.atmosenv.2012.02.022; McDonald AG, 2007, ATMOS ENVIRON, V41, P8455, DOI 10.1016/j.atmosenv.2007.07.025; PAW KT, 1992, AEROSOL SCI TECH, V17, P278; Penuelas J, 2010, TRENDS PLANT SCI, V15, P133, DOI 10.1016/j.tplants.2009.12.005; Petroff A, 2008, ATMOS ENVIRON, V42, P3625, DOI 10.1016/j.atmosenv.2007.09.043; Prajapati S.K., 2012, ENV SKEPT CRIT, V1, P12; Prajapati SK, 2008, J ENVIRON QUAL, V37, P865, DOI 10.2134/jeq2006.0511; Qu WJ, 2010, ATMOS CHEM PHYS, V10, P5641, DOI 10.5194/acp-10-5641-2010; Raupach MR, 2001, ATMOS ENVIRON, V35, P3373, DOI 10.1016/S1352-2310(01)00139-X; Reinap A, 2009, TREES-STRUCT FUNCT, V23, P1263, DOI 10.1007/s00468-009-0366-4; Sternberg T, 2010, SCI TOTAL ENVIRON, V409, P162, DOI 10.1016/j.scitotenv.2010.09.022; [苏航 Su Hang], 2010, [气候与环境研究, Climatic and Environmental Research], V15, P636; Sun FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097723; Tiwary A, 2008, J AEROSOL SCI, V39, P40, DOI 10.1016/j.jaerosci.2007.09.011; Turan D, 2011, ENVIRON SCI POLLUT R, V18, P355, DOI 10.1007/s11356-010-0378-z; [王赞红 Wang Zanhong], 2006, [生态环境, Ecology and Environment], V15, P327; Yang Jun, 2005, Urban Forestry & Urban Greening, V3, P65, DOI 10.1016/j.ufug.2004.09.001; [殷杉 YIN Shan], 2007, [生态学报, Acta Ecologica Sinica], V27, P4590; Zhang LM, 2001, ATMOS ENVIRON, V35, P549, DOI 10.1016/S1352-2310(00)00326-5	45	7	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0189640	10.1371/journal.pone.0189640	http://dx.doi.org/10.1371/journal.pone.0189640			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324847	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400010
J	Christie, J; Gray, TA; Dumville, JC; Cullum, NA				Christie, Janice; Gray, Trish A.; Dumville, Jo C.; Cullum, Nicky A.			Do systematic reviews address community healthcare professionals' wound care uncertainties? Results from evidence mapping in wound care	PLOS ONE			English	Review							RESEARCH INFORMATION; RESEARCH PRIORITIES; CLINICIAN; WASTE	Background Complex wounds such as leg and foot ulcers are common, resource intensive and have negative impacts on patients' wellbeing. Evidence-based decision-making, substantiated by high quality evidence such as from systematic reviews, is widely advocated for improving patient care and healthcare efficiency. Consequently, we set out to classify and map the extent to which up-to-date systematic reviews containing robust evidence exist for wound care uncertainties prioritised by community-based healthcare professionals. Methods We asked healthcare professionals to prioritise uncertainties based on complex wound care decisions, and then classified 28 uncertainties according to the type and level of decision. For each uncertainty, we searched for relevant systematic reviews. Two independent reviewers screened abstracts and full texts of reviews against the following criteria: meeting an a priori definition of a systematic review, sufficiently addressing the uncertainty, published during or after 2012, and identifying high quality research evidence. Results The most common uncertainty type was 'interventions' 24/28 (85%); the majority concerned wound level decisions 15/28 (53%) however, service delivery level decisions (10/28) were given highest priority. Overall, we found 162 potentially relevant reviews of which 57 (35%) were not systematic reviews. Of 106 systematic reviews, only 28 were relevant to an uncertainty and 18 of these were published within the preceding five years; none identified high quality research evidence. Conclusions Despite the growing volume of published primary research, healthcare professionals delivering wound care have important clinical uncertainties which are not addressed by up-todate systematic reviews containing high certainty evidence. These are high priority topics requiring new research and systematic reviews which are regularly updated. To reduce clinical and research waste, we recommend systematic reviewers and researchers make greater efforts to ensure that research addresses important clinical uncertainties and is of sufficient rigour to inform practice.	[Christie, Janice; Gray, Trish A.; Dumville, Jo C.; Cullum, Nicky A.] Univ Manchester, Fac Biol Med & Hlth, Manchester Acad Hlth Sci Ctr, Sch Hlth Sci,Div Nursing Midwifery & Social Work, Manchester, Lancs, England; [Cullum, Nicky A.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Res & Innovat Div, Manchester, Lancs, England	University of Manchester; University of Manchester	Christie, J (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Manchester Acad Hlth Sci Ctr, Sch Hlth Sci,Div Nursing Midwifery & Social Work, Manchester, Lancs, England.	Janice.christie@manchester.ac.uk	Cullum, Nicky/AAT-5888-2020; Christie, Janice/O-9320-2014; Dumville, Jo/O-7867-2014	Cullum, Nicky/0000-0003-2631-123X; Christie, Janice/0000-0001-6176-6075; Dumville, Jo/0000-0002-6546-3685	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Greater Manchester	National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Greater Manchester	This project was funded by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Greater Manchester. The NIHR CLAHRC Greater Manchester is a partnership between providers and commissioners from the NHS, industry and the third sector, as well as clinical and research staff from the University of Manchester. NC received funding for the project, details of which can be found at http://clahrc-gm.nihr.ac.uk/our-work/wound-care/. NC, JD and TG are partially supported by the funding. The views expressed in this article are those of the authors and not necessarily those of the NHS, NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Katy Rothwell, Programme Manager, NIHR CLAHRC Greater Manchester and many colleagues within the CLAHRC Wound Care Programme, who have assisted with and supported this work. We also thank the four community NHS Trusts in Greater Manchester for their backing and Reetu Child, Academic Engagement Librarian at the University of Manchester, who helped us to define wound care terms and refine our initial search strategies.	Akobeng AK, 2005, ARCH DIS CHILD, V90, P837, DOI 10.1136/adc.2005.071761; Balsa AI, 2003, AM J LAW MED, V29, P203; Bartunek Jean, 2003, J Health Serv Res Policy, V8 Suppl 2, P62, DOI 10.1258/135581903322405199; Bell-Syer Sally E M, 2007, Adv Skin Wound Care, V20, P283, DOI 10.1097/01.ASW.0000269316.68757.0e; Bragge P, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-92; Bronfenbrenner U., 1992, 6 THEORIES CHILD DEV, P187, DOI DOI 10.1037/10518-046; Bronfenbrenner U, 1979, ECOLOGY HUMAN DEV EX; CARROUGHER G J, 1991, Journal of Burn Care and Rehabilitation, V12, P272, DOI 10.1097/00004630-199105000-00015; Chalmers I, 2014, LANCET, V383, P156, DOI 10.1016/S0140-6736(13)62229-1; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chalmers RJG, 2005, CLIN MED, V5, P230, DOI 10.7861/clinmedicine.5-3-230; Cochrane, 2013, COCHR STRAT 2020; Cochrane collaboration, 2016, EPOC SCOP OUR WORK; Cowman S, 2012, J CLIN NURS, V21, P344, DOI 10.1111/j.1365-2702.2011.03950.x; Crowe Sally, 2015, Res Involv Engagem, V1, P2, DOI 10.1186/s40900-015-0003-x; Cullum N, 2016, PROGRAMME GRANTS APP, V4, P1; Dicenso Alba, 2009, Evid Based Nurs, V12, P99, DOI 10.1136/ebn.12.4.99-b; Dumville JC, 2009, J CLIN NURS, V18, P1422, DOI 10.1111/j.1365-2702.2008.02293.x; French B, 2006, NURS EDUC TODAY, V26, P245, DOI 10.1016/j.nedt.2005.10.005; Gray TA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188958; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Hall D. A., 2013, Clinical Investigation, V3, P21, DOI 10.4155/cli.12.129; Han PKJ, 2011, MED DECIS MAKING, V31, P828, DOI 10.1177/0272989X11393976; Haynes Brian, 2007, Evid Based Nurs, V10, P6, DOI 10.1136/ebn.10.1.6; Heaton J, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0383-9; Herber OR, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-44; Hodgson R, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-19; LAZARUS GS, 1994, ARCH DERMATOL, V130, P489, DOI 10.1001/archderm.130.4.489; Logan G., 2015, BR J COMMUNITY NU S3, V20, pS21, DOI [DOI 10.12968/BJCN.2015.20.SUP3.S21, 10.12968/bjcn.2015.20.sup3.s21]; Lophatananon A, 2011, BJU INT, V108, P1040, DOI 10.1111/j.1464-410X.2011.10609.x; McCaughan D, 2005, FAM PRACT, V22, P490, DOI 10.1093/fampra/cmi042; McCaughan D, 2002, J ADV NURS, V39, P46, DOI 10.1046/j.1365-2648.2002.02241.x; McDermott-Scales L, 2009, J Wound Care, V18, P405; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; O'Connor D, 2011, COCHRANE HDB SYSTEMA; Palacios-Cena D, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009678; Phillips CJ, 2016, INT WOUND J, V13, P1193, DOI 10.1111/iwj.12443; Schlosser R, 2009, EVID BASED COMMUN AS, V3, P1, DOI DOI 10.1080/17489530902801067; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Soares MO, 2013, MED DECIS MAKING, V33, P415, DOI 10.1177/0272989X12451058; Straus SE, 1998, BRIT MED J, V317, P339, DOI 10.1136/bmj.317.7154.339; Thompson C, 2001, INT J NURS STUD, V38, P609, DOI 10.1016/S0020-7489(00)00103-6; Thompson C, 2000, NURSES USE RES INFOR; Tong A, 2015, AM J KIDNEY DIS, V66, P212, DOI 10.1053/j.ajkd.2015.02.341; United Nations Department of Economic and Social Affairs, 2001, WORLD POP AG 1950 20; Viergever RF, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-36	46	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190045	10.1371/journal.pone.0190045	http://dx.doi.org/10.1371/journal.pone.0190045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS3NS	29320522	Green Submitted, gold, Green Published			2022-12-26	WOS:000419689600029
J	Santiago-Avila, FJ; Cornman, AM; Treves, A				Santiago-Avila, Francisco J.; Cornman, Ari M.; Treves, Adrian			Killing wolves to prevent predation on livestock may protect one farm but harm neighbors	PLOS ONE			English	Article							SURVIVAL ANALYSIS; WOLF DEPREDATION; SPATIAL MODEL; CONSERVATION; INFERENCE; MONTANA; HAZARDS; FLADRY; CATTLE	Large carnivores, such as gray wolves, Canis lupus, are difficult to protect in mixed-use landscapes because some people perceive them as dangerous and because they sometimes threaten human property and safety. Governments may respond by killing carnivores in an effort to prevent repeated conflicts or threats, although the functional effectiveness of lethal methods has long been questioned. We evaluated two methods of government intervention following independent events of verified wolf predation on domestic animals (depredation) in the Upper Peninsula of Michigan, USA between 1998-2014, at three spatial scales. We evaluated two intervention methods using log-rank tests and conditional Cox recurrent event, gap time models based on retrospective analyses of the following quasi-experimental treatments: (1) selective killing of wolves by trapping near sites of verified depredation, and (2) advice to owners and haphazard use of non-lethal methods without wolf-killing. The government did not randomly assign treatments and used a pseudo-control (no removal of wolves was not a true control), but the federal permission to intervene lethally was granted and rescinded independent of events on the ground. Hazard ratios suggest lethal intervention was associated with an insignificant 27% lower risk of recurrence of events at trapping sites, but offset by an insignificant 22% increase in risk of recurrence at sites up to 5.42 km distant in the same year, compared to the non-lethal treatment. Our results do not support the hypothesis that Michigan's use of lethal intervention after wolf depredations was effective for reducing the future risk of recurrence in the vicinities of trapping sites. Examining only the sites of intervention is incomplete because neighbors near trapping sites may suffer the recurrence of depredations. We propose two new hypotheses for perceived effectiveness of lethal methods: (a) killing predators may be perceived as effective because of the benefits to a small minority of farmers, and (b) if neighbors experience side-effects of lethal intervention such as displaced depredations, they may perceive the problem growing and then demand more lethal intervention rather than detecting problems spreading from the first trapping site. Ethical wildlife management guided by the "best scientific and commercial data available" would suggest suspending the standard method of trapping wolves in favor of non-lethal methods (livestock guarding dogs or fladry) that have been proven effective in preventing livestock losses in Michigan and elsewhere.	[Santiago-Avila, Francisco J.; Treves, Adrian] Univ Wisconsin, Carnivore Coexistence Lab, Nelson Inst Environm Studies, Madison, WI 53706 USA; [Cornman, Ari M.] Little River Band Ottawa Indians, Dept Nat Resources, Manistee, MI USA	University of Wisconsin System; University of Wisconsin Madison	Santiago-Avila, FJ (corresponding author), Univ Wisconsin, Carnivore Coexistence Lab, Nelson Inst Environm Studies, Madison, WI 53706 USA.	santiagoavil@wisc.edu		Santiago-Avila, Francisco/0000-0003-4233-9128	Little River Band of Ottawa Indians; Therese Foundation, Inc. [MSN204166]; Nelson Institute for Environmental Studies	Little River Band of Ottawa Indians; Therese Foundation, Inc.; Nelson Institute for Environmental Studies	Funding and support for this research was provided by the Little River Band of Ottawa Indians, Therese Foundation, Inc. (grant #: MSN204166) and the Nelson Institute for Environmental Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer DE, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P65, DOI 10.1007/978-0-387-85952-1_5; Bradley E. H., 2004, EVALUATION WOLF LIVE; Bradley EH, 2005, WILDLIFE SOC B, V33, P1256, DOI 10.2193/0091-7648(2005)33[1256:AFRTWD]2.0.CO;2; Bradley EH, 2005, CONSERV BIOL, V19, P1498, DOI 10.1111/j.1523-1739.2005.00102.x; Bradley EH, 2015, J WILDLIFE MANAGE, V79, P1337, DOI 10.1002/jwmg.948; Brainerd SM, 2008, J WILDLIFE MANAGE, V72, P89, DOI 10.2193/2006-305; Bump JK, 2013, PLOS ONE; Chapron G, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2939; Chavez AS, 2006, J WILDLIFE MANAGE, V70, P1079, DOI 10.2193/0022-541X(2006)70[1079:LUAMOW]2.0.CO;2; Clark TG, 2003, BRIT J CANCER, V89, P232, DOI 10.1038/sj.bjc.6601118; Davidson-Nelson Sarah J., 2010, Human-Wildlife Interactions, V4, P87; Dubois S, 2017, CONSERV BIOL, V31, P753, DOI 10.1111/cobi.12896; Edge JL, 2011, WILDLIFE BIOL, V17, P1, DOI 10.2981/10-043; Edge Justin L., 2011, Human-Wildlife Interactions, V5, P66; Eklund A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02323-w; Flesher J., 2014, MICHIGAN HUNT TARGET; Gehring TM, 2010, WILDLIFE RES, V37, P715, DOI 10.1071/WR10023; Haber GC, 1996, CONSERV BIOL, V10, P1068, DOI 10.1046/j.1523-1739.1996.10041068.x; Herfindal I, 2005, J WILDLIFE MANAGE, V69, P1034, DOI 10.2193/0022-541X(2005)069[1034:DRHOLR]2.0.CO;2; Hogberg J, 2016, ENVIRON CONSERV, V43, P45, DOI 10.1017/S037689291500017X; Hosmer DW, 2008, APPL SURVIVAL ANAL R, V2nd; Kelly PJ, 2000, STAT MED, V19, P13, DOI 10.1002/(SICI)1097-0258(20000115)19:1&lt;13::AID-SIM279&gt;3.0.CO;2-5; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Linnell JDC, 1999, WILDLIFE SOC B, V27, P698; Lynn W. S., 2012, BARRED OWLS PACIFIC; MAS S, 2012, MICH AGR STAT; Miller JRB, 2016, WILDLIFE SOC B, V40, P806, DOI 10.1002/wsb.720; Mukherjee S., 2012, J POSTGRAD MED ED RE, V46, P112, DOI [10.5005/jp-journals-10028-1025, DOI 10.5005/JP-JOURNALS-10028-1025]; Musiani M, 2001, WILDLIFE SOC B, V29, P91; Olson ER, 2014, CONSERVATION LETT; PLATT JR, 1964, SCIENCE, V146, P347, DOI 10.1126/science.146.3642.347; Poudyal N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148743; Refsnider RL, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P311, DOI 10.1007/978-0-387-85952-1_20; Ruid DB, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P279, DOI 10.1007/978-0-387-85952-1_18; Treves A, 2004, CONSERV BIOL, V18, P114, DOI 10.1111/j.1523-1739.2004.00189.x; Treves A, 2002, WILDLIFE SOC B, V30, P231; Treves A, 2005, CONSERV BIOL SER, V9, P86; Treves A, 2013, EVALUATION LOCALIZED; Treves A, 2016, FRONT ECOL ENVIRON, V14, P380, DOI 10.1002/fee.1312; Treves A, 2013, CONSERV BIOL, V27, P315, DOI 10.1111/cobi.12009; Treves A, 2011, BIOSCIENCE, V61, P584, DOI 10.1525/bio.2011.61.8.2; Treves A, 2011, BIOSCIENCE, V61, P451, DOI 10.1525/bio.2011.61.6.7; van Eeden LM, 2017, CONSERV BIOL; Voyles Z, 2015, URSUS, V26, P11, DOI 10.2192/URSUS-D-14-00038.1; Wielgus RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113505; Woodroffe R, 2015, SCIENCE, V348, P1312, DOI 10.1126/science.aaa8465; Wydeven AP, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P87, DOI 10.1007/978-0-387-85952-1_6; Wydeven AP, 2004, CHARACTERISTICS WOLF, P28; Xu Y, 2015, STATA J, V15, P135, DOI 10.1177/1536867X1501500109	49	23	23	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0189729	10.1371/journal.pone.0189729	http://dx.doi.org/10.1371/journal.pone.0189729			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320512	Green Published, gold, Green Submitted			2022-12-26	WOS:000419689600013
J	Tang, Y; Winkler, JA; Vina, A; Liu, JG; Zhang, YB; Zhang, XF; Li, XH; Wang, F; Zhang, JD; Zhao, ZQ				Tang, Ying; Winkler, Julie A.; Vina, Andres; Liu, Jianguo; Zhang, Yuanbin; Zhang, Xiaofeng; Li, Xiaohong; Wang, Fang; Zhang, Jindong; Zhao, Zhiqiang			Uncertainty of future projections of species distributions in mountainous regions	PLOS ONE			English	Article							CLIMATE-CHANGE; DISTRIBUTION MODELS; GIANT PANDA; QINLING MOUNTAINS; TEMPERATURE; HABITAT; VULNERABILITY; PREDICTIONS; COMPLEXITY; EXPANSION	Multiple factors introduce uncertainty into projections of species distributions under climate change. The uncertainty introduced by the choice of baseline climate information used to calibrate a species distribution model and to downscale global climate model (GCM) simulations to a finer spatial resolution is a particular concern for mountainous regions, as the spatial resolution of climate observing networks is often insufficient to detect the steep climatic gradients in these areas. Using the maximum entropy (MaxEnt) modeling framework together with occurrence data on 21 understory bamboo species distributed across the mountainous geographic range of the Giant Panda, we examined the differences in projected species distributions obtained from two contrasting sources of baseline climate information, one derived from spatial interpolation of coarse-scale station observations and the other derived from fine-spatial resolution satellite measurements. For each bamboo species, the MaxEnt model was calibrated separately for the two datasets and applied to 17 GCM simulations downscaled using the delta method. Greater differences in the projected spatial distributions of the bamboo species were observed for the models calibrated using the different baseline datasets than between the different downscaled GCM simulations for the same calibration. In terms of the projected future climatically-suitable area by species, quantification using a multi-factor analysis of variance suggested that the sum of the variance explained by the baseline climate dataset used for model calibration and the interaction between the baseline climate data and the GCM simulation via downscaling accounted for, on average, 40% of the total variation among the future projections. Our analyses illustrate that the combined use of gridded datasets developed from station observations and satellite measurements can help estimate the uncertainty introduced by the choice of baseline climate information to the projected changes in species distribution.	[Tang, Ying; Winkler, Julie A.] Michigan State Univ, Dept Geog Environm & Spatial Sci, E Lansing, MI 48824 USA; [Tang, Ying; Vina, Andres; Liu, Jianguo; Wang, Fang; Zhang, Jindong; Zhao, Zhiqiang] Michigan State Univ, Dept Fisheries & Wildlife, Ctr Syst Integrat & Sustainabil, E Lansing, MI 48824 USA; [Vina, Andres] Univ N Carolina, Dept Geog, Chapel Hill, NC USA; [Zhang, Yuanbin] Chinese Acad Sci, Inst Mt Hazards & Environm, Chengdu, Sichuan, Peoples R China; [Zhang, Xiaofeng] Shaanxi Forestry Dept, Xian, Shaanxi, Peoples R China; [Li, Xiaohong] Tianshui Normal Univ, Tianshui, Gansu, Peoples R China	Michigan State University; Michigan State University; University of North Carolina; University of North Carolina Chapel Hill; Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Tianshui Normal University	Winkler, JA (corresponding author), Michigan State Univ, Dept Geog Environm & Spatial Sci, E Lansing, MI 48824 USA.	winkler@msu.edu	Liu, Jianguo/G-5211-2015; li, xiaofeng/GXF-9442-2022; Wang, Fang/AIC-7698-2022; li, xiao/GSN-6181-2022	Liu, Jianguo/0000-0001-6344-0087; Vina, Andres/0000-0001-6240-6610; Zhao, Zhiqiang/0000-0002-6249-5702	National Science Foundation [BIO-1340812]; Michigan AgBioResearch	National Science Foundation(National Science Foundation (NSF)); Michigan AgBioResearch	The project was funded by the National Science Foundation under BIO-1340812 and Michigan AgBioResearch. Any opinions, findings, conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the view of the National Science Foundation.	Allen JM, 2016, BIOL CONSERV, V203, P306, DOI 10.1016/j.biocon.2016.09.015; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Ashraf U, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1825; Baker DJ, 2016, GLOBAL CHANGE BIOL, V22, P2392, DOI 10.1111/gcb.13273; Bedia J, 2013, GLOBAL PLANET CHANGE, V107, P1, DOI 10.1016/j.gloplacha.2013.04.005; Behnke R, 2016, ECOL APPL, V26, P1338, DOI 10.1002/15-1061; Boria RA, 2017, DIVERS DISTRIB, V23, P196, DOI 10.1111/ddi.12510; Bosso L, 2017, FOREST ECOL MANAG, V400, P655, DOI 10.1016/j.foreco.2017.06.044; Brun P, 2016, GLOBAL CHANGE BIOL, V22, P3170, DOI 10.1111/gcb.13274; Chefaoui RM, 2017, ECOL MODEL, V359, P229, DOI 10.1016/j.ecolmodel.2017.06.006; Chen J, 2015, J GEOPHYS RES-ATMOS, V120, P1123, DOI 10.1002/2014JD022635; Daly C., 2006, INT J CLIMATOL; de Pous P, 2016, REG ENV CHANG, P16; Deblauwe V, 2016, GLOBAL ECOL BIOGEOGR, V25, P443, DOI 10.1111/geb.12426; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Fan JT, 2014, ECOL MODEL, V274, P12, DOI 10.1016/j.ecolmodel.2013.11.023; Fei SL, 2016, LANDSCAPE ECOL, V31, P31, DOI 10.1007/s10980-015-0272-7; Fernandez M, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00049.1; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.50; Garcia-Callejas D, 2016, ECOL MODEL, V326, P4, DOI 10.1016/j.ecolmodel.2015.06.002; Guillera-Arroita G, 2015, GLOBAL ECOL BIOGEOGR, V24, P276, DOI 10.1111/geb.12268; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ., 2017, DISMO SPECIES DISTRI, V9, P1; Jobst AM, 2017, INT J CLIMATOL, V37, P214, DOI 10.1002/joc.4699; Kong LQ, 2017, BIOL CONSERV, V210, P83, DOI 10.1016/j.biocon.2016.03.028; Koshkina V, 2017, METHODS ECOL EVOL, V8, P420, DOI 10.1111/2041-210X.12738; Li J, 2017, ECOL EVOL, V7, P4003, DOI 10.1002/ece3.2981; Li R., 2015, J INEQUAL APPL, V2015, P1, DOI DOI 10.1016/J.BI0RTECH.2015.01.105; Li RQ, 2015, BIOL CONSERV, V182, P93, DOI 10.1016/j.biocon.2014.11.037; Liu G, 2016, ECOL EVOL, V6, P987, DOI 10.1002/ece3.1901; Liu J, 2016, PANDAS AND PEOPLE: COUPLING HUMAN AND NATURAL SYSTEMS FOR SUSTAINABILITY, P1, DOI 10.1093/acprof:oso/9780198703549.001.0001; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035420; Mainali KP, 2015, GLOBAL CHANGE BIOL, V21, P4464, DOI 10.1111/gcb.13038; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Moran-Ordonez A, 2017, ECOGRAPHY, P40; Nadeau CP, 2017, GLOBAL CHANGE BIOL, V23, P12, DOI 10.1111/gcb.13475; Nenzen HK, 2011, ECOL MODEL, V222, P3346, DOI 10.1016/j.ecolmodel.2011.07.011; Perdinan, 2014, ENVIRON MANAGE, V53, P42, DOI 10.1007/s00267-013-0125-6; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson TC, 1997, B AM METEOROL SOC, V78, P2837, DOI 10.1175/1520-0477(1997)078<2837:AOOTGH>2.0.CO;2; Petitpierre B, 2017, GLOBAL ECOL BIOGEOGR, V26, P275, DOI 10.1111/geb.12530; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Platts PJ, 2015, AFR J ECOL, V53, P103, DOI 10.1111/aje.12180; Rodriguez-Rodriguez D, 2012, MT RES DEV, V32, P197, DOI 10.1659/MRD-JOURNAL-D-10-00111.1; Searcy CA, 2016, AM NAT, V187, P423, DOI 10.1086/685387; Shen GZ, 2015, BIOL CONSERV, V190, P43, DOI 10.1016/j.biocon.2015.05.004; Smeraldo S, 2017, J NAT CONSERV, V37, P12, DOI 10.1016/j.jnc.2017.02.008; Steen V, 2017, ECOL EVOL, V7, P8841, DOI 10.1002/ece3.3403; Suggitt SJ, 2017, OIKOS; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tuanmu MN, 2013, NAT CLIM CHANGE, V3, P249, DOI [10.1038/nclimate1727, 10.1038/NCLIMATE1727]; Virkkala R, 2010, ACTA OECOL, V36, P269, DOI 10.1016/j.actao.2010.01.006; Wan ZM, 2014, REMOTE SENS ENVIRON, V140, P36, DOI 10.1016/j.rse.2013.08.027; Winkler JA, 2004, GEOGRAPHY TECHNOLOGY, P461; Winkler JA, 2016, ANN AM ASSOC GEOGR, V106, P1418, DOI 10.1080/24694452.2016.1207973; Winkler JA, 2011, GEOGR COMPASS, V5, P275, DOI 10.1111/j.1749-8198.2011.00425.x; Xiong X, 2006, P SPIE EARTH OBERSVI, V6296; Xu YF, 2009, ADV ATMOS SCI, V26, P265, DOI 10.1007/s00376-009-0265-z; Yang HB, 2017, BIOL CONSERV, V213, P203, DOI 10.1016/j.biocon.2017.07.010	61	17	18	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0189496	10.1371/journal.pone.0189496	http://dx.doi.org/10.1371/journal.pone.0189496			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320501	Green Published, Green Submitted, gold			2022-12-26	WOS:000419689600011
J	Ziai, J; Gilbert, HN; Foreman, O; Eastham-Anderson, J; Chu, FL; Huseni, M; Kim, JM				Ziai, James; Gilbert, Houston N.; Foreman, Oded; Eastham-Anderson, Jeffrey; Chu, Felix; Huseni, Mahrukh; Kim, Jeong M.			CD8+T cell infiltration in breast and colon cancer: A histologic and statistical analysis	PLOS ONE			English	Review							CD8(+) T-LYMPHOCYTES; PROGNOSTIC-FACTOR; IMMUNE CELLS; NEOADJUVANT CHEMOTHERAPY; FAVORABLE PROGNOSIS; PD-1 BLOCKADE; SURVIVAL; BIOMARKERS; RESPONSES; FOXP3	The prevalence of cytotoxic tumor infiltrating lymphocytes (TILs) has demonstrated prognostic value in multiple tumor types. In particular, CD8 counts (in combination with CD3 and CD45RO) have been shown to be superior to traditional UICC staging in colon cancer patients and higher total CD8 counts have been associated with better survival in breast cancer patients. However, immune infiltrate heterogeneity can lead to potentially significant misrepresentations of marker prevalence in routine histologic sections. We examined step sections of breast and colorectal cancer samples for CD8+ T cell prevalence by standard chromogenic immunohistochemistry to determine marker variability and inform practice of T cell biomarker assessment in formalin-fixed, paraffin-embedded (FFPE) tissue samples. Stained sections were digitally imaged and CD8+ lymphocytes within defined regions of interest (ROI) including the tumor and surrounding stroma were enumerated. Statistical analyses of CD8+ cell count variability using a linear model/ANOVA framework between patients as well as between levels within a patient sample were performed. Our results show that CD8+ T-cell distribution is highly homogeneous within a standard tissue sample in both colorectal and breast carcinomas. As such, cytotoxic T cell prevalence by immunohistochemistry on a single level or even from a subsample of biopsy fragments taken from that level can be considered representative of cytotoxic T cell infiltration for the entire tumor section within the block. These findings support the technical validity of biomarker strategies relying on CD8 immunohistochemistry.	[Ziai, James; Foreman, Oded; Eastham-Anderson, Jeffrey; Chu, Felix] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Gilbert, Houston N.] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA; [Huseni, Mahrukh] Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Kim, Jeong M.] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ziai, J (corresponding author), Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA.	ziai.james@gene.com			Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	We also confirm here that while all funding sources for this study were internal to Genentech, Inc., the funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Asano Y, 2016, BRIT J SURG, V103, P845, DOI 10.1002/bjs.10127; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Bromwich EJ, 2003, BRIT J CANCER, V89, P1906, DOI 10.1038/sj.bjc.6601400; Carroll KJ, 2007, PHARM STAT, V6, P253, DOI 10.1002/pst.269; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.3.CO;2-0; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dibben SM, 2012, J MOL DIAGN, V14, P130, DOI 10.1016/j.jmoldx.2011.10.002; Ferlay J, GLOBOCAN 2012 V1 0 C; Fridlyand J, 2013, CONTEMP CLIN TRIALS, V36, P624, DOI 10.1016/j.cct.2013.04.006; Fridlyand J, 2013, NAT REV DRUG DISCOV, V12, P743, DOI 10.1038/nrd4101; Fukunaga A, 2004, PANCREAS, V28, pE26, DOI 10.1097/00006676-200401000-00023; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Halama N, 2011, CANCER RES, V71, P5670, DOI 10.1158/0008-5472.CAN-11-0268; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Hiraoka K, 2006, BRIT J CANCER, V94, P275, DOI 10.1038/sj.bjc.6602934; Hiraoka N, 2006, CLIN CANCER RES, V12, P5423, DOI 10.1158/1078-0432.CCR-06-0369; Ito N, 2005, ANTICANCER RES, V25, P2027; Jenkins M, 2011, PHARM STAT, V10, P494, DOI 10.1002/pst.532; Karja V, 2005, ANTICANCER RES, V25, P4435; Kawai O, 2008, CANCER-AM CANCER SOC, V113, P1387, DOI 10.1002/cncr.23712; Lamb GWA, 2008, BJU INT, V102, P756, DOI 10.1111/j.1464-410X.2008.07666.x; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lee HJ, 2013, J BREAST CANCER, V16, P32, DOI 10.4048/jbc.2013.16.1.32; Liu FF, 2012, BREAST CANCER RES TR, V135, P459, DOI 10.1007/s10549-012-2132-3; Liu SZ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3148; Loddenkemper C, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-52; MACKENSEN A, 1993, CANCER RES, V53, P3569; Mackey HM, 2013, CONTEMP CLIN TRIALS, V36, P664, DOI 10.1016/j.cct.2013.09.005; Mahmoud S, 2012, ONCOIMMUNOLOGY, V1, P363, DOI 10.4161/onci.18614; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; McShane LM, 2013, CLIN TRIALS, V10, P653, DOI 10.1177/1740774513499458; Miyashita M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0632-x; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Nakakubo Y, 2003, BRIT J CANCER, V89, P1736, DOI 10.1038/sj.bjc.6601331; Nakano O, 2001, CANCER RES, V61, P5132; Olurinde MO, 2011, CELL MOL IMMUNOL, V8, P415, DOI 10.1038/cmi.2011.18; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Pennello GA, 2013, CLIN TRIALS, V10, P666, DOI 10.1177/1740774513497541; Petrau C, 2015, AM J CLIN PATHOL, V144, P555, DOI 10.1309/AJCP9KFVM2GZMNDV; R Core Team, 2013, R LANG ENV STAT COMP; Rehman JA, 2017, MODERN PATHOL, V30, P340, DOI 10.1038/modpathol.2016.186; Richardsen E, 2008, HISTOPATHOLOGY, V53, P30, DOI 10.1111/j.1365-2559.2008.03058.x; Ruffell B, 2012, P NATL ACAD SCI USA, V109, P2796, DOI 10.1073/pnas.1104303108; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Seo AN, 2013, BRIT J CANCER, V109, P2705, DOI 10.1038/bjc.2013.634; Sharma P, 2007, P NATL ACAD SCI USA, V104, P3967, DOI 10.1073/pnas.0611618104; Suzuki H, 2010, CANCER IMMUNOL IMMUN, V59, P653, DOI 10.1007/s00262-009-0781-9; TEFANY FJ, 1991, J INVEST DERMATOL, V97, P197, DOI 10.1111/1523-1747.ep12479662; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van Oijen M, 2004, CLIN CANCER RES, V10, P4754, DOI 10.1158/1078-0432.CCR-04-0260; Veta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070221; Wakabayashi O, 2003, CANCER SCI, V94, P1003, DOI 10.1111/j.1349-7006.2003.tb01392.x; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wu MLC, 2002, AM J CLIN PATHOL, V117, P424, DOI 10.1309/VBYP-UT2E-V198-M1TQ; Zeestraten ECM, 2013, CANCER MICROENVIRON, V6, P31, DOI 10.1007/s12307-011-0071-x	60	21	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190158	10.1371/journal.pone.0190158	http://dx.doi.org/10.1371/journal.pone.0190158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320521	Green Submitted, Green Published, gold			2022-12-26	WOS:000419689600034
J	Hwang, HV; Tran, DT; Rebuffatti, MN; Li, CS; Knowlton, AA				Hwang, HyunTae V.; Tran, Darlene Thuy; Rebuffatti, Michelle Nicole; Li, Chin-Shang; Knowlton, Anne A.			Investigation of quercetin and hyperoside as senolytics in adult human endothelial cells	PLOS ONE			English	Article							HEAT-SHOCK FACTOR-1; CELLULAR SENESCENCE; BETA-GALACTOSIDASE; EXPRESSION; HSF1; CYTOTOXICITY; ANTIOXIDANT; ACTIVATION; APOPTOSIS; CULTURE	Quercetin has been reported to act as a senolytic by selectively removing senescent endothelial cells, and thus it would seem quercetin could revolutionize the field of gerontology. However, given quercetin's narrow therapeutic index reported in work done with human umbilical vein endothelial cells (HUVECs), we hypothesized that quercetin is not innocuous for non-senescent adult human vascular endothelial cells at concentrations that have been reported to be safe for proliferating HUVECs. Furthermore, we investigated quercetin 3-D-galactoside (Q3G; hyperoside), an inactive quercetin derivative that needs to be cleaved by beta-galactosidase overexpressed in senescent cells to release quercetin, as a potential safer senolytic. We compared the effectiveness of quercetin and Q3G in primary human coronary artery endothelial cells (HCAEC), which are adult microvascular cells. We found that quercetin caused cell death in non-senescent endothelial cells at a concentration that has been reported to selectively remove senescent cells, and that Q3G was not cytotoxic to either young or senescent cells. Thus, in primary adult human endothelial cells, quercetin and Q3G are not senolytics. Earlier work reporting positive results was done with HUVECs, and given their origin and the disparate findings from the current study, these may not be the best cells for evaluating potential senolytics in clinically relevant endothelial cells.	[Hwang, HyunTae V.; Tran, Darlene Thuy; Rebuffatti, Michelle Nicole; Knowlton, Anne A.] Univ Calif Davis, Dept Internal Med, Cardiovasc Div, Mol & Cellular Cardiol, Davis, CA 95616 USA; [Li, Chin-Shang] Univ Calif Davis, Dept Publ Hlth Sci, Div Biostat, Davis, CA 95616 USA; [Knowlton, Anne A.] VA Med Ctr, Sacramento, CA 95655 USA; [Knowlton, Anne A.] Univ Calif Davis, Pharmacol Dept, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Knowlton, AA (corresponding author), Univ Calif Davis, Dept Internal Med, Cardiovasc Div, Mol & Cellular Cardiol, Davis, CA 95616 USA.; Knowlton, AA (corresponding author), VA Med Ctr, Sacramento, CA 95655 USA.; Knowlton, AA (corresponding author), Univ Calif Davis, Pharmacol Dept, Davis, CA 95616 USA.	aaknowlton@ucdavis.edu		Tran, Darlene/0000-0001-9424-7642; Hwang, Hyun Tae/0000-0002-6529-2345; Rebuffatti, Michelle/0000-0002-0562-5080	U.S. Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Program [5101BX000839]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001860] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Program(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by a Merit Award (5101BX000839) from the U.S. Department of Veterans Affairs, Office of Research and Development, Biomedical Laboratory Research Program (AAK), https://www.research.va.gov/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Disclaimer The contents reported do not represent the views of the Department of Veterans Affairs or the United States Government.	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Avci CB, 2011, HEMATOLOGY, V16, P303, DOI 10.1179/102453311X13085644680104; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bancirova M., 2015, CHEMOTHER J, V1, P31; Bernatoniene J, 2008, MEDICINA-LITHUANIA, V44, P706, DOI 10.3390/medicina44090091; Boesch-Saadatmandi C, 2011, J NUTR BIOCHEM, V22, P293, DOI 10.1016/j.jnutbio.2010.02.008; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Boukes GJ, 2016, BIOMED PHARMACOTHER, V83, P617, DOI 10.1016/j.biopha.2016.07.029; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Conde R, 2009, BIOCHEM CELL BIOL, V87, P845, DOI [10.1139/O09-049, 10.1139/o09-049]; D'Andrea G, 2015, FITOTERAPIA, V106, P256, DOI 10.1016/j.fitote.2015.09.018; Dabbagh-Bazarbachi H, 2014, J AGR FOOD CHEM, V62, P8085, DOI 10.1021/jf5014633; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Duo J, 2012, MOL MED REP, V5, P1453, DOI 10.3892/mmr.2012.845; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Fuhrmann-Stroissnigg H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00314-z; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Gutsmann-Conrad A, 1998, EXP CELL RES, V241, P404, DOI 10.1006/excr.1998.4069; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; Heron M., 2014, NATL VITAL STAT REP, V65, P5; Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001; Kim G, 2012, AGING CELL, V11, P617, DOI 10.1111/j.1474-9726.2012.00827.x; Kim HR, 1999, IUBMB LIFE, V48, P429, DOI 10.1080/713803536; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lee JC, 2003, EXP CELL RES, V291, P386, DOI 10.1016/S0014-4827(03)00410-5; Li ZL, 2012, J ETHNOPHARMACOL, V139, P388, DOI 10.1016/j.jep.2011.11.020; Liu ZY, 2005, BIOMED PHARMACOTHER, V59, P481, DOI 10.1016/j.biopha.2005.06.009; LUCE MC, 1992, EXP CELL RES, V202, P9, DOI 10.1016/0014-4827(92)90398-R; Malavolta M, 2017, EXP GERONTOL, V99, P35, DOI 10.1016/j.exger.2017.09.006; Matsuo M, 2005, BIOL PHARM BULL, V28, P253, DOI 10.1248/bpb.28.253; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; NAGAI N, 1995, BIOCHEM BIOPH RES CO, V208, P1099, DOI 10.1006/bbrc.1995.1447; Nishizawa J, 1999, CIRCULATION, V99, P934, DOI 10.1161/01.CIR.99.7.934; Powers MV, 2013, ONCOTARGET, V4, P1963, DOI 10.18632/oncotarget.1419; RAJAVASHISTH TB, 1990, NATURE, V344, P254, DOI 10.1038/344254a0; Samuel T, 2010, NUTR CANCER, V62, P1025, DOI 10.1080/01635581.2010.492087; SCAMBIA G, 1990, BRIT J CANCER, V62, P942, DOI 10.1038/bjc.1990.414; Shringarpure R, 2002, FREE RADICAL BIO MED, V32, P1084, DOI 10.1016/S0891-5849(02)00824-9; Stice JP, 2011, ENDOCRINOLOGY, V152, P1589, DOI 10.1210/en.2010-0627; Tan PH, 2004, ATHEROSCLEROSIS, V173, P171, DOI 10.1016/j.atherosclerosis.2003.12.011; Wang JD, 2006, J BIOL CHEM, V281, P2451, DOI 10.1074/jbc.M505890200; Wang L., 2016, BIOMED RES INT, V2016, DOI DOI 10.1155/2016/1068528; Wang YY, 2016, AGING-US, V8, P2915, DOI 10.18632/aging.101100; Webley K, 2000, MOL CELL BIOL, V20, P2803, DOI 10.1128/MCB.20.8.2803-2808.2000; Wright B, 2010, BRIT J PHARMACOL, V159, P1312, DOI 10.1111/j.1476-5381.2009.00632.x; Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344	48	24	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190374	10.1371/journal.pone.0190374	http://dx.doi.org/10.1371/journal.pone.0190374			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315311	Green Published, Green Submitted, gold			2022-12-26	WOS:000419655900011
J	Nakao, YM; Miyamoto, Y; Ueshima, K; Nakao, K; Nakai, M; Nishimura, K; Yasuno, S; Hosoda, K; Ogawa, Y; Itoh, H; Ogawa, H; Kangawa, K; Nakao, K				Nakao, Yoko M.; Miyamoto, Yoshihiro; Ueshima, Kenji; Nakao, Kazuhiro; Nakai, Michikazu; Nishimura, Kunihiro; Yasuno, Shinji; Hosoda, Kiminori; Ogawa, Yoshihiro; Itoh, Hiroshi; Ogawa, Hisao; Kangawa, Kenji; Nakao, Kazuwa			Effectiveness of nationwide screening and lifestyle intervention for abdominal obesity and cardiometabolic risks in Japan: The metabolic syndrome and comprehensive lifestyle intervention study on nationwide database in Japan (MetS ACTION-J study)	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; POOLED ANALYSIS; HEART-DISEASE; WEIGHT-LOSS; ADULTS; INTER99; BIAS; CARE; MANAGEMENT; OUTCOMES	Background Lifestyle interventions can substantially improve obesity and cardiometabolic risks. However, evidence of long-term benefits of national intervention is sparse. We aimed to evaluate the long-term effectiveness of a nationwide program for abdominal obesity. Methods A retrospective cohort study was performed using a longitudinal nationwide individual data in subjects aged 40 +/- 74 years who underwent checkups in fiscal year (FY) 2008. Lifestyle interventions were provided via interview in subjects with abdominal obesity and at least one cardiometabolic risk factor. Subjects who attended the lifestyle intervention (participants) were compared to those who did not attend (non-participants). Outcomes were waist circumferences (WC) and body mass index (BMI) reduction, reversal of metabolic syndrome (MetS), and changes in cardiometabolic risks. We used a three-step process with robust analytic approaches to account for selection bias that included traditional multivariate analysis, propensity-score matching and instrumental variable (IV) analyses. Results Of 19,969,722 subjects, 4,370,042 were eligible for analyses; 111,779 participants and 907,909 non-participants. A higher percentage of participants had >= 5% reductions in obesity profiles at year 3, compared to non-participants (WC, 21.4% vs 16.1%; BMI, 17.6% vs 13.6%; p< 0.001 each). Participants also had higher reversal for MetS (adjusted odds ratio 1.31; 95% confidence interval: 1.29 +/- 1.33; p< 0.001). Greater reductions in cardiometabolic risks were observed in participants. Those results were confirmed in analyses using a propensity score-matched cohort (n = 75,777, each) and IV analyses. Limitations of this work include the use of non-randomized national data in Japan to assess the effectiveness of the nationwide preventive program. Conclusions In the nationwide lifestyle intervention for abdominal obesity, the at-risk population achieved significant reductions in WC, BMI, and cardiometabolic risks in 3 years. This study provides evidence that the nationwide program effectively achieved long-term improvement in abdominal obesity and cardiometabolic risks.	[Nakao, Yoko M.; Miyamoto, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Suita, Osaka, Japan; [Ueshima, Kenji; Yasuno, Shinji] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Kyoto, Kyoto, Japan; [Nakao, Kazuhiro] Natl Cerebral & Cardiovasc Ctr, Dept Cardiovasc Med, Suita, Osaka, Japan; [Nakai, Michikazu; Nishimura, Kunihiro] Natl Cerebral & Cardiovasc Ctr, Ctr Cerebral & Cardiovasc Dis Informat, Dept Stat & Data Anal, Suita, Osaka, Japan; [Hosoda, Kiminori] Natl Cerebral & Cardiovasc Ctr, Dept Endocrinol & Metab, Suita, Osaka, Japan; [Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Tokyo, Japan; [Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Ogawa, Hisao; Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; [Nakao, Kazuwa] Kyoto Univ, Sch Med, Med Innovat Ctr, Kyoto, Kyoto, Japan	National Cerebral & Cardiovascular Center - Japan; Kyoto University; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; Tokyo Medical & Dental University (TMDU); Keio University; National Cerebral & Cardiovascular Center - Japan; Kyoto University	Miyamoto, Y (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Suita, Osaka, Japan.	miyamoty@ncvc.go.jp	Nakai, Michikazu/ADJ-0980-2022; Miyamoto, Yoshihiro/L-8583-2013	Miyamoto, Yoshihiro/0000-0002-1337-0508; Ogawa, Yoshihiro/0000-0002-0834-2836	Japan Agency for Medical Research and Development; Clinical and Epidemiologic Research of the Joint Project of Japan Heart Foundation; Japanese Society of Cardiovascular Disease Prevention - AstraZeneca	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Clinical and Epidemiologic Research of the Joint Project of Japan Heart Foundation; Japanese Society of Cardiovascular Disease Prevention - AstraZeneca	This work was supported Japan Agency for Medical Research and Development (https:// www.amed.go.jp) and the Clinical and Epidemiologic Research of the Joint Project of Japan Heart Foundation and the Japanese Society of Cardiovascular Disease Prevention sponsored by AstraZeneca (http://www.jhf.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2009, PREV MED, V48, P326, DOI 10.1016/j.ypmed.2009.01.015; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Artinian NT, 2010, CIRCULATION, V122, P406, DOI 10.1161/CIR.0b013e3181e8edf1; Balk EM, 2015, ANN INTERN MED, V163, P437, DOI 10.7326/M15-0452; Bauer UE, 2014, LANCET, V384, P45, DOI 10.1016/S0140-6736(14)60648-6; Baumann S, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0195-3; Booth CM, 2014, BRIT J CANCER, V110, P551, DOI 10.1038/bjc.2013.725; Cameron AJ, 2008, OBESITY, V16, P2707, DOI 10.1038/oby.2008.412; Cerhan JR, 2014, MAYO CLIN PROC, V89, P335, DOI 10.1016/j.mayocp.2013.11.011; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Ebrahim S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001561.pub3; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Frieden TR, 2015, NEW ENGL J MED, V373, P1748, DOI 10.1056/NEJMsa1511248; Garabedian LF, 2014, ANN INTERN MED, V161, P131, DOI 10.7326/M13-1887; Hlatky MA, 2013, ANN INTERN MED, V158, P727, DOI 10.7326/0003-4819-158-10-201305210-00639; Hu FB, 2015, JAMA-J AM MED ASSOC, V313, P2319, DOI 10.1001/jama.2015.5287; Hwang LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067436; Jorgensen T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3617; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Lau CJ, 2016, PREV MED, V91, P172, DOI 10.1016/j.ypmed.2016.08.016; LeBlanc ES, 2011, ANN INTERN MED, V155, P434, DOI 10.7326/0003-4819-155-7-201110040-00006; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; Nakao YM, 2012, P JPN ACAD B-PHYS, V88, P454, DOI 10.2183/pjab.88.454; National Institute for Health and Care Excellence, 2012, GUID MAN; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Organization WH, NON DIS NCD; Rassen JA, 2010, EUR HEART J, V31, P561, DOI 10.1093/eurheartj/ehp437; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rothman AJ, 2000, HEALTH PSYCHOL, V19, P64, DOI 10.1037/0278-6133.19.Suppl1.64; Sahakyan KR, 2015, ANN INTERN MED, V163, DOI 10.7326/P15-9040; Sarrafzadegan N, 2013, ARCH IRAN MED, V16, P4, DOI 013161/AIM.004; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; Wadden TA, 2011, NEW ENGL J MED, V365, P1969, DOI 10.1056/NEJMoa1109220	39	36	36	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190862	10.1371/journal.pone.0190862	http://dx.doi.org/10.1371/journal.pone.0190862			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315322	Green Published, Green Submitted, gold			2022-12-26	WOS:000419655900029
J	Tworkoski, E; Glucksberg, MR; Johnson, M				Tworkoski, Ellen; Glucksberg, Matthew R.; Johnson, Mark			The effect of the rate of hydrostatic pressure depressurization on cells in culture	PLOS ONE			English	Article							OPTIC-NERVE HEAD; VASCULAR ENDOTHELIAL-CELLS; RETINAL GANGLION-CELLS; IN-VITRO; GROWTH-FACTOR; STIMULATES PROLIFERATION; ASTROCYTE MIGRATION; AMBIENT-PRESSURE; SHEAR-STRESS; RESPONSES	Changes in hydrostatic pressure, at levels as low as 10 mm Hg, have been reported in some studies to alter cell function in vitro; however, other studies have found no detectable changes using similar methodologies. We here investigate the hypothesis that the rate of depressurization, rather than elevated hydrostatic pressure itself, may be responsible for these reported changes. Hydrostatic pressure (100 mm Hg above atmospheric pressure) was applied to bovine aortic endothelial cells (BAECs) and PC12 neuronal cells using pressurized gas for periods ranging from 3 hours to 9 days, and then the system was either slowly (similar to 30 minutes) or rapidly (similar to 5 seconds) depressurized. Cell viability, apoptosis, proliferation, and F-actin distribution were then assayed. Our results did not show significant differences between rapidly and slowly depressurized cells that would explain differences previously reported in the literature. Moreover, we found no detectable effect of elevated hydrostatic pressure (with slow depressurization) on any measured variables. Our results do not confirm the findings of other groups that modest increases in hydrostatic pressure affect cell function, but we are not able to explain their findings.	[Tworkoski, Ellen; Glucksberg, Matthew R.; Johnson, Mark] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Johnson, Mark] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Johnson, Mark] Northwestern Univ, Dept Ophthalmol, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University	Johnson, M (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.; Johnson, M (corresponding author), Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA.; Johnson, M (corresponding author), Northwestern Univ, Dept Ophthalmol, Chicago, IL 60611 USA.	m-johnson2@northwestern.edu	Glucksberg, Matthew R/B-7617-2009; Johnson, Mark/B-6921-2009		National Glaucoma Research, a division of the BrightFocus Foundation [G2013044]; National Glaucoma Research, a division of the BrightFocus Foundation	National Glaucoma Research, a division of the BrightFocus Foundation; National Glaucoma Research, a division of the BrightFocus Foundation	This work was supported by a grant from National Glaucoma Research, a division of the BrightFocus Foundation (G2013044) to Matthew R Glucksberg.; This work made use of the Northwestern University Center for Advanced Molecular Imaging (CAMI), the Northwestern University Flow Cytometry Facility, the Keck-II facility of the NUANCE Center at Northwestern University, and the Northwestern University Quantitative Bioelemental Imaging Center. This work was supported by a grant from National Glaucoma Research, a division of the BrightFocus Foundation.	ACEVEDO AD, 1993, J CELL PHYSIOL, V157, P603, DOI 10.1002/jcp.1041570321; Agar A, 2000, J NEUROSCI RES, V60, P495, DOI 10.1002/(SICI)1097-4547(20000515)60:4<495::AID-JNR8>3.0.CO;2-S; Agar A, 2006, BRAIN RES, V1086, P191, DOI 10.1016/j.brainres.2006.02.061; Astafurov K, 2014, MOL VIS, V20, P140; CAREW TE, 1968, CIRC RES, V23, P61, DOI 10.1161/01.RES.23.1.61; Ethier C, 2006, INVESTIG OPHTHALMOL, V47; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Haberstroh KM, 1999, J UROLOGY, V162, P2114, DOI 10.1016/S0022-5347(05)68136-0; Hernandez MR, 2000, GLIA, V32, P122, DOI 10.1002/1098-1136(200011)32:2<122::AID-GLIA20>3.0.CO;2-J; Johnson M, 2007, INVESTIG OPTHALMOLOG, V48; Ju WK, 2007, INVEST OPHTH VIS SCI, V48, P2145, DOI 10.1167/iovs.06-0573; Kalapesi FB, 2005, CLIN EXP OPHTHALMOL, V33, P210, DOI 10.1111/j.1442-9071.2005.00981.x; Kao YC, 2017, ONCOGENE, V36, P863, DOI 10.1038/onc.2016.255; Lee JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013437; Lei Y, 2011, INVEST OPHTH VIS SCI, V52, P6329, DOI 10.1167/iovs.11-7836; Liu B, 2003, NEUROBIOL DIS, V13, P109, DOI 10.1016/S0969-9961(03)00010-X; Liu B, 2012, NEUROSCI LETT, V526, P24, DOI 10.1016/j.neulet.2012.08.016; Luo N, 2014, P NATL ACAD SCI USA, V111, P12871, DOI 10.1073/pnas.1323292111; Mandal A, 2010, INVEST OPHTH VIS SCI, V51, P3129, DOI 10.1167/iovs.09-4614; Miao HX, 2010, INVEST OPHTH VIS SCI, V51, P4096, DOI 10.1167/iovs.10-5177; Ohashi T, 2007, J BIOMECH, V40, P2399, DOI 10.1016/j.jbiomech.2006.11.023; Ohashi T, 2016, BIOMED ENG LETT, V6, P31, DOI 10.1007/s13534-016-0210-x; Osborne A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115591; Ressler B, 2000, AM J PHYSIOL-LUNG C, V278, pL1264, DOI 10.1152/ajplung.2000.278.6.L1264; Resta V, 2007, EUR J NEUROSCI, V25, P2741, DOI 10.1111/j.1460-9568.2007.05528.x; Russ AL, 2009, ANN BIOMED ENG, V37, P1415, DOI 10.1007/s10439-009-9695-0; Salvador-Silva M, 2004, GLIA, V45, P364, DOI 10.1002/glia.10342; Salwen SA, 1998, MED BIOL ENG COMPUT, V36, P520, DOI 10.1007/BF02523225; Sappington RM, 2006, INVEST OPHTH VIS SCI, V47, P2932, DOI 10.1167/iovs.05-1407; Schwartz EA, 1999, CIRC RES, V84, P315, DOI 10.1161/01.RES.84.3.315; SLOAN CM, 1991, THROMB HAEMOSTASIS, V65, P961; Sugaya Y, 2003, JSME INT J C-MECH SY, V46, P1248, DOI 10.1299/jsmec.46.1248; SUMPIO BE, 1994, J CELL PHYSIOL, V158, P133, DOI 10.1002/jcp.1041580117; Tezel G, 2001, GLIA, V34, P178, DOI 10.1002/glia.1052; Tezel G, 2000, J NEUROSCI, V20, P8693; THOUMINE O, 1995, IN VITRO CELL DEV-AN, V31, P45; Tok L, 2014, J RECEPT SIG TRANSD, V34, P410, DOI 10.3109/10799893.2014.910812; TOKUNAGA O, 1987, IN VITRO CELL DEV B, V23, P528, DOI 10.1007/BF02620969; Wax MB, 2000, BRIT J OPHTHALMOL, V84, P423, DOI 10.1136/bjo.84.4.423; Yang P, 2004, PHYSIOL GENOMICS, V17, P157, DOI 10.1152/physiolgenomics.00182.2003; Yoshino D, 2015, CELL MOL BIOENG, V8, P296, DOI 10.1007/s12195-015-0385-8; Zhang SH, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00254	42	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0189890	10.1371/journal.pone.0189890	http://dx.doi.org/10.1371/journal.pone.0189890			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315329	gold, Green Published, Green Submitted			2022-12-26	WOS:000419655900005
J	Li, GB; Zhang, HW; Fu, RQ; Hu, XY; Liu, L; Li, YN; Liu, YX; Liu, X; Hu, JJ; Deng, Q; Luo, QS; Zhang, R; Gao, N				Li, Guo-Bing; Zhang, Hong-Wei; Fu, Ruo-Qiu; Hu, Xiao-Ye; Liu, Lei; Li, Yu-Nong; Liu, Yan-Xia; Liu, Xin; Hu, Jin-Jiao; Deng, Qin; Luo, Qing-Song; Zhang, Rong; Gao, Ning			Mitochondrial fission and mitophagy depend on cofilin-mediated actin depolymerization activity at the mitochondrial fission site	ONCOGENE			English	Article							PINK1; APOPTOSIS; DYNAMICS; TRANSLOCATION; CYTOSKELETON; PARKIN; CONTRIBUTES; MECHANISMS; REGULATORS; RELEASE	Mitochondria fission and mitophagy are fundamentally crucial to cellular physiology and play important roles in cancer progression. Developing a comprehensive understanding of the molecular mechanism underlying mitochondrial fission and mitophagy will provide novel strategies for cancer prevention and treatment. Actin has been shown to participate in mitochondrial fission and mitophagy regulation. Cofilin is best known as an actin-depolymerizing factor. However, the molecular mechanism by which cofilin regulates mitochondrial fission and mitophagy remains largely unknown. Here we report that knockdown of cofilin attenuates and overexpression of cofilin potentiates mitochondrial fission as well as PINK1/PARK2-dependent mitophagy induced by staurosporine (STS), etoposide (ETO), and carbonyl cyanide 3-chlorophenylhydrazone (CCCP). Cofilin-mediated-PINK1 (PTEN-induced putative kinase 1) accumulation mainly depends on its regulation of mitochondrial proteases, including peptidase mitochondrial processing beta (MPP beta), presenilin-associated rhomboid-like protease (PARL), and ATPase family gene 3-like 2 (AFG3L2), via mitochondrial membrane potential activity. We also found that the interaction and colocalization of G-actin/F-actin with cofilin at mitochondrial fission sites undergo constriction after CCCP treatment. Pretreatment with the actin polymerization inhibitor latrunculin B (LatB) increased and actin-depolymerization inhibitor jasplakinolide (Jas) decreased mitochondrial translocation of actin induced by STS, ETO, and CCCP. Both LatB and Jas abrogated CCCP-mediated mitochondrial fission and mitophagy. Our data suggest that G-actin is the actin form that is translocated to mitochondria, and the actin-depolymerization activity regulated by cofilin at the mitochondrial fission site is crucial for inducing mitochondrial fission and mitophagy.	[Li, Guo-Bing; Zhang, Hong-Wei; Fu, Ruo-Qiu; Hu, Xiao-Ye; Liu, Lei; Li, Yu-Nong; Liu, Yan-Xia; Liu, Xin; Hu, Jin-Jiao; Deng, Qin; Luo, Qing-Song; Gao, Ning] Third Mil Med Univ, Coll Pharm, Chongqing, Peoples R China; [Li, Guo-Bing; Zhang, Rong] Third Mil Med Univ, Affiliated Hosp 2, Dept Pharm, Chongqing, Peoples R China	Army Medical University; Army Medical University	Gao, N (corresponding author), Third Mil Med Univ, Coll Pharm, Chongqing, Peoples R China.; Zhang, R (corresponding author), Third Mil Med Univ, Affiliated Hosp 2, Dept Pharm, Chongqing, Peoples R China.	xqpharmacylab@126.com; gaoning59@163.com	Hu, Xiaoye/AAY-2495-2020		National Natural Science Foundation of China [31571425, 81402970, 81402013]; Clinical Research Projects of Xinqiao Hospital, Third Military Medical University [2016YLC12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical Research Projects of Xinqiao Hospital, Third Military Medical University	We thank James Bamburg (University of Wisconsin) for providing Cofilin-WT; Tamotsu Yoshimori (Osaka University) for RFP-LC3, and Nico Dantuma (Karolinska Institutet) for GFP-UB. This study was supported by the grants from National Natural Science Foundation of China (31571425; 81402970; 81402013) and Clinical Research Projects of Xinqiao Hospital, Third Military Medical University (2016YLC12).	Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Ban-Ishihara R, 2013, P NATL ACAD SCI USA, V110, P11863, DOI 10.1073/pnas.1301951110; Beck H, 2012, P NATL ACAD SCI USA, V109, pE2523, DOI 10.1073/pnas.1208141109; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bordi M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00081; Campello S, 2014, BBA-BIOENERGETICS, V1837, P451, DOI 10.1016/j.bbabio.2013.11.010; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Chourasia AH, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0130-8; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; de Vries RLA, 2013, MOL CELL NEUROSCI, V55, P37, DOI 10.1016/j.mcn.2012.07.008; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Fedorowicz MA, 2014, EMBO REP, V15, P86, DOI 10.1002/embr.201337294; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Hatch AL, 2014, J CELL SCI, V127, P4549, DOI 10.1242/jcs.153791; Huttemann M, 2008, J BIOENERG BIOMEMBR, V40, P445, DOI 10.1007/s10863-008-9169-3; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Ji WK, 2015, ELIFE, V4, DOI [10.7554/eLife.11553.001, 10.7554/eLife.11553]; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Karbowski M, 2010, ADV EXP MED BIOL, V687, P131; Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005; Kast DJ, 2015, AUTOPHAGY, V11, P1702, DOI 10.1080/15548627.2015.1073434; Kim JE, 2014, CELL DEATH DIFFER, V21, P1036, DOI 10.1038/cdd.2014.17; Korobova F, 2014, CURR BIOL, V24, P409, DOI 10.1016/j.cub.2013.12.032; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Kulikov AV, 2017, BIOCHEM BIOPH RES CO, V482, P432, DOI 10.1016/j.bbrc.2016.10.088; Li GB, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-50; Li GB, 2015, ONCOTARGET, V6, P1834, DOI 10.18632/oncotarget.2795; Li SA, 2015, J CELL BIOL, V208, P109, DOI 10.1083/jcb.201404050; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Matsuda S, 2015, FRONT BIOSCI-LANDMRK, V20, P491, DOI 10.2741/4321; Nagai Shoichi, 2011, Genes Cancer, V2, P859, DOI 10.1177/1947601911431839; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; O'Flanagan CH, 2014, BBA-REV CANCER, V1846, P590, DOI 10.1016/j.bbcan.2014.10.006; Aguilera MO, 2012, AUTOPHAGY, V8, P1590, DOI 10.4161/auto.21459; Pereira C, 2008, BBA-MOL CELL RES, V1783, P1286, DOI 10.1016/j.bbamcr.2008.03.010; Pi HF, 2013, AUTOPHAGY, V9, P1780, DOI 10.4161/auto.25665; Pon LA, 2013, CURR BIOL, V23, pR279, DOI 10.1016/j.cub.2013.02.042; Preau S, 2016, ANTIOXID REDOX SIGN, V24, P529, DOI 10.1089/ars.2015.6421; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Senft D, 2016, CURR OPIN CELL BIOL, V39, P43, DOI 10.1016/j.ceb.2016.02.001; Seo AY, 2010, J CELL SCI, V123, P2533, DOI 10.1242/jcs.070490; Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348; van Raam BJ, 2006, INT J HEMATOL, V84, P199, DOI 10.1532/IJH97.06131; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhu JS, 2012, PHARMACOLOGY, V89, P348, DOI 10.1159/000338757	50	33	34	1	27	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	11					1485	1502		10.1038/s41388-017-0064-4	http://dx.doi.org/10.1038/s41388-017-0064-4			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ3AZ	29321664				2022-12-26	WOS:000427459500007
J	Hildenbrand, G; Metzler, P; Pilarczyk, G; Bobu, V; Kriz, W; Hosser, H; Fleckenstein, J; Krufczik, M; Bestvater, F; Wenz, F; Hausmann, M				Hildenbrand, Georg; Metzler, Philipp; Pilarczyk, Goetz; Bobu, Vladimir; Kriz, Wilhelm; Hosser, Hiltraud; Fleckenstein, Jens; Krufczik, Matthias; Bestvater, Felix; Wenz, Frederik; Hausmann, Michael			Dose enhancement effects of gold nanoparticles specifically targeting RNA in breast cancer cells	PLOS ONE			English	Article							GADOLINIUM-BASED NANOPARTICLES; LOCALIZATION MICROSCOPY; RADIATION-THERAPY; CELLULAR UPTAKE; COPY NUMBER; RADIOTHERAPY; DEPENDENCE; GENE; NANOSTRUCTURES; CARCINOMA	Localization microscopy has shown to be capable of systematic investigations on the arrangement and counting of cellular uptake of gold nanoparticles (GNP) with nanometer resolution. In this article, we show that the application of specially modified RNA targeting gold nanoparticles ("SmartFlares") can result in ring like shaped GNP arrangements around the cell nucleus. Transmission electron microscopy revealed GNP accumulation in vicinity to the intracellular membrane structures including them of the endoplasmatic reticulum. A quantification of the radio therapeutic dose enhancement as a proof of principle was conducted with gamma H2AX foci analysis: The application of both-SmartFlares and unmodified GNPs-lead to a significant dose enhancement with a factor of up to 1.2 times the dose deposition compared to non-treated breast cancer cells. This enhancement effect was even more pronounced for SmartFlares. Furthermore, it was shown that a magnetic field of 1 Tesla simultaneously applied during irradiation has no detectable influence on neither the structure nor the dose enhancement dealt by gold nanoparticles.	[Hildenbrand, Georg; Metzler, Philipp; Pilarczyk, Goetz; Krufczik, Matthias; Hausmann, Michael] Heidelberg Univ, Fac Phys & Astron, Kirchhoff Inst Phys, Heidelberg, Germany; [Hildenbrand, Georg; Bobu, Vladimir; Fleckenstein, Jens; Wenz, Frederik] Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Dept Radiat Oncol, Mannheim, Germany; [Kriz, Wilhelm; Hosser, Hiltraud] Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Dept Neuroanat, Mannheim, Germany; [Bestvater, Felix] German Canc Res Ctr, Light Microscopy Fac, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Hildenbrand, G; Hausmann, M (corresponding author), Heidelberg Univ, Fac Phys & Astron, Kirchhoff Inst Phys, Heidelberg, Germany.; Hildenbrand, G (corresponding author), Heidelberg Univ, Univ Med Mannheim, Med Fac Mannheim, Dept Radiat Oncol, Mannheim, Germany.	georg.hildenbrand@umm.de; hausmann@kip.uni-heidelberg	Bobu, Vladimir/V-2696-2019		Innovation Fund "Frontier" of the Heidelberg University within the excellence initiative of the Deutsche Forschungsgemeinschaft (DFG); Deutsche Forschungsgemeinschaft; Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg; Innovation Fond "Frontier" of the Heidelberg University within the excellence initiative of the Deutsche Forschungsgemeinschaft (DFG)	Innovation Fund "Frontier" of the Heidelberg University within the excellence initiative of the Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg; Innovation Fond "Frontier" of the Heidelberg University within the excellence initiative of the Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The support of the Innovation Fund "Frontier" of the Heidelberg University within the excellence initiative of the Deutsche Forschungsgemeinschaft (DFG) to Georg Hildenbrand and Michael Hausmann is gratefully acknowledged. In addition, we acknowledge financial support by Deutsche Forschungsgemeinschaft within the funding programme Open Access Publishing, by the Baden-Wurttemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universitat Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The support of the Innovation Fond "Frontier" of the Heidelberg University within the excellence initiative of the Deutsche Forschungsgemeinschaft (DFG) to Georg Hildenbrand and Michael Hausmann is gratefully acknowledged. Furthermore the authors are indebted to the Indian Nigerian agricultural health connection Salawu & Salawu visiting the European Center of Feasibility Studies, Strasburg, for continuous promotion of abstract quality [32].	Abdelhalim M.A.K., 2012, J NANOMED NANOTECHOL, V3, DOI DOI 10.4172/2157-7439.1000133; [Anonymous], 1908, BIOMETRIKA, V6, P1; Arosio D, 2011, BIOCONJUGATE CHEM, V22, P664, DOI 10.1021/bc100448r; Bartolome J, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.247203; Burger N, 2014, NANOMED-NANOTECHNOL, V10, P1365, DOI 10.1016/j.nano.2014.03.011; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Chithrani DB, 2010, RECENT PAT NANOTECH, V4, P171, DOI 10.2174/187221010792483726; Chithrani DB, 2010, MOL MEMBR BIOL, V27, P299, DOI 10.3109/09687688.2010.507787; Chithrani DB, 2010, RADIAT RES, V173, P719, DOI 10.1667/RR1984.1; Cho SH, 2005, PHYS MED BIOL, V50, pN163, DOI 10.1088/0031-9155/50/15/N01; Cremer C, 2011, BIOTECHNOL J, V6, P1037, DOI 10.1002/biot.201100031; Dahmen V, 2012, INT J RADIAT BIOL, V88, P972, DOI 10.3109/09553002.2012.702298; Grull F., P 21 INT C FIELD PRO, P1; Hainfeld JF, 2008, J PHARM PHARMACOL, V60, P977, DOI 10.1211/jpp.60.8.0005; Hainfeld JF, 2013, NANOMEDICINE-UK, V8, P1601, DOI [10.2217/nnm.12.165, 10.2217/NNM.12.165]; Hainfeld JF, 2010, PHYS MED BIOL, V55, P3045, DOI 10.1088/0031-9155/55/11/004; Hainfeld JF, 2004, PHYS MED BIOL, V49, pN309, DOI 10.1088/0031-9155/49/18/N03; He H, 2008, ANAL CHEM, V80, P5951, DOI 10.1021/ac8005796; Holliday DL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2889; Hossain M, 2012, J PHYS CHEM C, V116, P23047, DOI 10.1021/jp306543q; Jain PK, 2007, PLASMONICS, V2, P107, DOI 10.1007/s11468-007-9031-1; Kaufmann R, 2011, J MICROSC-OXFORD, V242, P46, DOI 10.1111/j.1365-2818.2010.03436.x; Kaufmann R., 2009, P SOC PHOTO-OPT INS, V7185; Kaufmann R, 2011, MICRON, V42, P348, DOI 10.1016/j.micron.2010.03.006; Lagendijk JJW, 2014, PHYS MED BIOL, V59, pR349, DOI 10.1088/0031-9155/59/21/R349; Li CY, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.174446; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Merck-Millipore, 2015, TECHN GUID MAN; Mladenov E, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00113; Moser F, 2016, BIOPHYS J, V110, P947, DOI 10.1016/j.bpj.2016.01.004; Muller P, 2012, CURRENT MICROSCOPY C, V1, P3; Ngwa W, 2017, INT J RADIAT ONCOL, V97, P624, DOI 10.1016/j.ijrobp.2016.10.034; Ngwa W, 2014, NANOMEDICINE-UK, V9, P1063, DOI [10.2217/NNM.14.55, 10.2217/nnm.14.55]; Nikitaki Z, 2016, FREE RADICAL RES; Nikjoo H, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/075006; Porcel E, 2014, NANOMED-NANOTECHNOL, V10, P1601, DOI 10.1016/j.nano.2014.05.005; Prigodich AE, 2012, ANAL CHEM, V84, P2062, DOI 10.1021/ac202648w; Raaijmakers AJE, 2008, PHYS MED BIOL, V53, P909, DOI 10.1088/0031-9155/53/4/006; Roa W, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/37/375101; Salawu EO, 2011, IIOAB J, V2, P63; Sancey L, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140134; SCHMID G, 1992, CHEM REV, V92, P1709, DOI 10.1021/cr00016a002; Seferos DS, 2007, J AM CHEM SOC, V129, P15477, DOI 10.1021/ja0776529; Selim ME, 2012, ASIAN PAC J CANCER P, V13, P1617, DOI 10.7314/APJCP.2012.13.4.1617; Stefancikova L, 2016, J NANOBIOTECHNOL, V14, DOI 10.1186/s12951-016-0215-8; Stefancikova Lenka, 2014, Cancer Nanotechnol, V5, P6, DOI 10.1186/s12645-014-0006-6; Stuhlmuller M, 2015, NANOSCALE, V7, P17938, DOI 10.1039/c5nr04141d; SZOLLOSI J, 1995, CANCER RES, V55, P5400; TSUDA H, 1990, CANCER, V65, P1794, DOI 10.1002/1097-0142(19900415)65:8<1794::AID-CNCR2820650821>3.0.CO;2-Y; Wenz F, 2001, ONKOLOGIE, V24, P51, DOI 10.1159/000055187; Zygmanski P, 2013, PHYS MED BIOL, V58, P7961, DOI 10.1088/0031-9155/58/22/7961	52	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190183	10.1371/journal.pone.0190183	http://dx.doi.org/10.1371/journal.pone.0190183			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346397	Green Published, gold, Green Submitted			2022-12-26	WOS:000422749500010
J	Moretta, T; Buodo, G				Moretta, Tania; Buodo, Giulia			Autonomic stress reactivity and craving in individuals with problematic Internet use	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; PSYCHOLOGICAL STRESS; ADDICTION DISORDER; ALCOHOL-USE; SCALE; ASSOCIATION; PREVALENCE; SYMPTOMS; MODELS; MARKER	The link between autonomic stress reactivity and subjective urge/craving has been less systematically examined in behavioral addictions (i.e. problematic Internet use) than in substance use disorders. The present study investigated whether problematic Internet users (PU) show enhanced autonomic stress reactivity than non-PU, indexed by lower Heart Rate Variability (HRV) and higher Skin Conductance Level (SCL) reactivity during the Trier Social Stress Test (TSST), whether greater reactivity is related to stronger Internet craving, and whether problematic Internet usage is associated with some dysfunctional psychological features. Based on their Internet Addiction Test scores, participants were divided into PU (N = 24) and non-PU (N = 21). Their heart rate and skin conductance were continuously recorded during baseline, social stressors, and recovery. Craving for Internet usage were collected using a Likert scale before and after the TSST. The SDNN, an overall measure of HRV, was significantly lower in PU than non-PU during baseline, but not during and after stressful task. Furthermore, only among PU a significant negative correlation emerged between SDNN during recovery and craving ratings after the test. No group differences emerged for SCL. Lastly, PU endorsed more mood, obsessive-compulsive, and alcohol related problems. Our findings suggest that problems in controlling one's use of the Internet may be related to reduced autonomic balance at rest. Moreover, our results provide new insights into the characterization of craving in PIU, indicating the existence of a relationship between craving for Internet usage and reduced autonomic flexibility.	[Moretta, Tania; Buodo, Giulia] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua	Moretta, T (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	tania.moretta@phd.unipd.it	Moretta, Tania/M-5427-2019	Moretta, Tania/0000-0002-4734-1545				Akin A., 2011, INT ONLINE J ED SCI, V3, P138; Bagiella E, 2000, PSYCHOPHYSIOLOGY, V37, P13, DOI 10.1017/S0048577200980648; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Bastiani L, 2013, ADDICT BEHAV, V38, P2060, DOI 10.1016/j.addbeh.2012.12.016; Bates D, 2014, FITTING LINEAR MIXED, P1; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Berntson GG, 2004, DYNAMIC ELECTROCARDIOGRAPHY, P57, DOI 10.1002/9780470987483.ch7; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bottesi G, 2015, COMPR PSYCHIAT, V60, P170, DOI 10.1016/j.comppsych.2015.04.005; Bressi C, 1996, J PSYCHOSOM RES, V41, P551, DOI 10.1016/S0022-3999(96)00228-0; Cacioppo J. T., 2007, HDB PSYCHOPHYSIOLOGY, V44; Camm AJ, 1996, CIRCULATION, V93, P1043; Cano MA, 2014, EXP CLIN PSYCHOPHARM, V22, P332, DOI 10.1037/a0036749; Cash H, 2012, CURR PSYCHIATRY REV, V8, P292, DOI 10.2174/157340012803520513; Chamberlain SR, 2016, EUR NEUROPSYCHOPHARM, V26, P841, DOI 10.1016/j.euroneuro.2015.08.013; Cohen Sheldon, 1995, MEASURING STRESS GUI, P3; D'Orta Isabella, 2015, Addict Behav Rep, V2, P19, DOI 10.1016/j.abrep.2015.04.003; Davey HM, 2007, J CLIN EPIDEMIOL, V60, P356, DOI 10.1016/j.jclinepi.2006.07.015; Dawkins L, 2016, PSYCHOL ADDICT BEHAV, V30, P101, DOI 10.1037/adb0000112; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Ferraro G, 2007, CYBERPSYCHOL BEHAV, V10, P170, DOI 10.1089/cpb.2006.9972; Fossati A, 2001, J CLIN PSYCHOL, V57, P815, DOI 10.1002/jclp.1051; JACOBS SC, 1994, AM HEART J, V128, P1170, DOI 10.1016/0002-8703(94)90748-X; Jorgenson AG, 2016, CHILD ADOL PSYCH CL, V25, P509, DOI 10.1016/j.chc.2016.03.004; Kardefelt-Winther D, 2017, PSYCHIAT CLIN NEUROS, V71, P459, DOI 10.1111/pcn.12413; Kim BS, 2016, PSYCHIAT RES, V244, P249, DOI 10.1016/j.psychres.2016.07.009; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Ko CH, 2008, CYBERPSYCHOL BEHAV, V11, P571, DOI 10.1089/cpb.2008.0199; Kuss DJ, 2014, CURR PHARM DESIGN, V20, P4026, DOI 10.2174/13816128113199990617; Kuss DJ, 2016, WORLD J PSYCHIATR, V6, P143, DOI 10.5498/wjp.v6.i1.143; LaRose R, 2015, HBK COMMUN MEDIA, P365; LaRose R, 2010, COMMUN THEOR, V20, P194, DOI 10.1111/j.1468-2885.2010.01360.x; LAZARUS RS, 1963, PSYCHOSOM MED, V25, P19, DOI 10.1097/00006842-196301000-00004; Li DP, 2016, COMPUT HUM BEHAV, V63, P408, DOI 10.1016/j.chb.2016.05.070; Mantsch JR, 2016, NEUROPSYCHOPHARMACOL, V41, P335, DOI 10.1038/npp.2015.142; Meerkerk GJ, 2009, CYBERPSYCHOL BEHAV, V12, P1, DOI 10.1089/cpb.2008.0181; Morey R. D., 2014, R PACKAGE VERSION, V09, P8, DOI DOI 10.3758/BF03193811; Niu GF, 2016, ADDICT BEHAV, V62, P1, DOI 10.1016/j.addbeh.2016.06.012; Poli R, 2012, NORD J PSYCHIAT, V66, P55, DOI 10.3109/08039488.2011.605169; Potenza MN, 2006, ADDICTION, V101, P142, DOI 10.1111/j.1360-0443.2006.01591.x; Quintana DS, 2013, DRUG ALCOHOL DEPEN, V132, P395, DOI 10.1016/j.drugalcdep.2013.02.025; R Core Team, 2021, R LANGUAGE ENV STAT; Reinert DF, 2002, ALCOHOL CLIN EXP RES, V26, P272, DOI 10.1111/j.1530-0277.2002.tb02534.x; Schwabe L, 2012, J NEUROSCI, V32, P10146, DOI 10.1523/JNEUROSCI.1304-12.2012; Schwabe L, 2011, EXP CLIN PSYCHOPHARM, V19, P53, DOI 10.1037/a0022212; Schwabe L, 2010, J COGNITIVE NEUROSCI, V22, P1362, DOI 10.1162/jocn.2009.21278; Shapira NA, 2000, J AFFECT DISORDERS, V57, P267, DOI 10.1016/S0165-0327(99)00107-X; Sica C, 2009, J ANXIETY DISORD, V23, P204, DOI 10.1016/j.janxdis.2008.07.001; Sinha R, 2000, PSYCHOPHARMACOLOGY, V152, P140, DOI 10.1007/s002130000499; Sinha R, 2009, NEUROPSYCHOPHARMACOL, V34, P1198, DOI 10.1038/npp.2008.78; Sinha R, 2008, ANN NY ACAD SCI, V1141, P105, DOI 10.1196/annals.1441.030; Stavropoulos V, 2016, EUR J DEV PSYCHOL, V13, P99, DOI 10.1080/17405629.2015.1066670; Struzzo P., 2006, B FARMACODIPENDENZE, V29, P20; Taylor RN, 2014, PERS INDIVID DIF S, V60, pS50, DOI DOI 10.1016/J.PAID.2013.07.203; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Tiffany ST, 2012, ANN NY ACAD SCI, V1248, P1, DOI 10.1111/j.1749-6632.2011.06298.x; Van Rooij AJ, 2014, J BEHAV ADDICT, V3, P203, DOI 10.1556/JBA.3.2014.4.1; Velezmoro R, 2010, COMPUT HUM BEHAV, V26, P1526, DOI 10.1016/j.chb.2010.05.020; Venables W. N., 2002, MODERN APPL STAT S I, Vfourth; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Weber CS, 2010, EUR J APPL PHYSIOL, V109, P201, DOI 10.1007/s00421-009-1341-x; Wolfling K., 2010, PREVENTION DIAGNOSTI, P212; Yau Yvonne H C, 2012, Minerva Psichiatr, V53, P153; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Zhou Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155495	66	23	25	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190951	10.1371/journal.pone.0190951	http://dx.doi.org/10.1371/journal.pone.0190951			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29338020	gold, Green Published, Green Submitted			2022-12-26	WOS:000422652700024
J	Singh, G; Roy, J; Rout, P; Mallick, B				Singh, Garima; Roy, Jyoti; Rout, Pratiti; Mallick, Bibekanand			Genome-wide profiling of the PIWI-interacting RNA-mRNA regulatory networks in epithelial ovarian cancers	PLOS ONE			English	Article							BREAST-CANCER; DNA HYPOMETHYLATION; CELL-PROLIFERATION; IN-VITRO; PIRNAS; PROTEIN; METASTASIS; EXPRESSION; RETROTRANSPOSONS; SUPPRESSES	PIWI-interacting (piRNAs), similar to 23-36 nucleotide-long small non-coding RNAs (sncRNAs), earlier believed to be germline-specific, have now been identified in somatic cells, including cancer cells. These sncRNAs impact critical biological processes by fine-tuning gene expression at post-transcriptional and epigenetic levels. The expression of piRNAs in ovarian cancer, the most lethal gynecologic cancer is largely uncharted. In this study, we investigated the expression of PIWILs by qRT-PCR and western blotting and then identified piRNA transcriptomes in tissues of normal ovary and two most prevalent epithelial ovarian cancer subtypes, serous and endometrioid by small RNA sequencing. We detected 219, 256 and 234 piRNAs in normal ovary, endometrioid and serous ovarian cancer samples respectively. We observed piRNAs are encoded from various genomic regions, among which introns harbor the majority of them. Surprisingly, piRNAs originated from different genomic contexts showed the varied level of conservations across vertebrates. The functional analysis of predicted targets of differentially expressed piRNAs revealed these could modulate key processes and pathways involved in ovarian oncogenesis. Our study provides the first comprehensive piRNA landscape in these samples and a useful resource for further functional studies to decipher new mechanistic views of piRNA-mediated gene regulatory networks affecting ovarian oncogenesis. The RNA-seq data is submitted to GEO database (GSE83794).	[Singh, Garima; Roy, Jyoti; Rout, Pratiti; Mallick, Bibekanand] Natl Inst Technol, Dept Life Sci, RNAi & Funct Genom Lab, Rourkela, Odisha, India; [Roy, Jyoti] DKFZ ZMBH Alliance, German Canc Res Ctr, Div Mol Biol Cell 2, Heidelberg, Germany	National Institute of Technology (NIT System); National Institute of Technology Rourkela; Helmholtz Association; German Cancer Research Center (DKFZ)	Mallick, B (corresponding author), Natl Inst Technol, Dept Life Sci, RNAi & Funct Genom Lab, Rourkela, Odisha, India.	vivek.iitian@gmail.com	Mallick, Bibekanand/AAT-7013-2021	Mallick, Bibekanand/0000-0003-4311-0720; ROY, JYOTI/0000-0001-7530-9705	Department of Science and Technology, Govt. of India [SR/WOS-A/LS-311/2013]; Department of Biotechnology, Govt. of India [BT/PR6772/GBD/27/468/2012]	Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	This work was supported by Department of Science and Technology, Govt. of India (SR/WOS-A/LS-311/2013) awarded to G.S. and Department of Biotechnology, Govt. of India (BT/PR6772/GBD/27/468/2012) awarded to B.M.; We acknowledge the grant support by Department of Science and Technology, Govt. of India (SR/WOS-A/LS-311/2013) awarded to G.S. and Department of Biotechnology, Govt. of India (BT/PR6772/GBD/27/468/2012) awarded to B.M. We are also thankful to Dr. Bhagyalaxmi Nayak and Dr. D.R. Mishra for assisting in providing us the tissue samples.	ANDERS S, 2010, GENOME BIOL, V11; Bedi U, 2014, ONCOTARGET, V5, P2016, DOI 10.18632/oncotarget.1875; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Caffrey JJ, 2000, J BIOL CHEM, V275, P12730, DOI 10.1074/jbc.275.17.12730; Caffrey JJ, 2001, GENE, V269, P53, DOI 10.1016/S0378-1119(01)00446-2; Chen C, 2013, CANCER BIOMARK, V13, P315, DOI 10.3233/CBM-130360; Cheng J, 2012, CANCER LETT, V315, P12, DOI 10.1016/j.canlet.2011.10.004; Chu HY, 2015, CANCER LETT, V356, P561, DOI 10.1016/j.canlet.2014.10.004; Cunningham JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04026; Deng B, 2016, SCI REP-UK, V6, DOI 10.1038/srep28301; Devouassoux-Shisheboran M, 2015, CHIN J CANCER, V34, P50, DOI 10.5732/cjc.014.10273; Drerup CM, 2017, ELIFE, V6, DOI 10.7554/eLife.22234; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Eisele SC, 2015, CLIN CANCER RES, V21, P1978, DOI 10.1158/1078-0432.CCR-14-2604; Elbarbary RA, 2016, SCIENCE, V351, DOI 10.1126/science.aac7247; Feuerecker B, 2012, CANCER BIOL THER, V13, P1425, DOI 10.4161/cbt.22003; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Giurato G, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-362; Goh WSS, 2015, GENE DEV, V29, P1032, DOI 10.1101/gad.260455.115; Gou LT, 2014, CELL RES, V24, P680, DOI 10.1038/cr.2014.41; Grudzien-Nogalska E, 2016, RNA, V22, P773, DOI 10.1261/rna.055699.115; Gubbels JAA, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-8; Hashim A, 2014, ONCOTARGET, V5, P9901, DOI 10.18632/oncotarget.2476; Hendrix ND, 2006, CANCER RES, V66, P1354, DOI 10.1158/0008-5472.CAN-05-3694; Homolka D, 2015, CELL REP, V12, P418, DOI 10.1016/j.celrep.2015.06.030; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; James SJ, 2002, J NUTR, V132, p2361S, DOI 10.1093/jn/132.8.2361S; Jilaveanu LB, 2015, CLIN CANCER RES, V21, P2138, DOI 10.1158/1078-0432.CCR-14-0861; Kafara P, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0165-z; Kaur M, 2009, NUCLEIC ACIDS RES, V37, pD820, DOI 10.1093/nar/gkn593; Kokura K, 2010, EMBO J, V29, P3673, DOI 10.1038/emboj.2010.239; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Malone CD, 2009, COLD SH Q B, V74, P225, DOI 10.1101/sqb.2009.74.052; MOSIG RA, 2012, J OVARIAN RES, V5; Mourier T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-440; Pantano L, 2015, RNA, V21, P1085, DOI 10.1261/rna.046482.114; Qu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36264; Ravo M, 2015, ONCOTARGET, V6, P4677, DOI 10.18632/oncotarget.2911; Rearick D, 2011, NUCLEIC ACIDS RES, V39, P2357, DOI 10.1093/nar/gkq1080; Rizzo F, 2016, ONCOTARGET; Roy J., 2017, GENOMICS; Roy J, 2017, MOL BIOSYST, V13, P565, DOI 10.1039/c6mb00699j; Saavedra OM, 2009, BIOORG MED CHEM LETT, V19, P2747, DOI 10.1016/j.bmcl.2009.03.113; Samantarrai D, 2017, EXP CELL RES, V357, P33, DOI 10.1016/j.yexcr.2017.04.017; Samantarrai D, 2013, MOL CANCER RES, V11, P315, DOI 10.1158/1541-7786.MCR-12-0649; Shindo-Okada N, 2003, BIOCHEM BIOPH RES CO, V312, P889, DOI 10.1016/j.bbrc.2003.10.200; Spilka R, 2013, CANCER LETT, V340, P9, DOI 10.1016/j.canlet.2013.06.019; Sun L.N., 2015, IND SAFETY ENV PRO, V1, P8, DOI DOI 10.15252/EMBR.201439792; Sung PL, 2014, GYNECOL ONCOL, V133, P147, DOI 10.1016/j.ygyno.2014.02.016; Suzuki Ryusuke, 2012, Frontiers in Genetics, V3, P204, DOI 10.3389/fgene.2012.00204; Tarailo-Graovac M., 2009, CURR PROTOC BIOINFOR, V25, p4.10.11, DOI 10.1002/0471250953.bi0410s25; Vandewege MW, 2016, GENOME BIOL EVOL, V8, P1327, DOI 10.1093/gbe/evw078; Watanabe T, 2015, GENOME RES, V25, P368, DOI 10.1101/gr.180802.114; Wu JY, 2013, RNA BIOL, V10, P1087, DOI 10.4161/rna.25193; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Xiao BX, 2009, CLIN CHIM ACTA, V400, P97, DOI 10.1016/j.cca.2008.10.021; Yan H, 2015, LEUKEMIA, V29, P196, DOI 10.1038/leu.2014.135; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Yogev Ohad, 2011, Silence, V2, P6, DOI 10.1186/1758-907X-2-6; Zanni V, 2013, P NATL ACAD SCI USA, V110, P19842, DOI 10.1073/pnas.1313677110; Zhang H, 2013, SURG ONCOL, V22, P217, DOI 10.1016/j.suronc.2013.07.001; Zou Y, 2012, BIOCELL, V36, P127	62	31	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190485	10.1371/journal.pone.0190485	http://dx.doi.org/10.1371/journal.pone.0190485			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320577	Green Published, Green Submitted, gold			2022-12-26	WOS:000419689600053
J	Martins, MFD; Pereira, MB; Ferreira, JDG; Franca, AD; Cominetti, MC; Ferreira, ED; Dorval, MEMC; Rossi, CL; Mazon, SD; de Almeida, EA; Costa, SCB; Marcon, GEB				da Silva Martins, Mariana Furquim; Pereira, Mariane Barroso; Guimaraes Ferreira, Juliana de Jesus; Franca, Adriana de Oliveira; Cominetti, Marlon Cezar; Ferreira, Eduardo de Castro; Moraes Cavalheiros Dorval, Maria Elizabeth; Rossi, Claudio Lucio; Mazon, Silvia de Barros; de Almeida, Eros Antonio; Botelho Costa, Sandra Cecilia; Barbosa Marcon, Glaucia Elisete			Serological and molecular inquiry of Chagas disease in an Afro-descendant settlement in Mato Grosso do Sul State, Brazil	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI INFECTION; TRANSMISSION; DIAGNOSIS; ELIMINATION; SEROPREVALENCE; AMPLIFICATION; VECTORS; DOGS	Furnas do Dionoisio is a Brazilian Afro-descendant settlement in the city of Jaraguari, 21.4 miles from Campo Grande, Mato Grosso do Sul, Brazil. Approximately 96 families live in this quilombola (Maroon) settlement, also known in Brazil as a remnant community of descendants of African slaves. Recent studies found 20% of households were infested by triatomines, 18% of insects captured in the community were infected by Trypanosoma cruzi, and 22.7% of dogs presented T. cruzi antibodies. The low prevalence of Chagas disease observed in humans in Mato Grosso do Sul State is attributed to its arrival via colonist migration and subsequent transplacental transmission. In order to gain a better understanding of the T. cruzi cycle in residents of the study community, serological and molecular tests were carried out to diagnose Chagas disease. In the present study, 175 residents between 2 and 80 years old were included. A total of 175 participants were interviewed and 170 provided blood samples, which were tested for T. cruzi antibodies with serological tests. Molecular diagnosis was performed in 167 participants by PCR (KDNA) and NPCR (satellite DNA) tests. One of the 170 samples tested positive for all serological tests performed. The overall frequency of Chagas disease in the community was low (0.6%). Interview responses revealed that 66.3% knew of triatomine insects and 65.7% reported having had no contact with them. Physical improvements to residences, together with vector surveillance and control by the State and municipal governments and local ecological conservation contribute to the low frequency of the Chagas disease in this quilombola community.	[da Silva Martins, Mariana Furquim; Pereira, Mariane Barroso; Guimaraes Ferreira, Juliana de Jesus; Botelho Costa, Sandra Cecilia] Univ Estadual Campinas, UNICAMP, Fac Ciencias Med, Dept Clin Med, Campinas, SP, Brazil; [Franca, Adriana de Oliveira; Cominetti, Marlon Cezar; Moraes Cavalheiros Dorval, Maria Elizabeth] Univ Fed Mato do Grosso UFMS, Fac Farma, Ctr Ciencias Biol & Saude, Campo Grande, MS, Brazil; [Ferreira, Eduardo de Castro] Univ Anhanguera UNIDERP, Campo Grande, MS, Brazil; [Ferreira, Eduardo de Castro; Barbosa Marcon, Glaucia Elisete] Fundacao Oswaldo Cruz, FIOCRUZ Mato Grosso do Sul, Campo Grande, MS, Brazil; [Rossi, Claudio Lucio; Mazon, Silvia de Barros] Univ Estadual Campinas, UNICAMP, Fac Ciencias Med, Dept Patol Clin, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Federal de Mato Grosso do Sul; Universidade Anhanguera; Fundacao Oswaldo Cruz; Universidade Estadual de Campinas	Marcon, GEB (corresponding author), Fundacao Oswaldo Cruz, FIOCRUZ Mato Grosso do Sul, Campo Grande, MS, Brazil.	glauciamarcon@gmail.com	Marcon, Gláucia EB/B-7747-2016; de Barros-Mazon, Silvia/E-9299-2011	de Barros-Mazon, Silvia/0000-0002-4376-8189; Ferreira, Eduardo/0000-0002-4073-6704; Franca, Adriana de Oliveira/0000-0002-4994-1958	FUNDECT - Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul [04/2013]; Programa de Pesquisa para o Sistema Unico de Saude, Mato Grosso do Sul, PPSUS; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq; Ministerio da Saude,MS [0056/13]	FUNDECT - Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); Programa de Pesquisa para o Sistema Unico de Saude, Mato Grosso do Sul, PPSUS; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministerio da Saude,MS	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was supported by the FUNDECT - Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado de Mato Grosso do Sul, edital number 04/2013, Programa de Pesquisa para o Sistema Unico de Saude, Mato Grosso do Sul, PPSUS, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Ministerio da Saude,MS. Process: 0056/13, URL: http://fundect.ledes.net/.	Abad-Franch F, 2013, MEM I OSWALDO CRUZ, V108, P251, DOI 10.1590/0074-0276108022013022; Abras A, 2016, J CLIN MICROBIOL, V54, P1566, DOI 10.1128/JCM.00142-16; do Brasil PEAA, 2016, MEM I OSWALDO CRUZ, V111, P1, DOI 10.1590/0074-02760150296; Marcon GEB, 2011, MEM I OSWALDO CRUZ, V106, P85, DOI 10.1590/S0074-02762011000100014; Barros LEP, 2011, REV IDEAS, V5, P274; Batista AM, 2010, INT J INFECT DIS, V14, pE974, DOI 10.1016/j.ijid.2010.05.017; Borges-Pereira J, 2001, Rev Soc Bras Med Trop, V34, P459, DOI 10.1590/S0037-86822001000500009; Cominetti MC, 2013, REV SOC BRAS MED TRO, V46, P277, DOI 10.1590/0037-8682-0024-2013; Cominetti MC, 2011, REV SOC BRAS MED TRO, V44, P576, DOI 10.1590/S0037-86822011000500009; Coura JR, 2013, MEM I OSWALDO CRUZ, V108, P962, DOI 10.1590/0074-0276130565; Coura JR, 2012, REV SOC BRAS MED TRO, V45, P286, DOI 10.1590/S0037-86822012000300002; Coura JR, 2009, REV SOC BRAS MED TRO, V42, P106; de Almeida PS, 2008, REV SOC BRAS MED TRO, V41, P374, DOI 10.1590/S0037-86822008000400010; Dias JCP, 2015, EPIDEMIOLOGIA SERVIC, V25, P86; Forattini O P, 1980, Rev Saude Publica, V14, P265; Kramm MM, 2017, J WILDLIFE DIS, V53, P788, DOI 10.7589/2016-10-232; Malan AK, 2006, J MED MICROBIOL, V55, P171, DOI 10.1099/jmm.0.46149-0; Marcon GEB, 2001, DIAGNOSTIC MICROBIOL, V43, P39; Ferreira IDM, 2006, REV SOC BRAS MED TRO, V39, P507; Monteon Victor, 2015, Annals of Parasitology, V61, P263, DOI 10.17420/ap6104.17; Nunes V L, 1995, Rev Soc Bras Med Trop, V28, P185, DOI 10.1590/S0037-86821995000300004; Ochs DE, 1996, AM J TROP MED HYG, V54, P526, DOI 10.4269/ajtmh.1996.54.526; Dias JCP, 2009, MEM I OSWALDO CRUZ, V104, P41, DOI 10.1590/S0074-02762009000900007; Pompilio MA, 2005, REV SOC BRAS MED TRO, V38, P473, DOI 10.1590/S0037-86822005000600005; Pompilio MA, 1998, REV SOCIEDADE BRA S1, V31, P214; Roque ALR, 2008, AM J TROP MED HYG, V79, P742, DOI 10.4269/ajtmh.2008.79.742; Silveira A C, 1984, Rev Bras Malariol Doencas Trop, V36, P15; Silveira AC, 1999, MEM I OSWALDO CRUZ, V94, P405, DOI 10.1590/S0074-02761999000700080; Souza AI, 2009, PESQUI VET BRASIL, V29, P150, DOI 10.1590/S0100-736X2009000200011; STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0; Tarleton RL, 2016, TRENDS MOL MED, V22, P835, DOI 10.1016/j.molmed.2016.07.008; Umezawa ES, 2009, ACTA TROP, V111, P15, DOI 10.1016/j.actatropica.2009.01.006	32	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0189448	10.1371/journal.pone.0189448	http://dx.doi.org/10.1371/journal.pone.0189448			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315305	gold, Green Published, Green Submitted			2022-12-26	WOS:000419655900004
J	Dick, J; Gan, PY; Kitching, AR; Holdsworth, SR				Dick, Jonathan; Gan, Poh-Yi; Kitching, A. Richard; Holdsworth, Stephen R.			The C3aR promotes macrophage infiltration and regulates ANCA production but does not affect glomerular injury in experimental anti-myeloperoxidase glomerulonephritis	PLOS ONE			English	Article							ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; ALTERNATIVE COMPLEMENT PATHWAY; C5A RECEPTOR CD88; CRESCENTIC GLOMERULONEPHRITIS; FUNCTIONAL-RESPONSES; ANAPHYLATOXIN C3A; IMMUNE-RESPONSES; T-LYMPHOCYTES; CUTTING EDGE; CELL-LINE	The anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitides are autoimmune diseases associated with significant morbidity and mortality. They often affect the kidney causing rapidly progressive glomerulonephritis. While signalling by complement anaphylatoxin C5a though the C5a receptor is important in this disease, the role of the anaphylatoxin C3a signalling via the C3a receptor (C3aR) is not known. Using two different murine models of anti-myeloperoxidase (MPO) glomerulonephritis, one mediated by passive transfer of anti-MPO antibodies, the other by cell-mediated immunity, we found that the C3aR did not alter histological disease severity. However, it promoted macrophage recruitment to the inflamed glomerulus and inhibited the generation of MPO-ANCA whilst not influencing T cell autoimmunity. Thus, whilst the C3aR modulates some elements of disease pathogenesis, overall it is not critical in effector responses and glomerular injury caused by autoimmunity to MPO.	[Dick, Jonathan; Gan, Poh-Yi; Kitching, A. Richard; Holdsworth, Stephen R.] Monash Univ, Dept Med, Ctr Inflammatory Dis, Clayton, Vic, Australia; [Dick, Jonathan; Kitching, A. Richard; Holdsworth, Stephen R.] Monash Hlth, Dept Nephrol, Clayton, Vic, Australia; [Kitching, A. Richard] Monash Hlth, Dept Paediat Nephrol, Monash Childrens Hosp, Clayton, Vic, Australia	Monash University	Holdsworth, SR (corresponding author), Monash Univ, Dept Med, Ctr Inflammatory Dis, Clayton, Vic, Australia.; Holdsworth, SR (corresponding author), Monash Hlth, Dept Nephrol, Clayton, Vic, Australia.	Stephen.Holdsworth@monash.edu	Kitching, A Richard/B-6947-2013	Kitching, A Richard/0000-0002-2713-2391; Gan, Poh Yi/0000-0001-8373-7144	National Health and Medical Research Council of Australia [1046585, 1075803]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work received support from the National Health and Medical Research Council of Australia grant no: 1046585 and the National Health and Medical Research Council of Australia Postgraduate Scholarship number 1075803 (JD).	Apostolopoulos J, 2006, J IMMUNOL METHODS, V308, P167, DOI 10.1016/j.jim.2005.10.011; Augusto JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158871; Banda NK, 2012, J IMMUNOL, V188, P1469, DOI 10.4049/jimmunol.1102310; Bao LH, 2011, KIDNEY INT, V80, P524, DOI 10.1038/ki.2011.158; Braun MC, 2004, J IMMUNOL, V173, P4190, DOI 10.4049/jimmunol.173.6.4190; Camous L, 2011, BLOOD, V117, P1340, DOI 10.1182/blood-2010-05-283564; CHARLES LA, 1991, J LEUKOCYTE BIOL, V50, P539, DOI 10.1002/jlb.50.6.539; Chen M, 2009, NEPHROL DIAL TRANSPL, V24, P1247, DOI 10.1093/ndt/gfn586; Clarke EV, 2014, J LEUKOCYTE BIOL, V96, P745, DOI 10.1189/jlb.3MR0214-109R; Crass T, 1999, J BIOL CHEM, V274, P8367, DOI 10.1074/jbc.274.13.8367; DAFFERN PJ, 1995, J EXP MED, V181, P2119, DOI 10.1084/jem.181.6.2119; Duffield JS, 2005, AM J PATHOL, V167, P1207, DOI 10.1016/S0002-9440(10)61209-6; Dutow P, 2014, J INFECT DIS, V209, P1269, DOI 10.1093/infdis/jit640; Fischer WH, 1997, J IMMUNOL, V159, P4279; Gan PY, 2010, J AM SOC NEPHROL, V21, P925, DOI 10.1681/ASN.2009070763; Ghannam A, 2014, MOL IMMUNOL, V58, P98, DOI 10.1016/j.molimm.2013.11.010; Gou SJ, 2013, CLIN J AM SOC NEPHRO, V8, P1884, DOI 10.2215/CJN.02790313; Gou SJ, 2013, KIDNEY INT, V83, P129, DOI 10.1038/ki.2012.313; Hilhorst M, 2015, NEPHROL DIAL TRANSPL; Huang XR, 1997, KIDNEY INT, V51, P94, DOI 10.1038/ki.1997.12; HUANG XR, 1994, KIDNEY INT, V46, P69, DOI 10.1038/ki.1994.245; Huugen D, 2005, AM J PATHOL, V167, P47, DOI 10.1016/S0002-9440(10)62952-5; Huugen D, 2007, KIDNEY INT, V71, P646, DOI 10.1038/sj.ki.5002103; Jayne DRW, 2017, J AM SOC NEPHROL, V28, P2756, DOI 10.1681/ASN.2016111179; Kawamoto S, 2004, J CLIN INVEST, V114, P399, DOI 10.1172/jci200419082; Kildsgaard J, 2000, J IMMUNOL, V165, P5406, DOI 10.4049/jimmunol.165.10.5406; Kitching AR, 1999, J AM SOC NEPHROL, V10, P752; KLOS A, 1992, BIOCHEMISTRY-US, V31, P11274, DOI 10.1021/bi00161a003; Laumonnier Y, 2017, MOL IMMUNOL; Legler DF, 1996, EUR J IMMUNOL, V26, P753, DOI 10.1002/eji.1830260405; Li K, 2012, IMMUNOBIOLOGY, V217, P65, DOI 10.1016/j.imbio.2011.07.033; Lim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052666; Manenti L, 2015, CLIN J AM SOC NEPHRO; Martin U, 1997, J EXP MED, V186, P199, DOI 10.1084/jem.186.2.199; MORGAN EL, 1982, J EXP MED, V155, P1412, DOI 10.1084/jem.155.5.1412; Mueller-Ortiz SL, 2006, AM J PHYSIOL-LUNG C, V291, pL157, DOI 10.1152/ajplung.00358.2005; O'Flynn J, 2014, J INNATE IMMUN, V6, P417, DOI 10.1159/000356980; O'Sullivan KM, 2015, KIDNEY INT, V88, P1030, DOI 10.1038/ki.2015.202; Odobasic D, 2011, AM J PATHOL, V179, P1188, DOI 10.1016/j.ajpath.2011.05.039; Ooi JD, 2012, P NATL ACAD SCI USA, V109, pE2615, DOI 10.1073/pnas.1210147109; Peng Q, 2008, BLOOD, V111, P2452, DOI 10.1182/blood-2007-06-095018; Peng Q, 2012, J AM SOC NEPHROL, V23, P1474, DOI 10.1681/ASN.2011111072; Quell KM, 2017, J IMMUNOL; Rousselle A, 2017, AM J PATHOL, V187, P1908, DOI 10.1016/j.ajpath.2017.05.003; Ruth AJ, 2003, J AM SOC NEPHROL, V14, P2813, DOI 10.1097/01.ASN.0000091381.60059.FB; Ruth AJ, 2006, J AM SOC NEPHROL, V17, P1940, DOI 10.1681/ASN.2006020108; Sanders JSF, 2006, ANN RHEUM DIS, V65, P1484, DOI 10.1136/ard.2005.046219; Schreiber A, 2009, J AM SOC NEPHROL, V20, P289, DOI 10.1681/ASN.2008050497; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; Tan DSY, 2013, J AM SOC NEPHROL, V24, P573, DOI 10.1681/ASN.2012090898; Tang ZY, 2009, J AM SOC NEPHROL, V20, P593, DOI 10.1681/ASN.2008040434; van der Touw W, 2013, J IMMUNOL, V190, P5921, DOI 10.4049/jimmunol.1300847; Wenderfer SE, 2009, MOL IMMUNOL, V46, P1397, DOI 10.1016/j.molimm.2008.12.004; Werfel T, 2000, J IMMUNOL, V165, P6599, DOI 10.4049/jimmunol.165.11.6599; Wu MCL, 2013, P NATL ACAD SCI USA, V110, P9439, DOI 10.1073/pnas.1218815110; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Xiao H, 2007, AM J PATHOL, V170, P52, DOI 10.2353/ajpath.2007.060573; Xiao H, 2014, J AM SOC NEPHROL, V25, P225, DOI 10.1681/ASN.2013020143; Xing GQ, 2009, J CLIN IMMUNOL, V29, P282, DOI 10.1007/s10875-008-9268-2; Yuen J, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00137; Zwirner J, 1998, EUR J IMMUNOL, V28, P1570, DOI 10.1002/(SICI)1521-4141(199805)28:05<1570::AID-IMMU1570>3.0.CO;2-6	61	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190655	10.1371/journal.pone.0190655	http://dx.doi.org/10.1371/journal.pone.0190655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315316	Green Published, gold, Green Submitted			2022-12-26	WOS:000419655900017
J	Goodman, MC; Xu, S; Rouzer, CA; Banerjee, S; Ghebreselasie, K; Migliore, M; Piomelli, D; Marnett, LJ				Goodman, Michael C.; Xu, Shu; Rouzer, Carol A.; Banerjee, Surajit; Ghebreselasie, Kebreab; Migliore, Marco; Piomelli, Daniele; Marnett, Lawrence J.			Dual cyclooxygenase-fatty acid amide hydrolase inhibitor exploits novel binding interactions in the cyclooxygenase active site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEROXIDE-H SYNTHASE-1; TIME-DEPENDENT INHIBITION; CRYSTAL-STRUCTURE; ENDOCANNABINOID OXYGENATION; GASTROINTESTINAL-TRACT; ARACHIDONIC-ACID; STRUCTURAL BASIS; MOLECULAR-BASIS; PROSTAGLANDIN; SELECTIVITY	The cyclooxygenases COX-1 and COX-2 oxygenate arachidonic acid (AA) to prostaglandin H-2 (PGH(2)). COX-2 also oxygenates the endocannabinoids 2-arachidonoylglycerol (2-AG) and arachidonoylethanolamide (AEA) to the corresponding PGH2 analogs. Both enzymes are targets of nonsteroidal anti-inflammatory drugs (NSAIDs), but NSAID-mediated COX inhibition is associated with gastrointestinal toxicity. One potential strategy to counter this toxicity is to also inhibit fatty acid amide hydrolase (FAAH), which hydrolyzes bioactive fatty acid ethanolamides (FAEs) into fatty acids and ethanolamine. Here, we investigated the mechanism of COX inhibition by ARN2508, an NSAID that inhibits both COXs and FAAH with high potency, target selectivity, and decreased gastrointestinal toxicity in mouse models, presumably due to its ability to increase levels of FAEs. A 2.27-angstrom-resolution X-ray crystal structure of the COX-2.(S)-ARN2508 complex reveals that ARN2508 adopts a binding pose similar to that of its parent NSAID flurbiprofen. However, ARN2508's alkyl tail is inserted deep into the top channel, an active site region not exploited by any previously reported NSAID. As for flurbiprofen, ARN2508's potency is highly dependent on the configuration of the a-methyl group. Thus, (S)ARN2508 is more potent than (R)-ARN2508 for inhibition of AA oxygenation by both CO Xs and 2-AG oxygenation by COX-2. Also, similarly to (R)-flurbiprofen, (R)-ARN2508 exhibits substrate selectivity for inhibition of 2-AG oxygenation. Site-directed mutagenesis confirms the importance of insertion of the alkyl tail into the top channel for (S)ARN2508's potency and suggests a role for Ser-530 as a determinant of the inhibitor's slow rate of inhibition compared with that of (S)-flurbiprofen.	[Goodman, Michael C.; Xu, Shu; Rouzer, Carol A.; Ghebreselasie, Kebreab; Marnett, Lawrence J.] Vanderbilt Univ, Dept Biochem, Sch Med,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA; [Goodman, Michael C.; Xu, Shu; Rouzer, Carol A.; Ghebreselasie, Kebreab; Marnett, Lawrence J.] Vanderbilt Univ, Dept Chem, Sch Med,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA; [Goodman, Michael C.; Xu, Shu; Rouzer, Carol A.; Ghebreselasie, Kebreab; Marnett, Lawrence J.] Vanderbilt Univ, Dept Pharmacol, Sch Med,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA; [Goodman, Michael C.; Xu, Shu; Rouzer, Carol A.; Ghebreselasie, Kebreab; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Migliore, Marco; Piomelli, Daniele] Ist Italian Tecnol, Dept Drug Discovery & Dev, I-16163 Genoa, Italy; [Piomelli, Daniele] Univ Calif Irvine, Dept Anat, Irvine, CA 92697 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Neurobiol, Irvine, CA 92697 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; [Piomelli, Daniele] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Banerjee, Surajit] Argonne Natl Lab, Northeastern Collaborat Access Team, 9700 S Cass Ave, Argonne, IL 60439 USA; [Migliore, Marco] Aptuit Verona, Via Alessandro Fleming, I-37135 Verona, Italy	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Istituto Italiano di Tecnologia - IIT; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; United States Department of Energy (DOE); Argonne National Laboratory	Marnett, LJ (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA.; Marnett, LJ (corresponding author), Vanderbilt Univ, Dept Chem, Sch Med,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA.; Marnett, LJ (corresponding author), Vanderbilt Univ, Dept Pharmacol, Sch Med,Vanderbilt Inst Chem Biol, AB Hancock Jr Mem Lab Canc Res, Nashville, TN 37232 USA.; Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Ctr Mol Toxicol, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu	Xu, Shu/O-6667-2019	Xu, Shu/0000-0002-6876-7991; Rouzer, Carol/0000-0001-6827-1534	National Institute of General Medical Sciences, National Institutes of Health [P41 GM103403]; National Institutes of Health Office of Research Infrastructure Program High-end Instrumentation Grant [SI0OD021527]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA089450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030910, P41GM103403] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021527] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Office of Research Infrastructure Program High-end Instrumentation Grant; DOE Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Kristie Rose at the Vanderbilt Mass Spectrometry Proteomics Core for peptide adduct analysis. We thank Nathan Kett and the Vanderbilt Chemical Synthesis Core for preparation of the enantiomers ARN2508. The X-ray crystallographic work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by National Institute of General Medical Sciences, National Institutes of Health Grant P41 GM103403; the Eiger 16M detector-on 24-ID-E beam line is funded by National Institutes of Health Office of Research Infrastructure Program High-end Instrumentation Grant SI0OD021527). This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Blobaum AL, 2007, J MED CHEM, V50, P1425, DOI 10.1021/jm0613166; Blobaum AL, 2015, J BIOL CHEM, V290, P12793, DOI 10.1074/jbc.M114.635987; Callan OH, 1996, J BIOL CHEM, V271, P3548; Capone ML, 2010, PHARMACOL REP, V62, P530, DOI 10.1016/S1734-1140(10)70310-8; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Favia AD, 2012, J MED CHEM, V55, P8807, DOI 10.1021/jm3011146; Gupta K, 2006, ACTA CRYSTALLOGR D, V62, P151, DOI 10.1107/S0907444905036309; Hochgesang GP, 2000, J AM CHEM SOC, V122, P6514, DOI 10.1021/ja0003932; Kabsch W, 2010, D BIOL CRYSTALLOGR, V66, P12; Kalgutkar AS, 2000, P NATL ACAD SCI USA, V97, P925, DOI 10.1073/pnas.97.2.925; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kudalkar SN, 2015, J BIOL CHEM, V290, P7897, DOI 10.1074/jbc.M114.634014; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; LANEUVILLE O, 1994, J PHARMACOL EXP THER, V271, P927; Lucido MJ, 2016, BIOCHEMISTRY-US, V55, P1226, DOI 10.1021/acs.biochem.5b01378; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Marnett LJ, 2009, ANNU REV PHARMACOL, V49, P265, DOI 10.1146/annurev.pharmtox.011008.145638; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Migliore M, 2016, EUR J MED CHEM, V109, P216, DOI 10.1016/j.ejmech.2015.12.036; Mileni M, 2010, J MOL BIOL, V400, P743, DOI 10.1016/j.jmb.2010.05.034; Mitchener MM, 2015, P NATL ACAD SCI USA, V112, P12366, DOI 10.1073/pnas.1507307112; ODENWALLER R, 1990, METHOD ENZYMOL, V187, P479; Orlando BJ, 2015, J STRUCT BIOL, V189, P62, DOI 10.1016/j.jsb.2014.11.005; OUELLET M, 1995, BIOCHEM J, V306, P247, DOI 10.1042/bj3060247; Palermo G, 2016, CHEMMEDCHEM, V11, P1252, DOI 10.1002/cmdc.201500507; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; ROME LH, 1975, P NATL ACAD SCI USA, V72, P4863, DOI 10.1073/pnas.72.12.4863; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rowlinson SW, 2003, J BIOL CHEM, V278, P45763, DOI 10.1074/jbc.M305481200; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Sanger GJ, 2007, BRIT J PHARMACOL, V152, P663, DOI 10.1038/sj.bjp.0707422; Sasso O, 2015, FASEB J, V29, P2616, DOI 10.1096/fj.15-270637; Scarpignato C, 2010, GASTROENTEROL CLIN N, V39, P433, DOI 10.1016/j.gtc.2010.08.010; Selinsky BS, 2001, BIOCHEMISTRY-US, V40, P5172, DOI 10.1021/bi010045s; Sidhu RS, 2010, BIOCHEMISTRY-US, V49, P7069, DOI 10.1021/bi1003298; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; So OY, 1998, J BIOL CHEM, V273, P5801, DOI 10.1074/jbc.273.10.5801; Sostres C, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4175; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vecchio AJ, 2012, J BIOL CHEM, V287, P24619, DOI 10.1074/jbc.M112.372243; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Xu S, 2014, J BIOL CHEM, V289, P6799, DOI 10.1074/jbc.M113.517987; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181	51	11	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3028	3038		10.1074/jbc.M117.802058	http://dx.doi.org/10.1074/jbc.M117.802058			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29326169	Green Published, hybrid			2022-12-26	WOS:000426562800001
J	Sanfins, E; Correia, A; Gunnarsson, SB; Vilanova, M; Cedervall, T				Sanfins, Elodie; Correia, Alexandra; Gunnarsson, Stefan B.; Vilanova, Manuel; Cedervall, Tommy			Nanoparticle effect on neutrophil produced myeloperoxidase	PLOS ONE			English	Article							GOLD NANOPARTICLES; PROTEIN CORONA; SIZE; DENSITY; CHEMISTRY; BEHAVIOR; CELLS; KILL	Nanoparticles affect the immune system as they may interact directly with immune cells and activate them. However, it is possible that nanoparticles also interact with released cytokines and immunologically active enzymes. To test this hypothesis, the activity of myeloperoxidase released from activated neutrophils was measured in the presence of nanoparticles with different chemistry and size. In high concentrations of nanoparticles, myeloperoxidase activity is decreased whereas in low concentrations of nanoparticles the activity is increased. The effect of the nanoparticles on myeloperoxidase is dependent on the total protein concentration as low concentrations of bovine serum albumin together with nanoparticles further increase the myeloperoxidase activity. The results herein show that nanoparticles affect the immune response not only at the cellular level but also on released immune effectors. In particular, they show that the nanoparticle effect on myeloperoxidase activity in the neutrophil degranulation environment is the result of an intricate interplay between the enzyme and protein concentrations in the environment and the available surface area on the nanoparticle.	[Sanfins, Elodie; Gunnarsson, Stefan B.; Cedervall, Tommy] Lund Univ, Biochem & Struct Biol, Lund, Sweden; [Sanfins, Elodie; Gunnarsson, Stefan B.; Cedervall, Tommy] Lund Univ, NanoLund, Lund, Sweden; [Sanfins, Elodie] Univ Paris Saclay, CEA, Inst Francois Jacob, Fontenay Aux Roses, France; [Correia, Alexandra; Vilanova, Manuel] Univ Porto, ICBAS, Oporto, Portugal; [Correia, Alexandra; Vilanova, Manuel] Univ Porto, I3S Inst Invest & Inovacao Saude, Oporto, Portugal; [Correia, Alexandra; Vilanova, Manuel] Univ Porto, IBMC, Oporto, Portugal	Lund University; Lund University; CEA; UDICE-French Research Universities; Universite Paris Saclay; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto	Sanfins, E; Cedervall, T (corresponding author), Lund Univ, Biochem & Struct Biol, Lund, Sweden.; Sanfins, E; Cedervall, T (corresponding author), Lund Univ, NanoLund, Lund, Sweden.; Sanfins, E (corresponding author), Univ Paris Saclay, CEA, Inst Francois Jacob, Fontenay Aux Roses, France.	elodie.sanfins@cea.fr; tommy.cedervall@biochemistry.lu.se	Vilanova, Manuel/D-2127-2013; Cedervall, Tommy/AAT-9766-2021; Correia, Alexandra/AID-6313-2022	Vilanova, Manuel/0000-0001-7007-306X; Cedervall, Tommy/0000-0003-2255-8446; Correia, Alexandra/0000-0003-0408-6262	FCT [SFRH/BPD/91623/2012]; NanoLund at Lund University; People Programme (Marie Curie Actions) of the European Union'sSeventh Framework Programme (FP7) [608153]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); NanoLund at Lund University; People Programme (Marie Curie Actions) of the European Union'sSeventh Framework Programme (FP7)	AC was supported by FCT fellowship SFRH/BPD/91623/2012. This work was supported by grants from the NanoLund at Lund University. SBG was funded by People Programme (Marie Curie Actions) of the European Union'sSeventh Framework Programme (FP7/2007-2013) under REA grant agreementn 608153, PhD4Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Alexandra Correia was supported by FCT fellowship SFRH/BPD/91623/2012. Stefan B. Gunnarsson was supported by People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no 608153, PhD4Energy. This work was supported by grants from the NanoLund at Lund University	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Cedervall T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032254; Cukalevski R, 2011, LANGMUIR, V27, P14360, DOI 10.1021/la203290a; Dinauer Mary C, 2005, Hematology Am Soc Hematol Educ Program, P89; Dobrovolskaia MA, 2009, NANOMED-NANOTECHNOL, V5, P106, DOI 10.1016/j.nano.2008.08.001; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Fang RNH, 2016, ANNU REV CHEM BIOMOL, V7, P305, DOI 10.1146/annurev-chembioeng-080615-034446; Ferreira SA, 2013, NANOMED-NANOTECHNOL, V9, P159, DOI 10.1016/j.nano.2012.06.001; Gomez-Lopez N, 2014, CELL MOL IMMUNOL, V11, P571, DOI 10.1038/cmi.2014.46; Gottschalk F, 2011, J ENVIRON MONITOR, V13, P1145, DOI 10.1039/c0em00547a; Hazen SL, 1996, J BIOL CHEM, V271, P23080, DOI 10.1074/jbc.271.38.23080; Hazen SL, 1996, J CLIN INVEST, V98, P1283, DOI 10.1172/JCI118914; Johannssen T, 2017, TRENDS BIOTECHNOL, V35, P334, DOI 10.1016/j.tibtech.2016.10.002; Ju-Nam Y, 2008, SCI TOTAL ENVIRON, V400, P396, DOI 10.1016/j.scitotenv.2008.06.042; Kaplan MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4325; Kim ND, 2015, TRENDS IMMUNOL, V36, P547, DOI 10.1016/j.it.2015.07.007; Kruger P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004651; Lekstrom-Himes JA, 2000, NEW ENGL J MED, V343, P1703, DOI 10.1056/NEJM200012073432307; Liu F, 2015, ACS APPL MATER INTER, V7, P3717, DOI 10.1021/am5084545; Lundqvist M, 2004, LANGMUIR, V20, P10639, DOI 10.1021/la0484725; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Moghimi SM, 2011, ADV DRUG DELIVER REV, V63, P1000, DOI 10.1016/j.addr.2011.06.002; Nasir I, 2015, NANOSCALE, V7, P17504, DOI 10.1039/c5nr05360a; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nauseef WM, 2004, JPN J INFECT DIS, V57, pS4; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Newby AC, 2015, MATRIX BIOL, V44-46, P157, DOI 10.1016/j.matbio.2015.01.015; Nowack B, 2007, ENVIRON POLLUT, V150, P5, DOI 10.1016/j.envpol.2007.06.006; Oslakovic C, 2012, NANOMED-NANOTECHNOL, V8, P981, DOI 10.1016/j.nano.2011.12.001; Papandrea VA, 2009, SMALL WEINH BERGSTR, V5, P470; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Parker H, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00424; Parker H, 2012, J LEUKOCYTE BIOL, V91, P369, DOI 10.1189/jlb.0711387; Rahat MA, 2016, MEDIAT INFLAMM MEDIA, V2016; Saha B, 2015, ANALYST, V140, P532, DOI 10.1039/c4an01639d; Sanfins E, 2014, NANO LETT, V14, P4736, DOI 10.1021/nl501863u; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Shang W, 2007, NANO LETT, V7, P1991, DOI 10.1021/nl070777r; Shen CC, 2011, INT J NANOMED, V6, P1229, DOI 10.2147/IJN.S21019; Wolf-Grosse S, 2017, INT J NANOMED, V12, P3927, DOI 10.2147/IJN.S136453; Yue H, 2015, VACCINE, V33, P5927, DOI 10.1016/j.vaccine.2015.07.100	42	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191445	10.1371/journal.pone.0191445	http://dx.doi.org/10.1371/journal.pone.0191445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346422	Green Published, gold			2022-12-26	WOS:000422749500052
J	Amar, A; Zlochiver, S; Barnea, O				Amar, Ani; Zlochiver, Sharon; Barnea, Ofer			Mechano-electric feedback effects in a three-dimensional (3D) model of the contracting cardiac ventricle	PLOS ONE			English	Article							CELLULAR MECHANISMS; ARRHYTHMIAS; MYOCYTES; HEART; INDUCTION; DYNAMICS; CURRENTS; STRETCH; LENGTH	Mechano-electric feedback affects the electrophysiological and mechanical function of the heart and the cellular, tissue, and organ properties. To determine the main factors that contribute to this effect, this study investigated the changes in the action potential characteristics of the ventricle during contraction. A model of stretch-activated channels was incorporated into a three-dimensional multiscale model of the contracting ventricle to assess the effect of different preload lengths on the electrophysiological behavior. The model describes the initiation and propagation of the electrical impulse, as well as the passive (stretch) and active (contraction) changes in the cardiac mechanics. Simulations were performed to quantify the relationship between the cellular activation and recovery patterns as well as the action potential durations at different preload lengths in normal and heart failure pathological conditions. The simulation results showed that heart failure significantly affected the excitation propagation parameters compared to normal condition. The results showed that the mechano-electrical feedback effects appear to be most important in failing hearts with low ejection fraction.	[Amar, Ani; Zlochiver, Sharon; Barnea, Ofer] Tel Aviv Univ, Dept Biomed Engn, Fac Engn, Tel Aviv, Israel	Tel Aviv University	Barnea, O (corresponding author), Tel Aviv Univ, Dept Biomed Engn, Fac Engn, Tel Aviv, Israel.	barneao@eng.tau.ac.il	Amar, Ani/AAC-3581-2021	Amar, Ani/0000-0002-9149-2666				Amar A, 2012, IEEE 27 CONV EL EL E; Amar A, 2015, CARDIOVASC ENG TECHN, V6, P401, DOI 10.1007/s13239-015-0247-5; Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005; DEAN JW, 1990, J PHYSIOL-LONDON, V429, P387, DOI 10.1113/jphysiol.1990.sp018263; FRANZ MR, 1989, CARDIOVASC RES, V23, P213, DOI 10.1093/cvr/23.3.213; Garny A, 2004, ANN NY ACAD SCI, V1015, P133, DOI 10.1196/annals.1302.011; HANSEN DE, 1993, AM J PHYSIOL, V264, pH423, DOI 10.1152/ajpheart.1993.264.2.H423; Healy SN, 2005, EUROPACE, V7, pS128, DOI 10.1016/j.eupc.2005.03.019; Hu Y, 2013, 2013 2ND INTERNATIONAL SYMPOSIUM ON INSTRUMENTATION AND MEASUREMENT, SENSOR NETWORK AND AUTOMATION (IMSNA), P8, DOI 10.1109/IMSNA.2013.6742806; Isenberg G, 2003, PROG BIOPHYS MOL BIO, V82, P43, DOI 10.1016/S0079-6107(03)00004-X; Jie X, 2010, CIRC RES, V106, P185, DOI 10.1161/CIRCRESAHA.109.210864; Keldermann RH, 2010, AM J PHYSIOL-HEART C, V299, pH134, DOI 10.1152/ajpheart.00862.2009; Kohl P, 1998, CAN J CARDIOL, V14, P111; Li WH, 2004, J MOL HISTOL, V35, P679; Negroni JA, 1996, J MOL CELL CARDIOL, V28, P915, DOI 10.1006/jmcc.1996.0086; Noble D, 1998, CAN J CARDIOL, V14, P123; SACHS F, 1994, CELL MECHANICS AND CELLULAR ENGINEERING, P308; Shim EB, 2007, J PHYSIOL SCI, V57, P275, DOI 10.2170/physiolsci.RP006007; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; WHITE E, 1993, EXP PHYSIOL, V78, P65, DOI 10.1113/expphysiol.1993.sp003671; Wickenden AD, 1998, CARDIOVASC RES, V37, P312, DOI 10.1016/S0008-6363(97)00256-3; Witman S, 2011, COMPUT METHOD BIOMEC, V14, P957, DOI 10.1080/10255842.2010.502893; Zeng T, 2000, AM J PHYSIOL-HEART C, V278, pH548, DOI 10.1152/ajpheart.2000.278.2.H548; Zlochiver S, 2010, CARDIOVASC ENG, V10, P190, DOI 10.1007/s10558-010-9104-1	24	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191238	10.1371/journal.pone.0191238	http://dx.doi.org/10.1371/journal.pone.0191238			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342222	Green Published, Green Submitted, gold			2022-12-26	WOS:000422653800054
J	Ashraf, MI; Sinha, S				Ashraf, Md Izhar; Sinha, Sitabhra			The "handedness" of language: Directional symmetry breaking of sign usage in words	PLOS ONE			English	Article							ENTROPY; SCRIPT	Language, which allows complex ideas to be communicated through symbolic sequences, is a characteristic feature of our species and manifested in a multitude of forms. Using large written corpora for many different languages and scripts, we show that the occurrence probability distributions of signs at the left and right ends of words have a distinct heterogeneous nature. Characterizing this asymmetry using quantitative inequality measures, viz. information entropy and the Gini index, we show that the beginning of a word is less restrictive in sign usage than the end. This property is not simply attributable to the use of common affixes as it is seen even when only word roots are considered. We use the existence of this asymmetry to infer the direction of writing in undeciphered inscriptions that agrees with the archaeological evidence. Unlike traditional investigations of phonotactic constraints which focus on language-specific patterns, our study reveals a property valid across languages and writing systems. As both language and writing are unique aspects of our species, this universal signature may reflect an innate feature of the human cognitive phenomenon.	[Ashraf, Md Izhar; Sinha, Sitabhra] Inst Math Sci, Madras, Tamil Nadu, India; [Ashraf, Md Izhar] BS Abdur Rahman Univ, Madras, Tamil Nadu, India; [Sinha, Sitabhra] Natl Inst Adv Studies, Bengaluru, Karnataka, India	Institute of Mathematical Sciences (IMSc) India; B. S. Abdur Rahman Crescent Institute of Science & Technology	Sinha, S (corresponding author), Inst Math Sci, Madras, Tamil Nadu, India.; Sinha, S (corresponding author), Natl Inst Adv Studies, Bengaluru, Karnataka, India.	sitabhra@imsc.res.in		Sinha, Sitabhra/0000-0002-3004-1079	IMSc PRISM project - Department of Atomic Energy, Government of India	IMSc PRISM project - Department of Atomic Energy, Government of India	This work was partially supported by the IMSc PRISM project funded by the Department of Atomic Energy, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; We thank P. P. Divakaran, Deepak Dhar, Iravatham Mahadevan, Shakti N. Menon, Adwait Mevada, Ganesh Ramachandran and Chandrasekhar Subramanian for helpful discussions and suggestions. We also thank Bryan K. Wells for allowing the use of the IVC sequence database compiled by him. This work was partially supported by the IMSc PRISM project funded by the Department of Atomic Energy, Government of India.	[Anonymous], 2010, PATTERN THEORY STOCH; Breiman L., 1984, CLASSIFICATION REGRE; BROWN MC, 1994, SOC SCI MED, V38, P1243, DOI 10.1016/0277-9536(94)90189-9; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Coulmas F., 1996, BLACKWELL ENCY WRITI; Daniels PT., 1996, WORLDS WRITING SYSTE, V81, P588; Deacon T., 1997, SYMBOLIC SPECIES COE; DEFRANCIS J, 1994, LINGUISTICS, V32, P549, DOI 10.1515/ling.1994.32.3.549; Dodds PS, 2015, P NATL ACAD SCI USA, V112, P2389, DOI 10.1073/pnas.1411678112; Dunbar RIM, 1996, GROOMING GOSSIP EVOL; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Gini C, 2012, J ECON INEQUAL, V10, P421; Heaps Harold Stanley, 1978, INFORM RETRIEVAL COM; Hunter G, 1934, SCRIPT HARAPPA MOHEN; Lawler A, 2004, SCIENCE, V306, P2026, DOI 10.1126/science.306.5704.2026; Mahadevan I., 1977, MEMOIRS ARCHAEOLOGIC, V77; McMahon A., 2002, INTRO ENGLISH PHONOL; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Parpola A. H. S., 1994, DECIPHERING INDUS SC; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00943; Plag Ingo, 2003, WORD FORMATION ENGLI; Possehl Gregory L., 2002, INDUS CIVILIZATION C; Rao RPN, 2009, SCIENCE, V324, P1165, DOI 10.1126/science.1170391; Robinson A., 2009, WRITING AND SCRIPT; Schurmann T, 1996, CHAOS, V6, P414, DOI 10.1063/1.166191; Schurmann T, 1996, FRACTALS, V4, P1, DOI 10.1142/S0218348X96000029; SHANNON CE, 1951, BELL SYST TECH J, V30, P50, DOI 10.1002/j.1538-7305.1951.tb01366.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sinha S., 2011, ECONOPHYSICS INTRO; Sinha S, 2011, COMPUT SPEECH LANG, V25, P639, DOI 10.1016/j.csl.2010.05.007; Unger J. M., 2004, IDEOGRAM CHINESE CHA; Wells BK., 2015, ARCHAEOLOGY EPIGRAPH, DOI 10.2307/j.ctvr43jmf; Zipf G. K., 1932, SELECTED STUDIES PRI	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190735	10.1371/journal.pone.0190735	http://dx.doi.org/10.1371/journal.pone.0190735			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342176	Green Published, gold, Green Submitted			2022-12-26	WOS:000422653800032
J	Gracy, D; Fabian, A; Basch, CH; Scigliano, M; MacLean, SA; MacKenzie, RK; Redlener, IE				Gracy, Delaney; Fabian, Anupa; Basch, Corey Hannah; Scigliano, Maria; MacLean, Sarah A.; MacKenzie, Rachel K.; Redlener, Irwin E.			Missed opportunities: Do states require screening of children for health conditions that interfere with learning?	PLOS ONE			English	Article							ADVERSE CHILDHOOD EXPERIENCES; BLOOD LEAD LEVELS; EDUCATIONAL-ATTAINMENT; ACADEMIC-PERFORMANCE; SCHOOL PERFORMANCE; MENTAL-DISORDERS; FOOD INSECURITY; UNITED-STATES; HEARING-LOSS; ORAL-HEALTH	Strong evidence supports the existence of Health Barriers to Learning (HBLs)-health conditions that when untreated or unmanaged can interfere with a child's ability to learn and succeed in school. These HBLs include vision and hearing deficits, uncontrolled asthma, mental and behavioral problems, dental pain, persistent hunger, and the effects of lead exposure. However, 19% of US children aged 6 to 11 did not receive their annual checkup in the past year. School requirements for health screenings can help identify children with HBLs. This study explores which states require health screening for children in elementary school, and the extent to which the 7 HBLs are included. Methods Investigators reviewed websites of state departments of health and education, and legislation for all 50 states and DC. For states with mandated screenings and a required form, investigators applied structured analysis to assess HBL inclusion. Results No state mandated that schools require screening for all 7 HBLs. Less than half (49%) required comprehensive school health examinations and only 12 states plus DC required a specific form. Of these, 12 of the forms required documentation of vision screening, 11 of hearing screening, and 12 of dental screening. Ten forms asked about asthma and 9 required documentation of lead testing. Seven asked about general well-being, emotional problems, or mental health. None addressed hunger. When including states without comprehensive school health examination requirements, the most commonly required HBL screenings were for vision (80% of states; includes DC), hearing (75% of states; includes DC) and dental (24% of state; includes DC). Conclusion The lack of state mandated requirements for regular student health screening represents a missed opportunity to identify children with HBLs. Without state mandates, accompanying comprehensive forms, and protocols, children continue to be at risk of untreated health conditions that can undermine their success in school.	[Gracy, Delaney; Fabian, Anupa; Scigliano, Maria; MacKenzie, Rachel K.; Redlener, Irwin E.] Childrens Hlth Fund, New York, NY 10027 USA; [Basch, Corey Hannah] William Paterson Univ, Dept Publ Hlth, New York, NY USA; [MacLean, Sarah A.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Redlener, Irwin E.] Columbia Univ, Mailman Sch Publ Hlth, Dept Hlth Policy & Management, New York, NY USA	Columbia University; Columbia University	Gracy, D (corresponding author), Childrens Hlth Fund, New York, NY 10027 USA.	dgracy@chfund.org						Advisory Committee on Childhood Lead Poisoning Prevention of the Centers for Disease Control and Prevention, 2012, LOW LEV LEAD EXP HAR; Alaimo K, 2001, PEDIATRICS, V108, P44; Ashiabi G., 2005, J CHILD POVERTY, V11, P3, DOI [10.1080/1079612042000333027, DOI 10.1080/1079612042000333027]; Asthma and Allergy Foundation of America, 2016, STAT HON ROLL REP AS; Barnhardt C, 2005, OPTOMETRY VISION SCI, V82, P138, DOI 10.1097/01.OPX.0000153266.50875.53; Basch CE, 2015, HLTH BARRIERS LEARNI; Basch CE, 2011, J SCHOOL HEALTH, V81, P593, DOI 10.1111/j.1746-1561.2011.00632.x; Basch CE, 2011, J SCHOOL HEALTH, V81, P599, DOI 10.1111/j.1746-1561.2011.00633.x; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; Bethell CD, 2014, HEALTH AFFAIR, V33, P2106, DOI 10.1377/hlthaff.2014.0914; Blodgett C, 2014, ADVERSE CHILDHOOD EX; Bodack MI, 2010, OPTOMETRY, V81, P476, DOI 10.1016/j.optm.2010.05.006; Booth M, 2008, STATE LAWS DENT FEMI; Brandon RN, 2001, HLTH LEARN STATE REQ; Breslau J, 2008, J PSYCHIATR RES, V42, P708, DOI 10.1016/j.jpsychires.2008.01.016; Bright Futures American Academy of Pediatrics, 2017, REC PREV PED HLTH CA; Bright Futures American Academy of Pediatrics, 2017, REC PREV PED HLHT CA; Bright K., 2011, AM ACAD AUDIOLOGY CH; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; Centers for Disease Control and Prevention (CDC) and National Center for Health Statistics (NCHS), 2015, NAT HLTH NUTR EX SUR; Choi T B, 1995, J Am Optom Assoc, V66, P484; Coleman-Jensen A., 2016, ERR215 USDA EC RES S; COUNCIL COMMUNITY PEDIAT, 2015, PEDIATRICS, V136, pE1431, DOI 10.1542/peds.2015-3301; Council On Community P, 2016, PEDIATRICS, P137; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Diette GB, 2000, ARCH PEDIAT ADOL MED, V154, P923, DOI 10.1001/archpedi.154.9.923; Esch P, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0237-4; Evens A, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0008-9; Gracy D, 2017, HLTH BARRIERS LEARNI; Green DR, 2007, PUBLIC HEALTH REP, V122, P198, DOI 10.1177/003335490712200209; Hagan Jr JF, 2007, BRIGHT FUTURES; Halterman JS, 2001, AMBUL PEDIATR, V1, P201, DOI 10.1367/1539-4409(2001)001<0201:SRAUCW>2.0.CO;2; Henning-Smith C, 2016, J CHILD HEALTH CARE, V20, P185, DOI 10.1177/1367493514563855; Jackson SL, 2011, AM J PUBLIC HEALTH, V101, P1900, DOI 10.2105/AJPH.2010.200915; Jyoti DF, 2005, J NUTR, V135, P2831, DOI 10.1093/jn/135.12.2831; Kerker BD, 2015, ACAD PEDIATR, V15, P510, DOI 10.1016/j.acap.2015.05.005; Kleinman RE, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e3; Krumholtz I, 2000, Optometry, V71, P426; Kulp MT, 2016, OPHTHALMOLOGY, V123, P681, DOI 10.1016/j.ophtha.2015.11.023; Lanphear BP, 2000, PUBLIC HEALTH REP, V115, P521, DOI 10.1093/phr/115.6.521; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Lieu JEC, 2004, ARCH OTOLARYNGOL, V130, P524, DOI 10.1001/archotol.130.5.524; Lieu JEC, 2010, PEDIATRICS, V125, pE1348, DOI 10.1542/peds.2009-2448; Locker D, 2004, J PUBLIC HEALTH DENT, V64, P63, DOI 10.1111/j.1752-7325.2004.tb02729.x; McLaine P, 2013, PEDIATRICS, V131, P1081, DOI 10.1542/peds.2012-2277; McLoyd VC, 1998, AM PSYCHOL, V53, P185, DOI 10.1037/0003-066X.53.2.185; Meijer AM, 2004, PERS INDIV DIFFER, V37, P95, DOI 10.1016/j.paid.2003.08.002; Mensah George A, 2004, Prev Chronic Dis, V1, pA13; Michael SL, 2015, J SCHOOL HEALTH, V85, P740, DOI 10.1111/josh.12309; Miranda ML, 2009, NEUROTOXICOLOGY, V30, P1019, DOI 10.1016/j.neuro.2009.07.012; National Center for Environmental Health, 2015, NIM PERC ASTHM REL M; National Health Interview Survey-Child and Family Core NHIS-Child, 2014, NAT HLTH INT SURV CH; Ou SR, 2008, SCHOOL PSYCHOL QUART, V23, P199, DOI 10.1037/1045-3830.23.2.199; Pizzarello L, 1998, J AAPOS, V2, P372, DOI 10.1016/S1091-8531(98)90038-6; Pourat Nadereh, 2009, Policy Brief UCLA Cent Health Policy Res, P1; Preslan MW, 1996, OPHTHALMOLOGY, V103, P105, DOI 10.1016/S0161-6420(96)30753-7; Redlener I, 2016, UNFINISHED BUSINESS; Ruderman M., 2016, CHILDRENS VISION EYE, V1st; Seirawan H, 2012, AM J PUBLIC HEALTH, V102, P1729, DOI 10.2105/AJPH.2011.300478; Sekhar DL, 2016, J ADOLESCENT HEALTH, V59, P362, DOI 10.1016/j.jadohealth.2016.02.002; Sekhar DL, 2013, J COMMUN HEALTH, V38, P569, DOI 10.1007/s10900-013-9652-6; Simon AE, 2015, PSYCHIAT SERV, V66, P930, DOI 10.1176/appi.ps.201400342; Szefler SJ, 2011, ANN ALLERG ASTHMA IM, V107, P110, DOI 10.1016/j.anai.2011.04.008; Taras H, 2005, J SCHOOL HEALTH, V75, P296, DOI 10.1111/j.1746-1561.2005.00041.x; Third Expert Panel on the Management of Asthma National Asthma Education and Prevention Program Coordinating Committee, 2007, 3 US DEP HHS NAT I H; Wheeler W, 2013, MMWR-MORBID MORTAL W, V62, P245; Winicki J, 2003, CONTEMP ECON POLICY, V21, P145, DOI 10.1093/cep/byg001; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654	68	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190254	10.1371/journal.pone.0190254	http://dx.doi.org/10.1371/journal.pone.0190254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8II	29342147	Green Published, Green Submitted, gold			2022-12-26	WOS:000422653800016
J	Nixon, LJ; Morrison, WR; Rice, KB; Brockerhoff, EG; Leskey, TC; Guzman, F; Khrimian, A; Goldson, S; Rostas, M				Nixon, Laura J.; Morrison, William R.; Rice, Kevin B.; Brockerhoff, Eckehard G.; Leskey, Tracy C.; Guzman, Filadelfo; Khrimian, Ashot; Goldson, Stephen; Rostas, Michael			Identification of volatiles released by diapausing brown marmorated stink bug, Halyomorpha halys (Hemiptera: Pentatomidae)	PLOS ONE			English	Article							1855 HETEROPTERA-PENTATOMIDAE; CHEMICAL DEFENSE; STAL; COMPONENTS; ECOLOGY	The brown marmorated stink bug, Halyomorpha halys, is an agricultural and urban pest that has become widely established as an invasive species of major concern in the USA and across Europe. This species forms large aggregations when entering diapause, and it is often these aggregations that are found by officials conducting inspections of internationally shipped freight. Identifying the presence of diapausing aggregations of H. halys using their emissions of volatile organic compounds (VOCs) may be a potential means for detecting and intercepting them during international freight inspections. Headspace samples were collected from aggregations of diapausing H. halys using volatile collection traps (VCTs) and solid phase microextraction. The only compound detected in all samples was tridecane, with small amounts of (E)-2-decenal found in most samples. We also monitored the release of defensive odors, following mechanical agitation of diapausing and diapause-disrupted adult H. halys. Diapausing groups were significantly more likely to release defensive odors than diapause-disrupted groups. The predominant compounds consistently found from both groups were tridecane, (E)-2-decenal, and 4-oxo-(E)-2-hexenal, with a small abundance of dodecane. Our findings show that diapausing H. halys do release defensive compounds, and suggest that volatile sampling may be feasible to detect H. halys in freight.	[Nixon, Laura J.; Goldson, Stephen; Rostas, Michael] Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand; [Nixon, Laura J.; Brockerhoff, Eckehard G.] Better Border Biosecur Collaborat, Christchurch, New Zealand; [Morrison, William R.] USDA ARS, Ctr Grain & Anim Hlth, Manhattan, KS USA; [Morrison, William R.; Rice, Kevin B.; Leskey, Tracy C.] USDA, Appalachian Fruit Res Stn, Kearneysville, WV USA; [Brockerhoff, Eckehard G.] Scion, New Zealand Forest Res Inst, Christchurch, New Zealand; [Guzman, Filadelfo; Khrimian, Ashot] USDA ARS, NEA, IIBBL, 10300 Baltimore Blvd, Beltsville, MD USA; [Goldson, Stephen] AgResearch, Christchurch, New Zealand	Lincoln University - New Zealand; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Scion; United States Department of Agriculture (USDA); AgResearch - New Zealand	Nixon, LJ (corresponding author), Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand.; Nixon, LJ (corresponding author), Better Border Biosecur Collaborat, Christchurch, New Zealand.	laura.nixon@lincolnuni.ac.nz	Rostas, Michael/B-6769-2008; Morrison, William R/H-8596-2019; Brockerhoff, Eckehard Gustav/C-1528-2009	Rostas, Michael/0000-0001-9722-6513; Morrison, William R/0000-0002-1663-8741; Brockerhoff, Eckehard Gustav/0000-0002-5962-3208	New Zealand government via Ministry of Business, Innovation, and Employment core [C04X1104]; Better Border Biosecurity Collaboration; National Institue of Farming and Agriculture Speciality Crop Research Initiative CAP Grant [2011-51181-30937]	New Zealand government via Ministry of Business, Innovation, and Employment core; Better Border Biosecurity Collaboration; National Institue of Farming and Agriculture Speciality Crop Research Initiative CAP Grant	Contributions by L.J.N. and E.G.B. were supported by the New Zealand government via Ministry of Business, Innovation, and Employment core funding to Plant and Food Research and Scion (contract C04X1104), respectively, and the Better Border Biosecurity Collaboration (www.b3nz.org). Contributions by K.R. and W.R.M. were supported by National Institue of Farming and Agriculture Speciality Crop Research Initiative CAP Grant (#2011-51181-30937). The funders had no role in study design, data collection and analysis, decision to publisg, or preparation of manuscript.	Aigner J. D., 2016, Journal of Agricultural and Urban Entomology, V32, P1, DOI 10.3954/1523-5475-32.1.1; ALDRICH JR, 1988, ANNU REV ENTOMOL, V33, P211, DOI 10.1146/annurev.en.33.010188.001235; Baldwin RL, 2014, J DAIRY SCI, V97, P1877, DOI 10.3168/jds.2013-7545; Bergh JC, 2017, ENTOMOL EXP APPL, V162, P336, DOI 10.1111/eea.12539; Biasioli F, 2011, TRAC-TREND ANAL CHEM, V30, P1003, DOI 10.1016/j.trac.2011.04.005; BORGES M, 1992, EXPERIENTIA, V48, P893, DOI 10.1007/BF02118429; da Silva RA, 2015, J INVERTEBR PATHOL, V127, P93, DOI 10.1016/j.jip.2015.03.009; Direct P., 2011, ANAL CHEM, V30, P945; Faundez Eduardo I., 2017, Arquivos Entomoloxicos, V17, P305; Gapon D.A., 2016, ENTOMOL REV, V96, P1086, DOI [10.1134/S001387381608011X, DOI 10.1134/S001387381608011X]; Gunawardena NE, 2017, J NATL SCI FDN, V20; Harris C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140876; Haye T, 2015, J PEST SCI, V88, P665, DOI 10.1007/s10340-015-0670-2; Henderson WG, 2010, COMPUT ELECTRON AGR, V70, P157, DOI 10.1016/j.compag.2009.09.019; Krall BS, 1999, J CHEM ECOL, V25, P2477, DOI 10.1023/A:1020822107806; Lampson B. D., 2014, J INSECTS, V2014; Lampson B.D., 2017, ADV ENTOMOL, V05, P75, DOI [10.4236/ae.2017.53007, DOI 10.4236/AE.2017.53007]; Lee DH, 2015, B ENTOMOL RES, V105, P566, DOI 10.1017/S0007485315000462; Lee DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091575; Lee DH, 2013, ENVIRON ENTOMOL, V42, P627, DOI 10.1603/EN13006; Millar JG, 2005, TOP CURR CHEM, V240, P37, DOI 10.1007/b98315; Milonas P. G., 2014, Bulletin OEPP, V44, P183, DOI 10.1111/epp.12129; Mohekar P, 2017, J AGR FOOD CHEM, V65, P872, DOI 10.1021/acs.jafc.6b04268; Moreira JA, 2005, J CHEM ECOL, V31, P965, DOI 10.1007/s10886-004-1978-1; Morrison WR, 2017, J ECON ENTOMOL, V110, P1002, DOI 10.1093/jee/tox097; Nielsen AL, 2017, ECOL EVOL, V7, P6680, DOI 10.1002/ece3.3125; Nielsen AL, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00165; Rice KB, 2014, J INTEGR PEST MANAG, V5, DOI 10.1603/IPM14002; Schiestl FP, 2010, ECOL LETT, V13, P643, DOI 10.1111/j.1461-0248.2010.01451.x; Simov Nikolay, 2016, Ecologica Montenegrina, V9, P51; TSUYUKI T, 1965, AGR BIOL CHEM TOKYO, V29, P419, DOI 10.1080/00021369.1965.10858405; Valentin RE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10315-z; Vetek G, 2014, ZOOTAXA, V 3780, P194, DOI 10.11646/zootaxa.3780.1.8; Vichi S, 2007, FOOD CHEM, V102, P1260, DOI 10.1016/j.foodchem.2006.07.023; Zhu GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031246	35	15	16	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191223	10.1371/journal.pone.0191223	http://dx.doi.org/10.1371/journal.pone.0191223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342183	Green Published, Green Submitted, gold			2022-12-26	WOS:000422653800053
J	Orioli, R; Cremona, G; Ciancarella, L; Solimini, AG				Orioli, Riccardo; Cremona, Giuseppe; Ciancarella, Luisella; Solimini, Angelo G.			Association between PM10, PM2.5, NO2, O-3 and self-reported diabetes in Italy: A cross-sectional, ecological study	PLOS ONE			English	Article							FINE PARTICULATE MATTER; LONG-TERM EXPOSURE; AIR-POLLUTION EXPOSURE; INSULIN-RESISTANCE; MELLITUS; INFLAMMATION; RISK; PREVALENCE; ATHEROSCLEROSIS; HYPERTENSION	Introduction Air pollution represents a serious threat to health on a global scale, being responsible for a large portion of the global burden of disease from environmental factors. Current evidence about the association between air pollution exposure and Diabetes Mellitus (DM) is still controversial. We aimed to evaluate the association between area-level ambient air pollution and self-reported DM in a large population sample in Italy. Materials and methods We extracted information about self-reported and physician diagnosed DM, risk factors and socio-economic status from 12 surveys conducted nationwide between 1999 and 2013. We obtained annual averaged air pollution levels for the years 2003, 2005, 2007 and 2010 from the AMS-MINNI national integrated model, which simulates the dispersion and transformation of pollutants. The original maps, with a resolution of 4 x 4 km2, were normalized and aggregated at the municipality class of each Italian region, in order to match the survey data. We fit logistic regression models with a hierarchical structure to estimate the relationship between PM10, PM2.5, NO2 and 03 four-years mean levels and the risk of being affected by DM. Results We included 376,157 individuals aged more than 45 years. There were 39,969 cases of DM, with an average regional prevalence of 9.8% and a positive geographical North-to-South gradient, opposite to that of pollutants' concentrations. For each 10 fag/m3 increase, the resulting ORs were 1.04 (95% CI 1.01-1.07) for PM10, 1.04 (95% CI 1.02-1.07) for PM2.5, 1.03 (95% CI 1.01-1.05) for NO2 and 1.06 (95% CI 1.01-1.11) for 03, after accounting for relevant individual risk factors. The associations were robust to adjustment for other pollutants in two-pollutant models tested (ozone plus each other pollutant). Conclusions We observed a significant positive association between each examined pollutant and prevalent DM. Risk estimates were consistent with current evidence, and robust to sensitivity analysis. Our study adds evidence about the effects of air pollution on diabetes and suggests a possible role of ozone as an independent factor associated with the development of DM. Such relationship is of great interest for public health and deserves further investigation.	[Orioli, Riccardo; Solimini, Angelo G.] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy; [Cremona, Giuseppe; Ciancarella, Luisella] Natl Agcy New Technol Energy & Sustainable Econ D, Sustainable Terr & Prod Syst Dept, Bologna, Italy	Sapienza University Rome; Italian National Agency New Technical Energy & Sustainable Economics Development	Orioli, R (corresponding author), Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy.	riccardo.orioli@uniroma1.it	Solimini, Angelo G/C-9290-2018	Solimini, Angelo/0000-0002-5281-7624; Ciancarella, Luisella/0000-0002-7123-0909				Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Andersen ZJ, 2012, DIABETES CARE, V35, P92, DOI 10.2337/dc11-1155; Balti EV, 2014, DIABETES RES CLIN PR, V106, P161, DOI 10.1016/j.diabres.2014.08.010; BARON AD, 1995, J CLIN INVEST, V96, P786, DOI 10.1172/JCI118124; Bass V, 2013, TOXICOL APPL PHARM, V273, P551, DOI 10.1016/j.taap.2013.09.029; Bauer M, 2010, J AM COLL CARDIOL, V56, P1803, DOI 10.1016/j.jacc.2010.04.065; Beelen R, 2014, LANCET, V383, P785, DOI 10.1016/S0140-6736(13)62158-3; Brook RD, 2008, J OCCUP ENVIRON MED, V50, P32, DOI 10.1097/JOM.0b013e31815dba70; Bui DS, 2013, RESPIROLOGY, V18, P1101, DOI 10.1111/resp.12108; Chen H, 2013, ENVIRON HEALTH PERSP, V121, P804, DOI 10.1289/ehp.1205958; Coogan PF, 2012, CIRCULATION, V125, P767, DOI 10.1161/CIRCULATIONAHA.111.052753; Dijkema MBA, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-76; Dubowsky SD, 2006, ENVIRON HEALTH PERSP, V114, P992, DOI 10.1289/ehp.8469; Eze IC, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0120-5; Eze IC, 2015, ENVIRON HEALTH PERSP, V123, P381, DOI 10.1289/ehp.1307823; Eze IC, 2014, ENVIRON INT, V70, P95, DOI 10.1016/j.envint.2014.05.014; Gariazzo C, 2007, ATMOS ENVIRON, V41, P6432, DOI 10.1016/j.atmosenv.2007.06.005; Geiss LS, 2014, JAMA-J AM MED ASSOC, V312, P1218, DOI 10.1001/jama.2014.11494; Hansen AB, 2016, ENVIRON INT, V91, P243, DOI 10.1016/j.envint.2016.02.036; ISTAT, 2015, EP NAT DIAB FACT SHE; ISTAT, 2013, MULT SURV HOUS HLTH; Janghorbani M, 2014, EUR J EPIDEMIOL, V29, P231, DOI 10.1007/s10654-014-9907-2; Jerrett M, 2017, ENVIRON INT, V102, P42, DOI 10.1016/j.envint.2016.12.011; Kelishadi R, 2009, ATHEROSCLEROSIS, V203, P311, DOI 10.1016/j.atherosclerosis.2008.06.022; Kramer U, 2010, ENVIRON HEALTH PERSP, V118, P1273, DOI 10.1289/ehp.0901689; Kunzli N, 2009, THORAX, V64, P664, DOI 10.1136/thx.2008.110031; Kunzli N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009096; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lockwood AH, 2002, DIABETES CARE, V25, P1487, DOI 10.2337/diacare.25.8.1487; Miller DB, 2016, AM J RESP CRIT CARE, P1; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962; Mircea M, 2014, ATMOS ENVIRON, V84, P178, DOI 10.1016/j.atmosenv.2013.11.006; Mircea M, 2011, HARMO 2011 P 14 INT, P52; Pearson JF, 2010, DIABETES CARE, V33, P2196, DOI 10.2337/dc10-0698; Piersanti A, 2012, 6 BIENN M INT ENV MO, V2012, P1375; Puett RC, 2011, ENVIRON HEALTH PERSP, V119, P384, DOI 10.1289/ehp.1002344; Raaschou-Nielsen O, 2013, LANCET ONCOL, V14, P813, DOI 10.1016/S1470-2045(13)70279-1; Rajagopalan S, 2012, DIABETES, V61, P3037, DOI 10.2337/db12-0190; Rao XQ, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0603-8; Schikowski T, 2014, EUR RESPIR J, V44, P614, DOI 10.1183/09031936.00132213; Silibello C, 2008, ENVIRON MODELL SOFTW, V23, P333, DOI 10.1016/j.envsoft.2007.04.002; Solimini AG, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2018-5; Steinvil A, 2008, ENVIRON RES, V106, P51, DOI 10.1016/j.envres.2007.08.006; Sullivan JH, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-3; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Sun QH, 2009, CIRCULATION, V119, P538, DOI 10.1161/CIRCULATIONAHA.108.799015; Thomson EM, 2016, TOXICOL SCI; Weinmayr G, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0031-x; WHO, 2006, AIR QUAL GUID GLOB U, DOI DOI 10.1016/0004-6981(88)90109-6; World Health Organization, 2016, GLOB REP DIAB, V978, P88; Zanini G, 2005, MODSIM 2005: INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION: ADVANCES AND APPLICATIONS FOR MANAGEMENT AND DECISION MAKING, P2005; Zanobetti A, 2008, ENV HLTH, V7, P48, DOI DOI 10.1186/1476-069X-7-48	53	34	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191112	10.1371/journal.pone.0191112	http://dx.doi.org/10.1371/journal.pone.0191112			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342195	Green Submitted, Green Published, gold			2022-12-26	WOS:000422653800046
J	Wang, CY; Klistorner, A; Ly, L; Barnett, MH				Wang, Chenyu; Klistorner, Alexander; Ly, Linda; Barnett, Michael H.			White matter tract-specific quantitative analysis in multiple sclerosis: Comparison of optic radiation reconstruction techniques	PLOS ONE			English	Article							DIFFUSION MRI; TEMPORAL-LOBE; HUMAN BRAIN; TRACTOGRAPHY; VARIABILITY; DISABILITY; ANATOMY; DELINEATION; VISION; ROBUST	The posterior visual pathway is commonly affected by multiple sclerosis (MS) pathology that results in measurable clinical and electrophysiological impairment. Due to its highly structured retinotopic mapping, the visual pathway represents an ideal substrate for investigating patho-mechanisms in MS. Therefore, a reliable and robust imaging segmentation method for in-vivo delineation of the optic radiations (OR) is needed. However, diffusion based tractography approaches, which are typically used for OR segmentation are confounded by the presence of focal white matter lesions. Current solutions require complex acquisition paradigms and demand expert image analysis, limiting application in both clinical trials and clinical practice. In the current study, using data acquired in a clinical setting on a 3T scanner, we optimised and compared two approaches for optic radiation (OR) reconstruction: individual probabilistic tractography-based and template-based methods. OR segmentation results were applied to subjects with MS and volumetric and diffusivity parameters were compared between OR segmentation techniques. Despite differences in reconstructed OR volumes, both OR lesion volume and OR diffusivity measurements in MS subjects were highly comparable using optimised probabilistic tractography-based, and template-based, methods. The choice of OR reconstruction technique should be determined primarily by the research question and the nature of the available dataset. Template-based approaches are particularly suited to the semi-automated analysis of large image datasets and have utility even in the absence of dMRI acquisitions. Individual tractography methods, while more complex than template based OR reconstruction, permit measurement of diffusivity changes	[Wang, Chenyu; Klistorner, Alexander; Ly, Linda; Barnett, Michael H.] Sydney Neuroimaging Anal Ctr, Sydney, NSW, Australia; [Wang, Chenyu; Ly, Linda; Barnett, Michael H.] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia; [Klistorner, Alexander] Univ Sydney, Save Sight Inst, Dept Ophthalmol, Sydney, NSW, Australia; [Klistorner, Alexander] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW, Australia	University of Sydney; University of Sydney; Macquarie University	Barnett, MH (corresponding author), Sydney Neuroimaging Anal Ctr, Sydney, NSW, Australia.; Barnett, MH (corresponding author), Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia.	michael@sydneyneurology.com.au		Klistorner, Alexander/0000-0003-0361-6399	Research Training Program Stipend (RTP), Australia; National Multiple Sclerosis Society (NMSS) grant [RG 4716A6/3T]; Novartis "Save Neuron" Grant [CT 3437]; Novartis "Optic Radiation in MS" Grant; Sydney Eye Hospital foundation grant; Sydney Medical School Foundation grant	Research Training Program Stipend (RTP), Australia; National Multiple Sclerosis Society (NMSS) grant; Novartis "Save Neuron" Grant; Novartis "Optic Radiation in MS" Grant; Sydney Eye Hospital foundation grant; Sydney Medical School Foundation grant	CW was supported by Research Training Program Stipend (RTP), Australia. The work was partially supported by National Multiple Sclerosis Society (NMSS) grant RG 4716A6/3T, Novartis "Save Neuron" Grant CT 3437, Novartis "Optic Radiation in MS" Grant, Sydney Eye Hospital foundation grant, Sydney Medical School Foundation grant.	Alvarez I, 2015, BRAIN STRUCT FUNCT, V220, P2519, DOI 10.1007/s00429-014-0799-4; Anderson AW, 2005, MAGN RESON MED, V54, P1194, DOI 10.1002/mrm.20667; Arrigo A, 2016, INVEST OPHTH VIS SCI, V57, P1, DOI 10.1167/iovs.15-18082; Balcer LJ, 2015, BRAIN, V138, P11, DOI 10.1093/brain/awu335; Bassi L, 2008, BRAIN, V131, P573, DOI 10.1093/brain/awm327; Battaglini M, 2012, HUM BRAIN MAPP, V33, P2062, DOI 10.1002/hbm.21344; Burgel U, 1999, NEUROIMAGE, V10, P489, DOI 10.1006/nimg.1999.0497; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Chamberland M, 2017, HUM BRAIN MAPP, V38, P509, DOI 10.1002/hbm.23399; Clatworthy PL, 2010, NEUROIMAGE, V49, P2001, DOI 10.1016/j.neuroimage.2009.10.083; Coetzee T, 2015, LANCET NEUROL, V14, P132, DOI 10.1016/S1474-4422(14)70323-0; Coubard OA, 2005, J VISION, V5, P1, DOI 10.1167/5.1.1; Dayan M, 2015, BRAIN STRUCT FUNCT, V220, P291, DOI 10.1007/s00429-013-0655-y; de Gervai PD, 2014, EPILEPSY RES, V108, P872, DOI 10.1016/j.eplepsyres.2014.03.006; EBELING U, 1988, ACTA NEUROCHIR, V92, P29, DOI 10.1007/BF01401969; Friese MA, 2014, NAT REV NEUROL, V10, P225, DOI 10.1038/nrneurol.2014.37; Harrison DM, 2013, J NEUROL, V260, P397, DOI 10.1007/s00415-012-6638-8; Hofer S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00015; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Ide S, 2012, ACAD RADIOL, V19, P1283, DOI 10.1016/j.acra.2012.05.018; Kammen A, 2016, NEUROIMAGE, V125, P767, DOI 10.1016/j.neuroimage.2015.11.005; Klistorner A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149245; Klistorner A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122114; Klistorner A, 2014, NEUROLOGY, V82, P2165, DOI 10.1212/WNL.0000000000000522; Lagana MM, 2012, J NEUROIMAGING, V22, P355, DOI 10.1111/j.1552-6569.2011.00650.x; Lassmann H, 2012, NAT REV NEUROL, V8, P647, DOI 10.1038/nrneurol.2012.168; Lim JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118948; Martinez-Heras E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137064; Martinez-Lapiscina EH, 2014, MULT SCLER J, V20, P1678, DOI 10.1177/1352458514542862; Mori N, 2009, INVEST RADIOL, V44, P140, DOI 10.1097/RLI.0b013e318193ff25; Nilsson D, 2007, EPILEPSY RES, V77, P11, DOI 10.1016/j.eplepsyres.2007.07.012; Parraga RG, 2012, NEUROSURGERY, V71, P160, DOI 10.1227/NEU.0b013e3182556fde; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Peltier J, 2006, J NEUROSURG, V105, P294, DOI 10.3171/jns.2006.105.2.294; Reich DS, 2010, NEUROIMAGE, V49, P3047, DOI 10.1016/j.neuroimage.2009.11.043; Rubino PA, 2005, NEUROSURGERY, V57, P219, DOI 10.1227/01.NEU.0000176415.83417.16; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.9.15; Shiee N, 2011, I S BIOMED IMAGING, P1488, DOI 10.1109/ISBI.2011.5872682; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Tax CMW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101524; Toga AW, 2012, NEUROSURGERY, V71, P1, DOI 10.1227/NEU.0b013e318258e9ff; Toosy AT, 2004, NEUROIMAGE, V21, P1452, DOI 10.1016/j.neuroimage.2003.11.022; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Wilson M, 2003, J NEUROL NEUROSUR PS, V74, P203, DOI 10.1136/jnnp.74.2.203; Winston GP, 2012, ANN NEUROL, V71, P334, DOI 10.1002/ana.22619; Wu W, 2011, NEUROSURGERY, V70, P145; Yamamoto T, 2005, AM J OPHTHALMOL, V140, P781, DOI 10.1016/j.ajo.2005.05.018; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790	49	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191131	10.1371/journal.pone.0191131	http://dx.doi.org/10.1371/journal.pone.0191131			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342192	Green Published, Green Submitted, gold			2022-12-26	WOS:000422653800048
J	Yapp, M; Rennie, G; Hennessy, MP; Kalloniatis, M; Zangerl, B				Yapp, Michael; Rennie, George; Hennessy, Michael P.; Kalloniatis, Michael; Zangerl, Barbara			The impact of optic nerve and related characteristics on disc area measurements derived from different imaging techniques	PLOS ONE			English	Article							SCANNING LASER OPHTHALMOSCOPY; RETINAL VESSEL DIAMETER; COHERENCE-TOMOGRAPHY; GLAUCOMA PATIENTS; MARGIN ANATOMY; TILTED DISCS; NORMAL EYES; RIM AREA; DOMAIN; SIZE	Purpose Optic nerve head (ONH) assessment and its interpretation in healthy patients and those with glaucoma remains a pivotal topic specifically considering rapid advancements in imaging technologies. We undertook a large-scale, mixed cohort, comparative study to assess the correlation of optic disc measurements between different imaging modalities and investigated the impact of patient and disc associated parameters. Methods ONH sizes were obtained from one randomly selected eye of each of 209 patients using stereophotography, confocal scanning laser ophthalmoscopy and two different optical coherence tomographers (OCT). Patient related data, glaucoma status and optic disc variables, specifically oblique insertion, torsion, presence of beta PPA and spherical equivalent were recorded. Measurements between imaging modalities were analysed using Pearson correlation, linear regression analysis and Blend-Altman plots. Individual variables were compared applying multivariate regression analysis, ANOVA and chi square statistics was used to determine correlations between patient and clinical characteristics. Results Absolute measurements significantly differed between imaging modalities generally producing smaller measurements for OCT derived measurements of Bruch's membrane opening (BMO). Pairwise correlations between imaging modalities were between 0.83 and 0.93 for discs without myopia, oblique insertion, or beta PPA. These features impacted on measurements for individual modalities and consequently contributed to inconsistencies and variability. Conclusion In comparison to planimetry, OCT derived BMO measurements are more variable in the presence of oblique insertion, beta PPA or magnification errors due to myopia. Impact of these factors, however, differs between instruments and needs to be considered to accurately interpret optic disc features in particular within the context of glaucoma diagnosis.	[Yapp, Michael; Rennie, George; Hennessy, Michael P.; Kalloniatis, Michael; Zangerl, Barbara] UNSW Australia, Ctr Eye Hlth, Sydney, NSW, Australia; [Yapp, Michael; Kalloniatis, Michael; Zangerl, Barbara] UNSW Australia, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Rennie, George] Royal Prince Alfred Hosp, Camperdown, NSW, Australia; [Hennessy, Michael P.] Prince Wales Hosp, Dept Ophthalmol, Randwick, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney	Zangerl, B (corresponding author), UNSW Australia, Ctr Eye Hlth, Sydney, NSW, Australia.; Zangerl, B (corresponding author), UNSW Australia, Sch Optometry & Vis Sci, Sydney, NSW, Australia.	bzangerl@cfeh.com.au	Hennessy, Michael/AAN-8444-2021; Rennie, George/W-1210-2019; Zangerl, Barbara/K-7433-2016	Kalloniatis, Michael/0000-0002-5264-4639; Zangerl, Barbara/0000-0002-7470-6298; Hennessy, Michael/0000-0003-2750-9344	National Health and Medical Research Council [1033224]; University of New South Wales Faculty Research Grant	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of New South Wales Faculty Research Grant	This study was supported through National Health and Medical Research Council grant 1033224 and a University of New South Wales Faculty Research Grant held by Dr.Zangerl.	Agrawal A, 2016, INVEST OPHTH VIS SCI, V57; Ansari-Shahrezaei S, 2001, INVEST OPHTH VIS SCI, V42, P153; Barkana Y, 2006, AM J OPHTHALMOL, V142, P375, DOI 10.1016/j.ajo.2006.03.065; Bartling H, 2008, ACTA OPHTHALMOL, V86, P837, DOI 10.1111/j.1755-3768.2007.01146.x; Garas A, 2011, J GLAUCOMA, V20, P80, DOI 10.1097/IJG.0b013e3181d787fd; Garway-Heath DF, 1998, BRIT J OPHTHALMOL, V82, P643, DOI 10.1136/bjo.82.6.643; Gmeiner JM, 2016, INVEST OPHTH VIS SCI, V57; Hoffmann EM, 2007, SURV OPHTHALMOL, V52, P32, DOI 10.1016/j.survophthal.2006.10.002; Hu ZH, 2010, INVEST OPHTH VIS SCI, V51, P5708, DOI 10.1167/iovs.09-4838; Hwang YH, 2012, J GLAUCOMA, V21, P260, DOI 10.1097/IJG.0b013e31820719e1; Jamous KF, 2015, CLIN EXP OPHTHALMOL, V43, P308, DOI 10.1111/ceo.12466; Jamous KF, 2014, OPHTHAL PHYSL OPT, V34, P580, DOI 10.1111/opo.12146; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P1599; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P1604; Jonas JB, 1998, BRIT J OPHTHALMOL, V82, P362, DOI 10.1136/bjo.82.4.362; Jonas JB, 2000, PROG RETIN EYE RES, V19, P1, DOI 10.1016/S1350-9462(99)00002-6; JONAS JB, 1988, INVEST OPHTH VIS SCI, V29, P1151; Law SK, 2010, ARCH OPHTHALMOL-CHIC, V128, P141, DOI 10.1001/archophthalmol.2009.340; Lee M, 2013, CURR EYE RES, V38, P605, DOI 10.3109/02713683.2013.769059; Leung CKS, 2007, INVEST OPHTH VIS SCI, V48, P3178, DOI 10.1167/iovs.06-1315; Moghimi S, 2012, INVEST OPHTH VIS SCI, V53, P4519, DOI 10.1167/iovs.11-8362; Neubauer AS, 2006, OPHTHAL PHYSL OPT, V26, P13, DOI 10.1111/j.1475-1313.2005.00339.x; Rebolleda G, 2016, CLIN OPHTHALMOL, V10, P2417, DOI 10.2147/OPTH.S120237; Reis ASC, 2012, OPHTHALMOLOGY, V119, P738, DOI 10.1016/j.ophtha.2011.09.054; Reis ASC, 2017, ACTA OPHTHALMOLOGICA; Resch H, 2012, ACTA OPHTHALMOL, V90, pe225, DOI 10.1111/j.1755-3768.2012.02385.x; Samarawickrama C, 2009, J GLAUCOMA, V18, P571, DOI 10.1097/IJG.0b013e3181996da6; Savini G, 2013, J GLAUCOMA, V22, P384, DOI 10.1097/IJG.0b013e31824c9423; Schuman JS, 2003, AM J OPHTHALMOL, V135, P504, DOI 10.1016/S0002-9394(02)02093-7; Sharma A, 2011, OPHTHALMOLOGY, V118, P1348, DOI 10.1016/j.ophtha.2010.12.008; Shin HY, 2015, BRIT J OPHTHALMOL, V99, P69, DOI 10.1136/bjophthalmol-2014-305259; Strouthidis NG, 2009, INVEST OPHTH VIS SCI, V50, P4709, DOI 10.1167/iovs.09-3586; Vihanninjoki K, 1997, ACTA OPHTHALMOL SCAN, V75, P512; Witmer MT, 2010, SURV OPHTHALMOL, V55, P403, DOI 10.1016/j.survophthal.2010.01.002; Young M, 2014, J GLAUCOMA, V23, P360, DOI 10.1097/IJG.0b013e31829484a4	35	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190273	10.1371/journal.pone.0190273	http://dx.doi.org/10.1371/journal.pone.0190273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342153	Green Published, gold			2022-12-26	WOS:000422653800017
J	Baghirov, H; Snipstad, S; Sulheim, E; Berg, S; Hansen, R; Thorsen, F; Morch, Y; Davies, CD; Aslund, AKO				Baghirov, Habib; Snipstad, Sofie; Sulheim, Einar; Berg, Sigrid; Hansen, Rune; Thorsen, Frits; Morch, Yrr; Davies, Catharina de Lange; Aslund, Andreas K. O.			Ultrasound-mediated delivery and distribution of polymeric nanoparticles in the normal brain parenchyma of a metastatic brain tumour model	PLOS ONE			English	Article							FOCUSED ULTRASOUND; DRUG-DELIVERY; STABILIZED MICROBUBBLES; IMAGE-ANALYSIS; BLOOD; BARRIER; DISRUPTION; PERMEABILITY; MECHANISM; DISCOVERY	The treatment of brain diseases is hindered by the blood-brain barrier (BBB) preventing most drugs from entering the brain. Focused ultrasound (FUS) with microbubbles can open the BBB safely and reversibly. Systemic drug injection might induce toxicity, but encapsulation into nanoparticles reduces accumulation in normal tissue. Here we used a novel platform based on poly(2-ethyl-butyl cyanoacrylate) nanoparticle-stabilized microbubbles to permeabilize the BBB in a melanoma brain metastasis model. With a dual-frequency ultrasound transducer generating FUS at 1.1 MHz and 7.8 MHz, we opened the BBB using nanoparticle-microbubbles and low-frequency FUS, and applied high-frequency FUS to generate acoustic radiation force and push nanoparticles through the extracellular matrix. Using con focal microscopy and image analysis, we quantified nanoparticle extravasation and distribution in the brain parenchyma. We also evaluated haemorrhage, as well as the expression of P-glycoprotein, a key BBB component. FUS and microbubbles distributed nanoparticles in the brain parenchyma, and the distribution depended on the extent of BBB opening. The results from acoustic radiation force were not conclusive, but in a few animals some effect could be detected. P-glycoprotein was not significantly altered immediately after sonication. In summary, FUS with our nanoparticle-stabilized microbubbles can achieve accumulation and displacement of nanoparticles in the brain parenchyma.	[Baghirov, Habib; Snipstad, Sofie; Sulheim, Einar; Davies, Catharina de Lange; Aslund, Andreas K. O.] Norwegian Univ Sci & Technol NTNU, Dept Phys, Trondheim, Norway; [Sulheim, Einar; Morch, Yrr] SINTEF Mat & Chem, Trondheim, Norway; [Berg, Sigrid; Hansen, Rune] SINTEF Med Technol, Trondheim, Norway; [Berg, Sigrid; Hansen, Rune] Norwegian Univ Sci & Technol NTNU, Dept Circulat & Med Imaging, Trondheim, Norway; [Thorsen, Frits] Univ Bergen, Dept Biomed, Mol Imaging Ctr, Bergen, Norway; [Thorsen, Frits] Univ Bergen, Dept Biomed, Kristian Gerhard Jebsen Brain Tumour Res Ctr, Bergen, Norway; [Baghirov, Habib] Univ Coll Cork, Sch Pharm, Cork, Ireland	Norwegian University of Science & Technology (NTNU); SINTEF; SINTEF; Norwegian University of Science & Technology (NTNU); University of Bergen; University of Bergen; University College Cork	Davies, CD (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Phys, Trondheim, Norway.	catharina.davies@ntnu.no	Åslund, Andreas/M-4483-2019	Åslund, Andreas/0000-0001-5222-9307; Thorsen, Frits/0000-0002-7762-3703; Baghirov, Habib/0000-0002-3441-9825; Davies, Catharina/0000-0003-4371-5025; Morch, Yrr/0000-0001-5182-7276	Research Council of Norway [220005, 240316, 226159]; Central Norway Regional Health Authority	Research Council of Norway(Research Council of Norway); Central Norway Regional Health Authority	This study was funded by The Research Council of Norway, https://www.forskningsradet.no/no/Forsiden/1173185591033 (NANO2021 project number 220005, FRIMEDBIO project number 240316 and BIOTEK2021 project number 226159), and The Central Norway Regional Health Authority, https://helse-midt.no/.	Aryal M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166061; Aslund AKO, 2017, MOL PHARMACEUT, V14, P2560, DOI 10.1021/acs.molpharmaceut.6b01085; Aslund AKO, 2015, J CONTROL RELEASE, V220, P287, DOI 10.1016/j.jconrel.2015.10.047; Baghirov H, 2017, COLLOID SURFACE B, V150, P373, DOI 10.1016/j.colsurfb.2016.10.051; Burke CW, 2014, MOL THER, V22, P321, DOI 10.1038/mt.2013.259; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Chen H, 2014, J CEREBR BLOOD F MET, V34, P1197, DOI 10.1038/jcbfm.2014.71; Cho H, 2016, SCI REP-UK, V6, DOI 10.1038/srep31201; Choi JJ, 2010, ULTRASOUND MED BIOL, V36, P58, DOI 10.1016/j.ultrasmedbio.2009.08.006; Crowder KC, 2005, ULTRASOUND MED BIOL, V31, P1693, DOI 10.1016/j.ultrasmedbio.2005.07.022; Dayton P, 1999, ULTRASOUND MED BIOL, V25, P1195, DOI 10.1016/S0301-5629(99)00062-9; Dayton PA, 2006, MOL IMAGING, V5, P160, DOI 10.2310/7290.2006.00019; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Diaz RJ, 2014, NANOMED-NANOTECHNOL, V10, P1075, DOI 10.1016/j.nano.2013.12.006; Enochs WS, 1997, RADIOLOGY, V204, P417, DOI 10.1148/radiology.204.2.9240529; Etame AB, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2011.10.FOCUS11252; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Hynynen K, 2008, ADV DRUG DELIVER REV, V60, P1209, DOI 10.1016/j.addr.2008.03.010; Hynynen K, 2007, EXPERT OPIN DRUG DEL, V4, P27, DOI 10.1517/17425247.4.1.27; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; KANTE B, 1982, J PHARM SCI, V71, P786, DOI 10.1002/jps.2600710716; Klymchenko AS, 2012, RSC ADV, V2, P11876, DOI [10.1039/C2RA21544F, 10.1039/c2ra21544f]; Kumari A, 2010, COLLOID SURFACE B, V75, P1, DOI 10.1016/j.colsurfb.2009.09.001; Lammers T, 2015, ADV FUNCT MATER, V25, P36, DOI 10.1002/adfm.201401199; Laquintana V, 2009, EXPERT OPIN DRUG DEL, V6, P1017, DOI 10.1517/17425240903167942; Leighton T. G., 1994, ACOUSTIC BUBBLE, P531; Lum AFH, 2006, J CONTROL RELEASE, V111, P128, DOI 10.1016/j.jconrel.2005.11.006; Maeda H, 2016, MICROCIRCULATION, V23, P173, DOI 10.1111/micc.12228; Marty B, 2012, J CEREBR BLOOD F MET, V32, P1948, DOI 10.1038/jcbfm.2012.100; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mead BP, 2016, J CONTROL RELEASE, V223, P109, DOI 10.1016/j.jconrel.2015.12.034; Morch Y, 2015, CONTRAST MEDIA MOL I, V10, P356, DOI 10.1002/cmmi.1639; Nance E, 2014, J CONTROL RELEASE, V189, P123, DOI 10.1016/j.jconrel.2014.06.031; Nance EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003594; Pardridge William M, 2005, NeuroRx, V2, P3; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; Rychak JJ, 2005, IEEE T ULTRASON FERR, V52, P421, DOI 10.1109/TUFFC.2005.1417264; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shortencarier MJ, 2004, IEEE T ULTRASON FERR, V51, P822, DOI 10.1109/TUFFC.2004.1320741; Snipstad S, 2017, ULTRASOUND MED BIOL, V43, P2651, DOI 10.1016/j.ultrasmedbio.2017.06.029; Soma E, 2012, RSC DRUG DISCOV, V22, P591, DOI 10.1039/9781849735292-00591; Sulheim E, 2016, J NANOBIOTECHNOL, V14, DOI 10.1186/s12951-015-0156-7; Sun TM, 2014, ANGEW CHEM INT EDIT, V53, P12320, DOI 10.1002/anie.201403036; Thorsen F, 2013, J CONTROL RELEASE, V172, P812, DOI 10.1016/j.jconrel.2013.10.019; Wang J, 2011, NEUROPATH APPL NEURO, V37, P189, DOI 10.1111/j.1365-2990.2010.01119.x; Wilhelm S, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.14; Yildirimer L, 2011, NANO TODAY, V6, P585, DOI 10.1016/j.nantod.2011.10.001; Zhang ZG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054129, 10.1371/journal.pone.0056344, 10.1371/journal.pone.0054577, 10.1371/journal.pone.0065268]	49	32	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191102	10.1371/journal.pone.0191102	http://dx.doi.org/10.1371/journal.pone.0191102			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338016	gold, Green Published, Green Submitted			2022-12-26	WOS:000422652700031
J	de Luis, M; Bartolome, C; Cardo, OG; Alvarez-Jimenez, J				de Luis, Miguel; Bartolome, Carmen; Garcia Cardo, Oscar; Alvarez-Jimenez, Julio			Gypsophila bermejoi G. Lopez: A possible case of speciation repressed by bioclimatic factors	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; POTENTIAL DISTRIBUTIONS; HYBRIDIZATION; MECHANISMS; PREVALENCE; POLYPLOIDY; EVOLUTION; HABITAT; HYBRID; ROOTS	Gypsophila bermejoi G. Lopez is an allopolyploid species derived from the parental G. struthium L. subsp. struthium and G. tomentosa L. All these plants are gypsophytes endemic to the Iberian Peninsula of particular ecological, evolutionary and biochemical interest. In this study, we present evidence of a possible repression on the process of G. bermejoi speciation by climatic factors. We modelled the ecological niches of the three taxa considered here using a maximum entropy approach and employing a series of bioclimatic variables. Subsequently, we projected these models onto the geographical space of the Iberian Peninsula in the present age and at two past ages: the Last Glacial Maximum and the mid-Holocene period. Furthermore, we compared these niches using the statistical method devised by Warren to calculate their degree of overlap. We also evaluated the evolution of the bioclimatic habitat suitability at those sites were the soil favors the growth of these species. Both the maximum entropy model and the degree of overlap indicated that the ecological behavior of the hybrid differs notably from that of the parental species. During the Last Glacial Maximum, the two parental species appear to take refuge in the western coastal strip of the Peninsula, a region in which there are virtually no sites where G. bermejoi could potentially be found. However, in the mid-Holocene period the suitability of G. bermejoi to sites with favorable soils shifts from almost null to a strong adaptation, a clear change in this tendency. These results suggest that the ecological niches of hybrid allopolyploids can be considerably different to those of their parental species, which may have evolutionary and ecologically relevant consequences. The data obtained indicate that certain bioclimatic variables may possibly repress the processes by which new species are formed. The difference in the ecological niche of G. bermejoi with respect to its parental species prevented it from prospering during the Last Glacial Maximum. However, the climatic change in the mid-Holocene period released this block and as such, it permitted the new species to establish itself. Accordingly, we favor a recent origin of the current populations of G. bermejoi.	[de Luis, Miguel; Bartolome, Carmen; Alvarez-Jimenez, Julio] Univ Alcala, Fac Biol C Ambientales & Quim, Dept Ciencias Vida, Alcala De Henares, Madrid, Spain; [Garcia Cardo, Oscar] Empresa Publ Gest Ambiental Castilla La Mancha GE, Cuenca, Spain	Universidad de Alcala	Bartolome, C (corresponding author), Univ Alcala, Fac Biol C Ambientales & Quim, Dept Ciencias Vida, Alcala De Henares, Madrid, Spain.	carmen.bartolome@uah.es		de Luis, Miguel/0000-0002-5591-5721; Bartolome Esteban, Carmen/0000-0003-3204-7797				Acebes B, 1998, J NAT PROD, V61, P1557, DOI 10.1021/np9705221; Acebes B, 1998, PHYTOCHEMISTRY, V49, P2077, DOI 10.1016/S0031-9422(98)00404-X; Alcantar V. J. P, 2014, TEMAS CIENCIA Y TECN, V18, P17; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2014, EVOLUTIONARY BIOL GE, DOI DOI 10.1007/978-3-319-07623-2_5; Arieh Ben-Naim, 2012, ENTROPY 2 LAW; Audesirk T, 2002, BIOL UNDERSTANDING L; BENNETT MD, 1987, NEW PHYTOL, V106, P177, DOI 10.1111/j.1469-8137.1987.tb04689.x; Boscaiu M, 2010, B U AGR SCI VET MED, V67, P1843, DOI DOI 10.15835/BUASVMCN-H0RT:4903; Bosso L, 2017, FOREST ECOL MANAG, V400, P655, DOI 10.1016/j.foreco.2017.06.044; Bueno ML, 2017, ECOGRAPHY, V40, P403, DOI 10.1111/ecog.01860; Castro S., 2014, Ecosistemas, V23, P67, DOI 10.7818/ECOS.2014.23-3.09; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; CUBERO J. I., 2003, INTRO MEJORA GENETIC, V2013th; Cuevas E., 2013, BIOLOGICAS, V14, P7; Curtis H., 2008, CURTIS BIOL, V7th; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ferrandis P., 2005, INVEST AGRAR-SIST R, V14, P195; Ficetola GF, 2010, GLOBAL CHANGE BIOL, V16, P528, DOI 10.1111/j.1365-2486.2009.01957.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Freeman S., 2007, EVOLUTIONARY ANAL; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Gomez JM, 1996, OECOLOGIA, V105, P236, DOI 10.1007/BF00328552; Gonzalez G. Lopez, 1984, AN JARDIN BOT MADRID, V41, P35; Gormley AM, 2011, J APPL ECOL, V48, P25, DOI 10.1111/j.1365-2664.2010.01911.x; Griffiths AJF., 2005, INTRO GENETIC ANAL, DOI 10.1021/bi00201a011; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Horvitz N, 2017, J ECOL, V105, P85, DOI 10.1111/1365-2745.12692; Hutchinson G.E., 1978, INTRO POPULATION ECO; Kadereit JW, 2006, NEW PHYTOL, V169, P431, DOI 10.1111/j.1469-8137.2005.01604.x; Kaky E, 2016, J ARID ENVIRON, V135, P140, DOI 10.1016/j.jaridenv.2016.09.001; Kovalsky IE, 2014, B SOC ARGENT BOT, V49, P227; Lacadena JR., 1996, CITOGENETICA; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Madlung A, 2013, HEREDITY, V110, P99, DOI 10.1038/hdy.2012.79; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Martinez-Hernandez F, 2011, BIODIVERS CONSERV, V20, P1353, DOI 10.1007/s10531-011-0031-2; Mason AS, 2015, TRENDS BIOTECHNOL, V33, P436, DOI 10.1016/j.tibtech.2015.06.004; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Moreno-Amat E, 2017, QUATERNARY SCI REV, V170, P56, DOI 10.1016/j.quascirev.2017.06.022; Moruno F, 2011, NOT BOT HORTI AGROBO, V39, P18; Mota J.F., 2011, DIVERSIDAD VEGETAL Y; Mota JF, 2003, PHYTOCOENOLOGIA, V33, P13, DOI 10.1127/0340-269X/2003/0033-0013; Mota JF, 2016, LAZAROA, V37, P7, DOI 10.5209/LAZA.54044; NOVAK SJ, 1991, AM J BOT, V78, P1586, DOI 10.2307/2444984; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Petitpierre B, 2017, GLOBAL ECOL BIOGEOGR, V26, P275, DOI 10.1111/geb.12530; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Prentice IC, 2000, J BIOGEOGR, V27, P507, DOI 10.1046/j.1365-2699.2000.00425.x; QGIS Development Team, 2009, QGIS GEOGR INF SYST; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Raven P, 1991, BIOL PLANTAS; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Royzar C, 2016, FOREST ECOL MANAG, V369, P20, DOI 10.1016/j.foreco.2016.03.030; Sadava D, 2009, VIDA CIENCIA BIOL; Salmon A, 2005, MOL ECOL, V14, P1163, DOI 10.1111/j.1365-294X.2005.02488.x; Sattler MC, 2016, PLANTA, V243, P281, DOI 10.1007/s00425-015-2450-x; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Serrahima Ignasi, 2011, Boletin de la SEA, V48, P375; Smeraldo S, 2017, J NATURE CONSERVATIO; Smith AB, 2017, GLOBAL CHANGE BIOL, V23, P4365, DOI 10.1111/gcb.13666; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Stohlgren TJ, 2010, RISK ANAL, V30, P224, DOI 10.1111/j.1539-6924.2009.01343.x; Thompson GD, 2011, DIVERS DISTRIB, V17, P1001, DOI 10.1111/j.1472-4642.2011.00820.x; UDVARDY MFD, 1959, ECOLOGY, V40, P725, DOI 10.2307/1929830; Van der Vaart AW, 2000, ASYMPTOTIC STAT, V3; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Washburn JD, 2014, PLANT REPROD, V27, P1, DOI 10.1007/s00497-013-0237-4; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Zutta BR, 2017, FORESTS, V8, DOI 10.3390/f8070232	72	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190536	10.1371/journal.pone.0190536	http://dx.doi.org/10.1371/journal.pone.0190536			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338010	Green Published, Green Submitted, gold			2022-12-26	WOS:000422652700013
J	Goldman, SM; Henderson, BEP; Walters, TJ; Corona, BT				Goldman, Stephen M.; Henderson, Beth E. P.; Walters, Thomas J.; Corona, Benjamin T.			Co-delivery of a laminin-111 supplemented hyaluronic acid based hydrogel with minced muscle graft in the treatment of volumetric muscle loss injury	PLOS ONE			English	Article							SKELETAL-MUSCLES; MODEL; REPAIR; CELLS; TRANSPLANTATION; REGENERATION; ISCHEMIA; RECOVERY; SCAFFOLD; PROTEIN	Minced muscle autografting mediates de novo myofiber regeneration and promotes partial recovery of neuromuscular strength after volumetric muscle loss injury (VML). A major limitation of this approach is the availability of sufficient donor tissue for the treatment of relatively large VMLs without inducing donor site morbidity. This study evaluated a laminin-111 supplemented hyaluronic acid based hydrogel (HA+LMN) as a putative myoconductive scaffolding to be co-delivered with minced muscle grafts. In a rat tibialis anterior muscle VML model, delivery of a reduced dose of minced muscle graft (50% of VML defect) within HA+LMN resulted in a 42% improvement of peak tetanic torque production over unrepaired VML affected limbs. However, the improvement in strength was not improved compared to a 50% minced graft-only control group. Moreover, histological analysis revealed that the improvement in in vivo functional capacity mediated by minced grafts in HA+LMN was not accompanied by a particularly robust graft mediated regenerative response as determined through donor cell tracking of the GFP+ grafting material. Characterization of the spatial distribution and density of macrophage and satellite cell populations indicated that the combination therapy damps the heightened macrophage response while re-establishing satellite content 14 days after VML to a level consistent with an endogenously healing ischemia-reperfusion induced muscle injury. Moreover, regional analysis revealed that the combination therapy increased satellite cell density mostly in the remaining musculature, as opposed to the defect area. Based on the results, the following salient conclusions were drawn: 1) functional recovery mediated by the combination therapy is likely due to a superposition of de novo muscle fiber regeneration and augmented repair of muscle fibers within the remaining musculature, and 2) The capacity for VML therapies to augment regeneration and repair within the remaining musculature may have significant clinical impact and warrants further exploration.	[Goldman, Stephen M.; Henderson, Beth E. P.; Walters, Thomas J.; Corona, Benjamin T.] US Army, Inst Surg Res, Jbsa Ft Sam Houston, TX 78234 USA		Corona, BT (corresponding author), US Army, Inst Surg Res, Jbsa Ft Sam Houston, TX 78234 USA.	benjamin.t.corona.civ@mail.mil	Goldman, Stephen/AAT-7318-2020	Goldman, Stephen/0000-0002-2244-1443	United States Army Medical Research and Materiel Command, Clinical and Rehabilitative Medicine Research Program [C_003_USAISR]	United States Army Medical Research and Materiel Command, Clinical and Rehabilitative Medicine Research Program	This work was supported by award C_003_USAISR to BTC from the United States Army Medical Research and Materiel Command, Clinical and Rehabilitative Medicine Research Program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlson BM, 1972, REGENERATION MINCED; Corona BT, 2013, AM J PHYSIOL-CELL PH, V305, pC761, DOI 10.1152/ajpcell.00189.2013; Corona BT, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13249; Corona BT, 2015, CELLS TISSUES ORGANS, V202, P180, DOI 10.1159/000443925; Corona BT, 2015, J REHABIL RES DEV, V52, P785, DOI 10.1682/JRRD.2014.07.0165; Corona BT, 2014, MUSCLE NERVE, V49, P919, DOI 10.1002/mus.24160; Corona BT, 2016, BIOMATERIALS; Criswell TL, 2012, AM J PATHOL, V180, P787, DOI 10.1016/j.ajpath.2011.10.012; FAULKNER JA, 1983, EXP NEUROL, V80, P682, DOI 10.1016/0014-4886(83)90318-7; Francisco AT, 2013, BIOMATERIALS, V34, P7381, DOI 10.1016/j.biomaterials.2013.06.038; Garg K, 2015, J ORTHOP RES, V33, P40, DOI 10.1002/jor.22730; Garg K, 2014, CELL TISSUE RES, V358, P857, DOI 10.1007/s00441-014-2006-6; GHINS E, 1984, J MUSCLE RES CELL M, V5, P711, DOI 10.1007/BF00713929; GHINS E, 1986, J MUSCLE RES CELL M, V7, P151, DOI 10.1007/BF01753416; Goldman SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186593; Goldman SM, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0589-z; Greising SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13306-2; Hardy D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147198; Hurtgen BJ, 2016, J MUSCULOSKEL NEURON, V16, P122; Hurtgen BJ, 2015, ORTH RES SOC ANN M L; Hurtgen BJ, 2016, J MUSCULOSKELETAL NE; Hurtgen BJ, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13362; Hurtgen BJ, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1617-y; Johnson WL, 2008, J BIOMECH, V41, P610, DOI 10.1016/j.jbiomech.2007.10.004; Kasukonis B, 2016, TISSUE ENG PT A, V22, P1151, DOI 10.1089/ten.tea.2016.0134; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lim AYT, 2006, MUSCLE NERVE, V33, P377, DOI 10.1002/mus.20468; LOWE DA, 1995, J APPL PHYSIOL, V79, P1260, DOI 10.1152/jappl.1995.79.4.1260; MESSINA LM, 1991, CIRC RES, V68, P1600, DOI 10.1161/01.RES.68.6.1600; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Pilia M, 2014, EUR CELLS MATER, V28, P11, DOI 10.22203/eCM.v028a02; Plant DR, 2006, MUSCLE NERVE, V34, P577, DOI 10.1002/mus.20616; Pollot BE, 2016, J TRAUMA ACUTE CARE; Pollot BE, 2016, J TRAUMA ACUTE CARE, V81, pS184, DOI 10.1097/TA.0000000000001212; Prestwich Glenn D, 2008, Organogenesis, V4, P42; Sadtler K, 2016, SCIENCE, V352, P366, DOI 10.1126/science.aad9272; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Shu XZ, 2006, J BIOMED MATER RES A, V79A, P902, DOI 10.1002/jbm.a.30831; Shu XZ, 2004, J BIOMED MATER RES A, V68A, P365, DOI 10.1002/jbm.a.20002; Shu XZ, 2004, BIOMATERIALS, V25, P1339, DOI 10.1016/j.biomaterials.2003.08.014; Silva-Barbosa SD, 2008, TRANSPLANTATION, V85, P566, DOI 10.1097/TP.0b013e31815fee50; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; VRACKO R, 1972, J CELL BIOL, V55, P406, DOI 10.1083/jcb.55.2.406; Walters TJ, 2015, MUSCLE NERVE, V52, P640, DOI 10.1002/mus.24581; Ward CL, 2016, J ORTHOP TRAUMA, V30, pE396, DOI 10.1097/BOT.0000000000000673; Ward CL, 2015, BIORESEARCH OPEN ACC, V4, P198, DOI 10.1089/biores.2015.0009; Zou K, 2014, STEM CELL TRANSL MED, V3, P1013, DOI 10.5966/sctm.2014-0044	47	33	33	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191245	10.1371/journal.pone.0191245	http://dx.doi.org/10.1371/journal.pone.0191245			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329332	Green Submitted, Green Published, gold			2022-12-26	WOS:000419954100054
J	Conway, BN; Han, XJ; Munro, HM; Gross, AL; Shu, XO; Hargreaves, MK; Zheng, W; Powers, AC; Blot, WJ				Conway, Baqiyyah N.; Han, Xijing; Munro, Heather M.; Gross, Amy L.; Shu, Xiao-Ou; Hargreaves, Margaret K.; Zheng, Wei; Powers, Alvin C.; Blot, William J.			The obesity epidemic and rising diabetes incidence in a low-income racially diverse southern US cohort	PLOS ONE			English	Article							BODY-MASS INDEX; CAUSE-SPECIFIC MORTALITY; CORONARY-HEART-DISEASE; UNITED-STATES; ALCOHOL-CONSUMPTION; AFRICAN-AMERICANS; RISK; ASSOCIATION; HEALTH; ADULTS	Background Obesity is known to be a major risk factor for diabetes, but the magnitude of risk and variation between blacks and whites are less well documented in populations heavily affected by obesity. Herein we assess rates and risks of incident diabetes in a diverse southern population where obesity is common. Methods A total of 24,000 black and 14,064 white adults aged 40-79 in the Southern Community Cohort Study with no self-reported diabetes at study enrollment during 2002-2009 was followed for up to 10 (median 4.5) years. Incidence rates, odds ratios (OR) and accompanying 95% confidence intervals (CI) for medication-treated incident diabetes were determined according to body mass index (BMI) and other characteristics, including tobacco and alcohol consumption, healthy eating and physical activity indices, and socioeconomic status (SES). Results Risk of incident diabetes rose monotonically with increasing BMI, but the trends differed between blacks and whites (p(interaction) < .0001). Adjusted ORs (CIs) for diabetes among those with BMI >= 40 vs 20-25 kg/m(2) were 11.9 (8.4-16.8) for whites and 4.0 (3.3-4.8) for blacks. Diabetes incidence was more than twice as high among blacks than whites of normal BMI, but the racial difference became attenuated as BMI rose, with estimated 5-year probabilities of developing diabetes approaching 20% for both blacks and whites with BMI >= 40 kg/m(2) Diabetes risk was also associated with low SES, significantly (p(interaction) <= .02) more so for whites, current cigarette smoking, and lower healthy eating and physical activity indices, although high BMI remained the predominant risk factor among both blacks and whites. From baseline prevalence and 20-year projections of the incidence trends, we estimate that the large majority of surviving cohort participants with BMI >= 40 kg/m(2) will be diagnosed with diabetes. Conclusions Even using conservative criteria to ascertain diabetes incidence (i.e., requiring diabetes medication use and ignoring undiagnosed cases), rates of obesity-associated diabetes were exceptionally high in this low-income adult population. The findings indicate that effective strategies to halt the rising prevalence of obesity are needed to avoid substantial increases in diabetes in coming years.	[Conway, Baqiyyah N.] Univ Texas Hlth Ctr Tyler, Dept Epidemiol & Biostat, Tyler, TX USA; [Han, Xijing; Munro, Heather M.; Gross, Amy L.; Blot, William J.] Vanderbilt Univ, Vanderbilt Inst Clin & Translat Res, Int Epidemiol Field Stn, Med Ctr, Rockville, MD 20850 USA; [Shu, Xiao-Ou; Zheng, Wei; Blot, William J.] Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA; [Hargreaves, Margaret K.] Meharry Med Coll, Dept Internal Med, Nashville, TN 37208 USA; [Powers, Alvin C.] Vanderbilt Univ, Sch Med, Div Diabet Endocrinol & Metab, Nashville, TN 37212 USA; [Powers, Alvin C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Powers, Alvin C.] VA Tennessee Valley Healthcare Syst, Nashville, TN USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); Vanderbilt University; Vanderbilt University; Meharry Medical College; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Blot, WJ (corresponding author), Vanderbilt Univ, Vanderbilt Inst Clin & Translat Res, Int Epidemiol Field Stn, Med Ctr, Rockville, MD 20850 USA.; Blot, WJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Epidemiol, Nashville, TN 37212 USA.	william.j.blot@vanderbilt.edu			National Institutes of Health, National Cancer Institute [R01CA092447, U01CA202979]; National Institute of Diabetes and Digestive and Kidney Diseases [2P30DK20593, 2T32DK007061]; National Cancer Institute; NATIONAL CANCER INSTITUTE [U54CA163069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, P30DK092986] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007586] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was supported by the National Institutes of Health, National Cancer Institute, grants R01CA092447 and U01CA202979 (WJB, WZ) and by the National Institute of Diabetes and Digestive and Kidney Diseases, grants 2P30DK20593 and 2T32DK007061 (ACP). The funders (http://grants.nih.gov/) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is based on data obtained from the Southern Community Cohort Study (SCCS) database. This database was enabled by grant funding from the National Cancer Institute, and is managed by Vanderbilt University Medical Center. The authors' interpretations and conclusions do not necessarily represent those of the National Cancer Institute or Vanderbilt University Medical Center.	Advisory Committee to the Surgeon General of the Public Health Service, 1964, SMOK AND HLTH; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Andersen SW, 2016, AM J PREV MED, V51, P344, DOI 10.1016/j.amepre.2016.03.018; Andersen SW, 2016, CANCER EPIDEM BIOMAR, V25, P846, DOI 10.1158/1055-9965.EPI-15-1186; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Beydoun MA, 2009, OBESITY, V17, P169, DOI 10.1038/oby.2008.492; Buchowski MS, 2012, J PHYS ACT HEALTH, V9, P765, DOI 10.1123/jpah.9.6.765; Coleman NJ, 2014, J DIABETES COMPLICAT, V28, P500, DOI 10.1016/j.jdiacomp.2013.11.010; Conway BN, 2015, DIABETIC MED, V32, P33, DOI 10.1111/dme.12563; Conway BN, 2012, DIABETES CARE, V35, P2293, DOI 10.2337/dc11-2495; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Ganz ML, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-50; George AM, 2015, WORLD J DIABETES, V6, P613, DOI 10.4239/wjd.v6.i4.613; Guenther PM, 2008, J AM DIET ASSOC, V108, P1896, DOI 10.1016/j.jada.2008.08.016; Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hargreaves MK, 2006, MULTICULTURAL MED HL, P485; Hruby A, 2016, AM J PUBLIC HEALTH, V106, P1656, DOI 10.2105/AJPH.2016.303326; Huang J, 2017, J DIABETES INVEST, V8, P56, DOI 10.1111/jdi.12537; Huizinga M, 2009, P 69 ANN M AM DIAB A, pA279; Joseph JJ, 2016, DIABETOLOGIA, V59, P1893, DOI 10.1007/s00125-016-4003-7; Kasteridis P, 2012, HEALTH SERV RES, V47, P1580, DOI 10.1111/j.1475-6773.2012.01380.x; Klein BEK, 2007, OPHTHAL EPIDEMIOL, V14, P179, DOI 10.1080/09286580701396720; Knott C, 2015, DIABETES CARE, V38, P1804, DOI 10.2337/dc15-0710; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Krukowski RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151290; Laakso M, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0837-8; Lotta LA, 2016, JAMA-J AM MED ASSOC, V316, P1383, DOI 10.1001/jama.2016.14568; Lycett D, 2011, ADDICTION, V106, P188, DOI 10.1111/j.1360-0443.2010.03136.x; Macedo AF, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-51; Marcinkevage JA, 2013, DIABETES CARE, V36, P3033, DOI 10.2337/dc12-2312; Matthews CE, 2014, AM J EPIDEMIOL, V180, P394, DOI 10.1093/aje/kwu142; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Mondesir FL, 2016, AM HEART J, V181, P43, DOI 10.1016/j.ahj.2016.08.002; National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health, 2014, HLTH CONSMOK 50 YE; Patel K, 2011, AM J HEALTH BEHAV, V35, P627; Pi-Sunyer FX, 2002, OBES RES, V10, p97S, DOI 10.1038/oby.2002.202; Rana JS, 2016, J GEN INTERN MED, V31, P387, DOI 10.1007/s11606-015-3556-3; Schneider ALC, 2013, DIABETES CARE, V36, P1153, DOI 10.2337/dc12-1168; Selvin E, 2011, DIABETES, V60, P298, DOI 10.2337/db10-1198; Signorello LB, 2007, AM J PUBLIC HEALTH, V97, P2260, DOI 10.2105/AJPH.2006.094482; Signorello LB, 2010, J HEALTH CARE POOR U, V21, P26, DOI 10.1353/hpu.0.0245; Southern Community Cohort Study, 2015, THE SCCS COH; Surgeon General, 1989, RED HLTH CONS SMOK 2; Surgeon General, 2004, HLTH CONS SMOK; Tian J, 2015, OBES REV, V16, P883, DOI 10.1111/obr.12304; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wojcik NC, 2010, AM J EPIDEMIOL, V172, P469, DOI 10.1093/aje/kwq130	50	37	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190993	10.1371/journal.pone.0190993	http://dx.doi.org/10.1371/journal.pone.0190993			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BJ	29324894	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400088
J	Kaya, M				Kaya, Mitsunori			Impact of extra-articular pathologies on groin pain: An arthroscopic evaluation	PLOS ONE			English	Article							FEMOROACETABULAR IMPINGEMENT; LATERAL EPICONDYLITIS; HIP-DYSPLASIA; MANAGEMENT; CLASSIFICATION; OUTCOMES	Purpose For patients who have anterior hip pain evaluated by Patrick's test and tenderness at Scarpa's triangle, we perform periarticular debridement based on the hypothesis that extra-articular pathologies are responsible for the hip pain. The purpose of this study was to categorize the endoscopic extra-articular findings and to evaluate the clinical significance of periarticular pathologies in anterior hip pain. Methods Arthroscopic findings of 77 patients who underwent periarthritic debridement were evaluated. As extra-articular pathologies, injuries of the direct head and reflective head of the rectus femoris muscle were evaluated. A thin layer of fat tissue normally exists on the anterior inferior iliac spine (AIIS), the attachment site of the direct head of the rectus femoris muscle. The macroscopic appearance of the fat pad on the AIIS was categorized as normal, blood vessel-rich adipose tissue or adipose tissue with fibrosis or scar formation and histologically confirmed. Adhesion of gluteal muscles to the joint capsule was also evaluated. Results Of the 77 patients, 75 had rupture of the direct head of the rectus femoris. In contrast, rupture of the reflective head was extremely rare. Seven patients had a normal fat pad on the AIIS, 11 had blood vessel-rich adipose tissue and 55 had adipose tissue with fibrosis. Fat tissue was completely replaced by fibrous scar tissue in another 4 patients. In 64 patients, adhesion between the anterior joint capsule and gluteus muscles was marked. Groin pain disappeared soon after the operation even when labral tears were not repaired and all patients returned to daily life and sports activities within 2 weeks after operation. Conclusion Rectus femoris tendinosis, fibrosis of the AIIS fat pad, and adhesion of gluteal and rectus femoris muscles are common extra-articular pathologies in patients with anterior hip pain. Management of only these lesions induces rapid relief of anterior hip pain even in the absence of labral tear repair. My observations suggest that it is desirable to be aware of the presence of periarticular pathologies as a cause of groin pain.	[Kaya, Mitsunori] Hitsujigaoka Hosp, Sapporo, Hokkaido, Japan		Kaya, M (corresponding author), Hitsujigaoka Hosp, Sapporo, Hokkaido, Japan.	kayamitsunori@yahoo.co.jp						Ahmad Z, 2013, BONE JOINT J, V95B, P1158, DOI 10.1302/0301-620X.95B9.29285; Byrd JWT, 2011, ARTHROSCOPY, V27, P1379, DOI 10.1016/j.arthro.2011.05.018; Colvin AC, 2012, J BONE JOINT SURG AM, V94A, P227, DOI [10.2106/JBJS.J.00739, 10.2106/JBJS.J.01886]; Domb BG, 2013, AM J SPORT MED, V41, P2591, DOI 10.1177/0363546513499154; Draovitch P, 2012, CURR REV MUSCULOSKE, V5, P1, DOI 10.1007/s12178-011-9105-8; Faro F, 2007, J HAND SURG-AM, V32A, P1271, DOI 10.1016/j.jhsa.2007.07.019; Gray AJR, 1997, ARTHROSCOPY, V13, P575, DOI 10.1016/S0749-8063(97)90182-1; Imam S, 2011, INT ORTHOP, V35, P1427, DOI 10.1007/s00264-011-1278-7; Krych AJ, 2013, ARTHROSCOPY, V29, P46, DOI 10.1016/j.arthro.2012.07.011; Lage LA, 1996, ARTHROSCOPY, V12, P269, DOI 10.1016/S0749-8063(96)90057-2; Lynch TS, 2013, AM J SPORT MED, V41, P1174, DOI 10.1177/0363546513476281; Martin HD., 2015, HIP ARTHROSCOPY HIP, P139; Montgomery SR, 2013, ARTHROSCOPY, V29, P661, DOI 10.1016/j.arthro.2012.11.005; Nelitz M, 1999, BRIT J RADIOL, V72, P331, DOI 10.1259/bjr.72.856.10474491; Reiman MP, BR J SPORTS MED, V49, P782; Weir A, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2015-094869	16	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191091	10.1371/journal.pone.0191091	http://dx.doi.org/10.1371/journal.pone.0191091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324877	Green Submitted, Green Published, gold			2022-12-26	WOS:000419952400109
J	Park, JH; Cho, SJ; White, SK; Cox-Ganser, JM				Park, Ju-Hyeong; Cho, Sook Ja; White, Sandra K.; Cox-Ganser, Jean M.			Changes in respiratory and non-respiratory symptoms in occupants of a large office building over a period of moisture damage remediation attempts	PLOS ONE			English	Article							MOLD; ENDOTOXIN; DUST; ERGOSTEROL; MORBIDITY; FUNGAL; HEALTH; SCHOOL; ASSAY	There is limited information on the natural history of building occupants' health in relation to attempts to remediate moisture damage. We examined changes in respiratory and nonrespiratory symptoms in 1,175 office building occupants over seven years with multiple remediation attempts. During each of four surveys, we categorized participants using a severity score: 0 = asymptomatic; 1 = mild, symptomatic in the last 12 months, but not frequently in the last 4 weeks; 2 = severe, symptomatic at least once weekly in the last 4 weeks. Building-related symptoms were defined as improving away from the building. We used random intercept models adjusted for demographics, smoking, building tenure, and microbial exposures to estimate temporal changes in the odds of building-related symptoms or severity scores independent of the effect of microbial exposures. Trend analyses of combined mild/ severe symptoms showed no changes in the odds of respiratory symptoms but significant improvement in non-respiratory symptoms over time. Separate analyses showed increases in the odds of severe respiratory symptoms (odds ratio/ year = 1.15 +/- 1.16, p-values< 0.05) and severity scores (0.02/ year, p-values< 0.05) for wheezing and shortness of breath on exertion, due to worsening of participants in the mild symptom group. For nonrespiratory symptoms, we found no changes in the odds of severe symptoms but improvement in severity scores (-0.04 +/- -0.01/ year, p-values< 0.05) and the odds for mild fever and chills, excessive fatigue, headache, and throat symptoms (0.65 +/- 0.79/ year, p-values< 0.05). Our study suggests that after the onset of respiratory and severe non-respiratory symptoms associated with dampness/ mold, remediation efforts might not be effective in improving occupants' health.	[Park, Ju-Hyeong; Cho, Sook Ja; White, Sandra K.; Cox-Ganser, Jean M.] NIOSH, Resp Hlth Div, Morgantown, WV 26505 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Park, JH (corresponding author), NIOSH, Resp Hlth Div, Morgantown, WV 26505 USA.	gzp8@csc.gov			NIOSH intramural National Occupational Research Agenda program	NIOSH intramural National Occupational Research Agenda program	The study was funded by the NIOSH intramural National Occupational Research Agenda program.	Cho SJ, 2011, INDOOR AIR, V21, P417, DOI 10.1111/j.1600-0668.2011.00722.x; Cho SJ, 2013, J EXPO SCI ENV EPID, V23, P409, DOI 10.1038/jes.2012.89; Cox-Ganser JM, 2005, ENVIRON HEALTH PERSP, V113, P485, DOI 10.1289/ehp.7559; Ebbehoj NE, 2002, INDOOR AIR, V12, P273, DOI 10.1034/j.1600-0668.2002.02141.x; Haverinen-Shaughnessy U, 2008, SCI TOTAL ENVIRON, V399, P19, DOI 10.1016/j.scitotenv.2008.03.033; Heseltine E., 2009, WHO GUID IND AIR QUA; Iossifova YY, 2011, AM J IND MED, V54, P269, DOI 10.1002/ajim.20910; Jacqmin-Gadda H, 2007, COMPUT STAT DATA AN, V51, P5142, DOI 10.1016/j.csda.2006.05.021; Jarvis J Q, 2001, Appl Occup Environ Hyg, V16, P380, DOI 10.1080/104732201750154242; Kercsmar CM, 2006, ENVIRON HEALTH PERSP, V114, P1574, DOI 10.1289/ehp.8742; Mendell MJ, 2011, ENVIRON HEALTH PERSP, V119, P748, DOI 10.1289/ehp.1002410; MILTON DK, 1992, ENVIRON RES, V57, P212, DOI 10.1016/S0013-9351(05)80081-7; Mudarri D, 2007, INDOOR AIR, V17, P226, DOI 10.1111/j.1600-0668.2007.00474.x; Park J, 2011, 200104453141 NIOSH; Park JH, 2012, INDOOR AIR, V22, P396, DOI 10.1111/j.1600-0668.2012.00775.x; Park JH, 2006, INDOOR AIR, V16, P192, DOI 10.1111/j.1600-0668.2005.00415.x; Park JH, 2008, ENVIRON HEALTH PERSP, V116, P45, DOI 10.1289/ehp.10355; Park Ju-Hyeong, 2011, Front Biosci (Elite Ed), V3, P757, DOI 10.2741/e284; Patovirta R. L., 2004, Central European Journal of Public Health, V12, P36; Patovirta RL, 2004, INT J ENVIRON HEAL R, V14, P415, DOI 10.1080/09603120400012876; Rudblad S, 2002, INDOOR AIR, V12, P138, DOI 10.1034/j.1600-0668.2002.01112.x; Saraf A, 1997, APPL ENVIRON MICROB, V63, P2554, DOI 10.1128/AEM.63.7.2554-2559.1997; Sauni R, 2011, COCHRANE DB SYST REV, P1	23	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191165	10.1371/journal.pone.0191165	http://dx.doi.org/10.1371/journal.pone.0191165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324816	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400126
J	Primes, G; Fieder, M				Primes, Georg; Fieder, Martin			Real-life helping behaviours in North America: A genome-wide association approach	PLOS ONE			English	Article							PROSOCIAL BEHAVIOR; MONOAMINE-OXIDASE; DICTATOR GAME; VASOPRESSIN; OXYTOCIN; HERITABILITY; RISK; POLYMORPHISM; EVOLUTION; VARIANTS	In humans, prosocial behaviour is essential for social functioning. Twin studies suggest this distinct human trait to be partly hardwired. In the last decade research on the genetics of prosocial behaviour focused on neurotransmitters and neuropeptides, such as oxytocin, dopamine, and their respective pathways. Recent trends towards large scale medical studies targeting the genetic basis of complex diseases such as Alzheimer's disease and schizophrenia pave the way for new directions also in behavioural genetics. Based on data from 10,713 participants of the American Health and Retirement Study we estimated heritability of helping behaviour-its total variance explained by 1.2 million single nucleotide polymorphisms-to be 11%. Both, fixed models and mixed linear models identified rs11697300, an intergene variant on chromosome 20, as a candidate variant moderating this particular helping behaviour. We assume that this so far undescribed area is worth further investigation in association with human prosocial behaviour.	[Primes, Georg; Fieder, Martin] Univ Vienna, Dept Anthropol, Vienna, Austria	University of Vienna	Primes, G (corresponding author), Univ Vienna, Dept Anthropol, Vienna, Austria.	georg.primes@univie.ac.at		Primes, Georg/0000-0002-4789-0552	IP Projekt (molekulares Kompetenzzentrum UWNU) [IP547011]	IP Projekt (molekulares Kompetenzzentrum UWNU)	The authors gratefully acknowledge funding from the IP Projekt (IP547011, molekulares Kompetenzzentrum UWNU). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bruce DG, 2008, DIABETES CARE, V31, P2103, DOI 10.2337/dc08-0562; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; Dreber A, 2009, EVOL HUM BEHAV, V30, P85, DOI 10.1016/j.evolhumbehav.2008.11.001; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ebstein RP, 2012, HORM BEHAV, V61, P359, DOI 10.1016/j.yhbeh.2011.12.014; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Eisenberg NFR., 1998, PROSOCIAL DEV; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2011, J PUBLIC ECON, V95, P1144, DOI 10.1016/j.jpubeco.2011.05.013; Graziano WG, 2007, J PERS SOC PSYCHOL, V93, P583, DOI 10.1037/0022-3514.93.4.583; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Health and Retirement Study, U01AG009740 HLTH RET; Heinrichs M, 2009, FRONT NEUROENDOCRIN, V30, P548, DOI 10.1016/j.yfrne.2009.05.005; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Israel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005535; Kettunen J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11122; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; Knafo A, 2006, DEV PSYCHOL, V42, P771, DOI 10.1037/0012-1649.42.5.771; Knafo A, 2008, EMOTION, V8, P737, DOI 10.1037/a0014179; Kuhnen CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004362; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Levitt SD, 2007, J ECON PERSPECT, V21, P153, DOI 10.1257/jep.21.2.153; Listgarten J, 2012, NAT METHODS, V9, P525, DOI 10.1038/nmeth.2037; McDermott R, 2009, P NATL ACAD SCI USA, V106, P2118, DOI 10.1073/pnas.0808376106; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Nam D, 2010, NUCLEIC ACIDS RES; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Penner LA, 2005, ANNU REV PSYCHOL, V56, P365, DOI 10.1146/annurev.psych.56.091103.070141; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rushton JP, 2004, P ROY SOC B-BIOL SCI, V271, P2583, DOI 10.1098/rspb.2004.2941; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Team RC, 2014, R LANG ENV STAT COMP; Teumer A, 2015, DIABETES; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Visscher PM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004269; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Vupputuri S, 2008, KIDNEY INT, V73, P341, DOI 10.1038/sj.ki.5002672; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Westberg L., 2015, OXFORD HDB MOL PSYCH, V145; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Yaffe K, 2002, ARCH NEUROL-CHICAGO, V59, P378, DOI 10.1001/archneur.59.3.378; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zheng J., 2016, BIOINFORMATICS; Zhong SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008516	57	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190950	10.1371/journal.pone.0190950	http://dx.doi.org/10.1371/journal.pone.0190950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324852	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400080
J	Skrzat-Klapaczynska, A; Matlosz, B; Bednarska, A; Paciorek, M; Firlag-Burkacka, E; Horban, A; Kowalska, JD				Skrzat-Klapaczynska, Agata; Matlosz, Bartlomiej; Bednarska, Agnieszka; Paciorek, Marcin; Firlag-Burkacka, Ewa; Horban, Andrzej; Kowalska, Justyna D.			Factors associated with urinary tract infections among HIV-1 infected patients	PLOS ONE			English	Article							HEPATITIS-C VIRUS; ANTIRETROVIRAL THERAPY; VIRAL-HEPATITIS; HIV DISEASE; AIDS; RISK; EPIDEMIOLOGY; INDIVIDUALS; BACTERIURIA; COINFECTION	Background Urinary tract infections remain an important yet underinvestigated clinical problem among HIV infected patients. Here we analyze factors associated with its occurrence and the spectrum of bacterial pathogens identified in the group of patients followed at the HIV Out-Patient Clinic in Warsaw. Methods Clinic database collected all medical information on patients routinely followed since 1994 to 2015. All patients with available urine culture were included into analyses, only the first culture was included. In statistical analyses logistic regression models were used to identify factors associated with positive culture. Results In total 608 patients had urine culture performed, 176 (28.9%) were females and 432 (71,1%) were males, 378 (62.2%) registered in care before/in 2007, 258 (42.4%) infected through homosexual contact. Median baseline lymphocyte CD4+ count was 385 (IQR: 204 +/- 565) cells/mu l and median nadir lymphocyte CD4+ count 197 (86 +/- 306) cells/mu l. One hundred and eighteen patients were actively infected with HCV, as defined by positive real-time PCR. In total 141 (23.2%) patients had positive urine culture, the most common bacterial pathogen was E. coli (58.2%) and E. faecalis (12.8%). Patients with urinary tract infection were more likely to be female (51.8% vs. 22.1%, p<0.0001), infected through other than homosexual mode (80.1% vs. 50.7%, p<0.0001), with lower nadir CD4 count (139 vs. 221 cells/mu l, p<0.0001) and lower baseline HIV RNA (4.02 vs. 4.35 log copies/ml, p = 0.01) and less likely to be HCV RNA positive (26.9% vs. 49.2%, p = 0.01). In multivariate regression model being registered before/in 2007 (OR = 2.10; [95% CI: 1.24 +/- 3.56]), infected through other than homosexual mode (2.05;[1.18 +/- 3.56]) and female gender (2.14;[1.33 +/- 3.44]) were increasing and higher nadir CD4+ count decreasing (0.92;[0.85 +/- 0.99]) the odds of urinary tract infection. Conclusions We have identified that almost one third of patients had urinary tract infections with non-typical bacterial pathogens. Population with increased odds of urinary tract infections are women, patients infected through other than homosexual contacts and those registered before 2007.	[Skrzat-Klapaczynska, Agata; Bednarska, Agnieszka; Paciorek, Marcin; Horban, Andrzej; Kowalska, Justyna D.] Med Univ Warsaw, Dept Adults Infect Dis, Warsaw, Poland; [Skrzat-Klapaczynska, Agata; Matlosz, Bartlomiej; Bednarska, Agnieszka; Paciorek, Marcin; Firlag-Burkacka, Ewa; Horban, Andrzej; Kowalska, Justyna D.] HIV Out Patient Clin, Hosp Infect Dis, Warsaw, Poland	Medical University of Warsaw	Skrzat-Klapaczynska, A (corresponding author), Med Univ Warsaw, Dept Adults Infect Dis, Warsaw, Poland.; Skrzat-Klapaczynska, A (corresponding author), HIV Out Patient Clin, Hosp Infect Dis, Warsaw, Poland.	agata.skrzat@op.pl	Skrzat-Klapaczyńska, Agata/ABC-2271-2020	Skrzat-Klapaczyńska, Agata/0000-0002-6367-5633	Research Development Foundation in Hospital for Infectious Diseases	Research Development Foundation in Hospital for Infectious Diseases	The study has been funded by research grant issued by the Research Development Foundation in Hospital for Infectious Diseases. The funder had no role in study design, data collectionand analysis, decision to publish, or preparation of the manuscript.; The above findings were presented in part at the 15th EACS conference in Barcelona 2015 as a poster presentation. The study has been funded by a research grant issued by the Research Development Foundation in Hospital for Infectious Diseases.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; BANU A, 2013, J HIV HUM REPROD, V1, P54, DOI DOI 10.4103/2321-9157.126630; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; DEPINHO AMF, 1994, GENITOURIN MED, V70, P30; Donati KD, 2003, J CHEMOTHERAPY, V15, P60, DOI 10.1179/joc.2003.15.1.60; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Gugino, 1998, Prim Care Update Ob Gyns, V5, P146, DOI 10.1016/S1068-607X(98)00021-3; Herrmann V, 2002, INT UROGYNECOL J PEL, V13, P210, DOI 10.1007/s192-002-8355-4; Hleyhel M, 2014, AIDS, V28, P2109, DOI 10.1097/QAD.0000000000000382; Hrbacek Jan, 2010, Cas Lek Cesk, V149, P115; Iduoriyekemwen N. J., 2012, Journal of Medicine and Biomedical Research, V11, P88; Jackson SL, 2004, AM J MED, V117, P903, DOI 10.1016/j.amjmed.2004.07.045; Kowalska JD, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-015-0084-5; Kowalska JD, 2012, AIDS, V26, P315, DOI 10.1097/QAD.0b013e32834e8805; Lebovitch S, 2008, UROL CLIN N AM, V35, P59, DOI 10.1016/j.ucl.2007.09.001; Lombo Bernardo, 2015, Conn Med, V79, P277; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Magliano E, 2012, SCI WORLD J, DOI 10.1100/2012/349597; Matthews PC, 2014, J CLIN VIROL, V61, P20, DOI 10.1016/j.jcv.2014.05.018; Mladenovic J, 2015, VOJNOSANIT PREGL, V72, P883, DOI 10.2298/VSP140624078M; Nelson JM, 2015, NURSE PRACT, V40, P43, DOI 10.1097/01.NPR.0000460855.44987.c1; Nicolle LE, 2008, UROL CLIN N AM, V35, P1, DOI 10.1016/j.ucl.2007.09.004; Olowe OA, 2015, EUR J MICROBIOL IMMU, V5, P126, DOI [10.1556/EuJMI-D-14-00036, 10.1556/EUJMI-D-14-00036]; Ovalle A, 2001, Curr Opin Urol, V11, P55, DOI 10.1097/00042307-200101000-00008; Palmer CS, 2016, INT REV IMMUNOL, V35, P477, DOI 10.3109/08830185.2015.1082178; Petoumenos K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17426; Puoti M, 2007, CURR OPIN HIV AIDS, V2, P460, DOI 10.1097/COH.0b013e3282f11906; Rockstroh JK, 2006, J HEPATOL, V44, pS25, DOI 10.1016/j.jhep.2005.11.007; Sagnelli C, 2015, WORLD J HEPATOL, V7, P2510, DOI 10.4254/wjh.v7.i24.2510; SanchezQuijano A, 1995, EUR J CLIN MICROBIOL, V14, P949, DOI 10.1007/BF01691375; Sarsekeyeva N, 2015, Georgian Med News, P30; Schonwald S, 1999, INT J ANTIMICROB AG, V11, P309, DOI 10.1016/S0924-8579(99)00036-9; Vignesh R, 2008, NEPHRON CLIN PRACT, V110, pC55, DOI 10.1159/000151533; Worm SW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-471	34	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190564	10.1371/journal.pone.0190564	http://dx.doi.org/10.1371/journal.pone.0190564			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324763	gold, Green Submitted, Green Published			2022-12-26	WOS:000419952400039
J	Ugwu, DI; Okoro, UC; Mishra, NK				Ugwu, David Izuchukwu; Okoro, Uchechukwu Chris; Mishra, Narendra Kumar			Synthesis, characterization and in vitro antitrypanosomal activities of new carboxamides bearing quinoline moiety	PLOS ONE			English	Article							TRYPANOSOMA-BRUCEI-GAMBIENSE; CHAGAS-DISEASE; SLEEPING SICKNESS; NIFURTIMOX; SAFETY; FORMS	The reported toxicities of current antitrypanosomal drugs and the emergence of drug resistant trypanosomes underscore the need for the development of new antitrypanosomal agents. We report herein the synthesis and antitrypanosomal activity of 24 new amide derivatives of 3-aminoquinoline, bearing substituted benzenesulphonamide. Nine of the new derivatives showed comparable antitrypanosomal activities at IC50 range of 1-6 nM (melarsoprol 5 nM). Compound 11n and 11v are more promising antitrypanosomal agents with IC50 1.0 nM than the rest of the reported derivatives. The novel compounds showed satisfactory predicted physico-chemical properties including oral bioavailability, permeability and transport properties.	[Ugwu, David Izuchukwu; Okoro, Uchechukwu Chris] Univ Nigeria, Dept Pure & Ind Chem, Med Chem Unit, Nsukka, Nigeria; [Ugwu, David Izuchukwu; Mishra, Narendra Kumar] Indian Inst Technol, Dept Chem, Kanpur, Uttar Pradesh, India	University of Nigeria; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur	Ugwu, DI (corresponding author), Univ Nigeria, Dept Pure & Ind Chem, Med Chem Unit, Nsukka, Nigeria.; Ugwu, DI (corresponding author), Indian Inst Technol, Dept Chem, Kanpur, Uttar Pradesh, India.	izuchukwu.ugwu@unn.edu.ng	Mishra, Narendra Kumar/O-2394-2019; Ugwu, David Izuchukwu/AAV-8960-2020	Ugwu, David Izuchukwu/0000-0002-2370-6191; Mishra, Narendra Kumar/0000-0001-6251-7177				Agbo EC, 2001, EXP PARASITOL, V99, P123, DOI 10.1006/expr.2001.4666; Ajibade PA, 2008, B CHEM SOC ETHIOPIA, V22, P261; BALTZ T, 1985, EMBO J, V4, P1273, DOI 10.1002/j.1460-2075.1985.tb03772.x; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Burri C, 2000, LANCET, V355, P1419, DOI 10.1016/S0140-6736(00)02141-3; Caffrey C. R., 2000, Current Drug Targets, V1, P155, DOI 10.2174/1389450003349290; Coura JR, 2002, MEM I OSWALDO CRUZ, V97, P3, DOI 10.1590/S0074-02762002000100001; DrugBank ed, 2016, PENT; Estani SS, 1999, MEM I OSWALDO CRUZ, V94, P363, DOI 10.1590/S0074-02761999000700070; Faidallah HM, 2017, ARCH PHARM, V350, DOI 10.1002/ardp.201700025; Forsyth CJ, 2016, CLIN INFECT DIS, V63, P1056, DOI 10.1093/cid/ciw477; Ghosh MN, 1984, FUNDAMENTALS EXPT PH, P153; Grab DJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000479; Hollingham R, 2005, NEW SCI, V2482, P40; Jackson Y, 2010, CLIN INFECT DIS, V51, pE69, DOI 10.1086/656917; Lescure FX, 2010, LANCET INFECT DIS, V10, P556, DOI 10.1016/S1473-3099(10)70098-0; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; LONSDALEECCLES JD, 1987, EUR J BIOCHEM, V169, P467, DOI 10.1111/j.1432-1033.1987.tb13634.x; Otoguro K, 2008, J ANTIBIOT, V61, P372, DOI 10.1038/ja.2008.52; Papadopoulou MV, 2012, J MED CHEM, V55, P5554, DOI 10.1021/jm300508n; Pentamidine Isethionate, 2016, AM SOC HLTH SYST PHA; PEPIN J, 1989, T ROY SOC TROP MED H, V83, P514, DOI 10.1016/0035-9203(89)90270-8; Schaefer C, 2014, DRUGS PREGNANCY LACT; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Werbovetz KA, 2003, MOL PHARMACOL, V64, P1325, DOI 10.1124/mol.64.6.1325; Zhao YH, 2002, PHARM RES-DORDR, V19, P1446, DOI 10.1023/A:1020444330011	26	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191234	10.1371/journal.pone.0191234	http://dx.doi.org/10.1371/journal.pone.0191234			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324817	Green Submitted, Green Published, gold			2022-12-26	WOS:000419952400134
J	Arasumani, M; Khan, D; Das, A; Lockwood, I; Stewart, R; Kiran, RA; Muthukumar, M; Bunyan, M; Robin, VV				Arasumani, M.; Khan, Danish; Das, Arundhati; Lockwood, Ian; Stewart, Robert; Kiran, Ravi A.; Muthukumar, M.; Bunyan, Milind; Robin, V. V.			Not seeing the grass for the trees: Timber plantations and agriculture shrink tropical montane grassland by two-thirds over four decades in the Palani Hills, a Western Ghats Sky Island	PLOS ONE			English	Article							ENDEMIC BIRD; CONSERVATION; BIODIVERSITY; DIVERSITY; FORESTS	Tropical montane habitats, grasslands, in particular, merit urgent conservation attention owing to the disproportionate levels of endemic biodiversity they harbour, the ecosystem services they provide, and the fact that they are among the most threatened habitats globally. The Shola Sky Islands in the Western Ghats host a matrix of native forest-grassland matrix that has been planted over the last century, with exotic timber plantations. The popular discourse on the landscape change is that mainly forests have been lost to the timber plantations and recent court directives are to restore Shola forest trees. In this study, we examine spatiotemporal patterns of landscape change over the last 40 years in the Palani Hills, a significant part of the montane habitat in the Western Ghats. Using satellite imagery and field surveys, we find that 66% of native grasslands and 31% of native forests have been lost over the last 40 years. Grasslands have gone from being the dominant, most contiguous land cover to one of the rarest and most fragmented. They have been replaced by timber plantations and, to a lesser extent, expanding agriculture. We find that the spatial pattern of grassland loss to plantations differs from the loss to agriculture, likely driven by the invasion of plantation species into grasslands. We identify remnant grasslands that should be prioritised for conservation and make specific recommendations for conservation and restoration of grasslands in light of current management policy in the Palani Hills, which favours large-scale removal of plantations and emphasises the restoration of native forests.	[Arasumani, M.; Khan, Danish; Robin, V. V.] INTACH Kodaikanal, Wilbet House, Kodaikanal, India; [Arasumani, M.; Muthukumar, M.] Gandhigram Rural Inst, Dindigul, Tamil Nadu, India; [Arasumani, M.; Robin, V. V.] IISER Tirupati, Tirupati, Andhra Pradesh, India; [Lockwood, Ian] Overseas Sch Colombo, Colombo, Sri Lanka; [Stewart, Robert] Vattakanal Conservat Trust, Vattakanal, Kodaikanal, India; [Kiran, Ravi A.] Bot Survey India, Coimbatore, Tamil Nadu, India; [Bunyan, Milind] Ashoka Trust Res Ecol & Environm, Bangalore, Karnataka, India	Gandhigram Rural Institute; Indian Institute of Science Education & Research (IISER) - Tirupati; Botanical Survey of India (BSI)	Robin, VV (corresponding author), INTACH Kodaikanal, Wilbet House, Kodaikanal, India.; Robin, VV (corresponding author), IISER Tirupati, Tirupati, Andhra Pradesh, India.	robinvijayan@gmail.com	M, Arasumani/D-9215-2016; Arigela, Ravi Kiran/ABD-8497-2020; Robin, V.V./H-7299-2019; Das, Arundhati/H-5988-2019	M, Arasumani/0000-0003-3532-6767; Arigela, Ravi Kiran/0000-0001-5804-3423; Robin, V.V./0000-0003-3109-5498; Das, Arundhati/0000-0002-3103-5957; Bunyan, Milind/0000-0002-0810-7422	INTACH; IISER Tirupati; Tamil Nadu Forest Department	INTACH; IISER Tirupati; Tamil Nadu Forest Department	INTACH and IISER Tirupati provided all funding towards the project. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the Tamil Nadu Forest Department for permits and support. Anil Choudhary and Sunayana Choudhary provided support and encouragement throughout the project. We thank INTACH-Delhi, specifically Manu Bhatnagar, L.K. Gupta and Ritu Singh. We also thank members of the Kodaikanal community for having participated in our contact meetings, provided feedback and assistance in many ways Arun Govindarajulu, Corey Stixrud, Beulah Kolhatkar, Priyashri Mani & Nishitha Vasanth. We thank R. Prabhakar, Atul Joshi, Jayashree Ratnam, Nandini Rajamani and Devcharan Jathana for feedback and help during the project.	Adler PB, 1999, J RANGE MANAGE, V52, P471, DOI 10.2307/4003774; Ahrestani F., 2017, CHOP OT NOT CHOP ISS; Anderson J.R., 1976, LAND USE LAND COVER, DOI 10.3133/pp964; Balete Danilo S., 1998, Ecotropica, V3, P91; Bond WJ, 2008, J BIOGEOGR, V35, P1743, DOI 10.1111/j.1365-2699.2008.01923.x; Bond WJ, 2016, SCIENCE, V351, P120, DOI 10.1126/science.aad5132; Bond WJ, 2010, BIOL CONSERV, V143, P2395, DOI 10.1016/j.biocon.2009.12.012; Burgess ND, 2007, BIOL CONSERV, V134, P209, DOI 10.1016/j.biocon.2006.08.015; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Carine M.A., 2004, KEW B, V59, P1, DOI [10.2307/4111071, DOI 10.2307/4111071]; Change IPoC, 2014, CLIM CHANG 2014 IMP; Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042; Chen XL, 2006, REMOTE SENS ENVIRON, V104, P133, DOI 10.1016/j.rse.2005.11.016; Clewell A. F., 2013, ECOLOGICAL RESTORATI, DOI DOI 10.5822/978-1-59726-323-8; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Coop JD, 2007, J BIOGEOGR, V34, P914, DOI 10.1111/j.1365-2699.2006.01660.x; Dutta K, 2016, CURRENT SCI, P110; Eastman JR, 2015, TERRSET GEOSPATIAL M; ESRI A, 2001, COMP M; Fjeldsa J, 1999, ECOGRAPHY, V22, P63, DOI 10.1111/j.1600-0587.1999.tb00455.x; FSI, 2015, IND STAT FOR REP 201; *FSI, 2001, STAT FOR REP 2001; Geldenhuys C. J., 1986, The ecology and management of biological invasions in Southern Africa. Proceedings of the National Synthesis Symposium on the ecology of biological invasions., P119; Geldenhuys CJ, 1997, FOREST ECOL MANAG, V99, P101, DOI 10.1016/S0378-1127(97)00197-7; Gibson D. J., 2009, GRASSES GRASSLAND EC; Giriraj A, 2008, CURR SCI INDIA, V94, P1605; Guide EUs, 2008, ENVI ON LIN SOFTW US; Henderson JV, 2016, GLOBAL SPATIAL DISTR; HOUGHTON RA, 1994, BIOSCIENCE, V44, P305, DOI 10.2307/1312380; Jansen R, 2013, INSECT CONSERV DIVER, V6, P572, DOI 10.1111/icad.12013; Kabeer K, 2009, FLORA OF TAMIL NADU; Karnad D, 2014, TACKLING DEMON EUCAL; Kumar BA, 2013, HINDU; Kumar R, 2014, ECOL INDIC, V45, P444, DOI 10.1016/j.ecolind.2014.05.003; Kumar S., 1993, SURVEY MAPPING SHOLA; Lamb D, 1998, RESTOR ECOL, V6, P271, DOI 10.1046/j.1526-100X.1998.00632.x; LeJeune KD, 2001, CONSERV BIOL, V15, P1568, DOI 10.1046/j.1523-1739.2001.00242.x; Leo M., 1995, IMPORTANCE TROPICAL, P198; [Liu Linshan 刘林山], 2006, Journal of Geographical Sciences, V16, P131, DOI 10.1007/s11442-006-0201-4; Lockwood I, 2014, LAND COVER CHANGES P, V4; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Martin PH, 2016, J TROP ECOL, V32, P345, DOI 10.1017/S0266467416000432; Matthew KM, 1999, BIODIVERS CONSERV, V8, P779, DOI 10.1023/A:1008804029859; McCullagh P, 1989, GEN LINEAR MODELS NO; McGarigal K., 2012, FRAGSTATS V4 SPATIAL; Mitchell N., 1972, INDIAN HILL STATION; Mooney H.A., 2000, INVASIVE SPECIES CHA; Mudappa D., 2007, MAKING CONSERVATION, P210; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Norstrom C., 2003, THEY CALL US STRATEG; Peyre G., 2015, THESIS; Prakasam C., 2010, International Journal of Geomatics and Geosciences, V1, P150; Purushotham CB, 2016, ECOL EVOL, V6, P7334, DOI 10.1002/ece3.2475; Puyravaud JP, 2003, FOREST ECOL MANAG, V177, P593, DOI 10.1016/S0378-1127(02)00335-3; Ramirez-Marcial N, 2001, FOREST ECOL MANAG, V154, P311, DOI 10.1016/S0378-1127(00)00639-3; Rangan H, 2010, REG ENVIRON CHANGE, V10, P103, DOI 10.1007/s10113-009-0098-4; RCore Team, 2020, R LANG ENV STAT COMP; Reddy CS, 2016, J EARTH SYST SCI, V125, P103, DOI 10.1007/s12040-015-0645-y; Richardson DM, 2008, PERSPECT PLANT ECOL, V10, P161, DOI 10.1016/j.ppees.2008.03.001; Robin VV, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0861; Robin VV, 2014, CURR SCI INDIA, V107, P622; Robin VV, 2012, CURR SCI INDIA, V103, P1427; Robin VV, 2011, ANIM BEHAV, V82, P513, DOI 10.1016/j.anbehav.2011.05.032; Rosencranz A., 2008, EC POLIT WKLY, V43, P11; Sekar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071573; Srimathi A, 2012, REGENERATION SHOLA T, V8; Stewart R., 2003, SOC CHANGE, V33, P115, DOI DOI 10.1177/004908570303300308; Still CJ, 1999, NATURE, V398, P608, DOI 10.1038/19293; STONE TA, 1994, PHOTOGRAMM ENG REM S, V60, P541; Sukumar R, 1995, J BIOGEOGR, V22, P533, DOI 10.2307/2845951; Team RC, 2014, R LANG ENV STAT COMP; Van Wyk G, 1995, 867 FORDEA DIV FOR S, P867; Veldman JW, 2015, BIOSCIENCE, V65, P1011, DOI 10.1093/biosci/biv118	73	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190003	10.1371/journal.pone.0190003	http://dx.doi.org/10.1371/journal.pone.0190003			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320520	Green Published, gold, Green Submitted			2022-12-26	WOS:000419689600027
J	Balotf, S; Islam, S; Kavoosi, G; Kholdebarin, B; Juhasz, A; Ma, WJ				Balotf, Sadegh; Islam, Shahidul; Kavoosi, Gholamreza; Kholdebarin, Bahman; Juhasz, Angela; Ma, Wujun			How exogenous nitric oxide regulates nitrogen assimilation in wheat seedlings under different nitrogen sources and levels	PLOS ONE			English	Article							USE EFFICIENCY; GLUTAMINE-SYNTHETASE; NITRATE REDUCTASE; AMMONIUM; MECHANISMS; TOMATO; YIELD	Nitrogen (N) is one of the most important nutrients for plants and nitric oxide (NO) as a signaling plant growth regulator involved in nitrogen assimilation. Understanding the influence of exogenous NO on nitrogen metabolism at the gene expression and enzyme activity levels under different sources of nitrogen is vitally important for increasing nitrogen use efficiency (NUE). This study investigated the expression of key genes and enzymes in relation to nitrogen assimilation in two Australian wheat cultivars, a popular high NUE cv. Spitfire and a normal NUE cv. Westonia, under different combinations of nitrogen and sodium nitroprusside (SNP) as the NO donor. Application of NO increased the gene expressions and activities of nitrogen assimilation pathway enzymes in both cultivars at low levels of nitrogen. At high nitrogen supplies, the expressions and activities of N assimilation genes increased in response to exogenous NO only in cv. Spitfire but not in cv. Westonia. Exogenous NO caused an increase in leaf NO content at low N supplies in both cultivars, while under high nitrogen treatments, cv. Spitfire showed an increase under ammonium nitrate (NH4NO3) treatment but cv. Westonia was not affected. N assimilation gene expression and enzyme activity showed a clear relationship between exogenous NO, N concentration and N forms in primary plant nitrogen assimilation. Results reveal the possible role of NO and different nitrogen sources on nitrogen assimilation in Triticum aestivum plants.	[Balotf, Sadegh; Islam, Shahidul; Juhasz, Angela; Ma, Wujun] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Balotf, Sadegh; Kavoosi, Gholamreza] Shiraz Univ, Inst Biotechnol, Shiraz, Iran; [Kholdebarin, Bahman] Shiraz Univ, Fac Sci, Dept Biol, Shiraz, Iran	Murdoch University; Shiraz University; Shiraz University	Ma, WJ (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia.	W.Ma@murdoch.edu.au	Ma, Wujun/F-5957-2010; Balotf, Sadegh/AAH-1014-2022; Balotf, Sadegh/C-3821-2019; Juhasz, Angela/P-7169-2019; Juhasz, Angela/B-9727-2019; Kavoosi, Gholamreza/HII-4788-2022	Ma, Wujun/0000-0002-1264-866X; Balotf, Sadegh/0000-0001-9949-8571; Balotf, Sadegh/0000-0001-9949-8571; Juhasz, Angela/0000-0002-4317-2027; Juhasz, Angela/0000-0002-4317-2027; kavoosi, gholamreza/0000-0003-2920-3453; Islam, Shahidul/0000-0001-5994-0521	GRDC [UMU00048]	GRDC	This work was supported by GRDC, grant #UMU00048 (https://grdc.com.au). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanullah, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01773; Andrews M, 2013, ANN APPL BIOL, V163, P174, DOI 10.1111/aab.12045; Arora D, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1071753; Balotf S., 2012, Australian Journal of Crop Science, V6, P130; Balotf S, 2016, BIOTECHNOL APPL BIOC, V63, P220, DOI 10.1002/bab.1362; Betti M, 2014, J EXP BOT, V65, P5557, DOI 10.1093/jxb/eru260; Chen C, 2016, J PLANT NUTR SOIL SC, V179, P104, DOI 10.1002/jpln.201500179; Conner EM, 1996, NUTRITION, V12, P274, DOI 10.1016/S0899-9007(96)00000-8; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Frungillo L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6401; Funayama K, 2013, PLANT CELL PHYSIOL, V54, P934, DOI 10.1093/pcp/pct046; Glass ADM, 2002, J EXP BOT, V53, P855, DOI 10.1093/jexbot/53.370.855; Good AG, 2004, TRENDS PLANT SCI, V9, P597, DOI 10.1016/j.tplants.2004.10.008; Gupta KJ, 2011, TRENDS PLANT SCI, V16, P160, DOI 10.1016/j.tplants.2010.11.007; Hirel B, 2001, PLANT PHYSIOL, V125, P1258, DOI 10.1104/pp.125.3.1258; KEYS AJ, 1978, NATURE, V275, P741, DOI 10.1038/275741a0; Kiba T, 2016, PLANT CELL PHYSIOL, V57, P707, DOI 10.1093/pcp/pcw052; KING BJ, 1993, PLANT PHYSIOL, V102, P1279, DOI 10.1104/pp.102.4.1279; Krapp A, 2015, CURR OPIN PLANT BIOL, V25, P115, DOI 10.1016/j.pbi.2015.05.010; Lamotte O, 2004, PLANT PHYSIOL, V135, P516, DOI 10.1104/pp.104.038968; Li YL, 2008, PLANT CELL ENVIRON, V31, P73, DOI 10.1111/j.1365-3040.2007.01737.x; Lillo C, 2004, J EXP BOT, V55, P1275, DOI 10.1093/jxb/erh132; Liu LJ, 2015, J PLANT NUTR SOIL SC, V178, P297, DOI 10.1002/jpln.201400304; MacKintosh C, 2001, CELL MOL LIFE SCI, V58, P205, DOI 10.1007/PL00000848; Malagoli P, 2005, ANN BOT-LONDON, V95, P853, DOI 10.1093/aob/mci091; Manoli A, 2014, J EXP BOT, V65, P185, DOI 10.1093/jxb/ert358; Mounier E, 2014, PLANT CELL ENVIRON, V37, P162, DOI 10.1111/pce.12143; Mur LAJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00215; Nagy Z, 2013, PLANT PHYSIOL BIOCH, V67, P48, DOI 10.1016/j.plaphy.2013.03.001; Rosales EP, 2011, PLANT PHYSIOL BIOCH, V49, P124, DOI 10.1016/j.plaphy.2010.10.009; Perchlik M, 2017, PLANT PHYSIOL, V175, P235, DOI 10.1104/pp.17.00608; Perez-Delgado CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130438; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Ruffel S, 2011, P NATL ACAD SCI USA, V108, P18524, DOI 10.1073/pnas.1108684108; Sanz-Luque E, 2013, J EXP BOT, V64, P3373, DOI 10.1093/jxb/ert175; Seabra AR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00578; Sivakumaran A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00709; Stohr C, 2006, J EXP BOT, V57, P463, DOI 10.1093/jxb/erj058; Sun HW, 2015, J EXP BOT, V66, P2449, DOI 10.1093/jxb/erv030; WALLSGROVE RM, 1987, PLANT PHYSIOL, V83, P155, DOI 10.1104/pp.83.1.155; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Yamaya T, 2014, J EXP BOT, V65, P5519, DOI 10.1093/jxb/eru103; Zhang YH, 2007, PEDOSPHERE, V17, P792, DOI 10.1016/S1002-0160(07)60095-2; Zhou BY, 2005, J EXP BOT, V56, P3223, DOI 10.1093/jxb/eri319	44	29	30	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190269	10.1371/journal.pone.0190269	http://dx.doi.org/10.1371/journal.pone.0190269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320529	Green Published, Green Submitted, gold			2022-12-26	WOS:000419689600042
J	Byun, SJ; Kim, YS; Ahn, H; Kim, CS				Byun, Sang Jun; Kim, Young Seok; Ahn, Hanjong; Kim, Choung-Soo			Image-guided, whole-pelvic, intensity-modulated radiotherapy for biochemical recurrence following radical prostatectomy in high-risk prostate cancer patients	PLOS ONE			English	Article							LYMPH-NODE DISSECTION; SALVAGE RADIOTHERAPY; RADIATION-THERAPY; ENDORECTAL BALLOON; FREE SURVIVAL; TOXICITY; BED; ADJUVANT; ANTIGEN; RELAPSE	Background The optimal field size of salvage radiotherapy (SRT) for biochemical recurrence, particularly for patients with high-risk prostate cancer, remains undefined. This retrospective analysis was performed to investigate oncological outcomes as well as treatment-related toxicity following salvage intensity-modulated radiotherapy (IMRT) to the whole pelvis and to compare the results with other studies implementing a small field size of the prostate bed. Methods The medical records of 170 patients with high-risk prostate cancer who received SRT for biochemical recurrence following prostatectomy were reviewed. Whole-pelvic IMRT was administered with a median dose of 66 Gy in 30 fractions. To improve treatment accuracy, an endorectal balloon device and daily cone-beam computed tomography were utilized. Androgen-deprivation therapy combined with SRT was administered to 97 (57.1%) patients. Results Eventually, 68 (40.0%) patients showed biochemical progression (BCP) after SRT. With a median follow-up period of 56 months, the 5-year BCP-free survival was 38.6%. The overall and cause-specific survival rates were 90.9% and 96.7%, respectively. Regarding BCP-free survival analysis, pathological T stage, persistent prostate-specific antigen (PSA) elevation after prostatectomy, and preSRT PSA level were significant prognostic factors on univariate analysis. On multivariate analysis, pathological T stage and preSRT PSA value retained their significance. Acute and late grade-3 genitourinary toxicities were observed in one (0.6%) and five (2.9%) patients, respectively. One patient each developed acute and late grade-3 gastrointestinal toxicity. Conclusion SRT to whole pelvis using IMRT and image guidance is as safe as SRT to the prostate bed, but its efficacy should be confirmed in ongoing randomized trials. PreSRT PSA was the only controllable prognostic factor, suggesting the benefit of early SRT.	[Byun, Sang Jun] Keimyung Univ, Sch Med, Dongsan Med Ctr, Dept Radiat Oncol, Daegu, South Korea; [Kim, Young Seok] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea; [Ahn, Hanjong; Kim, Choung-Soo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Urol, Seoul, South Korea	Keimyung University; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, YS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea.	ysk@amc.seoul.kr		Kim, Young Seok/0000-0003-4739-4476; Byun, SangJun/0000-0002-6115-2804	National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [NRF-2016R1C1B2012823]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2016R1C1B2012823).	Abdollah F, 2013, ANN ONCOL, V24, P1459, DOI 10.1093/annonc/mdt120; Abugharib A, 2017, J UROLOGY, V197, P662, DOI 10.1016/j.juro.2016.08.106; Alongi F, 2009, RADIOTHER ONCOL, V93, P207, DOI 10.1016/j.radonc.2009.08.042; Bianco FJ, 2005, UROLOGY, V66, P83, DOI 10.1016/j.urology.2005.06.116; Chung HT, 2009, INT J RADIAT ONCOL, V73, P53, DOI 10.1016/j.ijrobp.2008.03.015; Deville C, 2012, INT J RADIAT ONCOL, V82, P1389, DOI 10.1016/j.ijrobp.2011.04.041; Eldredge HB, 2011, J MED IMAG RADIAT ON, V55, P507, DOI 10.1111/j.1754-9485.2011.02305.x; Freedland SJ, 2014, J CLIN ONCOL, V32, P3892, DOI 10.1200/JCO.2014.58.8525; Joo JH, 2016, ONCOTARGETS THER, V9, P3095, DOI 10.2147/OTT.S98112; Katayama S, 2014, INT J RADIAT ONCOL, V90, P926, DOI 10.1016/j.ijrobp.2014.07.015; Kim YJ, 2016, ONCOTARGETS THER, V9, P1319, DOI 10.2147/OTT.S96646; King CR, 2008, INT J RADIAT ONCOL, V71, P23, DOI 10.1016/j.ijrobp.2007.09.047; Lewis SL, 2016, INT J RADIAT ONCOL, V94, P605, DOI 10.1016/j.ijrobp.2015.11.025; Lips IM, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-15; Moghanaki D, 2013, CANCER-AM CANCER SOC, V119, P52, DOI 10.1002/cncr.27712; Morikawa LK, 2011, INT J RADIAT ONCOL, V80, P6, DOI 10.1016/j.ijrobp.2010.11.074; Nath SK, 2010, INT J RADIAT ONCOL, V78, P435, DOI 10.1016/j.ijrobp.2009.08.023; Parker C, 2007, CLIN ONCOL-UK, V19, P167, DOI 10.1016/j.clon.2007.01.001; Pearse M, 2008, INT J RADIAT ONCOL, V72, P792, DOI 10.1016/j.ijrobp.2008.05.063; Peterson JL, 2009, RADIOTHER ONCOL, V93, P203, DOI 10.1016/j.radonc.2009.08.035; Pfister D, 2014, EUR UROL, V65, P1034, DOI 10.1016/j.eururo.2013.08.013; Polkinghorn WR, 2013, CANCER DISCOV, V3, P1245, DOI 10.1158/2159-8290.CD-13-0172; Polterauer S, 2010, BRIT J CANCER, V103, P613, DOI 10.1038/sj.bjc.6605801; ROACH M, 1994, INT J RADIAT ONCOL, V28, P33, DOI 10.1016/0360-3016(94)90138-4; Roach M, 2003, J CLIN ONCOL, V21, P1904, DOI 10.1200/JCO.2003.05.004; Ross RW, 2009, CLIN IMAG, V33, P301, DOI 10.1016/j.clinimag.2009.01.013; Spiotto MT, 2007, INT J RADIAT ONCOL, V69, P54, DOI 10.1016/j.ijrobp.2007.02.035; Spratt DE, 2015, CANCER RES, V75, P4688, DOI 10.1158/0008-5472.CAN-15-0892; Tendulkar RD, 2016, J CLIN ONCOL; van der Wal BCH, 2002, EUR J SURG ONCOL, V28, P481, DOI 10.1053/ejso.2002.1239; van Lin ENJT, 2005, INT J RADIAT ONCOL, V61, P278, DOI 10.1016/j.ijrobp.2004.09.042; Wawroschek F, 2003, EUR UROL, V43, P132, DOI 10.1016/S0302-2838(02)00450-5	32	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190479	10.1371/journal.pone.0190479	http://dx.doi.org/10.1371/journal.pone.0190479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320570	Green Published, Green Submitted, gold			2022-12-26	WOS:000419689600052
J	Manav, MC; Beljantseva, J; Bojer, MS; Tenson, T; Ingmer, H; Hauryliuk, V; Brodersen, DE				Manav, Melek Cemre; Beljantseva, Jelena; Bojer, Martin S.; Tenson, Tanel; Ingmer, Hanne; Hauryliuk, Vasili; Brodersen, Ditlev E.			Structural basis for (p)ppGpp synthesis by the Staphylococcus aureus small alarmone synthetase RelP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC REGULATION; STRINGENT RESPONSE; ESCHERICHIA-COLI; RIBONUCLEIC-ACID; PROTEIN; METABOLISM; SYSTEM; ENZYME	The stringent response is a global reprogramming of bacterial physiology that renders cells more tolerant to antibiotics and induces virulence gene expression in pathogens in response to stress. This process is driven by accumulation of the intracellular alarmone guanosine-5'-di(tri)phosphate-3'-diphosphate ((p)ppGpp), which is produced by enzymes of the RelA SpoT homologue (RSH) family. The Gram-positive Firmicute pathogen, Staphylococcus aureus, encodes three RSH enzymes: a multidomain RSH (Rel) that senses amino acid starvation on the ribosome and two small alarmone synthetase (SAS) enzymes, RelQ (SAS1) and RelP (SAS2). In Bacillus subtilis, RelQ (SAS1) was shown to form a tetramer that is activated by pppGpp and inhibited by single-stranded RNA, but the structural and functional regulation of RelP (SAS2) is unexplored. Here, we present crystal structures of S. aureus RelP in two major functional states, pre-catalytic (bound to GTP and the non-hydrolyzable ATP analogue, adenosine 5'-(alpha,beta-methylene) triphosphate (AMP-CPP)), and post-catalytic (bound to pppGpp). We observed that RelP also forms a tetramer, but unlike RelQ (SAS1), it is strongly inhibited by both pppGpp and ppGpp and is insensitive to inhibition by RNA. We also identified putative metal ion-binding sites at the subunit interfaces that were consistent with the observed activation of the enzyme by Zn2+ ions. The structures reported here reveal the details of the catalytic mechanism of SAS enzymes and provide a molecular basis for understanding differential regulation of SAS enzymes in Firmicute bacteria.	[Manav, Melek Cemre; Brodersen, Ditlev E.] Ctr Bacterial Stress Response & Persistence, Dept Mol Biol & Genet, Gustav Wieds Vej 10c, DK-8000 Aarhus C, Denmark; [Beljantseva, Jelena; Tenson, Tanel; Hauryliuk, Vasili] Univ Tartu, Inst Technol, Nooruse 1, EE-50411 Tartu, Estonia; [Bojer, Martin S.; Ingmer, Hanne] Univ Copenhagen, Dept Vet & Anim Sci, DK-1870 Frederiksberg C, Denmark; [Hauryliuk, Vasili] Umea Univ, Dept Mol Biol, SE-90187 Umea, Sweden; [Hauryliuk, Vasili] Umea Univ, Lab Mol Infect Med Sweden MIMS, SE-90187 Umea, Sweden	University of Tartu; University of Copenhagen; Umea University; Umea University	Brodersen, DE (corresponding author), Ctr Bacterial Stress Response & Persistence, Dept Mol Biol & Genet, Gustav Wieds Vej 10c, DK-8000 Aarhus C, Denmark.	deb@mbg.au.dk	Hauryliuk, Vasili/J-3930-2019; Brodersen, Ditlev E./AAQ-5241-2020; Tenson, Tanel/I-6431-2015	Hauryliuk, Vasili/0000-0003-2389-5057; Ingmer, Hanne/0000-0002-8350-5631; Manav, M. Cemre/0000-0003-3540-2803; Bojer, Martin Saxtorph/0000-0002-8488-9593; Tenson, Tanel/0000-0002-0260-3601; Brodersen, Ditlev/0000-0002-5413-4667	Danish National Research Foundation [DNRF120]; Estonian Research Council [IUT2-22]; European Regional Development Fund through the Centre of Excellence for Molecular Cell Technology; Swedish Research Council Vetenskapsradet [2013-4680]; Ragnar Soderberg foundation	Danish National Research Foundation(Danmarks Grundforskningsfond); Estonian Research Council(Estonian Research Council); European Regional Development Fund through the Centre of Excellence for Molecular Cell Technology; Swedish Research Council Vetenskapsradet(Swedish Research Council); Ragnar Soderberg foundation	This work was supported by Danish National Research Foundation Grant DNRF120 (to D.E.B.), Estonian Research Council Grant IUT2-22 (to T.T.), the European Regional Development Fund through the Centre of Excellence for Molecular Cell Technology (to V.H. and T.T.), Swedish Research Council Vetenskapsradet Grant 2013-4680 (to V.H.), and the Ragnar Soderberg foundation (to V.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antoun Ayman, 2004, Biol Proced Online, V6, P35, DOI 10.1251/bpo71; Arenz S, 2016, NUCLEIC ACIDS RES, V44, P6471, DOI 10.1093/nar/gkw470; Atkinson GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023479; Avarbock D, 2000, BIOCHEMISTRY-US, V39, P11640, DOI 10.1021/bi001256k; Beljantseva J, 2017, P NATL ACAD SCI USA, V114, P3726, DOI 10.1073/pnas.1617868114; Boucher H, 2010, CLIN INFECT DIS, V51, pS183, DOI 10.1086/653519; Brown A, 2016, NATURE, V534, P277, DOI 10.1038/nature17675; CASHEL M, 1970, J BIOL CHEM, V245, P2309; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; Dalebroux ZD, 2010, MICROBIOL MOL BIOL R, V74, P171, DOI 10.1128/MMBR.00046-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedman YE, 2004, J BIOL CHEM, V279, P32100, DOI 10.1074/jbc.M404924200; Geiger T, 2014, J BACTERIOL, V196, P894, DOI 10.1128/JB.01201-13; Harms A, 2016, SCIENCE, V354, DOI 10.1126/science.aaf4268; HASELTINE WA, 1973, P NATL ACAD SCI USA, V70, P1564, DOI 10.1073/pnas.70.5.1564; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Laitaoja M, 2013, INORG CHEM, V52, P10983, DOI 10.1021/ic401072d; Lemos JA, 2007, MOL MICROBIOL, V65, P1568, DOI 10.1111/j.1365-2958.2007.05897.x; Loveland AB, 2016, ELIFE, V5, DOI 10.7554/eLife.17029; Luche S, 2016, J PROTEOMICS, V135, P170, DOI 10.1016/j.jprot.2015.07.018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mechold U, 2002, J BACTERIOL, V184, P2878, DOI 10.1128/JB.184.11.2878-2888.2002; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; PAO CC, 1981, BIOCHIM BIOPHYS ACTA, V677, P358, DOI 10.1016/0304-4165(81)90247-6; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Shyp V, 2012, EMBO REP, V13, P835, DOI 10.1038/embor.2012.106; Steinchen W, 2015, P NATL ACAD SCI USA, V112, P13348, DOI 10.1073/pnas.1505271112; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	32	28	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3254	3264		10.1074/jbc.RA117.001374	http://dx.doi.org/10.1074/jbc.RA117.001374			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29326162	Green Published, hybrid			2022-12-26	WOS:000426562800019
J	Cheng, TY; Yang, YC; Wang, HP; Tien, YW; Shun, CT; Huang, HY; Hsiao, M; Hua, KT				Cheng, Tsu-Yao; Yang, Yi-Chieh; Wang, Hsiu-Po; Tien, Yu-Wen; Shun, Chia-Tung; Huang, Hsin-Yi; Hsiao, Michael; Hua, Kuo-Tai			Pyruvate kinase M2 promotes pancreatic ductal adenocarcinoma invasion and metastasis through phosphorylation and stabilization of PAK2 protein	ONCOGENE			English	Article							TUMOR-CELLS; CANCER-CELLS; GENE-TRANSCRIPTION; PKM2; TUMORIGENESIS; ISOFORM; PROGRESSION; EXPRESSION; PROGNOSIS; STRESS	Pyruvate kinase muscle isozymes (PKMs) have crucial roles in regulating metabolic changes during carcinogenesis. A switch from PKM1 to PKM2 isoform was thought to lead to aerobic glycolysis promoting carcinogenesis, and was considered as one of the cancer signatures. However, recent evidence has argued against the existence of PKM isoform switch and related metabolic effects during cancer progression. We compared the effects of PKM1 and PKM2 in cell invasiveness and metastasis of pancreatic ductal adenocarcinoma (PDAC). Both PKM1 and PKM2 expression affected cell migration and invasion abilities of PDAC cells, but only knockdown of PKM2 suppressed metastasis in a xenograft model. By comparing the established PKM2 mutants in the regulation of cell invasion, we found that PKM2 may control cell mobility through its protein kinase and phopho-peptide binding abilities. Further survey for PKM2-associated proteins identified PAK2 as a possible phosphorylation target in PDAC. In vitro binding and kinase assays revealed that PKM2 directly phosphorylated PAK2 at Ser20, Ser141, and Ser192/197. Knockdown of PKM2 decreased PAK2 protein half-life by increasing ubiquitin-dependent proteasomal degradation. Moreover, we identified PAK2 as an HSP90 client protein and the mutation at Ser192/197 of PAK2 reduced PAK2-HSP90 association. Knockdown of PAK2 diminished in vitro cell mobility and in vivo metastatic ability of PKM2 overexpressed PDAC cells. PKM2 and PAK2 protein expression also positively correlated with each other in PDAC tissues. Our findings indicate that PKM2-PAK2 regulation is critical for developing metastasis in PDAC, and suggest that targeting the PKM2/HSP90/PAK2 complex has a potential therapeutic value in this deadly disease.	[Cheng, Tsu-Yao] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Cheng, Tsu-Yao; Wang, Hsiu-Po] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [Yang, Yi-Chieh] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Tien, Yu-Wen] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Shun, Chia-Tung; Huang, Hsin-Yi] Natl Taiwan Univ Hosp, Dept Pathol, Taipei, Taiwan; [Hsiao, Michael] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Hsiao, Michael] Kaohsiung Med Univ, Dept Biochem, Coll Med, Kaohsiung, Taiwan; [Hua, Kuo-Tai] Natl Taiwan Univ, Grad Inst Toxicol, Coll Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Academia Sinica - Taiwan; Kaohsiung Medical University; National Taiwan University	Hua, KT (corresponding author), Natl Taiwan Univ, Grad Inst Toxicol, Coll Med, Taipei, Taiwan.	kthua@ntu.edu.tw	Hsiao, Michael/U-6238-2019; Cheng, TY/X-1695-2019; Shun, Chia-Tung/M-1400-2019; Yang, Yi-Chieh/D-6248-2019	Hsiao, Michael/0000-0001-8529-9213; Hua, Kuo-Tai/0000-0002-8468-4977; TIEN, YU-WEN/0000-0002-9126-2705; SHUN, CHIA-TUNG/0000-0002-0468-4468; Huang, Hsin-Yi/0000-0003-0062-3091; CHENG, TSU-YAO/0000-0002-7370-5605	Ministry of Science and Technology of Taiwan [104-0210-01-09-02, 105-0210-01-13-01, 106-0210-01-15-02, 105-2320-B-002-035-MY3, 104-2314-B-002-027]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	We thank Dr. Zhi-Min Lu for the Flag-tagged K367M, K433E, and wild-type PKM2; Dr. Zhi-Ren Liu for HA-tagged R399E and wild-type PKM2. This work was supported by grants from the Ministry of Science and Technology of Taiwan, 104-0210-01-09-02, 105-0210-01-13-01, and 106-0210-01-15-02 (to M. H.); 105-2320-B-002-035-MY3 (to K.-T.H.); and 104-2314-B-002-027 (to T.-Y.C.).	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Bluemlein K, 2011, ONCOTARGET, V2, P393; Calabretta S, 2016, ONCOGENE, V35, P2031, DOI 10.1038/onc.2015.270; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Coniglio SJ, 2008, MOL CELL BIOL, V28, P4162, DOI 10.1128/MCB.01532-07; Desai S, 2014, ONCOTARGET, V5, P8202, DOI 10.18632/oncotarget.1159; EHRENFRIED JA, 1995, SURG ONCOL, V4, P197, DOI 10.1016/S0960-7404(10)80036-2; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Goonetilleke KS, 2007, PANCREAS, V34, P318, DOI 10.1097/MPA.0b013e31802ee9c7; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hosios AM, 2015, MOL CELL, V59, P850, DOI 10.1016/j.molcel.2015.07.013; IMAMURA K, 1972, J BIOCHEM-TOKYO, V71, P1043, DOI 10.1093/oxfordjournals.jbchem.a129852; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Jakobi R, 2003, J BIOL CHEM, V278, P38675, DOI 10.1074/jbc.M306494200; Jiang K, 2016, ONCOTARGET, V7, P23530, DOI 10.18632/oncotarget.8120; Jiang YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6566; Jiang YH, 2014, MOL CELL, V53, P75, DOI 10.1016/j.molcel.2013.11.001; Joergensen MT, 2010, PANCREAS, V39, P243, DOI 10.1097/MPA.0b013e3181bae8ab; Keller KE, 2014, MOL CELL, V53, P700, DOI 10.1016/j.molcel.2014.02.015; Kumar R, 2017, GENE, V605, P20, DOI 10.1016/j.gene.2016.12.014; Kumar Y, 2007, PANCREAS, V35, P114, DOI 10.1097/mpa.0b013e3180537237; Lang SA, 2007, MOL CANCER THER, V6, P1123, DOI 10.1158/1535-7163.MCT-06-0628; Li CG, 2016, DIGEST DIS SCI, V61, P767, DOI 10.1007/s10620-015-3931-2; Li ZW, 2014, BBA-REV CANCER, V1846, P285, DOI 10.1016/j.bbcan.2014.07.008; Liang J, 2017, CELL RES, V27, P329, DOI 10.1038/cr.2016.159; Lockney Natalie A, 2015, J Gastrointest Cancer, V46, P390, DOI 10.1007/s12029-015-9764-6; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; MELLATI AA, 1992, CANCER BIOCHEM BIOPH, V13, P33; Mohammad GH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151635; Nakatsu D, 2015, P NATL ACAD SCI USA, V112, pE1067, DOI 10.1073/pnas.1417197112; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Ogawa H, 2015, MOL CLIN ONCOL, V3, P563, DOI 10.3892/mco.2015.490; Radu M, 2014, NAT REV CANCER, V14, P13, DOI 10.1038/nrc3645; Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20; Vargas DA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005007; Wei Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14041; Wu JY, 2016, ONCOTARGETS THER, V9, P4277, DOI 10.2147/OTT.S106508; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yang YC, 2016, ONCOGENE, V35, P3387, DOI 10.1038/onc.2015.397; Zhan C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118663; Zhu HY, 2017, ONCOTARGET, V8, P1628, DOI 10.18632/oncotarget.13703	44	43	46	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	13					1730	1742		10.1038/s41388-017-0086-y	http://dx.doi.org/10.1038/s41388-017-0086-y			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GA9AE	29335522				2022-12-26	WOS:000428632600004
J	Herr, R; Halbach, S; Heizmann, M; Busch, H; Boerries, M; Brummer, T				Herr, Ricarda; Halbach, Sebastian; Heizmann, Miriam; Busch, Hauke; Boerries, Melanie; Brummer, Tilman			BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines	ONCOGENE			English	Article							MAMMARY EPITHELIAL-CELLS; ACQUIRED-RESISTANCE; MOLECULAR LANDSCAPE; FEEDBACK INHIBITION; PROGNOSTIC-FACTOR; GENE-EXPRESSION; MEK INHIBITORS; RAF INHIBITION; TUMOR-GROWTH; COLON-CANCER	BRAF mutations occur in similar to 10% of colorectal cancer (CRC) and are associated with poor prognosis. Inhibitors selective for the BRAF(V600E) oncoprotein, the most common BRAF mutant, elicit only poor response rates in BRAF-mutant CRC as single agents. This unresponsiveness was mechanistically attributed to the loss of negative feedbacks on the epidermal growth factor receptor (EGFR) and initiated clinical trials that combine BRAF (and MEK) inhibitors, either singly or in combination, with the anti-EGFR antibodies cetuximab or panitumumab. First results of these combinatorial studies demonstrated improved efficacy, however, the response rates still were heterogeneous. Here, we show that BRAF inhibition leads to the upregulation of a variety of receptor tyrosine kinases (RTKs) in CRC cell lines, including not only the EGFR, but also human epidermal growth factor receptor (HER) 2 and HER3. Importantly, combination of the BRAF inhibitors (BRAFi) vemurafenib (PLX4032), dabrafenib, or encorafenib with inhibitors dually targeting the EGFR and HER2 (such as lapatinib, canertinib, and afatinib) significantly reduced the metabolic activity and proliferative potential of CRC cells. This re-sensitization was also observed after genetic depletion of HER2 or HER3. Interestingly, BRAF inhibitors did not only upregulate RTKs, but also increased the abundance of the GRB2-associated binders (Gab) 1 and Gab2, two important amplifiers of RTK signaling. An allele-specific shRNA-mediated knockdown of BRAF(V600E) revealed that Gab2 upregulation was directly dependent on the loss of the oncoprotein and was not caused by an "off-target" effect of these kinase inhibitors. Furthermore, Gab2 and Gab2-mediated Shp2 signaling were shown to be functionally important in BRAFi resistance. These findings highlight potential new escape mechanisms to these targeted therapies and indicate that a broad suppression of RTK signaling might be beneficial and should be taken into account in future research addressing targeted therapy in BRAF-mutant CRC.	[Herr, Ricarda; Halbach, Sebastian; Heizmann, Miriam; Brummer, Tilman] Univ Freiburg, Inst Mol Med & Cell Res IMMZ, Signal Transduct Tumour Dev & Drug Resistance Grp, Fac Med, Freiburg, Germany; [Heizmann, Miriam] Univ Freiburg, Fac Biol, Freiburg, Germany; [Busch, Hauke; Boerries, Melanie] Univ Freiburg, Syst Biol Cellular Microenvironm, IMMZ, Fac Med, Freiburg, Germany; [Busch, Hauke] Univ Lubeck, Inst Expt Dermatol, Lubeck, Germany; [Busch, Hauke] Univ Lubeck, Inst Cardiogenet, Lubeck, Germany; [Boerries, Melanie; Brummer, Tilman] German Canc Res Ctr, German Canc Consortium DKTK Partner Site Freiburg, Partner Site Freiburg, Heidelberg, Germany; [Boerries, Melanie; Brummer, Tilman] Univ Freiburg, CCCF, Freiburg, Germany; [Brummer, Tilman] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Lubeck; University of Lubeck; Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; University of Freiburg	Herr, R; Brummer, T (corresponding author), Univ Freiburg, Inst Mol Med & Cell Res IMMZ, Signal Transduct Tumour Dev & Drug Resistance Grp, Fac Med, Freiburg, Germany.; Brummer, T (corresponding author), German Canc Res Ctr, German Canc Consortium DKTK Partner Site Freiburg, Partner Site Freiburg, Heidelberg, Germany.; Brummer, T (corresponding author), Univ Freiburg, CCCF, Freiburg, Germany.; Brummer, T (corresponding author), Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Freiburg, Germany.	ricarda.herr@mol-med.uni-freiburg.de; tilman.brummer@zbsa.de	Brummer, Tilman/B-6218-2016; Halbach, Sebastian/G-4021-2012; Boerries, Melanie/AAM-2602-2021; Brummer, Tilman/AAA-9428-2020; Busch, Hauke/R-6452-2016	Brummer, Tilman/0000-0003-4387-7905; Halbach, Sebastian/0000-0002-6827-8178; Brummer, Tilman/0000-0003-4387-7905; Griffin, Ricarda/0000-0003-1368-2832; Busch, Hauke/0000-0003-4763-4521	German Research Foundation (DFG) [SFB 850]; Heisenberg professorship [EXC 294 BIOSS]; BMBF [e:Bio 0316184D]; e:Med research and funding concept, DeCaRe [FKZ 01ZX1409B]	German Research Foundation (DFG)(German Research Foundation (DFG)); Heisenberg professorship(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); e:Med research and funding concept, DeCaRe	We thank Martin Kohler for valuable discussions, Roland Rad for sharing MouseT1 cells, and Silke Kowar for expert technical assistance. This work was supported by the German Research Foundation (DFG) through SFB 850, projects B4 (TB) and Z1 (HB and MB), a Heisenberg professorship to TB, EXC 294 BIOSS and the BMBF through e:Bio 0316184D, and MB within the framework of the e:Med research and funding concept, DeCaRe (FKZ 01ZX1409B).	Abel EV, 2013, J CLIN INVEST, V123, P2155, DOI 10.1172/JCI65780; Abreu MTH, 2011, MOL BIOL CELL, V22, P105, DOI 10.1091/mbc.E10-03-0185; Ahronian LG, 2015, CANCER DISCOV, V5, P358, DOI 10.1158/2159-8290.CD-14-1518; Bai RP, 2015, INT J CANCER, V137, P2310, DOI 10.1002/ijc.29607; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Bennett HL, 2008, ONCOGENE, V27, P2693, DOI 10.1038/sj.onc.1210928; Bentires-Alj M, 2006, NAT MED, V12, P114, DOI 10.1038/nm1341; Bier D, 2016, CHEMMEDCHEM, V11, P911, DOI 10.1002/cmdc.201500484; Boerries M, 2015, GENOM DATA, V4, P158, DOI 10.1016/j.gdata.2015.04.015; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Brummer T, 2006, J BIOL CHEM, V281, P626, DOI 10.1074/jbc.M509567200; Caenepeel S, 2017, ONCOTARGET, V8, P17795, DOI 10.18632/oncotarget.14855; Cagnol S, 2013, ONCOGENE, V32, P564, DOI 10.1038/onc.2012.88; Carraway KL, 2010, SEMIN CELL DEV BIOL, V21, P936, DOI 10.1016/j.semcdb.2010.09.006; Castellano E, 2013, CANCER CELL, V24, P617, DOI 10.1016/j.ccr.2013.09.012; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chaussepied M, 2004, MOL CELL, V16, P831, DOI 10.1016/j.molcel.2004.11.003; Chernoff KA, 2009, CLIN CANCER RES, V15, P4288, DOI 10.1158/1078-0432.CCR-09-0280; Clarke CN, 2015, J GASTROINTEST ONCOL, V6, P660, DOI 10.3978/j.issn.2078-6891.2015.077; Connolly K, 2014, CURR ONCOL, V21, pE151, DOI 10.3747/co.21.1661; Corcoran RB, 2015, J CLIN ONCOL, V33, P4023, DOI 10.1200/JCO.2015.63.2471; Corcoran RB, 2012, CANCER DISCOV, V2, P227, DOI 10.1158/2159-8290.CD-11-0341; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Daly RJ, 2002, ONCOGENE, V21, P5175, DOI 10.1038/sj.onc.1205522; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Ding CB, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0524-2; Ding CB, 2015, INT J CLIN EXP PATHO, V8, P2779; Duckworth C, 2016, ONCOGENE, V35, P4036, DOI 10.1038/onc.2015.472; Ellebaek S, 2016, INT J CANCER, V139, P2095, DOI 10.1002/ijc.30242; Fattore L, 2015, ONCOTARGET, V6, P24823, DOI 10.18632/oncotarget.4485; Fleuren EDG, 2016, NAT REV CANCER, V16, P83, DOI 10.1038/nrc.2015.18; Fleuren EDG, 2010, INT J CANCER, V127, P1486, DOI 10.1002/ijc.25172; Gala K, 2014, CLIN CANCER RES, V20, P1410, DOI 10.1158/1078-0432.CCR-13-1549; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Hafner C, 2004, CLIN CHEM, V50, P490, DOI 10.1373/clinchem.2003.026849; Halbach S, 2016, LEUKEMIA, V30, P1942, DOI 10.1038/leu.2016.92; Halbach S, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0129-y; Halbach S, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-30; Herr R, 2015, CANCER RES, V75, P216, DOI 10.1158/0008-5472.CAN-13-3686; Hoeben A, 2013, INT J CANCER, V132, P1042, DOI 10.1002/ijc.27763; Hong DS, 2016, CANCER DISCOV, V6, P1352, DOI 10.1158/2159-8290.CD-16-0050; Horst B, 2009, AM J PATHOL, V174, P1524, DOI 10.2353/ajpath.2009.080543; Hugo W, 2015, CELL, V162, P1271, DOI 10.1016/j.cell.2015.07.061; Jubb AM, 2005, CLIN CANCER RES, V11, P5181, DOI 10.1158/1078-0432.CCR-05-0143; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kidger AM, 2016, SEMIN CELL DEV BIOL, V50, P125, DOI 10.1016/j.semcdb.2016.01.009; King AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067583; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Klinger B, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.29; Kolch W, 2015, NAT REV CANCER, V15, P515, DOI 10.1038/nrc3983; Kopetz S, 2015, J CLIN ONCOL, V33, P4032, DOI 10.1200/JCO.2015.63.2497; Kugel CH, 2014, CANCER RES, V74, P4122, DOI 10.1158/0008-5472.CAN-14-0464; Little AS, 2013, ONCOGENE, V32, P1207, DOI 10.1038/onc.2012.160; Liu W, 2017, LEUKEMIA, V31, P1415, DOI 10.1038/leu.2016.326; Lynch DK, 2002, EMBO J, V21, P72, DOI 10.1093/emboj/21.1.72; Mao ML, 2013, CLIN CANCER RES, V19, P657, DOI 10.1158/1078-0432.CCR-11-1446; Matsumura T, 2014, ANN SURG ONCOL, V21, pS743, DOI 10.1245/s10434-014-3889-x; Medico E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8002; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Norz D, 2015, CELL SIGNAL, V27, P2191, DOI 10.1016/j.cellsig.2015.07.016; Oddo D, 2016, CANCER RES, V76, P4504, DOI 10.1158/0008-5472.CAN-16-0396; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Ortiz-Padilla C, 2013, ONCOGENE, V32, P2696, DOI 10.1038/onc.2012.271; Peng SB, 2015, CANCER CELL, V28, P384, DOI 10.1016/j.ccell.2015.08.002; Prahallad A, 2015, CELL REP, V12, P1978, DOI 10.1016/j.celrep.2015.08.037; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Rad R, 2013, CANCER CELL, V24, P15, DOI 10.1016/j.ccr.2013.05.014; Radic-Sarikas B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03129-6; Roring M, 2012, EMBO J, V31, P2629, DOI 10.1038/emboj.2012.100; Schwarz LJ, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx065; Smith MP, 2016, CLIN CANCER RES, V22, P5966, DOI 10.1158/1078-0432.CCR-16-0954; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sundar R, 2017, CANCER DISCOV, V7, P558, DOI 10.1158/2159-8290.CD-17-0087; Tran B, 2011, CANCER-AM CANCER SOC, V117, P4623, DOI 10.1002/cncr.26086; Vincent KM, 2017, ONCOTARGET, V8, P10498, DOI 10.18632/oncotarget.14443; Wang Y, 2012, ONCOGENE, V31, P2512, DOI 10.1038/onc.2011.435; Williams CB, 2015, ONCOTARGETS THER, V8, P3561, DOI 10.2147/OTT.S90766; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wohrle FU, 2013, LEUKEMIA, V27, P118, DOI 10.1038/leu.2012.222; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Wohrle FU, 2009, STRUCTURE, V17, P779, DOI 10.1016/j.str.2009.05.003; Wu XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19000; Xiang SH, 2017, BIOCHEM BIOPH RES CO, V484, P719, DOI 10.1016/j.bbrc.2017.01.095; Yaeger R, 2015, CLIN CANCER RES, V21, P1313, DOI 10.1158/1078-0432.CCR-14-2779; Yaeger R, 2014, CANCER-AM CANCER SOC, V120, P2316, DOI 10.1002/cncr.28729; Yang L, 2015, J BIOL CHEM, V290, P26627, DOI 10.1074/jbc.M115.667717; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020	91	26	26	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	12					1576	1593		10.1038/s41388-017-0063-5	http://dx.doi.org/10.1038/s41388-017-0063-5			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GA8YC	29326440				2022-12-26	WOS:000428626700003
J	Pruitt, HC; Metge, BJ; Weeks, SE; Chen, DQ; Wei, S; Kesterson, RA; Shevde, LA; Samant, RS				Pruitt, Hawley C.; Metge, Brandon J.; Weeks, Shannon E.; Chen, Dongquan; Wei, Shi; Kesterson, Robert A.; Shevde, Lalita A.; Samant, Rajeev S.			Conditional knockout of N-Myc and STAT interactor disrupts normal mammary development and enhances metastatic ability of mammary tumors	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BETA-CATENIN; STEM-CELLS; BREAST-CANCER; PROTEIN NMI; ACTIVATION; TARGET; GLAND; FATE; BETA-CATENIN/LEF-1	The process of organ development requires a delicate balance between cellular plasticity and differentiation. This balance is disrupted in cancer initiation and progression. N-Myc and STAT interactor (NMI: human or Nmi: murine) has emerged as a relevant player in the etiology of breast cancer. However, a fundamental understanding of its relevance to normal mammary biology is lacking. To gain insight into its normal function in mammary gland, we generated a mammary-specific Nmi knockout mouse model. We observed that Nmi protein expression is induced in mammary epithelium at the onset of pregnancy, in luminal cells and persists throughout lactation. Nmi knockout results in a precocious alveolar phenotype. These alveoli exhibit an extensive presence of nuclear beta-catenin and enhanced Wnt/beta-catenin signaling. The Nmi knockout pubertal ductal tree shows enhanced invasion of the mammary fatpad and increased terminal end bud numbers. Tumors from Nmi null mammary epithelium show a significant enrichment of poorly differentiated cells with elevated stem/progenitor markers, active Wnt/beta-catenin signaling, highly invasive morphology as well as, increased number of distant metastases. Our study demonstrates that Nmi has a distinct role in the differentiation process of mammary luminal epithelial cell compartment and developmental aberrations resulting from Nmi absence contribute to metastasis and demonstrates that aberration in normal developmental program can lead to metastatic disease, highlighting the contribution and importance of luminal progenitor cells in driving metastatic disease.	[Pruitt, Hawley C.; Metge, Brandon J.; Weeks, Shannon E.; Wei, Shi; Shevde, Lalita A.; Samant, Rajeev S.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Chen, Dongquan] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kesterson, Robert A.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA; [Shevde, Lalita A.; Samant, Rajeev S.] Univ Alabama Birmingham, Comprehens Canc Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Samant, RS (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.; Samant, RS (corresponding author), Univ Alabama Birmingham, Comprehens Canc Ctr, Birmingham, AL 35294 USA.	rsamant@uab.edu		Samant, Rajeev/0000-0001-5681-4976	Cancer Center Core grant [CA013148]; UAB CCTS award [UL1TR001417, BX003374]; NCI/NIH [CA194048, CA169202]; NATIONAL CANCER INSTITUTE [R01CA140472, R01CA169202, R01CA194048, P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003374] Funding Source: NIH RePORTER	Cancer Center Core grant; UAB CCTS award; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We acknowledge Sarah K. Bailey and Ann Hanna for their assistance during experimental procedures. We are grateful to Dr. Jeffrey Rosen and his graduate student Daisy for advice with X-gal staining of mammary tissues. We acknowledge the following grant support: Cancer Center Core grant CA013148, for the Heflin Genomics facility and UAB-Transgenic and knockout facility, to RAK. Support from UAB CCTS award #UL1TR001417 to DC BX003374 (VA) and CA194048 (NCI/NIH) to RSS and CA169202 (NCI/NIH) to LAS. HCP is a HHMI-Med-To-Grad Fellow (UAB).	Alexander C.M., 2012, COLD SPRING HARB PER, P1; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Boras-Granic K, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0487-6; Boras-Granic Kata, 2008, Organogenesis, V4, P116; Chakrabarti R, 2012, STEM CELLS, V30, P1496, DOI 10.1002/stem.1112; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Conacci-Sorrell ME, 2002, GENE DEV, V16, P2058, DOI 10.1101/gad.227502; DANIELSON KG, 1984, P NATL ACAD SCI-BIOL, V81, P3756, DOI 10.1073/pnas.81.12.3756; Delmas V, 2007, GENE DEV, V21, P2923, DOI 10.1101/gad.450107; Devine DJ, 2014, ONCOGENE, V33, P2620, DOI 10.1038/onc.2013.215; Feng X, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.200; Gauger KJ, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-25; Gross K, 2016, J DEV BIOL, V4, DOI 10.3390/jdb4010004; Harper KL, 2016, NATURE; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hosseini H., 2016, NATURE; Hou JJ, 2016, CANCER LETT, V376, P22, DOI 10.1016/j.canlet.2016.02.015; Joshi PA, 2012, TRENDS ENDOCRIN MET, V23, P299, DOI 10.1016/j.tem.2012.04.002; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030979; Kouros-Mehr H, 2008, CURR OPIN CELL BIOL, V20, P164, DOI 10.1016/j.ceb.2008.02.003; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Lebrun SJ, 1998, J INTERF CYTOK RES, V18, P767, DOI 10.1089/jir.1998.18.767; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Lin VTG, 2017, TRENDS CANCER, V3, P126, DOI 10.1016/j.trecan.2016.12.007; Lo PK, 2013, ONCOGENE, V32, P1338, DOI 10.1038/onc.2012.456; Lo PK, 2012, ONCOGENE, V31, P2614, DOI [10.1038/onc.2011.439, 10.1038/onc.2012.147]; Miyoshi K, 2002, P NATL ACAD SCI USA, V99, P219, DOI 10.1073/pnas.012414099; Perotti C, 2009, DIFFERENTIATION, V78, P269, DOI 10.1016/j.diff.2009.05.003; Pruitt HC, 2016, INT J CANCER, V139, P491, DOI 10.1002/ijc.30043; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Tiede B, 2011, CELL RES, V21, P245, DOI 10.1038/cr.2011.11; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhao J, 2017, ONCOTARGET, V8, P12174, DOI 10.18632/oncotarget.14556; Zhu MH, 1999, CELL, V96, P121, DOI 10.1016/S0092-8674(00)80965-4	39	8	8	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	12					1610	1623		10.1038/s41388-017-0037-7	http://dx.doi.org/10.1038/s41388-017-0037-7			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GA8YC	29326438	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000428626700005
J	McMillan, EA; Longo, SM; Smith, MD; Broskin, S; Lin, BC; Singh, NK; Strochlic, TI				McMillan, Emily A.; Longo, Sheila M.; Smith, Michael D.; Broskin, Sarah; Lin, Baicheng; Singh, Nisha K.; Strochlic, Todd I.			The protein kinase CK2 substrate Jabba modulates lipid metabolism during Drosophila oogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYCYSTIC-OVARY-SYNDROME; CATALYTIC-SUBUNIT; EMBRYONIC-DEVELOPMENT; ENERGY-METABOLISM; CELL-SURVIVAL; MICE LACKING; PERILIPIN-A; DROPLETS; PHOSPHORYLATION; LOCALIZATION	Lipid metabolism plays a critical role in female reproduction. During oogenesis, maturing oocytes accumulate high levels of neutral lipids that are essential for both energy production and the synthesis of other lipid molecules. Metabolic pathways within the ovary are partially regulated by protein kinases that link metabolic status to oocyte development. Although the functions of several kinases in this process are well established, the roles that many other kinases play in coordinating metabolic state with female germ cell development are unknown. Here, we demonstrate that the catalytic activity of casein kinase 2 (CK2) is essential for Drosophila oogenesis. Using an unbiased biochemical screen that leveraged an unusual catalytic property of the kinase, we identified a novel CK2 substrate in the Drosophila ovary, the lipid droplet-associated protein Jabba. We show that Jabba is essential for modulating ovarian lipid metabolism and for regulating female fertility in the fly. Our findings shed light on a CK2-dependent signaling pathway governing lipid metabolism in the ovary and provide insight into the long-recognized but poorly understood association between energy metabolism and female reproduction.	[McMillan, Emily A.; Longo, Sheila M.; Smith, Michael D.; Broskin, Sarah; Lin, Baicheng; Singh, Nisha K.; Strochlic, Todd I.] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St,MS 497, Philadelphia, PA 19102 USA	Drexel University	Strochlic, TI (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, 245 N 15th St,MS 497, Philadelphia, PA 19102 USA.	Todd.Strochlic@drexelmed.edu			Commonwealth Universal Research Enhancement grant from the Pennsylvania Department of Health; Drexel University College of Medicine	Commonwealth Universal Research Enhancement grant from the Pennsylvania Department of Health; Drexel University College of Medicine	This work was supported by a Commonwealth Universal Research Enhancement grant from the Pennsylvania Department of Health (to T. I. S.) and by start-up funds from Drexel University College of Medicine (to T. I. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Buszczak M, 2002, GENETICS, V160, P1511; Castanieto A, 2014, ELIFE, V3, DOI 10.7554/eLife.04437; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chang YF, 2006, J BIOL CHEM, V281, P4754, DOI 10.1074/jbc.M513064200; Della Torre S, 2014, NAT REV ENDOCRINOL, V10, P13, DOI 10.1038/nrendo.2013.203; Dunning KR, 2014, REPRODUCTION, V148, pR15, DOI 10.1530/REP-13-0251; Dunning KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087327; Escalier D, 2003, MOL REPROD DEV, V66, P190, DOI 10.1002/mrd.10346; Essah PA, 2006, J ENDOCRINOL INVEST, V29, P270, DOI 10.1007/BF03345554; Fei WH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002201; Felix M, 2015, DEVELOPMENT, V142, P3692, DOI 10.1242/dev.125682; Fontana R, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020087; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Gupta T, 2003, DEVELOPMENT, V130, P6075, DOI 10.1242/dev.00817; Herr DR, 2004, J BIOL CHEM, V279, P12685, DOI 10.1074/jbc.M310647200; Hsieh LS, 2016, J BIOL CHEM, V291, P9974, DOI 10.1074/jbc.M116.726588; Hudson AM, 2014, METHODS, V68, P207, DOI 10.1016/j.ymeth.2014.01.005; King R. C., 1970, OVARIAN DEV DROSOPHI; Kitamura T, 2015, BIOCHEM J, V465, P79, DOI 10.1042/BJ20140624; Kolkhof P, 2017, MOL CELL PROTEOMICS, V16, P329, DOI 10.1074/mcp.M116.061499; Kory N, 2016, TRENDS CELL BIOL, V26, P535, DOI 10.1016/j.tcb.2016.02.007; Kuhn H, 2015, DEVELOPMENT, V142, P3869, DOI 10.1242/dev.125419; Lai H, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.120063; LANE ME, 1995, MECH DEVELOP, V49, P191, DOI 10.1016/0925-4773(94)00317-G; Lee B, 2009, BBA-MOL CELL BIOL L, V1791, P1173, DOI 10.1016/j.bbalip.2009.08.002; Leung KF, 2007, J BIOL CHEM, V282, P1487, DOI 10.1074/jbc.M605557200; Li ZH, 2014, CURR BIOL, V24, P1485, DOI 10.1016/j.cub.2014.05.022; Li ZH, 2012, CURR BIOL, V22, P2104, DOI 10.1016/j.cub.2012.09.018; LIN WJ, 1994, J PROTEIN CHEM, V13, P217, DOI 10.1007/BF01891979; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Lou DY, 2008, MOL CELL BIOL, V28, P131, DOI 10.1128/MCB.01119-07; MAHAJANMIKLOS S, 1994, DEV BIOL, V165, P336, DOI 10.1006/dbio.1994.1257; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Niefind K, 1999, NAT STRUCT BIOL, V6, P1100, DOI 10.1038/70033; Parra-Peralbo E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001297; Pek JW, 2012, DEVELOPMENT, V139, P4505, DOI 10.1242/dev.082867; Pinna LA, 2009, CELL MOL LIFE SCI, V66, P1797, DOI 10.1007/s00018-009-9148-9; Sahu-Osen A, 2015, J LIPID RES, V56, P109, DOI 10.1194/jlr.M055004; Sarno S, 2002, J BIOL CHEM, V277, P22509, DOI 10.1074/jbc.M200486200; SAXENA A, 1987, MOL CELL BIOL, V7, P3409, DOI 10.1128/MCB.7.10.3409; Schneider LE, 1997, DEVELOPMENT, V124, P2591; Schwind L, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10010022; Sieber MH, 2016, CELL, V164, P420, DOI 10.1016/j.cell.2015.12.020; Sieber MH, 2015, CURR BIOL, V25, P993, DOI 10.1016/j.cub.2015.02.019; Sopko R, 2014, DEV CELL, V31, P114, DOI 10.1016/j.devcel.2014.07.027; Strochlic TI, 2014, EMBO REP, V15, P1184, DOI 10.15252/embr.201438688; Suzuki M, 2015, MOL BIOL CELL, V26, P2333, DOI 10.1091/mbc.E14-11-1504; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tan JL, 2014, J CELL SCI, V127, P954, DOI 10.1242/jcs.129031; Teixeira L, 2003, MECH DEVELOP, V120, P1071, DOI 10.1016/S0925-4773(03)00158-8; Tennessen JM, 2014, METHODS, V68, P105, DOI 10.1016/j.ymeth.2014.02.034; Turowec JP, 2010, METHOD ENZYMOL, V484, P471, DOI [10.1016/S0076-6879(10)84023-6, 10.1016/B978-0-12-381298-8.00023-X]; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Welte MA, 2015, CURR BIOL, V25, pR470, DOI 10.1016/j.cub.2015.04.004; Wilhelm N, 2012, MOL CELL BIOCHEM, V365, P37, DOI 10.1007/s11010-012-1241-y; Wood BR, 2008, ANAL CHEM, V80, P9065, DOI 10.1021/ac8015483; Xu X, 1999, NAT GENET, V23, P118, DOI 10.1038/12729	61	9	10	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2990	3002		10.1074/jbc.M117.814657	http://dx.doi.org/10.1074/jbc.M117.814657			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29326167	Green Published, hybrid			2022-12-26	WOS:000426051900031
J	Fores, R; Alzamora, MT; Pera, G; Baena-Diez, JM; Mundet-Tuduri, X; Toran, P				Fores, Rosa; Teresa Alzamora, Maria; Pera, Guillem; Miguel Baena-Diez, Jose; Mundet-Tuduri, Xavier; Toran, Pere			Contribution of the ankle-brachial index to improve the prediction of coronary risk: The ARTPER cohort	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; HEART-DISEASE; CARDIOVASCULAR-DISEASE; TASK-FORCE; OCCLUSIVE DISEASE; EUROPEAN-SOCIETY; ASSOCIATION; MORTALITY; MARKERS; EVENTS	Background The different cardiovascular risk prediction scales currently available are not sufficiently sensitive. Aim The aim of the present study was to analyze the contribution of the ankle-brachial index (ABI) added to the Framingham and REGICOR risk scales for the reclassification of cardiovascular risk after a 9-year follow up of a Mediterranean population with low cardiovascular risk. Design and setting A population-based prospective cohort study was performed in the province of Barcelona, Spain. Method A total of 3,786 subjects >49 years were recruited from 2006-2008. Baseline ABI was performed and cardiovascular risk was calculated with the Framingham and REGICOR scales. The participants were followed until November 2016 by telephone and review of the clinical history every 6 months to confirm the possible appearance of cardiovascular events. Results 2,716 individuals participated in the study. There were 126 incidental cases of first coronary events (5%) during follow up. The incidence of coronary events in patients with ABI <0.9 was 4-fold greater than that of subjects with a normal ABI (17.2/1,000 persons-year versus 4.8/1,000 persons-year). Improvement in the predictive capacity of REGICOR scale was observed on including ABI in the model, obtaining a net reclassification improvement of 7% (95% confidence interval 0%-13%) for REGICOR+ ABI. Framingham + ABI obtained a NRI of 4% (-2%-11%). Conclusion The results of the present study support the addition of the ABI as a tool to help in the reclassification of cardiovascular risk and to confirm the greater incidence of coronary events in patients with ABI < 0.9.	[Fores, Rosa; Teresa Alzamora, Maria] Inst Catala Salut, Direccio Atencio Primaria Barcelones Nord & Mares, Ctr Atencio Primaria Riu Nord Riu Sud Santa Colom, Barcelona, Spain; [Fores, Rosa; Teresa Alzamora, Maria; Pera, Guillem; Toran, Pere] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Metropolitana Nord, Mataro, Spain; [Fores, Rosa; Mundet-Tuduri, Xavier] Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain; [Miguel Baena-Diez, Jose] Inst Catala Salut, Direccio Atencio Primaria Barcelona Ciutat, Ctr Atencio Primaria La Marina, Barcelona, Spain; [Miguel Baena-Diez, Jose] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Barcelona, Spain; [Mundet-Tuduri, Xavier] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Barcelona, Barcelona, Spain	Autonomous University of Barcelona	Fores, R (corresponding author), Inst Catala Salut, Direccio Atencio Primaria Barcelones Nord & Mares, Ctr Atencio Primaria Riu Nord Riu Sud Santa Colom, Barcelona, Spain.; Fores, R (corresponding author), Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Unitat Suport Recerca Metropolitana Nord, Mataro, Spain.; Fores, R (corresponding author), Univ Autonoma Barcelona, Bellaterra, Cerdanyola Del, Spain.	rfores.bnm.ics@gencat.cat	Torán-Monserrat, Pere/AAY-4396-2021	Torán-Monserrat, Pere/0000-0002-9865-7427; Pera, Guillem/0000-0003-3188-7268; Fores Raurell, Rosa/0000-0001-7803-7442	Carlos III Institute of Health, Ministry of Economy and Competitiveness (Spain); National Research Program; Technical, Scientific and Innovation Research National Plan [PI15/00510]; European Union ERDF funds	Carlos III Institute of Health, Ministry of Economy and Competitiveness (Spain)(Spanish Government); National Research Program; Technical, Scientific and Innovation Research National Plan; European Union ERDF funds(European Commission)	This project received a research grant from the Carlos III Institute of Health, Ministry of Economy and Competitiveness (Spain), awarded in the 2015 call under the Health Strategy Action 2013-2016, within the National Research Program oriented to Societal Challenges, within the Technical, Scientific and Innovation Research National Plan 2013-2016, with reference PI15/00510 (to MTA), co-funded with European Union ERDF funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alzamora MT, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-348; [Anonymous], 2012, BRIT MED J, DOI DOI 10.1136/BMJ.E4181; Baena-Diez JM, 2011, REV ESP CARDIOL, V64, P186, DOI 10.1016/j.recesp.2010.10.024; Calonge N, 2009, ANN INTERN MED, V151, P474, DOI 10.7326/0003-4819-151-7-200910060-00008; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; Criqui MH, 2010, J AM COLL CARDIOL, V56, P1506, DOI 10.1016/j.jacc.2010.04.060; Davies JH, 2017, BRIT J GEN PRACT, V67, pE103, DOI 10.3399/bjgp17X689137; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Fowkes FGR, 2014, EUR J PREV CARDIOL, V21, P310, DOI 10.1177/2047487313516564; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hirsch AT, 2006, CIRCULATION, V113, P1474, DOI 10.1161/CIRCULATIONAHA.106.173994; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hooi JD, 2004, J CLIN EPIDEMIOL, V57, P294, DOI 10.1016/j.jclinepi.2003.09.003; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Lee AJ, 2004, CIRCULATION, V110, P3075, DOI 10.1161/01.CIR.0000143102.38256.DE; Lin JS, 2013, ANN INTERN MED, V159, P333, DOI 10.7326/0003-4819-159-5-201309030-00007; Marrugat J, 2003, J EPIDEMIOL COMMUN H, V57, P634, DOI 10.1136/jech.57.8.634; Marrugat J, 2011, REV ESP CARDIOL, V64, P385, DOI 10.1016/j.recesp.2010.12.011; Marrugat J, 2007, J EPIDEMIOL COMMUN H, V61, P40, DOI 10.1136/jech.2005.038505; Merino J, 2008, EUR J VASC ENDOVASC, V36, P71, DOI 10.1016/j.ejvs.2008.01.029; Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042; Murphy TP, 2012, ATHEROSCLEROSIS, V220, P160, DOI 10.1016/j.atherosclerosis.2011.10.037; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Peters SAE, 2012, HEART, V98, P177, DOI 10.1136/heartjnl-2011-300747; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1177/2047487316653709, 10.1016/j.atherosclerosis.2016.05.037]; Rodondi N, 2010, AM J EPIDEMIOL, V171, P540, DOI 10.1093/aje/kwp428; Taxes dIncidencia i prevalenqa a lAtencio Prima ria, 2002, TAX INC PREV AT PRIM; Alzamora MT, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-119; Alzamora MT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-38; Velescu A, 2015, ATHEROSCLEROSIS, V241, P357, DOI 10.1016/j.atherosclerosis.2015.05.017; Vlachopoulos C, 2015, ATHEROSCLEROSIS, V241, P507, DOI 10.1016/j.atherosclerosis.2015.05.007; Weatherley Beth D, 2007, BMC Cardiovasc Disord, V7, P3, DOI 10.1186/1471-2261-7-3; Wierzbicki AS, 2012, INT J CLIN PRACT, V66, P622, DOI 10.1111/j.1742-1241.2012.02956.x; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yeboah J, 2015, CIRCULATION, V132, P916, DOI 10.1161/CIRCULATIONAHA.115.016846; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624	40	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191283	10.1371/journal.pone.0191283	http://dx.doi.org/10.1371/journal.pone.0191283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338049	Green Submitted, Green Published, gold			2022-12-26	WOS:000422652700046
J	Farshadpour, F; Taherkhani, R; Ravanbod, MR; Eghbali, SS; Taherkhani, S; Mandavi, E				Farshadpour, Fatemeh; Taherkhani, Reza; Ravanbod, Mohamad Reza; Eghbali, Seyed Sajjad; Taherkhani, Sakineh; Mandavi, Easa			Prevalence, risk factors and molecular evaluation of hepatitis E virus infection among pregnant women resident in the northern shores of Persian Gulf, Iran	PLOS ONE			English	Article							HIGHLY PREVALENT; SEROPREVALENCE; PCR; EPIDEMIOLOGY; ANTIBODIES; AFRICA	Background Although Iran is reported to be an endemic country for hepatitis E virus (HEV), data on the prevalence of HEV infection among pregnant women are scarce and the epidemiology of HEV is unknown in most parts of the country. Therefore, this study was conducted to elucidate the prevalence, risk factors and genotypic pattern of HEV infection among pregnant women resident in the northern shores of Persian Gulf. This is the first report on the epidemiology of HEV infection among pregnant women in this territory. Methods From October 2016 to May 2017, 1331 pregnant women participated in this study. The mean age +/- SD of participants was 27.93 +/- 5.7 years with a range of 14-45 years. Serum samples of pregnant women were screened for the presence of anti-HEV total antibodies, anti-HEV IgG and anti-HEV IgM using commercially available ELISA kits (DIA.PRO, Milan, Italy). All anti-HEV IgG and anti-HEV IgM positive samples were tested for HEV RNA using two independent reverse transcriptase polymerase chain reaction (RT-PCR) assays, targeting ORF2 and ORF3 of HEV genome. In addition, 92 anti-HEV seronegative samples as well as 50 pooled seronegative samples were evaluated by two independent RT-PCR assays for validation of results. Results Of the 1331 pregnant women, 84 women (6.3%, 95% Cl: 5.1%-7.7%) were positive for anti-HEV antibodies, of which 83 women had anti-HEV IgG, and 11 women (0.83%, 95% Cl: 0.47%-1.47%) had anti-HEV IgM. The highest rate of HEV seroprevalence was observed among Afghan immigrants (68.0%), uneducated pregnant women (46.51 %) and those residents in Bushehr city (8.75%). All anti-HEV IgG and/or IgM positive samples were found to be negative for HEV RNA. In addition, all of the evaluated anti-HEV seronegative samples were negative for HEV RNA. HEV seropositivity among pregnant women was statistically associated with age, ethnicity, place of residence,number of pregnancies, and level of education. So that, low education levels, Afghan, residence in Bushehr city, age group >34 years, and more parities were risk factors for exposure to HEV. In contrast, HEV seropositivity was not associated with stage of gestation, history of abortion, and time of sampling. Conclusion The northern shores of Persian Gulf in Iran, with HEV seroprevalence of 6.3%, can be classified as an endemic geographical region for hepatitis E, and residents of Bushehr city, Afghan immigrants and uneducated women are the main at-risk populations in this territory.	[Farshadpour, Fatemeh; Taherkhani, Reza; Eghbali, Seyed Sajjad] Bushehr Univ Med Sci, Persian Gulf Trop Med Res Ctr, Bushehr, Iran; [Ravanbod, Mohamad Reza] Bushehr Univ Med Sci, Sch Med, Dept Internal Med, Bushehr, Iran; [Taherkhani, Sakineh] Shahroud Univ Med Sci, Sch Nursing & Midwifery, Reprod Hlth & Midwifery Dept, Shahroud, Iran; [Mandavi, Easa] Bushehr Univ Med Sci, Student Res Comm, Bushehr, Iran	Shahroud University Medical Sciences	Taherkhani, R (corresponding author), Bushehr Univ Med Sci, Persian Gulf Trop Med Res Ctr, Bushehr, Iran.	taherkhanireza2005@yahoo.com	Taherkhani, Sakineh/P-3990-2018; Eghnali, Sajjad/H-2810-2018	Taherkhani, Sakineh/0000-0003-3161-0963; 	Deputy Research and Affairs of Bushehr University of Medical Sciences [3253]	Deputy Research and Affairs of Bushehr University of Medical Sciences	This study was supported financially by the Deputy Research and Affairs of Bushehr University of Medical Sciences with grant number 3253. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180078; Adjei AA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-108; Ahmed A, 2015, INT J HEPATOL, V2015, DOI 10.1155/2015/872431; Alvarado-Esquivel C, 2014, ANN HEPATOL, V13, P510, DOI 10.1016/S1665-2681(19)31250-5; Asaei S, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.19311v2; Begum N, 2009, INDIAN J MED RES, V130, P709; Caron M, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-158; Cevrioglu AS, 2004, J OBSTET GYNAECOL RE, V30, P48, DOI 10.1111/j.1341-8076.2004.00155.x; De Paschale M, 2016, TROP MED INT HEALTH, V21, P108, DOI 10.1111/tmi.12632; Eick A, 2010, J INFECT DIS, V202, P1302, DOI 10.1086/656598; Farshadpour Fatemeh, 2015, Hepat Res Treat, V2015, P759589, DOI 10.1155/2015/759589; Ghezeldasht SA, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.10255; Gu GY, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1308-y; Huang FF, 2002, J CLIN MICROBIOL, V40, P1326, DOI 10.1128/JCM.40.4.1326-1332.2002; Inoue J, 2006, J VIROL METHODS, V137, P325, DOI 10.1016/j.jviromet.2006.07.004; Kamar N, 2014, CLIN MICROBIOL REV, V27, P116, DOI 10.1128/CMR.00057-13; Khameneh ZRostamzadeh, 2013, IRAN HEPAT MON, V13; Kumar A, 2010, JIMSA, V23, P281; Kumar RM, 2001, EUR J OBSTET GYN R B, V100, P9, DOI 10.1016/S0301-2115(01)00448-1; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Lee Ga Young, 2015, World J Virol, V4, P343, DOI 10.5501/wjv.v4.i4.343; Mamani M., 2015, AVICENNA J CLIN MICR, V2, P25339, DOI [10.17795/ajcmi-25339, DOI 10.17795/AJCMI-25339]; Marano G, 2015, BLOOD TRANSFUS-ITALY, V13, P6, DOI 10.2450/2014.0063-14; Lindemann MLM, 2010, J MED VIROL, V82, P1666, DOI 10.1002/jmv.21840; Musa AO, 2016, MEDITERR J BIO, V1, P83; Navaneethan U, 2008, LIVER INT, V28, P1190, DOI 10.1111/j.1478-3231.2008.01840.x; Rasti M, 2014, JENTASHAPIR J HLTH R, V5, P101; Renou C, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-68; Stoszek SK, 2006, T ROY SOC TROP MED H, V100, P95, DOI 10.1016/j.trstmh.2004.12.005; Tabarraei A, NORTH EAST OF CASPIA; Taherkhani R, 2016, J CLIN TRANSL HEPATO, V4, P269, DOI 10.14218/JCTH.2016.00013; Taherkhani R, 2016, WORLD J GASTROENTERO, V22, P5143, DOI 10.3748/wjg.v22.i22.5143; Taherkhani R, 2014, ANN LAB MED, V34, P118, DOI 10.3343/alm.2014.34.2.118; Perez-Gracia MT, 2015, J CLIN TRANSL HEPATO, V3, P117, DOI 10.14218/JCTH.2015.00009; Teshale EH, 2011, WORLD J HEPATOL, V3, P285, DOI 10.4254/wjh.v3.i12.285; Yazbek S, 2016, INFECTION, V44, P11, DOI 10.1007/s15010-015-0807-5	36	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191090	10.1371/journal.pone.0191090	http://dx.doi.org/10.1371/journal.pone.0191090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329329	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000419954100037
J	Kostyuk, SV; Kvasha, MA; Khrabrova, DA; Kirsanova, OV; Ershova, ES; Malinovskaya, EM; Veiko, NN; Ivanov, AA; Koval, VS; Zhuze, AL; Tashlitsky, VH; Umriukhin, PE; Kutsev, SI; Gromova, ES				Kostyuk, Svetlana V.; Kvasha, Margarita A.; Khrabrova, Daria A.; Kirsanova, Olga V.; Ershova, Elizaveta S.; Malinovskaya, Elena M.; Veiko, Natalia N.; Ivanov, Alexander A.; Koval, Vasiliy S.; Zhuze, Alexei L.; Tashlitsky, Vadim H.; Umriukhin, Pavel E.; Kutsev, Sergey I.; Gromova, Elizaveta S.			Symmetric dimeric bisbenzimidazoles DBP(n) reduce methylation of RARB and PTEN while significantly increase methylation of rRNA genes in MCF-7 cancer cells	PLOS ONE			English	Article							DNA METHYLATION; EPIGENETICS; ASSOCIATION	Background Hypermethylation is observed in the promoter regions of suppressor genes in the tumor cancer cells. Reactivation of these genes by demethylation of their promoters is a prospective strategy of the anticancer therapy. Previous experiments have shown that symmetric dimeric bisbenzimidazoles DBP(n) are able to block DNA methyltransferase activities. It was also found that DBP(n) produces a moderate effect on the activation of total gene expression in HeLa-TI population containing epigenetically repressed avian sarcoma genome. Principal findings It is shown that DBP(n) are able to penetrate the cellular membranes and accumulate in breast carcinoma cell MCF-7, mainly in the mitochondria and in the nucleus, excluding the nucleolus. The DBP(n) are non-toxic to the cells and have a weak overall demethylation effect on genomic DNA. DBP(n) demethylate the promoter regions of the tumor suppressor genes PTEN and RARB. DBP(n) promotes expression of the genes RARB, PTEN, CDKN2A, RUNX3, Apaf-1 and APC "silent" in the MCF-7 because of the hypermethylation of their promoter regions. Simultaneously with the demethylation of the DNA in the nucleus a significant increase in the methylation level of rRNA genes in the nucleolus was detected. Increased rDNA methylation correlated with a reduction of the rRNA amount in the cells by 20-30%. It is assumed that during DNA methyltransferase activity inhibition by the DBP(n) in the nucleus, the enzyme is sequestered in the nucleolus and provides additional methylation of the rDNA that are not shielded by DBP(n). Conclusions/Significance It is concluded that DBP (n) are able to accumulate in the nucleus (excluding the nucleolus area) and in the mitochondria of cancer cells, reducing mitochondrial potential. The DBP (n) induce the demethylation of a cancer cell's genome, including the demethylation of the promoters of tumor suppressor genes. DBP (n) significantly increase the methylation of ribo-somal RNA genes in the nucleoli. Therefore the further study of these compounds is needed; it could lead to the creation of new anticancer agents.	[Kostyuk, Svetlana V.; Ershova, Elizaveta S.; Malinovskaya, Elena M.; Veiko, Natalia N.] Res Ctr Med Genet, Moscow, Russia; [Kvasha, Margarita A.; Khrabrova, Daria A.; Kirsanova, Olga V.; Tashlitsky, Vadim H.; Kutsev, Sergey I.; Gromova, Elizaveta S.] Moscow MV Lomonosov State Univ, Chem Dept, Moscow, Russia; [Ivanov, Alexander A.] NN Blokhin Russian Canc Res Ctr, Moscow, Russia; [Koval, Vasiliy S.; Zhuze, Alexei L.] Engelhardt Inst Mol Biol, Moscow, Russia; [Umriukhin, Pavel E.] Sechenov Univ, IM Sechenov Moscow State Med Univ 1, Moscow, Russia; [Umriukhin, Pavel E.] PK Anokhin Inst Normal Physiol, Moscow, Russia	Research Centre for Medical Genetics; Lomonosov Moscow State University; N.N. Blokhin Russian Cancer Research Center; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Sechenov First Moscow State Medical University; Russian Academy of Medical Sciences; Anokhin Institute of Normal Physiology	Umriukhin, PE (corresponding author), Sechenov Univ, IM Sechenov Moscow State Med Univ 1, Moscow, Russia.; Umriukhin, PE (corresponding author), PK Anokhin Inst Normal Physiol, Moscow, Russia.	pavelum@mail.ru	Ershova, Elizaveta/E-3220-2015; Kutsev, Sergey I/L-3633-2018; Koval, Vasiliy/AAU-3357-2021; Kirsanova, Olga V/M-6492-2015; Umriukhin, Pavel/B-5898-2016; Tashlitsky, Vadim/M-7626-2019; Malinovskaya, Elena/H-8201-2017; Gromova, Elizaveta S/I-6305-2012	Kutsev, Sergey I/0000-0002-3133-8018; Koval, Vasiliy/0000-0002-1181-104X; Kirsanova, Olga V/0000-0003-2156-7252; Umriukhin, Pavel/0000-0001-8628-7353; Malinovskaya, Elena/0000-0001-5046-3247; Ershova, Elizaveta/0000-0003-1206-5832	Russian Foundation for Basic Research [16-04-01087, 14-04-00388]; Program of the Presidium of the Russian Academy of Sciences on the molecular and cellular biology	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program of the Presidium of the Russian Academy of Sciences on the molecular and cellular biology	This work was supported by Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/ru/), project No16-04-01087 - data collection and analysis (D.A. Khrabrova, O.V. Kirsanova, E.S. Gromova); Russian Foundation for Basic Research (http://www.rfbr.ru/rffi/ru/) No14-04-00388-data collection and analysis (A.L. Zhuze, A.A. Ivanov); Program of the Presidium of the Russian Academy of Sciences on the molecular and cellular biology-data collection and analysis (A.L. Zhuze).	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cherepanova NA, 2011, J ENZYM INHIB MED CH, V26, P295, DOI 10.3109/14756366.2010.499098; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Darii MV, 2013, MOL BIOL+, V47, P259, DOI 10.1134/S0026893313020040; Dundr M, 1998, MOL BIOL CELL, V9, P2407, DOI 10.1091/mbc.9.9.2407; Edwards JR, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0130-8; Ershova ES, 2016, MUTAT RES-GEN TOX EN, V805, P46, DOI 10.1016/j.mrgentox.2016.05.004; Esteller M, 2005, ANNU REV PHARMACOL, V45, P629, DOI 10.1146/annurev.pharmtox.45.120403.095832; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Hallgren J, 2014, BBA-MOL BASIS DIS, V1842, P860, DOI 10.1016/j.bbadis.2013.12.012; Hamperl S, 2013, BBA-GENE REGUL MECH, V1829, P405, DOI 10.1016/j.bbagrm.2012.12.007; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Ivanov AA, 2011, RUSS J BIOORG CHEM+, V37, P472, DOI 10.1134/S1068162011040054; Ivanov AA, 2015, BIOORG MED CHEM LETT, V25, P2634, DOI 10.1016/j.bmcl.2015.04.087; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kirsanova OV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1175, DOI 10.1134/S0006297909110017; Koch C, 2004, BIOCHEMISTRY-US, V43, P5011, DOI 10.1021/bi0359271; Kostyuk SV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077469; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lisitsina E S, 2012, Mol Biol (Mosk), V46, P922; Paredes S, 2009, P NATL ACAD SCI USA, V106, P17829, DOI 10.1073/pnas.0906811106; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Sigalotti L, 2007, J CELL PHYSIOL, V212, P330, DOI 10.1002/jcp.21066; Stults DM, 2009, CANCER RES, V69, P9096, DOI 10.1158/0008-5472.CAN-09-2680; Veiko NN, 2000, MOL BIOL+, V34, P250, DOI 10.1007/BF02759647; Veronezi GMB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170740; Weipoltshammer K, 1996, EXP CELL RES, V227, P374, DOI 10.1006/excr.1996.0287	27	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0189826	10.1371/journal.pone.0189826	http://dx.doi.org/10.1371/journal.pone.0189826			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329300	Green Published, gold, Green Submitted			2022-12-26	WOS:000419954100009
J	Matondo, RB; Moreno, E; Toussaint, MJM; Tooten, PCJ; van Essen, SC; van Liere, EA; Youssef, SA; Bongiovanni, L; de Bruin, A				Matondo, Ramadhan B.; Moreno, Eva; Toussaint, Mathilda J. M.; Tooten, Peter C. J.; van Essen, Saskia C.; van Liere, Elsbeth A.; Youssef, Sameh A.; Bongiovanni, Laura; de Bruin, Alain			Atypical E2f functions are critical for pancreas polyploidization	PLOS ONE			English	Article							MAMMALIAN-CELLS; MUTANT MICE; LIVER; ANGIOGENESIS; EXPRESSION; STRESS; MOUSE	The presence of polyploid cells in the endocrine and exocrine pancreas has been reported for four decades. In rodents, pancreatic polyploidization is initiated after weaning and the number of polyploid cells increases with age. Surprisingly the molecular regulators and biological functions of polyploidization in the pancreas are still unknown. We discovered that atypical E2f activity is essential for polyploidization in the pancreas, using an inducible Cre/LoxP approach in new-born mice to delete ubiquitously the atypical E2ftranscription factors, E2f7and E2f8. In contrast to its critical role in embryonic survival, conditional deletion of both of both atypical E2fs in newborn mice had no impact on postnatal survival and mice lived until old age. However, deficiency of E2f7or E2f8alone was sufficient to suppress polyploidization in the pancreas and associated with only a minor decrease in blood serum levels of glucose, insulin, amylase and lipase under 4 hours starvation condition compared to wildtype littermates. In mice with fewer pancreatic polyploid cells that were fed ad libitum, no major impact on hormones or enzymes levels was observed. In summary, we identified atypical E2fs to be essential for polyploidization in the pancreas and discovered that postnatal induced loss of both atypical E2fs in many organs is compatible with life until old age.	[Matondo, Ramadhan B.; Moreno, Eva; Toussaint, Mathilda J. M.; Tooten, Peter C. J.; van Essen, Saskia C.; van Liere, Elsbeth A.; Youssef, Sameh A.; Bongiovanni, Laura; de Bruin, Alain] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [de Bruin, Alain] Univ Groningen, Univ Med Ctr Groningen, Dept Paediat, Div Mol Genet, Groningen, Netherlands	Utrecht University; University of Groningen	de Bruin, A (corresponding author), Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands.; de Bruin, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Paediat, Div Mol Genet, Groningen, Netherlands.	A.deBruin@uu.nl	Bongiovanni, Laura/R-4056-2019; de Bruin, Alain/AAL-9195-2020	Matondo, Augustine/0000-0001-5529-100X; de Bruin, Alain/0000-0001-8579-2649	Nuffic (NFP grant) [DU.282001.1.3.]; Netherlands Organization for Scientific Research [NWO-ALW-IN/11-28, 834.11.002.]; Dutch Molecular Pathology Centre (DMPC)	Nuffic (NFP grant); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Molecular Pathology Centre (DMPC)	This work was supported in part by funding from Nuffic (NFP grant: R.B.M., DU.282001.1.3.), Netherlands Organization for Scientific Research (A.d.B., NWO-ALW-IN/11-28; 834.11.002.) and Dutch Molecular Pathology Centre (DMPC).	Anatskaya OV, 2010, FUNCT INTEGR GENOMIC, V10, P433, DOI 10.1007/s10142-010-0180-5; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen HZ, 2012, NAT CELL BIOL, V14, P1192, DOI 10.1038/ncb2595; de Bruin A, 2016, NUCLEIC ACIDS RES, V44, P3549, DOI 10.1093/nar/gkv1471; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; EHRIE MG, 1976, DIABETOLOGIA, V12, P167, DOI 10.1007/BF00428984; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Fox DT, 2013, DEVELOPMENT, V140, P3, DOI 10.1242/dev.080531; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Iglesias A, 2004, J CLIN INVEST, V113, P1398, DOI 10.1172/JCI200418879; Iglesias-Ara A, 2015, CELL DEATH DIFFER, V22, P1577, DOI 10.1038/cdd.2015.4; Kent LN, 2016, J CLIN INVEST, V126, P2955, DOI 10.1172/JCI85506; Li FX, 2003, P NATL ACAD SCI USA, V100, P12935, DOI 10.1073/pnas.2231861100; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Liu ZP, 2010, CIRC RES, V106, P1498, DOI 10.1161/CIRCRESAHA.109.211888; Milne LS, 1909, J PATHOL BACTERIOL, V13, P127, DOI 10.1002/path.1700130121; Ouseph MM, 2012, DEV CELL, V22, P849, DOI 10.1016/j.devcel.2012.01.013; Pandit SK, 2013, TRENDS CELL BIOL, V23, P556, DOI 10.1016/j.tcb.2013.06.002; Pandit SK, 2012, NAT CELL BIOL, V14, P1181, DOI 10.1038/ncb2585; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; POHL MN, 1979, ACTA ENDOCRINOL-COP, V90, P295, DOI 10.1530/acta.0.0900295; Reinert RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033529; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Thurlings I, 2016, ONCOGENE; Thurlings I, 2016, METHODS MOL BIOL, V1342, P71, DOI 10.1007/978-1-4939-2957-3_4; WEBB SR, 1982, BIOL NEONATE, V42, P73; Weijts BGMW, 2012, EMBO J, V31, P3871, DOI 10.1038/emboj.2012.231; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431	28	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190899	10.1371/journal.pone.0190899	http://dx.doi.org/10.1371/journal.pone.0190899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329320	Green Published, gold, Green Submitted			2022-12-26	WOS:000419954100026
J	Perry, BD; Rahnert, JA; Xie, Y; Zheng, B; Woodworth-Hobbs, ME; Price, SR				Perry, Ben D.; Rahnert, Jill A.; Xie, Yang; Zheng, Bin; Woodworth-Hobbs, Myra E.; Price, S. Russ			Palmitate-induced ER stress and inhibition of protein synthesis in cultured myotubes does not require Toll-like receptor 4	PLOS ONE			English	Article							SKELETAL-MUSCLE CELLS; ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE; INDUCED INFLAMMATION; MYOKINE GENES; ACTIVATION; EXPRESSION; CASPASE-3; TAK-242; ATROPHY	Saturated fatty acids, such as palmitate, are elevated in metabolically dysfunctional conditions like type 2 diabetes mellitus. Palmitate has been shown to impair insulin sensitivity and suppress protein synthesis while upregulating proteolytic systems in skeletal muscle. Increased sarco/endoplasmic reticulum (ER) stress and subsequent activation of the unfolded protein response may contribute to the palmitate-induced impairment of muscle protein synthesis. In some cell types, ER stress occurs through activation of the Toll-like receptor 4 (TLR4). Given the link between ER stress and suppression of protein synthesis, we investigated whether palmitate induces markers of ER stress and protein synthesis by activating TLR4 in cultured mouse C2C12 myotubes. Myotubes were treated with vehicle, a TLR4-specific ligand (lipopolysaccharides), palmitate, or a combination of palmitate plus a TLR4-specific inhibitor (TAK-242). Inflammatory indicators of TLR4 activation (IL-6 and TNF-alpha) and markers of ER stress were measured, and protein synthesis was assessed using puromycin incorporation. Palmitate substantially increased the levels of IL-6, TNF-alpha, CHOP, XBP1 s, and ATF 4 mRNAs and augmented the levels of CHOP, XBP1 s, phospho-PERK and phospho-elF2 alpha proteins. The TLR4 antagonist attenuated both acute palmitate and LPS-induced increases in IL-6 and TNF alpha, but did not reduce ER stress signaling with either 6 h or 24 h palmitate treatment. Similarly, treating myotubes with palmitate for 6 h caused a 43% decline in protein synthesis consistent with an increase in phospho-elF2 alpha, and the TLR4 antagonist did not alter these responses. These results suggest that palmitate does not induce ER stress through TLR4 in muscle, and that palmitate impairs protein synthesis in skeletal muscle in part by induction of ER stress.	[Perry, Ben D.; Rahnert, Jill A.; Xie, Yang; Zheng, Bin; Woodworth-Hobbs, Myra E.; Price, S. Russ] Emory Univ, Dept Med, Renal Div, Atlanta, GA 30322 USA; [Woodworth-Hobbs, Myra E.] Emory Univ, Emory Coll Arts & Sci, Ctr Study Human Hlth, Atlanta, GA 30322 USA; [Price, S. Russ] Atlanta VA Med Ctr, Decatur, GA 30033 USA; [Price, S. Russ] East Carolina Univ, Dept Biochem & Mol Biol, Brody Sch Med, Greenville, NC 27858 USA	Emory University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Atlanta VA Medical Center; University of North Carolina; East Carolina University	Price, SR (corresponding author), Emory Univ, Dept Med, Renal Div, Atlanta, GA 30322 USA.; Price, SR (corresponding author), Atlanta VA Med Ctr, Decatur, GA 30033 USA.; Price, SR (corresponding author), East Carolina Univ, Dept Biochem & Mol Biol, Brody Sch Med, Greenville, NC 27858 USA.	Pricest17@ecu.edu		Perry, Ben/0000-0002-2834-8004	National Institutes of Health [R01 DK95610, T32 DK007656]; Department of Veteran's Affairs Merit [X01BX001456]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran's Affairs Merit(US Department of Veterans Affairs)	This study was funded through the following grants: Professor Russ Price was awarded a National Institutes of Health R01 DK95610, and Department of Veteran's Affairs Merit X01BX001456 and Dr. Ben Perry was awarded a National Institutes of Health T32 DK007656 fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrazi A, 2014, J BIOL CHEM, V289, P9584, DOI 10.1074/jbc.M113.526517; Almurdhi MM, 2016, DIABETES CARE, V39, P441, DOI 10.2337/dc15-0995; BRODIE C, 1990, CELL MOL NEUROBIOL, V10, P217, DOI 10.1007/BF00734575; Bryner RW, 2012, ISRN OBES, V2012, P647348; Cao SS, 2016, J CELL PHYSIOL, V231, P288, DOI 10.1002/jcp.25098; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Deldicque L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020993; Doyle A, 2011, FASEB J, V25, P99, DOI 10.1096/fj.10-164152; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Ebert SM, 2015, J BIOL CHEM, V290, P25497, DOI 10.1074/jbc.M115.681445; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Endo M, 2006, J IMMUNOL, V176, P6245, DOI 10.4049/jimmunol.176.10.6245; FALHOLT K, 1988, DIABETIC MED, V5, P27, DOI 10.1111/j.1464-5491.1988.tb00936.x; Fox DK, 2014, AM J PHYSIOL-ENDOC M, V307, pE245, DOI 10.1152/ajpendo.00010.2014; Gao YM, 2008, J APPL PHYSIOL, V105, P1772, DOI 10.1152/japplphysiol.90636.2008; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Goodpaster BH, 2004, PEDIATR DIABETES, V5, P219, DOI 10.1111/j.1399-543X.2004.00071.x; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hussey SE, 2014, DIABETOLOGIA, V57, P582, DOI 10.1007/s00125-013-3111-x; Hussey SE, 2013, BIOSCIENCE REP, V33, P37, DOI 10.1042/BSR20120098; Ii M, 2006, MOL PHARMACOL, V69, P1288, DOI 10.1124/mol.105.019695; Jove M, 2005, ENDOCRINOLOGY, V146, P3087, DOI 10.1210/en.2004-1560; KANNEL WB, 1985, AM HEART J, V110, P1100, DOI 10.1016/0002-8703(85)90224-8; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kozlov AV, 2009, BBA-MOL BASIS DIS, V1792, P521, DOI 10.1016/j.bbadis.2009.03.004; Kuribayashi JS, 2008, MOL IMMUNOL, V45, P2990, DOI 10.1016/j.molimm.2008.01.013; Kwon B, 2015, BIOCHIMIE, V118, P141, DOI 10.1016/j.biochi.2015.09.006; Leamy AK, 2014, J LIPID RES, V55, P1478, DOI 10.1194/jlr.M050237; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Nozhenko Y, 2015, CELL PHYSIOL BIOCHEM, V35, P92, DOI 10.1159/000369678; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Patsouris D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110653; Perry BD, 2016, EXERC IMMUNOL REV, V22, P94; Pierre N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065061; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Sadeghi A, 2017, J CELL BIOCHEM, V118, P2654, DOI 10.1002/jcb.25868; Salvado L, 2013, DIABETOLOGIA, V56, P1372, DOI 10.1007/s00125-013-2867-3; Santomauro ATMG, 1999, DIABETES, V48, P1836, DOI 10.2337/diabetes.48.9.1836; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoulders MD, 2013, CELL REP, V3, P1279, DOI 10.1016/j.celrep.2013.03.024; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Tardif N, 2014, AGING CELL, V13, P1001, DOI 10.1111/acel.12263; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Urano F, 2000, J CELL SCI, V113, P3697; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; Wang XNH, 2010, J BIOL CHEM, V285, P21249, DOI 10.1074/jbc.M109.041707; Woo CW, 2012, NAT CELL BIOL, V14, P192, DOI 10.1038/ncb2408; Woodworth-Hobbs ME, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13530; Woodworth-Hobbs ME, 2014, J NUTR BIOCHEM, V25, P868, DOI 10.1016/j.jnutbio.2014.03.017; Yang M, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-104; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010; Zhang Q, 2016, DIS MARKERS, V2016, P1, DOI 10.1155/2016/3547096; Zheng B, 2010, FASEB J, V24, P2660, DOI 10.1096/fj.09-151480	59	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191313	10.1371/journal.pone.0191313	http://dx.doi.org/10.1371/journal.pone.0191313			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329354	gold, Green Published, Green Submitted			2022-12-26	WOS:000419954100059
J	Haight, T; Bryan, RN; Meirelles, O; Tracy, R; Fornage, M; Richard, M; Nasrallah, I; Yaffe, K; Jacobs, DR; Lewis, C; Schreiner, P; Sidney, S; Davatzikos, C; Launer, LJ				Haight, Thaddeus; Bryan, R. Nick; Meirelles, Osorio; Tracy, Russell; Fornage, Myriam; Richard, Melissa; Nasrallah, Ilya; Yaffe, Kristine; Jacobs, David R., Jr.; Lewis, Cora; Schreiner, Pamela; Sidney, Stephen; Davatzikos, Christos; Launer, Lenore J.			Associations of plasma clusterin and Alzheimer's disease-related MRI markers in adults at mid-life: The CARDIA Brain MRI sub-study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; GENOME-WIDE ASSOCIATION; GRAY-MATTER LOSS; NEUROFIBRILLARY CHANGES; IDENTIFIES VARIANTS; METABOLIC SYNDROME; ATROPHY; PROGRESSION; IMAGES; RISK	Background Clinical and epidemiological studies of older persons have implicated clusterin in Alzheimer's disease (AD) pathogenesis. In the context of identifying early biomarkers of risk, we examined associations of plasma clusterin and characteristics of AD in middle-aged individuals from the community. Materials and methods Subjects were 639 cognitively normal individuals (mean age 50 +/- 3.5) from the Coronary Artery Risk Development in Young Adults (CARDIA) Brain MRI sub-study. Clusterin was quantified using ELISA (mean 255 +/- 31 ng/ml). Associations were assessed between clusterin and volumes of brain regions known to atrophy in early AD, including entorhinal cortex (ECV), hippocampus (HV), and medial temporal lobe (MTLV) volumes (cm 3). Total brain volume (TBV) and volumes of structures affected in later AD were examined for comparison. Results In multivariable models, higher clusterin had a negative non-linear association with ECV (combined left and right hemispheres), and this association was influenced by the highest clusterin levels. Compared to mean clusterin, 1 and 2 standard deviation (SD) level increases in clusterin were associated with -2.1% (95% CI: -3.3,-0.9) and -7.3% (95% CI: -11.3,-3.3) lower ECV, respectively. Similar relationships were observed between clusterin and HV, although the relationship was stronger for left-side HV than the right-side. However, the association was not significant after adjusting for covariates. Negative non-linear associations between clusterin and MTLV were strongest for the left side: compared to mean clusterin, 1 and 2 SD level increases in clusterin were associated with -0.9% (95% CI: -1.9, 0.1) and -3.7% (95% CI: -7.1, -0.3) lower MTLV. There were no significant associations between clusterin and brain structures affected in later AD. Conclusions In middle-aged adults unselected for AD, plasma clusterin was associated with lower volume of the entorhinal cortex, an area that atrophies early in AD. Clusterin could be informative as part of a multi-component preclinical marker for AD.	[Haight, Thaddeus; Meirelles, Osorio; Launer, Lenore J.] NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA; [Bryan, R. Nick; Nasrallah, Ilya; Davatzikos, Christos] Univ Penn Hlth Syst, Dept Radiol, Philadelphia, PA USA; [Tracy, Russell] Univ Vermont, Coll Med, Dept Pathol & Lab Med, Burlington, VT USA; [Tracy, Russell] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; [Fornage, Myriam; Richard, Melissa] Univ Texas Houston, Inst Mol Med, Res Human Genet, Houston, TX USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Jacobs, David R., Jr.; Schreiner, Pamela] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Lewis, Cora] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA; [Sidney, Stephen] Kaiser Permanente, Div Res, Oakland, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Pennsylvania; University of Vermont; University of Vermont; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham; Kaiser Permanente	Launer, LJ (corresponding author), NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA.	LaunerL@nia.nih.gov	s, s/HIK-1178-2022; s, s/GYR-2278-2022; Davatzikos, Christos/ABE-2057-2021; s, s/HHD-0404-2022	Nasrallah, Ilya/0000-0003-2346-7562; Schreiner, Pamela/0000-0002-9920-6257; Jacobs, David/0000-0002-7232-0543	Coronary Artery Risk Development in Young Adults Study (CARDIA) from National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, HHSN268200900041C]; Intramural Research Program of the National Institute on Aging (NIA); NATIONAL INSTITUTE ON AGING [RF1AG054409] Funding Source: NIH RePORTER	Coronary Artery Risk Development in Young Adults Study (CARDIA) from National Heart, Lung, and Blood Institute (NHLBI); Intramural Research Program of the National Institute on Aging (NIA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Coronary Artery Risk Development in Young Adults Study (CARDIA) is supported by contracts HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, and HHSN268200900041C from the National Heart, Lung, and Blood Institute (NHLBI), the Intramural Research Program of the National Institute on Aging (NIA), and an intra-agency agreement between NIA and NHLBI (AG0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Coronary Artery Risk Development in Young Adults Study (CARDIA) is supported by contracts HH5N268201300025C, HH5N268201300026C, HH5N268201300027C, HHSN268201300028C, HHSN268201300029C, and HHSN268200900041C from the National Heart, Lung, and Blood Institute (NHLBI), the Intramural Research Program of the National Institute on Aging (NIA), and an intra-agency agreement between NIA and NHLBI (AG0005).	BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; Braak H, 1996, NEUROSCI LETT, V210, P87, DOI 10.1016/0304-3940(96)12668-9; DeMattos RB, 2002, P NATL ACAD SCI USA, V99, P10843, DOI 10.1073/pnas.162228299; Desikan RS, 2014, JAMA NEUROL, V71, P180, DOI 10.1001/jamaneurol.2013.4560; Du AT, 2004, NEUROLOGY, V62, P422, DOI 10.1212/01.WNL.0000106462.72282.90; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Goldszal AF, 1998, J COMPUT ASSIST TOMO, V22, P827, DOI 10.1097/00004728-199809000-00030; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Holland D, 2009, P NATL ACAD SCI USA, V106, P20954, DOI 10.1073/pnas.0906053106; Jack CR, 2012, ANN NEUROL, V71, P765, DOI 10.1002/ana.22628; Jagust W., 2009, IMAGING AGING BRAIN; Jayaraman A, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0476-2; Johnson K. A., 2012, COLD SPRING HARB PER, V2, DOI 10.1101; Jongbloed W, 2015, J ALZHEIMERS DIS, V46, P1103, DOI 10.3233/JAD-150036; Kabani N. J., 1998, 4 INT C FUNCT MAPP H; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lao ZQ, 2008, ACAD RADIOL, V15, P300, DOI 10.1016/j.acra.2007.10.012; Launer LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122138; Lord J, 2013, GENETIC VARIANTS ALZ, P25; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Park S, 2014, REV ENDOCR METAB DIS, V15, P45, DOI 10.1007/s11154-013-9275-3; Proust-Lima C, 2007, AM J EPIDEMIOL, V165, P344, DOI 10.1093/aje/kwk017; Razay G, 2007, ARCH NEUROL-CHICAGO, V64, P93, DOI 10.1001/archneur.64.1.93; Schmidt M., 1996, W PSYCHOL SERVICES; Schrijvers EMC, 2011, JAMA-J AM MED ASSOC, V305, P1322, DOI 10.1001/jama.2011.381; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; SIDNEY S, 1991, AM J EPIDEMIOL, V133, P1231, DOI 10.1093/oxfordjournals.aje.a115835; Sluimer JD, 2009, EUR RADIOL, V19, P2826, DOI 10.1007/s00330-009-1512-5; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Thambisetty M, 2012, NEUROIMAGE, V59, P212, DOI 10.1016/j.neuroimage.2011.07.056; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Thompson PM, 2003, J NEUROSCI, V23, P994; Vanhanen M, 2006, NEUROLOGY, V67, P843, DOI 10.1212/01.wnl.0000234037.91185.99; Verhaaren BFJ, 2015, CIRC-CARDIOVASC GENE, V8, P398, DOI 10.1161/CIRCGENETICS.114.000858; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P117, DOI 10.2174/156720507780362065; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112; Won JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103351; Zacharaki EI, 2008, LECT NOTES COMPUT SC, V5241, P620, DOI 10.1007/978-3-540-85988-8_74	41	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190478	10.1371/journal.pone.0190478	http://dx.doi.org/10.1371/journal.pone.0190478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324756	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400035
J	Imaizumi, S; Koyama, S; Tanno, Y				Imaizumi, Shu; Koyama, Shinichi; Tanno, Yoshihiko			Development of the Japanese version of the Visual Discomfort Scale	PLOS ONE			English	Article							CORTICAL HYPEREXCITABILITY; SPATIAL-FREQUENCY; PROBABLE MIGRAINE; MECHANICAL TURK; GLOBAL MOTION; SENSITIVITY; PREVALENCE; QUALITY; ADULTS; DYSLEXIA	Background Visual stimuli, such as stripes and texts, can induce "visual discomfort" including perceptual and somatic symptoms. Individuals reporting high levels of visual discomfort might experience migraine headache and may have reduced reading efficiency due to visual perceptual difficulties. This study aimed to develop and validate the Japanese version of the Visual Discomfort Scale, which measures proneness to visual discomfort. Methods and results In Survey 1, 428 adults completed the Japanese version and a questionnaire assessing migraine morbidity. Rasch analysis revealed that the Japanese version is a unidimensional scale with a high amount of unexplained variance due to random noise rather than another dimension, and has high person and item reliabilities. Participants with migraine exhibited high scores in the Japanese version, indicating the construct validity of the scale. Survey 2 with 118 adults revealed a strong test-retest correlation for the Japanese version, indicating the stability of the scale. Conclusion The Japanese version of the Visual Discomfort Scale is a sufficiently reliable and valid scale for assessing visual discomfort, although its unidimensionality leaves room for further improvements.	[Imaizumi, Shu; Tanno, Yoshihiko] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Imaizumi, Shu] Japan Soc Promot Sci, Tokyo, Japan; [Koyama, Shinichi] Chiba Univ, Grad Sch Engn, Chiba, Japan; [Koyama, Shinichi] Univ Tsukuba, Sch Art & Design, Tsukuba, Ibaraki, Japan	University of Tokyo; Japan Society for the Promotion of Science; Chiba University; University of Tsukuba	Imaizumi, S (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan.; Imaizumi, S (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.	shuimaizumi@gmail.com	Imaizumi, Shu/N-7069-2018	Imaizumi, Shu/0000-0002-8978-4125	Japan Society for the Promotion of Science [16J00411, 17K12701]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in Aids for JSPS Research Fellow (16J00411) and Young Scientists (B) (17K12701) to SI from the Japan Society for the Promotion of Science (http:// www.jsps.go.jp/english/e-grants/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Behrend TS, 2011, BEHAV RES METHODS, V43, P800, DOI 10.3758/s13428-011-0081-0; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bond T. G, 2015, APPLYING RASCH MODEL, V3rd, DOI DOI 10.4324/9781315814698; Borsting E, 2008, OPTOMETRY VISION SCI, V85, P992, DOI 10.1097/OPX.0b013e31818883cd; Borsting E, 2007, OPTOMETRY VISION SCI, V84, P745, DOI 10.1097/OPX.0b013e31812f5f51; Borsting E, 2010, OPTOMETRY VISION SCI, V87, P760, DOI 10.1097/OPX.0b013e3181f31f4e; Boulloche N, 2010, J NEUROL NEUROSUR PS, V81, P978, DOI 10.1136/jnnp.2009.190223; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cacho-Martinez P, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/549435; Carr A., 2014, THESIS; Chandler J, 2016, ANNU REV CLIN PSYCHO, V12, P53, DOI 10.1146/annurev-clinpsy-021815-093623; Chase C, 2009, OPTOM VIS DEV, V40, P239; Chase C, 2009, OPTOMETRY VISION SCI, V86, P883, DOI 10.1097/OPX.0b013e3181ae1b7c; CHATRIAN GE, 1970, EPILEPSIA, V11, P125, DOI 10.1111/j.1528-1157.1970.tb03876.x; Chuah SC, 2006, J RES PERS, V40, P359, DOI 10.1016/j.jrp.2005.01.006; Conlon E, 2001, VISION RES, V41, P3063, DOI 10.1016/S0042-6989(01)00204-8; Conlon E, 2001, PERCEPTION, V30, P571, DOI 10.1068/p2954; Conlon E, 2000, CEPHALALGIA, V20, P708, DOI 10.1046/j.1468-2982.2000.00120.x; Conlon E. G., 2012, VISUAL 0SPECTS DYSLE, P79; Conlon EG, 1999, VIS COGN, V6, P637, DOI 10.1080/135062899394885; Conlon E, 2011, J RES READ, V34, P193, DOI 10.1111/j.1467-9817.2009.01421.x; Conlon EG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00859; Conlon EG, 2009, NEUROPSYCHOLOGIA, V47, P907, DOI 10.1016/j.neuropsychologia.2008.12.037; Cucchiara B, 2015, CEPHALALGIA, V35, P585, DOI 10.1177/0333102414547782; Datta R, 2013, CEPHALALGIA, V33, P365, DOI 10.1177/0333102412474503; Downing SM, 2006, HANDBOOK OF TEST DEVELOPMENT, P3; Drew SA, 2013, OPTOMETRY VISION SCI, V90, P1149, DOI 10.1097/OPX.0000000000000006; Fernandez D, 2008, PERCEPTION, V37, P1098, DOI 10.1068/p5814; Gonzalez-Perez M, 2014, INVEST OPHTH VIS SCI, V55, P4504, DOI 10.1167/iovs.13-13818; Goodman JK, 2013, J BEHAV DECIS MAKING, V26, P213, DOI 10.1002/bdm.1753; Granziera C, 2006, PLOS MED, V3, P1915, DOI 10.1371/journal.pmed.0030402; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Haigh SM, 2015, NEUROIMAGE, V111, P379, DOI 10.1016/j.neuroimage.2015.02.034; Haigh SM, 2012, CEPHALALGIA, V32, P236, DOI 10.1177/0333102411433301; Haigh SM, 2013, VISION RES, V89, P47, DOI 10.1016/j.visres.2013.07.003; Hieda S, 2007, CEPHALALGIA, V27, P663; Huang J, 2003, HEADACHE, V43, P664, DOI 10.1046/j.1526-4610.2003.03110.x; Huang J, 2011, CEPHALALGIA, V31, P925, DOI 10.1177/0333102411409076; Imaizumi S, 2013, PERCEPTION, V42, P83; Imaizumi S., 2011, B JPN SOC SCI DES, V58, P69, DOI DOI 10.11247/JSSDJ.58.69; Imaizumi S, 2014, 2 VIS SCI A IN PRESS; Imaizumi S., 2016, JPN J PERS, V25, P171, DOI [10.2132/personality.25.171, DOI 10.2132/PERS0NALITY.25.171]; Imaizumi S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00542; Irlen H, 1991, READING COLORS OVERC; Juricevic I, 2010, PERCEPTION, V39, P884, DOI 10.1068/p6656; Kennerknecht I, 2007, J HUM GENET, V52, P230, DOI 10.1007/s10038-006-0101-6; Khadka J, 2014, INVEST OPHTH VIS SCI, V55, P4413, DOI 10.1167/iovs.14-14017; Khadka J, 2013, OPTOMETRY VISION SCI, V90, P720, DOI 10.1097/OPX.0000000000000001; Khadka J, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-80; Koyama S, 2007, BEHAV NEUROL, V18, P187, DOI 10.1155/2007/274276; Lambooij M, 2010, J SOC INF DISPLAY, V18, P931, DOI 10.1889/JSID18.11.931; Lambooij M, 2009, J IMAGING SCI TECHN, V53, DOI 10.2352/J.ImagingSci.Technol.2009.53.3.030201; Linacre JM, 2016, USERS GUIDE WINSTEPS; Majima Y, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00378; MARCUS DA, 1989, ARCH NEUROL-CHICAGO, V46, P1129, DOI 10.1001/archneur.1989.00520460125024; McAlinden C, 2011, OPHTHAL PHYSL OPT, V31, P330, DOI 10.1111/j.1475-1313.2011.00851.x; McKendrick AM, 2001, INVEST OPHTH VIS SCI, V42, P626; O'Hare L, 2017, EUR J NEUROSCI, V45, P410, DOI 10.1111/ejn.13479; O'Hare L, 2016, CEPHALALGIA, V36, P1057, DOI 10.1177/0333102415618952; O'Hare L, 2011, VISION RES, V51, P1767, DOI 10.1016/j.visres.2011.06.002; Patel NV, 2004, NEUROLOGY, V63, P1432, DOI 10.1212/01.WNL.0000142044.22226.54; Penacchio O, 2015, VISION RES, V108, P1, DOI 10.1016/j.visres.2014.12.013; Pesudovs K, 2007, OPTOMETRY VISION SCI, V84, P663, DOI 10.1097/OPX.0b013e318141fe75; Ramsey SR, 2016, COMPUT HUM BEHAV, V58, P354, DOI 10.1016/j.chb.2015.12.049; Rasch G., 1960, PROBABILISTIC MODELS; Reips UD, 2002, EXP PSYCHOL, V49, P243, DOI 10.1027//1618-3169.49.4.243; Robertson AE, 2013, J AUTISM DEV DISORD, V43, P775, DOI 10.1007/s10803-012-1608-7; RUSSELL MB, 1995, INT J EPIDEMIOL, V24, P612, DOI 10.1093/ije/24.3.612; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Sakai F, 1997, CEPHALALGIA, V17, P15, DOI 10.1046/j.1468-2982.1997.1701015.x; Schleider JL, 2015, J CHILD FAM STUD, V24, P3235, DOI 10.1007/s10826-015-0126-6; Shapiro DN, 2013, CLIN PSYCHOL SCI, V1, P213, DOI 10.1177/2167702612469015; Sheedy JE, 2003, OPTOMETRY VISION SCI, V80, P732, DOI 10.1097/00006324-200311000-00008; Shepherd AJ, 2013, HEADACHE, V53, P1087, DOI 10.1111/head.12062; Shepherd AJ, 2012, CEPHALALGIA, V32, P554, DOI 10.1177/0333102412445222; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Silberstein S, 2007, CEPHALALGIA, V27, P220, DOI 10.1111/j.1468-2982.2006.01275.x; The Japanese Headache Society, 2014, INT CLASS HEAD DIS; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Tosha C, 2009, OPHTHAL PHYSL OPT, V29, P625, DOI 10.1111/j.1475-1313.2009.00687.x; Vanagaite J, 1997, CEPHALALGIA, V17, P733, DOI 10.1046/j.1468-2982.1997.1707733.x; Vera J, 2017, APPL ERGON, V60, P313, DOI 10.1016/j.apergo.2016.12.011; Vera J, 2016, PHYSIOL BEHAV, V164, P47, DOI 10.1016/j.physbeh.2016.05.043; WILKINS A, 1984, BRAIN, V107, P989, DOI 10.1093/brain/107.4.989; Wilkins A.J., 1995, VISUAL STRESS; WILKINS AJ, 1979, BRAIN, V102, P1, DOI 10.1093/brain/102.1.1; WILKINS AJ, 1980, PROG NEUROBIOL, V15, P85, DOI 10.1016/0301-0082(80)90004-0; Wilkins AJ, 2012, VISUAL ASPECTS DYSLE, P63; WOODHOUSE A, 1993, CEPHALALGIA, V13, P417, DOI 10.1046/j.1468-2982.1993.1306417.x; Wright BD, 1982, RATING SCALE ANAL	91	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191094	10.1371/journal.pone.0191094	http://dx.doi.org/10.1371/journal.pone.0191094			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BJ	29324819	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400111
J	Lee, YT; Ko, EJ; Lee, Y; Kim, KH; Kim, MC; Lee, YN; Kang, SM				Lee, Young-Tae; Ko, Eun-Ju; Lee, Youri; Kim, Ki-Hye; Kim, Min-Chul; Lee, Yu-Na; Kang, Sang-Moo			Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses	PLOS ONE			English	Article							M2 EXTRACELLULAR DOMAINS; A VACCINE; MATRIX PROTEIN-2; CONJUGATE VACCINES; MEDIATE PROTECTION; GAMMA-INTERFERON; H5N1 VIRUS; INFECTION; MUCOSAL; MICE	Current influenza vaccines do not provide broad cross-protection. Here, we report that intranasal vaccination with virus-like particles containing the highly conserved multiple ectodomains of matrix protein 2 (M2e5x VLP) of influenza virus induces broad cross-protection by M2-specific humoral and cellular immune responses. M2e5x VLP intranasal vaccination prevented severe weight loss, attenuated inflammatory cytokines and cellular infiltrates, and lowered viral loads, and induced germinal center phenotypic B and plasma cells. In addition, depletion studies demonstrate the protective roles of CD4 and CD8 T cells induced by M2e5x VLP intranasal vaccination. Thus, this study provides evidence that mucosal delivery of M2e5x VLP vaccine provides cross-protection by inducing humoral and cellular immune responses.	[Lee, Young-Tae; Ko, Eun-Ju; Lee, Youri; Kim, Ki-Hye; Kim, Min-Chul; Lee, Yu-Na; Kang, Sang-Moo] Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect Inst, Atlanta, GA 30303 USA; [Kim, Min-Chul; Lee, Yu-Na] Anim & Plant Quarantine Agcy, Gimcheon, Gyeongsangbukdo, South Korea	University System of Georgia; Georgia State University; Animal & Plant Quarantine Agency	Kang, SM (corresponding author), Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect Inst, Atlanta, GA 30303 USA.	skang24@gsu.edu		Kang, SAng Moo/0000-0001-6198-331X	National Institutes of Health/National Institute of Allergy and Infectious Diseases [AI105170, AI093772, AI119366]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093772, R21AI119366, R01AI105170] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases grants AI105170 (S.M.K), AI093772 (S.M.K), and AI119366 (S.M.K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgarth N, 1996, J VIROL, V70, P4411, DOI 10.1128/JVI.70.7.4411-4418.1996; Bessa J, 2008, EUR J IMMUNOL, V38, P114, DOI 10.1002/eji.200636959; Brito LA, 2011, J PHARM SCI-US, V100, P34, DOI 10.1002/jps.22267; Brown DM, 2012, J VIROL, V86, P6792, DOI 10.1128/JVI.07172-11; De Filette M, 2005, VIROLOGY, V337, P149, DOI 10.1016/j.virol.2005.04.004; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; Denis J, 2008, VACCINE, V26, P3395, DOI 10.1016/j.vaccine.2008.04.052; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Ernst WA, 2006, VACCINE, V24, P5158, DOI 10.1016/j.vaccine.2006.04.008; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Fu TM, 2009, VACCINE, V27, P1440, DOI 10.1016/j.vaccine.2008.12.034; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Heinen PP, 2002, J GEN VIROL, V83, P1851, DOI 10.1099/0022-1317-83-8-1851; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; Kim MC, 2013, MOL THER, V21, P485, DOI 10.1038/mt.2012.246; Lee YT, 2016, J VIROL, V90, P6746, DOI 10.1128/JVI.00605-16; Lee YN, 2014, VACCINE, V32, P4578, DOI 10.1016/j.vaccine.2014.06.040; Liu Q, 2016, CELL MOL IMMUNOL, V13, P3, DOI 10.1038/cmi.2015.74; Liu WL, 2005, MICROBES INFECT, V7, P171, DOI 10.1016/j.micinf.2004.10.006; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Pei SB, 2009, BIOTECHNOL LETT, V31, P1851, DOI 10.1007/s10529-009-0102-6; Price GE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013162; REED L. J., 1938, AMER JOUR HYG, V27, P493; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Song JM, 2010, ANTIVIR RES, V88, P244, DOI 10.1016/j.antiviral.2010.09.001; Suarez-Ramirez JE, 2011, EUR J IMMUNOL, V41, P2632, DOI 10.1002/eji.201141546; Sui ZW, 2010, ARCH VIROL, V155, P535, DOI 10.1007/s00705-010-0621-4; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Tamura S, 2016, JPN J INFECT DIS, V69, P165, DOI 10.7883/yoken.JJID.2015.560; Tissot AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009809; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Viboud C, 2010, PLOS CURR; WANG L, 2013, SCI WORLD J, P20832, DOI DOI 10.1155/2013/; Wu F, 2009, VACCINE, V27, P4320, DOI 10.1016/j.vaccine.2009.04.075; Yokota S, 2000, PEDIATR INT, V42, P197, DOI 10.1046/j.1442-200x.2000.01204.x	41	43	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190868	10.1371/journal.pone.0190868	http://dx.doi.org/10.1371/journal.pone.0190868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324805	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400065
J	Leidich, A; Achiro, L; Kwena, ZA; McFarland, W; Neilands, TB; Cohen, CR; Bukusi, EA; Camlin, CS				Leidich, Aimee; Achiro, Lillian; Kwena, Zachary A.; McFarland, Willi; Neilands, Torsten B.; Cohen, Craig R.; Bukusi, Elizabeth A.; Camlin, Carol S.			Methods for sampling geographically mobile female traders in an East African market setting	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUAL-BEHAVIOR; HIV-INFECTION; MIGRATION; COUPLES; RISK; MIGRANTS	Background The role of migration in the spread of HIV in sub-Saharan Africa is well-documented. Yet migration and HIV research have often focused on HIV risks to male migrants and their partners, or migrants overall, often failing to measure the risks to women via their direct involvement in migration. Inconsistent measures of mobility, gender biases in those measures, and limited data sources for sex-specific population-based estimates of mobility have contributed to a paucity of research on the HIV prevention and care needs of migrant and highly mobile women. This study addresses an urgent need for novel methods for developing probability- based, systematic samples of highly mobile women, focusing on a population of female traders operating out of one of the largest open air markets in East Africa. Our method involves three stages: 1.) identification and mapping of all market stall locations using Global Positioning System (GPS) coordinates; 2.) using female market vendor stall GPS coordinates to build the sampling frame using replicates; and 3.) using maps and GPS data for recruitment of study participants. Results The location of 6,390 vendor stalls were mapped using GPS. Of these, 4,064 stalls occupied by women (63.6%) were used to draw four replicates of 128 stalls each, and a fifth replicate of 15 pre-selected random alternates for a total of 527 stalls assigned to one of five replicates. Staff visited 323 stalls from the first three replicates and from these successfully recruited 306 female vendors into the study for a participation rate of 94.7%. Mobilization strategies and involving traders association representatives in participant recruitment were critical to the study's success. Conclusion The study's high participation rate suggests that this geospatial sampling method holds promise for development of probability-based samples in other settings that serve as transport hubs for highly mobile populations.	[Leidich, Aimee] mSurvey, San Francisco, CA 94109 USA; [Achiro, Lillian; Kwena, Zachary A.; Bukusi, Elizabeth A.] Kenya Med Res Inst KEMRI, Ctr Microbiol Res, Nairobi, Kenya; [McFarland, Willi; Cohen, Craig R.] Univ Calif San Francisco, Global Hlth Sci, San Francisco, CA 94143 USA; [Neilands, Torsten B.; Camlin, Carol S.] Univ Calif San Francisco, Ctr AIDS Res, San Francisco, CA 94143 USA; [Cohen, Craig R.; Camlin, Carol S.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA	Kenya Medical Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Leidich, A (corresponding author), mSurvey, San Francisco, CA 94109 USA.	aimee.leidich@msurvey.co; carol.camlin@ucsf.edu			National Institutes of Health, University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (UCSF-CFAR) [P30-AI027763]; Research Scientist Development Award from the National Institute of Mental Health (NIMH) [K01MH093205]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	National Institutes of Health, University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (UCSF-CFAR); Research Scientist Development Award from the National Institute of Mental Health (NIMH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a grant from the National Institutes of Health, University of California, San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research (UCSF-CFAR), P30-AI027763. Dr. Camlin was supported by a Research Scientist Development Award from the National Institute of Mental Health (NIMH), K01MH093205. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The corresponding author, Aimee Leidich, currently employed by mSurvey, was employed by the University of California, San Francisco during the period of this study. There were no interests on the part of her current employer, mSurvey, in any aspect of this research, and no conflicts of interest for any other author.	Abdool KQ, 1992, THE GLOBAL DIMENSION, V6, P1535; BILSBORROW RE, 1992, INT MIGR REV, V26, P138, DOI 10.2307/2546941; Bilsborrow RE, 1992, AFRICA ON THE MOVE A, V26, P138; Boerma JT, 2002, SEX TRANSM INFECT, V78, pI97, DOI 10.1136/sti.78.suppl_1.i97; Brockerhoff M, 1999, INT MIGR REV, V33, P833, DOI 10.2307/2547354; BWAYO J, 1994, ARCH INTERN MED, V154, P1391, DOI 10.1001/archinte.154.12.1391; Camlin CS, 2017, JAIDS-J ACQ IMM DEF, V74, pE121, DOI 10.1097/QAI.0000000000001252; Camlin CS, 2014, POPUL SPACE PLACE, V20, P528, DOI 10.1002/psp.1794; Camlin CS, 2014, SOC SCI MED, V102, P146, DOI 10.1016/j.socscimed.2013.11.004; Camlin CS, 2013, AIDS EDUC PREV, V25, P216, DOI 10.1521/aeap.2013.25.3.216; Camlin CS, 2010, PUBMED, V5; CASSELS S, 2014, AIDS BEHAV, V18, P12; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Cohen CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004573; Collinson M, 2006, HIGHLY PREVALENT CIR; FLEISS J, 2003, JOHN, P3; Fleiss J LBaPM, 2003, NEW YORK; GARIN B, 1993, ANN SOC BELG MED TR, V73, P143; Glynn JR, 2001, AIDS, V15, P2025, DOI 10.1097/00002030-200110190-00016; HIV/ AIDS JUNPo, 2014, THE GAP REPORT 2014; Hope K R Sr, 2000, AIDS Anal Afr, V10, P6; Hope KR, 2000, NEW YORK, V10, P6; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Hugo GJ, 1993, PROCEEDINGS OF THE U; JOCHELSON K, 1991, INT J HEALTH SERV, V21, P157, DOI 10.2190/11UE-L88J-46HN-HR0K; KARIM QA, 1992, AIDS, V6, P1535, DOI 10.1097/00002030-199212000-00018; Khan MR, 2008, AIDS BEHAV, V12, P202, DOI 10.1007/s10461-007-9314-8; Kimanga DO, 2014, J ACQ IMMUN DEF SYND, V66; KIMANGA DO, 2014, JAIDS SUPPL S13 S26, V64, P66; Kishamawe C, 2006, AIDS, V20, P601, DOI 10.1097/01.aids.0000210615.83330.b2; Kulzer JL, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-8; Kwena ZA, 2014, SEX TRANSM INFECT, V90, P139, DOI 10.1136/sextrans-2013-051168; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Lydie N, 2004, JAIDS-J ACQ IMM DEF, V35, P67, DOI 10.1097/00126334-200401010-00010; McDonald D., 2000, ON BORDERS PERSPECTI; NEW Y, 2012, NEW YORK; NEW Y, 1967, NEW YORK; NUNN AJ, 1995, AIDS, V9, P503, DOI 10.1097/00002030-199509050-00013; PISON G, 1993, J ACQ IMMUN DEF SYND, V6, P196; POSEL D., 2004, NEW YORK, P277; Posel D., 2004, J INTERDISC ECON, V15, P277, DOI [10.1177/02601079x04001500303, DOI 10.1177/02601079X04001500303]; *PROGR KNASC, 2012, KENYA AIDS INDICATOR, P2012; RaM Kearns, 2002, PROGR HUMAN GEOGRAPH, V26; Shisana O., 2005, S AFRICAN NATL HIV P, P2005; TAYLOR JABM, 2012, POPUL SPACE PLACE, V18, P5; Zuma K, 2003, INT J STD AIDS, V14, P814, DOI 10.1258/095646203322556147	46	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190395	10.1371/journal.pone.0190395	http://dx.doi.org/10.1371/journal.pone.0190395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BJ	29324780	Green Submitted, Green Published, gold			2022-12-26	WOS:000419952400033
J	Ozel, C; Gurgenc, T				Ozel, Cihan; Gurgenc, Turan			Effect of heat input on microstructure, wear and friction behavior of (wt.-%) 50FeCrC-20FeW-30FeB coating on AISI 1020 produced by using PTA welding	PLOS ONE			English	Article							COMPOSITE COATINGS; HARDFACING ALLOYS; FE; SURFACE; STEEL	In this study, AISI 1020 steel surface was coated in different heat inputs with (wt.-%) 50FeCrC-20FeW-30FeB powder mixture by using plasma transferred arc (PTA) welding method. The microstructure of the coated samples were investigated by using optical microscope (OM), scanning electron microscope (SEM), X-ray diffraction (XRD) and energy dispersive X-ray (EDS). The hardness was measured with micro hardness test device. The dry sliding wear and friction coefficient properties were determined using a block-on-disk type wear test device. Wear tests were performed at 19.62 N, 39.24 N, 58.86 N load and the sliding distance of 900 m. The results were shown that different microstructures formed due to the heat input change. The highest average micro hardness value was measured at 1217 HV on sample coated with low heat input. It was determined that the wear resistance decreased with increasing heat input.	[Ozel, Cihan] Firat Univ, Engn Fac, Dept Mech Engn, Elazig, Turkey; [Gurgenc, Turan] Firat Univ, Technol Fac, Dept Automot Engn, Elazig, Turkey	Firat University; Firat University	Ozel, C (corresponding author), Firat Univ, Engn Fac, Dept Mech Engn, Elazig, Turkey.	cozel@firat.edu.tr	Özel, Cihan/W-1714-2018; Gürgenç, Turan/V-8472-2018	Gurgenc, Turan/0000-0002-7678-2673; Ozel, Cihan/0000-0002-3227-6875	Firat University Research Fund [FUBAP-MF.15.09]	Firat University Research Fund(Firat University)	The authors thank the Firat University Research Fund (FUBAP-MF.15.09) for their financial contribution to this research.	Acevedo-Davila JL, 2017, VACUUM, V143, P14, DOI 10.1016/j.vacuum.2017.05.033; Barbosa Nunes Everton, 2017, Welding International, V31, P173, DOI 10.1080/09507116.2016.1218616; Buchely MF, 2005, WEAR, V259, P52, DOI 10.1016/j.wear.2005.03.002; Demian C, 2016, SURF COAT TECH, V300, P104, DOI 10.1016/j.surfcoat.2016.05.046; Ferozhkhan MM, 2017, ARAB J SCI ENG, V42, P2067, DOI 10.1007/s13369-017-2457-7; Gou JF, 2017, J ALLOY COMPD, V691, P800, DOI 10.1016/j.jallcom.2016.08.323; GURGENC T., 2017, TURK J SCI TECHNOL, V12, P43; Huang HH, 2017, J MAGN MAGN MATER, V443, P281, DOI 10.1016/j.jmmm.2017.07.067; Kilicay K, 2017, SURF ENG, V33, P886, DOI 10.1080/02670844.2017.1317452; Li M, 2012, SURF COAT TECH, V206, P4021, DOI 10.1016/j.surfcoat.2012.03.082; Li Q, 2016, INT J MODERN PHYS B, V30; Li Q., 2016, J COMPUT THEOR NANOS, V13, P4629; Lin YC, 2013, SURF COAT TECH, V236, P410, DOI 10.1016/j.surfcoat.2013.10.027; Liu S, 2017, J ALLOY COMPD, V691, P239, DOI 10.1016/j.jallcom.2016.08.133; Matik U, 2015, MATER TEST, V57, P431, DOI 10.3139/120.110719; Sadeghi F, 2017, SURF COAT TECH, V324, P85, DOI 10.1016/j.surfcoat.2017.05.067; Sahin Y, 2006, MATER DESIGN, V27, P455, DOI 10.1016/j.matdes.2004.11.031; Sawant MS, 2017, MAT MANUFACTURING PR; Ulutan M, 2016, J MATER PROCESS TECH, V236, P26, DOI 10.1016/j.jmatprotec.2016.04.032; Wang XH, 2006, SURF COAT TECH, V200, P6117, DOI 10.1016/j.surfcoat.2005.09.021; Wieczerzak K, 2015, ARCH METALL MATER, V60, P779, DOI 10.1515/amm-2015-0206; Yongtao Z., 2009, MAT T, V50, P2507, DOI DOI 10.2320/MATERTRANS.M2009172; Yuan YL, 2014, SURF COAT TECH, V248, P9, DOI 10.1016/j.surfcoat.2014.03.029	23	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190243	10.1371/journal.pone.0190243	http://dx.doi.org/10.1371/journal.pone.0190243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324875	gold, Green Submitted, Green Published			2022-12-26	WOS:000419952400025
J	Placzek, WJ; Yanagawa, H; Makita, Y; Renfrow, MB; Julian, BA; Rizk, DV; Suzuki, Y; Novak, J; Suzuki, H				Placzek, William J.; Yanagawa, Hiroyuki; Makita, Yuko; Renfrow, Matthew B.; Julian, Bruce A.; Rizk, Dana V.; Suzuki, Yusuke; Novak, Jan; Suzuki, Hitoshi			Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy	PLOS ONE			English	Article							GALACTOSE-DEFICIENT IGA1; ABERRANTLY GLYCOSYLATED IGA1; O-GLYCOSYLATION; ANTIBODIES; DEPOSITION; PROGRESSION; COMPLEXES; C1GALT1; COHORT	IgA nephropathy is an autoimmune disease characterized by IgA1-containing glomerular immune deposits. We previously proposed a multi-hit pathogenesis model in which patients with IgA nephropathy have elevated levels of circulatory IgA1 with some O-glycans deficient in galactose (Gd-IgA1, autoantigen). Gd-IgA1 is recognized by anti-glycan IgG and/or IgA autoantibodies, resulting in formation of pathogenic immune complexes. Some of these immune complexes deposit in the kidney, activate mesangial cells, and incite glomerular injury leading to clinical presentation of IgA nephropathy. Several studies have demonstrated that elevated circulatory levels of either Gd-IgA1 or the corresponding autoantibodies predict progressive loss of renal clearance function. In this study we assessed a possible association between serum levels of Gd-IgA1 and IgG or IgA autoantibodies specific for Gd-IgA1 in serum samples from 135 patients with biopsy-proven IgA nephropathy, 76 patients with other renal diseases, and 106 healthy controls. Our analyses revealed a correlation between the concentrations of the autoantigen and the corresponding IgG autoantibodies in sera of patients with IgA nephropathy, but not of disease or healthy controls. Moreover, our data suggest that IgG is the predominant isotype of Gd-IgA1-specific autoantibodies in IgA nephropathy. This work highlights the importance of both initial hits in the pathogenesis of IgA nephropathy.	[Placzek, William J.; Renfrow, Matthew B.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Yanagawa, Hiroyuki; Makita, Yuko; Suzuki, Yusuke; Suzuki, Hitoshi] Juntendo Univ, Fac Med, Dept Nephrol, Tokyo, Japan; [Julian, Bruce A.; Rizk, Dana V.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Julian, Bruce A.; Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Juntendo University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Placzek, WJ (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	placzek@uab.edu	Placzek, William/AAG-1172-2020	Placzek, William/0000-0003-4096-8617; Rizk, Dana/0000-0002-6877-2811; Renfrow, Matthew B./0000-0002-4193-7305	National Institutes of Health [DK078244, GM098539]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082753, R01DK078244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health DK078244 and GM098539, and by a gift from the IGA Nephropathy Foundation of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; Arroyo AH, 2015, CLIN NEPHROL, V84, P145, DOI 10.5414/CN108556; Bellur SS, 2011, NEPHROL DIAL TRANSPL, V26, P2533, DOI 10.1093/ndt/gfq812; Berger J, 1968, J Urol Nephrol (Paris), V74, P694; Berthelot L, 2015, KIDNEY INT, V88, P815, DOI 10.1038/ki.2015.158; Berthoux F, 2017, J AM SOC NEPHROL, V28, P1943, DOI 10.1681/ASN.2016060670; Berthoux F, 2012, J AM SOC NEPHROL, V23, P1579, DOI 10.1681/ASN.2012010053; CONLEY ME, 1980, J CLIN INVEST, V66, P1432, DOI 10.1172/JCI109998; DAGOSTIN.RB, 1970, BIOMETRIKA, V57, P679, DOI 10.1093/biomet/57.3.679; Gale DP, 2017, J AM SOC NEPHROL, V28, P2158, DOI 10.1681/ASN.2016091043; Gharavi AG, 2008, J AM SOC NEPHROL, V19, P1008, DOI 10.1681/ASN.2007091052; Hastings MC, 2010, CLIN J AM SOC NEPHRO, V5, P2069, DOI 10.2215/CJN.03270410; Hiki Y, 2001, KIDNEY INT, V59, P1077, DOI 10.1046/j.1523-1755.2001.00591.x; Huang ZQ, 2016, J AM SOC NEPHROL, V27, P3278, DOI 10.1681/ASN.2014101044; Kiryluk K, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006609; Lai KN, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.1; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; RUSSELL MW, 1986, J CLIN IMMUNOL, V6, P74, DOI 10.1007/BF00915367; Shin DH, 2016, MODERN PATHOL, V29, P743, DOI 10.1038/modpathol.2016.77; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Suzuki H, 2014, J BIOL CHEM, V289, P5330, DOI 10.1074/jbc.M113.512277; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Suzuki Y, 2014, CLIN EXP NEPHROL, V18, P770, DOI 10.1007/s10157-013-0921-6; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Yanagawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098081; Zhao N, 2012, KIDNEY INT, V82, P790, DOI 10.1038/ki.2012.197	28	32	37	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190967	10.1371/journal.pone.0190967	http://dx.doi.org/10.1371/journal.pone.0190967			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324897	Green Submitted, Green Published, gold			2022-12-26	WOS:000419952400082
J	Suraida, A; Ibrahim, M; Zunaina, E				Suraida, Abd-Rashid; Ibrahim, Mohtar; Zunaina, Embong			Correlation of the anterior ocular segment biometry with HbA1c level in type 2 diabetes mellitus patients	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; CENTRAL CORNEAL THICKNESS; ANGLE-CLOSURE; REFRACTIVE SURGERY; CHAMBER WIDTH; BLOOD-GLUCOSE; AQUEOUS-HUMOR; RISK-FACTORS; RETINOPATHY; ASSOCIATION	Objectives To compare the anterior ocular segment biometry among Type 2 diabetes mellitus (DM) with no diabetic retinopathy (DR) and non-proliferative diabetic retinopathy (NPDR), and to evaluate the correlation of anterior ocular segment biometry with HbA1c level. Methods A cross-sectional study was conducted in Hospital Universiti Sains Malaysia, Kelantan from November 2013 till May 2016 among Type 2 DM patients (DM with no DR and DM with NPDR). The patients were evaluated for anterior ocular segment biometry [ central corneal thickness (CCT), anterior chamber width (ACW), angle opening distance (AOD) and anterior chamber angle (ACA)] by using Anterior Segment Optical Coherence Tomography (ASOCT). Three ml venous blood was taken for the measurement of HbA1c. Results A total of 150 patients were included in this study (DM with no DR: 50 patients, DM with NPDR: 50 patients, non DM: 50 patients as a control group). The mean CCT and ACW showed significant difference among the three groups (p < 0.001 and p = 0.015 respectively). Based on post hoc result, there were significant mean difference of CCT between non DM and DM with NPDR (mean difference 36.14 mu m, p < 0.001) and also between non DM and DM with no DR (mean difference 31.48 mu m, p = 0.003). The ACW was significantly narrower in DM with NPDR (11.39 mm SD 0.62) compared to DM with no DR (11.76 mm SD 0.53) (p = 0.012). There were no significant correlation between HbA1c and all the anterior ocular segment biometry. Conclusion Diabetic patients have significantly thicker CCT regardless of retinopathy status whereas ACW was significantly narrower in DM with NPDR group compared to DM with no DR. There was no significant correlations between HbA1c and all anterior ocular segment biometry in diabetic patients regardless of DR status.	[Suraida, Abd-Rashid; Ibrahim, Mohtar; Zunaina, Embong] Univ Sains Malaysia, Sch Med Sci, Dept Ophthalmol, Kubang Kerian, Kelantan, Malaysia; [Suraida, Abd-Rashid; Ibrahim, Mohtar; Zunaina, Embong] Hosp Univ Sains Malaysia, Jalan Raja Perempuan Zainab 2, Kubang Kerian, Kelantan, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Zunaina, E (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Ophthalmol, Kubang Kerian, Kelantan, Malaysia.; Zunaina, E (corresponding author), Hosp Univ Sains Malaysia, Jalan Raja Perempuan Zainab 2, Kubang Kerian, Kelantan, Malaysia.	zunaina@usm.my	Embong, Zunaina/C-7386-2018; Ibrahim, Mohtar/D-4870-2016	Zunaina, Embong/0000-0001-5394-6105; Ibrahim, Mohtar/0000-0001-8657-3368				Agte V, 2010, OPHTHALMIC RES, V44, P166, DOI 10.1159/000316477; AlKharashi M, 2014, MIDDLE EAST AFR J OP, V21, P18, DOI 10.4103/0974-9233.124082; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Amerasinghe N, 2009, INVEST OPHTH VIS SCI, V50, P2626, DOI 10.1167/iovs.08-2582; [Anonymous], 1991, OPHTHALMOLOGY, V98, P741; British Cardiac Society British Heart Society Diabetes UK Heart UK Primary Care Cardiovascular Society The Stroke Association, 2005, HEART, V91; Chang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027218; Chen HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041374; Clinical Practice Guidelines, 2009, MAN TYP 2 DIAB MELL; Clinical Practice Guidelines, 2015, MOHPPAK30315GU; Cobo-Soriano R, 2006, OPHTHALMOLOGY, V113, P1118, DOI 10.1016/j.ophtha.2006.02.023; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dave A, 2013, INT OPHTHALMOL, V33, P527, DOI 10.1007/s10792-013-9737-3; Doors M, 2010, J CATARACT REFR SURG, V36, P1213, DOI 10.1016/j.jcrs.2010.05.002; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; El-Agamy A, 2017, CLIN OPHTHALMOL, V11, P481, DOI 10.2147/OPTH.S126217; Fukuda S, 2010, J CATARACT REFR SURG, V36, P1867, DOI 10.1016/j.jcrs.2010.05.024; Goldsmith JA, 2005, OPHTHALMOLOGY, V112, P238, DOI 10.1016/j.ophtha.2004.09.019; Goyal A, 2014, CURR EYE RES, V39, P823, DOI 10.3109/02713683.2011.556299; Halkiadakis I, 2005, J CATARACT REFR SURG, V31, P1895, DOI 10.1016/j.jcrs.2005.03.075; Institute for Public Health (IPH), 2008, DIABETES MELLITUS; Kahn R, 2001, DIABETES CARE, V24, P775; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KLEIN R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1217, DOI 10.1001/archopht.1994.01090210105023; Kulaksizoglu S, 2016, CAN J DIABETES, V40, P115, DOI 10.1016/j.jcjd.2015.07.002; Lee JS, 2006, EYE, V20, P315, DOI 10.1038/sj.eye.6701868; Lim SH, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/605729; Lin C-W, 2013, TAIWAN J OPHTHALMOL, V3, P98; Mansoori T, 2017, SAUDI J OPHTHALMOL, V31, P65, DOI 10.1016/j.sjopt.2017.04.003; McNamara NA, 1998, INVEST OPHTH VIS SCI, V39, P3; MEYER LA, 1988, INVEST OPHTH VIS SCI, V29, P940; NATHAN DM, 1986, DIABETES, V35, P797, DOI 10.2337/diabetes.35.7.797; Nongpiur ME, 2010, OPHTHALMOLOGY, V117, P1967, DOI 10.1016/j.ophtha.2010.02.007; Nor-Sharina Y, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.1000298; Norsaadah B., 2011, BASIC STAT, p43 ; Perez-Rico C, 2015, ACTA OPHTHALMOL, V93, pe193, DOI 10.1111/aos.12530; PIERRO L, 1993, ACTA OPHTHALMOL, V71, P169; Ramesh PV, 2017, J CLIN DIAGN RES, V11, pNC8, DOI 10.7860/JCDR/2017/25595.10420; Ramos JLB, 2009, CLIN EXP OPHTHALMOL, V37, P81, DOI 10.1111/j.1442-9071.2008.01823.x; Riemens A, 2014, ACTA OPHTHALMOL, V92, pE159, DOI 10.1111/aos.12064; Saini JS, 1996, ARCH OPHTHALMOL-CHIC, V114, P649, DOI 10.1001/archopht.1996.01100130641001; Saudek CD, 2006, JAMA-J AM MED ASSOC, V295, P1688, DOI 10.1001/jama.295.14.1688; Saw SM, 2007, AM J OPHTHALMOL, V144, P325, DOI 10.1016/j.ajo.2007.03.038; Sayin N, 2015, WORLD J DIABETES, V6, P92, DOI 10.4239/wjd.v6.i1.92; Senthil S, 2010, OPHTHALMOLOGY, V117, P1729, DOI 10.1016/j.ophtha.2010.01.021; Simpson RG, 2012, CLIN OPHTHALMOL, V6, P1665, DOI 10.2147/OPTH.S36382; Spadea L, 2012, CLIN OPHTHALMOL, V6, P1775, DOI 10.2147/OPTH.S37384; Stanga P E, 1999, Curr Opin Ophthalmol, V10, P483, DOI 10.1097/00055735-199912000-00018; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Su DHW, 2008, OPHTHALMOLOGY, V115, P964, DOI 10.1016/j.ophtha.2007.08.021; Sugimoto M, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/569215; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vollmer L, 2012, OPTOMETRY, V83, P167; Wang YE, 2013, INVEST OPHTH VIS SCI, V54, P7717, DOI 10.1167/iovs.13-12850; WESTON BC, 1995, INVEST OPHTH VIS SCI, V36, P586; Wiemer NGM, 2007, CORNEA, V26, P1165, DOI 10.1097/ICO.0b013e31814fa82f; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Yazgan S, 2014, CLIN OPHTHALMOL, V8, P1549, DOI 10.2147/OPTH.S67984; YEE RW, 1985, CURR EYE RES, V4, P759, DOI 10.3109/02713688509020031	61	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191134	10.1371/journal.pone.0191134	http://dx.doi.org/10.1371/journal.pone.0191134			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324896	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400120
J	Suroto, DA; Kitani, S; Arai, M; Ikeda, H; Nihira, T				Suroto, Dian Anggraini; Kitani, Shigeru; Arai, Masayoshi; Ikeda, Haruo; Nihira, Takuya			Characterization of the biosynthetic gene cluster for cryptic phthoxazolin A in Streptomyces avermitilis	PLOS ONE			English	Article							MODULAR POLYKETIDE SYNTHASES; RECEPTOR HOMOLOG AVAR3; CELLULOSE BIOSYNTHESIS; NONRIBOSOMAL PEPTIDES; EXTENDER UNITS; GENOME; DOMAIN; OXAZOLOMYCIN; STRAIN; INHIBITOR	Phthoxazolin A, an oxazole-containing polyketide, has a broad spectrum of anti-oomycete activity and herbicidal activity. We recently identified phthoxazolin A as a cryptic metabolite of Streptomyces avermitilis that produces the important anthelmintic agent avermectin. Even though genome data of S. avermitilis is publicly available, no plausible biosynthetic gene cluster for phthoxazolin A is apparent in the sequence data. Here, we identified and characterized the phthoxazolin A (ptx) biosynthetic gene cluster through genome sequencing, comparative genomic analysis, and gene disruption. Sequence analysis uncovered that the putative ptx biosynthetic genes are laid on an extra genomic region that is not found in the public database, and 8 open reading frames in the extra genomic region could be assigned roles in the biosynthesis of the oxazole ring, triene polyketide and carbamoyl moieties. Disruption of the ptxA gene encoding a discrete acyltransferase resulted in a complete loss of phthoxazolin A production, confirming that the trans-AT type I PKS system is responsible for the phthoxazolin A biosynthesis. Based on the predicted functional domains in the ptx assembly line, we propose the biosynthetic pathway of phthoxazolin A.	[Suroto, Dian Anggraini; Kitani, Shigeru; Nihira, Takuya] Osaka Univ, Int Ctr Biotechnol, Suita, Osaka, Japan; [Arai, Masayoshi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan; [Ikeda, Haruo] Kitasato Univ, Kitasato Inst Life Sci, Sagamihara, Kanagawa, Japan; [Nihira, Takuya] Mahidol Univ, Fac Sci, MU OU Collaborat Res Ctr Biosci & Biotechnol, Bangkok, Thailand	Osaka University; Osaka University; Kitasato University; Mahidol University	Nihira, T (corresponding author), Osaka Univ, Int Ctr Biotechnol, Suita, Osaka, Japan.; Nihira, T (corresponding author), Mahidol Univ, Fac Sci, MU OU Collaborat Res Ctr Biosci & Biotechnol, Bangkok, Thailand.	nihira@icb.osaka-u.ac.jp	Suroto, Dian Anggraini/GOP-2406-2022	Kitani, Shigeru/0000-0003-2583-6798	Japan Society for the Promotion of Science [JP15K07358]; Japan Association for Chemical Innovation (New Chemical Technology Research Encouragement Award)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Association for Chemical Innovation (New Chemical Technology Research Encouragement Award)	This study was supported by the Japan Society for the Promotion of Science (JP15K07358, http://www.jsps.go.jp/index.html, SK); and the Japan Association for Chemical Innovation (New Chemical Technology Research Encouragement Award, http://jaci.or.jp/, SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORK P, 1994, PROTEINS, V20, P347, DOI 10.1002/prot.340200407; Caffrey P, 2003, CHEMBIOCHEM, V4, P654, DOI 10.1002/cbic.200300581; Cheng YQ, 2009, METHOD ENZYMOL, V459, P165, DOI 10.1016/S0076-6879(09)04608-4; Du LC, 2010, NAT PROD REP, V27, P255, DOI 10.1039/b912037h; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Fisch KM, 2013, RSC ADV, V3, P18228, DOI 10.1039/c3ra42661k; GRAFE U, 1992, LIEBIGS ANN CHEM, P429; He M, 2000, J BACTERIOL, V182, P2619, DOI 10.1128/JB.182.9.2619-2623.2000; Helfrich EJN, 2016, NAT PROD REP, V33, P231, DOI 10.1039/c5np00125k; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; IKEDA H, 1987, J BACTERIOL, V169, P5615, DOI 10.1128/jb.169.12.5615-5621.1987; Ikeda H, 2014, J IND MICROBIOL BIOT, V41, P233, DOI 10.1007/s10295-013-1327-x; Katz L, 1997, CHEM REV, V97, P2557, DOI 10.1021/cr960025+; Keatinge-Clay AT, 2007, CHEM BIOL, V14, P898, DOI 10.1016/j.chembiol.2007.07.009; Komatsu M., 2010, P NATL ACAD SCI USA, V107, P7422; Komatsu M, 2013, ACS SYNTH BIOL, V2, P384, DOI 10.1021/sb3001003; Kopp F, 2007, CURR OPIN BIOTECH, V18, P513, DOI 10.1016/j.copbio.2007.09.009; Lai JR, 2006, BIOCHEMISTRY-US, V45, P14869, DOI 10.1021/bi061979p; Matilla MA, 2012, J BIOL CHEM, V287, P39125, DOI 10.1074/jbc.M112.401026; Miyamoto KT, 2011, MICROBIOL-SGM, V157, P2266, DOI 10.1099/mic.0.048371-0; MORI T, 1985, TETRAHEDRON LETT, V26, P1073, DOI 10.1016/S0040-4039(00)98515-0; Musiol EM, 2013, CHEMBIOCHEM, V14, P1343, DOI 10.1002/cbic.201300211; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; OMURA S, 1990, J ANTIBIOT, V43, P1034, DOI 10.7164/antibiotics.43.1034; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Perlova O, 2006, J BIOTECHNOL, V121, P174, DOI 10.1016/j.jbiotec.2005.10.011; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Pistorius D, 2012, CHEMBIOCHEM, V13, P416, DOI 10.1002/cbic.201100575; Pulsawat N, 2009, MICROBIOL-SGM, V155, P1250, DOI 10.1099/mic.0.022467-0; Reid R, 2003, BIOCHEMISTRY-US, V42, P72, DOI 10.1021/bi0268706; Schoenafinger G, 2006, J AM CHEM SOC, V128, P7406, DOI 10.1021/ja0611240; Soehano I, 2012, CHEM SCI, P1; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Suroto DA, 2017, J BIOSCI BIOENG, V124, P611, DOI 10.1016/j.jbiosc.2017.06.014; TANAKA Y, 1995, J ANTIBIOT, V48, P720, DOI 10.7164/antibiotics.48.720; TANAKA Y, 1993, J ANTIBIOT, V46, P1214, DOI 10.7164/antibiotics.46.1214; Wagner DT, 2017, STRUCTURE, V25, P1045, DOI 10.1016/j.str.2017.05.011; Wang H, 2014, P NATL ACAD SCI USA, V111, P9259, DOI 10.1073/pnas.1401734111; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Wu JQ, 2005, J AM CHEM SOC, V127, P17393, DOI 10.1021/ja055672+; Yadav G, 2003, J MOL BIOL, V328, P335, DOI 10.1016/S0022-2836(03)00232-8; Zhao CH, 2010, J BIOL CHEM, V285, P20097, DOI 10.1074/jbc.M109.090092; Zhou YJ, 2015, CHEM BIOL, V22, P745, DOI 10.1016/j.chembiol.2015.05.010	43	12	13	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190973	10.1371/journal.pone.0190973	http://dx.doi.org/10.1371/journal.pone.0190973			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324854	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400085
J	Broberg, G; Wang, JR; Ostberg, AL; Adolfsson, A; Nemes, S; Sparen, P; Strander, B				Broberg, Gudrun; Wang, Jiangrong; Ostberg, Anna-Lena; Adolfsson, Annsofie; Nemes, Szilard; Sparen, Par; Strander, Bjorn			Socio-economic and demographic determinants affecting participation in the Swedish cervical screening program: A population-based case-control study	PLOS ONE			English	Article							BREAST-CANCER; WOMEN; NONPARTICIPATION; EPIDEMIOLOGY; DISTANCE; TESTS; TRIAL; BORN	Background Cervical screening programs are highly protective for cervical cancer, but only for women attending screening procedure. Objective Identify socio-economic and demographic determinants for non-attendance in cervical screening. Methods Design: Population-based case-control study. Setting: Sweden. Population: Source population was all women eligible for screening. Based on complete screening records, two groups of women aged 30-60 were compared. The case group, non-attending women, (N = 314,302) had no smear registered for 6-8 years. The control group (N = 266,706) attended within 90 days of invitation. Main outcome measures: Risk of non-attendance by 9 groups of socioeconomic and demographic variables. Analysis: Unadjusted odds ratios (OR) and OR after adjustment for all variables in logistic regression models were calculated. Results Women with low disposable family income (adjOR 2.06; 95% confidence interval (CI) 2.01-2.11), with low education (adjOR 1.77; CI 1.73-1.81) and not cohabiting (adjOR 1.47; CI 1.45-1.50) were more likely to not attend cervical screening. Other important factors for non-attendance were being outside the labour force and receiving welfare benefits. Swedish counties are responsible for running screening programs; adjusted OR for non-participation in counties ranged from OR 4.21 (CI 4.06-4.35) to OR 0.54 (CI 0.52-0.57), compared to the reference county. Being born outside Sweden was a risk factor for non-attendance in the unadjusted analysis but this disappeared in certain large groups after adjustment for socioeconomic factors. Conclusion County of residence and socio-economic factors were strongly associated with lower attendance in cervical screening, while being born in another country was of less importance. This indicates considerable potential for improvement of cervical screening attendance in several areas if best practice of routines is adopted.	[Broberg, Gudrun; Strander, Bjorn] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynaecol, Gothenburg, Sweden; [Broberg, Gudrun; Nemes, Szilard; Strander, Bjorn] Reg Canc Ctr Western Hlth Care Reg, Gothenburg, Sweden; [Broberg, Gudrun] Narhalsan Primary Care Western Hlth Care Reg, Skovde, Sweden; [Wang, Jiangrong; Sparen, Par] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ostberg, Anna-Lena] Publ Dent Hlth Serv, Region Vastra Gotaland, Sweden; [Ostberg, Anna-Lena] Univ Gothenburg, Sahlgrenska Acad, Inst Odontol, Dept Behav & Community Dent, Gothenburg, Sweden; [Adolfsson, Annsofie] Orebro Univ, Sch Hlth & Med Sci, Orebro, Sweden; [Adolfsson, Annsofie] Buskerud & Vestfold Univ Coll, Fac Hlth Sci, Ctr Womens Family & Child Hlth, Kongsberg, Norway; [Nemes, Szilard] Swedish Hip Arthroplasty Register, Gothenburg, Sweden	University of Gothenburg; Karolinska Institutet; University of Gothenburg; Orebro University; University College of Southeast Norway	Strander, B (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynaecol, Gothenburg, Sweden.; Strander, B (corresponding author), Reg Canc Ctr Western Hlth Care Reg, Gothenburg, Sweden.	bjorn.strander@rccvast.se	Strander, Björn/AAB-2609-2021	Strander, Björn/0000-0001-8369-7955; Sparen, Par/0000-0002-5184-8971; Nemes, Szilard/0000-0002-4145-1786	Swedish Cancer Society [12 0870]	Swedish Cancer Society(Swedish Cancer Society)	The study was supported by the Swedish Cancer Society, Grant Contract nr 12 0870, www.cancerfonden.se. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae B, 2008, JNCI-J NATL CANCER I, V100, P622, DOI 10.1093/jnci/djn099; [Anonymous], 2016, BMJ, V353, pi2823, DOI 10.1136/bmj.i2823; [Anonymous], SWED NAT CERV SCREEN; [Anonymous], 2013, NAT KVAL GYN CELLPR; Azerkan F, 2012, INT J CANCER, V130, P937, DOI 10.1002/ijc.26084; Berardi R, 2013, TUMORI J, V99, P565, DOI 10.1700/1377.15303; Broberg G, 2014, INT J CANCER, V134, P2223, DOI 10.1002/ijc.28545; Broberg G, 2013, INT J CANCER, V133, P164, DOI 10.1002/ijc.27985; Bulliard JL, 2004, BREAST, V13, P284, DOI 10.1016/j.breast.2004.03.001; Eaker S, 2004, CANCER EPIDEM BIOMAR, V13, P346; Eaker S, 2001, PREV MED, V32, P482, DOI 10.1006/pmed.2001.0844; IARC, 2005, CERV CANC SCREEN; Ibfelt E, 2012, CANCER EPIDEM BIOMAR, V21, P835, DOI 10.1158/1055-9965.EPI-11-1159; Jensen KE, 2008, EUR J CANCER, V44, P2003, DOI 10.1016/j.ejca.2008.06.014; Jensen LF, 2014, J PUBLIC HEALTH-UK, V36, P292, DOI 10.1093/pubmed/fdt068; Kristensson JH, 2014, CANCER EPIDEMIOL, V38, P174, DOI 10.1016/j.canep.2013.12.007; Link BG, 1998, MILBANK Q, V76, P375, DOI 10.1111/1468-0009.00096; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Maheswaran R, 2006, J EPIDEMIOL COMMUN H, V60, P208, DOI 10.1136/jech.200X.038398; Morrell S, 2005, AUST NZ J PUBL HEAL, V29, P78, DOI 10.1111/j.1467-842X.2005.tb00753.x; Olsson E, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0062-x; Rodvall Y, 2005, EUR J CANCER PREV, V14, P459, DOI 10.1097/01.cej.0000178078.21910.da; RONCO G, 1991, INT J EPIDEMIOL, V20, P349, DOI 10.1093/ije/20.2.349; Segnan N, 1998, TUMORI J, V84, P348, DOI 10.1177/030089169808400307; Seidel D, 2009, J CANCER RES CLIN, V135, P533, DOI 10.1007/s00432-008-0485-0; Socialstyrelsen, 199815 SOS NAT BOARD; Socialstyrelsen, 2011, CANC INC SWED 2010; Soneji S, 2013, REV PANAM SALUD PUBL, V33, P174, DOI 10.1590/S1020-49892013000300003; Swedish National Board of Health and Welfare, NAT PAT REG; Virtanen A, 2011, CANCER EPIDEM BIOMAR, V20, P1960, DOI 10.1158/1055-9965.EPI-11-0307; Virtanen A, 2011, INT J CANCER, V128, P2681, DOI 10.1002/ijc.25581; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wikstrom I, 2007, ACTA OBSTET GYN SCAN, V86, P720, DOI 10.1080/00016340701303747	34	34	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190171	10.1371/journal.pone.0190171	http://dx.doi.org/10.1371/journal.pone.0190171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS3NS	29320536	gold, Green Published, Green Submitted			2022-12-26	WOS:000419689600036
J	Ishikawa-Kakiya, Y; Shiba, M; Maruyama, H; Kato, K; Fukunaga, S; Sugimori, S; Otani, K; Hosomi, S; Tanaka, F; Nagami, Y; Taira, K; Yamagami, H; Tanigawa, T; Watanabe, T; Fujiwara, Y				Ishikawa-Kakiya, Yuki; Shiba, Masatsugu; Maruyama, Hirotsugu; Kato, Kunihiro; Fukunaga, Shusei; Sugimori, Satoshi; Otani, Koji; Hosomi, Shuhei; Tanaka, Fumio; Nagami, Yasuaki; Taira, Koichi; Yamagami, Hirokazu; Tanigawa, Tetsuya; Watanabe, Toshio; Fujiwara, Yasuhiro			Risk of pancreatitis after pancreatic duct guidewire placement during endoscopic retrograde cholangiopancreatography	PLOS ONE			English	Article							POST-ERCP PANCREATITIS; SELECTIVE BILIARY CANNULATION; BILE-DUCT; PRECUT SPHINCTEROTOMY; EUROPEAN-SOCIETY; PROPHYLAXIS; COMPLICATIONS; PREVENTION; STENTS; TRIAL	Background & aims Advanced techniques have been developed to overcome difficult cannulation cases in endoscopic retrograde cholangiopancreatography (ERCP). Pancreatic duct guidewire placement method (PGW) is performed in difficult cannulation cases; it is possible that it places patients at risk of post-ERCP pancreatitis (PEP). The mechanism of PEP is still unclear, but pancreatic duct pressure and injury of pancreatic duct are known causes of PEP. Therefore, we hypothesized a relationship between pancreatic duct diameter and PEP and predicted that PGW would increase the risk of PEP in patients with non-dilated pancreatic ducts. This study aimed to investigate whether PGW increased the risk of PEP in patients with pancreatic duct diameter <= 3 mm. Methods We analyzed 332 patients with pancreatic duct <= 3 mm who performed first time ERCP session. The primary endpoint was the rate of adverse event of PEP. We evaluated the risk of PEP in patients who had undergone PGW compared to those who had not, using the inverse probability of treatment weighting (IPTW) analysis. Results PGW was found to be an independent risk factor for PEP by univariate analysis (odds ratio [OR], 2.45; 95% confidence interval [CI], 1.12 +/- 5.38; p = 0.03) after IPTW in patients with pancreatic duct diameter <= 3 mm. Adjusted for all covariates, PGW remained an independent risk factor for PEP (OR, 3.12; 95% CI, 1.33 +/- 7.33; p = 0.01). Conclusion Our results indicate that PGW in patients with pancreatic duct diameter <= 3 mm increases the risk of PEP.	[Ishikawa-Kakiya, Yuki; Shiba, Masatsugu; Maruyama, Hirotsugu; Kato, Kunihiro; Fukunaga, Shusei; Sugimori, Satoshi; Otani, Koji; Hosomi, Shuhei; Tanaka, Fumio; Nagami, Yasuaki; Taira, Koichi; Yamagami, Hirokazu; Tanigawa, Tetsuya; Watanabe, Toshio; Fujiwara, Yasuhiro] Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka, Japan	Osaka Metropolitan University	Shiba, M (corresponding author), Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka, Japan.	shiba@med.osaka-cu.ac.jp	Tanigawa, Tetsuya/J-6131-2019; Tanaka, Fumio/HCI-5442-2022	Tanigawa, Tetsuya/0000-0002-9305-1637; Tanaka, Fumio/0000-0002-9186-1249; Ishikawa-Kakiya, Yuki/0000-0001-6889-0677				Angsuwatcharakon P, 2012, J GASTROEN HEPATOL, V27, P356, DOI 10.1111/j.1440-1746.2011.06927.x; Austin PC, 2016, STAT METHODS MED RES, V25, P2214, DOI 10.1177/0962280213519716; Choudhary A, 2011, GASTROINTEST ENDOSC, V73, P275, DOI 10.1016/j.gie.2010.10.039; Cote GA, 2012, DIGEST DIS SCI, V57, P3271, DOI 10.1007/s10620-012-2269-2; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Dumonceau JM, 2014, ENDOSCOPY, V46, P798, DOI 10.1055/s-0034-1377875; Dumonceau JM, 1998, ENDOSCOPY, V30, pS80, DOI 10.1055/s-2007-1001379; Freeman ML, 1996, NEW ENGL J MED, V335, P909, DOI 10.1056/NEJM199609263351301; Freeman ML, 2004, GASTROINTEST ENDOSC, V59, P845, DOI 10.1016/S0016-5107(04)00353-0; Gillams AR, 2006, AM J ROENTGENOL, V186, P499, DOI 10.2214/AJR.04.1775; Gronroos JM, 2011, SURG ENDOSC, V25, P1599, DOI 10.1007/s00464-010-1458-3; de Tejada AH, 2009, GASTROINTEST ENDOSC, V70, P700, DOI 10.1016/j.gie.2009.03.031; Ito K, 2008, WORLD J GASTROENTERO, V14, P5595, DOI 10.3748/wjg.14.5595; Ito K, 2014, DIGEST ENDOSC, V26, P442, DOI 10.1111/den.12158; Ito K, 2010, J GASTROENTEROL, V45, P1183, DOI 10.1007/s00535-010-0268-7; Maeda S, 2003, ENDOSCOPY, V35, P721, DOI 10.1055/s-2003-41576; Mazaki T, 2010, ENDOSCOPY, V42, P842, DOI 10.1055/s-0030-1255781; Miyamoto N, 2015, JPN J RADIOL, V33, P59, DOI 10.1007/s11604-014-0377-y; Paroder V, 2016, EUR J RADIOL, V85, P1622, DOI 10.1016/j.ejrad.2016.06.017; Pezzi A, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0253-9; Phillip V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177874; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Sakai Y, 2014, WORLD J CLIN CASES, V2, P426, DOI 10.12998/wjcc.v2.i9.426; Sasahira N, 2015, ENDOSCOPY, V47, P421, DOI 10.1055/s-0034-1391228; SHERMAN S, 1991, PANCREAS, V6, P350, DOI 10.1097/00006676-199105000-00013; Sofuni A, 2007, CLIN GASTROENTEROL H, V5, P1339, DOI 10.1016/j.cgh.2007.07.008; Sofuni A, 2011, CLIN GASTROENTEROL H, V9, P851, DOI 10.1016/j.cgh.2011.06.033; Testoni PA, 2016, ENDOSCOPY, V48, P657, DOI 10.1055/s-0042-108641; Tse F, 2017, ENDOSCOPY, V49, P15, DOI 10.1055/s-0042-119035; Yasuda I, 2016, DIGEST ENDOSC, V28, P62, DOI 10.1111/den.12591; Yoo YW, 2013, WORLD J GASTROENTERO, V19, P108, DOI 10.3748/wjg.v19.i1.108	31	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190379	10.1371/journal.pone.0190379	http://dx.doi.org/10.1371/journal.pone.0190379			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320523	Green Published, gold, Green Submitted			2022-12-26	WOS:000419689600048
J	Hernandez-Flores, A; Cuevas-Jimenez, A; Poot-Salazar, A; Condal, A; Espinoza-Mendez, JC				Hernandez-Flores, Alvaro; Cuevas-Jimenez, Alfonso; Poot-Salazar, Alicia; Condal, Alfonso; Carlos Espinoza-Mendez, Juan			Bioeconomic modeling for a small-scale sea cucumber fishery in Yucatan, Mexico	PLOS ONE			English	Article							ISOSTICHOPUS-BADIONOTUS; ECHINODERMATA; COMANAGEMENT; DENSITY	Due to the heavy exploitation of holothurians over the last few decades, it is necessary to implement fishing regulations aimed at reversing this situation. Holothurians require specific regulations that take into account their biology and ecology. Their behavior to group and form patches as a strategy for feeding, defense and reproduction, makes them vulnerable to overfishing. The higher the population density, the higher the catchability coefficient, and because they are sedentary organisms, the catchability does not change significantly until the density is very low. Hence, the stock assessment of holothurians can be improved by analyzing their spatial distribution. This paper proposes a stock assessment technique that considers the spatial distribution pattern of the sea cucumber Isostichopus badionotus from Yucatan, Mexico. A bioeconomic spatial model was developed to explain the interactions between fishing effort allocation, quasi-profits and the population in the short term. Because of the high price of the species and the low production costs, artisanal fishers preferred to maximize short-term quasi-profits, rather than the long-term benefits they could gain with low fishing mortality rates.	[Hernandez-Flores, Alvaro; Cuevas-Jimenez, Alfonso] Univ Marista Merida, Carretera Merida Progreso, Merida, Yucatan, Mexico; [Poot-Salazar, Alicia; Carlos Espinoza-Mendez, Juan] Inst Nacl Pesca, Ctr Reg Invest Pesqueras Yucalpeten, Blvd Pescador S-N, Progreso, Yucatan, Spain; [Condal, Alfonso] Laval Univ, Dept Sci Geomat, Laval, PQ, Canada	Laval University	Poot-Salazar, A (corresponding author), Inst Nacl Pesca, Ctr Reg Invest Pesqueras Yucalpeten, Blvd Pescador S-N, Progreso, Yucatan, Spain.	alipootsalazar@gmail.com		Poot-Salazar, Alicia/0000-0002-7963-5142; HERNANDEZ-FLORES, ALVARO/0000-0003-1900-9868	Institute Nacional de Pesca (INAPESCA) [066]	Institute Nacional de Pesca (INAPESCA)	This study was part of the proyect 066, funded by the Institute Nacional de Pesca (INAPESCA, http://www.gob.mx/inapescaJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis P, 2009, FISH RES, V100, P215, DOI 10.1016/j.fishres.2009.07.008; Akamine J., 2004, ADV SEA CUCUMBER AQU, P39; Alfonso I, ADV SEA CUCUMBER AQU; Altamirano Manfred, 2004, FAO Fisheries Technical Paper, V463, P247; Anderson SC, 2011, FISH FISH, V12, P317, DOI 10.1111/j.1467-2979.2010.00397.x; [Anonymous], 1998, FISHERIES BIOECONOMI; Bell JD, 2008, OCEAN COAST MANAGE, V51, P589, DOI 10.1016/j.ocecoaman.2008.06.011; Bruckner A.W., 2006, P CITES WORKSH CONS; Cacho O.J., 1997, AQUACULT ECON MANAG, V1, P45, DOI [10.1080/13657309709380202, DOI 10.1080/13657309709380202]; Castilla JC, 2001, REV FISH BIOL FISHER, V11, P1, DOI 10.1023/A:1014235924952; Choo PohSze, 2008, FAO Fisheries and Aquaculture Technical Paper, P81; Clark JE, 2009, FISHERY DATA SERIES, V09-12; Conand C., 2008, FAO Fisheries and Aquaculture Technical Paper, P143; Conand C., 1989, THESIS; Conand C, 2004, ADV SEA CUUMBER AQUA; COUSENS R, 1985, ANN APPL BIOL, V107, P239, DOI 10.1111/j.1744-7348.1985.tb01567.x; Csirke J., 1989, 192 FAO, V192; de Graaf M, 1999, B MAR SCI, V64, P189; De Smith M.J., 2007, GEOSPATIAL ANAL COMP; Defeo O, 2005, REV FISH BIOL FISHER, V15, P265, DOI 10.1007/s11160-005-4865-0; FAO, 2015, VOL GUID SEC SUST SM; Foglietta LM, 2004, J EXP MAR BIOL ECOL, V303, P19, DOI 10.1016/j.jembe.2003.10.019; Friedman K, 2008, SEA CUCUMBER FISHERI; Gascoigne JC, 2004, J APPL ECOL, V41, P801, DOI 10.1111/j.0021-8901.2004.00944.x; Guzman HM, 2002, CARIBB J SCI, V38, P230; Hamel J.F., 2008, SEA CUCUMBERS GLOBAL; Hamel JF, 1996, CAN J FISH AQUAT SCI, V53, P253, DOI 10.1139/cjfas-53-2-253; Hasan Mohamed Hamza, 2012, Beche-de-mer Information Bulletin, V32, P53; Hernandez-Flores A, 2015, FISH RES, V172, P114, DOI 10.1016/j.fishres.2015.07.005; HILBORN R, 1992; Holling C. S., 1959, Canadian Entomologist, V91, P385; Humann P., 2013, REEF CREATURE IDENTI; Kar TK., 2007, TRENDS APPL SCI RES, V2, P271, DOI [10.3923/tasr.2007.271.283, DOI 10.3923/TASR.2007.271.283]; Kinch J., 2008, FAO Fisheries and Aquaculture Technical Paper, P57; Leopold M, 2013, ENVIRON CONSERV, V40, P367, DOI 10.1017/S037689291300009X; Marzolff I, 2009, GEOMORPHOLOGY, V111, P48, DOI 10.1016/j.geomorph.2008.05.047; Mercier A, 2009, ADV MAR BIOL, V55, P1, DOI 10.1016/S0065-2881(09)55001-8; MicroImages Inc, 2014, TNTMIPS BAS 2014; Orensanz J. M., 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P441; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; Poot-Salazar A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05151; Purcell S.W., 2010, FAO FISHERIES AQUACU; Purcell SW, 2013, FISH FISH, V14, P34, DOI 10.1111/j.1467-2979.2011.00443.x; Salas S, 2006, WHAT IS FUTURE YUCAT; Seijo J., 2010, BIOECONOMICS FISHERI; Seijo J. C., 1994, FAO COMPUTERIZED INF; Seijo JC, 1998, FISH RES, V91, P336; Shepherd SA, 2004, ENVIRON CONSERV, V31, P102, DOI 10.1017/S0376892903001188; Sutinen J.G., 1999, INT J SOC ECON, V26, P174, DOI [10.1108/03068299910229569, DOI 10.1108/03068299910229569]; Tagliafico A, 2011, REV BIOL TROP, V59, P843; Toral-Granda M. Veronica, 2005, Beche-de-mer Information Bulletin, V21, P5; Toral-Granda V., 2008, FAO Fisheries and Aquaculture Technical Paper, P213; Uthicke Sven, 2004, FAO Fisheries Technical Paper, V463, P163; Wilberg MJ, 2010, REV FISH SCI, V18, P7, DOI 10.1080/10641260903294647; Zacarias-Soto M, 2013, J WORLD AQUACULT SOC, V44, P694, DOI 10.1111/jwas.12061	55	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190857	10.1371/journal.pone.0190857	http://dx.doi.org/10.1371/journal.pone.0190857			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315339	Green Published, Green Submitted, gold			2022-12-26	WOS:000419655900028
J	Liu, GH; Feng, S; Jia, L; Wang, CY; Fu, Y; Luo, YZ				Liu, Guanghua; Feng, Shi; Jia, Lin; Wang, Chunying; Fu, Yan; Luo, Yongzhang			Lung fibroblasts promote metastatic colonization through upregulation of stearoyl-CoA desaturase 1 in tumor cells	ONCOGENE			English	Article							CATHEPSIN-B; CYSTEINE CATHEPSINS; THERAPEUTIC TARGET; CANCER-CELLS; PROGRESSION; PROLIFERATION; SURVIVAL; NETWORK; MTOR; LIPOGENESIS	As a rate-limiting step in metastasis, metastatic colonization requires survival signals from supportive stroma. However, the mechanisms driving this process are incompletely understood. Here, we showed that the proliferation of B16F10 cells was promoted when cocultured with lung fibroblasts. Meanwhile, co-injection of B16F10 tumor cells with mouse lung fibroblasts significantly increased lung metastasis. Based on GEO database, we identified stearoyl-CoA desaturase 1 (SCD1) as a novel factor promoting metastatic colonization. Importantly, we found that fibroblast-secreted cathepsin B (CTSB) induced the upregulation of SCD1 in B16F10 through Annexin A2 (ANXA2) and PI3K/Akt/mTOR pathway. The elevated SCD1 induced a higher ratio of monounsaturated fatty acids to saturated fatty acids in B16F10 cells. The changes in fatty acid composition contributed to tumor cell proliferation and metastatic colonization. Furthermore, targeting SCD1 effectively inhibited lung metastasis and prolonged the overall survival of mice. Meanwhile, the expression of SCD1 was negatively correlated with disease-free survival in five types of cancer patients. Collectively, our study identifies SCD1 as a critical modulator of tumor cell proliferation that is activated by cathepsin B, secreted by lung fibroblasts at the metastatic niche. Our novel findings provide potential therapeutic targets to prevent tumor metastasis.	[Liu, Guanghua; Feng, Shi; Jia, Lin; Wang, Chunying; Fu, Yan; Luo, Yongzhang] Tsinghua Univ, Natl Engn Lab Antitumor Prot Therapeut, Beijing, Peoples R China; [Liu, Guanghua; Feng, Shi; Jia, Lin; Wang, Chunying; Fu, Yan; Luo, Yongzhang] Tsinghua Univ, Beijing Key Lab Prot Therapeut, Beijing, Peoples R China; [Liu, Guanghua; Feng, Shi; Jia, Lin; Wang, Chunying; Fu, Yan; Luo, Yongzhang] Tsinghua Univ, Sch Life Sci, Canc Biol Lab, Beijing, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Luo, YZ (corresponding author), Tsinghua Univ, Natl Engn Lab Antitumor Prot Therapeut, Beijing, Peoples R China.; Luo, YZ (corresponding author), Tsinghua Univ, Beijing Key Lab Prot Therapeut, Beijing, Peoples R China.; Luo, YZ (corresponding author), Tsinghua Univ, Sch Life Sci, Canc Biol Lab, Beijing, Peoples R China.	yluo@mail.tsinghua.edu.cn			General Programs of the National Natural Science Foundation of China [81672865, 81472667, 81461148021, 81272529]; Major Scientific and Technological Special Project for "significant new drugs creation" [2013ZX09509103]	General Programs of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Scientific and Technological Special Project for "significant new drugs creation"	This work was supported in part by the General Programs of the National Natural Science Foundation of China (Nos. 81672865, 81472667, 81461148021, and 81272529) and the Major Scientific and Technological Special Project for "significant new drugs creation" (No. 2013ZX09509103).	AbuAli G, 2015, ONCOGENE, V34, P1718, DOI 10.1038/onc.2014.93; Aggarwal N, 2014, PROTEOM CLIN APPL, V8, P427, DOI 10.1002/prca.201300105; Atilla-Gokcumen GE, 2014, CELL, V156, P428, DOI 10.1016/j.cell.2013.12.015; Bansal S, 2014, J SURG RES, V186, P29, DOI 10.1016/j.jss.2013.07.001; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Chen Y, 2015, INT J CANCER, V136, P182, DOI 10.1002/ijc.28950; Du XN, 2012, CANCER RES, V72, P5843, DOI 10.1158/0008-5472.CAN-12-1329; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Harbeck N, 2001, CLIN CANCER RES, V7, P2757; Huang GM, 2015, CANCER LETT, V358, P180, DOI 10.1016/j.canlet.2014.12.036; Huang J, 2016, ONCOTARGET, V7, P39970, DOI 10.18632/oncotarget.9461; Huang YJ, 2009, CANCER RES, V69, P7529, DOI 10.1158/0008-5472.CAN-08-4382; Igal RA, 2016, BBA-MOL CELL BIOL L, V1861, P1865, DOI 10.1016/j.bbalip.2016.09.009; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Jedeszko C, 2004, BIOL CHEM, V385, P1017, DOI 10.1515/BC.2004.132; Jia L, 2017, J PATHOL, V243, P255, DOI 10.1002/path.4952; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Kim M, 2010, ANTIVIR THER, V15, P897, DOI 10.3851/IMP1646; Lewis CA, 2015, ONCOGENE, V34, P5128, DOI 10.1038/onc.2014.439; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu GH, 2015, J PATHOL, V237, P190, DOI 10.1002/path.4564; Luyimbazi D, 2010, MOL CANCER THER, V9, P2770, DOI 10.1158/1535-7163.MCT-09-0980; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Miranda F, 2016, CANCER CELL, V30, P273, DOI 10.1016/j.ccell.2016.06.020; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Nodomi S, 2016, ONCOGENE, V35, P5317, DOI 10.1038/onc.2016.72; Noto A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.444; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Qi FF, 2015, CLIN CANCER RES, V21, P3071, DOI 10.1158/1078-0432.CCR-14-2785; Qiang L, 2015, CELL REP, V11, P1797, DOI 10.1016/j.celrep.2015.05.025; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5; Roy D, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-13; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; von Roemeling CA, 2013, CLIN CANCER RES, V19, P2368, DOI 10.1158/1078-0432.CCR-12-3249; Wang H, 2015, DIABETES, V64, P2442, DOI 10.2337/db14-0528; Wang JQ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5692852; Wculek SK, 2015, NATURE, V528, P413, DOI 10.1038/nature16140; Wu JB, 2017, CANCER CELL, V31, P368, DOI 10.1016/j.ccell.2017.02.003; Zhang L, 2016, ONCOGENE, V35, P5641, DOI 10.1038/onc.2016.100	53	23	24	0	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	11					1519	1533		10.1038/s41388-017-0062-6	http://dx.doi.org/10.1038/s41388-017-0062-6			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ3AZ	29326439				2022-12-26	WOS:000427459500009
J	Schabort, DWP; Kilian, SG; du Preez, JC				Schabort, Du Toit W. P.; Kilian, Stephanus G.; du Preez, James C.			Gene regulation in Kluyveromyces marxianus in the context of chromosomes	PLOS ONE			English	Article							REPRESSOR; GROWTH; MIG1	Eukaryotes, including the unicellular eukaryotes such as yeasts, employ multiple levels of gene regulation. Regulation of chromatin structure through chromatin compaction cascades, and influenced by transcriptional insulators, might play a role in the coordinated regulation of genes situated at adjacent loci and expressed as a co-regulated cluster. Subtelomeric gene silencing, which has previously been described in the yeast Saccharomyces cerevisiae, is an example of this phenomenon. Transcription from a common regulatory element located around a shared intergenic region is another factor that could coordinate the transcription of genes at adjacent loci. Additionally, the presence of DNA binding sites for the same transcription factor may coordinate expression of multiple genes. Yeasts such as the industrially important Kluyveromyces marxianus may also display these modes of regulation, but this has not been explored to date. An exploration was done using a complete genome and RNA-seq data from a previous study of the transcriptional response to glucose or xylose as the carbon source in a defined culture medium, and investigating whether the species displays clusters of co-localised differentially expressed genes. Regions of possible subtelomeric silencing were evident, but were non-responsive to the carbon sources tested here. Additionally, glucose or xylose responsive clusters were discovered far from telomeres which contained some of the most significantly differentially expressed genes, encoding enzymes involved in the utilisation of alternative carbon sources such as the industrially important inulinase gene INU1. These clusters contained putative binding sites for the carbon source responsive transcription factors Mig1 and Adr1. Additionally, we investigated the potential contribution of common intergenic regions in co-regulation. Some observations were also made in terms of the evolutionary conservation of these clusters among yeast species and the presence of potential transcriptional insulators at the periphery of these clusters.	[Schabort, Du Toit W. P.; Kilian, Stephanus G.; du Preez, James C.] Univ Free State, Dept Microbial Biochem & Food Biotechnol, Bloemfontein, South Africa	University of the Free State	Schabort, DWP (corresponding author), Univ Free State, Dept Microbial Biochem & Food Biotechnol, Bloemfontein, South Africa.	dutoit.schabort@gmail.com			National Research Foundation of South Africa (ZA), CSPG - Thuthuka (PhD Track) [TTK20110831000026600, UID: 80657]	National Research Foundation of South Africa (ZA), CSPG - Thuthuka (PhD Track)	This work was supported by National Research Foundation of South Africa (ZA), CSPG - Thuthuka (PhD Track), http://www.nrf.ac.za/, Reference: TTK20110831000026600, UID: 80657, Awarded to: Mr. WPD Schabort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140829; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; CHENG C, 1994, MOL CELL BIOL, V14, P3842, DOI 10.1128/MCB.14.6.3842; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Cherry JM, 2011, NUCLEIC ACIDS RES, V1, P1; De Freitas JM, 2004, J BIOL CHEM, V279, P4450, DOI 10.1074/jbc.M212308200; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Fonseca GG, 2008, APPL MICROBIOL BIOT, V79, P339, DOI 10.1007/s00253-008-1458-6; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lane Melanie M., 2010, Fungal Biology Reviews, V24, P17, DOI 10.1016/j.fbr.2010.01.001; Lepoivre C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-914; Lertwattanasakul N, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0227-x; Lertwattanasakul N, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-20; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; NEHLIN JO, 1991, EMBO J, V10, P3373, DOI 10.1002/j.1460-2075.1991.tb04901.x; NEHLIN JO, 1990, EMBO J, V9, P2891, DOI 10.1002/j.1460-2075.1990.tb07479.x; Sasson O, 2003, NUCLEIC ACIDS RES, V31, P348, DOI 10.1093/nar/gkg096; Schabort DTWP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156242; Schabort DWP, 2017, THESIS; Smith JJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.110; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TREITEL MA, 1995, P NATL ACAD SCI USA, V92, P3132, DOI 10.1073/pnas.92.8.3132; Tu JL, 1996, MOL CELL BIOL, V16, P4199; van Bakel H, 2005, PHYSIOL GENOMICS, V22, P356, DOI 10.1152/physiolgenomics.00055.2005; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Yun CW, 2000, J BIOL CHEM, V275, P10709, DOI 10.1074/jbc.275.14.10709	31	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190913	10.1371/journal.pone.0190913	http://dx.doi.org/10.1371/journal.pone.0190913			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346402	Green Submitted, Green Published, gold			2022-12-26	WOS:000422749500020
J	Okumura, N; Matsumoto, D; Fukui, Y; Teramoto, M; Imai, H; Kurosawa, T; Shimada, T; Kruse, F; Schlotzer-Schrehardt, U; Kinoshita, S; Koizumi, N				Okumura, Naoki; Matsumoto, Daiki; Fukui, Yuya; Teramoto, Masataka; Imai, Hirofumi; Kurosawa, Tetta; Shimada, Tomoki; Kruse, Friedrich; Schloetzer-Schrehardt, Ursula; Kinoshita, Shigeru; Koizumi, Noriko			Feasibility of cell-based therapy combined with descemetorhexis for treating Fuchs endothelial corneal dystrophy in rabbit model	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; ROCK INHIBITOR; IN-VITRO; TRANSPLANTATION; KERATOPLASTY; MEMBRANE; SURVIVAL; ENABLES; SHEET	Corneal transparency is maintained by the corneal endothelium through its pump and barrier function. Severe corneal endothelial damage results in dysregulation of water flow and eventually causes corneal haziness and deterioration of visual function. In 2013, we initiated clinical research of cell-based therapy for treating corneal decompensation. In that study, we removed an 8-mm diameter section of damaged corneal endothelium without removing Descemet's membrane (the basement membrane of the corneal endothelium) and then injected cultured human corneal endothelial cells (CECs) into the anterior chamber. However, Descemet's membrane exhibits clinically abnormal structural features [i.e., multiple collagenous excrescences (guttae) and thickening] in patients with Fuchs endothelial corneal dystrophy (FECD) and the advanced cornea guttae adversely affects the quality of vision, even in patients without corneal edema. The turnover time of cornea guttae is also not certain. Therefore, we used a rabbit model to evaluate the feasibility of Descemet's membrane removal in the optical zone only, by performing a small 4-mm diameter descemetorhexis prior to CEC injection. We showed that the corneal endothelium is regenerated both on the corneal stroma (the area of Descemet's membrane removal) and on the intact peripheral Descemet's membrane, based on the expression of function-related markers and the restoration of corneal transparency. Recovery of the corneal transparency and central corneal thickness was delayed in areas of Descemet's membrane removal, but the cell density of the regenerated corneal endothelium and the thickness of the central corneal did not differ between the areas with and without residual Descemet's membrane at 14 days after CEC injection. Here, we demonstrate that removal of a pathological Descemet's membrane by a small descemetorhexis is a feasible procedure for use in combination with cell-based therapy. The current strategy might be beneficial for improving visual quality after CEC injection as a treatment for FECD.	[Okumura, Naoki; Matsumoto, Daiki; Fukui, Yuya; Teramoto, Masataka; Imai, Hirofumi; Kurosawa, Tetta; Shimada, Tomoki; Koizumi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan; [Kruse, Friedrich; Schloetzer-Schrehardt, Ursula] Univ Erlangen Nurnberg, Dept Ophthalmol, Erlangen, Germany; [Kinoshita, Shigeru] Kyoto Prefectural Univ Med, Dept Frontier Med Sci & Technol Ophthalmol, Kyoto, Japan	Doshisha University; University of Erlangen Nuremberg; Kyoto Prefectural University of Medicine	Koizumi, N (corresponding author), Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan.	nkoizumi@mail.doshisha.ac.jp			Program for the Strategic Research Foundation at Private Universities from MEXT	Program for the Strategic Research Foundation at Private Universities from MEXT	This study was supported by the Program for the Strategic Research Foundation at Private Universities from MEXT (Koizumi, N. and Okumura, N.) (http://www.mext.go.jp/a_menu/Koutou/shinkou/07021403/002/1218299.htm).	ADAMIS AP, 1993, SURV OPHTHALMOL, V38, P149, DOI 10.1016/0039-6257(93)90099-S; [Anonymous], EYE BANK STAT REP; Dapena I, 2009, CURR OPIN OPHTHALMOL, V20, P299, DOI 10.1097/ICU.0b013e32832b8d18; Delon I, 2007, CURR OPIN CELL BIOL, V19, P43, DOI 10.1016/j.ceb.2006.12.013; DiPersio CM, 2016, CELL TISSUE RES, V365, P467, DOI 10.1007/s00441-016-2446-2; Gain P, 2016, JAMA OPHTHALMOL, V134, P167, DOI 10.1001/jamaophthalmol.2015.4776; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Guell JL, 2014, OPHTHALMOL THER, V3, P1, DOI 10.1007/s40123-014-0022-y; HOGAN MJ, 1974, AM J OPHTHALMOL, V78, P363, DOI 10.1016/0002-9394(74)90224-4; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Liu SC, 2000, J CELL SCI, V113, P3563; Ljubimov AV, 2002, CORNEA, V21, P74, DOI 10.1097/00003226-200201000-00016; LORENZETTI DW, 1967, AM J OPHTHALMOL, V64, P1155, DOI 10.1016/0002-9394(67)93073-5; Melles GRJ, 2008, AM J OPHTHALMOL, V145, P222, DOI 10.1016/j.ajo.2007.09.021; Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174; Mimura T, 2003, EXP EYE RES, V76, P745, DOI 10.1016/S0014-4835(03)00057-5; Nijm L. M., 2011, CORNEA, V2, P1321; Nishida T., 2011, CORNEA, P3; OKUMURA N, 2017, J OPHTHALMOL, V2017, DOI DOI 10.1155/2017/2646904; Okumura N, 2016, SCI REP-UK, V6, DOI 10.1038/srep26113; Okumura N, 2015, LAB INVEST, V95, P1291, DOI 10.1038/labinvest.2015.111; Okumura N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15005; Okumura N, 2015, INVEST OPHTH VIS SCI, V56, P2933, DOI 10.1167/iovs.14-15163; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Patel SV, 2012, EXP EYE RES, V95, P40, DOI 10.1016/j.exer.2011.05.013; Price MO, 2010, CLIN EXP OPHTHALMOL, V38, P128, DOI 10.1111/j.1442-9071.2010.02213.x; Schlotzer-Schrehardt U, 2011, OPHTHALMOLOGY, V118, P1950, DOI 10.1016/j.ophtha.2011.03.025; Sumide T, 2006, FASEB J, V20, P392, DOI 10.1096/fj.04-3035fje; Tan DTH, 2012, LANCET, V379, P1749, DOI 10.1016/S0140-6736(12)60437-1; Wacker K, 2015, OPHTHALMOLOGY, V122, P1645, DOI 10.1016/j.ophtha.2015.05.005; Watanabe S, 2015, OPHTHALMOLOGY, V122, P2103, DOI 10.1016/j.ophtha.2015.06.019; Weller JM, 2014, INVEST OPHTH VIS SCI, V55, P3700, DOI 10.1167/iovs.14-14154	35	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191306	10.1371/journal.pone.0191306	http://dx.doi.org/10.1371/journal.pone.0191306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338061	Green Submitted, Green Published, gold			2022-12-26	WOS:000422652700048
J	Yang, X; Chung, JY; Rai, U; Esumi, N				Yang, Xue; Chung, Jin-Yong; Rai, Usha; Esumi, Noriko			Cadherins in the retinal pigment epithelium (RPE) revisited: P-cadherin is the highly dominant cadherin expressed in human and mouse RPE in vivo	PLOS ONE			English	Article							JUVENILE MACULAR DYSTROPHY; TRANSCRIPTION FACTOR MITF; CELL-ADHESION MOLECULES; MESENCHYMAL TRANSITION; BETA-CATENIN; OXIDATIVE STRESS; N-CADHERIN; PROLIFERATIVE VITREORETINOPATHY; BEST1 EXPRESSION; EYE DEVELOPMENT	The retinal pigment epithelium (RPE) supports the health and function of retinal photoreceptors and is essential for normal vision. RPE cells are post-mitotic, terminally differentiated, and polarized epithelial cells. In pathological conditions, however, they lose their epithelial integrity, become dysfunctional, even dedifferentiate, and ultimately die. The integrity of epithelial cells is maintained, in part, by adherens junctions, which are composed of cadherin homodimers and p120-, beta-, and alpha-catenins linking to actin filaments. While E-cadherin is the major cadherin for forming the epithelial phenotype in most epithelial cell types, it has been reported that cadherin expression in RPE cells is different from other epithelial cells based on results with cultured RPE cells. In this study, we revisited the expression of cadherins in the RPE to clarify their relative contribution by measuring the absolute quantity of cDNAs produced from mRNAs of three classical cadherins (E-, N-, and P-cadherins) in the RPE in vivo. We found that P-cadherin (CDH3) is highly dominant in both mouse and human RPE in situ. The degree of dominance of P-cadherin is surprisingly large, with mouse Cdh3 and human CDH3 accounting for 82-85% and 92-93% of the total of the three cadherin mRNAs, respectively. We confirmed the expression of P-cadherin protein at the cell-cell border of mouse RPE in situ by immunofluorescence. Furthermore, we found that oxidative stress induces dissociation of P-cadherin and beta-catenin from the cell membrane and subsequent translocation of 8-catenin into the nucleus, resulting in activation of the canonical Wnt-beta-catenin pathway. This is the first report of absolute comparison of the expression of three cadherins in the RPE, and the results suggest that the physiological role of P-cadherin in the RPE needs to be reevaluated.	[Yang, Xue; Chung, Jin-Yong; Rai, Usha; Esumi, Noriko] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Esumi, N (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.	nesumi1@jhmi.edu		Chung, Jin-Yong/0000-0001-8149-584X; Esumi, Noriko/0000-0001-7995-4023	BrightFocus Foundation [M2015220]; US National Institutes of Health [EY001765]; Wilmer Pooled Professor Research Fund; Research to Prevent Blindness, Inc.	BrightFocus Foundation(BrightFocus Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wilmer Pooled Professor Research Fund; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB))	This work was supported by grants from the BrightFocus Foundation (M2015220 to NE), US National Institutes of Health (Core grant EY001765 to Wilmer Eye Institute), Wilmer Pooled Professor Research Fund (NE), and unrestricted funds from Research to Prevent Blindness, Inc. (Wilmer Eye Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angst BD, 2001, J CELL SCI, V114, P629; Bailey TA, 2004, INVEST OPHTH VIS SCI, V45, P675, DOI 10.1167/iovs.03-0351; Bharti K, 2008, DEVELOPMENT, V135, P1169, DOI 10.1242/dev.014142; Blanco-Kelly F, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-016-0364-5; Burke JM, 2008, PROG RETIN EYE RES, V27, P579, DOI 10.1016/j.preteyeres.2008.08.002; Burke JM, 1999, INVEST OPHTH VIS SCI, V40, P2963; Burke JM, 2000, INVEST OPHTH VIS SCI, V41, P1945; CAMPOCHIARO PA, 1993, EXP EYE RES, V57, P539, DOI 10.1006/exer.1993.1158; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; Datta S, 2017, PROG RETIN EYE RES; Esumi N, 2007, J BIOL CHEM, V282, P1838, DOI 10.1074/jbc.M609517200; Esumi N, 2009, HUM MOL GENET, V18, P128, DOI 10.1093/hmg/ddn323; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Funato Y, 2010, CURR BIOL, V20, P1945, DOI 10.1016/j.cub.2010.09.065; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Greene WA, 2016, INVEST OPHTH VIS SCI, V57, P4428, DOI 10.1167/iovs.16-19192; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Ho TC, 2006, BIOCHEM BIOPH RES CO, V342, P372, DOI 10.1016/j.bbrc.2006.01.164; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Huang XG, 2012, BIOCHEM BIOPH RES CO, V419, P395, DOI 10.1016/j.bbrc.2012.02.033; Indelman M, 2002, J INVEST DERMATOL, V119, P1210, DOI 10.1046/j.1523-1747.2002.19528.x; Inumaru J, 2009, GENES CELLS, V14, P703, DOI 10.1111/j.1365-2443.2009.01303.x; Iwai-Takekoshi L, 2016, J COMP NEUROL, V524, P3696, DOI 10.1002/cne.24025; JONAS JB, 1992, GRAEF ARCH CLIN EXP, V230, P505, DOI 10.1007/BF00181769; Kaida M, 2000, INVEST OPHTH VIS SCI, V41, P3215; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kemler R, 2004, DEVELOPMENT, V131, P5817, DOI 10.1242/dev.01458; Kim JW, 2008, GENE DEV, V22, P3147, DOI 10.1101/gad.1700108; Kimura K, 2015, J MOL MED, V93, P749, DOI 10.1007/s00109-015-1289-8; Kjaer KW, 2005, J MED GENET, V42, P292, DOI 10.1136/jmg.2004.027821; Kutty RK, 2016, MOL VIS, V22, P1156; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Maruotti J, 2012, PIGM CELL MELANOMA R, V25, P641, DOI 10.1111/j.1755-148X.2012.01033.x; Masuda T, 2010, J BIOL CHEM, V285, P26933, DOI 10.1074/jbc.M110.130294; McCrea PD, 2015, CURR TOP DEV BIOL, V112, P129, DOI 10.1016/bs.ctdb.2014.11.018; McKay BS, 1997, EXP EYE RES, V65, P661, DOI 10.1006/exer.1997.0374; MCLEOD DS, 1994, INVEST OPHTH VIS SCI, V35, P3799; Mesa KR, 2015, NATURE, V522, P94, DOI 10.1038/nature14306; Mettu PS, 2012, MOL ASPECTS MED, V33, P376, DOI 10.1016/j.mam.2012.04.006; Miura Y, 2009, GRAEF ARCH CLIN EXP, V247, P641, DOI 10.1007/s00417-009-1041-6; Narimatsu T, 2013, INVEST OPHTH VIS SCI, V54, P4555, DOI 10.1167/iovs.12-11572; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Radice GL, 1997, J CELL BIOL, V139, P1025, DOI 10.1083/jcb.139.4.1025; Radice GL, 2013, PROG MOL BIOL TRANSL, V116, P263, DOI 10.1016/B978-0-12-394311-8.00012-1; Ribeiro AS, 2013, J PATHOL, V229, P705, DOI 10.1002/path.4143; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Shimomura Y, 2008, DEVELOPMENT, V135, P743, DOI 10.1242/dev.006718; Singh MS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23674; Sprecher E, 2001, NAT GENET, V29, P134, DOI 10.1038/ng716; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; Tamiya S, 2016, EXP EYE RES, V142, P26, DOI 10.1016/j.exer.2015.02.008; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Theocharidis G, 2016, J INVEST DERMATOL, V136, P74, DOI 10.1038/JID.2015.352; Tinkle CL, 2008, P NATL ACAD SCI USA, V105, P15405, DOI 10.1073/pnas.0807374105; van Roy F, 2014, NAT REV CANCER, V14, P121, DOI 10.1038/nrc3647; Vieira AF, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0448-4; Wang CXZ, 2012, EXP EYE RES, V102, P1, DOI 10.1016/j.exer.2012.06.003; Wei H, 2016, EXP EYE RES, V145, P450, DOI 10.1016/j.exer.2015.09.015; Xu L, 2002, EXP EYE RES, V74, P753, DOI 10.1006/exer.2002.1175; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Youn YH, 2006, INVEST OPHTH VIS SCI, V47, P2675, DOI 10.1167/iovs.05-1335; Zhang L, 2013, MOL VIS, V19, P1371; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhou T, 2011, DIABETOLOGIA, V54, P459, DOI 10.1007/s00125-010-1943-1	73	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191279	10.1371/journal.pone.0191279	http://dx.doi.org/10.1371/journal.pone.0191279			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338041	Green Published, Green Submitted, gold			2022-12-26	WOS:000422652700044
J	Jeong, BY; Lee, HY; Park, CG; Kang, J; Yu, SL; Choi, DR; Han, SY; Park, MH; Cho, S; Lee, SY; Hwang, WM; Yun, SR; Ryu, HM; Oh, EJ; Park, SH; Kim, YL; Yoon, SH				Jeong, Bo Young; Lee, Hoi Young; Park, Chang Gyo; Kang, Jaeku; Yu, Seong-Lan; Choi, Du-ri; Han, Seung-Yun; Park, Moon Hyang; Cho, Sungkwon; Lee, Soo Young; Hwang, Won-Min; Yun, Sung-Ro; Ryu, Hye-Myung; Oh, Eun-Joo; Park, Sun-Hee; Kim, Yong-Lim; Yoon, Se-Hee			Oxidative stress caused by activation of NADPH oxidase 4 promotes contrast-induced acute kidney injury	PLOS ONE			English	Article							INDUCED NEPHROPATHY; SIGNALING PATHWAYS; CELL-DEATH; DIFFERENTIAL ACTIVATION; INDUCED APOPTOSIS; RENAL-FUNCTION; IN-VIVO; NOX4; MEDIA; INHIBITION	Contrast-induced acute kidney injury (CIAKI) is a leading cause of acute kidney injury following radiographic procedures. Intrarenal oxidative stress plays a critical role in CIAKI. Nicotinamide adenine dinucleotide 3-phosphate (NADPH) oxidases (Noxs) are important sources of reactive oxygen species (ROS). Among the various types of Noxs, Nox4 is expressed predominantly in the kidney in rodents. Here, we evaluated the role of Nox4 and benefit of Nox4 inhibition on CIAKI using in vivo and in vitro models. HK-2 cells were treated with iohexol, with or without Nox4 knockdown, or the most specific Nox1/4 inhibitor (GKT137831). Effects of Nox4 inhibition on CIAKI mice were examined. Expression of Nox4 in HK-2 cells was significantly increased following iohexol exposure. Silencing of Nox4 rescued the production of ROS, downregulated pro-inflammatory markers (particularly phospho-p38) implicated in CIAKI, and reduced Bax and caspase 3/7 activity, which resulted in increased cellular survival in iohexol-treated HK-2 cells. Pretreatment with GKT137831 replicated these effects by decreasing levels of phospho-p38. In a CIAKI mouse model, even though the improvement of plasma blood urea nitrogen was unclear, pretreatment with GKT137831 resulted in preserved structure, reduced expression of 8-hydroxy-2'-deoxyguanosine (8OHdG) and kidney injury molecule-1 (KIM-1), and reduced number of TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling)-positive cells. These results suggest Nox4 as a key source of reactive oxygen species responsible for CIAKI and provide a novel potential option for prevention of CIAKI.	[Jeong, Bo Young; Lee, Hoi Young; Park, Chang Gyo; Kang, Jaeku] Konyang Univ, Coll Med, Dept Pharmacol, Daejeon, South Korea; [Yu, Seong-Lan; Lee, Soo Young] Konyang Univ, Coll Med, Myunggok Med Res Inst, Daejeon, South Korea; [Choi, Du-ri; Han, Seung-Yun] Konyang Univ, Coll Med, Dept Anat, Daejeon, South Korea; [Park, Moon Hyang] Konyang Univ, Coll Med, Dept Pathol, Daejeon, South Korea; [Cho, Sungkwon; Hwang, Won-Min; Yun, Sung-Ro; Yoon, Se-Hee] Konyang Univ, Coll Med, Myunggok Med Res Inst, Div Nephrol, Daejeon, South Korea; [Cho, Sungkwon; Hwang, Won-Min; Yun, Sung-Ro; Yoon, Se-Hee] Konyang Univ, Coll Med, Myunggok Med Res Inst, Dept Internal Med, Daejeon, South Korea; [Ryu, Hye-Myung; Oh, Eun-Joo; Park, Sun-Hee; Kim, Yong-Lim] Kyungpook Natl Univ Hosp, Div Nephrol, Daegu, South Korea; [Ryu, Hye-Myung; Oh, Eun-Joo; Park, Sun-Hee; Kim, Yong-Lim] Kyungpook Natl Univ Hosp, Dept Internal Med, Daegu, South Korea	Konyang University; Konyang University Hospital; Konyang University; Konyang University Hospital; Konyang University; Konyang University Hospital; Konyang University; Konyang University Hospital; Konyang University; Konyang University Hospital; Konyang University; Konyang University Hospital; Kyungpook National University; Kyungpook National University Hospital; Kyungpook National University; Kyungpook National University Hospital	Yoon, SH (corresponding author), Konyang Univ, Coll Med, Myunggok Med Res Inst, Div Nephrol, Daejeon, South Korea.; Yoon, SH (corresponding author), Konyang Univ, Coll Med, Myunggok Med Res Inst, Dept Internal Med, Daejeon, South Korea.	sehei@hanmail.net	Kang, Jaeku/D-4933-2011; Park, Sun/GSD-9620-2022	Kang, Jaeku/0000-0002-8660-7940; 	Konyang University Myunggok Research Fund of 20 [2014-5]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016914796]; NRF-Fostering Core Leaders of the Future Basic Science Program/Global Ph.D. Fellowship Program	Konyang University Myunggok Research Fund of 20; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; NRF-Fostering Core Leaders of the Future Basic Science Program/Global Ph.D. Fellowship Program	This research was supported by the Konyang University Myunggok Research Fund of 20 (No 2014-5) to SHY and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No 2016914796) to SHY, NRF-2016-Fostering Core Leaders of the Future Basic Science Program/Global Ph.D. Fellowship Program to BYJ.	Ahmad A, 2012, EUR J PHARMACOL, V674, P397, DOI 10.1016/j.ejphar.2011.10.041; Al Ghouleh I, 2011, FREE RADICAL BIO MED, V51, P1271, DOI 10.1016/j.freeradbiomed.2011.06.011; Andreucci M, 2014, J CELL BIOCHEM, V115, P281, DOI 10.1002/jcb.24662; Andreucci M, 2011, TOXICOL SCI, V119, P408, DOI 10.1093/toxsci/kfq332; Aspelin P, 2003, NEW ENGL J MED, V348, P491, DOI 10.1056/NEJMoa021833; Barrett BJ, 2006, NEW ENGL J MED, V354, P379, DOI 10.1056/NEJMcp050801; Berwanger O, 2011, CIRCULATION, V124, P1250, DOI 10.1161/CIRCULATIONAHA.111.038943; Brandes RP, 2011, ARTERIOSCL THROM VAS, V31, P1255, DOI 10.1161/ATVBAHA.111.226894; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chen F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00412; Erley CM, 1997, J AM SOC NEPHROL, V8, P1125; Goldenberg I, 2005, CAN MED ASSOC J, V172, P1461, DOI 10.1503/cmaj.1040847; Gong XZ, 2010, AM J NEPHROL, V31, P178, DOI 10.1159/000268161; Gorin Y, 2015, MOL CELLS, V38, P285, DOI 10.14348/molcells.2015.0010; Gorin Y, 2013, KIDNEY INT, V83, P541, DOI 10.1038/ki.2012.434; Green DE, 2012, AM J RESP CELL MOL, V47, P718, DOI 10.1165/rcmb.2011-0418OC; Gruberg L, 2000, J AM COLL CARDIOL, V36, P1542, DOI 10.1016/S0735-1097(00)00917-7; He XY, 2017, MOL MED REP, V15, P1963, DOI 10.3892/mmr.2017.6251; Heyman SN, 2010, INVEST RADIOL, V45, P188, DOI 10.1097/RLI.0b013e3181d2eed8; Jha JC, 2014, J AM SOC NEPHROL, V25, P1237, DOI 10.1681/ASN.2013070810; Jiao ZQ, 2015, RENAL FAILURE, V37, P1349, DOI 10.3109/0886022X.2015.1068031; Johnson DK, 2002, ENDOTHELIUM-J ENDOTH, V9, P191, DOI 10.1080/10623320213638; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim JA, 2011, EXPERT OPIN THER PAT, V21, P1147, DOI 10.1517/13543776.2011.584870; Kim YM, 2017, AM J PHYSIOL-CELL PH, V312, pC749, DOI 10.1152/ajpcell.00346.2016; Kongkham S, 2013, NEFROLOGIA, V33, P116, DOI 10.3265/Nefrologia.pre2012.Nov.11736; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee HC, 2010, AM J NEPHROL, V31, P125, DOI 10.1159/000259899; Lee HT, 2006, AM J PHYSIOL-RENAL, V290, pF1367, DOI 10.1152/ajprenal.00347.2005; Liu TQ, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/427560; MANSKE CL, 1990, AM J MED, V89, P615, DOI 10.1016/0002-9343(90)90180-L; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Netti GS, 2014, FREE RADICAL BIO MED, V68, P35, DOI 10.1016/j.freeradbiomed.2013.11.016; Nlandu-Khodo S, 2016, SCI REP-UK, V6, DOI 10.1038/srep38598; Pannu N, 2006, JAMA-J AM MED ASSOC, V295, P2765, DOI 10.1001/jama.295.23.2765; Pisani A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/868321; Quintavalle C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.38; Rollins K, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0498-5; Romano G, 2008, EUR HEART J, V29, P2569, DOI 10.1093/eurheartj/ehn197; Sedeek M, 2013, J AM SOC NEPHROL, V24, P1512, DOI 10.1681/ASN.2012111112; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Stacul F, 2006, AM J CARDIOL, V98, p59K, DOI 10.1016/j.amjcard.2006.01.024; STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341; Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304; Wong GTC, 2007, BRIT J ANAESTH, V99, P474, DOI 10.1093/bja/aem237; Yan F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.551; YOSHIOKA T, 1992, KIDNEY INT, V41, P1008, DOI 10.1038/ki.1992.153	47	34	35	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191034	10.1371/journal.pone.0191034	http://dx.doi.org/10.1371/journal.pone.0191034			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329317	Green Submitted, Green Published, gold			2022-12-26	WOS:000419954100033
J	Lee, JW; Heo, W; Lee, J; Jin, N; Yoon, SM; Park, KY; Kim, EY; Kim, WT; Kim, JY				Lee, Jin Won; Heo, Woon; Lee, Jinu; Jin, Narae; Yoon, Sei Mee; Park, Ki Youl; Kim, Eun Yu; Kim, Woo Taek; Kim, Joo Young			The B cell death function of obinutuzumab-HDEL produced in plant (Nicotiana benthamiana L.) is equivalent to obinutuzumab produced in CHO cells	PLOS ONE			English	Article							RETICULUM-RETENTION SIGNAL; MONOCLONAL-ANTIBODY; EBOLA-VIRUS; N-GLYCANS; GLYCOSYLATION; EXPRESSION; GA101; LOCALIZATION; PROTEINS; THERAPY	Plants have attracted attention as bio-drug production platforms because of their economical and safety benefits. The preliminary efficacy of ZMapp, a cocktail of antibodies produced in N. benthamiana (Nicotiana benthamiana L.), suggested plants may serve as a platform for antibody production. However, because the amino acid sequences of the Fab fragment are diverse and differences in post-transcriptional processes between animals and plants remain to be elucidated, it is necessary to confirm functional equivalence of plant-produced antibodies to the original antibody. In this study, Obinutuzumab, a third generation anti-CD-20 antibody, was produced in N. benthamiana leaves (plant-obinutuzumab) and compared to the original antibody produced in glyco-engineered Chinese hamster ovary (CHO) cells (CHO-obinutuzumab). Two forms (with or without an HDEL tag) were generated and antibody yields were compared. The HDEL-tagged form was more highly expressed than the non-HDEL-tagged form which was cleaved in the N-terminus. To determine the equivalence in functions of the Fab region between the two forms, we compared the CD20 binding affinities and direct binding induced cell death of a CD20-positive B cells. Both forms showed similar CD20 binding affinities and direct cell death of B cell. The results suggested that plant-obinutuzumab was equivalent to CHO-obinutuzumab in CD20 binding, cell aggregation, and direct cell death via binding. Therefore, our findings suggest that Obinutuzumab is a promising biosimilar candidate that can be produced efficiently in plants.	[Lee, Jin Won; Park, Ki Youl; Kim, Eun Yu; Kim, Woo Taek] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Syst Biol, Seoul, South Korea; [Heo, Woon; Jin, Narae; Kim, Joo Young] Yonsei Univ, Coll Med, Dept Pharmacol, Seoul, South Korea; [Heo, Woon; Jin, Narae; Kim, Joo Young] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea; [Lee, Jinu; Yoon, Sei Mee] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Incheon, South Korea; [Yoon, Sei Mee] Yonsei Univ, Dept Integrated OMICS Biomed Sci, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University	Kim, WT (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Syst Biol, Seoul, South Korea.; Kim, JY (corresponding author), Yonsei Univ, Coll Med, Dept Pharmacol, Seoul, South Korea.; Kim, JY (corresponding author), Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea.	wtkim@yonsei.ac.kr; jooyoungkim@yuhs.ac	Kim, Joo Young/X-7562-2019	Kim, Joo Young/0000-0003-2623-1491; Kim, Eunyu/0000-0002-6506-9725; Heo, Woon/0000-0001-5435-2595	National Research Foundation of Korea [NRF-2013M3A9A9050574, NFR-2017R1A2134010319]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by grants from the National Research Foundation of Korea, Project Nos. NRF-2013M3A9A9050574 to W.T.K. and NFR-2017R1A2134010319 to J.Y.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Research Foundation of Korea, Project Nos. NRF-2013M3A9A9050574 to W.T.K. and NFR-2017R1A2B4010319 to J.Y.K.	Alduaij W, 2011, BLOOD, V117, P4519, DOI 10.1182/blood-2010-07-296913; Cartron G, 2014, BLOOD, V124, P2196, DOI 10.1182/blood-2014-07-586610; Conrad U, 1998, PLANT MOL BIOL, V38, P101, DOI 10.1023/A:1006029617949; Cragg MS, 2011, BLOOD, V118, P219, DOI 10.1182/blood-2011-04-346700; Delannoy M, 2008, PROTEOMICS, V8, P2285, DOI 10.1002/pmic.200700507; Dicker M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00018; Ferrara C, 2006, J BIOL CHEM, V281, P5032, DOI 10.1074/jbc.M510171200; Ferrara C, 2006, BIOTECHNOL BIOENG, V93, P851, DOI 10.1002/bit.20777; Frenzel A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00217; Gomord V, 2004, CURR OPIN PLANT BIOL, V7, P171, DOI 10.1016/j.pbi.2004.01.015; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Hehle VK, 2015, PLANT BIOTECHNOL J, V13, P235, DOI 10.1111/pbi.12266; Herter S, 2013, MOL CANCER THER, V12, P2031, DOI 10.1158/1535-7163.MCT-12-1182; Huang Z, 2010, BIOTECHNOL BIOENG, V106, P9, DOI 10.1002/bit.22652; Jak M, 2011, BLOOD, V118, P5178, DOI 10.1182/blood-2011-01-331702; Ko KS, 2003, P NATL ACAD SCI USA, V100, P8013, DOI 10.1073/pnas.0832472100; Lee JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068772; Li J, 2016, PLANT BIOTECHNOL J, V14, P533, DOI 10.1111/pbi.12403; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Mossner E, 2010, BLOOD, V115, P4393, DOI 10.1182/blood-2009-06-225979; Murin CD, 2014, P NATL ACAD SCI USA, V111, P17182, DOI 10.1073/pnas.1414164111; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Park KY, 2016, PROTEIN EXPRES PURIF, V119, P69, DOI 10.1016/j.pep.2015.11.014; Rogers LM, 2014, IMMUNOL RES, V59, P203, DOI 10.1007/s12026-014-8542-z; Sainsbury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013976; Seo DH, 2016, PLANT CELL, V28, P2952, DOI 10.1105/tpc.16.00347; Seo YS, 2012, PLANT CELL REP, V31, P1659, DOI 10.1007/s00299-012-1278-0; Shaaltiel Y, 2016, NAT BIOTECHNOL, V34, P706, DOI 10.1038/nbt.3556; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2013, BIOENGINEERED, V4, P191, DOI 10.4161/bioe.22857; Triguero A, 2005, PLANT BIOTECHNOL J, V3, P449, DOI 10.1111/j.1467-7652.2005.00137.x; Triguero A, 2011, PLANT BIOTECHNOL J, V9, P1120, DOI 10.1111/j.1467-7652.2011.00638.x; Ullrich KK, 2015, CURR OPIN BIOTECH, V32, P61, DOI 10.1016/j.copbio.2014.11.011; Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191075	10.1371/journal.pone.0191075	http://dx.doi.org/10.1371/journal.pone.0191075			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324849	gold, Green Published			2022-12-26	WOS:000419952400105
J	Someya, Y; Tamura, Y; Kohmura, Y; Aoki, K; Kawai, S; Daida, H				Someya, Yuki; Tamura, Yoshifumi; Kohmura, Yoshimitsu; Aoki, Kazuhiro; Kawai, Sachio; Daida, Hiroyuki			Slightly increased BMI at young age is a risk factor for future hypertension in Japanese men	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC-DISORDERS; INCIDENT HYPERTENSION; WEIGHT CHANGE; OBESITY; OVERWEIGHT; HEALTH; ADULTS; TAIWANESE; FITNESS	Background Hypertension is developed easily in Asian adults with normal body mass index (BMI) (similar to 23 kg/m(2)), compared with other ethnicities with similar BMI. This study tested the hypothesis that slightly increased BMI at young age is a risk factor for future hypertension in Japanese men by historical cohort study. Methods The study participants were 636 male alumni of the physical education school. They had available data on their physical examination at college age and follow-up investigation between 2007 and 2011. The participants were categorized into six categories: BMI at college age of < 20.0 kg/m(2), 20.0 +/- 21.0kg/m(2), 21.0 +/- 22.0kg/m(2), 22.0 +/- 23.0kg/m(2), 23.0 +/- 24.0kg/ m(2), and >= 24.0kg/m(2), and the incidence of hypertension was compared. Results This study covered 27-year follow-up period (interquartile range: IQR: 23 +/- 31) which included 17,059 person-years of observation. Subjects were 22 (22 +/- 22) years old at graduated college, and 49 (45 +/- 53) years old at first follow-up investigation. During the period, 120 men developed hypertension. The prevalence rates of hypertension for lowest to highest BMI categories were 9.4%, 14.6%, 16.1%, 17.5%, 30.3%, and 29.3%, respectively (p< 0.001 for trend), and their hazard ratios were 1.00 (reference), 1.80 (95% CI: 0.65 +/- 4.94), 2.17 (0.83 +/- 5.64), 2.29 (0.89 +/- 5.92), 3.60 (1.37 +/- 9.47) and 4.72 (1.78 +/- 12.48), respectively (p< 0.001 for trend). This trend was similar after adjustment for age, year of graduation, smoking, current exercise status and current dietary intake Conclusion Slightly increased BMI at young age is a risk factor for future hypertension in Japanese men.	[Someya, Yuki; Tamura, Yoshifumi] Juntendo Univ, Sportol Ctr, Grad Sch Med, Tokyo, Japan; [Someya, Yuki; Tamura, Yoshifumi] Juntendo Univ, Dept Metab & Endocrinol, Grad Sch Med, Tokyo, Japan; [Someya, Yuki; Kohmura, Yoshimitsu; Aoki, Kazuhiro] Juntendo Univ, Fac Hlth & Sports Sci, Chiba, Japan; [Kawai, Sachio] Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan; [Daida, Hiroyuki] Juntendo Univ, Dept Cardiol, Grad Sch Med, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Juntendo University; Juntendo University	Someya, Y (corresponding author), Juntendo Univ, Sportol Ctr, Grad Sch Med, Tokyo, Japan.; Someya, Y (corresponding author), Juntendo Univ, Dept Metab & Endocrinol, Grad Sch Med, Tokyo, Japan.; Someya, Y (corresponding author), Juntendo Univ, Fac Hlth & Sports Sci, Chiba, Japan.	yksomeya@juntendo.ac.jp	Tamura, Yoshifumi/AFK-2430-2022	Tamura, Yoshifumi/0000-0002-1685-7821; Someya, Yuki/0000-0003-1657-3199	High Technology Research Center Grant; Ministry of Education, Culture, Sports, Science and Technology of Japan [17K13229]	High Technology Research Center Grant; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by High Technology Research Center Grant and KAKENHI (Grants-in-Aid for Young Scientists (B)) (17K13229) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; [Anonymous], 2017, J PHYS FIT SPORTS ME, DOI DOI 10.7600/JPFSM.6.167; BARRETTCONNOR EL, 1985, ANN INTERN MED, V103, P1010, DOI 10.7326/0003-4819-103-6-1010; Boffetta P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019930; Chandra A, 2014, J AM COLL CARDIOL, V64, P997, DOI 10.1016/j.jacc.2014.05.057; Chang CJ, 2003, INT J OBESITY, V27, P253, DOI 10.1038/sj.ijo.802197; Crump C, 2016, JAMA INTERN MED, V176, P210, DOI 10.1001/jamainternmed.2015.7444; Gallagher D, 2004, OBES RES, V12, P440, DOI 10.1038/oby.2004.48; Gelber RP, 2007, AM J HYPERTENS, V20, P370, DOI 10.1016/j.amjhyper.2006.10.011; Hayashi T, 1999, ANN INTERN MED, V131, P21, DOI 10.7326/0003-4819-131-1-199907060-00005; Heianza Y, 2014, HYPERTENSION, V64, P247, DOI 10.1161/HYPERTENSIONAHA.113.02918; Hirose H, 2003, HYPERTENS RES, V26, P795, DOI 10.1291/hypres.26.795; Hsu WC, 2015, DIABETES CARE, V38, P150, DOI 10.2337/dc14-2391; Hu G, 2004, HYPERTENSION, V43, P25, DOI 10.1161/01.HYP.0000107400.72456.19; Huang ZP, 1998, ANN INTERN MED, V128, P81, DOI 10.7326/0003-4819-128-2-199801150-00001; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P56, DOI 10.1016/S0929-6646(09)60109-1; Ishikawa-Takata K, 2002, EUR J CLIN NUTR, V56, P601, DOI 10.1038/sj.ejcn.1601364; Ito H, 2003, INT J OBESITY, V27, P232, DOI 10.1038/sj.ijo.802226; Kim Y, 2004, OBES RES, V12, P445, DOI 10.1038/oby.2004.50; Lee JSW, 2011, J NUTR HEALTH AGING, V15, P857, DOI 10.1007/s12603-011-0134-1; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; PAFFENBARGER RS, 1973, AM J EPIDEMIOL, V97, P314, DOI 10.1093/oxfordjournals.aje.a121511; Pan WH, 2004, AM J CLIN NUTR, V79, P31; Sakuta Hidenari, 2008, Environmental Health and Preventive Medicine, V13, P116, DOI 10.1007/s12199-007-0010-0; Shihab HM, 2012, CIRCULATION, V126, P2983, DOI 10.1161/CIRCULATIONAHA.112.117333; Someya Y, 2010, J HLTH SPORTS SCI JU, V1, P421; Someya Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-493; Takeno K, 2016, J CLIN ENDOCR METAB, V101, P3676, DOI 10.1210/jc.2016-1650; Talavera-Garcia E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153096; Tirosh A, 2010, HYPERTENSION, V56, P203, DOI 10.1161/HYPERTENSIONAHA.109.146415; Wu CL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095300, 10.1371/journal.pone.0102589]	31	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191170	10.1371/journal.pone.0191170	http://dx.doi.org/10.1371/journal.pone.0191170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324821	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400127
J	Zimbelman, EG; Keefe, RF				Zimbelman, Eloise G.; Keefe, Robert F.			Real-time positioning in logging: Effects of forest stand characteristics, topography, and line-of-sight obstructions on GNSS-RF transponder accuracy and radio signal propagation	PLOS ONE			English	Article							SYSTEMS GPS RECEIVER; WAVE-PROPAGATION; COLLAR PERFORMANCE; MIXED PATHS; ATTENUATION; VEGETATION; HAZARDS; TERRAIN; CANOPY; RANGE	Real-time positioning on mobile devices using global navigation satellite system (GNSS) technology paired with radio frequency (RF) transmission (GNSS-RF) may help to improve safety on logging operations by increasing situational awareness. However, GNSS positional accuracy for ground workers in motion may be reduced by multipath error, satellite signal obstruction, or other factors. Radio propagation of GNSS locations may also be impacted due to line-of-sight (LOS) obstruction in remote, forested areas. The objective of this study was to characterize the effects of forest stand characteristics, topography, and other LOS obstructions on the GNSS accuracy and radio signal propagation quality of multiple Raveon Atlas PT GNSS-RF transponders functioning as a network in a range of forest conditions. Because most previous research with GNSS in forestry has focused on stationary units, we chose to analyze units in motion by evaluating the time-to-signal accuracy of geofence crossings in 21 randomly-selected stands on the University of Idaho Experimental Forest. Specifically, we studied the effects of forest stand characteristics, topography, and LOS obstructions on (1) the odds of missed GNSS-RF signals, (2) the root mean squared error (RMSE) of Atlas PTs, and (3) the time-to-signal accuracy of safety geofence crossings in forested environments. Mixed-effects models used to analyze the data showed that stand characteristics, topography, and obstructions in the LOS affected the odds of missed radio signals while stand variables alone affected RMSE. Both stand characteristics and topography affected the accuracy of geofence alerts.	[Zimbelman, Eloise G.; Keefe, Robert F.] Univ Idaho, Dept Forest Rangeland & Fire Sci, Moscow, ID 83843 USA	Idaho; University of Idaho	Zimbelman, EG (corresponding author), Univ Idaho, Dept Forest Rangeland & Fire Sci, Moscow, ID 83843 USA.	eloisez@uidaho.edu		Zimbelman, Eloise/0000-0001-6859-400X	U.S. Centers for Disease Control and Prevention (CDC) National Institute for Occupational Safety and Health (NIOSH) at the University of Idaho [5 U01 OH010841]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U01OH010841] Funding Source: NIH RePORTER	U.S. Centers for Disease Control and Prevention (CDC) National Institute for Occupational Safety and Health (NIOSH) at the University of Idaho; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This work was funded by the U.S. Centers for Disease Control and Prevention (CDC) National Institute for Occupational Safety and Health (NIOSH) (https://www.cdc.gov/niosh/index.htm) grant number 5 U01 OH010841 at the University of Idaho (RFK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nuaimi MO, 1998, IEE P-MICROW ANTEN P, V145, P201, DOI 10.1049/ip-map:19981883; Andersen HE, 2009, WEST J APPL FOR, V24, P128, DOI 10.1093/wjaf/24.3.128; [Anonymous], NAT MAP DOWNL; [Anonymous], 2014, ARR 100 SUBF GNSS; [Anonymous], NIST INT TIM SERV; [Anonymous], RAV SUPP; [Anonymous], GNSS PLANN ONL; Azevedo JAR, 2011, IEEE T ANTENN PROPAG, V59, P2357, DOI 10.1109/TAP.2011.2143664; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Becker RM, 2017, FORESTS, V8, DOI 10.3390/f8020044; Bettinger P, 2010, MATH COMPUT FOR NAT-, V2, P153; Bilodeau J, 1993, P GIS 93 S FEBR VANC, P196; Bolstad P, 2005, NORTH J APPL FOR, V22, P5, DOI 10.1093/njaf/22.1.5; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; D'Eon RG, 2002, WILDLIFE SOC B, V30, P430; Danskin S, 2009, FOREST SCI, V55, P109; Danskin SD, 2009, SOUTH J APPL FOR, V33, P9, DOI 10.1093/sjaf/33.1.9; Deckert C, 1996, PHOTOGRAMM ENG REM S, V62, P317; Devlin G. J., 2009, International Journal of Forest Engineering, V20, P45; Evans D. L., 1992, Southern Journal of Applied Forestry, V16, P67; Freeland RS, 2014, APPL ENG AGRIC, V30, P97; Gallo R, 2013, J AGRIC ENG, V44, P140, DOI 10.4081/jae.2013.s2.e27; Grayson LM, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16060912; Holden N. M., 2001, International Journal of Forest Engineering, V12, P51; Johnson CE, 2004, FRONT ECOL ENVIRON, V2, P475, DOI 10.2307/3868336; Johnson T, 2017, TRTOOLS MISCELLANEOU; Kaartinen H, 2015, FORESTS, V6, P3218, DOI 10.3390/f6093218; Karsky D, 2004, 047132307MTDC; Keefe RF, 2014, P 47 INT S FOR MECH; Kos T, 2010, P ELMAR 2010 S 2010; KURNER T, 1993, IEEE J SEL AREA COMM, V11, P1002, DOI 10.1109/49.233213; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Li XX, 2015, SCI REP-UK, V5, DOI 10.1038/srep08328; LIU CJ, 1995, CAN J FOREST RES, V25, P1795, DOI 10.1139/x95-194; Liu JB, 2017, IEEE T GEOSCI REMOTE, V55, P4855, DOI [10.1109/tgrs.2017.2650944, 10.1109/TGRS.2017.2650944]; Liu JB, 2016, INT J APPL EARTH OBS, V50, P74, DOI 10.1016/j.jag.2016.03.007; LOW K, 1988, IEEE T VEH TECHNOL, V37, P121, DOI 10.1109/25.16537; Lutes DC, 2006, RMRSGTR164CD US DEP; Mazerolle MJ, 2016, AICCMODAVG MODEL SEL; McDonald TP, 2005, COMPUT ELECTRON AGR, V48, P19, DOI 10.1016/j.compag.2005.01.004; McDonald TP, 2002, CAN J FOREST RES, V32, P310, DOI 10.1139/X01-189; Meng Y. S., 2009, Progress In Electromagnetics Research B, V17, P117, DOI 10.2528/PIERB09071901; Meng YS, 2009, IEEE T VEH TECHNOL, V58, P4023, DOI 10.1109/TVT.2009.2021480; Naesset E, 2000, PHOTOGRAMM ENG REM S, V66, P403; NASA, 2012, GLOB POS SYST HIST; Piedallu C, 2005, PHOTOGRAMM ENG REM S, V71, P1071, DOI 10.14358/PERS.71.9.1071; R Core Team, 2021, R LANGUAGE ENV STAT; Savage N, 2003, RADIO SCI, V38, DOI 10.1029/2002RS002758; SEKER SS, 1989, IEE PROC-H, V136, P13, DOI 10.1049/ip-h-2.1989.0002; Sigrist P, 1999, INT J REMOTE SENS, V20, P3595, DOI 10.1080/014311699211228; Sygnatur E.F, 1998, COMPENSATION WORKING, P3; TAMIR T, 1977, IEEE T ANTENN PROPAG, V25, P471, DOI 10.1109/TAP.1977.1141620; TEWARI RK, 1990, IEEE T ANTENN PROPAG, V38, P433, DOI 10.1109/8.52261; U. S. Bureau of Labor Statistics, 2016, CURR POP SURV CENS F; Veal MW, 2001, T ASAE, V44, P1903; Wempe AM, 2017, FORESTS, V8, DOI 10.3390/f8100357; WILKIE DS, 1989, PHOTOGRAMM ENG REM S, V55, P1747; Wing M. G., 2011, Research Journal of Forestry, V5, P78, DOI 10.3923/rjf.2011.78.88; Wing MG, 2005, J FOREST, V103, P169, DOI 10.1093/jof/103.4.169; Wing MG, 2008, J FOREST, V106, P185; Wing MG, 2007, J FOREST, V105, P9; Zimbelman EG, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040822	62	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191017	10.1371/journal.pone.0191017	http://dx.doi.org/10.1371/journal.pone.0191017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324794	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400093
J	Kim, KH; Heo, HI; Park, SH				Kim, Ki Hwan; Heo, Hyo-Im; Park, Sung-Hong			Detection of fast oscillating magnetic fields using dynamic multiple TR imaging and Fourier analysis	PLOS ONE			English	Article							NEURONAL CURRENT MRI; RESTING-STATE NETWORKS; HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; BLOOD OXYGENATION; VISUAL-CORTEX; MOTOR CORTEX; CURRENTS; SIGNAL; BOLD	Neuronal oscillations produce oscillating magnetic fields. There have been trials to detect neuronal oscillations using MRI, but the detectability in in vivo is still in debate. Major obstacles to detecting neuronal oscillations are (i) weak amplitudes, (ii) fast oscillations, which are faster than MRI temporal resolution, and (iii) random frequencies and on/off intervals. In this study, we proposed a new approach for direct detection of weak and fast oscillating magnetic fields. The approach consists of (i) dynamic acquisitions using multiple times to repeats (TRs) and (ii) an expanded frequency spectral analysis. Gradient echo echo-planar imaging was used to test the feasibility of the proposed approach with a phantom generating oscillating magnetic fields with various frequencies and amplitudes and random on/off intervals. The results showed that the proposed approach could precisely detect the weak and fast oscillating magnetic fields with random frequencies and on/off intervals. Complex and phase spectra showed reliable signals, while no meaningful signals were observed in magnitude spectra. A two-TR approach provided an absolute frequency spectrum above Nyquist sampling frequency pixel by pixel with no a priori target frequency information. The proposed dynamic multiple-TR imaging and Fourier analysis are promising for direct detection of neuronal oscillations and potentially applicable to any pulse sequences.	[Kim, Ki Hwan; Heo, Hyo-Im; Park, Sung-Hong] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea; [Kim, Ki Hwan; Park, Sung-Hong] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Park, SH (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea.; Park, SH (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea.	sunghongpark@kaist.ac.kr	Park, Sung-Hong/B-3393-2012	Park, Sung-Hong/0000-0002-1731-0668	Samsung Research Funding Center of Samsung Electronics [SRFC-IT1401-05]	Samsung Research Funding Center of Samsung Electronics(Samsung)	This work was supported by Samsung Research Funding Center of Samsung Electronics (https://www.samsungftf.com) under Project Number SRFC-IT1401-05. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazhenov M, 2011, PHILOS T R SOC A, V369, P3802, DOI 10.1098/rsta.2011.0119; Bianciardi M, 2004, MAGN RESON IMAGING, V22, P1429, DOI 10.1016/j.mri.2004.10.009; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bodurka J, 2002, MAGNET RESON MED, V47, P1052, DOI 10.1002/mrm.10159; Boubela RN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00168; Boyacioglu R, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00156; Buracas GT, 2008, MAGN RESON MED, V59, P140, DOI 10.1002/mrm.21457; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Chen JYE, 2015, NEUROIMAGE, V107, P207, DOI 10.1016/j.neuroimage.2014.12.012; Chow LS, 2008, MAGN RESON MED, V60, P1147, DOI 10.1002/mrm.21753; Chow LS, 2006, MAGN RESON IMAGING, V24, P681, DOI 10.1016/j.mri.2006.01.005; Chu RN, 2004, NEUROIMAGE, V23, P1059, DOI 10.1016/j.neuroimage.2004.07.003; DOBELBOWER RR, 1980, MED PHYS, V7, P449; Du JX, 2014, NEUROIMAGE, V94, P1, DOI 10.1016/j.neuroimage.2014.03.015; DUYN JH, 1994, NMR BIOMED, V7, P83, DOI 10.1002/nbm.1940070113; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; FRAHM J, 1994, NMR BIOMED, V7, P45, DOI 10.1002/nbm.1940070108; Gohel SR, 2015, BRAIN CONNECT, V5, P23, DOI 10.1089/brain.2013.0210; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; HAACKE EM, 1994, NMR BIOMED, V7, P54, DOI 10.1002/nbm.1940070109; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Huang J, 2014, MAGN RESON MED, V71, P756, DOI 10.1002/mrm.24720; Jiang X, 2016, MAGN RESON MED, V75, P519, DOI 10.1002/mrm.25553; Konn D, 2004, MAGN RESON IMAGING, V22, P1413, DOI 10.1016/j.mri.2004.10.012; Konn D, 2003, MAGN RESON MED, V50, P40, DOI 10.1002/mrm.10494; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Lee HL, 2013, NEUROIMAGE, V65, P216, DOI 10.1016/j.neuroimage.2012.10.015; Leopold DA, 2012, NEUROIMAGE, V62, P2190, DOI 10.1016/j.neuroimage.2011.10.059; Luo QF, 2011, MAGN RESON MED, V66, P492, DOI 10.1002/mrm.22842; Luo QF, 2011, MAGN RESON MED, V65, P1680, DOI 10.1002/mrm.22764; Luo QF, 2009, NEUROIMAGE, V47, P1268, DOI 10.1016/j.neuroimage.2009.06.017; Mandelkow H, 2007, NEUROIMAGE, V37, P149, DOI 10.1016/j.neuroimage.2007.04.034; Miller KJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000609; Niazy RK, 2011, PROG BRAIN RES, V193, P259, DOI 10.1016/B978-0-444-53839-0.00017-X; Nyquist H, 2002, P IEEE, V90, P280, DOI 10.1109/5.989875; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Parkes LM, 2007, MAGN RESON MED, V57, P411, DOI 10.1002/mrm.21129; Petridou N, 2006, P NATL ACAD SCI USA, V103, P16015, DOI 10.1073/pnas.0603219103; SEGEBARTH C, 1994, NEUROREPORT, V5, P813, DOI 10.1097/00001756-199403000-00019; Sundarama P, 2016, NEUROIMAGE, V132, P477, DOI 10.1016/j.neuroimage.2016.01.059; Tang L, 2008, MAGN RESON IMAGING, V26, P484, DOI 10.1016/j.mri.2007.09.003; Truong TK, 2006, P NATL ACAD SCI USA, V103, P12598, DOI 10.1073/pnas.0605486103; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Witzel T, 2008, NEUROIMAGE, V42, P1357, DOI 10.1016/j.neuroimage.2008.05.010; Wu CWW, 2008, NEUROIMAGE, V42, P1047, DOI 10.1016/j.neuroimage.2008.05.035; Xiong JH, 2003, HUM BRAIN MAPP, V20, P41, DOI 10.1002/hbm.10124; Xue YQ, 2009, MAGN RESON MED, V61, P1073, DOI 10.1002/mrm.21857	48	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0189916	10.1371/journal.pone.0189916	http://dx.doi.org/10.1371/journal.pone.0189916			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320580	Green Submitted, gold, Green Published			2022-12-26	WOS:000419689600022
J	Rettig, TA; Ward, C; Bye, BA; Pecaut, MJ; Chapes, SK				Rettig, Trisha A.; Ward, Claire; Bye, Bailey A.; Pecaut, Michael J.; Chapes, Stephen K.			Characterization of the naive murine antibody repertoire using unamplified high-throughput sequencing	PLOS ONE			English	Article							HUMAN-IMMUNOGLOBULIN HEAVY; VARIABLE REGION GENE; SOMATIC GENERATION; C57BL/6 MICE; CHAIN GENES; SELECTION; DIVERSITY; SEGMENTS; DNA; REARRANGEMENT	Antibody specificity and diversity are generated through the enzymatic splicing of genomic gene segments within each B cell. Antibodies are heterodimers of heavy-and light-chains encoded on separate loci. We studied the antibody repertoire from pooled, splenic tissue of unimmunized, adult female C57BL/6J mice, using high-throughput sequencing (HTS) without amplification of antibody transcripts. We recovered over 90,000 heavy-chain and over 135,000 light-chain immunoglobulin sequences. Individual V-, D-, and J-gene segment usage was uniform among the three mouse pools, particularly in highly abundant gene segments, with low frequency V-gene segments not being detected in all pools. Despite the similar usage of individual gene segments, the repertoire of individual B-cell CDR3 amino acid sequences in each mouse pool was highly varied, affirming the combinatorial diversity in the B-cell pool that has been previously demonstrated. There also was some skewing in the V-gene segments that were detected depending on chromosomal location. This study presents a unique, non-primer biased glimpse of the conventionally housed, unimmunized antibody repertoire of the C57BL6/J mouse.	[Rettig, Trisha A.; Ward, Claire; Bye, Bailey A.; Chapes, Stephen K.] Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA; [Pecaut, Michael J.] Loma Linda Univ, Div Biomed Engn Sci, Loma Linda, CA 92350 USA	Kansas State University; Loma Linda University	Chapes, SK (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	skcbiol@ksu.edu	Pecaut, Michael J/P-6481-2015	Pecaut, Michael J/0000-0002-2915-9686; Rettig, Trisha/0000-0001-7434-9182; Ward, Claire/0000-0002-1486-4403	National Aeronautics and Space Administration [NNX13AN34G, NNX15AB45G]; National Institute of Health [GM103418]; College of Veterinary Medicine at Kansas State University; Kansas State University Johnson Cancer - Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418] Funding Source: NIH RePORTER	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Veterinary Medicine at Kansas State University; Kansas State University Johnson Cancer - Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NNX13AN34G and NNX15AB45G from National Aeronautics and Space Administration (https://www.nasa.gov/) (SKC and MJP); GM103418 from the National Institute of Health (https://www.nih.gov/) (SKC); College of Veterinary Medicine at Kansas State University (http://www.vet.k-state.edu/); and Kansas State University Johnson Cancer - Research Center (http://cancer.k-state.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademokun A, 2011, AGING CELL, V10, P922, DOI 10.1111/j.1474-9726.2011.00732.x; Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; ALLMAN DM, 1993, J IMMUNOL, V151, P4431; Aoki-Ota M, 2012, J IMMUNOL, V188, P2305, DOI 10.4049/jimmunol.1103484; Banga S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125090; Bashford-Rogers RJM, 2016, LEUKEMIA, V30, P2312, DOI 10.1038/leu.2016.142; Bashford-Rogers RJM, 2013, GENOME RES, V23, P1874, DOI 10.1101/gr.154815.113; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Briney BS, 2012, GENES IMMUN, V13, P469, DOI 10.1038/gene.2012.20; Busse CE, 2014, EUR J IMMUNOL, V44, P597, DOI 10.1002/eji.201343917; Calis JJA, 2014, TRENDS IMMUNOL, V35, P581, DOI 10.1016/j.it.2014.09.004; Chao A, 2001, STAT MED, V20, P3123, DOI 10.1002/sim.996.abs; Chapman DG, 1951, SOME PROPERTIES HYPE; Choi NM, 2013, J IMMUNOL, V191, P2393, DOI 10.4049/jimmunol.1301279; Collins AM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0236; Cory S, 2015, J IMMUNOL, V195, P763, DOI 10.4049/jimmunol.1501277; de Bono B, 2004, J MOL BIOL, V342, P131, DOI 10.1016/j.jmb.2004.06.055; DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; EARLY P, 1980, CELL, V19, P981, DOI 10.1016/0092-8674(80)90089-6; Galson JD, 2014, TRENDS IMMUNOL, V35, P319, DOI 10.1016/j.it.2014.04.005; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Glanville J, 2011, P NATL ACAD SCI USA, V108, P20066, DOI 10.1073/pnas.1107498108; Gray SA, 2016, ANTIVIR RES, V131, P100, DOI 10.1016/j.antiviral.2016.04.001; Greiff V, 2017, CELL REP, V19, P1467, DOI 10.1016/j.celrep.2017.04.054; Greiff V, 2015, TRENDS IMMUNOL, V36, P738, DOI 10.1016/j.it.2015.09.006; Greiff V, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0169-8; Greiff V, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0040-5; HOZUMI N, 1976, P NATL ACAD SCI USA, V73, P3628, DOI 10.1073/pnas.73.10.3628; Huerkamp MJ, 2000, TECH TALK, V5, P3; Ippolito GC, 2006, J EXP MED, V203, P1567, DOI 10.1084/jem.20052217; Jiang N, 2011, P NATL ACAD SCI USA, V108, P5348, DOI 10.1073/pnas.1014277108; KABAT EA, 1979, J EXP MED, V149, P1299, DOI 10.1084/jem.149.6.1299; Kaplinsky J, 2014, P NATL ACAD SCI USA, V111, pE2622, DOI 10.1073/pnas.1403278111; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KLEINSCHNEEGANS AS, 1989, J AUTOIMMUN, V2, P869, DOI 10.1016/0896-8411(89)90013-9; Kono N, 2017, BIOCHEM BIOPH RES CO, V487, P300, DOI 10.1016/j.bbrc.2017.04.054; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kunik V, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002388; Lu J, 2014, MOL IMMUNOL, V57, P274, DOI 10.1016/j.molimm.2013.09.008; Milner ECB, 1995, ANN NY ACAD SCI, V764, P50; Parameswaran P, 2013, CELL HOST MICROBE, V13, P691, DOI 10.1016/j.chom.2013.05.008; Racanelli V, 2001, J IMMUNOL, V167, P21, DOI 10.4049/jimmunol.167.1.21; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Rettig Trisha A, 2017, Gravit Space Res, V5, P2; Rosenquist R, 1999, EUR J HAEMATOL, V63, P171; SASSO EH, 1990, J IMMUNOL, V145, P2751; Sela-Culang I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00302; Shahaf G, 2008, J THEOR BIOL, V255, P210, DOI 10.1016/j.jtbi.2008.08.005; Tan YC, 2014, ARTHRITIS RHEUMATOL, V66, P2706, DOI 10.1002/art.38754; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TONEGAWA S, 1976, P NATL ACAD SCI USA, V73, P203, DOI 10.1073/pnas.73.1.203; vanBelzen N, 1997, LEUKEMIA, V11, P1742, DOI 10.1038/sj.leu.2400797; Wang Y, 2011, IMMUNOGENETICS, V63, P259, DOI 10.1007/s00251-010-0510-8; Wang Z, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0120482, 10.1371/journal.pone.0145726]; Ward C, 2018, LIFE SCI SPACE RES, V16, P63, DOI 10.1016/j.lssr.2017.11.003; Watson CT, 2013, AM J HUM GENET, V92, P530, DOI 10.1016/j.ajhg.2013.03.004; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216; Zuckerman NS, 2010, EUR J IMMUNOL, V40, P1150, DOI 10.1002/eji.200939914	61	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190982	10.1371/journal.pone.0190982	http://dx.doi.org/10.1371/journal.pone.0190982			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320559	Green Published, Green Submitted, gold			2022-12-26	WOS:000419689600076
J	Burgoyne, T; Lane, A; Laughlin, WE; Cheetham, ME; Futter, CE				Burgoyne, Thomas; Lane, Amelia; Laughlin, William E.; Cheetham, Michael E.; Futter, Clare E.			Correlative light and immuno-electron microscopy of retinal tissue cryostat sections	PLOS ONE			English	Article							MEMBRANE CONTACT SITES; PIGMENT EPITHELIUM; ER; CHOLESTEROL; PEROXISOMES; PHAGOCYTOSIS; GOLGI	Correlative light-electron microscopy (CLEM) is a powerful technique allowing localisation of specific macromolecules within fluorescence microscopy (FM) images to be mapped onto corresponding high-resolution electron microscopy (EM) images. Existing methods are applicable to limited sample types and are technically challenging. Here we describe novel methods to perform CLEM and immuno-electron microscopy (iEM) on cryostat sections utilising the popular FM embedding solution, optimal cutting temperature (OCT) compound. Utilising these approaches, we have (i) identified the same phagosomes by FM and EM in the retinal pigment epithelium (RPE) of retinal tissue (ii) shown the correct localisation of rhodopsin on photoreceptor outer segment disc like-structures in iPSC derived optic cups and (iii) identified a novel interaction between peroxisomes and melanosomes as well as phagosomes in the RPE. These data show that cryostat sections allow easy characterisation of target macromolecule localisation within tissue samples, thus providing a substantial improvement over many conventional methods that are limited to cultured cells. As OCT embedding is routinely used for FM this provides an easily accessible and robust method for further analysis of existing samples by high resolution EM.	[Burgoyne, Thomas; Lane, Amelia; Laughlin, William E.; Cheetham, Michael E.; Futter, Clare E.] UCL, Inst Ophthalmol, London, England; [Burgoyne, Thomas] Royal Brompton Hosp, Dept Paediat, Elect Microscopy Unit, Primary Ciliary Dyskinesia Serv, Sydney St, London, England	University of London; University College London; Royal Brompton Hospital	Futter, CE (corresponding author), UCL, Inst Ophthalmol, London, England.	c.futter@ucl.ac.uk	Burgoyne, Thomas/HCI-9054-2022	Burgoyne, Thomas/0000-0002-8428-720X; Futter, Clare/0000-0001-5559-9389; Cheetham, Michael/0000-0001-6429-654X	Wellcome Trust [093445, 205041]; MRC [MR/P010091/1]; Fight for Sight; NC3Rs; Medical Research Council [MR/P010091/1] Funding Source: researchfish; Fight for Sight [1511/12] Funding Source: researchfish; National Centre for the Replacement [NC/C016104/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fight for Sight; NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight; National Centre for the Replacement	This work was funded by a grant from the Wellcome Trust (https://wellcome.ac.uk/) 093445 and MRC (https://www.mrc.ac.uk/) MR/P010091/1 to C.E.F and Wellcome Trust (205041), Fight for Sight (https://www.fightforsight.org.uk/) and NC3Rs (https://www.nc3rs.org.uk/) to M.E.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Burgoyne T, 2015, P NATL ACAD SCI USA, V112, P15922, DOI 10.1073/pnas.1509285113; Chu BB, 2015, CELL, V161, P291, DOI 10.1016/j.cell.2015.02.019; DUBOCHET J, 1995, TRENDS CELL BIOL, V5, P366, DOI 10.1016/S0962-8924(00)89071-6; Eden ER, 2016, DEV CELL, V37, P473, DOI 10.1016/j.devcel.2016.05.005; Elbaz-Alon Y, 2017, BIOCHEM SOC T, V45, P477, DOI 10.1042/BST20160130; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; GOCHT A, 1992, ACTA ANAT, V145, P327; Goldberg AFX, 2006, INT REV CYTOL, V253, P131, DOI 10.1016/S0074-7696(06)53004-9; Kennedy CJ, 1995, EYE, V9, P763, DOI 10.1038/eye.1995.192; Kim Soo-Young, 2015, Macrophage (Houst), V2; Lahiri S, 2015, CURR OPIN CELL BIOL, V33, P82, DOI 10.1016/j.ceb.2014.12.004; McDonald K, 1999, METH MOL B, V117, P77; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Parfitt DA, 2016, BIOCHEM SOC T, V44, P1245, DOI 10.1042/BST20160156; Parfitt DA, 2016, CELL STEM CELL, V18, P769, DOI 10.1016/j.stem.2016.03.021; Pearring JN, 2015, ELIFE, V4, DOI 10.7554/eLife.12058; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Polishchuk RS, 2000, J CELL BIOL, V148, P45, DOI 10.1083/jcb.148.1.45; Raiborg C, 2015, EMBO J, V34, P1848, DOI 10.15252/embj.201591481; Raychaudhuri S, 2008, P NATL ACAD SCI USA, V105, P15785, DOI 10.1073/pnas.0808321105; Razi M, 2009, METHOD ENZYMOL, V452, P261, DOI 10.1016/S0076-6879(08)03617-3; Reyes-Reveles J, 2017, J BIOL CHEM, V292, P8038, DOI 10.1074/jbc.M116.770784; ROBISON WG, 1975, INVEST OPHTH VISUAL, V14, P866; Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056; Schorb M, 2014, ULTRAMICROSCOPY, V143, P24, DOI 10.1016/j.ultramic.2013.10.015; Schwarz N, 2012, ADV EXP MED BIOL, V723, P527, DOI 10.1007/978-1-4614-0631-0_66; SINGH I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P44, DOI 10.1016/0005-2760(93)90174-8; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Sugiura A, 2017, NATURE, V542, P251, DOI 10.1038/nature21375; van der Kant R, 2014, J CELL SCI, V127, P929, DOI 10.1242/jcs.137539; van Rijnsoever C, 2008, NAT METHODS, V5, P973, DOI 10.1038/nmeth.1263; Watanabe S, 2011, NAT METHODS, V8, P80, DOI 10.1038/NMETH.1537; Wavre-Shapton ST, 2015, HUM MOL GENET, V24, P7060, DOI 10.1093/hmg/ddv406; Wavre-Shapton ST, 2014, J CELL SCI, V127, P3852, DOI 10.1242/jcs.154757; Wavre-Shapton ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057769; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61	37	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0191048	10.1371/journal.pone.0191048	http://dx.doi.org/10.1371/journal.pone.0191048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315318	Green Published, Green Submitted, gold			2022-12-26	WOS:000419655900039
J	Vallabhajosyula, S; Sakhuja, A; Geske, JB; Kumar, M; Kashyap, R; Kashani, K; Jentzer, JC				Vallabhajosyula, Saraschandra; Sakhuja, Ankit; Geske, Jeffrey B.; Kumar, Mukesh; Kashyap, Rahul; Kashani, Kianoush; Jentzer, Jacob C.			Clinical profile and outcomes of acute cardiorenal syndrome type-5 in sepsis: An eight-year cohort study	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; 11TH CONSENSUS CONFERENCE; SEPTIC SHOCK; SURVEILLANCE; PATHOPHYSIOLOGY; DYSFUNCTION; STRATEGIES; INITIATION; ELEVATION; FAILURE	Background To evaluate the clinical features and outcomes of acute cardiorenal syndrome type-5 in patients with severe sepsis and septic shock. Methods Historical cohort study of all adult patients with severe sepsis and septic shock admitted to the intensive care units (ICU) at Mayo Clinic Rochester from January 1, 2007 through December 31, 2014. Patients with prior renal or cardiac dysfunction were excluded. Patients were divided into groups with and without cardiorenal syndrome type-5. Acute Kidney Injury (AKI) was defined by both serum creatinine and urine output criteria of the AKI Network and the cardiac injury was determined by troponin-T levels. Outcomes included in-hospital mortality, ICU and hospital length of stay, and one-year survival. Results Of 602 patients meeting the study inclusion criteria, 430 (71.4%) met criteria for acute cardiorenal syndrome type-5. Patients with cardiorenal syndrome type-5 had higher severity of illness, greater vasopressor and mechanical ventilation use. Cardiorenal syndrome type-5 was associated higher unadjusted in-hospital mortality, ICU and hospital lengths of stay, and lower one-year survival. When adjusted for age, gender, severity of illness and mechanical ventilation, cardiorenal syndrome type-5 was independently associated with 1.7-times greater odds of in-hospital mortality (p = .03), but did not predict one-year survival (p = .06) compared to patients without cardiorenal syndrome. Conclusions In sepsis, acute cardiorenal syndrome type-5 is associated with worse in-hospital mortality compared to patients without cardiorenal syndrome.	[Vallabhajosyula, Saraschandra; Geske, Jeffrey B.; Jentzer, Jacob C.] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55902 USA; [Vallabhajosyula, Saraschandra; Sakhuja, Ankit; Kashani, Kianoush; Jentzer, Jacob C.] Mayo Clin, Dept Med, Div Pulm & Crit Care Med, Rochester, MN 55902 USA; [Vallabhajosyula, Saraschandra; Kumar, Mukesh; Kashyap, Rahul; Kashani, Kianoush] Mayo Clin, Multidisciplinary Epidemiol & Translat Res Intens, Rochester, MN USA; [Vallabhajosyula, Saraschandra] Mayo Clin, Grad Sch Biomed Sci, Ctr Clin & Translat Sci, Rochester, MN USA; [Kumar, Mukesh; Kashyap, Rahul] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN USA; [Kashani, Kianoush] Mayo Clin, Dept Med, Div Nephrol & Hypertens, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Jentzer, JC (corresponding author), Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55902 USA.; Jentzer, JC (corresponding author), Mayo Clin, Dept Med, Div Pulm & Crit Care Med, Rochester, MN 55902 USA.	Jentzer.Jacob@mayo.edu	Vallabhajosyula, Saraschandra/I-9707-2019	Vallabhajosyula, Saraschandra/0000-0002-1631-8238; Kashyap, Rahul/0000-0002-4383-3411	CTSA Grant from the National Center for Advancing Translational Sciences (NCATS) [UL1 TR000135]; Critical Care Research Committee, Critical Care Independent Multidisciplinary Program, Mayo Clinic, Rochester MN [15-006554]	CTSA Grant from the National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Critical Care Research Committee, Critical Care Independent Multidisciplinary Program, Mayo Clinic, Rochester MN	This work was supported, in part, by CTSA Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) to SV. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH and also supported, in part, by intramural funding from the Critical Care Research Committee, Critical Care Independent Multidisciplinary Program, Mayo Clinic, Rochester MN, Grant Number 15-006554 to SV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2015, J CRIT CARE, V30, P988, DOI 10.1016/j.jcrc.2015.05.007; Ammann P, 2001, INTENS CARE MED, V27, P965, DOI 10.1007/s001340100920; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Antonucci E, 2014, J CRIT CARE, V29, P500, DOI 10.1016/j.jcrc.2014.03.028; Arlati S, 2000, INTENS CARE MED, V26, P31, DOI 10.1007/s001340050008; Bagshaw SM, 2009, INTENS CARE MED, V35, P871, DOI 10.1007/s00134-008-1367-2; Berrios RAS, 2014, J CRIT CARE, V29, P495, DOI 10.1016/j.jcrc.2014.03.007; Bessiere F, 2013, INTENS CARE MED, V39, P1181, DOI 10.1007/s00134-013-2902-3; Gaudry S, 2016, NEW ENGL J MED, V375, P122, DOI 10.1056/NEJMoa1603017; Harrison AM, 2015, MAYO CLIN PROC, V90, P166, DOI 10.1016/j.mayocp.2014.11.014; Herasevich V, 2011, J AM MED INFORM ASSN, V18, P639, DOI 10.1136/amiajnl-2011-000228; Herasevich V, 2010, MAYO CLIN PROC, V85, P247, DOI 10.4065/mcp.2009.0479; Huang SJ, 2013, CRIT CARE, V17, DOI 10.1186/cc12741; Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503; Kotecha A, J CRITICAL CARE, V43, P122; Landesberg G, 2014, CRIT CARE MED, V42, P790, DOI 10.1097/CCM.0000000000000107; Lanspa MJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1421-3; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; McCullough PA, 2013, CONTRIB NEPHROL, V182, P82, DOI [10.1159/000349966, 10.1159/000361059]; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mehta RL, 2013, CONTRIB NEPHROL, V182, P174, DOI 10.1159/000349970; Plataki M, 2011, CLIN J AM SOC NEPHRO, V6, P1744, DOI 10.2215/CJN.05480610; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Ronco C, 2010, CONTRIB NEPHROL, V165, P54, DOI 10.1159/000313745; Sturgess DJ, 2010, CRIT CARE, V14, DOI 10.1186/cc8931; Vallabhajosyula S, 2017, SHOCK; Vallabhajosyula S, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005930; Vallabhajosyula S, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0319-9; Virzi GM, 2016, KIDNEY BLOOD PRESS R, V41, P1008, DOI 10.1159/000452602; Walkey AJ, 2014, CHEST, V146, P1187, DOI 10.1378/chest.14-0003; Yadav H, 2015, CRIT CARE MED, V43, P1449, DOI 10.1097/CCM.0000000000000929	32	25	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190965	10.1371/journal.pone.0190965	http://dx.doi.org/10.1371/journal.pone.0190965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315332	Green Published, gold			2022-12-26	WOS:000419655900035
J	Holcomb, J; Doughan, M; Spellmon, N; Lewis, B; Perry, E; Zhang, YX; Nico, L; Wan, JM; Chakravarthy, S; Shang, WF; Miao, Q; Stemmler, T; Yang, Z				Holcomb, Joshua; Doughan, Maysaa; Spellmon, Nicholas; Lewis, Brianne; Perry, Emerson; Zhang, Yingxue; Nico, Lindsey; Wan, Junmei; Chakravarthy, Srinivas; Shang, Weifeng; Miao, Qing; Stemmler, Timothy; Yang, Zhe			SAXS analysis of a soluble cytosolic NgBR construct including extracellular and transmembrane domains	PLOS ONE			English	Article							NOGO-B RECEPTOR; BIOLOGICAL MACROMOLECULES; MEMBRANE-PROTEINS; IDENTIFICATION; GLYCOSYLATION; ACTIVATION; TOPOLOGY; PROMOTES	The Nogo-B receptor (NgBR) is involved in oncogenic Ras signaling through directly binding to farnesylated Ras. It recruits farnesylated Ras to the non-lipid-raft membrane for interaction with downstream effectors. However, the cytosolic domain of NgBR itself is only partially folded. The lack of several conserved secondary structural elements makes this domain unlikely to form a complete farnesyl binding pocket. We find that inclusion of the extracellular and transmembrane domains that contain additional conserved residues to the cytosolic region results in a well folded protein with a similar size and shape to the E. coli cis-isoprenyl transferase (UPPs). Small Angle X-ray Scattering (SAXS) analysis reveals the radius of gyration (R-g) of our NgBR construct to be 18.2 A with a maximum particle dimension (D-max) of 61.0 A. Ab initio shape modeling returns a globular molecular envelope with an estimated molecular weight of 23.0 kD closely correlated with the calculated molecular weight. Both Kratky plot and pair distribution function of NgBR scattering reveal a bell shaped peak which is characteristic of a single globularly folded protein. In addition, circular dichroism (CD) analysis reveals that our construct has the secondary structure contents similar to the UPPs. However, this result does not agree with the currently accepted topological orientation of NgBR which might partition this construct into three separate domains. This discrepancy suggests another possible NgBR topology and lends insight into a potential molecular basis of how NgBR facilitates farnesylated Ras recruitment.	[Holcomb, Joshua; Doughan, Maysaa; Spellmon, Nicholas; Perry, Emerson; Zhang, Yingxue; Wan, Junmei; Yang, Zhe] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA; [Lewis, Brianne; Nico, Lindsey; Stemmler, Timothy] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI USA; [Chakravarthy, Srinivas; Shang, Weifeng] IIT, Ctr Synchrotron Radiat Res & Instrumentat, Chicago, IL 60616 USA; [Chakravarthy, Srinivas; Shang, Weifeng] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA; [Miao, Qing] Med Coll Wisconsin, Dept Surg, Childrens Res Inst, Milwaukee, WI 53226 USA	Wayne State University; Wayne State University; Illinois Institute of Technology; Illinois Institute of Technology; Medical College of Wisconsin	Yang, Z (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA.	zyang@med.wayne.edu	Lewis, Brianne/AAU-5344-2021; Miao, Qing/K-3186-2019	Miao, Qing/0000-0002-3125-1238; Stemmler, Timothy/0000-0002-6298-088X; Lewis, Brianne/0000-0003-1584-6407	National Institutes of Health [GM103622, 1S100D018090-01, R01HL108938, R01DK112971]; T32 training grant [HL120822]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL120822, R01HL108938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018090] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 training grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grant number GM103622 (for access to the BioCAT beamline), 1S100D018090-01 (for use of the PILATUS-3-1M detector), R01HL108938 (to QM) and R01DK112971 (to QM) and T32 training grant HL120822 (to JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institutes of Health grant number GM103622 (for access to the BioCAT beamline), 1S100D018090-01 (for use of the PILATUS-3-1M detector), R01HL108938 (to QM) and R01DK112971 (to QM) and T32 training grant HL120822 (to JH).	Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Bogdanov M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404103; Dong CY, 2016, ONCOTARGET, V7, P8850, DOI 10.18632/oncotarget.7091; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Guo RT, 2005, J BIOL CHEM, V280, P20762, DOI 10.1074/jbc.M502121200; Harrison KD, 2011, EMBO J, V30, P2490, DOI 10.1038/emboj.2011.147; Harrison KD, 2009, CELL METAB, V10, P208, DOI 10.1016/j.cmet.2009.07.003; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Jiang YY, 2016, METHODS MOL BIOL, V1366, P207, DOI 10.1007/978-1-4939-3127-9_16; Li MF, 2007, BIOCHEM BIOPH RES CO, V360, P128, DOI 10.1016/j.bbrc.2007.06.031; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Park EJ, 2016, EMBO REP, V17, P167, DOI 10.15252/embr.201540789; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rana U, 2016, DEV BIOL, V410, P190, DOI 10.1016/j.ydbio.2015.12.023; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Schuldiner S, 2012, TRENDS BIOCHEM SCI, V37, P215, DOI 10.1016/j.tibs.2012.02.006; Sirinupong N, 2011, J MOL BIOL, V406, P149, DOI 10.1016/j.jmb.2010.12.014; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Vitrac H, 2015, P NATL ACAD SCI USA, V112, P13874, DOI 10.1073/pnas.1512994112; Wang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078083; Zhao B, 2017, ONCOGENE, V36, P3406, DOI 10.1038/onc.2016.484; Zhao BF, 2010, BLOOD, V116, P5423, DOI 10.1182/blood-2010-02-271577	24	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191371	10.1371/journal.pone.0191371	http://dx.doi.org/10.1371/journal.pone.0191371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346419	gold, Green Submitted, Green Published			2022-12-26	WOS:000422749500045
J	Lin, W; McBroome, J; Rehman, M; Johnson, BR				Lin, Wei; McBroome, Jakob; Rehman, Mahwish; Johnson, Brian R.			Africanized bees extend their distribution in California	PLOS ONE			English	Article							APIS-MELLIFERA L.; HONEY-BEE; MITOCHONDRIAL-DNA; UNITED-STATES; HYMENOPTERA; APIDAE; IDENTIFICATION; POPULATIONS; BRAZIL; LIMITS	Africanized honey bees (Apis mellifera) arrived in the western hemisphere in the 1950s and quickly spread north reaching California in the 1990s. These bees are highly defensive and somewhat more difficult to manage for commercial purposes than the European honey bees traditionally kept. The arrival of these bees and their potentially replacing European bees over much of the state is thus of great concern. After a 25 year period of little systematic sampling, a recent small scale study found Africanized honey bees in the Bay Area of California, far north of their last recorded distribution. The purpose of the present study was to expand this study by conducting more intensive sampling of bees from across northern California. We found Africanized honey bees as far north as Napa and Sacramento. We also found Africanized bees in all counties south of these counties. Africanized honey bees were particularly abundant in parts of the central valley and Monterey. This work suggests the northern spread of Africanized honey bees may not have stopped. They may still be moving north at a slow rate, although due to the long gaps in sampling it is currently impossible to tell for certain. Future work should routinely monitor the distribution of these bees to distinguish between these two possibilities.	[Lin, Wei; McBroome, Jakob; Johnson, Brian R.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Rehman, Mahwish] Agr Res Inst, Dept Entomol, Peshawar, Pakistan	University of California System; University of California Davis	Johnson, BR (corresponding author), Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.	brnjohnson@ucdavis.edu		McBroome, Jakob/0000-0002-5002-5156	University of California Agriculture and Natural Resources; Hatch grant [CA-D-ENM 2161-H]	University of California Agriculture and Natural Resources; Hatch grant	This work was funded by a grant from the University of California Agriculture and Natural Resources (Edwin C. Pohle Fund), and a Hatch grant to Brian Johnson (CA-D-ENM 2161-H).	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Clarke KE, 2002, EVOLUTION, V56, P1462; Collet T, 2006, HEREDITY, V97, P329, DOI 10.1038/sj.hdy.6800875; DeJong D, 1996, BEE WORLD, V77, P67, DOI 10.1080/0005772X.1996.11099289; Delaney DA, 2009, ANN ENTOMOL SOC AM, V102, P666, DOI 10.1603/008.102.0411; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; KERR WE, 1982, AM BEE J, V122, P196; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kono Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137407; Meixner MD, 1991, J APICULT RES, V52, P1; Nielsen DI, 2000, ANN ENTOMOL SOC AM, V93, P1, DOI 10.1603/0013-8746(2000)093[0001:IPCRBM]2.0.CO;2; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Pinto MA, 2007, ANN ENTOMOL SOC AM, V100, P289, DOI 10.1603/0013-8746(2007)100[289:HBHAOA]2.0.CO;2; Pinto MA, 2003, ANN ENTOMOL SOC AM, V96, P679, DOI 10.1603/0013-8746(2003)096[0679:IOAHBH]2.0.CO;2; Rangel J, 2016, ECOL EVOL, V6, P2158, DOI 10.1002/ece3.1974; RINDERER TE, 1993, SCI AM, V269, P84, DOI 10.1038/scientificamerican1293-84; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; SCHUMACHER MJ, 1995, ARCH INTERN MED, V155, P2038, DOI 10.1001/archinte.155.19.2038; Seeley T.D., 1985, HONEY BEE ECOLOGY; Sheppard WS, 2000, ANN ENTOMOL SOC AM, V93, P159, DOI 10.1603/0013-8746(2000)093[0159:IOADBI]2.0.CO;2; TAYLOR OR, 1984, BEE WORLD, V65, P38, DOI 10.1080/0005772X.1984.11098769; Visscher P.K., 1997, CALIF AGR, V51, P22, DOI [10.3733/ca.v051n01p22, DOI 10.3733/CA.V051N01P22]; WINSTON ML, 1992, ANNU REV ENTOMOL, V37, P173, DOI 10.1146/annurev.en.37.010192.001133	24	11	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190604	10.1371/journal.pone.0190604	http://dx.doi.org/10.1371/journal.pone.0190604			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346390	gold, Green Published, Green Submitted			2022-12-26	WOS:000422749500015
J	Ma, J; Zhou, P; Ahmad, B; Ren, GD; Wang, CN				Ma, Jun; Zhou, Ping; Ahmad, Bashir; Ren, Guodong; Wang, Chunni			Chaos and multi-scroll attractors in RCL-shunted junction coupled Jerk circuit connected by memristor	PLOS ONE			English	Article							NEURONAL NETWORK; SECURE COMMUNICATION; JOSEPHSON-JUNCTION; BACKSTEPPING DESIGN; NEURAL OSCILLATORS; DYNAMICAL-SYSTEMS; ELECTRIC-ACTIVITY; CANONIC MODELS; TIME-DELAY; SYNCHRONIZATION	In this paper, a new four-variable dynamical system is proposed to set chaotic circuit composed of memristor and Josephson junction, and the dependence of chaotic behaviors on nonlinearity is investigated. A magnetic flux-controlled memristor is used to couple with the RCL-shunted junction circuit, and the dynamical behaviors can be modulated by changing the coupling intensity between the memristor and the RCL-shunted junction. Bifurcation diagram and Lyapunov exponent are calculated to confirm the emergence of chaos in the improved dynamical system. The outputs and dynamical behaviors can be controlled by the initial setting and external stimulus as well. As a result, chaos can be suppressed and spiking occurs in the sampled outputs under negative feedback, while applying positive feedback type via memristor can be effective to trigger chaos. Furthermore, it is found that the number of multi-attractors in the Jerk circuit can be modulated when memristor coupling is applied on the circuit. These results indicate that memristor coupling can be effective to control chaotic circuits and it is also useful to reproduce dynamical behaviors for neuronal activities.	[Ma, Jun; Zhou, Ping] Chongqing Univ Posts & Telecommun, Sch Sci, Chongqing, Peoples R China; [Ma, Jun; Ren, Guodong; Wang, Chunni] Lanzhou Univ Technol, Dept Phys, Lanzhou, Gansu, Peoples R China; [Ahmad, Bashir] King Abdulaziz Univ, Dept Math, NAAM Res Grp, Jeddah, Saudi Arabia	Chongqing University of Posts & Telecommunications; Lanzhou University of Technology; King Abdulaziz University	Ma, J (corresponding author), Chongqing Univ Posts & Telecommun, Sch Sci, Chongqing, Peoples R China.; Ma, J (corresponding author), Lanzhou Univ Technol, Dept Phys, Lanzhou, Gansu, Peoples R China.	hyperchaos@163.com	Zhou, Ping/G-8298-2011; Wang, Chunni/J-2666-2012; Ahmad, Bashir/B-1977-2012; Ma, Jun/G-2376-2010	Zhou, Ping/0000-0002-9103-9546; Wang, Chunni/0000-0002-4688-7888; Ahmad, Bashir/0000-0001-5350-2977; Ma, Jun/0000-0002-6127-000X	National Natural Science Foundation of China [11672122, 11365014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is supported by National Natural Science Foundation of China under Grant Nos. 11672122 and 11365014. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekkers JM, 2003, CURR BIOL, V13, pR433, DOI 10.1016/S0960-9822(03)00363-4; Biswas D, 2016, NONLINEAR DYNAM, V83, P2331, DOI 10.1007/s11071-015-2484-4; Boichenko V. A., 2005, DIMENSION THEORY ORD; Camara BI, 2016, PHYSICA A, V461, P374, DOI 10.1016/j.physa.2016.05.054; Chen G, 2017, INT J BIFURCAT CHAOS, V27, DOI 10.1142/S0218127417501152; Chen JX, 2018, COMMUN NONLINEAR SCI, V54, P202, DOI 10.1016/j.cnsns.2017.05.034; Chen P, 2016, NONLINEAR DYNAM, V86, P725, DOI 10.1007/s11071-016-2933-8; Christini DJ, 1996, PHYS REV E, V53, pR49, DOI 10.1103/PhysRevE.53.R49; Chua L, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S021812741230011X; Correia M J, 2010, INT J BIFURCAT CHAOS, V20, P2395; Crotty P, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011914; Fairhurst D, 2010, MATH MODEL NAT PHENO, V5, P146, DOI 10.1051/mmnp/20105206; Gambuzza LV, 2015, INT J BIFURCAT CHAOS, V25, DOI 10.1142/S0218127415501011; Guo SL, 2017, CHAOS SOLITON FRACT, V105, P120, DOI 10.1016/j.chaos.2017.10.019; Hao YH, 2010, NEUROCOMPUTING, V73, P2998, DOI 10.1016/j.neucom.2010.07.011; Hassan MF, 2016, NONLINEAR DYNAM, V83, P2183, DOI 10.1007/s11071-015-2474-6; Herrmann CS, 2004, INT J BIFURCAT CHAOS, V14, P623, DOI 10.1142/S0218127404009338; Itoh M, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S0218127413300012; Itoh M, 2008, INT J BIFURCAT CHAOS, V18, P3183, DOI 10.1142/S0218127408022354; Kawaguchi T., 2011, PHYSICA C, V471, P21; Khan M, 2015, NONLINEAR DYNAM, V82, P527, DOI 10.1007/s11071-015-2173-3; Kondo S, 2017, J THEOR BIOL, V414, P120, DOI 10.1016/j.jtbi.2016.11.003; Leonov GA, 2015, EUR PHYS J-SPEC TOP, V224, P1421, DOI 10.1140/epjst/e2015-02470-3; Li D, 2016, NEUROCOMPUTING, V216, P39, DOI 10.1016/j.neucom.2016.07.013; Li F, 2012, NONLINEAR DYNAM, V69, P2169, DOI 10.1007/s11071-012-0417-z; Li QD, 2015, NONLINEAR DYNAM, V79, P2295, DOI 10.1007/s11071-014-1812-4; Liu ST, 2014, NONLINEAR DYNAM, V76, P1087, DOI 10.1007/s11071-013-1192-1; Lu L, 2017, PHYSICA A, V469, P429, DOI 10.1016/j.physa.2016.11.093; Lv M, 2016, NONLINEAR DYNAM, V85, P1479, DOI 10.1007/s11071-016-2773-6; Lv M, 2016, NEUROCOMPUTING, V205, P375, DOI 10.1016/j.neucom.2016.05.004; Ma J, 2017, NONLINEAR DYNAM, V89, P1569, DOI 10.1007/s11071-017-3565-3; Ma J, 2017, CHAOS, V27, DOI 10.1063/1.4983469; Ma J, 2017, INT J MOD PHYS B, V31, DOI 10.1142/S0217979216502519; Ma J, 2017, APPL MATH COMPUT, V298, P65, DOI 10.1016/j.amc.2016.11.004; Ma J, 2015, SCI CHINA TECHNOL SC, V58, P2038, DOI 10.1007/s11431-015-5961-6; Ma J, 2015, CHAOS SOLITON FRACT, V80, P31, DOI 10.1016/j.chaos.2015.02.005; Ma J, 2015, NEUROCOMPUTING, V167, P378, DOI 10.1016/j.neucom.2015.04.056; Ma J, 2015, INT J MOD PHYS B, V29, DOI 10.1142/S0217979214502397; Ma J, 2014, NONLINEAR DYNAM, V76, P1951, DOI 10.1007/s11071-014-1260-1; Ma J, 2011, COMMUN NONLINEAR SCI, V16, P3770, DOI 10.1016/j.cnsns.2010.12.030; Ma J, 2010, APPL MATH COMPUT, V215, P3318, DOI 10.1016/j.amc.2009.10.020; Machura L, 2010, PHYSICA E, V42, P590, DOI 10.1016/j.physe.2009.06.062; Mengue AD, 2012, NONLINEAR DYNAM, V70, P1241, DOI 10.1007/s11071-012-0528-6; Mobayen S, 2017, ASIAN J CONTROL; Mobayen S, 2017, J VIB CONTROL, V23, P2912, DOI 10.1177/1077546315623887; Mobayen S, 2016, COMPLEXITY, V21, P14, DOI 10.1002/cplx.21624; Mofid O, 2017, J VIBRATION CONTROL; Muthuswamy B, 2009, IETE TECH REV, V26, P417, DOI 10.4103/0256-4602.57827; Nakata M, 1999, CHALLENGES FOR THE 21ST CENTURY, VOL I, P113; Nazzal JM, 2007, CHAOS SOLITON FRACT, V33, P695, DOI 10.1016/j.chaos.2006.01.071; Njah AN, 2010, PHYSICA C, V470, P558, DOI 10.1016/j.physc.2010.05.009; Pogromsky A, 1999, INT J BIFURCAT CHAOS, V9, P629, DOI 10.1142/S0218127499000444; PYRAGAS K, 1993, PHYS LETT A, V180, P99, DOI 10.1016/0375-9601(93)90501-P; Ren GD, 2015, ACTA PHYS SIN-CH ED, V64, DOI 10.7498/aps.64.058702; Ren GD, 2017, NONLINEAR DYNAM, V88, P893, DOI 10.1007/s11071-016-3283-2; Savi MA, 2002, INT J BIFURCAT CHAOS, V12, P645, DOI 10.1142/S0218127402004607; Shi XR, 2012, NONLINEAR DYNAM, V69, P1177, DOI 10.1007/s11071-012-0339-9; Song XL, 2015, SCI CHINA TECHNOL SC, V58, P1007, DOI 10.1007/s11431-015-5826-z; Sprott JC, 2000, PHYS LETT A, V266, P19, DOI 10.1016/S0375-9601(00)00026-8; Sprott JC, 2000, AM J PHYS, V68, P758, DOI 10.1119/1.19538; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Tavazoei MS, 2008, PHYS LETT A, V372, P798, DOI 10.1016/j.physleta.2007.08.040; Tyukin I, 2010, INT J NEURAL SYST, V20, P193, DOI 10.1142/S0129065710002358; Ucar A, 2007, CHAOS SOLITON FRACT, V31, P105, DOI 10.1016/j.chaos.2005.09.035; Vincent UE, 2008, PHYSICA C, V468, P374, DOI 10.1016/j.physc.2007.11.012; Vincent UE, 2007, PHYSICA D, V231, P130, DOI 10.1016/j.physd.2007.04.003; Wang CN, 2012, DYNAM SYST, V27, P253, DOI 10.1080/14689367.2012.667788; Wang CN, 2018, INT J MOD PHYS B, V32, DOI 10.1142/S0217979218300037; Wang CN, 2017, COMPLEXITY, DOI 10.1155/2017/5436737; Wang CN, 2015, COMPLEXITY, V21, P370, DOI 10.1002/cplx.21572; Wang CN, 2014, COMPLEXITY, V20, P64, DOI 10.1002/cplx.21497; Wang GP, 2015, NONLINEAR DYNAM, V81, P1453, DOI 10.1007/s11071-015-2080-7; Wang HT, 2014, CHAOS, V24, DOI 10.1063/1.4892769; Wang Y, 2017, NONLINEAR DYNAM, V89, P1967, DOI 10.1007/s11071-017-3564-4; Whan CB, 1996, PHYS REV E, V53, P405, DOI 10.1103/PhysRevE.53.405; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Wu FQ, 2017, PHYSICA A, V469, P81, DOI 10.1016/j.physa.2016.11.056; Wu FQ, 2016, SCI REP-UK, V6, DOI 10.1038/s41598-016-0031-2; Xiao WW, 2016, SCI CHINA TECHNOL SC, V59, P1943, DOI 10.1007/s11431-016-6046-x; Xu Y, 2017, CHAOS SOLITON FRACT, V104, P435, DOI 10.1016/j.chaos.2017.09.002; Yang XS, 2006, CHAOS SOLITON FRACT, V27, P25, DOI 10.1016/j.chaos.2005.04.017; Yu HT, 2013, NEUROCOMPUTING, V99, P178, DOI 10.1016/j.neucom.2012.03.019; Yu WT, 2016, EPL-EUROPHYS LETT, V114, DOI 10.1209/0295-5075/114/50006; Yuan F, 2016, INT J BIFURCAT CHAOS, V26, DOI 10.1142/S0218127416501303; Zhang QY, 2014, NONLINEAR DYNAM, V78, P1489, DOI 10.1007/s11071-014-1530-y; Zheng QQ, 2015, COMPUT MATH APPL, V70, P1082, DOI 10.1016/j.camwa.2015.06.031; Zhou L, 2016, NONLINEAR DYNAM, V85, P2653, DOI 10.1007/s11071-016-2852-8	87	45	46	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191120	10.1371/journal.pone.0191120	http://dx.doi.org/10.1371/journal.pone.0191120			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342178	Green Published, gold, Green Submitted			2022-12-26	WOS:000422653800047
J	Nugroho, A; Erasmus, V; Coulter, RWS; Koirala, S; Nampaisan, O; Pamungkas, W; Richardus, JH				Nugroho, Adi; Erasmus, Vicki; Coulter, Robert W. S.; Koirala, Sushil; Nampaisan, Oranuch; Pamungkas, Wirastra; Richardus, Jan Hendrik			Driving factors of retention in care among HIV-positive MSM and transwomen in Indonesia: A cross-sectional study	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT ACCESS; TRANSGENDER WOMEN; VIRAL LOAD; HEALTH INFORMATION; INTERNET USE; SEX; MEN; TREAT; ENGAGEMENT; PREVENTION	Little is known about the prevalence of and factors that influence retention in HIV-related care among Indonesian men who have sex with men (MSM) and transgender women (trans women, or waria in Indonesian term). Therefore, we explored the driving factors of retention in care among HIV-positive MSM and waria in Indonesia. This cross-sectional study involved 298 self-reported HIV-positive MSM (n = 165) and waria (n = 133). Participants were recruited using targeted sampling and interviewed using a structured questionnaire. We applied a four-step model building process using multivariable logistic regression to examine how sociodemographic, predisposing, enabling, and reinforcing factors were associated with retention in care. Overall, 78.5% of participants were linked to HIV care within 3 months after diagnosis or earlier, and 66.4% were adequately retained in care (at least one health care visit every three months once a person is diagnosed with HIV). Being on antiretroviral therapy (adjusted odds ratio [AOR] = 6.00; 95% confidence interval [CI]: 2.93-12.3), using the Internet to find HIV-related information (AOR = 2.15; 95% CI: 1.00-4.59), and having medical insurance (AOR = 2.84; 95% CI: 1.27-6.34) were associated with adequate retention in care. Involvement with an HIV-related organization was associated negatively with retention in care (AOR = 0.47; 95% CI: 0.24-0.95). Future interventions should increase health insurance coverage and utilize the Internet to help MSM and waria to remain in HIV-related care, thereby assisting them in achieving viral suppression.	[Nugroho, Adi; Erasmus, Vicki; Richardus, Jan Hendrik] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Nugroho, Adi] Lambung Mangkurat Univ, Sch Publ Hlth, Med Fac, Banjarbaru, Indonesia; [Nugroho, Adi; Pamungkas, Wirastra] GWL INA Network, Jakarta, Indonesia; [Coulter, Robert W. S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA USA; [Coulter, Robert W. S.] Univ Pittsburgh, Grad Sch Publ Hlth, Ctr LGBT Hlth Res, Pittsburgh, PA USA; [Koirala, Sushil; Nampaisan, Oranuch] Asia Pacific Network People Living HIV AIDS, Bangkok, Thailand	Erasmus University Rotterdam; Erasmus MC; Universitas Lambung Mangkurat; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Nugroho, A (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.; Nugroho, A (corresponding author), Lambung Mangkurat Univ, Sch Publ Hlth, Med Fac, Banjarbaru, Indonesia.; Nugroho, A (corresponding author), GWL INA Network, Jakarta, Indonesia.	a.nugroho@erasmusmc.nl	Richardus, Jan Hendrik/AAE-1278-2021; Coulter, Robert WS/H-4532-2019	Richardus, Jan Hendrik/0000-0003-0564-6313; Coulter, Robert WS/0000-0001-8350-0075; Nugroho, Adi/0000-0002-6717-5740	Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) round 10 grant for Asia & the Pacific through Monitoring Treatment Access (MATA) Project; National Institute on Drug Abuse [F31DA037647]	Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) round 10 grant for Asia & the Pacific through Monitoring Treatment Access (MATA) Project; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was made possible with support from the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) round 10 grant for Asia & the Pacific through Monitoring Treatment Access (MATA) Project. Robert W.S. Coulter's contribution in this manuscript was also supported by the National Institute on Drug Abuse (award F31DA037647 at the National Institutes of Health (NIH). The opinions expressed in this work are those of the authors and do not necessarily represent those of our funders. The funders had no role in study design, data analysis, or preparation of the manuscript.	AIDS Data Hub, 2014, COUNTR PROF IND HIV; Alliance China, COMM RESP HIV MEN WH; [Anonymous], 2009, ENS UN ACC COMPR HIV; Ayala G, 2014, J AIDS CLIN RES, V5, P8, DOI DOI 10.4172/2155-6113.1000331; Belzer ME, 2014, AIDS BEHAV, V18, P686, DOI 10.1007/s10461-013-0661-3; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Brennan A, 2015, AIDS BEHAV, V19, P104, DOI 10.1007/s10461-014-0814-z; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Chakrapani V, 2014, AIDS CARE, V26, P835, DOI 10.1080/09540121.2013.861573; Chakrapani V, 2011, AIDS CARE, V23, P1687, DOI 10.1080/09540121.2011.582076; Chow JY, 2016, INT J STD AIDS, V27, P1039, DOI 10.1177/0956462416645727; Christopoulos KA, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0718-6; Christopoulos KA, 2011, CLIN INFECT DIS, V52, pS214, DOI 10.1093/cid/ciq045; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dabis F, 2014, LANCET GLOB HEALTH, V2, pE2, DOI 10.1016/S2214-109X(13)70178-5; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Glanz K, 1995, 053896 NIH; Gurol-Urganci I, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007458.pub3; Halkitis PN, 2014, AIDS CARE, V26, P1426, DOI 10.1080/09540121.2014.921276; Hallett TB, 2013, JAIDS-J ACQ IMM DEF, V63, pS228, DOI 10.1097/QAI.0b013e318298721b; Harper GW, 2013, AIDS BEHAV, V17, P213, DOI 10.1007/s10461-011-0071-3; Horvath KJ, 2012, AIDS BEHAV, V16, P900, DOI 10.1007/s10461-012-0164-7; Horvath KJ, 2009, AIDS PATIENT CARE ST, V23, P1033, DOI 10.1089/apc.2009.0163; Hussen SA, 2015, AIDS PATIENT CARE ST, V29, P77, DOI 10.1089/apc.2014.0117; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kalichman SC, 2002, PATIENT EDUC COUNS, V46, P109, DOI 10.1016/S0738-3991(01)00134-3; Kalichman SC, 2002, AIDS EDUC PREV, V14, P51, DOI 10.1521/aeap.14.1.51.24335; Kohut A., 2013, GLOBAL DIVIDE HOMOSE; Lessells RJ, 2011, JAIDS-J ACQ IMM DEF, V56, pE79, DOI 10.1097/QAI.0b013e3182075ae2; Maek-a-nantawat W, 2014, AIDS CARE, V26, P1298, DOI 10.1080/09540121.2014.911810; Mbuagbaw L, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0654-6; Ministry of Health of the Republic of Indonesia, 2011, CARD DIS RISK FACT C, V1; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; National AIDS Commission of Indonesia, 2014, GLOB AIDS RESP PROGR; Parchure R, 2015, AIDS CARE, V27, P716, DOI 10.1080/09540121.2014.996518; Perera AI, 2014, AIDS PATIENT CARE ST, V28, P579, DOI 10.1089/apc.2014.0156; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Santos GM, 2014, SEX TRANSM INFECT, V90, P430, DOI 10.1136/sextrans-2013-051342; Schwarcz S, 2011, AIDS CARE, V23, P892, DOI 10.1080/09540121.2010.534436; Sevelius JM, 2014, AIDS CARE, V26, P976, DOI 10.1080/09540121.2014.896451; Sevelius JM, 2014, ANN BEHAV MED, V47, P5, DOI 10.1007/s12160-013-9565-8; Stricker SM, 2014, AIDS BEHAV, V18, pS465, DOI 10.1007/s10461-013-0598-6; Tominari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069603; Udeagu CCN, 2013, AIDS, V27, P2271, DOI 10.1097/QAD.0b013e328362fdde; van der Kop ML, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003155; WATTERS JK, 1989, SOC PROBL, V36, P416, DOI 10.1525/sp.1989.36.4.03a00070; Wei CY, 2014, AIDS CARE, V26, P372, DOI 10.1080/09540121.2013.824538; Wohl AR, 2011, AIDS BEHAV, V15, P1098, DOI 10.1007/s10461-010-9833-6; Wong NS, 2017, AIDS BEHAV; World Health Organization, 2010, ANT THER HIV INF AD; Yang GLL, 2015, ASIA-PAC J PUBLIC HE, V27, p86S, DOI 10.1177/1010539514548758; Yehia BR, 2013, CLIN INFECT DIS, V57, P774, DOI 10.1093/cid/cit363; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	55	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191255	10.1371/journal.pone.0191255	http://dx.doi.org/10.1371/journal.pone.0191255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8II	29342172	Green Published, Green Submitted, gold			2022-12-26	WOS:000422653800056
J	Vicari, S; Piccini, G; Mercuri, E; Battini, R; Chieffo, D; Bulgheroni, S; Pecini, C; Lucibello, S; Lenzi, S; Moriconi, F; Pane, M; D'Amico, A; Astrea, G; Baranello, G; Riva, D; Cioni, G; Alfieri, P				Vicari, Stefano; Piccini, Giorgia; Mercuri, Eugenio; Battini, Roberta; Chieffo, Daniela; Bulgheroni, Sara; Pecini, Chiara; Lucibello, Simona; Lenzi, Sara; Moriconi, Federica; Pane, Marika; D'Amico, Adele; Astrea, Guja; Baranello, Giovanni; Riva, Daria; Cioni, Giovanni; Alfieri, Paolo			Implicit learning deficit in children with Duchenne muscular dystrophy: Evidence for a cerebellar cognitive impairment?	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; PARKINSONS-DISEASE; BRAIN; DISORDER; LESIONS; PET; LOCALIZATION; ATTENTION; NETWORKS; ABILITY	This study aimed at comparing implicit sequence learning in individuals affected by Duchenne Muscular Dystrophy without intellectual disability and age-matched typically developing children. A modified version of the Serial Reaction Time task was administered to 32 Duchenne children and 37 controls of comparable chronological age. The Duchenne group showed a reduced rate of implicit learning even if in the absence of global intellectual disability. This finding provides further evidence of the involvement of specific aspects of cognitive function in Duchenne muscular dystrophy and on its possible neurobiological substrate.	[Vicari, Stefano; Piccini, Giorgia; Alfieri, Paolo] Bambino Gesu Pediat Hosp, IRCCS, Child Neuropsychiat Unit, Dept Neurosci, Rome, Italy; [Mercuri, Eugenio; Chieffo, Daniela; Lucibello, Simona; Moriconi, Federica; Pane, Marika] Catholic Univ, Pediat Neurol Unit, Rome, Italy; [Mercuri, Eugenio; Chieffo, Daniela; Lucibello, Simona; Moriconi, Federica; Pane, Marika] Nemo Ctr, Rome, Italy; [Battini, Roberta; Pecini, Chiara; Lenzi, Sara; Astrea, Guja; Cioni, Giovanni] IRCCS Stella Maris, Dept Dev Neurosci, Pisa, Italy; [Battini, Roberta; Cioni, Giovanni] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Bulgheroni, Sara; Baranello, Giovanni; Riva, Daria] IRCCS Fdn Ist Neurol C Besta, Dev Neurol Div, Milan, Italy; [D'Amico, Adele] Bambino Gesu Pediat Hosp, IRCCS, Dept Neurosci, Neuromuscular & Neurodegenerat Dis Unit, Rome, Italy	IRCCS Bambino Gesu; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Fondazione Stella Maris; University of Pisa; IRCCS Bambino Gesu	Alfieri, P (corresponding author), Bambino Gesu Pediat Hosp, IRCCS, Child Neuropsychiat Unit, Dept Neurosci, Rome, Italy.	paolo.alfieri@opbg.net	Astrea, Guja/F-8960-2019; battini, roberta/P-9095-2017; Lucibello, Simona/AAB-6848-2022; Lenzi, Sara/AAB-6181-2020; Cioni, Giovanni/A-4178-2015; Astrea, Guja/K-7339-2014; Vicari, Stefano/J-3008-2012; Pecini, Chiara/AAD-7805-2021; Bulgheroni, Sara/AAV-2402-2021; Mercuri, Eugenio/G-1351-2015	Astrea, Guja/0000-0001-8588-0323; battini, roberta/0000-0002-7889-1355; Lucibello, Simona/0000-0003-0970-5755; Lenzi, Sara/0000-0002-5740-2831; Cioni, Giovanni/0000-0002-6526-5566; Astrea, Guja/0000-0001-8588-0323; Bulgheroni, Sara/0000-0002-0905-8810; PECINI, CHIARA/0000-0002-7857-7884; Pane, Marika/0000-0002-4851-6124; Mercuri, Eugenio/0000-0002-9851-5365				Astrea G, 2015, RES DEV DISABIL, V45-46, P168, DOI 10.1016/j.ridd.2015.07.025; Battini R, 2018, NEUROMUSCUL IN PRESS; Billard C, 1998, DEV MED CHILD NEUROL, V40, P12, DOI 10.1111/j.1469-8749.1998.tb15351.x; Bodranghien F, 2016, CEREBELLUM, V15, P369, DOI 10.1007/s12311-015-0687-3; Colombo P, 2017, EUR J PAEDIATR NEURO, V21, P639, DOI 10.1016/j.ejpn.2017.02.007; Cyrulnik SE, 2008, NEUROSCI BIOBEHAV R, V32, P486, DOI 10.1016/j.neubiorev.2007.09.001; D'Angelo MG, 2011, PEDIATR NEUROL, V45, P292, DOI 10.1016/j.pediatrneurol.2011.08.003; Daoud F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006574; Daoud F, 2009, HUM MOL GENET, V18, P3779, DOI 10.1093/hmg/ddp320; Doyon J, 1996, EUR J NEUROSCI, V8, P637, DOI 10.1111/j.1460-9568.1996.tb01249.x; De Moura MCDS, 2010, DEV MED CHILD NEUROL, V52, pe10, DOI 10.1111/j.1469-8749.2009.03540.x; Exner C, 2002, LEARN MEMORY, V9, P376, DOI 10.1101/lm.48402; Ferrucci R, 2013, CEREBELLUM, V12, P485, DOI 10.1007/s12311-012-0436-9; Gomez-Beldarrain M, 1998, EXP BRAIN RES, V120, P25, DOI 10.1007/s002210050374; Hazeltine E, 1997, BRAIN, V120, P123, DOI 10.1093/brain/120.1.123; HODGSON SV, 1992, NEUROMUSCULAR DISORD, V2, P269, DOI 10.1016/0960-8966(92)90059-F; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Honda M, 1998, BRAIN, V121, P2159, DOI 10.1093/brain/121.11.2159; HUARD J, 1992, NEUROSCI LETT, V137, P105, DOI 10.1016/0304-3940(92)90309-U; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; KIM TW, 1995, ANN NEUROL, V38, P446, DOI 10.1002/ana.410380315; KIM TW, 1992, P NATL ACAD SCI USA, V89, P11642, DOI 10.1073/pnas.89.23.11642; Leggio M, 2015, CEREBELLUM, V14, P35, DOI 10.1007/s12311-014-0616-x; LIDOV HGW, 1990, NATURE, V348, P725, DOI 10.1038/348725a0; Magri F, 2011, J NEUROL, V258, P1610, DOI 10.1007/s00415-011-5979-z; Menghini D, 2006, NEUROIMAGE, V33, P1218, DOI 10.1016/j.neuroimage.2006.08.024; Moizard MP, 1998, AM J MED GENET, V80, P32, DOI 10.1002/(SICI)1096-8628(19981102)80:1<32::AID-AJMG6>3.0.CO;2-Y; Molinari M, 1997, BRAIN, V120, P1753, DOI 10.1093/brain/120.10.1753; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Pane M, 2012, J PEDIATR-US, V161, P705, DOI 10.1016/j.jpeds.2012.03.020; PASCUALLEONE A, 1993, ANN NEUROL, V34, P594, DOI 10.1002/ana.410340414; Piccini G, 2015, RES DEV DISABIL, V36, P55, DOI 10.1016/j.ridd.2014.09.021; Quintero-Gallego E.A., 2006, BEHAV BRAIN FUNCT, V2, P1; Rauch SL, 1997, J NEUROPSYCH CLIN N, V9, P568; RAUCH SL, 1995, COMPR PSYCHIAT, V36, P141, DOI 10.1016/S0010-440X(95)90109-4; Ricotti V, 2011, DEV MED CHILD NEUROL, V53, P12, DOI 10.1111/j.1469-8749.2010.03836.x; Riva D, 1998, CORTEX, V34, P279, DOI 10.1016/S0010-9452(08)70755-X; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; Schara U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126528; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Shin JC, 2003, J COGNITIVE NEUROSCI, V15, P1232, DOI 10.1162/089892903322598175; Snow WM, 2013, NEUROSCI BIOBEHAV R, V37, P743, DOI 10.1016/j.neubiorev.2013.03.016; Taylor PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008803; TINSLEY JM, 1993, CURR OPIN GENET DEV, V3, P484, DOI 10.1016/0959-437X(93)90124-8; Torriero S, 2007, NEUROPSYCHOLOGIA, V45, P1208, DOI 10.1016/j.neuropsychologia.2006.10.007; Tzvi E, 2015, NEUROIMAGE, V122, P52, DOI 10.1016/j.neuroimage.2015.07.077; Vicari S, 2007, J INTELL DISABIL RES, V51, P932, DOI 10.1111/j.1365-2788.2007.01003.x; Vicari S, 2005, J NEUROL NEUROSUR PS, V76, P1392, DOI 10.1136/jnnp.2004.061093; Vicari S, 2001, NEUROPSYCHOLOGIA, V39, P665, DOI 10.1016/S0028-3932(01)00012-4; Vicari S, 2000, NEUROPSYCHOLOGIA, V38, P240, DOI 10.1016/S0028-3932(99)00081-0	50	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191164	10.1371/journal.pone.0191164	http://dx.doi.org/10.1371/journal.pone.0191164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29338029	Green Published, gold			2022-12-26	WOS:000422652700034
J	Xie, JF; Robertson, JM; Chen, CW; Zhang, WX; Coopersmith, CM; Ford, ML				Xie, Jianfeng; Robertson, Jennifer M.; Chen, Ching-wen; Zhang, Wenxiao; Coopersmith, Craig M.; Ford, Mandy L.			Pre-existing malignancy results in increased prevalence of distinct populations of CD4(+)T cells during sepsis	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; REGULATORY T-CELLS; INFILTRATING LYMPHOCYTES; INHIBITORY RECEPTORS; IMPROVES SURVIVAL; PROGNOSTIC VALUE; CANCER-PATIENTS; SEPTIC SHOCK; MORTALITY; PD-1	The presence of pre-existing malignancy in murine hosts results in increased immune dys-regulation and risk of mortality following a septic insult. Based on the known systemic immunologic changes that occur in cancer hosts, we hypothesized that the presence of preexisting malignancy would result in phenotypic and functional changes in CD4(+)T cell responses following sepsis. In order to conduct a non-biased, unsupervised analysis of phenotypic differences between CD4(+)T cell compartments, cohorts of mice were injected with LLC1 tumor cells and tumors were allowed to grow for 3 weeks. These cancer hosts and age-matched non-cancer controls were then subjected to CLP. Splenocytes were harvested at 24h post CLP and flow cytometry and SPADE (Spanning-tree Progression Analysis of Density-normalized Events) were used to analyze populations of CD4(+) cells most different between the two groups. Results indicated that relative to non-cancer controls, cancer mice contained more resting memory CD4(+)T cells, more activated CD4(+) effectors, and fewer naive CD4(+)T cells during sepsis, suggesting that the CD4(+) T cell compartment in cancer septic hosts is one of increased activation and differentiation. Moreover, cancer septic animals exhibited expansion of two distinct subsets of CD4(+) T cells relative to previously healthy septic controls. Specifically, we identified increases in both a PD-1(hi) population and a distinct 2B4(hi) BTLA(hi) LAG-3(hi) population in cancer septic animals. By combining phenotypic analysis of exhaustion markers with functional analysis of cytokine production, we found that PD-1(+) CD4(+) cells in cancer hosts failed to make any cytokines following CLP, while the 2B4(+)PD-1(lo) cells in cancer mice secreted increased TNF during sepsis. In sum, the immunophenotypic landscape of cancer septic animals is characterized by both increased CD4(+)T cell activation and exhaustion, findings that may underlie the observed increased mortality in mice with pre-existing malignancy following sepsis.	[Xie, Jianfeng; Robertson, Jennifer M.; Chen, Ching-wen; Zhang, Wenxiao; Coopersmith, Craig M.; Ford, Mandy L.] Emory Univ, Dept Surg, Atlanta, GA 30322 USA	Emory University	Ford, ML (corresponding author), Emory Univ, Dept Surg, Atlanta, GA 30322 USA.	mandy.ford@emory.edu	Chen, Ching-wen/ABH-8484-2020	Robertson, Jennifer/0000-0002-1613-0091	National Institutes of Health grants [GM104323, GM109779, GM113228, GM072808, GM095442]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072808, R01GM113228, T32GM095442, R01GM104323, R01GM109779] Funding Source: NIH RePORTER	National Institutes of Health grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health grants GM104323, GM109779, and GM113228 (to MLF and CMC), GM072808 and GM095442 (to CMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Chang K, 2014, CRIT CARE, V18, DOI 10.1186/cc13176; Chang KC, 2013, CRIT CARE, V17, DOI 10.1186/cc12711; Chang KY, 2013, J BIOMED SCI, V20, DOI [10.1186/1423-0127-20-43, 10.5953/JMJH.2013.20.1.1]; Coopersmith CM, 2002, CRIT CARE MED, V30, P195, DOI 10.1097/00003246-200201000-00028; Danai PA, 2006, CHEST, V129, P1432, DOI 10.1378/chest.129.6.1432; de Montmollin E, 2013, SHOCK, V39, P250, DOI 10.1097/SHK.0b013e3182866d32; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Fabre J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091433; Fan J, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/8596181; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Fourcade J, 2012, CANCER RES, V72, P887, DOI 10.1158/0008-5472.CAN-11-2637; Fox AC, 2011, J IMMUNOL, V187, P1950, DOI 10.4049/jimmunol.1003391; Fox AC, 2010, CRIT CARE MED, V38, P886, DOI 10.1097/CCM.0b013e3181c8fdb1; Gao DN, 2015, INT J CLIN EXP MED, V8, P18998; Goyert SM, 2010, J LEUKOCYTE BIOL, V88, P225, DOI 10.1189/jlb.0410240; Grau GE, 1997, NAT MED, V3, P1193, DOI 10.1038/nm1197-1193; Guignant C, 2011, CRIT CARE, V15, DOI 10.1186/cc10112; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Lyons JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149069; Melamed A, 2009, CRIT CARE, V13, DOI 10.1186/cc7733; Mittal R, 2015, J SURG RES, V195, P541, DOI 10.1016/j.jss.2015.02.004; Molinaro R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133227; Monaghan SF, 2012, SHOCK, V38, P117, DOI 10.1097/SHK.0b013e31825de6a3; Monaghan SF, 2012, ANN SURG, V255, P158, DOI 10.1097/SLA.0b013e31823433ca; Monneret G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1370-x; Nair JR, 2011, J IMMUNOL, V187, P1243, DOI 10.4049/jimmunol.1100016; Patera AC, 2016, J LEUKOC BIOL; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Remick DG, 2005, INFECT IMMUN, V73, P2751, DOI 10.1128/IAI.73.5.2751-2757.2005; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Rhee C, 2017, JAMA; Rosolem MM, 2012, J CRIT CARE, V27, P301, DOI 10.1016/j.jcrc.2011.06.014; Safdar A, 2001, CRIT CARE CLIN, V17, P531, DOI 10.1016/S0749-0704(05)70198-6; Serbanescu MA, 2016, J LEUKOC BIOL; Shang B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15179; Shubin NJ, 2013, CRIT CARE, V17, DOI 10.1186/cc13131; Shubin NJ, 2012, J LEUKOCYTE BIOL, V92, P593, DOI 10.1189/jlb.1211641; Soares M, 2010, CRIT CARE MED, V38, P9, DOI 10.1097/CCM.0b013e3181c0349e; Stieglitz D, 2015, IMMUN INFLAMM DIS, V3, P374, DOI 10.1002/iid3.75; Tang LX, 2014, J LEUKOCYTE BIOL, V96, P809, DOI 10.1189/jlb.4MA1213-647RR; Torres VBL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164537; Torres VBL, 2015, ANN AM THORAC SOC, V12, P1185, DOI 10.1513/AnnalsATS.201501-046OC; Wang F, 2016, AM J PHYSIOL-GASTR L, V311, pG237, DOI 10.1152/ajpgi.00371.2015; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Williams MD, 2004, CRIT CARE, V8, pR291, DOI 10.1186/cc2893; Wisnoski N, 2007, SHOCK, V27, P251, DOI 10.1097/01.shk.0000239780.33398.e4; Young JS, 2016, SHOCK, V45, P534, DOI 10.1097/SHK.0000000000000553	54	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191065	10.1371/journal.pone.0191065	http://dx.doi.org/10.1371/journal.pone.0191065			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338031	Green Published, Green Submitted, gold			2022-12-26	WOS:000422652700029
J	Shen, CY; Yan, YR; Zhao, H; Pan, JY; Devlin, AT				Shen, Chunyan; Yan, Yunrong; Zhao, Hui; Pan, Jiayi; Devlin, Adam T.			Influence of monsoonal winds on chlorophyll-alpha distribution in the Beibu Gulf	PLOS ONE			English	Article							SOUTH CHINA SEA; IN-SITU; OCEAN; WATER; VARIABILITY; CIRCULATION; BLOOMS	The influence of seasonal, monsoonal winds on the temporal and spatial variability of chlorophyll-a (chl-a) in the Beibu Gulf is studied based on long-term satellite data of sea surface winds, chl-a concentration and sea surface temperature (SST) and in-situ observations for the years from 2002 to 2014. The analysis results indicated that under northeasterly monsoonal winds, chl-a concentrations were substantially elevated in most area of the Beibu Gulf, with a high chl-a concentration (>2 mg m(-3)) patch extending southwestward from the coastal water of the northeastern Gulf, consistent with the winter wind pattern. Meanwhile, the spatial distribution of high chl-a concentration is correlated with low SST in the northeastern Gulf. In the southern Gulf, there was generally low chl-a, except in the coastal waters southwest of Hainan Island. Here, the upwelling cold water prevails outside the mouth of the Beibu Gulf, driven by the southwesterly monsoonal winds and the runoff from the Changhua River, as implied by low observed SST. Correlation analysis indicated the chl-a concentration was strongly modulated by wind speed (r = 0.63, p<0.001), particularly in the middle of the northern Gulf and southern Hainan Island (r>0.7, p<0.001). Integrated analysis also showed that stratification is weak and mixing is strong in winter as affected by the high wind speed, which suggests that the wind-induced mixing is a dominant mechanism for entrainment of nutrients and the spatial distribution of chl-a in winter.	[Shen, Chunyan; Yan, Yunrong] Guangdong Ocean Univ, Coll Fisheries, Zhanjiang, Peoples R China; [Shen, Chunyan; Yan, Yunrong] Guangdong Ocean Univ, Ctr South China Sea Fisheries Resources Monitoring, Zhanjiang, Peoples R China; [Zhao, Hui] Guangdong Ocean Univ, Fac Chem & Environm Sci, Zhanjiang, Peoples R China; [Pan, Jiayi; Devlin, Adam T.] Chinese Univ Hong Kong, Inst Space & Earth Informat Sci, Hong Kong, Hong Kong, Peoples R China; [Pan, Jiayi] Chinese Univ Hong Kong, Shenzhen Res Inst, Hong Kong, Hong Kong, Peoples R China; [Pan, Jiayi] Nanjing Univ Informat Sci & Technol, Coll Marine Sci, Nanjing, Jiangsu, Peoples R China	Guangdong Ocean University; Guangdong Ocean University; Guangdong Ocean University; Chinese University of Hong Kong; Chinese University of Hong Kong; Nanjing University of Information Science & Technology	Yan, YR (corresponding author), Guangdong Ocean Univ, Coll Fisheries, Zhanjiang, Peoples R China.; Yan, YR (corresponding author), Guangdong Ocean Univ, Ctr South China Sea Fisheries Resources Monitoring, Zhanjiang, Peoples R China.; Zhao, H (corresponding author), Guangdong Ocean Univ, Fac Chem & Environm Sci, Zhanjiang, Peoples R China.	tuna_ps@126.com; huizhao1978@163.com			National Natural Science Foundation of China [41376125, 41376158, 41476066, 41406113, 41406041]; Natural Science Foundation of Guangdong Province [2016A030313754]; Open Foundation of State Key Laboratory of Tropical Oceanography, South China Sea Institute of Oceanology, Chinese Academy of Sciences; General Research Fund of Hong Kong Research Grants Council (RGC) [CUHK402912, 403113]; Hong Kong Innovation and Technology Fund [ITS/321/13]; Chinese University of Hong Kong, the Foundation for Distinguished Young Teacher in Higher Education of Guangdong [Yq2014004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Open Foundation of State Key Laboratory of Tropical Oceanography, South China Sea Institute of Oceanology, Chinese Academy of Sciences; General Research Fund of Hong Kong Research Grants Council (RGC); Hong Kong Innovation and Technology Fund; Chinese University of Hong Kong, the Foundation for Distinguished Young Teacher in Higher Education of Guangdong	This study is supported by the National Natural Science Foundation of China (Nos. 41376125, 41376158, 41476066, 41406113, 41406041), the Natural Science Foundation of Guangdong Province (No. 2016A030313754), the Open Foundation of State Key Laboratory of Tropical Oceanography, South China Sea Institute of Oceanology, Chinese Academy of Sciences. This work is also supported by the General Research Fund of Hong Kong Research Grants Council (RGC) under Grants CUHK402912 and 403113, the Hong Kong Innovation and Technology Fund under Grant ITS/321/13, and the direct grants of the Chinese University of Hong Kong, the Foundation for Distinguished Young Teacher in Higher Education of Guangdong (Yq2014004).	[Anonymous], 1998, ACTA OCEANOL SIN, DOI DOI 10.1088/0256-307X/15/12/024; [Anonymous], 2013, THESIS; Botsford LW, 2006, DEEP-SEA RES PT II, V53, P3116, DOI 10.1016/j.dsr2.2006.07.011; Chai F, 2009, J OCEANOGR, V65, P703, DOI 10.1007/s10872-009-0061-5; Chao SY, 1996, DEEP-SEA RES PT I, V43, P445, DOI 10.1016/0967-0637(96)00025-8; Chen B., 1986, J GUANGXI ACAD SCI, V2, P93; Chen CC, 2006, J MARINE SYST, V59, P97, DOI 10.1016/j.jmarsys.2005.09.002; Chen ZZ, 2006, SECTIONAL FEATURES T; Deng J.Z., 1999, NANHAI YANJIU YU KAI, V2, P41; Dwivedi RM, 2008, INT J REMOTE SENS, V29, P4537, DOI 10.1080/01431160802029693; Gao J. S., 2014, GUANGXI SCI, V21, P64; Gao JS, 2017, CONT SHELF RES, V138, P106, DOI 10.1016/j.csr.2017.02.009; GORDON HR, 1990, APPL OPTICS, V29, P3228, DOI 10.1364/AO.29.003228; Hu JY, 2008, MARINE SCI RES PAPER; Huang Yi-chen, 2008, Xiamen Daxue Xuebao (Ziran Kexue Ban), V47, P856; Jing ZY, 2009, CONT SHELF RES, V29, P467, DOI 10.1016/j.csr.2008.11.008; Kahru M, 2014, REMOTE SENS-BASEL, V6, P8524, DOI 10.3390/rs6098524; Levitus S, 1983, EOS T AM GEOPHYS UNI, V64, P962; Liu G, 2009, ICES J MAR SCI, V66, P420, DOI 10.1093/icesjms/fsn219; Liu KK, 2002, DEEP-SEA RES PT I, V49, P1387, DOI 10.1016/S0967-0637(02)00035-3; Lu XG, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032440; Manh D.V., 2000, J OCEANOGR, V56, P59, DOI [10.1023/A:1011162524466, DOI 10.1023/A.1011162524466, DOI 10.1023/A:1011162524466]; Martin MC, 2007, IAG SYMP, V130, P84; Melin F, 2007, REMOTE SENS ENVIRON, V110, P192, DOI 10.1016/j.rse.2007.02.026; Monterey G. I., 1997, NOAA ATLAS NESDIS, V14; Ning X, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002365; Parsons T., 2013, MANUAL CHEM BIOL MET, DOI DOI 10.1016/B978-0-08-030287-4.50011-6; Qi-Zhou H, 1994, OCEANOLOGY CHINA SEA, P113; Sathyendranath S., 2000, REPORTS INT OCEAN CO, DOI DOI 10.25607/OBP-95; Shang SL, 2016, REMOTE SENS ENVIRON, V186, P22, DOI 10.1016/j.rse.2016.08.020; SHAW PT, 1994, DEEP-SEA RES PT I, V41, P1663, DOI 10.1016/0967-0637(94)90067-1; Shen CY, 2014, INT J REMOTE SENS, V35, P4127, DOI 10.1080/01431161.2014.916056; Siegel H, 2007, CONT SHELF RES, V27, P258, DOI 10.1016/j.csr.2006.10.003; Su J.L., 2005, HYDROGRAPHY CHINA SE; Sun H.L., 2001, OCEANOLOGIA LIMNOLOG, V5, P561; [孙欢 Sun Huan], 2017, [海洋环境科学, Marine Environmental Science], V36, P343; Tan SC, 2014, ATMOS ENVIRON, V99, P491, DOI 10.1016/j.atmosenv.2014.10.016; Tang DL, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC002045; Tang DL, 2004, MAR ECOL PROG SER, V268, P31, DOI 10.3354/meps268031; Tang DL, 2003, REMOTE SENS ENVIRON, V85, P475, DOI 10.1016/S0034-4257(03)00049-X; Tasnim A, 2015, ESTIMATION CHEM OXYG; van Maren DS, 2007, J ASIAN EARTH SCI, V29, P508, DOI 10.1016/j.jseaes.2006.03.012; van Maren DS, 2005, CONT SHELF RES, V25, P503, DOI 10.1016/j.csr.2004.10.010; Wang B, 2009, DYNAM ATMOS OCEANS, V47, P15, DOI 10.1016/j.dynatmoce.2008.09.004; Wei MX, 1988, MAR SCI, V4, P46; Wu YC, 2014, GUANGZHOU CHEM IND, V42, P144, DOI DOI 10.3969/j.issn.1001-9677.2014.08.051; Xiao M., 2011, APPL GIS WATERSHED E; Yang YJ, 2012, ATMOS OCEAN SCI LETT, V5, P15, DOI 10.1080/16742834.2012.11446961; Ye HJ, 2013, J MARINE SYST, V128, P138, DOI 10.1016/j.jmarsys.2013.04.010; Zhao H., 2006, ADV GEOSCIENCES, V5, P7, DOI [10.1142/9789812707215_0002, DOI 10.1142/9789812707215_0002]; Zu T.T., 2005, ANAL CURRENT ITS MEC	52	14	16	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191051	10.1371/journal.pone.0191051	http://dx.doi.org/10.1371/journal.pone.0191051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329314	Green Published, Green Submitted, gold			2022-12-26	WOS:000419954100035
J	Corby-Harris, V; Snyder, L; Meador, C; Ayotte, T				Corby-Harris, Vanessa; Snyder, Lucy; Meador, Charlotte; Ayotte, Trace			Honey bee (Apis mellifera) nurses do not consume pollens based on their nutritional quality	PLOS ONE			English	Article							FORAGING BEHAVIOR; L HYMENOPTERA; COLONIES; PROTEIN; FORAGERS; BROOD; SURVIVAL; BALANCE; APIDAE; DIETS	Honey bee workers (Apis mellifera) consume a variety of pollens to meet the majority of their requirements for protein and lipids. Recent work indicates that honey bees prefer diets that reflect the proper ratio of nutrients necessary for optimal survival and homeostasis. This idea relies on the precept that honey bees evaluate the nutritional composition of the foods provided to them. While this has been shown in bumble bees, the data for honey bees are mixed. Further, there is controversy as to whether foragers can evaluate the nutritional value of pollens, especially if they do not consume it. Here, we focused on nurse workers, who eat most of the pollen coming into the hive. We tested the hypothesis that nurses prefer diets with higher nutritional value. We first determined the nutritional profile, number of plant taxa (richness), and degree of hypopharyngeal gland (HG) growth conferred by three honey bee collected pollens. We then presented nurses with these same three pollens in paired choice assays and measured consumption. To further test whether nutrition influenced preference, we also presented bees with natural pollens supplemented with protein or lipids and liquid diets with protein and lipid ratios equal to the natural pollens. Different pollens conferred different degrees of HG growth, but despite these differences, nurse bees did not always prefer the most nutritious pollens. Adding protein and/or lipids to less desirable pollens minimally increased pollen attractiveness, and nurses did not exhibit a strong preference for any of the three liquid diets. We conclude that different pollens provide different nutritional benefits, but that nurses either cannot or do not assess pollen nutritional value. This implies that the nurses may not be able to communicate information about pollen quality to the foragers, who regulate the pollens coming into the hive.	[Corby-Harris, Vanessa; Snyder, Lucy; Meador, Charlotte; Ayotte, Trace] USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA	United States Department of Agriculture (USDA)	Corby-Harris, V (corresponding author), USDA ARS, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA.	vanessa.corby@ars.usda.gov		Corby-Harris, Vanessa/0000-0001-7680-0328	USDA-ARS [2022-21000-017-00-D]	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by internal funds from the USDA-ARS (Project Number: 2022-21000-017-00-D). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge Vincent Ricigliano and Mark Carroll and two anonymous reviewers for comments on a previous version of the manuscript, Dr. Vaughn M. Bryant at the Texas A&M Palynology Laboratory, and Dr. Bradley S. Evans at the Donald Danforth Plant Science Center. This work was supported by internal funds from the USDA-ARS (Project Number: 2022-21000-017-00-D). The ARS/USDA is an equal opportunity employer and provider.	Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Anderson KE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058425, 10.1371/journal.pone.0083125]; Arien Y, 2015, P NATL ACAD SCI USA, V112, P15761, DOI 10.1073/pnas.1517375112; Baum KA, 2004, ENVIRON ENTOMOL, V33, P727, DOI 10.1603/0046-225X-33.3.727; Beekman M, 2016, INSECT SOC, V63, P117, DOI 10.1007/s00040-015-0443-1; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Calderone NW, 2002, ANIM BEHAV, V63, P749, DOI 10.1006/anbe.2001.1957; Camazine S, 1998, APIDOLOGIE, V29, P113, DOI 10.1051/apido:19980107; CAMAZINE S, 1993, BEHAV ECOL SOCIOBIOL, V32, P265, DOI 10.1007/BF00166516; Cook SM, 2003, ECOL ENTOMOL, V28, P622, DOI 10.1046/j.1365-2311.2003.00548.x; Corby-Harris V, 2016, J INSECT PHYSIOL, V85, P65, DOI 10.1016/j.jinsphys.2015.11.016; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; Corby-Harris V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-134; Cornman RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145365; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; CRAILSHEIM K, 1990, APIDOLOGIE, V21, P417, DOI 10.1051/apido:19900504; DeGrandi-Hoffman G, 2008, J APICULT RES, V47, P265, DOI 10.3896/IBRA.1.47.4.06; DeGrandi-Hoffman G, 2016, APIDOLOGIE, V47, P186, DOI 10.1007/s13592-015-0386-6; DeGrandi-Hoffman G, 2010, J INSECT PHYSIOL, V56, P1184, DOI 10.1016/j.jinsphys.2010.03.017; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Di Pasquale G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162818; Dreller C, 2000, ANIM BEHAV, V59, P91, DOI 10.1006/anbe.1999.1303; Dreller C, 1999, BEHAV ECOL SOCIOBIOL, V45, P227, DOI 10.1007/s002650050557; Fowler RE, 2016, INSECT CONSERV DIVER, V9, P481, DOI 10.1111/icad.12197; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Haydak MH, 1935, J ECON ENTOMOL, V28, P657, DOI 10.1093/jee/28.4.657; Haydak MH, 1937, ANN ENTOMOL SOC AM, V30, P252; Hendriksma HP, 2016, BEHAV ECOL SOCIOBIOL, V70, P509, DOI 10.1007/s00265-016-2067-5; HOPKINS CY, 1969, CAN J BIOCHEM CELL B, V47, P433, DOI 10.1139/o69-067; Keller A, 2015, PLANT BIOLOGY, V17, P558, DOI 10.1111/plb.12251; Kitaoka TK, 2009, BEHAV ECOL SOCIOBIOL, V63, P501, DOI 10.1007/s00265-008-0684-3; Lehotay SJ, 2005, J AOAC INT, V88, P615; Leonhardt SD, 2012, APIDOLOGIE, V43, P449, DOI 10.1007/s13592-011-0112-y; LEPAGE M, 1968, LIPIDS, V3, P530, DOI 10.1007/BF02530897; Little DP, 2004, AM J BOT, V91, P1872, DOI 10.3732/ajb.91.11.1872; London-Shafir I, 2003, PLANT SYST EVOL, V238, P87, DOI 10.1007/s00606-003-0272-y; Lundin O, 2017, ENVIRON ENTOMOL, V46, P559, DOI 10.1093/ee/nvx052; MORITZ B, 1987, J INSECT PHYSIOL, V33, P923, DOI 10.1016/0022-1910(87)90004-7; Nicholls E, 2014, J EXP BIOL, V217, P2783, DOI 10.1242/jeb.106120; Omar E, 2017, APIDOLOGIE, V48, P425, DOI 10.1007/s13592-016-0487-x; Pankiw T, 1998, BEHAV ECOL SOCIOBIOL, V44, P193, DOI 10.1007/s002650050531; Paoli PP, 2014, AMINO ACIDS, V46, P1449, DOI 10.1007/s00726-014-1706-2; Pernal SF, 2000, APIDOLOGIE, V31, P387, DOI 10.1051/apido:2000130; Pernal SF, 2001, BEHAV ECOL SOCIOBIOL, V51, P53, DOI 10.1007/s002650100412; Pernal SF, 2002, ANIM BEHAV, V63, P369, DOI 10.1006/anbe.2001.1904; REGALI A, 1995, APIDOLOGIE, V26, P273, DOI 10.1051/apido:19950401; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1500043; Ricigliano VA, 2017, ARCH INSECT BIOCHEM, V96, DOI 10.1002/arch.21406; RINDERER TE, 1974, J INVERTEBR PATHOL, V23, P347, DOI 10.1016/0022-2011(74)90100-1; Ruedenauer FA, 2016, BEHAV ECOL SOCIOBIOL, V70, P1209, DOI 10.1007/s00265-016-2129-8; Ruedenauer FA, 2015, J EXP BIOL, V218, P2233, DOI 10.1242/jeb.118554; Sagili RR, 2007, BEHAV ECOL SOCIOBIOL, V61, P1471, DOI 10.1007/s00265-007-0379-1; Schmehl DR, 2014, J INSECT PHYSIOL, V71, P177, DOI 10.1016/j.jinsphys.2014.10.002; SCHMIDT JO, 1987, ANN ENTOMOL SOC AM, V80, P176, DOI 10.1093/aesa/80.2.176; SCHMIDT LS, 1995, J ECON ENTOMOL, V88, P1591, DOI 10.1093/jee/88.6.1591; Smart MD, 2017, ENVIRON ENTOMOL, V46, P38, DOI 10.1093/ee/nvw159; STANDIFER LN, 1967, INSECT SOC, V14, P415, DOI 10.1007/BF02223687; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; Vaudo AD, 2016, J EXP BIOL, V219, P3962, DOI 10.1242/jeb.140772; Vaudo AD, 2016, P NATL ACAD SCI USA, V113, pE4035, DOI 10.1073/pnas.1606101113; Vaudo AD, 2015, CURR OPIN INSECT SCI, V10, P133, DOI 10.1016/j.cois.2015.05.008; Vaughan DM, 2002, INSECT SOC, V49, P23, DOI 10.1007/s00040-002-8273-3; Waddington KD, 1998, ANIM BEHAV, V56, P35, DOI 10.1006/anbe.1998.0736; WAHL O, 1983, OECOLOGIA, V59, P106, DOI 10.1007/BF00388082; WALDBAUER GP, 1991, ANNU REV ENTOMOL, V36, P43, DOI 10.1146/annurev.en.36.010191.000355; Weidenmuller A, 2002, ETHOLOGY, V108, P205, DOI 10.1046/j.1439-0310.2002.00759.x; Wilson EE, 2010, MOL ECOL, V19, P4823, DOI 10.1111/j.1365-294X.2010.04849.x; Winston M., 1987, The biology of the honey bee.; Woodard SH, 2017, CURR OPIN INSECT SCI, V22, P101, DOI 10.1016/j.cois.2017.06.001; Zarchin S, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2394-1	72	28	28	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191050	10.1371/journal.pone.0191050	http://dx.doi.org/10.1371/journal.pone.0191050			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324841	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400101
J	Ertl, HMH; Mora, MA; Brightsmith, DJ; Navarro-Alberto, JA				Ertl, Hannah M. H.; Mora, Miguel A.; Brightsmith, Donald J.; Navarro-Alberto, Jorge A.			Potential impact of neonicotinoid use on Northern bobwhite (Colinus virginianus) in Texas: A historical analysis	PLOS ONE			English	Article							METHYL PARATHION; QUAIL ABUNDANCE; BIRDS; PESTICIDES; EXPOSURE; INSECTICIDES; TOXICITY; RISKS; PRECIPITATION; FIPRONIL	The widespread use of neonicotinoid insecticides in recent years has led to increasing environmental concern, including impacts to avian populations. In Texas and across their range, Northern bobwhite (Colinus virginianus) habitat frequently overlaps cultivated cropland protected by neonicotinoids. To address the effects of neonicotinoid use on bobwhites in Texas, we conducted a historical analysis from 1978-2012 in Texas' ecological regions using quail count data collected from North American Breeding Bird Survey and Texas Parks and Wildlife Department, and neonicotinoid use data from the U.S. Geological Survey. We considered bobwhite abundance, neonicotinoid use, climate, and land-use variables in our analysis. Neonicotinoid use was significantly (p<0.05) negatively associated with bobwhite abundance in the High Plains, Rolling Plains, Gulf Coast Prairies & Marshes, Edwards Plateau, and South Texas Plains ecological regions in the time periods following neonicotinoid introduction (1994-2003) or after their widespread use (2004-2012). Our analyses suggest that the use of neonicotinoid insecticides may negatively affect bobwhite populations in crop-producing regions of Texas.	[Ertl, Hannah M. H.; Mora, Miguel A.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Brightsmith, Donald J.] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX USA; [Navarro-Alberto, Jorge A.] Univ Autonoma Yucatan, Dept Ecol Trop, Yucatan, Mexico	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Mora, MA (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	mmora@tamu.edu	Alberto, Jorge A. Navarro/A-5086-2016; Alberto, Jorge Navarro/AAG-9078-2019; Mora, Miguel/B-1344-2009	Mora, Miguel/0000-0002-8393-0216	Reversing the Quail Decline in Texas Initiative; Upland Game Bird Stamp Fund; Texas Parks and Wildlife Department; Texas A&M AgriLife Extension Service [40035692720]	Reversing the Quail Decline in Texas Initiative; Upland Game Bird Stamp Fund; Texas Parks and Wildlife Department; Texas A&M AgriLife Extension Service	Funding was provided through the Reversing the Quail Decline in Texas Initiative and the Upland Game Bird Stamp Fund based on a collaborative effort between Texas Parks and Wildlife Department and Texas A&M AgriLife Extension Service. Grant number 40035692720.; Funding was provided through the Reversing the Quail Decline in Texas Initiative and the Upland Game Bird Stamp Fund based on a collaborative effort between Texas Parks and Wildlife Department and Texas A&M AgriLife Extension Service. We thank Mike Frisbee and Texas Parks and Wildlife Department for allowing us to utilize bobwhite data as well as Dale Rollins and Diane Boellstorff for reviewing earlier versions of this manuscript.	ALLEN CR, 1995, ECOL APPL, V5, P632, DOI 10.2307/1941972; ArcGIS, 2011, BREED BIRD SURV ROUT; Badgujar PC, 2013, ENVIRON TOXICOL PHAR, V35, P408, DOI 10.1016/j.etap.2013.01.012; Baker N.T., 2015, US GEOLOGICAL SURVEY, V907, DOI [DOI 10.3133/DS907, 10.3133/ds907]; Balani Tarun, 2011, Toxicol Int, V18, P2, DOI 10.4103/0971-6580.75843; Beecher NA, 2002, CONSERV BIOL, V16, P1620, DOI 10.1046/j.1523-1739.2002.01228.x; Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; Berny PJ, 1999, J LIQ CHROMATOGR R T, V22, P1547, DOI 10.1081/JLC-100101750; BEST LB, 1990, AM MIDL NAT, V123, P84, DOI 10.2307/2425762; BirdLife International, 2016, COL VIRG IUCN RED LI; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Boatman ND, 2004, IBIS, V146, P131, DOI 10.1111/j.1474-919X.2004.00347.x; BRENNAN L. A., 2007, TEXAS QUAILS ECOLOGY; Brennan LA, 2005, J WILDLIFE MANAGE, V69, P1, DOI 10.2193/0022-541X(2005)069&lt;0001:NAGBAU&gt;2.0.CO;2; BRENNAN LA, 1991, WILDLIFE SOC B, V19, P544; Bridges AS, 2001, J WILDLIFE MANAGE, V65, P10, DOI 10.2307/3803270; Bro E., 2010, FAUNE SAUVAGE, V289, P26; BUERGER TT, 1991, ENVIRON TOXICOL CHEM, V10, P527, DOI 10.1897/1552-8618(1991)10[527:EOMPON]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chagnon M, 2015, ENVIRON SCI POLLUT R, V22, P119, DOI 10.1007/s11356-014-3277-x; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; de Snoo GR, 1999, PESTIC SCI, V55, P47, DOI 10.1002/(SICI)1096-9063(199901)55:1&lt;47::AID-PS859&gt;3.0.CO;2-#; Douglas MR, 2015, ENVIRON SCI TECHNOL, V49, P5088, DOI 10.1021/es506141g; Dunham NR, 2014, J WILDLIFE DIS, V50, P552, DOI 10.7589/2013-10-275; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Environmental Systems Research Institute (ESRI), 2011, ARCGIS DESKT; EROS, 2013, LANDC MODE; Fairbrother A, 2014, ENVIRON TOXICOL CHEM, V33, P719, DOI 10.1002/etc.2527; Fossen M., 2006, ENV FATE IMIDACLOPRI; GALINDO JC, 1985, BEHAV NEURAL BIOL, V43, P21, DOI 10.1016/S0163-1047(85)91454-2; Gibbons D, 2015, ENVIRON SCI POLLUT R, V22, P103, DOI 10.1007/s11356-014-3180-5; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Gobeli A, 2017, COMP BIOCHEM PHYS C, V195, P9, DOI 10.1016/j.cbpc.2017.02.001; Gould F.W., 1975, TEXAS PLANTS CHECKLI; Goulson D, 2014, NATURE, V511, P295, DOI 10.1038/nature13642; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Greatti Moreno, 2006, Bulletin of Insectology, V59, P99; Guthery F.S., 2000, ON BOBWHITES; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Heddinghaus T, 1991, REV PALMER DROUGHT S, P242; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hernandez F, 2005, WILDLIFE SOC B, V33, P1071, DOI 10.2193/0091-7648(2005)33[1071:IOPODO]2.0.CO;2; Hladik ML, 2014, ENVIRON POLLUT, V193, P189, DOI 10.1016/j.envpol.2014.06.033; Janke AK, 2013, J WILDLIFE MANAGE, V77, P405, DOI 10.1002/jwmg.461; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Johnson R., 2015, C RES SERVICE REPORT; Kohler HR, 2013, SCIENCE, V341, P759, DOI 10.1126/science.1237591; Kreutzweiser DP, 2009, ECOTOX ENVIRON SAFE, V72, P1053, DOI 10.1016/j.ecoenv.2008.09.017; Krohn PW, 2008, SYNERGISTIC MIXTURES; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Larson JA, 2010, TEXAS BOBWHITES GUID; Lewis K. A., 2015, PESTICIDE PROPERTIES, P2006; Lopez-Antia A, 2015, ENVIRON RES, V136, P97, DOI 10.1016/j.envres.2014.10.023; Lopez-Antia A, 2014, SCI TOTAL ENVIRON, V496, P179, DOI 10.1016/j.scitotenv.2014.07.031; Lopez-Antia A, 2013, ECOTOXICOLOGY, V22, P125, DOI 10.1007/s10646-012-1009-x; Lusk JJ, 2002, J WILDLIFE MANAGE, V66, P1040, DOI 10.2307/3802936; Madison LA, 2001, WILDLIFE SOC B, V29, P1219; Main AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092821; Mason R., 2013, J ENV IMMUNOLOGY TOX, V1, P3, DOI DOI 10.7178/JEIT.1; MICHAEL VICTOR C., 1955, JOUR WILDLIFE MANAGEMENT, V19, P281, DOI 10.2307/3796864; Mineau P, 2005, ECOTOXICOLOGY, V14, P775, DOI 10.1007/s10646-005-0028-2; Mineau P., 2013, AM BIRD CONSERV; Mineau P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057457; Moorman CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083815; Morrissey CA, 2015, ENVIRON INT, V74, P291, DOI 10.1016/j.envint.2014.10.024; NOAA, 2015, PALM DROUGHT SEV IND; Pandey SP, 2015, CHEMOSPHERE, V122, P227, DOI 10.1016/j.chemosphere.2014.11.061; Pardieck K. L., 2015, N AM BREEDING BIRD S; Peterson MJ, 2000, P NATL QUAIL S, V4, P85, DOI DOI 10.2307/3803032; R_Core_Team, 2015, R LANG ENV STAT COMP; Sauer JR, 1997, N AM BREEDING BIRD S; Sauer JR, 2012, N AM BREEDING BIRD S; Texas Almanac, 2014, TEX CROP PROD ACR YE; Thelin GP, 2013, 20135009 US GEOL SUR; Thyssen J., 1999, NICOTINOID INSECTICI, P213, DOI 10.1007/978-4-431-67933-2_9; TNRIS, 2015, DAT CAT; Tokumoto J, 2013, J VET MED SCI, V75, P755, DOI 10.1292/jvms.12-0544; Toll PA, 1990, 33893 NTN; Tomecek JM, 2015, WILDLIFE BIOL, V21, P303, DOI 10.2981/wlb.00075; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Tri AN, 2013, J WILDLIFE MANAGE, V77, P579, DOI 10.1002/jwmg.490; Turaga U., 2015, ENV TOXICOL CHEM; United States Department of Agriculture (USDA), 2010, AGR HDB, V628, P51; USEPA, 2007, EFED SECT 3 IR 4 RIS, P72; van der Sluijs JP, 2015, ENVIRON SCI POLLUT R, V22, P148, DOI 10.1007/s11356-014-3229-5; Walker CH, 2003, ECOTOXICOLOGY, V12, P307, DOI 10.1023/A:1022523331343; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Wilson JD, 1999, AGR ECOSYST ENVIRON, V75, P13, DOI 10.1016/S0167-8809(99)00064-X; Zuur Alain F., 2009, P1	89	15	16	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191100	10.1371/journal.pone.0191100	http://dx.doi.org/10.1371/journal.pone.0191100			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324902	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400115
J	Kabacinski, J; Murawa, M; Mackala, K; Dworak, LB				Kabacinski, Jaroslaw; Murawa, Michal; Mackala, Krzysztof; Dworak, Lechoslaw Bogdan			Knee strength ratios in competitive female athletes	PLOS ONE			English	Article							PROFESSIONAL BASKETBALL PLAYERS; ISOKINETIC PEAK TORQUE; BILATERAL LEG STRENGTH; COUNTERMOVEMENT JUMP; VOLLEYBALL PLAYERS; DEFICIT; CONTRACTIONS; QUADRICEPS; ELITE; YOUNG	Knee strength ratios are related to the movement patterns, sport-specific training and knee injuries in athletes. The purpose of this study was to determine the ratios in the concentric isokinetic strength of the hamstrings and quadriceps and the isometric strength of the knee extensors. In female basketball players (n = 14) and female volleyball players (n = 12) were evaluated: the hamstrings to quadriceps peak torque ratio (H/Q) and side-to-side peak torque ratio (TR) for hamstrings and quadriceps; the ratio of the maximal bilateral strength to the summed maximal unilateral strength (B/U) and side-to-side maximal strength ratio (SR) for knee extensors. For the H/Q values, a 2 x 2 x 3 mixed-factorial analysis of variance and Bonferroni post hoc test were computed. The H/Q values increased from 48.0 (3.9)% at 60 degrees/s to 70.4 (7.9)% at 300 degrees/s. Furthermore, there were significant differences in the H/Q values between 300 degrees/s and 180 degrees/s, 300 degrees/s and 60 degrees/s in basketball and volleyball athletes, and between 180 degrees/s and 60 degrees/s only in basketball athletes (p<.05). Significantly higher H/Q results at 60 degrees/s demonstrated basketball players than volleyball players (p<.05). Differences in the TR and SR mean values ranged from 4.4% to 8.6% and indicated no significant side-to-side strength deficits (p>.05). In both groups, greater isometric strength developed bilaterally was found (B/U > 100%). The findings revealed the magnitude of knee strength ratios in female athletes determined by sport-specific movements in basketball and volleyball. This study highlighted the importance of the bilateral strength deficit and muscular balance between the hamstrings and quadriceps in basketball and volleyball athletes in activities related to their movement patterns and specific training.	[Kabacinski, Jaroslaw; Murawa, Michal] Poznan Univ Phys Educ, Dept Biomech, Poznan, Poland; [Mackala, Krzysztof] Univ Sch Phys Educ, Dept Track & Field, Wroclaw, Poland; [Dworak, Lechoslaw Bogdan] Univ Arts, Dept Bion, Poznan, Poland		Kabacinski, J (corresponding author), Poznan Univ Phys Educ, Dept Biomech, Poznan, Poland.	biomechanics.awf.poznan@gmail.com	Mackala, Krzysztof/AAK-2841-2021	Mackala, Krzysztof/0000-0001-6750-4316; Kabacinski, Jaroslaw/0000-0002-6478-6116; Murawa, Michal/0000-0003-4987-4131; Dworak, Lechoslaw B./0000-0002-9771-9905	Polish Ministry of Science and Higher Education within the 'Development of Academic Sport' program [RSA2 042 52]	Polish Ministry of Science and Higher Education within the 'Development of Academic Sport' program	This study was funded by the Polish Ministry of Science and Higher Education within the 'Development of Academic Sport' program (grant number RSA2 042 52). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank all the participating players as well as the Club's coaching team for their cooperation. This study was funded by the Polish Ministry of Science and Higher Education within the 'Development of Academic Sport' program (grant number RSA2 042 52).	Beurskens R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118535; Botton CE, 2016, J STRENGTH COND RES, V30, P1924, DOI 10.1519/JSC.0000000000001125; Botton CE, 2013, ISOKINET EXERC SCI, V21, P161, DOI 10.3233/IES-130492; Cheung RTH, 2012, J HUM KINET, V33, P63, DOI 10.2478/v10078-012-0045-1; Coh M, 2013, J STRENGTH COND RES, V27, P3021, DOI 10.1519/JSC.0b013e31828c14d8; Cumps E, 2008, EUR J SPORT SCI, V8, P183, DOI 10.1080/17461390802067711; Dvir Z, 2004, ISOKINETICS MUSCLE T, V2rd; FLECK SJ, 1987, DESIGNING RESISTANCE; Gerodimos V, 2003, J SPORT MED PHYS FIT, V43, P444; Hewett TE, 1996, AM J SPORT MED, V24, P765, DOI 10.1177/036354659602400611; Hewett TE, 2008, J SCI MED SPORT, V11, P452, DOI 10.1016/j.jsams.2007.04.009; HOWARD JD, 1991, J APPL PHYSIOL, V70, P306, DOI 10.1152/jappl.1991.70.1.306; Huston LJ, 1996, AM J SPORT MED, V24, P427, DOI 10.1177/036354659602400405; Jakobi JM, 2001, CAN J APPL PHYSIOL, V26, P12, DOI 10.1139/h01-002; Kawakami Y, 1998, EUR J APPL PHYSIOL O, V77, P212, DOI 10.1007/s004210050324; KOH TJ, 1993, J APPL PHYSIOL, V74, P1200, DOI 10.1152/jappl.1993.74.3.1200; Kollock R, 2015, J ATHL TRAINING, V50, P14, DOI 10.4085/1062-6050-49.3.49; Kong PW, 2010, PHYS THER SPORT, V11, P12, DOI 10.1016/j.ptsp.2009.09.004; Kuruganti U, 2006, EUR J APPL PHYSIOL, V97, P322, DOI 10.1007/s00421-006-0188-7; Lees A, 1988, J SPORTS SCI, V16, P211; Lehance C, 2004, ISOKINET EXERC SCI, V12, P62; Mackala K, 2013, J STRENGTH COND RES, V27, P2650, DOI 10.1519/JSC.0b013e31828909ec; Magalhaes J, 2004, J SPORT MED PHYS FIT, V44, P119; Magnus CRA, 2008, APPL PHYSIOL NUTR ME, V33, P1132, DOI 10.1139/H08-101; MERO A, 1987, MED SCI SPORT EXER, V19, P266; Myer GD, 2004, J ATHL TRAINING, V39, P352; Orchard J., 2002, NZ J SPORTS MED, V30, P92; Owings TM, 1998, J GERONTOL A-BIOL, V53, pB425, DOI 10.1093/gerona/53A.6.B425; Reeser JC, 2006, BRIT J SPORT MED, V40, P594, DOI 10.1136/bjsm.2005.018234; Rosene JM, 2001, J ATHL TRAINING, V36, P378; Rouis M, 2015, J SPORT MED PHYS FIT, V55, P1502; Salci Y, 2004, CLIN BIOMECH, V19, P622, DOI 10.1016/j.clinbiomech.2004.03.006; Sale DG., 2008, STRENGTH POWER SPORT, P281; Schiltz M, 2009, J ATHL TRAINING, V44, P39, DOI 10.4085/1062-6050-44.1.39; Theoharopoulos A, 2000, J STRENGTH COND RES, V14, P457; VANDERVOORT AA, 1984, J APPL PHYSIOL, V56, P46, DOI 10.1152/jappl.1984.56.1.46; Visnes H, 2005, CLIN J SPORT MED, V15, P225; Zakas A, 2006, J SPORT MED PHYS FIT, V46, P28	38	20	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0191077	10.1371/journal.pone.0191077	http://dx.doi.org/10.1371/journal.pone.0191077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315348	Green Published, gold, Green Submitted			2022-12-26	WOS:000419655900041
J	Ohneck, EJ; Arivett, BA; Fiester, SE; Wood, CR; Metz, ML; Simeone, GM; Actis, LA				Ohneck, Emily J.; Arivett, Brock A.; Fiester, Steven E.; Wood, Cecily R.; Metz, Maeva L.; Simeone, Gabriella M.; Actis, Luis A.			Mucin acts as a nutrient source and a signal for the differential expression of genes coding for cellular processes and virulence factors in Acinetobacter baumannii	PLOS ONE			English	Article							LUNG EPITHELIAL-CELLS; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; VI SECRETION; NECROTIZING FASCIITIS; IRON ACQUISITION; ESCHERICHIA-COLI; ABIOTIC SURFACES; GASTRIC MUCIN; STRAIN	The capacity of Acinetobacter baumannii to persist and cause infections depends on its interaction with abiotic and biotic surfaces, including those found on medical devices and host mucosal surfaces. However, the extracellular stimuli affecting these interactions are poorly understood. Based on our previous observations, we hypothesized that mucin, a glycoprotein secreted by lung epithelial cells, particularly during respiratory infections, significantly alters A. baumannii's physiology and its interaction with the surrounding environment. Biofilm, virulence and growth assays showed that mucin enhances the interaction of A. baumannii ATCC 19606(T) with abiotic and biotic surfaces and its cytolytic activity against epithelial cells while serving as a nutrient source. The global effect of mucin on the physiology and virulence of this pathogen is supported by RNA-Seq data showing that its presence in a low nutrient medium results in the differential transcription of 427 predicted protein-coding genes. The reduced expression of ion acquisition genes and the increased transcription of genes coding for energy production together with the detection of mucin degradation indicate that this host glycoprotein is a nutrient source. The increased expression of genes coding for adherence and biofilm biogenesis on abiotic and biotic surfaces, the degradation of phenylacetic acid and the production of an active type VI secretion system further supports the role mucin plays in virulence. Taken together, our observations indicate that A. baumannii recognizes mucin as an environmental signal, which triggers a response cascade that allows this pathogen to acquire critical nutrients and promotes host-pathogen interactions that play a role in the pathogenesis of bacterial infections.	[Ohneck, Emily J.; Arivett, Brock A.; Fiester, Steven E.; Wood, Cecily R.; Metz, Maeva L.; Simeone, Gabriella M.; Actis, Luis A.] Miami Univ, Dept Microbiol, Oxford, OH 45056 USA; [Arivett, Brock A.] Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37130 USA; [Fiester, Steven E.] Univ South Carolina, Dept Biomed Sci, Sch Med Greenville, Greenville, SC USA; [Metz, Maeva L.] Weill Cornell Med, Joan & Sanford I Weill Dept Med, New York, NY USA	University System of Ohio; Miami University; Middle Tennessee State University; Cornell University	Actis, LA (corresponding author), Miami Univ, Dept Microbiol, Oxford, OH 45056 USA.	actisla@MiamiOH.edu	Fiester, Steven/K-6058-2019; Arivett, Brock/T-2569-2018	Arivett, Brock/0000-0002-1291-3814; Metz, Maeva/0000-0002-4575-8347	Miami University Research Funds	Miami University Research Funds	This work was funded by Miami University Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Miami University research funds. We are thankful to Dr. A. Kiss and the Miami University Center of Bioinformatics and Functional Genomics for support and assistance with the RNA-Seq experiments. We are grateful to Drs. E. Lafontaine (College of Veterinary Medicine, University of Georgia, USA) and F. Blattner (University of Wisconsin) for providing the A549 cell line and the E. coli MG1655, respectively. We thank Dr. E. Skaar (Vanderbilt University) for providing us with a protocol used to prepare biological samples for ICP-OES analyses and Dr. R. Edelmann, Director of the Miami University Center for Advanced Microscopy and Imaging, for his assistance in TEM analysis.	ACTIS LA, 1985, J BACTERIOL, V161, P736, DOI 10.1128/JB.161.2.736-742.1985; Alvarez-Fraga L, 2016, VIRULENCE, V7, P443, DOI 10.1080/21505594.2016.1145335; ARCHIBALD FS, 1980, INFECT IMMUN, V27, P322, DOI 10.1128/IAI.27.2.322-334.1980; Aristoteli LP, 2003, INFECT IMMUN, V71, P5565, DOI 10.1128/IAI.71.10.5565-5575.2003; Arivett BA, 2015, ANTIMICROB AGENTS CH, V59, P7657, DOI 10.1128/AAC.01472-15; Bachmann V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004031; Beloborodova N, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-89; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Bhuiyan MS, 2016, P NATL ACAD SCI USA, V113, P9599, DOI 10.1073/pnas.1523116113; Bongaerts GPA, 1997, MICROB PATHOGENESIS, V22, P253, DOI 10.1006/mpat.1996.0119; Brachelente C, 2007, VET DERMATOL, V18, P432, DOI 10.1111/j.1365-3164.2007.00624.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brock M, 2002, EUR J BIOCHEM, V269, P6184, DOI 10.1046/j.1432-1033.2002.03336.x; Caldara M, 2012, CURR BIOL, V22, P2325, DOI 10.1016/j.cub.2012.10.028; Carruthers MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059388; Carterson AJ, 2005, INFECT IMMUN, V73, P1129, DOI 10.1128/IAI.73.2.1129-1140.2005; Cerqueira GM, 2014, J INFECT DIS, V210, P46, DOI 10.1093/infdis/jiu024; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Chakraborty S, 2011, J BIOL CHEM, V286, P39417, DOI 10.1074/jbc.M111.295188; Charnot-Katsikas A, 2009, J CLIN MICROBIOL, V47, P258, DOI 10.1128/JCM.01250-08; Chen LH, 2015, MICROBIOL RES, V172, P19, DOI 10.1016/j.micres.2015.01.004; Clark TJ, 2002, MICROBIOL-SGM, V148, P1213, DOI 10.1099/00221287-148-4-1213; CONRAD ME, 1991, GASTROENTEROLOGY, V100, P129, DOI 10.1016/0016-5085(91)90592-9; Corradino B, 2010, INT J LOW EXTR WOUND, V9, P152, DOI 10.1177/1534734610389598; Croce M V, 1999, Pathol Oncol Res, V5, P197, DOI 10.1053/paor.1999.0212; de Breij A, 2009, RES MICROBIOL, V160, P213, DOI 10.1016/j.resmic.2009.01.002; Dennesen P, 2003, INTENS CARE MED, V29, P715, DOI 10.1007/s00134-003-1701-7; DEWITT CW, 1958, J BACTERIOL, V76, P631, DOI 10.1128/JB.76.6.631-639.1958; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dorsey CW, 2004, MICROBIOL-SGM, V150, P3657, DOI 10.1099/mic.0.27371-0; Eijkelkamp BA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1020; Eijkelkamp BA, 2011, FEMS MICROBIOL LETT, V323, P44, DOI 10.1111/j.1574-6968.2011.02362.x; Fernandez C, 2014, ENV MICROBIOL REP, V6, P239, DOI 10.1111/1758-2229.12117; Flynn JM, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00182-17; Flynn JM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005846; Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Goh WI, 2012, J BIOL CHEM, V287, P4702, DOI 10.1074/jbc.M111.305102; Hachani A, 2016, CURR OPIN MICROBIOL, V29, P81, DOI 10.1016/j.mib.2015.11.006; Haley CL, 2014, CAN J MICROBIOL, V60, P155, DOI 10.1139/cjm-2013-0570; Henke MO, 2011, INFECT IMMUN, V79, P3438, DOI 10.1128/IAI.01252-10; Ho BT, 2014, CELL HOST MICROBE, V15, P9, DOI 10.1016/j.chom.2013.11.008; Horswill AR, 1999, J BACTERIOL, V181, P5615, DOI 10.1128/JB.181.18.5615-5623.1999; Huang JX, 2015, ANTIMICROB AGENTS CH, V59, P5925, DOI 10.1128/AAC.00808-15; Johnston JW., CURR PROTOC MICROBIO; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Landry RM, 2006, MOL MICROBIOL, V59, P142, DOI 10.1111/j.1365-2958.2005.04941.x; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Longo F, 2014, NEW MICROBIOL, V37, P119; Lu WJ, 2005, AM J PHYSIOL-LUNG C, V288, pL52, DOI 10.1152/ajplung.00104.2004; Luna CM, 2007, RESPIROLOGY, V12, P787, DOI 10.1111/j.1440-1843.2007.01147.x; Magalhaes A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25575; MARKS MI, 1982, INFECTION, V10, P261, DOI 10.1007/BF01640870; MASON RJ, 1980, BIOCHIM BIOPHYS ACTA, V617, P36, DOI 10.1016/0005-2760(80)90222-2; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; Michalski JC, 2000, METH MOL B, V125, P159; Neonakis IK, 2011, INT J ANTIMICROB AG, V37, P102, DOI 10.1016/j.ijantimicag.2010.10.014; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046984; Penwell WF, 2015, CHEMBIOCHEM, V16, P1896, DOI 10.1002/cbic.201500147; Richet H, 2006, INFECT CONT HOSP EP, V27, P645, DOI 10.1086/505900; Rodriguez-Hernandez MJ, 2000, J ANTIMICROB CHEMOTH, V45, P493, DOI 10.1093/jac/45.4.493; Rose MC, 2006, PHYSIOL REV, V86, P245, DOI 10.1152/physrev.00010.2005; Salvador VBDG, 2010, ASIAN J SURG, V33, P51, DOI 10.1016/S1015-9584(10)60009-7; Sambrook J., 2001, MOL CLONING LAB MANU; Sana TG, 2012, J BIOL CHEM, V287, P27095, DOI 10.1074/jbc.M112.376368; Sigurdsson HH, 2013, INT J PHARMACEUT, V453, P56, DOI 10.1016/j.ijpharm.2013.05.040; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Sriramulu DD, 2005, J MED MICROBIOL, V54, P667, DOI 10.1099/jmm.0.45969-0; Starai VJ, 2004, CELL MOL LIFE SCI, V61, P2020, DOI 10.1007/s00018-004-3448-x; STEPHENS JM, 1959, CAN J MICROBIOL, V5, P73, DOI 10.1139/m59-009; Textor S, 1997, ARCH MICROBIOL, V168, P428, DOI 10.1007/s002030050518; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Wang ND, 2014, MBIO, V5, DOI 10.1128/mBio.01163-14; Weber BS, 2015, P NATL ACAD SCI USA, V112, P9442, DOI 10.1073/pnas.1502966112; Weber BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055142; Wiggins R, 2002, INT J STD AIDS, V13, P755, DOI 10.1258/095646202320753709; Yamada K, 2014, PULM PHARMACOL THER, V28, P165, DOI 10.1016/j.pupt.2014.05.006; YAMAMOTO S, 1994, ARCH MICROBIOL, V162, P249, DOI 10.1007/s002030050133; Yeung ATY, 2012, MBIO, V3, DOI 10.1128/mBio.00073-12; Young DM, 2005, ANNU REV MICROBIOL, V59, P519, DOI 10.1146/annurev.micro.59.051905.105823	86	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2018	13	1							e0190599	10.1371/journal.pone.0190599	http://dx.doi.org/10.1371/journal.pone.0190599			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS0GW	29309434	gold, Green Published, Green Submitted			2022-12-26	WOS:000419453100014
J	Rismondo, J; Percy, MG; Grundling, A				Rismondo, Jeanine; Percy, Matthew G.; Grundling, Angelika			Discovery of genes required for lipoteichoic acid glycosylation predicts two distinct mechanisms for wall teichoic acid glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; CELL-WALL; LISTERIA-MONOCYTOGENES; ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; BIOSYNTHESIS; IDENTIFICATION; GLYCOSYLTRANSFERASE; RESISTANCE; SEQUENCE	The bacterial cell wall is an important and highly complex structure that is essential for bacterial growth because it protects bacteria from cell lysis and environmental insults. Atypical Gram-positive bacterial cell wall is composed of peptidoglycan and the secondary cell wall polymers, wall teichoic acid (WTA) and lipoteichoic acid (LTA). In many Gram-positive bacteria, LTA is a polyglycerol-phosphate chain that is decorated with D-alanine and sugar residues. However, the function of and proteins responsible for the glycosylation of LTA are either unknown or not well-characterized. Here, using bioinformatics, genetic, and NMR spectroscopy approaches, we found that the Bacillus subtilis csbB and yfhO genes are essential for LTA glycosylation. Interestingly, the Listeria monocytogenes gene lmo1079, which encodes a YfhO homolog, was not required for LTA glycosylation, but instead was essential for WTA glycosylation. LTA is polymerized on the outside of the cell and hence can only be glycosylated extracellularly. Based on the similarity of the genes coding for YfhO homologs that are required in B. subtilis for LTA glycosylation or in L. monocytogenes for WTA glycosylation, we hypothesize that WTA glycosylation might also occur extracellularly in Listeria species. Finally, we discovered that in L. monocytogenes, lmo0626 (gtlB) was required for LTA glycosylation, indicating that the encoded protein has a function similar to that of YfhO, although the proteins are not homologous. Together, our results enable us to propose an updated model for LTA glycosylation and also indicate that glycosylation of WTA might occur through two different mechanisms in Gram-positive bacteria.	[Grundling, Angelika] Imperial Coll London, Microbiol Sect, London SW7 2AZ, England; [Grundling, Angelika] Imperial Coll London, MRC, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England	Imperial College London; Imperial College London	Grundling, A (corresponding author), Imperial Coll London, Microbiol Sect, London SW7 2AZ, England.; Grundling, A (corresponding author), Imperial Coll London, MRC, Ctr Mol Bacteriol & Infect, London SW7 2AZ, England.	a.grundling@irnperial.ac.uk		Rismondo, Jeanine/0000-0001-5337-3829; Grundling, Angelika/0000-0002-6235-8687	European Research Council [260371]; Wellcome Trust [100289]; German Research Foundation (DFG) [RI 2920/1-1]; UK Clinical Research Collaboration (Centre for Infection Prevention and Management); MRC [MR/P028225/1, G0800777] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); UK Clinical Research Collaboration (Centre for Infection Prevention and Management); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by European Research Council Grant 260371 and Wellcome Trust Grant 100289 (to A. G.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by the German Research Foundation (DFG) Grant RI 2920/1-1.r Supported by a studentship provided by the UK Clinical Research Collaboration (Centre for Infection Prevention and Management).	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Akbar S, 1996, GENE, V177, P123, DOI 10.1016/0378-1119(96)00287-9; Allison SE, 2011, J BIOL CHEM, V286, P23708, DOI 10.1074/jbc.M111.241265; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amer AO, 2002, MICROBIOL-SGM, V148, P571, DOI 10.1099/00221287-148-2-571; ARAKI Y, 1989, CRIT REV MICROBIOL, V17, P121, DOI 10.3109/10408418909105745; Arrieta-Ortiz ML, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156236; Autret N, 2001, INFECT IMMUN, V69, P2054, DOI 10.1128/IAI.69.4.2054-2065.2001; Berg S, 2007, GLYCOBIOLOGY, V17, p35R, DOI 10.1093/glycob/cwm010; Bernal P, 2009, J ANTIMICROB CHEMOTH, V63, P1156, DOI 10.1093/jac/dkp094; Brauge T, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnv229; Breazeale SD, 2005, J BIOL CHEM, V280, P14154, DOI 10.1074/jbc.M414265200; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Breton C, 1998, J BIOCHEM, V123, P1000; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Brown S, 2012, P NATL ACAD SCI USA, V109, P18909, DOI 10.1073/pnas.1209126109; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; Cao M, 2004, J BACTERIOL, V186, P1136, DOI 10.1128/JB.186.4.1136-1146.2004; Chan YGY, 2013, J BACTERIOL, V195, P4650, DOI 10.1128/JB.00544-13; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Denes T, 2015, APPL ENVIRON MICROB, V81, P4295, DOI 10.1128/AEM.00087-15; Dengler V, 2012, FEMS MICROBIOL LETT, V333, P109, DOI 10.1111/j.1574-6968.2012.02603.x; Eugster MR, 2015, MOL MICROBIOL, V97, P33, DOI 10.1111/mmi.13009; Eugster MR, 2011, MOL MICROBIOL, V81, P1419, DOI 10.1111/j.1365-2958.2011.07774.x; FIEDLER F, 1988, INFECTION, V16, pS92, DOI 10.1007/BF01639729; FISCHER W, 1994, MED MICROBIOL IMMUN, V183, P61, DOI 10.1007/BF00277157; FISCHER W, 1988, ADV MICROB PHYSIOL, V29, P233, DOI 10.1016/S0065-2911(08)60349-5; FISCHER W, 1980, FEBS LETT, V119, P224, DOI 10.1016/0014-5793(80)80257-2; Fischer W., 1990, HDB LIPID RES, P123; Graves L. M., 1999, LISTERIA LISTERIOSIS, P251; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; HEATON MP, 1992, J BACTERIOL, V174, P4707, DOI 10.1128/JB.174.14.4707-4717.1992; HETHER NW, 1983, J BACTERIOL, V156, P809, DOI 10.1128/JB.156.2.809-817.1983; Huang XJ, 1998, J MOL BIOL, V279, P165, DOI 10.1006/jmbi.1998.1765; Inoue H, 2013, BIOCHEM BIOPH RES CO, V436, P6, DOI 10.1016/j.bbrc.2013.04.064; IWASAKI H, 1989, J BACTERIOL, V171, P424, DOI 10.1128/jb.171.1.424-429.1989; IWASAKI H, 1986, J BACTERIOL, V167, P508, DOI 10.1128/jb.167.2.508-516.1986; KAMISANGO K, 1983, J BIOCHEM-TOKYO, V93, P1401, DOI 10.1093/oxfordjournals.jbchem.a134275; Kawai Y, 2011, EMBO J, V30, P4931, DOI 10.1038/emboj.2011.358; Kiriukhin MY, 2001, J BACTERIOL, V183, P3506, DOI 10.1128/JB.183.11.3506-3514.2001; Kobayashi K, 2001, J BACTERIOL, V183, P7365, DOI 10.1128/JB.183.24.7365-7370.2001; Kolly GS, 2015, J BACTERIOL, V197, P3686, DOI 10.1128/JB.00628-15; Kopp U, 1996, MICROB DRUG RESIST, V2, P29, DOI 10.1089/mdr.1996.2.29; Krawczyk-Balska A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077808; Kus JV, 2008, J BACTERIOL, V190, P7464, DOI 10.1128/JB.01075-08; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Larrouy-Maumus G, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.400986; LAZAREVIC V, 1995, MOL MICROBIOL, V16, P345, DOI 10.1111/j.1365-2958.1995.tb02306.x; Liu J, 2003, PROTEIN SCI, V12, P1418, DOI 10.1110/ps.0302103; Mahne M, 2006, FEMS MICROBIOL LETT, V259, P226, DOI 10.1111/j.1574-6968.2006.00269.x; Mamou G, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01991; MANCUSO DJ, 1982, J BACTERIOL, V152, P616; Mishra AK, 2008, MOL MICROBIOL, V68, P1595, DOI 10.1111/j.1365-2958.2008.06265.x; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Morath S, 2002, INFECT IMMUN, V70, P938, DOI 10.1128/IAI.70.2.938-944.2002; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Ogura M, 2008, BIOSCI BIOTECH BIOCH, V72, P186, DOI 10.1271/bbb.70548; Ogura M, 2010, ARCH MICROBIOL, V192, P569, DOI 10.1007/s00203-010-0586-4; Pasquina LW, 2013, CURR OPIN MICROBIOL, V16, P531, DOI 10.1016/j.mib.2013.06.014; Percy MG, 2016, J BACTERIOL, V198, P2029, DOI 10.1128/JB.00116-16; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; Promadej N, 1999, J BACTERIOL, V181, P418, DOI 10.1128/JB.181.2.418-425.1999; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Reichmann NT, 2013, MICROBIOL-SGM, V159, P1868, DOI 10.1099/mic.0.069898-0; Reichmann NT, 2011, FEMS MICROBIOL LETT, V319, P97, DOI 10.1111/j.1574-6968.2011.02260.x; Richter SG, 2013, P NATL ACAD SCI USA, V110, P3531, DOI 10.1073/pnas.1217337110; Schirner K, 2011, ACS CHEM BIOL, V6, P407, DOI 10.1021/cb100390w; Schirner K, 2009, EMBO J, V28, P830, DOI 10.1038/emboj.2009.25; Seeliger H.P.R., 1979, METHOD MICROBIOL, V13, P31, DOI [10.1016/S0580-9517(08)70372-6, DOI 10.1016/S0580-9517(08)70372-6]; Shen Y, 2017, J BIOL CHEM, V292, P17832, DOI 10.1074/jbc.M117.813964; Sobhanifar S, 2015, P NATL ACAD SCI USA, V112, pE576, DOI 10.1073/pnas.1418084112; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Spears PA, 2016, MOL MICROBIOL, V101, P714, DOI 10.1111/mmi.13353; Stranden AM, 1997, J BACTERIOL, V179, P9, DOI 10.1128/jb.179.1.9-16.1997; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; UCHIKAWA KI, 1986, J BACTERIOL, V168, P115, DOI 10.1128/jb.168.1.115-122.1986; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb AJ, 2009, MOL MICROBIOL, V74, P299, DOI 10.1111/j.1365-2958.2009.06829.x; Winstel V, 2014, INT J MED MICROBIOL, V304, P215, DOI 10.1016/j.ijmm.2013.10.009; Wormann ME, 2011, MOL MICROBIOL, V79, P566, DOI 10.1111/j.1365-2958.2010.07472.x; Xia G, 2008, CHEM BIOL, V15, P95, DOI 10.1016/j.chembiol.2008.02.005; Xia GQ, 2010, J BIOL CHEM, V285, P13405, DOI 10.1074/jbc.M109.096172; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; YOKOYAMA K, 1988, EUR J BIOCHEM, V173, P453, DOI 10.1111/j.1432-1033.1988.tb14020.x	85	27	27	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3293	3306		10.1074/jbc.RA117.001614	http://dx.doi.org/10.1074/jbc.RA117.001614			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29343515	hybrid, Green Published			2022-12-26	WOS:000426562800022
J	Liu, MX; Jin, L; Sun, SJ; Liu, P; Feng, X; Cheng, ZL; Liu, WR; Guan, KL; Shi, YH; Yuan, HX; Xiong, Y				Liu, Meng-Xi; Jin, Lei; Sun, Si-Jia; Liu, Peng; Feng, Xu; Cheng, Zhou-Li; Liu, Wei-Ren; Guan, Kun-Liang; Shi, Ying-Hong; Yuan, Hai-Xin; Xiong, Yue			Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma	ONCOGENE			English	Article							CYTOSOLIC PHOSPHOENOLPYRUVATE CARBOXYKINASE; TUMOR-GROWTH; FATTY LIVER; MOUSE-LIVER; MICROENVIRONMENT; GLUCONEOGENESIS; CYCLE; ACID; GLUTATHIONE; WARBURG	Phosphoenolpyruvate carboxykinase (PEPCK or PCK) catalyzes the first rate-limiting step in hepatic gluconeogenesis pathway to maintain blood glucose levels. Mammalian cells express two PCK genes, encoding for a cytoplasmic (PCPEK-C or PCK1) and a mitochondrial (PEPCK-M or PCK2) isoforms, respectively. Increased expressions of both PCK genes are found in cancer of several organs, including colon, lung, and skin, and linked to increased anabolic metabolism and cell proliferation. Here, we report that the expressions of both PCK1 and PCK2 genes are downregulated in primary hepatocellular carcinoma (HCC) and low PCK expression was associated with poor prognosis in patients with HCC. Forced expression of either PCK1 or PCK2 in liver cancer cell lines results in severe apoptosis under the condition of glucose deprivation and suppressed liver tumorigenesis in mice. Mechanistically, we show that the pro-apoptotic effect of PCK1 requires its catalytic activity. We demonstrate that forced PCK1 expression in glucose-starved liver cancer cells induced TCA cataplerosis, leading to energy crisis and oxidative stress. Replenishing TCA intermediate a-ketoglutarate or inhibition of reactive oxygen species production blocked the cell death caused by PCK expression. Taken together, our data reveal that PCK1 is detrimental to malignant hepatocytes and suggest activating PCK1 expression as a potential treatment strategy for patients with HCC.	[Liu, Meng-Xi; Sun, Si-Jia; Liu, Peng; Feng, Xu; Cheng, Zhou-Li; Guan, Kun-Liang; Yuan, Hai-Xin; Xiong, Yue] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Mol & Cell Biol Res Lab, Shanghai, Peoples R China; [Liu, Meng-Xi; Sun, Si-Jia; Liu, Peng; Feng, Xu; Cheng, Zhou-Li; Guan, Kun-Liang; Yuan, Hai-Xin; Xiong, Yue] Fudan Univ, Sch Basic Med Sci, Minist Educ, Key Lab Metab & Mol Med, Shanghai, Peoples R China; [Liu, Meng-Xi; Sun, Si-Jia; Liu, Peng; Feng, Xu; Cheng, Zhou-Li; Guan, Kun-Liang; Yuan, Hai-Xin; Xiong, Yue] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai, Peoples R China; [Liu, Meng-Xi; Guan, Kun-Liang; Yuan, Hai-Xin; Xiong, Yue] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai, Peoples R China; [Jin, Lei; Liu, Wei-Ren; Shi, Ying-Hong] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Dept Liver Surg, Shanghai, Peoples R China; [Jin, Lei; Liu, Wei-Ren; Shi, Ying-Hong] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill	Yuan, HX; Xiong, Y (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Mol & Cell Biol Res Lab, Shanghai, Peoples R China.; Yuan, HX; Xiong, Y (corresponding author), Fudan Univ, Sch Basic Med Sci, Minist Educ, Key Lab Metab & Mol Med, Shanghai, Peoples R China.; Yuan, HX; Xiong, Y (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai, Peoples R China.; Yuan, HX; Xiong, Y (corresponding author), Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai, Peoples R China.; Shi, YH (corresponding author), Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Dept Liver Surg, Shanghai, Peoples R China.; Shi, YH (corresponding author), Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China.; Xiong, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	shi.yinghong@zs-hospital.sh.cn; yuanhaixin@fudan.edu.cn; yxiong@email.unc.edu	Guan, Kun-Liang/ADK-7088-2022; Liu, Mengxi/N-7308-2019		National Science and Technology Major Project of China [2017ZX10203207-002-004]; 973 Program [2015CB910401]; NSFC [31570784, 81773190]; NIH [CA163834, CA196878, GM51586]; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA163834, R35CA196878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051586] Funding Source: NIH RePORTER	National Science and Technology Major Project of China; 973 Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Bin Zhao (Zhejiang University, Hangzhou, China) for providing plasmids used for inducing liver tumor in mice, including PB[CMV-myc-YAP-5SA] DS, PB[Act-RFP] DS, and Act-PB Transposase. We thank Xiaocan Guo for technical help on hydrodynamic injection. We also thank Dr Jiahuai Han (Xiamen University, Xiamen, China) for generously offering cDNAs for human PCK1 and PCK2 genes. This work was supported by the National Science and Technology Major Project of China (No. 2017ZX10203207-002-004 to HXY), the 973 Program (No. 2015CB910401 to YX), the NSFC grants (No. 31570784 and 81773190 to HXY), and NIH grants (CA163834 to YX; CA196878 and GM51586 to K-LG).	Balan MD, 2015, BIOCHEMISTRY-US, V54, P5878, DOI 10.1021/acs.biochem.5b00822; Beale EG, 2007, CELL BIOCHEM BIOPHYS, V48, P89, DOI 10.1007/s12013-007-0025-6; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Dunten P, 2002, J MOL BIOL, V316, P257, DOI 10.1006/jmbi.2001.5364; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Haslene-Hox H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019217; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Hitosugi T, 2012, CANCER CELL, V22, P585, DOI 10.1016/j.ccr.2012.09.020; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jin LT, 2015, CANCER CELL, V27, P257, DOI 10.1016/j.ccell.2014.12.006; Leithner K, 2015, ONCOGENE, V34, P1044, DOI 10.1038/onc.2014.47; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Ma SH, 2015, ONCOTARGET, V6, P8606, DOI 10.18632/oncotarget.3330; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Mendez-Lucas A, 2013, J HEPATOL, V59, P105, DOI 10.1016/j.jhep.2013.02.020; Montal ED, 2015, MOL CELL, V60, P571, DOI 10.1016/j.molcel.2015.09.025; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Satapati S, 2015, J CLIN INVEST, V125, P4447, DOI 10.1172/JCI82204; Shen SY, 2015, CELL RES, V25, P997, DOI 10.1038/cr.2015.98; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Vincent EE, 2015, MOL CELL, V60, P195, DOI 10.1016/j.molcel.2015.08.013; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yang H, 2015, EMBO J, V34, P1110, DOI 10.15252/embj.201591041; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Zheng L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7001	32	75	81	10	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	12					1637	1653		10.1038/s41388-017-0070-6	http://dx.doi.org/10.1038/s41388-017-0070-6			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GA8YC	29335519	Green Submitted, Green Accepted			2022-12-26	WOS:000428626700007
J	Sun, LL; Yu, SY; Xu, H; Zheng, YW; Lin, JT; Wu, MY; Wang, JD; Wang, AD; Lan, Q; Furnari, F; Cavenee, W; Purow, B; Li, M				Sun, Lili; Yu, Shuye; Xu, Hui; Zheng, Yanwen; Lin, Juntang; Wu, Meiyan; Wang, Jide; Wang, Aidong; Lan, Qing; Furnari, Frank; Cavenee, Webster; Purow, Benjamin; Li, Ming			FHL2 interacts with EGFR to promote glioblastoma growth	ONCOGENE			English	Article							ONLY PROTEIN FHL2; FACTOR RECEPTOR; SCAFFOLD PROTEIN; ACTIVATION; EXPRESSION; TRANSCRIPTION; LOCALIZATION; DEGRADATION; CONTRIBUTES; CANCER	Four-and-a-half LIM protein2 (FHL2) is a member of the LIM-only protein family, which plays a critical role in tumorigenesis. We previously reported that FHL2 is upregulated and plays an oncogenic role in glioblastoma (GBM), the most common and aggressive brain tumor. GBM is also marked by amplification of the epidermal growth factor receptor (EGFR) gene and its mutations, of which EGFRvIII is the most common and functionally significant. Here we report that FHL2 physically interacts with the wild-type EGFR and its mutated EGFRvIII form in GBM cells. Expression of FHL2 caused increased EGFR and EGFRvIII protein levels and this was due to an increase in protein stability rather than an increase in EGFR mRNA expression. In contrast, FHL2 knockdown using RNA interference reduced EGFR and EGFRvIII protein expression and the phosphorylation levels of EGFR and AKT. Consistent with these features, EGFR expression was significantly lower in mouse FHL2-null astrocytes, where reintroduction of FHL2 was able to restore EGFR levels. Using established GBM cell lines and patient-derived neurosphere lines, FHL2 silencing markedly induced cell apoptosis in EGFRvIII-positive cells. Targeting FHL2 significantly prevented EGFRvIII-positive GBM tumor growth in vivo. FHL2 expression also positively correlated with EGFR expression in GBM samples from patients. Taken together, our results demonstrate that FHL2 interacts with EGFR and EGFRvIII to increase their levels and this promotes glioma growth, representing a novel mechanism that may be therapeutically targetable.	[Sun, Lili; Yu, Shuye; Xu, Hui; Zheng, Yanwen; Wang, Aidong; Li, Ming] Soochow Univ, Affiliated Hosp 2, Expt Ctr, Suzhou, Peoples R China; [Yu, Shuye] Soochow Univ, Affiliated Hosp 2, Dept Neurol, Suzhou, Peoples R China; [Xu, Hui; Lan, Qing; Li, Ming] Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou, Peoples R China; [Lin, Juntang] Xinxiang Med Univ, Stem Cells & Biotherapy Engn Res Ctr Henan, Xinxiang, Peoples R China; [Wu, Meiyan; Wang, Jide] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Furnari, Frank; Cavenee, Webster] Univ Calif San Diego, Ludwig Inst Canc Res, San Diego, CA 92103 USA; [Purow, Benjamin; Li, Ming] Univ Virginia, Dept Neurol, Charlottesville, VA 22904 USA	Soochow University - China; Soochow University - China; Soochow University - China; Xinxiang Medical University; Southern Medical University - China; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of Virginia	Li, M (corresponding author), Soochow Univ, Affiliated Hosp 2, Expt Ctr, Suzhou, Peoples R China.; Li, M (corresponding author), Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou, Peoples R China.; Li, M (corresponding author), Univ Virginia, Dept Neurol, Charlottesville, VA 22904 USA.	m2liva@hotmail.com	Sun, lili/GQH-2057-2022	Li, Ming/0000-0002-2540-1738	National Natural Science Foundation of China [81572480, 81172401]; Second Affiliated Hospital of Soochow University Youth pre-Research Fund [SDFEYQN1607]; Jiangsu distinguished Medical Professorship award	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Second Affiliated Hospital of Soochow University Youth pre-Research Fund; Jiangsu distinguished Medical Professorship award	This work was supported by grants from the National Natural Science Foundation of China (81572480 and 81172401, to M.L.) and the Second Affiliated Hospital of Soochow University Youth pre-Research Fund (SDFEYQN1607, to L.S.). We thank Drs. Yu Wei and Ju Chen for the generous gifts of FHL2 null MEF cells and FHL2 knockout newborn mice. M.L. was also partially supported by Jiangsu distinguished Medical Professorship award.	Chu PH, 2000, MOL CELL BIOL, V20, P7460, DOI 10.1128/MCB.20.20.7460-7462.2000; Cvrljevic AN, 2011, J CELL SCI, V124, P2938, DOI 10.1242/jcs.083295; Dahan J, 2013, MOL CELL BIOL, V33, P3299, DOI 10.1128/MCB.00105-13; Davies GC, 2006, ONCOGENE, V25, P6497, DOI 10.1038/sj.onc.1209662; Del Vecchio CA, 2012, EXPERT REV VACCINES, V11, P133, DOI [10.1586/ERV.11.177, 10.1586/erv.11.177]; Fielitz J, 2007, P NATL ACAD SCI USA, V104, P4377, DOI 10.1073/pnas.0611726104; Fomchenko EI, 2006, CLIN CANCER RES, V12, P5288, DOI 10.1158/1078-0432.CCR-06-0438; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gabriel B, 2006, J SOC GYNECOL INVEST, V13, P69, DOI 10.1016/j.jsgi.2005.10.001; Genini M, 1997, DNA CELL BIOL, V16, P433, DOI 10.1089/dna.1997.16.433; Hiratani I, 2003, DEVELOPMENT, V130, P4161, DOI 10.1242/dev.00621; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Hsu SC, 2009, AM J TRANSL RES, V1, P249; Hua G, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.207; Jahani-Asl A, 2016, NAT NEUROSCI, V19, P798, DOI 10.1038/nn.4295; Jin H, 2016, ONCOGENE, V35, P5106, DOI 10.1038/onc.2016.54; Labalette C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003761; Lan Q, 2016, ONCOTARGET, V7, P9680, DOI 10.18632/oncotarget.7109; Latha K, 2013, INT J CANCER, V132, P509, DOI 10.1002/ijc.27690; Li L, 2015, ONCOGENE, V34, P129, DOI 10.1038/onc.2013.534; Li M, 2008, GLIA, V56, P1328, DOI 10.1002/glia.20701; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu ZY, 2016, ONCOTARGET, V7, P4680, DOI 10.18632/oncotarget.6730; Nishi H, 2002, CANCER RES, V62, P827; Nouet Y, 2012, J HEPATOL, V57, P1029, DOI 10.1016/j.jhep.2012.06.035; Padfield E, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00005; Paul C, 2006, ONCOGENE, V25, P5475, DOI 10.1038/sj.onc.1209567; Purow BW, 2008, CARCINOGENESIS, V29, P918, DOI 10.1093/carcin/bgn079; Read RD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000374; Sangadala S, 2006, J BIOL CHEM, V281, P17212, DOI 10.1074/jbc.M511013200; Schildge S, 2013, JOVE-J VIS EXP, DOI 10.3791/50079; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stutz MA, 2008, ONCOGENE, V27, P5741, DOI 10.1038/onc.2008.185; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Thorne AH, 2016, NEURO-ONCOLOGY, V18, P914, DOI 10.1093/neuonc/nov319; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Verset L, 2016, HISTOL HISTOPATHOL, V31, P469, DOI 10.14670/HH-11-709; Vouri M, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.66; Wang JD, 2007, GASTROENTEROLOGY, V132, P1066, DOI 10.1053/j.gastro.2006.12.004; Zhu H, 2010, CANCER LETT, V294, P101, DOI 10.1016/j.canlet.2010.01.028	40	19	19	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	10					1386	1398		10.1038/s41388-017-0068-0	http://dx.doi.org/10.1038/s41388-017-0068-0			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ0RI	29321665	Green Accepted			2022-12-26	WOS:000427279300009
J	Chen, JJ; OuYang, H; An, XM; Liu, SX				Chen, Jianjun; OuYang, Hui; An, Xuemei; Liu, Shixi			Vault RNAs partially induces drug resistance of human tumor cells MCF-7 by binding to the RNA/DNA-binding protein PSF and inducing oncogene GAGE6	PLOS ONE			English	Article							BREAST-CANCER CELL; MULTIDRUG-RESISTANCE; NONCODING RNA; EXPRESSION; LINES; COMPLEX; TUMORIGENESIS; ASSOCIATION; DOXORUBICIN; SUFFICIENT	Background Vault is the largest nonicosahedral cytosolic nucleoprotein particle, which is widely involved in induction of chemoresistance and lead to failure in long-term chemotherapy. Vault contains three different major vault proteins (MVPs) and four vault RNAs paralogues (vtRNAs, vtRNA1-1, vtRNA1-2, vtRNA1-3 and vtRNA2-1). Disruption of the MVPs do not induce hypersensitivity while expression of vtRNAs contributes to cells' drug resistance, indicates that vtRNAs, but not MVPs play an important role in causing drug resistance. Polypyrimidine tract binding protein associated splicing factor (PSF) contributes to cell sensitivity to chemotherapy by its transcriptional activity, promotes us to figure out its potential association with vtRNAs. Methods We investigate the interaction between PSF and vtRNAs by electrophoretic mobility shift assays (EMSA) and RNA-immunoprecipitation (IP), and showed the binding between PSF and vtRNAs. Chromatin Immunoprecipitation (ChIP) was performed to detect the effects of vtRNAs on the interaction of PSF with GAGE6 promoter. The role of vtRNAs on chemoresistance in MCF-7 was detected by CCK-8 and EdU staining. The independent role of vtRNAs with MVP is detected by MVP or vtRNAs knockdown. Results The complex with vtRNA1-1 releases PSF, allowing transcription of GAGE6 to proceed. Then we showed that induction of GAGE6 caused drug resistance by promoting cell proliferation and colony formation in soft agar. Ectopic expression of shRNA targets to vtRNA1-1 further confirmed the role of vtRNA1-1 in regulating PSF transcriptional activity independent with the expression of MVP. By vtRNA1-1 or MVP knockdown, it is revealed that vtRNA1-1 caused chemoresistance independent of MVP. Furthermore, knockdown of GAGE6 does not cause drug resistance, indicates the GAGE6 is directly involved in cell proliferation, but not the drug resistance. Conclusion These results suggest that vtRNAs regulates cell proliferation, drug resistance, and possibly other physiological processes of humans, by complex formation with PSF.	[Chen, Jianjun; Liu, Shixi] Sichuan Univ, West China Hosp, Dept ENT, Chengdu, Sichuan, Peoples R China; [OuYang, Hui] First Peoples Hosp Neijiang, Dept ENT, Neijiang, Peoples R China; [An, Xuemei] Chengdu Univ, TCM, Dept Neurol, Chengdu, Sichuan, Peoples R China	Sichuan University; Chengdu University	Liu, SX (corresponding author), Sichuan Univ, West China Hosp, Dept ENT, Chengdu, Sichuan, Peoples R China.	liushixi1983@163.com						Abbondanza C, 1998, J CELL BIOL, V141, P1301, DOI 10.1083/jcb.141.6.1301; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Christine H, 1999, J CELL BIOL, V144, P1163; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Duan ZF, 2003, CLIN CANCER RES, V9, P2778; Gopinath SCB, 2010, MOL CANCER RES, V8, P1536, DOI 10.1158/1541-7786.MCR-10-0242; Han M, 2012, J CONTROL RELEASE, V163, P136, DOI 10.1016/j.jconrel.2012.08.020; Hu Y, 2002, INT J CANCER, V97, P149, DOI 10.1002/ijc.1590; Huffman KE, 2005, BIOCHEMISTRY-US, V44, P2253, DOI 10.1021/bi047948g; Izquierdo MA, 1996, AM J PATHOL, V148, P877; Izquierdo MA, 1996, INT J CANCER, V65, P230; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Ji Q, 2014, BRIT J CANCER, V111, P736, DOI 10.1038/bjc.2014.383; KEDERSHA NL, 1986, ANAL BIOCHEM, V156, P161, DOI 10.1016/0003-2697(86)90168-5; KEDERSHA NL, 1991, J CELL BIOL, V112, P225, DOI 10.1083/jcb.112.2.225; KEDERSHA NL, 1986, J CELL BIOL, V103, P699, DOI 10.1083/jcb.103.3.699; Kickhoefer VA, 1998, J BIOL CHEM, V273, P8971, DOI 10.1074/jbc.273.15.8971; Kitazono M, 1999, JNCI-J NATL CANCER I, V91, P1647, DOI 10.1093/jnci/91.19.1647; Li L, 2009, P NATL ACAD SCI USA, V106, P12956, DOI 10.1073/pnas.0906005106; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Ohno N, 2001, BLOOD, V98, P1160, DOI 10.1182/blood.V98.4.1160; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; Poderycki MJ, 2005, NUCLEIC ACIDS RES, V33, P893, DOI 10.1093/nar/gki234; Sherman-Baust CA, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-21; Shoham T, 2003, ANN NY ACAD SCI, V996, P245, DOI 10.1111/j.1749-6632.2003.tb03253.x; Siva AC, 2001, INT J CANCER, V92, P195, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1168>3.0.CO;2-7; Song X, 2005, P NATL ACAD SCI USA, V102, P12189, DOI 10.1073/pnas.0505179102; Steiner E, 2006, CURR DRUG TARGETS, V7, P923, DOI 10.2174/138945006778019345; TAYLOR CW, 1991, BRIT J CANCER, V63, P923, DOI 10.1038/bjc.1991.202; TAYLOR PD, 1994, BRIT J PHARMACOL, V111, P35, DOI 10.1111/j.1476-5381.1994.tb14020.x; van Zon A, 2001, J BIOL CHEM, V276, P37715, DOI 10.1074/jbc.M106055200; VERSANTVOORT CHM, 1995, INT J CANCER, V61, P375, DOI 10.1002/ijc.2910610317; Wang G, 2009, P NATL ACAD SCI USA, V106, P16794, DOI 10.1073/pnas.0909022106; ZIJLSTRA JG, 1987, CANCER RES, V47, P1780	35	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191325	10.1371/journal.pone.0191325	http://dx.doi.org/10.1371/journal.pone.0191325			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346433	Green Submitted, gold, Green Published			2022-12-26	WOS:000422749500041
J	Maymo, JL; Riedel, R; Perez-Perez, A; Magatti, M; Maskin, B; Duenas, JL; Parolini, O; Sanchez-Margalet, V; Varone, CL				Maymo, Julieta L.; Riedel, Rodrigo; Perez-Perez, Antonio; Magatti, Marta; Maskin, Bernardo; Luis Duenas, Jose; Parolini, Ornella; Sanchez-Margalet, Victor; Varone, Cecilia L.			Proliferation and survival of human amniotic epithelial cells during their hepatic differentiation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HEPATOCYTE-LIKE CELLS; EPIDERMAL-GROWTH-FACTOR; HUMAN FETAL MEMBRANES; ACUTE LIVER-FAILURE; PROGENITOR CELLS; CYCLE REGULATION; IMMUNOMODULATORY PROPERTIES; SIGNALING PATHWAY; TERM PLACENTA	Stem cells derived from placental tissues are an attractive source of cells for regenerative medicine. Amniotic epithelial cells isolated from human amnion (hAECs) have desirable and competitive characteristics that make them stand out between other stem cells. They have the ability to differentiate toward all three germ layers, they are not tumorigenic and they have immunosuppressive properties. Although liver transplantation is the best way to treat acute and chronic hepatic failure patients, there are several obstacles. Recently, stem cells have been spotlighted as alternative source of hepatocytes because of their potential for hepatogenic differentiation. In this work, we aimed to study the proliferation and survival of the hAECs during their hepatic differentiation. We have also analyzed the changes in pluripotency and hepatic markers. We differentiated amniotic cells applying a specific hepatic differentiation (HD) protocol. We determined by qRT-PCR that hAECs express significant levels of SOX-2, OCT-4 and NANOG during at least 15 days in culture and these pluripotent markers diminish during HD. SSEA-4 expression was reduced during HD, measured by immunofluorescence. Morphological characteristics became more similar to hepatic ones in differentiated cells and representative hepatic markers significantly augmented their expression, measured by qRT-PCR and Western blot. Cells achieved a differentiation efficiency of 75%. We observed that HD induced proliferation and promoted survival of hAECs, during 30 days in culture, evaluated by 3 H-thymidine incorporation and MTT assay. HD also promoted changes in hAECs cell cycle. Cyclin D1 expression increased, while p21 and p53 levels were reduced. Immunofluorescence analysis showed that Ki-67 expression was upregulated during HD. Finally, ERK 1/2 phosphorylation, which is intimately linked to proliferation and cell survival, augmented during all HD process and the inhibition of this signaling pathway affected not only proliferation but also differentiation. Our results suggest that HD promotes proliferation and survival of hAECs, providing important evidence about the mechanisms governing their hepatic differentiation. We bring new knowledge concerning some of the optimal transplantation conditions for these hepatic like cells.	[Maymo, Julieta L.; Riedel, Rodrigo; Varone, Cecilia L.] Univ Buenos Aires, Fac Ciencias Exactas & Nat IQUIBICEN, CONICET, Inst Quim Biol, Ciudad Univ Pabellon 2,4 Piso, RA-1428 Buenos Aires, DF, Argentina; [Maymo, Julieta L.; Riedel, Rodrigo; Varone, Cecilia L.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Ciudad Univ Pabellon 2,4 Piso, RA-1428 Buenos Aires, DF, Argentina; [Perez-Perez, Antonio; Sanchez-Margalet, Victor] Univ Seville, Hosp Univ Virgen Macarena, Fac Med, Dept Bioqum Med & Biol Mol, Ave Sanchez Pizjuan 4, E-41009 Seville, Spain; [Magatti, Marta; Parolini, Ornella] Fdn Poliambulanza Ist Osped, Ctr Ric E Menni, Brescia, Italy; [Maskin, Bernardo] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina; [Luis Duenas, Jose] Hosp Univ Virgen Macarena, Serv Ginecol & Obstet, Seville, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Hospital Universitario Virgen Macarena; University of Sevilla; Hospital Universitario Virgen Macarena	Maymo, JL (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat IQUIBICEN, CONICET, Inst Quim Biol, Ciudad Univ Pabellon 2,4 Piso, RA-1428 Buenos Aires, DF, Argentina.; Maymo, JL (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Ciudad Univ Pabellon 2,4 Piso, RA-1428 Buenos Aires, DF, Argentina.	jmaymo@qb.fcen.uba.ar	Sánchez-Margalet, Victor/AAB-9986-2021; Dueñas-Díez, José-Luis/E-6320-2010; Maymo, Julieta/AAU-3777-2020; PAROLINI, ORNELLA/ABI-7862-2020	Sánchez-Margalet, Victor/0000-0001-8638-8680; Dueñas-Díez, José-Luis/0000-0001-7596-6289; Maymo, Julieta/0000-0003-1308-9887; PAROLINI, ORNELLA/0000-0002-5211-6430; Perez Perez, Antonio/0000-0002-5660-735X	Subsidio a la Investigacion Biomedica Fundacion F. Fiorini; Subsidio a la Investigacion Fundacion A. Roemmers; Proyectos de Investigacion Cientifica y Tecnologica [PICT-2013-0231]; Proyectos de investigacion plurianuales [PIP 0217/14 (20142016) CONICET]; Proyecto UBACyT [20122015, 20020110100022]; Instituto de Salud Carlos III, Spain [PS09/00119, PI12/00172];  [PICT 2012-1366]	Subsidio a la Investigacion Biomedica Fundacion F. Fiorini; Subsidio a la Investigacion Fundacion A. Roemmers; Proyectos de Investigacion Cientifica y Tecnologica; Proyectos de investigacion plurianuales; Proyecto UBACyT; Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); 	This work was supported by Subsidio a la Investigacion Biomedica Fundacion F. Fiorini, J.M., http://www.fff.org.ar/; Subsidio a la Investigacion Fundacion A. Roemmers 2012, 2015, J.M., http://www.roemmers.com.ar/es/compromiso/fundacion/investigacion; Proyectos de Investigacion Cientifica y Tecnologica (2013-2015) PICT-2013-0231 (JOVEN), J.M.; PICT 2012-1366, C.V., http://www.agencia.mincyt.gob.ar/frontend/agencia/convocatoria/369; Proyectos de investigacion plurianuales PIP 0217/14 (20142016) CONICET, C.V., J.M., http://convocatorias.conicet.gov.ar/investigacion-y-desarrollo/; Proyecto UBACyT (20122015), Grupo consolidado 20020110100022, C.V., http://www.uba.ar/secyt/contenido.php?id=42 & Instituto de Salud Carlos III (PS09/00119; PI12/00172), Spain, V.S.M., http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-financiacion/convocatorias-ayudas-accion-estrategica-salud.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Antoniadou E, 2016, BEST PRACT RES CL OB, V31, P13, DOI 10.1016/j.bpobgyn.2015.08.014; Asahina K, 2004, GENES CELLS, V9, P1297, DOI 10.1111/j.1365-2443.2004.00809.x; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; Banas RA, 2008, HUM IMMUNOL, V69, P321, DOI 10.1016/j.humimm.2008.04.007; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; BHORA FY, 1995, J SURG RES, V59, P236, DOI 10.1006/jsre.1995.1160; Bilic G, 2008, CELL TRANSPLANT, V17, P955, DOI 10.3727/096368908786576507; Bilir BM, 2000, LIVER TRANSPLANT, V6, P32, DOI 10.1016/S1527-6465(00)80030-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brolen G, 2010, J BIOTECHNOL, V145, P284, DOI 10.1016/j.jbiotec.2009.11.007; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Carbone A, 2014, CURR STEM CELL RES T, V9, P297, DOI 10.2174/1574888X0904140429142451; Cargnoni A, 2009, CELL TRANSPLANT, V18, P1147, DOI 10.3727/096368909X12483162196764; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; Chen YT, 2007, STEM CELLS, V25, P1995, DOI 10.1634/stemcells.2006-0677; Chien CC, 2006, STEM CELLS, V24, P1759, DOI 10.1634/stemcells.2005-0521; Chun JS, 2004, METH MOLEC MED, V100, P291; Dalton S, 2015, TRENDS CELL BIOL, V25, P592, DOI 10.1016/j.tcb.2015.07.007; DELLAQUILA ML, 1982, EXP CELL RES, V137, P441, DOI 10.1016/0014-4827(82)90047-7; Delo DM, 2006, METHOD ENZYMOL, V419, P426, DOI 10.1016/S0076-6879(06)19017-5; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Evangelista M, 2008, CYTOTECHNOLOGY, V58, P33, DOI 10.1007/s10616-008-9162-z; Fatimah SS, 2012, J BIOSCI BIOENG, V114, P220, DOI 10.1016/j.jbiosc.2012.03.021; Fatimah SS, 2010, HUM CELL, V23, P141, DOI 10.1111/j.1749-0774.2010.00096.x; Fauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001; Fierabracci A, 2015, EXPERT OPIN BIOL TH, V15, P613, DOI 10.1517/14712598.2015.1000856; Gao W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112698; Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138; GERDES J, 1984, J IMMUNOL, V133, P1710; Hakomori S, 2004, GLYCOCONJUGATE J, V21, P125, DOI 10.1023/B:GLYC.0000044844.95878.cf; Hansen K, 2008, LIVER TRANSPLANT, V14, P713, DOI 10.1002/lt.21520; Harding A, 2017, STEM CELLS, V35, P909, DOI 10.1002/stem.2577; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Hengstler Jan G, 2005, Expert Opin Drug Metab Toxicol, V1, P61, DOI 10.1517/17425255.1.1.61; Hennerbichler S, 2014, CELL TISSUE BANK, V15, P175, DOI 10.1007/s10561-014-9441-1; Hindley C, 2013, BIOCHEM J, V451, P135, DOI 10.1042/BJ20121627; Hori J, 2006, CORNEA, V25, pS53, DOI 10.1097/01.ico.0000247214.31757.5c; Huang HI, 2007, CURR PROTOC STEM CEL; Ilancheran S, 2009, PLACENTA, V30, P2, DOI 10.1016/j.placenta.2008.09.009; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; Insausti CL, 2014, STEM CELLS CLONING, V7, P53, DOI 10.2147/SCCAA.S58696; Izumi M, 2009, J REPROD IMMUNOL, V81, P39, DOI 10.1016/j.jri.2009.02.007; Kakishita K, 2000, EXP NEUROL, V165, P27, DOI 10.1006/exnr.2000.7449; Lee WM, 2012, SEMIN RESP CRIT CARE, V33, P36, DOI 10.1055/s-0032-1301733; LI Y, 1994, ONCOGENE, V9, P2261; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Lin JS, 2015, J GASTROEN HEPATOL, V30, P1673, DOI 10.1111/jgh.12991; Liu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035758; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu T, 2014, GENET MOL RES, V13, P415, DOI 10.4238/2014.January.21.9; Garcia-Castro IL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146082; Malek Antoine, 2011, J Stem Cells, V6, P75; Mamede AC, 2012, CELL TISSUE RES, V349, P447, DOI 10.1007/s00441-012-1424-6; Manuelpillai U, 2011, PLACENTA, V32, pS320, DOI 10.1016/j.placenta.2011.04.010; Manuelpillai U, 2010, CELL TRANSPLANT, V19, P1157, DOI 10.3727/096368910X504496; MARCHESE C, 1990, J CELL PHYSIOL, V144, P326, DOI 10.1002/jcp.1041440219; Marongiu F, 2011, HEPATOLOGY, V53, P1719, DOI 10.1002/hep.24255; Marongiu M, 2015, STEM CELLS DEV, V24, P1429, DOI 10.1089/scd.2014.0532; Matikainen Tiina, 2005, Toxicol Appl Pharmacol, V207, P544, DOI 10.1016/j.taap.2005.01.039; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Miki T, 2006, STEM CELL REV, V2, P133, DOI 10.1007/s12015-006-0020-0; Miki Toshio, 2009, V481, P155, DOI 10.1007/978-1-59745-201-4_13; Murphy S., 2010, CURR PROTOC STEM CEL; Ochsenbein-Kolble N, 2003, J PERINAT MED, V31, P287, DOI 10.1515/JPM.2003.040; Oliveira MS, 2015, WORLD J STEM CELLS, V7, P769, DOI 10.4252/wjsc.v7.i4.769; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Park HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132992; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Parolini O, 2010, STEM CELLS DEV, V19, P143, DOI 10.1089/scd.2009.0404; Parolini O, 2009, REGEN MED, V4, P275, DOI 10.2217/17460751.4.2.275; Peng SL, 2009, CELL PHYSIOL BIOCHEM, V23, P165, DOI 10.1159/000204105; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Rescan C, 2001, MOL BIOL CELL, V12, P725, DOI 10.1091/mbc.12.3.725; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; SAKURAGAWA N, 1992, BRAIN DEV-JPN, V14, P7, DOI 10.1016/S0387-7604(12)80272-5; Sakuragawa N, 2000, J HUM GENET, V45, P171, DOI 10.1007/s100380050205; Sakuragawa N, 2004, J NEUROSCI RES, V78, P208, DOI 10.1002/jnr.20257; Sankar V, 2003, NEUROSCIENCE, V118, P11, DOI 10.1016/S0306-4522(02)00929-6; SCAGGIANTE B, 1987, TRANSPLANTATION, V44, P59, DOI 10.1097/00007890-198707000-00014; Si JW, 2015, WORLD J STEM CELLS, V7, P149, DOI 10.4252/wjsc.v7.i1.149; Simat S F, 2008, Med J Malaysia, V63 Suppl A, P53; Strom SC, 2006, CELL TRANSPLANT, V15, pS105; Strom SC, 1999, SEMIN LIVER DIS, V19, P39, DOI 10.1055/s-2007-1007096; Tabatabaei Meraj, 2014, Avicenna Journal of Medical Biotechnology, V6, P10; Takahashi N, 2002, CELL TRANSPLANT, V11, P443; Takashima S, 2004, CELL STRUCT FUNCT, V29, P73, DOI 10.1247/csf.29.73; Tee JY, 2013, CURR STEM CELL RES T, V8, P91; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CR0070034; Torok NJ, 2008, J GASTROENTEROL, V43, P315, DOI 10.1007/s00535-008-2181-x; Tsujimura T, 2009, J PHYSIOL-LONDON, V587, P805, DOI 10.1113/jphysiol.2008.165324; Vaghjiani V, 2014, STEM CELLS DEV, V23, P866, DOI 10.1089/scd.2013.0485; Wang H, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431X20165988, 10.1590/1414-431x20165988]; Wang Jia-Ping, 2014, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V22, P187, DOI 10.7534/j.issn.1009-2137.2014.01.036; Wang Y, 2009, AM J PHYSIOL-CELL PH, V297, pC1284, DOI 10.1152/ajpcell.00183.2009; Wei JP, 2003, CELL TRANSPLANT, V12, P545, DOI 10.3727/000000003108747000; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Yu SJ, 2009, CELL TRANSPLANT, V18, P111, DOI 10.3727/096368909788341243; Zhang ZZ, 2013, J CELL PHYSIOL, V228, P298, DOI 10.1002/jcp.24150; Zhou JJ, 2011, INT ORTHOP, V35, P941, DOI 10.1007/s00264-010-1116-3; Zhu CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep35489	102	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191489	10.1371/journal.pone.0191489	http://dx.doi.org/10.1371/journal.pone.0191489			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346426	Green Published, Green Submitted, gold			2022-12-26	WOS:000422749500055
J	Otegbeye, F; Ojo, E; Moreton, S; Mackowski, N; Lee, DA; de Lima, M; Wald, DN				Otegbeye, Folashade; Ojo, Evelyn; Moreton, Stephen; Mackowski, Nathan; Lee, Dean A.; de Lima, Marcos; Wald, David N.			Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SMALL-MOLECULE INHIBITOR; VIVO; THROMBOPOIETIN; CYTOTOXICITY; TGF-BETA-1; EXPANSION; NKG2D	Natural killer cells harnessed from healthy individuals can be expanded ex vivo using various platforms to produce large doses for adoptive transfer into cancer patients. During such expansion, NK cells are increasingly activated and more efficient at killing cancer cells. Adoptive transfer however introduces these activated cells into a highly immunosuppressive tumor microenvironment mediated in part by excessive transforming growth factor beta (TGF-beta) from both cancer cells and their surrounding stroma. This microenvironment ultimately limits the clinical efficacy of NK cell therapy. In this study, we examined the use of a TGF-beta receptor kinase inhibitor, LY2157299, in preserving the cytotoxic function of ex vivo expanded, highly activated NK cells following sustained exposure to pathologic levels of TGF-beta in vitro and in a liver metastases model of colon cancer. Using myeloid leukemia and colon cancer cell lines, we show that the TGF-beta driven impairment of NK cell cytotoxicity is mitigated by LY2157299. We demonstrate this effect using quantitative cytotoxicity assays as well as by showing a preserved activated phenotype with high NKG2D/ CD16 expression and enhanced cytokine production. In a mouse liver metastases model of colon cancer, we observed significantly improved eradication of liver metastases in mice treated with adoptive NK cells combined with LY2157299 compared with mice receiving NK cells or TGF beta inhibition alone. We propose that the therapeutic efficacy of adoptive NK cell therapy clinically will be markedly enhanced by complementary approaches targeting TGF-beta signaling in vivo.	[Otegbeye, Folashade; de Lima, Marcos] Univ Hosp Cleveland, Med Ctr, Dept Med, Div Hematol & Oncol, Cleveland, OH 44106 USA; [Otegbeye, Folashade; Ojo, Evelyn; Moreton, Stephen; Mackowski, Nathan; de Lima, Marcos; Wald, David N.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Lee, Dean A.] Nationwide Childrens Hosp, Div Hematol Oncol, Columbus, OH USA; [Wald, David N.] Univ Hosp Cleveland, Med Ctr, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland	Otegbeye, F (corresponding author), Univ Hosp Cleveland, Med Ctr, Dept Med, Div Hematol & Oncol, Cleveland, OH 44106 USA.; Otegbeye, F (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.	folashade.otegbeye@uhhospitals.org; dnw@case.edu		Otegbeye, Folashade/0000-0002-9978-4719; Lee, Darrall/0000-0002-6990-4441	American Society of Hematology (Research Training Award for Fellows); Leukemia and Lymphoma Society; Case Comprehensive Cancer Center GI SPORE grant; Tissue Resources, Cytometry and Imaging Microscopy; Hematopoietic Biorepository and Cellular Therapy Core Facilites of the Case Comprehensive Cancer Center [P30 CA043703]; NATIONAL CANCER INSTITUTE [P50CA150964, P30CA043703] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021559] Funding Source: NIH RePORTER	American Society of Hematology (Research Training Award for Fellows); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Case Comprehensive Cancer Center GI SPORE grant; Tissue Resources, Cytometry and Imaging Microscopy; Hematopoietic Biorepository and Cellular Therapy Core Facilites of the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	FO receives salary support for this research effort through grant funding from the American Society of Hematology (Research Training Award for Fellows). The work was funded partially through a grant to DNW from the Leukemia and Lymphoma Society. Research-grade LY2157299 was provided by Lilly Oncology. Colon cancer studies were supported by a Case Comprehensive Cancer Center GI SPORE grant awarded to DNW. Tissue analysis was supported by the Tissue Resources, Cytometry and Imaging Microscopy and the Hematopoietic Biorepository and Cellular Therapy Core Facilites of the Case Comprehensive Cancer Center (P30 CA043703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2005, LEUKEMIA, V19, P1558, DOI 10.1038/sj.leu.2403875; Baginska J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00490; BELLONE G, 1995, J IMMUNOL, V155, P1066; Bergmann L, 1995, EXP HEMATOL, V23, P1574; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Childs RW, 2013, HEMATOL-AM SOC HEMAT, P234, DOI 10.1182/asheducation-2013.1.234; Cho D, 2009, KOREAN J LAB MED, V29, P89, DOI 10.3343/kjlm.2009.29.2.89; Chretien AS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00122; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Dasgupta S, 2005, J IMMUNOL, V175, P5541, DOI 10.4049/jimmunol.175.8.5541; Dong M, 2006, BLOOD, V107, P4589, DOI 10.1182/blood-2005-10-4169; Geller MA, 2011, IMMUNOTHERAPY-UK, V3, P1445, DOI [10.2217/IMT.11.131, 10.2217/imt.11.131]; Herbertz S, 2015, DRUG DES DEV THER, V9, P4479, DOI 10.2147/DDDT.S86621; Hirayama Y, 2003, AM J HEMATOL, V73, P285, DOI 10.1002/ajh.10345; Hong CS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00160; Kang L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00101; Knorr DA, 2014, SEMIN IMMUNOL, V26, P161, DOI 10.1016/j.smim.2014.02.002; Konjevic G, 2012, IMMUNOL RES, V52, P139, DOI 10.1007/s12026-012-8285-7; Lapteva N, 2012, CYTOTHERAPY, V14, P1131, DOI 10.3109/14653249.2012.700767; Lee HM, 2014, CELL IMMUNOL, V290, P52, DOI 10.1016/j.cellimm.2014.05.001; Lee JC, 2004, J IMMUNOL, V172, P7335, DOI 10.4049/jimmunol.172.12.7335; Narai S, 2002, INT J CANCER, V97, P508, DOI 10.1002/ijc.1631; Park CY, 2011, CANCER SCI, V102, P1889, DOI 10.1111/j.1349-7006.2011.02014.x; Shah N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076781; Somanchi SS, 2011, J VIS EXP; Spanholtz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020740; Szmania S, 2015, J IMMUNOTHER, V38, P24, DOI 10.1097/CJI.0000000000000059; Tomchuck S, 2013, J IMMUNOL, V190; Trotta R, 2008, J IMMUNOL, V181, P3784, DOI 10.4049/jimmunol.181.6.3784; Yang B, 2013, INT IMMUNOPHARMACOL, V17, P198, DOI 10.1016/j.intimp.2013.06.003; Yoon JH, 2013, EMBO MOL MED, V5, P1720, DOI 10.1002/emmm.201302524	31	75	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191358	10.1371/journal.pone.0191358	http://dx.doi.org/10.1371/journal.pone.0191358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342200	gold, Green Published, Green Submitted			2022-12-26	WOS:000422653800067
J	Almeida, VM; Frutuoso, MA; Marana, SR				Almeida, Vitor M.; Frutuoso, Maira A.; Marana, Sandro R.			Search for independent (beta/alpha)(4) subdomains in a (beta/alpha)(8) barrel beta-glucosidase	PLOS ONE			English	Article							LINEAR EXTRAPOLATION METHOD; TRIOSEPHOSPHATE ISOMERASE; SUBSTRATE-SPECIFICITY; HALF-BARRELS; PROTEIN; RESIDUES; FOLD; GLYCOSIDASE; EVOLUTION; ENZYMES	Proteins that fold as (beta/alpha)(8) barrels are thought to have evolved from half-barrels that underwent duplication and fusion events. The evidence is particularly clear for small barrels, which have almost identical halves. Additionally, computational calculations of the thermodynamic stability of these structures in the presence of denaturants have revealed that (beta/alpha)(8) barrels contain two subunits or domains corresponding to half -barrels. Hence, within (beta/alpha)(8) barrels, half -barrels are self-contained units. Here, we tested this hypothesis using 6-glucosidase from the bacterium Thermotoga maritima (bglTm), which has a (beta/alpha)(8) barrel structure. Mutations were introduced to disrupt the noncovalent contacts between its halves and reveal the presence of two domains within bglTm, thus resulting in the creation of mutants T1 (containing W12A and I217A mutations) and T2 (containing W12A, H195A, I217A and F404A mutations). Mutants T1 and T2 were properly folded, as indicated by their fluorescence spectra and enzyme kinetic parameters. T1 and wild-type bglTm were equally stable, as shown by the results of thermal inactivation, differential scanning fluorimetry and guanidine hydrochloride denaturation experiments. However, T2 showed a first-order inactivation at 80 degrees C, a single melting temperature of 82 degrees C and only one transition concentration (c(50)) in 2.4 M guanidine hydrochloride. Additionally, T1 and T2 exhibited a cooperative denaturation process that followed a two-state model (m-values equal to 1.4 and 1.6 kcal/mol/M, respectively), similar to that of wild-type bglTm (1.2 kcal/mol/M). Hence, T1 and T2 each denatured as a single unit, although they contained different degrees of disruption between their halves. In conclusion, bglTm halves are equivalent in terms of their thermal and chemical stability; thus, their separate contributions to (beta/alpha)(8) barrel unfolding cannot be disentangled.	[Almeida, Vitor M.; Frutuoso, Maira A.; Marana, Sandro R.] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Marana, SR (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil.	srmarana@iq.usp.br	Frutuoso, Maira Artischeff/O-1473-2015; Frutuoso, Maira Artischeff/I-2654-2016; Marana, Sandro/D-3867-2012	Marana, Sandro/0000-0002-5117-1921; Almeida, Vitor Medeiros/0000-0003-4972-3341	FAPESP (Fundagao de Amparo a Pesquisa do Estado de Sao Paulo) [14/19439-5, 16/22365-9]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior)	FAPESP (Fundagao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This project was supported by FAPESP (Fundagao de Amparo a Pesquisa do Estado de Sao Paulo; Grants 14/19439-5 and 16/22365-9), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and CAPES (Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanuma S, 2008, J MOL BIOL, V382, P458, DOI 10.1016/j.jmb.2008.07.040; Beton D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139673; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Frutuoso MA, 2013, PROTEIN PEPTIDE LETT, V20, P102, DOI 10.2174/092986613804096757; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goldman AD, 2016, J MOL EVOL, V82, P17, DOI 10.1007/s00239-015-9722-8; Hancock SM, 2006, CURR OPIN CHEM BIOL, V10, P509, DOI 10.1016/j.cbpa.2006.07.015; Hocker B, 2004, P NATL ACAD SCI USA, V101, P16448, DOI 10.1073/pnas.0405832101; Hocker B, 2001, CURR OPIN BIOTECH, V12, P376, DOI 10.1016/S0958-1669(00)00230-5; Hocker B, 2001, NAT STRUCT BIOL, V8, P32; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Leatherbarrow R.J, 1987, ENZFITTER NONLINEAR; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Marana SR, 2002, EUR J BIOCHEM, V269, P3705, DOI 10.1046/j.1432-1033.2002.03061.x; Mendonca LMF, 2008, FEBS J, V275, P2536, DOI 10.1111/j.1742-4658.2008.06402.x; MURZIN AG, 1994, J MOL BIOL, V236, P1369, DOI 10.1016/0022-2836(94)90064-7; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Ochoa-Leyva A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070582; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Pace CN, 2005, PROTEIN FOLDING HANDBOOK, P45, DOI 10.1002/9783527619498.ch3; Pace CN, 2000, PROTEINS, P1; Pan H, 2004, J MOL BIOL, V336, P1251, DOI 10.1016/j.jmb.2003.12.076; Porter LL, 2012, P NATL ACAD SCI USA, V109, P9420, DOI 10.1073/pnas.1202604109; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Segel IH., 1993, ENZYME KINETICS BEHA; Seitz T, 2007, J MOL BIOL, V372, P114, DOI 10.1016/j.jmb.2007.06.036; Sharma P, 2016, FEBS J, V283, P4340, DOI 10.1111/febs.13927; Shukla A, 2004, PROTEINS, V55, P548, DOI 10.1002/prot.20066; Smith MA, 2013, PROTEIN SCI, V22, P231, DOI 10.1002/pro.2202; Souza VP, 2016, FEBS J, V283, P1124, DOI 10.1111/febs.13659; Sperl JM, 2013, FEBS LETT, V587, P2798, DOI 10.1016/j.febslet.2013.06.022; Tamaki FK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096627; Vega MC, 2003, CURR OPIN CHEM BIOL, V7, P694, DOI 10.1016/j.cbpa.2003.10.004; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Zechel DL, 2003, J AM CHEM SOC, V125, P14313, DOI 10.1021/ja036833h; Zitzewitz JA, 1999, PROTEIN SCI, V8, P1200, DOI 10.1110/ps.8.6.1200	38	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191282	10.1371/Journal.pone.0191282	http://dx.doi.org/10.1371/Journal.pone.0191282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338043	gold, Green Published, Green Submitted			2022-12-26	WOS:000422652700045
J	Granger, BL				Granger, Bruce L.			Accessibility and contribution to glucan masking of natural and genetically tagged versions of yeast wall protein 1 of Candida albicans	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS; CELL-WALL; BETA-GLUCAN; IN-VITRO; FUNGAL PATHOGENS; GENE-EXPRESSION; KINASE PATHWAY; ALS ADHESINS; RECOGNITION	Yeast wall protein 1 (Ywp1) is an abundant glycoprotein of the cell wall of the yeast form of Candida albicans, the most prevalent fungal pathogen of humans. Antibodies that bind to the polypeptide backbone of isolated Ywp1 show little binding to intact yeast cells, presumably because the Ywp1 epitopes are masked by the polysaccharides of the mannoproteins that form the outer layer of the cell wall. Rare cells do exhibit much greater anti-Ywp1 binding, however, and one of these was isolated and characterized. No differences were seen in its Ywp1, but it exhibited greater adhesiveness, sensitivity to wall perturbing agents, and exposure of its underlying beta-1,3-glucan layer to external antibodies. The molecular basis for this greater epitope accessibility has not been determined, but has facilitated exploration of how these properties change as a function of cell growth and morphology. In addition, previously engineered strains with reduced quantities of Ywp1 in their cell walls were also found to have greater beta-1,3-glucan exposure, indicating that Ywp1 itself contributes to the masking of wall epitopes, which may be important for understanding the anti-adhesive effect of Ywp1. Ectopic production of Ywp1 by hyphae, which reduces the adhesivity of these filamentous forms of C. albicans, was similarly found to reduce exposure of the beta-1,3-glucan in their walls. To monitor Ywp1 in the cell wall irrespective of its accessibility, green fluorescent protein (Gfp) was genetically inserted into wall-anchored Ywp1 using a bifunctional cassette that also allowed production from a single transfection of a soluble, anchor-free version. The wall-anchored Ywp1 -Gfp-Ywp1 accumulated in the wall of the yeast forms but not hyphae, and appeared to have properties similar to native Ywp1, including its adhesion-inhibiting effect. Some pseudohyphal walls also detectably accumulated this probe. Strains of C. albicans w\Vr tandem hemagglutinin (HA) epitopes inserted into wall-anchored Ywp1 were previously created by others, and were further explored here. As above, rare cells with much greater accessibility of the HA epitopes were isolated, and also found to exhibit greater exposure of Ywp1 and beta-1,3-glucan. The placement of the HA cassette inhibited the normal N-glycosylation and propeptide cleavage of Ywp1, but the wall-anchored Ywp1-HA-Ywp1 still accumulated in the cell wall of yeast forms. Bifunctional transformation cassettes were used to additionally tag these molecules with Gfp, generating soluble Ywp1 -HA-Gfp and wall-anchored Ywp1- HA-Gfp-Ywp1 molecules. The former revealed unexpected electrophoretic properties caused by the HA insertion, while the latter further highlighted differences between the presence of a tagged Ywp1 molecule (as revealed by Gfp fluorescence) and its accessibility in the cell wall to externally applied antibodies specific for HA, Gfp and Ywp1, with accessibility being greatest in the rapidly expanding walls of budding daughter cells. These strains and results increase our understanding of cell wall properties and how C. albicans masks itself from recognition by the human immune system.	[Granger, Bruce L.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Granger, BL (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.	bgranger@montana.edu		Granger, Bruce/0000-0002-9308-0331				Abbey D, 2011, G3-GENES GENOM GENET, V1, P523, DOI 10.1534/g3.111.000885; Angiolella L, 2005, J CHEMOTHERAPY, V17, P409, DOI 10.1179/joc.2005.17.4.409; Ballou ER, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.238; Beaussart A, 2012, ACS NANO, V6, P10950, DOI 10.1021/nn304505s; Beucher B, 2009, FEMS IMMUNOL MED MIC, V55, P314, DOI 10.1111/j.1574-695X.2008.00502.x; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; Boisrame A, 2011, EUKARYOT CELL, V10, P1317, DOI 10.1128/EC.05044-11; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Caminero A, 2014, YEAST, V31, P137, DOI 10.1002/yea.3003; Carlisle PL, 2013, MOL BIOL CELL, V24, P246, DOI 10.1091/mbc.E12-01-0065; Cassone A, 2013, NAT REV MICROBIOL, V11, P884, DOI 10.1038/nrmicro3156; Coleman DA, 2012, FEMS IMMUNOL MED MIC, V64, P321, DOI 10.1111/j.1574-695X.2011.00914.x; Coleman DA, 2010, MICROBIOL-SGM, V156, P3645, DOI 10.1099/mic.0.043851-0; Coleman DA, 2009, J MICROBIOL METH, V78, P71, DOI 10.1016/j.mimet.2009.05.002; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Cutler JE, 2007, NAT REV MICROBIOL, V5, P13, DOI 10.1038/nrmicro1537; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Davis SE, 2014, INFECT IMMUN, V82, P4405, DOI 10.1128/IAI.01612-14; de Groot PWJ, 2013, EUKARYOT CELL, V12, P470, DOI 10.1128/EC.00364-12; de Groot PWJ, 2004, EUKARYOT CELL, V3, P955, DOI 10.1128/EC.3.4.955-965.2004; De Nobel Hans, 1994, Trends in Cell Biology, V4, P42, DOI 10.1016/0962-8924(94)90003-5; Denning DW, 2003, LANCET, V362, P1142, DOI 10.1016/S0140-6736(03)14472-8; Deslauriers N, 1996, MICROBIOL-SGM, V142, P1239, DOI 10.1099/13500872-142-5-1239; Dongari-Bagtzoglou A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007967; Douglas LM, 2007, EUKARYOT CELL, V6, P2214, DOI 10.1128/EC.00284-06; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; Erwig LP, 2016, NAT REV MICROBIOL, V14, P163, DOI 10.1038/nrmicro.2015.21; Frieman MB, 2002, MOL MICROBIOL, V46, P479, DOI 10.1046/j.1365-2958.2002.03166.x; Fu Y, 2002, MOL MICROBIOL, V44, P61, DOI 10.1046/j.1365-2958.2002.02873.x; Galan-Diez M, 2010, INFECT IMMUN, V78, P1426, DOI 10.1128/IAI.00989-09; Ganguly S, 2011, EUKARYOT CELL, V10, P1448, DOI 10.1128/EC.05196-11; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Garcia MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017632; Gelis S, 2012, FUNGAL GENET BIOL, V49, P322, DOI 10.1016/j.fgb.2012.01.010; Gerami-Nejad M, 2012, YEAST, V29, P303, DOI 10.1002/yea.2910; Gerami-Nejad M, 2009, YEAST, V26, P399, DOI 10.1002/yea.1674; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gomathinayagam S, 2014, APPL MICROBIOL BIOT, V98, P2545, DOI 10.1007/s00253-013-5478-5; Gonzalez M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-213; Gonzalez M, 2010, YEAST, V27, P583, DOI 10.1002/yea.1797; Gow NAR, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0035-2016; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Granger BL, 2005, MICROBIOL-SGM, V151, P1631, DOI 10.1099/mic.0.27663-0; Granger BL, 2012, EUKARYOT CELL, V11, P795, DOI 10.1128/EC.00026-12; Green CB, 2005, MICROBIOL-SGM, V151, P1051, DOI 10.1099/mic.0.27696-0; Grumaz C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-212; Hall RA, 2015, MOL MICROBIOL, V97, P7, DOI 10.1111/mmi.13020; Hall RA, 2013, MOL MICROBIOL, V90, P1147, DOI 10.1111/mmi.12426; Hall RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003276; Han Y, 1997, INFECT IMMUN, V65, P4100, DOI 10.1128/IAI.65.10.4100-4107.1997; Han Y, 2000, INFECT IMMUN, V68, P1649, DOI 10.1128/IAI.68.3.1649-1654.2000; Hasim S, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00601-16; Heilmann CJ, 2011, MICROBIOL-SGM, V157, P2297, DOI 10.1099/mic.0.049395-0; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; Hopke A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005644; Hoyer LL, 1998, J BACTERIOL, V180, P5334, DOI 10.1128/JB.180.20.5334-5343.1998; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Ibrahim AS, 2013, VACCINE, V31, P5549, DOI 10.1016/j.vaccine.2013.09.016; Ikeh M, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5030048; Ikeh MAC, 2016, MOL BIOL CELL, V27, P2784, DOI 10.1091/mbc.E16-05-0266; Kapitan M, 2016, MICROBIOL-SGM, V162, P1310, DOI 10.1099/mic.0.000329; Kapteyn JC, 2000, MOL MICROBIOL, V35, P601, DOI 10.1046/j.1365-2958.2000.01729.x; Klippel N, 2010, MICROBIOL-SGM, V156, P3432, DOI 10.1099/mic.0.040006-0; Klis FM, 2001, MED MYCOL, V39, P1, DOI 10.1080/744118876; Klis FM, 2009, FEMS YEAST RES, V9, P1013, DOI 10.1111/j.1567-1364.2009.00541.x; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; Kumamoto CA, 2005, ANNU REV MICROBIOL, V59, P113, DOI 10.1146/annurev.micro.59.030804.121034; Lamarre C, 2000, MOL MICROBIOL, V35, P444, DOI 10.1046/j.1365-2958.2000.01715.x; Lavigne LM, 2006, J IMMUNOL, V177, P8667, DOI 10.4049/jimmunol.177.12.8667; Li F, 2008, MICROBIOL-SGM, V154, P1193, DOI 10.1099/mic.0.2007/013789-0; Li F, 2007, EUKARYOT CELL, V6, P931, DOI 10.1128/EC.00049-07; Lin JF, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9213034; Lipke PN, 2012, TRENDS MICROBIOL, V20, P59, DOI 10.1016/j.tim.2011.10.002; Machova E, 2015, CARBOHYD RES, V408, P12, DOI 10.1016/j.carres.2015.03.001; Maddi A, 2009, FUNGAL GENET BIOL, V46, P768, DOI 10.1016/j.fgb.2009.06.005; Mao YX, 2008, EUKARYOT CELL, V7, P1906, DOI 10.1128/EC.00148-08; Mao YX, 2003, MOL MICROBIOL, V50, P1617, DOI 10.1046/j.1365-2958.2003.03794.x; Marakalala MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003315; McLellan CA, 2012, ACS CHEM BIOL, V7, P1520, DOI 10.1021/cb300235m; MEIKLE PJ, 1991, PLANTA, V185, P1, DOI 10.1007/BF00194507; Monniot C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082395; Moreno-Ruiz E, 2009, MICROBIOL-SGM, V155, P2004, DOI 10.1099/mic.0.028902-0; Muzzey D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r97; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Noble SM, 2017, NAT REV MICROBIOL, V15, P96, DOI 10.1038/nrmicro.2016.157; Oh SH, 2005, MICROBIOL-SGM, V151, P673, DOI 10.1099/mic.0.27680-0; Otoo HN, 2008, EUKARYOT CELL, V7, P776, DOI 10.1128/EC.00309-07; Pappas HC, 2016, ANTIMICROB AGENTS CH, V60, P4519, DOI 10.1128/AAC.00317-16; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Ramsook CB, 2010, EUKARYOT CELL, V9, P393, DOI 10.1128/EC.00068-09; Richard ML, 2007, EUKARYOT CELL, V6, P119, DOI 10.1128/EC.00297-06; Roman E, 2016, VIRULENCE, V7, P558, DOI 10.1080/21505594.2016.1163458; Rosenbach A, 2010, EUKARYOT CELL, V9, P1075, DOI 10.1128/EC.00034-10; Sanchez Philip, 2014, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V33, P80, DOI 10.1089/mab.2013.0089; Schild L, 2011, EUKARYOT CELL, V10, P98, DOI 10.1128/EC.00210-10; Sem X, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00186; Shahana S, 2013, FUNGAL GENET BIOL, V56, P107, DOI 10.1016/j.fgb.2013.03.009; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shen H, 2015, INFECT IMMUN, V83, P2694, DOI 10.1128/IAI.00097-15; Sherrington SL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006403; SHIBATA N, 1992, BIOCHEMISTRY-US, V31, P5680, DOI 10.1021/bi00139a036; SHIBATA N, 1995, J BIOL CHEM, V270, P1113, DOI 10.1074/jbc.270.3.1113; Singleton DR, 2005, EUKARYOT CELL, V4, P639, DOI 10.1128/EC.4.4.639-648.2005; Spellberg BJ, 2006, J INFECT DIS, V194, P256, DOI 10.1086/504691; Staab JF, 2003, MICROBIOL-SGM, V149, P2977, DOI 10.1099/mic.0.26445-0; Staab JF, 1996, J BIOL CHEM, V271, P6298, DOI 10.1074/jbc.271.11.6298; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749; Tournu H, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00276-17, 10.1128/msphere.00276-17]; Wester MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188599; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; Wild R, 2016, SCIENCE, V352, P986, DOI 10.1126/science.aad9858; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Xin H, 2006, INFECT IMMUN, V74, P4310, DOI 10.1128/IAI.00234-06; Xin H, 2016, VACCINE, V34, P245, DOI 10.1016/j.vaccine.2015.11.035; Xin H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035106; Xu HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063736; Zhang SK, 2016, 2016 12TH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, FUZZY SYSTEMS AND KNOWLEDGE DISCOVERY (ICNC-FSKD), P1, DOI 10.1109/FSKD.2016.7603141	123	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191194	10.1371/journal.pone.0191194	http://dx.doi.org/10.1371/journal.pone.0191194			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329339	Green Published, Green Submitted, gold			2022-12-26	WOS:000419954100045
J	Singh, S; Gupta, M; Pandher, S; Kaur, G; Rathore, P; Palli, SR				Singh, Satnam; Gupta, Mridula; Pandher, Suneet; Kaur, Gurmeet; Rathore, Pankaj; Palli, Subba Reddy			Selection of housekeeping genes and demonstration of RNAi in cotton leafhopper, Amrasca biguttula biguttula (Ishida)	PLOS ONE			English	Article							REAL-TIME PCR; RHODNIUS-PROLIXUS HEMIPTERA; POLYMERASE-CHAIN-REACTION; DOUBLE-STRANDED-RNA; BETA-ACTIN; BEMISIA-TABACI; PHYSIOLOGICAL ROLES; RIBOSOMAL-RNA; EXPRESSION; INTERFERENCE	Amrasca biguttula biguttula (Ishida) commonly known as cotton leafhopper is a severe pest of cotton and okra. Not much is known on this insect at molecular level due to lack of genomic and transcriptomic data. To prepare for functional genomic studies in this insect, we evaluated 15 common housekeeping genes (Tub, B-Tub, EFalpha, GADPH, UbiCF, RP13, Ubiq, G3PD, VATPase, Actin, 18s, 28s, TATA, ETF, SOD and Cytolytic actiri) during different developmental stages and under starvation stress. We selected early (1st and 2nd), late (3rd and 4th) stage nymphs and adults for identification of stable housekeeping genes using geNorm, NormFinder, BestKeeper and FtefFinder software. Based on the different algorithms, RP13 and VATPase are identified as the most suitable reference genes for quantification of gene expression by reverse transcriptase quantitative PCR (RT-qPCR). Based on RefFinder which comprehended the results of three algorithms, RP13 in adults, Tubulin (Tub) in late nymphs, 28S in early nymph and UbiCF under starvation stress were identified as the most stable genes. We also developed methods for feeding double-stranded RNA (dsRNA) incorporated in the diet. Feeding dsRNA targeting Snf7, IAP, AQP1, and VATPase caused 56.17-77.12% knockdown of targeted genes compared to control and 16 to 48% mortality of treated insects when compared to control.	[Singh, Satnam; Gupta, Mridula; Pandher, Suneet; Kaur, Gurmeet; Rathore, Pankaj] Punjab Agr Univ, Reg Stn, Faridkot, Punjab, India; [Palli, Subba Reddy] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Punjab Agricultural University; University of Kentucky	Singh, S (corresponding author), Punjab Agr Univ, Reg Stn, Faridkot, Punjab, India.	satnam@pau.edu	Gupta, Mridula/V-9620-2019; PALLI, SUBBA REDDY/AAU-8289-2020	Gupta, Mridula/0000-0003-0620-7515; PALLI, SUBBA REDDY/0000-0002-0873-3247; Singh, Satnam/0000-0002-5298-6954	Punjab Agricultural University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070559] Funding Source: NIH RePORTER	Punjab Agricultural University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors received no specific funds for this work. The internal funding of Punjab Agricultural University supported this research.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Ahmad M, 1999, J ECON ENTOMOL, V92, P1246, DOI 10.1093/jee/92.6.1246; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Bagnall NH, 2010, MED VET ENTOMOL, V24, P176, DOI 10.1111/j.1365-2915.2010.00866.x; Bansal R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152730; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Benga G, 2009, IUBMB LIFE, V61, P112, DOI 10.1002/iub.156; Bettencourt R, 2002, INSECT MOL BIOL, V11, P267, DOI 10.1046/j.1365-2583.2002.00334.x; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Bhat A, 1986, TURKIYE BUTKI KURUME, V6, P3; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Campbell EM, 2008, J COMP PHYSIOL B, V178, P935, DOI 10.1007/s00360-008-0288-2; CHAN YL, 1995, BIOCHEM BIOPH RES CO, V215, P682, DOI 10.1006/bbrc.1995.2518; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Christiaens O, 2014, CURR OPIN INSECT SCI, V6, P15, DOI 10.1016/j.cois.2014.09.012; Dhawan A., 1986, INDIAN J PLANT PROT, V14, P45; Foss DL, 1998, ANIM BIOTECHNOL, V9, P67, DOI 10.1080/10495399809525893; Gandhe AS, 2007, J IMMUNOL, V179, P6943, DOI 10.4049/jimmunol.179.10.6943; Garbutt JS, 2012, INSECT BIOCHEM MOLEC, V42, P621, DOI 10.1016/j.ibmb.2012.05.001; Ge LQ, 2013, MOL ECOL, V22, P5624, DOI 10.1111/mec.12502; Ghanim M, 2007, INSECT BIOCHEM MOLEC, V37, P732, DOI 10.1016/j.ibmb.2007.04.006; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Haberhausen G, 1998, J CLIN MICROBIOL, V36, P628, DOI 10.1128/JCM.36.3.628-633.1998; Hajeri S, 2014, J BIOTECHNOL, V176, P42, DOI 10.1016/j.jbiotec.2014.02.010; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187; Hirai M, 2004, INSECT MOL BIOL, V13, P399, DOI 10.1111/j.0962-1075.2004.00497.x; Huis R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-71; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Kim DW, 2011, MOL CELLS, V31, P585, DOI 10.1007/s10059-011-1045-z; Koramutla MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep25883; Koyama K, 1988, JARQ, V22, P1; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Kranthi S., 2011, World Cotton Research Conference-5, Mumbai, India, 7-11 November 2011, P281; Kreuzer KA, 1999, CLIN CHEM, V45, P297; LeCaherec F, 1996, EUR J BIOCHEM, V241, P707, DOI 10.1111/j.1432-1033.1996.00707.x; Lee JA, 2008, AUTOPHAGY, V4, P230, DOI 10.4161/auto.5384; Li BJ, 1999, MOL CELL BIOL, V19, P5393; Li ZJ, 2010, FISH SHELLFISH IMMUN, V29, P89, DOI 10.1016/j.fsi.2010.02.021; Liu GQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159060; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Lu ZC, 2011, J EXP BIOL, V214, P764, DOI 10.1242/jeb.047415; Majerowicz D, 2011, INSECT MOL BIOL, V20, P713, DOI 10.1111/j.1365-2583.2011.01101.x; Mamidala P, 2011, J MED ENTOMOL, V48, P947, DOI 10.1603/ME10262; Mao JJ, 2014, TRANSGENIC RES, V23, P145, DOI 10.1007/s11248-013-9739-y; Maroniche GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-308; Mathew LG, 2011, INSECT BIOCHEM MOLEC, V41, P178, DOI 10.1016/j.ibmb.2010.12.002; Nielsen MG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-113; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; O'Riordan MXD, 2008, DEV CELL, V15, P497, DOI 10.1016/j.devcel.2008.09.012; Okazaki K, 2000, EXP CELL RES, V254, P143, DOI 10.1006/excr.1999.4728; Orme M, 2009, APOPTOSIS, V14, P950, DOI 10.1007/s10495-009-0358-2; Palli SR, 2014, CURR OPIN INSECT SCI, V6, P1, DOI 10.1016/j.cois.2014.09.011; Pan HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125868; Peng R, 2012, ACTA BIOCH BIOPH SIN, V44, P614, DOI 10.1093/abbs/gms040; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pitino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025709; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Ramaseshadri P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054270; Rodrigues TB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109825; Rumble JM, 2008, J CELL SCI, V121, P3505, DOI 10.1242/jcs.040303; Rusten TE, 2008, CELL CYCLE, V7, P1166, DOI 10.4161/cc.7.9.5784; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shakesby AJ, 2009, INSECT BIOCHEM MOLEC, V39, P1, DOI 10.1016/j.ibmb.2008.08.008; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Slagsvold T, 2006, TRENDS CELL BIOL, V16, P317, DOI 10.1016/j.tcb.2006.04.004; SPANAKIS E, 1993, NUCLEIC ACIDS RES, V21, P3809, DOI 10.1093/nar/21.16.3809; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sun W, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.20801; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Terenius O, 2007, DEV COMP IMMUNOL, V31, P571, DOI 10.1016/j.dci.2006.09.006; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Thakur N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087235; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Thirasack S., 2001, J KASETSART NAT SCI, V35, P271; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Upadhyay SK, 2011, J BIOSCIENCES, V36, P153, DOI 10.1007/s12038-011-9009-1; Vaccari T, 2009, J CELL SCI, V122, P2413, DOI 10.1242/jcs.046391; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vyas M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168921; Wan PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086675; Wang KX, 2016, INSECT BIOCHEM MOLEC, V77, P1, DOI 10.1016/j.ibmb.2016.07.007; Wang L, 2013, TRANSCRIPTOME SEQUEN, P53; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wieczorek H, 1999, BIOESSAYS, V21, P637, DOI 10.1002/(SICI)1521-1878(199908)21:8<637::AID-BIES3>3.3.CO;2-N; [吴玉 Wu Yu], 2013, [中国细胞生物学学报, Chinese Journal of Cell Biology], V35, P423; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Xue JL, 2010, J VIROL METHODS, V163, P210, DOI 10.1016/j.jviromet.2009.09.019; Yang Y, 2014, PESTIC BIOCHEM PHYS, V108, P58, DOI 10.1016/j.pestbp.2013.12.004; Yeung AT, 2004, BIOTECHNIQUES, V36, P266, DOI 10.2144/04362RR01; Yool AJ, 2007, CURR PHARM DESIGN, V13, P3212, DOI 10.2174/138161207782341349; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang SD, 2015, GENE, V555, P393, DOI 10.1016/j.gene.2014.11.038; Zheng YL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109765, 10.1371/journal.pone.0093624]; Zhu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084730	101	30	32	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191116	10.1371/journal.pone.0191116	http://dx.doi.org/10.1371/journal.pone.0191116			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329327	Green Published, Green Submitted, gold			2022-12-26	WOS:000419954100039
J	Li, SF; Lang, XD; Liu, WD; Ou, GL; Xu, H; Su, JR				Li, Shuaifeng; Lang, Xuedong; Liu, Wande; Ou, Guanglong; Xu, Hui; Su, Jianrong			The relationship between species richness and aboveground biomass in a primary Pinus kesiya forest of Yunnan, southwestern China	PLOS ONE			English	Article							PLANT DIVERSITY; PRODUCTIVITY RELATIONSHIPS; SUBTROPICAL CHINA; BIODIVERSITY; COMMUNITIES; STABILITY; DYNAMICS; MODEL	The relationship between biodiversity and biomass is an essential element of the natural ecosystem functioning. Our research aims at assessing the effects of species richness on the aboveground biomass and the ecological driver of this relationship in a primary Pinus kesiya forest. We sampled 112 plots of the primary P. kesiya forests in Yunnan Province. The general linear model and the structural equation model were used to estimate relative effects of multivariate factors among aboveground biomass, species richness and the other explanatory variables, including climate moisture index, soil nutrient regime and stand age. We found a positive linear regression relationship between the species richness and aboveground biomass using ordinary least squares regressions. The species richness and soil nutrient regime had no direct significant effect on aboveground biomass. However, the climate moisture index and stand age had direct effects on aboveground biomass. The climate moisture index could be a better link to mediate the relationship between species richness and aboveground biomass. The species richness affected aboveground biomass which was mediated by the climate moisture index. Stand age had direct and indirect effects on aboveground biomass through the climate moisture index. Our results revealed that climate moisture index had a positive feedback in the relationship between species richness and aboveground biomass, which played an important role in a link between biodiversity maintenance and ecosystem functioning. Meanwhile, climate moisture index not only affected positively on aboveground biomass, but also indirectly through species richness. The information would be helpful in understanding the biodiversity-aboveground biomass relationship of a primary P. kesiya forest and for forest management.	[Li, Shuaifeng; Lang, Xuedong; Liu, Wande; Su, Jianrong] Chinese Acad Forestry, Res Inst Resource Insects, Kunming, Yunnan, Peoples R China; [Li, Shuaifeng; Lang, Xuedong; Liu, Wande; Su, Jianrong] Chinas State Forestry Adm, Puer Forest Ecosys Res Stn, Kunming, Yunnan, Peoples R China; [Ou, Guanglong; Xu, Hui] Southwest Forestry Univ, Key Lab State Forest Adm Biodivers Conservat South, Kunming, Yunnan, Peoples R China	Chinese Academy of Forestry; Research Institute of Resources Insects, CAF; Southwest Forestry University - China	Su, JR (corresponding author), Chinese Acad Forestry, Res Inst Resource Insects, Kunming, Yunnan, Peoples R China.; Su, JR (corresponding author), Chinas State Forestry Adm, Puer Forest Ecosys Res Stn, Kunming, Yunnan, Peoples R China.; Xu, H (corresponding author), Southwest Forestry Univ, Key Lab State Forest Adm Biodivers Conservat South, Kunming, Yunnan, Peoples R China.	swfc213@126.com; Jianrongsu@vip.sina.com	Ou, Guanglong/GWC-3710-2022	Ou, Guanglong/0000-0003-1925-6690	Fundamental Research Funds of CAF [CAFYBB2017ZX002]; Yunnan Provincial Science and Technology Department [2013RA004]	Fundamental Research Funds of CAF; Yunnan Provincial Science and Technology Department	This work was supported by Fundamental Research Funds of CAF (CAFYBB2017ZX002) and the Yunnan Provincial Science and Technology Department (2013RA004) to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2015, SILVA FENN, V49; Barnes AD, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0279; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Chen Qing, 2014, Journal of Yunnan University - Natural Sciences Edition, V36, P439; Clark JS, 2010, SCIENCE, V327, P1129, DOI 10.1126/science.1183506; Dang CL, 1992, J YUNNAN U, V14, P95; de Aguiar MI, 2013, AGROFOREST SYST, V87, P699, DOI 10.1007/s10457-012-9590-9; Forrester DI, 2014, FOREST ECOL MANAG, V312, P282, DOI 10.1016/j.foreco.2013.10.003; Fowler MS, 2012, ECOL LETT, V15, P1387, DOI 10.1111/j.1461-0248.2012.01862.x; Grace JB, 2016, NATURE, V529, P390, DOI 10.1038/nature16524; Grace JB, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00048.1; Grace JB, 2006, ECOL APPL, V16, P503, DOI 10.1890/1051-0761(2006)016[0503:ASEMAO]2.0.CO;2; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Guo QF, 2007, BASIC APPL ECOL, V8, P199, DOI 10.1016/j.baae.2006.02.005; He YJ, 2013, FOREST ECOL MANAG, V295, P193, DOI 10.1016/j.foreco.2013.01.020; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Jerzy S, 2007, J VEG SCI, V18, P563; Kenkel NC, 2000, COMMUNITY ECOL, V1, P165, DOI 10.1556/ComEc.1.2000.2.6; Laossi KR, 2008, PEDOBIOLOGIA, V51, P397, DOI 10.1016/j.pedobi.2007.11.001; Laughlin DC, 2006, OIKOS, V114, P60, DOI 10.1111/j.0030-1299.2006.14424.x; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Li GuiXiang, 2006, Journal of Zhejiang Forestry College, V23, P362; Li Shuai-feng, 2013, Shengtaixue Zazhi, V32, P3152; Li SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135946; Liang JJ, 2016, SCIENCE, V354, DOI 10.1126/science.aaf8957; Liang N, 2007, J W CHINA FORESTRY S, V36, P44; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Morin X, 2011, ECOL LETT, V14, P1211, DOI 10.1111/j.1461-0248.2011.01691.x; Namgail T, 2012, J PLANT RES, V125, P93, DOI 10.1007/s10265-011-0430-1; Oberle B, 2009, GLOBAL ECOL BIOGEOGR, V18, P416, DOI 10.1111/j.1466-8238.2009.00457.x; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Tilman D, 2012, P NATL ACAD SCI USA, V109, P10394, DOI 10.1073/pnas.1208240109; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Wang TL, 2012, J FOREST RES, V27, P469; Warren J, 2009, THEOR ECOL-NETH, V2, P119, DOI 10.1007/s12080-008-0035-z; Wu X, 2015, ECOGRAPHY, V38, P602, DOI 10.1111/ecog.00940; Wu Z, 1987, YUNNAN VEGETATION; Zhang H-Q, 2005, FOREST INVENTORY PLA, V30, P43; Zhang Y, 2017, FUNCT ECOL, V31, P419, DOI 10.1111/1365-2435.12699; Zhang Y, 2015, J ECOL, V103, P1245, DOI 10.1111/1365-2745.12425; Zheng Z, 2006, BIOTROPICA, V38, P318, DOI 10.1111/j.1744-7429.2006.00148.x; Zuo Shu-di, 2015, Yingyong Shengtai Xuebao, V26, P356	43	17	18	9	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191140	10.1371/journal.pone.0191140	http://dx.doi.org/10.1371/journal.pone.0191140			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324901	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400121
J	Osterndorff-Kahanek, EA; Tiwari, GR; Lopez, MF; Becker, HC; Harris, RA; Mayfield, RD				Osterndorff-Kahanek, Elizabeth A.; Tiwari, Gayatri R.; Lopez, Marcelo F.; Becker, Howard C.; Harris, R. Adron; Mayfield, R. Dayne			Long-term ethanol exposure: Temporal pattern of microRNA expression and associated mRNA gene networks in mouse brain	PLOS ONE			English	Article							NF-KAPPA-B; POSTTRANSCRIPTIONAL REGULATION; BDNF EXPRESSION; ANIMAL-MODEL; ALCOHOL; DRINKING; TARGET; STRESS; SIGNAL; MODULATION	Long-term alcohol use can result in lasting changes in brain function, ultimately leading to alcohol dependence. These functional alterations arise from dysregulation of complex gene networks, and growing evidence implicates microRNAs as key regulators of these networks. We examined time-and brain region-dependent changes in microRNA expression after chronic intermittent ethanol (CIE) exposure in C57BL/6J mice. Animals were sacrificed at 0, 8, and 120h following the last exposure to four weekly cycles of CIE vapor and we measured microRNA expression in prefrontal cortex (PFC), nucleus accumbens (NAC), and amygdala (AMY). The number of detected (395 +/- 419) and differentially expressed (DE, 42 +/- 47) microRNAs was similar within each brain region. However, the DE microRNAs were distinct among brain regions and across time within each brain region. DE microRNAs were linked with their DE mRNA targets across each brain region. In all brain regions, the greatest number of DE mRNA targets occurred at the 0 or 8h time points and these changes were associated with microRNAs DE at 0 or 8h. Two separate approaches (discrete temporal association and hierarchical clustering) were combined with pathway analysis to further characterize the temporal relationships between DE microRNAs and their 120h DE targets. We focused on targets dysregulated at 120h as this time point represents a state of protracted withdrawal known to promote an increase in subsequent ethanol consumption. Discrete temporal association analysis identified networks with highly connected genes including ERK1/2 (mouse equivalent Mapk3, Mapk1), Bcl2 (in AMY networks) and Srf (in PFC networks). Similarly, the cluster-based analysis identified hub genes that include Bcl2 (in AMY networks) and Srf in PFC networks, demonstrating robust microRNA-mRNA network alterations in response to CIE exposure. In contrast, datasets utilizing targets from 0 and 8h microRNAs identified NF-kappa B-centered networks (in NAC and PFC), and Smad3-centered networks (in AMY). These results demonstrate that CIE exposure results in dynamic and complex temporal changes in microRNAmRNA gene network structure.	[Osterndorff-Kahanek, Elizabeth A.; Tiwari, Gayatri R.; Harris, R. Adron; Mayfield, R. Dayne] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; [Lopez, Marcelo F.; Becker, Howard C.] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC USA	University of Texas System; University of Texas Austin; Medical University of South Carolina	Osterndorff-Kahanek, EA (corresponding author), Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA.	elizabetho@austin.utexas.edu			National Institute on Alcohol Abuse and Alcoholism (NIAAA) [AA020926, AA020683, AA012404, AA010761, AA014095, AA020929]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA020929, P50AA010761, U01AA020926, U01AA014095, R01AA012404] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000813] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA, https://niaaa.nih.gov) grants AA020926 and AA020683 (RDM); AA012404 and AA010761 (RAH); AA014095 (HCB); and AA020929 (MFL).	Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Bahi A, 2013, EUR J NEUROSCI, V38, P2328, DOI 10.1111/ejn.12228; Becker HC, 2016, INT REV NEUROBIOL, V126, P157, DOI 10.1016/bs.irn.2016.02.006; BECKER HC, 1993, ALCOHOL CLIN EXP RES, V17, P94, DOI 10.1111/j.1530-0277.1993.tb00731.x; Becker HC, 2004, ALCOHOL CLIN EXP RES, V28, P1829, DOI 10.1097/01.ALC.0000149977.95306.3A; Becker HC, 2017, NEUROPHARMACOLOGY, V122, P115, DOI 10.1016/j.neuropharm.2017.04.028; Becker HC, 2014, ALCOHOL, V48, P205, DOI 10.1016/j.alcohol.2014.04.001; Bernardo BC, 2012, HEART LUNG CIRC, V21, P131, DOI 10.1016/j.hlc.2011.11.002; Brock G, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i04; Brock GN, 2013, SOURCE CODE BIOL MED, V8, DOI 10.1186/1751-0473-8-1; Clark TA, 2007, GENOME BIOL, P8; Cook SJS, 2017, FEBS J; Darcq E, 2015, MOL PSYCHIATR, V20, P1240, DOI 10.1038/mp.2014.120; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Doura MB, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00125; Du HY, 2016, NEUROSCI LETT, V611, P21, DOI 10.1016/j.neulet.2015.11.016; Farris SP, 2015, MOL PSYCHIATR, V20, P1438, DOI 10.1038/mp.2014.159; Farris SP, 2012, NEUROBIOL DIS, V45, P115, DOI 10.1016/j.nbd.2011.04.013; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gonsalvez D, 2016, NEUROPHARMACOLOGY, V110, P586, DOI 10.1016/j.neuropharm.2015.04.024; Gorini G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082565; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo AY, 2009, NUCLEIC ACIDS RES, V37, pD840, DOI 10.1093/nar/gkn816; Gurgis FMS, 2014, MOL PHARMACOL, V85, P345, DOI 10.1124/mol.113.090365; Heaton MB, 1999, BRAIN RES, V817, P13, DOI 10.1016/S0006-8993(98)01173-1; Heyer MP, 2015, BRAIN RES, V1628, P2, DOI 10.1016/j.brainres.2015.07.047; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lewohl JM, 2011, ALCOHOL CLIN EXP RES, V35, P1928, DOI 10.1111/j.1530-0277.2011.01544.x; Li JY, 2013, EMBO MOL MED, V5, P1402, DOI 10.1002/emmm.201201900; Lopez MF, 2005, PSYCHOPHARMACOLOGY, V181, P688, DOI 10.1007/s00213-005-0026-3; Lotfullina N, 2017, NEUROSCIENTIST; Mamdani M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137671; Mandala M, 2017, LAB INVEST, V97, P166, DOI 10.1038/labinvest.2016.132; Manzardo AM, 2013, GENE, V526, P356, DOI 10.1016/j.gene.2013.05.052; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Miranda RC, 2010, ALCOHOL CLIN EXP RES, V34, P575, DOI 10.1111/j.1530-0277.2009.01126.x; Mohr AM, 2015, SEMIN LIVER DIS, V35, P3, DOI 10.1055/s-0034-1397344; Most D, 2016, NEUROPSYCHOPHARMACOL, V41, P538, DOI 10.1038/npp.2015.179; Most Dana, 2014, Handb Clin Neurol, V125, P89, DOI 10.1016/B978-0-444-62619-6.00006-9; Moustakas A, 2001, J CELL SCI, V114, P4359; Muller MM, 2006, P NATL ACAD SCI USA, V103, P14250, DOI 10.1073/pnas.0606668103; Mulligan MK, 2011, ALCOHOL CLIN EXP RES, V35, P659, DOI 10.1111/j.1530-0277.2010.01384.x; Nennig SE, 2017, ALCOHOL ALCOHOLISM, V52, P172, DOI 10.1093/alcalc/agw098; Nunez YO, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-725; Osterndorff-Kahanek EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121522; Pascoli V, 2014, BIOL PSYCHIAT, V76, P917, DOI 10.1016/j.biopsych.2014.04.005; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Pietrzykowski AZ, 2010, INT REV NEUROBIOL, V91, P1, DOI 10.1016/S0074-7742(10)91001-5; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Rudolph JL, 2007, BBA-MOL CELL RES, V1773, P1793, DOI 10.1016/j.bbamcr.2007.09.008; Sariyer R, 2017, ALCOHOL CLIN EXP RES, V41, P1715, DOI 10.1111/acer.13474; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Smith ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146257; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tapocik JD, 2013, PHARMACOGENOMICS J, V13, P286, DOI 10.1038/tpj.2012.17; Tapocik JD, 2014, J NEUROSCI, V34, P4581, DOI 10.1523/JNEUROSCI.0445-14.2014; Teppen TL, 2016, BIOL PSYCHIAT, V80, P711, DOI 10.1016/j.biopsych.2015.10.028; Tian H, 2016, FREE RADICAL BIO MED, V96, P362, DOI 10.1016/j.freeradbiomed.2016.03.039; Van Peer G, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau080; Wang F, 2013, J ADDICT RES THER, P4; Warden AS, 2017, NEUROPHARMACOLOGY, V122, P161, DOI 10.1016/j.neuropharm.2017.02.017; Whelan JT, 2012, J CELL PHYSIOL, V227, P1235, DOI 10.1002/jcp.22899	65	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190841	10.1371/journal.pone.0190841	http://dx.doi.org/10.1371/journal.pone.0190841			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315347	gold, Green Published, Green Submitted			2022-12-26	WOS:000419655900026
J	Sarika, K; Hossain, F; Muthusamy, V; Zunjare, RU; Baveja, A; Goswami, R; Thirunavukkarasu, N; Jha, SK; Gupta, HS				Sarika, Konsam; Hossain, Firoz; Muthusamy, Vignesh; Zunjare, Rajkumar U.; Baveja, Aanchal; Goswami, Rajat; Thirunavukkarasu, Nepolean; Jha, Sunil K.; Gupta, Hari S.			Opaque16, a high lysine and tryptophan mutant, does not influence the key physico-biochemical characteristics in maize kernel	PLOS ONE			English	Article							ENDOSPERM MODIFICATION; PROTEIN BODIES; O2 GENE; QUALITY; ENCODES; MUTATION; QPM	The enhancement of lysine and tryptophan in maize is so far basedon opaque2(o2)mutant, that along with the endosperm-modifiersled to development of Quality Protein Maize[QPM]. Though many mutants improving the endospermic protein quality were discovered, they could not be successfully deployed. Recently discovered opaque16 (o16) mutant enhances the lysine and tryptophan content in maize endosperm. In the present study, the influence of o16 on the endosperm modification was analyzed in four F-2 populations, two each segregating for o16 allele alone and in combination with o2. The recessive o16o16 seed endosperm was found to be vitreousphenotypically similar to wild-O16O16. The mutant did not influence the degree of kernel opaqueness in o2o2 genetic background as opaqueness in o2o2/O16O16 and o2o2/o16o16 was similar. Grain hardness of o16o16 was comparable with the normal and QPM maize. The pattern of microscopic organization of proteinaceous matrix and starch granules, and zein profiling of the storage protein in o16o16 were found to be similar with normal maize endosperm, but distinct from the o2o2-soft genotype. The pattern in o2o2/o16o16 was unique and different from o2o2 and o16o16 as well. Here we demonstrated the effects of o16 on physico-biochemical characteristics of endosperm and report of o16 possessing negligible influence on kernel modification and hardness, which holds a great significance in maize quality breeding programme.	[Sarika, Konsam; Hossain, Firoz; Muthusamy, Vignesh; Zunjare, Rajkumar U.; Baveja, Aanchal; Goswami, Rajat; Thirunavukkarasu, Nepolean; Gupta, Hari S.] ICAR Indian Agr Res Inst, Div Genet, New Delhi, India; [Jha, Sunil K.] ICAR Indian Agr Res Inst, Div Postharvest & Technol, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Hossain, F (corresponding author), ICAR Indian Agr Res Inst, Div Genet, New Delhi, India.	fh_gpb@yahoo.com	Zunjare, Rajkumar/AAI-6417-2021; Muthusamy, Vignesh/AAB-6224-2022; Muthusamy, Vignesh/AAU-5785-2020	Zunjare, Rajkumar/0000-0001-5001-2681; Muthusamy, Vignesh/0000-0003-3169-890X; 	Department of Biotechnology, Government of India [BT/PR11708/AGR/02/649/2008, BT/PR10922/AGII/106/944/2014]; Council of Scientific and Industrial Research-University Grant Commission	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research-University Grant Commission(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India)	This work was funded by the Department of Biotechnology, Government of India sponsored network projects (BT/PR11708/AGR/02/649/2008 & BT/PR10922/AGII/106/944/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Dr. Wenpeng Yang, Guizhou Institute of Upland Food Crops, Guizhou Academy of Agricultural Sciences, China for making initial crosses and providing the F<INF>1</INF>s. First author is thankful to the Council of Scientific and Industrial Research-University Grant Commission for Junior Research Fellowship during the doctoral programme.	Balconi C, 2007, MAYDICA, V52, P357; Bhan MK, 2003, BMJ-BRIT MED J, V326, P146, DOI 10.1136/bmj.326.7381.146; BJARNASON M, 1976, Cereal Research Communications, V4, P401; Bjarnason M, 1992, PLANT BREEDING REV, P181; DANNENHOFFER JM, 1995, P NATL ACAD SCI USA, V92, P1931, DOI 10.1073/pnas.92.6.1931; Garcia-Lara S, 2014, CROP SCI, V54, P2423, DOI 10.2135/cropsci2014.03.0223; GEETHA KB, 1991, PLANT CELL, V3, P1207, DOI 10.1105/tpc.3.11.1207; Gibbon BC, 2005, TRENDS GENET, V21, P227, DOI 10.1016/j.tig.2005.02.009; Gibbon BC, 2003, P NATL ACAD SCI USA, V100, P15329, DOI 10.1073/pnas.2136854100; HARTINGS H, 1989, EMBO J, V8, P2795, DOI 10.1002/j.1460-2075.1989.tb08425.x; Holding DR, 2006, MAYDICA, V51, P243; Holding DR, 2007, PLANT CELL, V19, P2569, DOI 10.1105/tpc.107.053538; Hossain F, 2008, INDIAN J GENET PL BR, V68, P132; Hunter BG, 2002, PLANT CELL, V14, P2591, DOI 10.1105/tpc.003905; Krivanek AF, 2007, AFR J BIOTECHNOL, V6, P312; LENDING CR, 1989, PLANT CELL, V1, P1011, DOI 10.1105/tpc.1.10.1011; LOPES MA, 1991, CROP SCI, V31, P1655, DOI 10.2135/cropsci1991.0011183X003100060055x; MERTZ ET, 1964, SCIENCE, V145, P279, DOI 10.1126/science.145.3629.279; MERTZ ET, 1965, SCIENCE, V148, P1741, DOI 10.1126/science.148.3678.1741; Mohsenin N. N., 1986, PHYS PROPERTIES PLAN, P60; MORO GL, 1995, CEREAL CHEM, V72, P94; Morton KJ, 2015, J EXP BOT, V67; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Myers AM, 2011, PLANT CELL, V23, P2331, DOI 10.1105/tpc.111.087205; Pandey N, 2015, PLANT BREED; Prasanna BM, 2001, CURR SCI INDIA, V81, P1308; Sarika K, 2017, INDIAN J GENET PL BR, V77, P59, DOI 10.5958/0975-6906.2017.00008.6; SCHMIDT RJ, 1992, PLANT CELL, V4, P689, DOI 10.1105/tpc.4.6.689; Segal G, 2003, GENETICS, V165, P387; Shiferaw B, 2011, FOOD SECUR, V3, P475, DOI 10.1007/s12571-011-0153-0; Siwale J., 2009, AFR CROP SCI J, V17, P1, DOI DOI 10.4314/ACSJ.V17I1.54206; Vasal S. K., 1980, Improvement of quality traits of maize for grain and silage use., P37; Wu YR, 2010, P NATL ACAD SCI USA, V107, P12810, DOI 10.1073/pnas.1004721107; Wu YR, 2010, PLANT PHYSIOL, V153, P337, DOI 10.1104/pp.110.154690; Yadav OP, 2015, AGR RES, V4, P325, DOI 10.1007/s40003-015-0180-8; Yang LQ, 2013, MOL BREEDING, V31, P767, DOI 10.1007/s11032-012-9830-8; Yang W, 2004, PLANT MOL BIOL REP, V22, P361, DOI 10.1007/BF02772679; Yang WP, 2008, HEREDITAS, V145, P225, DOI 10.1111/j.1601-5223.2008.02056.x; Yang WP, 2005, MOL BREEDING, V15, P257, DOI 10.1007/s11032-004-5947-8; Yue J, 2014, INT J MOL SCI, V15, P5350, DOI 10.3390/ijms15045350; Zhang WW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052849, 10.1371/journal.pone.0054779]; Zhang WenLong, 2010, Acta Agronomica Sinica, V36, P1302, DOI 10.3724/SP.J.1006.2010.01302	42	15	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2018	13	1							e0190945	10.1371/journal.pone.0190945	http://dx.doi.org/10.1371/journal.pone.0190945			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS0GW	29309428	Green Submitted, Green Published, gold			2022-12-26	WOS:000419453100020
J	Zhao, XH; Lanz, J; Steinberg, D; Pease, T; Ahearn, JM; Bersonov, EE; Staguhn, ED; Eisenberg, E; Masison, DC; Greene, LE				Zhao, Xiaohong; Lanz, Jenna; Steinberg, Danielle; Pease, Tyler; Ahearn, Joseph M.; Bersonov, Evgeny E.; Staguhn, Elena D.; Eisenberg, Evan; Masison, Daniel C.; Greene, Lois E.			Real-time imaging of yeast cells reveals several distinct mechanisms of curing of the [URE3] prion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE PSI+; POLYGLUTAMINE PEPTIDES; CHAPERONE HSP104; HSP70 CHAPERONE; PROTEIN; PROPAGATION; CURE; OVEREXPRESSION; DNAJB6; SIS1	The [URE3] yeast prion is the self-propagating amyloid form of the Ure2 protein. [URE3] is cured by overexpression of several yeast proteins, including Yd11, Btn2, Curl, Hsp42, and human DnaJB6. To better understand [URE3] curing, we used real-time imaging with a yeast strain expressing a GFP-labeled full-length Ure2 construct to monitor the curing of [URE3] over time. [URE3] yeast cells exhibited numerous fluorescent foci, and expression of the GFP-labeled Ure2 affected neither mitotic stability of [URE3] nor the rate of [URE3] curing by the curing proteins. Using guanidine to cure [URE3] via Hsp104 inactivation, we found that the fluorescent foci are progressively lost as the cells divide until they are cured; the fraction of cells that retained the foci was equivalent to the [URE3] cell fraction measured by a plating assay, indicating that the foci were the prion seeds. During the curing of [URE3] by Btn2, Curl, Hsp42, or Ydj 1 overexpression, the foci formed aggregates, many of which were 0.5 pm or greater in size, and [URE3] was cured by asymmetric segregation of the aggregated seeds, In contrast, DnaJ136 overexpression first caused a loss of detectable foci in cells that were still [URE3] before there was complete dissolution of the seeds, and the cells were cured. We conclude that GFP labeling of full-length Ure2 enables differentiation among the different [URE3]-curing mechanisms, including inhibition of severing followed by seed dilution, seed clumping followed by asymmetric segregation between mother and daughter cells, and seed dissolution.	[Zhao, Xiaohong; Lanz, Jenna; Steinberg, Danielle; Pease, Tyler; Ahearn, Joseph M.; Staguhn, Elena D.; Eisenberg, Evan; Greene, Lois E.] NHLBI, Cell Biol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Bersonov, Evgeny E.; Masison, Daniel C.] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Greene, LE (corresponding author), NHLBI, Cell Biol Lab, 50 South Dr,Rm 2537,MSC 8017, Bethesda, MD 20892 USA.	greenel@helix.nih.gov	Bezsonov, Evgeny/AAL-1982-2021	Bezsonov, Evgeny/0000-0002-9382-8338; Pease, Tyler/0000-0003-0372-9270	National Institutes of Health [HL000516]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000516, Z01HL000516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant HL000516. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aron R, 2007, EMBO J, V26, P3794, DOI 10.1038/sj.emboj.7601811; Barbitoff YA, 2017, MOL MICROBIOL, V105, P242, DOI 10.1111/mmi.13697; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Bradley ME, 2002, P NATL ACAD SCI USA, V99, P16392, DOI 10.1073/pnas.152330699; Derdowski A, 2010, SCIENCE, V330, P680, DOI 10.1126/science.1197785; Derkatch IL, 1996, GENETICS, V144, P1375; Duennwald ML, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001346; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Fernandez-Bellot E, 2002, EMBO REP, V3, P76, DOI 10.1093/embo-reports/kvf011; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gillis J, 2013, J BIOL CHEM, V288, P17225, DOI 10.1074/jbc.M112.421685; Higurashi T, 2008, P NATL ACAD SCI USA, V105, P16596, DOI 10.1073/pnas.0808934105; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kryndushkin DS, 2008, EMBO J, V27, P2725, DOI 10.1038/emboj.2008.198; Kryndushkin DS, 2011, J MOL BIOL, V409, P263, DOI 10.1016/j.jmb.2011.03.067; Kushnirov VV, 2000, CURR BIOL, V10, P1443, DOI 10.1016/S0960-9822(00)00802-2; Lian HY, 2007, J BIOL CHEM, V282, P11931, DOI 10.1074/jbc.M606856200; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Malinovska L, 2012, MOL BIOL CELL, V23, P3041, DOI 10.1091/mbc.E12-03-0194; Mansson C, 2014, J BIOL CHEM, V289, P31066, DOI 10.1074/jbc.M114.595124; Mansson C, 2014, CELL STRESS CHAPERON, V19, P227, DOI 10.1007/s12192-013-0448-5; Mathur V, 2009, J MOL BIOL, V390, P155, DOI 10.1016/j.jmb.2009.04.063; Miller SBM, 2015, EMBO J, V34, P778, DOI 10.15252/embj.201489524; Moosavi B, 2010, YEAST, V27, P167, DOI 10.1002/yea.1742; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Ness F, 2017, MOL MICROBIOL, V104, P125, DOI 10.1111/mmi.13617; Newnam GP, 2011, J MOL BIOL, V408, P432, DOI 10.1016/j.jmb.2011.02.034; Park YN, 2014, EUKARYOT CELL, V13, P635, DOI 10.1128/EC.00300-13; Park YN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037692; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Reidy M, 2016, J BIOL CHEM, V291, P4035, DOI 10.1074/jbc.M115.700393; Reidy M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004720; Reidy M, 2010, MOL CELL BIOL, V30, P3542, DOI 10.1128/MCB.01292-09; Ripaud L, 2003, EMBO J, V22, P5251, DOI 10.1093/emboj/cdg488; Satpute-Krishnan P, 2005, NATURE, V437, P262, DOI 10.1038/nature03981; Satpute-Krishnan P, 2007, PLOS BIOL, V5, P251, DOI 10.1371/journal.pbio.0050024; Sharma D, 2008, GENETICS, V179, P1301, DOI 10.1534/genetics.108.089458; Sharma D, 2009, GENETICS, V181, P129, DOI 10.1534/genetics.108.098699; Song YT, 2005, EUKARYOT CELL, V4, P289, DOI 10.1128/EC.4.2.289-297.2005; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; Wickner RB, 2014, P NATL ACAD SCI USA, V111, pE2711, DOI 10.1073/pnas.1409582111; Wickner RB, 2012, METHODS MOL BIOL, V849, P321, DOI 10.1007/978-1-61779-551-0_22; Zhao XH, 2017, J BIOL CHEM, V292, P8630, DOI 10.1074/jbc.M116.770719	46	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3104	3117		10.1074/jbc.M117.809079	http://dx.doi.org/10.1074/jbc.M117.809079			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29330300	Green Published, hybrid			2022-12-26	WOS:000426562800006
J	Wanzira, H; Eganyu, T; Mulebeke, R; Bukenya, F; Echodu, D; Adoke, Y				Wanzira, Humphrey; Eganyu, Thomas; Mulebeke, Ronald; Bukenya, Fred; Echodu, Dorothy; Adoke, Yeka			Long lasting insecticidal bed nets ownership, access and use in a high malaria transmission setting before and after a mass distribution campaign in Uganda	PLOS ONE			English	Article							CHILD-MORTALITY; WESTERN KENYA; MORBIDITY; COVERAGE	Introduction Uganda is conducting a second mass LLIN distribution campaign and Katakwi district recently received LLINs as part of this activity. This study was conducted to measure the success of the campaign in this setting, an area of high transmission, with the objectives to estimate LLIN ownership, access and use pre and post campaign implementation. Methods Two identical cross sectional surveys, based on the Malaria Indicator Survey methodology, were conducted in three sub-counties in this district (Kapujan, Magoro and Toroma), six months apart, one before and another after the mass distribution campaign. Data on three main LLIN indicators including; household LLIN ownership, population with access to an LLIN and use were collected using a household and a women's questionnaire identical to the Malaria Indicator Survey. Results A total of 601 and 607 households were randomly selected in survey one and two respectively. At baseline, 60.57% (56.53-64.50) of households owned at least one net for every two persons who stayed in the household the night before the survey which significantly increased to 70.35% (66.54-73.96) after the campaign (p = 0.001). Similarly, the percentage of the household population with access to an LLIN significantly increased from 84.76% (82.99-86.52) to 91.57% (90.33-92.81), p = 0.001 and the percentage of household population that slept under an LLIN the night before the survey also significantly increased from 56.85% (55.06-58.82) to 81.72% (76.75-83.21), p = 0.001. Conclusion The LLIN mass campaign successfully achieved the national target of over eighty-five percent of the population with access to an LLIN in this setting, however, universal household coverage and use were fourteen and three percent points less than the national target respectively. This is useful for malaria programs to consider during the planning of future campaigns by tailoring efforts around deficient areas like mechanisms to increase universal coverage and behavior change communication.	[Wanzira, Humphrey; Eganyu, Thomas; Mulebeke, Ronald; Bukenya, Fred; Echodu, Dorothy] Pilgrim Africa, Kampala, Uganda; [Adoke, Yeka] Makerere Univ, Sch Publ Hlth, Kampala, Uganda	Makerere University	Wanzira, H (corresponding author), Pilgrim Africa, Kampala, Uganda.	wanzirah@yahoo.com	Wanzira, Humphrey/AAF-1373-2020; Mulebeke, Ronald/ABE-6099-2021	Wanzira, Humphrey/0000-0003-1074-5340; Echodu, Dorothy/0000-0002-0597-6120	Bill and Melinda Gates Foundation [OPP1148566]; DE	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); DE	This study was made possible through the funding from the Bill and Melinda Gates Foundation, OPP1148566, https.//www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database/Grants/2016/04/0001148566. This funding was received by DE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, UG MAL RED STRAT PLA; [Anonymous], UG MAL IND SURV 2014; [Anonymous], 2012, TOOLK MASS DISTR CAM; [Anonymous], 2013, WHO REC ACH UN COV L; Bennett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037927; Gamble C, 2007, PLOS MED, V4, P506, DOI 10.1371/journal.pmed.0040107; Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16; Gimnig JE, 2003, AM J TROP MED HYG, V68; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hwang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011692; Koenker H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-1; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Ministry of Health, UG HLTH MAN INF SYST; Ministry of Health, MAL IND SURV 2009; Ministry of Health, 2015, MASS DISTR LONG LAST; Ministry of Health, 2016, DET IMPL GUID UN COV; Ministry of Health, 2015, NIG MAL IND SURV; Ministry of Health, TANZ DEM HLTH SURV M; Ministry of Health, KEN MAL IND SURV 201; Ministry of Health, 2013, MASS DISTR LONG LAST; Mugisa M, 2012, PAN AFR MED J S1, V13; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P10, DOI 10.4269/ajtmh.2003.68.10; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; Wanzira H, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1360-0; WHO (World Health Organization), 2013, METH MAINT COV LONG; World Health Organization, 2012, WORLD MAL REP 2012	26	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191191	10.1371/journal.pone.0191191	http://dx.doi.org/10.1371/journal.pone.0191191			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346408	Green Published, gold, Green Submitted			2022-12-26	WOS:000422749500036
J	Chaorattanakawee, S; Nuchnoi, P; Hananantachai, H; Tumkosit, U; Saunders, D; Naka, I; Ohashi, J; Patarapotikul, J				Chaorattanakawee, Suwanna; Nuchnoi, Pornlada; Hananantachai, Hathairad; Tumkosit, Uranan; Saunders, David; Naka, Izumi; Ohashi, Jun; Patarapotikul, Jintana			Sequence variation in Plasmodium falciparum merozoite surface protein-2 is associated with virulence causing severe and cerebral malaria	PLOS ONE			English	Article							GENETIC DIVERSITY; VACCINE CANDIDATE; CLINICAL MALARIA; ANTIBODIES; INFECTIONS; COMPLEXITY; PATTERNS; CHILDREN; LOCUS; SURFACE-ANTIGEN-2	Parasite virulence, an important factor contributing to the severity of Plasmodium falciparum infection, varies among P. falciparum strains. Relatively little is known regarding markers of virulence capable of identifying strains responsible for severe malaria. We investigated the effects of genetic variations in the P.f. merozoite surface protein 2 gene (msp2) on virulence, as it was previously postulated as a factor. We analyzed 300 msp2 sequences of single P. falciparum clone infection from patients with uncomplicated disease as well as those admitted for severe malaria with and without cerebral disease. The association of msp2 variations with disease severity was examined. We found that the N allele at codon 8 of Block 2 in the FC27-like msp2 gene was significantly associated with severe disease without cerebral complications (odds ratio = 2.73, P = 0.039), while the K allele at codon 17 of Block 4 in the 3D7-like msp2 gene was associated with cerebral malaria (odds ratio = 3.52, P = 0.024). The data suggests possible roles for the associated alleles on parasite invasion processes and immune-mediated pathogenicity. Multiplicity of infection was found to associate with severe disease without cerebral complications, but not cerebral malaria. Variations in the msp2-FC27-block 2-8N and 3D7-block 4-17K allele appear to be parasite virulence markers, and may be useful in determining the likelihood for severe and cerebral malaria. Their interactions with potential host factors for severe diseases should also be explored.	[Chaorattanakawee, Suwanna] Thammasat Univ, Fac Allied Hlth Sci, Dept Med Technol, Rangsit, Patumthani, Thailand; [Chaorattanakawee, Suwanna] Mahidol Univ, Fac Publ Hlth, Dept Parasitol & Entomol, Bangkok, Thailand; [Nuchnoi, Pornlada] Mahidol Univ, Fac Med Technol, Dept Clin Microscopy, Nakhon Pathum, Thailand; [Hananantachai, Hathairad] Mahidol Univ, Fac Trop Med, Dept Social & Environm Med, Bangkok, Thailand; [Tumkosit, Uranan; Patarapotikul, Jintana] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Saunders, David] US Army Med Mat Dev Act, Ft Detrick, MD USA; [Naka, Izumi; Ohashi, Jun] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan; [Tumkosit, Uranan] Thailand Japan Res Collaborat Ctr Emerging & Reem, Dept Med Sci, Sect Viral Infect, Nonthaburi, Thailand	Thammasat University; Mahidol University; Mahidol University; Mahidol University; Mahidol University; United States Department of Defense; United States Army; University of Tokyo	Chaorattanakawee, S (corresponding author), Thammasat Univ, Fac Allied Hlth Sci, Dept Med Technol, Rangsit, Patumthani, Thailand.; Chaorattanakawee, S (corresponding author), Mahidol Univ, Fac Publ Hlth, Dept Parasitol & Entomol, Bangkok, Thailand.	suwann67@yahoo.com	Nuchnoi, Pornlada/K-7125-2017	Nuchnoi, Pornlada/0000-0002-1123-1037	Thammasat university research grant; Thailand Research Fund through Royal Golden Jubilee PhD programme; China Medical Board (CMB), Faculty of Public Health, Mahidol University, Bangkok, Thailand	Thammasat university research grant; Thailand Research Fund through Royal Golden Jubilee PhD programme; China Medical Board (CMB), Faculty of Public Health, Mahidol University, Bangkok, Thailand	This study was supported by the Thammasat university research grant and the Thailand Research Fund through the Royal Golden Jubilee PhD programme. The study was partially supported for publication by the China Medical Board (CMB), Faculty of Public Health, Mahidol University, Bangkok, Thailand.	A-Elbasit IE, 2007, PARASITOL RES, V102, P29, DOI 10.1007/s00436-007-0716-3; Agrawal S, 2017, J INFECT DIS, V216, P468, DOI 10.1093/infdis/jix334; Amodu OK, 2008, ANN TROP MED PARASIT, V102, P95, DOI 10.1179/136485908X252340; Anong DN, 2010, ANN TROP MED PARASIT, V104, P25, DOI 10.1179/136485910X12607012373876; Auburn S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032891; Balam S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-510; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Boehringer S, 2000, HUM GENET, V107, P197, DOI 10.1007/s004390000353; Cornejo OE, 2015, GENOME BIOL EVOL, V7, P106, DOI 10.1093/gbe/evu267; Courtin D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007590; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; ENGELBRECHT F, 1995, EXP PARASITOL, V81, P90, DOI 10.1006/expr.1995.1096; EPPING RJ, 1988, MOL BIOCHEM PARASIT, V28, P1, DOI 10.1016/0166-6851(88)90173-9; Farnert A, 2001, T ROY SOC TROP MED H, V95, P225, DOI 10.1016/S0035-9203(01)90175-0; Farooq U, 2006, EXP PARASITOL, V112, P139, DOI 10.1016/j.exppara.2005.10.002; Felger I, 1997, J MOL EVOL, V45, P154, DOI 10.1007/PL00006215; Ferreira MU, 2007, EXP PARASITOL, V115, P32, DOI 10.1016/j.exppara.2006.05.003; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; GUPTA S, 1994, P NATL ACAD SCI USA, V91, P3715, DOI 10.1073/pnas.91.9.3715; Gurling H, 2007, SCHIZOPHR RES, V89, P357, DOI 10.1016/j.schres.2006.08.024; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamid MMA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1641-z; Hoffmann EHE, 2001, ANN TROP MED PARASIT, V95, P117, DOI 10.1080/00034980120045833; Issifou S, 2003, PARASITOL RES, V90, P423, DOI 10.1007/s00436-003-0854-1; Kang JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-131; Kiwuwa MS, 2013, PARASITOL RES, V112, P1691, DOI 10.1007/s00436-013-3325-3; Koller DL, 2004, J BONE MINER RES, V19, P1291, DOI 10.1359/JBMR.040409; Liljander A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-78; Maitland K, 2004, ACTA TROP, V90, P131, DOI 10.1016/j.actatropica.2003.11.010; McCarthy JS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0024413, 10.1371/journal.pone.0021914]; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; Montgomery J, 2006, J INFECT DIS, V194, P115, DOI 10.1086/504689; Murray L, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1324-4; Mwingira F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-79; Ocampo M, 2000, J PEPT RES, V55, P216, DOI 10.1034/j.1399-3011.2000.00174.x; Osier FHA, 2010, PARASITE IMMUNOL, V32, P193, DOI 10.1111/j.1365-3024.2009.01178.x; Paul REL, 1998, AM J TROP MED HYG, V58, P195, DOI 10.4269/ajtmh.1998.58.195; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Putaporntip C, 2008, GENE, V427, P51, DOI 10.1016/j.gene.2008.09.009; Ranjit MR, 2005, T ROY SOC TROP MED H, V99, P389, DOI 10.1016/j.trstmh.2004.09.010; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Rout R, 2009, TROP BIOMED, V26, P165; Scopel KKG, 2007, AM J TROP MED HYG, V76, P1084, DOI 10.4269/ajtmh.2007.76.1084; Shigidi MMT, 2004, AM J TROP MED HYG, V71, P754, DOI 10.4269/ajtmh.2004.71.754; Silverman EK, 2000, AM J RESP CELL MOL, V22, P645, DOI 10.1165/ajrcmb.22.6.f191; Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406; Tsuchiya N, 2002, IMMUNOL REV, V190, P169, DOI 10.1034/j.1600-065X.2002.19013.x; Wang ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep33891	49	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190418	10.1371/journal.pone.0190418	http://dx.doi.org/10.1371/journal.pone.0190418			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342212	Green Submitted, gold, Green Published			2022-12-26	WOS:000422653800022
J	Jones, DC; Scanteianu, A; DiStefano, M; Bouhaddou, M; Birtwistle, MR				Jones, DeAnalisa C.; Scanteianu, Adriana; DiStefano, Matthew; Bouhaddou, Mehdi; Birtwistle, Marc R.			Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma	PLOS ONE			English	Article							CANCER; MODELS; MUTATIONS; THERAPY; GENOME	Current treatments for glioblastoma multiforme (GBM)-an aggressive form of brain cancer-are minimally effective and yield a median survival of 14.6 months and a two-year survival rate of 30%. Given the severity of GBM and the limitations of its treatment, there is a need for the discovery of novel drug targets for GBM and more personalized treatment approaches based on the characteristics of an individual's tumor. Most receptor tyrosine kinases-such as EGFR-act as oncogenes, but publicly available data from the Cancer Cell Line Encyclopedia (CCLE) indicates copy number loss in the ERBB4 RTK gene across dozens of GBM cell lines, suggesting a potential tumor suppressor role. This loss is mutually exclusive with loss of its cognate ligand NRG1 in CCLE as well, more strongly suggesting a functional role. The availability of higher resolution copy number data from clinical GBM patients in The Cancer Genome Atlas (TCGA) revealed that a region in Intron 1 of the ERBB4 gene was deleted in 69.1% of tumor samples harboring ERBB4 copy number loss; however, it was also found to be deleted in the matched normal tissue samples from these GBM patients (n = 81). Using the DECIPHER Genome Browser, we also discovered that this mutation occurs at approximately the same frequency in the general population as it does in the disease population. We conclude from these results that this loss in Intron 1 of the ERBB4 gene is neither a de novo driver mutation nor a predisposing factor to GBM, despite the indications from CCLE. A biological role of this significantly occurring genetic alteration is still unknown. While this is a negative result, the broader conclusion is that while copy number data from large cell line-based data repositories may yield compelling hypotheses, careful follow up with higher resolution copy number assays, patient data, and general population analyses are essential to codify initial hypotheses prior to investing experimental resources.	[Jones, DeAnalisa C.; Scanteianu, Adriana; DiStefano, Matthew; Bouhaddou, Mehdi; Birtwistle, Marc R.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Birtwistle, MR (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY 10029 USA.	marc.birtwistle@mssm.edu		Scanteianu, Adriana/0000-0001-5491-0227; Jones, DeAnalisa/0000-0002-8737-6152; Birtwistle, Marc/0000-0002-0341-0705; Bouhaddou, Mehdi/0000-0002-9526-1427	National Institute of General Medical Sciences [R25GM064118]; Diversity Supplement to National Institutes of Health [R01GM104184]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104184, R25GM064118] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Diversity Supplement to National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institute of General Medical Sciences award number R25GM064118 (DCJ) and a Diversity Supplement to National Institutes of Health award number R01GM104184 (MRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], BIOINF PIP COP NUMB; Balani S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15422; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barrette AM, 2018, ACS CHEM NEUROSCI, V9, P118, DOI 10.1021/acschemneuro.7b00197; Bean JC, 2014, J NEUROSCI, V34, P13549, DOI 10.1523/JNEUROSCI.2021-14.2014; Birtwistle MR, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.51; Birtwistle M. R., SYSTEMS PHARM PHARM; Bouhaddou M., 2017, BIORXIV; Bouhaddou M, 2016, AAPS ADV PHARM SCI, V23, P105, DOI 10.1007/978-3-319-44534-2_6; Bouhaddou M, 2016, NATURE, V540, pE9, DOI 10.1038/nature20580; Bowers G, 2001, ONCOGENE, V20, P1388, DOI 10.1038/sj.onc.1204255; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen L., 2017, CELLULAR MOL IMMUNOL; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Davies MA, 2010, ONCOGENE, V29, P5545, DOI 10.1038/onc.2010.323; Firth H. V., 2009, AM J HUMAN GENETICS; Gallo JM, 2015, WIRES SYST BIOL MED, V7, P243, DOI 10.1002/wsbm.1300; Gharwan H, 2016, NAT REV CLIN ONCOL, V13, P209, DOI 10.1038/nrclinonc.2015.213; Haskins JW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005770; Huang NC., 2011, THESIS; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Levin VA, 2015, NEURO-ONCOLOGY, V17, P1, DOI 10.1093/neuonc/nov169; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Ricci C, 2000, INT J CANCER, V87, P29, DOI 10.1002/1097-0215(20000701)87:1<29::AID-IJC5>3.3.CO;2-A; Xie Y, 2015, EBIOMEDICINE, V2, P1351, DOI 10.1016/j.ebiom.2015.08.026; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871	28	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190664	10.1371/journal.pone.0190664	http://dx.doi.org/10.1371/journal.pone.0190664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342193	Green Published, Green Submitted, gold			2022-12-26	WOS:000422653800030
J	Parsons, DM; MacDonald, I; Buckthought, D; Middleton, C				Parsons, Darren M.; MacDonald, Iain; Buckthought, Dane; Middleton, Crispin			Do nursery habitats provide shelter from flow for juvenile fish?	PLOS ONE			English	Article							NEW-ZEALAND ESTUARY; SNAPPER CHRYSOPHRYS-AURATUS; MARINE NURSERIES; PAGRUS-AURATUS; ZOOPLANKTON; MANAGEMENT; TURBULENCE; ABUNDANCE; BEHAVIOR; COASTAL	Juvenile fish nurseries are an essential life stage requirement for the maintenance of many fish populations. With many inshore habitats globally in decline, optimising habitat management by increasing our understanding of the relationship between juvenile fish and nursery habitats may be a prudent approach. Previous research on post-settlement snapper (Chrysophrys auratus) has suggested that structure may provide a water flow refuge, allowing snapper to access high water flow sites that will also have a high flux of their pelagic prey. We investigated this hypothesis by describing how Artificial Seagrass Units (ASUs) modified water flow while also using a multi-camera set up to quantify snapper position in relation to this water flow environment. Horizontal water flow was reduced on the down-current side of ASUs, but only at the height of the seagrass canopy. While the highest abundance of snapper did occur down-current of the ASUs, many snapper also occupied other locations or were too high in the water column to receive any refuge from water flow. The proportion of snapper within the water column was potentially driven by strategy to access zooplankton prey, being higher on the up-current side of ASUs and on flood tides. It is possible that post-settlement snapper alternate position to provide opportunities for both feeding and flow refuging. An alternative explanation relates to an observed interaction between post settlement snapper and a predator, which demonstrated that snapper can utilise habitat structure when threatened. The nature of this relationship, and its overall importance in determining the value of nursery habitats to post-settlement snapper remains an elusive next step.	[Parsons, Darren M.; Buckthought, Dane] NIWA, Auckland, New Zealand; [Parsons, Darren M.] Univ Auckland, Inst Marine Sci, Auckland, New Zealand; [MacDonald, Iain] NIWA, Hamilton, New Zealand; [Middleton, Crispin] NIWA, Bream Bay, Ruakaka, New Zealand	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Auckland; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Parsons, DM (corresponding author), NIWA, Auckland, New Zealand.; Parsons, DM (corresponding author), Univ Auckland, Inst Marine Sci, Auckland, New Zealand.	darren.parsons@niwa.co.nz		Parsons, Darren/0000-0002-4030-512X	NIWA's Coasts and Oceans research programme 3	NIWA's Coasts and Oceans research programme 3	Funding was provided by NIWA's Coasts and Oceans research programme 3 (2016/17 Statement of Corporate Intent). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrhman MA, 2003, MAR ECOL PROG SER, V248, P67, DOI 10.3354/meps248067; Adams AJ, 2006, MAR ECOL PROG SER, V318, P287, DOI 10.3354/meps318287; Anderson MJ, 2008, J EXP MAR BIOL ECOL, V366, P16, DOI 10.1016/j.jembe.2008.07.006; Asaeda T, 2005, T AM FISH SOC, V134, P537, DOI 10.1577/T03-083.1; Banas NS, 2007, MAR ECOL PROG SER, V341, P123, DOI 10.3354/meps341123; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bray R.N, 1981, FISHERY B, V78, P829; CARLSON DJ, 1984, CAN J FISH AQUAT SCI, V41, P1523, DOI 10.1139/f84-188; Clarke RD, 2005, MAR BIOL, V146, P1145, DOI 10.1007/s00227-004-1528-y; Dahlgren CP, 2006, MAR ECOL PROG SER, V312, P291, DOI 10.3354/meps312291; FAUSCH KD, 1981, CAN J FISH AQUAT SCI, V38, P1220, DOI 10.1139/f81-164; FRANCIS MP, 1994, NEW ZEAL J MAR FRESH, V28, P201, DOI 10.1080/00288330.1994.9516608; GAMBI MC, 1990, MAR ECOL PROG SER, V61, P159, DOI 10.3354/meps061159; Ghisalberti M, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000871; Goring DG, 2002, J HYDRAUL ENG-ASCE, V128, P117, DOI 10.1061/(ASCE)0733-9429(2002)128:1(117); Heck KL, 2003, MAR ECOL PROG SER, V253, P123, DOI 10.3354/meps253123; Hixon MA, 1997, SCIENCE, V277, P946, DOI 10.1126/science.277.5328.946; HUNTLEY DA, 1988, J PHYS OCEANOGR, V18, P339, DOI 10.1175/1520-0485(1988)018<0339:AMIDMF>2.0.CO;2; KAMERMANS P, 1994, MAR ECOL PROG SER, V104, P63, DOI 10.3354/meps104063; KINGSFORD MJ, 1988, MAR ECOL PROG SER, V48, P103, DOI 10.3354/meps048103; Lundquist C, 2012, PREDICTING SUITABLE; Morrison M., 2014, NZ AQUATIC ENV BIODI; Morrison MA, 2009, NZ AQUATIC ENV BIODI; Nagelkerken I., ECOLOGICAL CONNECTIV; Parsons DM, 2016, NEW ZEAL J MAR FRESH, V50, P358, DOI 10.1080/00288330.2016.1146310; Parsons DM, 2014, NEW ZEAL J MAR FRESH, V48, P256, DOI 10.1080/00288330.2014.892013; Parsons DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122137; Parsons DM, 2013, MAR ECOL-EVOL PERSP, V34, P492, DOI 10.1111/maec.12050; PETERSON CH, 1991, ESTUAR COAST SHELF S, V32, P405, DOI 10.1016/0272-7714(91)90052-D; Prins TC, 1996, MAR ECOL PROG SER, V142, P121, DOI 10.3354/meps142121; Rosenberg A, 2000, B MAR SCI, V66, P535; Sim-Smith CJ, 2013, MAR FRESHWATER RES, V64, P1003, DOI 10.1071/MF12345; Tennekes H., 1972, 1 COURSE TURBULENCE; Thrush SF, 2004, FRONT ECOL ENVIRON, V2, P299, DOI 10.1890/1540-9295(2004)002[0299:MWESIT]2.0.CO;2; Trevethan M, 2007, ESTUAR COAST SHELF S, V73, P341, DOI 10.1016/j.ecss.2007.01.014; Usmar NR, 2012, NEW ZEAL J MAR FRESH, V46, P31, DOI 10.1080/00288330.2011.587824; Voulgaris G, 1998, J ATMOS OCEAN TECH, V15, P272, DOI 10.1175/1520-0426(1998)015<0272:EOTADV>2.0.CO;2; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106	38	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0186889	10.1371/journal.pone.0186889	http://dx.doi.org/10.1371/journal.pone.0186889			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342152	Green Published, gold, Green Submitted			2022-12-26	WOS:000422653800002
J	Beaton, LE; Azma, S; Marinkovic, K				Beaton, Lauren E.; Azma, Sheeva; Marinkovic, Ksenija			When the brain changes its mind: Oscillatory dynamics of conflict processing and response switching in a flanker task during alcohol challenge	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL NETWORK; MEDIAL FRONTAL-CORTEX; MOVEMENT-RELATED POTENTIALS; AUTOMATIC MOTOR ACTIVATION; HUMAN SENSORIMOTOR-CORTEX; SURFACE-BASED ANALYSIS; EXECUTIVE FUNCTIONS; CORTICAL SURFACE; STROOP TASK	Despite the subjective experience of being in full and deliberate control of our actions, our daily routines rely on a continuous and interactive engagement of sensory evaluation and response preparation streams. They unfold automatically and unconsciously and are seamlessly integrated with cognitive control which is mobilized by stimuli that evoke ambiguity or response conflict. Methods with high spatio-temporal sensitivity are needed to provide insight into the interplay between automatic and controlled processing. This study used anatomically-constrained MEG to examine the underlying neural dynamics in a flanker task that manipulated S-R incongruity at the stimulus (SI) and response levels (Rl). Though irrelevant, flankers evoked automatic preparation of motor plans which had to be suppressed and reversed following the target presentation on Rl trials. Event-related source power estimates in beta (15-25 Hz) frequency band in the sensorimotor cortex tracked motor preparation and response in real time and revealed switching from the incorrectly-primed to the correctly-responding hemisphere. In contrast, theta oscillations (4-7 Hz) were sensitive to the levels of incongruity as the medial and ventrolateral frontal cortices were especially activated by response conflict. These two areas are key to cognitive control and their integrated contributions to response inhibition and switching were revealed by phase-locked co-oscillations. These processes were pharmacologically manipulated with a moderate alcohol beverage or a placebo administered to healthy social drinkers. Alcohol selectively decreased accuracy to response conflict. It strongly attenuated theta oscillations during decision making and partly re-sculpted relative contributions of the frontal network without affecting the motor switching process subserved by beta band. Our results indicate that motor preparation is initiated automatically even when counterproductive but that it is monitored and regulated by the prefrontal cognitive control processes under conflict. They further confirm that the regulative top-down functions are particularly vulnerable to alcohol intoxication.	[Beaton, Lauren E.; Marinkovic, Ksenija] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Azma, Sheeva; Marinkovic, Ksenija] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Marinkovic, Ksenija] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Marinkovic, Ksenija] San Diego State Univ, San Diego, CA 92182 USA	California State University System; San Diego State University; Harvard University; Massachusetts General Hospital; University of California System; University of California San Diego; California State University System; San Diego State University	Marinkovic, K (corresponding author), San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA.; Marinkovic, K (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.; Marinkovic, K (corresponding author), Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA.; Marinkovic, K (corresponding author), San Diego State Univ, San Diego, CA 92182 USA.	kmarinkovic@mail.sdsu.edu	Marinkovic, Ksenija/AAD-4701-2020	Marinkovic, Ksenija/0000-0003-1658-4496	National Institutes of Health [R01-AA016624]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institutes of Health (R01-AA016624) to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Amodeo LR, 2017, BEHAV BRAIN RES, V330, P25, DOI 10.1016/j.bbr.2017.05.007; Archambault PS, 2015, VISION RES, V110, P244, DOI 10.1016/j.visres.2014.09.009; Ariani G, 2015, J NEUROSCI, V35, P14160, DOI 10.1523/JNEUROSCI.0596-15.2015; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Barchiesi G, 2015, NEUROPSYCHOLOGIA, V69, P93, DOI 10.1016/j.neuropsychologia.2015.01.030; Barchiesi G, 2013, SOC COGN AFFECT NEUR, V8, P711, DOI 10.1093/scan/nss049; Bartholow BD, 2003, BIOL PSYCHOL, V64, P167, DOI 10.1016/S0301-0511(03)00108-X; Becker Howard C, 2014, Handb Clin Neurol, V125, P133, DOI 10.1016/B978-0-444-62619-6.00009-4; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Burle B, 2004, BRAIN COGNITION, V56, P153, DOI 10.1016/j.bandc.2004.06.004; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Chanraud Sandra, 2014, Handb Clin Neurol, V125, P369, DOI 10.1016/B978-0-444-62619-6.00022-7; Cheyne DO, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00237; Cisek P, 2010, ANNU REV NEUROSCI, V33, P269, DOI 10.1146/annurev.neuro.051508.135409; Cisek P, 2007, PROG BRAIN RES, V165, P475, DOI 10.1016/S0079-6123(06)65030-9; Cohen MX, 2008, BRAIN RES, V1238, P127, DOI 10.1016/j.brainres.2008.07.114; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; COLES MGH, 1988, BIOL PSYCHOL, V26, P69, DOI 10.1016/0301-0511(88)90014-2; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Desoto MC, 2001, J COGNITIVE NEUROSCI, V13, P523, DOI 10.1162/08989290152001934; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Donner TH, 2009, CURR BIOL, V19, P1581, DOI 10.1016/j.cub.2009.07.066; Ehlers CL, 2012, BRAIN RES, V1450, P67, DOI 10.1016/j.brainres.2012.02.039; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Erika-Florence M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5073; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; Field M, 2010, ALCOHOL CLIN EXP RES, V34, P1346, DOI 10.1111/j.1530-0277.2010.01218.x; Fillmore Mark T, 2003, Behav Cogn Neurosci Rev, V2, P179, DOI 10.1177/1534582303257007; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fodor JA, 1983, MODULARITY OF MIND A; Fogelson N, 2006, CEREB CORTEX, V16, P64, DOI 10.1093/cercor/bhi084; Gibson J.J, 1977, PERCEIVING ACTING KN, P62; Goodale MA, 1998, CURR BIOL, V8, pR489, DOI 10.1016/S0960-9822(98)70314-8; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Grent-'t-Jong T, 2013, NEUROIMAGE, V83, P27, DOI 10.1016/j.neuroimage.2013.06.051; Halgren E, 2015, NEUROPSYCHOLOGIA, V76, P108, DOI 10.1016/j.neuropsychologia.2015.03.021; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Hasselmo ME, 2014, NEUROIMAGE, V85, P656, DOI 10.1016/j.neuroimage.2013.06.022; Hazeltine E, 2000, J COGNITIVE NEUROSCI, V12, P118, DOI 10.1162/089892900563984; Isabella S, 2015, NEUROIMAGE, V118, P268, DOI 10.1016/j.neuroimage.2015.05.081; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Jacobs J, 2007, J NEUROSCI, V27, P3839, DOI 10.1523/JNEUROSCI.4636-06.2007; Jarosz AF, 2014, J PROBL SOLVING, V7, P2, DOI 10.7771/1932-6246.1167; Jenkinson N, 2011, TRENDS NEUROSCI, V34, P611, DOI 10.1016/j.tins.2011.09.003; Jensen O, 2005, NEUROIMAGE, V26, P347, DOI 10.1016/j.neuroimage.2005.02.008; Jentsch JD, 2014, NEUROPHARMACOLOGY, V76, P479, DOI 10.1016/j.neuropharm.2013.05.022; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; Kato Y, 2006, EXP BRAIN RES, V168, P51, DOI 10.1007/s00221-005-0090-2; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kilavik BE, 2013, EXP NEUROL, V245, P15, DOI 10.1016/j.expneurol.2012.09.014; Klopp J, 2000, HUM BRAIN MAPP, V11, P286, DOI 10.1002/1097-0193(200012)11:4<286::AID-HBM80>3.3.CO;2-I; KOELEGA HS, 1995, PSYCHOPHARMACOLOGY, V118, P233, DOI 10.1007/BF02245951; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kovacevic S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043957; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Laird AR, 2005, HUM BRAIN MAPP, V25, P6, DOI 10.1002/hbm.20129; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; Le Berre AP, 2017, ALCOHOL CLIN EXP RES, V41, P1432, DOI 10.1111/acer.13431; Leunissen I, 2013, HUM BRAIN MAPP, V34, P1254, DOI 10.1002/hbm.21508; Liang J, 2014, ACTA PHARMACOL SIN, V35, P981, DOI 10.1038/aps.2014.50; Lin FH, 2004, NEUROIMAGE, V23, P582, DOI 10.1016/j.neuroimage.2004.04.027; Lyvers M, 2000, EXP CLIN PSYCHOPHARM, V8, P225, DOI 10.1037/1064-1297.8.2.225; Marinkovic K, 2004, NEUROSCIENTIST, V10, P142, DOI 10.1177/1073858403261018; Marinkovic K, 2001, ALCOHOL ALCOHOLISM, V36, P529, DOI 10.1093/alcalc/36.6.529; Marinkovic K, 2000, J STUD ALCOHOL, V61, P24, DOI 10.15288/jsa.2000.61.24; Marinkovic K, 2012, J ADDICT RES THER SU; Marinkovic K., 2014, MAGNETOENCEPHALOGRAP; Marinkovic K, 2013, PSYCHOPHARMACOLOGY, V230, P487, DOI 10.1007/s00213-013-3173-y; Marinkovic K, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00121; Marinkovic K, 2010, IFMBE PROC, V28, P374; Marinkovic K, 2012, HUM BRAIN MAPP, V33, P319, DOI 10.1002/hbm.21213; MARTIN CS, 1993, ALCOHOL CLIN EXP RES, V17, P140, DOI 10.1111/j.1530-0277.1993.tb00739.x; Mattler U, 2003, EXP BRAIN RES, V151, P272, DOI 10.1007/s00221-003-1486-5; McBride J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00082; McBride J, 2012, Q J EXP PSYCHOL, V65, P13, DOI 10.1080/17470218.2011.588336; McDermott TJ, 2017, NEUROIMAGE, V156, P277, DOI 10.1016/j.neuroimage.2017.05.014; Medalla M, 2009, NEURON, V61, P609, DOI 10.1016/j.neuron.2009.01.006; Meyer DE, 1997, PSYCHOL REV, V104, P3, DOI 10.1037/0033-295X.104.1.3; Michelet T, 2010, J NEUROPHYSIOL, V104, P119, DOI 10.1152/jn.00819.2009; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Morsella E., 2011, OXFORD HDB SOCIAL NE, P335, DOI DOI 10.1093/OXFORDHB/9780195342161.013; Most Dana, 2014, Handb Clin Neurol, V125, P89, DOI 10.1016/B978-0-444-62619-6.00006-9; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Neta M, 2015, J NEUROSCI, V35, P253, DOI 10.1523/JNEUROSCI.1313-14.2015; Neumann J, 2005, HUM BRAIN MAPP, V25, P165, DOI 10.1002/hbm.20133; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Nigbur R, 2012, J COGNITIVE NEUROSCI, V24, P1264, DOI 10.1162/jocn_a_00128; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Osiurak F, 2017, NEUROSCI BIOBEHAV RE; Papadelis C, 2016, BRAIN RES, V1650, P252, DOI 10.1016/j.brainres.2016.09.011; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rickenbacher E, 2011, ALCOHOL, V45, P725, DOI 10.1016/j.alcohol.2011.04.002; Ridderinkhof KR, 2011, WIRES COGN SCI, V2, P174, DOI 10.1002/wcs.99; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Roberto M, 2017, NEUROPHARMACOLOGY, V122, P85, DOI 10.1016/j.neuropharm.2017.01.013; Roger C, 2014, PSYCHOPHYSIOLOGY, V51, P746, DOI 10.1111/psyp.12224; Rosen BQ, 2016, ALCOHOL CLIN EXP RES, V40, P743, DOI 10.1111/acer.13014; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Schneider W, 2003, COGNITIVE SCI, V27, P525, DOI 10.1016/S0364-0213(03)00011-9; SHIFFRIN RM, 1984, PSYCHOL REV, V91, P269, DOI 10.1037/0033-295X.91.2.269; Singh A, BAYES FACTOR DIENES; SMID HGOM, 1990, ACTA PSYCHOL, V74, P169, DOI 10.1016/0001-6918(90)90005-Z; Srinivasan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055247; Sullivan EV, 2005, PSYCHOPHARMACOLOGY, V180, P583, DOI 10.1007/s00213-005-2267-6; Sumner P, 2008, NEUROSCIENTIST, V14, P474, DOI 10.1177/1073858408314435; Sundermann B, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-119; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Taylor PCJ, 2007, CEREB CORTEX, V17, P391, DOI 10.1093/cercor/bhj156; Ubaldi S, 2015, CEREB CORTEX, V25, P1032, DOI 10.1093/cercor/bht295; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; van Veen V, 2005, NEUROIMAGE, V27, P497, DOI 10.1016/j.neuroimage.2005.04.042; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; van Zoest W, 2012, J VISION, V12, DOI 10.1167/12.8.16; van Zoest W, 2010, CONSCIOUS COGN, V19, P861, DOI 10.1016/j.concog.2010.04.001; Verleger R, 2009, EUR J NEUROSCI, V30, P318, DOI 10.1111/j.1460-9568.2009.06817.x; Wang CM, 2005, J NEUROSCI, V25, P604, DOI 10.1523/JNEUROSCI.4151-04.2005; Yeung N., 2013, OXFORD HDB COGNITIVE, V2, P275, DOI DOI 10.1093/OXFORDHB/9780199988709.013.0018	134	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191200	10.1371/journal.pone.0191200	http://dx.doi.org/10.1371/journal.pone.0191200			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BY	29329355	Green Published, Green Submitted, gold			2022-12-26	WOS:000419954100047
J	Kumar, S; Cieplak, P				Kumar, Sonu; Cieplak, Piotr			Role of N-glycosylation in activation of proMMP-9. A molecular dynamics simulations study	PLOS ONE			English	Article							GELATINASE-A ACTIVATION; MATRIX-METALLOPROTEINASE; HUMAN MATRIX-METALLOPROTEINASE-9; TISSUE INHIBITOR; PROGELATINASE-B; IV COLLAGENASE; 4-AMINOPHENYLMERCURIC ACETATE; 92-KDA GELATINASE; CATALYTIC DOMAIN; TERMINAL DOMAIN	Human matrix metalloproteinase proMMP-9 is secreted as latent zymogen, which requires two-steps proteolytic activation. The secreted proMMP-9 is glycosylated at two positions: Asn38 and Asn120 located in the prodomain and catalytic domain, respectively. It has been demonstrated that glycosylation at Asn120 is required for secretion of the enzyme, while the role of Asn38 glycosylation is not well understood, but is usually linked to the activation process. One hypothesis stated that the Asn38 glycosylation might protect against proteolytic activation. However, the activation process occurs with or without the presence of this glycosylation. We conducted molecular dynamics (MD) simulations on the glycosylated and non-glycosylated proMMP-9 to elucidate the effect of Asn38 glycosylation on this two-step activation process. The simulation results suggest that Asn38 glycosylation does not hinder the activation process directly, but induces conformational changes in the vicinity of the first proteolytic region in such a way that E-59-M-60 cleavage is processed before R-106-F-107. These results correlate with analysis provided by Boon et al. and experimental data from Ogata et al. who attempted to determine the order of events in activation of proMMP-9. Results from additional MD simulations for the model of glycosylated proMMP-9 bound to galectin-8 N-domain suggest that Gal-8 by interacting with Asn38 glycan might further facilitate processing of the first cleavage between E-59-M-60. Thus, our simulation results suggest that both Asn38 glycosylation and interaction with Gal-8N may be involved in facilitating and the temporal order of the activation process of prodomain of MMP9.	[Kumar, Sonu; Cieplak, Piotr] SBP Med Discovery Inst, La Jolla, CA 92037 USA; [Kumar, Sonu] Scripps Res Inst, La Jolla, CA USA	Scripps Research Institute	Cieplak, P (corresponding author), SBP Med Discovery Inst, La Jolla, CA 92037 USA.	pcieplak@sbpdiscovery.org	Kumar, Sonu/AAH-2962-2019; Kumar, Sonu/AAA-1746-2019; Kumar, Sonu/GZA-9110-2022	Kumar, Sonu/0000-0003-0423-2880; Cieplak, Piotr/0000-0003-0700-5691	NIH, National Institute of General Medicinal Sciences [R01GM098835]; National Institute of General Medicinal Sciences [R01GM079383]	NIH, National Institute of General Medicinal Sciences; National Institute of General Medicinal Sciences	This work was supported by R01GM098835 (PC) NIH, National Institute of General Medicinal Sciences; R01GM079383 (PC) National Institute of General Medicinal Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson SJ, 1995, J BIOL CHEM, V270, P30479, DOI 10.1074/jbc.270.51.30479; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boon L, 2016, BIOCHEM J, V473, P1471, DOI 10.1042/BJ20151154; Case DA, 2012, AMBER 12; DESRIVIERES S, 1993, J CELL PHYSIOL, V157, P587, DOI 10.1002/jcp.1041570319; Duellman T, 2015, TRAFFIC, V16, P1108, DOI 10.1111/tra.12312; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Fang KC, 1997, J BIOL CHEM, V272, P25628, DOI 10.1074/jbc.272.41.25628; FRIDMAN R, 1995, CANCER RES, V55, P2548; Fry SA, 2006, BIOCHEMISTRY-US, V45, P15249, DOI 10.1021/bi061254l; GABIUS HJ, 1990, ANAL BIOCHEM, V189, P91, DOI 10.1016/0003-2697(90)90050-J; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; Golubkov VS, 2007, J BIOL CHEM, V282, P36283, DOI 10.1074/jbc.M706290200; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Ideo H, 2011, J BIOL CHEM, V286, P11346, DOI 10.1074/jbc.M110.195925; Jackson C, 2001, INFLAMM RES, V50, P183, DOI 10.1007/s000110050743; John Anitha, 2001, Pathology and Oncology Research, V7, P14; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Knauper V, 1997, EUR J BIOCHEM, V248, P369, DOI 10.1111/j.1432-1033.1997.00369.x; Kotra LP, 2002, BIOORG CHEM, V30, P356, DOI 10.1016/S0045-2068(02)00501-1; Kumar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059761; Levy Y, 2006, GLYCOBIOLOGY, V16, P463, DOI 10.1093/glycob/cwj097; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Nishi N, 2003, GLYCOBIOLOGY, V13, P755, DOI 10.1093/glycob/cwg102; OCONNELL JP, 1994, J BIOL CHEM, V269, P14967; OGATA Y, 1995, J BIOL CHEM, V270, P18506, DOI 10.1074/jbc.270.31.18506; OGATA Y, 1992, J BIOL CHEM, V267, P3581; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Overall CM, 2000, J BIOL CHEM, V275, P39497, DOI 10.1074/jbc.M005932200; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Rudd PM, 1999, BIOCHEMISTRY-US, V38, P13937, DOI 10.1021/bi991162e; RUDD PM, 1994, BIOCHEMISTRY-US, V33, P17, DOI 10.1021/bi00167a003; SHAPIRO SD, 1995, J BIOL CHEM, V270, P6351, DOI 10.1074/jbc.270.11.6351; Skjrven L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0399-6; SOPATA I, 1974, BIOCHIM BIOPHYS ACTA, V370, P510, DOI 10.1016/0005-2744(74)90112-0; Sorsa T, 1997, J BIOL CHEM, V272, P21067, DOI 10.1074/jbc.272.34.21067; Van den Steen PE, 2001, BBA-GEN SUBJECTS, V1528, P61, DOI 10.1016/S0304-4165(01)00190-8; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; von Bredow DC, 1998, BIOCHEM J, V331, P965, DOI 10.1042/bj3310965; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Yoshida H, 2012, FEBS J, V279, P3937, DOI 10.1111/j.1742-4658.2012.08753.x	47	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191157	10.1371/journal.pone.0191157	http://dx.doi.org/10.1371/journal.pone.0191157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329315	Green Submitted, Green Published, gold			2022-12-26	WOS:000419954100042
J	Contina, A; Bridge, ES; Ross, JD; Shipley, JR; Kelly, JF				Contina, Andrea; Bridge, Eli S.; Ross, Jeremy D.; Shipley, J. Ryan; Kelly, Jeffrey F.			Examination of Clock and Adcyap1 gene variation in a neotropical migratory passerine	PLOS ONE			English	Article							LONG-DISTANCE MIGRATION; POPULATION-STRUCTURE; PAINTED BUNTINGS; CANDIDATE GENES; LINKAGE DISEQUILIBRIUM; CIRCADIAN CLOCKS; BEHAVIOR; POLYMORPHISM; EXPRESSION; SELECTION	Complex behavioral traits, such as those making up a migratory phenotype, are regulated by multiple environmental factors and multiple genes. We investigated possible relationships between microsatellite variation at two candidate genes implicated in the control of migratory behavior, Clock and Adcyap1, and several aspects of migratory life-history and evolutionary divergence in the Painted Bunting (Passerina ciris), a species that shows wide variation in migratory and molting strategies across a disjunct distribution. We focused on Clock and Adcyap1 microsatellite variation across three Painted Bunting populations in Oklahoma, Louisiana, and North Carolina, and for the Oklahoma breeding population we used published migration tracking data on adult males to explore phenotypic variation in individual migratory behavior. We found no correlation between microsatellite allele size within either Clock and Adcyap1 relative to the initiation or duration of fall migration in adult males breeding in Oklahoma. We also show the lack of significant correlations with aspects of the migratory phenotype for the Louisiana population. Our research highlights the limitations of studying microsatellite allelic mutations that are of undetermined functional influence relative to complex behavioral phenotypes.	[Contina, Andrea; Bridge, Eli S.; Ross, Jeremy D.; Kelly, Jeffrey F.] Univ Oklahoma, Oklahoma Biol Survey, Norman, OK 73019 USA; [Shipley, J. Ryan] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Kelly, Jeffrey F.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Kelly, Jeffrey F.] Univ Oklahoma, Corix Plains Inst, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman; Cornell University; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Contina, A (corresponding author), Univ Oklahoma, Oklahoma Biol Survey, Norman, OK 73019 USA.	andrea.contina@ou.edu	Contina, Andrea/X-8438-2019; Bridge, Eli/AAN-1928-2020; Shipley, Ryan/HDN-3208-2022; Ross, Jeremy/B-9918-2014	Contina, Andrea/0000-0002-0484-6711; Shipley, Jeremy Ryan/0000-0001-9864-2498; Ross, Jeremy/0000-0001-7518-5845	National Science Foundation [IDBR 1014891, DEB 0946685]; United States Department of Agriculture [NIFA-AFRI-003536]; Direct For Education and Human Resources [1545261] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This research was funded by the National Science Foundation (grants nos. IDBR 1014891 and DEB 0946685) and by the United States Department of Agriculture (grant no. NIFA-AFRI-003536). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinsoft. XLSTAT, 2014, DAT AN STAT SOFTW MI; Albert FW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002962; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Amos W, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0929; Amos W, 2010, J MOL EVOL, V71, P192, DOI 10.1007/s00239-010-9377-4; Avise John C., 2008, P5; Bayard De Volo S, 2008, CONDOR, V110, P762, DOI 10.1525/cond.2008.8586; Bazzi G, 2015, SCI REP-UK, V5, DOI 10.1038/srep12443; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bourret A, 2015, ECOL EVOL, V5, P3628, DOI 10.1002/ece3.1630; Bridge ES, 2011, CAN J ZOOL, V89, P951, DOI 10.1139/Z11-064; Cai D, 2011, IEEE T PATTERN ANAL, V33, P1548, DOI 10.1109/TPAMI.2010.231; Caye K, 2016, MOL ECOL RESOUR, V16, P540, DOI 10.1111/1755-0998.12471; Chakarov N, 2013, MOL ECOL, V22, P5430, DOI 10.1111/mec.12493; Contina A, 2017, CONSERVATION GENETIC; Contina A, 2016, CONSERVATION GENETIC, V8; Contina A, 2016, INTEGR ZOOL, V11, P240, DOI 10.1111/1749-4877.12199; Contina A, 2013, AUK, V130, P265, DOI 10.1525/auk.2013.13003; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Earl DA, 2009, STRUCTURE HARVESTER; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frichot E, 2014, GENETICS, V196, P973, DOI 10.1534/genetics.113.160572; Fudickar AM, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0069; Gautier M, 2013, MOL BIOL EVOL, V30, P654, DOI 10.1093/molbev/mss257; Gilad Y, 2006, TRENDS GENET, V22, P456, DOI 10.1016/j.tig.2006.06.002; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hedenstrom A, 2008, PHILOS T R SOC B, V363, P287, DOI 10.1098/rstb.2007.2140; Herzog ED, 2000, J COMP NEUROL, V424, P86, DOI 10.1002/1096-9861(20000814)424:1<86::AID-CNE7>3.0.CO;2-W; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jin L, 1996, P NATL ACAD SCI USA, V93, P15285, DOI 10.1073/pnas.93.26.15285; Johnsen A, 2007, MOL ECOL, V16, P4867, DOI 10.1111/j.1365-294X.2007.03552.x; Johnston RA, 2016, MOL ECOL, V25, P5680, DOI 10.1111/mec.13879; Kitano J, 2012, ICHTHYOL RES, V59, P293, DOI 10.1007/s10228-012-0289-8; Kwon JM, 2000, ALCOHOL RES HEALTH, V24, P164; Liedvogel M, 2011, TRENDS ECOL EVOL, V26, P561, DOI 10.1016/j.tree.2011.07.009; Lowther Peter E., 1999, Birds of North America, V398, P1; Merlin C, 2009, SCIENCE, V325, P1700, DOI 10.1126/science.1176221; Mueller JC, 2011, P ROY SOC B-BIOL SCI, V278, P2848, DOI 10.1098/rspb.2010.2567; O'Malley KG, 2007, MOL ECOL, V16, P4930, DOI 10.1111/j.1365-294X.2007.03565.x; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Paynter Jr RA, 1970, CHECKLIST BIRDS WORL, V13, P216; Peterson MP., 2013, F1000RESEARCH, P1; Poelstra JW, 2013, HEREDITY, V111, P467, DOI 10.1038/hdy.2013.68; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2015, R FDN STAT COMP; Rappole J.H., 1980, P353; Riley RM, 2003, MOL ECOL, V12, P1315, DOI 10.1046/j.1365-294X.2003.01741.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Saino N, 2015, MOL ECOL, V24, P1758, DOI 10.1111/mec.13159; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; Steinmeyer C, 2009, GENETICA, V136, P109, DOI 10.1007/s10709-008-9318-y; Storer R.W., 1951, OCC PAPERS MUS ZOOL, V532, P1; THOMPSON CW, 1991, CONDOR, V93, P209, DOI 10.2307/1368938; THOMPSON CW, 1991, CONDOR, V93, P987, DOI 10.2307/3247733; THOMPSON CW, 1992, J FIELD ORNITHOL, V63, P445; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Zakas C, 2015, EVOL DEV, V17, P240, DOI 10.1111/ede.12128	63	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190859	10.1371/journal.pone.0190859	http://dx.doi.org/10.1371/journal.pone.0190859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324772	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400064
J	Gari, T; Loha, E; Deressa, W; Solomon, T; Lindtjorn, B				Gari, Taye; Loha, Eskindir; Deressa, Wakgari; Solomon, Tarekegn; Lindtjorn, Bernt			Malaria increased the risk of stunting and wasting among young children in Ethiopia: Results of a cohort study	PLOS ONE			English	Article							NUTRITIONAL-STATUS; PLASMODIUM-FALCIPARUM; UNDERNUTRITION; MALNUTRITION; INFECTIONS; VIVAX; TRANSMISSION; ASSOCIATION; PREVALENCE; DIARRHEA	Introduction Given the high prevalence of malnutrition in a malaria-endemic setting, improving nutritional status could serve as a tool to prevent malaria. However, the relationship between the two conditions remains unclear. Therefore, this study assessed the association between undernutrition and malaria among a cohort of children aged 6 to 59 months old. Methods Two cohorts of children were followed for 89 weeks in a rural Rift Valley area of Ethiopia. In the first approach (malaria-malnutrition), a cohort of 2,330 non-stunted and 4,204 non-wasted children were included to assess under-nutrition (outcome) based on their previous malaria status (exposure). In the second approach (malnutrition-malaria), a cohort of 4,468 children were followed-up to measure malaria (outcome), taking under-nutrition as an exposure. A weekly home visit was carried out to identify malaria cases. Four anthropometry surveys were conducted, and generalized estimating equation (GEE) method was used to measure the association between undernutrition and malaria. Results The prevalence of stunting was 44.9% in December 2014, 51.5% in August 2015, 50.7% in December 2015 and 48.1% in August 2016. We observed 103 cases with 118 episodes of malaria, 684 new stunting and 239 new wasting cases. The incidence rate per 10,000 weeks of observation was 3.8 for malaria, 50.4 for stunting and 8.2 for wasting. Children with malaria infection, [Adjusted Odds Ratio (AOR) = 1.9; 95% Confidence Interval (CI), 1.2-2.9)] and younger age (AOR = 1.3; 95% CI, 1.1-1.5) were more likely to be stunted. Furthermore, children with malaria infection (AOR = 8.5; 95% CI, 5.0-14.5) and young age group (AOR = 1.6; 95% CI, 1.2-2.1) were more likely to be wasted. However, stunting and wasting were not risk factors of subsequent malaria illness. Conclusions Malaria infection was a risk factor for stunting and wasting, but stunting or wasting was not associated with subsequent malaria illness. As our study shows that malaria is a risk factor for stunting and wasting, a close follow-up of the nutritional status of such children may be needed.	[Gari, Taye; Loha, Eskindir; Solomon, Tarekegn] Hawassa Univ, Coll Med & Hlth Sci, Sch Publ & Environm Hlth, Hawassa, Ethiopia; [Gari, Taye; Solomon, Tarekegn; Lindtjorn, Bernt] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Deressa, Wakgari] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Prevent Med, Addis Ababa, Ethiopia	Hawassa University; University of Bergen; Addis Ababa University	Gari, T (corresponding author), Hawassa Univ, Coll Med & Hlth Sci, Sch Publ & Environm Hlth, Hawassa, Ethiopia.; Gari, T (corresponding author), Univ Bergen, Ctr Int Hlth, Bergen, Norway.	tayegari@ymail.com	Lindtjorn, Bernt/K-9465-2018; Shumbullo, Eskindir Loha/ABB-6422-2021; loha, eskindir/AAN-4925-2020	Lindtjorn, Bernt/0000-0002-6267-6984; Shumbullo, Eskindir Loha/0000-0003-0003-2734; 	Norwegian Research Council [220554]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This study was funded by the Norwegian Research Council (project number: 220554).	AHMAD S H, 1985, Indian Journal of Pediatrics, V52, P285, DOI 10.1007/BF02754860; Alemayehu M., 2014, INT J NUTR FOOD SCI, V3, P579; Alemu A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-30; [Anonymous], 2011, UN ACC MAL DIAGN TES; Alexandre MAA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003743; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Calder PC, 2000, NUTR RES REV, V13, P3, DOI 10.1079/095442200108728981; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Central Statistical Agency (CSA), 2011, ETH DEM HLTH SURV; CSA, 2007, ETH POP HOUS CENS; (CSA) CSA, 2016, EM OBST NEWB CAR NEE; Danquah I, 2009, ANTIMICROB AGENTS CH, V53, P1753, DOI 10.1128/AAC.01723-08; Degarege A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-291; Deressa W, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1154-2; Deribew A, 2010, PLOS ONE, V5; Egata G, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-864; Ehrhardt S, 2006, J INFECT DIS, V194, P108, DOI 10.1086/504688; Erhardt J, INVENTORS EMERGENCY; Ersino G, 2016, FOOD NUTR B; Ferreira ED, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0870-5; Friedman JF, 2005, AM J TROP MED HYG, V73, P698, DOI 10.4269/ajtmh.2005.73.698; Gari T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170898; Gari T, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1199-4; Golassa L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1070-1; Golassa L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-352; Hailu T., 2014, CLIN MICROBIAL, V3, P4, DOI DOI 10.4172/2327-5073.1000155; IFRC, 2015, EM PLAN ACT ETH DROU; Kateera F, 2015, MALAR J, V14; Kloos H., 1993, ECOLOGY HLTH DIS ETH, P196; Lehmann Deborah, 2005, Papua New Guinea Medical Journal, V48, P87; Maketa V, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0595-5; MCGREGOR IA, 1982, REV INFECT DIS, V4, P798; Medhin G, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-27; Mitangala PN, 2013, REV EPIDEMIOL SANTE, V61, P111, DOI 10.1016/j.respe.2012.06.404; MOH, 2013, TRAIN COURS MAN AC S; MOH, 2016, ETH NAT MAL IND SURV; MOH, 2014, EP PROF MAL ETH ADD; MOH, 2012, ETH NAT MAL IND SURV; MOH, 2012, NAT MAL GUID ADD AB; NMA, 2016, AD TUL ZIW TOWN ANN; Nyakeriga AM, 2004, AM J CLIN NUTR, V80, P1604, DOI 10.1093/ajcn/80.6.1604; Padonou G, 2014, ACTA TROP, V135, P1, DOI 10.1016/j.actatropica.2014.03.005; Prudence MN, 2012, J CLIN EXP PATHOL, pS3; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Shikur B, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2838-y; Tadesse FG, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1749-4; Twisk JWR, 2003, APPL LONGITUDINAL DA; United Nations Children's Fund (UNICEF), 2013, IMPR CHILD NUTR ACH; USAID, 2016, PRES MAL IN ETH; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; *WHO, 2015, CHILDR RED MORT; WHO, 2014, AFR REG HLTH REP; WHO, 2006, ACTA PAEDIAT; WHO, 2006, ACTA PAEDIAT S450; WHO, 2012, GLOB NUTR TARG 2015; WHO/UNICEF, 2012, GLOB NUTR TARG 2025; Williams TN, 1997, QJM-INT J MED, V90, P751; World Health Organization, 2015, WORLD MAL REP 2015; World Health Organization, 2015, GUID TREATM MAL, Vthird; World Health Organization (WHO), 2005, MALN QUANT HLTH IMP; Yisak H, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0535-0	62	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190983	10.1371/journal.pone.0190983	http://dx.doi.org/10.1371/journal.pone.0190983			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324840	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400086
J	Gookin, JL; Mathews, KG; Cullen, J; Seiler, G				Gookin, Jody L.; Mathews, Kyle G.; Cullen, John; Seiler, Gabriela			Qualitative metabolomics profiling of serum and bile from dogs with gallbladder mucocele formation	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; GALL-BLADDER MUCOCELES; CYSTIC-FIBROSIS; EPITHELIAL-CELLS; ACID-COMPOSITION; MUCIN SECRETION; FATTY-ACIDS; AMINO-ACID; CLINICAL FINDINGS; ARACHIDONIC-ACID	Mucocele formation is characterized by secretion of abnormally thick mucus by the gallbladder epithelium of dogs that may cause obstruction of the bile duct or rupture of the gallbladder. The disease is increasingly recognized and is associated with a high morbidity and mortality. The cause of gallbladder mucocele formation in dogs is unknown. There is a strong breed predisposition and affected dogs have a high incidence of concurrent endocrinopathy or hyperlipidemia. These observations suggest a significant influence of both genetic and metabolic factors on disease pathogenesis. In this study, we investigated a theory that mucocele formation is associated with a syndrome of metabolic disruption. We surmised that a global, untargeted metabolomics approach could provide unique insight into the systemic pathogenesis of gallbladder mucocele formation and identify specific compounds as candidate biomarkers or treatment targets. Moreover, concurrent examination of the serum and hepatic duct bile metabolome would enable the construction of mechanism-based theories or identification of specific compounds responsible for altered function of the gallbladder epithelium. Abnormalities observed in dogs with gallbladder mucocele formation, including a 33-fold decrease in serum adenosine 5'-monophosphate (AMP), lower quantities of precursors required for synthesis of energy transporting nucleotides, and increases in citric acid cycle intermediates, suggest excess metabolic energy and a carbon surplus. Altered quantities of compounds involved in protein translation and RNA turnover, together with accumulation of gamma-glutamylated and N-acetylated amino acids in serum suggest abnormal regulation of protein and amino acid metabolism. Increases in lathosterol and 7 alpha-hydroxycholesterol suggest a primary increase in cholesterol synthesis and diversion to bile acid formation. A number of specific biomarker compounds were identified for their ability to distinguish between control dogs and those that formed a gallbladder mucocele. Particularly noteworthy was a significant decrease in quantity of biologically active compounds that stimulate biliary ductal fluid secretion including adenosine, cAMP, taurolithocholic acid, and taurocholic acid. These findings support the presence of significant metabolic disruption in dogs with mucocele formation. A targeted, quantitative analysis of the identified serum biomarkers is warranted to determine their utility for diagnosis of this disease. Finally, repletion of compounds whose biological activity normally promotes biliary ductal secretion should be examined for any therapeutic impact for resolution or prevention of mucocele formation.	[Gookin, Jody L.; Mathews, Kyle G.] North Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27695 USA; [Gookin, Jody L.; Mathews, Kyle G.; Cullen, John; Seiler, Gabriela] North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA; [Cullen, John] North Carolina State Univ, Dept Populat Hlth & Pathobiol, Coll Vet Med, Raleigh, NC USA; [Seiler, Gabriela] North Carolina State Univ, Dept Mol Biomed Sci, Coll Vet Med, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Gookin, JL (corresponding author), North Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27695 USA.; Gookin, JL (corresponding author), North Carolina State Univ, Comparat Med Inst, Raleigh, NC 27695 USA.	Jody_Gookin@ncsu.edu	Fiumefreddo, Andrea/T-2977-2019; Cullen, John M/I-2051-2019	Gookin, Jody/0000-0002-2911-0874	Morris Animal Foundation [D12CA-044]; American Kennel Club Canine Health Foundation; American Shetland Sheepdog Association; Collie Health Foundation [01986]	Morris Animal Foundation; American Kennel Club Canine Health Foundation; American Shetland Sheepdog Association; Collie Health Foundation	These studies were supported by grants from the Morris Animal Foundation (Grant #D12CA-044 to JLG, KGM, JC, GS) and the American Kennel Club Canine Health Foundation with contributions from the American Shetland Sheepdog Association and Collie Health Foundation (Grant #01986 to JLG, KGM, JC, GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AL, 2007, JAVMA-J AM VET MED A, V231, P79, DOI 10.2460/javma.231.1.79; Alpini G, 1999, GASTROENTEROLOGY, V116, P179, DOI 10.1016/S0016-5085(99)70242-8; ALVARO D, 1986, COMP BIOCHEM PHYS B, V83, P551, DOI 10.1016/0305-0491(86)90295-6; BALLATORI N, 1988, AM J PHYSIOL, V254, pG1, DOI 10.1152/ajpgi.1988.254.1.G1; BALLATORI N, 1989, AM J PHYSIOL, V256, pG22, DOI 10.1152/ajpgi.1989.256.1.G22; Ballatori N, 2009, MOL ASPECTS MED, V30, P13, DOI 10.1016/j.mam.2008.08.004; Banales JM, 2006, HEPATOLOGY, V43, P266, DOI 10.1002/hep.21042; Bennett SL, 2007, AUST VET J, V85, P397, DOI 10.1111/j.1751-0813.2007.00182.x; BERNHOFT RA, 1983, GASTROENTEROLOGY, V85, P1166; Besso JG, 2000, VET RADIOL ULTRASOUN, V41, P261, DOI 10.1111/j.1740-8261.2000.tb01489.x; BIANCHETTI R, 1977, J BIOL CHEM, V252, P2519; Brevik A, 2005, EUR J CLIN NUTR, V59, P1417, DOI 10.1038/sj.ejcn.1602256; Cai L, 2011, COLD SH Q B, V76, P195, DOI 10.1101/sqb.2011.76.010769; Coker M, 1996, J INHERIT METAB DIS, V19, P743, DOI 10.1007/BF01799166; Cowling VH, 2010, BIOCHEM J, V425, P295, DOI 10.1042/BJ20091352; Crews LJ, 2009, JAVMA-J AM VET MED A, V234, P359, DOI 10.2460/javma.234.3.359; Cullen JM, 2014, J VET DIAGN INVEST, V26, P434, DOI 10.1177/1040638714532099; Debray D, 2012, GASTROENTEROLOGY, V142, P1581, DOI 10.1053/j.gastro.2012.02.033; EDQVIST J, 1995, BIOCHIMIE, V77, P54, DOI 10.1016/0300-9084(96)88104-1; Fausther M, 2007, AM J PHYSIOL-GASTR L, V292, pG785, DOI 10.1152/ajpgi.00293.2006; Feranchak AP, 2002, SEMIN LIVER DIS, V22, P251, DOI 10.1055/s-2002-34503; Fischer H, 2004, P NATL ACAD SCI USA, V101, P3691, DOI 10.1073/pnas.0308393100; FLECK C, 1992, PHYSIOL RES, V41, P273; Gao L, 2001, AM J PHYSIOL-LUNG C, V281, pL1123, DOI 10.1152/ajplung.2001.281.5.L1123; Goldstein BA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-49; Gookin JL, 2015, J VET INTERN MED, V29, P1464, DOI 10.1111/jvim.13649; Hattori Y, 2000, DIGEST DIS SCI, V45, P1413, DOI 10.1023/A:1005524624411; Hayashi A, 1996, AM J PHYSIOL-GASTR L, V271, pG410, DOI 10.1152/ajpgi.1996.271.3.G410; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hoegger MJ, 2014, SCIENCE, V345, P818, DOI 10.1126/science.1255825; Hohenester S, 2011, DIGEST DIS, V29, P62, DOI 10.1159/000324687; Hori H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00144; Kakimoto T, 2017, AM J VET RES, V78, P223, DOI 10.2460/ajvr.78.2.223; Keitel V, 2015, CLIN REV ALLERG IMMU, V48, P218, DOI 10.1007/s12016-014-8443-x; Kesimer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138988; KLINKSPOOR JH, 1995, GASTROENTEROLOGY, V109, P264, DOI 10.1016/0016-5085(95)90293-7; Kook PH, 2011, AM J VET RES, V72, P1607, DOI 10.2460/ajvr.72.12.1607; KOVATCH RM, 1965, PATHOL VET, V2, P574, DOI 10.1177/030098586500200605; Kutsunai M, 2014, VET J, V199, P76, DOI 10.1016/j.tvjl.2013.10.019; KUVER R, 1994, AM J PHYSIOL-GASTR L, V267, pG998, DOI 10.1152/ajpgi.1994.267.6.G998; LAMONT JT, 1983, AM J PHYSIOL, V245, pG92, DOI 10.1152/ajpgi.1983.245.1.G92; Li Y, 2006, AM J RESP CELL MOL, V34, P600, DOI 10.1165/rcmb.2005-0421OC; Lindner H, 2000, BIOCHIMIE, V82, P129, DOI 10.1016/S0300-9084(00)00191-7; Lindner HA, 2008, BIOCHIMIE, V90, P773, DOI 10.1016/j.biochi.2007.12.006; Linsdell P, 2000, CAN J PHYSIOL PHARM, V78, P490, DOI 10.1139/cjpp-78-6-490; Liu JH, 2015, J CLIN INVEST, V125, P1056, DOI 10.1172/JCI73193; Makide K, 2014, J LIPID RES, V55, P1986, DOI 10.1194/jlr.R046920; Malek S, 2013, VET SURG, V42, P418, DOI 10.1111/j.1532-950X.2012.01072.x; Mayhew PD, 2008, VET SURG, V37, P625, DOI 10.1111/j.1532-950X.2008.00428.x; Mehler SJ, 2004, VET SURG, V33, P644, DOI 10.1111/j.1532-950X.2004.04087.x; Menni C, 2013, INT J EPIDEMIOL, V42, P1111, DOI 10.1093/ije/dyt094; Mesich MLL, 2009, J SMALL ANIM PRACT, V50, P630, DOI 10.1111/j.1748-5827.2009.00811.x; Meyer DJ, 1997, J VET INTERN MED, V11, P195, DOI 10.1111/j.1939-1676.1997.tb00090.x; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; MINGRONE G, 1988, BIOCHIM BIOPHYS ACTA, V958, P52, DOI 10.1016/0005-2760(88)90245-7; MIRKOVITCH V, 1975, PFLUG ARCH EUR J PHY, V355, P319, DOI 10.1007/BF00579853; NEWELL SM, 1995, J AM ANIM HOSP ASSOC, V31, P467, DOI 10.5326/15473317-31-6-467; ORLOWSKI M, 1970, P NATL ACAD SCI USA, V67, P1248, DOI 10.1073/pnas.67.3.1248; Palmieri G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025888; Perrier J, 2005, BIOCHIMIE, V87, P673, DOI 10.1016/j.biochi.2005.04.002; Pike FS, 2004, JAVMA-J AM VET MED A, V224, P1615, DOI 10.2460/javma.2004.224.1615; Plumb RS, 2009, J PROTEOME RES, V8, P2495, DOI 10.1021/pr801078a; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; Shi L, 2015, CURR OPIN CELL BIOL, V33, P125, DOI 10.1016/j.ceb.2015.02.003; Shoda J, 2003, CLIN GASTROENTEROL H, V1, P285, DOI 10.1016/S1542-3565(03)00133-2; Smith RP, 2017, J VET INTERN MED, V31, P1451, DOI 10.1111/jvim.14792; Soga T, 2011, J HEPATOL, V55, P896, DOI 10.1016/j.jhep.2011.01.031; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun XS, 2014, AM J PATHOL, V184, P1309, DOI 10.1016/j.ajpath.2014.01.035; Tabibian JH, 2013, COMPR PHYSIOL, V3, P541, DOI 10.1002/cphy.c120019; Tang XX, 2016, J CLIN INVEST, V126, P879, DOI 10.1172/JCI83922; Tauscher A, 2003, BIOCHEM BIOPH RES CO, V307, P1021, DOI 10.1016/S0006-291X(03)01296-8; Tietz PS, 2003, J BIOL CHEM, V278, P20413, DOI 10.1074/jbc.M302108200; Tsukagoshi T, 2012, VET RADIOL ULTRASOUN, V53, P84, DOI 10.1111/j.1740-8261.2011.01868.x; Uno T, 2009, J VET MED SCI, V71, P1295, DOI 10.1292/jvms.001295; WASHIZU T, 1990, JPN J VET SCI, V52, P423; Wetmore DR, 2010, J BIOL CHEM, V285, P30516, DOI 10.1074/jbc.M110.140806; Woods KS, 2012, CAN VET J, V53, P269; Worley DR, 2004, JAVMA-J AM VET MED A, V225, P1418, DOI 10.2460/javma.2004.225.1418; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024	80	19	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191076	10.1371/journal.pone.0191076	http://dx.doi.org/10.1371/journal.pone.0191076			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324798	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400106
J	Iyer, JK; Dickey, A; Rouhani, P; Kaul, A; Govindaraju, N; Singh, RN; Kaul, R				Iyer, Janaki Kannan; Dickey, Alexia; Rouhani, Parvaneh; Kaul, Anil; Govindaraju, Nirmal; Singh, Raj Narain; Kaul, Rashmi			Nanodiamonds facilitate killing of intracellular uropathogenic E. coli in an in vitro model of urinary tract infection pathogenesis	PLOS ONE			English	Article							ESCHERICHIA-COLI; DIAMOND NANOPARTICLES; CARBON NANOTUBES; BIOMEDICAL APPLICATIONS; UROLOGIC DISEASES; AMERICA PROJECT; DELIVERY; BIOCOMPATIBILITY; FIMBRIAE; CELLS	About 25 +/- 44% of women will experience at least one episode of recurrent UTI and the causative agent in over 70% of UTI cases is uropathogenic Escherichia coli (UPEC). UPEC cause recurrent UTI by evading the bladder's innate immune system through internalization into the bladder epithelium where antibiotics cannot reach or be effective. Thus, it is important to develop novel therapeutics to eliminate these intracellular pathogens. Nanodiamonds (NDs) are biocompatible nanomaterials that serve as promising candidates for targeted therapeutic applications. The objective of the current study was to investigate if 6 or 25 nm NDs can kill extracellular and intracellular UPEC in infected bladder cells. We utilized the human bladder epithelial cell line, T24, and an invasive strain of UPEC that causes recurrent UTI. We found that acid-purified 6 nm NDs displayed greater antibacterial properties towards UPEC than 25 nm NDs (11.5% vs 94.2% CFU/mL at 100 mu g/mL of 6 and 25 nm, respectively; P<0.001). Furthermore, 6 nm NDs were better than 25 nm NDs in reducing the number of UPEC internalized in T24 bladder cells (46.1% vs 81.1% CFU/mL at 100 mu g/mL of 6 and 25 nm, respectively; P<0.01). Our studies demonstrate that 6 nm NDs interacted with T24 bladder cells in a dose-dependent manner and were internalized in 2 hours through an actin-dependent mechanism. Finally, internalization of NDs was required for reducing the number of intracellular UPEC in T24 bladder cells. These findings suggest that 6 nm NDs are promising candidates to treat recurrent UTIs.	[Iyer, Janaki Kannan; Dickey, Alexia; Kaul, Rashmi] Oklahoma State Univ, Ctr Hlth Sci, Dept Biochem & Microbiol, Tulsa, OK 74106 USA; [Rouhani, Parvaneh; Govindaraju, Nirmal; Singh, Raj Narain] Oklahoma State Univ, Sch Mat Sci & Engn, Tulsa, OK USA; [Kaul, Anil] Oklahoma State Univ, Ctr Hlth Sci, Hlth Care Adm, Tulsa, OK USA; [Iyer, Janaki Kannan] Northeastern State Univ, Dept Nat Sci, Tahlequah, OK USA	Oklahoma State University System; Oklahoma State University Center for Health Sciences; Oklahoma State University System; Oklahoma State University - Tulsa; Oklahoma State University System; Oklahoma State University Center for Health Sciences	Kaul, R (corresponding author), Oklahoma State Univ, Ctr Hlth Sci, Dept Biochem & Microbiol, Tulsa, OK 74106 USA.	rashmi.kaul10@okstate.edu	Rouhani, Parvaneh/AAP-2872-2021; Rouhani, Parvaneh/AAU-6261-2021; Singh, Raj/HDN-1244-2022; kaul, Rashmi/A-3374-2008	Kaul, Rashmi/0000-0002-1060-759X; Singh, Raj/0000-0001-5277-0603	Cancer Sucks, Bixby, Oklahoma; Oklahoma State University Center for Health Sciences Intramural Research Award; Oklahoma Center for the Advancement of Science Technology [HR 14-065]; Williams Companies Distinguished Chair; NSF MRI	Cancer Sucks, Bixby, Oklahoma; Oklahoma State University Center for Health Sciences Intramural Research Award; Oklahoma Center for the Advancement of Science Technology; Williams Companies Distinguished Chair; NSF MRI(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study was supported by funds from Cancer Sucks, Bixby, Oklahoma awarded to RK; Oklahoma State University Center for Health Sciences Intramural Research Award to RK; grant from Oklahoma Center for the Advancement of Science & Technology (HR 14-065) awarded to RK and Williams Companies Distinguished Chair to RNS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Lisa Whitworth from the Oklahoma State University Microscopy Laboratory for her technical assistance in TEM imaging. Parts of this work were carried out in the Microscopy Laboratory, Oklahoma State University, which received funds for purchasing the equipment from the NSF MRI program.	Alhaddad A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052207; Alhaddad A, 2011, SMALL, V7, P3087, DOI 10.1002/smll.201101193; Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550; Beranova J, 2014, FEMS MICROBIOL LETT, V351, P179, DOI 10.1111/1574-6968.12373; Bhattacharya K, 2016, NANOMED-NANOTECHNOL, V12, P333, DOI 10.1016/j.nano.2015.11.011; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; Brumbaugh AR, 2012, EXPERT REV VACCINES, V11, P663, DOI [10.1586/erv.12.36, 10.1586/ERV.12.36]; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; Chatterjee A, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.5.051014; Chen YC, 2014, ACTA BIOMATER, V10, P2187, DOI 10.1016/j.actbio.2014.01.014; Clemens DL, 2012, ANTIMICROB AGENTS CH, V56, P2535, DOI 10.1128/AAC.06049-11; Czaja CA, 2007, CLIN INFECT DIS, V45, P273, DOI 10.1086/519268; DeFrances CJ, 2006, NATL HLTH STAT REPOR, V2008, P1; Doern CD, 2016, J CLIN MICROBIOL, V54, P2233, DOI 10.1128/JCM.00189-16; Ejrnaes K, 2006, J CLIN MICROBIOL, V44, P1776, DOI 10.1128/JCM.44.5.1776-1781.2006; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; Faklaris O, 2009, ACS NANO, V3, P3955, DOI 10.1021/nn901014j; Faklaris O, 2008, SMALL, V4, P2236, DOI 10.1002/smll.200800655; Fang L, 2004, INFECT IMMUN, V72, P2907, DOI 10.1128/IAI.72.5.2907-2914.2004; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Goluszko P, 1997, J CLIN INVEST, V99, P1662, DOI 10.1172/JCI119329; Griebling TL, 2005, J UROLOGY, V173, P1288, DOI 10.1097/01.ju.0000155595.98120.8e; Gupta K, 2001, CLIN INFECT DIS, V33, P89, DOI 10.1086/320880; Hadduck AN, 2010, APPL ENVIRON MICROB, V76, P8239, DOI 10.1128/AEM.01925-10; Holt KB, 2007, PHILOS T R SOC A, V365, P2845, DOI 10.1098/rsta.2007.0005; Hsu TC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05004; Huttner A, 2017, LANCET INFECT DIS, V17, P528, DOI [10.1016/s1473-3099(17)30108-1, 10.1016/S1473-3099(17)30108-1]; Ikaheimo R, 1996, CLIN INFECT DIS, V22, P91, DOI 10.1093/clinids/22.1.91; Iyer JK, 2010, INFECT IMMUN, V78, P2418, DOI 10.1128/IAI.00170-10; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Jorgensen I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002907; Kang S, 2008, LANGMUIR, V24, P6409, DOI 10.1021/la800951v; Kaul AK, 1999, INFECT IMMUN, V67, P5958, DOI 10.1128/IAI.67.11.5958-5966.1999; Khanal M, 2015, NANOSCALE, V7, P2325, DOI 10.1039/c4nr05906a; Kodner CM, 2010, AM FAM PHYSICIAN, V82, P638; Lai L, 2015, J NANOSCI NANOTECHNO, V15, P989, DOI 10.1166/jnn.2015.9735; Lewis AJ, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0026-2016; Litwin MS, 2005, J UROLOGY, V173, P933, DOI 10.1097/01.ju.0000152365.43125.3b; Man HB, 2014, NANOMED-NANOTECHNOL, V10, P359, DOI 10.1016/j.nano.2013.07.014; Moore L, 2016, ACS NANO, V10, P7385, DOI 10.1021/acsnano.6b00839; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mysorekar IU, 2006, P NATL ACAD SCI USA, V103, P14170, DOI 10.1073/pnas.0602136103; NOWICKI B, 1986, MICROB PATHOGENESIS, V1, P169, DOI 10.1016/0882-4010(86)90019-7; Partha R, 2009, INT J NANOMED, V4, P261; Rojas S, 2011, ACS NANO, V5, P5552, DOI 10.1021/nn200986z; Rouhani P, 2016, MAT SCI ENG C-MATER, V63, P323, DOI 10.1016/j.msec.2016.02.075; Salaam AD, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/42/425103; Sanchez GV, 2012, ANTIMICROB AGENTS CH, V56, P2181, DOI 10.1128/AAC.06060-11; Schrand AM, 2007, DIAM RELAT MATER, V16, P2118, DOI 10.1016/j.diamond.2007.07.020; Servin AL, 2005, CLIN MICROBIOL REV, V18, P264, DOI 10.1128/CMR.18.2.264-292.2005; Sharma P, 2016, CURR DRUG DELIV, V13, P796, DOI 10.2174/1567201813666160623091814; Shenderova OA, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4927679; Solarska K, 2012, J NANOSCI NANOTECHNO, V12, P5117, DOI 10.1166/jnn.2012.4952; Taylor E, 2011, INT J NANOMED, V6, P1463, DOI 10.2147/IJN.S22021; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Vaitkuviene A, 2015, MOL CELL PROBE, V29, P25, DOI 10.1016/j.mcp.2014.10.005; Vellinga A, 2012, J ANTIMICROB CHEMOTH, V67, P2523, DOI 10.1093/jac/dks222; Wang X, 2014, ACS NANO, V8, P12151, DOI 10.1021/nn503491e; Wehling J, 2014, ACS NANO, V8, P6475, DOI 10.1021/nn502230m; Xiao JS, 2013, BIOMATERIALS, V34, P9648, DOI 10.1016/j.biomaterials.2013.08.056; Yu M, 2015, J CONTROL RELEASE, V215, P91, DOI 10.1016/j.jconrel.2015.08.003; Zakrzewska KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122579; Zhu Y, 2012, THERANOSTICS, V2, P302, DOI 10.7150/thno.3627	63	17	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191020	10.1371/journal.pone.0191020	http://dx.doi.org/10.1371/journal.pone.0191020			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324795	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400095
J	Jenny, L; Dobo, J; Gal, P; Pal, G; Lam, WA; Schroeder, V				Jenny, Lorenz; Dobo, Jozsef; Gal, Peter; Pal, Gabor; Lam, Wilbur A.; Schroeder, Verena			MASP-1 of the complement system enhances clot formation in a microvascular whole blood flow model	PLOS ONE			English	Article							LECTIN-PATHWAY ACTIVATION; SERINE PROTEASES MASPS; ENDOTHELIAL-CELLS; COAGULATION; PLATELET; THROMBOINFLAMMATION; COMPONENTS; THROMBOSIS; MOLECULES; ADHESION	The complement and coagulation systems closely interact with each other. These interactions are believed to contribute to the proinflammatory and prothrombotic environment involved in the development of thrombotic complications in many diseases. Complement MASP-1 (mannan-binding lectin-associated serine protease-1) activates coagulation factors and promotes clot formation. However, this was mainly shown in purified or plasma-based static systems. Here we describe the role of MASP-1 and complement activation in fibrin clot formation in a microvascular, whole blood flow model. This microfluidic system simulates blood flow through microvessels at physiological flow and shear rates and represents the closest model system to human physiology so far. It features parallel microchannels cultured with endothelial cells in a transparent microfluidic chip allowing real-time evaluation of clot formation by confocal microscopy. To test their effects on clot formation, we added the following activators or inhibitors (individually or in combination) to whole blood and performed perfusion experiments: rMASP-1cf (recombinant active form of MASP-1), complement activator zymosan, selective MASP-1 inhibitor SGMI-1 (based on the Schistocerca gregaria protease inhibitor scaffold), classical pathway inhibitor rSALO (recombinant salivary anti-complement from Lutzomyia longipalpis). Addition of rMASP-1cf resulted in accelerated fibrin clot formation while addition of SGMI-1 delayed it. Complement activation by zymosan led to increased clot formation and this effect was partially reversed by addition of rSALO and almost abolished in combination with SGMI-1. We show for the first time a strong influence of MASP-1, complement activation and pathway-specific inhibition on coagulation in a microvascular flow system that is closest to human physiology, further underpinning the in vivo relevance of coagulation and complement interactions.	[Jenny, Lorenz; Schroeder, Verena] Univ Bern, Dept BioMed Res, Expt Haemostasis Grp, Bern, Switzerland; [Dobo, Jozsef; Gal, Peter] Hungarian Acad Sci, Biol Res Ctr, Inst Enzymol, Budapest, Hungary; [Pal, Gabor] Eotvos Lorand Univ, Dept Biochem, Budapest, Hungary; [Lam, Wilbur A.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Lam, Wilbur A.] Emory Univ, Atlanta, GA 30322 USA	University of Bern; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Research Centre for Natural Sciences; Eotvos Lorand University; University System of Georgia; Georgia Institute of Technology; Emory University	Schroeder, V (corresponding author), Univ Bern, Dept BioMed Res, Expt Haemostasis Grp, Bern, Switzerland.	verena.schroeder@dbmr.unibe.ch	Gal, Peter/B-5886-2011	Schroeder, Verena/0000-0001-6508-3271; Pal, Gabor/0000-0001-7868-7971; Dobo, Jozsef/0000-0001-9187-8502	Swiss National Science Foundation [310030_140925, 310030_166413, IZK0Z3_171194/1]; OPO foundation; National Research, Development and Innovation Office OTKA [K119374]; Hungarian Academy of Sciences	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); OPO foundation; National Research, Development and Innovation Office OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the Swiss National Science Foundation (http://www.snf.ch, grants 310030_140925, 310030_166413, and IZK0Z3_171194/1) and the OPO foundation (http://www.opo-stiftung.ch/). P.G. and J.D. were supported by the National Research, Development and Innovation Office OTKA (http://nkfih.gov.hu/english, grant K119374) and the MedInProt program of the Hungarian Academy of Sciences (http://medinprot.chem.elte.hu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ciciliano JC, 2014, THROMB RES, V133, P532, DOI 10.1016/j.thromres.2013.12.037; Conway EM, 2015, J THROMB HAEMOST, V13, pS121, DOI 10.1111/jth.12950; Dobo J, 2014, MOL IMMUNOL, V61, P69, DOI 10.1016/j.molimm.2014.05.013; Dobo J, 2009, J IMMUNOL, V183, P1207, DOI 10.4049/jimmunol.0901141; Ekdahl KN, 2016, IMMUNOL REV, V274, P245, DOI 10.1111/imr.12471; Fay ME, 2016, P NATL ACAD SCI USA, V113, P1987, DOI 10.1073/pnas.1508920113; Ferreira VP, 2016, SCI REP-UK, V6, DOI 10.1038/srep19300; Frauenknecht V, 2013, CLIN EXP IMMUNOL, V173, P112, DOI 10.1111/cei.12093; Gulla KC, 2010, IMMUNOLOGY, V129, P482, DOI 10.1111/j.1365-2567.2009.03200.x; Heja D, 2012, P NATL ACAD SCI USA, V109, P10498, DOI 10.1073/pnas.1202588109; Heja D, 2012, J BIOL CHEM, V287, P20290, DOI 10.1074/jbc.M112.354332; Hess K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035690; Ikeda K, 1997, THROMB HAEMOSTASIS, V77, P394; Jenny L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144633; Jenny L, 2015, MOL IMMUNOL, V65, P398, DOI 10.1016/j.molimm.2015.02.014; Johnson N.D., 2011, THESIS U MANCHESTER; Kozarcanin H, 2016, J THROMB HAEMOST, V14, P531, DOI 10.1111/jth.13208; Krarup A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000623; Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020; La Bonte LR, 2012, J IMMUNOL, V188, P885, DOI 10.4049/jimmunol.1102916; Mannino RG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12401; Megyeri M, 2013, J BIOL CHEM, V288, P8922, DOI 10.1074/jbc.M112.446500; Megyeri M, 2009, J IMMUNOL, V183, P3409, DOI 10.4049/jimmunol.0900879; MINTA JO, 1983, METHOD ENZYMOL, V93, P375; Nan RD, 2017, STRUCTURE, V25, P364, DOI 10.1016/j.str.2016.12.014; Noris M, 2013, SEMIN NEPHROL, V33, P479, DOI 10.1016/j.semnephrol.2013.08.001; Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x; POLLEY MJ, 1983, J EXP MED, V158, P603, DOI 10.1084/jem.158.2.603; Qiu YZ, 2014, P NATL ACAD SCI USA, V111, P14430, DOI 10.1073/pnas.1322917111; Rajwal S, 2004, PEDIATR ANESTH, V14, P656, DOI 10.1111/j.1460-9592.2004.01275.x; Takahashi K, 2011, IMMUNOBIOLOGY, V216, P96, DOI 10.1016/j.imbio.2010.02.005; Tedesco F, 1997, J EXP MED, V185, P1619, DOI 10.1084/jem.185.9.1619; Thiel S, 2012, CLIN EXP IMMUNOL, V169, P38, DOI 10.1111/j.1365-2249.2012.04584.x; Tsai M, 2012, J CLIN INVEST, V122, P408, DOI 10.1172/JCI58753	34	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191292	10.1371/journal.pone.0191292	http://dx.doi.org/10.1371/journal.pone.0191292			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324883	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000419952400136
J	Raoult, V; Howell, N; Zahra, D; Peddemors, VM; Howard, DL; de Jonge, MD; Buchan, BLy; Williamson, JE				Raoult, Vincent; Howell, Nicholas; Zahra, David; Peddemors, Victor M.; Howard, Daryl L.; de Jonge, Martin D.; Buchan, Benjamin L.; Williamson, Jane E.			Localized zinc distribution in shark vertebrae suggests differential deposition during ontogeny and across vertebral structures'	PLOS ONE			English	Article							TIGER SHARKS; FEEDING ECOLOGY; STABLE-ISOTOPES; GROWTH; AGE; MINERALIZATION; CONSEQUENCES; SIGNATURES; NITROGEN; CADMIUM	The development of shark vertebrae and the possible drivers of inter-and intra-specific differences in vertebral structure are poorly understood. Shark vertebrae are used to examine life-history traits related to trophic ecology, movement patterns, and the management of fisheries; a better understanding of their development would be beneficial to many fields of research that rely on these calcified structures. This study used Scanning X-ray Fluorescence Microscopy to observe zinc distribution within vertebrae of ten shark species from five different orders. Zinc was mostly localised within the intermedialis and was generally detected at levels an order of magnitude lower in the corpus calcareum. In most species, zinc concentrations were higher pre-birth mark, indicating a high rate of pre-natal zinc deposition. These results suggest there are inter-specific differences in elemental deposition within vertebrae. Since the deposition of zinc is physiologically-driven, these differences suggest that the processes of growth and deposition are potentially different in the intermedialis and corpus calcareum, and that caution should be taken when extrapolating information such as annual growth bands from one structure to the other. Together these results suggest that the high inter-specific variation in vertebral zinc deposition and associated physiologies may explain the varying effectiveness of ageing methodologies applied to elasmobranch vertebrae.	[Raoult, Vincent; Buchan, Benjamin L.; Williamson, Jane E.] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia; [Howell, Nicholas; Zahra, David] ANSTO, Lucas Heights, NSW, Australia; [Peddemors, Victor M.] Sydney Inst Marine Sci, NSW DPI Fisheries, Mosman, NSW, Australia; [Howard, Daryl L.; de Jonge, Martin D.] Australian Synchrotron, Clayton, Vic, Australia; [Raoult, Vincent] Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia	Macquarie University; Australian Nuclear Science & Technology Organisation; Sydney Institute of Marine Science; University of Newcastle	Raoult, V (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia.; Raoult, V (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Ourimbah, NSW, Australia.	Vincent.raoult@newcastle.edu.ac	de Jonge, Martin D/C-3400-2011; Peddemors, Victor M/Q-4281-2016; Raoult, Vincent/H-6038-2019; Howard, Daryl/E-9107-2013	de Jonge, Martin D/0000-0001-7731-6175; Raoult, Vincent/0000-0001-9459-111X; Peddemors, Victor/0000-0002-8743-9782; Howard, Daryl/0000-0001-6071-2382; Williamson, Jane/0000-0003-3627-4508; Howell, Nicholas/0000-0003-3703-7598	NSW Department of Primary Industries; Department of Biological Sciences at Macquarie University; AINSE research award [ALNGRA13029]; NSW Industry Synchrotron Access Scheme - NSW Office of Science and Research; Macquarie University; NSW DPI, Fisheries	NSW Department of Primary Industries; Department of Biological Sciences at Macquarie University; AINSE research award; NSW Industry Synchrotron Access Scheme - NSW Office of Science and Research; Macquarie University; NSW DPI, Fisheries	We thank the NSW Department of Primary Industries and the Department of Biological Sciences at Macquarie University for providing funding and some of the samples for this research. An AINSE research award ALNGRA13029 allowed a dialogue between ANSTO and Macquarie University that led to this project. Access to the Australian Synchrotron was supported under the NSW Industry Synchrotron Access Scheme, funded by the NSW Office of Science and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Many thanks to Richard Bagnato and his crew for graciously collaborating and assisting with obtaining samples. Many thanks also to the crew of the AMC Bluefin, the Australian Maritime College and Dr. Troy Gaston. This research was undertaken on the XFM beamline at the Australian Synchrotron, Australia. Many thanks to those involved in the SXFM: Kathryn M. Spiers, Simon A. James, and David J. Paterson. Thanks to Macquarie University for scholarship support of V.V.R., and to the Department of Biological Sciences at Macquarie University and to NSW DPI, Fisheries for financial support for J.E.W. and V.M.P. Thanks to Ashley Fowler for helping to improve this manuscript.	Arai T, 2007, WATER AIR SOIL POLL, V179, P255, DOI 10.1007/s11270-006-9229-4; Baremore IE, 2009, FISH RES, V99, P203, DOI 10.1016/j.fishres.2009.06.006; Biller DV, 2013, MAR CHEM, V155, P50, DOI 10.1016/j.marchem.2013.06.003; Bonaventura P, 2015, AUTOIMMUN REV, V14, P277, DOI 10.1016/j.autrev.2014.11.008; Braccini JM, 2010, AQUAT BIOL, V9, P131, DOI 10.3354/ab00246; Burridge L, 2010, AQUACULTURE, V306, P7, DOI 10.1016/j.aquaculture.2010.05.020; Bury NR, 2003, J EXP BIOL, V206, P11, DOI 10.1242/jeb.00068; Cailliet G., 2006, SPECIAL ISSUE AGE GR, V25, P211; Cailliet GM, 2015, J FISH BIOL, V87, P1271, DOI 10.1111/jfb.12829; Cailliet G.M., 1983, P INT WORKSH AG DET; CAILLIET GM, 1992, AUST J MAR FRESH RES, V43, P1313; Campana SE, 2013, AGE DETERMINATION EL; Canli M, 2003, ENVIRON POLLUT, V121, P129, DOI 10.1016/S0269-7491(02)00194-X; Cotton CF, 2011, MAR FRESHWATER RES, V62, P811, DOI 10.1071/MF10307; Domi N, 2005, MAR ENVIRON RES, V60, P551, DOI 10.1016/j.marenvres.2005.03.001; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Endo T, 2015, ECOL INDIC, V55, P86, DOI 10.1016/j.ecolind.2015.03.008; Estrada JA, 2006, ECOLOGY, V87, P829, DOI 10.1890/0012-9658(2006)87[829:UOIAOV]2.0.CO;2; Estupinan-Montano C, 2017, J MAR BIOL ASSOC UK, P1, DOI DOI 10.1017/S002531541600179X; FERREIRA BP, 1991, FISH B-NOAA, V89, P19; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Frias-Espericueta MG, 2014, B ENVIRON CONTAM TOX, V93, P532, DOI 10.1007/s00128-014-1360-0; Fukada T, 2013, J BONE MINER METAB, V31, P129, DOI 10.1007/s00774-012-0409-6; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Goldman KJ, 2006, ENVIRON BIOL FISH, V77, P241, DOI 10.1007/s10641-006-9128-y; Goldman KJ, 2012, CRC MAR BIOL SER, P423; Harry AV, 2017, FISH FISH; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hogstrand C, 1996, SEMINAR SERIES SOC E; Howell NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01878-y; Hussey NE, 2012, J FISH BIOL, V80, P1449, DOI 10.1111/j.1095-8649.2012.03251.x; Irvine SB, 2006, ENVIRON BIOL FISH, V77, P253, DOI 10.1007/s10641-006-9130-4; Izzo C, 2016, MAR ECOL PROG SER, V556, P195, DOI 10.3354/meps11840; Lansdown ABG, 2007, WOUND REPAIR REGEN, V15, P2, DOI 10.1111/j.1524-475X.2006.00179.x; Lewis JP, 2016, MAR FRESHWATER RES, V67, P1014, DOI 10.1071/MF15088; Li MH, 1996, AQUACULTURE, V146, P237, DOI 10.1016/S0044-8486(96)01388-9; Lombi E, 2011, ANAL BIOANAL CHEM, V400, P1637, DOI 10.1007/s00216-011-4829-2; Matich P, 2010, CAN J FISH AQUAT SCI, V67, P877, DOI 10.1139/F10-037; McMillan MN, 2017, J FISH BIOL, V90, P559, DOI 10.1111/jfb.13189; McMillan MN, 2017, ICES J MAR SCI, V74, P793, DOI 10.1093/icesjms/fsw176; Mohanasrinivasan V, 2014, 3 BIOTECH, V4, P167, DOI 10.1007/s13205-013-0140-6; Musick J.A, 2005, MANAGEMENT TECHNIQUE; Musick JA, 2000, FISHERIES, V25, P9, DOI 10.1577/1548-8446(2000)025<0009:MOSATR>2.0.CO;2; Natanson LJ, 2015, MAR FRESHWATER RES, V66, P387, DOI 10.1071/MF14127; NATANSON LJ, 1990, COPEIA, P1133, DOI 10.2307/1446499; Nevatte RJ, 2017, J FISH BIOL, V91, P1582, DOI 10.1111/jfb.13467; Nevatte RJ, 2017, J FISH BIOL, V90, P1906, DOI 10.1111/jfb.13275; Olin JA, 2011, RAPID COMMUN MASS SP, V25, P1008, DOI 10.1002/rcm.4946; Paterson D, 2011, 10 INT C X RAY MICR; Raoult V., 2015, BIOL FISHERIES ANGEL; Raoult V, 2016, SCI REP-UK, V6, DOI 10.1038/srep29698; Raoult V, 2015, CAN J FISH AQUAT SCI, V72, P1769, DOI 10.1139/cjfas-2015-0307; RCore Team, 2020, R LANG ENV STAT COMP; Roff G, 2016, TRENDS ECOL EVOL, V31, P395, DOI 10.1016/j.tree.2016.02.014; Ryan CG, 2001, NUCL INSTRUM METH B, V181, P170, DOI 10.1016/S0168-583X(01)00374-3; Simpfendorfer CA, 2017, CURR BIOL, V27, pR97, DOI 10.1016/j.cub.2016.12.017; Smith WD, 2016, MAR ECOL PROG SER, V556, P173, DOI 10.3354/meps11844; Smith WD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062423; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043; Tillett BJ, 2014, ENDANGER SPECIES RES, V25, P283, DOI 10.3354/esr00615; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood CM, 2012, HOMEOSTASIS TOXICOLO	63	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190927	10.1371/journal.pone.0190927	http://dx.doi.org/10.1371/journal.pone.0190927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324879	Green Submitted, gold, Green Published			2022-12-26	WOS:000419952400074
J	Saeidi, S; Shapouri, F; de Iongh, RU; Casagranda, F; Sutherland, JM; Western, PS; McLaughlin, EA; Familari, M; Hime, GR				Saeidi, Shaghayegh; Shapouri, Farnaz; de Iongh, Robb U.; Casagranda, Franca; Sutherland, Jessie M.; Western, Patrick S.; McLaughlin, Eileen A.; Familari, Mary; Hime, Gary R.			Esrp1 is a marker of mouse fetal germ cells and differentially expressed during spermatogenesis	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; SR PROTEINS; PLURIPOTENCY; TESTIS; LINE; TRANSCRIPTOMES; GENERATION; GONADS; GENES; PLZF	ESRP1 regulates alternative splicing, producing multiple transcripts from its target genes in epithelial tissues. It is upregulated during mesenchymal to epithelial transition associated with reprogramming of fibroblasts to iPS cells and has been linked to pluripotency. Mouse fetal germ cells are the founders of the adult gonadal lineages and we found that Esrp1 mRNA was expressed in both male and female germ cells but not in gonadal somatic cells at various stages of gonadal development (E12.5-E15.5). In the postnatal testis, Esrp1 mRNA was highly expressed in isolated cell preparations enriched for spermatogonia but expressed at lower levels in those enriched for pachytene spermatocytes and round spermatids. Co-labelling experiments with PLZF and c-KIT showed that ESRP1 was localized to nuclei of both Type A and B spermatogonia in a speckled pattern, but was not detected in SOX9(+) somatic Sertoli cells. No co-localization with the nuclear speckle marker, SC35, which has been associated with post-transcriptional splicing, was observed, suggesting that ESRP1 may be associated with co-transcriptional splicing or have other functions. RNA interference mediated knockdown of Esrp1 expression in the seminoma-derived Tcam-2 cell line demonstrated that ESRP1 regulates alternative splicing of mRNAs in a non-epithelial cell germ cell tumour cell line.	[Saeidi, Shaghayegh; Shapouri, Farnaz; de Iongh, Robb U.; Casagranda, Franca; Hime, Gary R.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic, Australia; [Sutherland, Jessie M.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia; [Western, Patrick S.] Monash Univ, Hudson Inst Med Res, Ctr Genet Dis, Clayton, Vic, Australia; [Western, Patrick S.] Monash Univ, Dept Mol & Translat Sci, Clayton, Vic, Australia; [McLaughlin, Eileen A.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia; [McLaughlin, Eileen A.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Familari, Mary] Univ Melbourne, Sch Biosci, Parkville, Vic, Australia	University of Melbourne; University of Newcastle; Hudson Institute of Medical Research; Monash University; Monash University; University of Newcastle; University of Auckland; University of Melbourne	Hime, GR (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic, Australia.	g.hime@unimelb.edu.au	De Iongh, Robb U/H-9646-2019; McLaughlin, Eileen A/G-7620-2013; McLaughlin, Eileen/AAF-5588-2021; Hime, Gary/B-7162-2015	De Iongh, Robb U/0000-0001-7013-1610; Western, Patrick/0000-0002-7587-8227; McLaughlin, Eileen/0000-0002-5837-3876; Hime, Gary/0000-0003-4732-3184; Sutherland, Jessie/0000-0001-9672-2371; Familari, Mary/0000-0002-2275-9582	School of Biosciences, University of Melbourne; Australian Research Council Discovery Project [DP170102379]	School of Biosciences, University of Melbourne; Australian Research Council Discovery Project(Australian Research Council)	These studies were supported by funds provided to MF by the School of Biosciences, University of Melbourne and by an Australian Research Council Discovery Project Grant DP170102379 to GH.	Baleato RM, 2005, DEV BIOL, V286, P78, DOI 10.1016/j.ydbio.2005.07.009; Bao JQ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004825; BELLVE AR, 1977, J HISTOCHEM CYTOCHEM, V25, P480, DOI 10.1177/25.7.893996; Bettegowda A, 2010, PHILOS T R SOC B, V365, P1637, DOI 10.1098/rstb.2009.0196; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Cieply B, 2016, CELL REP, V15, P247, DOI 10.1016/j.celrep.2016.03.025; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Elliott DJ, 2006, REPRODUCTION, V132, P811, DOI 10.1530/REP-06-0147; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; FU XD, 1993, NATURE, V365, P82, DOI 10.1038/365082a0; Gan QA, 2010, CELL RES, V20, P763, DOI 10.1038/cr.2010.64; Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998; Golestaneh N, 2009, STEM CELLS DEV, V18, P1115, DOI 10.1089/scd.2008.0347; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Iwamori N, 2016, P NATL ACAD SCI USA, V113, pE5408, DOI 10.1073/pnas.1611995113; Izadyar F, 2008, REPRODUCTION, V135, P771, DOI 10.1530/REP-07-0479; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P681, DOI 10.1095/biolreprod.107.066068; Kossack N, 2009, STEM CELLS, V27, P138, DOI 10.1634/stemcells.2008-0439; Kuijk EW, 2011, HUM REPROD UPDATE, V17, P254, DOI 10.1093/humupd/dmq035; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li Shengqiang, 2014, J Reprod Infertil, V15, P122; Margolin G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-39; McIver SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035553; Meyer S, 2010, MOL HUM REPROD, V16, P846, DOI 10.1093/molehr/gaq060; Miyake H, 1998, AM J PATHOL, V152, P1157; Mizuno Y, 1993, Nihon Hinyokika Gakkai Zasshi, V84, P1211; O'Bryan MK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003628; Ortiz MA, 2014, G3-GENES GENOM GENET, V4, P1765, DOI 10.1534/g3.114.012351; Paronetto MP, 2011, NUCLEIC ACIDS RES, V39, P4961, DOI 10.1093/nar/gkr085; Sahebi M, 2016, GENE, V587, P107, DOI 10.1016/j.gene.2016.04.057; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schmid R, 2013, NUCLEIC ACIDS RES, V41, P10170, DOI 10.1093/nar/gkt811; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shapouri F, 2016, CELL TISSUE RES, V364, P443, DOI 10.1007/s00441-015-2328-z; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; van den Bergen JA, 2009, BIOL REPROD, V81, P362, DOI 10.1095/biolreprod.109.076224; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; White-Cooper H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002626; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Wrobel G, 2005, REPRODUCTION, V129, P1, DOI 10.1530/rep.1.00408; Young JC, 2011, INT J ANDROL, V34, pE204, DOI 10.1111/j.1365-2605.2011.01170.x	45	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190925	10.1371/journal.pone.0190925	http://dx.doi.org/10.1371/journal.pone.0190925			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324788	Green Published, gold			2022-12-26	WOS:000419952400073
J	Fard, MA; Suwan, Y; Moghimi, S; Geyman, LS; Chui, TY; Rosen, RB; Ritch, R				Fard, Masoud Aghsaei; Suwan, Yanin; Moghimi, Sasan; Geyman, Lawrence S.; Chui, Toco Y.; Rosen, Richard B.; Ritch, Robert			Pattern of peripapillary capillary density loss in ischemic optic neuropathy compared to that in primary open-angle glaucoma	PLOS ONE			English	Article							COHERENCE TOMOGRAPHY ANGIOGRAPHY; OCULAR BLOOD-FLOW; MICROVASCULAR DENSITY; VESSEL DENSITY; NERVE HEAD; SUSPECT; RETINA; EYES	Purpose Both non-arteritic anterior ischemic optic neuropathy (NAION) and primary open-angle glaucoma (POAG) damage retinal ganglion cell axons, which are perfused by the radial peripapillary capillaries. To evaluate the pattern of ischemia, we compared peripapillary capillary density (PCD) in NAION eyes to POAG eyes matched for visual field mean deviation and retinal nerve fiber layer thickness. Methods 31 chronic NAION (>6 months after the acute event) and unaffected fellow eyes (31 subjects), 42 moderate and severe POAG eyes (27 subjects), and 77 control eyes (46 healthy subjects) were imaged with a commercial optical coherence tomography angiography system (AngioVue, Avanti RTVue-XR, Optovue, CA) at two academic institutions. Two concentric circles of diameters 1.95mm (inner) and 3.45mm (outer) were manually placed on images centered on the optic nerve head, producing an annular region-of-interest. Image analysis with major vessel removal was performed using a custom program. Whole-image, whole-annulus, and sectoral PCDs were measured. Results Whole-image and whole-annulus PCDs in NAION and moderate and severe POAG eyes were significantly decreased compared to unaffected fellow eyes and control eyes (all P<0.001). Superior and temporal PCD values were affected more than other sectors in both NAION and POAG groups compared to control group. Whole-image and whole-annulus PCDs were not statistically different between NAION and POAG eyes (both P = 0.99). However, of all peripapillary sectors, the inferior sector PCD value was less affected in POAG eyes compared to NAION eyes (P = 0.001). Univariate analysis results also revealed a significant positive correlation between superior and inferior PCDs and corresponding RNFL thicknesses. The inferior sector correlation was greater in POAG than NAION eyes. Conclusion While the whole PCD values were not different in chronic NAION and POAG, the greater correlation of inferior PCD with corresponding RNFL sectors in POAG compared to NAION suggests greater susceptibility of the inferior radial peripapillary capillary in the pathogenesis of POAG.	[Fard, Masoud Aghsaei; Moghimi, Sasan] Univ Tehran Med Sci, Farabi Eye Hosp, Tehran, Iran; [Suwan, Yanin] Mahidol Univ, Ramathibodi Hosp, Dept Ophthalmol, Bangkok, Thailand; [Suwan, Yanin; Chui, Toco Y.; Rosen, Richard B.; Ritch, Robert] New York Eye & Ear Infirm Mt Sinai, Einhorn Clin Res Ctr, New York, NY 10003 USA; [Geyman, Lawrence S.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Tehran University of Medical Sciences; Mahidol University; New York Eye & Ear Infirmary of Mount Sinai; Icahn School of Medicine at Mount Sinai	Ritch, R (corresponding author), New York Eye & Ear Infirm Mt Sinai, Einhorn Clin Res Ctr, New York, NY 10003 USA.	ritchmd@earthlink.net	Aghsaei Fard, Masoud/D-4652-2011; Fard, Masoud Aghsaei/M-3530-2019	Ritch, Robert/0000-0002-9368-7547; Fard, Masoud Aghsaei/0000-0003-4005-2967; Chui, Toco YP/0000-0003-2060-3848	Ablon Family Research Fund of New York Glaucoma Research Institute, New York, NY	Ablon Family Research Fund of New York Glaucoma Research Institute, New York, NY	The Ablon Family Research Fund of New York Glaucoma Research Institute, New York, NY provided funding for this study. The sponsor or funding organization had no role in the design or conduct of this research.	Akagi T, 2016, AM J OPHTHALMOL, V168, P237, DOI 10.1016/j.ajo.2016.06.009; [Anonymous], WALSH HOYTS CLIN NEU; Bojikian KD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154691; Chen CL, 2017, JAMA OPHTHALMOL, V135, P461, DOI 10.1001/jamaophthalmol.2017.0261; Fard MA, 2016, INVEST OPHTH VIS SCI, V57, P1011, DOI 10.1167/iovs.15-18618; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Geyman LS, 2017, BRIT J OPHTHALMOL, V101, P1261, DOI 10.1136/bjophthalmol-2016-309642; Hata M, 2017, J NEURO-OPHTHALMOL, V37, P140, DOI 10.1097/WNO.0000000000000470; Hodapp E, 1993, CLIN DECISIONS GLAUC, P52; Jia YL, 2014, OPHTHALMOLOGY, V121, P1322, DOI 10.1016/j.ophtha.2014.01.021; Lee EJ, 2016, INVEST OPHTH VIS SCI, V57, P6265, DOI 10.1167/iovs.16-20287; Lin SC, 2007, OPHTHALMOLOGY, V114, P1937, DOI 10.1016/j.ophtha.2007.07.005; Liu CH, 2017, INVEST OPHTH VIS SCI, V58, P3350, DOI 10.1167/iovs.17-22021; Liu L, 2015, JAMA OPHTHALMOL, V133, P1045, DOI 10.1001/jamaophthalmol.2015.2225; Mammo Z, 2016, AM J OPHTHALMOL, V170, P41, DOI 10.1016/j.ajo.2016.07.015; Mayes E Wright, 2017, J NEUROOPHTHALMOL; Petrig BL, 1999, AM J OPHTHALMOL, V127, P413, DOI 10.1016/S0002-9394(98)00437-1; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; RADER J, 1994, AM J OPHTHALMOL, V117, P72, DOI 10.1016/S0002-9394(14)73017-X; Scripsema Nicole K, 2016, Invest Ophthalmol Vis Sci, V57, pOCT611, DOI 10.1167/iovs.15-18945; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Yarmohammadi A, 2016, OPHTHALMOLOGY, V123, P2498, DOI 10.1016/j.ophtha.2016.08.041; Yarmohammadi A, 2016, INVEST OPHTH VIS SCI, V57, pOCT451, DOI 10.1167/iovs.15-18944; Yu PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135151	24	30	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0189237	10.1371/journal.pone.0189237	http://dx.doi.org/10.1371/journal.pone.0189237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320503	Green Submitted, Green Published, gold			2022-12-26	WOS:000419689600006
J	Tarigan, S; Wibowo, MH; Indriani, R; Sumarningsih, S; Artanto, S; Idris, S; Durr, PA; Asmara, W; Ebrahimie, E; Stevenson, MA; Ignjatovic, J				Tarigan, Simson; Wibowo, Michael Haryadi; Indriani, Risa; Sumarningsih, Sumarningsih; Artanto, Sidna; Idris, Syafrison; Durr, Peter A.; Asmara, Widya; Ebrahimie, Esmaeil; Stevenson, Mark A.; Ignjatovic, Jagoda			Field effectiveness of highly pathogenic avian influenza H5N1 vaccination in commercial layers in Indonesia	PLOS ONE			English	Article							VIRUS; CHICKENS; VACCINES; EFFICACY; POULTRY; TRANSMISSION; STRATEGIES; PROTECTION; CHALLENGE; IMMUNITY	Although vaccination of poultry for control of highly pathogenic avian influenza virus (HPAIV) H5N1 has been practiced during the last decade in several countries, its effectiveness under field conditions remains largely unquantified. Effective HPAI vaccination is however essential in preventing incursions, silent infections and generation of new H5N1 antigenic variants. The objective of this study was to asses the level and duration of vaccine induced immunity in commercial layers in Indonesia. Titres of H5N1 haemagglutination inhibition (HI) antibodies were followed in individual birds from sixteen flocks, age 18-68 week old (wo). The study revealed that H5N1 vaccination had highly variable outcome, including vaccination failures, and was largely ineffective in providing long lasting protective immunity. Flocks were vaccinated with seven different vaccines, administer at various times that could be grouped into three regimes: In regime A, flocks (n = 8) were vaccinated two or three times before 19 wo; in regime B (n = 2), two times before and once after 19 wo; and in regime C (n = 6) three to four times before and two to three times after 19 wo. HI titres in regime C birds were significantly higher during the entire observation period in comparison to titres of regime A or B birds, which also differed significantly from each other. The HI titres of individual birds in each flock differed significantly from birds in other flocks, indicating that the effectiveness of field vaccination was highly variable and farm related. Protective HI titres of >4log(2), were present in the majority of flocks at 18 wo, declined thereafter at variable rate and only two regime C flocks had protective HI titres at 68 wo. Laboratory challenge with HPAIV H5N1 of birds from regime A and C flocks confirmed that protective immunity differed significantly between flocks vaccinated by these two regimes. The study revealed that effectiveness of the currently applied H5N1 vaccination could be improved and measures to achieve this are discussed.	[Tarigan, Simson; Indriani, Risa; Sumarningsih, Sumarningsih] Indonesian Res Ctr Vet Sci, Bogor, Indonesia; [Wibowo, Michael Haryadi; Artanto, Sidna; Asmara, Widya] Univ Gadjah Mada, Fac Vet Sci, Yogyakarta, Indonesia; [Idris, Syafrison] Directorate Gen Livestock & Anim Hlth Serv, Jakarta, Indonesia; [Durr, Peter A.] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia; [Ebrahimie, Esmaeil] Univ South Australia, Sch Informat Technol & Math Sci, Div Informat Technol Engn & Environm, Adelaide, SA, Australia; [Stevenson, Mark A.; Ignjatovic, Jagoda] Univ Melbourne, Sch Vet & Agr Sci, Melbourne, Vic, Australia	Gadjah Mada University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of South Australia; University of Melbourne	Tarigan, S (corresponding author), Indonesian Res Ctr Vet Sci, Bogor, Indonesia.	sitariganta@gmail.com	Wibowo, Michael Haryadi/GVS-1580-2022; Ebrahimie, Esmaeil/AAN-2611-2020; Durr, Peter/O-2948-2014; Ebrahimi, Mansour/AAO-9096-2021	Ebrahimie, Esmaeil/0000-0002-4431-2861; Durr, Peter/0000-0003-0851-5300; Ebrahimi, Mansour/0000-0001-7011-2567; Tarigan, Simson/0000-0002-2024-1456	Australian Center for International Agricultural Research (ACIAR) [AH2010/039]	Australian Center for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res)	Financial support was provided by Australian Center for International Agricultural Research (ACIAR), WWW.aciar.gov.au, Grant No: AH2010/039, Author received the funding: JI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwhab EM, 2012, VET MICROBIOL, V155, P13, DOI 10.1016/j.vetmic.2011.08.004; Abdelwhab EM, 2011, VACCINE, V29, P6219, DOI 10.1016/j.vaccine.2011.06.090; Bates D, 1999, COMPUT SCI STAT, V31, P150; Bett B, 2015, TRANSBOUND EMERG DIS, V62, P163, DOI 10.1111/tbed.12101; Bouma A, 2008, REV SCI TECH OIE, V27, P633, DOI 10.20506/rst.27.3.1823; Bouma A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000281; Busani L, 2009, VACCINE, V27, P3655, DOI 10.1016/j.vaccine.2009.03.033; Capua I, 2007, REV SCI TECH OIE, V26, P217, DOI 10.20506/rst.26.1.1741; Dharmayanti NLPI, 2014, EMERG INFECT DIS, V20, P671, DOI 10.3201/eid2004.130517; Do Hwang S, 2011, VACCINE, V29, P2178, DOI 10.1016/j.vaccine.2010.12.013; Domenech J, 2009, REV SCI TECH OIE, V28, P293, DOI 10.20506/rst.28.1.1865; Durr PA, 2016, AVIAN DIS, V60, P183, DOI 10.1637/11134-050815-Reg; Ellis TM, 2004, AVIAN PATHOL, V33, P405, DOI 10.1080/03079450410001724012; Fouchier RAM, 2010, AVIAN DIS, V54, P220, DOI 10.1637/8740-032509-ResNote.1; Hartaningsih N, 2015, PREV VET MED, V120, P96, DOI 10.1016/j.prevetmed.2015.02.015; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Koel BF, 2014, MBIO, V5, P1, DOI DOI 10.1128/MBI0.01070-14; Kumar M, 2007, AVIAN DIS, V51, P481, DOI 10.1637/7605-041706R1.1; Lam TTY, 2012, MOL ECOL, V21, P3062, DOI 10.1111/j.1365-294X.2012.05577.x; MEULEMANS G, 1987, AVIAN DIS, V31, P560, DOI 10.2307/1590740; Mooney AJ, 2013, FUTURE VIROL, V8, P25, DOI 10.2217/FVL.12.122; OIE, 2008, AVIAN INFLUENZA MANU; Peyre M, 2009, EPIDEMIOL INFECT, V137, P1, DOI 10.1017/S0950268808001039; Poetri ON, 2009, VACCINE, V27, P2864, DOI 10.1016/j.vaccine.2009.02.085; Poetri ON, 2014, RES VET SCI, V97, P637, DOI 10.1016/j.rvsc.2014.09.013; Rudolf M, 2010, VACCINE, V28, P6832, DOI 10.1016/j.vaccine.2010.08.038; Sasaki T, 2009, VACCINE, V27, P5174, DOI 10.1016/j.vaccine.2009.06.070; Sims LD, 2007, AVIAN DIS, V51, P174, DOI 10.1637/7637-042806R.1; Siregar ES, 2007, DEV BIOLOGICALS, V130, P151; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; Spackman E, 2013, VIRUS RES, V178, P121, DOI 10.1016/j.virusres.2013.03.004; Swayne DE, 2011, REV SCI TECH OIE, V30, P839; Swayne DE, 2015, J VIROL, V89, P3746, DOI 10.1128/JVI.00025-15; Swayne DE, 2012, VACCINE, V30, P4964, DOI 10.1016/j.vaccine.2012.05.041; Swayne DE, 1999, AVIAN PATHOL, V28, P245, DOI 10.1080/03079459994731; Swayne DE, 2001, AVIAN DIS, V45, P355, DOI 10.2307/1592975; Takano R, 2009, VIROLOGY, V390, P13, DOI 10.1016/j.virol.2009.04.024; Tarigan S, 2015, AVIAN PATHOL, V44, P259, DOI 10.1080/03079457.2015.1042428; van den Berg T, 2008, COMP IMMUNOL MICROB, V31, P121, DOI 10.1016/j.cimid.2007.07.004; Veits J, 2008, VACCINE, V26, P1688, DOI 10.1016/j.vaccine.2008.01.016; Wang J, 2008, J VIROL, V82, P3405, DOI 10.1128/JVI.02468-07; Yupiana Y, 2010, INT J INFECT DIS, V14, pE800, DOI 10.1016/j.ijid.2010.03.014	43	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190947	10.1371/journal.pone.0190947	http://dx.doi.org/10.1371/journal.pone.0190947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320563	Green Published, gold, Green Accepted			2022-12-26	WOS:000419689600074
J	Voldby, C; Green, K; Rosthoj, S; Kongstad, T; Philipsen, L; Buchvald, F; Skov, M; Pressler, T; Gustafsson, P; Nielsen, KG				Voldby, Christian; Green, Kent; Rosthoj, Susanne; Kongstad, Thomas; Philipsen, Lue; Buchvald, Frederik; Skov, Marianne; Pressler, Tania; Gustafsson, Per; Nielsen, Kim G.			The effect of time-of-day and chest physiotherapy on multiple breath washout measures in children with clinically stable cystic fibrosis	PLOS ONE			English	Article							POSITIVE EXPIRATORY PRESSURE; INERT-GAS WASHOUT; LUNG CLEARANCE INDEX; PULMONARY-FUNCTION; DISEASE; SPIROMETRY; STANDARDIZATION; EXACERBATIONS; DRAINAGE; VOLUMES	Background In this pilot study we investigated daytime variation of multiple breath nitrogen washout (N2MBW) measures in children with clinically stable cystic fibrosis. To our knowledge the effect of time-of-day on multiple breath washout measures in patients with cystic fibrosis has not previously been reported. Furthermore, we assessed the influence of chest physiotherapy on N2MBW measures. Methods Ten school children with cystic fibrosis performed N2MBW followed by spirometry and plethysmography in the morning and afternoon at three visits that were one month apart. Chest physiotherapy was performed immediately before the afternoon measurements at visit 2 and immediately before morning and afternoon measurements at visit 3. The influence of time-of-day and chest physiotherapy on the measures was evaluated using linear mixed models. Results There were adequate quality data from 8 children with median age (range) 9.6 (6.0; 15.1) years. Baseline lung clearance index (LCI) (range) was 9.0 (7.1; 13.0) and baseline FEV1% predicted was 97.5 (78.5; 117.9). No N2MBW measures were significantly influenced by time-of-day or chest physiotherapy. LCI (95% confidence interval) decreased non-significantly 0.05 (-0.32; 0.22) during the day and increased non-significantly 0.08 (-0.26; 0.42) after chest physiotherapy. All spirometric measures were unaffected by time-of-day and chest physiotherapy. For plethysmographic measures FRCpleth decreased significantly (p<0.01) 110 mL during the day, whereas a borderline significant (p = 0.046) decrease in Delta FRCpleth-MBW during the day and a borderline significant (p = 0.03) increase in TLC after CPT were observed. Conclusion This study demonstrated that the time-of-day as well as chest physiotherapy performed immediately prior to N2MBW had no consistent or significant influence on N2MBW measures. However, we emphasize that further studies of the effect of both daytime variation and the effect of chest physiotherapy on multiple breath washout measures are warranted.	[Voldby, Christian; Green, Kent; Kongstad, Thomas; Philipsen, Lue; Buchvald, Frederik; Skov, Marianne; Pressler, Tania; Nielsen, Kim G.] Univ Copenhagen, Paediat Pulm Serv, CF Ctr Copenhagen, Copenhagen, Denmark; [Green, Kent; Kongstad, Thomas] Univ Copenhagen, Womens & Childrens Hlth, Res Unit, Copenhagen, Denmark; [Rosthoj, Susanne] Univ Copenhagen, Fac Hlth Sci, Dept Biostat, Inst Publ Hlth, Copenhagen, Denmark; [Gustafsson, Per] Cent Hosp Skovde, Dept Paediat, Skovde, Sweden	University of Copenhagen; University of Copenhagen; University of Copenhagen	Voldby, C (corresponding author), Univ Copenhagen, Paediat Pulm Serv, CF Ctr Copenhagen, Copenhagen, Denmark.	christian_voldby@hotmail.com	Nielsen, KG/AAE-6575-2020	Nielsen, KG/0000-0001-5906-9449; Rosthoj, Susanne/0000-0002-3619-413X	John & Birthe Meyer Foundation; Aase & Einar Danielsen Foundation	John & Birthe Meyer Foundation; Aase & Einar Danielsen Foundation	This study was funded by the John & Birthe Meyer Foundation (no available URL) and Aase & Einar Danielsen Foundation (URL: http://www.danielsensfond.dk/Default.aspx). There are no available grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2016, RESP MED, V112, P59, DOI 10.1016/j.rmed.2016.01.020; BATEMAN JRM, 1978, CLIN SCI MOL MED, V55, P523, DOI 10.1042/cs0550523; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRAGGION C, 1995, PEDIATR PULM, V19, P16, DOI 10.1002/ppul.1950190104; Fainardi Valentina, 2011, J Clin Med Res, V3, P279, DOI 10.4021/jocmr697w; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Fuchs SI, 2010, PEDIATR PULM, V45, P301, DOI 10.1002/ppul.21180; Grosse-Onnebrink J, 2017, CHEST PHYSIOTHERAPY, P1; Gustafsson PM, 2008, THORAX, V63, P129, DOI 10.1136/thx.2007.077784; Gustafsson PM, 2003, EUR RESPIR J, V22, P972, DOI 10.1183/09031936.03.00049502; HASANI A, 1993, THORAX, V48, P287, DOI 10.1136/thx.48.3.287; HOFMEYR JL, 1986, THORAX, V41, P951, DOI 10.1136/thx.41.12.951; Hortal MCR, 2014, RESP CARE, V59, P1537, DOI 10.4187/respcare.02823; Houltz B, 2012, EUR RESP J S56, V40, pP3797; Lannefors L, 2004, J ROY SOC MED, V97, P8; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MORTENSEN J, 1991, CHEST, V100, P1350, DOI 10.1378/chest.100.5.1350; Pfleger A, 2015, J CYST FIBROS, V14, P627, DOI 10.1016/j.jcf.2014.12.017; PFLEGER A, 1992, LUNG, V170, P323; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Robinson PD, 2013, EUR RESPIR J, V41, P507, DOI 10.1183/09031936.00069712; Robinson PD, 2009, RESPIRATION, V78, P339, DOI 10.1159/000225373; Ruppel GL, 2012, RESP CARE, V57, P26, DOI 10.4187/respcare.01374; Singer F, 2013, PEDIATR PULM, V48, P739, DOI 10.1002/ppul.22651; VANDERSCHANS CP, 1991, THORAX, V46, P252, DOI 10.1136/thx.46.4.252; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; WELLER PH, 1980, RESPIRATION, V40, P53, DOI 10.1159/000194251	27	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190894	10.1371/journal.pone.0190894	http://dx.doi.org/10.1371/journal.pone.0190894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320566	gold, Green Published, Green Submitted			2022-12-26	WOS:000419689600072
J	Cyronak, T; Andersson, AJ; Langdon, C; Albright, R; Bates, NR; Caldeira, K; Carlton, R; Corredor, JE; Dunbar, RB; Enochs, I; Erez, J; Eyre, BD; Gattuso, JP; Gledhill, D; Kayanne, H; Kline, DI; Koweek, DA; Lantz, C; Lazar, B; Manzello, D; McMahon, A; Melendez, M; Page, HN; Santos, IR; Schulz, KG; Shaw, E; Silverman, J; Suzuki, A; Teneva, L; Watanabe, A; Yamamoto, S				Cyronak, Tyler; Andersson, Andreas J.; Langdon, Chris; Albright, Rebecca; Bates, Nicholas R.; Caldeira, Ken; Carlton, Renee; Corredor, Jorge E.; Dunbar, Rob B.; Enochs, Ian; Erez, Jonathan; Eyre, Bradley D.; Gattuso, Jean-Pierre; Gledhill, Dwight; Kayanne, Hajime; Kline, David I.; Koweek, David A.; Lantz, Coulson; Lazar, Boaz; Manzello, Derek; McMahon, Ashly; Melendez, Melissa; Page, Heather N.; Santos, Isaac R.; Schulz, Kai G.; Shaw, Emily; Silverman, Jacob; Suzuki, Atsushi; Teneva, Lida; Watanabe, Atsushi; Yamamoto, Shoji			Taking the metabolic pulse of the world's coral reefs	PLOS ONE			English	Article							DISSOLVED INORGANIC CARBON; OCEAN ACIDIFICATION; TOTAL ALKALINITY; BARRIER-REEF; COMMUNITY METABOLISM; BUFFER CAPACITY; CLIMATE-CHANGE; SEAWATER; CALCIFICATION; CHEMISTRY	Worldwide, coral reef ecosystems are experiencing increasing pressure from a variety of anthropogenic perturbations including ocean warming and acidification, increased sedimentation, eutrophication, and overfishing, which could shift reefs to a condition of net calcium carbonate (CaCO3) dissolution and erosion. Herein, we determine the net calcification potential and the relative balance of net organic carbon metabolism (net community production; NCP) and net inorganic carbon metabolism (net community calcification; NCC) within 23 coral reef locations across the globe. In light of these results, we consider the suitability of using these two metrics developed from total alkalinity (TA) and dissolved inorganic carbon (DIC) measurements collected on different spatiotemporal scales to monitor coral reef biogeochemistry under anthropogenic change. All reefs in this study were net calcifying for the majority of observations as inferred from alkalinity depletion relative to offshore, although occasional observations of net dissolution occurred at most locations. However, reefs with lower net calcification potential (i.e., lower TA depletion) could shift towards net dissolution sooner than reefs with a higher potential. The percent influence of organic carbon fluxes on total changes in dissolved inorganic carbon (DIC) (i.e., NCP compared to the sum of NCP and NCC) ranged from 32% to 88% and reflected inherent biogeochemical differences between reefs. Reefs with the largest relative percentage of NCP experienced the largest variability in seawater pH for a given change in DIC, which is directly related to the reefs ability to elevate or suppress local pH relative to the open ocean. This work highlights the value of measuring coral reef carbonate chemistry when evaluating their susceptibility to ongoing global environmental change and offers a baseline from which to guide future conservation efforts aimed at preserving these valuable ecosystems.	[Cyronak, Tyler; Andersson, Andreas J.; Kline, David I.; Page, Heather N.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Langdon, Chris] Univ Miami, Rosential Sch Marine & Atmospher Sci, Miami, FL USA; [Albright, Rebecca; Caldeira, Ken] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA USA; [Bates, Nicholas R.] Bermuda Inst Ocean Sci, St Georges, Bermuda; [Bates, Nicholas R.] Univ Southampton, Southampton, Hants, England; [Carlton, Renee; Enochs, Ian; Manzello, Derek] NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA; [Carlton, Renee; Enochs, Ian] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Cooperat Inst Marine & Atmospher Studies, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Corredor, Jorge E.] Univ Puerto Rico, Dept Marine Sci, Mayaguez, PR 00709 USA; [Dunbar, Rob B.; Koweek, David A.; Teneva, Lida] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Erez, Jonathan; Lazar, Boaz] Hebrew Univ Jerusalem, Inst Earth Sci, Jerusalem, Israel; [Eyre, Bradley D.; Lantz, Coulson; Schulz, Kai G.] Southern Cross Univ, Ctr Coastal Biogeochem Res, Lismore, NSW, Australia; [Gattuso, Jean-Pierre] CNRS INSU, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Gattuso, Jean-Pierre] Univ Paris 06, UPMC, Sorbonne Univ, Observ Oceanolog, Villefranche Sur Mer, France; [Gattuso, Jean-Pierre] Inst Sustainable Dev & Int Relat, Paris, France; [Gledhill, Dwight] NOAA, Ocean Acidificat Program, Silver Spring, MD USA; [Kayanne, Hajime; Yamamoto, Shoji] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo, Japan; [Kline, David I.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [McMahon, Ashly; Santos, Isaac R.] Southern Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Melendez, Melissa] Univ New Hampshire, Sch Marine Sci & Ocean Engn, Durham, NH 03824 USA; [Shaw, Emily] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA; [Silverman, Jacob] Natl Inst Oceanog, Haifa, Israel; [Suzuki, Atsushi] Natl Inst Adv Ind Sci & Technol, Geol Survey Japan, Tsukuba, Ibaraki, Japan; [Teneva, Lida] Conservat Int, Ctr Oceans, Honolulu, HI USA; [Watanabe, Atsushi] Tokyo Inst Technol, Dept Mech & Environm Informat, Tokyo, Japan	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Miami; Carnegie Institution for Science; Bermuda Institute of Ocean Sciences; University of Southampton; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); University of Miami; University of Puerto Rico; University of Puerto Rico Mayaguez; Stanford University; Hebrew University of Jerusalem; Southern Cross University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; National Oceanic Atmospheric Admin (NOAA) - USA; University of Tokyo; Smithsonian Institution; Smithsonian Tropical Research Institute; Southern Cross University; University System Of New Hampshire; University of New Hampshire; California State University System; California State University Northridge; Israel Oceanographic & Limnological Research Institute; National Institute of Advanced Industrial Science & Technology (AIST); Conservation International; Tokyo Institute of Technology	Cyronak, T; Andersson, AJ (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	tcyronak@gmail.com; aandersson@ucsd.edu	Santos, Isaac R./A-3960-2019; Kayanne, Hajime/F-3025-2012; Page, Heather/AAP-4668-2021; Eyre, Bradley/C-2527-2013; Schulz, Kai/AEZ-9073-2022; Manzello, Derek P/A-8661-2014; Schulz, Kai G./Q-5608-2017; Langdon, Chris/A-1543-2016; Caldeira, Ken/E-7914-2011; Suzuki, Atsushi/L-6120-2018; Gattuso, Jean-Pierre/AAG-8643-2019	Santos, Isaac R./0000-0003-0524-842X; Kayanne, Hajime/0000-0002-6382-095X; Eyre, Bradley/0000-0001-5502-0680; Schulz, Kai/0000-0002-8481-4639; Manzello, Derek P/0000-0002-0720-3041; Schulz, Kai G./0000-0002-8481-4639; Langdon, Chris/0000-0002-3043-3806; Caldeira, Ken/0000-0002-4591-643X; Suzuki, Atsushi/0000-0002-0266-5765; Gattuso, Jean-Pierre/0000-0002-4533-4114; Silverman, Jacob/0000-0001-5910-1234; Lazar, Boaz/0000-0002-2304-8993; Dunbar, Robert/0000-0002-9728-5609; Cyronak, Tyler/0000-0003-3556-7616; Albright, Rebecca/0000-0003-3409-8766; Koweek, David/0000-0002-8846-6344; Kline, David/0000-0001-5128-9439; Lantz, Coulson/0000-0003-0901-7506	Scripps Postdoctoral Fellowship program; National Science Foundation [OCE 09-28406, OCE 12-55042]; Australian Research Council [DP150102092]; Nationale de la Recherche STORISK project [ANR15-CE03-0003-08]; Scripps Institution of Oceanography Postdoctoral Fellowship program; NSF [OCE 12-55042]; Directorate For Geosciences [1255042] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [15H02813] Funding Source: KAKEN	Scripps Postdoctoral Fellowship program; National Science Foundation(National Science Foundation (NSF)); Australian Research Council(Australian Research Council); Nationale de la Recherche STORISK project; Scripps Institution of Oceanography Postdoctoral Fellowship program; NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors acknowledge support from the Scripps Postdoctoral Fellowship program (TC) and National Science Foundation (OCE 09-28406, OCE 12-55042, AJA). BE and AJA had support from the Australian Research Council grant DP150102092. This is a contribution to the Agence Nationale de la Recherche STORISK project (ANR15-CE03-0003-08, J-PG).; The authors acknowledge funding support from the Scripps Institution of Oceanography Postdoctoral Fellowship program (TC) and NSF OCE 12-55042 (AJA). We thank two anonymous reviewers for their thoughtful comments.	Albright R, 2013, BIOGEOSCIENCES, V10, P6747, DOI 10.5194/bg-10-6747-2013; Albright R, 2015, GEOPHYS RES LETT, V42, P3980, DOI 10.1002/2015GL063488; Andersson AJ, 2014, NAT CLIM CHANGE, V4, P56, DOI 10.1038/NCLIMATE2050; Andersson AJ, 2013, ANNU REV MAR SCI, V5, P321, DOI 10.1146/annurev-marine-121211-172241; Anthony KRN, 2013, BIOGEOSCIENCES, V10, P4897, DOI 10.5194/bg-10-4897-2013; Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P3655, DOI 10.1111/j.1365-2486.2011.02510.x; Barkley HC, 2017, J EXP MAR BIOL ECOL, V489, P7, DOI 10.1016/j.jembe.2017.01.003; Bates NR, 2010, BIOGEOSCIENCES, V7, P2509, DOI 10.5194/bg-7-2509-2010; Bates NR, 2001, LIMNOL OCEANOGR, V46, P833, DOI 10.4319/lo.2001.46.4.0833; Beijbom O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130312; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Brewin RJW, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00351; Briggs EM, 2017, ACS SENSORS, V2, P1302, DOI 10.1021/acssensors.7b00305; Byrne RH, 2014, ENVIRON SCI TECHNOL, V48, P5352, DOI 10.1021/es405819p; Camp EF, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00052; Camp EF, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0442; Chan NCS, 2013, GLOBAL CHANGE BIOL, V19, P282, DOI 10.1111/gcb.12011; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Cohen AL, 2009, OCEANOGRAPHY, V22, P118, DOI 10.5670/oceanog.2009.102; Comeau S, 2014, MAR ECOL PROG SER, V501, P99, DOI 10.3354/meps10690; Cyronak T, 2013, GEOPHYS RES LETT, V40, P4876, DOI 10.1002/grl.50948; Cyronak T, 2013, BIOGEOSCIENCES, V10, P2467, DOI 10.5194/bg-10-2467-2013; Cyronak T, 2014, GEOPHYS RES LETT, V41, P5538, DOI 10.1002/2014GL060849; Cyronak T, 2014, GLOBAL BIOGEOCHEM CY, V28, P398, DOI 10.1002/2013GB004598; DEFFEYES KENNETH S., 1965, LIMNOL OCEANOGR, V10, P412; Dickson A.G., 2007, GUIDE BEST PRACTICES, V3; Dufault AM, 2012, P ROY SOC B-BIOL SCI, V279, P2951, DOI 10.1098/rspb.2011.2545; Edmunds PJ, 2016, BIOSCIENCE, V66, P350, DOI 10.1093/biosci/biw023; Enochs IC, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1742; Eyre BD, 2014, NAT CLIM CHANGE, V4, P969, DOI 10.1038/NCLIMATE2380; Falter JL, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007268; Gabrie C., 1985, P 5 INT COR REEF C T; Gattuso JP, 1996, MAR ECOL PROG SER, V145, P109, DOI 10.3354/meps145109; Gattuso JP, 1999, AM ZOOL, V39, P160; Glynn Peter W., 1997, P68; Gonzalez-Rivero M, 2014, AQUAT CONSERV, V24, P184, DOI 10.1002/aqc.2505; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jury CP, 2013, WATER-SUI, V5, P1303, DOI 10.3390/w5031303; Kawahata H, 2000, MAR CHEM, V72, P257, DOI 10.1016/S0304-4203(00)00085-2; Kawahata H, 1999, J OCEANOGR, V55, P731, DOI DOI 10.1023/A:1007872314591; KAYANNE H, 1995, SCIENCE, V269, P214, DOI 10.1126/science.269.5221.214; Kayanne H, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002400; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Kleypas JA, 2011, GLOBAL CHANGE BIOL, V17, P3667, DOI 10.1111/j.1365-2486.2011.02530.x; Kline DI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127648; Koweek D, 2015, CORAL REEFS, V34, P339, DOI 10.1007/s00338-014-1217-3; Koweek DA, 2015, CORAL REEFS, V34, P979, DOI 10.1007/s00338-015-1308-9; Lantz CA, 2014, CORAL REEFS, V33, P105, DOI 10.1007/s00338-013-1082-5; Lantz CA, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00298; Lebrato M, 2016, GLOBAL BIOGEOCHEM CY, V30, P1038, DOI 10.1002/2015GB005260; Manzello DP, 2008, P NATL ACAD SCI USA, V105, P10450, DOI 10.1073/pnas.0712167105; McMahon A, 2013, GEOPHYS RES LETT, V40, P4675, DOI 10.1002/grl.50802; MILLERO FJ, 1995, GEOCHIM COSMOCHIM AC, V59, P661, DOI 10.1016/0016-7037(94)00354-O; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Muehllehner N, 2016, GLOBAL BIOGEOCHEM CY, V30, P661, DOI 10.1002/2015GB005327; Page HN, 2016, CORAL REEFS, P1; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Rivest EB, 2017, CURR CLIM CHANGE REP, V3, P271, DOI 10.1007/s40641-017-0082-x; SCHMALZ RF, 1969, J SEDIMENT PETROL, V39, P255; Shamberger KEF, 2011, MAR CHEM, V127, P64, DOI 10.1016/j.marchem.2011.08.003; Shamberger KEF, 2014, GEOPHYS RES LETT, V41, P499, DOI 10.1002/2013GL058489; Shaw EC, 2015, LIMNOL OCEANOGR, V60, P777, DOI 10.1002/lno.10048; Shaw EC, 2013, GLOBAL CHANGE BIOL, V19, P1632, DOI 10.1111/gcb.12154; Shaw EC, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007655; Silverman J, 2014, GEOCHIM COSMOCHIM AC, V144, P72, DOI 10.1016/j.gca.2014.09.011; Silverman J, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001974; Silverman J, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003770; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; SMITH SV, 1974, PAC SCI, V28, P225; Suzuki A, 2003, TELLUS B, V55, P428, DOI 10.3402/tellusb.v55i2.16761; Teneva L, 2013, LIMNOL OCEANOGR, V58, P1851, DOI 10.4319/lo.2013.58.5.1851; Venti A, 2012, LIMNOL OCEANOGR-METH, V10, P1078, DOI 10.4319/lom.2012.10.1078; Watanabe A, 2006, LIMNOL OCEANOGR, V51, P1614, DOI 10.4319/lo.2006.51.4.1614; Wilkinson C, 2008, STATUS CORAL REEFS W; Yeakel KL, 2015, P NATL ACAD SCI USA, V112, P14512, DOI 10.1073/pnas.1507021112; Zeebe R.E., 2001, ELSEV OCEANOGR SERIE; Zhang Z., 2012, J GEOPHYS RES OCEANS, V117	80	69	69	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190872	10.1371/journal.pone.0190872	http://dx.doi.org/10.1371/journal.pone.0190872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315312	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000419655900030
J	Marshall, HH; Griffiths, DJ; Mwanguhya, F; Businge, R; Griffiths, AGF; Kyabulima, S; Mwesige, K; Sanderson, JL; Thompson, FJ; Vitikainen, EIK; Cant, MA				Marshall, Harry H.; Griffiths, David J.; Mwanguhya, Francis; Businge, Robert; Griffiths, Amber G. F.; Kyabulima, Solomon; Mwesige, Kenneth; Sanderson, Jennifer L.; Thompson, Faye J.; Vitikainen, Emma I. K.; Cant, Michael A.			Data collection and storage in long-term ecological and evolutionary studies: The Mongoose 2000 system	PLOS ONE			English	Article							BANDED MONGOOSES; CONSEQUENCES	Studying ecological and evolutionary processes in the natural world often requires research projects to follow multiple individuals in the wild over many years. These projects have provided significant advances but may also be hampered by needing to accurately and efficiently collect and store multiple streams of the data from multiple individuals concurrently. The increase in the availability and sophistication of portable computers (smartphones and tablets) and the applications that run on them has the potential to address many of these data collection and storage issues. In this paper we describe the challenges faced by one such long-term, individual-based research project: the Banded Mongoose Research Project in Uganda. We describe a system we have developed called Mongoose 2000 that utilises the potential of apps and portable computers to meet these challenges. We discuss the benefits and limitations of employing such a system in a long-term research project. The app and source code for the Mongoose 2000 system are freely available and we detail how it might be used to aid data collection and storage in other long-term individual-based projects.	[Marshall, Harry H.; Sanderson, Jennifer L.; Thompson, Faye J.; Vitikainen, Emma I. K.; Cant, Michael A.] Univ Exeter, Ctr Ecol & Conservat, Penryn Campus, Penryn, Cornwall, England; [Marshall, Harry H.] Univ Roehampton, Ctr Res Ecol Evolut & Behav, London, England; [Griffiths, David J.; Griffiths, Amber G. F.] FoAM Kernow, Jubilee Warehouse, Penryn, Cornwall, England; [Mwanguhya, Francis; Businge, Robert; Kyabulima, Solomon; Mwesige, Kenneth] Banded Mongoose Res Project, Queen Elizabeth Natl Pk, Rubirizi, Uganda; [Vitikainen, Emma I. K.] Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Exeter; Roehampton University; University of Helsinki	Marshall, HH (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn Campus, Penryn, Cornwall, England.; Marshall, HH (corresponding author), Univ Roehampton, Ctr Res Ecol Evolut & Behav, London, England.	harry.marshall@roehampton.ac.uk	Marshall, Harry/D-4945-2014; Vitikainen, Emma/F-2099-2010; Cant, Michael/B-1982-2009	Marshall, Harry/0000-0003-2120-243X; Vitikainen, Emma/0000-0003-3718-0941; Griffiths, Amber/0000-0002-7455-6795; Griffiths, David/0000-0003-1227-1695; Thompson, Faye/0000-0001-7581-2204; Cant, Michael/0000-0002-1530-3077	European Research Council Starting Grant [309249]; Natural Environment Research Council (UK) Standard Grant [NE/J010278/1]; NERC [NE/J010278/1] Funding Source: UKRI; Natural Environment Research Council [NE/J010278/1] Funding Source: researchfish	European Research Council Starting Grant(European Research Council (ERC)); Natural Environment Research Council (UK) Standard Grant; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by a European Research Council Starting Grant (309249) and Natural Environment Research Council (UK) Standard Grant (NE/J010278/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006968; Ahmed Z, 2015, F1000RESEARCH, V3, P311; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Bruna, 2012, B ECOL SOC AM, V93, P390; Cant Michael A., 2016, P318; Cant MA, 2013, ADV STUD BEHAV, V45, P407, DOI 10.1016/B978-0-12-407186-5.00006-9; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Koenig WD, 2016, COOPERATIVE BREEDING; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P745, DOI 10.1111/j.1442-9993.2011.02351.x; Marshall HH, 2017, ECOL EVOL, V7, P1712, DOI 10.1002/ece3.2747; Marshall HH, 2012, AM NAT, V180, P481, DOI 10.1086/667587; Nadkarni PM, 1999, J AM MED INFORM ASSN, V6, P478, DOI 10.1136/jamia.1999.0060478; ROOD J P, 1975, East African Wildlife Journal, V13, P89; ROOD JP, 1974, NATURE, V248, P176, DOI 10.1038/248176a0; Sanderson JL, 2014, FUNCT ECOL, V28, P1377, DOI 10.1111/1365-2435.12307; Snaddon J, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1029; Starr J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111433; Teacher AGF, 2013, ECOL EVOL, V3, P5268, DOI 10.1002/ece3.888; Thompson FJ, 2017, ANIM BEHAV, V126, P31, DOI 10.1016/j.anbehav.2017.01.017; Thompson FJ, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2607; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Vitikainen EIK, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2384; Vitikainen EIK, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00058; Willis KJ, 2007, PHILOS T R SOC B, V362, P175, DOI 10.1098/rstb.2006.1977; Young AJ, 2006, P NATL ACAD SCI USA, V103, P12005, DOI 10.1073/pnas.0510038103	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190740	10.1371/journal.pone.0190740	http://dx.doi.org/10.1371/journal.pone.0190740			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315317	gold, Green Published, Green Submitted			2022-12-26	WOS:000419655900021
J	Lloyd-Lewis, B; Krueger, CC; Sargeant, TJ; D'Angelo, ME; Deery, MJ; Feret, R; Howard, JA; Lilley, KS; Watson, CJ				Lloyd-Lewis, Bethan; Krueger, Caroline C.; Sargeant, Timothy J.; D'Angelo, Michael E.; Deery, Michael J.; Feret, Renata; Howard, Julie A.; Lilley, Kathryn S.; Watson, Christine J.			Stat3-mediated alterations in lysosomal membrane protein composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; MASS-SPECTROMETRY; FUNCTIONAL-CHARACTERIZATION; LATE ENDOSOMES; NPC2 PROTEIN; IN-VIVO; IDENTIFICATION; TRANSPORTER; ACID; TRAFFICKING	Lysosome function is essential in cellular homeostasis. In addition to its recycling role, the lysosome has recently been recognized as a cellular signaling hub. We have shown in mammary epithelial cells, both in vivo and in vitro, that signal transducer and activator of transcription 3 (Stat3) modulates lysosome biogenesis and can promote the release of lysosomal proteases that culminates in cell death. To further investigate the impact of Stat3 on lysosomal function, we conducted a proteomic screen of changes in lysosomal membrane protein components induced by Stat3 using an iron nanoparticle enrichment strategy. Our results show that Stat3 activation not only elevates the levels of known membrane proteins but results in the appearance of unexpected factors, including cell surface proteins such as annexins and flotillins. These data suggest that Stat3 may coordinately regulate endocytosis, intracellular trafficking, and lysosome biogenesis to drive lysosome-mediated cell death in mammary epithelial cells. The methodologies described in this study also provide significant improvements to current techniques used for the purification and analysis of the lysosomal proteome.	[Lloyd-Lewis, Bethan; Krueger, Caroline C.; D'Angelo, Michael E.; Watson, Christine J.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Sargeant, Timothy J.] South Australian Hlth & Med Res Inst, Lysosomal Dis Res Unit, Adelaide, SA 5000, Australia; [Deery, Michael J.; Feret, Renata; Howard, Julie A.; Lilley, Kathryn S.] Univ Cambridge, Dept Biochem, Cambridge Ctr Prote, Tennis Court Rd, Cambridge CB2 1QR, England; [Krueger, Caroline C.] Univ Bern, Bern Univ Hosp, Inselspital, Dept Immunol,Univ Clin Rheumatol Immunol & Allerg, CH-3010 Bern, Switzerland	University of Cambridge; South Australian Health & Medical Research Institute (SAHMRI); University of Cambridge; University of Bern; University Hospital of Bern	Watson, CJ (corresponding author), Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England.; Lloyd-Lewis, B (corresponding author), Inst Curie, Dept Genet & Dev Biol, Paris 05, France.	bethan.lloyd-lewis@curie.fr; cjw53@cam.ac.uk	Lilley, Kathryn/ABF-5787-2020; watson, Christine J/B-1431-2012; Sargeant, Timothy/K-8144-2018	Lilley, Kathryn/0000-0003-0594-6543; Sargeant, Timothy/0000-0003-1254-4390; Kruger, Caroline/0000-0002-2889-526X; Lloyd-Lewis, Bethan/0000-0001-6511-1818; D'Angelo, Michael/0000-0001-9342-0132	Medical Research Council [MR/J001023/1]; MRC [MR/J001023/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Grant MR/J001023/1 from the Medical Research Council (to C.J.W., B.L., M.E.D., and T.J.S.). All data supporting the findings of this study are available in the manuscript and its supporting data files and are available from the corresponding author upon request. The authors declare that they have no conflicts of interest with the contents of this article.	Abell K, 2005, NAT CELL BIOL, V7, P392, DOI 10.1038/ncb1242; Alvarez-Guaita A, 2015, BRIT J PHARMACOL, V172, P1677, DOI 10.1111/bph.13022; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Becken U, 2010, P NATL ACAD SCI USA, V107, P20726, DOI 10.1073/pnas.1007295107; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Broker LE, 2004, CANCER RES, V64, P27, DOI 10.1158/0008-5472.CAN-03-3060; Chapel A, 2013, MOL CELL PROTEOMICS, V12, P1572, DOI 10.1074/mcp.M112.021980; Chapuy B, 2009, HAEMATOL-HEMATOL J, V94, P1528, DOI 10.3324/haematol.2009.008631; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen FW, 2005, BIOCHEM J, V390, P549, DOI 10.1042/BJ20050236; Chikh K, 2004, MOL GENET METAB, V83, P220, DOI 10.1016/j.ymgme.2004.06.013; Christoforou A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms9992; Clarkson RWE, 2004, BREAST CANCER RES, V6, pR92, DOI 10.1186/bcr754; CORNILLON S, 1994, J CELL SCI, V107, P2691; Cox TM, 2012, J PATHOL, V226, P241, DOI 10.1002/path.3021; Demirel O, 2007, J BIOL CHEM, V282, P37836, DOI 10.1074/jbc.M708139200; Diettrich O, 1998, FEBS LETT, V441, P369, DOI 10.1016/S0014-5793(98)01578-6; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Falcon-Perez JM, 2007, EXP CELL RES, V313, P1473, DOI 10.1016/j.yexcr.2007.02.006; Fan XL, 2006, AM J HUM GENET, V79, P738, DOI 10.1086/508068; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Grewal T, 2016, BIOL CHEM, V397, P1031, DOI 10.1515/hsz-2016-0168; Hara-Nishimura I, 2011, CELL DEATH DIFFER, V18, P1298, DOI 10.1038/cdd.2011.70; HILDRETH J, 1986, BIOCHEM BIOPH RES CO, V139, P838, DOI 10.1016/S0006-291X(86)80066-3; Honscher C, 2014, DEV CELL, V30, P86, DOI 10.1016/j.devcel.2014.06.006; Hofmann D, 2014, ACS NANO, V8, P10077, DOI 10.1021/nn502754c; Hulsbusch N, 2015, EUR J CELL BIOL, V94, P531, DOI 10.1016/j.ejcb.2015.07.003; IMAI K, 1985, J BIOCHEM, V98, P1405, DOI 10.1093/oxfordjournals.jbchem.a135408; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Johnson DE, 2016, J CELL BIOL, V212, P677, DOI 10.1083/jcb.201507112; Kieffer-Jaquinod Sylvie, 2008, V432, P243, DOI 10.1007/978-1-59745-028-7_17; Kollmann K, 2005, PROTEOMICS, V5, P3966, DOI 10.1002/pmic.200401247; Kreuzaler P, 2012, NAT REV CANCER, V12, P411, DOI 10.1038/nrc3264; Kreuzaler PA, 2011, NAT CELL BIOL, V13, P303, DOI 10.1038/ncb2171; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kundra R, 1999, J BIOL CHEM, V274, P31039, DOI 10.1074/jbc.274.43.31039; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Lim CY, 2016, J CELL BIOL, V214, P653, DOI 10.1083/jcb.201607005; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Maltese WA, 2014, AM J PATHOL, V184, P1630, DOI 10.1016/j.ajpath.2014.02.028; Meister M, 2014, MEMBRANES-BASEL, V4, P356, DOI 10.3390/membranes4030356; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Miyaji T, 2011, J NEUROCHEM, V119, P1, DOI 10.1111/j.1471-4159.2011.07388.x; Nakamura H, 2012, MOL HUM REPROD, V18, P204, DOI 10.1093/molehr/gar070; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Otto GP, 2011, J CELL SCI, V124, P3933, DOI 10.1242/jcs.092015; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Pensa S, 2014, FEBS J, V281, P4557, DOI 10.1111/febs.13035; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; REICHMANN E, 1989, J CELL BIOL, V108, P1127, DOI 10.1083/jcb.108.3.1127; Resemann HK, 2014, MOL CELL ENDOCRINOL, V382, P603, DOI 10.1016/j.mce.2013.06.029; Rutsch F, 2009, NAT GENET, V41, P234, DOI 10.1038/ng.294; Saftig P, 2010, BIOCHEM SOC T, V38, P1420, DOI 10.1042/BST0381420; Sakata K, 2001, BIOCHEM J, V356, P53, DOI 10.1042/0264-6021:3560053; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sargeant TJ, 2014, NAT CELL BIOL, V16, P1057, DOI 10.1038/ncb3043; Schieweck O, 2009, BIOCHEM J, V422, P83, DOI 10.1042/BJ20090567; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt K, 2009, BIOCHEM BIOPH RES CO, V383, P198, DOI 10.1016/j.bbrc.2009.03.151; Schmidt S, 2009, AM J PHYSIOL-ENDOC M, V296, pE614, DOI 10.1152/ajpendo.91019.2008; Schroder B, 2007, TRAFFIC, V8, P1676, DOI 10.1111/j.1600-0854.2007.00643.x; Schroder BA, 2010, PROTEOMICS, V10, P4053, DOI 10.1002/pmic.201000196; Schroder J, 2009, MOL CELL BIOL, V29, P1083, DOI 10.1128/MCB.01163-08; Schwake M, 2013, TRAFFIC, V14, P739, DOI 10.1111/tra.12056; Shibata H, 2015, J BIOL CHEM, V290, P4981, DOI 10.1074/jbc.M114.592089; Sickmann A, 2002, IUBMB LIFE, V54, P51, DOI 10.1080/15216540214314; Siintola E, 2007, AM J HUM GENET, V81, P136, DOI 10.1086/518902; Sleat DE, 2008, J PROTEOME RES, V7, P3010, DOI 10.1021/pr800135v; Sleat DE, 2013, MOL CELL PROTEOMICS, V12, P1806, DOI 10.1074/mcp.M112.026179; Tabuchi M, 2000, J BIOL CHEM, V275, P22220, DOI 10.1074/jbc.M001478200; Tan KP, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.243; Tharkeshwar A. K., 2017, SCI REP, V7, P565; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; TULP A, 1993, ELECTROPHORESIS, V14, P1295, DOI 10.1002/elps.11501401198; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Ungewickell A, 2005, P NATL ACAD SCI USA, V102, P18854, DOI 10.1073/pnas.0509740102; Walker MW, 2015, METHOD CELL BIOL, V126, P21, DOI 10.1016/bs.mcb.2014.10.019; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Zeevi DA, 2007, BBA-MOL BASIS DIS, V1772, P851, DOI 10.1016/j.bbadis.2007.01.004	89	17	17	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 23	2018	293	12					4244	4261		10.1074/jbc.RA118.001777	http://dx.doi.org/10.1074/jbc.RA118.001777			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GA3CC	29343516	Green Published, hybrid			2022-12-26	WOS:000428204300002
J	Wong, YK; Wong, WW; Lui, KFH; Wong, ACN				Wong, Yetta Kwailing; Wong, Wing Wah; Lui, Kelvin F. H.; Wong, Alan C. -N.			Revisiting facial resemblance in couples	PLOS ONE			English	Article							MARITAL SATISFACTION; PERSONALITY; ATTRACTIVENESS; PERCEPTION; SYMMETRY; FACES	It is widely believed that couples look alike. Consistently, previous research reported higher facial similarity for couples than non-couples, and that facial similarity predicts marital satisfaction. However, it is unclear if facial similarity in couples shown in previous studies was solely driven by extrinsic features like hairstyle, glasses, etc. Also unclear is what attributes are perceived as similar from the faces of a couple. In three experiments, we showed that faces were considered more similar in couples than non-couples even without extrinsic features. Personality and age perceived from faces were also more similar in couples. Importantly, by matching pairs of faces according to their perceived personality, we found that a higher similarity in the perceived personality of a face pair led to higher facial similarity and couple likelihood ratings. These findings suggest that, instead of a result of pure physical analyses, facial similarity in couples is partly based on active social cognitive judgments on perceived personality, which may reveal the actual personality of the couples and thus inform relationship quality.	[Wong, Yetta Kwailing] Chinese Univ Hong Kong, Fac Educ, Dept Educ Psychol, Shatin, Hong Kong, Peoples R China; [Wong, Wing Wah] City Univ Hong Kong, Dept Appl Social Sci, Kowloon Tong, Hong Kong, Peoples R China; [Lui, Kelvin F. H.; Wong, Alan C. -N.] Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; City University of Hong Kong; Chinese University of Hong Kong	Wong, YK (corresponding author), Chinese Univ Hong Kong, Fac Educ, Dept Educ Psychol, Shatin, Hong Kong, Peoples R China.; Wong, ACN (corresponding author), Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China.	yetta.wong@gmail.com; alanwong@cuhk.edu.hk	Wong, Alan C.-N./H-3414-2019; Lui, Kelvin Fai Hong/AAX-9734-2020	Wong, Alan C.-N./0000-0002-2129-3485; Lui, Kelvin Fai Hong/0000-0003-4818-3136	Department of Applied Social Sciences of City University of Hong Kong; Department of Psychology of the Chinese University of Hong Kong	Department of Applied Social Sciences of City University of Hong Kong; Department of Psychology of the Chinese University of Hong Kong	The study was funded by internal funding of the Department of Applied Social Sciences of City University of Hong Kong to YKW and WWW, and by internal funding of the Department of Psychology of the Chinese University of Hong Kong to AW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez L, 2004, EVOLUTIONARY PSYCHOL, V2, P177, DOI DOI 10.1177/1474704904002001223; Botwin MD, 1997, J PERS, V65, P107, DOI 10.1111/j.1467-6494.1997.tb00531.x; Burriss RP, 2011, PERS SOC PSYCHOL B, V37, P601, DOI 10.1177/0146167211399584; FEINGOLD A, 1988, PSYCHOL BULL, V104, P226, DOI 10.1037/0033-2909.104.2.226; Freeman JB, 2016, TRENDS COGN SCI, V20, P362, DOI 10.1016/j.tics.2016.03.003; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; GRIFFITHS RW, 1973, SOC BIOL, V20, P448, DOI 10.1080/19485565.1973.9988075; Hassin R, 2000, J PERS SOC PSYCHOL, V78, P837, DOI 10.1037/0022-3514.78.5.837; HINSZ VB, 1989, J SOC PERS RELAT, V6, P223, DOI 10.1177/026540758900600205; Honekopp J, 2004, HUM NATURE-INT BIOS, V15, P147, DOI 10.1007/s12110-004-1018-4; KELLY EL, 1987, J PERS SOC PSYCHOL, V52, P27, DOI 10.1037/0022-3514.52.1.27; Little AC, 2006, PERS INDIV DIFFER, V40, P973, DOI 10.1016/j.paid.2005.09.016; Little AC, 2007, BRIT J PSYCHOL, V98, P111, DOI 10.1348/000712606X109648; Little AC, 2006, PERS INDIV DIFFER, V41, P1107, DOI 10.1016/j.paid.2006.04.015; MCCRAE RR, 1987, J PERS SOC PSYCHOL, V52, P81, DOI 10.1037/0022-3514.52.1.81; OToole AJ, 1997, PERCEPTION, V26, P719, DOI 10.1068/p260719; SPUHLER JN, 1968, EUGEN QUART, V15, P128, DOI 10.1080/19485565.1968.9987763; THIESSEN D, 1980, ETHOL SOCIOBIOL, V1, P111, DOI 10.1016/0162-3095(80)90003-5; ZAJONC RB, 1987, MOTIV EMOTION, V11, P335, DOI 10.1007/BF00992848	19	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191456	10.1371/journal.pone.0191456	http://dx.doi.org/10.1371/journal.pone.0191456			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS9PC	29346428	Green Published, gold, Green Submitted			2022-12-26	WOS:000422749500053
J	Szabo, E; Turk, D; Telbisz, A; Kucsma, N; Horvath, T; Szakacs, G; Homolya, L; Sarkadi, B; Varady, G				Szabo, Edit; Tuerk, Dora; Telbisz, Agnes; Kucsma, Nora; Horvath, Tamas; Szakacs, Gergely; Homolya, Laszlo; Sarkadi, Balazs; Varady, Gyoergy			A new fluorescent dye accumulation assay for parallel measurements of the ABCG2, ABCB1 and ABCC1 multidrug transporter functions	PLOS ONE			English	Article							SIDE POPULATION; P-GLYCOPROTEIN; RESISTANCE; MODIFY; CELLS	ABC multidrug transporters are key players in cancer multidrug resistance and in general xenobiotic elimination, thus their functional assays provide important tools for research and diagnostic applications. In this study we have examined the potential interactions of three key human ABC multidrug transporters with PhenGreen diacetate (PGD), a cell permeable fluorescent metal ion indicator. The non-fluorescent, hydrophobic PGD rapidly enters the cells and, after cleavage by cellular esterases, in the absence of quenching metal ions, PhenGreen (PG) becomes highly fluorescent. We found that in cells expressing functional ABCG2, ABCB1, or ABCC1 transporters, cellular PG fluorescence is strongly reduced. This fluorescence signal in the presence of specific transporter inhibitors is increased to the fluorescence levels in the control cells. Thus the PG accumulation assay is a new, unique tool for the parallel determination of the function of the ABCG2, ABCB1, and ABCC1 multidrug transporters. Since PG has very low cellular toxicity, the PG accumulation assay also allows the selection, separation and culturing of selected cell populations expressing either of these transporters.	[Szabo, Edit; Telbisz, Agnes; Kucsma, Nora; Horvath, Tamas; Szakacs, Gergely; Homolya, Laszlo; Sarkadi, Balazs; Varady, Gyoergy] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Tuerk, Dora] Natl Inst Oncol, Dept Expt Pharmacol, Budapest, Hungary; [Szakacs, Gergely] Med Univ Vienna, Inst Canc Res, Vienna, Austria; [Sarkadi, Balazs] Semmelweis Univ, Dept Biophys & Radiat Biol, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; National Institute of Oncology Hungary; Medical University of Vienna; Semmelweis University	Varady, G (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary.	varady.gyorgy@ttk.mta.hu	Homolya, Laszlo/N-1154-2016; György, Várady/J-8118-2017; Szakacs, Gergely/A-2580-2009	Homolya, Laszlo/0000-0003-1639-8140; Szakacs, Gergely/0000-0002-9311-7827; Turk, Dora/0000-0003-1215-3453; Gyorgy, Varady/0000-0003-2012-9680; Szabo, Edit Zsuzsanna/0000-0002-0150-0926	National Research, Development and Innovation Fund (Hungary) [TET_13_DST-1-2013-0012, OTKA_K 115375, FIEK_16-1-2016-0005]; Momentum Program of the Hungarian Academy of Sciences [LP2012-025]	National Research, Development and Innovation Fund (Hungary); Momentum Program of the Hungarian Academy of Sciences	This research has been supported by the National Research, Development and Innovation Fund (Hungary) (grant numbers: TET_13_DST-1-2013-0012, to G.Sz, OTKA_K 115375 to B.S., and FIEK_16-1-2016-0005 to L.H. and B.S.), as well as by the Momentum Program of the Hungarian Academy of Sciences (LP2012-025).	Boesch M, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1652389; Boesch M, 2012, CYTOM PART A, V81A, P517, DOI 10.1002/cyto.a.22038; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Elkind NB, 2005, MULTIDRUG TRANSPORTE, P1770; Gorbunov NV, 2012, BIOMETALS, V25, P203, DOI 10.1007/s10534-011-9498-2; Hegedus C, 2009, ADV DRUG DELIVER REV, V61, P47, DOI 10.1016/j.addr.2008.09.007; Hollo Z, 1998, ANTICANCER RES, V18, P2981; HOMOLYA L, 1993, J BIOL CHEM, V268, P21493; Homolya L, 1996, BRIT J CANCER, V73, P849, DOI 10.1038/bjc.1996.151; Homolya L, 2011, BBA-BIOMEMBRANES, V1808, P154, DOI 10.1016/j.bbamem.2010.07.031; Horsey AJ, 2016, BIOCHEM SOC T, V44, P824, DOI 10.1042/BST20160014; Illing AC, 2012, J BIOL CHEM, V287, P30485, DOI 10.1074/jbc.M112.364208; Karaszi E, 2001, BRIT J HAEMATOL, V112, P308, DOI 10.1046/j.1365-2141.2001.02554.x; Kovacik J, 2014, PLANT PHYSIOL BIOCH, V80, P33, DOI 10.1016/j.plaphy.2014.03.015; Laszlo L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164426; Lebedeva IV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022429; Ma YM, 2015, METALLOMICS, V7, P212, DOI 10.1039/c4mt00214h; Mathew G, 2009, CELL CYCLE, V8, P1053, DOI 10.4161/cc.8.7.8043; Morisaki K, 2005, CANCER CHEMOTH PHARM, V56, P161, DOI 10.1007/s00280-004-0931-x; Nerada Z, 2016, CYTOM A; Ozvegy-Laczka C, 2005, J BIOL CHEM, V280, P4219, DOI 10.1074/jbc.M411338200; Robey RW, 2011, CURR PHARM BIOTECHNO, V12, P595; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; She JJ, 2008, CANCER BIOL THER, V7, P1663, DOI 10.4161/cbt.7.10.6637; Strouse JJ, 2013, ANAL BIOCHEM, V437, P77, DOI 10.1016/j.ab.2013.02.018; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; Taylor NMI, 2017, NATURE, V546, P504, DOI 10.1038/nature22345; Telford WG, 2007, STEM CELLS, V25, P1029, DOI 10.1634/stemcells.2006-0567; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	31	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190629	10.1371/journal.pone.0190629	http://dx.doi.org/10.1371/journal.pone.0190629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342177	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000422653800027
J	Wedell-Neergaard, AS; Eriksen, L; Gronbaek, M; Pedersen, BK; Krogh-Madsen, R; Tolstrup, J				Wedell-Neergaard, Anne-Sophie; Eriksen, Louise; Gronbaek, Morten; Pedersen, Bente Klarlund; Krogh-Madsen, Rikke; Tolstrup, Janne			Low fitness is associated with abdominal adiposity and low-grade inflammation independent of BMI	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIORESPIRATORY FITNESS; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; BREAST-CANCER; NORMAL-WEIGHT; RISK; OBESITY; MORTALITY; FAT	Objective Up to 30% of obese individuals are metabolically healthy. Metabolically healthy obese (MHO) individuals are characterized by having low abdominal adiposity, low inflammation level and low risk of developing metabolic comorbidity. In this study, we hypothesize that cardiorespiratory fitness (fitness) is a determinant factor for the MHO individuals and aim to investigate the associations between fitness, abdominal adiposity and low-grade inflammation within different BMI categories. Method Data from 10,976 individuals from the general population, DANHES 2007-2008, on waist circumference, fitness and C-reactive protein (hsCRP) were analysed using multiple linear and median quantile regressions. Results In men, an inverse association between fitness (+5 mL min(-1) kg(-1)) and waist circumference (-1.45 cm; 95% CI: -1.55 to -1.35 cm; p<0.001), and an inverse association between fitness (+5 mL min(-1) kg(-1)) and hsCRP (-0.22 mg/L; 95% CI: -0.255 to -0.185 mg/L; p<0.001) was found, all independent of BMI. Similarly in women, an inverse association between fitness (+5 mL min(-1) kg(-1)) and waist circumference (-1.15 cm; 95% CI: -1.25 to -1.0 cm; p<0.001), and an inverse association between fitness (+5 mL min(-1) kg(-1)) and hsCRP (-0.26 mg/L; 95% CI: -0.3 to -0.22 mg/L; p<0.001) was found, all independent of BMI. Additionally, significant positive associations between waist circumference and hsCRP were found for both men and women, independently of BMI. Conclusion Fitness was found to be inversely associated with both abdominal adiposity and low-grade inflammation independent of BMI. These data suggest that, in spite of BMI, high fitness levels lead to a reduction in abdominal fat mass and low-grade inflammation.	[Wedell-Neergaard, Anne-Sophie; Pedersen, Bente Klarlund; Krogh-Madsen, Rikke] Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, Copenhagen, Denmark; [Wedell-Neergaard, Anne-Sophie; Pedersen, Bente Klarlund; Krogh-Madsen, Rikke] Univ Copenhagen, Rigshosp, Ctr Phys Act Res, Copenhagen, Denmark; [Eriksen, Louise; Gronbaek, Morten; Tolstrup, Janne] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Southern Denmark	Krogh-Madsen, R (corresponding author), Univ Copenhagen, Rigshosp, Ctr Inflammat & Metab, Copenhagen, Denmark.; Krogh-Madsen, R (corresponding author), Univ Copenhagen, Rigshosp, Ctr Phys Act Res, Copenhagen, Denmark.	krogh-madsen@inflammation-metabolism.dk	Pedersen, Bente Klarlund/AGR-3217-2022; Stefanadis, Christodoulos/ABH-2232-2020	Pedersen, Bente Klarlund/0000-0001-6508-6288; Stefanadis, Christodoulos/0000-0001-5974-6454; Wedell-Neergaard, Anne-Sophie/0000-0001-9316-0748; Gronbaek, Morten Klocker/0000-0002-8473-6474; Krogh-Madsen, Rikke/0000-0003-4914-2715; Tolstrup, Janne/0000-0002-9796-3967	TrygFonden; Centre of Inflammation and Metabolism (CIM); Danish National Research Foundation [DNRF55]; Danish Council for Strategic Research [09-067009, 09-075724]	TrygFonden; Centre of Inflammation and Metabolism (CIM); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The Centre for Physical Activity Research (CFAS), supported by a grant from TrygFonden and The Centre of Inflammation and Metabolism (CIM), supported by a grant from the Danish National Research Foundation (DNRF55), executed this study. CIM is a member of DD2 - the Danish Centre for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09-075724). The Danish Ministry of Health and Prevention together with Trygfonden, Denmark, founded the DANHES 2007-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen L. B., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P318; Araujo JP, 2009, J CARD FAIL, V15, P256, DOI 10.1016/j.cardfail.2008.10.030; Aronson D, 2004, ATHEROSCLEROSIS, V176, P173, DOI 10.1016/j.atherosclerosis.2004.04.025; Belavy DL, 2014, INT J OBESITY, V38, P1478, DOI 10.1038/ijo.2014.26; Biolo G, 2005, J RENAL NUTR, V15, P49, DOI 10.1053/j.jrn.2004.09.009; Boonchaya-Anant P, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0441-1; Borg G, 1998, BORGS PERCEIVED EXER; Church TS, 2002, ARTERIOSCL THROM VAS, V22, P1869, DOI 10.1161/01.ATV.0000036611.77940.F8; Debette S, 2010, ANN NEUROL, V68, P136, DOI 10.1002/ana.22062; DeFina LF, 2013, ANN INTERN MED, V158, P162, DOI 10.7326/0003-4819-158-3-201302050-00005; Eriksen L, 2011, SCAND J PUBLIC HEALT, V39, P203, DOI 10.1177/1403494810393557; Farooq A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/497324; Forouhi NG, 2001, INT J OBESITY, V25, P1327, DOI 10.1038/sj.ijo.0801723; Fuentes E, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/136584; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Goedecke JH, 2014, MED SPORT SCI, V60, P82, DOI 10.1159/000357338; Groenwold RHH, 2013, CAN MED ASSOC J, V185, P401, DOI 10.1503/cmaj.120592; Haffner SM, 2007, AM J MED, V120, P10, DOI 10.1016/j.amjmed.2007.06.006; Harder-Iauridsen XNM, 2017, EFFECT ALTERNATE DAY, P230; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Janssen I, 2004, OBES RES, V12, P525, DOI 10.1038/oby.2004.60; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; KOENKER R., 2005, ECONOMETRIC SOC MONO, V38, DOI [10.1017/CBO9780511754098, DOI 10.1017/CBO9780511754098]; Kramer CK, 2013, ANN INTERN MED, V159, P758, DOI 10.7326/0003-4819-159-11-201312030-00008; Laukkanen JA, 2010, EUR J CANCER, V46, P355, DOI 10.1016/j.ejca.2009.07.013; Lavie CJ, 2011, J CARDIOPULM REHABIL, V31, P137, DOI 10.1097/HCR.0b013e3182122827; MYERS J, 1990, CIRCULATION, V82, P1839, DOI 10.1161/01.CIR.82.5.1839; Oliveros E, 2014, PROG CARDIOVASC DIS, V56, P426, DOI 10.1016/j.pcad.2013.10.003; Olsen RH, 2008, JAMA-J AM MED ASSOC, V299, P1261, DOI 10.1001/jama.299.11.1259; Panagiotakos DB, 2005, ATHEROSCLEROSIS, V183, P308, DOI 10.1016/j.atherosclerosis.2005.03.010; Peel JB, 2009, MED SCI SPORT EXER, V41, P742, DOI 10.1249/MSS.0b013e31818edac7; Primeau V, 2011, INT J OBESITY, V35, P971, DOI 10.1038/ijo.2010.216; Ridker PM, 1998, CIRCULATION, V97, P425; Ross R, 2003, INT J OBESITY, V27, P204, DOI 10.1038/sj.ijo.802222; Sassen B, 2009, EUR J CARDIOV PREV R, V16, P677, DOI 10.1097/HJR.0b013e3283312e94; Shi H, 2009, PHYSIOL BEHAV, V97, P199, DOI 10.1016/j.physbeh.2009.02.017; SHINE B, 1981, CLIN CHIM ACTA, V117, P13, DOI 10.1016/0009-8981(81)90005-X; Shomaker LB, 2012, J ADOLESCENT HEALTH, V50, P87, DOI 10.1016/j.jadohealth.2011.05.015; Thompson PD, 2013, CURR SPORT MED REP, V12, P215, DOI 10.1249/JSR.0b013e31829a68cf; Vanhees L, 2005, EUR J CARDIOV PREV R, V12, P102, DOI 10.1097/00149831-200504000-00004; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Williams MJA, 2005, EUR J CARDIOV PREV R, V12, P216, DOI 10.1097/00149831-200506000-00005; Williams PT, 2001, MED SCI SPORT EXER, V33, P754, DOI 10.1097/00005768-200105000-00012; Wong SL, 2004, MED SCI SPORT EXER, V36, P286, DOI 10.1249/01.MSS.0000113665.40775.35; Xue F, 2007, AM J CLIN NUTR, V86, p823S, DOI 10.1093/ajcn/86.3.823S; Zaccardi F, 2015, ATHEROSCLEROSIS, V243, P131, DOI 10.1016/j.atherosclerosis.2015.09.016; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714; Zhao GC, 2005, FRONT BIOSCI-LANDMRK, V10, P2005, DOI 10.2741/1675	49	45	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190645	10.1371/journal.pone.0190645	http://dx.doi.org/10.1371/journal.pone.0190645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342196	Green Submitted, Green Published, gold			2022-12-26	WOS:000422653800029
J	Yamada, K; Mizukoshi, E; Seike, T; Horii, R; Kitahara, M; Sunagozaka, H; Arai, K; Yamashita, T; Honda, M; Kaneko, S				Yamada, Kazutoshi; Mizukoshi, Eishiro; Seike, Takuya; Horii, Rika; Kitahara, Masaaki; Sunagozaka, Hajime; Arai, Kuniaki; Yamashita, Tatsuya; Honda, Masao; Kaneko, Shuichi			Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease	PLOS ONE			English	Article							KILLER T-CELLS; DECREASED PREVALENCE; STEATOHEPATITIS; RISK; NAFLD; DIET; PROGRESSION; TOLERANCE; MECHANISM; CYTOKINES	Background & aims The modest consumption of alcohol has been reported to decrease the incidence of fatty liver or prevalence of steatohepatitis. In this study, we investigated the effect of light alcohol consumption on liver function and gene expression in patients with non-alcoholic fatty liver disease (NAFLD). Methods The study group was formed of 178 patients diagnosed with non-alcoholic fatty liver disease, subclassified into two groups for analysis based on the daily alcohol consumption: non-alcohol group and light alcohol consumer group (<20 g of ethanol/day). Clinical characteristics, liver histological features, gene expression, comprehensively analyzed using microarrays (BRB-Array tools), and molecular network were evaluated and compared between the two groups. Results No significant differences in steatosis or inflammation score were noted among the groups. However, the ballooning and fibrosis scores were significantly lower in the light alcohol consumer group than in the non-alcohol group. Gene expression analysis revealed a marked inhibition of the pathways involved in the immune response in the light alcohol group compared to that in the non-alcohol group. Conclusions Light alcohol consumption might suppress activity of non-alcoholic steatohepatitis by reducing gene expression levels involved in the immune response. This inhibition in gene expression was associated with a lowering of liver fibrosis and hepatocellular injury.	[Yamada, Kazutoshi; Mizukoshi, Eishiro; Seike, Takuya; Horii, Rika; Kitahara, Masaaki; Sunagozaka, Hajime; Arai, Kuniaki; Yamashita, Tatsuya; Honda, Masao; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan	Kanazawa University	Mizukoshi, E (corresponding author), Kanazawa Univ, Grad Sch Med, Dept Gastroenterol, Kanazawa, Ishikawa, Japan.	eishirom@m-kanazawa.jp	Yamashita, Tatsuya/K-8648-2015	Yamashita, Tatsuya/0000-0002-3602-8086; Seike, Takuya/0000-0002-4787-6910	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [26253046] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan. There was no additional external funding received for this study.	Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Dunn W, 2008, HEPATOLOGY, V47, P1947, DOI 10.1002/hep.22292; Dunn W, 2012, J HEPATOL, V57, P384, DOI 10.1016/j.jhep.2012.03.024; Gabele E, 2011, ALCOHOL CLIN EXP RES, V35, P1361, DOI 10.1111/j.1530-0277.2011.01472.x; Galli A, 2001, J BIOL CHEM, V276, P68, DOI 10.1074/jbc.M008791200; Hashimoto Y, 2015, J GASTROEN HEPATOL, V30, P546, DOI 10.1111/jgh.12786; Hellerbrand C, 2010, DIGEST DIS, V28, P783, DOI 10.1159/000324286; Honda M, 2006, HEPATOLOGY, V44, P1122, DOI 10.1002/hep.21383; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Jin CC, 2013, CELL METAB, V17, P873, DOI 10.1016/j.cmet.2013.05.011; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kwon HK, 2014, LIVER INT, V34, P129, DOI 10.1111/liv.12230; LIEBER CS, 1989, J CLIN INVEST, V83, P1682, DOI 10.1172/JCI114068; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Lu B, 2014, ARTHRITIS RHEUMATOL, V66, P1998, DOI 10.1002/art.38634; Miyake T, 2016, J GASTROENTEROL, V51, P1090, DOI 10.1007/s00535-016-1194-0; Muralidharan S, 2014, J IMMUNOL, V193, P1975, DOI 10.4049/jimmunol.1303468; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Rao R, 2009, HEPATOLOGY, V50, P638, DOI 10.1002/hep.23009; ROTILY M, 1990, EUR J CLIN NUTR, V44, P595; Sacco RL, 1999, JAMA-J AM MED ASSOC, V281, P53, DOI 10.1001/jama.281.1.53; Saha B, 2015, J IMMUNOL, V194, P3079, DOI 10.4049/jimmunol.1402190; Seitz HK, 2015, HEPATOBIL SURG NUTR, V4, P147, DOI 10.3978/j.issn.2304-3881.2014.12.01; Soderberg C, 2010, HEPATOLOGY, V51, P595, DOI 10.1002/hep.23314; Sookoian S, 2014, GUT, V63, P530, DOI 10.1136/gutjnl-2013-305718; Syn WK, 2010, HEPATOLOGY, V51, P1998, DOI 10.1002/hep.23599; Szabo G, 2015, GASTROENTEROLOGY, V148, P30, DOI 10.1053/j.gastro.2014.10.042; Tajiri K, 2009, EUR J GASTROEN HEPAT, V21, P673, DOI 10.1097/MEG.0b013e32831bc3d6; Tilg H, 2000, NEW ENGL J MED, V343, P1467, DOI 10.1056/NEJM200011163432007; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wakabayashi I, 2012, GERONTOLOGY, V58, P24, DOI 10.1159/000323080; Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342	33	22	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191026	10.1371/journal.pone.0191026	http://dx.doi.org/10.1371/journal.pone.0191026			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342182	Green Published, Green Submitted, gold			2022-12-26	WOS:000422653800041
J	Feindt, W; Oppenheim, SJ; DeSalle, R; Goldstein, PZ; Hadrys, H				Feindt, Wiebke; Oppenheim, Sara J.; DeSalle, Robert; Goldstein, Paul Z.; Hadrys, Heike			Transcriptome profiling with focus on potential key genes for wing development and evolution in Megaloprepus caerulatus, the damselfly species with the world's largest wings	PLOS ONE			English	Article							DE-NOVO TRANSCRIPTOME; DROSOPHILA-MELANOGASTER; HELICONIUS BUTTERFLIES; FUNCTIONAL ANNOTATION; EVO-DEVO; PROTEIN; BIOLOGY; DIVERSITY; DATABASE; ODONATA	The evolution, development and coloration of insect wings remains a puzzling subject in evolutionary research. In basal flying insects such as Odonata, genomic research regarding bauplan evolution is still rare. Here we focus on the world's largest odonate species-the "forest giant" Megaloprepus caerulatus, to explore its potential for looking deeper into the development and evolution of wings. A recently discovered cryptic species complex in this genus previously considered monotypic is characterized by morphological differences in wing shape and color patterns. As a first step toward understanding wing pattern divergence and pathways involved in adaptation and speciation at the genomic level, we present a transcriptome profiling of M. caerulatus using RNA-Seq and compare these data with two other odonate species. The de novo transcriptome assembly consists of 61,560 high quality transcripts and is approximately 93% complete. For almost 75% of the identified transcripts a possible function could be assigned: 48,104 transcripts had a hit to an InterPro protein family or domain, and 28,653 were mapped to a Gene Ontology term. In particular, we focused on genes related to wing development and coloration. The comparison with two other species revealed larva-specific genes and a conserved 'core' set of over 8,000 genes forming ortho-logous clusters with Ischnura elegans and Ladona fulva. This transcriptome may provide a first point of reference for future research in odonates addressing questions surrounding the evolution of wing development, wing coloration and their role in speciation.	[Feindt, Wiebke; Hadrys, Heike] Univ Vet Med Hannover, ITZ, Div Ecol & Evolut, Hannover, Germany; [Feindt, Wiebke] Leibniz Univ Hannover, Hannover, Germany; [Oppenheim, Sara J.; DeSalle, Robert; Hadrys, Heike] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Goldstein, Paul Z.] USDA ARS, Systemat Entomol Lab, Natl Museum Nat Hist, Washington, DC 20250 USA; [Hadrys, Heike] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	University of Veterinary Medicine Hannover, Foundation; Leibniz University Hannover; American Museum of Natural History (AMNH); Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Agriculture (USDA); Yale University	Feindt, W (corresponding author), Univ Vet Med Hannover, ITZ, Div Ecol & Evolut, Hannover, Germany.; Feindt, W (corresponding author), Leibniz Univ Hannover, Hannover, Germany.	wiebke.feindt@ecolevol.de	Oppenheim, Sara/A-4641-2014	Oppenheim, Sara/0000-0003-1109-3639	Annette Kade Graduate Student Fellowship Program of the RGGS at the American Museum of Natural History through generous contributions of the Annette Kade Charitable Trust; German Academic Exchange Service (DAAD); Lewis and Dorothy Cullman Program for Molecular Systematics; Korein Foundation; NSF [DBI-1307844]; DFG [HA-1947/6-1]; Deutsche Forschungsgemeinschaft; University of Veterinary Medicine Hannover, Foundation	Annette Kade Graduate Student Fellowship Program of the RGGS at the American Museum of Natural History through generous contributions of the Annette Kade Charitable Trust; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Lewis and Dorothy Cullman Program for Molecular Systematics; Korein Foundation; NSF(National Science Foundation (NSF)); DFG(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Veterinary Medicine Hannover, Foundation	This work was supported by the Annette Kade Graduate Student Fellowship Program of the RGGS at the American Museum of Natural History through generous contributions of the Annette Kade Charitable Trust given to WF. We are grateful for financial support from the German Academic Exchange Service (DAAD) and the Graduate Academy of the Leibniz University Hannover (WF). Further support was given by the Lewis and Dorothy Cullman Program for Molecular Systematics; the Korein Foundation; and NSF DBI-1307844 (SO). HH was supported by the DFG (HA-1947/6-1). This publication was also supported by Deutsche Forschungsgemeinschaft and University of Veterinary Medicine Hannover, Foundation within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Abouheif E, 2014, ADV EXP MED BIOL, V781, P107, DOI [10.1007/978-94-007-7347-9__6, 10.1007/978-94-007-7347-9_6]; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez M, 2015, MOL ECOL, V24, P710, DOI 10.1111/mec.13055; Andrews S., 2010, REFERENCE SOURCE; Ardila-Garcia AM, 2009, J ZOOL, V278, P163, DOI 10.1111/j.1469-7998.2009.00557.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berens AJ, 2015, MOL BIOL EVOL, V32, P690, DOI 10.1093/molbev/msu330; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boutet E, 2016, METHODS MOL BIOL, V1374, P23, DOI 10.1007/978-1-4939-3167-5_2; Bray S, 1999, CURR BIOL, V9, pR245, DOI 10.1016/S0960-9822(99)80154-7; Bybee S, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0176-7; Chauhan P, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3334-6; Chauhan P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-808; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Connahs H, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2586-5; Cordoba-Aguilar A, 2008, DRAGONFLIES AND DAMS; Engel Michael S., 2013, P269; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Feindt W, 2014, CONSERV GENET, V15, P469, DOI 10.1007/s10592-013-0554-z; Ferguson LC, 2011, DEV GENES EVOL, V221, P297, DOI 10.1007/s00427-011-0380-6; Fincke OM, 2008, STUD NEOTROP FAUNA E, V43, P35, DOI 10.1080/01650520701504597; Fincke Ola M., 1992, P102; Fincke OM, 1998, INSECT POPULATIONS IN THEORY AND IN PRACTICE, P391; Fincke OM, 2006, FOR DRAG 4 WDA INT S; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerstein MB, 2014, NATURE, V512, P445, DOI 10.1038/nature13424; Gilbert SF, 2015, NAT REV GENET, V16, P611, DOI 10.1038/nrg3982; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOCOLS, V8; Hadrys H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034682; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Herboso L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12383; Ioannidis P, 2017, GENOME BIOL EVOL, V9, P415, DOI 10.1093/gbe/evx006; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kronforst MR, 2015, GENETICS, V200, P1, DOI 10.1534/genetics.114.172387; Kronforst MR, 2012, PIGM CELL MELANOMA R, V25, P411, DOI 10.1111/j.1755-148X.2012.01014.x; Kubota K, 2000, DEVELOPMENT, V127, P3769; Lancaster LT, 2016, MOL ECOLOGY; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li B, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0553-5; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106770; Lyalin D, 2006, GENETICS, V172, P343, DOI 10.1534/genetics.105.049650; Massey JH, 2016, CURR TOP DEV BIOL, V119, P27, DOI 10.1016/bs.ctdb.2016.03.004; Medved V, 2015, P NATL ACAD SCI USA, V112, P15946, DOI 10.1073/pnas.1509517112; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Monteiro A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005529; Nishikawa H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03184; Oppenheim SJ, 2015, INSECT MOL BIOL, V24, P139, DOI 10.1111/imb.12154; Ou J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-820; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Punta M, 2011, NUCLEIC ACIDS RES; Racine JS, 2012, J APPL ECONOMET, V27, P167, DOI 10.1002/jae.1278; Reed RD, 2005, EVOL DEV, V7, P301, DOI 10.1111/j.1525-142X.2005.05036.x; Roux J, 2015, J EXP ZOOL PART B, V324, P372, DOI 10.1002/jez.b.22618; Selys Longchamps, 1860, B ACAD ROYALE SCI LE, V2, P9; Shanku AG, 2013, G3-GENES GENOM GENET, V3, P763, DOI 10.1534/g3.113.005637; Shimmi O, 2014, P R SOC B; Simao FA, 2015, BIOINFORMATICS, DOI DOI 10.1093/BIOINFORMATICS/BTV351; Simon S, 2017, SCI REPORTS, V7, P2045; Simon S, 2013, BIOESSYAS; Simon S, 2009, MOL BIOL EVOL, V26, P2719, DOI 10.1093/molbev/msp191; Sullivan KMC, 2000, P NATL ACAD SCI USA, V97, P5942, DOI 10.1073/pnas.110145997; Swarup S, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007930; Tomoyasu Y, 2005, NATURE, V433, P643, DOI 10.1038/nature03272; Tomoyasu Y, 2017, CURR OPIN INSECT SCI, V19, P8, DOI 10.1016/j.cois.2016.10.007; Tripp HJ, 2011, NUCLEIC ACIDS RES, V39, P8792, DOI 10.1093/nar/gkr576; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; van't Hof AE, 2016, NATURE, V534, P102, DOI 10.1038/nature17951; Wadi L, 2016, BIORXIV; Wang Y, 2015, EVID-BASED COMPL ALT, V2015, P1, DOI DOI 10.1016/J.MSEA.2015.01.021; Wheeler TJ, 2013, BIOINFORMATICS, V29, P2487, DOI 10.1093/bioinformatics/btt403; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Yan SJ, 2004, DEVELOPMENT, V131, P285, DOI 10.1242/dev.00934; Yang CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120833; Yanoviak SP, 2005, METH ECOL, P168, DOI 10.1002/9780470750513.ch8; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhao L, 2012, ISJ-INVERT SURVIV J, V9, P93; Zhong Yf, 2011, EVOL DEV, V13, pW78; Zhong YF, 2008, EVOL DEV, V10, P516, DOI 10.1111/j.1525-142X.2008.00266.x; Zhong YF, 2011, EVOL DEV, V13, P567, DOI 10.1111/j.1525-142X.2011.00513.x	85	1	1	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0189898	10.1371/journal.pone.0189898	http://dx.doi.org/10.1371/journal.pone.0189898			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329292	Green Published, Green Submitted, gold			2022-12-26	WOS:000419954100010
J	Su, YK; Wang, JH; Hsieh, SY; Liu, XZ; Lam, CF; Huang, SC				Su, Yi-Kai; Wang, Jen-Hung; Hsieh, Shiu-Ying; Liu, Xiu-Zhu; Lam, Chen-Fuh; Huang, Shian-Che			Incidence and risk factors for postoperative lingual neuropraxia following airway instrumentation: A retrospective matched case-control study	PLOS ONE			English	Article							NERVE INJURY; INTUBATION; COMPLICATION; SELECTION	Background Lingual nerve injury or neuropraxia is a rare but potentially serious perioperative complication following airway instrumentation during general anesthesia. This study explored the the incidence and perioperative risk factors for lingual nerve injury in patients receiving laryngeal mask (LMA) or endotracheal (ETGA) general anesthesia in a single center experience. Methods and results All surgical patients in our hospital who received LMA or ETGA from 2009 to 2013 were included, and potential perioperative risk factors were compared. Matched controls were randomly selected (in 1:5 ratio) from the same database in non-case patients. A total of 36 patients in the records had reported experiencing tongue numbness after anesthesia in this study. Compared with the non-case surgical population (n = 54314), patients with tongue numbness were significantly younger (52.2 +/- 19.5 vs 42.0 +/- 14.5; P = 0.002) and reported lower ASA physical statuses (2.3 +/- 0.7 vs 1.6 +/- 0.6; P<0.001). Patient gender, anesthesia technique used, and airway device type (LMA or ETGA) did not differ significantly across the two groups. A significantly higher proportion of patients underwent operations of the head-and-neck region (38.9 vs 15.6%; P = 0.002) developed tongue numbness after anesthesia. Multivariate logistic regression analysis indicated that head-and-neck operations remained the most significant independent risk factor for postoperative lingual nerve injury (AOR 7.63; 95% Cl 2.03-28.70). Conclusion The overall incidence rate of postoperative lingual neuropraxy was 0.066% in patients receiving general anesthesia with airway device in place. Young and generally healthy patients receiving head-and-neck operation are at higher risk in developing postoperative lingual neuropraxy. Attention should be particularly exercised to reduce the pressure of endotracheal tube or laryngeal mask on the tongue during head-and-neck operation to avert the occurrence of postoperative lingual neuropraxy.	[Su, Yi-Kai; Hsieh, Shiu-Ying; Liu, Xiu-Zhu; Lam, Chen-Fuh; Huang, Shian-Che] Buddhist Tzu Chi Gen Hosp, Dept Anesthesiol, Hualien, Taiwan; [Su, Yi-Kai; Hsieh, Shiu-Ying; Liu, Xiu-Zhu; Lam, Chen-Fuh; Huang, Shian-Che] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Wang, Jen-Hung] Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan; [Lam, Chen-Fuh] I Shou Univ, E Da Canc Hosp, E Da Hosp, Dept Anesthesiol, Kaohsiung, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; E-Da Hospital; I Shou University	Lam, CF; Huang, SC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Anesthesiol, Hualien, Taiwan.; Lam, CF; Huang, SC (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Lam, CF (corresponding author), I Shou Univ, E Da Canc Hosp, E Da Hosp, Dept Anesthesiol, Kaohsiung, Taiwan.	ed110208@edah.org.tw; e1380@tzuchi.com.tw			Ministry of Science and Technology of Taiwan [MOST 105-2314-B-303-007-MY2]; Buddhist Tzu Chi General Hospital, Taiwan [TC RD105-06]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Buddhist Tzu Chi General Hospital, Taiwan	This study was funded, in part, by the Ministry of Science and Technology of Taiwan (grant number MOST 105-2314-B-303-007-MY2) and the Buddhist Tzu Chi General Hospital, Taiwan (grant number TCRD105-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Eid R, 2012, AGE, V34, P651, DOI 10.1007/s11357-011-9261-1; Biglioli F, 2010, Minerva Stomatol, V59, P561; BRIMACOMBE J, 1993, ANAESTH INTENS CARE, V21, P107, DOI 10.1177/0310057X9302100127; Cardoso Hugo Eckener Dantas de Pereira, 2007, Rev. Bras. Anestesiol., V57, P410, DOI 10.1590/S0034-70942007000400009; Farrow S, 2012, ANAESTHESIA, V67, P815, DOI 10.1111/j.1365-2044.2012.07250.x; Foley E, 2010, IRISH J MED SCI, V179, P297, DOI 10.1007/s11845-009-0347-z; HEGTVEDT AK, 1990, J ORAL MAXIL SURG, V48, P647, DOI 10.1016/S0278-2391(10)80485-9; JONES BC, 1971, BRIT J ANAESTH, V43, P730; Kadry MA, 2001, EUR J ANAESTH, V18, P264, DOI 10.1046/j.0265-0215.2000.00838.x; Kihara S, 2003, ANESTH ANALG, V97, P280, DOI 10.1213/01.ANE.0000068824.86773.B0; Koyama Tomohiro, 2006, Masui, V55, P445; Mckenna Gerald, 2010, Dent Update, V37, P519; Pippi R, 2017, J ORAL MAXIL SURG, V75, P890, DOI 10.1016/j.joms.2016.12.040; Song JW, 2010, PLAST RECONSTR SURG, V126, P2234, DOI 10.1097/PRS.0b013e3181f44abc; Thiruvenkatarajan V, 2015, ANAESTHESIA, V70, P344, DOI 10.1111/anae.12917; Thiruvenkatarajan V, 2014, J CLIN ANESTH, V26, P65, DOI 10.1016/j.jclinane.2013.10.003; Ulusoy H, 2014, REV BRAS ANESTESIOL, V64, P124, DOI [10.1016/j.bjan.2012.12.003, 10.1016/j.bjane.2012.12.003]; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398	18	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190589	10.1371/journal.pone.0190589	http://dx.doi.org/10.1371/journal.pone.0190589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329350	gold, Green Submitted, Green Published			2022-12-26	WOS:000419954100017
J	Choi, JH; Shin, KC; Oh, DK				Choi, Ji-Hyeon; Shin, Kyung-Chul; Oh, Deok-Kun			An L213A variant of beta-glycosidase from Sulfolobus solfataricus with increased alpha-L-arabinofuranosidase activity converts ginsenoside Rc to compound K	PLOS ONE			English	Article							CALDICELLULOSIRUPTOR-SACCHAROLYTICUS; ENZYMATIC TRANSFORMATION; GLUCOSIDASE; RD; BIOCONVERSION; EXPRESSION; RB1; ACTIVATION; CLONING; RB-1	Compound K (C-K) is a crucial pharmaceutical and cosmetic component because of disease prevention and skin anti-aging effects. For industrial application of this active compound, the protopanaxadiol (PPD)-type ginsenosides should be transformed to C-K. beta-Glycosidase from Sulfolobus solfataricus has been reported as an efficient C-K-producing enzyme, using glycosylated PPD-type ginsenosides as substrates. beta-Glycosidase from S. solfataricus can hydrolyze beta-D-glucopyranoside in ginsenosides Rc, C-Mc(1), and C-Mc, but not a-L-arabinofuranoside in these ginsenosides. To determine candidate residues involved in a-L-arabinofuranosidase activity, compound Mc (C-Mc) was docking to beta-glycosidase from S. solfataricus in homology model and sequence was aligned with beta-glycosidase from Pyrococcus furiosus that has alpha-L-arabinofuranosidase activity. A L213A variant beta-glycosidase with increased alpha-L-arabinofuranosidase activity was selected by substitution of other amino acids for candidate residues. The increased alpha-L-arabinofuranosidase activity of the L213A variant was confirmed through the determination of substrate specificity, change in binding energy, transformation pathway, and C-K production from ginsenosides Rc and C-Mc. The L213A variant beta-glycosidase catalyzed the conversion of Rc to Rd by hydrolyzing a-L-arabinofuranoside linked to Rc, whereas the wild-type beta-glycosidase did not. The variant enzyme converted ginsenosides Rc and C-Mc into C-K with molar conversions of 97%, which were 1.5- and 2-fold higher, respectively, than those of the wild-type enzyme. Therefore, protein engineering is a useful tool for enhancing the hydrolytic activity on specific glycoside linked to ginsenosides.	[Choi, Ji-Hyeon; Shin, Kyung-Chul; Oh, Deok-Kun] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea	Konkuk University	Oh, DK (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea.	deokkun@konkuk.ac.kr	Shin, Kyung-Chul/E-9681-2017	Shin, Kyung-Chul/0000-0002-1527-0164	Rural Development Administration, Republic of Korea [PJ01222601]	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ01222601), Rural Development Administration, Republic of Korea.	Chen Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-24; Choo MK, 2003, PLANTA MED, V69, P518, DOI 10.1055/s-2003-40653; He DW, 2011, J FORMOS MED ASSOC, V110, P153, DOI 10.1016/S0929-6646(11)60025-9; Hu C, 2012, J CELL MOL MED, V16, P96, DOI 10.1111/j.1582-4934.2011.01278.x; Im K, 2016, J GINSENG RES, V40, P309, DOI 10.1016/j.jgr.2015.09.002; Jin F., 2012, INT J BIOMED PHARM S, V6, P33; Joh EH, 2011, BIOCHEM PHARMACOL, V82, P278, DOI 10.1016/j.bcp.2011.05.003; Kim MK, 2005, J MICROBIOL, V43, P456; Kim S, 2004, BIOCHEM BIOPH RES CO, V316, P348, DOI 10.1016/j.bbrc.2004.02.046; Kim SH, 2012, J GINSENG RES, V36, P291, DOI 10.5142/jgr.2012.36.3.291; Kimura Y, 2006, BRIT J PHARMACOL, V148, P860, DOI 10.1038/sj.bjp.0706794; Law CKM, 2014, CHIN MED-UK, V9, DOI 10.1186/1749-8546-9-11; Lee GW, 2013, APPL MICROBIOL BIOT, V97, P6315, DOI 10.1007/s00253-013-4828-7; Lee GW, 2012, BIOTECHNOL LETT, V34, P1679, DOI 10.1007/s10529-012-0949-9; Lee JH, 2011, J APPL MICROBIOL, V111, P1097, DOI 10.1111/j.1365-2672.2011.05128.x; Liu KK, 2014, ACTA PHARMACOL SIN, V35, P599, DOI 10.1038/aps.2014.7; Liu QM, 2013, ANTON LEEUW INT J G, V103, P747, DOI 10.1007/s10482-012-9856-2; Lu JM, 2009, CURR VASC PHARMACOL, V7, P293, DOI 10.2174/157016109788340767; NUCCI R, 1993, BIOTECHNOL APPL BIOC, V17, P239; Park CS, 2010, APPL MICROBIOL BIOT, V87, P9, DOI 10.1007/s00253-010-2567-6; Quan LH, 2012, J IND MICROBIOL BIOT, V39, P1557, DOI 10.1007/s10295-012-1158-1; Quan LH, 2011, BRAZ J MICROBIOL, V42, P1227, DOI [10.1590/S1517-83822011000300049, 10.1590/S1517-838220110003000049]; Shin DJ, 2014, J CELL BIOCHEM, V115, P1702, DOI 10.1002/jcb.24833; Shin HY, 2003, APPL ENVIRON MICROB, V69, P7116, DOI 10.1128/AEM.69.12.7116-7123.2003; Shin KC, 2016, CRIT REV BIOTECHNOL, V36, P1036, DOI 10.3109/07388551.2015.1083942; Shin KC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145876; Shin KC, 2014, J BIOTECHNOL, V172, P30, DOI 10.1016/j.jbiotec.2013.11.026; Shin KC, 2013, J BIOTECHNOL, V167, P33, DOI 10.1016/j.jbiotec.2013.06.003; Shin KC, 2013, J MICROBIOL BIOTECHN, V23, P483, DOI 10.4014/jmb.1211.11012; Son JW, 2008, BIOTECHNOL LETT, V30, P713, DOI 10.1007/s10529-007-9590-4; Wang L, 2011, J BIOTECHNOL, V156, P125, DOI 10.1016/j.jbiotec.2011.07.024; Wu CF, 2007, INT IMMUNOPHARMACOL, V7, P313, DOI 10.1016/j.intimp.2006.04.021; Xiang YZ, 2008, PHYTOTHER RES, V22, P851, DOI 10.1002/ptr.2384; Xie J, 2016, J APPL MICROBIOL, V120, P647, DOI 10.1111/jam.13040; Yan Q, 2010, PROCESS BIOCHEM, V45, P1550, DOI 10.1016/j.procbio.2010.06.007; Yayeh T, 2016, J GINSENG RES, V40, P445, DOI 10.1016/j.jgr.2016.08.006; Yoo MH, 2011, APPL MICROBIOL BIOT, V89, P1019, DOI 10.1007/s00253-010-2960-1; Yoshikawa M, 2003, J NAT PROD, V66, P922, DOI 10.1021/np030015l; Yuan HD, 2011, METABOLISM, V60, P43, DOI 10.1016/j.metabol.2009.12.024; Zhang CZ, 2002, PROCESS BIOCHEM, V37, P793, DOI 10.1016/S0032-9592(01)00275-8; Zhou W, 2006, J ASIAN NAT PROD RES, V8, P519, DOI 10.1080/10286020500208600	41	11	13	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191018	10.1371/journal.pone.0191018	http://dx.doi.org/10.1371/journal.pone.0191018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324789	Green Submitted, gold, Green Published			2022-12-26	WOS:000419952400094
J	Echebli, N; Tchitchek, N; Dupuy, S; Bruel, T; Passaes, CPB; Bosquet, N; Grand, RL; Bourgeois, C; Favier, B; Cheynier, R; Lambotte, O; Vaslin, B				Echebli, Nadia; Tchitchek, Nicolas; Dupuy, Stephanie; Bruel, Timothee; Passaes, Caroline Peireira Bittencourt; Bosquet, Nathalie; Le Grand, Roger; Bourgeois, Christine; Favier, Benoit; Cheynier, Remi; Lambotte, Olivier; Vaslin, Bruno			Stage-specific IFN-induced and IFN gene expression reveal convergence of type I and type II IFN and highlight their role in both acute and chronic stage of pathogenic SIV infection	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; INTERFERON-STIMULATED GENES; PLASMACYTOID DENDRITIC CELLS; INNATE IMMUNITY; RHESUS MACAQUES; T-CELLS; GAMMA-INTERFERON; CUTTING EDGE; LYMPH-NODES; HIV-1	Interferons (IFNs) play a major role in controlling viral infections including HIV/SIV infections. Persistent up-regulation of interferon stimulated genes (ISGs) is associated with chronic immune activation and progression in SIV/HIV infections, but the respective contribution of different IFNs is unclear. We analyzed the expression of IFN genes and ISGs in tissues of SIV infected macaques to understand the respective roles of type I and type II IFNs. Both IFN types were induced in lymph nodes during early stage of primary infection and to some extent in rectal biopsies but not in PBMCs. Induction of Type II IFN expression persisted during the chronic phase, in contrast to undetectable induction of type I IFN expression. Global gene expression analysis with a major focus on ISGs revealed that at both acute and chronic infection phases most differentially expressed ISGs were inducible by both type I and type II IFNs and displayed the highest increases, indicating strong convergence and synergy between type I and type II IFNs. The analysis of functional signatures of ISG expression revealed temporal changes in IFN expression patterns identifying phase-specific ISGs. These results suggest that IFN-gamma strongly contribute to shape ISG upregulationin addition to type I IFN.	[Echebli, Nadia; Tchitchek, Nicolas; Dupuy, Stephanie; Bruel, Timothee; Passaes, Caroline Peireira Bittencourt; Bosquet, Nathalie; Le Grand, Roger; Bourgeois, Christine; Favier, Benoit; Lambotte, Olivier; Vaslin, Bruno] Univ Paris Sud, CEA, INSERM,IBFJ, U1184,Immunol Viral Infect & Autoimmune Dis IMVA,I, Fontenay Aux Roses, France; [Cheynier, Remi] Inst Cochin, INSERM, U1016, Cytokines & Viral Infect,Immunol Infect & Inflamma, Paris, France; [Cheynier, Remi] CNRS, UMR8104, Paris, France; [Cheynier, Remi] Univ Paris 05, Paris, France; [Lambotte, Olivier] Hop Univ Paris Sud, AP HP, Serv Med Interne Immunol Clin, Le Kremlin Bicetre, France; [Dupuy, Stephanie] Univ Paris 05, CICB, Paris, France; [Bruel, Timothee] Inst Pasteur, Dept Virol, Paris, France; [Passaes, Caroline Peireira Bittencourt] Inst Pasteur, HIV Inflammat & Persistence Unit, Paris, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Vaslin, B (corresponding author), Univ Paris Sud, CEA, INSERM,IBFJ, U1184,Immunol Viral Infect & Autoimmune Dis IMVA,I, Fontenay Aux Roses, France.	bruno.vaslin@cea.fr	Bourgeois, Christine/ABA-1432-2021; Cheynier, Remi/E-9921-2010; Bourgeois, Christine/L-5944-2018; Passaes, Caroline/AAH-3392-2020; FAVIER, Benoit/W-7379-2019; Bruel, Timothée/AAI-4632-2020; Lambotte, Olivier/GRT-0160-2022	Bourgeois, Christine/0000-0003-1146-6087; Cheynier, Remi/0000-0003-1146-660X; Bourgeois, Christine/0000-0003-1146-6087; Passaes, Caroline/0000-0002-0813-2521; Tchitchek, Nicolas/0000-0003-3307-0446; Bruel, Timothee/0000-0002-3952-4261	Agence Nationale de Recherches sur le SIDA et les hepatites virales; ANRS; Agence Nationale de Recherches sur le SIDA et les hepatites virales (ANRS) [11360]; agence Nationale de la Recherche "Programme d'Investissements d'Avenir" (PIA) [ANR-11-INBS-0008]; Infectious Disease Models and Innovative Therapies (IDMIT, Fontenay-aux-Roses, France) infrastructure; PIA [ANR-10-EQPX-02-01]	Agence Nationale de Recherches sur le SIDA et les hepatites virales(ANRSFrench National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR)); Agence Nationale de Recherches sur le SIDA et les hepatites virales (ANRS)(ANRSFrench National Research Agency (ANR)); agence Nationale de la Recherche "Programme d'Investissements d'Avenir" (PIA)(French National Research Agency (ANR)); Infectious Disease Models and Innovative Therapies (IDMIT, Fontenay-aux-Roses, France) infrastructure; PIA	This work was supported by the Agence Nationale de Recherches sur le SIDA et les hepatites virales (www.anrs.fr). NE, SD and CPBP benefited from ANRS post-doctoral fellowships. This work was also supported by Agence Nationale de Recherches sur le SIDA et les hepatites virales (ANRS) through research project grant 11360 attributed to BV, by the agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr) "Programme d'Investissements d'Avenir" (PIA) under Grant ANR-11-INBS-0008, that funds the Infectious Disease Models and Innovative Therapies (IDMIT, Fontenay-aux-Roses, France) infrastructure, and PIA grant ANR-10-EQPX-02-01 that funds the FlowCyTech facility (project investigator RLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel K, 2005, J VIROL, V79, P12164, DOI 10.1128/JVI.79.19.12164-12172.2005; Abel K, 2004, J VIROL, V78, P841, DOI 10.1128/JVI.78.2.841-854.2004; Abel K, 2002, J VIROL, V76, P8433, DOI 10.1128/JVI.76.16.8433-8445.2002; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Benlhassan-Chahour K, 2003, J VIROL, V77, P12479, DOI 10.1128/JVI.77.23.12479-12493.2003; Benlhassan-Chahour K, 2003, PUBMED, V77, P12479; Beq S, 2009, BLOOD, V114, P816, DOI 10.1182/blood-2008-11-191288; Beutler B, 2005, CURR OPIN IMMUNOL, V17, P36, DOI 10.1016/j.coi.2004.11.004; Blaszczyk K, 2015, BIOCHEM J, V466, P511, DOI 10.1042/BJ20140644; Borrow P, 2011, CURR OPIN HIV AIDS, V6, P353, DOI 10.1097/COH.0b013e3283495996; Borrow P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-84; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Bruel T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003915; Cha L, 2014, J IMMUNOL, V193, P2178, DOI 10.4049/jimmunol.1302536; Chang JJ, 2010, J INFECT DIS, V202, pS297, DOI 10.1086/655657; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Cheng L, 2017, J CLIN INVEST, V127, P269, DOI 10.1172/JCI90745; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Division of AIDS (DAIDS), 2014, PUBMED; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Doyle T, 2015, NAT REV MICROBIOL, V13, P403, DOI 10.1038/nrmicro3449; Dutrieux J, 2014, AIDS, V28, P1101, DOI 10.1097/QAD.0000000000000249; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Fenton-May AE, 2013, PLOS PATHOGENS, V10, P146; Fenton-May AE, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-146; FINK K, 2013, STAT; Gibbert K, 2013, BRIT J PHARMACOL, V168, P1048, DOI 10.1111/bph.12010; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Harris LD, 2010, J VIROL, V84, P7886, DOI 10.1128/JVI.02612-09; Heim MH, 2014, J HEPATOL, V61, pS14, DOI 10.1016/j.jhep.2014.06.035; HTTPS, 1991, PUBMED; HTTPS, 2019, PUBMED; HTTPS, PUBMED; HTTPS, PUBMED, P1549; HTTPS, 2012, PUBMED; HTTPS, 2011, PUBMED; HTTPS, 2005, PUBMED; HTTPS, 2013, PUBMED; HTTPS, 1972, PUBMED; Hubbard JJ, 2012, J INFECT DIS, V205, P1443, DOI 10.1093/infdis/jis211; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; JACQUELIN B, 2014, ISI; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; Kane M, 2016, CELL HOST MICROBE, V20, P392, DOI 10.1016/j.chom.2016.08.005; Karlsson I, 2007, J VIROL, V81, P13444, DOI 10.1128/JVI.01466-07; Khatissian E, 1996, RES VIROLOGY, V147, P181, DOI 10.1016/0923-2516(96)80233-0; Krug A, 2002, J IMMUNOL, V169, P6079, DOI 10.4049/jimmunol.169.11.6079; Lackmann M, 1998, GROWTH FACTORS, V16, P39, DOI 10.3109/08977199809017490; Lederer S, 2009, PUBMED, V5; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Liovat AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046143; Majoros A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00029; Malleret B, 2008, BLOOD, V112, P4598, DOI 10.1182/blood-2008-06-162651; MORROW AN, 2011, ISI; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; O'Brien M, 2013, ADV EXP MED BIOL, V762, P71, DOI 10.1007/978-1-4614-4433-6_3; OGY, 2016, NATURE, V1038; PALUDAN SR, INNATE ANTIVIRAL DEF; Penna G, 2001, J IMMUNOL, V167, P1862, DOI 10.4049/jimmunol.167.4.1862; Pereira LE, 2008, CELL IMMUNOL, V254, P10, DOI 10.1016/j.cellimm.2008.06.006; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Ploquin MJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005774; PONTE R, 2017, PUBMED; RAUCH I, 2013, PUBMED; Reed JM, 2008, J INTERF CYTOK RES, V28, P611, DOI 10.1089/jir.2007.0145; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Roff SR, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00498; Roff SR, 2014, PUBMED, V4, P498; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; SCHILLER JH, 1986, CANCER RES, V46, P483; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Taylor MD, 1998, VIROLOGY, V241, P156, DOI 10.1006/viro.1997.8964; Thomas C, 2009, NAT MED, V15, P855, DOI 10.1038/nm0809-855; Wang WS, 2017, TRENDS MICROBIOL, V25, P574, DOI 10.1016/j.tim.2017.01.001; Wong MT, 2016, CELL MOL IMMUNOL, V13, P11, DOI 10.1038/cmi.2014.127; Zhao YH, 2013, ASIAN PAC J CANCER P, V14, P5513, DOI 10.7314/APJCP.2013.14.9.5513; Zhen A, 2017, J CLIN INVEST, V127, P260, DOI 10.1172/JCI89488; Zuniga EI, 2015, ANNU REV VIROL, V2, P573, DOI 10.1146/annurev-virology-100114-055226	94	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190334	10.1371/journal.pone.0190334	http://dx.doi.org/10.1371/journal.pone.0190334			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324751	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400030
J	Avong, YK; Aliyu, GG; Jatau, B; Gurumnaan, R; Danat, N; Kayode, GA; Adekanmbi, V; Dakum, P				Avong, Yohanna Kambai; Aliyu, Gambo Gumel; Jatau, Bolajoko; Gurumnaan, Ritmwa; Danat, Nanfwang; Kayode, Gbenga Ayodele; Adekanmbi, Victor; Dakum, Patrick			Integrating community pharmacy into community based anti-retroviral therapy program: A pilot implementation in Abuja, Nigeria	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; MEDI-CAL BENEFICIARIES; HIV/AIDS CARE; HIV-INFECTION; ADHERENCE; MANAGEMENT; MORTALITY; BARRIERS; COMPLICATIONS; METAANALYSIS	Background The landscape of Human Immunodeficiency Virus (HIV) epidemic control is shifting with the United Nations Programme on HIV/ AIDS (UNAIDS) 90-90-90 benchmarks for epidemic control. Community-based Antiretroviral Therapy (CART) models have improved treatment uptake and demonstrated good clinical outcomes. We assessed the feasibility of integrating community pharmacy as a task shift structure for differentiated community ART in AbujaNigeria. Methods Stable patients on first line ART regimens from public health facilities were referred to community pharmacies in different locations within the Federal Capital Territory, Abuja for prescription refills and treatment maintenance. Bio-demographic and clinical data were collected from February 25, 2016 to May 31 st, 2017 and descriptive statistics analysis applied. The outcomes of measure were prescription refill and patient retention in care at the community pharmacy. Results Almost 10% of stable patients on treatment were successfully devolved from eight health facilities to ten community pharmacies. Median age of the participants was 35 years [ interquartile range (IQR); 30, 41] with married women in the majority. Prescription refill was 100% and almost all the participants (99.3%) were retained in care after they were devolved to the community pharmacies. Only one participant was lost-to-follow-up as a result of death. Conclusion Excellent prescription refill and high retention in care with very low loss-to-follow-up were associated with the community pharmacy model. The use of community pharmacy for community ART is feasible in Nigeria. We recommend the scale up of the model in all the 36 states of Nigeria.	[Avong, Yohanna Kambai; Jatau, Bolajoko; Gurumnaan, Ritmwa; Danat, Nanfwang; Kayode, Gbenga Ayodele; Dakum, Patrick] Inst Human Virol Nigeria, Herbert Macaulay Way, Abuja, Nigeria; [Aliyu, Gambo Gumel] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Adekanmbi, Victor] Cardiff Univ, Sch Med, Div Populat Med, Cardiff, S Glam, Wales	University System of Maryland; University of Maryland Baltimore; Cardiff University	Avong, YK (corresponding author), Inst Human Virol Nigeria, Herbert Macaulay Way, Abuja, Nigeria.	yavong@gmail.com	Avong, Yohanna/AAS-4891-2020	Avong, Yohanna/0000-0001-6798-8576; Adekanmbi, Victor/0000-0002-7394-1640	ACTION PLUS UP grant - United States Centers for Disease Control and Prevention	ACTION PLUS UP grant - United States Centers for Disease Control and Prevention	This work was funded through the ACTION PLUS UP grant awarded to the Institute of Human Virology Nigeria by the United States Centers for Disease Control and Prevention. The funder did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this publication are entirely those of the authors and do not in any way represent those of their affiliated institutions.	Adejumo OA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20049; Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; Avong YK, 2015, CURR HIV RES, V13, P268, DOI 10.2174/1570162X13666150202094120; Barbaro G, 2006, CURR HIV RES, V4, P79, DOI 10.2174/157016206775197664; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Biron A, 2012, AIDS RES HUM RETROV, V28, P1672, DOI [10.1089/aid.2012.0048, 10.1089/AID.2012.0048]; Cocohoba JM, 2012, J AM PHARM ASSOC, V52, pE67, DOI 10.1331/JAPhA.2012.11112; Coombes R, 2005, BRIT MED J, V330, P923, DOI 10.1136/bmj.330.7497.923-b; Dangerous Drugs England Dangerous Drugs Scotland., 2013, CONTROLLED DRUGS SUP; Decroo T, 2014, LANCET GLOB HEALTH, V2, pE262, DOI 10.1016/S2214-109X(14)70038-5; Decroo T, 2013, INT HEALTH, V5, P169, DOI 10.1093/inthealth/iht016; Dillon DG, 2013, INT J EPIDEMIOL, V42, P1754, DOI 10.1093/ije/dyt198; Fatti G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012888; Feleke Yeweyenhareg, 2012, Ethiop Med J, V50, P221; Gill CJ, 2005, AIDS, V19, P1243, DOI 10.1097/01.aids.0000180094.04652.3b; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Grinsztejn B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059768; Hirsch JD, 2011, J MANAGE CARE PHARM, V17, P213, DOI 10.18553/jmcp.2011.17.3.213; Hirsch JD, 2009, J MANAGE CARE PHARM, V15, P32, DOI 10.18553/jmcp.2009.15.1.32; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Kredo T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009987.pub2; Lynen L, 2010, CURR OPIN HIV AIDS, V5, P1, DOI 10.1097/COH.0b013e3283333762; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Moatti JP, 2000, REV EPIDEMIOL SANTE, V48, P182; Morse CG, 2006, JAMA-J AM MED ASSOC, V296, P844, DOI 10.1001/jama.296.7.844; Mothobi NZ, 2012, CURR OPIN INFECT DIS, V25, P4, DOI 10.1097/QCO.0b013e32834ef586; Murphy P, 2012, AIDS PATIENT CARE ST, V26, P526, DOI 10.1089/apc.2012.0189; Mwagomba B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010452; National Agency for the Control of AIDS, 2014, NAT HIV AIDS EP IMP; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; PEPFAR, 2016, PEPFAR COUNTRY OPERA; Rosenquist A, 2010, J EVAL CLIN PRACT, V16, P1142, DOI 10.1111/j.1365-2753.2009.01283.x; Roura M, 2009, AIDS PATIENT CARE ST, V23, P203, DOI 10.1089/apc.2008.0129; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; WHO, 2016, CONGUID UANT DRU; Wools-Kaloustian KK, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-22	40	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190286	10.1371/journal.pone.0190286	http://dx.doi.org/10.1371/journal.pone.0190286			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320531	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000419689600043
J	Hermansson, RS; Olovsson, M; Hoxell, E; Lindstrom, AK				Hermansson, Ruth S.; Olovsson, Matts; Hoxell, Emelie; Lindstrom, Annika K.			HPV prevalence and HPV-related dysplasia in elderly women	PLOS ONE			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; HUMAN-PAPILLOMAVIRUS PERSISTENCE; FOLLOW-UP; CANCER; PERFORMANCE; POPULATION; CYTOLOGY; DNA	Introduction In Sweden, where screening ends at the age of 60, about 30% of the cervical cancer cases occur in women older than 60. The aim of the present study was to investigate the prevalence of HPV and cervical dysplasia in women of 60 years and above. Patients and methods From September 2013 until June 2015, 1051 women aged 60-89 years (mean 68 years) were sampled for an HPV test when attending an outpatient gynecology clinic. Women with positive results had a second HPV test and liquid based cytology (LBC), after 3.5 months on average. Those with a positive second HPV test were examined by colposcopy, and biopsy and a sample for LBC was obtained. Results The prevalence of HPV was 4.1%, (95% CI 3.0-5.5, n = 43) at the first test, and at the second test 2.6% remained positive (95% CI 1.7-3.8, n = 27). The majority of women positive in both HPV tests, had dysplasia in histology, 81.5% (22/27) (4 CIN 2-0.4%, 18 CIN 1-1.7%). HPV-related dysplasia was found in 2.1%, (95% CI 1.3-3.2,n = 22) of the 1051 women. Four of the 22 women with positive HPV tests also had abnormal cytology, one ASCUS and three CIN 1. No cancer or glandular dysplasia was detected. Conclusion A significant proportion of elderly women were found to have a persistent cervical HPV infection. Among them there was a high prevalence of CIN diagnosed by histology. The HPV test showed high sensitivity and specificity in detecting CIN in elderly women, while cytology showed extremely low sensitivity.	[Hermansson, Ruth S.; Olovsson, Matts; Lindstrom, Annika K.] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Hermansson, Ruth S.] Orebro Univ, Fac Med & Hlth, Dept Oncol, Orebro, Sweden; [Lindstrom, Annika K.] Uppsala Univ, Clin Res Ctr, Uppsala, Sweden; [Lindstrom, Annika K.] Orebro Univ, Fac Med & Hlth, Clin Res Ctr, Orebro, Sweden	Uppsala University; Orebro University; Uppsala University; Orebro University	Lindstrom, AK (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.; Lindstrom, AK (corresponding author), Uppsala Univ, Clin Res Ctr, Uppsala, Sweden.; Lindstrom, AK (corresponding author), Orebro Univ, Fac Med & Hlth, Clin Res Ctr, Orebro, Sweden.	annika.lindstrom@ltdalarna.se	Lindstrom, Annika K./ABB-7829-2020	Lindstrom, Annika K./0000-0002-7407-9642; Hermansson, Ruth/0000-0002-6549-9311	Center for Clinical Research, Dalarna, Sweden [CKFUU-506211]	Center for Clinical Research, Dalarna, Sweden	This work was supported by the Center for Clinical Research, Dalarna, Sweden Grant number CKFUU-506211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschkenazi-Steinberg Sarit O, 2005, J Low Genit Tract Dis, V9, P19, DOI 10.1097/00128360-200501000-00005; Beckman N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a279; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; Carpenter AB, 1999, CANCER CYTOPATHOL, V87, P105, DOI 10.1002/(SICI)1097-0142(19990625)87:3<105::AID-CNCR2>3.0.CO;2-Z; Rodriguez AC, 2010, JNCI-J NATL CANCER I, V102, P315, DOI 10.1093/jnci/djq001; Charlton BM, 2013, J LOW GENIT TRACT DI, V17, P242, DOI 10.1097/LGT.0b013e3182730fec; Colgan TJ, 2002, CANCER CYTOPATHOL, V96, P195, DOI 10.1002/cncr.10723; Commission E., 2015, HLTH GLANC EUR 2014; Darlin L, 2014, ANTICANCER RES, V34, P5147; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Ferenczy A, 1997, OBSTET GYNECOL, V90, P7, DOI 10.1016/S0029-7844(97)00217-2; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Gilani SM, 2013, ACTA CYTOL, V57, P575, DOI 10.1159/000353769; Gustafsson L, 1995, INT J CANCER, V63, P804, DOI 10.1002/ijc.2910630610; Gustavsson I, 2009, J CLIN VIROL, V46, P112, DOI 10.1016/j.jcv.2009.06.021; Gustavsson I, 2009, J CLIN VIROL, V45, P85, DOI 10.1016/j.jcv.2009.04.012; Gyllensten U, 2011, BRIT J CANCER, V105, P694, DOI 10.1038/bjc.2011.277; Gyllensten U, 2012, GYNECOL ONCOL, V125, P343, DOI 10.1016/j.ygyno.2012.01.036; Gyllensten U, 2010, LANCET ONCOL, V11, P509, DOI 10.1016/S1470-2045(10)70064-4; Korostil IA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-312; Meijer CJLM, 2009, INT J CANCER, V124, P516, DOI 10.1002/ijc.24010; Petignat P, 2005, CANCER CYTOPATHOL, V105, P126, DOI 10.1002/cncr.21060; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Socialstyrelsen, 2011, DODS 2009; Socialstyrelsen, 2015, SCREEN LIVM REK BEH, V2015, P1; Strander B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7361; The Board of Health and Welfare CfE, 2015, CANC INC SWED 2014; The Board of Health and Welfare CfE, 2015, CAUS OF DEATH 2013, P277; Tranbaloc P, 2008, GYNECOL OBSTET FERTI, V36, P650, DOI 10.1016/j.gyobfe.2008.03.016; Virtej P, 1998, EUR J GYNAECOL ONCOL, V19, P179; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	32	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0189300	10.1371/journal.pone.0189300	http://dx.doi.org/10.1371/journal.pone.0189300			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320507	Green Published, gold, Green Submitted			2022-12-26	WOS:000419689600008
J	Rahman, H; Bennett, RA; Kebede, B				Rahman, Habibur; Bennett, Rick A.; Kebede, Berisso			Molecular mapping of QTL alleles of Brassica oleracea affecting days to flowering and photosensitivity in spring Brassica napus	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ARABIDOPSIS-THALIANA; PHOTOPERIOD RESPONSE; CAMPESTRIS L; TIME GENES; SEED YIELD; CANOLA; L.; TEMPERATURE; WINTER	Earliness of flowering and maturity are important traits in spring Brassica napus canola-whether grown under long-or short-day condition. By use of a spring B. napus mapping population carrying the genome content of B. oleracea and testing this population under 10 to 18 h photoperiod and 18 to 20 0 C (day) temperature conditions, we identified a major QTL on the chromosome C1 affecting flowering time without being influenced by photoperiod and temperature, and a major QTL on C9 affecting flowering time under a short photoperiod (10 h); in both cases, the QTL alleles reducing the number of days to flowering in B. napus were introgressed from the late flowering species B. oleracea. Additive effect of the C1 QTL allele at 14 to 18 h photoperiod was 1.1 to 2.9 days; however, the same QTL allele exerted an additive effect of 6.2 days at 10 h photoperiod. Additive effect of the C9 QTL at 10 h photoperiod was 2.8 days. These two QTL also showed significant interaction in the control of flowering only under a short-day (10 h photoperiod) condition with an effect of 2.3 days. A few additional QTL were also detected on the chromosomes C2 and C8; however, none of these QTL could be detected under all photoperiod and temperature conditions. BLASTn search identified several putative flowering time genes on the chromosomes C1 and C9 and located the physical position of the QTL markers in the Brassica genome; however, only a few of these genes were found within the QTL region. Thus, the molecular markers and the genomic regions identified in this research could potentially be used in breeding for the development of early flowering photoinsensitive B. napus canola cultivars, as well as for identification of candidate genes involved in flowering time variation and photosensitivity.	[Rahman, Habibur; Bennett, Rick A.; Kebede, Berisso] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Bennett, Rick A.] Agrisoma Biosci Inc, 110 Gymnasium Pl, Saskatoon, SK, Canada	University of Alberta	Rahman, H (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	habibur.rahman@ualberta.ca			Natural Sciences and Engineering Research Council (NSERC) [298778-2011 RGPIN]; Alberta Innovates Bio Solutions (AI Bio) [2011F006R/RES0008449]; Alberta Crop Industry Development Fund (ACIDF) [2011F006R/RES0008449]; Alberta Canola Producers Commission (ACPC) [2011F006R/RES0008449]; Crop Production Services (CPS); Natural Sciences and Engineering Research Council (NSERC); Alberta Innovates Bio Solutions (AI Bio); Alberta Crop Industry Development Fund (ACIDF); Alberta Canola Producers Commission (ACPC); Canada Foundation of Innovation (CFI)	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Bio Solutions (AI Bio); Alberta Crop Industry Development Fund (ACIDF); Alberta Canola Producers Commission (ACPC); Crop Production Services (CPS); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Bio Solutions (AI Bio); Alberta Crop Industry Development Fund (ACIDF); Alberta Canola Producers Commission (ACPC); Canada Foundation of Innovation (CFI)(Canada Foundation for Innovation)	This work was supported by the Natural Sciences and Engineering Research Council (NSERC), Grant # 298778-2011 RGPIN (http://www.nserc-crsng.gc.ca/index_eng.asp) to HR; Alberta Innovates Bio Solutions (AI Bio), Grant# 2011F006R/RES0008449 (http://bio.albertainnovates.ca/) to HR; Alberta Crop Industry Development Fund (ACIDF), Grant# 2011F006R/RES0008449 (http://www.acidf.ca/) to HR; Alberta Canola Producers Commission (ACPC), Grant# 2011F006R/RES0008449 (http://albertacanola.corn/) to HR; Crop Production Services (CPS), (http://www.cpsagu.ca/) to HR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; H.R. thanks Natural Sciences and Engineering Research Council (NSERC), Alberta Innovates Bio Solutions (AI Bio), Alberta Crop Industry Development Fund (ACIDF), Alberta Canola Producers Commission (ACPC), and the industry partner Crop Production Services (CPS) for providing financial support to this project. Financial support from Canada Foundation of Innovation (CFI) for infrastructure development in the Canola Program, and infrastructure provided by University of Alberta is also gratefully acknowledged. Thanks also to other personnel's from the Canola Program including summer students for assistance in different routine operations.	Angadi SV, 2000, CAN J PLANT SCI, V80, P693, DOI 10.4141/P99-152; [Anonymous], THESIS; [Anonymous], 2004, STAT US GUID; Axelsson T, 2001, GENOME, V44, P856, DOI 10.1139/gen-44-5-856; Bohuon EJR, 1998, GENETICS, V150, P393; Cai CC, 2008, RUSS J GENET+, V44, P326, DOI 10.1134/S1022795408030137; Chen G, 2010, EUPHYTICA, V175, P161, DOI 10.1007/s10681-010-0144-9; Cheng XM, 2009, THEOR APPL GENET, V118, P1121, DOI 10.1007/s00122-009-0967-8; Ehrenreich IM, 2009, GENETICS, V183, P325, DOI 10.1534/genetics.109.105189; Gan Y, 2004, CAN J PLANT SCI, V84, P697, DOI 10.4141/P03-109; Gan YT, 2016, CAN J PLANT SCI, V96, P151, DOI 10.1139/cjps-2015-0093; Guo Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00282; GUSTA LV, 1987, CAN J PLANT SCI, V67, P1155, DOI 10.4141/cjps87-155; Habekotte B, 1997, FIELD CROP RES, V54, P109, DOI 10.1016/S0378-4290(97)00041-5; Honsdorf N, 2010, GENOME, V53, P899, DOI 10.1139/G10-049; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; KING JR, 1986, FIELD CROP RES, V13, P367, DOI 10.1016/0378-4290(86)90037-7; Kole C, 2001, THEOR APPL GENET, V102, P425, DOI 10.1007/s001220051663; KONDRA ZP, 1983, CAN J PLANT SCI, V63, P1063, DOI 10.4141/cjps83-135; Liu HD, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0477-8; Long Y, 2007, GENETICS, V177, P2433, DOI 10.1534/genetics.107.080705; Lowe AJ, 2004, THEOR APPL GENET, V108, P1103, DOI 10.1007/s00122-003-1522-7; Luo YX, 2014, EUPHYTICA, V200, P321, DOI 10.1007/s10681-014-1140-2; Mahmood T, 2007, EUPHYTICA, V154, P101, DOI 10.1007/s10681-006-9276-3; MAJOR DJ, 1980, CAN J PLANT SCI, V60, P777, DOI 10.4141/cjps80-115; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; MILLS JT, 1984, CAN J PLANT SCI, V64, P841, DOI 10.4141/cjps84-115; Morrison MJ, 2002, CROP SCI, V42, P797, DOI 10.2135/cropsci2002.0797; Nanda R, 1996, FIELD CROP RES, V46, P93, DOI 10.1016/0378-4290(95)00090-9; Okazaki K, 2007, THEOR APPL GENET, V114, P595, DOI 10.1007/s00122-006-0460-6; Parkin I, 2011, PLANT GENET GENOMICS, V9, P153, DOI 10.1007/978-1-4419-7118-0_5; Piquemal J, 2005, THEOR APPL GENET, V111, P1514, DOI 10.1007/s00122-005-0080-6; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Rae AM, 1999, HEREDITY, V83, P586, DOI 10.1038/sj.hdy.6886050; Rahman H, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-016-0608-2; Rahman H, 2013, CAN J PLANT SCI, V93, P363, DOI [10.4141/CJPS2012-074, 10.4141/cjps2012-074]; Rahman MH, 2011, EUPHYTICA, V177, P365, DOI 10.1007/s10681-010-0253-5; Raja P, 2014, INT J GENETIC ENG BI, V5, P133; Raman H, 2014, PLANT BIOTECHNOL J, V12, P851, DOI 10.1111/pbi.12186; Raman H, 2013, THEOR APPL GENET, V126, P119, DOI 10.1007/s00122-012-1966-8; Raman R, 2016, CROP PASTURE SCI, V67, P298, DOI 10.1071/CP15283; Razi H, 2008, THEOR APPL GENET, V116, P179, DOI 10.1007/s00122-007-0657-3; Robert LS, 1998, PLANT MOL BIOL, V37, P763, DOI 10.1023/A:1006064514311; Robertson MJ, 2002, AUST J AGR RES, V53, P793, DOI 10.1071/AR01182; Schiessl S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00404; Scortecci K, 2003, PLANT MOL BIOL, V52, P915, DOI 10.1023/A:1025426920923; Scortecci KC, 2001, PLANT J, V26, P229, DOI 10.1046/j.1365-313x.2001.01024.x; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Strasser B, 2009, PLANT J, V58, P629, DOI 10.1111/j.1365-313X.2009.03811.x; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; Suwabe K, 2006, GENETICS, V173, P309, DOI 10.1534/genetics.104.038968; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Wang J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-271; Wang S, 2012, WINDOWS QTL CARTOGRA; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; Zaman M. W., 1995, Sveriges Utsadesforenings Tidskrift, V105, P59; Zou J, 2014, THEOR APPL GENET, V127, P1593, DOI 10.1007/s00122-014-2321-z	58	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0189723	10.1371/journal.pone.0189723	http://dx.doi.org/10.1371/journal.pone.0189723			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320498	Green Published, Green Submitted, gold			2022-12-26	WOS:000419689600012
J	Zhao, WM; Wang, XY; Sun, KH; Zhou, L				Zhao, Wanming; Wang, Xingyu; Sun, Kai-Hui; Zhou, Lan			alpha-smooth muscle actin is not a marker of fibrogenic cell activity in skeletal muscle fibrosis	PLOS ONE			English	Article							COLLAGEN GENE-EXPRESSION; MOLECULAR-MECHANISMS; MUSCULAR-DYSTROPHY; MDX MOUSE; MYOFIBROBLASTS; INJURY; MICE; CCR2; INFLAMMATION; MACROPHAGES	alpha-Smooth muscle actin (alpha-SMA) is used as a marker for a subset of activated fibrogenic cells, myofibroblasts, which are regarded as important effector cells of tissue fibrogenesis. We address whether alpha-SMA-expressing myofibroblasts are detectable in fibrotic muscles of mdx(5cv) mice, a mouse model for Duchenne muscular dystrophy (DMD), and whether the alpha-SMA expression correlates with the fibrogenic function of intramuscular fibrogenic cells. alpha-SMA immunostaining signal was not detected in collagen I (GFP)-expressing cells in fibrotic muscles of ColI-GFP/mdx(5cv) mice, but it was readily detected in smooth muscle cells lining intramuscular blood vessel walls. alpha-SMA expression was detected by quantitative RT-PCR and Western blot in fibrogenic cells sorted from diaphragm and quadriceps muscles of the ColI-GFP/mdx(5cv) mice. Consistent with the more severe fibrosis in the ColI-GFP/mdx(5cv) diaphragm, the fibrogenic cells in the diaphragm exerted a stronger fibrogenic function than the fibrogenic cells in the quadriceps as gauged by their extracellular matrix gene expression. However, both gene and protein expression of alpha-SMA was lower in the diaphragm fibrogenic cells than in the quadriceps fibrogenic cells in the ColI-GFP/mdx(5cv) mice. We conclude that myofibroblasts are present in fibrotic skeletal muscles, but their expression of alpha-SMA is not detectable by immunostaining. The level of alpha-SMA expression by intramuscular fibrogenic cells does not correlate positively with the level of collagen gene expression or the severity of skeletal muscle fibrosis in the mdx(5cv) mice. alpha-SMA is not a functional marker of fibrogenic cells in skeletal muscle fibrosis associated with muscular dystrophy.	[Zhao, Wanming; Wang, Xingyu; Zhou, Lan] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Sun, Kai-Hui] Univ Calif San Francisco, Dept Med, Lung Biol Lab, San Francisco, CA 94143 USA; [Zhao, Wanming] Mem Sloan Kettering Canc Ctr, Dept Human Oncol, 1275 York Ave, New York, NY 10021 USA; [Wang, Xingyu; Zhou, Lan] UT Southwestern Med Ctr, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Wang, Xingyu; Zhou, Lan] UT Southwestern Med Ctr, Dept Pathol, Dallas, TX 75390 USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California San Francisco; Memorial Sloan Kettering Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhou, L (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.; Zhou, L (corresponding author), UT Southwestern Med Ctr, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA.; Zhou, L (corresponding author), UT Southwestern Med Ctr, Dept Pathol, Dallas, TX 75390 USA.	lan.zhou@UTSouthwestern.edu			U.S. National Institutes of Health/NIAMS [R01AR059702]; UT Southwestern Department of Pathology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059702] Funding Source: NIH RePORTER	U.S. National Institutes of Health/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); UT Southwestern Department of Pathology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study is supported by the U.S. National Institutes of Health/NIAMS grant R01AR059702 (L.Z.) and the research fund from UT Southwestern Department of Pathology. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is supported by the U.S. National Institutes of Health/NIAMS grant R01AR059702 (L.Z.) and the research fund from UT Southwestern Department of Pathology. We thank the Flow Cytometry Core at the Icahn School of Medicine at Mount Sinai and the UT Southwestern Medical Center for the technical support. We thank Dr. Dean Sheppard for providing mouse lung sections with fibrosis induced by bleomycin.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Beastrom N, 2011, AM J PATHOL, V179, P2464, DOI 10.1016/j.ajpath.2011.07.009; Bochaton-Piallat ML, 2016, F1000RESEAR, V5; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Carpenter S., 2001, PATHOLOGY SKELETAL M, P314; Chapman MA, 2017, AM J PHYSIOL-CELL PH, V312, pC131, DOI 10.1152/ajpcell.00226.2016; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; Cordier L, 2000, MOL THER, V1, P119, DOI 10.1006/mthe.1999.0019; Desguerre I, 2009, J NEUROPATH EXP NEUR, V68, P762, DOI 10.1097/NEN.0b013e3181aa31c2; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848; DUPONTVERSTEEGDEN EE, 1992, MUSCLE NERVE, V15, P1105, DOI 10.1002/mus.880151008; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Emery A.E.H., 1993, DUCHENNE MUSCULAR DY; Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852; GOLDSPINK G, 1994, NEUROMUSCULAR DISORD, V4, P183, DOI 10.1016/0960-8966(94)90019-1; Hartel JV, 2001, MUSCLE NERVE, V24, P428, DOI 10.1002/1097-4598(200103)24:3<428::AID-MUS1018>3.3.CO;2-5; Hinz B, 2016, EXP EYE RES, V142, P56, DOI 10.1016/j.exer.2015.07.009; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Huang P, 2011, MUSCLE NERVE, V43, P263, DOI 10.1002/mus.21848; Huang P, 2009, FASEB J, V23, P2539, DOI 10.1096/fj.09-129833; Huebner KD, 2008, AM J PHYSIOL-HEART C, V294, pH1550, DOI 10.1152/ajpheart.01253.2007; Ieronimakis N, 2016, J PATHOL, V240, P410, DOI 10.1002/path.4801; Krempen K, 1999, GENE EXPRESSION, V8, P151; Leaf IA, 2017, J CLIN INVEST, V127, P321, DOI 10.1172/JCI87532; Lepreux S, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00173; Lieber RL, 2013, AM J PHYSIOL-CELL PH, V305, pC241, DOI 10.1152/ajpcell.00173.2013; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Lu HY, 2011, FASEB J, V25, P3344, DOI 10.1096/fj.10-178939; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Mercuri E, 2013, CURR OPIN PEDIATR, V25, P701, DOI 10.1097/MOP.0b013e328365ace5; Mercuri E, 2013, LANCET, V381, P845, DOI 10.1016/S0140-6736(12)61897-2; Peters W, 2000, J IMMUNOL, V165, P7072, DOI 10.4049/jimmunol.165.12.7072; POVYSIL C, 1979, VIRCHOWS ARCH A, V381, P189, DOI 10.1007/BF01257884; Rockey DC, 2015, NEW ENGL J MED, V373, P96, DOI 10.1056/NEJMc1504848; Seki E, 2015, J HEPATO-BIL-PAN SCI, V22, P512, DOI 10.1002/jhbp.245; Serrano AL, 2016, SEMIN CELL DEV BIOL; Spurney CF, 2011, J CARDIOVASC PHARM T, V16, P87, DOI 10.1177/1074248410381757; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Sun DX, 2009, FASEB J, V23, P382, DOI 10.1096/fj.07-095901; Sun KH, 2016, AM J PHYSIOL-LUNG C, V310, pL824, DOI 10.1152/ajplung.00350.2015; Taniguti APT, 2011, MUSCLE NERVE, V43, P82, DOI 10.1002/mus.21869; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Turgeman T, 2008, NEUROMUSCULAR DISORD, V18, P857, DOI 10.1016/j.nmd.2008.06.386; Uezumi A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.161; Uezumi A, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00068; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Wang HZ, 2014, AM J PATHOL, V184, P1167, DOI 10.1016/j.ajpath.2013.12.020; Wang XY, 2016, J IMMUNOL, V197, P4750, DOI 10.4049/jimmunol.1601308; Wells RG, 2015, SEMIN LIVER DIS, V35, P97, DOI [10.1055/s-0035-1550061, 10.1055/s-0035-1554915]; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; WIRMAN JA, 1976, CANCER-AM CANCER SOC, V38, P2378, DOI 10.1002/1097-0142(197612)38:6<2378::AID-CNCR2820380626>3.0.CO;2-X; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yata Y, 2003, HEPATOLOGY, V37, P267, DOI 10.1053/jhep.2003.50067; Zhao W, 2016, FASEB J; Zhao WM, 2017, FASEB J, V31, P35, DOI 10.1096/fj.201600619R; Zhao WM, 2016, FASEB J, V30, P380, DOI 10.1096/fj.14-270090; Zhou L, 2006, NEUROMUSCULAR DISORD, V16, P32, DOI 10.1016/j.nmd.2005.09.009; Zhou L, 2008, J NEUROL SCI, V264, P106, DOI 10.1016/j.jns.2007.08.029; Zhou Y, 2010, J BIOL CHEM, V285, P22382, DOI 10.1074/jbc.M110.126227	61	28	32	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0191031	10.1371/journal.pone.0191031	http://dx.doi.org/10.1371/journal.pone.0191031			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320561	Green Submitted, Green Published, gold			2022-12-26	WOS:000419689600082
J	Gu, YF; Zhou, QW; Zhang, SP; Lu, CF; Gong, F; Tan, YQ; Lu, GX; Lin, G				Gu, Yi-Fan; Zhou, Qin-Wei; Zhang, Shuo-Ping; Lu, Chang-Fu; Gong, Fei; Tan, Yue-Qiu; Lu, Guang-Xiu; Lin, Ge			Inner cell mass incarceration in 8-shaped blastocysts does not increase monozygotic twinning in preimplantation genetic diagnosis and screening patients	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGIES; STAGE EMBRYO-TRANSFER; ZONA-PELLUCIDA; IN-VITRO; STRUCTURAL DEFECTS; MOUSE BLASTOCYSTS; RISK-FACTORS; TWINS; VIVO; IVF	Background The use of assisted reproductive technology (ART) has been reported to increase the incidence of monozygotic twinning (MZT) compared with the incidence following natural conception. It has been hypothesized that splitting of the inner cell mass (ICM) through a small zona hole may result in MZT. In this study, using a cohort of patients undergoing preimplantation genetic diagnosis/screening (PGD/PGS), we compared the clinical and neonatal outcomes of human 8-shaped blastocysts hatching with ICM incarceration with partially or fully hatched blastocysts, and attempted to verify whether this phenomenon increases the incidence of MZT pregnancy or negatively impact newborns. Methods This retrospective study included 2059 patients undergoing PGD/PGS between March 1, 2013, and December 31, 2015. Clinical and neonatal outcomes were only collected from patients who received a single blastocyst transfer after PGD/PGS (n = 992). A 25-to 30-mu m hole was made in the zona of day 3 embryos by laser. The blastocysts were biopsied and vitrified on day 6. The biopsied trophectoderm (TE) cells were analyzed using different genetic methods. One tested blastocyst was thawed and transferred to each patient in the subsequent frozen embryo transfer cycle. All the biopsied blastocysts were divided into three types: 8-shaped with ICM incarceration (type I), partially hatched without ICM incarceration (type II), and fully hatched (type III). ICM/TE grading, clinical and neonatal outcomes were compared between the groups. Results The percentage of grade A ICMs in type I blastocysts (22.2%) was comparable to that in type III blastocysts (20.1%) but higher than that in type II blastocysts (4.5%). The percentage of grade A TEs in type I blastocysts (4.2%) was comparable to that in type II (3.6%) but lower than that in type III (13.5%). There were no significant differences in clinical pregnancy, MZT pregnancy, miscarriage, live birth, MZT births, and neonatal outcomes between the groups. Conclusions Compared to partially and fully hatched blastocysts, 8-shaped blastocysts with ICM incarceration showed relatively higher ICM and lower TE grades. ICM incarceration in 8-shaped blastocysts does not increase the incidence of MZT and has no negative effects on new-borns in PGD/PGS patients.	[Gu, Yi-Fan; Zhou, Qin-Wei; Zhang, Shuo-Ping; Lu, Chang-Fu; Gong, Fei; Tan, Yue-Qiu; Lu, Guang-Xiu; Lin, Ge] Cent S Univ, Inst Reprod & Stem Cell Engn, Sch Basic Med Sci, Changsha, Peoples R China; [Gu, Yi-Fan; Zhang, Shuo-Ping; Lu, Chang-Fu; Gong, Fei; Tan, Yue-Qiu; Lu, Guang-Xiu; Lin, Ge] Reprod & Genet Hosp CITIC XIANGYA, Changsha, Hunan, Peoples R China; [Lu, Guang-Xiu; Lin, Ge] Natl Engn & Res Ctr Human Stem Cell, Changsha, Hunan, Peoples R China; [Lu, Guang-Xiu; Lin, Ge] Natl Hlth & Family Planning Commiss, Key Lab Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China	Central South University; Central South University	Lin, G (corresponding author), Cent S Univ, Inst Reprod & Stem Cell Engn, Sch Basic Med Sci, Changsha, Peoples R China.; Lin, G (corresponding author), Natl Engn & Res Ctr Human Stem Cell, Changsha, Hunan, Peoples R China.; Lin, G (corresponding author), Natl Hlth & Family Planning Commiss, Key Lab Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China.	linggf@hotmail.com			National Natural Science Foundation of China [31401069]; Natural Science Foundation of Hunan Province of China [2017JJ2327]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province of China(Natural Science Foundation of Hunan Province)	This work was supported by the National Natural Science Foundation of China, 31401069 (http://www.nsfc.gov.cn/) and the Natural Science Foundation of Hunan Province of China, 2017JJ2327 (http://www.hnst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIKANI M, 1994, HUM REPROD, V9, P1318, DOI 10.1093/oxfordjournals.humrep.a138701; Aston KI, 2008, REPRODUCTION, V136, P377, DOI 10.1530/REP-08-0206; Behr B, 2003, FERTIL STERIL, V80, P1502, DOI 10.1016/j.fertnstert.2003.07.001; Behr B, 2000, J ASSIST REPROD GEN, V17, P349, DOI 10.1023/A:1009461213139; Blickstein I, 2005, AM J OBSTET GYNECOL, V192, P365, DOI 10.1016/j.ajog.2004.11.012; Blickstein I, 1999, NEW ENGL J MED, V340, P738, DOI 10.1056/NEJM199903043400916; Blickstein I, 2007, TWIN RES HUM GENET, V10, P394, DOI 10.1375/twin.10.2.394; DEROM C, 1987, LANCET, V1, P1236; EDWARDS R G, 1986, Journal of In Vitro Fertilization and Embryo Transfer, V3, P114, DOI 10.1007/BF01139357; Franasiak JM, 2015, FERTIL STERIL, V103, P95, DOI 10.1016/j.fertnstert.2014.10.013; Frankfurter D, 2001, FERTIL STERIL, V76, pS144, DOI 10.1016/S0015-0282(01)02422-0; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; GONZALES DS, 1995, BIOL REPROD, V52, P470, DOI 10.1095/biolreprod52.2.470; Gonzales DS, 2001, BIOL REPROD, V64, P222, DOI 10.1095/biolreprod64.1.222; Hershlag A, 1999, FERTIL STERIL, V71, P144, DOI 10.1016/S0015-0282(98)00402-6; Hillman SC, 2011, OBSTET GYNECOL, V118, P928, DOI 10.1097/AOG.0b013e31822f129d; JONES KL, 1983, SEMIN PERINATOL, V7, P239; Kawachiya S, 2011, FERTIL STERIL, V95, P2140, DOI 10.1016/j.fertnstert.2010.12.018; Knopman J, 2010, FERTIL STERIL, V94, P502, DOI 10.1016/j.fertnstert.2009.03.064; Knopman JM, 2014, FERTIL STERIL, V102, P82, DOI 10.1016/j.fertnstert.2014.03.039; Lambers MJ, 2008, HUM REPROD, V23, P889, DOI 10.1093/humrep/dem409; Leroy F., 1985, IMPLANTATION HUMAN E; Lin SP, 2001, J ASSIST REPROD GEN, V18, P341, DOI 10.1023/A:1016640923269; LIVINGSTON JE, 1980, TERATOLOGY, V21, P139, DOI 10.1002/tera.1420210202; Lyu Q, 2015, FERTIL STERIL, V104, pE314, DOI 10.1016/j.fertnstert.2015.07.984; MACGILLIVRAY I, 1986, SEMIN PERINATOL, V10, P4; McNamara HC, 2016, AM J OBSTET GYNECOL, V214, P172, DOI 10.1016/j.ajog.2015.10.930; Menezo YJR, 2002, HUM REPROD, V17, P247, DOI 10.1093/humrep/17.1.247; Milki AA, 2003, FERTIL STERIL, V79, P503, DOI 10.1016/S0015-0282(02)04754-4; Montag M, 2000, BIOL REPROD, V62, P1738, DOI 10.1095/biolreprod62.6.1738; Papanikolaou EG, 2010, FERTIL STERIL, V93, P592, DOI 10.1016/j.fertnstert.2008.12.088; Schachter M, 2001, HUM REPROD, V16, P1264, DOI 10.1093/humrep/16.6.1264; SCHIEWE MC, 1995, FERTIL STERIL, V63, P288; SCHINZEL AAGL, 1979, J PEDIATR-US, V95, P921, DOI 10.1016/S0022-3476(79)80278-4; Scott Lynette, 2002, Reprod Biomed Online, V5, P276; Sills ES, 2000, HUM REPROD, V15, P890, DOI 10.1093/humrep/15.4.890; Skiadas CC, 2008, HUM REPROD, V23, P1366, DOI 10.1093/humrep/den045; Tan YQ, 2013, HUM REPROD, V28, P2581, DOI 10.1093/humrep/det271; Tarlatzis BC, 2002, FERTIL STERIL, V77, P196, DOI 10.1016/S0015-0282(01)02958-2; Van Langendonckt A, 2000, FERTIL STERIL, V74, P1047, DOI 10.1016/S0015-0282(00)01554-5; Verpoest W, 2009, HUM REPROD, V24, P2945, DOI 10.1093/humrep/dep280; Vitthala S, 2009, HUM REPROD UPDATE, V15, P45, DOI 10.1093/humupd/dmn045; Yan Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145172	43	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190776	10.1371/journal.pone.0190776	http://dx.doi.org/10.1371/journal.pone.0190776			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315321	gold, Green Published, Green Submitted			2022-12-26	WOS:000419655900023
J	Burgin, T; Stahlberg, J; Mayes, HB				Burgin, Tucker; Stahlberg, Jerry; Mayes, Heather B.			Advantages of a distant cellulase catalytic base	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY 6 CELLOBIOHYDROLASE; SUBSTRATE RING DISTORTION; TRICHODERMA-REESEI; GLYCOSIDE HYDROLASES; HUMICOLA-INSOLENS; CRYSTAL-STRUCTURE; ACTIVE-SITE; THERMOMONOSPORA-FUSCA; ANGSTROM RESOLUTION; MOLECULAR-DYNAMICS	The inverting glycoside hydrolase Trichoderma reesei (Hypocrea jecorina) Cel6A is a promising candidate for protein engineering for more economical production of biofuels. Until recently, its catalytic mechanism had been uncertain: The best candidate residue to serve as a catalytic base, Asp-175, is farther from the glycosidic cleavage site than in other glycoside hydrolase enzymes. Recent unbiased transition path sampling simulations revealed the hydrolytic mechanism for this more distant base, employing a water wire; however, it is not clear why the enzyme employs a more distant catalytic base, a highly conserved feature among homologs across different kingdoms. In this work, we describe molecular dynamics simulations designed to uncover how a base with a longer side chain, as in a D175E mutant, affects procession and active site alignment in the Michaelis complex. We show that the hydrogen bond network is tuned to the shorter aspartate side chain, and that a longer glutamate side chain inhibits procession as well as being less likely to adopt a catalytically productive conformation. Furthermore, we draw comparisons between the active site in Trichoderma reesei Cel6A and another inverting, processive cellulase to deduce the contribution of the water wire to the overall enzyme function, revealing that the more distant catalytic base enhances product release. Our results can inform efforts in the study and design of enzymes by demonstrating how counterintuitive sacrifices in chemical reactivity can have worthwhile benefits for other steps in the catalytic cycle.	[Burgin, Tucker; Mayes, Heather B.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Stahlberg, Jerry] Swedish Univ Agr Sci, Dept Mol Sci, SE-75007 Uppsala, Sweden	University of Michigan System; University of Michigan; Swedish University of Agricultural Sciences	Mayes, HB (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	hbmayes@umich.edu	Stahlberg, Jerry/D-4163-2013; Mayes, Heather/D-8755-2016	Mayes, Heather/0000-0001-9373-0106; Burgin, Tucker/0000-0002-3714-3537	National Science Foundation [ACI-1548562]	National Science Foundation(National Science Foundation (NSF))	This work used the Extreme Science and Engineering Discovery Environment (XSEDE) (47), which is supported by National Science Foundation Grant ACI-1548562. The authors declare that they have no conflicts of interest with the contents of this article.	ANDREA TA, 1983, J CHEM PHYS, V79, P4576, DOI 10.1063/1.446373; Beckham GT, 2014, CURR OPIN BIOTECH, V27, P96, DOI 10.1016/j.copbio.2013.12.002; BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Biddy MJ, 2016, ACS SUSTAIN CHEM ENG, V4, P3196, DOI 10.1021/acssuschemeng.6b00243; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2013, J BIOL CHEM, V288, P12175, DOI 10.1074/jbc.M113.462465; Case D.A, 2014, AMBER 14; Cragg SM, 2015, CURR OPIN CHEM BIOL, V29, P108, DOI 10.1016/j.cbpa.2015.10.018; Crowley MF, 2009, INT J QUANTUM CHEM, V109, P3767, DOI 10.1002/qua.22372; DAMUDE HG, 1995, BIOCHEMISTRY-US, V34, P2220, DOI 10.1021/bi00007a016; Davies GJ, 2000, BIOCHEM J, V348, P201, DOI 10.1042/0264-6021:3480201; Garcia-Guevara F., 2015, BIOCATALYSIS, V1, P109, DOI DOI 10.1515/BOCA-2015-0009; Gregg KJ, 2015, J BIOL CHEM, V290, P25657, DOI 10.1074/jbc.M115.680470; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kastner J, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2206775; Kastner J, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2052648; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Larsson AM, 2005, BIOCHEMISTRY-US, V44, P12915, DOI 10.1021/bi0506730; Li YC, 2007, APPL ENVIRON MICROB, V73, P3165, DOI 10.1128/AEM.02960-06; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mayes HB, 2016, CHEM SCI, V7, P5955, DOI 10.1039/c6sc00571c; Mayes HB, 2014, J AM CHEM SOC, V136, P1008, DOI 10.1021/ja410264d; Mertz B, 2005, BIOPOLYMERS, V79, P197, DOI 10.1002/bip.20347; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Nakamura A, 2016, J BIOL CHEM, V291, P22404, DOI 10.1074/jbc.M116.752048; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Renata H, 2015, ANGEW CHEM INT EDIT, V54, P3351, DOI 10.1002/anie.201409470; Riccardi D, 2008, BIOCHEMISTRY-US, V47, P2369, DOI 10.1021/bi701950j; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Sandgren M, 2013, J MOL BIOL, V425, P622, DOI 10.1016/j.jmb.2012.11.039; SPEZIO M, 1993, BIOCHEMISTRY-US, V32, P9906, DOI 10.1021/bi00089a006; STAHLBERG J, 1993, BIOCHIM BIOPHYS ACTA, V1157, P107, DOI 10.1016/0304-4165(93)90085-M; Thompson AJ, 2012, ACTA CRYSTALLOGR D, V68, P875, DOI 10.1107/S0907444912016496; Towns J, 2014, COMPUT SCI ENG, V16, P62, DOI 10.1109/MCSE.2014.80; Varrot A, 1999, BIOCHEM J, V337, P297, DOI 10.1042/0264-6021:3370297; Wolfgang DE, 1999, BIOCHEMISTRY-US, V38, P9746, DOI 10.1021/bi990401v; Wu M, 2013, J BIOL CHEM, V288, P33107, DOI 10.1074/jbc.M113.502765; Zhou WL, 2004, BIOCHEMISTRY-US, V43, P9655, DOI 10.1021/bi049394n; Zou JY, 1999, STRUCTURE, V7, P1035, DOI 10.1016/S0969-2126(99)80171-3	47	6	7	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 30	2018	293	13					4680	4687		10.1074/jbc.RA117.001186	http://dx.doi.org/10.1074/jbc.RA117.001186			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GB1YT	29321205	Green Published, hybrid			2022-12-26	WOS:000428848300011
J	Solomon, H; Dinowitz, N; Pateras, IS; Cooks, T; Shetzer, Y; Molchadsky, A; Charni, M; Rabani, S; Koifman, G; Tarcic, O; Porat, Z; Kogan-Sakin, I; Goldfinger, N; Oren, M; Harris, CC; Gorgoulis, VG; Rotter, V				Solomon, Hilla; Dinowitz, Nathan; Pateras, Ioannis S.; Cooks, Tomer; Shetzer, Yoav; Molchadsky, Alina; Charni, Meital; Rabani, Stav; Koifman, Gabriela; Tarcic, Ohad; Porat, Ziv; Kogan-Sakin, Ira; Goldfinger, Naomi; Oren, Moshe; Harris, Curtis C.; Gorgoulis, Vassilis G.; Rotter, Varda			Mutant p53 gain of function underlies high expression levels of colorectal cancer stem cells markers	ONCOGENE			English	Article							INFLAMMATION; ACTIVATION; HALLMARKS; PARADIGM; CULTURE; CRYPT	Emerging notion in carcinogenesis ascribes tumor initiation and aggressiveness to cancer stem cells (CSCs). Specifically, colorectal cancer (CRC) development was shown to be compatible with CSCs hypothesis. Mutations in p53 are highly frequent in CRC, and are known to facilitate tumor development and aggressiveness. Yet, the link between mutant p53 and colorectal CSCs is not well-established. In the present study, we set to examine whether oncogenic mutant p53 proteins may augment colorectal CSCs phenotype. By genetic manipulation of mutant p53 in several cellular systems, we demonstrated that mutant p53 enhances colorectal tumorigenesis. Moreover, mutant p53-expressing cell lines harbor larger sub-populations of cells highly expressing the known colorectal CSCs markers: CD44, Lgr5, and ALDH. This elevated expression is mediated by mutant p53 binding to CD44, Lgr5, and ALDH1A1 promoter sequences. Furthermore, ALDH1 was found to be involved in mutant p53-dependent chemotherapy resistance. Finally, analysis of ALDH1 and CD44 in human CRC biopsies indicated a positive correlation between their expression and the presence of oncogenic p53 missense mutations. These findings suggest novel insights pertaining the mechanism by which mutant p53 enhances CRC development, which involves the expansion of CSCs sub-populations within CRC tumors, and underscore the importance of targeting these sub-populations for CRC therapy.	[Solomon, Hilla; Dinowitz, Nathan; Shetzer, Yoav; Molchadsky, Alina; Charni, Meital; Rabani, Stav; Koifman, Gabriela; Tarcic, Ohad; Kogan-Sakin, Ira; Goldfinger, Naomi; Oren, Moshe; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Pateras, Ioannis S.; Gorgoulis, Vassilis G.] Univ Athens, Sch Med, Dept Histol Embryol, Mol Carcinogenesis Grp, Athens, Greece; [Cooks, Tomer; Harris, Curtis C.] NCI, Lab Human Carcinogenesis, NIH, Bldg 37, Bethesda, MD 20892 USA; [Porat, Ziv] Weizmann Inst Sci, Life Sci Fac, Flow Cytometry Unit, Rehovot, Israel	Weizmann Institute of Science; Athens Medical School; National & Kapodistrian University of Athens; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Weizmann Institute of Science	Rotter, V (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.	varda.rotter@weizmann.ac.il	Porat, Ziv/K-1672-2012; Ponce, Richard/A-3109-2017; Gorgoulis, Vassilis/AAD-3630-2019	Porat, Ziv/0000-0003-3059-181X; Ponce, Richard/0000-0001-5077-8417; Gorgoulis, Vassilis/0000-0001-9001-4112; koifman, gabriela/0000-0002-7728-5214; Cooks, Tomer/0000-0003-0853-3437; Charni-Natan, Meital/0000-0003-0221-1664; Oren, Moshe/0000-0003-4311-7172	Center of Excellence grant from Flight Attendant Medical Research Institute (FAMRI); Israel Science Foundation ISF-MOKED; Philip Garoon grant; NATIONAL CANCER INSTITUTE [Z01BC005795, ZIABC011496] Funding Source: NIH RePORTER	Center of Excellence grant from Flight Attendant Medical Research Institute (FAMRI); Israel Science Foundation ISF-MOKED; Philip Garoon grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to thank Dr. Ori Brenner for tumor histology analysis, to Dr. Ayala Sharp and Eitan Ariel for their help with the FACS experiments and to Dr. Tamar Unger for cloning consultation. This research was supported by a Center of Excellence grant from Flight Attendant Medical Research Institute (FAMRI), Israel Science Foundation ISF-MOKED and Philip Garoon grant. V.R. is the incumbent of the Norman and Helen Asher Professorial Chair for Cancer Research at the Weizmann Institute.	Alexandrova EM, 2015, NATURE, V523, P352, DOI 10.1038/nature14430; Aloni-Grinstein R, 2014, FEBS LETT, V588, P2580, DOI 10.1016/j.febslet.2014.02.011; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Boman BM, 2008, J CLIN ONCOL, V26, P2828, DOI 10.1200/JCO.2008.17.6941; Bouaoun L, 2016, HUM MUTAT, V37, P865, DOI 10.1002/humu.23035; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Cammareri P, 2008, METHOD CELL BIOL, V86, P311, DOI 10.1016/S0091-679X(08)00014-9; Charni M, 2016, CELL DEATH DIFFER, V23, P509, DOI 10.1038/cdd.2015.119; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; Deng Y, 2014, BRIT J CANCER, V110, P430, DOI 10.1038/bjc.2013.767; Di Fiore R, 2014, BONE, V60, P198, DOI 10.1016/j.bone.2013.12.021; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Januchowski R, 2013, BIOMED PHARMACOTHER, V67, P669, DOI 10.1016/j.biopha.2013.04.005; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Milyavsky M, 2003, CANCER RES, V63, P7147; Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108; Molchadsky A, 2017, CARCINOGENESIS, V38, P347, DOI 10.1093/carcin/bgw092; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sarig R, 2010, J EXP MED, V207, P2127, DOI 10.1084/jem.20100797; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shetzer Y, 2014, CELL DEATH DIFFER, V21, P1419, DOI 10.1038/cdd.2014.57; Shetzer Y, 2014, CARCINOGENESIS, V35, P1196, DOI 10.1093/carcin/bgu073; Solomon H, 2012, J CELL SCI, V125, P3144, DOI 10.1242/jcs.099663; Solomon H, 2011, J PATHOL, V225, P475, DOI 10.1002/path.2988; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Valent P, 2012, NAT REV CANCER, V12, P767, DOI 10.1038/nrc3368; Zeilstra J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072849; Zeuner A, 2014, CELL STEM CELL, V15, P692, DOI 10.1016/j.stem.2014.11.012; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	45	57	58	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	12					1669	1684		10.1038/s41388-017-0060-8	http://dx.doi.org/10.1038/s41388-017-0060-8			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GA8YC	29343849	hybrid, Green Accepted			2022-12-26	WOS:000428626700009
J	Croft, T; Raj, CJT; Salemi, M; Phinney, BS; Lin, SJ				Croft, Trevor; Raj, Christol James Theoga; Salemi, Michelle; Phinney, Brett S.; Lin, Su-Ju			A functional link between NAD(+) homeostasis and N-terminal protein acetylation in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN EXTENSION; NICOTINAMIDE MONONUCLEOTIDE ADENYLYLTRANSFERASE; CALORIE RESTRICTION; NMN ADENYLYLTRANSFERASE; CELLULAR-PROTEINS; GENE DISRUPTION; ACTIN CABLES; YEAST; TROPOMYOSIN; ACETYLTRANSFERASE	Nicotinamide adenine dinucleotide (NAD(+)) is an essential metabolite participating in cellular redox chemistry and signaling, and the complex regulation of NAD(+) metabolism is not yet fully understood. To investigate this, we established a NAD(+) intermediate specific reporter system to identify factors required for salvage of metabolically linked nicotinamide (NAM) and nicotinic acid (NA). Mutants lacking components of the NatB complex, NAT3 and MDM20, appeared as hits in this screen. NatB is an N-alpha-terminal acetyltransferase responsible for acetylation of the N terminus of specific Met-retained peptides. In NatB mutants, increased NA/NAM levels were concomitant with decreased NAD(+). We identified the vacuolar pool of nicotinamide riboside (NR) as the source of this increased NA/NAM. This NR pool is increased by nitrogen starvation, suggesting NAD(+) and related metabolites may be trafficked to the vacuole for recycling. Supporting this, increased NA/NAM release in NatB mutants was abolished by deleting the autophagy protein ATG14. We next examined Tpm1 (tropomyosin), whose function is regulated by NatB-mediated acetylation, and Tpm1 overexpression (TPM1-oe) was shown to restore some NatB mutant defects. Interestingly, although TPM1-oe largely suppressed NA/NAM release in NatB mutants, it did not restore NAD(+) levels. We showed that decreased nicotinamide mononucleotide adenylyltransferase (Nma1/Nma2) levels probably caused the NAD(+) defects, and NMA1-oe was sufficient to restore NAD(+). NatB-mediated N-terminal acetylation of Nma1 and Nma2 appears essential for maintaining NAD(+) levels. In summary, our results support a connection between NatB-mediated protein acetylation and NAD(+) homeostasis. Our findings may contribute to understanding the molecular basis and regulation of NAD(+) metabolism.	[Croft, Trevor; Raj, Christol James Theoga; Lin, Su-Ju] Univ Calif Davis, Coll Biol Sci, Dept Microbiol & Mol Genet, One Shields Ave, Davis, CA 95616 USA; [Salemi, Michelle; Phinney, Brett S.] Univ Calif Davis, Prote Core Facil, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Lin, SJ (corresponding author), Univ Calif Davis, Coll Biol Sci, Dept Microbiol & Mol Genet, One Shields Ave, Davis, CA 95616 USA.	slin@ucdavis.edu	Phinney, Brett/S-6404-2016	Phinney, Brett/0000-0003-3870-3302	NIGMS, National Institutes of Health [GM102297]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102297] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIGMS, National Institutes of Health, Grant GM102297. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aksnes H, 2015, INT REV CEL MOL BIO, V316, P267, DOI 10.1016/bs.ircmb.2015.01.001; An ZY, 2014, AUTOPHAGY, V10, P1702, DOI 10.4161/auto.32122; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bedalov A, 2003, MOL CELL BIOL, V23, P7044, DOI 10.1128/MCB.23.19.7044-7054.2003; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019710; Bern Marshall, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1320s40; Bieganowski P, 2006, J BIOL CHEM, V281, P22439, DOI 10.1074/jbc.M513919200; Brachmann CB, 1998, YEAST, V14, P115; Brown KD, 2014, CELL METAB, V20, P1059, DOI 10.1016/j.cmet.2014.11.003; Burke D., 2000, METHODS YEAST GENETI, P171; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chen SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aal3655; Chini CCS, 2017, MOL CELL ENDOCRINOL, V455, P62, DOI 10.1016/j.mce.2016.11.003; Delorme-Axford E, 2015, METHODS, V75, P3, DOI 10.1016/j.ymeth.2014.12.008; DREES B, 1995, J CELL BIOL, V128, P383, DOI 10.1083/jcb.128.3.383; Easlon E, 2008, GENE DEV, V22, P931, DOI 10.1101/gad.1648308; Effelsberg D, 2015, J BIOL CHEM, V290, P25333, DOI 10.1074/jbc.M115.653451; Emanuelli M, 1999, FEBS LETT, V455, P13, DOI 10.1016/S0014-5793(99)00852-2; Emanuelli M, 2003, PROTEIN EXPRES PURIF, V27, P357, DOI 10.1016/S1046-5928(02)00645-9; Fogel AI, 2013, MOL CELL BIOL, V33, P3675, DOI 10.1128/MCB.00079-13; Gallo CA, 2004, MOL CELL BIOL, V24, P1301, DOI 10.1128/MCB.24.3.1301-1312.2004; Garten A, 2015, NAT REV ENDOCRINOL, V11, P535, DOI 10.1038/nrendo.2015.117; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Giardina BJ, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-9; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Helbig AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-685; HERMANN GJ, 1997, J CELL BIOL, V137, P141, DOI 10.1083/jcb.137.1.141; Hong HY, 2017, STRUCTURE, V25, P641, DOI 10.1016/j.str.2017.03.003; Huckaba TM, 2006, J CELL BIOL, V175, P957, DOI 10.1083/jcb.200609155; Huckaba TM, 2004, J CELL BIOL, V167, P519, DOI 10.1083/jcb.200404173; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Kato M, 2014, DNA REPAIR, V23, P49, DOI 10.1016/j.dnarep.2014.07.009; Kato M, 2014, J BIOL CHEM, V289, P15577, DOI 10.1074/jbc.M114.558643; Kim HK, 2014, CELL, V156, P158, DOI 10.1016/j.cell.2013.11.031; Kulikova V, 2015, J BIOL CHEM, V290, P27124, DOI 10.1074/jbc.M115.664458; Lee KE, 2016, MOL CELLS, V39, P169, DOI 10.14348/molcells.2016.2329; Lin JB, 2016, CELL REP, V17, P69, DOI 10.1016/j.celrep.2016.08.073; LIU H, 1989, CELL, V57, P233, DOI 10.1016/0092-8674(89)90961-6; LIU HP, 1992, J CELL BIOL, V118, P285, DOI 10.1083/jcb.118.2.285; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu SP, 2011, J BIOL CHEM, V286, P14271, DOI 10.1074/jbc.M110.217885; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Monda JK, 2013, STRUCTURE, V21, P42, DOI 10.1016/j.str.2012.10.013; NATALINI P, 1986, BIOCHEMISTRY-US, V25, P3725, DOI 10.1021/bi00360a037; Nikiforov A, 2015, CRIT REV BIOCHEM MOL, V50, P284, DOI 10.3109/10409238.2015.1028612; Polevoda B, 2003, J BIOL CHEM, V278, P30686, DOI 10.1074/jbc.M304690200; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Prosser DC, 2011, J CELL BIOL, V195, P657, DOI 10.1083/jcb.201104045; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Shemorry A, 2013, MOL CELL, V50, P540, DOI 10.1016/j.molcel.2013.03.018; Singer JM, 2000, GENETICS, V156, P523; Singer JM, 2003, P NATL ACAD SCI USA, V100, P7644, DOI 10.1073/pnas.1232343100; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Steiger MA, 2005, RNA, V11, P99, DOI 10.1261/rna.7194605; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263; TOHE A, 1973, J BACTERIOL, V113, P727, DOI 10.1128/JB.113.2.727-738.1973; Tsang F, 2015, J BIOL CHEM, V290, P12753, DOI 10.1074/jbc.M115.644534; Van Damme P, 2012, P NATL ACAD SCI USA, V109, P12449, DOI 10.1073/pnas.1210303109; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; Williams PA, 2017, SCIENCE, V355, P756, DOI 10.1126/science.aal0092; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu YF, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.21; Yang Y, 2016, BBA-PROTEINS PROTEOM, V1864, P1787, DOI 10.1016/j.bbapap.2016.06.014; Yoon MJ, 2015, CELL METAB, V21, P706, DOI 10.1016/j.cmet.2015.04.002; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247	75	14	14	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2927	2938		10.1074/jbc.M117.807214	http://dx.doi.org/10.1074/jbc.M117.807214			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29317496	Green Published, hybrid			2022-12-26	WOS:000426051900026
J	Herbert, JA; Mitchell, AM; Ritchie, R; Ma, JT; Ross-Hutchinson, K; Mitchell, TJ				Herbert, Jenny A.; Mitchell, Andrea M.; Ritchie, Ryan; Ma, Jiangtao; Ross-Hutchinson, Kirsty; Mitchell, Timothy J.			Expression of the lux genes in Streptococcus pneumoniae modulates pilus expression and virulence	PLOS ONE			English	Article							COLI CHEMOSTAT CULTURES; PROTEIN-KINASE STKP; ESCHERICHIA-COLI; BACTERIAL BIOLUMINESCENCE; PNEUMOCOCCAL PILUS; LACTOCOCCUS-LACTIS; GLUCOSE-METABOLISM; NADH AVAILABILITY; INVASIVE DISEASE; IN-VIVO	Bioluminescence has been harnessed for use in bacterial reporter systems and for in vivo imaging of infection in animal models. Strain Xen35, a bioluminescent derivative of Streptococcus pneumoniae serotype 4 strain TIGR4 was previously constructed for use for in vivo imaging of infections in animal models. We have shown that strain Xen35 is less virulent than its parent TIGR4 and that this is associated with the expression of the genes for bioluminescence. The expression of the luxA-E genes in the pneumococcus reduces virulence and down regulates the expression of the pneumococcal pilus.	[Herbert, Jenny A.; Mitchell, Andrea M.; Mitchell, Timothy J.] Univ Birmingham, Coll Med & Dent Sci, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Herbert, Jenny A.; Mitchell, Andrea M.; Ritchie, Ryan; Ma, Jiangtao; Ross-Hutchinson, Kirsty; Mitchell, Timothy J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Mitchell, Andrea M.] Univ Birmingham, Coll Med & Dent Sci, Infrastruct & Facil, Birmingham, W Midlands, England	University of Birmingham; University of Glasgow; University of Birmingham	Mitchell, TJ (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Microbiol & Infect, Birmingham, W Midlands, England.; Mitchell, TJ (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	t.j.mitchell@bham.ac.uk		Herbert, Jenny/0000-0003-4179-775X; Mitchell, Andrea/0000-0002-2530-4460	Biotechnology and Biological Sciences Research Council (BBSRC)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work was funded using a PhD studentship for Dr Jenny Herbert from the Biotechnology and Biological Sciences Research Council (BBSRC).; We would like to thank Ms Julie Glabraith and Dr Pawel Herzyk of the Glasgow Polyomics Facility for their help in processing DNA samples and running the sequencing for the WGS and RNA-seq, and post sequencing processing. We would also like to thank the BBSRC for funding.	Auzat I, 1999, MOL MICROBIOL, V34, P1018, DOI 10.1046/j.1365-2958.1999.01663.x; Barman Tarani Kanta, 2011, Indian J Med Res, V134, P688, DOI 10.4103/0971-5916.90997; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Basset A, 2011, INFECT IMMUN, V79, P2974, DOI 10.1128/IAI.05117-11; Beilharz K, 2012, P NATL ACAD SCI USA, V109, pE905, DOI 10.1073/pnas.1119172109; Berrios-Rivera SJ, 2002, METAB ENG, V4, P230, DOI 10.1006/mben.2002.0228; Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; Blue CE, 2003, INFECT IMMUN, V71, P4405, DOI 10.1128/IAI.71.8.4405-4413.2003; BOYLAN M, 1989, PHOTOCHEM PHOTOBIOL, V49, P681, DOI 10.1111/j.1751-1097.1989.tb08441.x; Carvalho SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026707; Chi F, 2007, J BACTERIOL, V189, P6085, DOI 10.1128/JB.00468-07; Croucher NJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002745; De Angelis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021269; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Francis KP, 2001, INFECT IMMUN, V69, P3350, DOI 10.1128/IAI.69.5.3350-3358.2001; Guiral S, 2006, MICROBIOL-SGM, V152, P343, DOI 10.1099/mic.0.28433-0; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Havarstein LS, 1996, MOL MICROBIOL, V21, P863, DOI 10.1046/j.1365-2958.1996.521416.x; HAVARSTEIN LS, 1995, P NATL ACAD SCI USA, V92, P11140, DOI 10.1073/pnas.92.24.11140; Hendriksen WT, 2007, J BACTERIOL, V189, P1382, DOI 10.1128/JB.01144-06; Henken S, 2010, ANTIMICROB AGENTS CH, V54, P3155, DOI 10.1128/AAC.00310-10; Herbert JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127212; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; JABLONSKI E, 1977, BIOCHEMISTRY-US, V16, P2932, DOI 10.1021/bi00632a020; Johnson AW, 2013, ANN OTO RHINOL LARYN, V122, P344, DOI 10.1177/000348941312200510; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; MICHALISZYN GA, 1977, J BIOL CHEM, V252, P7495; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Molzen TE, 2011, INFECT IMMUN, V79, P288, DOI 10.1128/IAI.00631-10; Neves AR, 2002, APPL ENVIRON MICROB, V68, P6332, DOI 10.1128/AEM.68.12.6332-6342.2002; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Orihuela CJ, 2003, SCAND J INFECT DIS, V35, P647, DOI 10.1080/00365540310015854; Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000; Pericone CD, 2003, J BACTERIOL, V185, P6815, DOI 10.1128/JB.185.23.6815-6825.2003; Ramos A, 2004, MICROBIOL-SGM, V150, P1103, DOI 10.1099/mic.0.26695-0; Ramos-Montanez S, 2010, J BACTERIOL, V192, P6390, DOI 10.1128/JB.00995-10; Read HM, 2016, PEERJ, V4, DOI 10.7717/peerj.2130; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; Saanchez AM, 2005, J BIOTECHNOL, V117, P395, DOI 10.1016/j.jbiotec.2005.02.006; Sandgren A, 2005, J INFECT DIS, V192, P791, DOI 10.1086/432513; Saskova L, 2007, J BACTERIOL, V189, P4168, DOI 10.1128/JB.01616-06; Silva NA, 2006, INFECT IMMUN, V74, P3513, DOI 10.1128/IAI.00079-06; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; van der Linden M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008286; Vemuri GN, 2006, APPL ENVIRON MICROB, V72, P3653, DOI 10.1128/AEM.72.5.3653-3661.2006	51	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0189426	10.1371/journal.pone.0189426	http://dx.doi.org/10.1371/journal.pone.0189426			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342160	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000422653800007
J	Lee, EY; Choi, HY; Cho, H; Kim, BH; Ki, M				Lee, Eun-young; Choi, Hwa Young; Cho, Hyunsoon; Kim, Bo Hyun; Ki, Moran			Health behavior associated with liver enzymes among obese Korean adolescents, 2009-2014	PLOS ONE			English	Article							DISEASE; CHILDREN; PREVALENCE; DIET	Aims Obesity is major risk factor for liver health. This study aimed to clarify whether specific health behaviors were associated with liver function in obese adolescents in Korea. Methods Based on national school health examination data from 2009 to 2014, 25,142 obese or overweight students were examined for aspartate transaminase and alanine transaminase levels, and health behaviors. Multiple logistic regression was used to calculate the odds ratio for liver enzyme elevation. Results Subjects who thought of themselves as "very fat" had a 1.6 times higher odds ratio for liver enzyme elevations than those who thought of themselves as "normal." Those who consumed fast food 3 to 5 times weekly had 1.3 times higher odds ratio (OR = 1.27, 95% confidence interval = 1.05-1.54) for the elevation of ALT than those who did not consume fast food. Those who took sugar-sweetened beverage 3 to 5 times weekly had 1.2 times higher odds ratio (OR = 1.24, 95% confidence interval = 1.07-1.42) for the elevation of ALT than those who did not take it. Those who played computer game more than 2 hours a day showed 1.1 times higher odds ratio (OR = 1.10, 95% confidence interval = 1.01-1.21) for the elevation of ALT than those who did not. Conclusions Specific food item and its frequency of consumption were identified for the positive and negative association with the elevation of liver enzymes. Self-image of body shape, sleeping time and need of help for alcohol or smoking problems also showed substantial association with the elevation.	[Lee, Eun-young; Choi, Hwa Young; Cho, Hyunsoon; Ki, Moran] Natl Canc Ctr Goyang, Grad Sch Canc Sci & Policy, Dept Canc Control & Populat Hlth, Goyang, South Korea; [Kim, Bo Hyun] Natl Canc Ctr Goyang, Ctr Liver Canc, Goyang, South Korea		Ki, M (corresponding author), Natl Canc Ctr Goyang, Grad Sch Canc Sci & Policy, Dept Canc Control & Populat Hlth, Goyang, South Korea.	moranki@ncc.re.kr	Ki, Moran/R-6600-2019	Ki, Moran/0000-0002-8892-7104	National Cancer Center, Korea [NCC-1410860]; International Cooperation & Education Program of National Cancer Center, Korea [NCCRI.NCCI 52210-52211]	National Cancer Center, Korea; International Cooperation & Education Program of National Cancer Center, Korea	This work was supported in part by grants from the National Cancer Center, Korea (NCC-1410860) and International Cooperation & Education Program (#NCCRI.NCCI 52210-52211, 2017) of National Cancer Center, Korea.	Ahmad A, 2015, J ORAL SCI, V57, P335, DOI 10.2334/josnusd.57.335; [Anonymous], 2014, RES SCH HLTH EX 2014; [Anonymous], 2015, 11 KOR YOUTH BEH WEB, P204; Fraser A, 2007, GASTROENTEROLOGY, V133, P1814, DOI 10.1053/j.gastro.2007.08.077; Gibson PS, 2015, NUTRIENTS, V7, P9721, DOI 10.3390/nu7125494; Iwata KA Toyoto, ASS DIETARY LIFESTYL; Ma JT, 2015, J HEPATOL, V63, P462, DOI 10.1016/j.jhep.2015.03.032; Navarro-Jarabo JM, 2013, J GASTROEN HEPATOL, V28, P1532, DOI 10.1111/jgh.12276; Martins C, 2015, J SPORT SCI MED, V14, P103; Nho HN, 2009, PEDIATR GASTROENTERO, V12, P207, DOI 10.5223/kjpgn.2009.12.2.207; Oddy WH, 2013, AM J GASTROENTEROL, V108, P778, DOI 10.1038/ajg.2013.95; Park HS, 2005, AM J CLIN NUTR, V82, P1046, DOI 10.1093/ajcn/82.5.1046; Park NH, 2010, INTERVIROLOGY, V53, P20, DOI 10.1159/000252780; Park SH, 2012, J PEDIATR GASTR NUTR, V55, P668, DOI 10.1097/MPG.0b013e3182660669; Reinehr T, 2009, ARCH DIS CHILD, V94, P437, DOI 10.1136/adc.2008.143594; Skinner AC, 2014, JAMA PEDIATR, V168, P561, DOI 10.1001/jamapediatrics.2014.21; Vere CC, 2009, WORLD J GASTROENTERO, V15, P2980, DOI 10.3748/wjg.15.2980; Wiener RC, 2016, INT J INFLAMM, V2016, DOI 10.1155/2016/3901402	18	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190535	10.1371/journal.pone.0190535	http://dx.doi.org/10.1371/journal.pone.0190535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342171	gold, Green Published, Green Submitted			2022-12-26	WOS:000422653800025
J	Chen, F; Yang, M; Li, Q; Pan, J; Li, XS; Meng, Q				Chen, Fei; Yang, Min; Li, Qian; Pan, Jay; Li, Xiaosong; Meng, Qun			Does providing more services increase the primary hospitals' revenue? An assessment of national essential medicine policy based on 2,675 counties in China	PLOS ONE			English	Article							MULTILEVEL ANALYSIS; SOCIAL EPIDEMIOLOGY; CARE FACILITIES; PROVINCE; IMPACT	Objective To understand whether the increased outpatient service provision (OSP) brings in enough additional income (excluding income from essential medicine) for primary hospitals (INCOME) to compensate for reduced costs of medicine. Methods The two outcomes, annual OSP and INCOME for the period of 2008-2012, were collected from 34,506 primary hospitals in 2,675 counties in 31 provinces in China by the national surveillance system. The data had a four-level hierarchical structure; time points were nested within primary hospital, hospitals within county, and counties within province. We fitted bivariate five-level random effects regression models to examine correlations between OSP and INCOME in terms of their mean values and dose-response effects of the essential medicine policy (EMP). We adjusted for the effects of time period and selected hospital resources. Findings The estimated correlation coefficients between the two outcomes' mean values were strongly positive among provinces (r = 0.910), moderately positive among counties (r = 0.380), and none among hospitals (r = 0.002) and time (r = 0.007). The correlation between their policy effects was weakly positive among provinces (r = 0.234), but none at the county and hospital levels. However, there were markedly negative correlation coefficients between the mean and policy effects at -0.328 for OSP and -0.541 for INCOME at the hospital level. Conclusion There was no evidence to suggest an association between the two outcomes in terms of their mean values and dose-response effects of EMP at the hospital level. This indicated that increased OSP did not bring enough additional INCOME. Sustainable mechanisms to for this work.	[Chen, Fei; Pan, Jay; Li, Xiaosong] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China; [Yang, Min; Li, Qian; Pan, Jay] Sichuan Univ, West China Res Ctr Rural Hlth Dev, Chengdu, Sichuan, Peoples R China; [Meng, Qun] Natl Hlth & Family Planning Commiss China, Ctr Hlth Informat & Stat, Beijing, Peoples R China	Sichuan University; Sichuan University	Li, XS (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China.; Yang, M (corresponding author), Sichuan Univ, West China Res Ctr Rural Hlth Dev, Chengdu, Sichuan, Peoples R China.	yangmin2013@scu.edu.cn; lixiaosong1101@126.com	Pan, Jay/Z-4492-2019	Pan, Jay/0000-0001-9501-1535				Ai-tian Y, 2011, CHINESE HLTH EC, V04, P20; Chen L, 2012, CHINESE J HLTH POLIC, V4, P7; China Central Government, 2009, IMPL PLAN REC PRIOR; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Du N, 2015, CHINA EC STUDIES, V1, P8; Fang Y, 2013, LANCET GLOB HEALTH, V1, pE227, DOI 10.1016/S2214-109X(13)70072-X; Gai X, 2005, PSYCHOL SCI, V28, P429; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; Goldstein H, 2009, STAT MODEL, V9, P173, DOI 10.1177/1471082X0800900301; Hipgrave D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001337; Huang Donghong, 2015, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V40, P222, DOI 10.11817/j.issn.1672-7347.2015.02.018; [金芳 Jin Fang], 2004, [中国卫生统计, Chinese Journal of Health Statistics], V21, P204; [金有豫 Jin Youyu], 2011, [中国药房, China Pharmacy], V22, P293; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Liu H, 2012, CHINESE J DRUG EVALU, V29, P270; Liu Z, 2014, CHINESE HLTH EC, V33, P8; Merlo J, 2003, J EPIDEMIOL COMMUN H, V57, P550, DOI 10.1136/jech.57.8.550; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Ministry of Health of China, 2011, EST NAT ESS MED SYST; National Bureau of Statistics of China, 2013, CHIN CIT STAT YB 201; National Health and Family Planning Commission, 2013, NAT HLTH FAM PLAN CO; Rasbash J., 2012, USERS GUIDE MLWIN VE; Rasbash J, 2009, MLWIN VERSION 21; Roux AVD, 2002, J EPIDEMIOL COMMUN H, V56, P588, DOI 10.1136/jech.56.8.588; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Song Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0507-3; Song Yan, 2014, J Pharm Policy Pract, V7, P12, DOI 10.1186/2052-3211-7-12; Tang YQ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-183; Wang S, 2011, CHINESE J HLTH POLIC, V4, P30; Wang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090365; Xu SM, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1073-z; Yang C, 2012, CHIN J HLTH POLICY, V05, P35; Yang H, 2014, PRACTICAL PREVENTIVE, V21, P1405; Yang L, 2013, B WORLD HEALTH ORGAN, V91, P184, DOI 10.2471/BLT.11.097998; Yang LP, 2013, HEALTH POLICY PLANN, V28, P750, DOI 10.1093/heapol/czs116; Yang M, 2015, LANCET, V386, P28, DOI 10.1016/S0140-6736(15)00606-6; Yu F, 2011, CHINESE HLTH EC, V1, P18; Yu W, 2015, SHANGHAI MED PHARM J, V3, P16; [曾丽 Zeng Li], 2011, [中国药房, China Pharmacy], V22, P3758; Zhou L, 2013, CHONGQING MED, V5, P20; Zhou Z, 2015, PLOS ONE, V10	41	0	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190855	10.1371/journal.pone.0190855	http://dx.doi.org/10.1371/journal.pone.0190855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29338028	gold, Green Published, Green Submitted			2022-12-26	WOS:000422652700021
J	Bonaudo, M; Martorana, M; Dimonte, V; D'Alfonso, A; Fornero, G; Politano, G; Gianino, MM				Bonaudo, Marco; Martorana, Maria; Dimonte, Valerio; D'Alfonso, Alessandra; Fornero, Giulio; Politano, Gianfranco; Gianino, Maria Michela			Medication discrepancies across multiple care transitions: A retrospective longitudinal cohort study in Italy	PLOS ONE			English	Article							PATIENTS AFTER-DISCHARGE; PATIENT SAFETY; HOSPITAL DISCHARGE; ADVERSE EVENTS; RECONCILIATION; ADMISSION; INPATIENT; ERRORS; IMPLEMENTATION; INFORMATION	Purpose Medication discrepancies are defined as unexplained differences among regimens across different sites of care. The problem of medication discrepancies that occur during the entire care pathway from hospital admission to a local care setting discharge (namely all types of settings dedicated to formal care other than hospitals) has received little attention in the medical literature. The present study aims to (1) determine the prevalence of medication discrepancies that occur during the entire care pathway from hospital admission to local care setting discharge, (2) describe the discrepancy and medication type, and (3) identify potential risk factors for experiencing medication discrepancies in patient care transitions. Evidence from an integrated health care system, such as the Italian one, may explain results from other studies in different healthcare systems. Methods A retrospective longitudinal cohort study of patients admitted from July 2015 to July 2016 to the Giovanni Bosco Hospital serving Turin, Italy and its surrounding territory was performed. Discrepancies were recorded at the following four care transitions: T1: Hospital admission; T2: Hospital discharge; T3: Admission into local care settings; T4: Discharge from local care settings. All evaluations were based on documented regimens and were performed by a team (doctor, nurse and pharmacists). Results Of 366 included patients, 25.68% had at least one discrepancy. The most frequent type of discrepancy was from medication omission (N =74; 71.15%). Only discharge from a long-stay care setting (T4) was significantly associated with the onset of discrepancies (p = 0.045). When considering a lack of adequate documentation, not as missing data but as a discrepancy, 43.72% of patients had at least one discrepancy. Conclusions This study suggests that an integrated health care system, such as Italian system, may influence the prevalence of discrepancies, thus highlighting the need for structured multidisciplinary and, if possible, computerized medication reconciliation to prevent medication discrepancies and improve the quality of medical documentation.	[Bonaudo, Marco; Martorana, Maria; Dimonte, Valerio; Gianino, Maria Michela] Univ Torino, Dept Publ Hlth Sci & Pediat, Turin, Italy; [D'Alfonso, Alessandra] ASLTO2, Publ Hlth Author, Turin, Italy; [Fornero, Giulio] Teaching Hosp, AOU Citta Salute & Sci, Turin, Italy; [Politano, Gianfranco] Politecn Torino, Dept Control & Comp Engn, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; Polytechnic University of Turin	Bonaudo, M (corresponding author), Univ Torino, Dept Publ Hlth Sci & Pediat, Turin, Italy.	marco.bonaudo@unito.it		Bonaudo, Marco/0000-0001-9278-8998; DIMONTE, Valerio/0000-0002-0003-3481				[Anonymous], 2021, LANG ENV STAT COMP; ASL TO2, 2015, ATT AZ ASL TO2; Bayoumi I, 2009, ANN PHARMACOTHER, V43, P1667, DOI 10.1345/aph.1M059; Belda-Rustarazo S, 2015, INT J CLIN PRACT, V69, P1268, DOI 10.1111/ijcp.12701; Blank LJ, 2012, GERIATR NURS, V33, P401, DOI 10.1016/j.gerinurse.2012.07.007; Bruce Bayley K, 2007, Ther Clin Risk Manag, V3, P695; Huynh C, 2016, INT J PHARM PRACT, V24, P196, DOI 10.1111/ijpp.12229; Climente-Marti M, 2010, ANN PHARMACOTHER, V44, P1747, DOI 10.1345/aph.1P184; Coleman EA, 2005, ARCH INTERN MED, V165, P1842, DOI 10.1001/archinte.165.16.1842; Cornish PL, 2005, ARCH INTERN MED, V165, P424, DOI 10.1001/archinte.165.4.424; Cua YM, 2008, ANN ACAD MED SINGAP, V37, P136; Delate T, 2008, PHARMACOTHERAPY, V28, P444, DOI 10.1592/phco.28.4.444; Forster AJ, 2004, CAN MED ASSOC J, V170, P345; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Gonzalez-Garcia L, J EVAL CLIN PRACT; Hellstrom Lina M, 2012, BMC Clin Pharmacol, V12, P9, DOI 10.1186/1472-6904-12-9; Kramer JS, 2007, AM J HEALTH-SYST PH, V64, P404, DOI 10.2146/ajhp060506; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Kwan JL, 2013, ANN INTERN MED, V158, P397, DOI 10.7326/0003-4819-158-5-201303051-00006; Lau HS, 2000, BRIT J CLIN PHARMACO, V49, P597, DOI 10.1046/j.1365-2125.2000.00204.x; Laugaland K, 2012, WORK, V41, P2915, DOI 10.3233/WOR-2012-0544-2915; Maresca ER, 2012, BOLL SIFO, V58, P17; Ministero della Salute-D.G. Programmazione sanitaria, 2015, RIC TER FARM; Monfort AS, 2016, INT J CLIN PHARM-NET, V38, P838, DOI 10.1007/s11096-016-0292-7; Monte AA, 2015, J EMERG MED, V49, P78, DOI 10.1016/j.jemermed.2014.12.052; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Agud MM, 2016, INT J CLIN PHARM-NET, V38, P996, DOI 10.1007/s11096-016-0331-4; Mueller SK, 2012, ARCH INTERN MED, V172, P1057, DOI 10.1001/archinternmed.2012.2246; Nemeth Lynne S, 2010, J Patient Saf, V6, P238, DOI 10.1097/PTS.0b013e3181fe401f; Pherson EC, 2014, AM J HEALTH-SYST PH, V71, P1576, DOI 10.2146/ajhp130764; Pippins JR, 2008, J GEN INTERN MED, V23, P1414, DOI 10.1007/s11606-008-0687-9; Redmond P, 2016, FAM PRACT, V33, P172, DOI 10.1093/fampra/cmw006; Smith Jodi D, 2004, Am J Geriatr Pharmacother, V2, P141, DOI 10.1016/S1543-5946(04)90019-0; Stewart AL, 2014, PHARM PRACT, V12; Tam VC, 2005, CAN MED ASSOC J, V173, P510, DOI 10.1503/cmaj.045311; Tjia J, 2009, J GEN INTERN MED, V24, P630, DOI 10.1007/s11606-009-0948-2; Unroe KT, 2010, AM J GERIATR PHARMAC, V8, P115, DOI 10.1016/j.amjopharm.2010.04.002; van Sluisveld N, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-170; Varadarajan RR, 2016, RES SOC ADM PHARM, V12; Whittington John, 2004, Qual Manag Health Care, V13, P53; Wong JD, 2008, ANN PHARMACOTHER, V42, P1373, DOI 10.1345/aph.1L190; World Health Organization (WHO), 2013, ACT PAT SAF HIGH 5S	42	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191028	10.1371/journal.pone.0191028	http://dx.doi.org/10.1371/journal.pone.0191028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329310	Green Published, gold, Green Submitted			2022-12-26	WOS:000419954100032
J	Kyrklund, M; Kummu, O; Kankaanpaa, J; Akhi, R; Nissinen, A; Turunen, SP; Pussinen, P; Wang, CG; Horkko, S				Kyrklund, Mikael; Kummu, Outi; Kankaanpaa, Jari; Akhi, Ramin; Nissinen, Antti; Turunen, S. Pauliina; Pussinen, Pirkko; Wang, Chunguang; Horkko, Sohvi			Immunization with gingipain A hemagglutinin domain of Porphyromonas gingivalis induces IgM antibodies binding to malondialdehyde-acetaldehyde modified low-density lipoprotein	PLOS ONE			English	Article							FC-ALPHA-RI; NATURAL ANTIBODIES; PERIODONTAL-DISEASE; ATHEROSCLEROSIS; INTERLEUKIN-6; CELLS; PROTEINS; IMMUNITY; INFLAMMATION; MECHANISMS	Treatment of periodontitis has beneficial effects on systemic inflammation markers that relate to progression of atherosclerosis. We aimed to investigate whether immunization with A hemagglutinin domain (Rgp44) of Porphyromonas gingivalis (Pg), a major etiologic agent of periodontitis, would lead to an antibody response cross-reacting with oxidized low-density lipoprotein (OxLDL) and how it would affect the progression of atherosclerosis in low-density lipoprotein receptor-deficient (LDLR-/-) mice. The data revealed a prominent IgM but not IgG response to malondialdehyde-acetaldehyde modified LDL (MAA-LDL) after Rgp44 and Pg immunizations, implying that Rgp44/Pgand MAA adducts may share cross-reactive epitopes that prompt IgM antibody production and consequently confer atheroprotection. A significant negative association was observed between atherosclerotic lesion and plasma IgA to Rgp44 in Rgp44 immunized mice, supporting further the anti-atherogenic effect of Rgp44 immunization. Plasma IgA levels to Rgp44 and to Pg in both Rgp44-and Pg-immunized mice were significantly higher than those in saline control, suggesting that IgA to Rgp44 could be a surrogate marker of immunization in Pg-immunized mice. Distinct antibody responses in plasma IgA levels to MAA-LDL, to Pg lipopolysaccharides (Pg-LPS), and to phosphocholine (PCho) were observed after Rgp44 and Pg immunizations, indicating that different immunogenic components between Rpg44 and Pg may behave differently in regard of their roles in the development of atherosclerosis. Immunization with Rgp44 also displayed atheroprotective features in modulation of plaque size through association with plasma levels of IL-1 alpha whereas whole Pg bacteria achieved through regulation of antiinflammatory cytokine levels of IL-5 and IL-10. The present study may contribute to refining therapeutic approaches aiming to modulate immune responses and inflammatory/antiinflammatory processes in atherosclerosis.	[Kyrklund, Mikael; Kummu, Outi; Kankaanpaa, Jari; Akhi, Ramin; Nissinen, Antti; Turunen, S. Pauliina; Wang, Chunguang; Horkko, Sohvi] Univ Oulu, Fac Med, Res Unit Biomed, Med Microbiol & Immunol, Oulu, Finland; [Kyrklund, Mikael; Kummu, Outi; Kankaanpaa, Jari; Akhi, Ramin; Nissinen, Antti; Turunen, S. Pauliina; Wang, Chunguang; Horkko, Sohvi] Univ Hosp, Med Res Ctr, Oulu, Finland; [Kyrklund, Mikael; Kummu, Outi; Kankaanpaa, Jari; Akhi, Ramin; Nissinen, Antti; Turunen, S. Pauliina; Wang, Chunguang; Horkko, Sohvi] Univ Hosp, Nordlab Oulu, Oulu, Finland; [Kyrklund, Mikael; Kummu, Outi; Kankaanpaa, Jari; Akhi, Ramin; Nissinen, Antti; Turunen, S. Pauliina; Wang, Chunguang; Horkko, Sohvi] Univ Oulu, Oulu, Finland; [Pussinen, Pirkko] Univ Helsinki, Oral & Maxillofacial Dis, Helsinki, Finland; [Pussinen, Pirkko] Helsinki Univ Hosp, Helsinki, Finland; [Turunen, S. Pauliina] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	University of Oulu; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Karolinska Institutet	Wang, CG; Horkko, S (corresponding author), Univ Oulu, Fac Med, Res Unit Biomed, Med Microbiol & Immunol, Oulu, Finland.; Wang, CG; Horkko, S (corresponding author), Univ Hosp, Med Res Ctr, Oulu, Finland.; Wang, CG; Horkko, S (corresponding author), Univ Hosp, Nordlab Oulu, Oulu, Finland.; Wang, CG; Horkko, S (corresponding author), Univ Oulu, Oulu, Finland.	chunguang.wang@oulu.fi; sohvi.horkko@oulu.fi	Wang, Chunguang/AAE-7054-2020; Wang, Chunguang/AAE-6997-2020	Wang, Chunguang/0000-0001-5569-321X; Pussinen, Pirkko/0000-0003-3563-1876; Akhi, Ramin/0000-0003-1783-5330; Nissinen, Antti/0000-0003-4771-2753; Turunen, S. Pauliina/0000-0001-8060-9876; Kummu, Outi/0000-0003-0327-3496	Sigrid Juselius Foundation; Finnish Foundation for Cardiovascular Research	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Cardiovascular Research	This study was funded by Sigrid Juselius Foundation and Finnish Foundation for Cardiovascular Research. Sigrid Juselius Foundation webpage: http://sigridjuselius.fi/sv/Finnish Foundation for Cardiovascular Research (Sydantutkimussaatio) webpage: http://www.sydantutkimussaatio.fi/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhi R, 2017, J CLIN PERIODONTOL, V44, P682, DOI 10.1111/jcpe.12748; Amar S, 2015, MOL ORAL MICROBIOL, V30, P171, DOI 10.1111/omi.12087; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Antoniak DT, 2015, FREE RADICAL BIO MED, V89, P409, DOI 10.1016/j.freeradbiomed.2015.09.003; Binder CJ, 2010, J CLIN IMMUNOL, V30, pS56, DOI 10.1007/s10875-010-9396-3; Binder CJ, 2005, J LIPID RES, V46, P1353, DOI 10.1194/jlr.R500005-JLR200; Binder CJ, 2004, J CLIN INVEST, V114, P427, DOI 10.1172/jci200420479; de Faire U, 2009, ANN NY ACAD SCI, V1173, P292, DOI 10.1111/j.1749-6632.2009.04748.x; Deshpande Rajashri G., 1998, Invasion and Metastasis, V18, P57, DOI 10.1159/000024499; Duryee MJ, 2010, FREE RADICAL BIO MED, V49, P1480, DOI 10.1016/j.freeradbiomed.2010.08.001; Elhage R, 2001, ATHEROSCLEROSIS, V156, P315, DOI 10.1016/S0021-9150(00)00682-1; Foey AD, 2017, ARCH ORAL BIOL, V73, P282, DOI 10.1016/j.archoralbio.2016.10.029; Freigang S, 2013, NAT IMMUNOL, V14, P1045, DOI 10.1038/ni.2704; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; HABEEB AFS, 1966, ANAL BIOCHEM, V14, P328, DOI 10.1016/0003-2697(66)90275-2; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Horkko S, 1999, J CLIN INVEST, V103, P117, DOI 10.1172/JCI4533; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Lichtman AH, 2013, J CLIN INVEST, V123, P27, DOI 10.1172/JCI63108; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Mallat Z, 1999, ARTERIOSCL THROM VAS, V19, P611, DOI 10.1161/01.ATV.19.3.611; McLaren JE, 2011, PROG LIPID RES, V50, P331, DOI 10.1016/j.plipres.2011.04.002; Miyamoto T, 2006, INFECT IMMUN, V74, P1376, DOI 10.1128/IAI.74.2.1376-1380.2006; Nikoopour E, 2015, CYTOKINE, V74, P35, DOI 10.1016/j.cyto.2014.09.007; Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322; Papadopoulos G, 2013, J IMMUNOL, V190, P1148, DOI 10.4049/jimmunol.1202511; Piconi S, 2009, FASEB J, V23, P1196, DOI 10.1096/fj.08-119578; Pussinen PJ, 2007, ATHEROSCLEROSIS, V193, P222, DOI 10.1016/j.atherosclerosis.2006.06.027; Pussinen PJ, 2004, EUR J CARDIOV PREV R, V11, P408, DOI 10.1097/00149831-200410000-00008; Qian K, 2008, J LEUKOCYTE BIOL, V84, P1492, DOI 10.1189/jlb.0508327; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schieffer B, 2004, CIRCULATION, V110, P3493, DOI 10.1161/01.CIR.0000148135.08582.97; Schuett H, 2009, THROMB HAEMOSTASIS, V102, P215, DOI 10.1160/TH09-05-0297; Shimomoto T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172172; Silveira A, 2015, ATHEROSCLEROSIS, V239, P125, DOI 10.1016/j.atherosclerosis.2014.12.046; Tsiantoulas D, 2014, CIRC RES, V114, P1743, DOI 10.1161/CIRCRESAHA.113.301145; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P2218, DOI 10.1016/j.jacc.2012.08.979; Turunen SP, 2015, INNATE IMMUN-LONDON, V21, P370, DOI 10.1177/1753425914542444; Turunen SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034910; van Egmond M, 2000, NAT MED, V6, P680, DOI 10.1038/76261; Wang C, 2015, SCI BULL, V60, P2016, DOI 10.1007/s11434-015-0941-6; Wang CG, 2017, METHODS MOL BIOL, V1643, P155, DOI 10.1007/978-1-4939-7180-0_12; Wang CG, 2013, INT IMMUNOL, V25, P575, DOI 10.1093/intimm/dxt022; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; Zhang D, 2008, INNATE IMMUN-LONDON, V14, P99, DOI 10.1177/1753425907088244	49	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191216	10.1371/journal.pone.0191216	http://dx.doi.org/10.1371/journal.pone.0191216			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329335	Green Published, gold, Green Submitted			2022-12-26	WOS:000419954100051
J	Das, S; Paul, S				Das, Shubhadip; Paul, Sandip			Exploring the binding sites and binding mechanism for hydrotrope encapsulated griseofulvin drug on gamma-tubulin protein	PLOS ONE			English	Article							SODIUM CUMENE SULFONATE; MOLECULAR-DYNAMICS; MICROTUBULE; AGGREGATION; INHIBITION; CENTROSOME; APOPTOSIS; ARREST; AGENTS; CELLS	The protein gamma-tubulin plays an important role in centrosomal clustering and this makes it an attractive therapeutic target for treating cancers. Griseofulvin, an antifungal drug, has recently been used to inhibit proliferation of various types of cancer cells. It can also affect the microtubule dynamics by targeting the gamma-tubulin protein. So far, the binding pockets of gamma-tubulin protein are not properly identified and the exact mechanism by which the drug binds to it is an area of intense speculation and research. The aim of the present study is to investigate the binding mechanism and binding affinity of griseofulvin on gamma-tubulin protein using classical molecular dynamics simulations. Since the drug griseofulvin is sparingly soluble in water, here we also present a promising approach for formulating and achieving delivery of hydrophobic griseofulvin drug via hydrotrope sodium cumene sulfonate (SCS) cluster. We observe that the binding pockets of gamma-tubulin protein are mainly formed by the H8, H9 helices and S7, S8, S14 strands and the hydrophobic interactions between the drug and gamma-tubulin protein drive the binding process. The release of the drug griseofulvin from the SCS cluster is confirmed by the coordination number analysis. We also find hydrotrope-induced alteration of the binding sites of gamma-tubulin protein and the weakening of the drugprotein interactions.	[Das, Shubhadip; Paul, Sandip] Indian Inst Technol Guwahati, Dept Chem, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati	Paul, S (corresponding author), Indian Inst Technol Guwahati, Dept Chem, Gauhati, Assam, India.	sandipp@iitg.ernet.in	Paul, Sandip/E-9346-2018; Das, Shubhadip/AAX-4160-2021	Das, Shubhadip/0000-0003-4432-7657				[Anonymous], 1996, INS 2; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bhakta-Guha D, 2015, CURR MED CHEM, V22, P685, DOI 10.2174/0929867322666141212114529; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; BRIAN PW, 1949, ANN BOT-LONDON, V13, P59, DOI 10.1093/oxfordjournals.aob.a083206; BROWN RC, 1992, J CELL SCI, V103, P1031; Cahn YC, 2004, CURR OPIN INFECT DIS, V17, P97, DOI [10.1097/01.qco.0000124362.27345.0f, 10.1097/00001432-200404000-00005]; Case DA, 2012, AMBER 12; Chaudhuri AR, 1996, BIOCHEM PHARMACOL, V51, P903; Czymmek KJ, 2005, PROTOPLASMA, V225, P23, DOI 10.1007/s00709-004-0081-3; Barros MED, 2007, J MED MICROBIOL, V56, P514, DOI 10.1099/jmm.0.46542-0; Das S, 2016, J PHYS CHEM B, V120, P3540, DOI 10.1021/acs.jpcb.5b11902; Das S, 2016, J PHYS CHEM B, V120, P173, DOI 10.1021/acs.jpcb.5b09668; Das S, 2015, J PHYS CHEM B, V119, P3142, DOI 10.1021/jp512282x; De CL, 1988, MUTAT RES, V195, P91; Friesen DE, 2012, CHEM BIOL DRUG DES, V79, P639, DOI 10.1111/j.1747-0285.2012.01340.x; Gergely F, 2008, GENE DEV, V22, P2291, DOI 10.1101/gad.1715208; He XB, 2010, J PHYS CHEM B, V114, P9787, DOI 10.1021/jp101860v; Ho YS, 2001, INT J CANCER, V91, P393, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1070&gt;3.0.CO;2-#; Hodgdon TK, 2007, CURR OPIN COLLOID IN, V12, P121, DOI 10.1016/j.cocis.2007.06.004; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hussain SA, 2013, JPN J CLIN ONCOL, V43, P1159, DOI 10.1093/jjco/hyt140; Kasim NA, 2004, MOL PHARMACEUT, V1, P85, DOI 10.1021/mp034006h; Kasimova AO, 2012, J PHYS CHEM B, V116, P4338, DOI 10.1021/jp2104819; Kramer A, 2011, MOL ONCOL, V5, P324, DOI 10.1016/j.molonc.2011.05.003; Kumbhar BV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156048; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Madej T, 2014, NUCLEIC ACIDS RES, V42, pD297, DOI 10.1093/nar/gkt1208; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; Natarajan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042351; Neuberg C, 1916, BIOCHEM Z, V76, P107; Nguyen CL, 2007, J VIROL, V81, P13533, DOI 10.1128/JVI.01669-07; O'Toole E, 2012, PLOS ONE, V7, P140, DOI 10.1371/journal.pone.0029795; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Panda D, 2005, P NATL ACAD SCI USA, V102, P9878, DOI 10.1073/pnas.0501821102; Rebacz B, 2007, CANCER RES, V67, P6342, DOI 10.1158/0008-5472.CAN-07-0663; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; ROOBOL A, 1977, BIOCHEM J, V167, P39, DOI 10.1042/bj1670039; ROOBOL A, 1976, FEBS LETT, V67, P248, DOI 10.1016/0014-5793(76)80539-X; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALEH AM, 1985, INT J PHARM, V24, P231, DOI 10.1016/0378-5173(85)90023-7; Singh P, 2008, IUBMB LIFE, V60, P368, DOI 10.1002/iub.42; SLOBODA RD, 1982, BIOCHEM BIOPH RES CO, V105, P882, DOI 10.1016/0006-291X(82)91052-X; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; Subbarao CV, 2012, CHEM ENG TECHNOL, V35, P225, DOI 10.1002/ceat.201100484; Uen YH, 2007, J CELL BIOCHEM, V101, P1165, DOI 10.1002/jcb.21240; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Voutsinas G, 1997, CELL BIOL INT, V21, P411, DOI 10.1006/cbir.1997.0171; WEBER K, 1976, J MOL BIOL, V102, P817, DOI 10.1016/0022-2836(76)90293-X; WEHLAND J, 1977, J MOL BIOL, V111, P329, DOI 10.1016/S0022-2836(77)80055-7	54	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190209	10.1371/journal.pone.0190209	http://dx.doi.org/10.1371/journal.pone.0190209			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324869	gold, Green Submitted, Green Published			2022-12-26	WOS:000419952400024
J	Hazeleger, WC; Jacobs-Reitsma, WF; Lina, PHC; de Boer, AG; Bosch, T; van Hoek, AHAM; Beumer, RR				Hazeleger, Wilma C.; Jacobs-Reitsma, Wilma F.; Lina, Peter H. C.; de Boer, Albert G.; Bosch, Thijs; van Hoek, Angela H. A. M.; Beumer, Rijkelt R.			Wild, insectivorous bats might be carriers of Campylobacter spp.	PLOS ONE			English	Article							SEQUENCE TYPING SYSTEM; REAL-TIME PCR; SALMONELLA; JEJUNI; FLIES; COLI; RESERVOIR; ASSAY; SPP.	Background The transmission cycles of the foodborne pathogens Campylobacter and Salmonella are not fully elucidated. Knowledge of these cycles may help reduce the transmission of these pathogens to humans. Methodology/principal findings The presence of campylobacters and salmonellas was examined in 631 fresh fecal samples of wild insectivorous bats using a specially developed method for the simultaneous isolation of low numbers of these pathogens in small-sized fecal samples (<= 0.1 g). Salmonella was not detected in the feces samples, but thermotolerant campylobacters were confirmed in 3% (n = 17) of the bats examined and these pathogens were found in six different bat species, at different sites, in different ecosystems during the whole flying season of bats. Molecular typing of the 17 isolated strains indicated C. jejuni (n = 9), C. coli (n = 7) and C. lari (n = 1), including genotypes also found in humans, wildlife, environmental samples and poultry. Six strains showed unique sequence types. Conclusion/significance This study shows that insectivorous bats are not only carriers of viral pathogens, but they can also be relevant for the transmission of bacterial pathogens. Bats should be considered as carriers and potential transmitters of Campylobacter and, where possible, contact between bats (bat feces) and food or feed should be avoided.	[Hazeleger, Wilma C.; Beumer, Rijkelt R.] Wageningen Univ & Res, Lab Food Microbiol, Wageningen, Netherlands; [Jacobs-Reitsma, Wilma F.] RIKILT Inst Food Safety, Wageningen, Netherlands; [Lina, Peter H. C.] Naturalis Biodivers Ctr, Leiden, Netherlands; [de Boer, Albert G.] Wageningen Univ & Res, Wageningen Biovet Res, Lelystad, Netherlands; [Bosch, Thijs] Ad Hoc Ecotech, Arnhem, Netherlands; [Jacobs-Reitsma, Wilma F.; van Hoek, Angela H. A. M.] RIVM Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands	Wageningen University & Research; Wageningen University & Research; Naturalis Biodiversity Center; Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	Hazeleger, WC (corresponding author), Wageningen Univ & Res, Lab Food Microbiol, Wageningen, Netherlands.	Wilma.Hazeleger@wur.nl			Ad Hoc	Ad Hoc	Ad Hoc provided support in the form of salaries for author TB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesiyun AA, 2009, J WILDLIFE DIS, V45, P952, DOI 10.7589/0090-3558-45.4.952; [Anonymous], 2006, 1027212006 ISO; [Anonymous], 2002, 6579 ISO, V4th; ARATA AA, 1968, AM J TROP MED HYG, V17, P92, DOI 10.4269/ajtmh.1968.17.92; Reyes AWB, 2011, ACTA SCI VET, V39; Bessede E, 2011, CLIN MICROBIOL INFEC, V17, P1735, DOI 10.1111/j.1469-0691.2011.03468.x; Best EL, 2003, FEMS MICROBIOL LETT, V229, P237, DOI 10.1016/S0378-1097(03)00845-0; Brown PE, 2004, APPL ENVIRON MICROB, V70, P6501, DOI 10.1128/AEM.70.11.6501-6511.2004; CHILD J, 1994, LANCET, V343, P5, DOI 10.1016/S0140-6736(94)90870-2; Clayton BA, 2013, ZOONOSES PUBLIC HLTH, V60, P69, DOI 10.1111/j.1863-2378.2012.01501.x; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4329; Habib I, 2011, FOOD MICROBIOL, V28, P1117, DOI 10.1016/j.fm.2011.03.001; Hald B, 2004, EMERG INFECT DIS, V10, P1490, DOI 10.3201/eid1008.040129; Hatta Y, 2016, J VET MED SCI, V78, P1347, DOI 10.1292/jvms.15-0621; Hazeleger WC, 2009, 15 NIT WORKSH CAMP H, P66; Hazeleger WC, 2008, APPL ENVIRON MICROB, V74, P6887, DOI 10.1128/AEM.00451-08; Hazeleger WC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01430; Hilbert F, 2012, FOOD RES INT, V45, P603, DOI 10.1016/j.foodres.2011.08.015; Ivanek R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034660; Jasson V, 2009, INT J FOOD MICROBIOL, V135, P248, DOI 10.1016/j.ijfoodmicro.2009.09.007; Jensen AN, 2005, J APPL MICROBIOL, V99, P292, DOI 10.1111/j.1365-2672.2005.02616.x; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; KLITE PD, 1965, J BACTERIOL, V90, P831, DOI 10.1128/JB.90.3.831-831.1965; Kwan PSL, 2008, APPL ENVIRON MICROB, V74, P5130, DOI 10.1128/AEM.02198-07; Mian LS, 2002, J VECTOR ECOL, V27, P82; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Muhldorfer K, 2013, ZOONOSES PUBLIC HLTH, V60, P93, DOI 10.1111/j.1863-2378.2012.01536.x; Muhldorfer K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029773; Ng JHJ, 2013, AUST J ZOOL, V61, P48, DOI 10.1071/ZO12126; PALMER SR, 1983, LANCET, V1, P287, DOI 10.1016/S0140-6736(83)91698-7; Schets C, 2017, J WATER HEALTH; Sippy R, 2012, VET MICROBIOL, V157, P369, DOI 10.1016/j.vetmic.2011.12.026; Szalanski AL, 2004, MED VET ENTOMOL, V18, P241, DOI 10.1111/j.0269-283X.2004.00502.x; van Schaik J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130850; Veikkolainen V, 2014, EMERG INFECT DIS, V20, P960, DOI 10.3201/eid2006.130956; Wahlstrom H, 2003, VET REC, V153, P74, DOI 10.1136/vr.153.3.74; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	39	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190647	10.1371/journal.pone.0190647	http://dx.doi.org/10.1371/journal.pone.0190647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324839	gold, Green Submitted, Green Published			2022-12-26	WOS:000419952400044
J	He, XN; Wu, J; Holtorf, AP; Rinde, H; Xie, SS; Shen, W; Hou, JC; Li, XH; Li, ZP; Lai, JM; Wang, YT; Zhang, L; Wang, J; Li, XS; Ma, KS; Ye, F; Ouyang, H; Zhao, H				He, Xiaoning; Wu, Jing; Holtorf, Anke-Peggy; Rinde, Harald; Xie, Shuangshuang; Shen, Wen; Hou, Jiancun; Li, Xuehua; Li, Ziping; Lai, Jiaming; Wang, Yuting; Zhang, Lin; Wang, Jian; Li, Xuesong; Ma, Kuansheng; Ye, Feng; Ouyang, Han; Zhao, Hong			Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China	PLOS ONE			English	Article							LIVER-LESIONS; ENHANCED MRI; MDCT; PERFORMANCE; GADOLINIUM; NODULES; SMALLER	Limited data exists in China on the comparative cost of gadolinium ethoxybenzyl diethylenetriamine magnetic resonance imaging (Gd-EOB-DTPA-MRI) with other imaging techniques. This study compared the total cost of Gd-EOB-DTPA-MRI with multidetector computed tomography (MDCT) and extracellular contrast media-enhanced MRI (ECCM-MRI) as initial imaging procedures in patients with suspected hepatocellular carcinoma (HCC). We developed a decision-tree model on the basis of the Chinese clinical guidelines for HCC, which was validated by clinical experts from China. The model compared the diagnostic accuracy and costs of alternative initial imaging procedures. Compared with MDCT and ECCM-MRI, Gd-EOB-DTPA-MRI imaging was associated with higher rates of diagnostic accuracy, i.e. higher proportions of true positives (TP) and true negatives (TN) with lower false positives (FP). Total diagnosis and treatment cost per patient after the initial Gd-EOB-DTPA-MRI evaluation was similar to MDCT ((sic) 30,360 vs. (sic) 30,803) and lower than that reported with ECCM-MRI ((sic) 30,360 vs. (sic) 31,465). Lower treatment cost after initial Gd-EOB-DTPA-MRI was driven by reduced utilization of confirmatory diagnostic procedures and unnecessary treatments. The findings reported that Gd-EOB-DTPA-MRI offered higher diagnostic accuracy compared with MDCT and ECCM-MRI at a comparable cost, which indicates Gd-EOBDTPA-MRI could be the preferred initial imaging procedure for the diagnosis of HCC in China.	[He, Xiaoning; Wu, Jing] Tianjin Univ, Sch Pharmaceut Sci & Technol, Dept Hlth & Pharm Adm, Tianjin, Peoples R China; [Holtorf, Anke-Peggy; Rinde, Harald] Hlth Outcomes Strategies, Basel, Switzerland; [Xie, Shuangshuang; Shen, Wen] Tianjin First Ctr Hosp, Dept Radiol, Tianjin, Peoples R China; [Hou, Jiancun] Tianjin First Ctr Hosp, Dept Hepatobiliary Surg, Tianjin, Peoples R China; [Li, Xuehua; Li, Ziping] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Lai, Jiaming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China; [Wang, Yuting; Zhang, Lin; Wang, Jian] Southwestern Hosp, Dept Radiol, Chongqing, Peoples R China; [Li, Xuesong; Ma, Kuansheng] Southwestern Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China; [Ye, Feng; Ouyang, Han] Chinese Acad Med Sci, Canc Hosp, Dept Radiol, Beijing, Peoples R China; [Zhao, Hong] Chinese Acad Med Sci, Canc Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China	Tianjin University; Sun Yat Sen University; Sun Yat Sen University; Army Medical University; Army Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Wu, J (corresponding author), Tianjin Univ, Sch Pharmaceut Sci & Technol, Dept Hlth & Pharm Adm, Tianjin, Peoples R China.	jingwu@tju.edu.cn		Wu, Jing/0000-0002-6012-2785; Holtorf, Anke-Peggy/0000-0002-4638-5351	Bayer Healthcare Co. Ltd; Bayer Healthcare Company Ltd.	Bayer Healthcare Co. Ltd; Bayer Healthcare Company Ltd.	Bayer Healthcare Co. Ltd., the manufacturer of the drug (Gd-EOB-DTPA, PrimovistTM), supported this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge Karan Sharma (M. Pharm) and Dr. Amit Bhat (Ph.D.) (Indegene Pvt. Ltd, Bangalore) for providing medical writing support and technical assistance in the preparation of this manuscript, with funding from Bayer Healthcare Company Ltd.	Alaboudy A, 2011, ONCOLOGY-BASEL, V81, P66, DOI 10.1159/000333264; [Anonymous], 2009, CAT DRUGS BAS NAT ME; Assy N, 2009, WORLD J GASTROENTERO, V15, P3217, DOI 10.3748/wjg.15.3217; Bottcher J, 2013, EUR J RADIOL, V82, P1860, DOI 10.1016/j.ejrad.2013.06.013; Chen LH, 2013, GUT, V62, P1520, DOI 10.1136/gutjnl-2013-305231; Choi JY, 2014, RADIOLOGY, V272, P634, DOI 10.1148/radiol.14132361; Chou R, 2014, IMAGING TECHNIQUES D, V14; Descamps MJL, 2010, CLEFT PALATE-CRAN J, V47, P578, DOI 10.1597/09-070; Desmet VJ, 2009, HEPATOLOGY, V49, P355, DOI 10.1002/hep.22681; Fletcher JG, 2010, AM J ROENTGENOL, V195, P117, DOI 10.2214/AJR.09.3659; Forner A, 2008, HEPATOLOGY, V47, P97, DOI 10.1002/hep.21966; Gluecker T, 2002, EUR RADIOL, V12, P1405, DOI 10.1007/s00330-001-1280-3; Graves JM, 2014, HEALTH SERV RES, V49, P645, DOI 10.1111/1475-6773.12098; Hennedige T, 2013, CANCER IMAGING, V12, P530, DOI 10.1102/1470-7330.2012.0044; Huppertz A, 2004, RADIOLOGY, V230, P266, DOI 10.1148/radiol.2301020269; Inoue T, 2012, J GASTROENTEROL, V47, P1036, DOI 10.1007/s00535-012-0571-6; Kim KA, 2014, ABDOM IMAGING, V39, P291, DOI 10.1007/s00261-013-0064-y; Kim SH, 2009, AM J ROENTGENOL, V192, P1675, DOI 10.2214/AJR.08.1262; Kitao A, 2010, RADIOLOGY, V256, P817, DOI 10.1148/radiol.10092214; Lafaro KJ, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/572307; Lang K, 2009, J HEPATOL, V50, P89, DOI 10.1016/j.jhep.2008.07.029; Lee JM, 2016, J MED ECON, V19, P759, DOI 10.3111/13696998.2016.1171230; Lee YJ, 2015, RADIOLOGY, V275, P97, DOI 10.1148/radiol.14140690; Lei JQ, 2014, J MAGN RESON IMAGING, V39, P1079, DOI 10.1002/jmri.24354; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070896; London WT, 2006, CANC EPIDEMIOLOGY PR, P763, DOI DOI 10.1093/ACPROF:OSO/9780195149616.003.0039; Nishie A, 2017, CLIN THER, V39, P738, DOI 10.1016/j.clinthera.2017.03.006; Pauleit D, 2002, RADIOLOGY, V222, P73, DOI 10.1148/radiol.2221001599; Qin SK, 2012, CHIN CLIN ONCOL, V1, DOI 10.3978/j.issn.2304-3865.2012.07.01; Saba L, 2011, EUR J RADIOL, V79, P237, DOI 10.1016/j.ejrad.2010.01.019; Schlachterman A, 2015, WORLD J GASTROENTERO, V21, P8478, DOI 10.3748/wjg.v21.i28.8478; Thein HH, 2013, HEPATOLOGY, V58, P1375, DOI 10.1002/hep.26231; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wu LM, 2013, DIGEST DIS SCI, V58, P3313, DOI 10.1007/s10620-013-2790-y; Ye F, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001157; Yoon SH, 2009, AM J ROENTGENOL, V193, pW482, DOI 10.2214/AJR.08.1818; Yousuf M.I., 2007, PRACT ASSESS RES EVA, V12, P8, DOI [10.7275/rrph-t210, DOI 10.7275/RRPH-T210]; Zech CJ, 2009, EUR RADIOL, V19, pS753, DOI 10.1007/s00330-009-1432-4; Zech CJ, 2016, EUR RADIOL, V26, P4121, DOI 10.1007/s00330-016-4271-0	39	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191095	10.1371/journal.pone.0191095	http://dx.doi.org/10.1371/journal.pone.0191095			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324837	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400112
J	Shawki, HH; Oishi, H; Usui, T; Kitadate, Y; Basha, WA; Abdellatif, AM; Hasegawa, K; Okada, R; Mochida, K; El-Shemy, HA; Muratani, M; Ogura, A; Yoshida, S; Takahashi, S				Shawki, Hossam H.; Oishi, Hisashi; Usui, Toshiaki; Kitadate, Yu; Basha, Walaa A.; Abdellatif, Ahmed M.; Hasegawa, Kazunori; Okada, Risa; Mochida, Keiji; El-Shemy, Hany A.; Muratani, Masafumi; Ogura, Atsuo; Yoshida, Shosei; Takahashi, Satoru			MAFB is dispensable for the fetal testis morphogenesis and the maintenance of spermatogenesis in adult mice	PLOS ONE			English	Article							RETINOIC ACID METABOLISM; SERTOLI-CELLS; TARGETED DISRUPTION; SPERMATOGONIA DIFFERENTIATION; MOUSE SPERMATOGENESIS; GENE-EXPRESSION; SELF-RENEWAL; LACKING; PHAGOCYTOSIS; MACROPHAGES	The transcription factor MAFB is an important regulator of the development and differentiation of various organs and tissues. Previous studies have shown that MAFB is expressed in embryonic and adult mouse testes and is expected to act as the downstream target of retinoic acid (RA) to initiate spermatogenesis. However, its exact localization and function remain unclear. Here, we localized MAFB expression in embryonic and adult testes and analyzed its gene function using Mafb-deficient mice. We found that MAFB and c-MAF are the only large MAF transcription factors expressed in testes, while MAFA and NRL are not. MAFB was localized in Leydig and Sertoli cells at embryonic day (E) 18.5 but in Leydig cells, Sertoli cells, and pachytene spermatocytes in adults. Mafb-deficient testes at E18.5 showed fully formed seminiferous tubules with no abnormal structure or differences in testicular somatic cell numbers compared with those of control wild-type mice. Additionally, the expression levels of genes related to development and function of testicular cells were unchanged between genotypes. In adults, the expression of MAFB in Sertoli cells was shown to be stage specific and induced by RA. By generating Mafb(fl/fl) CAG-CreER (TM) (Mafb-cKO) mice, in which Cre recombinase was activated upon tamoxifen treatment, we found that the neonatal cKO mice died shortly upon Mafb deletion, but adult cKO mice were alive upon deletion. Adult cKO mice were fertile, and spermatogenesis maintenance was normal, as indicated by histological analysis, hormone levels, and germ cell stage-specific markers. Moreover, there were no differences in the proportion of seminiferous stages between cKO mice and controls. However, RNA-Seq analysis of cKO Sertoli cells revealed that the down-regulated genes were related to immune function and phagocytosis activity but not spermatogenesis. In conclusion, we found that MAFB is dispensable for fetal testis morphogenesis and spermatogenesis maintenance in adult mice, despite the significant gene expression in different cell types, but MAFB might be critical for phagocytosis activity of Sertoli cells.	[Shawki, Hossam H.; Oishi, Hisashi; Usui, Toshiaki; Basha, Walaa A.; Abdellatif, Ahmed M.; Okada, Risa; Takahashi, Satoru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan; [Shawki, Hossam H.] Natl Gene Bank, Dept Anim Genet Resources, Giza, Egypt; [Oishi, Hisashi] Nagoya City Univ, Grad Sch Med Sci, Dept Comparat & Expt Med, Nagoya, Aichi, Japan; [Kitadate, Yu; Yoshida, Shosei] Natl Inst Basic Biol, Div Germ Cell Biol, Okazaki, Aichi, Japan; [Hasegawa, Kazunori] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Mochida, Keiji; Ogura, Atsuo] RIKEN, BioResource Ctr, Tsukuba, Ibaraki, Japan; [El-Shemy, Hany A.] Cairo Univ, Cairo Univ Res Pk, Giza, Egypt; [Muratani, Masafumi] Univ Tsukuba, Fac Med, Dept Genome Biol, Tsukuba, Ibaraki, Japan	University of Tsukuba; Nagoya City University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Stanford University; RIKEN; Egyptian Knowledge Bank (EKB); Cairo University; University of Tsukuba	Shawki, HH; Oishi, H (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Anat & Embryol, Tsukuba, Ibaraki, Japan.; Shawki, HH (corresponding author), Natl Gene Bank, Dept Anim Genet Resources, Giza, Egypt.; Oishi, H (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Comparat & Expt Med, Nagoya, Aichi, Japan.	S1336027@u.tsukuba.ac.jp; hoishi@med.nagoya-cu.ac.jp	Abdellatif, Ahmed M./Y-2793-2018; El-Shemy, Hany A./A-6367-2008; Ogura, Atsuo/J-3916-2014	Abdellatif, Ahmed M./0000-0001-9235-2449; Ogura, Atsuo/0000-0003-0447-1988; Yoshida, Shosei/0000-0001-8861-1866; Kitadate, Yu/0000-0003-0562-320X; Shawki, Hossam/0000-0002-1962-9701	 [25114004];  [16H02507]	; 	Dr. Shosei Yoshida received a Grant-in-Aid for Scientific Research on Innovative Areas #25114004 "Mechanisms regulating gamete formation in animals". Dr. Shosei Yoshida also received a Grant-in-Aid for Scientific Research(A) #16H02507.	Al-Soudy AS, 2016, GENESIS, V54, P389, DOI 10.1002/dvg.22944; Aziz A, 2006, MOL CELL BIOL, V26, P6808, DOI 10.1128/MCB.00245-06; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Bedard N, 2005, MOL CELL BIOL, V25, P6346, DOI 10.1128/MCB.25.15.6346-6354.2005; Blanchi B, 2003, NAT NEUROSCI, V6, P1091, DOI 10.1038/nn1129; Blank V, 1997, BLOOD, V89, P3925, DOI 10.1182/blood.V89.11.3925; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; De Rooij DG, 2000, J ANDROL, V21, P776; DeFalco T, 2015, CELL REP, V12, P1107, DOI 10.1016/j.celrep.2015.07.015; DeFalco T, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106138; DeFalco T, 2011, DEV BIOL, V352, P14, DOI 10.1016/j.ydbio.2011.01.011; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Fantz DA, 2001, BIOL REPROD, V64, P425, DOI 10.1095/biolreprod64.2.425; FUJIWARA KT, 1993, ONCOGENE, V8, P2371; Gely-Pernot A, 2012, ENDOCRINOLOGY, V153, P438, DOI 10.1210/en.2011-1102; Godmann M, 2009, MECH DEVELOP, V126, P650, DOI 10.1016/j.mod.2009.06.1081; Hasegawa K, 2013, STEM CELLS, V31, P2517, DOI 10.1002/stem.1486; Hasegawa K, 2012, DEVELOPMENT, V139, P4347, DOI 10.1242/dev.080119; Hasegawa K, 2012, MOL CELL BIOL, V32, P206, DOI 10.1128/MCB.06063-11; Hasegawa Y, 2013, EXP ANIM TOKYO, V62, P295; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hogarth CA, 2013, CURR OPIN ENDOCRINOL, V20, P217, DOI 10.1097/MED.0b013e32836067cf; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; Iwamori N, 2011, BIOL REPROD, V84, P1225, DOI 10.1095/biolreprod.110.088955; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Kataoka K, 2007, J BIOCHEM, V141, P775, DOI 10.1093/jb/mvm105; Katsuoka F, 2016, GENE, V586, P197, DOI 10.1016/j.gene.2016.03.058; Kotaja N, 2004, NAT METHODS, V1, P249, DOI 10.1038/nmeth1204-249; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Lindeboom F, 2003, NUCLEIC ACIDS RES, V31, P5405, DOI 10.1093/nar/gkg723; Liu C, 2016, DEVELOPMENT, V143, P3700, DOI 10.1242/dev.135756; Liu YQ, 2014, GENET MOL BIOL, V37, P708, DOI [10.1590/S1415-47572014005000013, 10.1590/S1415-47572014000500014]; LOK D, 1982, ANAT REC, V203, P83, DOI 10.1002/ar.1092030109; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Mannan AU, 2003, BIOL REPROD, V69, P788, DOI 10.1095/biolreprod.103.017400; Marschang P, 2004, MOL CELL BIOL, V24, P3782, DOI 10.1128/MCB.24.9.3782-3793.2004; McLean DJ, 2003, BIOL REPROD, V69, P2085, DOI 10.1095/biolreprod.103.017020; Meistrich Marvin L, 2013, Methods Mol Biol, V927, P299; Moriguchi T, 2006, MOL CELL BIOL, V26, P5715, DOI 10.1128/MCB.00001-06; Nagao M, 2016, OSTEOARTHR CARTILAGE, V24, P188, DOI 10.1016/j.joca.2015.07.025; Nakagawa A, 2005, MOL REPROD DEV, V71, P166, DOI 10.1002/mrd.20278; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Nakanishi Y, 2004, BIOL PHARM BULL, V27, P13, DOI 10.1248/bpb.27.13; Nayernia K, 2003, BIOL REPROD, V69, P1973, DOI 10.1095/biolreprod.103.018564; Nemoto T, 2017, BIOCHEM BIOPH RES CO, V482, P375, DOI 10.1016/j.bbrc.2016.11.070; OAKBERG EF, 1971, ANAT REC, V169, P515, DOI 10.1002/ar.1091690305; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Prabhu SM, 2006, REPRODUCTION, V131, P489, DOI 10.1530/rep.1.00968; Raverdeau M, 2012, P NATL ACAD SCI USA, V109, P16582, DOI 10.1073/pnas.1214936109; Sato-Nishiwaki M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073963; Shawki HH, 2016, EXP ANIM TOKYO, V65, P253, DOI 10.1538/expanim.15-0104; Shiratsuchi A, 2013, DRUG DISCOV THER, V7, P73, DOI 10.5582/ddt.2013.v7.2.73; Shyr CR, 2002, MOL CELL BIOL, V22, P4661, DOI 10.1128/MCB.22.13.4661-4666.2002; Snyder EM, 2010, BIOL REPROD, V83, P783, DOI 10.1095/biolreprod.110.085811; STEPHAN JP, 1995, BIOCHEM BIOPH RES CO, V213, P218, DOI 10.1006/bbrc.1995.2119; Sugimoto R, 2012, MECH DEVELOP, V128, P610, DOI 10.1016/j.mod.2011.12.003; Tillmanns S, 2007, MOL CELL BIOL, V27, P5554, DOI 10.1128/MCB.01811-06; TOKUDA N, 1992, J UROLOGY, V147, P278, DOI 10.1016/S0022-5347(17)37213-0; Tong MH, 2013, P NATL ACAD SCI USA, V110, P543, DOI 10.1073/pnas.1214883110; Vernet N, 2006, ENDOCRINOLOGY, V147, P96, DOI 10.1210/en.2005-0953; Wakayama T, 2015, J HISTOCHEM CYTOCHEM, V63, P190, DOI 10.1369/0022155414564870; Wang HZ, 2006, REPRODUCTION, V132, P485, DOI 10.1530/rep.1.01213; Xue JP, 2002, MOL CELL BIOL, V22, P1993, DOI 10.1128/MCB.22.7.1993-1997.2002; Yang Ying, 2007, Einstein J Biol Med, V23, P2; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Yoshida T, 2005, NUCLEIC ACIDS RES, V33, P3465, DOI 10.1093/nar/gki653; Zhang XY, 2013, MOL CELL ENDOCRINOL, V365, P162, DOI 10.1016/j.mce.2012.10.016; Zhang Y, 2010, FASEB J, P24	70	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190800	10.1371/journal.pone.0190800	http://dx.doi.org/10.1371/journal.pone.0190800			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324782	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400059
J	Kawaguchi, T; Desrochers, A				Kawaguchi, Toshinori; Desrochers, Andre			A time-lagged effect of conspecific density on habitat selection by snowshoe hare	PLOS ONE			English	Article							BOREAL FOREST; POPULATION-DYNAMICS; VARIABILITY; MANAGEMENT; ABUNDANCE; LEMMINGS; ECOLOGY; MARTEN; CYCLE	Ideal free distribution theory predicts that increased conspecific density redistributes individuals to low-density, suboptimal habitat. However, possible lags in response to population density remain poorly documented. Snowshoe hares (Lepus americanus) may exhibit den-sity-dependent habitat selection due to its marked variation in population density. Based on 11 years (2004-2014) of snow tracking in Quebec (Canada), we investigated snowshoe hares' short-term and delayed habitat selection responses to population density. We predicted that at high densities, hare distribution expands into low-density habitat, thus weakening the association between hares and high-density habitat. We surveyed hare tracks along 95 km of transects on average each year and georeferenced 14,240 tracks. We used Generalized Estimating Equations for track count per 100 m transect segment as a function of the proportion of different forest age classes (0-20 y, 20-40 y and 40-80 y) within 50 m of the segments. We used model coefficients for each age class as a measure of habitat preference, and modeled those coefficients as a function of a population density index in current and previous winters. Coefficients for 20-to 40-y-old forests were positive each year, indicating that this habitat was preferred. The association between track counts and 20-to 40-yold forest significantly declined with density during the previous winter, suggesting that hare spread from preferred forest with a lagged response to density. To our knowledge, no previous empirical studies have documented a lagged habitat selection response to population density. Time lags offer possible explanation for documented deviations from ideal free distribution models.	[Kawaguchi, Toshinori] Univ Laval, Ctr Etud Foret, Quebec City, PQ, Canada; Univ Laval, Dept Sci Bois & Foret, Quebec City, PQ, Canada	Laval University; Laval University	Kawaguchi, T (corresponding author), Univ Laval, Ctr Etud Foret, Quebec City, PQ, Canada.	tkawaguchi907@gmail.com			Natural Sciences and Engineering Research Council of Canada (NSERC) [170173]; Foundation F.-K.-Morrow; Universite Laval	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Foundation F.-K.-Morrow; Universite Laval	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) Number: 170173 to AD (URL: www.nserc-crsng.gc.ca/index_eng.asp), the Foundation F.-K.-Morrow to TK, and the Universite Laval to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguie B, 2017, GRIDEXTRA MISCELLANE; Beaudoin C, 2004, ECOSCIENCE, V11, P370, DOI 10.1080/11956860.2004.11682844; Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; BROWN JL, 1969, AM NAT, V103, P347, DOI 10.1086/282607; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; de Bellefeuille S, 2001, CAN J FOREST RES, V31, P41, DOI 10.1139/x00-140; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; DREISIG H, 1995, OIKOS, V72, P161, DOI 10.2307/3546218; Erb J, 2001, OIKOS, V92, P3, DOI 10.1034/j.1600-0706.2001.920101.x; Framstad E, 1997, P ROY SOC B-BIOL SCI, V264, P31, DOI 10.1098/rspb.1997.0005; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; FRYXELL JM, 1991, J WILDLIFE MANAGE, V55, P377, DOI 10.2307/3808963; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; Gilroy JJ, 2007, TRENDS ECOL EVOL, V22, P351, DOI 10.1016/j.tree.2007.03.014; Hache S, 2013, ECOLOGY, V94, P861, DOI 10.1890/12-1025.1; HILDEN OLAVL, 1965, ANN ZOOL FEN NICI, V2, P53; Hodges KE, 2005, CAN J ZOOL, V83, P280, DOI 10.1139/Z05-015; Hodson J, 2011, CAN J ZOOL, V89, P908, DOI [10.1139/Z11-079, 10.1139/z11-079]; Hodson J, 2010, J MAMMAL, V91, P607, DOI 10.1644/09-MAMM-A-289.1; Horstkotte T, 2013, FOREST ECOL MANAG, V291, P162, DOI 10.1016/j.foreco.2012.10.044; Jensen WE, 2005, OECOLOGIA, V142, P136, DOI 10.1007/s00442-004-1709-x; Kawaguchi T, 2015, NORTHEAST NAT, V22, P798, DOI 10.1656/045.022.0413; Kielland K, 2010, CAN J FOREST RES, V40, P1265, DOI 10.1139/X10-053; Krebs CJ, 2011, P ROY SOC B-BIOL SCI, V278, P481, DOI 10.1098/rspb.2010.1992; Krebs CJ, 2001, BIOSCIENCE, V51, P25, DOI 10.1641/0006-3568(2001)051[0025:WDTYCO]2.0.CO;2; Latombe G, 2014, J ANIM ECOL, V83, P185, DOI 10.1111/1365-2656.12108; LITVAITIS JA, 1985, J WILDLIFE MANAGE, V49, P866, DOI 10.2307/3801359; MAGNUSON JJ, 1990, BIOSCIENCE, V40, P495, DOI 10.2307/1311317; Martin Sandra K., 1994, P297; McDaniel LS, 2015, GEEM SOLVE GEN ESTIM; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Mobaek R, 2009, OIKOS, V118, P209, DOI 10.1111/j.1600-0706.2008.16935.x; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Morris DW, 2005, OIKOS, V109, P239, DOI 10.1111/j.0030-1299.2005.13789.x; Oro D, 2008, ECOLOGY, V89, P838, DOI 10.1890/06-1936.1; Piper WH, 2011, BEHAV ECOL SOCIOBIOL, V65, P1329, DOI 10.1007/s00265-011-1195-1; Poole KG, 1996, CAN J ZOOL, V74, P456, DOI 10.1139/z96-053; Potvin F, 1999, CAN J FOREST RES, V29, P1120, DOI 10.1139/cjfr-29-7-1120; Reid DG, 2012, OECOLOGIA, V168, P935, DOI 10.1007/s00442-011-2167-x; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; Shenbrot G, 2004, OIKOS, V106, P359, DOI 10.1111/j.0030-1299.2004.13123.x; Stamps JA, 2005, ECOLOGY, V86, P510, DOI 10.1890/04-0516; THOMPSON ID, 1989, CAN J ZOOL, V67, P1816, DOI 10.1139/z89-258; Thornton DH, 2013, ECOGRAPHY, V36, P610, DOI 10.1111/j.1600-0587.2012.07737.x; Venables M.N., 2002, MODERN APPLIED STATI, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2]; Vigeant-Langlois C, 2011, CAN J FOREST RES, V41, P2202, DOI [10.1139/X11-133, 10.1139/x11-133]; WOLFF JO, 1980, ECOL MONOGR, V50, P111, DOI 10.2307/2937249	47	5	5	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190643	10.1371/journal.pone.0190643	http://dx.doi.org/10.1371/journal.pone.0190643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320564	Green Submitted, Green Published, gold			2022-12-26	WOS:000419689600059
J	Xie, SS; Yang, XK; Wang, DH; Zhu, F; Yang, N; Hou, ZC; Ning, ZH				Xie, Shanshan; Yang, Xukai; Wang, Dehe; Zhu, Feng; Yang, Ning; Hou, Zhuocheng; Ning, Zhonghua			Thyroid transcriptome analysis reveals different adaptive responses to cold environmental conditions between two chicken breeds	PLOS ONE			English	Article							MESSENGER-RNA DECAY; METABOLIC ADAPTATION; GEOGRAPHIC-VARIATION; EXPRESSION ANALYSIS; SEASONAL-VARIATION; STRESS RESPONSES; BROILER-CHICKENS; GENE-EXPRESSION; WHITE LEGHORN; EVOLUTION	Selection for cold tolerance in chickens is important for improving production performance and animal welfare. The identification of chicken breeds with higher cold tolerance and production performance will help to target candidates for the selection. The thyroid gland plays important roles in thermal adaptation, and its function is influenced by breed differences and transcriptional plasticity, both of which remain largely unknown in the chicken thyroid transcriptome. In this study, we subjected Bashang Long-tail (BS) and Rhode Island Red (RIR) chickens to either cold or warm environments for 21 weeks and investigated egg production performance, body weight changes, serum thyroid hormone concentrations, and thyroid gland transcriptome profiles. RIR chickens had higher egg production than BS chickens under warm conditions, but BS chickens produced more eggs than RIRs under cold conditions. Furthermore, BS chickens showed stable body weight gain under cold conditions while RIRs did not. These results suggested that BS breed is a preferable candidate for cold-tolerance selection and that the cold adaptability of RIRs should be improved in the future. BS chickens had higher serum thyroid hormone concentrations than RIRs under both environments. RNA-Seq generated 344.3 million paired-end reads from 16 sequencing libraries, and about 90% of the processed reads were concordantly mapped to the chicken reference genome. Differential expression analysis identified 46 +/- 1,211 genes in the respective comparisons. With regard to breed differences in the thyroid transcriptome, BS chickens showed higher cell replication and development, and immune response-related activity, while RIR chickens showed higher carbohydrate and protein metabolism activity. The cold environment reduced breed differences in the thyroid transcriptome compared with the warm environment. Transcriptional plasticity analysis revealed different adaptive responses in BS and RIR chickens to cope with the cold, and showed higher responsiveness in BS compared with RIR chickens, suggesting greater adaptability of the thyroid in BS chickens. Moreover, 10,053 differential splicing events were revealed among the groups, with RNA splicing and processing, gene expression, transport, and metabolism being the main affected biological processes, identifying a valuable alternative splicing repertoire for the chicken thyroid. A short isoform of TPO (encoding thyroid peroxidase) containing multiple open reading frames was generated in both breeds by skipping exons 4 and 5 in the cold environment. These findings provide novel clues for future studies of the molecular mechanisms underlying cold adaptation and/or acclimation in chickens.	[Ning, Zhonghua] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing, Peoples R China; China Agr Univ, Coll Anim Sci & Technol, MOA Key Lab Anim Genet & Breeding, Beijing, Peoples R China	China Agricultural University; China Agricultural University	Ning, ZH (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing, Peoples R China.	ningzhh@cau.edu.cn	xie, shanshan/GSM-8999-2022	Yang, Ning/0000-0001-5772-3320	Chinese Agricultural Research System [CARS-41]	Chinese Agricultural Research System	The author (ZHN) received the funding from Chinese Agricultural Research System (CARS-41) for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; ARAD Z, 1982, BRIT POULTRY SCI, V23, P333, DOI 10.1080/00071688208447966; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; BEILHARZ RG, 1993, J ANIM BREED GENET, V110, P161, DOI 10.1111/j.1439-0388.1993.tb00728.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Blahova J, 2007, ACTA VET BRNO, V76, pS17, DOI 10.2754/avb200776S8S017; Bojko E R, 1997, Int J Circumpolar Health, V56, P134; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brix K, 2011, THYROID RES, V4, DOI 10.1186/1756-6614-4-S1-S9; Burger MF, 2002, PHYSIOL BIOCHEM ZOOL, V75, P187, DOI 10.1086/338955; Campo JL, 2008, POULTRY SCI, V87, P621, DOI 10.3382/ps.2007-00466; Carvalho D. P., 2017, MOL CELL ENDOCRINOL; Castellani JW, 2016, AUTON NEUROSCI-BASIC, V196, P63, DOI 10.1016/j.autneu.2016.02.009; Cheng HW, 2010, POULTRY SCI, V89, P805, DOI 10.3382/ps.2009-00361; Cheviron ZA, 2012, P NATL ACAD SCI USA, V109, P8635, DOI 10.1073/pnas.1120523109; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Coble DJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1084; Collin A, 2005, DOMEST ANIM ENDOCRIN, V29, P78, DOI 10.1016/j.domaniend.2005.02.007; Collin A, 2003, GEN COMP ENDOCR, V130, P70, DOI 10.1016/S0016-6480(02)00571-3; Cuccurese M, 2005, NUCLEIC ACIDS RES, V33, P5965, DOI 10.1093/nar/gki905; de Jong G, 2002, EVOL ECOL RES, V4, P1; Dunlap K. L., 2008, American Journal of Animal and Veterinary Sciences, V3, P96; Dutertre M, 2011, RNA BIOL, V8, P740, DOI 10.4161/rna.8.5.16016; Fallahsharoudi A, 2015, SCI REP-UK, V5, DOI 10.1038/srep15345; Farid NR, 2004, ENDOCRINOLOGY, V145, P4048, DOI 10.1210/en.2004-0437; Faure J, 2013, J ANIM SCI, V91, P1893, DOI 10.2527/jas.2012-5828; Glazier DS, 2002, EVOLUTION, V56, P1696, DOI 10.1111/j.0014-3820.2002.tb01481.x; Hoskins AA, 2012, TRENDS BIOCHEM SCI, V37, P179, DOI 10.1016/j.tibs.2012.02.009; HURNIK JF, 1990, POULTRY SCI, V69, P1827, DOI 10.3382/ps.0691827; Ibarra A, 2015, GENE DEV, V29, P337, DOI 10.1101/gad.256495.114; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Ishikawa A., 2012, THYROID HORMONE, P37, DOI DOI 10.5772/45969; Kassahn KS, 2009, BIOL REV, V84, P277, DOI 10.1111/j.1469-185X.2008.00073.x; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim J., 2015, PLOS ONE, V10; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Koulouri O, 2013, BEST PRACT RES CL EN, V27, P745, DOI 10.1016/j.beem.2013.10.003; KUHN ER, 1984, J EXP ZOOL, V232, P653, DOI 10.1002/jez.1402320334; Lan X, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3291-0; Lancaster LT, 2016, MOL ECOL, V25, P1141, DOI 10.1111/mec.13548; Leonard WR, 2005, ANNU REV ANTHROPOL, V34, P451, DOI 10.1146/annurev.anthro.34.081804.120558; LEVINE M, 1995, COMP BIOCHEM PHYS A, V111, P209, DOI 10.1016/0300-9629(95)00016-Z; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; London B, 2007, CIRCULATION, V116, P2260, DOI 10.1161/CIRCULATIONAHA.107.703330; Long Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-612; Lund SP, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1826; Maes M, 1997, CLIN ENDOCRINOL, V46, P587, DOI 10.1046/j.1365-2265.1997.1881002.x; MAHLBERG FH, 1992, J BIOL CHEM, V267, P4541; Mastrangelo AM, 2012, PLANT SCI, V185, P40, DOI 10.1016/j.plantsci.2011.09.006; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; McNabb FMA, 2006, GEN COMP ENDOCR, V147, P93, DOI 10.1016/j.ygcen.2005.12.011; McNabb FM, 1985, STURKIES AVIAN PHYSL, P461; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mitrovich QM, 2000, GENE DEV, V14, P2173, DOI 10.1101/gad.819900; Nakamura M, 1994, Nihon Rinsho, V52, P857; Olkowski AA, 2007, POULTRY SCI, V86, P999, DOI 10.1093/ps/86.5.999; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Pleiss JA, 2007, MOL CELL, V27, P928, DOI 10.1016/j.molcel.2007.07.018; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; RISING JD, 1974, CONDOR, V76, P198, DOI 10.2307/1366730; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rokita SE, 2010, BIOCHIMIE, V92, P1227, DOI 10.1016/j.biochi.2010.02.013; Ruf J, 2006, ARCH BIOCHEM BIOPHYS, V445, P269, DOI 10.1016/j.abb.2005.06.023; Saltzman AL, 2011, GENE DEV, V25, P373, DOI 10.1101/gad.2004811; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; Schmid M, 2015, CYTOGENET GENOME RES, V145, P78, DOI 10.1159/000430927; Shen YF, 2016, GENES-BASEL, V7, DOI 10.3390/genes7070034; Shoemaker CJ, 2012, NAT STRUCT MOL BIOL, V19, P594, DOI 10.1038/nsmb.2301; Shy D, 2013, BBA-MOL CELL RES, V1833, P886, DOI 10.1016/j.bbamcr.2012.10.026; SIEGEL HS, 1995, BRIT POULTRY SCI, V36, P3, DOI 10.1080/00071669508417748; SPINU M, 1993, BRIT POULTRY SCI, V34, P177, DOI 10.1080/00071669308417573; Stager M, 2014, GENE, V546, P104, DOI 10.1016/j.gene.2014.05.019; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun L, 2015, CELL STRESS CHAPERON, V20, P939, DOI 10.1007/s12192-015-0621-0; Thomas SR, 2009, J BIOL CHEM, V284, P19659, DOI 10.1074/jbc.M109.013458; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Valdivia CR, 2009, AM J PHYSIOL-HEART C, V297, pH1446, DOI 10.1152/ajpheart.00513.2009; VANHERLE AJ, 1979, NEW ENGL J MED, V301, P239, DOI 10.1056/NEJM197908023010504; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang J, 2017, NUCL ACIDS RES; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Will C. L., 2011, COLD SPRING HARBOR P, V3, ppii; Windisch HS, 2014, MOL ECOL, V23, P3469, DOI 10.1111/mec.12822; Wrutniak-Cabello C, 2001, J MOL ENDOCRINOL, V26, P67, DOI 10.1677/jme.0.0260067; Xie SS, 2017, ASIAN AUSTRAL J ANIM, V30, P1507, DOI 10.5713/ajas.16.0957; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yin XM, 2014, J CLIN ENDOCR METAB, V99, pE2076, DOI 10.1210/jc.2014-1735; Zhang JB, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3675-9; Zhang ZW, 2011, POULTRY SCI, V90, P1555, DOI 10.3382/ps.2010-01333; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zheng WH, 2013, COMP BIOCHEM PHYS A, V164, P483, DOI 10.1016/j.cbpa.2012.12.004	101	5	5	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0191096	10.1371/journal.pone.0191096	http://dx.doi.org/10.1371/journal.pone.0191096			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320582	Green Submitted, gold, Green Published			2022-12-26	WOS:000419689600086
J	Cronin, JC; Loftus, SK; Baxter, LL; Swatkoski, S; Gucek, M; Pavan, WJ				Cronin, Julia C.; Loftus, Stacie K.; Baxter, Laura L.; Swatkoski, Steve; Gucek, Marjan; Pavan, William J.			Identification and functional analysis of SOX10 phosphorylation sites in melanoma	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SOX10; WAARDENBURG-SYNDROME; STEM-CELLS; DOPACHROME-TAUTOMERASE; EXPRESSION; MUTATIONS; RESISTANCE; PROTEIN; MITF; ACTIVATION	The transcription factor SOX10 plays an important role in vertebrate neural crest development, including the establishment and maintenance of the melanocyte lineage. SOX10 is also highly expressed in melanoma tumors, and SOX10 expression increases with tumor progression. The suppression of SOX10 in melanoma cells activates TGF-beta signaling and can promote resistance to BRAF and MEK inhibitors. Since resistance to BRAF/MEK inhibitors is seen in the majority of melanoma patients, there is an immediate need to assess the underlying biology that mediates resistance and to identify new targets for combinatorial therapeutic approaches. Previously, we demonstrated that SOX10 protein is required for tumor initiation, maintenance and survival. Here, we present data that support phosphorylation as a mechanism employed by melanoma cells to tightly regulate SOX10 expression. Mass spectrometry identified eight phosphorylation sites contained within SOX10, three of which (S24, S45 and T240) were selected for further analysis based on their location within predicted MAPK/CDK binding motifs. SOX10 mutations were generated at these phosphorylation sites to assess their impact on SOX10 protein function in melanoma cells, including transcriptional activation on target promoters, subcellular localization, and stability. These data further our understanding of SOX10 protein regulation and provide critical information for identification of molecular pathways that modulate SOX10 protein levels in melanoma, with the ultimate goal of discovering novel targets for more effective combinatorial therapeutic approaches for melanoma patients.	[Cronin, Julia C.; Loftus, Stacie K.; Baxter, Laura L.; Pavan, William J.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA; [Swatkoski, Steve; Gucek, Marjan] NHLBI, Prote Core, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Pavan, WJ (corresponding author), NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA.	bpavan@mail.nih.gov		Loftus, Stacie/0000-0002-1958-4689; Baxter, Laura/0000-0001-7941-1088	Intramural Research Program of the National Institutes of Health, National Human Genome Research Institute [1ZIAHG000136-18]; Intramural Research Program of the NIH, NHGRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005903] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000136, ZIAHG000070] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Human Genome Research Institute; Intramural Research Program of the NIH, NHGRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Human Genome Research Institute (1ZIAHG000136-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Guanghi Wang for mass spectometry analysis and the members of the Pavan laboratory for helpful discussions. This research was supported by the Intramural Research Program of the NIH, NHGRI.	Ascierto PA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-85; BENTLEY NJ, 1994, MOL CELL BIOL, V14, P7996, DOI 10.1128/MCB.14.12.7996; Bondurand N, 2007, AM J HUM GENET, V81, P1169, DOI 10.1086/522090; Chaoui A, 2011, HUM MUTAT, V32, P1436, DOI 10.1002/humu.21583; Cimino-Mathews A, 2013, HUM PATHOL, V44, P959, DOI 10.1016/j.humpath.2012.09.005; Coricor G, 2016, SCI REP-UK, V6, DOI 10.1038/srep38616; Cronin JC, 2013, CANCER RES, V73, P5709, DOI 10.1158/0008-5472.CAN-12-4620; Cronin JC, 2009, PIGM CELL MELANOMA R, V22, P435, DOI 10.1111/j.1755-148X.2009.00578.x; Dravis C, 2015, CELL REP, V12, P2035, DOI 10.1016/j.celrep.2015.08.040; Ehsani L, 2014, APPL IMMUNOHISTO M M, V22, P648, DOI 10.1097/PAI.0000000000000013; Fallahi-Sichani M, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20166796; Feng W, 2017, BIOCHEM BIOPH RES CO, V485, P522, DOI 10.1016/j.bbrc.2017.02.014; Filtz TM, 2014, TRENDS PHARMACOL SCI, V35, P76, DOI 10.1016/j.tips.2013.11.005; Fufa TD, 2015, HUM MOL GENET, V24, P5433, DOI 10.1093/hmg/ddv267; Girard M, 2006, FEBS LETT, V580, P1635, DOI 10.1016/j.febslet.2006.02.011; Greaves WO, 2013, J MOL; Haldin CE, 2010, INT J BIOCHEM CELL B, V42, P441, DOI 10.1016/j.biocel.2009.11.014; Harris ML, 2010, PIGM CELL MELANOMA R, V23, P496, DOI 10.1111/j.1755-148X.2010.00711.x; He DY, 2016, NAT NEUROSCI, V19, P678, DOI 10.1038/nn.4258; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Huang YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10398; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Inoue K, 1999, ANN NEUROL, V46, P313, DOI 10.1002/1531-8249(199909)46:3<313::AID-ANA6>3.0.CO;2-7; Ivanov SV, 2013, BRIT J CANCER, V109, P444, DOI 10.1038/bjc.2013.326; Iyengar AS, 2014, PIGM CELL MELANOMA R, V27, P846, DOI 10.1111/pcmr.12277; Jiao ZX, 2004, PIGM CELL RES, V17, P352, DOI 10.1111/j.1600-0749.2004.00154.x; Jo A, 2014, GENES DIS, V1, P149, DOI 10.1016/j.gendis.2014.09.004; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kim H, 2015, CELL REP, V11, P1458, DOI 10.1016/j.celrep.2015.04.049; Kornitzer D, 2000, J CELLULAR PHYSL; Krings G, 2017, MOD PATHOL; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P23033, DOI 10.1074/jbc.273.36.23033; Kumar D, 2009, MOL CELL BIOL, V29, P4262, DOI 10.1128/MCB.01779-08; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurette P, 2015, ELIFE, V4, DOI 10.7554/eLife.06857; Luanpitpong S, 2016, ONCOGENE, V35, P2824, DOI 10.1038/onc.2015.351; Ludwig A, 2004, FEBS LETT, V556, P236, DOI 10.1016/S0014-5793(03)01446-7; Lv XB, 2015, ONCOTARGET, V6, P36370, DOI 10.18632/oncotarget.5639; Malki S, 2005, EMBO J, V24, P1798, DOI 10.1038/sj.emboj.7600660; Marathe HG, 2017, NUCLEIC ACIDS RES, V45, P6442, DOI 10.1093/nar/gkx259; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Min L, 2017, ONCOTARGET, V8, P21938, DOI 10.18632/oncotarget.15749; Mollaaghababa R, 2003, ONCOGENE, V22, P3024, DOI 10.1038/sj.onc.1206442; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Old WM, 2009, MOL CELL, V34, P115, DOI 10.1016/j.molcel.2009.03.007; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Panaccione A, 2017, CLIN BREAST CANCER, V17, P298, DOI 10.1016/j.clbc.2017.01.007; Peirano RI, 2000, NUCLEIC ACIDS RES, V28, P3047, DOI 10.1093/nar/28.16.3047; Peirano RI, 2000, MOL CELL BIOL, V20, P3198, DOI 10.1128/MCB.20.9.3198-3209.2000; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Ploper D, 2015, P NATL ACAD SCI USA, V112, pE420, DOI 10.1073/pnas.1424576112; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Potterf SB, 2001, DEV BIOL, V237, P245, DOI 10.1006/dbio.2001.0372; Ravnan MC, 2012, VEMURAFENIB PATIENTS; Rehberg S, 2002, MOL CELL BIOL, V22, P5826, DOI 10.1128/MCB.22.16.5826-5834.2002; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Rubinstein JC, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-67; Schreiner S, 2007, DEVELOPMENT, V134, P3271, DOI 10.1242/dev.003350; Serao NVL, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-49; Shaffer SM, 2017, NATURE, V546, P431, DOI 10.1038/nature22794; Shakhova O, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004877; Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535; Stuart SA, 2015, MOL CELL PROTEOMICS, V14, P1599, DOI 10.1074/mcp.M114.047233; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Svajdler M, 2015, HISTOL; Touraine, 2000, AM J HUM GENET, V66, P2020; Touraine RL, 2000, AM J HUM GENET, V66, P1496, DOI 10.1086/302895; Villanueva J, 2013, CELL REP, V4, P1090, DOI 10.1016/j.celrep.2013.08.023; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Wang YC, 2011, J BIOL CHEM, V286, P18190, DOI 10.1074/jbc.M111.236133; Watanabe A, 1998, NAT GENET, V18, P283, DOI 10.1038/ng0398-283; Weider M, 2017, SEMIN CELL DEV BIOL, V63, P35, DOI 10.1016/j.semcdb.2016.08.013; Whitmarsh AJ, 2000, CELL MOL LIFE SCI, V57, P1172, DOI 10.1007/PL00000757; Wissmuller S, 2006, NUCLEIC ACIDS RES, V34, P1735, DOI 10.1093/nar/gkl105; Zang HY, 2017, GYNECOL ENDOCRINOL, V33, P193, DOI 10.1080/09513590.2016.1239253; Zanivan S, 2008, J PROTEOME RES, V7, P5314, DOI 10.1021/pr800599n; Zhou DJ, 2014, TUMOR BIOL, V35, P9935, DOI 10.1007/s13277-014-1893-1	80	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190834	10.1371/journal.pone.0190834	http://dx.doi.org/10.1371/journal.pone.0190834			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315345	gold, Green Published, Green Submitted			2022-12-26	WOS:000419655900025
J	Jung, J; Nidetzky, B				Jung, Jihye; Nidetzky, Bernd			Evidence of a sequestered imine intermediate during reduction of nitrile to amine by the nitrile reductase QueF from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-GUANINE TRANSGLYCOSYLASE; HMG-COA REDUCTASE; STRUCTURAL BASIS; MECHANISM; BIOSYNTHESIS; QUEUOSINE; OXIDOREDUCTASE; DEHYDROGENASE; SUBSTRATE; CATALYSIS	In the biosynthesis of the tRNA-inserted nucleoside queuosine, the nitrile reductase QueF catalyzes conversion of 7-cyano-7-deazaguanine (preQ(0)) to 7-aminomethyl-7-deazaguanine (preQ(1)), a biologically unique four-electron reduction of a nitrile to an amine. The QueF mechanism involves a covalent thioimide adduct between the enzyme and preQ0 that undergoes reduction to preQ1 in two NADPH-dependent steps, presumably via an imine intermediate. Protecting a labile imine from interception by water is fundamental to QueF catalysis for proper enzyme function. In the QueF from Escherichia coli, the conserved Glu(89) and Phe(228) residues together with a mobile structural element composing the catalytic Cys(190) form a substrate-binding pocket that secludes the bound preQ(0) completely from solvent. We show here that residue substitutions (E89A, E89L, and F228A) targeted at opening up the binding pocket weakened preQ(0) binding at the preadduct stage by up to +10 kJ/mol and profoundly affected catalysis. Unlike wildtype enzyme, the QueF variants, including L191A and I192A, were no longer selective for preQ(1) formation. The E89A, E89L, and F228A variants performed primarily (>= 90%) a two-electron reduction of preQ(0), releasing hydrolyzed imine (7-formyl-7-deazaguanine) as the product. The preQ(0) reduction by L191A and I192A gave preQ(1) and 7-formyl-7-deazaguanine at a 4:1 and 1: 1 ratio, respectively. The proportion of 7- formyl-7-deazaguanine in total product increased with increasing substrate concentration, suggesting a role for preQ(0) in a competitor-induced release of the imine intermediate. Collectively, these results provide direct evidence for the intermediacy of an imine in the QueF-catalyzed reaction. They reveal determinants of QueF structure required for imine sequestration and hence for a complete nitrile-to-amine conversion by this class of enzymes.	[Jung, Jihye; Nidetzky, Bernd] Graz Univ Technol, Austrian Ctr Ind Biotechnol, A-8010 Graz, Austria; [Jung, Jihye; Nidetzky, Bernd] Graz Univ Technol, NAWI Graz, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria	Austrian Centre of Industrial Biotechnology; Graz University of Technology; Graz University of Technology	Nidetzky, B (corresponding author), Graz Univ Technol, Austrian Ctr Ind Biotechnol, A-8010 Graz, Austria.; Nidetzky, B (corresponding author), Graz Univ Technol, NAWI Graz, Inst Biotechnol & Biochem Engn, A-8010 Graz, Austria.	bernd.nidetzky@tugraz.at		Nidetzky, Bernd/0000-0002-5030-2643; Jung, Jihye/0000-0001-9186-7176	Federal Ministry of Economy, Family and Youth (BMWFW); Federal Ministry for Transport, Innovation and Technology (BMVIT); Styrian Business Promotion Agency SFG; Vienna Business Agency; Standortagentur Tirol; Government of Lower Austria; Styrian Provincial Government Economic Affairs and Innovation through the COMET-Funding Program	Federal Ministry of Economy, Family and Youth (BMWFW); Federal Ministry for Transport, Innovation and Technology (BMVIT); Styrian Business Promotion Agency SFG; Vienna Business Agency; Standortagentur Tirol; Government of Lower Austria; Styrian Provincial Government Economic Affairs and Innovation through the COMET-Funding Program	This work has been supported by the Federal Ministry of Economy, Family and Youth (BMWFW), the Federal Ministry for Transport, Innovation and Technology (BMVIT), the Styrian Business Promotion Agency SFG, the Vienna Business Agency, the Standortagentur Tirol, the Government of Lower Austria, and Styrian Provincial Government Economic Affairs and Innovation through the COMET-Funding Program managed by the Austrian Research Promotion Agency FFG. The authors declare that they have no conflicts of interest with the contents of this article.	Barajas JF, 2015, CHEM BIOL, V22, P1018, DOI 10.1016/j.chembiol.2015.06.022; BRUNHUBER NMW, 1994, CRIT REV BIOCHEM MOL, V29, P415, DOI 10.3109/10409239409083486; Brunhuber NMW, 2000, BIOCHEMISTRY-US, V39, P9174, DOI 10.1021/bi000494c; Chhabra A, 2012, P NATL ACAD SCI USA, V109, P5681, DOI 10.1073/pnas.1118680109; Chikwana VM, 2012, J BIOL CHEM, V287, P30560, DOI 10.1074/jbc.M112.388538; Colloc'h N, 2000, PROTEINS, V39, P142, DOI 10.1002/(SICI)1097-0134(20000501)39:2<142::AID-PROT4>3.0.CO;2-X; de Maria PD, 2011, CHEMCATCHEM, V3, P1683, DOI 10.1002/cctc.201100220; Dineshkumar TK, 2002, MICROBIOL-SGM, V148, P3779, DOI 10.1099/00221287-148-12-3779; DURAND JM, 1994, J BACTERIOL, V176, P4627, DOI 10.1128/JB.176.15.4627-4634.1994; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Friesen JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-248; Gjonaj L, 2016, CATAL SCI TECHNOL, V6, P7391, DOI 10.1039/c6cy01140c; Gradler U, 2001, J MOL BIOL, V306, P455, DOI 10.1006/jmbi.2000.4256; Haines BE, 2013, ACCOUNTS CHEM RES, V46, P2416, DOI 10.1021/ar3003267; HARADA F, 1972, BIOCHEMISTRY-US, V11, P301, DOI 10.1021/bi00752a024; Iwata-Reuyl D, 2003, BIOORG CHEM, V31, P24, DOI 10.1016/S0045-2068(02)00513-8; JEONG SS, 1994, ANAL BIOCHEM, V221, P273, DOI 10.1006/abio.1994.1411; Jung JY, 2016, J BIOL CHEM, V291, P25411, DOI 10.1074/jbc.M116.747014; Kim Y, 2010, J MOL BIOL, V404, P127, DOI 10.1016/j.jmb.2010.09.042; Klepper F, 2005, HELV CHIM ACTA, V88, P2610, DOI 10.1002/hlca.200590201; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Lee BWK, 2007, BIOCHEMISTRY-US, V46, P12844, DOI 10.1021/bi701265r; Li M, 2016, J MOL CATAL B-ENZYM, V131, P47, DOI 10.1016/j.molcatb.2016.06.001; Moeller K, 2013, ENZYME MICROB TECH, V52, P129, DOI 10.1016/j.enzmictec.2012.12.003; Mohammad A, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010030; Oliveira EF, 2016, CATAL SCI TECHNOL, V6, P7172, DOI 10.1039/c6cy00356g; Paramanathan T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6207; RAGG E, 1991, BIOCHIM BIOPHYS ACTA, V1076, P49, DOI 10.1016/0167-4838(91)90218-O; Reader JS, 2004, J BIOL CHEM, V279, P6280, DOI 10.1074/jbc.M310858200; Ribeiro AJM, 2015, ACS CATAL, V5, P3740, DOI 10.1021/acscatal.5b00528; Richard JP, 2014, CURR OPIN CHEM BIOL, V21, P1, DOI 10.1016/j.cbpa.2014.03.001; Schmolzer K, 2014, FEBS LETT, V588, P2978, DOI 10.1016/j.febslet.2014.05.053; STILLMAN TJ, 1993, J MOL BIOL, V234, P1131, DOI 10.1006/jmbi.1993.1665; Van Lanen SG, 2005, P NATL ACAD SCI USA, V102, P4264, DOI 10.1073/pnas.0408056102; Vinayak M, 2010, BIOSCIENCE REP, V30, P135, DOI 10.1042/BSR20090057; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wilding B, 2013, CHEM-EUR J, V19, P7007, DOI 10.1002/chem.201300163; Wilding B, 2012, ADV SYNTH CATAL, V354, P2191, DOI 10.1002/adsc.201200109	38	4	4	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3720	3733		10.1074/jbc.M117.804583	http://dx.doi.org/10.1074/jbc.M117.804583			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29339556	Green Published, hybrid			2022-12-26	WOS:000427030200025
J	Zeden, MS; Schuster, CF; Bowman, L; Zhong, QY; Williams, HD; Grundling, A				Zeden, Merve S.; Schuster, Christopher F.; Bowman, Lisa; Zhong, Qiyun; Williams, Huw D.; Grundling, Angelika			Cyclic di-adenosine monophosphate (c-di-AMP) is required for osmotic regulation in Staphylococcus aureus but dispensable for viability in anaerobic conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PROTEIN; BETAINE TRANSPORT-SYSTEM; GRAM-POSITIVE BACTERIA; SMALL-COLONY-VARIANT; LISTERIA-MONOCYTOGENES; STRESS RESISTANCE; BACILLUS-SUBTILIS; GLYCINE BETAINE; GENE-EXPRESSION; HEMB MUTANT	Cyclic di-adenosine monophosphate (c-di-AMP) is a recently discovered signaling molecule important for the survival of Firmicutes, a large bacterial group that includes notable pathogens such as Staphylococcus aureus. However, the exact role of this molecule has not been identified. dacA, the S. aureus gene encoding the diadenylate cyclase enzyme required for c-di-AMP production, cannot be deleted when bacterial cells are grown in rich medium, indicating that c-di-AMP is required for growth in this condition. Here, we report that an S. aureus dacA mutant can be generated in chemically defined medium. Consistent with previous findings, this mutant had a severe growth defect when cultured in rich medium. Using this growth defect in rich medium, we selected for suppressor strains with improved growth to identify c-di-AMP-requiring pathways. Mutations bypassing the essentiality of dacA were identified in alsT and opuD, encoding a predicted amino acid and osmolyte transporter, the latter of which we show here to be the main glycine betaine-uptake system in S. aureus. Inactivation of these transporters likely prevents the excessive osmolyte and amino acid accumulation in the cell, providing further evidence for a key role of c-di-AMP in osmotic regulation. Suppressor mutations were also obtained in hepS, hemB, ctaA, and qoxB, coding proteins required for respiration. Furthermore, we show that dacA is dispensable for growth in anaerobic conditions. Together, these findings reveal an essential role for the c-di-AMP signaling network in aerobic, but not anaerobic, respiration in S. aureus.	[Zeden, Merve S.; Schuster, Christopher F.; Bowman, Lisa; Zhong, Qiyun; Grundling, Angelika] Imperial Coll London, Microbiol Sect, London SW7 2AZ, England; [Zeden, Merve S.; Schuster, Christopher F.; Bowman, Lisa; Zhong, Qiyun; Grundling, Angelika] Imperial Coll London, Med Res Council Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Williams, Huw D.] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [Bowman, Lisa] Univ Dundee, Sch Life Sci, Div Mol Microbiol, Dundee DD1 5EH, Scotland	Imperial College London; Imperial College London; Imperial College London; University of Dundee	Grundling, A (corresponding author), Imperial Coll London, Microbiol Sect, London SW7 2AZ, England.; Grundling, A (corresponding author), Imperial Coll London, Med Res Council Ctr Mol Bacteriol & Infect, London SW7 2AZ, England.	a.grundling@imperial.ac.uk	Zeden, Merve/GXF-9824-2022; Schuster, Christopher F./J-9904-2015	Grundling, Angelika/0000-0002-6235-8687; Schuster, Christopher F./0000-0002-4566-7226; Zhong, Qiyun/0000-0001-7053-9640; Williams, Huw/0000-0003-2225-6413; Zeden, Merve Suzan/0000-0003-3636-700X	European Research Council [260371]; Wellcome Trust [100289]; Medical Research Council Centre for Molecular Bacteriology and Infection (MRC CMBI) studentship; German Research Foundation (DFG) [SCHU 3159/1-1]; BBSRC [BB/L024209/1] Funding Source: UKRI; MRC [MR/P028225/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Centre for Molecular Bacteriology and Infection (MRC CMBI) studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Research Foundation (DFG)(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by European Research Council Grant 260371 and Wellcome Trust Grant 100289 (to A. G.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Medical Research Council Centre for Molecular Bacteriology and Infection (MRC CMBI) studentship.; Supported by German Research Foundation (DFG) Grant SCHU 3159/1-1.	Angelidis AS, 2003, APPL ENVIRON MICROB, V69, P1013, DOI 10.1128/AEM.69.2.1013-1022.2003; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Behrends V, 2013, J BIOL CHEM, V288, P15098, DOI 10.1074/jbc.M112.442814; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Bowman L, 2016, J BIOL CHEM, V291, P26970, DOI 10.1074/jbc.M116.747709; Campeotto I, 2015, J BIOL CHEM, V290, P2888, DOI 10.1074/jbc.M114.621789; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Chin KH, 2015, BIOCHEMISTRY-US, V54, P4936, DOI 10.1021/acs.biochem.5b00633; Choi PH, 2015, MICROBIOLOGYOPEN, V4, P361, DOI 10.1002/mbo3.243; Choi S, 2014, APPL MICROBIOL BIOT, V98, P807, DOI 10.1007/s00253-013-5436-2; COLLINS MD, 1981, MICROBIOL REV, V45, P316, DOI 10.1128/MMBR.45.2.316-354.1981; Commichau F. M., 2017, TRENDS MICROBIOL; Commichau FM, 2015, MOL MICROBIOL, V97, P189, DOI 10.1111/mmi.13026; Corrigan RM, 2016, P NATL ACAD SCI USA, V113, pE1710, DOI 10.1073/pnas.1522179113; Corrigan RM, 2015, J BIOL CHEM, V290, P5826, DOI 10.1074/jbc.M114.598300; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Dengler V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073512; Ferreira MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058277; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Fuchs S, 2007, J BACTERIOL, V189, P4275, DOI 10.1128/JB.00081-07; Gotz F, 2013, MBIO, V4, DOI 10.1128/mBio.00976-13; Gries CM, 2013, MOL MICROBIOL, V89, P760, DOI 10.1111/mmi.12312; Griffiths JM, 2012, ANTIMICROB AGENTS CH, V56, P579, DOI 10.1128/AAC.05148-11; Grundling A, 2007, J BACTERIOL, V189, P2521, DOI 10.1128/JB.01683-06; Gundlach J., 2017, CURR GENET; Gundlach J, 2017, MBIO, V8, DOI 10.1128/mBio.00861-17; Gundlach J, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal3011; Gundlach J, 2015, J BACTERIOL, V197, P3265, DOI 10.1128/JB.00564-15; Halsey CR, 2017, MBIO, V8, DOI 10.1128/mBio.01434-16; Hammer N. D., 2013, MBIO, V4, DOI DOI 10.1128/MBIO.00241-13; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hiron A, 2007, J BACTERIOL, V189, P5119, DOI 10.1128/JB.00274-07; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; KAFALA B, 1994, CAN J MICROBIOL, V40, P651, DOI 10.1139/m94-103; Kim H, 2015, J BIOL CHEM, V290, P16393, DOI 10.1074/jbc.M115.641340; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Ko R, 1999, APPL ENVIRON MICROB, V65, P4040; Kohler C, 2003, J BACTERIOL, V185, P6928, DOI 10.1128/JB.185.23.6928-6937.2003; Kohler C, 2008, J BACTERIOL, V190, P6351, DOI 10.1128/JB.00505-08; Li GQ, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140167; Mayer S, 2015, J BACTERIOL, V197, P794, DOI 10.1128/JB.02127-14; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Monk IR, 2015, MBIO, V6, DOI 10.1128/mBio.00308-15; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; Moscoso JA, 2016, J BACTERIOL, V198, P98, DOI 10.1128/JB.00480-15; Muller M, 2015, FEBS LETT, V589, P45, DOI 10.1016/j.febslet.2014.11.022; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Pader V, 2014, INFECT IMMUN, V82, P4337, DOI 10.1128/IAI.02254-14; Pagels M, 2010, MOL MICROBIOL, V76, P1142, DOI 10.1111/j.1365-2958.2010.07105.x; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Price-Whelan A, 2013, MBIO, V4, DOI 10.1128/mBio.00407-13; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; RUDIN L, 1974, J BACTERIOL, V118, P155, DOI 10.1128/JB.118.1.155-164.1974; Schuster CF, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7279; Seggewiss J, 2006, J BACTERIOL, V188, P7765, DOI 10.1128/JB.00774-06; Shapiro Howard M., 2008, V142, P175, DOI 10.1007/978-1-59745-246-5_14; Sleator RD, 1999, APPL ENVIRON MICROB, V65, P2078; Tavares AFN, 2011, J BIOL CHEM, V286, P26708, DOI 10.1074/jbc.M111.255752; TOWNSEND DE, 1992, J BACTERIOL, V174, P2702, DOI 10.1128/jb.174.8.2702-2710.1992; Huynh TN, 2016, MOL MICROBIOL, V102, P233, DOI 10.1111/mmi.13456; Tynecka Z, 1999, RES MICROBIOL, V150, P555, DOI 10.1016/S0923-2508(99)00102-3; vonEiff C, 1997, J BACTERIOL, V179, P4706, DOI 10.1128/jb.179.15.4706-4712.1997; Wetzel KJ, 2011, FEMS IMMUNOL MED MIC, V61, P346, DOI 10.1111/j.1574-695X.2011.00781.x; Whiteley AT, 2017, MOL MICROBIOL, V104, P212, DOI 10.1111/mmi.13622; Whiteley AT, 2015, CELL HOST MICROBE, V17, P788, DOI 10.1016/j.chom.2015.05.006; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yu DL, 2014, GENOMICS, V104, P8, DOI 10.1016/j.ygeno.2014.04.003; Zamboni N, 2003, FEMS MICROBIOL LETT, V226, P121, DOI 10.1016/S0378-1097(03)00614-1	75	52	53	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3180	3200		10.1074/jbc.M117.818716	http://dx.doi.org/10.1074/jbc.M117.818716			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29326168	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000426562800013
J	Shen, LL; Qu, X; Li, HC; Xu, CS; Wei, MY; Wang, QH; Ru, Y; Liu, B; Xu, YQ; Li, K; Hu, JB; Wang, LF; Ma, YZ; Li, MY; Lai, XF; Gao, L; Wu, KC; Yao, LB; Zheng, JY; Zhang, J				Shen, Liangliang; Qu, Xuan; Li, Huichen; Xu, Chunsheng; Wei, Mengying; Wang, Qinhao; Ru, Yi; Liu, Bei; Xu, Yuqiao; Li, Kai; Hu, Junbi; Wang, Lifeng; Ma, Yongzheng; Li, Mengyang; Lai, Xiaofeng; Gao, Lei; Wu, Kaichun; Yao, Libo; Zheng, Jianyong; Zhang, Jian			NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis	ONCOGENE			English	Article							BETA-CATENIN; CELL-CYCLE; TUMOR-SUPPRESSOR; COLON-CARCINOMA; C-MYC; UBIQUITIN LIGASES; BREAST-CANCER; EXPRESSION; SKP2; PATHWAY	Poorly differentiated colorectal cancers (CRCs) are more aggressive and lack targeted therapies. We and others previously reported the predominant role of tumor-suppressor NDRG2 in promoting CRC differentiation, but the underlying mechanism is largely unknown. Herein, we demonstrate that NDRG2 induction of CRC cell differentiation is dependent on the repression of E3 ligase Skp2 activity. In patients and Ndrg2 knockout mice, NDRG2 and Skp2 are negatively correlated and associated with cell differentiation stage. Further, NDRG2 suppression of Skp2 contributes to the inductions and stabilizations of p21 and p27, which are Skp2 target proteins for degradation. The reduction of either p21 or p27 levels by shRNA can decrease NDRG2-induced AKP activity and resume cell growth inhibition, thus both p21 and p27 are required for NDRG2 effect on the promotion of cell differentiation in CRCs. The mechanistic study shows that NDRG2 suppresses beta-catenin nuclear translocation and decreases the occupancy of beta-catenin/TCF complex on Skp2 promoter, potentially through dephosphorylating GSK-3 beta. By subjecting a series of NDRG2 deletion mutants to Skp2 expression, the loss of NH2-terminal domain can completely abolish NDRG2-dependent differentiation induction. Supporting the biological significance of the reciprocal relationship between NDRG2 and Skp2, an NDRG2(low)/Skp2(high) gene expression signature correlates with poor CRC patient outcome and could be considered as a diagnostic marker of CRCs.	[Shen, Liangliang; Li, Huichen; Wei, Mengying; Wang, Qinhao; Ru, Yi; Wang, Lifeng; Ma, Yongzheng; Li, Mengyang; Lai, Xiaofeng; Yao, Libo; Zhang, Jian] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China; [Qu, Xuan] Shaanxi Univ Chinese Med, Xianyang, Peoples R China; [Xu, Chunsheng] 537 Hosp PLA, Dept Gen Surg, Baoji, Peoples R China; [Liu, Bei] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, Xian, Shaanxi, Peoples R China; [Liu, Bei] Fourth Mil Med Univ, Tangdu Hosp, Inst Funct Brain Disorders, Xian, Shaanxi, Peoples R China; [Xu, Yuqiao] Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China; [Xu, Yuqiao] Fourth Mil Med Univ, Xijing Hosp, Dept Pathol, Xian, Shaanxi, Peoples R China; [Li, Kai] Gen Hosp Xinjiang Mil Command, Dept Clin Lab, Xinjiang, Peoples R China; [Hu, Junbi] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Gastroenterol, Xian, Shaanxi, Peoples R China; [Gao, Lei] Wuhan Gen Hosp Guangzhou Mil Reg, Dept Urol, Wuhan, Hubei, Peoples R China; [Wu, Kaichun] Fourth Mil Med Univ, Natl Clin Res Ctr Digest Dis, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China; [Wu, Kaichun] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian, Shaanxi, Peoples R China; [Zheng, Jianyong] Fourth Mil Med Univ, Xijing Hosp, Dept Gastrointestinal Surg, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China	Air Force Military Medical University; Shaanxi University of Chinese Medicine; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Xi'an Jiaotong University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Shen, LL; Zhang, J (corresponding author), Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China.; Zheng, JY (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Gastrointestinal Surg, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China.	bioliangshen@fmmu.edu.cn; zhjy68@163.com; biozhangj@fmmu.edu.cn		Li, Mengyang/0000-0001-8973-0445	National Natural Science Foundation of China [31401161, 81230043, 31571437, 81502370, 81401069, 81770523, 81502210]; Founds for Creative Research Groups of China [81421003]; State Key Laboratory of Cancer Biology Project [CBSKL2017Z11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Founds for Creative Research Groups of China; State Key Laboratory of Cancer Biology Project	This work was financially sponsored by grants from the National Natural Science Foundation of China (no. 31401161; no. 81230043; no. 31571437; no. 81502370; no. 81401069; no. 81770523; and no. 81502210), the Founds for Creative Research Groups of China (no. 81421003), and the State Key Laboratory of Cancer Biology Project (CBSKL2017Z11).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Chan CH, 2013, CELL, V154, P556, DOI 10.1016/j.cell.2013.06.048; Chen J, 1996, ONCOGENE, V13, P1395; Chu D, 2011, MOL CANCER THER, V10, P47, DOI 10.1158/1535-7163.MCT-10-0614; Craig C, 1997, ONCOGENE, V14, P2283, DOI 10.1038/sj.onc.1201064; Deng YC, 2003, INT J CANCER, V106, P342, DOI 10.1002/ijc.11228; Derwinger K, 2010, ACTA ONCOL, V49, P57, DOI 10.3109/02841860903334411; Evers BM, 1996, AM J PHYSIOL-GASTR L, V271, pG722, DOI 10.1152/ajpgi.1996.271.4.G722; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Goss KH, 2000, J CLIN ONCOL, V18, P1967, DOI 10.1200/JCO.2000.18.9.1967; Guo YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077305; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hershko DD, 2008, CANCER-AM CANCER SOC, V112, P1415, DOI 10.1002/cncr.23317; Kang K, 2015, BIOCHEM BIOPH RES CO, V468, P611, DOI 10.1016/j.bbrc.2015.10.167; Kim SJ, 2014, CELL DEATH DIFFER, V21, P1769, DOI 10.1038/cdd.2014.88; Kim YJ, 2013, ONCOL REP, V30, P1890, DOI 10.3892/or.2013.2642; Kim YJ, 2009, CARCINOGENESIS, V30, P598, DOI 10.1093/carcin/bgp047; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li X, 2007, CANCER RES, V67, P8716, DOI 10.1158/0008-5472.CAN-06-3731; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Lorentzen A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-192; Marikawa Y, 1998, MECH DEVELOP, V77, P75, DOI 10.1016/S0925-4773(98)00134-8; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nakahata S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4393; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Ng RCL, 2014, CELL DEATH DIFFER, V21, P978, DOI 10.1038/cdd.2014.20; Pfeuty B, 2008, CELL CYCLE, V7, P3246, DOI 10.4161/cc.7.20.6853; PONCECASTANEDA MV, 1995, CANCER RES, V55, P1211; Qu X, 2014, J INVEST DERMATOL, V134, P159, DOI 10.1038/jid.2013.281; Shapira M, 2005, CANCER-AM CANCER SOC, V103, P1336, DOI 10.1002/cncr.20917; Shen L, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2013.48; Shen LL, 2015, P NATL ACAD SCI USA, V112, P5425, DOI 10.1073/pnas.1501555112; Shiohara M, 1997, LEUKEMIA LYMPHOMA, V26, P35, DOI 10.3109/10428199709109155; STEINMAN RA, 1994, ONCOGENE, V9, P3389; Tang YX, 2009, MOL CANCER THER, V8, P458, DOI 10.1158/1535-7163.MCT-08-0885; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tian YF, 2013, TUMOR BIOL, V34, P1107, DOI 10.1007/s13277-013-0652-z; Xu XY, 2015, ONCOTARGET, V6, P26161, DOI 10.18632/oncotarget.4544; Yao LB, 2008, ACTA BIOCH BIOPH SIN, V40, P625, DOI 10.1111/j.1745-7270.2008.00434.x; Zhang J, 2006, J BIOL CHEM, V281, P39159, DOI 10.1074/jbc.M605820200	41	36	36	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	13					1759	1774		10.1038/s41388-017-0118-7	http://dx.doi.org/10.1038/s41388-017-0118-7			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GA9AE	29343851	Green Published, hybrid			2022-12-26	WOS:000428632600006
J	Kumar, S; Choudhary, AK; Rana, KS; Sarker, A; Singh, M				Kumar, Sandeep; Choudhary, Anil Kumar; Rana, Kuldeep Singh; Sarker, Ashutosh; Singh, Mohar			Bio-fortification potential of global wild annual lentil core collection	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; BIOFORTIFICATION	Lentil, generally known as poor man's' meat due to its high protein value is also a good source of dietary fiber, antioxidants and vitamins along with fast cooking characteristics. It could be used globally as a staple food crop to eradicate hidden hunger, if this nutritionally rich crop is further enriched with essential minerals. This requires identification of essential mineral rich germplasm. So, in the present study, a core set of 96 wild accessions extracted from 405 global wild annual collections comprising different species was analyzed to determine its bio-fortification potential. Impressive variation (mg/100 g) was observed for different minerals including Na (30-318), K (138.29-1578), P (37.50-593.75), Ca (4.74-188.75), Mg (15-159), Fe (2.82-14.12), Zn (1.29-12.62), Cu (0.5-7.12), Mn (1.22-9.99), Mo (1.02-11.89), Ni (0.16-3.49), Pb (0.01-0.58), Cd (0-0.03), Co (0-0.63) and As (0-0.02). Hierarchical clustering revealed high intra-and inter-specific variability. Further, correlation study showed positive significant association among minerals and between minerals including agro-morphological traits. Accessions representation from Turkey and Syria had maximum variability for different minerals. Diversity analysis exhibited wide geographical variations across gene-pool in core set. Potential use of the identified trait-specific genetic resources could be initial genetic material, for genetic base broadening and biofortification of cultivated lentil.	[Kumar, Sandeep] ICAR Natl Bur Plant Genet Resources, New Delhi, India; [Choudhary, Anil Kumar; Rana, Kuldeep Singh] ICAR Indian Agr Res Inst, Dept Agron, New Delhi, India; [Sarker, Ashutosh] Int Ctr Agr Res Dry Areas, SACRP, DPS Marg Pusa Campus, New Delhi, India; [Singh, Mohar] ICAR Natl Bur Plant Genet Resources, Reg Stn, Shimla, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources	Singh, M (corresponding author), ICAR Natl Bur Plant Genet Resources, Reg Stn, Shimla, India.	singhmohar_2003@yahoo.com		singh, mohar/0000-0002-5644-9144	Department of Agriculture Cooperation and Farmers' right; Indian Council of Agricultural Research; International Centre for Agricultural Research in Dry Area, India office New Delhi	Department of Agriculture Cooperation and Farmers' right(Department of Agriculture Cooperation & Farmers Welfare (DACFW), India); Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR)); International Centre for Agricultural Research in Dry Area, India office New Delhi	The authors acknowledge the help and support provided by Department of Agriculture Cooperation and Farmers' right, Indian Council of Agricultural Research and International Centre for Agricultural Research in Dry Area, India office New Delhi. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright SC, 2010, DATA ANAL DECISION M, P1061; Alghamdi SS, 2014, INT J MOL SCI, V15, P277, DOI 10.3390/ijms15010277; [Anonymous], 2009, ICRISAT ARCH REP; Burton G.W., 1952, P 6 INT GRASSLAND C, V1, P227; Cabrera C, 2003, SCI TOTAL ENVIRON, V308, P1, DOI 10.1016/S0048-9697(02)00611-3; Cundeva K, 2007, J BRAZIL CHEM SOC, V18, P1207, DOI 10.1590/S0103-50532007000600015; Distelfeld A, 2007, PHYSIOL PLANTARUM, V129, P635, DOI 10.1111/j.1399-3054.2006.00841.x; Dutta M., 2015, ADV WHEAT GENETICS G, P33, DOI 10.1007/978-4-431-55675-6_4; Erskine W, 1997, EUPHYTICA, V93, P107, DOI 10.1023/A:1002939704321; FAO, 2014, FAO STAT DAT; Fennema OR, 2000, FOOD CHEM; Gupta DS, 2017, FRONT PLANT SCI, V8, P1; International Zinc Consultative Group, 2004, FOOD NUTR BULL, V25, pS99, DOI DOI 10.1177/15648265040251S205; Jitendra Kumar, 2016, Biofortification of food crops, P147; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Karakoy Tolga, 2012, ScientificWorldJournal, V2012, P710412, DOI 10.1100/2012/710412; Laghetti G., 2008, EUR J PLANT SCI BIOT, V2, P48; Leshe S., 2014, AFRICAN J CHEM ED, V4, P16; Melchinger AE, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P99; Pogatschnik C, 2014, PRACT GASTROENTEROL, V38, P27; Singh A, 2017, J PLANT BIOCHEM BIOT, V26, P199, DOI 10.1007/s13562-016-0382-6; Singh M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107781; Stehle P, 2016, EUR J CLIN NUTR, V70, P886, DOI 10.1038/ejcn.2016.53; Toklu F, 2009, PLANT BREEDING, V128, P178, DOI 10.1111/j.1439-0523.2008.01548.x; Upadhyaya HD, 2011, FIELD CROP RES, V124, P459, DOI 10.1016/j.fcr.2011.08.004; Vadivel V, 2001, FOOD CHEM, V74, P507, DOI 10.1016/S0308-8146(01)00175-3; Vieira EA, 2007, GENET MOL BIOL, V30, P392, DOI 10.1590/S1415-47572007000300016; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; Yang XE, 2007, ENVIRON GEOCHEM HLTH, V29, P413, DOI 10.1007/s10653-007-9086-0; Yucel C, 2009, TURK J AGRIC FOR, V33, P525, DOI 10.3906/tar-0901-8; ZARCINAS BA, 1987, COMMUN SOIL SCI PLAN, V18, P131, DOI 10.1080/00103628709367806; Zia-Ul-Haq M, 2011, PAK J BOT, V43, P1563	32	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191122	10.1371/journal.pone.0191122	http://dx.doi.org/10.1371/journal.pone.0191122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346404	Green Published, gold, Green Submitted			2022-12-26	WOS:000422749500029
J	Teshima, T; Matsumoto, H; Koyama, H				Teshima, Takahiro; Matsumoto, Hirotaka; Koyama, Hidekazu			Soluble factors from adipose tissue-derived mesenchymal stem cells promote canine hepatocellular carcinoma cell proliferation and invasion	PLOS ONE			English	Article							ACUTE LIVER-FAILURE; IN-VITRO; REGENERATIVE MEDICINE; SIGNALING PATHWAYS; HUMAN CANCER; BONE-MARROW; GROWTH; EXPRESSION; SECRETOME; FIBROSIS	The potential effects of adipose tissue-derived mesenchymal stem cells (AT-MSCs) on the growth and invasion of canine tumours including hepatocellular carcinoma (HCC) are not yet understood. Moreover in humans, the functional contribution of AT-MSCs to malignancies remains controversial. The purpose of this study was to investigate the effects of AT-MSCs on the proliferation and invasion of canine HCC cells in vitro. The effect of AT-MSCs on mRNA levels of factors related to HCC progression were also evaluated. Conditioned medium from AT-MSCs (AT-MSC-CM) significantly enhanced canine HCC cell proliferation and invasion. Moreover, mRNA expression levels of transforming growth factor-beta 1, epidermal growth factor A, hepatocyte growth factor, platelet-derived growth factor-beta, vascular endothelial growth factor, and insulin-like growth factor 2 were 2.3 +/- 0.4, 2.0 +/- 0.5, 5.7 +/- 1.9, 1.7 +/- 0.2, 2.1 +/- 0.4, and 1.4 +/- 0.3 times higher, respectively (P < 0.05). The mRNA expression level of MMP-2 also increased (to 4.0 +/- 1.2 times control levels) in canine HCC cells co-cultured with AT-MSCs, but MMP-9 mRNA significantly decreased (to 0.5 +/- 0.1 times control levels). These findings suggest that soluble factors from AT-MSCs promote the proliferation and invasion of canine HCC cells.	[Teshima, Takahiro; Matsumoto, Hirotaka; Koyama, Hidekazu] Nippon Vet & Life Sci Univ, Fac Vet Sci, Sch Vet Med, Dept Vet Clin Med,Lab Vet Internal Med, Musashino, Tokyo, Japan	Nippon Veterinary & Life Science University	Teshima, T (corresponding author), Nippon Vet & Life Sci Univ, Fac Vet Sci, Sch Vet Med, Dept Vet Clin Med,Lab Vet Internal Med, Musashino, Tokyo, Japan.	teshima63@nvlu.ac.jp		Teshima, Takahiro/0000-0001-9646-6785	Japan Society for the Promotion of Science KAKENHI Grant [16K18808]	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TT received Japan Society for the Promotion of Science KAKENHI Grant Number 16K18808 (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Chen GF, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0040-2; Chen RX, 2012, ANN SURG ONCOL, V19, pS375, DOI 10.1245/s10434-011-1836-7; Galuppo R, 2014, DIGEST DIS SCI, V59, P1688, DOI 10.1007/s10620-014-3058-x; Gao J, 2013, MOL CELL BIOCHEM, V376, P21, DOI 10.1007/s11010-012-1545-y; Harn HJ, 2012, CELL TRANSPLANT, V21, P2753, DOI 10.3727/096368912X652959; Huang PX, 2014, J CELL MOL MED, V18, P218, DOI 10.1111/jcmm.12153; Ji SQ, 2013, BRAZ J MED BIOL RES, V46, P758, DOI 10.1590/1414-431X20132907; Kapur SK, 2013, BIOCHIMIE, V95, P2222, DOI 10.1016/j.biochi.2013.06.001; Katsuda T, 2014, METHODS MOL BIOL, V1213, P57, DOI 10.1007/978-1-4939-1453-1_6; Kisiel AH, 2012, AM J VET RES, V73, P1305, DOI 10.2460/ajvr.73.8.1305; Kohga K, 2010, J HEPATOL, V52, P872, DOI 10.1016/j.jhep.2009.12.030; Kudo M, 2012, WORLD J GASTROENTERO, V18, P6005, DOI 10.3748/wjg.v18.i42.6005; Li GC, 2010, CANCER SCI, V101, P2546, DOI 10.1111/j.1349-7006.2010.01738.x; Liptak J. M., 2007, WITHROW MACEWENS SMA, P483; Liptak JM, 2004, JAVMA-J AM VET MED A, V225, P1225, DOI 10.2460/javma.2004.225.1225; Llovet JM, 2014, CANCER CELL, V25, P560, DOI 10.1016/j.ccr.2014.04.019; Maass T, 2011, INT J CANCER, V128, P1259, DOI 10.1002/ijc.25469; Makridakis M, 2013, BBA-PROTEINS PROTEOM, V1834, P2380, DOI 10.1016/j.bbapap.2013.01.032; Marx C, 2015, STEM CELLS DEV, V24, P803, DOI 10.1089/scd.2014.0407; Michishita M, 2014, RES VET SCI, V96, P315, DOI 10.1016/j.rvsc.2014.01.004; Miyazono K, 2000, J CELL SCI, V113, P1101; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Moeini A, 2012, LIVER CANCER, V1, P83, DOI 10.1159/000342405; Nagaraj NS, 2010, EXPERT OPIN INV DRUG, V19, P77, DOI 10.1517/13543780903382609; Neupane M, 2008, TISSUE ENG PT A, V14, P1007, DOI [10.1089/ten.tea.2007.0207, 10.1089/tea.2007.0207]; Niess H, 2011, ANN SURG, V254, P767, DOI 10.1097/SLA.0b013e3182368c4f; Okada H, 2012, CANCER RES, V72, P4459, DOI 10.1158/0008-5472.CAN-12-0028; Okura H, 2015, BIOCHEM BIOPH RES CO, V456, P860, DOI 10.1016/j.bbrc.2014.11.122; Roomi MW, 2009, ONCOL REP, V21, P1323, DOI 10.3892/or_00000358; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; SCHIRMACHER P, 1992, CANCER RES, V52, P2549; Schweizer R, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/120949; Screven R, 2014, VET IMMUNOL IMMUNOP, V161, P21, DOI 10.1016/j.vetimm.2014.06.002; Sun XY, 2011, ANTICANCER RES, V31, P3705; Takemitsu H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-150; Venepalli NK, 2013, INT J HEPATOL, V2013, DOI 10.1155/2013/341636; Volarevic V, 2014, STEM CELLS, V32, P2818, DOI 10.1002/stem.1818; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yang D, 2015, J DIGEST DIS, V16, P489, DOI 10.1111/1751-2980.12268; Zhao P, 2010, CANCER SCI, V101, P387, DOI 10.1111/j.1349-7006.2009.01420.x; Zhao WX, 2012, CANCER BIOTHER RADIO, V27, P606, DOI 10.1089/cbr.2011.1150	42	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191539	10.1371/journal.pone.0191539	http://dx.doi.org/10.1371/journal.pone.0191539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346427	Green Submitted, gold, Green Published			2022-12-26	WOS:000422749500061
J	Kohli, N; Crisp, Z; Riordan, R; Li, M; Alaniz, RC; Jayaraman, A				Kohli, Nandita; Crisp, Zeni; Riordan, Rebekah; Li, Michael; Alaniz, Robert C.; Jayaraman, Arul			The microbiota metabolite indole inhibits Salmonella virulence: Involvement of the PhoPQ two-component system	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI O157-H7; GENE-EXPRESSION; COLONIZATION RESISTANCE; GASTROINTESTINAL-TRACT; INTESTINAL COLONIZATION; CLOSTRIDIUM-DIFFICILE; SEROTYPE TYPHIMURIUM; INVASION GENES	The microbial community present in the gastrointestinal tract is an important component of the host defense against pathogen infections. We previously demonstrated that indole, a microbial metabolite of tryptophan, reduces enterohemorrhagic Escherichia coli O157:H7 attachment to intestinal epithelial cells and biofilm formation, suggesting that indole may be an effector/attenuator of colonization for a number of enteric pathogens. Here, we report that indole attenuates Salmonella Typhimurium (Salmonella) virulence and invasion as well as increases resistance to colonization in host cells. Indole-exposed Salmonella colonized mice less effectively compared to solvent-treated controls, as evident by competitive index values less than 1 in multiple organs. Indole-exposed Salmonella demonstrated 160-fold less invasion of HeLa epithelial cells and 2-fold less invasion of J774A. 1 macrophages compared to solvent-treated controls. However, indole did not affect Salmonella intracellular survival in J774A. 1 macrophages suggesting that indole primarily affects Salmonella invasion. The decrease in invasion was corroborated by a decrease in expression of multiple Salmonella Pathogenicity Island-1 (SPI-1) genes. We also identified that the effect of indole was mediated by both PhoPQ-dependent and independent mechanisms. Indole also synergistically enhanced the inhibitory effect of a short chain fatty acid cocktail on SPI-1 gene expression. Lastly, indole-treated HeLa cells were 70% more resistant to Salmonella invasion suggesting that indole also increases resistance of epithelial cells to colonization. Our results demonstrate that indole is an important microbiota metabolite that has direct anti-infective effects on Salmonella and host cells, revealing novel mechanisms of pathogen colonization resistance.	[Kohli, Nandita; Li, Michael; Jayaraman, Arul] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA; [Crisp, Zeni; Riordan, Rebekah; Alaniz, Robert C.; Jayaraman, Arul] Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, College Stn, TX 77845 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Jayaraman, A (corresponding author), Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA.; Alaniz, RC; Jayaraman, A (corresponding author), Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, College Stn, TX 77845 USA.	alaniz@medicine.tamhsc.edu; arulj@tamu.edu						Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; ARGENZIO RA, 1975, AM J PHYSIOL, V228, P454, DOI 10.1152/ajplegacy.1975.228.2.454; ARGENZIO RA, 1974, AM J PHYSIOL, V226, P1043, DOI 10.1152/ajplegacy.1974.226.5.1043; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; BERNET MF, 1994, GUT, V35, P483, DOI 10.1136/gut.35.4.483; Bogomolnaya LM, 2008, MOL MICROBIOL, V70, P1105, DOI 10.1111/j.1365-2958.2008.06461.x; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Dabard J, 2001, APPL ENVIRON MICROB, V67, P4111, DOI 10.1128/AEM.67.9.4111-4118.2001; Darkoh C, 2015, APPL ENVIRON MICROB, V81, P8093, DOI 10.1128/AEM.02787-15; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FRETER R, 1983, INFECT IMMUN, V39, P676, DOI 10.1128/IAI.39.2.676-685.1983; Gantois I, 2006, APPL ENVIRON MICROB, V72, P946, DOI 10.1128/AEM.72.1.946-949.2006; Gong HS, 2010, J BASIC MICROB, V50, pS37, DOI 10.1002/jobm.201000130; Groisman EA, 2006, NAT REV MICROBIOL, V4, P705, DOI 10.1038/nrmicro1478; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Huang Y, 2008, J BACTERIOL, V190, P4233, DOI 10.1128/JB.00205-08; Hung CC, 2013, MOL MICROBIOL, V87, P1045, DOI 10.1111/mmi.12149; Josenhans C, 2002, INT J MED MICROBIOL, V291, P605, DOI 10.1078/1438-4221-00173; Kanamaru K, 2000, MOL MICROBIOL, V38, P805, DOI 10.1046/j.1365-2958.2000.02171.x; Kingsley RA, 2003, INFECT IMMUN, V71, P629, DOI 10.1128/IAI.71.2.629-640.2003; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; Lawley TD, 2013, IMMUNOLOGY, V138, P1, DOI 10.1111/j.1365-2567.2012.03616.x; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Lee YK, 2003, J MED MICROBIOL, V52, P925, DOI 10.1099/jmm.0.05009-0; Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lostroh CP, 2001, MICROBES INFECT, V3, P1281; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; Nikaido E, 2008, J BIOL CHEM, V283, P24245, DOI 10.1074/jbc.M804544200; Nikaido E, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-5; Oh S, 2012, J APPL MICROBIOL, V113, P622, DOI 10.1111/j.1365-2672.2012.05372.x; Rea MC, 2010, P NATL ACAD SCI USA, V107, P9352, DOI 10.1073/pnas.0913554107; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; SNELL EE, 1975, ADV ENZYMOL RAMB, V42, P287; Sridharan GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6492; Stecher B, 2005, INFECT IMMUN, V73, P3228, DOI 10.1128/IAI.73.6.3228-3241.2005; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Sun Y, 2013, ADV APPL MICROBIOL, V85, P93, DOI 10.1016/B978-0-12-407672-3.00003-4; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Van Deun K, 2008, BRIT J NUTR, V100, P480, DOI 10.1017/S0007114508921693; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; Vega NM, 2013, P NATL ACAD SCI USA, V110, P14420, DOI 10.1073/pnas.1308085110; Weening EH, 2005, INFECT IMMUN, V73, P3358, DOI 10.1128/IAI.73.6.3358-3366.2005; WHITT DD, 1975, APPL MICROBIOL, V30, P609, DOI 10.1128/AEM.30.4.609-615.1975; WILSON KH, 1988, INFECT IMMUN, V56, P2610, DOI 10.1128/IAI.56.10.2610-2614.1988	54	31	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190613	10.1371/journal.pone.0190613	http://dx.doi.org/10.1371/journal.pone.0190613			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342189	Green Published, gold, Green Submitted			2022-12-26	WOS:000422653800026
J	Prioreschi, A; Munthali, RJ; Kagura, J; Said-Mohamed, R; Rolfe, ED; Micklesfield, LK; Norris, SA				Prioreschi, Alessandra; Munthali, Richard J.; Kagura, Juliana; Said-Mohamed, Rihlat; Rolfe, Emanuella De Lucia; Micklesfield, Lisa K.; Norris, Shane A.			The associations between adult body composition and abdominal adiposity outcomes, and relative weight gain and linear growth from birth to age 22 in the Birth to Twenty Plus cohort, South Africa	PLOS ONE			English	Article							CHILDHOOD GROWTH; RISK-FACTORS; MASS INDEX; LATER LIFE; SIZE; FETAL; COUNTRIES; INFANT; NUTRITION; CHILDREN	Background The growing prevalence of overweight and obesity in low- or middle-income countries precipitates the need to examine early life predictors of adiposity. Objectives To examine growth trajectories from birth, and associations with adult body composition in the Birth to Twenty Plus Cohort, Soweto, South Africa. Methods Complete data at year 22 was available for 1088 participants (536 males and 537 females). Conditional weight and height indices were generated indicative of relative rate of growth between years 0-2, 2-5, 5-8, 8-18, and 18-22. Whole body composition was measured at year 22 (range 21-25 years) using dual energy x-ray absorptiometry (DXA). Total fat free soft tissue mass (FFSTM), fat mass, and abdominal visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) were recorded. Results Birth weight was positively associated with FFSTM and fat mass at year 22 (beta = 0.11, p<0.01 and beta = 0.10, p<0.01 respectively). Relative weight gain from birth to year 22 was positively associated with FFSTM, fat mass, VAT, and SAT at year 22. Relative linear growth from birth to year 22 was positively associated with FFSTM at year 22. Relative linear growth from birth to year 2 was positively associated with VAT at year 22. Being born small for gestational age and being stunted at age 2 years were inversely associated with FFSTM at year 22. Conclusions The importance of optimal birth weight and growth tempos during early life for later life body composition, and the detrimental effects of pre- and postnatal growth restriction are clear; yet contemporary weight-gain most strongly predicted adult body composition. Thus interventions should target body composition trajectories during childhood and prevent excessive weight gain in early adulthood.	[Prioreschi, Alessandra; Munthali, Richard J.; Kagura, Juliana; Said-Mohamed, Rihlat; Micklesfield, Lisa K.; Norris, Shane A.] Univ Witwatersrand, MRC WITS Dev Pathways Hlth Res Unit, Dept Paediat, Sch Clin Med,Fac Hlth Sci, Johannesburg, South Africa; [Rolfe, Emanuella De Lucia] Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, Inst Metab Sci, Cambridge Biomed Campus, Cambridge, England	University of Witwatersrand; University of Cambridge	Prioreschi, A (corresponding author), Univ Witwatersrand, MRC WITS Dev Pathways Hlth Res Unit, Dept Paediat, Sch Clin Med,Fac Hlth Sci, Johannesburg, South Africa.	alessandra.prioreschi@wits.ac.za	Munthali, Richard/AAU-6205-2021; Micklesfield, Lisa/AAR-8262-2021; Norris, Shane/C-4664-2014	Munthali, Richard/0000-0001-8492-7409; Micklesfield, Lisa/0000-0002-4994-0779; Norris, Shane/0000-0001-7124-3788; SAID MOHAMED, Rihlat/0000-0003-1592-5412; Prioreschi, Alessandra/0000-0002-6913-0706	DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg in the Republic of South Africa; Claude Leon Foundation; Medical Research Council [MC_UU_12015/2]; Wellcome Trust (UK); University of the Witwatersrand; South African Medical Research Council; Human Sciences Research Council; MRC [MC_UU_12015/2] Funding Source: UKRI	DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg in the Republic of South Africa; Claude Leon Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (UK)(Wellcome Trust); University of the Witwatersrand; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Sciences Research Council; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The support of the DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg in the Republic of South Africa towards this research is hereby acknowledged by AP. The Claude Leon Foundation also supported the work of AP. EDLR is supported by the Medical Research Council (Unit Programme number MC_UU_12015/2). Birth to Twenty Plus cohort was funded by the Wellcome Trust (UK), University of the Witwatersrand, South African Medical Research Council and the Human Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The support of the DST-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg in the Republic of South Africa towards this research is hereby acknowledged by AP. Opinions expressed and conclusions arrived at, are those of the authors and are not to be attributed to the CoE in Human Development. The Claude Leon Foundation also supported the work of AP. EDLR is supported by the Medical Research Council (Unit Programme number MC_UU_12015/2).	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; de Franca GVA, 2016, INT J OBESITY, V40, P14, DOI 10.1038/ijo.2015.192; de Franca GVA, 2014, OBES REV, V15, P77, DOI 10.1111/obr.12109; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Brown LD, 2014, J ENDOCRINOL, V221, pR13, DOI 10.1530/JOE-13-0567; Corvalan C, 2007, INT J EPIDEMIOL, V36, P550, DOI 10.1093/ije/dym010; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; FALL CHD, 1995, BRIT MED J, V310, P428, DOI 10.1136/bmj.310.6977.428; Jones LL, 2009, AM J HUM BIOL, V21, P395, DOI 10.1002/ajhb.20868; Kolcic Ivana, 2012, J Glob Health, V2, P020303, DOI 10.7189/jogh.02.020303; Kuzawa CW, 2012, AM J HUM BIOL, V24, P5, DOI 10.1002/ajhb.21227; Li HJ, 2003, AM J CLIN NUTR, V77, P1498, DOI 10.1093/ajcn/77.6.1498; Micklesfield LK, 2012, OBESITY, V20, P1109, DOI 10.1038/oby.2011.367; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Munthali RJ, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3337-x; Musa MG, 2016, J DEV ORIG HLTH DIS, V7, P132, DOI 10.1017/S2040174415007953; Norris SA, 2012, DIABETES CARE, V35, P72, DOI 10.2337/dc11-0456; Popkin BM, 1996, J NUTR, V126, P3009, DOI 10.1093/jn/126.12.3009; Pradeilles R, 2014, CHILDREN YOUTH ENV, V24, P173, DOI DOI 10.7721/CHILYOUTENVI.24.3.0173; Richter L, 2007, INT J EPIDEMIOL, V36, P504, DOI 10.1093/ije/dym016; Rogers I, 2003, INT J OBESITY, V27, P755, DOI 10.1038/sj.ijo.0802316; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; Shisana O, 2013, S AFRICAN NATL HLTH; Simmons R, 2008, SEMIN PERINATOL, V32, P371, DOI 10.1053/j.semperi.2008.08.004; Twig G, 2016, NEW ENGL J MED, V374, P2430, DOI 10.1056/NEJMoa1503840; Victora CG, 2001, INT J EPIDEMIOL, V30, P217, DOI 10.1093/ije/30.2.217; Wells JCK, 2007, P NUTR SOC, V66, P423, DOI 10.1017/S0029665107005691; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233	30	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190483	10.1371/journal.pone.0190483	http://dx.doi.org/10.1371/journal.pone.0190483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338002	Green Published, Green Submitted, gold			2022-12-26	WOS:000422652700010
J	Liu, ZL; Dugan, B; Masiello, CA; Wahab, LM; Gonnermann, HM; Nittrouer, JA				Liu, Zuolin; Dugan, Brandon; Masiello, Caroline A.; Wahab, Leila M.; Gonnermann, Helge M.; Nittrouer, Jeffrey A.			Effect of freeze-thaw cycling on grain size of biochar	PLOS ONE			English	Article							PARTICLE-SIZE; WATER-CONTENT; SOIL; CHARCOAL; IMPACT	Biochar may improve soil hydrology by altering soil porosity, density, hydraulic conductivity, and water-holding capacity. These properties are associated with the grain size distributions of both soil and biochar, and therefore may change as biochar weathers. Here we report how freeze-thaw (F-T) cycling impacts the grain size of pine, mesquite, miscanthus, and sewage waste biochars under two drainage conditions: undrained (all biochars) and a gravity-drained experiment (mesquite biochar only). In the undrained experiment plant biochars showed a decrease in median grain size and a change in grain-size distribution consistent with the flaking off of thin layers from the biochar surface. Biochar grain size distribution changed from unimodal to bimodal, with lower peaks and wider distributions. For plant biochars the median grain size decreased by up to 45.8% and the grain aspect ratio increased by up to 22.4% after 20 F-T cycles. F-T cycling did not change the grain size or aspect ratio of sewage waste biochar. We also observed changes in the skeletal density of biochars (maximum increase of 1.3%), envelope density (maximum decrease of 12.2%), and intraporosity (porosity inside particles, maximum increase of 3.2%). In the drained experiment, mesquite biochar exhibited a decrease of median grain size (up to 4.2%) and no change of aspect ratio after 10 F-T cycles. We also document a positive relationship between grain size decrease and initial water content, suggesting that, biochar properties that increase water content, like high intraporosity and pore connectivity large intrapores, and hydrophilicity, combined with undrained conditions and frequent F-T cycles may increase biochar breakdown. The observed changes in biochar particle size and shape can be expected to alter hydrologic properties, and thus may impact both plant growth and the hydrologic cycle.	[Liu, Zuolin; Dugan, Brandon; Masiello, Caroline A.; Wahab, Leila M.; Gonnermann, Helge M.; Nittrouer, Jeffrey A.] Rice Univ, Dept Earth Environm & Planetary Sci, Houston, TX 77005 USA; [Masiello, Caroline A.] Rice Univ, Dept Chem & Biosci, Houston, TX USA; [Dugan, Brandon] Colorado Sch Mines, Dept Geophys, Golden, CO 80401 USA	Rice University; Rice University; Colorado School of Mines	Liu, ZL (corresponding author), Rice Univ, Dept Earth Environm & Planetary Sci, Houston, TX 77005 USA.	zl17@rice.edu	Gonnermann, Helge M/B-1054-2012		United States National Science Foundation [NSF-EAR-0911685]	United States National Science Foundation(National Science Foundation (NSF))	This study was funded by United States National Science Foundation with fund number NSF-EAR-0911685 received by CAM and BD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abel S, 2013, GEODERMA, V202, P183, DOI 10.1016/j.geoderma.2013.03.003; Ajayi AE, 2016, SOIL TILL RES, V155, P166, DOI 10.1016/j.still.2015.08.007; Barnes RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108340; Bayat H, 2015, J HYDROL, V529, P872, DOI 10.1016/j.jhydrol.2015.08.067; Berner R.A., 2012, GLOBAL ENV WATER AIR, Vsecond; Brewer CE, 2014, BIOMASS BIOENERG, V66, P176, DOI 10.1016/j.biombioe.2014.03.059; BULLOCK MS, 1988, SOIL SCI SOC AM J, V52, P770, DOI 10.2136/sssaj1988.03615995005200030031x; Carcaillet C, 2001, HOLOCENE, V11, P231, DOI 10.1191/095968301674071040; Githinji L, 2014, ARCH AGRON SOIL SCI, V60, P457, DOI 10.1080/03650340.2013.821698; Haley JS, 2011, CLIMATOLOGY FREEZE T; Jones DL, 2011, SOIL BIOL BIOCHEM, V43, P804, DOI 10.1016/j.soilbio.2010.12.015; Kameyama K, 2014, EUR J SOIL SCI, V65, P105, DOI 10.1111/ejss.12083; Kinney TJ, 2012, BIOMASS BIOENERG, V41, P34, DOI 10.1016/j.biombioe.2012.01.033; Lehmann J, 2003, PLANT SOIL, V249, P343, DOI 10.1023/A:1022833116184; Lehmann J., 2009, BIOCHAR ENV MANAGEME, DOI DOI 10.1007/S13593-016-0372-Z; Lim TJ, 2016, CHEMOSPHERE, V142, P136, DOI 10.1016/j.chemosphere.2015.06.069; Liu J, 2012, J PLANT NUTR SOIL SC, V175, P698, DOI 10.1002/jpln.201100172; Liu ZL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179079; Liu ZL, 2016, J HYDROL, V533, P461, DOI 10.1016/j.jhydrol.2015.12.007; Molina M, 2009, P NATL ACAD SCI USA, V106, P20616, DOI 10.1073/pnas.0902568106; Ponge JF, 2006, SOIL BIOL BIOCHEM, V38, P2008, DOI 10.1016/j.soilbio.2005.12.024; Spokas KA, 2014, ENVIRON SCI TECH LET, V1, P326, DOI 10.1021/ez500199t; Sun H, 2012, IND ENG CHEM RES, V51, P3587, DOI 10.1021/ie201309r; Vipulanandan C, 2009, J GEOTECH GEOENVIRON, V135, P1190, DOI 10.1061/(ASCE)GT.1943-5606.0000064; Wang DJ, 2013, ENVIRON SCI TECHNOL, V47, P821, DOI 10.1021/es303794d; Woolf D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1053	26	13	14	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191246	10.1371/journal.pone.0191246	http://dx.doi.org/10.1371/journal.pone.0191246			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329343	Green Published, gold, Green Submitted			2022-12-26	WOS:000419954100055
J	Peltenburg, NC; Bierau, J; Bakker, JA; Schippers, JA; Lowe, SH; Paulussen, ADC; van den Bosch, BJC; Leers, MPG; Hansen, BE; Verbon, A				Peltenburg, N. Chantal; Bierau, Jorgen; Bakker, Jaap A.; Schippers, Jolanda A.; Lowe, Selwyn H.; Paulussen, Aimee D. C.; van den Bosch, Bianca J. C.; Leers, Mathie P. G.; Hansen, Bettina E.; Verbon, Annelies			Erythrocyte Inosine triphosphatase activity: A potential biomarker for adverse events during combination antiretroviral therapy for HIV	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RIBAVIRIN-INDUCED ANEMIA; REVERSE-TRANSCRIPTASE; INFECTED PATIENTS; GENETIC-BASIS; ITPA; POLYMORPHISMS; INHIBITION; VARIANTS; CARBOVIR	The purine analogues tenofovir and abacavir are precursors of potential substrates for the enzyme Inosine 5'-triphosphate pyrophosphohydrolase (ITPase). Here, we investigated the association of ITPase activity and ITPA genotype with the occurrence of adverse events (AEs) during combination antiretroviral therapy (cART) for human immunodeficiency virus (HIV) infection. In 393 adult HIV-seropositive patients, AEs were defined as events that led to stop of cART regimen. ITPase activity >= 4 mmol IMP/mmol Hb/hour was considered as normal. ITPA genotype was determined by testing two ITPA polymorphisms: c.94C>A (p.Pro32Thr, rs1127354) and c.124+21 A>C (rs7270101). Logistic regression analysis determined odds ratios for developing AEs. In tenofovir-containing regimens decreased ITPase activity was associated with less AEs (p = 0.01) and longer regimen duration (p = 0.001). In contrast, in abacavir-containing regimens decreased ITPase activity was associated with more AEs (crude p = 0.02) and increased switching of medication due to AEs (p = 0.03). ITPA genotype wt/wt was significantly associated with an increase in the occurrence of AEs in tenofovir-containing regimens. Decreased ITPase activity seems to be protective against occurrence of AEs in tenofovir-containing cART, while it is associated with an increase in AEs in abacavir-containing regimens.	[Peltenburg, N. Chantal; Verbon, Annelies] Erasmus MC, Dept Internal Med, Div Infect Dis, Rotterdam, Netherlands; [Peltenburg, N. Chantal; Verbon, Annelies] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Bierau, Jorgen; Paulussen, Aimee D. C.; van den Bosch, Bianca J. C.] Maastricht Univ, Med Ctr, Dept Clin Genet, Maastricht, Netherlands; [Bakker, Jaap A.] Leiden Univ, Med Ctr, Dept Clin Chem, Leiden, Netherlands; [Bakker, Jaap A.] Leiden Univ, Med Ctr, Lab Med, Leiden, Netherlands; [Schippers, Jolanda A.] Maastricht Univ, Med Ctr, Dept Integrated Care, Maastricht, Netherlands; [Lowe, Selwyn H.] Maastricht Univ, Med Ctr, Dept Internal Med, Div Infect Dis, Maastricht, Netherlands; [Lowe, Selwyn H.] Maastricht Univ, Med Ctr, Sch CAPHRI, Dept Med Microbiol, Maastricht, Netherlands; [Leers, Mathie P. G.] Zuyderland Med Ctr, Dept Clin Chem & Hematol, Heerlen, Netherlands; [Hansen, Bettina E.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Maastricht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Erasmus University Rotterdam; Erasmus MC	Verbon, A (corresponding author), Erasmus MC, Dept Internal Med, Div Infect Dis, Rotterdam, Netherlands.; Verbon, A (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	a.verbon@erasmusmc.nl	Leers, Mathie/AFV-8239-2022; Bakker, J. A./H-7910-2019	Leers, Mathie/0000-0001-5186-5600; Bakker, Jaap A./0000-0002-2918-7361	Janssen pharmaceutical companies of Johnson Johnson	Janssen pharmaceutical companies of Johnson Johnson	This work was supported by Janssen pharmaceutical companies of Johnson & Johnson through an unrestricted scientific grant.	Arenas M, 2007, BBA-MOL BASIS DIS, V1772, P96, DOI 10.1016/j.bbadis.2006.10.006; Bakker JA, 2010, EUR RESPIR J, V36, P684, DOI 10.1183/09031936.00026610; Baum PD, 2011, AIDS, V25, P2243, DOI 10.1097/QAD.0b013e32834d3cc3; Bierau J, 2006, NUCLEOS NUCLEOT NUCL, V25, P1129, DOI 10.1080/15257770600894253; Bierau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030175; BONDOC LL, 1990, BIOCHEMISTRY-US, V29, P9839, DOI 10.1021/bi00494a013; Cheon JH, 2009, HEPATO-GASTROENTEROL, V56, P421; Cihlar T., 2008, MODIFIED NUCLEOSIDES, P601; Coelho AVC, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16019373; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Kevelam SH, 2015, ANN NEUROL, V78, P649, DOI 10.1002/ana.24496; Kudo M, 2009, DRUG METAB PHARMACOK, V24, P557, DOI 10.2133/dmpk.24.557; Kurosaki M, 2011, ANTIVIR THER, V16, P685, DOI 10.3851/IMP1796; Lotsch J, 2011, PHARMACOGENOMICS, V12, P1729, DOI [10.2217/PGS.11.99, 10.2217/pgs.11.99]; Maeda T, 2005, MOL GENET METAB, V85, P271, DOI 10.1016/j.ymgme.2005.03.011; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Marinaki AM, 2004, NUCLEOS NUCLEOT NUCL, V23, P1393, DOI 10.1081/NCN-200027639; Marinaki AM, 2004, PHARMACOGENETICS, V14, P181, DOI 10.1097/00008571-200403000-00006; Marsh S, 2004, J HUM GENET, V49, P579, DOI 10.1007/s10038-004-0183-y; Nishimura T, 2012, MOL MED REP, V5, P517, DOI 10.3892/mmr.2011.659; PARKER WB, 1991, J BIOL CHEM, V266, P1754; Peltenburg NC, 2016, JAIDS-J ACQ IMM DEF, V73, P390, DOI 10.1097/QAI.0000000000001130; Peltenburg NC, 2015, CLIN CHEM LAB MED, V53, P2021, DOI 10.1515/cclm-2015-0057; Shipkova M, 2006, CLIN CHEM, V52, P240, DOI 10.1373/clinchem.2005.059501; Stepchenkova EI, 2009, J MOL BIOL, V392, P602, DOI 10.1016/j.jmb.2009.07.051; Sumi S, 2002, HUM GENET, V111, P360, DOI 10.1007/s00439-002-0798-z; Suo ZC, 1998, J BIOL CHEM, V273, P27250, DOI 10.1074/jbc.273.42.27250; Thompson AJ, 2011, HEPATOLOGY, V53, P389, DOI 10.1002/hep.24068; Van Dieren JM, 2007, ALIMENT PHARM THERAP, V26, P643, DOI 10.1111/j.1365-2036.2007.03412.x; Yuen GJ, 2008, CLIN PHARMACOKINET, V47, P351, DOI 10.2165/00003088-200847060-00001	30	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191069	10.1371/journal.pone.0191069	http://dx.doi.org/10.1371/journal.pone.0191069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329318	Green Published, gold, Green Submitted			2022-12-26	WOS:000419954100036
J	Cibicek, N; Ehrmann, J; Proskova, J; Vecera, R				Cibicek, Norbert; Ehrmann, Jiri; Proskova, Jitka; Vecera, Rostislav			Critical evaluation of colon submucosal microdialysis in awake, mobile rats	PLOS ONE			English	Article							INTRAPERITONEAL MICRODIALYSIS; INTESTINAL ISCHEMIA; UREA CLEARANCE; BLOOD-FLOW; PERMEABILITY; HISTAMINE; PERFUSION; LACTATE; SURGERY; PLASMA	Sensors able to record large bowel physiology and biochemistry in situ in awake rodents are lacking. Microdialysis is a mini-invasive technique that may be utilized to continuously deliver or recover low-molecular substances from various tissues. In this experiment we evaluated the feasibility of in vivo microdialysis to monitor extracellular fluid chemistry in the descending colon submucosa of conscious, freely moving rodents. Following surgical implantation of a microdialysis probe, male Wistar rats were housed in metabolic cages where they were analgized and clinically followed for four days with free access to standard diet and water. To assess local microcirculation and probe function, glucose, lactate, glucose-to-lactate ratio and urea clearance were determined in the dialysates from the three postoperative days with focus on the final 24-h period. In an attempt to mitigate the expected tissue inflammatory response, one group of animals had the catheters perfused with 5-aminosalicylic acid-enriched medium with final concentration 1 mu mol/L. For verification of probe position and the assessment of the surrounding foreign body reaction, standard histological and immunohistochemical methods were employed. Microdialysis of rat gut is associated with considerable technical challenges that may lead to the loss of probe function and high drop-out rate. In this setting, limited data did not allow to draw any firm conclusion regarding local anti-inflammatory effectiveness of 5-aminosalicylic acid perfusion. Although intestinal microdialysis may be suitable for larger anesthetized animals, low reproducibility of the presented method compromises its routine experimental use in awake and freely moving smallsized rodents.	[Cibicek, Norbert] Palacky Univ, Fac Med & Dent, Dept Med Chem & Biochem, Olomouc, Czech Republic; [Ehrmann, Jiri] Palacky Univ, Fac Med & Dent, Dept Histol & Embryol, Olomouc, Czech Republic; [Proskova, Jitka] Univ Hosp, Dept Clin Biochem, Olomouc, Czech Republic; [Vecera, Rostislav] Palacky Univ, Fac Med & Dent, Dept Pharmacol, Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; University Hospital Olomouc; Palacky University Olomouc	Cibicek, N (corresponding author), Palacky Univ, Fac Med & Dent, Dept Med Chem & Biochem, Olomouc, Czech Republic.	norbert.cibicek@upol.cz	Ehrmann, Jiri/C-9074-2009	Ehrmann, Jiri/0000-0002-8419-3414	Czech Science Foundation [303/12/G163]	Czech Science Foundation(Grant Agency of the Czech Republic)	This study was funded by the Czech Science Foundation, https://gacr.cz/en/ (No. 303/12/G163) to NC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beier H, 2007, EUR J PHARM SCI, V30, P75, DOI 10.1016/j.ejps.2006.10.005; BJARNASON I, 1983, GASTROENTEROLOGY, V85, P318; Boehm O, 2007, BIOL CHEM, V388, P547, DOI 10.1515/BC.2007.061; Boerma EC, 2011, MINERVA ANESTESIOL, V77, P698; Bourne JA, 2003, CLIN EXP PHARMACOL P, V30, P16, DOI 10.1046/j.1440-1681.2003.03789.x; Cibicek N, 2007, PHYSIOL RES, V56, P611, DOI 10.33549/physiolres.931004; Cibicek N, 2010, PHYSIOL MEAS, V31, P1355, DOI 10.1088/0967-3334/31/10/005; Ericsson P, 2010, REGUL PEPTIDES, V163, P24, DOI 10.1016/j.regpep.2010.03.006; Farnebo S, 2010, EUR SURG RES, V45, P105, DOI 10.1159/000319868; Farnebo S, 2010, CLIN PHYSIOL FUNCT I, V30, P57, DOI 10.1111/j.1475-097X.2009.00904.x; Farnebo S, 2011, MICROCIRCULATION, V18, P198, DOI 10.1111/j.1549-8719.2010.00077.x; Frojse R, 2004, SHOCK, V21, P241; Giknis ML, 2008, CHARLES RIVER LAB, P1; Hammarlund-Udenaes M, 2007, HBK BEHAV NEUROSCI, V16, P589, DOI 10.1016/S1569-7339(06)16031-2; Hogberg N, 2012, SCAND J CLIN LAB INV, V72, P59, DOI 10.3109/00365513.2011.629307; Holbeck S, 2002, SHOCK, V18, P367, DOI 10.1097/00024382-200210000-00013; Iwaya H, 2012, EXP BIOL MED, V237, P451, DOI 10.1258/ebm.2011.011269; Jansson K, 2004, SCAND J CLIN LAB INV, V64, P63, DOI 10.1080/00365510410004100; Jansson K, 2003, SCAND J GASTROENTERO, V38, P1007, DOI 10.1080/00365520310004065; Kitano M, 2000, REGUL PEPTIDES, V86, P113, DOI 10.1016/S0167-0115(99)00096-8; Kobayashi N, 2000, ANAL BIOCHEM, V287, P272, DOI 10.1006/abio.2000.4840; Krejci V, 2006, CRIT CARE MED, V34, P2406, DOI 10.1097/01.CCM.0000233855.34344.29; Liang MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163684; Lippi G, 2012, CLIN CHEM LAB MED, V50, P1281, DOI 10.1515/cclm-2012-0081; LONNROTH P, 1987, AM J PHYSIOL, V253, pE228, DOI 10.1152/ajpendo.1987.253.2.E228; Mou X, 2010, BIOMATERIALS, V31, P4530, DOI 10.1016/j.biomaterials.2010.02.016; Mupanomunda MM, 1999, AM J PHYSIOL-HEART C, V276, pH1035, DOI 10.1152/ajpheart.1999.276.3.H1035; Obata T, 1998, COMP BIOCHEM PHYS A, V119, P309, DOI 10.1016/S1095-6433(97)00431-5; Pedersen ME, 2009, SCAND J SURG, V98, P148, DOI 10.1177/145749690909800304; Pedersen ME, 2011, J PEDIATR SURG, V46, P352, DOI 10.1016/j.jpedsurg.2010.11.015; Plock N, 2005, EUR J PHARM SCI, V25, P1, DOI 10.1016/j.ejps.2005.01.017; Pynnonen L, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-170; Rixen D, 2002, SHOCK, V18, P355, DOI 10.1097/00024382-200210000-00011; Schwalbe O, 2006, J PHARMACEUT BIOMED, V41, P233, DOI 10.1016/j.jpba.2005.11.017; Solligard E, 2008, SHOCK, V29, P245, DOI 10.1097/SHK.0b013e3180cab3ce; Sommer T, 2004, SCAND J GASTROENTERO, V39, P493, DOI 10.1080/00365520310008791; Sommer T, 2003, WORLD J SURG, V27, P416, DOI 10.1007/s00268-002-6594-z; Udassin R, 1998, PEDIATR SURG INT, V13, P112, DOI 10.1007/s003830050261; Woo KL, 2008, J PHARMACEUT BIOMED, V48, P85, DOI 10.1016/j.jpba.2008.05.014	39	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191041	10.1371/journal.pone.0191041	http://dx.doi.org/10.1371/journal.pone.0191041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324792	Green Submitted, gold, Green Published			2022-12-26	WOS:000419952400100
J	Damas, F; Libardi, CA; Ugrinowitsch, C; Vechin, FC; Lixandrao, ME; Snijders, T; Nederveen, JP; Bacurau, AV; Brum, P; Tricoli, V; Roschel, H; Parise, G; Phillips, SM				Damas, Felipe; Libardi, Cleiton A.; Ugrinowitsch, Carlos; Vechin, Felipe C.; Lixandrao, Manoel E.; Snijders, Tim; Nederveen, Joshua P.; Bacurau, Aline V.; Brum, Patricia; Tricoli, Valmor; Roschel, Hamilton; Parise, Gianni; Phillips, Stuart M.			Early- and later-phases satellite cell responses and myonuclear content with resistance training in young men	PLOS ONE			English	Article							SKELETAL-MUSCLE REGENERATION; PROTEIN-SYNTHESIS; LENGTHENING CONTRACTIONS; DISUSE ATROPHY; OLDER MEN; EXERCISE; HYPERTROPHY; FIBERS; INCREASES; MECHANISM	Satellite cells (SC) are associated with skeletal muscle remodelling after muscle damage and/or extensive hypertrophy resulting from resistance training (RT). We recently reported that early increases in muscle protein synthesis (MPS) during RT appear to be directed toward muscle damage repair, but MPS contributes to hypertrophy with progressive muscle damage attenuation. However, modulations in acute-chronic SC content with RT during the initial (1st-wk: high damage), early (3rd-wk: attenuated damage), and later (10th-wk: no damage) stages is not well characterized. Ten young men (27 +/- 1 y, 23.6 +/- 1.0 kg.m(-2)) underwent 10-wks of RT and muscle biopsies (vastus-lateralis) were taken before (Pre) and post (48h) the 1st (T1), 5th (T2) and final (T3) RT sessions to evaluate fibre type specific SC content, cross-sectional area (fCSA) and myonuclear number by immunohistochemistry. We observed RT-induced hypertrophy after 10-wks of RT (fCSA increased similar to 16% in type II, P < 0.04; similar to 8% in type I [ns]). SC content increased 48h post-exercise at T1 (similar to 69% in type I [P = 0.014]; similar to 42% in type II [ns]), and this increase was sustained throughout RT (pre T2: similar to 65%, similar to 92%; pre T3: similar to 30% [ns], similar to 87%, for the increase in type I and II, respectively, vs. pre T1 [P < 0.05]). Increased SC content was not coupled with changes in myonuclear number. SC have a more pronounced role in muscle repair during the initial phase of RT than muscle hypertrophy resulted from 10-wks RT in young men. Chronic elevated SC pool size with RT is important providing proper environment for future stresses or larger fCSA increases.	[Damas, Felipe; Ugrinowitsch, Carlos; Vechin, Felipe C.; Lixandrao, Manoel E.; Bacurau, Aline V.; Brum, Patricia; Tricoli, Valmor; Roschel, Hamilton] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, SP, Brazil; [Damas, Felipe; Libardi, Cleiton A.] Univ Fed Sao Carlos, Dept Phys Educ, Sao Carlos, SP, Brazil; [Snijders, Tim] Maastricht Univ, Dept Human Movement Sci, Maastricht, Limburg, Netherlands; [Nederveen, Joshua P.; Parise, Gianni; Phillips, Stuart M.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada	Universidade de Sao Paulo; Universidade Federal de Sao Carlos; Maastricht University; McMaster University	Parise, G (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	pariseg@mcmaster.ca	VECHIN, FELIPE CASSARO/G-9439-2012; Roschel, Hamilton/D-4353-2012; Lixandrão, Manoel E/C-4093-2014; Libardi, Cleiton/AAB-2850-2020; Ugrinowitsch, Carlos/A-3925-2010; Damas, Felipe/S-7122-2019; Damas, Felipe/F-1143-2013; Libardi, Cleiton/O-7501-2019; Brum, Patricia C/E-6605-2011; Phillips, Stuart/B-2343-2009; Bacurau, Aline Villa Nova/AAK-7446-2021	VECHIN, FELIPE CASSARO/0000-0003-0975-8654; Roschel, Hamilton/0000-0002-9513-6132; Lixandrão, Manoel E/0000-0003-4149-7327; Ugrinowitsch, Carlos/0000-0001-8547-419X; Damas, Felipe/0000-0001-9049-3598; Damas, Felipe/0000-0001-9049-3598; Libardi, Cleiton/0000-0002-9003-7610; Brum, Patricia C/0000-0002-4750-6506; Phillips, Stuart/0000-0002-1956-4098; Bacurau, Aline Villa Nova/0000-0002-5129-5115; Snijders, Tim/0000-0002-5874-1245	Sao Paulo Research Foundation (FAPESP) [2013/21218-4]; Natural Science and Engineering Research Council (NSERC) of Canada [RGPIN-2015-04613]; Canada Research Chairs program; FAPESP [2012/24499-1, 2014/19594-0, 2016/24259-1]; National Council for Scientific and Technological Development (CNPq) [303085/2015-0, 448387/2014-0, 307023/2014-1, 310823/2013-7]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The present study was funded by the Sao Paulo Research Foundation (FAPESP) grants (#2013/21218-4 to CAL) and Natural Science and Engineering Research Council (NSERC) of Canada (RGPIN-2015-04613 to SMP). SMP also acknowledges support from the Canada Research Chairs program. FD was supported by FAPESP grants (#2012/24499-1, #2014/19594-0, and #2016/24259-1). CU, HR and VT are supported by the National Council for Scientific and Technological Development (CNPq) grant (CU: #303085/2015-0 and #448387/2014-0; HR: #307023/2014-1; VT: #310823/2013-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexakis C, 2007, AM J PHYSIOL-CELL PH, V293, pC661, DOI 10.1152/ajpcell.00061.2007; Andersen LL, 2009, J APPL PHYSIOL, V107, P1413, DOI 10.1152/japplphysiol.00555.2009; Bellamy LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109739; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; CHEEK DB, 1985, EARLY HUM DEV, V12, P211, DOI 10.1016/0378-3782(85)90144-6; Damas F, 2016, J PHYSIOL-LONDON, V594, P5209, DOI 10.1113/JP272472; Damas F, 2016, EUR J APPL PHYSIOL, V116, P49, DOI 10.1007/s00421-015-3243-4; Dirks ML, 2014, J NUTR, V144, P1196, DOI 10.3945/jn.114.194217; GUERIN CW, 1995, DEV DYNAM, V202, P91, DOI 10.1002/aja.1002020109; Hyldahl RD, 2015, FASEB J, V29, P2894, DOI 10.1096/fj.14-266668; Kadi F, 2005, PFLUG ARCH EUR J PHY, V451, P319, DOI 10.1007/s00424-005-1406-6; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; MacDougall J D, 1995, Can J Appl Physiol, V20, P480; Mackey AL, 2011, J PHYSIOL-LONDON, V589, P5503, DOI 10.1113/jphysiol.2011.217885; Mackey AL, 2011, FASEB J, V25, P1943, DOI 10.1096/fj.10-176487; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McCarthy JJ, 2007, J APPL PHYSIOL, V103, P1100, DOI 10.1152/japplphysiol.00101.2007a; McKay BR, 2012, FASEB J, V26, P2509, DOI 10.1096/fj.11-198663; MOSS FP, 1970, J CELL BIOL, V44, P459, DOI 10.1083/jcb.44.2.459; Nederveen JP, 2017, AM J PHYSIOL-REG I, V312, pR85, DOI 10.1152/ajpregu.00221.2016; O'Connor RS, 2007, J APPL PHYSIOL, V103, P1099, DOI 10.1152/japplphysiol.00101.2007; O'Reilly C, 2008, MUSCLE NERVE, V38, P1434, DOI 10.1002/mus.21146; Paulsen G, 2012, EXERC IMMUNOL REV, V18, P42; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Petrella JK, 2006, AM J PHYSIOL-ENDOC M, V291, pE937, DOI 10.1152/ajpendo.00190.2006; Phillips SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE99, DOI 10.1152/ajpendo.1997.273.1.E99; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schmalbruch H, 2000, MUSCLE NERVE, V23, P617, DOI 10.1002/(SICI)1097-4598(200004)23:4<617::AID-MUS22>3.0.CO;2-Y; Snijders T, 2016, ACTA PHYSIOL, V216, P231, DOI 10.1111/apha.12609; Snijders T, 2014, CLIN SCI, V126, P557, DOI 10.1042/CS20130295; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	32	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191039	10.1371/journal.pone.0191039	http://dx.doi.org/10.1371/journal.pone.0191039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324825	Green Submitted, gold, Green Published			2022-12-26	WOS:000419952400098
J	Jiao, AL; Foster, DJ; Dixon, J; Slack, FJ				Jiao, Alan L.; Foster, Daniel J.; Dixon, Julia; Slack, Frank J.			lin-4 and the NRDE pathway are required to activate a transgenic lin-4 reporter but not the endogenous lin-4 locus in C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MIRNA EXPRESSION; RNA; TRANSLATION; MICRORNAS; TRANSCRIPTION; BIOGENESIS; PROMOTER; PROTEIN; SYSTEM	As the founding member of the microRNA (miRNA) gene family, insights into lin-4 regulation and function have laid a conceptual foundation for countless miRNA-related studies that followed. We previously showed that a transcriptional lin-4 reporter in C. elegans was positively regulated by a lin-4-complementary element (LCE), and by lin-4 itself. In this study, we sought to (1) identify additional factors required for lin-4 reporter expression, and (2) validate the endogenous relevance of a potential positive autoregulatory mechanism of lin-4 expression. We report that all four core nuclear RNAi factors (nrde-1, nrde-2, nrde-3 and nrde-4), positively regulate lin-4 reporter expression. In contrast, endogenous lin-4 levels were largely unaffected in nrde-2; nrde-3 mutants. Further, an endogenous LCE deletion generated by CRISPR-Cas9 revealed that the LCE was also not necessary for the activity of the endogenous lin-4 promoter. Finally, mutations in mature lin-4 did not reduce primary lin-4 transcript levels. Taken together, these data indicate that under growth conditions that reveal effects at the transgenic locus, a direct, positive autoregulatory mechanism of lin-4 expression does not occur in the context of the endogenous lin-4 locus.	[Jiao, Alan L.; Foster, Daniel J.; Slack, Frank J.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Inst RNA Med, Boston, MA 02115 USA; [Jiao, Alan L.; Dixon, Julia] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Foster, Daniel J.] Harvard Univ, Dept Biol & Biomed Sci, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Yale University; Harvard University	Slack, FJ (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Pathol, Inst RNA Med, Boston, MA 02115 USA.	fslack@bidmc.harvard.edu		Foster, Daniel/0000-0002-2466-9484; Slack, Frank/0000-0001-8263-0409	National Institutes of Health [R01AG033921]; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health, Grant R01AG033921, awarded to FJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Slack Lab for insightful discussions, experimental suggestions, and critical reading of the manuscript. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We are also grateful to Dr. Scott Kennedy for providing strains. We thank Dr. Marc Hammarlund for providing CRISPR plasmids.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bracht JR, 2010, DEV BIOL, V348, P210, DOI 10.1016/j.ydbio.2010.10.003; Burkhart KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002249; Chu YJ, 2010, NUCLEIC ACIDS RES, V38, P7736, DOI 10.1093/nar/gkq648; Esquela-Kerscher A, 2005, DEV DYNAM, V234, P868, DOI 10.1002/dvdy.20572; Feinbaum R, 1999, DEV BIOL, V210, P87, DOI 10.1006/dbio.1999.9272; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Jiao AL, 2013, EPIGENETICS, V9, P1; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Martinez NJ, 2008, GENOME RES, V18, P2005, DOI 10.1101/gr.083055.108; McCulloch KA, 2014, P NATL ACAD SCI USA, V111, P15450, DOI 10.1073/pnas.1414856111; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Perales R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004486; Turner MJ, 2014, CELL CYCLE, V13, P772, DOI 10.4161/cc.27679; Van Wynsberghe PM, 2014, DEV BIOL, P1; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503	22	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190766	10.1371/journal.pone.0190766	http://dx.doi.org/10.1371/journal.pone.0190766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324872	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400055
J	Poljak, S; Ferreiro, AM; Chiappero, MB; Sanchez, J; Gabrielli, M; Lizarralde, MS				Poljak, Sebastian; Ferreiro, Alejandro M.; Chiappero, Marina B.; Sanchez, Julieta; Gabrielli, Magali; Lizarralde, Marta S.			Phylogeography of screaming hairy armadillo Chaetophractus vellerosus: Successive disjunctions and extinctions due to cyclical climatic changes in southern South America	PLOS ONE			English	Article							PAMPEAN REGION ARGENTINA; BUENOS-AIRES PROVINCE; MITOCHONDRIAL-DNA; POPULATION HISTORY; XENARTHRA; HOLOCENE; MAMMALIA; CONSERVATION; DASYPODIDAE; PLEISTOCENE	Little is known about phylogeography of armadillo species native to southern South America. In this study we describe the phylogeography of the screaming hairy armadillo Chaetophractus vellerosus, discuss previous hypothesis about the origin of its disjunct distribution and propose an alternative one, based on novel information on genetic variability. Variation of partial sequences of mitochondrial DNA Control Region (CR) from 73 individuals from 23 localities were analyzed to carry out a phylogeographic analysis using neutrality tests, mismatch distribution, median-joining (MJ) network and paleontological records. We found 17 polymorphic sites resulting in 15 haplotypes. Two new geographic records that expand known distribution of the species are presented; one of them links the distributions of recently synonimized species C. nationi and C. vellerosus. Screaming hairy armadillo phylogeographic pattern can be addressed as category V of Avise: common widespread linages plus closely related lineages confined to one or a few nearby locales each. The older linages are distributed in the north-central area of the species distribution range in Argentina (i.e. ancestral area of distribution). C. vellerosus seems to be a low vagility species that expanded, and probably is expanding, its distribution range while presents signs of genetic structuring in central areas. To explain the disjunct distribution, a hypothesis of extinction of the species in intermediate areas due to quaternary climatic shift to more humid conditions was proposed. We offer an alternative explanation: long distance colonization, based on null genetic variability, paleontological record and evidence of alternance of cold/arid and temperate/humid climatic periods during the last million years in southern South America.	[Poljak, Sebastian; Sanchez, Julieta; Lizarralde, Marta S.] Consejo Nacl Invest Cient & Tecn, Ctr Austral Invest Cient, Lab Ecol Mol, Ushuaia, Tierra Del Fueg, Argentina; [Poljak, Sebastian; Sanchez, Julieta] Univ Nacl Tierra del Fuego, Inst Ciencias Polares Ambiente & Recursos Nat, Ushuaia, Tierra Del Fueg, Argentina; [Ferreiro, Alejandro M.; Chiappero, Marina B.] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Catedra Genet Poblac & Evoluc, Cordoba, Argentina; [Ferreiro, Alejandro M.; Chiappero, Marina B.] Consejo Nacl Invest Cient & Tecn, Inst Diversidad & Ecol Anim, Cordoba, Argentina; [Gabrielli, Magali; Lizarralde, Marta S.] Univ Nacl La Plata, Lab Ecol Mol, Ctr Reg Estudios Genom, Fac Ciencias Exactas, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Poljak, S (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Austral Invest Cient, Lab Ecol Mol, Ushuaia, Tierra Del Fueg, Argentina.	s.poljak@cadic-conicet.gob.ar		Ferreiro, Alejandro Manuel/0000-0002-0921-6137	Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina [2012-2014 GI 11220110100233]; Fondos iBOL-CONICET Argentina; Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina [PICT-R 2004-74, PICT 2010-1853]	Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fondos iBOL-CONICET Argentina; Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina(ANPCyT)	This work has been financially supported by the Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina (http:/www.conicet.gov.ar/) PIP No. 2012-2014 GI 11220110100233 and Fondos iBOL-CONICET Argentina and Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina (http://www.agencia.mincyt.gob.ar/) PICT-R 2004-74, PICT 2010-1853. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba AM, 2012, MAMMALIA, V76, P123, DOI 10.1515/mammalia-2011-0089; Abba AM, 2011, REV CHIL HIST NAT, V84, P51, DOI 10.4067/S0716-078X2011000100004; Abba AM, 2015, J MAMMAL; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; CARLINI AA, 1987, STUD NEOTROP FAUNA E, V22, P53, DOI 10.1080/01650528709360718; Carlini AA, 17 JORN ARG MAST AOA; CRANDALL KA, 1993, GENETICS, V134, P959; de Moraes-Barros N, 2007, GENET MOL BIOL, V30, P1181, DOI 10.1590/S1415-47572007000600024; DEL PAPA L.M., 2013, CUADERNOS I NACL ANT, V1, P168; Del Papa LM, 2011, TEMAS ARQUEOLOGIA ES, P1; del Papa Luis, 2017, ZOOARCHAEOLOGY NEOTR, P137; Delsuc F, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-11; Delsuc F, 2012, MOL PHYLOGENET EVOL, V62, P673, DOI 10.1016/j.ympev.2011.11.008; Deschamps CM, 2005, AMEGHINIANA, V42, P733; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Fu YX, 1997, GENETICS, V147, P915; Galíndez Elena Juana, 2006, Int. J. Morphol., V24, P339, DOI 10.4067/S0717-95022006000400008; Gibb GC, 2016, MOL BIOL EVOL, V33, P621, DOI 10.1093/molbev/msv250; GLAZ D, 1999, 14 JORN ARG MAST SAL, P18; Greegor D.H. Jr, 1985, P397; GREEGOR DH, 1975, J MAMMAL, V56, P626, DOI 10.2307/1379475; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARPENDING HC, 1994, HUM BIOL, V66, P591; Huchon D, 1999, MOL ECOL, V8, P1743, DOI 10.1046/j.1365-294x.1999.00768.x; ISLA FI, 1989, QUATERNARY SCI REV, V8, P359, DOI 10.1016/0277-3791(89)90036-X; Loughry W.J., 2013, 9 BANDED ARMADILLO N; Lyman RL, 2006, EVOL ANTHROPOL, V15, P11, DOI 10.1002/evan.20083; Marshall L.G., 1990, Palaeovertebrata (Montpellier), V19, P169; MCNAB BK, 1980, J MAMMAL, V61, P606, DOI 10.2307/1380307; Messineo PG, 2016, INVESTIGACIONES ARQU; Moraes-Barros N, 2015, J MAMMAL, V96, P690, DOI 10.1093/jmammal/gyv077; Morrone JJ, 2006, ANNU REV ENTOMOL, V51, P467, DOI 10.1146/annurev.ento.50.071803.130447; NATH HB, 1993, J MATH BIOL, V31, P841, DOI 10.1007/BF00168049; NEIGEL JE, 1993, GENETICS, V135, P1209; NEIGEL JE, 1991, EVOLUTION, V45, P423, DOI [10.1111/j.1558-5646.1991.tb04415.x, 10.2307/2409675]; PATTERSON B, 1968, Q REV BIOL, V43, P409, DOI 10.1086/405916; Poljak S, 2010, MOL PHYLOGENET EVOL, V55, P38, DOI 10.1016/j.ympev.2009.12.021; Rabassa J, 2005, J S AM EARTH SCI, V20, P81, DOI 10.1016/j.jsames.2005.07.004; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shackleton N., 1995, NEW DATA EVOLUTION P, P242; Shackleton NJ, 1995, P ODP SCI RESULTS; SLATKIN M, 1991, GENET RES, V58, P167, DOI 10.1017/S0016672300029827; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Soibelzon E, 2013, QUATERN INT, V299, P72, DOI 10.1016/j.quaint.2012.09.009; Soibelzon E, 2006, NEUES JB GEOL PALA E; Soibelzon E., 2017, J MAMM EVOL, P1; Soibelzon E, 2017, J ARCHAEOL SCI-REP, V11, P90, DOI 10.1016/j.jasrep.2016.11.038; Soibelzon E, 2010, REV MEX CIENC GEOL, V27, P449; Soibelzon Esteban, 2009, Current Research in the Pleistocene, V26, P175; TAJIMA F, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P37; TEMPLETON AR, 1995, GENETICS, V140, P767; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tonni E. P., 2006, N JB GEOL PALAONT MH, V12, P734; Tonni Eduardo P., 1990, Paula-Coutiana, V4, P3; TONNI EP, 1992, PALAEOGEOGR PALAEOCL, V95, P179, DOI 10.1016/0031-0182(92)90140-Z; Tonni EP, 1999, PALAEOGEOGR PALAEOCL, V147, P257, DOI 10.1016/S0031-0182(98)00140-0; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Vizcaino Sergio F., 1993, Ameghiniana, V30, P435; Wetzel R.M., 1985, P23	62	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190944	10.1371/journal.pone.0190944	http://dx.doi.org/10.1371/journal.pone.0190944			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324793	Green Submitted, Green Published, gold			2022-12-26	WOS:000419952400078
J	Yu, Y; Wu, YG; Hu, BQ; Liu, XL				Yu, Yi; Wu, Yonggang; Hu, Binqi; Liu, Xinglong			An enhanced artificial bee colony algorithm (EABC) for solving dispatching of hydrothermal system (DHTS) problem	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; DIFFERENTIAL EVOLUTION; GENETIC ALGORITHM; SEARCH ALGORITHM; HYBRID	The dispatching of hydro-thermal system is a nonlinear programming problem with multiple constraints and high dimensions and the solution techniques of the model have been a hotspot in research. Based on the advantage of that the artificial bee colony algorithm (ABC) can efficiently solve the high-dimensional problem, an improved artificial bee colony algorithm has been proposed to solve DHTS problem in this paper. The improvements of the proposed algorithm include two aspects. On one hand, local search can be guided in efficiency by the information of the global optimal solution and its gradient in each generation. The global optimal solution improves the search efficiency of the algorithm but loses diversity, while the gradient can weaken the loss of diversity caused by the global optimal solution. On the other hand, inspired by genetic algorithm, the nectar resource which has not been updated in limit generation is transformed to a new one by using selection, crossover and mutation, which can ensure individual diversity and make full use of prior information for improving the global search ability of the algorithm. The two improvements of ABC algorithm are proved to be effective via a classical numeral example at last. Among which the genetic operator for the promotion of the ABC algorithm's performance is significant. The results are also compared with those of other state-of-the-art algorithms, the enhanced ABC algorithm has general advantages in minimum cost, average cost and maximum cost which shows its usability and effectiveness. The achievements in this paper provide a new method for solving the DHTS problems, and also offer a novel reference for the improvement of mechanism and the application of algorithms.	[Yu, Yi; Wu, Yonggang; Liu, Xinglong] Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan, Hubei, Peoples R China; [Hu, Binqi] State Grid Hunan Elect Power Co, Dispatching & Commun Bur, Changsha, Hunan, Peoples R China	Huazhong University of Science & Technology; State Grid Corporation of China	Wu, YG (corresponding author), Huazhong Univ Sci & Technol, Sch Hydropower & Informat Engn, Wuhan, Hubei, Peoples R China.	wyghust@163.com			National Natural Science Foundation of China [51379081]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was partly supported by the National Natural Science Foundation of China (No. 51379081) to YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Akbari R, 2010, COMMUN NONLINEAR SCI, V15, P3142, DOI 10.1016/j.cnsns.2009.11.003; Amjady N, 2010, ELECTR POW SYST RES, V80, P723, DOI 10.1016/j.epsr.2009.11.004; [Anonymous], 2017, RES NEURAL NETWORK A; Bagheri A, 2010, FUTURE GENER COMP SY, V26, P533, DOI 10.1016/j.future.2009.10.004; Bao L, 2009, HIS 2009: 2009 NINTH INTERNATIONAL CONFERENCE ON HYBRID INTELLIGENT SYSTEMS, VOL 1, PROCEEDINGS, P411, DOI 10.1109/HIS.2009.319; Bao Li, 2010, Application Research of Computers, V27, P1330; Bhattacharjee K, 2014, INT J ELEC POWER, V63, P145, DOI 10.1016/j.ijepes.2014.05.065; [毕晓君 Bi Xiaojun], 2011, [系统工程与电子技术, Systems Engineering & Electronics], V33, P2564; Blum C, 2003, ACM COMPUT SURV, V35, P268, DOI 10.1145/937503.937505; Bonyadi MR, 2017, EVOL COMPUT, V25, P1, DOI 10.1162/EVCO_r_00180; Bouaziz A, 2013, 2013 11TH INTERNATIONAL SYMPOSIUM ON PROGRAMMING AND SYSTEMS (ISPS), P81, DOI 10.1109/ISPS.2013.6581498; Chen F, 2017, ENERGY, V121, P276, DOI 10.1016/j.energy.2017.01.010; Colorni A, 1994, OPERATIONS RES STAT, V34; Conejo AJ, 1998, IEEE T POWER SYST, V13, P517; de Queiroz AR, 2016, RENEW SUST ENERG REV, V62, P382, DOI 10.1016/j.rser.2016.04.065; Fang N, 2014, INT J ELEC POWER, V62, P617, DOI 10.1016/j.ijepes.2014.05.017; Gao Wei-feng, 2011, Systems Engineering and Electronics, V33, P1167, DOI 10.3969/j.issn.1001-506X.2011.05.41; Gotman N, 2014, ELECT LOAD FORECASTI; Gunasekaran L, 2016, INT ARAB J INF TECHN, V13, P1045; Guo P, 2011, INT C NAT COMP; HOLLAND J. H, 1992, ADAPTATION NATURAL A, V126, P37; Hollstien RB, 1971, ARTIFICIAL GENETIC A; Jiang M., 2014, ARTIFICIAL BEE COLON; Jin X, 1999, EV COMP 1999 CEC 99; Ju Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep33870; Lakshminarasimman L, 2008, ENERG CONVERS MANAGE, V49, P2513, DOI 10.1016/j.enconman.2008.05.021; Lakshminarasimman L, 2006, IEE P-GENER TRANSM D, V153, P693, DOI 10.1049/ip-gtd:20050407; Li X.-L., 2002, XITONG GONGCHENG LIL, V22, P32, DOI DOI 10.12011/1000-6788(2002)11-32; Liu H, 2013, CONTR DEC C; Lu YL, 2010, ENERG CONVERS MANAGE, V51, P1481, DOI 10.1016/j.enconman.2010.02.006; Luo Jun, 2010, Control and Decision, V25, P1913; Montane FAT, 2006, COMPUT OPER RES, V33, P595, DOI 10.1016/j.cor.2004.07.009; Narang N, 2012, ENERGY, V47, P237, DOI 10.1016/j.energy.2012.09.004; Qin Q, 2014, CAAI T INTELLIGENT S, V5, P123; Quan HY, 2008, ICNC 2008: FOURTH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, VOL 7, PROCEEDINGS, P654, DOI 10.1109/ICNC.2008.211; Richardson J, 1989, INT C GEN ALG; SELIM SZ, 1991, PATTERN RECOGN, V24, P1003, DOI 10.1016/0031-3203(91)90097-O; Shaik S, 2012, INT C MACH LEARN CYB; Sinha N, 2003, IEEE T POWER SYST, V18, P214, DOI 10.1109/TPWRS.2002.807053; SOARES S, 1980, IEEE T POWER AP SYST, V99, P1107, DOI 10.1109/TPAS.1980.319741; Wu HS, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/465082; Xu N, 2002, SYSTEMS ENG ELECT; Yang XW, 2014, ADV MATER SCI ENG, V2014, DOI 10.1155/2014/697170; Yang XS, 2014, INT J SWARM INTELL R, V5, P1, DOI 10.4018/ijsir.2014040101; Yang XS, 2011, INT J BIO-INSPIR COM, V3, P267, DOI 10.1504/IJBIC.2011.042259; Yanhua Y., 2012, GENETIC BEE COLONY A; Yogesh CK, 2017, EXPERT SYST APPL, V69, P149, DOI 10.1016/j.eswa.2016.10.035; Yuan XH, 2008, ENERG CONVERS MANAGE, V49, P2966, DOI 10.1016/j.enconman.2008.06.017; Yuan XH, 2014, APPL MATH COMPUT, V247, P535, DOI 10.1016/j.amc.2014.09.017; Yuan XH, 2011, SOFT COMPUT, V15, P139, DOI 10.1007/s00500-010-0541-y; Zeng XX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184242; Zeng XX, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005420; Zeng XX, 2014, NEURAL COMPUT, V26, P1340, DOI 10.1162/NECO_a_00605; Zhao L, 2016, INT C CONTR SCI SYST; Zhu GP, 2010, APPL MATH COMPUT, V217, P3166, DOI 10.1016/j.amc.2010.08.049	55	2	2	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0189282	10.1371/journal.pone.0189282	http://dx.doi.org/10.1371/journal.pone.0189282			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324743	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400006
J	Bell, RD; Rudmann, C; Wood, RW; Schwarz, EM; Rahimi, H				Bell, Richard D.; Rudmann, Christopher; Wood, Ronald W.; Schwarz, Edward M.; Rahimi, Homaira			Longitudinal micro-CT as an outcome measure of interstitial lung disease in TNF-transgenic mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; FACTOR-ALPHA; PULMONARY-FIBROSIS; MOUSE MODEL; OVEREXPRESSION; STATEMENT; DIAGNOSIS	Introduction Rheumatoid arthritis associated interstitial lung disease (RA-ILD) is a debilitating condition with poor survival prognosis. High resolution computed tomography (CT) is a common clinical tool to diagnose RA-ILD, and is increasingly being adopted in pre-clinical studies. However, murine models recapitulating RA-ILD are lacking, and CT outcomes for inflammatory lung disease have yet to be formally validated. To address this, we validate mu CT outcomes for ILD in the tumor necrosis factor transgenic (TNF-Tg) mouse model of RA. Methods Cross sectional mu CT was performed on cohorts of male TNF-Tg mice and their WT litter-mates at 3, 4, 5.5 and 12 months of age (n = 4-6). Lung mu CT outcomes measures were determined by segmentation of the mu CT datasets to generate Aerated and Tissue volumes. After each scan, lungs were obtained for histopathology and 3 sections stained with hematoxylin and eosin. Automated histomorphometry was performed to quantify the tissue area (nuclei, cytoplasm, and extracellular matrix) and aerated area (white space) within the tissue sections. Spearman's correlation coefficients were used to evaluate the extent of association between mu CT imaging and histopathology endpoints. Results TNF-Tg mice had significantly greater tissue volume, total lung volume and mean intensity at all timepoints compared to age matched WT littermates. Histomorphometry also demonstrated a significant increase in tissue area at 3, 4, and 5.5 months of age in TNF-Tg mice.Lung tissue volume was correlated with lung tissue area (rho = 0.81, p<0.0001), and normalize lung aerated volume was correlated with normalized lung air area (rho = 0.73, p<0.0001). Conclusions We have validated in vivo mu CT as a quantitative biomarker of ILD in mice. Further, development of longitudinal measures is critical for dissecting pathologic progression of ILD, and mu CT is a useful non-invasive method to study lung inflammation in the TNF-Tg mouse model.	[Bell, Richard D.; Rudmann, Christopher; Wood, Ronald W.; Schwarz, Edward M.; Rahimi, Homaira] Univ Rochester, Sch Med & Dent, Ctr Musculoskeletal Res, Rochester, NY 14642 USA; [Bell, Richard D.; Schwarz, Edward M.] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY USA; [Wood, Ronald W.] Univ Rochester, Sch Med & Dent, Dept Obstet & Gynecol, Rochester, NY 14627 USA; [Wood, Ronald W.; Schwarz, Edward M.] Univ Rochester, Sch Med & Dent, Dept Urol, Rochester, NY USA; [Wood, Ronald W.] Univ Rochester, Sch Med & Dent, Dept Neurosci, Rochester, NY USA; [Schwarz, Edward M.] Univ Rochester, Sch Med & Dent, Dept Orthopaed, Rochester, NY USA; [Rahimi, Homaira] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Rahimi, H (corresponding author), Univ Rochester, Sch Med & Dent, Ctr Musculoskeletal Res, Rochester, NY 14642 USA.; Rahimi, H (corresponding author), Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA.	Homaira_Rahimi@URMC.Rochester.edu	Wood, Ronald W/J-5481-2015	Wood, Ronald W/0000-0002-9691-5111; Bell, Richard/0000-0003-1562-3879	National Institute of Health: National Institute of Arthritis and Musculoskeletal and Skin [T32 AR053459, P30 AR061307, K08 AR067885, R01 AR56702]; National Institute of Health: National Institute of Child Health and Human Development [HD068373-04]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR067885, R01AR056702, T32AR053459, P30AR069655] Funding Source: NIH RePORTER	National Institute of Health: National Institute of Arthritis and Musculoskeletal and Skin; National Institute of Health: National Institute of Child Health and Human Development; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Health: National Institute of Arthritis and Musculoskeletal and Skin, T32 AR053459 (https://www.niams.nin.gov/); National Institute of Health: National Institute of Arthritis and Musculoskeletal and Skin, P30 AR061307, EMS (https://www.niarns.nih.gov/); National Institute of Health: National Institute of Arthritis and Musculoskeletal and Skin, K08 AR067885, HR (https://www.niams.nih.gov/); National Institute of Health: National Institute of Arthritis and Musculoskeletal and Skin, R01 AR56702 EMS (https://www.niams.nih.gov/); National Institute of Health: National Institute of Child Health and Human Development, HD068373-04 (https://www.nichd.nih.gov/Pagesiindex.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bawadekar M, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1068-0; Bongartz T, 2010, ARTHRITIS RHEUM-US, V62, P1583, DOI 10.1002/art.27405; Clark DP, 2014, PHYS MEDICA, V30, P619, DOI 10.1016/j.ejmp.2014.05.011; De Langhe E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043123; Douni E, 1996, J INFLAMM, V47, P27; Doyle JJ, 2000, CLIN RHEUMATOL, V19, P217, DOI 10.1007/s100670050160; Fujita M, 2001, AM J PHYSIOL-LUNG C, V280, pL39, DOI 10.1152/ajplung.2001.280.1.L39; Fujita M, 2016, INT J CHRONIC OBSTR, V11, P1705, DOI 10.2147/COPD.S108919; Gruden JF, 2016, AM J ROENTGENOL, V206, P495, DOI 10.2214/AJR.15.15674; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Kang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016161; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kim EJ, 2010, EUR RESPIR J, V35, P1322, DOI 10.1183/09031936.00092309; Li P, 2003, SPRINGER SEMIN IMMUN, V25, P19, DOI 10.1007/s00281-003-0125-3; Lundblad LKA, 2005, AM J RESP CRIT CARE, V171, P1363, DOI 10.1164/rccm.200410-1349OC; MIYAZAKI Y, 1995, J CLIN INVEST, V96, P250, DOI 10.1172/JCI118029; Plathow C, 2004, INVEST RADIOL, V39, P600, DOI 10.1097/01.rli.0000138134.89050.a5; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rodt T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-181; Shaw M, 2015, EUR RESPIR REV, V24, P1, DOI 10.1183/09059180.00008014; Slight SR, 2013, J CLIN INVEST, V123, P712, DOI 10.1172/JCI65728; Thomson EM, 2012, AM J PATHOL, V180, P1413, DOI 10.1016/j.ajpath.2011.12.020; Vande Velde G, 2016, DIS MODEL MECH, V9, P91, DOI 10.1242/dmm.020321	23	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190678	10.1371/journal.pone.0190678	http://dx.doi.org/10.1371/journal.pone.0190678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320550	Green Published, Green Submitted, gold			2022-12-26	WOS:000419689600060
J	Damm, P; Zonneveld, J; Brackertz, S; Streitparth, F; Winkler, T				Damm, Philipp; Zonneveld, Jip; Brackertz, Sophie; Streitparth, Florian; Winkler, Tobias			Gluteal muscle damage leads to higher in vivo hip joint loads 3 months after total hip arthroplasty	PLOS ONE			English	Article							SURGICAL APPROACH; COMPUTED-TOMOGRAPHY; FATTY DEGENERATION; MINIMUS MUSCLE; NORMAL WALKING; OSTEOARTHRITIS; GAIT; REPLACEMENT; RELIABILITY; PATTERNS	Background Total hip arthroplasty (THA) is in most cases improving patients A life quality immediately after surgery. However, a closer look at these patients, especially with modern gait analysis methods, reveals also negative consequences due to the surgical approach related injury to the pelvic muscles. We hypothesized that this damage will have a negative impact on hip joint contact forces during activities of daily living (ADL). Methods 10 patients undergoing THA received an instrumented hip joint implant enabling real time in vivo measurements of hip joint loads using a direct lateral approach. Pre-and 3 months postoperative computed tomography (CT) scans were used for evaluation of the periarticular muscle status, using muscle volume, fat ratio and lean muscle volume as parameters. An analysis of in vivo hip contact forces was made 3 months after THA during ADL (walking, stair climbing, chair rising and sitting) and correlated with the morphology of the periarticular muscles. Results We found a significant decrease of volume by 25% (-3 to -45, p = 0.005) and increase in fat ratio of the Gluteus Minimus (Gmin), resulting in a decrease in lean muscle volume of 28% (-48 to 0, p = 0.008). This was accompanied by an inverse development in the Tensor Fasciae Latae (TFL) resulting in a lean muscle volume increase of 34% (-2 to -102, p = 0.013). Changes in Gluteus Medius (Gmed) and Gluteus Maximus (Gmax) have not been observed in the short-term follow up. A decreased Gmin lean muscle volume was found to strongly correlate with high in vivo joint contact forces in all tested ADL. Conclusion The decrease of Gmin volume can be seen as a direct effect of THA surgery, whereas the increase of TFL might compensate for loss of Gmin volume. Lean muscle volume and fat ratio were better predictors for joint contact forces than total muscle volume. These effects were most pronounced during sitting down and standing up due to the higher demand on the gluteal muscles during these activities.	[Damm, Philipp; Zonneveld, Jip; Brackertz, Sophie; Winkler, Tobias] Charite Univ Med Berlin, Julius Wolff Inst, Berlin, Germany; [Streitparth, Florian] Charite Univ Med Berlin, Klin Radiol, Berlin, Germany; [Winkler, Tobias] Charite Univ Med Berlin, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Winkler, Tobias] Charite Univ Med Berlin, Ctr Musculoskeletal Surg, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Damm, P (corresponding author), Charite Univ Med Berlin, Julius Wolff Inst, Berlin, Germany.	philipp.damm@charite.de	winkler, tobias/AAL-6324-2020	Winkler, Tobias/0000-0003-0727-4680; Damm, Philipp/0000-0001-8471-7284	Deutsche Forschungsgemeinschaft [Be 804/19-1]; German Federal Ministry of Education and Research [BMBF 01EC1408A]; Deutsche Arthrose-Hilfe e.V.; OrthoLoadClub	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Arthrose-Hilfe e.V.; OrthoLoadClub	This work was supported by Deutsche Forschungsgemeinschaft (Be 804/19-1) (http://www.dfg.de/) - no role; German Federal Ministry of Education and Research (BMBF 01EC1408A; Overload-PrevOP; SPO3) (https://www.bmbf.de) - no role; Deutsche Arthrose-Hilfe e.V. (http://www.arthrose.de/) - no role; and OrthoLoadClub (http://www.arthrose.de/) - no role (IPD).; This work was supported by Deutsche Forschungsgemeinschaft (Be 804/19-1), the German Federal Ministry of Education and Research (BMBF 01EC1408A; Overload-PrevOP; SPO3), Deutsche Arthrose-Hilfe e.V. and the OrthoLoadClub.	ADOLPHSON P, 1993, ACTA ORTHOP SCAND, V64, P181, DOI 10.3109/17453679308994566; Anderson FC, 2003, GAIT POSTURE, V17, P159, DOI 10.1016/S0966-6362(02)00073-5; Arokoski MH, 2002, J RHEUMATOL, V29, P2185; BERGMANN G, 1993, J BIOMECH, V26, P969, DOI 10.1016/0021-9290(93)90058-M; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Bergmann G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155612; Boren K, 2011, INT J SPORTS PHYS TH, V6, P206; Chang A, 2005, ARTHRITIS RHEUM-US, V52, P3515, DOI 10.1002/art.21406; Colgan G, 2016, J ORTHOP, V13, P171, DOI 10.1016/j.jor.2016.03.005; Correa TA, 2010, J BIOMECH, V43, P1618, DOI 10.1016/j.jbiomech.2010.02.008; Daguet E, 2011, J BONE JOINT SURG AM, V93A, P1897, DOI 10.2106/JBJS.J.00509; Damm P, 2013, PLOS ONE, V8, P1, DOI DOI 10.1371/J0URNAL.P0NE; Eng JJ, 2002, ARCH PHYS MED REHAB, V83, P1138, DOI 10.1053/apmr.2002.33644; Engelken F, 2014, J ARTHROPLASTY, V29, P149, DOI 10.1016/j.arth.2013.04.045; Gladstone JN, 2007, SPORT MED, P719; Goodpaster BH, 2000, J APPL PHYSIOL, V89, P104, DOI 10.1152/jappl.2000.89.1.104; Gottschall JS, 2012, J ELECTROMYOGR KINES, V22, P67, DOI 10.1016/j.jelekin.2011.10.003; Heller MO, 2007, ORTHOPADE, V36, P188, DOI 10.1007/s00132-007-1054-y; Heller MO, 2001, J BIOMECH, V34, P883, DOI 10.1016/S0021-9290(01)00039-2; Kienapfel H, 2012, AE MANUAL ENDOPROTHE, P419; Kiyoshige Y, 2015, ARCH GERONTOL GERIAT, V60, P59, DOI 10.1016/j.archger.2014.07.013; LIN H.-C., 2004, BIOMEDICAL ENG APPL, V16, P101, DOI DOI 10.4015/S1016237204000153; Masonis JL, 2002, CLIN ORTHOP RELAT R, P46, DOI 10.1097/01.blo.0000038476.05771.6c; Muller M, 2011, ARCH ORTHOP TRAUM SU, V131, P179, DOI 10.1007/s00402-010-1117-0; Muller M, 2010, ARCH ORTHOP TRAUM SU, V130, P927, DOI 10.1007/s00402-010-1085-4; Mundermann A, 2005, ARTHRITIS RHEUM-US, V52, P2835, DOI 10.1002/art.21262; Naal FD, 2015, QUAL LIFE RES, V24, P2917, DOI 10.1007/s11136-015-1042-3; OECD, 2013, HLTH GLANC 2013 OECD; Petis S, 2015, CAN J SURG, V58, P128, DOI 10.1503/cjs.007214; Putz C, 2016, GAIT POSTURE, V49, P290, DOI 10.1016/j.gaitpost.2016.06.034; Rahemi H, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0365; Rasch A, 2009, J BONE JOINT SURG BR, V91B, P583, DOI 10.1302/0301-620X.91B5.21477; Rodriguez-Roiz Juan Miguel, 2017, Eur J Orthop Surg Traumatol, V27, P255, DOI 10.1007/s00590-016-1854-z; Schwachmeyer V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077807; Semciw AI, 2014, GAIT POSTURE, V39, P822, DOI 10.1016/j.gaitpost.2013.11.008; Shakoor N, 2003, ARTHRITIS RHEUM-US, V48, P1556, DOI 10.1002/art.11034; Springer I, 2012, EUR J RADIOL, V81, P928, DOI 10.1016/j.ejrad.2011.01.113; Suetta C, 2004, J APPL PHYSIOL, V97, P1954, DOI 10.1152/japplphysiol.01307.2003; Sutter R, 2013, SKELETAL RADIOL, V42, P627, DOI 10.1007/s00256-012-1514-2; Uemura K, 2016, J ARTHROPLASTY, V31, P906, DOI 10.1016/j.arth.2015.10.036; Unis DB, 2013, J ARTHROPLASTY, V28, P663, DOI 10.1016/j.arth.2012.06.032; VonRoth P, 2014, SIGNIFICANT MUSCLE D, P1618	42	14	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190626	10.1371/journal.pone.0190626	http://dx.doi.org/10.1371/journal.pone.0190626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315350	gold, Green Published, Green Submitted			2022-12-26	WOS:000419655900016
J	Invernizzi, C; Nogueira, E; Juri, P; Santos, E; Arredondo, D; Branchiccela, B; Mendoza, Y; Antunez, K				Invernizzi, Ciro; Nogueira, Enrique; Juri, Pablo; Santos, Estela; Arredondo, Daniela; Branchiccela, Belen; Mendoza, Yamandu; Antunez, Karina			Epormenis cestri secretions in Sebastiania schottiana trees cause mass death of honey bee Apis mellifera larvae in Uruguay	PLOS ONE			English	Article							HEALTH; POLLINATORS; AMERICA; IMPACTS	For more than 60 years, sporadic cases of massive summer honey bee larvae mortality in colonies located near freshwater systems with abundant riparian vegetation have been reported in Uruguay. This odd phenomenon, known as "feminine ordinal indicator" River disease by beekeepers, can lead to colony death by depopulation. The aim of this study was to detect the causes of larvae death. Different experiments and analyses were performed using affected apiaries located between two important water courses. 1 day old larvae were the most susceptible and substances that killed the larvae were present in the nectar but not in the pollen. A palynological analysis of nectar samples showed that bees collect this resource from commonly pollinated floral species in the country. However, abundant fungi spores and conidia were found, which indicates that the bees also collected honeydews. In the riparian vegetation, bees were observed collecting the secretions of the planthopper Epormenis cestri on Sebastiania schottiana trees. It was found that the mortality period of larvae overlaps with the presence of E. cestri. Larvae maintained in the laboratory were fed (i) nectar from healthy colonies, (ii) nectar from affected colonies, and (iii) secretions of E. cestri. The mortality of the larvae that received nectar from colonies affected with River disease and secretions of E. cestri was higher than the mortality of those receiving nectar from healthy colonies. This represents the first report of planthopper honeydew causing mass larval mortality in honey bees.	[Invernizzi, Ciro; Santos, Estela] Fac Ciencias, Inst Biol, Secc Etol, Montevideo, Uruguay; [Nogueira, Enrique; Juri, Pablo] Fac Vet, Inst Prod Anim, Montevideo, Uruguay; [Arredondo, Daniela; Branchiccela, Belen; Antunez, Karina] Inst Invest Biol Clemente Estable, Lab Microbiol, Montevideo, Uruguay; [Mendoza, Yamandu] Inst Invest Agr, Lab Apicultura, Colonia, Uruguay	Universidad de la Republica, Uruguay; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Instituto Nacional de Investigacion Agropecuaria Uruguay (INIA)	Invernizzi, C (corresponding author), Fac Ciencias, Inst Biol, Secc Etol, Montevideo, Uruguay.	ciro@fcien.edu.uy		Nogueira, Enrique/0000-0001-8577-6585; Santos, Estela/0000-0002-0648-3926	Institute Nacional de Investigacion Agropecuaria, Uruguay [FPTA 2012 322]	Institute Nacional de Investigacion Agropecuaria, Uruguay	Institute Nacional de Investigacion Agropecuaria, Uruguay (http://www.inia.uy/). Grant number FPTA 2012 322 (CI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Atkins EL, 1997, HIVE HONEY BEE, P1153; Bentancourt C, 2009, INSECTOS DEL URUGUAY; CALIXTO JB, 1990, PLANTA MED, V56, P31, DOI 10.1055/s-2006-960878; Carvalho PC, 2004, APIDOLOGIE, V35, P89; CECHINEL V, 1995, J PHARM SCI, V84, P473, DOI 10.1002/jps.2600840416; Chomnunti P, 2014, FUNGAL DIVERS, V66, P1, DOI 10.1007/s13225-014-0278-5; Collison C, 2016, BEE CULTURE; Daners G, 1998, J APICULT RES, V37, P221, DOI 10.1080/00218839.1998.11100976; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Detzel Andreas, 1993, Chemoecology, V4, P8, DOI 10.1007/BF01245891; EICKWORT GC, 1980, ANNU REV ENTOMOL, V25, P421, DOI 10.1146/annurev.en.25.010180.002225; Evans JD, 2004, J INVERTEBR PATHOL, V85, P105, DOI 10.1016/j.jip.2004.02.004; GAROFALO CA, 1977, J APICULT RES, V16, P3; Harriet J., 2012, ACTUALIDAD APICOLA, V95, P27; Irwin RE, 2014, J AGR FOOD CHEM, V62, P7335, DOI 10.1021/jf500521w; Johnson RM, 2015, ANNU REV ENTOMOL, V60, P415, DOI 10.1146/annurev-ento-011613-162005; LOUVEAUX J, 1978, BEE WORLD, V59, P139, DOI 10.1080/0005772X.1978.11097714; Maggi M, 2016, APIDOLOGIE, V47, P835, DOI 10.1007/s13592-016-0445-7; Mendoza Y., 2012, ACTUALIDAD APICOLA, V94, P8; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Sagili RR, 2015, HORTTECHNOLOGY, V25, P98, DOI 10.21273/HORTTECH.25.1.98; Santos E, 2009, AGROCIENCIA-URUGUAY, V13, P9; Simone-Finstrom M, 2010, APIDOLOGIE, V41, P295, DOI 10.1051/apido/2010016; Stevenson PC, 2017, FUNCT ECOL, V31, P65, DOI 10.1111/1365-2435.12761; Tworek K., 1994, Apidologie, V25, P504; Vandame R, 2010, APIDOLOGIE, V41, P243, DOI 10.1051/apido/2010025; Vargas N, 2015, MYCOLOGY GUIDE KEY T; Wright GA, 2010, CURR BIOL, V20, P2234, DOI 10.1016/j.cub.2010.11.040	29	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190697	10.1371/journal.pone.0190697	http://dx.doi.org/10.1371/journal.pone.0190697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315331	Green Published, Green Submitted, gold			2022-12-26	WOS:000419655900020
J	Kucukseymen, S; Cekin, AH; Bayar, N; Arslan, S; Kucukseymen, EU; Mercan, T; Ozdemir, S				Kucukseymen, Selcuk; Cekin, Ayhan Hilmi; Bayar, Nermin; Arslan, Sakir; Kucukseymen, Elif Uygur; Mercan, Tanju; Ozdemir, Semir			A novel biomarker for prediction of atrial fibrillation susceptibility in patients with celiac disease	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ELECTROMECHANICAL DELAY; CARDIOVASCULAR RISK; ADVANCED FIBROSIS; INFLAMMATION; PATHOGENESIS; MECHANISMS; STROKE	Background Celiac disease (CD), a serious autoimmune disorder that occurs in people who are genetically predisposed, is induced by dietary gluten intake and affects primarily the small intestine. Many studies have identified an increased risk of cardiovascular problems in patients with CD. Moreover, these patients are susceptible to certain liver diseases, as well as fibrosis. Objective The aim of this study was to assess the presence of fibrosis using the De Ritis ratio, determining its effect on the electromechanical features of the left atrium and its susceptibility to atrial fibrillation (AF) in patients with CD. Methods A total of 97 patients diagnosed with CD by antibody test and biopsy were included in this prospective study. Two groups were created from these patients, a fibrosis-prone (FP) group and a non-fibrosis-prone (NFP) group, according to the cut-off value, as defined in previously published reports, for the AST/ALT ratio. Electrocardiographic and echocardio-graphic examinations were performed as part of the study. Results There were no differences in the baseline characteristics and conventional echocardio-graphic parameters of the defined groups. However, the patients in the FP group, as compared to those in the NFP group, had significantly increased PWD (56.68 +/- 6.48 ms vs. 37.49 +/- 6.22 ms, P<0.001). Additionally, significantly higher interatrial (60.50 +/- 13.05 ms vs. 29.40 +/- 11.55 ms, P<0.001), intra-left atrial (44.18 +/- 14.12 ms vs. 21.02 +/- 11.99 ms, P<0.001), andintra-right atrial (15.61 +/- 8.91 ms vs. 8.38 +/- 4.50 ms, P<0.001) EMD was found among the patients in the FP group compared to that of the NFP group. Conclusion It is believed that the susceptibility to AF cited in previous studies may be related to fibrosis. Our study is the first to examine the possible effects of fibrosis on AF susceptibility in patients with CD, whereby we propose a new biomarker for prediction of AF susceptibility of these patients.	[Kucukseymen, Selcuk; Bayar, Nermin; Arslan, Sakir] Univ Hlth Sci, Antalya Educ & Res Hosp, Dept Cardiol, Antalya, Turkey; [Kucukseymen, Selcuk; Mercan, Tanju; Ozdemir, Semir] Akdeniz Univ, Dept Biophys, Fac Med, Antalya, Turkey; [Cekin, Ayhan Hilmi] Univ Hlth Sci, Antalya Educ & Res Hosp, Dept Gastroenterol, Antalya, Turkey; [Kucukseymen, Elif Uygur] Univ Hlth Sci, Antalya Educ & Res Hosp, Dept Neurol, Antalya, Turkey	Antalya Training & Research Hospital; University of Health Sciences Turkey; Akdeniz University; Antalya Training & Research Hospital; University of Health Sciences Turkey; Antalya Training & Research Hospital; University of Health Sciences Turkey	Kucukseymen, S (corresponding author), Univ Hlth Sci, Antalya Educ & Res Hosp, Dept Cardiol, Antalya, Turkey.; Kucukseymen, S (corresponding author), Akdeniz Univ, Dept Biophys, Fac Med, Antalya, Turkey.	skucukseymen@gmail.com	Ozdemir, Semir/P-8727-2015; cekin, ayhan hilmi/AAL-4341-2020; Kucukseymen, Selcuk/Q-4135-2018; arslan, sakir/A-3933-2017; Bayar, Nermin/ADR-4702-2022	Ozdemir, Semir/0000-0002-4807-7344; cekin, ayhan hilmi/0000-0001-7464-8297; Kucukseymen, Selcuk/0000-0002-9757-3088; arslan, sakir/0000-0002-2907-4957; Mercan, Tanju/0000-0002-6711-6003				Akil MA, 2015, ANATOL J CARDIOL, V15, P565, DOI 10.5152/akd.2014.5558; Aras D, 2005, INT J CARDIOL, V99, P59, DOI 10.1016/j.ijcard.2003.11.040; Ari H, 2013, CARDIOL J, V20, P639, DOI 10.5603/CJ.2013.0164; Assa A, 2016, J PEDIAT GASTROENTER; Aviles RJ, 2003, CIRCULATION, V108, P3006, DOI 10.1161/01.CIR.0000103131.70301.4F; Bayar N, 2016, KOREAN CIRC J, V46, P239, DOI 10.4070/kcj.2016.46.2.239; Bayar N, 2015, ECHOCARDIOGR-J CARD, V32, P1802, DOI 10.1111/echo.12963; Bayar N, 2015, KOREAN CIRC J, V45, P242, DOI 10.4070/kcj.2015.45.3.242; Boos CJ, 2006, EUR HEART J, V27, P136, DOI 10.1093/eurheartj/ehi645; Boriani G, 2016, VASC PHARMACOL, V83, P26, DOI 10.1016/j.vph.2016.03.006; Botros Mona, 2013, Clin Biochem Rev, V34, P117; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158; Dzeshka MS, 2015, J AM COLL CARDIOL, V66, P943, DOI 10.1016/j.jacc.2015.06.1313; Efe TH, 2016, HEART LUNG CIRC, V25, P160, DOI 10.1016/j.hlc.2015.08.003; Elmoniem Alaa Abd, 2011, Int J Health Sci (Qassim), V5, P25; Emilsson L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001594; Emilsson L, 2011, EUR HEART J, V32, P2430, DOI 10.1093/eurheartj/ehr167; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Ferretti G, 2012, NUTRIENTS, V4, P243, DOI 10.3390/nu4040243; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Hu YF, 2015, NAT REV CARDIOL, V12, P230, DOI 10.1038/nrcardio.2015.2; Jansen H, 2015, MOL GENET GENOMICS, V290, P1911, DOI 10.1007/s00438-015-1045-3; Kruger FC, 2011, SAMJ S AFR MED J, V101, P477; Lioudaki E, 2011, CURR PHARM DESIGN, V17, P3632, DOI 10.2174/138161211798220945; Long MT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157517; Long MT, 2015, ARTERIOSCL THROM VAS, V35, P1284, DOI 10.1161/ATVBAHA.114.305200; McPherson S, 2010, GUT, V59, P1265, DOI 10.1136/gut.2010.216077; Peters U, 2003, ARCH INTERN MED, V163, P1566, DOI 10.1001/archinte.163.13.1566; Reilly NR, 2015, J HEPATOL, V62, P1405, DOI 10.1016/j.jhep.2015.01.013; Rief P, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003843; Russo V, 2015, EUR REV MED PHARMACO, V19, P1241; Sari C, 2015, KARDIOL POL, V73, P1108, DOI 10.5603/KP.a2015.0097; Sari C, 2012, ECHOCARDIOGR-J CARD, V29, P471, DOI 10.1111/j.1540-8175.2011.01598.x; Sesti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104941; Shahid F, 2017, SEMIN THROMB HEMOST, V43, P505, DOI 10.1055/s-0036-1597285; Stein AC, 2016, J CLIN GASTROENTEROL, V50, P545, DOI 10.1097/MCG.0000000000000422; Van Wagoner DR, 2008, J CARDIOVASC PHARM, V52, P306, DOI 10.1097/FJC.0b013e31817f9398; Weng SF, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2015-000272; Yokoyama M, 2016, DIS MARKERS, V2016, P1, DOI 10.1155/2016/4857917; Zoppini G, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004821	41	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190382	10.1371/journal.pone.0190382	http://dx.doi.org/10.1371/journal.pone.0190382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315324	Green Published, Green Submitted, gold			2022-12-26	WOS:000419655900012
J	Kuo, G; Lee, CC; Yang, SY; Hsiao, YC; Chuang, SS; Chang, SW; Tu, KH; Fan, PC; Tian, YC; Chen, YC; Chang, CH				Kuo, George; Lee, Cheng-Chia; Yang, Shih-Yi; Hsiao, Yen-Chang; Chuang, Shiow-Shuh; Chang, Su-Wei; Tu, Kun-Hua; Fan, Pei-Chun; Tian, Ya-Chung; Chen, Yung-Chang; Chang, Chih-Hsiang			Hyperphosphatemia is associated with high mortality in severe burns	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; SCORING SYSTEMS; BAUX SCORE; HYPOPHOSPHATEMIA; AGE; VALIDATION; PREDICTION; RISK; INSUFFICIENCY; PROBABILITY	Introduction Phosphate level is often deranged during acute illness, regardless of the presence of kidney injury or not. A few studies described that hypophosphatemia may associated with outcome in patients admitted to the burn unit, but the literatures for hyperphosphatemia is limited. Our study aims to evaluate if hyperphosphatemia, one of the sign of severe tissue damage or kidney injury, will associate with mortality of patients with severe burns. Materials and methods The study was a post hoc analysis of prospectively collected data from patients admitted to the burn unit between September 2006 and December 2011. Patients were stratified into normophosphatemic or hyperphosphatemic group by baseline plasma phosphate level. The primary endpoint is 90-day mortality. Results Total 301 patients were included (hyperphosphatemia: n = 52; normophosphatemia: n = 249). The hyperphosphatemic group had lower Glasgow Coma Scale, mean arterial blood pressure, hemoglobin level, albumin, and higher TBSA of burns, APACHE II score, ABSI score, Acute kidney injury (AKI), and creatinine. The 90-day mortality was higher in the hyperphosphatemic group than in the normal group (53.8% vs 18.1%, P < .001) and this difference was still significant when adjusting for several confounding factors (hazard ratio, 2.05; 95% CI, 1.17-3.59). Multivariable Cox analysis showed risk factors of mortality included TBSA of burns, hyperphosphatemia, reduced urine output, and APACHE II score. Conclusions Our study found in addition to TBSA of burns and inhalation injury, baseline hyperphosphatemia in patients with severe burns is also associated with higher mortality.	[Kuo, George; Lee, Cheng-Chia; Tu, Kun-Hua; Fan, Pei-Chun; Tian, Ya-Chung; Chang, Chih-Hsiang] Change Gung Mem Hosp, Kidney Res Ctr, Dept Nephrol, Linkou branch, Taoyuan, Taiwan; [Yang, Shih-Yi; Hsiao, Yen-Chang; Chuang, Shiow-Shuh] Chang Gung Mem Hosp, Linkou Burn Ctr, Dept Plast Surg, Taipei, Taiwan; [Chang, Su-Wei] Chang Gung Univ, Coll Med, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Chang, Su-Wei] Chang Gung Mem Hosp, Dept Pediat, Div Allergy Asthma & Rheumatol, Taoyuan, Taiwan; [Fan, Pei-Chun; Tian, Ya-Chung; Chang, Chih-Hsiang] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan; [Chen, Yung-Chang] Chang Gung Mem Hosp, Keelung Branch, Dept Nephrol, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chang, CH (corresponding author), Change Gung Mem Hosp, Kidney Res Ctr, Dept Nephrol, Linkou branch, Taoyuan, Taiwan.; Chang, CH (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan.	sunchang@cgmh.org.tw	Tu, Kun-Hua/ABD-1751-2021; Kuo, George/AGE-0252-2022; Kuo, George/ABA-3641-2021	Tu, Kun-Hua/0000-0002-7146-4481; Kuo, George/0000-0002-5908-403X; Kuo, George/0000-0002-5908-403X; Lee, Cheng-Chia/0000-0002-6973-5908	Chang Gung Memorial Hospital Research Program [CORPG5G0081]	Chang Gung Memorial Hospital Research Program(Chang Gung Memorial Hospital)	This study was supported by grants from the Chang Gung Memorial Hospital Research Program (CORPG5G0081). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachelder VD, 2001, J BURN CARE REHABIL, V22, P187, DOI 10.1097/00004630-200103000-00019; Betro MG, 1978, BMJ-BRIT MED J, V29, P273; Blot S, 2009, BRIT J SURG, V96, P111, DOI 10.1002/bjs.6329; Brusselaers N, 2010, INTENS CARE MED, V36, P915, DOI 10.1007/s00134-010-1861-1; Cassidy JT, 2014, BURNS, V40, P805, DOI 10.1016/j.burns.2013.10.010; Castana O, 2009, Ann Burns Fire Disasters, V22, P59; Chung PY, 2003, LIVER TRANSPLANT, V9, P248, DOI 10.1053/jlts.2003.50053; Cohen J, 2004, EUR J CARDIO-THORAC, V26, P306, DOI 10.1016/j.ejcts.2004.03.004; Coste J, 1996, J CLIN EPIDEMIOL, V49, P1125, DOI 10.1016/0895-4356(96)00197-7; Dokter J, 2014, J TRAUMA ACUTE CARE, V76, P840, DOI 10.1097/TA.0000000000000124; Galeiras R, 2009, BURNS, V35, P201, DOI 10.1016/j.burns.2008.07.019; Haider DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133426; Hallet J, 2016, HEPATOL SURG NUTR, V5, P217, DOI 10.21037/hbsn.2015.12.13; Jackson PC, 2014, ANN SURG, V259, P979, DOI 10.1097/SLA.0b013e31829160ca; Kahn SA, 2015, J BURN CARE RES, V36, pE220, DOI 10.1097/BCR.0000000000000114; Ketteler M, 2017, KIDNEY INT, V92, P26, DOI 10.1016/j.kint.2017.04.006; Kuo G, 2016, J FORMOS MED ASSOC, V115, P1046, DOI 10.1016/j.jfma.2016.10.012; LENNQUIST S, 1979, ACTA CHIR SCAND, V145, P1; Lionelli GT, 2005, BURNS, V31, P958, DOI 10.1016/j.burns.2005.06.006; Loghmani S, 2010, BURNS, V36, P1112, DOI 10.1016/j.burns.2009.12.009; Lorente JA, 2009, SHOCK, V31, P125, DOI 10.1097/SHK.0b013e31817fc3ef; Lundgren RS, 2009, J BURN CARE RES, V30, P307, DOI 10.1097/BCR.0b013e318198a416; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Moore EC, 2010, BURNS, V36, P1086, DOI 10.1016/j.burns.2010.03.013; Moreau AR, 2005, J TRAUMA, V58, P967, DOI 10.1097/01.TA.0000162729.24548.00; Mosier MJ, 2010, J BURN CARE RES, V31, P83, DOI 10.1097/BCR.0b013e3181cb8c87; Naffaa ME, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1094-6; O'Keefe GE, 2001, J AM COLL SURGEONS, V192, P153, DOI 10.1016/S1072-7515(00)00785-7; Osler T, 2010, J TRAUMA, V68, P690, DOI 10.1097/TA.0b013e3181c453b3; Pavoni V, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-24; Pompermaier L, 2015, BURNS, V41, P1868, DOI 10.1016/j.burns.2015.09.017; Ryan CM, 1998, NEW ENGL J MED, V338, P362, DOI 10.1056/NEJM199802053380604; Schneider DF, 2012, J BURN CARE RES, V33, P242, DOI 10.1097/BCR.0b013e318239cc24; Sheppard NN, 2011, BURNS, V37, P1288, DOI 10.1016/j.burns.2011.07.017; Shor R, 2006, ANN CLIN LAB SCI, V36, P67; Squires MH, 2014, HPB, V16, P884, DOI 10.1111/hpb.12276; Steinvall I, 2008, CRIT CARE, V12, DOI 10.1186/cc7032; Steinvall I, 2016, BURNS, V42, P28, DOI 10.1016/j.burns.2015.10.032; Steinvall I, 2011, J TRAUMA, V70, P959, DOI 10.1097/TA.0b013e3181e59dbe; Stewart IJ, 2012, CLIN J AM SOC NEPHRO, V7, P199, DOI 10.2215/CJN.04420511; Tagami T, 2015, BURNS, V41, P1169, DOI 10.1016/j.burns.2015.02.017; Tanaka Y, 2007, BURNS, V33, P316, DOI 10.1016/j.burns.2006.07.004; TOBIASEN J, 1982, ANN EMERG MED, V11, P260, DOI 10.1016/S0196-0644(82)80096-6; Yang HT, 2014, CRIT CARE, V18, DOI 10.1186/cc13989; Yang HT, 2012, J TRAUMA ACUTE CARE, V73, P1298, DOI 10.1097/TA.0b013e3182701e09	45	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190978	10.1371/journal.pone.0190978	http://dx.doi.org/10.1371/journal.pone.0190978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315336	Green Submitted, gold, Green Published			2022-12-26	WOS:000419655900037
J	Niu, Y; Jin, Y; Deng, SC; Deng, SJ; Zhu, S; Liu, Y; Li, X; He, C; Liu, ML; Zeng, Z; Chen, HY; Zhong, JX; Ye, Z; Wang, CY; Zhao, G				Niu, Yi; Jin, Yan; Deng, Shi-Chang; Deng, Shi-Jiang; Zhu, Shuai; Liu, Yang; Li, Xiang; He, Chi; Liu, Ming-Liang; Zeng, Zhu; Chen, Heng-Yu; Zhong, Jian-Xin; Ye, Zeng; Wang, Chun-You; Zhao, Gang			MiRNA-646-mediated reciprocal repression between HIF-1 alpha and MIIP contributes to tumorigenesis of pancreatic cancer	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; CELLULAR-RESPONSE; BREAST-CANCER; HYPOXIA; EXPRESSION; CELLS; MIGRATION; INVASION; TARGETS; GENE	Migration and invasion inhibitory protein (MIIP) is recently identified as an inhibitor in tumor development. However, the regulatory mechanism and biological contributions of MIIP in pancreatic cancer (PC) have been not elucidated. In this study, we demonstrated a negative feedback of MIIP and hypoxia-induced factor-1 alpha (HIF-1 alpha), which was mediated by a hypoxia-induced microRNA. Compared with paracarcinoma tissues, MIIP was downregulated in PC tissues. Overexpression of MIIP significantly impeded the proliferation and invasion of PC cells both in vitro and in mouse xenograft models. We further verified MIIP was downregulated under hypoxia in a HIF-1 alpha-mediated manner. Interestingly, although MIIP promoter containing two putative hypoxia response elements (HREs), the chromatin immunoprecipitation (ChIP) and luciferase reporter assays did not support an active interaction between HIF-1a and MIIP promoter. Meanwhile, microRNA array revealed a hypoxia-induced microRNA, miR-646, impaired stability of MIIP mRNA and consequently inhibited its expression by targeting the coding sequence (CDS). Coincidently, knockdown of miR-646 significantly repressed proliferation and invasion ability of PC cells both in vitro and in vivo by upregulating MIIP expression. Besides, ChIP and luciferase reporter assays further validated that HIF-1 alpha activated transcription of miR-646 in hypoxia condition. Therefore, these results suggested HIF-1 alpha indirectly regulated MIIP expression in post-transcriptional level through upregulating miR-646 transcription. Conversely, our results further revealed that MIIP suppressed deacetylase ability of histone deacetylase 6 (HDAC6) to promote the acetylation and degradation of HIF-1 alpha, by which impairing HIF-1 alpha accumulation. What is more, a specific relationship between downregulated MIIP and upregulated miR-646 expression was validated in PC samples. Moreover, the dysregulated miR-646 and MIIP expression was correlated with advanced tumor stage, lymphatic invasion, metastasis and shorter overall survival in PC patients. Together, our results highlight that the reciprocal loop of HIF-1 alpha/miR-646/MIIP might be implemented as an applicable target for pancreatic cancer therapy.	[Niu, Yi; Jin, Yan; Deng, Shi-Chang; Deng, Shi-Jiang; Zhu, Shuai; Liu, Yang; Li, Xiang; He, Chi; Liu, Ming-Liang; Zeng, Zhu; Chen, Heng-Yu; Zhong, Jian-Xin; Ye, Zeng; Wang, Chun-You; Zhao, Gang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Pancreat Dis Inst,Dept Pancreat Surg, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Zhao, G (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Pancreat Dis Inst,Dept Pancreat Surg, Wuhan, Hubei, Peoples R China.	gangzhao@aliyun.com	fuliyun_new, fuliyun_new/AAZ-4437-2020	Jin, Yan/0000-0001-5957-7443; Li, Xiang/0000-0002-5942-7282	National Natural Science Foundation of China [81672406, 81372666, 30972900, 81502076]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (no. 81672406, no. 81372666, no. 30972900, and no. 81502076).	Azam AT, 2016, TUMOR BIOL, V37, P5769, DOI 10.1007/s13277-015-3821-4; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chen J, 2016, ONCOGENE, V35, P2506, DOI 10.1038/onc.2015.316; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; Deng SC, 2015, ONCOTARGET, V6, P39661, DOI 10.18632/oncotarget.5350; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Feldser D, 1999, CANCER RES, V59, P3915; Gomez-Roman N, 2016, ONCOTARGET, V7, P22650, DOI 10.18632/oncotarget.7998; Hausser J, 2013, GENOME RES, V23, P604, DOI 10.1101/gr.139758.112; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Ji P, 2010, ONCOGENE, V29, P3501, DOI 10.1038/onc.2010.114; Jing W, 2011, ONCOTARGET, V7, P9118; Jones MF, 2015, P NATL ACAD SCI USA, V112, pE1550, DOI 10.1073/pnas.1503370112; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Krzywinski M, 2013, NAT METHODS, V10, P1139, DOI 10.1038/nmeth.2738; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lee KJ, 2010, BBA-MOL CELL RES, V1803, P608, DOI 10.1016/j.bbamcr.2010.01.004; Li W., 2011, J NUCL ACIDS, V2011, P1, DOI DOI 10.4061/2011/870726; Li X, 2016, ONCOTARGET, V7, P6000, DOI 10.18632/oncotarget.6830; Liu GJ, 2015, MOL BIOL EVOL, V32, P623, DOI 10.1093/molbev/msu323; Liu Y, 2015, GENE THER, V22, P729, DOI 10.1038/gt.2015.39; Loscalzo J, 2010, J CLIN INVEST, V120, P3815, DOI 10.1172/JCI45105; Mace TA, 2013, J SURG RES, V184, P855, DOI 10.1016/j.jss.2013.04.061; Nallamshetty S, 2013, FREE RADICAL BIO MED, V64, P20, DOI 10.1016/j.freeradbiomed.2013.05.022; Pothula SP, 2015, CANC LETT, V24, P232; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Sermeus A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.48; Song FF, 2015, ONCOL REP, V33, P2771, DOI 10.3892/or.2015.3905; Sun Y, 2017, J PATHOL, V241, P67, DOI 10.1002/path.4823; Vaiman D, 2017, PLACENTA, V52, P127, DOI 10.1016/j.placenta.2016.12.026; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wang R, 2014, SCI WORLD J, DOI 10.1155/2014/312704; Wang XC, 2016, ONCOTARGET, V7, P13717, DOI 10.18632/oncotarget.7263; Wang Y, 2011, CANCER RES, V70, P423; Wang YM, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0342-6; Wang YM, 2011, CURR PROTEIN PEPT SC, V12, P68; Wen W, 2010, CANCER RES, V70, P2010, DOI 10.1158/0008-5472.CAN-08-4910; Wu C, 2011, MOL CELL BIOL, V31, P4760, DOI 10.1128/MCB.05776-11; Wu Q, 2015, J BIOL CHEM, V290, P1170, DOI 10.1074/jbc.M114.601203; Wu Y, 2010, J BIOL CHEM, V285, P3554, DOI 10.1074/jbc.M109.063354; Ying Q, 2011, HEPATOLOGY, V54, P2064, DOI 10.1002/hep.24614; Zhang D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.240; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448; Zhang Z, 2009, CELL CYCLE, V8, P2756, DOI 10.4161/cc.8.17.9387; Zhao G, 2013, MOL CANCER THER, V12, P83, DOI 10.1158/1535-7163.MCT-12-0534-T; Zhou HL, 2014, RNA, V20, P1431, DOI 10.1261/rna.045757.114; Zhu S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.189	49	33	35	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	13					1743	1758		10.1038/s41388-017-0082-2	http://dx.doi.org/10.1038/s41388-017-0082-2			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GA9AE	29343850				2022-12-26	WOS:000428632600005
J	Ferrigno, A; Di Pasqua, LG; Berardo, C; Siciliano, V; Rizzo, V; Adorini, L; Richelmi, P; Vairetti, M				Ferrigno, Andrea; Di Pasqua, Laura Giuseppina; Berardo, Clarissa; Siciliano, Veronica; Rizzo, Vittoria; Adorini, Luciano; Richelmi, Plinio; Vairetti, Mariapia			The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury	PLOS ONE			English	Article							ORGANIC CATION TRANSPORTERS; VASCULAR ENDOTHELIAL-CELLS; PLACEBO-CONTROLLED TRIAL; PORTAL-HYPERTENSION; NUCLEAR RECEPTORS; BILE-ACIDS; FXR; LIVER; RATS; EXPRESSION	Background We previously showed that increased asymmetric dimethylarginine (ADMA) biliary excretion occurs during hepatic ischemia/reperfusion (I/R), prompting us to study the effects of the farnesoid X receptor (FXR) agonist obeticholic acid (OCA) on bile, serum and tissue levels of ADMA after I/R. Material and methods Male Wistar rats were orally administered 10mg/kg/day of OCA or vehicle for 5 days and were subjected to 60 min partial hepatic ischemia or sham-operated. After a 60 min reperfusion, serum, tissue and bile ADMA levels, liver mRNA and protein expression of ADMA transporters (CAT-1, CAT-2A, CAT-2B, OCT-1, MATE-1), and enzymes involved in ADMA synthesis (protein-arginine-N-methyltransferase-1, PRMT-1) and metabolism (dimethylarginine-dimethylaminohydrolase-1, DDAH-1) were measured. Results OCA administration induced a further increase in biliary ADMA levels both in sham and I/R groups, with no significant changes in hepatic ADMA content. A reduction in CAT-1, CAT2A or CAT-2B transcripts was found in OCA-treated sham-operated rats compared with vehicle. Conversely, OCA administration did not change CAT-1, CAT-2A or CAT-2B expression, already reduced by I/R. However, a marked decrease in OCT-1 and increase in MATE-1 expression was observed. A similar trend occurred with protein expression. Conclusion The reduced mRNA expression of hepatic CAT transporters suggests that the increase in serum ADMA levels is probably due to decreased liver uptake of ADMA from the systemic circulation. Conversely, the mechanism involved in further increasing biliary ADMA levels in sham and I/R groups treated with OCA appears to be MATE-1-dependent.	[Ferrigno, Andrea; Di Pasqua, Laura Giuseppina; Berardo, Clarissa; Siciliano, Veronica; Richelmi, Plinio; Vairetti, Mariapia] Univ Pavia, Dept Internal Med & Therapeut, Pavia, Italy; [Rizzo, Vittoria] Univ Pavia, IRCCS San Matteo, Dept Mol Med, Pavia, Italy; [Adorini, Luciano] Intercept Pharmaceut, San Diego, CA USA	University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; Intercept Pharmaceuticals	Vairetti, M (corresponding author), Univ Pavia, Dept Internal Med & Therapeut, Pavia, Italy.	mariapia.vairetti@unipv.it	Berardo, Clarissa/U-7316-2019; Vairetti, Mariapia/AAM-1757-2020; Adorini, Luciano/AAE-5149-2020; Di Pasqua, Laura Giuseppina/Y-3987-2019; Ferrigno, Andrea/J-2087-2019	Berardo, Clarissa/0000-0002-1257-5843; Vairetti, Mariapia/0000-0002-2464-6127; Di Pasqua, Laura Giuseppina/0000-0003-0103-1493; Ferrigno, Andrea/0000-0003-2337-2897; Siciliano, Veronica/0000-0002-5831-0226	University of Pavia	University of Pavia	The Department of Internal Medicine and Therapeutics had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Funds from University of Pavia were used. Intercept Pharmaceutical provided support in the form of research material, precisely by supplying obeticholic acid, but did not have any additional role in the study design, data collection and analysis, decision to publish manuscript. The specific roles of this author are articulated in the 'author contributions' section'.	Abdel-Gaber SA, 2015, LIFE SCI, V134, P42, DOI 10.1016/j.lfs.2015.04.025; Abel U, 2010, BIOORG MED CHEM LETT, V20, P4911, DOI 10.1016/j.bmcl.2010.06.084; Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200; Ceulemans LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169331; Chen N, 2011, CELL PHYSIOL BIOCHEM, V27, P341, DOI 10.1159/000327960; Chen TH, 2014, TRANSPL P, V46, P1112, DOI [10.1016/j.transproceed.2014.01.002, 10.1016/j.transproceed.2013.12.018]; CHOMCZYNSKI P, 1995, ANAL BIOCHEM, V225, P163, DOI 10.1006/abio.1995.1126; Closs EI, 1997, NITRIC OXIDE-BIOL CH, V1, P65, DOI 10.1006/niox.1996.0106; Closs EI, 1997, BIOCHEMISTRY-US, V36, P6462, DOI 10.1021/bi962829p; Cui JY, 2012, AM J PHYSIOL-GASTR L, V302, pG979, DOI 10.1152/ajpgi.00370.2011; Ferrigno A, 2016, BASIC CLIN PHARMACOL, V119, P101, DOI 10.1111/bcpt.12540; Ferrigno A, 2015, WORLD J GASTROENTERO, V21, P1108, DOI 10.3748/wjg.v21.i4.1108; Ferrigno A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/627434; Ferrigno A, 2011, CRYOBIOLOGY, V62, P152, DOI 10.1016/j.cryobiol.2011.02.004; Ghebremariam YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060653; Hattori Y, 1999, AM J PHYSIOL-HEART C, V276, pH2020, DOI 10.1152/ajpheart.1999.276.6.H2020; Hirschfield GM, 2015, GASTROENTEROLOGY, V148, P751, DOI 10.1053/j.gastro.2014.12.005; Hu XL, 2009, CIRCULATION, V120, P2222, DOI 10.1161/CIRCULATIONAHA.108.819912; Huber RM, 2002, GENE, V290, P35, DOI 10.1016/S0378-1119(02)00557-7; Hyrsova L, 2016, DRUG METAB REV, V48, P139, DOI 10.1080/03602532.2016.1188936; Jonker JW, 2004, J PHARMACOL EXP THER, V308, P2, DOI 10.1124/jpet.103.053298; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Kock K, 2012, CLIN PHARMACOL THER, V92, P599, DOI 10.1038/clpt.2012.79; Laleman W, 2005, HEPATOLOGY, V42, P1382, DOI 10.1002/hep.20968; Lee H, 2006, J LIPID RES, V47, P201, DOI 10.1194/jlr.M500417-JLR200; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Li CY, 2015, J AM SOC HYPERTENS, V9, P507, DOI 10.1016/j.jash.2015.04.006; Li J, 2008, CARDIOVASC RES, V77, P169, DOI 10.1093/cvr/cvm016; Li J, 2009, J PHARMACOL EXP THER, V331, P234, DOI 10.1124/jpet.109.153510; Liu YP, 2003, J CLIN INVEST, V112, P1678, DOI 10.1172/JCI200318945; Maeda T, 2004, MOL PHARMACEUT, V1, P281, DOI 10.1021/mp0499656; Mazuy C, 2015, CELL MOL LIFE SCI, V72, P1631, DOI 10.1007/s00018-014-1805-y; Mookerjee RP, 2007, HEPATOLOGY, V45, P62, DOI 10.1002/hep.21491; Mookerjee RP, 2015, J HEPATOL, V62, P325, DOI 10.1016/j.jhep.2014.08.024; Motohashi H, 2013, AAPS J, V15, P581, DOI 10.1208/s12248-013-9465-7; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Nevens F, 2016, NEW ENGL J MED, V375, P631, DOI 10.1056/NEJMoa1509840; Nies AT, 2011, HANDB EXP PHARMACOL, V201, P105, DOI 10.1007/978-3-642-14541-4_3; Otsuka M, 2005, P NATL ACAD SCI USA, V102, P17923, DOI 10.1073/pnas.0506483102; Palladini G, 2012, TOXICOL PATHOL, V40, P722, DOI 10.1177/0192623312441403; Pelis RM, 2014, CURR TOP MEMBR, V73, P233, DOI 10.1016/B978-0-12-800223-0.00006-2; Pellicciari R, 2002, J MED CHEM, V45, P3569, DOI 10.1021/jm025529g; Porcelli V, 2016, AMINO ACIDS, V48, P427, DOI 10.1007/s00726-015-2096-9; Roda A, 2014, J PHARMACOL EXP THER, V350, P56, DOI 10.1124/jpet.114.214650; Sepe V, 2015, EXPERT OPIN THER PAT, V25, P885, DOI 10.1517/13543776.2015.1045413; Strobel J, 2013, AMINO ACIDS, V45, P989, DOI 10.1007/s00726-013-1556-3; Tain YL, 2007, KIDNEY INT, V72, P886, DOI 10.1038/sj.ki.5002446; Teerlink T, 2009, PHARMACOL RES, V60, P448, DOI 10.1016/j.phrs.2009.08.002; Vaquero J, 2013, BIOCHEM PHARMACOL, V86, P926, DOI 10.1016/j.bcp.2013.07.022; Vaquero J, 2013, BBA-MOL CELL RES, V1833, P2212, DOI 10.1016/j.bbamcr.2013.05.006; Verbeke L, 2016, SCI REP-UK, V6, DOI 10.1038/srep33453; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wagner M, 2011, HEPATOLOGY, V53, P1023, DOI 10.1002/hep.24148; Xu JY, 2014, WORLD J GASTROENTERO, V20, P13493, DOI 10.3748/wjg.v20.i37.13493; Yokoo S, 2007, BIOCHEM PHARMACOL, V74, P477, DOI 10.1016/j.bcp.2007.03.004; Zhang R, 2012, J PHYSIOL PHARMACOL, V63, P367; Zhang R, 2016, CLIN EXP PHARMACOL P, V43, P327, DOI 10.1111/1440-1681.12535	58	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191430	10.1371/journal.pone.0191430	http://dx.doi.org/10.1371/journal.pone.0191430			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346429	Green Published, Green Submitted, gold			2022-12-26	WOS:000422749500049
J	Sun, L; Zou, T; Wang, BZ; Liu, F; Yuan, QH; Ma, YT; Ma, X				Sun, Ling; Zou, Ting; Wang, Bao-Zhu; Liu, Fen; Yuan, Qing-Hua; Ma, Yi-Tong; Ma, Xiang			Epidemiological investigation into the prevalence of abnormal inter-arm blood pressure differences among different ethnicities in Xinjiang, China	PLOS ONE			English	Article							DISEASE; HYPERTENSION	Objectives The prevalence of and risk factors for IAD among different ethnicity groups was unknown. Our aim was to investigate the prevalence of and risk factors for IAD among Han, Uygur and Kazakh ethnicities in Xinjiang. China. Methods In total, 14,618 adult participants (7,799 males and 6,819 females) were recruited from the Cardiovascular Risk Survey. A 4-stage stratified cluster random sampling method was used. The participants' personal information and medical history were assessed by questionnaire. IAD was diagnosed by a noninvasive arteriosclerosis analyzer. Results The prevalence of abnormal IAD among the general population was 14.3%, with 12.5% in the Han, 14.9% in the Uygur, and 16.4% in the Kazakh populations. The prevalence of abnormal IAD among the hypertensive population was 19.4%, with 17.0% in the Han, 18.1% in the Uygur, and 22.7% in the Kazakh populations. The prevalence of abnormal IAD increased with age (all P < 0.01) but was not significantly different between the genders (all P>0.05). Multivariate logistic regression analysis showed that age more than 45 years, obesity and hypertriglyceridemia were significantly associated with a higher prevalence of IAD. There were different risk factors for abnormal IAD in different ethnicities. Middle or old age, obesity, ABI and diabetes mellitus were risk factors for the Han population, smoking was a risk factor in the Uygur population, and obesity and PAD were risk factors in the Kazakh population. Conclusion The prevalence of abnormal IAD in the Kazakh participants was higher than that in the Han and Uygur populations among both the general population and the hypertensive population in Xinjiang, China. The main risk factors of IAD were age, obesity, and triglyceride levels. Different ethnicities had different kinds of risk factors for IAD.	[Sun, Ling; Wang, Bao-Zhu; Liu, Fen; Yuan, Qing-Hua; Ma, Yi-Tong; Ma, Xiang] Xingjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Zou, Ting] Xinjiang Med Univ, Affiliated Hosp 5, Dept Cardiol, Urumqi, Henan, Peoples R China; [Liu, Fen; Ma, Yi-Tong; Ma, Xiang] Xinjiang Med Univ, Affiliated Hosp 1, Clin Med Res Inst, Xin Jiang Key Lab Cardiovasc Dis, Urumqi, Peoples R China	Xinjiang Medical University; Xinjiang Medical University	Ma, X (corresponding author), Xingjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China.; Ma, X (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Clin Med Res Inst, Xin Jiang Key Lab Cardiovasc Dis, Urumqi, Peoples R China.	maxiangxj@yeah.net						[Anonymous], 1985, World Health Organ Tech Rep Ser, V727, P1; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Arnett DK, 2005, J HYPERTENS, V23, P1141, DOI 10.1097/01.hjh.0000170376.23461.f7; Arroyo D, 2017, NEPHROL DIAL TRANSPL, V32, P513, DOI 10.1093/ndt/gfw039; Clark CE, 2016, BRIT J GEN PRACT, V66, pE838, DOI 10.3399/bjgp16X687553; Clark CE, 2015, CURR PHARM DESIGN, V21, P737; Clark CE, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1327; Clark CE, 2012, LANCET, V379, P905, DOI 10.1016/S0140-6736(11)61710-8; FOTHERBY MD, 1993, POSTGRAD MED J, V69, P194, DOI 10.1136/pgmj.69.809.194; Gao Xia, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P857; Grossman A, 2014, J CLIN HYPERTENS, V16, P518, DOI 10.1111/jch.12345; Kim SA, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003888; Kimura A, 2004, J HYPERTENS, V22, P2277, DOI 10.1097/00004872-200412000-00009; Lane D, 2002, J HYPERTENS, V20, P1089, DOI 10.1097/00004872-200206000-00019; Liu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145325; Liu Fen, 2010, Zhonghua Yi Xue Za Zhi, V90, P3259; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; McManus RJ, 2012, BMJ-BRIT MED J, V344, pe181, DOI DOI 10.1136/BMJ.E181; Mumford SL, 2011, CLIN LIPIDOL, V6, P225, DOI 10.2217/CLP.11.9; National Institue for Health and Clinical Excellence, 2011, HYP CLIN MAN PRIM HY, V127, P905; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Orme S, 1999, AGE AGEING, V28, P537, DOI 10.1093/ageing/28.6.537; Pan SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053746; Singh S, 2015, BLOOD PRESS MONIT, V20, P178, DOI 10.1097/MBP.0000000000000115; Song BM, 2016, KOREAN CIRC J, V46, P374, DOI 10.4070/kcj.2016.46.3.374; Su HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041173; Weinberg I, 2014, AM J MED, V127, P209, DOI 10.1016/j.amjmed.2013.10.027; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015181; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Zhang RB, 2000, AM J HYPERTENS, V13, P1308, DOI 10.1016/S0895-7061(00)01254-1	30	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0188546	10.1371/journal.pone.0188546	http://dx.doi.org/10.1371/journal.pone.0188546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346374	Green Published, gold, Green Submitted			2022-12-26	WOS:000422749500002
J	Clarke, SB; Deighton, K; Newman, C; Nicholson, G; Gallagher, L; Boos, CJ; Mellor, A; Woods, DR; O'Hara, JP				Clarke, Sarah B.; Deighton, Kevin; Newman, Caroline; Nicholson, Gareth; Gallagher, Liam; Boos, Christopher J.; Mellor, Adrian; Woods, David R.; O'Hara, John P.			Changes in balance and joint position sense during a 12-day high altitude trek: The British Services Dhaulagiri medical research expedition	PLOS ONE			English	Article							ACUTE MOUNTAIN-SICKNESS; POSTURAL STABILITY; DYNAMIC POSTUROGRAPHY; VISUAL INFORMATION; NORMOBARIC HYPOXIA; HYPOBARIC HYPOXIA; PART I; ATAXIA; RELIANCE; PROGRAM	Postural control and joint position sense are essential for safely undertaking leisure and professional activities, particularly at high altitude. We tested whether exposure to a 12-day trek with a gradual ascent to high altitude impairs postural control and joint position sense. This was a repeated measures observational study of 12 military service personnel (28 4 years). Postural control (sway velocity measured by a portable force platform) during standing balance, a Sharpened Romberg Test and knee joint position sense were measured, in England (113m elevation) and at 3 research camps (3619m, 4600m and 5140m) on a 12-day high altitude trek in the Dhaulagiri region of Nepal. Pulse oximetry, and Lake Louise scores were also recorded on the morning and evening of each trek day. Data were compared between altitudes and relationships between pulse oximetry, Lake Louise score, and sway velocity were explored. Total sway velocity during standing balance with eyes open (p = 0.003, d = 1.9) and during Sharpened Romberg test with eyes open (p = 0.007, d = 1.6) was significantly greater at altitudes of 3619m and 5140m when compared with sea level. Anterior-posterior sway velocity during standing balance with eyes open was also significantly greater at altitudes of 3619m and 5140m when compared with sea level (p = 0.001, d = 1.9). Knee joint position sense was not altered at higher altitudes. There were no significant correlations between Lake Louise scores, pulse oximetry and postural sway. Despite a gradual ascent profile, exposure to 3619 m was associated with impairments in postural control without impairment in knee joint position sense. Importantly, these impairments did not worsen at higher altitudes of 4600 m or 5140 m. The present findings should be considered during future trekking expeditions when developing training strategies targeted to manage impairments in postural control that occur with increasing altitude.	[Clarke, Sarah B.; Deighton, Kevin; Nicholson, Gareth; Gallagher, Liam; Boos, Christopher J.; Mellor, Adrian; Woods, David R.; O'Hara, John P.] Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England; [Clarke, Sarah B.] Northern Michigan Univ, Sch Hlth & Human Performance, Marquette, MI 49855 USA; [Newman, Caroline; Boos, Christopher J.; Mellor, Adrian; Woods, David R.] Def Med Serv, Lichfield, England; [Boos, Christopher J.] Poole Hosp NHS Trust, Dept Cardiol, Longfleet Rd, Poole, Dorset, England; [Boos, Christopher J.] Bournemouth Univ, Dept Postgrad Med Educ, Bournemouth, Dorset, England; [Mellor, Adrian] James Cook Univ Hosp, South Tees Hosp NHS Trust, Middlesbrough, Cleveland, England; [Woods, David R.] Wansbeck Gen & Royal Victoria Infirm, Northumbria & Newcastle NHS Trusts, Newcastle Upon Tyne, Tyne & Wear, England; [Woods, David R.] Univ Newcastle, Newcastle Upon Tyne, Tyne & Wear, England	Leeds Beckett University; Northern Michigan University; Bournemouth University; James Cook University Hospital; Newcastle University - UK	Clarke, SB (corresponding author), Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England.; Clarke, SB (corresponding author), Northern Michigan Univ, Sch Hlth & Human Performance, Marquette, MI 49855 USA.	sabreen@nmu.edu	Breen, Sarah/AAD-7910-2022; Nicholson, Gareth/X-1657-2019; Breen, Sarah/H-3682-2019	Breen, Sarah/0000-0002-6101-5359; Nicholson, Gareth/0000-0002-9559-0562; Breen, Sarah/0000-0002-6101-5359; Deighton, Kevin/0000-0001-7994-2137	Surgeon General (Defence Medical Services) Research Fund, UK; Leeds Beckett University	Surgeon General (Defence Medical Services) Research Fund, UK; Leeds Beckett University	Research reported in this study was supported by the Surgeon General (Defence Medical Services) Research Fund, UK and Leeds Beckett University.	Baumgartner RW, 2002, EUR J APPL PHYSIOL, V86, P322, DOI 10.1007/s00421-001-0534-8; Binks AP, 2008, J APPL PHYSIOL, V104, P212, DOI 10.1152/japplphysiol.00069.2007; Bird BA, 2011, WILD ENVIRON MED, V22, P172, DOI 10.1016/j.wem.2011.02.001; Bonan IV, 2004, ARCH PHYS MED REHAB, V85, P274, DOI 10.1016/j.apmr.2003.06.016; Bonan IV, 2004, ARCH PHYS MED REHAB, V85, P268, DOI 10.1016/j.apmr.2003.06.017; Cohen J, 1988, STAT POWER ANAL BEHA, DOI 10.1234/12345678; Costello JT, 2012, SCAND J MED SCI SPOR, V22, P190, DOI 10.1111/j.1600-0838.2011.01292.x; Cymerman A, 2001, HIGH ALT MED BIOL, V2, P509, DOI 10.1089/152702901753397072; Degache F, 2012, HIGH ALT MED BIOL, V13, P40, DOI 10.1089/ham.2011.1042; Dewhurst S, 2007, J ELECTROMYOGR KINES, V17, P292, DOI 10.1016/j.jelekin.2006.03.002; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FOWLER B, 1995, AVIAT SPACE ENVIR MD, V66, P645; FRASER WD, 1987, AVIAT SPACE ENVIR MD, V58, P768; His Majesty's Government of Nepal, 1986, NEP TOUR STAT 1986; His Majesty's Government of Nepal, 2015, NEP TOUR STAT 2015; Hopper DM, 2003, ARCH PHYS MED REHAB, V84, P868, DOI 10.1016/S0003-9993(03)00007-8; Hoshikawa M, 2010, EUR J APPL PHYSIOL, V110, P539, DOI 10.1007/s00421-010-1530-7; Johnson BG, 2005, WILD ENVIRON MED, V16, P62, DOI 10.1580/PR02-04.1; Mellor A, J R ARMY ME IN PRESS; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Nordahl SHG, 1998, AVIAT SPACE ENVIR MD, V69, P590; Raymakers JA, 2005, GAIT POSTURE, V21, P48, DOI 10.1016/j.gaitpost.2003.11.006; Redfern MS, 2001, J ANXIETY DISORD, V15, P81, DOI 10.1016/S0887-6185(00)00043-8; Relph N, 2015, J SPORT REHABIL; Relph N, 2014, J SPORT REHABIL; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Roach RC, 2000, J APPL PHYSIOL, V88, P581, DOI 10.1152/jappl.2000.88.2.581; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; SEVERINGHAUS JW, 1995, J APPL PHYSIOL, V79, P375, DOI 10.1152/jappl.1995.79.2.375; Sparrer I, ACTA OTOLARYNGOL STO; Stadelmann K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116695; Tredici TJ, 2008, FUNDAMENTALS AEROSPA, P356; Wagner DR, 2016, HIGH ALT MED BIOL, V17, P222, DOI 10.1089/ham.2016.0040; Wagner LS, 2011, AVIAT SPACE ENVIR MD, V82, P518, DOI 10.3357/ASEM.2885.2011; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9	35	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190919	10.1371/journal.pone.0190919	http://dx.doi.org/10.1371/journal.pone.0190919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342191	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000422653800038
J	Diaz-Mazariegos, S; Cabrera, N; Perez-Montfort, R				Diaz-Mazariegos, Selma; Cabrera, Nallely; Perez-Montfort, Ruy			Three unrelated and unexpected amino acids determine the susceptibility of the interface cysteine to a sulfhydryl reagent in the triosephosphate isomerases of two trypanosomes	PLOS ONE			English	Article							SPECIES-SPECIFIC INHIBITION; DIMER-INTERFACE; CRUZI; BRUCEI; SEQUENCE; REACTIVITY; PROTEINS; RESIDUES; ENZYME	Proteins with great sequence similarity usually have similar structure, function and other physicochemical properties. But in many cases, one or more of the physicochemical or functional characteristics differ, sometimes very considerably, among these homologous proteins. To better understand how critical amino acids determine quantitative properties of function in proteins, the responsible residues must be located and identified. This can be difficult to achieve, particularly in cases where multiple amino acids are involved. In this work, two triosephosphate isomerases with very high similarity from two related human parasites were used to address one such problem. We demonstrate that a seventy-fold difference in the reactivity of an interface cysteine to the sulfhydryl reagent methylmethane sulfonate in these two enzymes depends on three amino acids located far away from this critical residue and which could not have been predicted using other current methods. Starting from previous observations with chimeric proteins involving these two triosephosphate isomerases, we developed a strategy involving additive mutant enzymes and selected site directed mutants to locate and identify the three amino acids. These three residues seem to induce changes in the interface cysteine in reactivity by increasing (or decreasing) its apparent pKa. Some enzymes with four to seven mutations also exhibited altered reactivity. This study completes a strategy for identifying key residues in the sequences of proteins that can have applications in future protein structure-function studies.	[Diaz-Mazariegos, Selma; Cabrera, Nallely; Perez-Montfort, Ruy] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioqum & Biol Estruct, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Perez-Montfort, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Bioqum & Biol Estruct, Mexico City, DF, Mexico.	ruy@ifc.unam.mx		Perez-Montfort, Ruy/0000-0003-0810-1159; Cabrera Gonzalez, Elizabeth Nallely/0000-0001-8766-6996	Consejo Nacional de Ciencia y Tecnologia [254694]; Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico [IN206816]; CONACyT [263707]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grant no. 254694 from the Consejo Nacional de Ciencia y Tecnologia and grant no. IN206816 from the Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (to RP-M). SD-M was the recipient of a fellowship from CONACyT (no. 263707). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORCHERT TV, 1993, EUR J BIOCHEM, V211, P703, DOI 10.1111/j.1432-1033.1993.tb17599.x; Cabrera N, 2008, BIOCHEMISTRY-US, V47, P3499, DOI 10.1021/bi702439r; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Garcia-Torres I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018791; Garza-Ramos G, 1998, EUR J BIOCHEM, V253, P684, DOI 10.1046/j.1432-1327.1998.2530684.x; GarzaRamos G, 1996, EUR J BIOCHEM, V241, P114, DOI 10.1111/j.1432-1033.1996.0114t.x; GomezPuyou A, 1995, CHEM BIOL, V2, P847, DOI 10.1016/1074-5521(95)90091-8; Kaczanowski S, 2010, THEOR CHEM ACC, V125, P643, DOI 10.1007/s00214-009-0656-3; Kosloff M, 2008, PROTEINS, V71, P891, DOI 10.1002/prot.21770; Maldonado E, 1997, PROTEIN PEPTIDE LETT, V4, P139; Maldonado E, 1998, J MOL BIOL, V283, P193, DOI 10.1006/jmbi.1998.2094; Olivares-Illana V, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000001; OstoaSaloma P, 1997, EUR J BIOCHEM, V244, P700, DOI 10.1111/j.1432-1033.1997.00700.x; Pearson WR, 2013, CURR PROTOC BIOINFOR, V42, DOI 10.1002/0471250953.bi0301s42; Perez-Montfort R, 1999, BIOCHEMISTRY-US, V38, P4114, DOI 10.1021/bi982425s; Reyes-Vivas H, 2002, PROTEINS, V48, P580, DOI 10.1002/prot.10179; Reyes-Vivas H, 2001, BIOCHEMISTRY-US, V40, P3134, DOI 10.1021/bi002619j; ROBERTS DD, 1986, BIOCHEMISTRY-US, V25, P5595, DOI 10.1021/bi00367a038; Rodriguez-Bolanos M, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160161; Tellez-Valencia A, 2002, BIOCHEM BIOPH RES CO, V295, P958, DOI 10.1016/S0006-291X(02)00796-9; Zomosa-Signoret V, 2003, BIOCHEMISTRY-US, V42, P3311, DOI 10.1021/bi0206560	21	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0189525	10.1371/journal.pone.0189525	http://dx.doi.org/10.1371/journal.pone.0189525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342154	Green Published, Green Submitted, gold			2022-12-26	WOS:000422653800008
J	Schoening, JM; Corner, LAL; Messam, LLM; Cassidy, JP; Wolfe, A				Schoening, Janne M.; Corner, Leigh A. L.; Messam, Locksley L. McV.; Cassidy, Joseph P.; Wolfe, Alan			Environmental dust inhalation in the European badger (Meles meles): Systemic distribution of silica-laden macrophages, pathological changes, and association with Mycobacterium bovis infection status	PLOS ONE			English	Article							FRESHLY FRACTURED SILICA; AFRICAN GOLD MINERS; EXTRAPULMONARY SILICOSIS; ALVEOLAR MACROPHAGES; NITRIC-OXIDE; PULMONARY SILICOSIS; POTENTIAL ROLE; FREE-RADICALS; LUNG INJURY; TUBERCULOSIS	Chronic inhalation of crystalline silica and silicates may lead to severe lung disease in humans, termed silicosis. The disease is an occupational health concern in miners and related professions worldwide. Silicosis is also a strong risk factor for tuberculosis in humans. Due to its subterranean lifestyle, the European badger (Meles meles) is continuously exposed to environmental dust, while this species is also susceptible to tuberculosis, caused by Mycobacterium bovis. To date, a thorough investigation of mineral dust retention and its possible implication as a risk factor for mycobacterial infection in badgers has not been performed. The aims of this retrospective histological study were (1) to describe the systemic tissue distribution of silica-laden macrophages (SLMs) in badgers; (2) to compare the amount of SLMs in tissues of badgers of differing M. bovis infection status, pulmonary SLM burden and age; and (3) to assess whether inflammation was associated with SLMs. We assessed lung, lymph nodes, liver and spleen of 60 wild-caught badgers of known M. bovis infection status for the presence of SLMs using polarizing light microscopy. SLMs were consistently present within the lungs and were widely distributed throughout the lymphatic system. No inflammatory reaction to SLMs, as occurs in human silicosis, was observed in any tissue. Distribution and amount of SLMs were similar between M. bovis positive and negative badgers, and we were not able to show an association between the amount of SLMs and M. bovis infection status. The amount of SLMs within intra-and extra-thoracic lymph nodes was positively associated with the amount of pulmonary SLMs, and with age. This is the first report of substantial and systemic tissue retention of mineral dust particles in a mammalian species lacking associated chronic inflammation (i.e. silicosis). We further highlight different pathogenetic mechanisms underlying silicosis and benign SLM accumulations following siliceous dust inhalation.	[Schoening, Janne M.; Corner, Leigh A. L.; Messam, Locksley L. McV.; Cassidy, Joseph P.; Wolfe, Alan] Univ Coll Dublin, Sch Vet Med, Dublin, Ireland	University College Dublin	Schoening, JM (corresponding author), Univ Coll Dublin, Sch Vet Med, Dublin, Ireland.	janne.schoening@ucdconnect.ie		Messam, Locksley L. McV./0000-0001-5791-555X; Cassidy, Joseph/0000-0002-9229-1831	Department of Agriculture, Food; Marine	Department of Agriculture, Food; Marine	Tissue samples for this study were funded by the Department of Agriculture, Food and the Marine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barboza Carlos Eduardo Galvão, 2008, J. bras. pneumol., V34, P959, DOI 10.1590/S1806-37132008001100012; BARZIV J, 1974, ARCH ENVIRON HEALTH, V29, P121, DOI 10.1080/00039896.1974.10666548; Bilham K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45470; BLACKFORD JA, 1994, AM J RESP CELL MOL, V11, P426, DOI 10.1165/ajrcmb.11.4.7522485; Borges VM, 2001, J EXP MED, V194, P155, DOI 10.1084/jem.194.2.155; BRAMBILLA C, 1979, AM J PATHOL, V96, P149; BROWN GM, 1989, TOXICOL APPL PHARM, V101, P95, DOI 10.1016/0041-008X(89)90215-9; Castranova V, 2000, ENVIRON HEALTH PERSP, V108, P675, DOI 10.2307/3454404; Castranova V, 2000, INHAL TOXICOL, V12, P7, DOI 10.1080/08958378.2000.11463226; Castranova V., 1996, APPL OCCUP ENVIRON H, V11, P937, DOI [10.1080/1047322X.1996.10389993, DOI 10.1080/1047322X.1996.10389993]; Charalambous S, 2001, INT J TUBERC LUNG D, V5, P1044; Corbett EL, 2000, AIDS, V14, P2759, DOI 10.1097/00002030-200012010-00016; Corner LAL, 2011, J COMP PATHOL, V144, P1, DOI 10.1016/j.jcpa.2010.10.003; Corner LAL, 2012, VET J, V194, P166, DOI 10.1016/j.tvjl.2012.03.013; COWIE RL, 1994, AM J RESP CRIT CARE, V150, P1460, DOI 10.1164/ajrccm.150.5.7952577; Cox-Ganser JM, 2009, J OCCUP ENVIRON MED, V51, P164, DOI 10.1097/JOM.0b013e31818f6a0f; Day MJ, 1996, VET PATHOL, V33, P29, DOI 10.1177/030098589603300104; Domingo-Neumann R, 2009, PORTL GSA ANN M PORT; Environmental Protection Agency, IR SOIL INF SYST 201; GALLAGHER J, 1976, VET REC, V98, P9, DOI 10.1136/vr.98.1.9; Gilberti RM, 2008, AM J RESP CELL MOL, V39, P619, DOI 10.1165/rcmb.2008-0046OC; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Greenberg MI, 2007, DM-DIS MON, V53, P394, DOI 10.1016/j.disamonth.2007.09.020; Hamilton RF, 2008, FREE RADICAL BIO MED, V44, P1246, DOI 10.1016/j.freeradbiomed.2007.12.027; Hammond RF, 2001, PREV VET MED, V51, P137, DOI 10.1016/S0167-5877(01)00230-6; HIGGINS DA, 1985, INFECT IMMUN, V48, P252, DOI 10.1128/IAI.48.1.252-256.1985; Hnizdo E, 1998, OCCUP ENVIRON MED, V55, P496, DOI 10.1136/oem.55.7.496; HUERGO DG, 1991, REV ESP ENFERM DIG, V80, P95; Joshi GN, 2013, APOPTOSIS, V18, P271, DOI 10.1007/s10495-012-0798-y; Kuehn BM, 2006, JAMA-J AM MED ASSOC, V295, P2463, DOI 10.1001/jama.295.21.2463; LANGLOIS SLP, 1977, AUSTRALAS RADIOL, V21, P143, DOI 10.1111/j.1440-1673.1977.tb03185.x; Liebich H.-G, 2014, VET ANATOMY DOMESTIC; Martin Larranaga N, 2004, An Med Interna, V21, P187; McCarthy G, 2009, VET CLIN PATH, V38, P381, DOI 10.1111/j.1939-165X.2009.00127.x; MCDONALD JW, 1995, ARCH PATHOL LAB MED, V119, P242; Messmer UK, 1996, BIOCHEM J, V319, P299, DOI 10.1042/bj3190299; Morman SA, 2013, AEOLIAN RES, V9, P203, DOI 10.1016/j.aeolia.2012.12.001; Porter DW, 2002, TOXICOLOGY, V175, P63, DOI 10.1016/S0300-483X(02)00061-6; Rimal B, 2005, CURR OPIN PULM MED, V11, P169, DOI 10.1097/01.mcp.0000152998.11335.24; ROPERTO F, 1995, J COMP PATHOL, V112, P97, DOI 10.1016/S0021-9975(05)80092-1; Schenker MB, 2009, ENVIRON HEALTH PERSP, V117, P988, DOI 10.1289/ehp.0800144; Schwartz L W, 1981, Chest, V80, P82; SLAVIN RE, 1985, HUM PATHOL, V16, P393, DOI 10.1016/S0046-8177(85)80233-1; Smal C, 1995, BADGER HABITAT SURVE; SMITH BL, 1973, VET PATHOL, V10, P94, DOI 10.1177/030098587301000202; Stafoggia M, 2016, ENVIRON HEALTH PERSP, V124, P413, DOI 10.1289/ehp.1409164; Suedmeyer WK, 1999, J ZOO WILDLIFE MED, V30, P564; teWaterNaude JM, 2006, OCCUP ENVIRON MED, V63, P187, DOI 10.1136/oem.2004.018614; Tripathi S., 2011, J APP PHARM SCI, V1, P1; VALLYATHAN V, 1995, AM J RESP CRIT CARE, V152, P1003, DOI 10.1164/ajrccm.152.3.7663775; VALLYATHAN V, 1988, AM REV RESPIR DIS, V138, P1213, DOI 10.1164/ajrccm/138.5.1213; Wong T W, 1998, Respirology, V3, P281	52	3	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190230	10.1371/journal.pone.0190230	http://dx.doi.org/10.1371/journal.pone.0190230			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342164	Green Published, gold, Green Submitted			2022-12-26	WOS:000422653800015
J	Hsia, HP; Yang, YH; Szeto, WC; Nilsson, BE; Lo, CY; Ng, AKL; Fodor, E; Shaw, PC				Hsia, Ho-Pan; Yang, Yin-Hua; Szeto, Wun-Chung; Nilsson, Benjamin E.; Lo, Chun-Yeung; Ng, Andy Ka-Leung; Fodor, Ervin; Shaw, Pang-Chui			Amino acid substitutions affecting aspartic acid 605 and valine 606 decrease the interaction strength between the influenza virus RNA polymerase PB2 '627' domain and the viral nucleoprotein	PLOS ONE			English	Article							STRUCTURAL INSIGHT; A VIRUSES; PROTEIN; REPLICATION; BINDING; IDENTIFICATION; MECHANISMS; ABSENCE	The influenza virus RNA genome is transcribed and replicated in the context of the viral ribonucleoprotein (vRNP) complex by the viral RNA polymerase. The nucleoprotein (NP) is the structural component of the vRNP providing a scaffold for the viral RNA. In the vRNP as well as during transcription and replication the viral polymerase interacts with NP but it is unclear which parts of the polymerase and NP mediate these interactions. Previously the C-terminal '627' domain (amino acids 538-693) of PB2 was shown to interact with NP. Here we report that a fragment encompassing amino acids 146-185 of NP is sufficient to mediate this interaction. Using NMR chemical shift perturbation assays we show that amino acid region 601 to 607 of the PB2 '627' domain interacts with this fragment of NP. Substitutions of these PB2 amino acids resulted in diminished RNP activity and surface plasmon resonance assays showed that amino acids D605 was essential for the interaction with NP and V606 may also play a partial role in the interaction. Collectively these results reveal a possible interaction surface between NP and the PB2 subunit of the RNA polymerase complex.	[Hsia, Ho-Pan; Yang, Yin-Hua; Szeto, Wun-Chung; Lo, Chun-Yeung; Ng, Andy Ka-Leung; Shaw, Pang-Chui] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China; [Nilsson, Benjamin E.; Fodor, Ervin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England	Chinese University of Hong Kong; University of Oxford	Shaw, PC (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Shatin, Hong Kong, Peoples R China.	pcshaw@cuhk.edu.hk	Nilsson-Payant, Benjamin/AAQ-5302-2020	Nilsson-Payant, Benjamin/0000-0003-2661-7837; Fodor, Ervin/0000-0003-3249-196X; Shaw, Pang-Chui/0000-0001-6848-5073	Research Grants Council of Hong Kong SAR [473111, T11-705/14N]; Area of Excellent Scheme of the University Grants Committee of HKSAR [AoE/M-12/06]; Medical Research Council (MRC) program grant [MR/K000241/1]; Wellcome Trust studentship [102053/Z/13/Z]; Medical Research Council [MR/K000241/1] Funding Source: researchfish; MRC [MR/K000241/1] Funding Source: UKRI	Research Grants Council of Hong Kong SAR(Hong Kong Research Grants Council); Area of Excellent Scheme of the University Grants Committee of HKSAR; Medical Research Council (MRC) program grant; Wellcome Trust studentship(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant (Project number: 473111) from the Research Grants Council of Hong Kong SAR, in part from the Area of Excellent Scheme of the University Grants Committee of HKSAR (Grant AoE/M-12/06) on the Control of Pandemic and Inter-Pandemic Influenza and Theme-based Research from the Research Grants Council of Hong Kong SAR (T11-705/14N) to PC. S., Medical Research Council (MRC) program grant MR/K000241/1 to E.F. and Wellcome Trust studentship 102053/Z/13/Z to B.E. N. http://www.ugc.edu.hk/eng/rgc/; https://wellcome.ac.uk/; https://www.mrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arranz R, 2012, SCIENCE, V338, P1634, DOI 10.1126/science.1228172; BEATON AR, 1986, P NATL ACAD SCI USA, V83, P6282, DOI 10.1073/pnas.83.17.6282; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Cauldwell AV, 2013, J VIROL, V87, P1278, DOI 10.1128/JVI.02597-12; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Goddard TD, 1993, SPARKY 3; Hengrung N, 2015, NATURE, V527, P114, DOI 10.1038/nature15525; Hutchinson EC, 2012, PLOS PATHOG, V8; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Li OTW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005658; Moeller A, 2012, SCIENCE, V338, P1631, DOI 10.1126/science.1227270; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Ng AKL, 2012, PLOS ONE, V7; Ng AKL, 2008, FASEB J, V22, P3638, DOI 10.1096/fj.08-112110; Nilsson BE, 2017, J VIROL, V91, DOI [10.1128/JVI.02467-16, 10.1128/JVI.00523-17]; PALESE P, 1977, CELL, V10, P1, DOI 10.1016/0092-8674(77)90133-7; Paterson D, 2014, J VIROL, V88, P339, DOI 10.1128/JVI.02022-13; Pflug A., 2017, VIRUS RES; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; SHAPIRO GI, 1988, J VIROL, V62, P2285, DOI 10.1128/JVI.62.7.2285-2290.1988; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; te Velthuis AJW, 2016, NAT REV MICROBIOL, V14, P479, DOI 10.1038/nrmicro.2016.87; Turrell L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2589; Vasin AV, 2014, VIRUS RES, V185, P53, DOI 10.1016/j.virusres.2014.03.015; Vidic J, 2016, BIOCHEMISTRY-US, V55, P4259, DOI 10.1021/acs.biochem.6b00514; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004; York A, 2013, P NATL ACAD SCI USA, V110, pE4238, DOI 10.1073/pnas.1315068110	33	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191226	10.1371/journal.pone.0191226	http://dx.doi.org/10.1371/journal.pone.0191226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338047	Green Submitted, Green Published, gold			2022-12-26	WOS:000422652700041
J	ArchMiller, AA; Dorazio, RM; St Clair, K; Fieberg, JR				ArchMiller, Althea A.; Dorazio, Robert M.; St Clair, Katherine; Fieberg, John R.			Time series sightability modeling of animal populations	PLOS ONE			English	Article							ABUNDANCE; BIAS	Logistic regression models-or "sightability models"-fit to detection/non-detection data from marked individuals are often used to adjust for visibility bias in later detection-only surveys, with population abundance estimated using a modified Horvitz-Thompson (mHT) estimator. More recently, a model-based alternative for analyzing combined detection/non-detection and detection-only data was developed. This approach seemed promising, since it resulted in similar estimates as the mHT when applied to data from moose (Alces alces) surveys in Minnesota. More importantly, it provided a framework for developing flexible models for analyzing multiyear detection-only survey data in combination with detection/non-detection data. During initial attempts to extend the model-based approach to multiple years of detection-only data, we found that estimates of detection probabilities and population abundance were sensitive to the amount of detection-only data included in the combined (detection/non-detection and detection-only) analysis. Subsequently, we developed a robust hierarchical modeling approach where sightability model parameters are informed only by the detection/non-detection data, and we used this approach to fit a fixed-effects model (FE model) with year-specific parameters and a temporally-smoothed model (TS model) that shares information across years via random effects and a temporal spline. The abundance estimates from the TS model were more precise, with decreased interannual variability relative to the FE model and mHT abundance estimates, illustrating the potential benefits from model-based approaches that allow information to be shared across years.	[ArchMiller, Althea A.; Fieberg, John R.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Dorazio, Robert M.] US Geol Survey, Wetland & Aquat Res Ctr, Gainesville, FL USA; [St Clair, Katherine] Carleton Coll, Dept Math & Stat, Northfield, MN 55057 USA; [ArchMiller, Althea A.] Concordia Coll, Dept Biol, Moorhead, MN 56562 USA	University of Minnesota System; University of Minnesota Twin Cities; United States Department of the Interior; United States Geological Survey; Carleton College	ArchMiller, AA (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.; ArchMiller, AA (corresponding author), Concordia Coll, Dept Biol, Moorhead, MN 56562 USA.	althea.archmiller@gmail.com	Archer, Althea/AAV-9801-2020; Fieberg, John/Y-3988-2019	Fieberg, John/0000-0002-3180-7021; Archer, Althea/0000-0003-1927-0783	Minnesota Department of Natural Resources (Game Fish Fund); federal Wildlife Restoration (Pittman-Robertson) Program; Minnesota Department of Natural Resources; Minnesota Agricultural Experimental Station	Minnesota Department of Natural Resources (Game Fish Fund); federal Wildlife Restoration (Pittman-Robertson) Program; Minnesota Department of Natural Resources; Minnesota Agricultural Experimental Station	This project was funded in part by the Minnesota Department of Natural Resources (Game & Fish Fund) and federal Wildlife Restoration (Pittman-Robertson) Program (https://wsfrprograms.fws.gov/subpages/grantprograms/wr/wr.htm) to Althea A. ArchMiller. The Minnesota Department of Natural Resources provided funding and field support for the sightability trials and operational surveys. JF received partial support from the Minnesota Agricultural Experimental Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CR, 1996, WILDLIFE SOC B, V24, P247; Anderson CR, 1998, J WILDLIFE MANAGE, V62, P1055, DOI 10.2307/3802558; Buckland ST, 2015, METH STAT ECOL, P1, DOI 10.1007/978-3-319-19219-2; Chandler RB, 2013, ANN APPL STAT, V7, P936, DOI 10.1214/12-AOAS610; Cogan RD, 1998, J WILDLIFE MANAGE, V62, P269, DOI 10.2307/3802288; Conroy MJ, 2014, J WILDLIFE MANAGE, V78, P904, DOI 10.1002/jwmg.731; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; Davis AJ, 2016, ECOL APPL, V26, P2339, DOI 10.1002/eap.1383; DelGiudice GD., 2014, AERIAL MOOSE SURVEY; Dorazio RM, 2014, GLOBAL ECOL BIOGEOGR, V23, P1472, DOI 10.1111/geb.12216; Fieberg J, 2008, J WILDLIFE MANAGE, V72, P837, DOI 10.2193/2007-329; Fieberg J, 2013, METHODS ECOL EVOL, V4, DOI 10.1111/2041-210X.12078; Fieberg JR, 2012, J STAT SOFTW, V51, P1; Fieberg John R., 2012, Alces, V48, P79; GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776; Giudice JH, 2012, J WILDLIFE MANAGE, V76, P75, DOI 10.1002/jwmg.213; Givens GH, 2015, ENVIRONMETRICS, P1; Harris Richard B., 2015, Alces, V51, P57; Jenkins KJ, 2016, MOUNTAIN GOAT ABUNDA; Kery M, 2015, APPL HIERARCHICAL MO, V1; Lele SR, 2007, ECOL LETT, V10, P551, DOI 10.1111/j.1461-0248.2007.01047.x; Lenarz MS, 1998, ALCES-N AM MOOSE CON, V34, P117; Michaud JS, 2014, REMOTE SENS ENVIRON, V152, P190, DOI 10.1016/j.rse.2014.06.005; Peters WEB, 2010, RESOURCE SELECTION A; R Development Core Team, 2014, R LANG ENV STAT COMP; Rice CG, 2009, J WILDLIFE MANAGE, V73, P468, DOI 10.2193/2008-196; Royle JA, 2007, ECOLOGY, V88, P1813, DOI 10.1890/06-0669.1; Royle JA, 2007, J COMPUT GRAPH STAT, V16, P67, DOI 10.1198/106186007X181425; Royle J. Andrew, 2012, Journal of Ornithology, V152, pS521, DOI 10.1007/s10336-010-0619-4; Sollmann R, 2015, ECOLOGY, V96, P325, DOI 10.1890/14-1625.1; STEINHORST RK, 1989, BIOMETRICS, V45, P415, DOI 10.2307/2531486	31	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190706	10.1371/journal.pone.0190706	http://dx.doi.org/10.1371/journal.pone.0190706			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329309	Green Published, Green Submitted, gold			2022-12-26	WOS:000419954100019
J	Baille, G; Perez, T; Devos, D; Deken, V; Defebvre, L; Moreau, C				Baille, Guillaume; Perez, Thierry; Devos, David; Deken, Valerie; Defebvre, Luc; Moreau, Caroline			Early occurrence of inspiratory muscle weakness in Parkinson's disease	PLOS ONE			English	Article							PULMONARY DYSFUNCTIONS; LEVODOPA; STRENGTH; PROGRESSION; SCALE; ONSET; MILD	Introduction In Parkinson's disease (PD), respiratory insufficiency (including functional and muscle disorders) can impact dysarthria and swallowing. Most studies of this topic have been performed retrospectively in populations of patients with advanced PD. The objective of the present study was to characterize lung function (under off-drug conditions) in early-stage PD patients at baseline and then again two years later. Methods Forty-one early-stage PD patients (mean +/- SD age: 61.7 +/- 7.7; mean +/- SD disease duration: 1.9 +/- 1.7 years) were prospectively enrolled and compared with 36 age-matched healthy controls. Neurological evaluations and pulmonary function testing were performed in the off-drug condition at the inclusion visit and then two years later. Results Pulmonary function testing did not reveal any restrictive or obstructive disorders; at baseline, inspiratory muscle weakness was the only abnormality observed in the PD group (in 53.7% of the patients, vs. 25% in controls; p = 0.0105). The PD patients had a lower mean maximal inspiratory mouth pressure than controls and a lower sniff nasal inspiratory pressure. Two years after the initiation of chronic treatment with antiparkinsonian medications, the maximal inspiratory mouth pressure and the sniff nasal inspiratory pressure tended to be higher. Lastly, overall motor outcomes were not significantly worse in patients with inspiratory muscle weakness than in patients without inspiratory muscle weakness. Conclusion Inspiratory muscle weakness seems to be common in patients with early-stage PD, and was seen to be stable over a two-year period. Additional long-term follow-up studies are required to specify the impact of this new feature of PD.	[Baille, Guillaume; Devos, David; Defebvre, Luc; Moreau, Caroline] Lille Univ, Med Ctr, Dept Neurol & Movement Disorders, Lille, France; [Baille, Guillaume; Perez, Thierry; Devos, David; Defebvre, Luc; Moreau, Caroline] Univ Lille, INSERM, UMR 1171, Lille, France; [Perez, Thierry] Lille Univ, Med Ctr, Lung Funct Dept, Lille, France; [Devos, David] Lille Univ, Med Ctr, Dept Med Pharmacol, Lille, France; [Deken, Valerie] Lille Univ, Med Ctr, Dept Biostat, Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Moreau, C (corresponding author), Lille Univ, Med Ctr, Dept Neurol & Movement Disorders, Lille, France.; Moreau, C (corresponding author), Univ Lille, INSERM, UMR 1171, Lille, France.	caroline.moreau@chru-lille.fr	Thierry, PEREZ/AAB-4853-2020; Devos, David/E-4059-2013	Devos, David/0000-0002-2417-799X	French Association France Parkinson in 2011	French Association France Parkinson in 2011	This study was founded by the French Association France Parkinson in 2011. Caroline MOREAU is scientific advisor for Abbvie, Medtronics et Bial. David Devos is scientific advisor for Orkyn, Aguettant, Apopharma. Luc Defebvre is scientific advisor for Abbvie, Zambon, Aguettant. Thierry perez, Valerie DEKEN and Guillaume Bailie have nothing to disclose.	AUBIER M, 1989, ANN INTERN MED, V110, P17, DOI 10.7326/0003-4819-110-1-17; BATEMAN DN, 1981, BRIT MED J, V283, P190, DOI 10.1136/bmj.283.6285.190-a; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; BOGAARD JM, 1989, AM REV RESPIR DIS, V139, P610, DOI 10.1164/ajrccm/139.3.610; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cardoso SRX, 2002, ARQ NEURO-PSIQUIAT, V60, P91, DOI 10.1590/S0004-282X2002000100016; De Pandis MF, 2002, NEUROL SCI, V23, pS69, DOI 10.1007/s100720200074; DEBRUIN PFC, 1993, AM REV RESPIR DIS, V148, P1576, DOI 10.1164/ajrccm/148.6_Pt_1.1576; ENRIGHT PL, 1994, AM J RESP CRIT CARE, V149, P430, DOI 10.1164/ajrccm.149.2.8306041; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujii Y, 2006, CURR THER RES CLIN E, V67, P204, DOI 10.1016/j.curtheres.2006.06.003; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Guedes LU, 2012, ARQ NEURO-PSIQUIAT, V70, P847, DOI 10.1590/S0004-282X2012001100005; Haas BM, 2004, AM J PHYS MED REHAB, V83, P601, DOI 10.1097/01.PHM.0000133436.61009.02; Hammer MJ, 2013, J PARKINSON DIS, V3, P173, DOI 10.3233/JPD-130180; Harrison MB, 2009, MOVEMENT DISORD, V24, P224, DOI 10.1002/mds.22335; Herer B, 2001, CHEST, V119, P387, DOI 10.1378/chest.119.2.387; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; IZQUIERDOALONSO JL, 1994, LUNG, V172, P47; Kazemi H, 2002, ENCY HUMAN BRAIN, V4, P209; Kim SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081808; MARTINEZMARTIN P, 1994, MOVEMENT DISORD, V9, P76, DOI 10.1002/mds.870090112; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; OBENOUR WH, 1972, AM REV RESPIR DIS, V105, P382; Pal PK, 2007, MOVEMENT DISORD, V22, P420, DOI 10.1002/mds.21330; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Reinoso G, 2015, EUR J NEUROL, V22, P457, DOI 10.1111/ene.12476; Rice JE, 2002, MOVEMENT DISORD, V17, P524, DOI 10.1002/mds.10072; Sabate M, 1996, J NEUROL SCI, V138, P114, DOI 10.1016/0022-510X(96)00003-2; Sathyaprabha T N, 2005, Indian J Chest Dis Allied Sci, V47, P251; Shiota S, 2013, J ALZHEIMERS DIS, V37, P325, DOI 10.3233/JAD-130419; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Troche MS, 2011, DYSPHAGIA, V26, P218, DOI 10.1007/s00455-010-9289-x; Uc EY, 2009, NEUROLOGY, V73, P1469, DOI 10.1212/WNL.0b013e3181bf992f; ULDRY C, 1995, THORAX, V50, P371, DOI 10.1136/thx.50.4.371; VINCKEN WG, 1984, NEW ENGL J MED, V311, P438, DOI 10.1056/NEJM198408163110704; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005	37	33	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190400	10.1371/journal.pone.0190400	http://dx.doi.org/10.1371/journal.pone.0190400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329328	Green Submitted, Green Published, gold			2022-12-26	WOS:000419954100014
J	Burgess, KB; Guerrero, M; Marshall, AD; Richardson, AJ; Bennett, MB; Couturier, LIE				Burgess, Katherine B.; Guerrero, Michel; Marshall, Andrea D.; Richardson, Anthony J.; Bennett, Mike B.; Couturier, Lydie I. E.			Novel signature fatty acid profile of the giant manta ray suggests reliance on an uncharacterised mesopelagic food source low in polyunsaturated fatty acids	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; LIPID-COMPOSITION; STABLE-ISOTOPE; BIROSTRIS; SHARKS; PREDATOR; ECOLOGY; BLUBBER; WHALES; CHONDRICHTHYES	Traditionally, large planktivorous elasmobranchs have been thought to predominantly feed on surface zooplankton during daytime hours. However, the recent application of molecular methods to examine long-term assimilated diets, has revealed that these species likely gain the majority from deeper or demersal sources. Signature fatty acid analysis (FA) of muscle tissue was used to examine the assimilated diet of the giant manta ray Mobula birostris, and then compared with surface zooplankton that was collected during feeding and non-feeding events at two aggregation sites off mainland Ecuador. The FA profiles of M. birostris and surface zooplankton were markedly different apart from similar proportions of arachidonic acid, which suggests daytime surface zooplankton may comprise a small amount of dietary intake for M. birostris. The FA profile of M. birostris muscle was found to be depleted in polyunsaturated fatty acids, and instead comprised high proportions of 18:1 omega 9 isomers. While 18:1 omega 9 isomers are not explicitly considered dietary FAs, they are commonly found in high proportions in deep-sea organisms, including elasmobranch species. Overall, the FA profile of M. birostris suggests a diet that is mesopelagic in origin, but many mesopelagic zooplankton species also vertically migrate, staying deep during the day and moving to shallower waters at night. Here, signature FA analysis is unable to resolve the depth at which these putative dietary items were consumed and how availability of this prey may drive distribution and movements of this large filter-feeder.	[Burgess, Katherine B.; Bennett, Mike B.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Burgess, Katherine B.; Marshall, Andrea D.] Marine Megafauna Fdn, Truckee, CA 96161 USA; [Burgess, Katherine B.; Richardson, Anthony J.] CSIRO Oceans & Atmosphere Flagship, EcoSci Precinct, Dutton Pk, Qld, Australia; [Guerrero, Michel] Fdn Megafauna Marina Ecuador, Proyecto Mantas Ecuador, Quito, Ecuador; [Richardson, Anthony J.] Univ Queensland, Ctr Applicat Nat Resource Math, St Lucia, Qld, Australia; [Couturier, Lydie I. E.] Univ Bretagne Occidentale, UMR LEMAR IRD UBO CNRS Ifremer 6539, Lab Sci Environm Marin, IUEM, Rue Dumont Urville, Plouzane, France	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Burgess, KB (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.; Burgess, KB (corresponding author), Marine Megafauna Fdn, Truckee, CA 96161 USA.; Burgess, KB (corresponding author), CSIRO Oceans & Atmosphere Flagship, EcoSci Precinct, Dutton Pk, Qld, Australia.	k.burgess@uq.edu.au	Couturier, Lydie I. E./J-9695-2014; Bennett, Michael/A-7218-2012; Couturier, Lydie/I-9793-2019; Richardson, Anthony J/B-3649-2010; Bennett, Michael/L-4483-2019	Couturier, Lydie I. E./0000-0002-3885-3397; Couturier, Lydie/0000-0002-3885-3397; Richardson, Anthony J/0000-0002-9289-7366; Bennett, Michael/0000-0001-8051-0040; Burgess, Katherine/0000-0002-5793-9823				Armstrong AO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153393; Arts MT, 2001, CAN J FISH AQUAT SCI, V58, P122, DOI 10.1139/cjfas-58-1-122; BAKES MJ, 1995, COMP BIOCHEM PHYS B, V110, P267, DOI 10.1016/0305-0491(94)00083-7; Bakun A, 2003, FISH OCEANOGR, V12, P458, DOI 10.1046/j.1365-2419.2003.00258.x; BENAMOTZ A, 1985, J PHYCOL, V21, P72; Bennett MB, 2016, MAR FRESHW RES; Bertrand A, 2004, FISH FISH, V5, P296, DOI 10.1111/j.1467-2679.2004.00165.x; BOLLENS SM, 1992, HYDROBIOLOGIA, V234, P33, DOI 10.1007/BF00010777; Braun CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088170; Budge SM, 2008, J EXP MAR BIOL ECOL, V359, P40, DOI 10.1016/j.jembe.2008.02.014; Burgess KB, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160717; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; Cass CJ, 2011, MAR ECOL PROG SER, V439, P127, DOI 10.3354/meps09324; COHEN Z, 1988, J PHYCOL, V24, P328, DOI 10.1111/j.1529-8817.1988.tb04474.x; Colombo SM, 2016, ENVIRON REV, V999, P1; Coutteau Peter, 1995, ICES Cooperative Research Report, V211, P1; Couturier LIE, 2013, LIPIDS, V48, P1029, DOI 10.1007/s11745-013-3829-8; Couturier LIE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077152; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Dale JJ, 2011, MAR ECOL PROG SER, V433, P221, DOI 10.3354/meps09171; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Del Raye G, 2015, DEEP-SEA RES PT II, V113, P280, DOI 10.1016/j.dsr2.2015.01.014; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; DOLPHIN WF, 1987, EXPERIENTIA, V43, P468, DOI 10.1007/BF01940459; Duffy CAJ, 2003, NEW ZEAL J MAR FRESH, V37, P715, DOI 10.1080/00288330.2003.9517201; Dulvy NK, 2014, PEERJ, V2, DOI 10.7717/peerj.400; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gadig OBF, 2003, J MAR BIOL ASSOC UK, V83, P869, DOI 10.1017/S0025315403007914h; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hays GC, 2003, HYDROBIOLOGIA, V503, P163, DOI 10.1023/B:HYDR.0000008476.23617.b0; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Hearn AR, 2014, SOC ECOL INTERACT GA, P23, DOI 10.1007/978-3-319-02769-2_2; Henderson RJ, 1998, POLAR BIOL, V20, P48, DOI 10.1007/s003000050275; Herman DP, 2005, MAR ECOL PROG SER, V302, P275, DOI 10.3354/meps302275; Hixson SM, 2014, FOOD CHEM, V157, P51, DOI 10.1016/j.foodchem.2014.02.026; Irigoien X, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4271; Iverson SJ, 2004, ECOL MONOGR, V74, P211, DOI 10.1890/02-4105; Jaine FRA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046170; Jarman SN, 2004, J FISH BIOL, V65, P586, DOI 10.1111/j.0022-1112.2004.00466.x; KOVEN WM, 1990, AQUACULTURE, V91, P131, DOI 10.1016/0044-8486(90)90182-M; Lee RF, 2006, MAR ECOL PROG SER, V307, P273, DOI 10.3354/meps307273; LEWIS RW, 1967, J FISH RES BOARD CAN, V24, P1101, DOI 10.1139/f67-093; Litzow MA, 2006, MAR ECOL PROG SER, V315, P1, DOI 10.3354/meps315001; Luiz OJ, 2009, ICHTHYOL RES, V56, P96, DOI 10.1007/s10228-008-0060-3; MacNeil MA, 2006, CAN J FISH AQUAT SCI, V63, P345, DOI 10.1139/F05-219; Malpica-Cruz L, 2012, CAN J FISH AQUAT SCI, V69, P551, DOI 10.1139/F2011-172; Marcus L, 2016, MAR ECOL PROG SER, V554, P115, DOI 10.3354/meps11807; Marshall AD, 2010, J FISH BIOL, V77, P169, DOI 10.1111/j.1095-8649.2010.02669.x; Marshall AD, MANTA BIROSTRIS; Mauchline J, 1969, Adv. mar. Biol., V7, P1; McMeans BC, 2012, J EXP MAR BIOL ECOL, V429, P55, DOI 10.1016/j.jembe.2012.06.017; NOTARBARTOLODISCIARA G, 1988, FISH B-NOAA, V86, P45; O'Malley MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065051; Parrish CC, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P309, DOI 10.1007/978-0-387-89366-2_13; Pethybridge H, 2011, J EXP MAR BIOL ECOL, V409, P290, DOI 10.1016/j.jembe.2011.09.009; Pethybridge H, 2010, MAR BIOL, V157, P1367, DOI 10.1007/s00227-010-1416-6; Pethybridge HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097877; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Pohl P., 1979, MARINE ALGAE PHARM S, P473; Pond DW, 2008, DEEP-SEA RES PT I, V55, P1718, DOI 10.1016/j.dsr.2008.07.006; Remme JF, 2006, COMP BIOCHEM PHYS B, V143, P459, DOI 10.1016/j.cbpb.2005.12.018; Rohner CA, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.161060; Rohner CA, 2013, MAR ECOL PROG SER, V493, P219, DOI 10.3354/meps10500; Ruchonnet D, 2006, MAR ECOL PROG SER, V311, P165, DOI 10.3354/meps311165; Sargent J, 1999, AQUACULTURE, V177, P191, DOI 10.1016/S0044-8486(99)00083-6; Sawamoto Shozo, 2012, Plankton & Benthos Research, V7, P203; Schreck C.B., 2016, BIOL STRESS FISH; STARESINIC N, 1978, LIMNOL OCEANOGR, V23, P559, DOI 10.4319/lo.1978.23.3.0559; Stevens CJ, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2934-7; Stewart JD, 2016, ZOOLOGY, V119, P406, DOI 10.1016/j.zool.2016.05.010; Stewart JD, 2016, BIOL CONSERV, V200, P178, DOI 10.1016/j.biocon.2016.05.016; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Thorrold SR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5274; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Wakeham S.G., 1983, ADV ORGANIC GEOCHEMI, P185; Watanabe H, 1999, FISH OCEANOGR, V8, P115, DOI 10.1046/j.1365-2419.1999.00103.x; Werbrouck E, 2016, J SEA RES, V112, P41, DOI 10.1016/j.seares.2016.03.001; White WT, 2017, ZOOL J LINN SOC-LOND; Wilson SE, 2010, DEEP-SEA RES PT I, V57, P1278, DOI 10.1016/j.dsr.2010.07.005; Young JW, 2010, PROG OCEANOGR, V86, P139, DOI 10.1016/j.pocean.2010.04.028	80	4	4	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0186464	10.1371/journal.pone.0186464	http://dx.doi.org/10.1371/journal.pone.0186464			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329295	Green Submitted, Green Published, gold			2022-12-26	WOS:000419954100003
J	Tian, XF; Li, CL; Zhang, M; Wan, YS; Xie, ZH; Chen, BC; Li, WQ				Tian, Xiaofei; Li, Chengliang; Zhang, Min; Wan, Yongshan; Xie, Zhihua; Chen, Baocheng; Li, Wenqing			Biochar derived from corn straw affected availability and distribution of soil nutrients and cotton yield	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; ORGANIC-CARBON; MAIZE YIELD; CROP YIELDS; RICE PADDY; QUALITY; FERTILIZER; FEEDSTOCKS; AMENDMENT; SORPTION	Biochar application as a soil amendment has been proposed as a strategy to improve soil fertility and increase crop yields. However, the effects of successive biochar applications on cotton yields and nutrient distribution in soil are not well documented. A three-year field study was conducted to investigate the effects of successive biochar applications at different rates on cotton yield and on the soil nutrient distribution in the 0-100 cm soil profile. Biochar was applied at 0, 5, 10, and 20 t ha(-1) (expressed as Control, BC5, BC10, and BC20, respectively) for each cotton season, with identical doses of chemical fertilizers. Biochar enhanced the cotton lint yield by 8.0-15.8%, 9.3-13.9%, and 9.2-21.9% in 2013, 2014, and 2015, respectively, and high levels of biochar application achieved high cotton yields each year. Leaching of soil nitrate was reduced, while the pH values, soil organic carbon, total nitrogen (N), and available K content of the 0-20 cm soil layer were increased in 2014 and 2015. However, the changes in the soil available P content were less substantial. This study suggests that successive biochar amendments have the potential to enhance cotton productivity and soil fertility while reducing nitrate leaching.	[Tian, Xiaofei; Li, Chengliang; Zhang, Min; Chen, Baocheng; Li, Wenqing] Shandong Agr Univ, Coll Resources & Environm, Natl Engn Technol Res Ctr Slow & Controlled Releas, Natl Engn Lab Efficient Utilizat Soil & Fertilizer, Tai An, Shandong, Peoples R China; [Wan, Yongshan] Univ Florida, Ctr Trop Res & Educ, Soil & Water Sci Dept, Homestead, FL 33031 USA; [Xie, Zhihua] Jining Acad Agr Sci, Jining, Shandong, Peoples R China	Shandong Agricultural University; State University System of Florida; University of Florida	Li, CL; Zhang, M (corresponding author), Shandong Agr Univ, Coll Resources & Environm, Natl Engn Technol Res Ctr Slow & Controlled Releas, Natl Engn Lab Efficient Utilizat Soil & Fertilizer, Tai An, Shandong, Peoples R China.	chengliang_li11@163.com; minzhang-2002@163.com	Tian, Xiaofei/ABB-2884-2021		National Key Research and Development Program of China [2017YFD0201901, 2017YFD0200706]; Natural Science Foundation of China [41571236, 21377074]	National Key Research and Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by the National Key Research and Development Program of China (2017YFD0201901 and 2017YFD0200706) and the Natural Science Foundation of China (Grant no. 41571236 and 21377074).	Agegnehu G, 2016, SCI TOTAL ENVIRON, V543, P295, DOI 10.1016/j.scitotenv.2015.11.054; Ali MA, 2015, SCI TOTAL ENVIRON, V529, P140, DOI 10.1016/j.scitotenv.2015.04.090; Alburquerque JA, 2014, J PLANT NUTR SOIL SC, V177, P16, DOI 10.1002/jpln.201200652; Burke J.M., 2014, INT J PLANT SOIL SCI, V3, P995; Butnan S, 2015, GEODERMA, V237, P105, DOI 10.1016/j.geoderma.2014.08.010; Cameron KC, 2013, ANN APPL BIOL, V162, P145, DOI 10.1111/aab.12014; Chaudhary S, 2017, SOIL TILL RES, V166, P59, DOI 10.1016/j.still.2016.10.005; Chen Y, 2016, FIELD CROP RES, V192, P126, DOI 10.1016/j.fcr.2016.04.025; Dempster DN, 2012, PLANT SOIL, V354, P311, DOI 10.1007/s11104-011-1067-5; Dong XL, 2016, J SOIL SEDIMENT, V16, P1481, DOI 10.1007/s11368-015-1338-5; Gai XP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113888, 10.1371/journal.pone.0097730]; Gaskin JW, 2010, AGRON J, V102, P623, DOI 10.2134/agronj2009.0083; Geng JB, 2015, FIELD CROP RES, V184, P65, DOI 10.1016/j.fcr.2015.09.003; Han FP, 2016, CATENA, V137, P554, DOI 10.1016/j.catena.2015.11.002; Jones DL, 2012, SOIL BIOL BIOCHEM, V45, P113, DOI 10.1016/j.soilbio.2011.10.012; Kanthle AK, 2016, SOIL TILL RES, V157, P65, DOI 10.1016/j.still.2015.11.009; Karhu K, 2011, AGR ECOSYST ENVIRON, V140, P309, DOI 10.1016/j.agee.2010.12.005; Kloss S, 2012, J ENVIRON QUAL, V41, P990, DOI 10.2134/jeq2011.0070; Laird DA, 2017, GEODERMA, V289, P46, DOI 10.1016/j.geoderma.2016.11.025; Lehmann J, 2003, PLANT SOIL, V249, P343, DOI 10.1023/A:1022833116184; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; [李琦 Li Qi], 2014, [农业环境科学学报, Journal of Agro-Environment Science], V33, P1987; [廖娜 Liao Na], 2015, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V21, P782; Liu XY, 2013, PLANT SOIL, V373, P583, DOI 10.1007/s11104-013-1806-x; Major J, 2012, J ENVIRON QUAL, V41, P1076, DOI 10.2134/jeq2011.0128; Major J, 2010, PLANT SOIL, V333, P117, DOI 10.1007/s11104-010-0327-0; Marks EAN, 2014, PLANT SOIL, V385, P87, DOI 10.1007/s11104-014-2198-2; Mengel K, 1982, Principles of plant nutrition.; Mukherjee A, 2011, GEODERMA, V163, P247, DOI 10.1016/j.geoderma.2011.04.021; Olmo M, 2016, PLANT SOIL, V399, P333, DOI 10.1007/s11104-015-2700-5; Parvage MM, 2013, BIOL FERT SOILS, V49, P245, DOI 10.1007/s00374-012-0746-6; Paz-Ferreiro J, 2012, BIOL FERT SOILS, V48, P511, DOI 10.1007/s00374-011-0644-3; Rajkovich S, 2012, BIOL FERT SOILS, V48, P271, DOI 10.1007/s00374-011-0624-7; Sanger A, 2017, ARCH AGRON SOIL SCI, V63, P213, DOI 10.1080/03650340.2016.1223289; Schulz H, 2013, AGRON SUSTAIN DEV, V33, P817, DOI 10.1007/s13593-013-0150-0; Silber A, 2010, ENVIRON SCI TECHNOL, V44, P9318, DOI 10.1021/es101283d; Soil Survey Staff, 2003, KEYS SOIL TAXONOMY, V9; Spokas KA, 2012, J ENVIRON QUAL, V41, P973, DOI 10.2134/jeq2011.0069; Tammeorg P, 2014, AGR ECOSYST ENVIRON, V191, P108, DOI 10.1016/j.agee.2014.01.007; [田晓飞 Tian Xiaofei], 2015, [农业环境科学学报, Journal of Agro-Environment Science], V34, P745; Vaccari FP, 2011, EUR J AGRON, V34, P231, DOI 10.1016/j.eja.2011.01.006; Xu G, 2014, ECOL ENG, V62, P54, DOI 10.1016/j.ecoleng.2013.10.027; Yao Y, 2012, CHEMOSPHERE, V89, P1467, DOI 10.1016/j.chemosphere.2012.06.002; Yao YK., 2008, EFFECTS PHOSPHORUS F, P29; YEOMANS JC, 1988, COMMUN SOIL SCI PLAN, V19, P1467, DOI 10.1080/00103628809368027; Yuan HR, 2016, GEODERMA, V267, P17, DOI 10.1016/j.geoderma.2015.12.020; Zeng LH, 2015, FIELD CROP RES, V171, P176, DOI 10.1016/j.fcr.2014.10.004; Zhang AF, 2012, FIELD CROP RES, V127, P153, DOI 10.1016/j.fcr.2011.11.020; Zhang DX, 2016, CHEMOSPHERE, V142, P106, DOI 10.1016/j.chemosphere.2015.04.088; Zhao J, 2016, APPL SOIL ECOL, V99, P1, DOI 10.1016/j.apsoil.2015.11.006; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	51	35	36	5	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0189924	10.1371/journal.pone.0189924	http://dx.doi.org/10.1371/journal.pone.0189924			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324750	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400014
J	Topcagic, J; Feldman, R; Ghazalpour, A; Swensen, J; Gatalica, Z; Vranic, S				Topcagic, Jasmina; Feldman, Rebecca; Ghazalpour, Anatole; Swensen, Jeffrey; Gatalica, Zoran; Vranic, Semir			Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; TRANSPORTER GENES; BREAST-CANCER; ESTHESIONEUROBLASTOMA; BIOMARKERS; TUMORS; ABC; CHEMOTHERAPY; RESISTANCE; MUTATIONS	Olfactory neuroblastoma (ONB) is a rare, locally aggressive, malignant neoplasm originating in the olfactory epithelium in the nasal vault. The recurrence rate of ONB remains high and there are no specific treatment guidelines for recurrent/metastatic ONBs. This study retrospectively evaluated 23 ONB samples profiled at Caris Life Sciences (Phoenix, Arizona) using DNA sequencing (Sanger/NGS [Illumina], n = 15) and gene fusions (Archer Fusion-Plex, n = 6), whole genome RNA microarray (HumanHT-12 v4 beadChip, Illumina, n = 4), gene copy number assays (chromogenic and fluorescent in situ hybridization), and immunohistochemistry. Mutations were detected in 63% ONBs including TP53, CTNNB1, EGFR, APC, cKIT, cMET, PDGFRA, CDH1, FH, and SMAD4 genes. Twenty-one genes were over-expressed and 19 genes under-expressed by microarray assay. Some of the upregulated genes included CD24, SCG2, and IGFBP-2. None of the cases harbored copy number variations of EGFR, HER2 and cMET genes, and no gene fusions were identified. Multiple protein biomarkers of potential response or resistance to classic chemotherapy drugs were identified, such as low ERCC1 [cisplatin sensitivity in 10/12], high TOPO1 [irinotecan sensitivity in 12/19], high TUBB3 [vincristine resistance in 13/14], and high MRP1 [multidrug resistance in 6/6 cases]. None of the cases (0/10) were positive for PD-L1 in tumor cells. Overexpression of pNTRK was observed in 67% (4/6) of the cases without underlying genetic alterations. Molecular alterations detected in our study (e.g., Wnt and cKIT/PDGFRA pathways) are potentially treatable using novel therapeutic approaches. Identified protein biomarkers of response or resistance to classic chemotherapy could be useful in optimizing existing chemotherapy treatment(s) in ONBs.	[Topcagic, Jasmina; Vranic, Semir] Assoc Basic Med Sci Federat Bosnia & Herzegovina, Sarajevo, Bosnia & Herceg; [Feldman, Rebecca; Ghazalpour, Anatole; Swensen, Jeffrey; Gatalica, Zoran] Caris Life Sci, Phoenix, AZ USA; [Vranic, Semir] Univ Sarajevo, Dept Pathol, Clin Ctr, Sarajevo, Bosnia & Herceg; [Vranic, Semir] Univ Sarajevo, Sch Med, Sarajevo, Bosnia & Herceg; [Vranic, Semir] Qatar Univ, Coll Med, Doha, Qatar	University of Sarajevo; University of Sarajevo; Qatar University	Vranic, S (corresponding author), Assoc Basic Med Sci Federat Bosnia & Herzegovina, Sarajevo, Bosnia & Herceg.; Vranic, S (corresponding author), Univ Sarajevo, Dept Pathol, Clin Ctr, Sarajevo, Bosnia & Herceg.; Vranic, S (corresponding author), Univ Sarajevo, Sch Med, Sarajevo, Bosnia & Herceg.; Vranic, S (corresponding author), Qatar Univ, Coll Med, Doha, Qatar.	semir.vranic@gmail.com	Vranic, Semir/I-6823-2019	Vranic, Semir/0000-0001-9743-7265; , Jasmina/0000-0002-5653-4007	Canis Life Sciences	Canis Life Sciences	The Canis Life Sciences provided support in the form of salaries for authors [RF, AG, JS, ZG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amatu A, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2015-000023; Bachar G, 2008, HEAD NECK-J SCI SPEC, V30, P1607, DOI 10.1002/hed.20920; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Bauman JE, 2014, CLIN CANCER RES, V20, P4173, DOI 10.1158/1078-0432.CCR-14-0720; Bhupalam L, 2004, J CLIN ONCOL, V22, p518S; Birendra K C, 2015, J Exp Ther Oncol, V11, P27; Blagodatski Artem, 2014, Mol Cell Ther, V2, P28, DOI 10.1186/2052-8426-2-28; Bockmuhl U, 2004, BRAIN PATHOL, V14, P158, DOI 10.1111/j.1750-3639.2004.tb00048.x; Boussiotis VA, 2016, NEW ENGL J MED, V375, P1767, DOI 10.1056/NEJMra1514296; Braun MS, 2008, J CLIN ONCOL, V26, P2690, DOI 10.1200/JCO.2007.15.5580; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Cha S, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2209-1; Curtin JC, 2010, ONCOTARGET, V1, P563, DOI 10.18632/oncotarget.191; Czapiewski P, 2016, ONCOTARGET, V7, P52584, DOI 10.18632/oncotarget.9683; Demidenko R, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1689-8; Dey N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-537; Diaz EM, 2005, HEAD NECK-J SCI SPEC, V27, P138, DOI 10.1002/hed.20127; Dulguerov P, 2001, LANCET ONCOL, V2, P683, DOI 10.1016/S1470-2045(01)00558-7; Dvorak P, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317699800; Faragalla H, 2009, ADV ANAT PATHOL, V16, P322, DOI 10.1097/PAP.0b013e3181b544cf; Gatalica Z, 2016, ONCOTARGET, V7, P1707, DOI 10.18632/oncotarget.6421; Gatalica Z, 2014, CANCER EPIDEM BIOMAR, V23, P2965, DOI 10.1158/1055-9965.EPI-14-0654; Gay LM, 2017, ONCOLOGIST, V22, P834, DOI 10.1634/theoncologist.2016-0287; Gomes AL, 2008, J CLIN PATHOL, V61, P203, DOI 10.1136/jcp.2007.047043; Guevara-Aguirre J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001845; Guled M, 2008, MODERN PATHOL, V21, P770, DOI 10.1038/modpathol.2008.57; Hirai Y, 2011, ANTICANCER RES, V31, P999; Hlavac V, 2013, PHARMACOGENOMICS, V14, P515, DOI [10.2217/PGS.13.26, 10.2217/pgs.13.26]; Holland H, 2007, CANCER GENET CYTOGEN, V173, P89, DOI 10.1016/j.cancergencyto.2006.09.024; Ingram WJ, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-26; Januchowski R, 2013, BIOMED PHARMACOTHER, V67, P240, DOI 10.1016/j.biopha.2012.11.011; Kalkat M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060151; Kim S, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.e12513; Lazo de la Vega L, 2017, MOL CANC RES; Lee JH, 2013, J GASTROINTEST LIVER, V22, P413; Li S, 2014, ANTI-CANCER DRUG, V25, P106, DOI 10.1097/CAD.0000000000000021; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao L, 2009, ONCOLOGY-BASEL, V77, P231, DOI 10.1159/000236047; Millis SZ, 2015, CLIN BREAST CANCER, V15, P473, DOI 10.1016/j.clbc.2015.04.008; Porter AB, 2008, J NEURO-ONCOL, V90, P201, DOI 10.1007/s11060-008-9645-y; Preusser M, 2010, J NEURO-ONCOL, V97, P305, DOI 10.1007/s11060-009-0027-x; Sabongi JG, 2016, EXP THER MED, V12, P3078, DOI 10.3892/etm.2016.3732; Sethi S, 2013, INT J MOL SCI, V14, P14771, DOI 10.3390/ijms140714771; Shah N, 2014, CLIN CANCER RES, V20, P4400, DOI 10.1158/1078-0432.CCR-13-1486; Silva E, 2015, BREAST J, V21, P205, DOI 10.1111/tbj.12380; Song CM, 2012, LARYNGOSCOPE, V122, P2389, DOI 10.1002/lary.23641; Thompson LDR, 2009, HEAD NECK PATHOL, V3, P252, DOI 10.1007/s12105-009-0125-2; Valli R, 2015, GENE CHROMOSOME CANC, V54, P771, DOI 10.1002/gcc.22288; Von Hoff DD, 2010, J CLIN ONCOL, V28, P4877, DOI 10.1200/JCO.2009.26.5983; Wang LZ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003536; Weiss GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037029; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Young KA G., 2015, ENDOCRINE ABSTR, V38, pP153	54	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191244	10.1371/journal.pone.0191244	http://dx.doi.org/10.1371/journal.pone.0191244			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324814	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400135
J	Yang, M; Yang, D; Yu, X				Yang, Miao; Yang, Dan; Yu, Xuan			Soil microbial communities and enzyme activities in sea-buckthorn (Hippophae rhamnoides) plantation at different ages	PLOS ONE			English	Article							LOESS PLATEAU; FUNGAL COMMUNITIES; SUBSTRATE USE; LEAF-LITTER; STAND AGE; LAND-USE; FOREST; CARBON; CHINA; NITROGEN	The aim of this study was to assess the impact of forest age and season on the soil microbial community and enzyme activities in sea-buckthorn plantation system and to determine the relative contributions to soil microbial properties. Soil sampling was carried out in the dry season (April) and wet season (September) in four areas, including: abandoned farmland (NH), an 8-year- old plantation (young plantation, 8Y), a 13-year-old plantation (middle-aged plantation, 13Y), and an 18-year-old plantation (mature plantation, 18Y). The results showed that forest age and season have a significant effect on soil microbial community structure and enzyme activities. The total, bacterial, fungal, Gram-negative (G(+)), and Gram-positive (G(-)) PLFAs increased gradually with forest age, with the highest values detected in 18Y. All the detected enzyme activities showed the trend as a consequence of forest age. The microbial PLFAs and soil enzyme activities were higher in the wet season than the dry season. However, there were no significant interactions between forest age and season. A Correlation analysis suggested that soil microbial communities and enzyme activities were significantly and positively correlated with pH, total nitrogen (TN) and available phosphorus (AP). Season had a stronger influence on soil microbial communities than forest age. In general, sea-buckthorn plantations establishment might be a potential tool for maintaining and increasing soil fertility in arid and semi-arid regions.	[Yang, Miao; Yang, Dan; Yu, Xuan] Northwest A&F Univ, Dept Forestry, Coll Forestry, Yangling, Peoples R China; [Yang, Miao; Yang, Dan; Yu, Xuan] Key Comprehens Lab Forestry, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Yu, X (corresponding author), Northwest A&F Univ, Dept Forestry, Coll Forestry, Yangling, Peoples R China.; Yu, X (corresponding author), Key Comprehens Lab Forestry, Yangling, Shaanxi, Peoples R China.	yux@nwsuaf.edu.cn			Ph.D. programs Foundation of Ministry of Education of China [20120204120043]; National Natural Science Foundation of China [31670629]; China Postdoctoral Science Foundation [2016M600822]; Northwest AF University; College of Forestry of Northwest AF University [Z111021602]	Ph.D. programs Foundation of Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Northwest AF University; College of Forestry of Northwest AF University	Ph.D. programs Foundation of Ministry of Education of China (20120204120043, http://www.moe.gov.cn/), Project supported by the National Natural Science Foundation of China (31670629, http://www.nsfc.gov.cn/), China Postdoctoral Science Foundation (2016M600822, http://www.chinapostdoctor.org.cn/WebSite/program/Default.aspx), Tang Scholar Program of Northwest A&F University (http://edf.nwafu.edu.cn/index.do), and Young Teacher Culture Programs of College of Forestry of Northwest A&F University (Z111021602, http://cf.nwafu.edu.cn/) to XY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bossio DA, 2006, SOIL BIOL BIOCHEM, V38, P1223, DOI 10.1016/j.soilbio.2005.09.027; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Broz AK, 2007, ISME J, V1, P763, DOI 10.1038/ismej.2007.81; Bunemann EK, 2004, SOIL BIOL BIOCHEM, V36, P889, DOI [10.1016/j.soilbio.2004.02.002, 10.1016/S0038-0717(04)00052-5]; Burns RG, 2013, SOIL BIOL BIOCHEM, V58, P216, DOI 10.1016/j.soilbio.2012.11.009; Caldwell BA, 2005, PEDOBIOLOGIA, V49, P637, DOI 10.1016/j.pedobi.2005.06.003; CAMPBELL BM, 1994, AGROFOREST SYST, V28, P159, DOI 10.1007/BF00704827; Cao YS, 2010, EUR J SOIL BIOL, V46, P128, DOI 10.1016/j.ejsobi.2009.12.006; Chen FL, 2013, J ENVIRON SCI-CHINA, V25, P2102, DOI 10.1016/S1001-0742(12)60319-2; [陈金泉 CHEN Jinquan], 2011, [土壤通报, Journal of Soil Science], V42, P616; Dong Z, 2013, ASIAN J CHEM, V25, P10076, DOI 10.14233/ajchem.2013.15152; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Gentili F, 2006, SYMBIOSIS, V41, P39; Grayston SJ, 1997, APPL SOIL ECOL, V5, P29, DOI 10.1016/S0929-1393(96)00126-6; Guan S.Y., 1986, SOIL ENZYME ITS STUD, P270; Guo WH, 2010, AGROFOREST SYST, V80, P423, DOI 10.1007/s10457-010-9337-4; Han WY, 2007, SOIL BIOL BIOCHEM, V39, P1468, DOI 10.1016/j.soilbio.2006.12.029; Han ZG, 2016, INDIAN J MICROBIOL, V56, P328, DOI 10.1007/s12088-016-0577-5; Hansson K, 2011, FOREST ECOL MANAG, V262, P522, DOI 10.1016/j.foreco.2011.04.021; Hobbie SE, 2010, OECOLOGIA, V162, P505, DOI 10.1007/s00442-009-1479-6; Jin K, 2009, SOIL TILL RES, V104, P115, DOI 10.1016/j.still.2009.02.004; Kalia RK, 2011, TREES-STRUCT FUNCT, V25, P559, DOI 10.1007/s00468-011-0543-0; Lang Y, 2013, PHOTOSYNTHETICA, V51, P370, DOI 10.1007/s11099-013-0036-z; Li Q, 2013, SCAND J FOREST RES, V28, P642, DOI 10.1080/02827581.2013.826273; Li Y, 2011, TREES-STRUCT FUNCT, V25, P1073, DOI 10.1007/s00468-011-0582-6; Li YX, 2011, J NW A F U, V38, P67; Liu G., 1996, SOIL PHYS CHEM ANAL; Mackay JE, 2016, SCI TOTAL ENVIRON, V566, P960, DOI 10.1016/j.scitotenv.2016.05.045; Moore-Kucera J, 2008, MICROB ECOL, V55, P500, DOI 10.1007/s00248-007-9295-1; Myers RT, 2001, SOIL SCI SOC AM J, V65, P359, DOI 10.2136/sssaj2001.652359x; Lino IAN, 2016, LAND DEGRAD DEV, V27, P77, DOI 10.1002/ldr.2454; Paz-Ferreiro J, 2007, NEW ZEAL J AGR RES, V50, P537, DOI 10.1080/00288230709510321; Rinklebe J, 2006, SOIL BIOL BIOCHEM, V38, P2144, DOI 10.1016/j.soilbio.2006.01.018; Rogers BF, 2001, SOIL BIOL BIOCHEM, V33, P1389, DOI 10.1016/S0038-0717(01)00044-X; ROSS DJ, 1995, SOIL BIOL BIOCHEM, V27, P1431, DOI 10.1016/0038-0717(95)00069-Q; Selvaraj S, 2017, GEODERMA, V306, P127, DOI 10.1016/j.geoderma.2017.07.014; Suding KN, 2004, PLANT ECOL, V175, P47, DOI 10.1023/B:VEGE.0000048093.92118.27; Trasar-Cepeda C, 1999, SOIL BIOL BIOCHEM, V31, P483, DOI 10.1016/S0038-0717(98)00153-9; Vasconcellos RLF, 2013, ECOL ENG, V53, P313, DOI 10.1016/j.ecoleng.2012.12.067; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; Waring BG, 2016, NEW PHYTOL, V209, P845, DOI 10.1111/nph.13654; WHITE DC, 1979, OECOLOGIA, V40, P51, DOI 10.1007/BF00388810; Wilson GWT, 2009, ECOL LETT, V12, P452, DOI 10.1111/j.1461-0248.2009.01303.x; Xiang D, 2014, NEW PHYTOL, V204, P968, DOI 10.1111/nph.12961; Yang Q, 2014, MAR POLLUT BULL, V85, P754, DOI 10.1016/j.marpolbul.2014.02.024; Yannikos N, 2014, SOIL BIOL BIOCHEM, V70, P5, DOI 10.1016/j.soilbio.2013.11.025; Yarwood SA, 2009, FEMS MICROBIOL ECOL, V70, P151, DOI 10.1111/j.1574-6941.2009.00733.x; Yu XB., 2015, SHOCK VIB, V2015, P1, DOI DOI 10.1016/J.MICRES.2015.06.004; Yuan BC, 2012, PEDOSPHERE, V22, P1, DOI 10.1016/S1002-0160(11)60186-0; Zhang C, 2013, EUR J SOIL BIOL, V54, P16, DOI 10.1016/j.ejsobi.2012.10.007; Zhang WW, 2017, APPL SOIL ECOL, V111, P73, DOI 10.1016/j.apsoil.2016.11.019; Zheng H, 2005, FOREST ECOL MANAG, V217, P244, DOI 10.1016/j.foreco.2005.06.005	54	25	27	10	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190959	10.1371/journal.pone.0190959	http://dx.doi.org/10.1371/journal.pone.0190959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324845	Green Submitted, Green Published, gold			2022-12-26	WOS:000419952400081
J	Peterson, T; Muller, GB				Peterson, Tim; Mueller, Gerd B.			Developmental finite element analysis of cichlid pharyngeal jaws: Quantifying the generation of a key innovation	PLOS ONE			English	Article							ASTATOREOCHROMIS-ALLUAUDI TELEOSTEI; ASTATOTILAPIA-ELEGANS; PHENOTYPIC PLASTICITY; MECHANICAL MODELS; NEUROCRANIAL BASE; CARTILAGE GROWTH; BONE; BIOMECHANICS; EVOLUTION; FISH	Advances in imaging and modeling facilitate the calculation of biomechanical forces in biological specimens. These factors play a significant role during ontogenetic development of cichlid pharyngeal jaws, a key innovation responsible for one of the most prolific species diversifications in recent times. MicroCT imaging of radiopaque-stained vertebrate embryos were used to accurately capture the spatial relationships of the pharyngeal jaw apparatus in two cichlid species |(Haplochromis elegans and Amatitlania nigrofasciata) for the purpose of creating a time series of developmental stages using finite element models, which can be used to assess the effects of biomechanical forces present in a system at multiple points of its ontogeny. Changes in muscle vector orientations, bite forces, force on the neurocranium where cartilage originates, and stress on upper pharyngeal jaws are analyzed in a comparative context. In addition, microCT scanning revealed the presence of previously unreported cement glands in A. nigrofasciata. The data obtained provide an underrepresented dimension of information on physical forces present in developmental processes and assist in interpreting the role of developmental dynamics in evolution.	[Peterson, Tim; Mueller, Gerd B.] Univ Vienna, Dept Theoret Biol, Vienna, Austria; [Mueller, Gerd B.] KLI Inst, Klosterneuburg, Austria	University of Vienna	Peterson, T (corresponding author), Univ Vienna, Dept Theoret Biol, Vienna, Austria.	tim.a.peterson@gmail.com			Open Access Publishing Fund of the University of Vienna	Open Access Publishing Fund of the University of Vienna	We would like to thank the Open Access Publishing Fund of the University of Vienna for funding the publication, but there is no financial disclosure for the research.; The authors would like to thank Brian Metscher for his help with the microCT scans and radiopaque staining procedures, the department of Theoretical Biology at the University of Vienna for stimulating discussions, and the Zierfische Aquarium for locating the required cichlid species for the project. We would like to thank the Open Access Publishing Fund of the University of Vienna for funding the publication.	AERTS P, 1982, J MORPHOL, V173, P225, DOI 10.1002/jmor.1051730209; Aerts P., 1987, J MORPHOL, P109; Allena R, 2010, J MECH BEHAV BIOMED, V3, P313, DOI 10.1016/j.jmbbm.2010.01.001; ANKER GC, 1986, NETH J ZOOL, V36, P498, DOI 10.1163/002829686X00207; Arbour VM, 2009, ANAT REC, V292, P1412, DOI 10.1002/ar.20987; Arbour VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006738; Attard MRG, 2011, J ZOOL, V285, P292, DOI 10.1111/j.1469-7998.2011.00844.x; Carter DR, 1998, ZOOL J LINN SOC-LOND, V123, P163, DOI 10.1006/zjls.1997.0108; Chen XG, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015003; DAVIDSON LA, 1995, DEVELOPMENT, V121, P2005; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; Elder SH, 2000, J ORTHOPAED RES, V18, P78, DOI 10.1002/jor.1100180112; Erickson GM, 2002, ANAT RECORD, V268, P115, DOI 10.1002/ar.10145; Ferrara TL, 2011, J BIOMECH, V44, P430, DOI 10.1016/j.jbiomech.2010.09.028; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Galis F, 1996, J EVOLUTION BIOL, V9, P641, DOI 10.1046/j.1420-9101.1996.9050641.x; GALIS F, 1992, J THEOR BIOL, V155, P343, DOI 10.1016/S0022-5193(05)80603-4; Grad S, 2011, CLIN ORTHOP RELAT R, V469, P2764, DOI 10.1007/s11999-011-1819-9; Greenwood P. H., 1965, Proceedings of the Linnean Society of London, V176, P1; GREENWOOD P H, 1973, Bulletin of the British Museum (Natural History) Zoology, V25, P139; Hall B. K, 2005, BONES AND CARTILAGE; Heegaard JH, 2001, CLIN BIOMECH, V16, P415, DOI 10.1016/S0268-0033(01)00020-1; Heegaard JH, 1999, J ORTHOPAED RES, V17, P509, DOI 10.1002/jor.1100170408; Hegrenes S, 2001, ECOL FRESHW FISH, V10, P35, DOI 10.1034/j.1600-0633.2001.100105.x; Hernandez LF, 2007, J FOOD ENG, V78, P861, DOI 10.1016/j.jfoodeng.2005.12.003; Horton JM, 2009, J EXP BIOL, V212, P1413, DOI 10.1242/jeb.020636; Hulsey CD, 2006, EVOLUTION, V60, P2096, DOI 10.1111/j.0014-3820.2006.tb01847.x; Hulsey CD, 2008, EVOLUTION, V62, P1587, DOI 10.1111/j.1558-5646.2008.00384.x; HUYSSEUNE A, 1988, J ANAT, V158, P13; HUYSSEUNE A, 1986, AM J ANAT, V177, P527, DOI 10.1002/aja.1001770411; HUYSSEUNE A, 1986, AM J ANAT, V177, P119, DOI 10.1002/aja.1001770113; HUYSSEUNE A, 1994, J MORPHOL, V221, P25, DOI 10.1002/jmor.1052210103; HUYSSEUNE A, 1995, ARCH ORAL BIOL, V40, P1005, DOI 10.1016/0003-9969(95)00074-Y; ISMAIL MH, 1982, NETH J ZOOL, V32, P513; Kaufman L.S., 1982, Breviora, P1; Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173; Kesel AB, 1998, COMPUT BIOL MED, V28, P423, DOI 10.1016/S0010-4825(98)00018-3; Koolstra JH, 2012, OSTEOARTHR CARTILAGE, V20, P43, DOI 10.1016/j.joca.2011.10.009; Kranenbarg S, 2005, J EXP BIOL, V208, P3493, DOI 10.1242/jeb.01808; Kuchen EE, 2012, SCIENCE, V335, P1092, DOI 10.1126/science.1214678; le Pabic P, 2009, ANAT REC, V292, P1780, DOI 10.1002/ar.20960; LIEM KF, 1973, SYST ZOOL, V22, P425, DOI 10.2307/2412950; Lim CT, 2006, J BIOMECH, V39, P195, DOI 10.1016/j.jbiomech.2004.12.008; Lupke M, 2010, WIEN TIERARZTL MONAT, V97, P101; Mabuchi K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-10; Macho GA, 2005, ANAT REC PART A, V283A, P310, DOI 10.1002/ar.a.20175; Mahoney E, 2000, J DENT, V28, P589, DOI 10.1016/S0300-5712(00)00043-9; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Mchenry CR, 2006, ANAT REC PART A, V288A, P827, DOI 10.1002/ar.a.20360; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; MEYER A, 1990, BIOL J LINN SOC, V39, P279, DOI 10.1111/j.1095-8312.1990.tb00517.x; Moazen M, 2009, P NATL ACAD SCI USA, V106, P8273, DOI 10.1073/pnas.0813156106; MULLER GB, 1989, ANAT EMBRYOL, V179, P327, DOI 10.1007/BF00305059; Muschick M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-116; Nowlan NC, 2008, J BIOMECH, V41, P249, DOI 10.1016/j.jbiomech.2007.09.031; Oates AC, 2009, NAT REV GENET, V10, P517, DOI 10.1038/nrg2548; Oldfield CC, 2012, J ZOOL, V286, P163, DOI 10.1111/j.1469-7998.2011.00862.x; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Panagiotopoulou O, 2009, ANN HUM BIOL, V36, P609, DOI 10.1080/03014460903019879; Panagiotopoulou O, 2011, AM J PHYS ANTHROPOL, V146, P253, DOI 10.1002/ajpa.21573; Peterson T, 2016, EVOL BIOL, V43, P314, DOI 10.1007/s11692-016-9372-9; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; Schmitt J, 2000, BIOL CYBERN, V83, P501, DOI 10.1007/s004220000181; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Slater GJ, 2009, J EVOLUTION BIOL, V22, P2278, DOI 10.1111/j.1420-9101.2009.01845.x; Slater GJ, 2009, J ZOOL, V278, P181, DOI 10.1111/j.1469-7998.2009.00567.x; Smits JD, 1997, NETH J ZOOL, V47, P313; STIASSNY M L J, 1987, Bulletin of the Museum of Comparative Zoology, V151, P269; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Swart P, 2016, SCI REP-UK, V6, DOI 10.1038/srep39380; Taber LA, 2000, J ELASTICITY, V61, P165, DOI 10.1023/A:1011082712497; Tanner JB, 2008, BIOL J LINN SOC, V95, P246, DOI 10.1111/j.1095-8312.2008.01052.x; van der Meulen MCH, 2002, J BIOMECH, V35, P401, DOI 10.1016/S0021-9290(01)00184-1; WIMBERGER PH, 1992, BIOL J LINN SOC, V45, P197, DOI 10.1111/j.1095-8312.1992.tb00640.x; Witten PE, 2009, BIOL REV, V84, P315, DOI 10.1111/j.1469-185X.2009.00077.x; Witten PE, 2005, DIS AQUAT ORGAN, V64, P237, DOI 10.3354/dao064237; Wroe S, 2008, J ZOOL, V276, P336, DOI 10.1111/j.1469-7998.2008.00494.x; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; Yao HM, 2010, P NATL ACAD SCI USA, V107, P987, DOI 10.1073/pnas.0912988107	82	4	4	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0189985	10.1371/journal.pone.0189985	http://dx.doi.org/10.1371/journal.pone.0189985			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320528	Green Published, gold, Green Submitted			2022-12-26	WOS:000419689600026
J	Choi, JW; Kim, DK; Kim, JK; Lee, EJ; Kim, JY				Choi, Ji-Won; Kim, Duk-Kyung; Kim, Jin-Kyoung; Lee, Eun-Jee; Kim, Jea-Youn			A retrospective analysis on the relationship between intraoperative hypothermia and postoperative ileus after laparoscopic colorectal surgery	PLOS ONE			English	Article							PERIOPERATIVE CARE; ENHANCED-RECOVERY; RECOMMENDATIONS; MECHANISMS; INFECTION	Postoperative ileus (POI) is an important factor prolonging the length of hospital stay following colorectal surgery. We retrospectively explored whether there is a clinically relevant association between intraoperative hypothermia and POI in patients who underwent laparoscopic colorectal surgery for malignancy within the setting of an enhanced recovery after surgery (ERAS) program between April 2016 and January 2017 at our institution. In total, 637 patients were analyzed, of whom 122 (19.2%) developed clinically and radiologically diagnosed POI. Overall, 530 (83.2%) patients experienced intraoperative hypothermia. Although the mean lowest core temperature was lower in patients with POI than those without POI (35.3 +/- 0.5 degrees C vs. 35.5 +/- 0.5 degrees C, P = 0.004), the independence of intraoperative hypothermia was not confirmed based on multivariate logistic regression analysis. In addition to three variables (high age-adjusted Charlson comorbidity index score, long duration of surgery, high maximum pain score during the first 3 days postoperatively), cumulative dose of rescue opioids used during the first 3 days postoperatively was identified as an independent risk factor of POI (odds ratio = 1.027 for each 1-morphine equivalent [mg] increase, 95% confidence interval = 1.014-1.040, P < 0.001). Patients with hypothermia showed significant delays in both progression to a soft diet and discharge from hospital. In conclusion, intraoperative hypothermia was not independently associated with POI within an ERAS pathway, in which items other than thermal measures might offset its negative impact on POI. However, as it was associated with delayed discharge from the hospital, intraoperative maintenance of normothermia is still needed.	[Choi, Ji-Won; Kim, Duk-Kyung; Kim, Jin-Kyoung; Lee, Eun-Jee; Kim, Jea-Youn] Sungkyunkwan Univ, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Choi, JW (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Anesthesiol & Pain Med, Sch Med, Seoul, South Korea.	jiwon0715.choi@samsung.com			'Samsung' company	'Samsung' company	The authors received no specific funding for this work. The author did not receive any financial support from any pharmaceutical companies. 'Samsung' company provided support only in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Bernard SA, 1999, CRIT CARE, V3, P167, DOI 10.1186/cc371; Booker PD, 1996, BRIT J ANAESTH, V77, P591, DOI 10.1093/bja/77.5.591; Campana JP, 2017, INT J COLORECTAL DIS, V32, P907, DOI 10.1007/s00384-017-2776-x; Chang CJ, 2016, PROCEEDINGS OF THE 2016 INTERNATIONAL CONFERENCE ON ARTIFICIAL LIFE AND ROBOTICS (ICAROB 2016), P11; Dhar P, 2000, J Anesth, V14, P91, DOI 10.1007/s005400050073; Fintl C, 2016, EQUINE VET J, V48, P218, DOI 10.1111/evj.12401; Gustafsson UO, 2013, WORLD J SURG, V37, P259, DOI 10.1007/s00268-012-1772-0; Lassen K, 2009, ARCH SURG-CHICAGO, V144, P961, DOI 10.1001/archsurg.2009.170; Marshall JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122838; Mattei P, 2006, WORLD J SURG, V30, P1382, DOI 10.1007/s00268-005-0613-9; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; RAPP RP, 1989, DICP ANN PHARMAC, V23, P899, DOI 10.1177/106002808902301112; Scheer A, 2009, DIS COLON RECTUM, V52, P1746, DOI 10.1007/DCR.0b013e3181b55616; Sorensen LT, 2012, ARCH SURG-CHICAGO, V147, P373, DOI 10.1001/archsurg.2012.5; Stewart BT, 1999, DIS COLON RECTUM, V42, P1292, DOI 10.1007/BF02234217; Tian YH, 2017, ONCOTARGET, V8, P20794, DOI 10.18632/oncotarget.15285; Turrado-Rodriguez V, 2016, SURG ENDOSC, V30, P1413, DOI 10.1007/s00464-015-4345-0; Vather R, 2014, CLIN EXP PHARMACOL P, V41, P358, DOI 10.1111/1440-1681.12220; Whitney JD, 2015, SURG INFECT, V16, P595, DOI 10.1089/sur.2013.096	20	11	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2018	13	1							e0190711	10.1371/journal.pone.0190711	http://dx.doi.org/10.1371/journal.pone.0190711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS0GW	29309435	Green Published, Green Submitted, gold			2022-12-26	WOS:000419453100015
J	Huang, QQ; Stalnecker, C; Zhang, CL; McDermott, LA; Iyer, P; O'Neill, J; Reimer, S; Cerione, RA; Katt, WP				Huang, Qingqiu; Stalnecker, Clint; Zhang, Chengliang; McDermott, Lee A.; Iyer, Prema; O'Neill, Jason; Reimer, Shawn; Cerione, Richard A.; Katt, William P.			Characterization of the interactions of potent allosteric inhibitors with glutaminase C, a key enzyme in cancer cell glutamine metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KIDNEY-TYPE GLUTAMINASE; RENAL MITOCHONDRIAL GLUTAMINASE; MECHANISM; EXPRESSION; DESIGN; GROWTH	Altered glycolytic flux in cancer cells (the "Warburg effect") causes their proliferation to rely upon elevated glutamine metabolism ("glutamine addiction"). This requirement is met by the overexpression of glutaminase C (GAC), which catalyzes the first step in glutamine metabolism and therefore represents a potential therapeutic target. The small molecule CB-839 was reported to be more potent than other allosteric GAC inhibitors, including the parent compound bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl) ethyl (BPTES), and is in clinical trials. Recently, we described the synthesis of BPTES analogs having distinct saturated heterocyclic cores as a replacement for the flexible chain moiety, with improved microsomal stability relative to CB-839 and BPTES. Here, we show that one of these new compounds, UPGL00004, like CB-839, more potently inhibits the enzymatic activity of GAC, compared with BPTES. We also compare the abilities of UPGL00004, CB-839, and BPTES to directly bind to recombinant GAC and demonstrate that UPGL00004 has a similar binding affinity as CB-839 for GAC. We also show that UPGL00004 potently inhibits the growth of triple-negative breast cancer cells, as well as tumor growth when combined with the anti-vascular endothelial growth factor antibody bevacizumab. Finally, we compare the X-ray crystal structures for UPGL00004 and CB-839 bound to GAC, verifying that UPGL00004 occupies the same binding site as CB-839 or BPTES and that all three inhibitors regulate the enzymatic activity of GACvia a similar allosteric mechanism. These results provide insights regarding the potency of these inhibitors that will be useful in designing novel small-molecules that target a key enzyme in cancer cell metabolism.	[Huang, Qingqiu; Cerione, Richard A.] Cornell Univ, CHESS, Ithaca, NY 14853 USA; [Stalnecker, Clint; Cerione, Richard A.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Zhang, Chengliang; Cerione, Richard A.; Katt, William P.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA; [McDermott, Lee A.; Iyer, Prema; O'Neill, Jason; Reimer, Shawn] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [McDermott, Lee A.; Iyer, Prema] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA 15261 USA; [Stalnecker, Clint] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA	Cornell University; Cornell University; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu		Katt, William/0000-0001-5104-7667; Stalnecker, Clint/0000-0002-0570-4416; Zhang, Chengliang/0000-0001-6999-4670	National Institutes of Health [GM040654, CA210184, GM122575]; University of Pittsburgh Medical Center Competitive Medical Research Fund (CMRF); NATIONAL CANCER INSTITUTE [U54CA210184, R01CA201402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040654, P41GM103485, R35GM122575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Medical Center Competitive Medical Research Fund (CMRF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM040654, CA210184, and GM122575 and by a grant from the University of Pittsburgh Medical Center Competitive Medical Research Fund (CMRF). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BERNDT KD, 1993, BIOCHEMISTRY-US, V32, P4564, DOI 10.1021/bi00068a012; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; Chen L. J., 2013, Heterocyclic Inhibitors of Glutaminase., Patent No. [US 8604016B2, 8604016]; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; DeLaBarre B, 2011, BIOCHEMISTRY-US, V50, P10764, DOI 10.1021/bi201613d; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Englich U, 2011, J SYNCHROTRON RADIAT, V18, P70, DOI 10.1107/S0909049510036010; Erickson JW, 2010, ONCOTARGET, V1, P734, DOI 10.18632/oncotarget.208; Feng QY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14450; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Gogvadze V, 2010, MOL ASPECTS MED, V31, P60, DOI 10.1016/j.mam.2009.12.004; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Holcomb T, 2000, MOL BRAIN RES, V76, P56, DOI 10.1016/S0169-328X(99)00331-9; Huang QQ, 2016, J APPL CRYSTALLOGR, V49, P149, DOI 10.1107/S1600576715023195; Katt WP, 2015, MOL PHARMACEUT, V12, P46, DOI 10.1021/mp500405h; Katt WP, 2012, MOL CANCER THER, V11, P1269, DOI 10.1158/1535-7163.MCT-11-0942; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Li YX, 2016, J BIOL CHEM, V291, P20900, DOI 10.1074/jbc.M116.720268; Lukey MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11321; Lukey MJ, 2013, FUTURE MED CHEM, V5, P1685, DOI 10.4155/fmc.13.130; Mates JM, 2013, CURR MOL MED, V13, P514; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mcdermott LA, 2016, Patent No. [WO2016054388 A1, 2016054388, WO2016054388]; McDermott LA, 2016, BIOORGAN MED CHEM, V24, P1819, DOI 10.1016/j.bmc.2016.03.009; MOREHOUSE RF, 1981, BIOCHEM J, V193, P709, DOI 10.1042/bj1930709; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PERERA SY, 1990, J BIOL CHEM, V265, P17764; Pieter A, 2012, CANCER BIOL THER, V13, P1185, DOI 10.4161/cbt.21348; Ramachandran S, 2016, ONCOTARGET, V7, P57943, DOI 10.18632/oncotarget.10791; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Ferreira APS, 2013, J BIOL CHEM, V288, P28009, DOI 10.1074/jbc.M113.501346; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Shukla K, 2012, J MED CHEM, V55, P10551, DOI 10.1021/jm301191p; SRINIVASAN M, 1995, J BIOL CHEM, V270, P1185, DOI 10.1074/jbc.270.3.1185; SRINIVASAN M, 1995, J BIOL CHEM, V270, P1191, DOI 10.1074/jbc.270.3.1191; Stalnecker CA, 2017, J BIOL CHEM, V292, P6095, DOI 10.1074/jbc.M116.758219; Stalnecker CA, 2015, P NATL ACAD SCI USA, V112, P394, DOI 10.1073/pnas.1414056112; Thangavelu K, 2012, P NATL ACAD SCI USA, V109, P7705, DOI 10.1073/pnas.1116573109; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009	46	47	51	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 9	2018	293	10					3535	3545		10.1074/jbc.M117.810101	http://dx.doi.org/10.1074/jbc.M117.810101			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY7GQ	29317493	Green Published, hybrid			2022-12-26	WOS:000427030200007
J	Aleza, K; Villamor, GB; Nyarko, BK; Wala, K; Akpagana, K				Aleza, Koutchoukalo; Villamor, Grace B.; Nyarko, Benjamin Kofi; Wala, Kperkouma; Akpagana, Koffi			Shea (Vitellaria paradoxa Gaertn C. F.) fruit yield assessment and management by farm households in the Atacora district of Benin	PLOS ONE			English	Article							WEST-AFRICA; BURKINA-FASO; CF GAERTN.; AGROFORESTRY; TREES; SELECTION; IMPACT; RATES; MALI	Vitellaria paradoxa (Gaertn C. F.), or shea tree, remains one of the most valuable trees for farmers in the Atacora district of northern Benin, where rural communities depend on shea products for both food and income. To optimize productivity and management of shea agro-forestry systems, or "parklands," accurate and up-to-date data are needed. For this purpose, we monitored120 fruiting shea trees for two years under three land-use scenarios and different soil groups in Atacora, coupled with a farm household survey to elicit information on decision making and management practices. To examine the local pattern of shea tree productivity and relationships between morphological factors and yields, we used a randomized branch sampling method and applied a regression analysis to build a shea yield model based on dendrometric, soil and land-use variables. We also compared potential shea yields based on farm household socio-economic characteristics and management practices derived from the survey data. Soil and land-use variables were the most important determinants of shea fruit yield. In terms of land use, shea trees growing on farmland plots exhibited the highest yields (i.e., fruit quantity and mass) while trees growing on Lixisols performed better than those of the other soil group. Contrary to our expectations, dendrometric parameters had weak relationships with fruit yield regardless of land-use and soil group. There is an inter-annual variability in fruit yield in both soil groups and land-use type. In addition to observed inter-annual yield variability, there was a high degree of variability in production among individual shea trees. Furthermore, household socioeconomic characteristics such as road accessibility, landholding size, and gross annual income influence shea fruit yield. The use of fallow areas is an important land management practice in the study area that influences both conservation and shea yield.	[Aleza, Koutchoukalo] Univ Cape Coast, Dept Soil Sci, Sch Agr,Grad Res Programme, West African Sci Serv Ctr Climate Change & Adapte, Cape Coast, Ghana; [Aleza, Koutchoukalo; Wala, Kperkouma; Akpagana, Koffi] Univ Lome, Lab Bot & Ecol Vegetale, Lome, Togo; [Villamor, Grace B.] Univ Bonn, Ctr Dev Res, Bonn, Germany; [Nyarko, Benjamin Kofi] Univ Cape Coast, Dept Geog & Reg Planning, Cape Coast, Ghana	University of Cape Coast; University of Bonn; University of Cape Coast	Aleza, K (corresponding author), Univ Cape Coast, Dept Soil Sci, Sch Agr,Grad Res Programme, West African Sci Serv Ctr Climate Change & Adapte, Cape Coast, Ghana.; Aleza, K (corresponding author), Univ Lome, Lab Bot & Ecol Vegetale, Lome, Togo.	alezafaustin@gmail.com	Nyarko, Benjamin Kofi/I-2155-2019	Nyarko, Benjamin Kofi/0000-0002-6560-9613	German Federal Ministry of Education and Research (BMBF) through the West African Science Service Center on Climate Change and Adaptive Land Use (WASCAL)	German Federal Ministry of Education and Research (BMBF) through the West African Science Service Center on Climate Change and Adaptive Land Use (WASCAL)	This research was funded by the German Federal Ministry of Education and Research (BMBF) through the West African Science Service Center on Climate Change and Adaptive Land Use (WASCAL).; We are grateful to all of our field assistants from Dassaricatchmentin Benin for their valuable efforts and contributions. We also appreciate Guido Luchster for his valuable statistical suggestions. This research was financed by the German Federal Ministry of Education and Research through the West African Science Service Center on Climate Change and Adaptive Land Use (WASCAL).	AGBAHUNGBA G, 1989, BOIS FOR TROP, V222, P41; Akais Okia C, 2005, AFR CROP SCI SOC, V7, P5; Akpo LE, 2002, REV ELEVAGE MED VET, V55; Akpona T, 2015, AGROFOREST SYST, V89, p1 ; Aleza K., 2015, International Journal of Biodiversity and Conservation, V7, P245; Aleza K, 2015, AGROFOREST SYST, V89, P511, DOI 10.1007/s10457-015-9787-9; [Anonymous], 2005, CONDITIONS AGR GROWT; Bayala J., 2002, TREE CROWN PRUNING M; Bayala J, 2008, AGROFOREST SYST, V72, P187, DOI 10.1007/s10457-007-9099-9; Bellefontaine R, 2002, TREES OUTSIDE FOREST; Boffa J., 1999, AGROFORESTRY PARKLAN; Boffa J. M., 2000, Unasylva (English ed.), V51, P11; Bonkoungou E, 1987, BUTYROSPERMUM PARADO; Bonkoungou EG, 2004, INT WORKSH PROC MARK, P51; Byakagaba P., 2011, Agricultural Journal, V6, P14, DOI 10.3923/aj.2011.14.22; Byakagaba P, 2012, RES J APPL SCI, V7, p92 ; Dah-Dovonon JZ, 2006, EVALUATION POTENTIAL; Delolme A, 1947, OLEAGINEUX, V4, p186 ; Desmarest J, 1958, OBSERVATIONS POPULAT; Dianda M, 2009, BIOTECHNOL AGRON SOC, V13, P93; Djossa Bruno A., 2008, Ecotropica (Bonn), V14, P37; Djossa BA, 2008, AGROFOREST SYST, V72, P205, DOI 10.1007/s10457-007-9097-y; Elias M, 2013, AGROFOREST SYST, V87, P203, DOI 10.1007/s10457-012-9536-2; FAO IIASA ISRIC ISSCAS, 2014, HARM WORLD SOIL DAT; Feller C., 1995, AGR DEV, V8, P35; HALL JB, 1996, VITELLARIA PARADOXA; Houehanou TD, 2013, FRUITS, V68, P109, DOI 10.1051/fruits/2013057; INSAE, 2013, NOU, P8; JESSEN RJ, 1955, BIOMETRICS, V11, P99, DOI 10.2307/3001484; Jones A, 2013, SOIL ATLAS AFRICA UN; Kelly BA, 2004, AGROFOREST SYST, V60, P3, DOI 10.1023/B:AGFO.0000009400.24606.e3; Ker A., 1995, FARMING SYSTEMS AFRI; KESSLER JJ, 1991, AGROFOREST SYST, V13, P41, DOI 10.1007/BF00129618; Lamien N., 2004, Fruits (Paris), V59, P423, DOI 10.1051/fruits:2005004; Lamien N, 2007, AGROFOREST SYST, V69, P1, DOI 10.1007/s10457-006-9013-x; Lovett PN, 2000, AGROFOREST SYST, V48, P273, DOI 10.1023/A:1006379217851; Lovett PNC, 2000, GENETIC DIVERSITY SH; Luedeling E, 2012, CLIMATIC CHANGE, V115, P443, DOI 10.1007/s10584-012-0438-0; Martini E, 2012, AGROFOREST SYST, V86, P401, DOI 10.1007/s10457-011-9441-0; Naughton CC, 2015, APPL GEOGR, V58, P217, DOI 10.1016/j.apgeog.2015.02.007; Norman DW, 1981, RES B, V4, P94; NRC, 2006, VEGETABLES, VII; Odebiyi J., 2009, WEST AFR J APPL ECOL, V5, DOI [10.4314/wajae.v5i1.45597, DOI 10.4314/WAJAE.V5I1.45597]; Okiror P, 2012, INT J FORESTRY RES, V2012, p1 ; Okullo JBL, 2004, AGROFOREST SYST, V60, P77, DOI 10.1023/B:AGFO.0000009407.63892.99; Ouedraogo S, 1996, JACHERE LIEU PRODUCT, p81 ; Platts PJ., 2010, REPORT INNOVKAR WORK; Romain Glele K, 2011, AFRICAN J ECOLOGY, V49, p440 , DOI DOI 10.1111/j.1365-2028.2011.01279.x; Roshetko J. M., 2013, Forests, Trees and Livelihoods, V22, P241, DOI 10.1080/14728028.2013.855150; Ruthenberg H., 1980, FARMING SYSTEMS TROP, V3rd; RUYSSEN B., 1957, Agron. trop., V12, P279; Sanogo K, 2016, DENDROCHRONOLOGIA, V40, P26, DOI 10.1016/j.dendro.2016.05.004; Sanou H, 2004, AGROFOREST SYST, V60, P93, DOI 10.1023/B:AGFO.0000009408.03728.46; Schreckenberg K., 1996, FORESTS FIELDS MARKE; Schreckenberg K., 2004, FOREST PRODUCTS LIVE, V2, P91; Some N Antoine, 2007, Biotechnologie Agronomie Societe et Environnement, V11, P245; Soro D., 2012, Journal of Applied Biosciences, V52, P3676; Traore KM, 2002, INT WORKSH PROC MARK, P185; Ugese FD, 2010, AGROFOREST SYST, V79, P201, DOI 10.1007/s10457-009-9261-7; USSCS, 1975, SOIL TAX BAS SYST SO; WRB, 2015, WORLD REF BAS SOIL R	61	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190234	10.1371/journal.pone.0190234	http://dx.doi.org/10.1371/journal.pone.0190234			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346406	Green Published, gold, Green Submitted			2022-12-26	WOS:000422749500011
J	Lebenbaum, M; Espin-Garcia, O; Li, Y; Rosella, LC				Lebenbaum, Michael; Espin-Garcia, Osvaldo; Li, Yi; Rosella, Laura C.			Development and validation of a population based risk algorithm for obesity: The Obesity Population Risk Tool (OPoRT)	PLOS ONE			English	Article							MODELS; PERFORMANCE	Background Given the dramatic rise in the prevalence of obesity, greater focus on prevention is necessary. We sought to develop and validate a population risk tool for obesity to inform prevention efforts. Methods We developed the Obesity Population Risk Tool (OPoRT) using the longitudinal National Population Health Survey and sex-specific Generalized Estimating Equations to predict the 10-year risk of obesity among adults 18 and older. The model was validated using a boot-strap approach accounting for the survey design. Model performance was measured by the Brier statistic, discrimination was measured by the C-statistic, and calibration was assessed using the Hosmer-Lemeshow Goodness of Fit Chi Square (HL chi(2)). Results Predictive factors included baseline body mass index, age, time and their interactions, smoking status, living arrangements, education, alcohol consumption, physical activity, and ethnicity. OPoRT showed good performance for males and females (Brier 0.118 and 0.095, respectively), excellent discrimination (C statistic >= 0.89) and achieved calibration (HL chi(2) < 20). Conclusion OPoRT is a valid and reliable algorithm that can be applied to routinely collected survey data to estimate the risk of obesity and identify groups at increased risk of obesity. These results can guide prevention efforts aimed at reducing the population burden of obesity.	[Lebenbaum, Michael; Espin-Garcia, Osvaldo; Li, Yi; Rosella, Laura C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Lebenbaum, Michael; Rosella, Laura C.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Li, Yi; Rosella, Laura C.] Publ Hlth Ontario, Toronto, ON, Canada	University of Toronto; University of Toronto	Rosella, LC (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Rosella, LC (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.; Rosella, LC (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.	laura.rosella@utoronto.ca			Canadian Institutes of Health Research (CIHR) [MOP137130]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This project was funded a Canadian Institutes of Health Research (CIHR) Operating Grant held by LR (MOP137130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Echouffo-Tcheugui JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067370; Efron B, 1997, J AM STAT ASSOC, V92, P548, DOI 10.2307/2965703; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Harrell Jr FE, 2012, R PACKAGE VERSION 3; Kennedy KF, 2009 MIDWEST SAS US; Kuhle S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-173; Levy DT, 2011, OBES REV, V12, P378, DOI 10.1111/j.1467-789X.2010.00804.x; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Manuel DG, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002082; Manuel DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143342; Manuel DG, 2012, J EPIDEMIOL COMMUN H, V66, P859, DOI 10.1136/jech-2012-200971; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nichols MS, 2010, OBES REV, V11, P731, DOI 10.1111/j.1467-789X.2009.00705.x; Noble D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7163; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Rosella L, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-35; Rosella LC, 2014, PREV MED, V58, P17, DOI 10.1016/j.ypmed.2013.10.007; Rosella LC, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-20; Rosella LC, 2011, J EPIDEMIOL COMMUN H, V65, P613, DOI 10.1136/jech.2009.102244; Shields Margot, 2011, Health Rep, V22, P35; Statistics Canada, 2012, HLTH SURV PDHS 2012; Steffen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067429; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Swain L, 1999, Health Rep, V10, P69; Tambay J L, 1995, Health Rep, V7, P29; Vergouwe Y, 2010, J CLIN EPIDEMIOL, V63, P205, DOI 10.1016/j.jclinepi.2009.03.017; von Ruesten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027455; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; Withrow D, 2011, OBES REV, V12, P131, DOI 10.1111/j.1467-789X.2009.00712.x; Zaninotto P, 2009, J EPIDEMIOL COMMUN H, V63, P140, DOI 10.1136/jech.2008.077305	39	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191169	10.1371/journal.pone.0191169	http://dx.doi.org/10.1371/journal.pone.0191169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346391	Green Submitted, Green Published, gold			2022-12-26	WOS:000422749500033
J	Taylor, TE; Muls, HL; Costello, RW; Reilly, RB				Taylor, Terence E.; Muls, Helena Lacalle; Costello, Richard W.; Reilly, Richard B.			Estimation of inhalation flow profile using audio-based methods to assess inhaler medication adherence	PLOS ONE			English	Article							DRY POWDER INHALER; ASTHMA; DISEASE; SOUNDS	Asthma and chronic obstructive pulmonary disease (COPD) patients are required to inhale forcefully and deeply to receive medication when using a dry powder inhaler (DPI). There is a clinical need to objectively monitor the inhalation flow profile of DPIs in order to remotely monitor patient inhalation technique. Audio-based methods have been previously employed to accurately estimate flow parameters such as the peak inspiratory flow rate of inhalations, however, these methods required multiple calibration inhalation audio recordings. In this study, an audio-based method is presented that accurately estimates inhalation flow profile using only one calibration inhalation audio recording. Twenty healthy participants were asked to perform 15 inhalations through a placebo Ellipta (TM) DPI at a range of inspiratory flow rates. Inhalation flow signals were recorded using a pneumotachograph spirometer while inhalation audio signals were recorded simultaneously using the Inhaler Compliance Assessment device attached to the inhaler. The acoustic (amplitude) envelope was estimated from each inhalation audio signal. Using only one recording, linear and power law regression models were employed to determine which model best described the relationship between the inhalation acoustic envelope and flow signal. Each model was then employed to estimate the flow signals of the remaining 14 inhalation audio recordings. This process repeated until each of the 15 recordings were employed to calibrate single models while testing on the remaining 14 recordings. It was observed that power law models generated the highest average flow estimation accuracy across all participants (90.89 +/- 0.9% for power law models and 76.63 +/- 2.38% for linear models). The method also generated sufficient accuracy in estimating inhalation parameters such as peak inspiratory flow rate and inspiratory capacity within the presence of noise. Estimating inhaler inhalation flow profiles using audio based methods may be clinically beneficial for inhaler technique training and the remote monitoring of patient adherence.	[Taylor, Terence E.; Muls, Helena Lacalle; Reilly, Richard B.] Univ Dublin, Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland; [Taylor, Terence E.; Reilly, Richard B.] Univ Dublin, Trinity Coll Dublin, Sch Engn, Dublin, Ireland; [Muls, Helena Lacalle] Univ Barcelona, Fac Med, Barcelona, Spain; [Costello, Richard W.] Royal Coll Surgeons Ireland, Dept Med, Dublin, Ireland; [Reilly, Richard B.] Univ Dublin, Trinity Coll Dublin, Sch Med, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; University of Barcelona; Royal College of Surgeons - Ireland; Trinity College Dublin	Taylor, TE (corresponding author), Univ Dublin, Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland.; Taylor, TE (corresponding author), Univ Dublin, Trinity Coll Dublin, Sch Engn, Dublin, Ireland.	taylorte@tcd.ie	Taylor, Terence/M-2158-2019; Reilly, Richard/N-1080-2019; Reilly, Richard B/F-7034-2011	Reilly, Richard/0000-0001-8578-1245; Reilly, Richard B/0000-0001-8578-1245; Costello, Richard/0000-0003-1179-6692	Irish Research Council (IRC) Enterprise Partnership Scheme (EPS) scholarship; Vitalograph Ireland (Ltd.); Health Research Board (HRB) Clinician Scientist Award (CSA) [CSA/59]; Enterprise Ireland Innovation Partnership award [2015/0412/6]	Irish Research Council (IRC) Enterprise Partnership Scheme (EPS) scholarship; Vitalograph Ireland (Ltd.); Health Research Board (HRB) Clinician Scientist Award (CSA); Enterprise Ireland Innovation Partnership award	This research was part funded by an Irish Research Council (IRC) (http://www.research.ie/) Enterprise Partnership Scheme (EPS) scholarship to TET which was also part funded by Vitalograph Ireland (Ltd.) (https:Vitalograph.le/), a Health Research Board (HRB) (http://www.hrb.ie/home/) Clinician Scientist Award (CSA) to RWC (CSA/59) and an Enterprise Ireland (https://www.enterprise ireland:corn/en/) Innovation Partnership award to RBR (2015/0412/6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was part funded by an Irish Research Council (IRC) Enterprise Partnership Scheme (EPS) scholarship to TET which was also part funded by Vitalograph Ireland (Ltd.), a Health Research Board (HRB) Clinician Scientist Award (CSA/59) to RWC and an Enterprise Ireland Innovation Partnership award to RBR (2015/0412/B).	Azouz W, 2012, PRIM CARE RESP J, V21, P208, DOI 10.4104/pcrj.2012.00010; Broeders MEAC, 2004, RESP MED, V98, P1173, DOI 10.1016/j.rmed.2004.04.010; D'Arcy S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098701; Gavriely N, 1996, J APPL PHYSIOL, V80, P5, DOI 10.1152/jappl.1996.80.1.5; Hamilton M, 2015, J AEROSOL MED PULM D, V28, P498, DOI 10.1089/jamp.2015.1225; Holmes MS, 2014, IEEE J TRANSL ENG HE, V2, DOI 10.1109/JTEHM.2014.2310480; Holmes MS, 2013, PHYSIOL MEAS, V34, P903, DOI 10.1088/0967-3334/34/8/903; Holmes MS, 2012, AUTOMATIC IDENTIFICA; Laube BL, 2011, EUR RESPIR J, V37, P1308, DOI 10.1183/09031936.00166410; Mahler DA, 2013, J AEROSOL MED PULM D, V26, P174, DOI 10.1089/jamp.2012.0987; McCartan TA, 2016, ENG MED BIOL SOC EMB; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Prime D, 2015, J AEROSOL MED PULM D, V28, P486, DOI 10.1089/jamp.2015.1224; Que CL, 2002, J APPL PHYSIOL, V93, P1515, DOI 10.1152/japplphysiol.00028.2002; Reyes BA, 2014, SENSORS-BASEL, V14, P13830, DOI 10.3390/s140813830; Seheult JN, 2014, PHARM RES-DORDR, V31, P2735, DOI 10.1007/s11095-014-1371-x; Sulaiman I, 2016, J ALLER CL IMM-PRACT, V4, P900, DOI 10.1016/j.jaip.2016.07.009; Taylor TE, 2016, BIOMED PHYS ENG EXPR, V2, DOI 10.1088/2057-1976/2/5/055021; Taylor TE, 2016, J AEROSOL MED PULM D, V29, P439, DOI 10.1089/jamp.2015.1276; Westerik JAM, 2016, J ASTHMA, V53, P321, DOI 10.3109/02770903.2015.1099160; Yadollahi A, 2008, ENG MED BIOL SOC EMB; Yadollahi A, 2013, ANN BIOMED ENG, V41, P537, DOI 10.1007/s10439-012-0692-3; Yadollahi A, 2011, IEEE T BIO-MED ENG, V58, P1663, DOI 10.1109/TBME.2011.2109717	24	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191330	10.1371/journal.pone.0191330	http://dx.doi.org/10.1371/journal.pone.0191330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346430	Green Published, gold, Green Submitted			2022-12-26	WOS:000422749500042
J	Tutino, VM; Poppenberg, KE; Jiang, KY; Jarvis, JN; Sun, YJ; Sonig, A; Siddiqui, AH; Snyder, KV; Levy, EI; Kolega, J; Meng, H				Tutino, Vincent M.; Poppenberg, Kerry E.; Jiang, Kaiyu; Jarvis, James N.; Sun, Yijun; Sonig, Ashish; Siddiqui, Adnan H.; Snyder, Kenneth V.; Levy, Elad I.; Kolega, John; Meng, Hui			Circulating neutrophil transcriptome may reveal intracranial aneurysm signature	PLOS ONE			English	Article							HUMAN CEREBRAL ANEURYSMS; GENE-EXPRESSION; MYELOPEROXIDASE; INFLAMMATION; ASSOCIATION; LIPOPROTEIN; BIOMARKERS; MANAGEMENT; CUFFLINKS; TOPHAT	Background Unruptured intracranial aneurysms (lAs) are typically asymptomatic and undetected except for incidental discovery on imaging. Blood-based diagnostic biomarkers could lead to improvements in IA management. This exploratory study examined circulating neutrophils to determine whether they carry RNA expression signatures of lAs. Methods Blood samples were collected from patients receiving cerebral angiography. Eleven samples were collected from patients with lAs and 11 from patients without lAs as controls. Samples from the two groups were paired based on demographics and comorbidities. RNA was extracted from isolated neutrophils and subjected to next-generation RNA sequencing to obtain differential expressions for identification of an IA-associated signature. Bioinformatics analyses, including gene set enrichment analysis and Ingenuity Pathway Analysis, were used to investigate the biological function of all differentially expressed transcripts. Results Transcriptome profiling identified 258 differentially expressed transcripts in patients with and without lAs. Expression differences were consistent with peripheral neutrophil activation. An IA-associated RNA expression signature was identified in 82 transcripts (p<0.05, fold-change >= 2). This signature was able to separate patients with and without lAs on hierarchical clustering. Furthermore, in an independent, unpaired, replication cohort of patients with lAs (n = 5) and controls (n = 5), the 82 transcripts separated 9 of 10 patients into their respective groups. Conclusion Preliminary findings show that RNA expression from circulating neutrophils carries an IA associated signature. These findings highlight a potential to use predictive biomarkers from peripheral blood samples to identify patients with lAs.	[Tutino, Vincent M.; Poppenberg, Kerry E.; Sonig, Ashish; Siddiqui, Adnan H.; Snyder, Kenneth V.; Levy, Elad I.; Kolega, John; Meng, Hui] SUNY Buffalo, Toshiba Stroke & Vasc Res Ctr, Buffalo, NY 14260 USA; [Tutino, Vincent M.; Poppenberg, Kerry E.; Meng, Hui] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA; [Jiang, Kaiyu; Jarvis, James N.] SUNY Buffalo, Genet Genom & Bioinformat Program, Buffalo, NY 14260 USA; [Jarvis, James N.] SUNY Buffalo, Dept Pediat, Buffalo, NY 14260 USA; [Sun, Yijun] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Sun, Yijun] SUNY Buffalo, Dept Comp Sci & Engn, Buffalo, NY 14260 USA; [Sonig, Ashish; Siddiqui, Adnan H.; Snyder, Kenneth V.; Levy, Elad I.; Meng, Hui] SUNY Buffalo, Dept Neurosurg, Buffalo, NY 14260 USA; [Siddiqui, Adnan H.; Snyder, Kenneth V.; Levy, Elad I.] SUNY Buffalo, Dept Radiol, Buffalo, NY 14260 USA; [Snyder, Kenneth V.] SUNY Buffalo, Dept Neurol, Buffalo, NY 14260 USA; [Kolega, John] SUNY Buffalo, Dept Pathol & Anat Sci, Buffalo, NY 14260 USA; [Meng, Hui] SUNY Buffalo, Dept Mech & Aerosp Engn, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Meng, H (corresponding author), SUNY Buffalo, Toshiba Stroke & Vasc Res Ctr, Buffalo, NY 14260 USA.; Meng, H (corresponding author), SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA.; Meng, H (corresponding author), SUNY Buffalo, Dept Neurosurg, Buffalo, NY 14260 USA.; Meng, H (corresponding author), SUNY Buffalo, Dept Mech & Aerosp Engn, Buffalo, NY 14260 USA.	huimeng@buffalo.edu	Meng, Hui/F-7929-2010; Siddiqui, Adnan H./AAG-9781-2019; Kolega, John/J-8386-2016	Kolega, John/0000-0001-6933-8681; Poppenberg, Kerry/0000-0002-1748-887X	Brain Aneurysm Foundation Carol Harvey Chair of Research Grant; Team Cindy-Alcatraz Chair of Research Grant; NIH [R01-AR-060604]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125982] Funding Source: NIH RePORTER	Brain Aneurysm Foundation Carol Harvey Chair of Research Grant; Team Cindy-Alcatraz Chair of Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Brain Aneurysm Foundation Carol Harvey Chair of Research Grant (HM) and Team Cindy-Alcatraz Chair of Research Grant (HM), and NIH grant R01-AR-060604 (JNJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alg VS, 2013, NEUROLOGY, V80, P2154, DOI 10.1212/WNL.0b013e318295d751; Andrews S., 2017, FASTQC QUALITY CONTR; BAKER CJ, 1995, NEUROSURGERY, V37, P56, DOI 10.1227/00006123-199507000-00008; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chalouhi N, 2015, DNA CELL BIOL, V34, P78, DOI 10.1089/dna.2014.2618; Chalouhi N, 2013, STROKE, V44, P2594, DOI 10.1161/STROKEAHA.113.002361; Chen Jiadi, 2015, INT J ANTENN PROPAG, V2015, P12, DOI DOI 10.1016/J.EJPHAR.2015.12.038; Chu Y, 2015, STROKE, V46, P1651, DOI 10.1161/STROKEAHA.114.008589; Eteleeb A, 2013, OA BIOINFORMATICS, V1; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Frosen J, 2012, ACTA NEUROPATHOL, V123, P773, DOI 10.1007/s00401-011-0939-3; Ghosh S, 2016, METHODS MOL BIOL, V1374, P339, DOI 10.1007/978-1-4939-3167-5_18; Goff L, 2016, ANAL EXPLORATION MAN, P73; Gounis MJ, 2014, STROKE, V45, P1474, DOI 10.1161/STROKEAHA.114.004956; Hart SN, 2013, J COMPUT BIOL, V20, P970, DOI 10.1089/cmb.2012.0283; Hussain I, 2013, STROKE, V44, P2670, DOI 10.1161/STROKEAHA.113.001753; Hussain S, 2015, WORLD NEUROSURG, V84, P1473, DOI 10.1016/j.wneu.2015.06.034; Jarvis JN, 2004, ARTHRITIS RES THER, V6, pR15, DOI 10.1186/ar1018; Jiang KY, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0128-7; Jin HW, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-296; Kimura H, 2001, AM J RESP CRIT CARE, V164, P319, DOI 10.1164/ajrccm.164.2.2006154; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Langfelder P, 2012, J STAT SOFTW, V46, P1; Leopold JA, 2015, HYPERTENSION, V66, P20, DOI 10.1161/HYPERTENSIONAHA.115.05479; Li PX, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000972; Meng H, 2014, AM J NEURORADIOL, V35, P1254, DOI 10.3174/ajnr.A3558; Pera J, 2010, STROKE, V41, P224, DOI 10.1161/STROKEAHA.109.562009; Phillips J, 1997, NEUROSURGERY, V40, P1112, DOI 10.1097/00006123-199705000-00067; Phillipson M, 2011, NAT MED, V17, P1381, DOI 10.1038/nm.2514; Raaymakers TWM, 1999, NEW ENGL J MED, V341, P1344; Ray L, 2013, AGING DIS, V4, P57; Rozen S, 2000, Methods Mol Biol, V132, P365; Sabatino G, 2013, J BIOL REG HOMEOS AG, V27, P729; Sandalcioglu IE, 2006, NEUROSURG REV, V29, P26, DOI 10.1007/s10143-005-0411-8; Serra R., 2014, BRIT J NEUROSURGERY; Stapleton PP, 1998, ADV EXP MED BIOL, V442, P183; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tromp G, 2014, ANN MED, V46, P597, DOI 10.3109/07853890.2014.949299; Tulamo R, 2010, J NEUROINTERV SURG, V2, P120, DOI 10.1136/jnis.2009.002055; Vega C, 2002, AM FAM PHYSICIAN, V66, P601; Wang Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001050; Wardlaw JM, 2000, BRAIN, V123, P205, DOI 10.1093/brain/123.2.205; Yu LB, 2017, WORLD NEUROSURG, V105, P28, DOI 10.1016/j.wneu.2017.04.064; Zhang HF, 2013, INFLAMMATION, V36, P1195, DOI 10.1007/s10753-013-9655-6; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	47	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191407	10.1371/journal.pone.0191407	http://dx.doi.org/10.1371/journal.pone.0191407			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342213	Green Published, gold, Green Submitted			2022-12-26	WOS:000422653800069
J	Cherng, YG; Lin, CS; Shih, CC; Hsu, YH; Yeh, CC; Hu, CJ; Chen, TL; Liao, CC				Cherng, Yih-Giun; Lin, Chao-Shun; Shih, Chun-Chuan; Hsu, Yung-Ho; Yeh, Chun-Chieh; Hu, Chaur-Jong; Chen, Ta-Liang; Liao, Chien-Chang			Stroke risk and outcomes in patients with chronic kidney disease or end-stage renal disease: Two nationwide studies	PLOS ONE			English	Article							ERYTHROPOIESIS-STIMULATING AGENTS; ALL-CAUSE MORTALITY; MAINTENANCE HEMODIALYSIS; CKD; POPULATION; PREVALENCE; HEMORRHAGE; EVENTS; UREMIA; ADULTS	Background and aims Because the risk and outcomes of stroke in patients with chronic kidney disease (CKD) or end-stage renal disease (ESRD) were unclear, we evaluated these risks using a retrospective cohort study and a nested cohort study. Methods We used Taiwan's National Health Insurance Research Database to identify 1378 patients aged >= 20 years who had ESRD in 2000-2004. An age- and sex-matched CKD cohort (n = 5512) and a control cohort (n = 11,024) were selected for comparison. Events of incident stroke were considered as outcome during the follow-up period in 2000-2013, and we calculated adjusted hazard ratios (HR) and 95% CIs of stroke associated with CKD or ESRD. We further used matching procedure with propensity score to estimate the risk of stroke for control group, CKD patients, and EDRD patients. A nested cohort study of 318,638 hospitalized stroke patients between 2000 and 2010 also was conducted to analyze the impact of CKD and ESRD on post-stroke mortality. Results Before propensity-score matching, the incidences of stroke for controls, CKD patients and ESRD patients were 6.57, 13.3, and 21.7 per 1000 person-years, respectively. Compared with control group, the adjusted HRs of stroke were 1.49 (95% Cl, 1.32-1.68) and 2.39 (95% Cl, 1.39-2.87) for people with CKD or ESRD respectively, and were significantly higher in both sexes and every age group. After propensity-score matching, the HRs of stroke for patients with CKD and ESRD were 1.51 (95% Cl 1.24-1.85) and 2.08 (95% Cl 1.32-3.26), respectively, during the follow-up period. Among hospitalized stroke patients, adjusted rate ratio (RR) of post-stroke mortalityin CKD and ESRD cohorts were 1.44 (95% Cl, 1.33-1.56) and 2.62 (95% Cl, 2.43-2.82) respectively compared with control. Conclusions CKD and ESRD patient groupsthus faced significantly higher risk of stroke and post-stroke mortality. Risk factor identification and preventive strategies are needed to minimize stroke risk and post-stroke mortality in these vulnerable patient groups.	[Cherng, Yih-Giun; Liao, Chien-Chang] Taipei Med Univ, Shuang Ho Hosp, Dept Anesthesiol, New Taipei, Taiwan; [Cherng, Yih-Giun; Lin, Chao-Shun; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Lin, Chao-Shun; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Lin, Chao-Shun; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Anesthesiol & Hlth Policy Res Ctr, Taipei, Taiwan; [Shih, Chun-Chuan] I Shou Univ, Coll Med, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan; [Shih, Chun-Chuan] Taipei Med Univ, Program Clin Drug Discovery Bot Herbs, Taipei, Taiwan; [Hsu, Yung-Ho] Taipei Med Univ, Shuang Ho Hosp, Dept Nephrol, New Taipei, Taiwan; [Hsu, Yung-Ho] Taipei Med Univ, Coll Med, Dept Nephrol, Taipei, Taiwan; [Yeh, Chun-Chieh] China Med Univ Hosp, Dept Surg, Taichung, Taiwan; [Yeh, Chun-Chieh] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, New Taipei, Taiwan; [Liao, Chien-Chang] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; I Shou University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Taipei Medical University; Shuang Ho Hospital; China Medical University Taiwan	Liao, CC (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Anesthesiol, New Taipei, Taiwan.; Liao, CC (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Anesthesiol, Taipei, Taiwan.; Liao, CC (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan.; Liao, CC (corresponding author), Taipei Med Univ Hosp, Anesthesiol & Hlth Policy Res Ctr, Taipei, Taiwan.; Liao, CC (corresponding author), China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan.	jacky48863027@yahoo.com.tw	Yeh, Chun Chieh/I-4893-2019	Yeh, Chun Chieh/0000-0001-6753-7564; Cherng, Yih-Giun/0000-0002-0201-4380	Shuang Ho Hospital; Taipei Medical University [104TMU-SHH-23]; Taiwan Ministry of Science and Technology [MOST105-2629-B-038-001, MOST105-2314-B-038-025, MOST104-2314-B-038-027-MY2, NSC102-2314-B-038-021-MY3]; Clinical Trial and Research Center of Excellence, Taiwan Ministry of Health and Welfare [MOHW106-TDU-B-212-113004]	Shuang Ho Hospital; Taipei Medical University; Taiwan Ministry of Science and Technology; Clinical Trial and Research Center of Excellence, Taiwan Ministry of Health and Welfare	This research was supported in part by Shuang Ho Hospital, Taipei Medical University (104TMU-SHH-23 to CCL), Taiwan Ministry of Science and Technology (MOST105-2629-B-038-001 to CCL; MOST105-2314-B-038-025 to TLC; MOST104-2314-B-038-027-MY2 to CCL; NSC102-2314-B-038-021-MY3 to TLC), and Clinical Trial and Research Center of Excellence, Taiwan Ministry of Health and Welfare (MOHW106-TDU-B-212-113004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertrand ME, 2016, AM J CARDIOVASC DRUG, V16, P241, DOI 10.1007/s40256-016-0175-2; Berzigotti A, 2005, LIVER INT, V25, P331, DOI 10.1111/j.1478-3231.2005.01002.x; Bugnicourt JM, 2009, CLIN J AM SOC NEPHRO, V4, P284, DOI 10.2215/CJN.02140508; Chang YT, 2014, DIABETES CARE, V37, P277, DOI 10.2337/dc13-0781; Chen C., 2016, BIORESOURCES, V11, P1, DOI [10.15376/biores.11.2.Chen, DOI 10.1109/SIES.2016.7509422]; Cherng YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058942; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; DIMINNO G, 1985, AM J MED, V79, P552, DOI 10.1016/0002-9343(85)90051-8; Elias MF, 2009, NEPHROL DIAL TRANSPL, V24, P2446, DOI 10.1093/ndt/gfp107; Etgen T, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0115-4; Ifudu O, 1998, NEW ENGL J MED, V339, P1054, DOI 10.1056/NEJM199810083391507; Iseki K, 2000, NEPHROL DIAL TRANSPL, V15, P1808, DOI 10.1093/ndt/15.11.1808; ISEKI K, 1993, KIDNEY INT, V44, P1086, DOI 10.1038/ki.1993.352; ISEKI K, 1993, KIDNEY INT, V44, P115, DOI 10.1038/ki.1993.220; Kawamura M, 1998, AM J KIDNEY DIS, V31, P991, DOI 10.1053/ajkd.1998.v31.pm9631844; Kuwabara Y, 2002, KIDNEY INT, V61, P564, DOI 10.1046/j.1523-1755.2002.00142.x; Liao CC, 2014, BRIT J SURG, V101, P1616, DOI 10.1002/bjs.9639; Longenecker JC, 2002, J AM SOC NEPHROL, V13, P1918, DOI 10.1097/01.ASN.0000019641.41496.1E; Major RW, 2015, CLIN J AM SOC NEPHRO, V10, P732, DOI 10.2215/CJN.07460714; Masson P, 2015, NEPHROL DIAL TRANSPL, V30, P1162, DOI 10.1093/ndt/gfv009; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Muller KAL, 2015, THROMB HAEMOSTASIS, V114, P498, DOI 10.1160/TH14-11-0947; Muntner P, 2002, AM J KIDNEY DIS, V40, P323, DOI 10.1053/ajkd.2002.34515; National Institute of Diabetes and Digestive and Kidney Diseases. U.S. Renal Data System, 2014, USRDS 2014 ANNUAL DA; Ninomiya T, 2008, KIDNEY INT, V73, P963, DOI 10.1038/ki.2008.5; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Power A, 2012, AM J KIDNEY DIS, V59, P249, DOI 10.1053/j.ajkd.2011.07.016; Rahman M, 2014, CLIN J AM SOC NEPHRO, V9, P1190, DOI 10.2215/CJN.09320913; Sanchez-Perales C, 2010, NEPHROL DIAL TRANSPL, V25, P3343, DOI 10.1093/ndt/gfq220; Seliger SL, 2003, J AM SOC NEPHROL, V14, P2623, DOI 10.1097/01.ASN.0000088722.56342.A8; Seliger SL, 2003, KIDNEY INT, V64, P603, DOI 10.1046/j.1523-1755.2003.00101.x; Seliger SL, 2011, KIDNEY INT, V80, P288, DOI 10.1038/ki.2011.49; Sozio SM, 2009, AM J KIDNEY DIS, V54, P468, DOI 10.1053/j.ajkd.2009.01.261; Tamura MK, 2012, NEUROLOGY, V79, P981, DOI 10.1212/WNL.0b013e31826845e9; Tonelli M, 2016, CIRCULATION, V133, P518, DOI 10.1161/CIRCULATIONAHA.115.018713; Toyoda K, 2005, AM J KIDNEY DIS, V45, P1058, DOI 10.1053/j.ajkd.2005.02.028; Toyoda K, 2014, LANCET NEUROL, V13, P823, DOI 10.1016/S1474-4422(14)70026-2; Wang HH, 2014, AM J KIDNEY DIS, V63, P604, DOI 10.1053/j.ajkd.2013.10.013; Weiner DE, 2006, AM J KIDNEY DIS, V48, P392, DOI 10.1053/j.ajkd.2006.05.021; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Xu J, 2011, NEPHROL DIAL TRANSPL, V26, P2590, DOI 10.1093/ndt/gfq748; Yahalom G, 2009, STROKE, V40, P1296, DOI 10.1161/STROKEAHA.108.520882; Yoo DJ, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-39; Zheng G, 2016, SCI REP-UK, V6, DOI 10.1038/srep22346	44	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191155	10.1371/journal.pone.0191155	http://dx.doi.org/10.1371/journal.pone.0191155			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329323	gold, Green Published, Green Submitted			2022-12-26	WOS:000419954100041
J	Veerbeek, JM; Winters, C; van Wegen, EEH; Kwakkel, G				Veerbeek, Janne M.; Winters, Caroline; van Wegen, Erwin E. H.; Kwakkel, Gert			Is the proportional recovery rule applicable to the lower limb after a first-ever ischemic stroke?	PLOS ONE			English	Article							FUGL-MEYER ASSESSMENT; MOTOR RECOVERY; CORTICOSPINAL TRACT; IMPROVEMENT; IMPAIRMENT; POSTSTROKE; PREDICTION; REHABILITATION; VARIABILITY; PLASTICITY	Objective To investigate (a) the applicability of the proportional recovery rule of spontaneous neurobiological recovery to motor function of the paretic lower extremity (LE); and (b) the presence of fitters and non-fitters of this prognostic rule poststroke. When present, the clinical threshold for fitting nor non-fitting would be determined, as well as within-subject generalizability to the paretic upper extremity (UE). Methods Prospective cohort study in which the Fugl-Meyer Assessment (FMA)-LE and FMA-UE were measured <72 hours and 6 months poststroke. Predicted maximum potential recovery was defined as [FMA-LEmax-FMA-LEinitial = 34-FMA-LEinitial]. Hierarchical clustering in 202 first-ever ischemic stroke patients distinguished between fitting and not fitting the rule. Descriptive statistics determined whether fitters and non-fitters for LE were the same persons as for UE. Results 175 (87%) patients fitted the FMA-LE recovery rule. The observed average improvement of the fitters was similar to 64% of the predicted maximum potential recovery. In the non-fitter group, the maximum initial FMA-LE score was 13 points. Fifty-one out of 78 patients (similar to 65%) who scored below the identified 14-point threshold at baseline fitted the FMA-LE rule. Non-fitters were more severely affected than fitters. All non-fitters of the FMA-LE rule did also not fit the proportional recovery rule for FMA-UE. Conclusions Proportional recovery seems to be consistent within subjects across LE and UE motor impairment at the hemiplegic side in first-ever ischemic hemispheric stroke subjects. Future studies should investigate prospectively distinguishing between fitters and not-fitters within the subgroup of patients who have initial low FMA-LE scores. Subsequently, patients could be stratified based on fitting or not fitting the recovery rule as this would impact rehabilitation management and trial design.	[Veerbeek, Janne M.; Winters, Caroline; van Wegen, Erwin E. H.; Kwakkel, Gert] Vrije Univ Amsterdam, Dept Rehabil Med, Med Ctr, Amsterdam, Netherlands; [Veerbeek, Janne M.; Winters, Caroline; van Wegen, Erwin E. H.; Kwakkel, Gert] Amsterdam Movement Sci, Amsterdam, Netherlands; [Veerbeek, Janne M.; Winters, Caroline; van Wegen, Erwin E. H.; Kwakkel, Gert] Amsterdam Neurosci, Amsterdam, Netherlands; [Veerbeek, Janne M.] Univ Zurich, Div Vasc Neurol & Neu rorehabil, Zurich, Switzerland; [Veerbeek, Janne M.] Ctr Neurol & Rehabil, Cereneo, Vitznau, Switzerland; [Kwakkel, Gert] Rehabil Res Ctr, Amsterdam, Netherlands; [Kwakkel, Gert] Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Zurich; Northwestern University	Kwakkel, G (corresponding author), Vrije Univ Amsterdam, Dept Rehabil Med, Med Ctr, Amsterdam, Netherlands.; Kwakkel, G (corresponding author), Amsterdam Movement Sci, Amsterdam, Netherlands.; Kwakkel, G (corresponding author), Amsterdam Neurosci, Amsterdam, Netherlands.; Kwakkel, G (corresponding author), Rehabil Res Ctr, Amsterdam, Netherlands.; Kwakkel, G (corresponding author), Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.	g.kwakkel@vumc.nl	Veerbeek, Janne/W-7424-2019	Veerbeek, Janne/0000-0002-6337-6780; van Wegen, Erwin/0000-0002-7920-9995; Kwakkel, Gert/0000-0002-4041-4043	"Wetenschappelijk College Fysiotherapie" of the Royal Dutch Society for Physical Therapy (KNGF), the Netherlands [33368]; Dutch National Institute of Health (ZonMw), EXPLICIT-stroke programme [89000001]	"Wetenschappelijk College Fysiotherapie" of the Royal Dutch Society for Physical Therapy (KNGF), the Netherlands; Dutch National Institute of Health (ZonMw), EXPLICIT-stroke programme	The present work was part of the EPOS research project funded by the ''Wetenschappelijk College Fysiotherapie'' (grant number 33368) of the Royal Dutch Society for Physical Therapy (KNGF), the Netherlands. This part of the EPOS project was co-financed by the Dutch National Institute of Health (ZonMw) (grant number 89000001) as a part of the EXPLICIT-stroke programme (www.explicit-stroke.nl).	Berkhemer OA, 2016, STROKE, V47, P768, DOI 10.1161/STROKEAHA.115.011788; Bernhardt J, 2017, NEUROREHAB NEURAL RE, V31, P694, DOI 10.1177/1545968317724290; Bernhardt J, 2015, LANCET, V386, P46, DOI 10.1016/S0140-6736(15)60690-0; Bigourdan A, 2016, STROKE, V47, P1053, DOI 10.1161/STROKEAHA.115.011576; Buch ER, 2016, NEUROLOGY, V86, P1924, DOI 10.1212/WNL.0000000000002675; Buma F, 2013, RESTOR NEUROL NEUROS, V31, P707, DOI 10.3233/RNN-130332; Byblow WD, 2015, ANN NEUROL; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Cramer SC, 2012, EUR J NEUROL, V19, P718, DOI 10.1111/j.1468-1331.2011.03615.x; Di Pino G, 2014, NAT REV NEUROL, V10, P597, DOI 10.1038/nrneurol.2014.162; Dunn LE, 2016, CEREBROVASC DIS EXTR, V6, P12, DOI 10.1159/000444149; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Feng WW, 2015, ANN NEUROL, V78, P860, DOI 10.1002/ana.24510; Gladstone DJ, 2002, NEUROREHAB NEURAL RE, V16, P232, DOI 10.1177/154596802401105171; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Hiu T, 2016, BRAIN, V139, P468, DOI 10.1093/brain/awv360; Hunter AJ, 2011, PHYS THER, V91, P1503, DOI 10.2522/ptj.20100271; Khatri R, 2012, NEUROLOGY, V79, pS52, DOI 10.1212/WNL.0b013e3182697e70; Kim B, 2017, NEUROREHAB NEURAL RE, V31, P3, DOI 10.1177/1545968316662708; Kwakkel G, 2006, STROKE, V37, P2348, DOI 10.1161/01.STR.0000238594.91938.1e; Kwakkel G, 2016, NEUROREHAB NEURAL RE, V30, P804, DOI 10.1177/1545968315624784; Lazar RM, 2010, STROKE, V41, P1485, DOI 10.1161/STROKEAHA.109.577338; Lindau NT, 2014, BRAIN, V137, P739, DOI 10.1093/brain/awt336; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Ng YS, 2016, AM J PHYS MED REHAB, V95, P709, DOI 10.1097/PHM.0000000000000502; Nijboer TCW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100584; Prabhakaran S, 2008, NEUROREHAB NEURAL RE, V22, P64, DOI 10.1177/1545968307305302; SANFORD J, 1993, PHYS THER, V73, P447, DOI 10.1093/ptj/73.7.447; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Smith MC, 2017, STROKE, V48, P1400, DOI 10.1161/STROKEAHA.116.016478; Stanne TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114156; Stinear C, 2010, LANCET NEUROL, V9, P1228, DOI 10.1016/S1474-4422(10)70247-7; Stinear CM, 2017, STROKE, V48, P795, DOI 10.1161/STROKEAHA.116.016020; Turhan N, 2009, NEUROREHABILITATION, V24, P321, DOI 10.3233/NRE-2009-0485; Veerbeek JM, 2011, NEUROREHAB NEURAL RE, V25, P268, DOI 10.1177/1545968310384271; Veerbeek JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087987; Wahl AS, 2014, SCIENCE, V344, P1250, DOI 10.1126/science.1253050; Winters C, 2016, NEUROREHABIL NEURAL; Winters C, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1592-x; Winters C, 2015, NEUROREHAB NEURAL RE, V29, P614, DOI 10.1177/1545968314562115; Zarahn E, 2011, CEREB CORTEX, V21, P2712, DOI 10.1093/cercor/bhr047	42	27	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0189279	10.1371/journal.pone.0189279	http://dx.doi.org/10.1371/journal.pone.0189279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329286	Green Published, Green Submitted, gold			2022-12-26	WOS:000419954100006
J	Wang, MN; Duan, L; Qiao, Q; Wang, ZF; Zimmer, EA; Li, ZC; Chen, HF				Wang, Mei-Na; Duan, Lei; Qiao, Qi; Wang, Zheng-Feng; Zimmer, Elizabeth A.; Li, Zhong-Chao; Chen, Hong-Feng			Phylogeography and conservation genetics of the rare and relict Bretschneidera sinensis (Akaniaceae)	PLOS ONE			English	Article							CHLOROPLAST DNA PHYLOGEOGRAPHY; NONCODING REGIONS; GEOGRAPHICAL-DISTRIBUTION; EVOLUTIONARY HISTORY; UNIVERSAL PRIMERS; CPDNA HAPLOTYPES; AMPLIFICATION; MITOCHONDRIAL; SET; POPULATIONS	Bretschneidera sinensis, a class-l protected wild plant in China, is a relic of the ancient Tertiary tropical flora endemic to Asia. However, little is known about its genetics and phylogeography. To elucidate the current phylogeographic patterns and infer the historical population dynamics of B. sinensis, and to make recommendations for its conservation, three non-coding regions of chloroplast DNA (trnQ-rps16, rps8-rps11, and trnT-trnL) were amplified and sequenced across 256 individuals from 23 populations of B. sinensis, spanning 10 provinces of China. We recognized 13 haplotypes, demonstrating relatively high total haplotype diversity (h(T) = 0.739). Almost all of the variation existed among populations (98.09%, P<0.001), but that within populations was low (1.91%, P< 0.001). Strong genetic differentiation was detected among populations (G(ST)= 0.855, P < 0.001) with limited estimations of seed flow (N-m = 0.09), indicating that populations were strongly isolated from one another. According to SAMOVA analysis, populations of B. sinensis in China could be divided into five geographic groups: (1) eastern Yunnan to western Guangxi; (2) Guizhou-Hunan-Hubei; (3) central Guangdong; (4) northwestern Guangdong; and (5) the Luoxiao-Nanling-Wuyi-Yangming Mountain. Network analysis showed that the most ancestral haplotypes were located in the first group, i.e., the eastern Yungui Plateau and in eastern Yunnan, which is regarded as a putative glacial refugia for B. sinensis in China. B. sinensis may have expanded its range eastward from these refugia and experienced bottleneck or founder effects in southeastern China. Populations in Liping (Guizhou Province), Longsheng (Guangxi Province), Huizhou (Guangdong Province), Chongyi (Jiangxi Province), Dong-an (Hunan Province), Pingbian (Yunnan Province) and Xinning (Hunan Province) are proposed as the priority protection units.	[Wang, Mei-Na; Duan, Lei; Qiao, Qi; Wang, Zheng-Feng; Li, Zhong-Chao; Chen, Hong-Feng] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable Ut, Guangzhou, Guangdong, Peoples R China; [Wang, Mei-Na] Natl Orchid Conservat Ctr China, Shenzhen Key Lab Orchid Conservat & Utilizat, Shenzhen, Peoples R China; [Wang, Mei-Na] Orchid Conservat & Res Ctr Shenzhen, Shenzhen, Peoples R China; [Qiao, Qi] Henan Univ Sci & Technol, Coll Agr, Luoyang, Peoples R China; [Zimmer, Elizabeth A.] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, MRC 166, Washington, DC 20560 USA	Chinese Academy of Sciences; South China Botanical Garden, CAS; Henan University of Science & Technology; Smithsonian Institution; Smithsonian National Museum of Natural History	Chen, HF (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable Ut, Guangzhou, Guangdong, Peoples R China.	h.f.chen@scbg.ac.cn	Duan, Lei/HGT-9132-2022; Duan, Lei/HGT-9055-2022	Duan, Lei/0000-0001-6152-5458	National Natural Science Foundation of China [31570337, 31170196]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (31570337, 31170196). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2000, TAXON, V49, P721, DOI 10.2307/1223973; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BIRKY CW, 1989, GENETICS, V121, P613; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cao YN, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0636-x; Chen JM, 2015, CONSERV GENET, V16, P583, DOI 10.1007/s10592-014-0683-z; Chen YY, 1984, QUATERNARY GEOLOGY, P40; Chiang TY, 1999, MOL ECOL, V8, P1037, DOI 10.1046/j.1365-294x.1999.00668.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; DEMESURE B, 1995, MOL ECOL, V4, P129, DOI 10.1111/j.1365-294X.1995.tb00201.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Ebert D, 2009, MOL ECOL RESOUR, V9, P777, DOI 10.1111/j.1755-0998.2008.02320.x; Excoffier L, 2009, ARLEQUIN VER 3 5 INT; FU YX, 1993, GENETICS, V133, P693; Gao LM, 2007, MOL ECOL, V16, P4684, DOI 10.1111/j.1365-294X.2007.03537.x; Gong W, 2008, MOL PHYLOGENET EVOL, V48, P1094, DOI 10.1016/j.ympev.2008.05.003; Grivet D, 2001, MOL ECOL NOTES, V1, P345, DOI 10.1046/j.1471-8278.2001.00107.x; Hall JC, 2004, SYST BOT, V29, P654, DOI 10.1600/0363644041744491; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamilton MB, 1999, MOL ECOL, V8, P521; Hardy ME, 2002, MOL ECOL, V11, P2393, DOI 10.1046/j.1365-294X.2002.01616.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hoskin CJ, 2005, NATURE, V437, P1353, DOI 10.1038/nature04004; Huang S, 2001, MOL ECOL, V10, P2669, DOI 10.1046/j.0962-1083.2001.01395.x; Hwang SY, 2003, MOL ECOL, V12, P2689, DOI 10.1046/j.1365-294X.2003.01935.x; Lu AM, 1999, GEOGRAPHY SPERMATOPH, P358; Lu Jing, 1994, Acta Botanica Sinica, V36, P459; Lu LL, 2005, FLORA CHINA, V8, P197; Ma Q, 2015, SYST BOT, V40, P796, DOI 10.1600/036364415X689267; Ministry of Environmental Protection of the People's Republic of China, 2013, IUCN RED LIST CHIN A; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pons O, 1996, GENETICS, V144, P1237; Posada D, 2000, MOL ECOL, V9, P487, DOI 10.1046/j.1365-294x.2000.00887.x; Qi Q, 2009, SEED SCI TECHNOL, V37, P70, DOI 10.15258/sst.2009.37.1.09; Qi XS, 2012, NEW PHYTOL, V196, P617, DOI 10.1111/j.1469-8137.2012.04242.x; Qiao Q, 2010, THESIS; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saeki I, 2009, DIVERS DISTRIB, V15, P917, DOI 10.1111/j.1472-4642.2009.00609.x; Saltonstall K, 2001, MOL ECOL NOTES, V1, P76, DOI 10.1046/j.1471-8278.2001.00031.x; Schaal BA, 2000, P NATL ACAD SCI USA, V97, P7024, DOI 10.1073/pnas.97.13.7024; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI 10.1006/bojl.2000.0380; Sun YX, 2014, J BIOGEOGR, V41, P1721, DOI 10.1111/jbi.12323; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1995, GENETICS, V140, P767; TOBE H, 1995, BOT J LINN SOC, V118, P261; Tsy JMLP, 2009, MOL ECOL, V18, P1707, DOI 10.1111/j.1365-294X.2009.04144.x; Tzedakis PC, 2002, SCIENCE, V292, P267; Wang HW, 2006, MOL ECOL, V15, P4109, DOI 10.1111/j.1365-294X.2006.03086.x; Wang J, 2009, J BIOGEOGR, V36, P2156, DOI 10.1111/j.1365-2699.2009.02165.x; WANG WT, 1992, ACTA PHYTOTAXON SIN, V30, P1, DOI DOI 10.4324/9780429500190-1; Wang YL, 2010, MOL PHYLOGENET EVOL, V55, P721, DOI 10.1016/j.ympev.2010.02.010; Watanabe K, 2006, AM J BOT, V93, P442, DOI 10.3732/ajb.93.3.442; Wu Zhongliang, 1991, Acta Seismologica Sinica, V13, P1; Wu ZY, 2003, FAMILIES GENERA ANGI, P702; Yamane K, 2005, AM J BOT, V92, P1887, DOI 10.3732/ajb.92.11.1887; YING JS, 2001, BIODIVERSITY SCI, V9, P393, DOI DOI 10.17520/BI0DS.2001058; Ying T.S., 1996, J SYST EVOL, V34, P479; Yu Y. F., 1999, PLANTS, V5, P3; Zhang H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-21	67	6	10	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0189034	10.1371/journal.pone.0189034	http://dx.doi.org/10.1371/journal.pone.0189034			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329302	Green Published, gold, Green Submitted			2022-12-26	WOS:000419954100005
J	Harmon, BS; Martin, DR; Chizinski, CJ; Pope, KL				Harmon, Brian S.; Martin, Dustin R.; Chizinski, Christopher J.; Pope, Kevin L.			Variation in angler distribution and catch rates of stocked rainbow trout in a small reservoir	PLOS ONE			English	Article							ONCORHYNCHUS-MYKISS; FISHERIES; MOVEMENTS; DYNAMICS; FISH	We investigated the spatial and temporal relationship of catch rates and angler party location for two days following a publicly announced put-and-take stocking of rainbow trout (Oncorhynchus mykiss). Catch rates declined with time since stocking and distance from stocking. We hypothesized that opportunity for high catch rates would cause anglers to fish near the stocking location and disperse with time, however distance between angler parties and stocking was highly variable at any given time. Spatially explicit differences in catch rates can affect fishing quality. Further research could investigate the variation between angler distribution and fish distribution within a waterbody.	[Harmon, Brian S.; Martin, Dustin R.] Univ Nebraska, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE 68588 USA; [Harmon, Brian S.; Martin, Dustin R.; Chizinski, Christopher J.; Pope, Kevin L.] Univ Nebraska, Sch Nat Resources, Lincoln, NE 68588 USA; [Pope, Kevin L.] Univ Nebraska, US Geol Survey, Cooperat Fish & Wildlife Res Unit, Lincoln, NE USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; United States Department of the Interior; United States Geological Survey; University of Nebraska System; University of Nebraska Lincoln	Harmon, BS (corresponding author), Univ Nebraska, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE 68588 USA.; Harmon, BS (corresponding author), Univ Nebraska, Sch Nat Resources, Lincoln, NE 68588 USA.	brian.harmon@huskers.unl.edu	Pope, Kevin/D-8096-2011	Pope, Kevin/0000-0003-1876-1687	Federal Aid in Sport Fish Restoration [F-182-R]; U.S. Geological Survey; Nebraska Game and Parks Commission; University of Nebraska; U.S. Fish and Wildlife Service; Wildlife Management Institute	Federal Aid in Sport Fish Restoration; U.S. Geological Survey(United States Geological Survey); Nebraska Game and Parks Commission; University of Nebraska; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Wildlife Management Institute	All project funding was provided by the Federal Aid in Sport Fish Restoration project F-182-R, which was administered by the Nebraska Game and Parks Commission. Kevin L. Popes salary was provided by U.S. Geological Survey, and office and laboratory space was provided by the University of Nebraska. Non-financial support was provided by the U.S. Fish and Wildlife Service and the Wildlife Management Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. The Nebraska Cooperative Fish and Wildlife Research Unit is jointly supported by a cooperative agreement among the U.S. Geological Survey, the Nebraska Game and Parks Commission, the University of Nebraska, the U.S. Fish and Wildlife Service, and the Wildlife Management Institute. Although this software program has been used by the U.S. Geological Survey (USGS), no warranty, expressed or implied, is made by the USGS or the U.S. Government as to the accuracy and functioning of the program and related program material nor shall the fact of distribution constitute any such warranty, and no responsibility is assumed by the USGS in connection therewith."	Abernethy KE, 2007, CAN J FISH AQUAT SCI, V64, P1595, DOI 10.1139/F07-125; Arlinghaus R, 2006, N AM J FISH MANAGE, V26, P592, DOI 10.1577/M04-220.1; Baccante Dominic, 1995, North American Journal of Fisheries Management, V15, P661, DOI 10.1577/1548-8675(1995)015<0661:ACIIWA>2.3.CO;2; Bolker B., 2012, GETTING STARTED GLMM; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butler RL, 1965, CALIFORNIA CATCHABLE, V117, P6; Cabanellas-Reboredo M, 2017, FISH RES, V188, P100, DOI 10.1016/j.fishres.2016.12.008; FRETWELL S D, 1972, P217; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Gillis DM, 2001, ICES J MAR SCI, V58, P61, DOI 10.1006/jmsc.2000.0990; Hunt L.M., 2005, HUMAN DIMENSIONS WIL, V10, P153, DOI [10.1080/10871200591003409, DOI 10.1080/10871200591003409]; Ivasauskas T.J., 2011, P ANN C SE ASS FISH, V65, P83; James GD, 1995, NEW ZEAL J MAR FRESH, V29, P493, DOI 10.1080/00288330.1995.9516682; Johnston FD, 2013, FISH FISH, V14, P554, DOI 10.1111/j.1467-2979.2012.00487.x; JORGENSEN EH, 1993, AQUACULTURE, V110, P191, DOI 10.1016/0044-8486(93)90272-Z; Kopaska J, 2014, FISHERIES, V39, P6, DOI 10.1080/03632415.2013.865609; Matthias BG, 2014, FISHERIES, V39, P261, DOI 10.1080/03632415.2014.903836; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pollock K.H., 1994, AM FISHERIES SOC SPE, V25; Pope KL, 2016, J ENVIRON MANAGE, V183, P408, DOI 10.1016/j.jenvman.2016.04.024; Post JR, 2008, ECOL APPL, V18, P1038, DOI 10.1890/07-0465.1; Post JR, 2002, FISHERIES, V27, P6, DOI 10.1577/1548-8446(2002)027&lt;0006:CRF&gt;2.0.CO;2; R Core Team, 2013, R LANG ENV STAT COMP; Radinger J, 2014, FISH FISH, V15, P456, DOI 10.1111/faf.12028; Swain DP, 2003, CAN J FISH AQUAT SCI, V60, P897, DOI 10.1139/F03-076; van Poorten BT, 2005, N AM J FISH MANAGE, V25, P329, DOI 10.1577/M03-225.1; WARNER EJ, 1995, CAN J ZOOL, V73, P146, DOI 10.1139/z95-017; Young RG, 2004, N AM J FISH MANAGE, V24, P1203, DOI 10.1577/M03-177.1	28	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190745	10.1371/journal.pone.0190745	http://dx.doi.org/10.1371/journal.pone.0190745			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324836	Green Published, gold			2022-12-26	WOS:000419952400053
J	Kim, YK; Park, E; Lee, A; Im, CH; Kim, YH				Kim, Yun Kwan; Park, Eunhee; Lee, Ahee; Im, Chang-Hwan; Kim, Yun-Hee			Changes in network connectivity during motor imagery and executionChanges in network connectivity during motor imagery and execution	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; FUNCTIONAL-ANATOMY; MOVEMENTS; BRAIN; EEG; SUPPLEMENTARY; ORGANIZATION; HUMANS; SYSTEM; CORTEX	Background Recent studies of functional or effective connectivity in the brain have reported that motor-related brain regions were activated during motor execution and motor imagery, but the relationship between motor and cognitive areas has not yet been completely understood. The objectives of our study were to analyze the effective connectivity between motor and cognitive networks in order to define network dynamics during motor execution and motor imagery in healthy individuals. Second, we analyzed the differences in effective connectivity between correct and incorrect responses during motor execution and imagery using dynamic causal modeling (DCM) of electroencephalography (EEG) data. Method Twenty healthy subjects performed a sequence of finger tapping trials using either motor execution or motor imagery, and the performances were recorded. Changes in effective connectivity between the primary motor cortex (M1), supplementary motor area (SMA), premotor cortex (PMC), and dorsolateral prefrontal cortex (DLPFC) were estimated using dynamic causal modeling. Bayesian model averaging with family-level inference and fixed-effects analysis was applied to determine the most likely connectivity model for these regions. Results Motor execution and imagery showed inputs to distinct brain regions, the premotor cortex and the supplementary motor area, respectively. During motor execution, the coupling strength of a feedforward network from the DLPFC to the PMC was greater than that during motor imagery. During motor imagery, the coupling strengths of a feedforward network from the PMC to the SMA and of a feedback network from M1 to the PMC were higher than that during motor execution. In imagined movement, although there were connectivity differences between correct and incorrect task responses, each motor imagery task that included correct and incorrect responses showed similar network connectivity characteristics. Correct motor imagery responses showed connectivity from the PMC to the DLPFC, while the incorrect responses had characteristic connectivity from the SMA to the DLPFC. Conclusions These findings provide an understanding of effective connectivity between motor and cognitive areas during motor execution and imagery as well as the basis for future connectivity studies for patients with stroke.	[Kim, Yun Kwan; Kim, Yun-Hee] Sungkyunkwan Univ, Sch Cognit Sci, Seoul, South Korea; [Park, Eunhee] Kyungpook Natl Univ, Dept Phys & Rehabil Med, Chilgok Hosp, Daegu, South Korea; [Lee, Ahee; Kim, Yun-Hee] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea; [Im, Chang-Hwan] Hanyang Univ, Dept Biomed Engn, Seoul, South Korea; [Kim, Yun-Hee] Sungkyunkwan Univ, Ctr Prevent & Rehabil, Samsung Med Ctr, Heart Vasc Stroke Inst,Sch Med,Dept Phys & Rehabil, Seoul, South Korea	Sungkyunkwan University (SKKU); Kyungpook National University; Sungkyunkwan University (SKKU); Samsung Medical Center; Hanyang University; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, YH (corresponding author), Sungkyunkwan Univ, Sch Cognit Sci, Seoul, South Korea.; Kim, YH (corresponding author), Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea.; Kim, YH (corresponding author), Sungkyunkwan Univ, Ctr Prevent & Rehabil, Samsung Med Ctr, Heart Vasc Stroke Inst,Sch Med,Dept Phys & Rehabil, Seoul, South Korea.	yun1225.kim@samsung.com	Kim, Yun Hee/F-4600-2014; Kim, Yun-Hee/GVS-6426-2022; Im, Chang-Hwan/ABB-4391-2021	Im, Chang-Hwan/0000-0003-3795-3318	National Research Foundation of Korea - Korean government [NRF-2017R1A2A1A05000730]; National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2017R1A2A1A05000730]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government); National Research Foundation of Korea (NRF) - Korean government (MSIP)	This study was supported by the National Research Foundation of Korea grant funded by the Korean government (NRF-2017R1A2A1A05000730 to YHK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2017R1A2A1A05000730).	AERTSEN A, 1991, NONLIN SYST, V2, P281; Babiloni F, 2005, NEUROIMAGE, V24, P118, DOI 10.1016/j.neuroimage.2004.09.036; Chen HF, 2009, NEUROIMAGE, V47, P1844, DOI 10.1016/j.neuroimage.2009.06.026; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Deiber MP, 1996, J NEUROPHYSIOL, V75, P233, DOI 10.1152/jn.1996.75.1.233; Deiber MP, 1998, NEUROIMAGE, V7, P73, DOI 10.1006/nimg.1997.0314; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Diego MA, 1998, INT J NEUROSCI, V96, P217, DOI 10.3109/00207459808986469; Ding L, 2005, PHYS MED BIOL, V50, P45, DOI 10.1088/0031-9155/50/1/004; Edelman BJ, 2016, IEEE T BIO-MED ENG, V63, P4, DOI 10.1109/TBME.2015.2467312; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Friston KJ, 1995, HUM BRAIN MAPP, V3, P56, DOI 10.1002/hbm.460030106; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Fuster JM, 1982, PREFRONTAL CORTEX AN; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Goldman-Rakic PS, 1987, VB BROOKS MD BETHESD; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Gregg M, 2010, EVID-BASED COMPL ALT, V7, P249, DOI 10.1093/ecam/nem170; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; HE B, 1987, IEEE T BIO-MED ENG, V34, P406, DOI 10.1109/TBME.1987.326056; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; Henson RN, 2009, NEUROIMAGE, V46, P168, DOI 10.1016/j.neuroimage.2009.01.062; Hetu S, 2013, NEUROSCI BIOBEHAV R, V37, P930, DOI 10.1016/j.neubiorev.2013.03.017; Hoshi E, 2004, J NEUROPHYSIOL, V91, P2707, DOI 10.1152/jn.00904.2003; Hoshi E, 2006, J NEUROPHYSIOL, V95, P3596, DOI 10.1152/jn.01126.2005; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; Kasess CH, 2008, NEUROIMAGE, V40, P828, DOI 10.1016/j.neuroimage.2007.11.040; Lacourse MG, 2004, J REHABIL RES DEV, V41, P505, DOI 10.1682/JRRD.2004.04.0505; Lee KM, 1999, NEUROIMAGE, V9, P117, DOI 10.1006/nimg.1998.0393; Litvak V, 2011, COMPUT INTEL NEUROSC, V2011, P852; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Luppino G, 2000, NEWS PHYSIOL SCI, V15, P219; Mellet E, 1998, NEUROIMAGE, V8, P129, DOI 10.1006/nimg.1998.0355; Michelon P, 2006, J NEUROPHYSIOL, V95, P811, DOI 10.1152/jn.00488.2005; Minai AA, 2015, SPRINGER HDB COMPUTA; Mulder T, 2007, J NEURAL TRANSM, V114, P1265, DOI 10.1007/s00702-007-0763-z; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nair DG, 2003, COGNITIVE BRAIN RES, V15, P250, DOI 10.1016/S0926-6410(02)00197-0; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parsons LM, 1998, COGN NEUROPSYCHOL, V15, P583; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Penny WD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000709; Petrides Michael, 1994, Current Opinion in Neurobiology, V4, P207, DOI 10.1016/0959-4388(94)90074-4; Rehme AK, 2013, NEUROIMAGE, V67, P237, DOI 10.1016/j.neuroimage.2012.11.027; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rowe J, 2002, NEUROIMAGE, V17, P988, DOI 10.1006/nimg.2002.1156; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; STEPHAN KM, 1995, J NEUROPHYSIOL, V73, P373, DOI 10.1152/jn.1995.73.1.373; Szameitat AJ, 2007, NEUROIMAGE, V34, P702, DOI 10.1016/j.neuroimage.2006.09.033; Vorwerk J, 2012, BIOMED TECH, P57; Wang G, 2011, CLIN NEUROPHYSIOL, V122, P1098, DOI 10.1016/j.clinph.2010.10.043; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028	55	51	55	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e190715	10.1371/journal.pone.0190715	http://dx.doi.org/10.1371/journal.pone.0190715			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324886	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400050
J	Lavtar, P; Rudolf, G; Maver, A; Hodzic, A; Cizmarevic, NS; Zivkovic, M; Jazbec, SS; Ketis, ZK; Kapovic, M; Dincic, E; Raicevic, R; Sepcic, J; Lovrecic, L; Stankovic, A; Ristic, S; Peterlin, B				Lavtar, Polona; Rudolf, Gorazd; Maver, Ales; Hodzic, Alenka; Cizmarevic, Nada Starcevic; Zivkovic, Maja; Jazbec, Sasa Sega; Ketis, Zalika Klemenc; Kapovic, Miljenko; Dincic, Evica; Raicevic, Ranko; Sepcic, Juraj; Lovrecic, Luca; Stankovic, Aleksandra; Ristic, Smiljana; Peterlin, Borut			Association of circadian rhythm genes ARNTL/BMAL1 and CLOCK with multiple sclerosis	PLOS ONE			English	Article							RISK-FACTORS; SHIFT WORK; DISRUPTION; MELATONIN	Prevalence of multiple sclerosis varies with geographic latitude. We hypothesized that this fact might be partially associated with the influence of latitude on circadian rhythm and consequently that genetic variability of key circadian rhythm regulators, ARNTL and CLOCK genes, might contribute to the risk for multiple sclerosis. Our aim was to analyse selected polymorphisms of ARNTL and CLOCK, and their association with multiple sclerosis. A total of 900 Caucasian patients and 1024 healthy controls were compared for genetic signature at 8 SNPs, 4 for each of both genes. We found a statistically significant difference in genotype (ARNTL rs3789327, P = 7.5.10(-5); CLOCK rs6811520 P = 0.02) distributions in patients and controls. The ARNTL rs3789327 CC genotype was associated with higher risk for multiple sclerosis at an OR of 1.67 (95% CI 1.35-2.07, P = 0.0001) and the CLOCK rs6811520 genotype CC at an OR of 1.40 (95% CI 1.13-1.73, P = 0.002). The results of this study suggest that genetic variability in the ARNTL and CLOCK genes might be associated with risk for multiple sclerosis.	[Lavtar, Polona; Rudolf, Gorazd; Maver, Ales; Hodzic, Alenka; Lovrecic, Luca; Peterlin, Borut] Univ Med Ctr Ljubljana, Clin Inst Med Genet, Ljubljana, Slovenia; [Cizmarevic, Nada Starcevic; Kapovic, Miljenko; Ristic, Smiljana] Univ Rijeka, Sch Med, Dept Biol, Rijeka, Croatia; [Cizmarevic, Nada Starcevic; Kapovic, Miljenko; Ristic, Smiljana] Univ Rijeka, Sch Med, Dept Med Genet, Rijeka, Croatia; [Zivkovic, Maja; Stankovic, Aleksandra] Inst Nucl Sci Vinca, Labs Radiobiol & Mol Genet, Belgrade, Serbia; [Jazbec, Sasa Sega] Univ Med Ctr Ljubljana, Dept Neurol, Ljubljana, Slovenia; [Ketis, Zalika Klemenc] Univ Ljubljana, Med Sch, Dept Family Med, Ljubljana, Slovenia; [Ketis, Zalika Klemenc] Univ Maribor, Med Sch, Dept Family Med, Maribor, Slovenia; [Dincic, Evica; Raicevic, Ranko] Mil Med Acad, Dept Neurol, Belgrade, Serbia; [Sepcic, Juraj] Univ Rijeka, Sch Med, Postgrad Studies, Rijeka, Croatia	University Medical Centre Ljubljana; University of Rijeka; University of Rijeka; University of Belgrade; University Medical Centre Ljubljana; University of Ljubljana; University of Maribor; University of Rijeka	Peterlin, B (corresponding author), Univ Med Ctr Ljubljana, Clin Inst Med Genet, Ljubljana, Slovenia.	borut.peterlin@guest.arnes.si	Klemenc-Ketis, Zalika/V-6251-2019; Čizmarević, Nada Starčević/AAO-5262-2021; Kapović, Miljenko/S-8310-2018; Lovrecic, Luca/S-8196-2018; Zivkovic, Maja/T-1038-2018; Stankovic, Aleksandra D/T-1064-2018; Starčević Čizmarević, Nada/S-4488-2018; Ristić, Smiljana/R-5713-2018; sepčić, juraj/S-7687-2018	Klemenc-Ketis, Zalika/0000-0002-0270-1754; Čizmarević, Nada Starčević/0000-0002-7779-0237; Kapović, Miljenko/0000-0002-8466-1011; Lovrecic, Luca/0000-0003-4119-9530; Zivkovic, Maja/0000-0002-0447-6626; Stankovic, Aleksandra D/0000-0002-1050-5913; Starčević Čizmarević, Nada/0000-0002-7779-0237; Ristić, Smiljana/0000-0002-5484-6445; sepčić, juraj/0000-0002-5669-7981	Ministry of Science and Technology, Ljubljana, Republic of Slovenia [J3-3628]	Ministry of Science and Technology, Ljubljana, Republic of Slovenia	This research was supported by grants J3-3628 from the Ministry of Science and Technology, Ljubljana, Republic of Slovenia	Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; Arendt J, 2012, CHRONOBIOL INT, V29, P379, DOI 10.3109/07420528.2012.668997; Ascherio A, 2007, ANN NEUROL, V61, P504, DOI 10.1002/ana.21141; Buenafe AC, 2012, J NEUROIMMUNOL, V243, P12, DOI 10.1016/j.jneuroim.2011.12.002; Ciarleglio CM, 2008, J BIOL RHYTHM, V23, P330, DOI 10.1177/0748730408320284; EBERS GC, 1993, NEUROEPIDEMIOLOGY, V12, P1, DOI 10.1159/000110293; Evans JA, 2013, PROG MOL BIOL TRANSL, V119, P283, DOI 10.1016/B978-0-12-396971-2.00010-5; Farhadi Naser, 2014, Biomed J, V37, P90, DOI 10.4103/2319-4170.125885; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hastings MH, 2013, CURR OPIN NEUROBIOL, V23, P880, DOI 10.1016/j.conb.2013.05.004; Hedstrom AK, 2015, MULT SCLER J, V21, P1195, DOI 10.1177/1352458514563592; Hedstrom AK, 2011, ANN NEUROL, V70, P733, DOI 10.1002/ana.22597; Hodzic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059220; Jagannath A, 2013, CURR OPIN NEUROBIOL, V23, P888, DOI 10.1016/j.conb.2013.03.008; Kanabrocki EL, 2004, CHRONOBIOL INT, V21, P739, DOI 10.1081/CBI-200025981; Kelleher FC, 2014, CANCER LETT, V342, P9, DOI 10.1016/j.canlet.2013.09.040; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; Lucas RM, 2011, NEUROLOGY, V76, P540, DOI 10.1212/WNL.0b013e31820af93d; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Nagy AD, 2015, CHRONOBIOL INT, V32, P447, DOI 10.3109/07420528.2014.992525; Reiter RJ, 2000, ANN NY ACAD SCI, V917, P376; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Wang H, 2005, LIFE SCI, V77, P1902, DOI 10.1016/j.lfs.2005.04.013; Yoshida K, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/282495	25	23	23	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190601	10.1371/journal.pone.0190601	http://dx.doi.org/10.1371/journal.pone.0190601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324865	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400042
J	Roberts, JM; Maniskas, ME; Fraser, JF; Bix, GJ				Roberts, Jill M.; Maniskas, Michael E.; Fraser, Justin F.; Bix, Gregory J.			Internal carotid artery stenosis: A novel surgical model for moyamoya syndrome	PLOS ONE			English	Article							MICE LACKING RNF213; SUSCEPTIBILITY GENE; DISEASE; VESSELS; WHITE	Moyamoya is a cerebrovascular disorder characterized by progressive stenosis of the intracranial internal carotid arteries. There are two forms: Disease and Syndrome, with each characterized by the sub-population it affects. Moyamoya syndrome (MMS) is more prominent in adults in their 20's-40's, and is often associated with autoimmune diseases. Currently, there are no surgical models for inducing moyamoya syndrome, so our aim was to develop a new animal model to study this relatively unknown cerebrovascular disease. Here, we demonstrate a new surgical technique termed internal carotid artery stenosis (ICAS), to mimic MMS using micro-coils on the proximal ICA. We tested for Moyamoya-like vasculopathies by fluorescently labelling the mouse cerebrovasculature with Di I for visualization and analysis of vessel diameter at the distal ICA and anastomoses on the cortical surface. Results show a significant narrowing of the distal ICA and anterior cerebral artery (ACA) in the Circle of Willis, as observed in humans. There is also a significant decrease in the number of anastomoses between the middle cerebral artery (MCA) and the ACA in the watershed region of the cortex. While further characterization is needed, this ICAS model can be applied to transgenic mice displaying co-morbidities as observed within the Moyamoya syndrome population, allowing a better understanding of the disease and development of novel treatments.	[Roberts, Jill M.; Maniskas, Michael E.; Bix, Gregory J.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Roberts, Jill M.; Maniskas, Michael E.; Fraser, Justin F.; Bix, Gregory J.] Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA; [Maniskas, Michael E.; Fraser, Justin F.; Bix, Gregory J.] Univ Kentucky, Dept Neurosurg, Lexington, KY 40506 USA; [Fraser, Justin F.; Bix, Gregory J.] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Fraser, Justin F.] Univ Kentucky, Dept Radiol, Lexington, KY 40506 USA; [Maniskas, Michael E.] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Texas System; University of Texas Health Science Center Houston	Bix, GJ (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.; Bix, GJ (corresponding author), Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA.; Bix, GJ (corresponding author), Univ Kentucky, Dept Neurosurg, Lexington, KY 40506 USA.; Bix, GJ (corresponding author), Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA.	gregorybix@uky.edu			National Institute of Health [1 R01 NS089515-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089515] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Health, Grant # 1 R01 NS089515-01 (www.nih.gov) to GJB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bower RS, 2013, STROKE, V44, P1997, DOI 10.1161/STROKEAHA.111.000307; Hattori Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32179; Hishikawa T, 2016, ACTA MED OKAYAMA, V70, P229; Ito A, 2015, BRAIN RES, V1594, P310, DOI 10.1016/j.brainres.2014.11.014; Kamada F, 2011, J HUM GENET, V56, P34, DOI 10.1038/jhg.2010.132; Kanoke A, 2016, BRAIN RES, V1642, P1, DOI 10.1016/j.brainres.2016.03.009; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Mejia-Munne JC, 2017, WORLD NEUROSURG, V100, P575, DOI 10.1016/j.wneu.2017.01.012; Park MG, 2017, J NEUROL SCI, V375, P331, DOI 10.1016/j.jns.2017.02.033; Phi JH, 2015, J KOREAN NEUROSURG S, V57, P408, DOI 10.3340/jkns.2015.57.6.408; Sato-Maeda M, 2016, BRAIN RES, V1630, P50, DOI 10.1016/j.brainres.2015.10.055; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Smith ER, 2015, J KOREAN NEUROSURG S, V57, P415, DOI 10.3340/jkns.2015.57.6.415; Sonobe S, 2014, NEUROREPORT, V25, P1442, DOI 10.1097/WNR.0000000000000289; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012	16	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191312	10.1371/journal.pone.0191312	http://dx.doi.org/10.1371/journal.pone.0191312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324900	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400139
J	Santiago, TR; Pereira, VM; de Souza, WR; Steindorff, AS; Cunha, BADB; Gaspar, M; Favaro, LCL; Formighieri, EF; Kobayashi, AK; Molinari, HBC				Santiago, Thais R.; Pereira, Valquiria M.; de Souza, Wagner R.; Steindorff, Andrei S.; Cunha, Barbara A. D. B.; Gaspar, Marilia; Favaro, Leia C. L.; Formighieri, Eduardo F.; Kobayashi, Adilson K.; Molinari, Hugo B. C.			Genome-wide identification, characterization and expression profile analysis of expansins gene family in sugarcane (Saccharum spp.)	PLOS ONE			English	Article							PLANT-GROWTH; 2ND-GENERATION BIOETHANOL; ETHANOL-PRODUCTION; CELL; SUPERFAMILY	Expansins refer to a family of closely related non-enzymatic proteins found in the plant cell wall that are involved in the cell wall loosening. In addition, expansins appear to be involved in different physiological and environmental responses in plants such as leaf and stem initiation and growth, stomata opening and closing, reproduction, ripening and stress tolerance. Sugarcane (Saccharum spp.) is one of the main crops grown worldwide. Lignocellulosic biomass from sugarcane is one of the most promising raw materials for the ethanol industry. However, the efficient use of lignocellulosic biomass requires the optimization of several steps, including the access of some enzymes to the hemicellulosic matrix. The addition of expansins in an enzymatic cocktail or their genetic manipulation could drastically improve the saccharification process of feedstock biomass by weakening the hydrogen bonds between polysaccharides present in plant cell walls. In this study, the expansin gene family in sugarcane was identified and characterized by in silico analysis. Ninety two putative expansins in sugarcane (SacEXPs) were categorized in three subfamilies after phylogenetic analysis. The expression profile of some expansin genes in leaves of sugarcane in different developmental stages was also investigated. This study intended to provide suitable expansin targets for genetic manipulation of sugarcane aiming at biomass and yield improvement.	[Santiago, Thais R.; Pereira, Valquiria M.; de Souza, Wagner R.; Steindorff, Andrei S.; Cunha, Barbara A. D. B.; Favaro, Leia C. L.; Formighieri, Eduardo F.; Kobayashi, Adilson K.; Molinari, Hugo B. C.] Embrapa Agroenergia, Parque Estacao Biol,Av W3 Norte Final, Brasilia, DF, Brazil; [Gaspar, Marilia] Inst Bot Nucl Pesquisa Fisiol & Bioquim, Sao Paulo, SP, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Molinari, HBC (corresponding author), Embrapa Agroenergia, Parque Estacao Biol,Av W3 Norte Final, Brasilia, DF, Brazil.	hugo.molinari@embrapa.br	Steindorff, Andrei Stecca/I-3084-2013; Santiago, Thais/AAC-6911-2019; Formighieri, Eduardo F/F-2993-2012; de Souza, Wagner R/D-8907-2019; Formighieri, Eduardo/W-9242-2019; Santiago, Thaís/D-3366-2018; Gaspar, Marilia/J-4329-2014; DE LIMA FAVARO, LEIA CECILIA/F-7350-2012	Steindorff, Andrei Stecca/0000-0002-2052-2848; Santiago, Thais/0000-0002-5890-557X; de Souza, Wagner R/0000-0002-6287-0074; Santiago, Thaís/0000-0001-5740-8400; Gaspar, Marilia/0000-0002-6430-1502; DE LIMA FAVARO, LEIA CECILIA/0000-0003-3260-0310; Correa Molinari, Hugo Bruno/0000-0001-9951-8229	CAPES Foundation (CAPES-Embrapa Program); Embrapa [02.12.11.003.00.00]; Coordination for the Improvement of Higher Education Personnel (CAPES-Embrapa); Embrapa Macroprogram SEG [02.12.11.003.00.00]	CAPES Foundation (CAPES-Embrapa Program)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Coordination for the Improvement of Higher Education Personnel (CAPES-Embrapa); Embrapa Macroprogram SEG(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA))	HBCM and VMP thanks CAPES Foundation (CAPES-Embrapa Program) for their financial support. LCLF acknowledges Embrapa (Upzyme Project Number 02.12.11.003.00.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge funding from Coordination for the Improvement of Higher Education Personnel (CAPES-Embrapa) to HBCM and VMP and Embrapa Macroprogram SEG (Upzyme project number 02.12.11.003.00.00) to LCLF.	Bae JM, 2014, TRANSGENIC RES, V23, P657, DOI 10.1007/s11248-014-9804-1; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baker JO, 2000, APPL BIOCHEM BIOTECH, V84-6, P217, DOI 10.1385/ABAB:84-86:1-9:217; Belfield EJ, 2005, J EXP BOT, V56, P817, DOI 10.1093/jxb/eri076; Bezerra TL, 2016, BIOFUEL BIOPROD BIOR, V10, P634, DOI 10.1002/bbb.1662; Bonnet GD., 2014, SUGARCANE PHYSL BIOC, P35, DOI DOI 10.1002/9781118771280.CH3; Buckeridge MS, 2012, GCB BIOENERGY, V4, P119, DOI 10.1111/j.1757-1707.2011.01122.x; Cavalett O, 2013, INT J LIFE CYCLE ASS, V18, P647, DOI 10.1007/s11367-012-0465-0; Choi D, 2006, PHYSIOL PLANTARUM, V126, P511, DOI 10.1111/j.1399-3054.2005.00612.x; Cosgrove DJ, 2015, CURR OPIN PLANT BIOL, V25, P162, DOI 10.1016/j.pbi.2015.05.014; Dal Santo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062206; Dornbusch T, 2014, PLANT CELL, V26, P3911, DOI 10.1105/tpc.114.129031; Downes BP, 1998, PLANT MOL BIOL, V37, P437, DOI 10.1023/A:1005920732211; Feng K, 2016, FRONTIERS PLANT SCI, V7; Georgelis N, 2012, P NATL ACAD SCI USA, V109, P14830, DOI 10.1073/pnas.1213200109; Goldemberg J, 2010, BIOFUEL BIOPROD BIOR, V4, P17, DOI 10.1002/bbb.186; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hatfield RD, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02056; Hernandez-Garcia CM, 2014, PLANT SCI, V217, P109, DOI 10.1016/j.plantsci.2013.12.007; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Howe G. A., 2010, PLANT HORMONES BIOSY, P646; Jungbauer A, 2007, J BIOTECHNOL, V128, P587, DOI 10.1016/j.jbiotec.2006.12.004; Kende H, 2004, PLANT MOL BIOL, V55, P311, DOI 10.1007/s11103-004-0158-6; Kerff F, 2008, P NATL ACAD SCI USA, V105, P16876, DOI 10.1073/pnas.0809382105; Kuluev BR, 2013, RUSS J DEV BIOL+, V44, P28, DOI 10.1134/S1062360413010049; Lennartsson PR, 2014, BIORESOURCE TECHNOL, V165, P3, DOI 10.1016/j.biortech.2014.01.127; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lipchinsky A, 2013, ACTA PHYSIOL PLANT, V35, P3277, DOI 10.1007/s11738-013-1341-7; Liu XW, 2014, J BIOTECHNOL, V186, P148, DOI 10.1016/j.jbiotec.2014.07.013; Marowa P, 2016, PLANT CELL REP, V35, P949, DOI 10.1007/s00299-016-1948-4; Mattiello L, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0694-z; MCQUEENMASON S, 1992, PLANT CELL, V4, P1425, DOI 10.1105/tpc.4.11.1425; Pereira SC, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0224-0; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Riano-Pachon DM, 2017, F1000 RES, P6; Ruijter J., 2009, LINREGPCR ANAL QUANT; Sampedro J, 2006, J PLANT RES, V119, P11, DOI 10.1007/s10265-005-0253-z; Sampedro J, 2015, PLANT J, V81, P108, DOI 10.1111/tpj.12715; Sasidharan R, 2008, PLANT PHYSIOL, V148, P1557, DOI 10.1104/pp.108.125518; Shin JH, 2005, MOL CELLS, V20, P210; Wu YJ, 2001, PLANT PHYSIOL, V126, P222, DOI 10.1104/pp.126.1.222; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zhang WL, 2014, MOL GENET GENOMICS, V289, P373, DOI 10.1007/s00438-014-0814-8; Zhao YD, 2012, MOL PLANT, V5, P334, DOI 10.1093/mp/ssr104; Zhou S, 2015, J PLANT PHYSIOL, V183, P64, DOI 10.1016/j.jplph.2015.05.012; ZOU HY, 2015, MOL BREEDING, V35	46	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191081	10.1371/journal.pone.0191081	http://dx.doi.org/10.1371/journal.pone.0191081			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324804	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400108
J	Janjanam, J; Zhang, BL; Mani, AM; Singh, NK; Traylor, JG; Orr, AW; Rao, GN				Janjanam, Jagadeesh; Zhang, Baolin; Mani, Arul M.; Singh, Nikhlesh K.; Traylor, James G., Jr.; Orr, A. Wayne; Rao, Gadiparthi N.			LIM and cysteine-rich domains 1 is required for thrombin induced smooth muscle cell proliferation and promotes atherogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTOR AGONISTS; CYCLIN-A; PROTEIN; GROWTH; GENE; ACTIVATION; EXPRESSION; KINASE; INJURY	Restenosis arises after vascular injury and is characterized by arterial wall thickening and decreased arterial lumen space. Vascular injury induces the production of thrombin, which in addition to its role in blood clotting acts as a mitogenic and chemotactic factor. In exploring the molecular mechanisms underlying restenosis, here we identified LMCD1 (LIM and cysteine-rich domains 1) as a gene highly responsive to thrombin in human aortic smooth muscle cells (HASMCs). Of note, LMCD1 depletion inhibited proliferation of human but not murine vascular smooth muscle cells. We also found that by physically interacting with E2F transcription factor 1, LMCD1 mediates thrombin-induced expression of the CDC6 (cell division cycle 6) gene in the stimulation of HASMC proliferation. Thrombin-induced LMCD1 and CDC6 expression exhibited a requirement for protease-activated receptor 1-mediated Gaq-dependent activation of phospholipase C beta 3. Moreover, the expression of LMCD1 was highly induced in smooth muscle cells located at human atherosclerotic lesions and correlated with CDC6 expression and that of the proliferation marker Ki67. Furthermore, the LMCD1- and SMC alpha actin-positive cells had higher cholesterol levels in the atherosclerotic lesions. In conclusion, these findings indicate that by acting as a co-activator with E2F transcription factor 1 in CDC6 expression, LMCD1 stimulates HASMC proliferation and thereby promotes human atherogenesis, suggesting an involvement of LMCD1 in restenosis.	[Janjanam, Jagadeesh; Zhang, Baolin; Mani, Arul M.; Singh, Nikhlesh K.; Rao, Gadiparthi N.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 71 S Manassas St, Memphis, TN 38163 USA; [Traylor, James G., Jr.; Orr, A. Wayne] Louisiana State Univ, Hlth Sci Ctr, Dept Pathol, Shreveport, LA 71103 USA	University of Tennessee System; University of Tennessee Health Science Center; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Rao, GN (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 71 S Manassas St, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Singh, Nikhlesh/AAA-4253-2020; Orr, Anthony/P-8927-2015	Singh, Nikhlesh/0000-0002-3665-6023; Mani, Arul Murugan/0000-0002-8943-7406; Orr, Anthony/0000-0002-2377-213X	NHLBI, National Institutes of Health [HL069908, HL103575, HL098435, HL133497]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069908, R01HL098435, R01HL133497, R01HL103575] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI, National Institutes of Health Grants HL069908 and HL103575 (to G.N.R.) and HL098435 and HL133497 (to A.W.O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allahverdian S, 2014, CIRCULATION, V129, P1551, DOI 10.1161/CIRCULATIONAHA.113.005015; Austin KM, 2013, J BIOL CHEM, V288, P23105, DOI 10.1074/jbc.M113.467019; Ballantyne MD, 2016, CIRCULATION, V133, P2050, DOI 10.1161/CIRCULATIONAHA.115.021019; BARSHAVIT R, 1983, J CELL BIOL, V96, P282, DOI 10.1083/jcb.96.1.282; Bauters C, 1997, PROG CARDIOVASC DIS, V40, P107, DOI 10.1016/S0033-0620(97)80003-5; Berk BC, 2001, PHYSIOL REV, V81, P999, DOI 10.1152/physrev.2001.81.3.999; Bespalova IN, 2000, GENOMICS, V63, P69, DOI 10.1006/geno.1999.6049; Bian ZY, 2010, HYPERTENSION, V55, P257, DOI 10.1161/HYPERTENSIONAHA.109.135665; Chellan B, 2016, ARTERIOSCL THROM VAS, V36, P1101, DOI 10.1161/ATVBAHA.116.307306; Chen KH, 2004, NAT CELL BIOL, V6, P872, DOI 10.1038/ncb1161; Chen TC, 2014, J PROTEOME RES, V13, P5339, DOI 10.1021/pr5002737; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Funk SD, 2012, ARTERIOSCL THROM VAS, V32, P686, DOI 10.1161/ATVBAHA.111.242792; Huang WG, 2011, ACS CHEM BIOL, V6, P223, DOI 10.1021/cb100308n; IP JH, 1990, J AM COLL CARDIOL, V15, P1667, DOI 10.1016/0735-1097(90)92845-S; Janjanam J, 2015, MOL BIOL CELL, V26, P4589, DOI 10.1091/mbc.E15-08-0570; Johnson JL, 2014, CARDIOVASC RES, V103, P452, DOI 10.1093/cvr/cvu171; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Karpurapu M, 2008, J BIOL CHEM, V283, P26577, DOI 10.1074/jbc.M800423200; Kelley GG, 2006, J BIOL CHEM, V281, P2639, DOI 10.1074/jbc.M507681200; KREK W, 1994, CELL, V78, P161, DOI 10.1016/0092-8674(94)90582-7; Kundumani-Sridharan V, 2013, J BIOL CHEM, V288, P22150, DOI 10.1074/jbc.M113.454082; Lepore JJ, 2005, ARTERIOSCL THROM VAS, V25, P309, DOI 10.1161/01.ATV.0000152725.76020.3c; LIU MW, 1989, CIRCULATION, V79, P1374, DOI 10.1161/01.CIR.79.6.1374; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Lyon AM, 2014, STRUCTURE, V22, P1844, DOI 10.1016/j.str.2014.10.008; Ma L, 2005, P NATL ACAD SCI USA, V102, P216, DOI 10.1073/pnas.0406682102; MCNAMARA CA, 1993, J CLIN INVEST, V91, P94, DOI 10.1172/JCI116206; Ohtani K, 1998, ONCOGENE, V17, P1777, DOI 10.1038/sj.onc.1202105; Perlman H, 1998, J BIOL CHEM, V273, P13713, DOI 10.1074/jbc.273.22.13713; Rao GN, 1999, J BIOL CHEM, V274, P6003, DOI 10.1074/jbc.274.9.6003; Rath N, 2005, MOL CELL BIOL, V25, P8864, DOI 10.1128/MCB.25.20.8864-8873.2005; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Speck C, 2007, J BIOL CHEM, V282, P11705, DOI 10.1074/jbc.M700399200; Tanski WJ, 2004, J VASC SURG, V39, P639, DOI 10.1016/j.jvs.2003.10.052; WALZ DA, 1985, P SOC EXP BIOL MED, V180, P518; Wang DJ, 2005, ARTERIOSCL THROM VAS, V25, P2094, DOI 10.1161/01.ATV.0000179602.85797.3f; Wang D, 2009, CIRC RES, V104, P1066, DOI 10.1161/CIRCRESAHA.109.196691; WILNER GD, 1981, J LAB CLIN MED, V97, P403	40	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3088	3103		10.1074/jbc.RA117.000866	http://dx.doi.org/10.1074/jbc.RA117.000866			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29326163	Green Published, hybrid			2022-12-26	WOS:000426562800005
J	Liang, WC; Ren, JL; Wong, CW; Chan, SO; Waye, MMY; Fu, WM; Zhang, JF				Liang, Wei-Cheng; Ren, Jia-Lin; Wong, Cheuk-Wa; Chan, Sun-On; Waye, Mary Miu-Yee; Fu, Wei-Ming; Zhang, Jin-Fang			LncRNA-NEF antagonized epithelial to mesenchymal transition and cancer metastasis via cis-regulating FOXA2 and inactivating Wnt/beta-catenin signaling	ONCOGENE			English	Article							LONG NONCODING RNAS; BETA-CATENIN; DIFFERENTIATION; EXPRESSION; PROMOTES; GENE; SUPPRESSES; CARCINOMA; ASSOCIATE	Emerging evidence indicates that the long noncoding RNAs extensively participate in cancer progression. Nevertheless, the molecular pathogenesis of how these lncRNAs regulate tumorigenesis has not been fully elucidated especially in hepatocellular carcinoma (HCC). Here, we sought to define the role of a novel lncRNA named lncRNA-NEF in modulating epithelial to mesenchymal transition (EMT) in HCC. It was found that the lncRNA-NEF was transcriptionally activated by EMT suppressor FOXA2 and frequently downregulated in HCC cell lines as well as clinical specimens. Although enhanced expression of lncRNA-NEF did not affect tumor cell growth, ectopic expression of lncRNA-NEF significantly suppressed EMT program and cell migration. Animal studies validated that lncRNA-NEF alleviated in vivo tumor metastasis and protected mice from tumor-induced mortality. Interestingly, we verified that lncRNA-NEF acted as a novel activator of its neighbor gene FOXA2, which formed a positive feedback loop. Subsequent studies revealed that lncRNA-NEF physically interacted with beta-catenin to increase the binding of GSK3 beta with beta-catenin and therefore promoted the inhibitory phosphorylation of beta-catenin, leading to the suppression on Wnt/beta-catenin signaling and activation of FOXA2 expression. Hence, our findings illustrated a novel feedback loop including FOXA2 and its neighboring gene lncRNA-NEF, which might provide mechanistic insights into the metastatic progress of HCC.	[Liang, Wei-Cheng; Ren, Jia-Lin; Wong, Cheuk-Wa; Chan, Sun-On; Waye, Mary Miu-Yee] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Waye, Mary Miu-Yee] Chinese Univ Hong Kong, Nethersole Sch Nursing, Shatin, Hong Kong, Peoples R China; [Fu, Wei-Ming] Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China; [Fu, Wei-Ming] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou, Guangdong, Peoples R China; [Zhang, Jin-Fang] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Clin Med Coll 1, Key Lab Orthopaed & Traumatol, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Southern Medical University - China; Southern Medical University - China; Guangzhou University of Chinese Medicine	Fu, WM (corresponding author), Southern Med Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.; Fu, WM (corresponding author), Southern Med Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Screening, Guangzhou, Guangdong, Peoples R China.; Zhang, JF (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 1, Clin Med Coll 1, Key Lab Orthopaed & Traumatol, Guangzhou, Guangdong, Peoples R China.	fuweiming76@smu.edu.cn; zhangjf06@cuhk.edu.hk	韋妙宜教授, Mary Miu Yee Waye/A-9674-2008; Chan, Sun-On/R-6547-2018	韋妙宜教授, Mary Miu Yee Waye/0000-0002-2582-4917; Chan, Sun-On/0000-0002-3221-3786	National Natural Science Foundation of China [81773066, 81772404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81773066 to W.F. and 81772404 to J.Z.).	Akagi T, 2008, BRIT J CANCER, V99, P781, DOI 10.1038/sj.bjc.6604544; Nieto MA, 2012, SEMIN CANCER BIOL, V22, P361, DOI 10.1016/j.semcancer.2012.05.003; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Fu WM, 2016, ONCOTARGET, V7, P4712, DOI 10.18632/oncotarget.6731; Fu WM, 2015, J HEPATOL, V63, P886, DOI 10.1016/j.jhep.2015.05.016; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang W, 2015, CELL REP, V11, P137, DOI 10.1016/j.celrep.2015.03.008; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee HK, 2006, NUCLEIC ACIDS RES, V34, P5705, DOI 10.1093/nar/gkl698; Liang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep20121; Liang WC, 2015, ONCOTARGET, V6, P22513, DOI 10.18632/oncotarget.4154; Liang WC, 2015, J CELL BIOCHEM, V116, P2658, DOI 10.1002/jcb.25214; Liang WC, 2014, RNA BIOL, V11, P845, DOI 10.4161/rna.29356; Liang WC, 2013, J CELL BIOCHEM, V114, P2699, DOI 10.1002/jcb.24617; Liu M, 2012, MOL CELL, V45, P171, DOI 10.1016/j.molcel.2011.11.018; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Ng SY, 2013, MOL CELL, V51, P349, DOI 10.1016/j.molcel.2013.07.017; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Qi W, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/358902; Richards EJ, 2015, J BIOL CHEM, V290, P6857, DOI 10.1074/jbc.M114.610915; Rossi L, 2010, WORLD J GASTRO ONCOL, V2, P348, DOI 10.4251/wjgo.v2.i9.348; Simons BW, 2012, DEV BIOL, V371, P246, DOI 10.1016/j.ydbio.2012.08.016; Song Y, 2010, CANCER RES, V70, P2115, DOI 10.1158/0008-5472.CAN-09-2979; Tang YN, 2011, CELL RES, V21, P316, DOI 10.1038/cr.2010.126; Vance KW, 2014, EMBO J, V33, P296, DOI 10.1002/embj.201386225; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Wang D, 2015, HEPATOL INT, V9, P438, DOI 10.1007/s12072-015-9642-0; Wang J, 2014, CARCINOGENESIS, V35, P2576, DOI 10.1093/carcin/bgu180; Xiang C, 2015, FASEB J, V29, P1986, DOI 10.1096/fj.14-264580; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Yu X, 2011, ONCOGENE, V30, P1868, DOI 10.1038/onc.2010.560; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010	38	92	98	3	27	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	11					1445	1456		10.1038/s41388-017-0041-y	http://dx.doi.org/10.1038/s41388-017-0041-y			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ3AZ	29311643				2022-12-26	WOS:000427459500004
J	Peta, E; Sinigaglia, A; Masi, G; Di Camillo, B; Grassi, A; Trevisan, M; Messa, L; Loregian, A; Manfrin, E; Brunelli, M; Martignoni, G; Palu, G; Barzon, L				Peta, Elektra; Sinigaglia, Alessandro; Masi, Giulia; Di Camillo, Barbara; Grassi, Angela; Trevisan, Marta; Messa, Lorenzo; Loregian, Arianna; Manfrin, Erminia; Brunelli, Matteo; Martignoni, Guido; Palu, Giorgio; Barzon, Luisa			HPV16 E6 and E7 upregulate the histone lysine demethylase KDM2B through the c-MYC/miR-146a-5p axys	ONCOGENE			English	Article							HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; EXPRESSION; MIR-146A; CELLS; CONTRIBUTES; APOPTOSIS; MIR-34A; MICE; DYSREGULATION	Persistent infection by high-risk human papillomaviruses (HPVs) is associated with the development of cervical cancer and a subset of anogenital and head and neck squamous cell carcinomas. Abnormal expression of cellular microRNAs (miRNAs) plays an important role in the development of cancer, including HPV-related tumors. In this study, we demonstrated that miR-146a-5p was down-regulated by E6 and, less efficiently, by E7 of high-risk HPV16 in keratinocytes and the presence of low levels of this miRNA in cervical carcinoma cell lines and in high-risk HPV-positive cervical specimens. Downregulation of miR-146a-5p was mediated at least in part by the transcription repressor c-MYC, through binding sites in the miR-146a promoter. Overexpression of miR-146a-5p significantly inhibited proliferation and migration of keratinocytes and cervical cancer cells. The histone demethylase KDM2B was validated as a new direct target of miR-146a-5p and two putative binding sites for miR-146a-5p were identified in its 3'UTR sequence. Western blot analysis and immunohistochemistry showed that KDM2B was overexpressed in HPV16 E6/E7-positive keratinocytes, in cervical cancer cell lines, and in a subset of invasive cervical carcinomas and HPV-positive laryngeal squamous cell carcinomas. In these tumors, KDM2B overexpression was associated with c-MYC copy number gain. In vitro, silencing of KDM2B inhibited proliferation of cervical cancer cells. In conclusion, this study identified a novel player, the hystone demethylase KDM2B, in HPV-mediated tumorigenesis. E6 and, less efficiently, E7 of high-risk HPV16 up-regulated KDM2B expression in human keratinocytes through a pathway involving overexpression of c-MYC, which in turn downregulated miR-146a-5p.	[Peta, Elektra; Sinigaglia, Alessandro; Masi, Giulia; Trevisan, Marta; Messa, Lorenzo; Loregian, Arianna; Palu, Giorgio; Barzon, Luisa] Univ Padua, Dept Mol Med, Padua, Italy; [Di Camillo, Barbara] Univ Padua, Dept Informat Engn, Padua, Italy; [Grassi, Angela] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy; [Manfrin, Erminia; Brunelli, Matteo; Martignoni, Guido] AOUI Hosp Trust Verona, Dept Diagnost & Publ Hlth, Anat Pathol, Verona, Italy	University of Padua; University of Padua; University of Padua; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Barzon, L (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.	luisa.barzon@unipd.it	Masi, Giulia/K-1577-2016; Grassi, Angela/N-3085-2013; Barzon, Luisa/K-7961-2016; Brunelli, Matteo/AAA-7679-2019; TREVISAN, MARTA/K-6591-2016	Masi, Giulia/0000-0001-9138-9186; Grassi, Angela/0000-0002-8313-8384; Barzon, Luisa/0000-0003-0720-8456; LOREGIAN, ARIANNA/0000-0002-8900-861X; sinigaglia, alessandro/0000-0002-2386-1757; TREVISAN, MARTA/0000-0002-3148-7240; BRUNELLI, Matteo/0000-0002-3832-2676; Messa, Lorenzo/0000-0001-6850-0034	Italian Ministry for Education, University, and Research [2010Z9FLM8]; University of Padova [60A07-3380/10, 60A07-1431/11, 60A07-0183/12, CPDA101217]	Italian Ministry for Education, University, and Research(Ministry of Education, Universities and Research (MIUR)); University of Padova	The authors thank Dr. A Remo (Pathology Unit, Hospital "Mater Salutis" Legnago, Verona, Italy) for providing histological tissue samples. This work was supported by the Italian Ministry for Education, University, and Research (grant 2010Z9FLM8 to G Martignoni and GP); the University of Padova (grants 60A07-3380/10, 1431/11, and 0183/12 to LB; grant CPDA101217 to BD and LB).	Barzon L, 2014, AM J PATHOL, V184, P3376, DOI 10.1016/j.ajpath.2014.08.004; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burk RD, 2017, NATURE, V543, P378, DOI 10.1038/nature21386; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Gunasekharan V, 2013, J VIROL, V87, P6037, DOI 10.1128/JVI.00153-13; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; He J, 2011, BLOOD, V117, P3869, DOI 10.1182/blood-2010-10-312736; Honegger A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004712; Hong XH, 2016, ONCOTARGET, V7, P22092, DOI 10.18632/oncotarget.8020; Hu XX, 2010, CANCER RES, V70, P1441, DOI 10.1158/0008-5472.CAN-09-3289; Kottakis F, 2014, CANCER RES, V74, P3935, DOI 10.1158/0008-5472.CAN-13-2733; Labbaye C, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-13; Lajer CB, 2012, BRIT J CANCER, V106, P1526, DOI 10.1038/bjc.2012.109; Li SH, 2017, NEUROCHEM INT, V107, P156, DOI 10.1016/j.neuint.2017.01.011; Liang GY, 2012, NAT CELL BIOL, V14, P457, DOI 10.1038/ncb2483; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Martinez I, 2008, ONCOGENE, V27, P2575, DOI 10.1038/sj.onc.1210919; Melar-New M, 2010, J VIROL, V84, P5212, DOI 10.1128/JVI.00078-10; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Peta E, 2017, HUM PATHOL, V61, P33, DOI 10.1016/j.humpath.2016.10.019; Pichler K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-100; Punj V, 2010, ONCOGENE, V29, P1835, DOI 10.1038/onc.2009.460; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thomas M, 2008, ONCOGENE, V27, P7018, DOI 10.1038/onc.2008.351; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tzatsos A, 2013, J CLIN INVEST, V123, P727, DOI 10.1172/JCI64535; Tzatsos A, 2011, J BIOL CHEM, V286, P33061, DOI 10.1074/jbc.M111.257667; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; VONKNEBEL M, 1992, INT J CANCER, V51, P831, DOI 10.1002/ijc.2910510527; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; WANG XH, 2008, PLOS ONE, V3, DOI DOI 10.1371/JOURNAL.PONE.0002557; Wang XH, 2011, INT J CANCER, V129, P1362, DOI 10.1002/ijc.25800; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Zandberg DP, 2013, CA-CANCER J CLIN, V63, P57, DOI 10.3322/caac.21167; Zhang RY, 2016, INT J CANCER, V138, P1163, DOI 10.1002/ijc.29872; Zhao JL, 2013, ELIFE, V2, DOI 10.7554/eLife.00537; Zhao JL, 2011, P NATL ACAD SCI USA, V108, P9184, DOI 10.1073/pnas.1105398108	50	34	39	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	12					1654	1668		10.1038/s41388-017-0083-1	http://dx.doi.org/10.1038/s41388-017-0083-1			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GA8YC	29335520				2022-12-26	WOS:000428626700008
J	Deshpande, P; Dapkekar, A; Oak, M; Paknikar, K; Rajwade, J				Deshpande, Paresh; Dapkekar, Ashwin; Oak, Manoj; Paknikar, Kishore; Rajwade, Jyutika			Nanocarrier-mediated foliar zinc fertilization influences expression of metal homeostasis related genes in flag leaves and enhances gluten content in durum wheat	PLOS ONE			English	Article							GRAIN PROTEIN; ZIP FAMILY; ZN; IDENTIFICATION; DEFICIENCY; NICOTIANAMINE; TRANSPORT; RICE; BIOFORTIFICATION; TRANSLOCATION	Background Wheat is the staple food for most of the world's population; however, it is a poor source of zinc. Foliar fertilization of zinc via zinc loaded chitosan nanocarriers (Zn-CNP) post-anthesis has proved to be a promising approach for grain zinc enhancement in durum wheat as evidenced in our earlier study. However, the molecular mechanism of uptake of zinc via Zn-CNP remains unclear. Methods/Principle findings Foliar application of Zn-CNP was performed at post anthesis stages in two durum wheat cultivars (MACS 3125 and UC1114, containing the Gpc-B1 gene), and expression levels of several metal-related genes were analyzed during early senescence. Zn-CNP application indeed caused changes in gene expression as revealed by qPCR data on representative genes involved in metal homeostasis, phloem transporters, and leaf senescence. Furthermore, zinc-regulated transporters and iron (Fe)-regulated transporter-like protein (ZIP) family [ZIP1, ZIP7, ZIP15], CA (carbonic anhydrase), and DMAS (2'-deoxymugineic acid synthase) in flag leaves exhibited significant correlation with zinc content in the seeds. The analysis of grain endosperm proteins showed enhancement of gamma gliadins while other gluten subunits decreased. Gene expression within ZIP family members varied with the type of cultivar mostly attributed to the Gpc-B1, concentration of external zinc ions as well as the type of tissue analyzed. Correlation analysis revealed the involvement of the selected genes in zinc enhancement. Conclusion At the molecular level, uptake of zinc via Zn-CNP nanocarrier was comparable to the uptake of zinc via common zinc fertilizers i.e. ZnSO4.	[Deshpande, Paresh; Dapkekar, Ashwin; Paknikar, Kishore; Rajwade, Jyutika] Agharkar Res Inst, Nanobiosci Grp, Pune, Maharashtra, India; [Deshpande, Paresh; Dapkekar, Ashwin; Oak, Manoj; Paknikar, Kishore; Rajwade, Jyutika] Savitribai Phule Pune Univ, Pune, Maharashtra, India; [Oak, Manoj] Agharkar Res Inst, Genet & Plant Breeding, Pune, Maharashtra, India	Department of Science & Technology (India); Agharkar Research Institute (ARI); Savitribai Phule Pune University; Department of Science & Technology (India); Agharkar Research Institute (ARI)	Paknikar, K; Rajwade, J (corresponding author), Agharkar Res Inst, Nanobiosci Grp, Pune, Maharashtra, India.; Oak, M; Paknikar, K; Rajwade, J (corresponding author), Savitribai Phule Pune Univ, Pune, Maharashtra, India.; Oak, M (corresponding author), Agharkar Res Inst, Genet & Plant Breeding, Pune, Maharashtra, India.	mdoak@aripune.org; kmpaknikar@aripune.org; jrajwade@aripune.org	Rajwade, J/P-7813-2019; Paknikar, Kishore/A-4963-2010; Oak, Manoj/P-8612-2017	Paknikar, Kishore/0000-0001-5602-7518; Oak, Manoj/0000-0002-4073-5306; Rajwade, Jyutika/0000-0001-9465-3595	Indian Council for Agricultural Research (ICAR) Fund for Basic, Strategic and Frontier Application in Agriculture Research, New Delhi, India [Mn-3023]; Council of Scientific and Industrial Research (CSIR), New Delhi, India; University Grants Commission (UGC), New Delhi, India	Indian Council for Agricultural Research (ICAR) Fund for Basic, Strategic and Frontier Application in Agriculture Research, New Delhi, India; Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC), New Delhi, India(University Grants Commission, India)	The funding for the study was received from Indian Council for Agricultural Research (ICAR) Fund for Basic, Strategic and Frontier Application in Agriculture Research, New Delhi, India (Grant no. Mn-3023). Paresh Deshpande received fellowship from Council of Scientific and Industrial Research (CSIR), New Delhi, India. Ashwin Dapkekar received fellowship from University Grants Commission (UGC), New Delhi, India. There was no additional external funding received for this study.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Assuncao AGL, 2010, P NATL ACAD SCI USA, V107, P10296, DOI 10.1073/pnas.1004788107; Bonneau J, 2016, PLANT BIOTECHNOL J, V14, P2228, DOI 10.1111/pbi.12577; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Cakmak I, 2002, PLANT SOIL, V247, P3, DOI 10.1023/A:1021194511492; Cakmak I, 2008, PLANT SOIL, V302, P1, DOI 10.1007/s11104-007-9466-3; Cakmak I, 2010, CEREAL CHEM, V87, P10, DOI 10.1094/CCHEM-87-1-0010; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Corbo MD, 2013, J AM ACAD DERMATOL, V69, P616, DOI 10.1016/j.jaad.2013.04.028; Curie C, 2009, ANN BOT-LONDON, V103, P1, DOI 10.1093/aob/mcn207; Deshpande P, 2017, CARBOHYD POLYM, V165, P394, DOI 10.1016/j.carbpol.2017.02.061; Distelfeld A, 2007, PHYSIOL PLANTARUM, V129, P635, DOI 10.1111/j.1399-3054.2006.00841.x; DuPont FM, 2005, J AGR FOOD CHEM, V53, P1575, DOI 10.1021/jf048697l; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Erenoglu EB, 2011, NEW PHYTOL, V189, P438, DOI 10.1111/j.1469-8137.2010.03488.x; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Grotz N, 2006, BBA-MOL CELL RES, V1763, P595, DOI 10.1016/j.bbamcr.2006.05.014; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Hacisalihoglu G, 2003, NEW PHYTOL, V159, P341, DOI 10.1046/j.1469-8137.2003.00826.x; Hwalla N, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030229; Kade M, 2005, PLANT BREEDING, V124, P343, DOI 10.1111/j.1439-0523.2005.01110.x; Khalid N, 2014, CRIT REV FOOD SCI, V54, P1222, DOI 10.1080/10408398.2011.630541; Kutman UB, 2010, CEREAL CHEM, V87, P1, DOI 10.1094/CCHEM-87-1-0001; Liu DY, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050465; Liu HE, 2015, PLANT SOIL ENVIRON, V61, P195, DOI 10.17221/817/2014-PSE; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Millan AF, 2005, PLANT SCI, V168, P1015, DOI 10.1016/j.plantsci.2004.11.018; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Mikkelsen MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049027; Milner MJ, 2013, J EXP BOT, V64, P369, DOI 10.1093/jxb/ers315; Nishiyama R, 2012, PLANT CELL PHYSIOL, V53, P381, DOI 10.1093/pcp/pcr188; Noh YS, 1999, PLANT MOL BIOL, V41, P181, DOI 10.1023/A:1006342412688; Olsen LI, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.36, 10.1038/nplants.2016.36]; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; Pearce S, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0368-2; Peck AW, 2008, J CEREAL SCI, V47, P266, DOI 10.1016/j.jcs.2007.04.006; Pedas P, 2009, PLANT SIGNAL BEHAV, V4, P842, DOI 10.4161/psb.4.9.9375; Persson DP, 2009, METALLOMICS, V1, P418, DOI 10.1039/b905688b; Prasad AS, 2013, ADV NUTR, V4, P176, DOI 10.3945/an.112.003210; Ram H, 2015, CURR SCI INDIA, V109, P1171, DOI 10.18520/v109/i6/1171-1176; Ramos I, 2016, SPECTROCHIM ACTA B, V120, P30, DOI 10.1016/j.sab.2016.03.014; Shewry PR, 2002, J EXP BOT, V53, P947, DOI 10.1093/jexbot/53.370.947; Sperotto RA, 2010, J PLANT PHYSIOL, V167, P1500, DOI 10.1016/j.jplph.2010.05.003; STARKS TL, 1985, J AGR FOOD CHEM, V33, P691, DOI 10.1021/jf00064a032; Subbaiah LV, 2016, J AGR FOOD CHEM, V64, P3778, DOI 10.1021/acs.jafc.6b00838; Suzuki M, 2008, PLANT MOL BIOL, V66, P609, DOI 10.1007/s11103-008-9292-x; Tiong JW, 2015, NEW PHYTOL, V207, P1097, DOI 10.1111/nph.13413; Tiong J, 2014, NEW PHYTOL, V201, P131, DOI 10.1111/nph.12468; Uauy C, 2006, J EXP BOT, V57, P2785, DOI 10.1093/jxb/erl047; Uddin MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108546; Weiser H., 2000, EUROPEAN J FOOD RES, V211, P262; Weiser H, 1994, RELATIONSHIP AMOUNT, P141; White PJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00080	54	18	18	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191035	10.1371/journal.pone.0191035	http://dx.doi.org/10.1371/journal.pone.0191035			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342185	Green Submitted, Green Published, gold			2022-12-26	WOS:000422653800042
J	Makondi, PT; Lee, CH; Huang, CY; Chu, CM; Chang, YJ; Wei, PL				Makondi, Precious Takondwa; Lee, Chia-Hwa; Huang, Chien-Yu; Chu, Chi-Ming; Chang, Yu-Jia; Wei, Po-Li			Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; RECEPTOR 4; CYTOSCAPE PLUGIN; PHASE-III; EXPRESSION; THERAPY; SURVIVAL; CHEMOTHERAPY; COLON; FLUOROURACIL	Bevacizumab combined with cytotoxic chemotherapy is the backbone of metastatic colorectal cancer (mCRC) therapy; however, its treatment efficacy is hampered by therapeutic resistance. Therefore, understanding the mechanisms underlying bevacizumab resistance is crucial to increasing the therapeutic efficacy of bevacizumab. The Gene Expression Omnibus (GEO) database (dataset, GSE86525) was used to identify the key genes and pathways involved in bevacizumab-resistant mCRC. The GEO2R web tool was used to identify differentially expressed genes (DEGs). Functional and pathway enrichment analyses of the DEGs were performed using the Database for Annotation, Visualization, and Integrated Discovery(DAVID). Protein protein interaction (PPI) networks were established using the Search Tool for the Retrieval of Interacting Genes/Proteins database(STRING) and visualized using Cytoscape software. A total of 124 DEGs were obtained, 57 of which upregulated and 67 were downregulated. PPI network analysis showed that seven upregulated genes and nine downregulated genes exhibited high PPI degrees. In the functional enrichment, the DEGs were mainly enriched in negative regulation of phosphate metabolic process and positive regulation of cell cycle process gene ontologies (GOs); the enriched pathways were the phosphoinositide 3-kinase-serine/threonine kinase signaling pathway, bladder cancer, and microRNAs in cancer. Cyclin-dependent kinase inhibitor 1 A(CDKN1A), toll-like receptor 4 (TLR4), CD19 molecule (CD19), breast cancer 1, early onset (BRCA1), platelet-derived growth factor subunit A (PDGFA), and matrix metallopeptidase 1 (MMP1) were the DEGs involved in the pathways and the PPIs. The clinical validation of the DEGs in mCRC (TNM clinical stages 3 and 4) revealed that high PDGFA expression levels were associated with poor overall survival, whereas high BRCA1 and MMP1 expression levels were associated with favorable progress free survival(PFS). The identified genes and pathways can be potential targets and predictors of therapeutic resistance and prognosis in bevacizumab-treated patients with mCRC.	[Makondi, Precious Takondwa; Chang, Yu-Jia] Taipei Med Univ, Coll Med, Int PhD Program Med, Taipei, Taiwan; [Makondi, Precious Takondwa; Chang, Yu-Jia] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Lee, Chia-Hwa] Taipei Med Univ, Coll Med Sci & Technol, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan; [Huang, Chien-Yu; Wei, Po-Li] Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Huang, Chien-Yu] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Chu, Chi-Ming] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chang, Yu-Jia; Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Canc Res Ctr & Translat Lab, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Wan Fang Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; National Defense Medical Center; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Chang, YJ (corresponding author), Taipei Med Univ, Coll Med, Int PhD Program Med, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.; Wei, PL (corresponding author), Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan.; Chang, YJ; Wei, PL (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Canc Res Ctr & Translat Lab, Taipei, Taiwan.; Wei, PL (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan.; Wei, PL (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan.; Wei, PL (corresponding author), Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan.	r5424012@tmu.edu.tw; poliwei@tmu.edu.tw						Advani R, 2009, J CLIN ONCOLOGY OF S, V27, P11063; Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Anders CK, 2010, CLIN CANCER RES, V16, P4702, DOI 10.1158/1078-0432.CCR-10-0939; Andre F, 2012, ANN ONCOL, V23, P46, DOI 10.1093/annonc/mds195; Andre T, 2015, J CLIN ONCOL, V33, P4176, DOI 10.1200/JCO.2015.63.4238; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Cammarota R, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-112; Candeil L, 2004, INT J CANCER, V109, P848, DOI 10.1002/ijc.20032; Carser JE, 2011, GYNECOL ONCOL, V123, P492, DOI 10.1016/j.ygyno.2011.08.017; Davudian Sadaf, 2016, Biomed Pharmacother, V84, P191, DOI 10.1016/j.biopha.2016.09.021; de Groot JF, 2011, CLIN CANCER RES, V17, P4872, DOI 10.1158/1078-0432.CCR-11-0271; Des Guetz G, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007046.pub2; Earl TM, 2009, ANN SURG ONCOL, V16, P1043, DOI 10.1245/s10434-009-0325-8; El Khoury F, 2016, INT J ONCOL, V49, P2558, DOI 10.3892/ijo.2016.3725; Eyking A, 2011, GASTROENTEROLOGY, V141, P2154, DOI 10.1053/j.gastro.2011.08.043; Gallagher DJ, 2010, ONCOLOGY-BASEL, V78, P237, DOI 10.1159/000315730; Ganji PN, 2013, ANGIOGENESIS, V16, P903, DOI 10.1007/s10456-013-9364-7; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Gomyo Y, 1997, CANCER, V79, P2067, DOI 10.1002/(SICI)1097-0142(19970601)79:11<2067::AID-CNCR3>3.0.CO;2-M; Hay KA, 2017, DRUGS, V77, P237, DOI 10.1007/s40265-017-0690-8; Heinemann V, 2013, CANCER TREAT REV, V39, P592, DOI 10.1016/j.ctrv.2012.12.011; Huang CY, 2016, AM J TRANSL RES, V8, P384; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Ignatov T, 2014, J CANCER RES CLIN, V140, P1457, DOI 10.1007/s00432-014-1704-5; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3697, DOI 10.1200/JCO.2005.05.112; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kaplan JB, 2015, INVEST NEW DRUG, V33, P1271, DOI 10.1007/s10637-015-0289-4; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kramer I, 2007, J CLIN PHARM THER, V32, P1, DOI 10.1111/j.1365-2710.2007.00800.x; Le Cesne A, 2013, ONCOLOGIST, V18, P1192, DOI 10.1634/theoncologist.2012-0361; Lenz, 2016, ASCO ANN M P, V34, P493, DOI DOI 10.1200/jco.2016.34.4_suppl.493; Levy P, 2007, CLIN CANCER RES, V13, P398, DOI 10.1158/1078-0432.CCR-06-0182; Lips EH, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0642-8; Liu XC, 2016, ONCOTARGET, V7, P23227, DOI 10.18632/oncotarget.7594; Loupakis F, 2014, NEW ENGL J MED, V371, P1609, DOI 10.1056/NEJMoa1403108; Lu Zhen-hai, 2011, Zhonghua Yi Xue Za Zhi, V91, P2895; Lu-Emerson C, 2013, NEURO-ONCOLOGY, V15, P1079, DOI 10.1093/neuonc/not082; Luengo-Gil G, 2015, BREAST CANCER RES TR, V151, P577, DOI 10.1007/s10549-015-3421-4; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maru D, 2013, CLIN CANCER RES, V19, P2824, DOI 10.1158/1078-0432.CCR-12-3409; Maurel J, 2015, CURR CANCER DRUG TAR, V15, P703, DOI 10.2174/156800961508151001102822; Moench R, 2016, ONCOTARGET; Murad S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00313; Nordlinger B, 2009, ANN ONCOL, V20, P985, DOI 10.1093/annonc/mdn735; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Okamoto S, 2016, BRAIN TUMOR PATHOL, V33, P129, DOI 10.1007/s10014-016-0248-6; Paulsson J, 2014, FUTURE ONCOL, V10, P1695, DOI [10.2217/FON.14.83, 10.2217/fon.14.83]; Pietruszewska Wioletta, 2016, Otolaryngol Pol, V70, P32, DOI 10.5604/00306657.1202546; Piha-Paul SA, 2014, ONCOTARGET, V5, P1846, DOI 10.18632/oncotarget.1834; Quinn JE, 2007, CLIN CANCER RES, V13, P7413, DOI 10.1158/1078-0432.CCR-07-1083; Ramos CA, 2016, J CLIN INVEST, V126, P2588, DOI 10.1172/JCI86000; Raufi Ali, 2013, Cancer Manag Res, V5, P225, DOI 10.2147/CMAR.S45957; Riddell JR, 2011, CANCER RES, V71, P1637, DOI 10.1158/0008-5472.CAN-10-3674; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ross JS, 2010, AM J CLIN PATHOL, V134, P478, DOI 10.1309/AJCP2Y8KTDPOAORH; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Said AH, 2017, BIOCHEM J, V474, P647, DOI 10.1042/BCJ20160704; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Slattery ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116169; Slattery ML, 2012, INT J CANCER, V130, P2974, DOI 10.1002/ijc.26314; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Staub E, 2009, J MOL MED, V87, P633, DOI 10.1007/s00109-009-0467-y; Sun YL, 2016, EXP CELL RES, V347, P274, DOI 10.1016/j.yexcr.2016.07.009; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Taghavi N, 2010, WORLD J GASTROENTERO, V16, P4958, DOI 10.3748/wjg.v16.i39.4958; Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005; Tebbutt NC, 2002, EUR J CANCER, V38, P1000, DOI 10.1016/S0959-8049(02)00062-X; Turtle CJ, 2016, CLIN PHARMACOL THER, V100, P252, DOI 10.1002/cpt.392; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Venook Alan P, 2014, Am Soc Clin Oncol Educ Book, P83, DOI 10.14694/EdBook_AM.2014.34.83; Verstraete M, 2015, BRIT J CANCER, V112, P1314, DOI 10.1038/bjc.2015.93; Villaruz LC, 2011, SEMIN THORAC CARDIOV, V23, P281, DOI 10.1053/j.semtcvs.2012.01.001; Wadlow RC, 2010, CANCER-AM CANCER SOC, V116, P3537, DOI 10.1002/cncr.25155; Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558; Wu JJ, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0195-4; Xiong YQ, 2011, J CANCER RES CLIN, V137, P505, DOI 10.1007/s00432-010-0914-8; Yamazaki K, 2016, ANN ONCOL, V27, P1539, DOI 10.1093/annonc/mdw206	89	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0189582	10.1371/journal.pone.0189582	http://dx.doi.org/10.1371/journal.pone.0189582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342159	gold, Green Submitted, Green Published			2022-12-26	WOS:000422653800009
J	Mughini-Gras, L; Schaapveld, M; Kramers, J; Mooij, S; Neefjes-Borst, EA; van Pelt, W; Neefjes, J				Mughini-Gras, Lapo; Schaapveld, Michael; Kramers, Jolanda; Mooij, Sofie; Neefjes-Borst, E. Andra; van Pelt, Wilfrid; Neefjes, Jacques			Increased colon cancer risk after severe Salmonella infection	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; COLORECTAL-CANCER; HELICOBACTER-PYLORI; GASTRIC-CANCER; BACTERIAL; NETHERLANDS; HOST; MECHANISMS; TUMORIGENESIS; ASSOCIATIONS	Background Colon cancer constitutes one of the most frequent malignancies. Previous studies showed that Salmonella manipulates host cell signaling pathways and that Salmonella Typhimurium infection facilitates colon cancer development in genetically predisposed mice. This epidemiological study examined whether severe Salmonella infection, usually acquired from contaminated food, is associated with increased colon cancer risk in humans. Methods and findings We performed a nationwide registry-based study to assess colon cancer risk after diagnosed Salmonella infection. National infectious disease surveillance records (1999-2015) for Dutch residents aged >= 20 years when diagnosed with salmonellosis (n = 14,264) were linked to the Netherlands Cancer Registry. Salmonella-infected patients were laboratory-confirmed under medical consultation after 1-2 weeks of illness. These datasets also contained information on Salmonella serovar and type of infection. Colon cancer risk (overall and per colon subsite) among patients with a diagnosed Salmonella infection was compared with expected colon cancer risk in the general population. Data from the nationwide registry of histo-and cytopathology (PALGA) and Statistics Netherlands (CBS) allowed assessing potential effects of age, gender, latency, socioeconomic status, genetic predisposition, inflammatory bowel disease (IBD), and tumor features. We found that compared to the general population, colon cancer risk was significantly increased (standardized incidence ratio [SIR] 1.54; 95% CI 1.09-2.10) among patients with Salmonella infection diagnosed <60 years of age. Such increased risk concerned specifically the ascending/transverse colon (SIR 2.12; 95% CI 1.38-3.09) after S. Enteritidis infection (SIR 2.97; 95% CI 1.73-4.76). Salmonellosis occurred more frequently among colon cancer patients with pre-infectious IBD, a known risk factor for colon cancer. Colon tumors of patients with a history of Salmonella infection were mostly of low grade. Conclusions Patients diagnosed with severe salmonellosis have an increased risk of developing cancer in the ascending/transverse parts of the colon. This risk concerns particularly S. Enteritidis infection, suggesting a contribution of this major foodborne pathogen to colon cancer development.	[Mughini-Gras, Lapo; Kramers, Jolanda; Mooij, Sofie; van Pelt, Wilfrid] Natl Inst Publ Hlth & Environm RIVM, Antonie van Leeuwenhoeklaan 9, Bilthoven, Netherlands; [Mughini-Gras, Lapo] Univ Utrecht, Dept Infect Dis & Immunol, Yalelaan 1, Utrecht, Netherlands; [Schaapveld, Michael] Netherlands Canc Inst NKI, Div Epidemiol, Plesmanlaan 121, Amsterdam, Netherlands; [Neefjes-Borst, E. Andra] Free Univ Med Ctr VUmc, Dept Pathol, Boelelaan 1117, Amsterdam, Netherlands; [Neefjes, Jacques] Leiden Univ, Med Ctr, Dept Chem Immunol, Einthovenweg 20, Leiden, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Neefjes, J (corresponding author), Leiden Univ, Med Ctr, Dept Chem Immunol, Einthovenweg 20, Leiden, Netherlands.	j.j.c.neefjes@lumc.nl	Neefjes, Jacques J.C./H-8780-2017; Schaapveld, Michael/ABC-9714-2020	Neefjes, Jacques J.C./0000-0001-6763-2211; Neefjes-Borst, Andra/0000-0001-7945-7916; Schaapveld, Michael/0000-0003-4390-7182	KWF grant 'Salmonella infections and gallbladder cancer' (NKI) [2013-5969]; ERC Advanced grant ERCOPE	KWF grant 'Salmonella infections and gallbladder cancer' (NKI); ERC Advanced grant ERCOPE	This work was supported by KWF grant 'Salmonella infections and gallbladder cancer' (NKI 2013-5969); ERC Advanced grant ERCOPE. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlam SB, 2011, EPIDEMIOL INFECT, V139, P302, DOI 10.1017/S0950268810000932; Berger H, 2016, HELICOBACTER, V21, P34, DOI 10.1111/hel.12338; Boccellato F, 2015, CELL HOST MICROBE, V17, P728, DOI 10.1016/j.chom.2015.05.016; Casparie M, 2007, CELL ONCOL, V29, P19; CAYGILL CPJ, 1994, LANCET, V343, P83, DOI 10.1016/S0140-6736(94)90816-8; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Chumduri C, 2016, NAT REV MOL CELL BIO, V17, P659, DOI 10.1038/nrm.2016.100; Coghill AE, 2014, AM J EPIDEMIOL, V180, P687, DOI 10.1093/aje/kwu176; Darwin KH, 1999, CLIN MICROBIOL REV, V12, P405, DOI 10.1128/CMR.12.3.405; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Doorduyn Y, 2006, EPIDEMIOL INFECT, V134, P617, DOI 10.1017/S0950268805005406; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Figueira R, 2012, MICROBIOL-SGM, V158, P1147, DOI 10.1099/mic.0.058115-0; Friesema IHM, 2009, VACCINE, V27, P6353, DOI 10.1016/j.vaccine.2009.05.042; Gagnaire A, 2017, NAT REV MICROBIOL, V15, P109, DOI 10.1038/nrmicro.2016.171; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Havelaar AH, 2013, EPIDEMIOL INFECT, V141, P293, DOI 10.1017/S0950268812000568; Jacobsen A, 2011, MICROB ECOL, V62, P487, DOI 10.1007/s00248-011-9880-1; Kato I, 2013, NUTR CANCER, V65, P169, DOI 10.1080/01635581.2013.748922; Kuo SH, 2013, HEMATOL-AM SOC HEMAT, P109, DOI 10.1182/asheducation-2013.1.109; La Vecchia C, 2013, INT J CANCER, V133, P1447, DOI 10.1002/ijc.28133; Lamprecht SA, 2003, NAT REV CANCER, V3, P601, DOI 10.1038/nrc1144; Liu XY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-326; Liu XY, 2010, FEBS LETT, V584, P911, DOI 10.1016/j.febslet.2010.01.024; Lu R, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.20; Lu R, 2017, ONCOTARGET, V8, P55104, DOI 10.18632/oncotarget.19052; Lutgens MWMD, 2013, INFLAMM BOWEL DIS, V19, P789, DOI 10.1097/MIB.0b013e31828029c0; Mager DL, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-14; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Mughini-Gras L, 2014, INFECT GENET EVOL, V28, P251, DOI 10.1016/j.meegid.2014.10.003; Nath G, 2008, J INFECT DEV COUNTR, V2, P302; (NKR) NK, 2016, CIJF KANK INT KANK N; Samaras V, 2010, J INFECT DEV COUNTR, V4, P267, DOI 10.3855/jidc.819; Scanu T, 2015, CELL HOST MICROBE, V17, P763, DOI 10.1016/j.chom.2015.05.002; Scherer D, 2014, GENE CHROMOSOME CANC, V53, P568, DOI 10.1002/gcc.22167; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Stewart B, 2014, WORLD CANC REP 2014; Sun Jun, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P214; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Triantafillidis JK, 2009, ANTICANCER RES, V29, P2727; van Pelt W, 2003, EPIDEMIOL INFECT, V130, P431, DOI 10.1017/S0950268803008392; Vohlonen I, 2016, SCAND J GASTROENTERO, V51, P1159, DOI 10.1080/00365521.2016.1183225; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001	48	49	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0189721	10.1371/journal.pone.0189721	http://dx.doi.org/10.1371/journal.pone.0189721			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342165	Green Published, gold			2022-12-26	WOS:000422653800011
J	Geremew, A; Stiers, I; Sierens, T; Kefalew, A; Triest, L				Geremew, Addisie; Stiers, Iris; Sierens, Tim; Kefalew, Alemayehu; Triest, Ludwig			Clonal growth strategy, diversity and structure: A spatiotemporal response to sedimentation in tropical Cyperus papyrus swamps	PLOS ONE			English	Article							SPATIAL GENETIC-STRUCTURE; LAKE TANA BASIN; BURIAL DISTURBANCE; COMPUTER-PROGRAM; POPULATION; PLANT; SEAGRASS; DYNAMICS; RESILIENCE; WETLANDS	Land degradation and soil erosion in the upper catchments of tropical lakes fringed by papyrus vegetation can result in a sediment load gradient from land to lakeward. Understanding the dynamics of clonal modules (ramets and genets) and growth strategies of plants on such a gradient in both space and time is critical for exploring a species adaptation and processes regulating population structure and differentiation. We assessed the spatial and temporal dynamics in clonal growth, diversity, and structure of an emergent macrophyte, Cyperus papyrus (papyrus), in response to two contrasting sedimentation regimes by combining morphological traits and genotype data using 20 microsatellite markers. A total of 636 ramets from six permanent plots (18 x 30 m) in three Ethiopian papyrus swamps, each with discrete sedimentation regimes (high vs. low) were sampled for two years. We found that ramets under the high sedimentation regime (HSR) were significantly clumped and denser than the sparse and spreading ramets under the low sedimentation regime (LSR). The HSR resulted in significantly different ramets with short culm height and girth diameter as compared to the LSR. These results indicated that C. papyrus ameliorates the effect of sedimentation by shifting clonal growth strategy from guerrilla (in LSR) to phalanx (in HSR). Clonal richness, size, dominance, and clonal subrange differed significantly between sediment regimes and studied time periods. Each swamp under HSR revealed a significantly high clonal richness (R = 0.80) as compared to the LSR (R = 0.48). Such discrepancy in clonal richness reflected the occurrence of initial and repeated seedling recruitment strategies as a response to different sedimentation regimes. Overall, our spatial and short-term temporal observations highlighted that HSR enhances clonal richness and decreases clonal subrange owing to repeated seedling recruitment and genets turnover.	[Geremew, Addisie; Stiers, Iris; Sierens, Tim; Triest, Ludwig] Vrije Univ Brussel VUB, Dept Biol, Lab Plant Biol & Nat Management APNA, Brussels, Belgium; [Kefalew, Alemayehu] Addis Ababa Univ, Coll Nat Sci, Dept Plant Biol & Biodivers Management, Addis Ababa, Ethiopia	Vrije Universiteit Brussel; Addis Ababa University	Geremew, A (corresponding author), Vrije Univ Brussel VUB, Dept Biol, Lab Plant Biol & Nat Management APNA, Brussels, Belgium.	addisie2009@yahoo.com		Triest, Ludwig/0000-0002-4946-9614; Stiers, Iris/0000-0002-0367-1315; Geremew, Addisie/0000-0002-2895-5349	Development Cooperation; Vrije Universiteit Brussel, IRMO; VUB [BAS42]; Rufford Foundation [RUF-16029-1]	Development Cooperation; Vrije Universiteit Brussel, IRMO; VUB; Rufford Foundation	This work was supported by the Development Cooperation for funding field based research, PhD scholarship by the Vrije Universiteit Brussel, IRMO for Addisie Geremew and project funding from the VUB (BAS42). The Rufford Foundation is acknowledged for the grant provided with the goal of nature conservation (grant number RUF-16029-1).	Alberto F, 2005, MOL ECOL, V14, P2669, DOI 10.1111/j.1365-294X.2005.02640.x; Alberto F, 2008, J BIOGEOGR, V35, P1279, DOI 10.1111/j.1365-2699.2007.01876.x; Amare S., 2011, ETHIOPIAN J ENV STUD, V4, P56; Araki K, 2007, PLANT ECOL, V189, P175, DOI 10.1007/s11258-006-9173-9; Araki K, 2009, ANN BOT-LONDON, V104, P71, DOI 10.1093/aob/mcp092; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Arnaud-Haond S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030454; Arnaud-Haond S, 2010, ESTUAR COAST, V33, P878, DOI 10.1007/s12237-009-9238-9; Azzaa NGT, 2002, AQUAT BOT, V67, P169; Becheler R, 2014, HEREDITY, V112, P114, DOI 10.1038/hdy.2013.82; Binks RM, 2015, BIOL J LINN SOC, V114, P873, DOI 10.1111/bij.12465; Burgess SC, 2012, ECOLOGY, V93, P1378; Chebud YA, 2009, HYDROL PROCESS, V23, P3534, DOI 10.1002/hyp.7416; Chen XS, 2011, FLORA, V206, P347, DOI 10.1016/j.flora.2010.07.006; Chen XS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120846; Chen XS, 2014, AQUAT ECOL, V48, P409, DOI 10.1007/s10452-014-9493-0; Cornelissen JHC, 2014, ANN BOT-LONDON, V114, P369, DOI 10.1093/aob/mcu113; Dargahi B, 2011, J HYDROL, V398, P44, DOI 10.1016/j.jhydrol.2010.12.009; de Witte LC, 2010, ANN BOT-LONDON, V106, P859, DOI 10.1093/aob/mcq191; Dessie M, 2014, J HYDROL, V519, P699, DOI 10.1016/j.jhydrol.2014.08.007; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; Eckert CG, 2001, EVOL ECOL, V15, P501, DOI 10.1023/A:1016005519651; Ehlers A, 2008, MAR ECOL PROG SER, V355, P1, DOI 10.3354/meps07369; ERIKSSON O, 1993, TRENDS ECOL EVOL, V8, P313, DOI 10.1016/0169-5347(93)90237-J; Friess DA, 2012, BIOL REV, V87, P346, DOI 10.1111/j.1469-185X.2011.00198.x; Friis I., 2010, ATLAS POTENTIAL VEGE; Frosini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047561; Gaudet J., 2014, PAPYRUS PLANT CHANGE; Gilbert M, 2008, OECOLOGIA, V156, P169, DOI 10.1007/s00442-008-0968-3; Gilbert ME, 2010, AUSTRAL ECOL, V35, P53, DOI 10.1111/j.1442-9993.2009.02011.x; Goude J., 2002, FSTAT SOFTWARE V 2 9; Graae BJ, 2011, OECOLOGIA, V166, P565, DOI 10.1007/s00442-010-1878-8; Grimsby JL, 2007, AM J BOT, V94, P957, DOI 10.3732/ajb.94.6.957; Harper David M., 2011, Freshwater Reviews, V4, P89, DOI 10.1608/FRJ-4.2.149; Hazelton Eric L G, 2014, AoB Plants, V6, DOI 10.1093/aobpla/plu001; Holleley CE, 2009, BIOTECHNIQUES, V46, P511, DOI 10.2144/000113156; Hoyle M, 2005, CONSERV BIOL, V19, P1113, DOI 10.1111/j.1523-1739.2005.00166.x; Huang Y, 2015, PLANT BIOLOGY, V17, P1187, DOI 10.1111/plb.12368; Humphrey LD, 2001, CAN J BOT, V79, P1122, DOI 10.1139/cjb-79-9-1122; Jahnke M, 2015, MOL ECOL, V24, P2336, DOI 10.1111/mec.13174; Kansiime Frank, 2007, Wetlands Ecology and Management, V15, P443, DOI 10.1007/s11273-007-9043-9; Kartzinel TR, 2015, ANN BOT-LONDON, V116, P739, DOI 10.1093/aob/mcv117; Kebede S, 2006, J HYDROL, V316, P233, DOI 10.1016/j.jhydrol.2005.05.011; Kui L, 2013, WEED RES, V53, P370, DOI 10.1111/wre.12036; Kyambadde J, 2004, WATER RES, V38, P475, DOI 10.1016/j.watres.2003.10.008; Lamb HF, 2007, GEOPHYS RES, V8, P161; Lezberg AL, 2001, CAN J BOT, V79, P1028, DOI 10.1139/b01-083; Li F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121270; Li SL, 2015, SCI REP-UK, V5, DOI 10.1038/srep08935; Louapre P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038288; LYNCH M, 1984, Q REV BIOL, V59, P257, DOI 10.1086/413902; Maclean IMD, 2011, ENVIRON MANAGE, V47, P218, DOI 10.1007/s00267-010-9592-1; Macreadie PI, 2014, ECOL EVOL, V4, P450, DOI 10.1002/ece3.933; Massa SI, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-39; Maun MA, 1998, CAN J BOT, V76, P713, DOI 10.1139/cjb-76-5-713; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Mitsch WJ, 2010, WETL ECOL MANAG, V18, P573, DOI 10.1007/s11273-009-9164-4; Mnaya Bakari, 2002, Wetlands Ecology and Management, V10, P133; Mock KE, 2008, MOL ECOL, V17, P4827, DOI 10.1111/j.1365-294X.2008.03963.x; Morrison E. H. J., 2009, Ecohydrology and Hydrobiology, V9, P83, DOI 10.2478/v10104-009-0036-6; Mou XJ, 2011, J EXP MAR BIOL ECOL, V409, P99, DOI 10.1016/j.jembe.2011.08.006; Nanninga GB, 2014, MOL ECOL, V23, P591, DOI 10.1111/mec.12623; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Ohsako T, 2010, AM J BOT, V97, P458, DOI 10.3732/ajb.0900262; Owino Alfred O., 2007, Wetlands Ecology and Management, V15, P1, DOI 10.1007/s11273-006-9001-y; Pan Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05612; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perkol-Finkel S, 2012, J APPL ECOL, V49, P1457, DOI 10.1111/j.1365-2664.2012.02204.x; Poppe L, 2013, J MAPS, V9, P431, DOI 10.1080/17445647.2013.801000; Riginos C, 2013, GEOGR COMPASS, V7, P197, DOI 10.1111/gec3.12032; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryken N, 2015, SCI TOTAL ENVIRON, V511, P756, DOI 10.1016/j.scitotenv.2014.12.048; Setegn SG, 2010, HYDROL PROCESS, V24, P357, DOI 10.1002/hyp.7457; Setegne S. G., 2008, OPEN HYDROL J, V2, P24; Somme L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099295; Tamm A, 2001, EVOL ECOL, V15, P383, DOI 10.1023/A:1016093116926; Terer T, 2014, AQUAT BOT, V116, P93, DOI 10.1016/j.aquabot.2014.02.008; Thouvenot L, 2013, FLORA, V208, P430, DOI 10.1016/j.flora.2013.07.004; Tilahun SA., 2014, NILE RIVER BASIN, DOI DOI 10.1007/978-3-319-02720-3_9; Triest L, 2013, MOL ECOLOGY RESOURCE, V13, P546; Triest L, 2014, HYDROBIOLOGIA, V737, P131, DOI 10.1007/s10750-013-1584-8; Vallejo-Marin M, 2010, ANNU REV ECOL EVOL S, V41, P193, DOI 10.1146/annurev.ecolsys.110308.120258; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Veeneklaas R, 2011, PRESLIA, V83, P455; Vijverberg J, 2009, MONOGR BIOL, V89, P163; Wondie Ayalew, 2010, Ecohydrology & Hydrobiology, V10, P123, DOI 10.2478/v10104-011-0017-4; Ye D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094009; Ye XH, 2006, ANN BOT-LONDON, V98, P187, DOI 10.1093/aob/mcl086; Yu FH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01467	90	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190810	10.1371/journal.pone.0190810	http://dx.doi.org/10.1371/journal.pone.0190810			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338034	Green Published, gold			2022-12-26	WOS:000422652700018
J	Rimkus, SA; Wassarman, DA				Rimkus, Stacey A.; Wassarman, David A.			A pharmacological screen for compounds that rescue the developmental lethality of a Drosophila ATM mutant	PLOS ONE			English	Article							ATAXIA-TELANGIECTASIA; DNA-DAMAGE; IN-VIVO; PARKINSONS-DISEASE; NEURODEGENERATION; CELLS; ACTIVATION; MITOPHAGY; DEFENSE; REPAIR	Ataxia-telangiectasia (A-T) is a neurodegenerative disease caused by mutation of the A-T mutated (ATM) gene. ATM encodes a protein kinase that is activated by DNA damage and phosphorylates many proteins, including those involved in DNA repair, cell cycle control, and apoptosis. Characteristic biological and molecular functions of ATM observed in mammals are conserved in Drosophila melanogaster. As an example, conditional loss-of-function ATM alleles in flies cause progressive neurodegeneration through activation of the innate immune response. However, unlike in mammals, null alleles of ATM in flies cause lethality during development. With the goals of understanding biological and molecular roles of ATM in a whole animal and identifying candidate therapeutics for A-T, we performed a screen of 2400 compounds, including FDA-approved drugs, natural products, and bioactive compounds, for modifiers of the developmental lethality caused by a temperature-sensitive ATM allele (ATM(8)) that has reduced kinase activity at non-permissive temperatures. Ten compounds reproducibly suppressed the developmental lethality of ATM(8) flies, including Ronnel, which is an organophosphate. Ronnel and other suppressor compounds are known to cause mitochondrial dysfunction or to inhibit the enzyme acetylcholinesterase, which controls the levels of the neurotransmitter acetylcholine, suggesting that detrimental consequences of reduced ATM kinase activity can be rescued by inhibiting the function of mitochondria or increasing acetylcholine levels. We carried out further studies of Ronnel because, unlike the other compounds that suppressed the developmental lethality of homozygous ATM(8) flies, Ronnel was toxic to the development of heterozygous ATM(8) flies. Ronnel did not affect the innate immune response of ATM(8) flies, and it further increased the already high levels of DNA damage in brains of ATM(8) flies, but its effects were not harmful to the lifespan of rescued ATM(8) flies. These results provide new leads for understanding the biological and molecular roles of ATM and for the treatment of A-T.	[Rimkus, Stacey A.; Wassarman, David A.] Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Med Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Wassarman, DA (corresponding author), Univ Wisconsin Madison, Sch Med & Publ Hlth, Dept Med Genet, Madison, WI 53706 USA.	dawassarman@wisc.edu		Wassarman, David/0000-0002-7042-9561	National Institutes of Health (NIH) [R21 NS085302, R01 NS083596]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083596, R21NS085302] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NIH) (R21 NS085302 and R01 NS083596 to D.A.W.).	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Bessadottir M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051296; Biasibetti-Brendler H., 2017, MOL NEUROBIOL; Chang S, 2008, NAT CHEM BIOL, V4, P256, DOI 10.1038/nchembio.78; Chen JM, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0127-y; Choy KR, 2018, DEV DYNAM, V247, P33, DOI 10.1002/dvdy.24522; Colovic MB, 2013, CURR NEUROPHARMACOL, V11, P315, DOI 10.2174/1570159X11311030006; Du LT, 2009, J EXP MED, V206, P2285, DOI 10.1084/jem.20081940; Fakhoury M, 2016, J NEUROL, V263, P1683, DOI 10.1007/s00415-016-8052-0; Fang EF, 2016, CELL METAB, V24, P566, DOI 10.1016/j.cmet.2016.09.004; Farag MA, 2016, Z NATURFORSCH C, V71, P393, DOI 10.1515/znc-2016-0030; Fivenson E. M., 2017, NEUROCHEM INT; Gade S, 2017, BBA-GEN SUBJECTS, V1861, P541, DOI 10.1016/j.bbagen.2016.11.044; Galimberti D, 2016, CURR ALZHEIMER RES, V13, P1100; Gluck MR, 2004, J NEUROCHEM, V91, P788, DOI 10.1111/j.1471-4159.2004.02747.x; Guleria A, 2016, DNA REPAIR, V39, P1, DOI 10.1016/j.dnarep.2015.12.009; Gurley KE, 2001, CURR BIOL, V11, P191, DOI 10.1016/S0960-9822(01)00048-3; Jung MR, 2012, ADV EXP MED BIOL, V720, P181, DOI 10.1007/978-1-4614-0254-1_15; Karami-Mohajeri S, 2013, TOXICOL APPL PHARM, V270, P39, DOI 10.1016/j.taap.2013.04.001; Katzenberger RJ, 2016, G3-GENES GENOM GENET, V6, P4151, DOI 10.1534/g3.116.036194; Lee EA, 2015, CANCER RES, V75, P2478, DOI 10.1158/0008-5472.CAN-14-2676; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levine BD, 2016, CELL REP, V14, P1477, DOI 10.1016/j.celrep.2015.12.105; Liao WJ, 2009, METHODS, V48, P46, DOI 10.1016/j.ymeth.2009.02.016; Maciejczyk M, 2017, REDOX BIOL, V11, P375, DOI 10.1016/j.redox.2016.12.030; Mansouri A, 2008, NUTRITION, V24, P360, DOI 10.1016/j.nut.2007.12.008; McGrath-Morrow SA, 2016, J PEDIATR-US, V171, P256, DOI 10.1016/j.jpeds.2016.01.002; McGrath-Morrow SA, 2010, J PEDIATR-US, V156, P682, DOI 10.1016/j.jpeds.2009.12.007; Ojha A, 2013, ENVIRON TOXICOL, V28, P543, DOI 10.1002/tox.20748; Pagano G, 2015, J NEUROL NEUROSUR PS, V86, P767, DOI 10.1136/jnnp-2014-308764; Pedersen M, 2010, GENOME, V53, P778, DOI [10.1139/g10-067, 10.1139/G10-067]; Petersen AJ, 2013, GENETICS, V194, P133, DOI 10.1534/genetics.113.150854; Petersen AJ, 2012, P NATL ACAD SCI USA, V109, pE656, DOI 10.1073/pnas.1110470109; Rimkus SA, 2008, GENE DEV, V22, P1205, DOI 10.1101/gad.1639608; Rosati A, 2004, CELL DEATH DIFFER, V11, pS216, DOI 10.1038/sj.cdd.4401534; Rothblum-Oviatt C, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0543-7; Silva E, 2004, CURR BIOL, V14, P1341, DOI 10.1016/j.cub.2004.06.056; Song YH, 2004, CURR BIOL, V14, P1354, DOI 10.1016/j.cub.2004.06.064; Sunkaria A, 2013, J NEUROSCI RES, V91, P444, DOI 10.1002/jnr.23173; Wang LQ, 2016, J NEUROSCI, V36, P1445, DOI 10.1523/JNEUROSCI.0256-15.2016; Whitworth AJ, 2017, CURR OPIN GENET DEV, V44, P47, DOI 10.1016/j.gde.2017.01.016; Willoughby LF, 2013, DIS MODEL MECH, V6, P521, DOI 10.1242/dmm.009985	42	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190821	10.1371/journal.pone.0190821	http://dx.doi.org/10.1371/journal.pone.0190821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338042	Green Published, gold, Green Submitted			2022-12-26	WOS:000422652700020
J	Raffington, L; Schmiedek, F; Heim, C; Shing, YL				Raffington, Laurel; Schmiedek, Florian; Heim, Christine; Shing, Yee Lee			Cognitive control moderates parenting stress effects on children's diurnal cortisol	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; SALIVARY CORTISOL; YOUNG-CHILDREN; ALLOSTATIC LOAD; HAIR CORTISOL; INDIVIDUAL-DIFFERENCES; ADAPTIVE CALIBRATION; EXECUTIVE FUNCTIONS; AWAKENING RESPONSE; EARLY EXPERIENCE	This study investigated associations between parenting stress in parents and self-reported stress in children with children's diurnal cortisol secretion and whether these associations are moderated by known stress-regulating capacities, namely child cognitive control. Salivary cortisol concentrations were assessed from awakening to evening on two weekend days from 53 6-to-7-year-old children. Children completed a cognitive control task and a self-report stress questionnaire with an experimenter, while parents completed a parenting stress inventory. Hierarchical, linear mixed effects models revealed that higher parenting stress was associated with overall reduced cortisol secretion in children, and this effect was moderated by cognitive control. Specifically, parenting stress was associated with reduced diurnal cortisol levels in children with lower cognitive control ability and not in children with higher cognitive control ability. There were no effects of self-reported stress in children on their cortisol secretion, presumably because 6-to-7-year-old children cannot yet self-report on stress experiences. Our results suggest that higher cognitive control skills may buffer the effects of parenting stress in parents on their children's stress regulation in middle childhood. This could indicate that training cognitive control skills in early life could be a target to prevent stress-related disorders.	[Raffington, Laurel; Heim, Christine] Humboldt Univ, Berlin Sch Mind & Brain, Berlin, Germany; [Raffington, Laurel; Schmiedek, Florian; Shing, Yee Lee] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany; [Raffington, Laurel; Heim, Christine] Charite, Inst Med Psychol, Berlin, Germany; [Schmiedek, Florian] German Inst Int Educ Res DIPF, Frankfurt, Germany; [Heim, Christine] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA; [Shing, Yee Lee] Univ Stirling, Div Psychol, Stirling, Scotland; [Shing, Yee Lee] Goethe Univ Frankfurt, Dept Psychol, Frankfurt, Germany	Humboldt University of Berlin; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Institute for International Educational Research; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Stirling; Goethe University Frankfurt	Shing, YL (corresponding author), Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany.; Shing, YL (corresponding author), Univ Stirling, Div Psychol, Stirling, Scotland.; Shing, YL (corresponding author), Goethe Univ Frankfurt, Dept Psychol, Frankfurt, Germany.	shing@psych.uni-frankfurt.de	Heim, Christine/J-4693-2014	Shing, Yee Lee/0000-0001-8922-7292; Raffington, Laurel/0000-0002-0144-5605; Heim, Christine/0000-0002-6580-6326	Minerva Research Group; Max Planck Society; Berlin School of Mind and Brain Graduate Fellowship	Minerva Research Group; Max Planck Society(Max Planck Society); Berlin School of Mind and Brain Graduate Fellowship	This study was funded by a Minerva Research Group to YLS by the Max Planck Society and Laurel Raffington was supported by the Berlin School of Mind and Brain Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidin R.R., 1990, PARENTING STRESS IND; Adam EK, 2017, PSYCHONEUROENDOCRINO, V83, P25, DOI 10.1016/j.psyneuen.2017.05.018; ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Aiken L. S., 1991, MULTIPLE REGRESSION; [Anonymous], [No title captured]; Badanes LS, 2011, DEV PSYCHOPATHOL, V23, P881, DOI 10.1017/S095457941100037X; Baumler D, 2013, PSYCHONEUROENDOCRINO, V38, P2485, DOI 10.1016/j.psyneuen.2013.05.008; Baumler D, 2014, BIOL PSYCHOL, P59; Bernard K, 2010, ARCH PEDIAT ADOL MED, V164, P438, DOI 10.1001/archpediatrics.2010.54; Blair C, 2005, CHILD DEV, V76, P554, DOI 10.1111/j.1467-8624.2005.00863.x; Blair C, 2013, PSYCHONEUROENDOCRINO, V38, P2666, DOI 10.1016/j.psyneuen.2013.06.025; Blair C, 2012, AM PSYCHOL, V67, P309, DOI 10.1037/a0027493; Blair C, 2011, CHILD DEV, V82, P1970, DOI 10.1111/j.1467-8624.2011.01643.x; Blair C, 2011, DEV PSYCHOPATHOL, V23, P845, DOI 10.1017/S0954579411000344; Bogels SM, 2001, BEHAV RES THER, V39, P273, DOI 10.1016/S0005-7967(00)00005-X; Briley DA, 2017, J PERS, V85, P51, DOI 10.1111/jopy.12186; Broderick JE, 2004, PSYCHONEUROENDOCRINO, V29, P636, DOI 10.1016/S0306-4530(03)00093-3; Byrne DG, 2011, INT J STRESS MANAGE, V18, P88, DOI 10.1037/a0021577; CADET R, 1986, J DEV PHYSIOL, V8, P467; Carnegie R, 2014, BRIT J PSYCHIAT, V204, P137, DOI 10.1192/bjp.bp.113.126250; Caster JB, 1999, J ANXIETY DISORD, V13, P237, DOI 10.1016/S0887-6185(99)00002-X; Chen E, 2006, HEALTH PSYCHOL, V25, P704, DOI 10.1037/0278-6133.25.6.704; Chen E, 2010, PSYCHOL SCI, V21, P31, DOI 10.1177/0956797609355566; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; Davis EP, 2002, DEV PSYCHOBIOL, V40, P43, DOI 10.1002/dev.10012; Deary I, 2008, NATURE, V456, P175, DOI 10.1038/456175a; Deary Ian J, 2010, Psychol Sci Public Interest, V11, P53, DOI 10.1177/1529100610387081; Dedovic K, 2009, NEUROIMAGE, V47, P864, DOI 10.1016/j.neuroimage.2009.05.074; DEKLOET ER, 1991, FRONT NEUROENDOCRIN, V12, P95; Del Giudice M, 2011, NEUROSCI BIOBEHAV R, V35, P1562, DOI 10.1016/j.neubiorev.2010.11.007; Dettling AC, 1999, PSYCHONEUROENDOCRINO, V24, P519, DOI 10.1016/S0306-4530(99)00009-8; Dettling AC, 2000, PSYCHONEUROENDOCRINO, V25, P819, DOI 10.1016/S0306-4530(00)00028-7; Evans GW, 2004, AM PSYCHOL, V59, P77, DOI 10.1037/0003-066X.59.2.77; Finegood E.D., 2017, PARENTAL STRESS EARL, P181, DOI [10.1007/978-3-319-55376-4_8, DOI 10.1007/978-3-319-55376-4_8]; Fisher PA, 2008, DEV PSYCHOPATHOL, V20, P1003, DOI 10.1017/S0954579408000473; Flom M, 2017, DEV PSYCHOBIOL, V59, P26, DOI 10.1002/dev.21449; Fries E, 2009, INT J PSYCHOPHYSIOL, V72, P67, DOI 10.1016/j.ijpsycho.2008.03.014; Gershoff ET, 2007, CHILD DEV, V78, P70, DOI 10.1111/j.1467-8624.2007.00986.x; Gross JJ, 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Guerry JD, 2011, CLIN CHILD FAM PSYCH, V14, P135, DOI 10.1007/s10567-011-0084-5; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Gunnar MR, 2006, DEV PSYCHOPATHOL, V18, P651, DOI 10.1017/S0954579406060330; Gunnar MR, 2009, PSYCHONEUROENDOCRINO, V34, P953, DOI 10.1016/j.psyneuen.2009.02.010; Gunnar MR, 1997, DEV PSYCHOBIOL, V31, P65, DOI 10.1002/(SICI)1098-2302(199707)31:1<65::AID-DEV6>3.0.CO;2-S; Halberstadt AG, 1999, FAMILY EXPRESSIVENES; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Hostinar CE, 2015, DEV PSYCHOL, V51, P1597, DOI 10.1037/dev0000029; Hostinar CE, 2015, DEVELOPMENTAL SCI, V18, P281, DOI 10.1111/desc.12195; Hostinar CE, 2014, PSYCHOL BULL, V140, P256, DOI 10.1037/a0032671; Johnson MH, 2012, TRENDS COGN SCI, V16, P454, DOI 10.1016/j.tics.2012.07.001; Kliewer W, 2009, J BLACK PSYCHOL, V35, P24, DOI 10.1177/0095798408323355; Knudsen EI, 2006, P NATL ACAD SCI USA, V103, P10155, DOI 10.1073/pnas.0600888103; Koenen KC, 2009, AM J PSYCHIAT, V166, P50, DOI 10.1176/appi.ajp.2008.08030343; Koss KJ, 2016, PSYCHONEUROENDOCRINO, V66, P31, DOI 10.1016/j.psyneuen.2015.12.018; Koss KJ, 2014, PSYCHONEUROENDOCRINO, V50, P1, DOI 10.1016/j.psyneuen.2014.07.028; LaPrairie JL, 2010, IMPACT EARLY LIFE TR, P247; Lehman BJ, 2015, SOC PERSONAL PSYCHOL, V9, P551, DOI 10.1111/spc3.12202; LeMoult J, 2015, J ABNORM PSYCHOL, V124, P850, DOI 10.1037/abn0000087; LEVINE S, 1994, ANN NY ACAD SCI, V746, P275, DOI 10.1111/j.1749-6632.1994.tb39245.x; Llabre MM, 2004, PSYCHOSOM MED, V66, P29, DOI 10.1097/01.PSY.0000107886.51781.9C; Luna B, 2010, BRAIN COGNITION, V72, P101, DOI 10.1016/j.bandc.2009.08.005; Lupien SJ, 2001, DEV PSYCHOPATHOL, V13, P653, DOI 10.1017/S0954579401003133; Lupien SJ, 2000, BIOL PSYCHIAT, V48, P976, DOI 10.1016/S0006-3223(00)00965-3; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Maldonado EF, 2008, SPAN J PSYCHOL, V11, P3, DOI 10.1017/S1138741600004066; Martin CG, 2016, PSYCHONEUROENDOCRINO, V67, P18, DOI 10.1016/j.psyneuen.2016.01.025; Martin CG, 2014, PSYCHONEUROENDOCRINO, V40, P170, DOI 10.1016/j.psyneuen.2013.11.015; McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109; MCLOYD VC, 1990, CHILD DEV, V61, P311, DOI 10.1111/j.1467-8624.1990.tb02781.x; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Murgatroyd CA, 2013, PSYCHONEUROENDOCRINO, V38, P219, DOI 10.1016/j.psyneuen.2012.05.020; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Pagliaccio D, 2014, NEUROPSYCHOPHARMACOL, V39, P1245, DOI 10.1038/npp.2013.327; Peckins MK, 2015, DEV PSYCHOPATHOL, V27, P1461, DOI 10.1017/S0954579415000875; Quevedo K, 2012, INT J BEHAV DEV, V36, P19, DOI 10.1177/0165025411406860; Rippe RCA, 2016, PSYCHONEUROENDOCRINO, V66, P56, DOI 10.1016/j.psyneuen.2015.12.016; Ross KM, 2014, PSYCHONEUROENDOCRINO, V39, P184, DOI 10.1016/j.psyneuen.2013.09.016; Rotenberg S, 2012, PSYCHONEUROENDOCRINO, V37, P1981, DOI 10.1016/j.psyneuen.2012.04.014; Schmidt-Reinwald A, 1999, LIFE SCI, V64, P1653, DOI 10.1016/S0024-3205(99)00103-4; Smyth N, 2013, SOC PERSONAL PSYCHOL, V7, P605, DOI 10.1111/spc3.12057; Sroufe L.A., 1996, EMOTIONAL DEV ORG EM, DOI DOI 10.1017/CBO9780511527661; Stalder T, 2016, PSYCHONEUROENDOCRINO, V63, P414, DOI 10.1016/j.psyneuen.2015.10.010; Stalder T, 2009, PSYCHONEUROENDOCRINO, V34, P607, DOI 10.1016/j.psyneuen.2008.10.023; Suor JH, 2015, CHILD DEV, V86, P1142, DOI 10.1111/cdev.12376; TEIN JY, 1994, J MARRIAGE FAM, V56, P341, DOI 10.2307/353104; Tr/ster H., 2011, PARENTING STRESS INV; Tucker-Drob EM, 2017, PSYCHOL MED, V47, P1389, DOI 10.1017/S0033291716003068; Vaghri Z, 2013, PSYCHONEUROENDOCRINO, V38, P331, DOI 10.1016/j.psyneuen.2012.06.009; Wagner SL, 2016, CHILD NEUROPSYCHOL, V22, P853, DOI 10.1080/09297049.2015.1080232; Wang YN, 2016, HUM BRAIN MAPP, V37, P3757, DOI 10.1002/hbm.23273; Watamura SE, 2004, DEV PSYCHOBIOL, V45, P125, DOI 10.1002/dev.20026; WEISSMAN MM, 1980, J NERV MENT DIS, V168, P736, DOI 10.1097/00005053-198012000-00005; Williford AP, 2007, J ABNORM CHILD PSYCH, V35, P251, DOI 10.1007/s10802-006-9082-3; Wolf JM, 2008, BIOL PSYCHOL, V78, P20, DOI 10.1016/j.biopsycho.2007.12.004; Wright Andy, 2014, Front Psychol, V5, P213, DOI 10.3389/fpsyg.2014.00213; Wust S, 2000, PSYCHONEUROENDOCRINO, V25, P707, DOI 10.1016/s0306-4530(00)00021-4; Yim IS, 2015, PSYCHONEUROENDOCRINO, V57, P61, DOI 10.1016/j.psyneuen.2015.03.021; Zalewski M, 2012, INFANT CHILD DEV, V21, P537, DOI 10.1002/icd.1759	99	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191215	10.1371/journal.pone.0191215	http://dx.doi.org/10.1371/journal.pone.0191215			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BY	29329340	Green Published, Green Submitted, gold			2022-12-26	WOS:000419954100050
J	Poleszczuk, J; Debowska, M; Dabrowski, W; Wojcik-Zaluska, A; Zaluska, W; Waniewski, J				Poleszczuk, Jan; Debowska, Malgorzata; Dabrowski, Wojciech; Wojcik-Zaluska, Alicja; Zaluska, Wojciech; Waniewski, Jacek			Subject-specific pulse wave propagation modeling: Towards enhancement of cardiovascular assessment methods	PLOS ONE			English	Article							AORTIC BLOOD-PRESSURE; EXPERT CONSENSUS DOCUMENT; RADIAL ARTERY TONOMETRY; AUGMENTATION INDEX; EXPERIMENTAL VALIDATION; VASCULAR-DISEASE; FORM; FLOW; REFLECTION; STIFFNESS	Cardiovascular diseases are the leading cause of death worldwide. Pulse wave analysis (PWA) technique, which reconstructs and analyses aortic pressure waveform based on non-invasive peripheral pressure recording, became an important bioassay for cardiovascular assessment in a general population. The aim of our study was to establish a pulse wave propagation modeling framework capable of matching clinical PWA data from healthy individuals on a per-subject basis. Radial pressure profiles from 20 healthy individuals (10 males, 10 females), with mean age of 42 +/- 10 years, were recorded using applanation tonometry (SphygmoCor, AtCor Medical, Australia) and used to estimate subject-specific parameters of mathematical model of blood flow in the system of fifty-five arteries. The model was able to describe recorded pressure profiles with high accuracy (mean absolute percentage error of 1.87 +/- 0.75%) when estimating only 6 parameters for each subject. Cardiac output (CO) and stroke volume (SV) have been correctly identified by the model as lower in females than males (CO of 3.57 +/- 0.54 vs. 4.18 +/- 0.72 L/min with p-value < 0.05; SV of 49.5 +/- 10.1 vs. 64.2 +/- 16.8 ml with p-value = 0.076). Moreover, the model identified age related changes in the heart function, i.e. that the cardiac output at rest is maintained with age (r = 0.23; p-value = 0.32) despite the decreasing heart rate (r = -0.49; p-value < 0.05), because of the increase in stroke volume (r = 0.46; p-value < 0.05). Central PWA indices derived from recorded waveforms strongly correlated with those obtained using corresponding model-predicted radial waves (r > 0.99 and r > 0.97 for systolic (SP) and diastolic (DP) pressures, respectively; r > 0.77 for augmentation index (AI); all p-values < 0.01). Model-predicted central waveforms, however, had higher SP than those reconstructed by PWA using recorded radial waves (5.6 +/- 3.3 mmHg on average). From all estimated subject-specific parameters only the time to the peak of heart ejection profile correlated with clinically measured AI. Our study suggests that the proposed model may serve as a tool to computationally investigate virtual patient scenarios mimicking different cardiovascular abnormalities. Such a framework can augment our understanding and help with the interpretation of PWA results.	[Poleszczuk, Jan; Debowska, Malgorzata; Waniewski, Jacek] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Dept Math Modeling Physiol Proc, Warsaw, Poland; [Dabrowski, Wojciech] Med Univ Lublin, Dept Anesthesiol & Intens Therapy, Lublin, Poland; [Wojcik-Zaluska, Alicja] Med Univ Lublin, Dept Phys Therapy & Rehabil, Lublin, Poland; [Zaluska, Wojciech] Med Univ Lublin, Dept Nephrol, Lublin, Poland	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin	Poleszczuk, J (corresponding author), Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Dept Math Modeling Physiol Proc, Warsaw, Poland.	jpoleszczuk@ibib.waw.pl	Dabrowski, Wojciech/AAN-8425-2020; Debowska, Malgorzata/F-3035-2015	Dabrowski, Wojciech/0000-0003-0449-2375; Debowska, Malgorzata/0000-0001-8741-7930; Wojcik-Zaluska, Alicja/0000-0001-7971-0141; Zaluska, Wojciech/0000-0001-6043-3236; Poleszczuk, Jan/0000-0001-8758-7200	National Science Centre (Poland) [2013/11/B/ST7/01704]	National Science Centre (Poland)	The study was supported by the National Science Centre (Poland), grant No. 2013/11/B/ST7/01704. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adji A, 2007, AM J HYPERTENS, V20, P917, DOI 10.1016/j.amjhyper.2007.03.006; Agabiti-Rosei E, 2007, HYPERTENSION, V50, P154, DOI 10.1161/HYPERTENSIONAHA.107.090068; Ankiler M, 1971, Z ANGEW MATH PHYS, V22, p217 ; Avolio AP, 2010, PHYSIOL MEAS, V31, pR1, DOI 10.1088/0967-3334/31/1/R01; AVOLIO AP, 1983, CIRCULATION, V68, P50, DOI 10.1161/01.CIR.68.1.50; Blanco PJ, 2014, BIOMECH MODEL MECHAN, V13, P1303, DOI 10.1007/s10237-014-0574-8; BYRD RH, 1987, SIAM J NUMER ANAL, V24, P1152, DOI 10.1137/0724076; Carlsen RK, 2016, KIDNEY INT, V90, P869, DOI 10.1016/j.kint.2016.05.014; Cheitlin Melvin D, 2003, Am J Geriatr Cardiol, V12, P9, DOI 10.1111/j.1076-7460.2003.01751.x; Chen CH, 1997, CIRCULATION, V95, P1827; Collis T, 2001, CIRCULATION, V103, P820, DOI 10.1161/01.CIR.103.6.820; Dawson EA, 2009, J APPL PHYSIOL, V106, P1896, DOI 10.1152/japplphysiol.91564.2008; Doupis J, 2016, OPEN CARDIOVASC MED, V10, P188, DOI 10.2174/1874192401610010188; Guala A, 2015, ANN BIOMED ENG, V43, P222, DOI 10.1007/s10439-014-1163-9; Gurovich AN, 2011, HYPERTENS RES, V34, P166, DOI 10.1038/hr.2010.217; Gurovich AN, 2009, EXP BIOL MED, V234, P1339, DOI 10.3181/0902-RM-88; Hope SA, 2004, DIABETES CARE, V27, P746, DOI 10.2337/diacare.27.3.746; Hope SA, 2007, J HYPERTENS, V25, P1812, DOI 10.1097/HJH.0b013e328277595d; Huberts W, 2012, J BIOMECH, V45, P1684, DOI 10.1016/j.jbiomech.2012.03.028; Huberts W, 2012, MED ENG PHYS, V34, P233, DOI 10.1016/j.medengphy.2011.07.015; ICRP, 2002, ANN ICRP, V32, P1, DOI DOI 10.1016/S0146-6453(03)00002-2; KARAMANOGLU M, 1993, EUR HEART J, V14, P160, DOI 10.1093/eurheartj/14.2.160; Koivistoinen T, 2007, CLIN PHYSIOL FUNCT I, V27, P191, DOI 10.1111/j.1475-097X.2007.00734.x; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Leguy CAD, 2010, MED ENG PHYS, V32, P957, DOI 10.1016/j.medengphy.2010.06.010; Lehmann ED, 2000, DIABETES CARE, V23, P869, DOI 10.2337/diacare.23.6.869; MURGO JP, 1980, CIRCULATION, V62, P105, DOI 10.1161/01.CIR.62.1.105; Namasivayam M, 2009, HYPERTENSION, V53, P979, DOI 10.1161/HYPERTENSIONAHA.108.125179; Nichols WW, 2002, CURR OPIN CARDIOL, V17, P543, DOI 10.1097/00001573-200209000-00016; O'Rourke MF, 2004, HYPERTENSION, V44, pE10, DOI 10.1161/01.HYP.0000146403.99648.c6; O'Rourke MF, 2002, AM J HYPERTENS, V15, P426, DOI 10.1016/S0895-7061(01)02319-6; Olufsen M. S., 1998, THESIS; Olufsen MS, 2000, ANN BIOMED ENG, V28, P1281, DOI 10.1114/1.1326031; Patvardhan E, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/253758; Pauca AL, 2001, HYPERTENSION, V38, P932, DOI 10.1161/hy1001.096106; Reymond P, 2009, AM J PHYSIOL-HEART C, V297, pH208, DOI 10.1152/ajpheart.00037.2009; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Savage MT, 2002, AM J KIDNEY DIS, V40, P753, DOI 10.1053/ajkd.2002.35686; Segers P, 2007, PHYSIOL MEAS, V28, P1045, DOI 10.1088/0967-3334/28/9/006; STERGIOPULOS N, 1992, J BIOMECH, V25, P1477, DOI 10.1016/0021-9290(92)90060-E; Stergiopulos N, 1999, AM J PHYSIOL-HEART C, V276, pH81; STREETER VL, 1963, CIRC RES, V13, P3, DOI 10.1161/01.RES.13.1.3; Takazawa K, 1996, Z KARDIOL, V85, P137; Taylor CA, 2009, ANNU REV BIOMED ENG, V11, P109, DOI 10.1146/annurev.bioeng.10.061807.160521; Van Bortel LM, 2012, J HYPERTENS, V30, P445, DOI 10.1097/HJH.0b013e32834fa8b0; van de Vosse FN, 2003, J ENG MATH, V47, P335, DOI 10.1023/B:ENGI.0000007985.17625.43; van de Vosse FN, 2011, ANNU REV FLUID MECH, V43, P467, DOI 10.1146/annurev-fluid-122109-160730; WESTERHOF N, 1971, J APPL PHYSIOL, V31, P776, DOI 10.1152/jappl.1971.31.5.776; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496; Xiao XS, 2002, ANN BIOMED ENG, V30, P612, DOI 10.1114/1.1484217; Zhang YD, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/931256	51	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190972	10.1371/journal.pone.0190972	http://dx.doi.org/10.1371/journal.pone.0190972			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324835	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400084
J	Pujades-Rodriguez, M; Guttmann, OP; Gonzalez-Izquierdo, A; Duyx, B; O'Mahony, C; Elliott, P; Hemingway, H				Pujades-Rodriguez, Mar; Guttmann, Oliver P.; Gonzalez-Izquierdo, Arturo; Duyx, Bram; O'Mahony, Constantinos; Elliott, Perry; Hemingway, Harry			Identifying unmet clinical need in hypertrophic cardiomyopathy using national electronic health records	PLOS ONE			English	Article							12 CARDIOVASCULAR-DISEASES; LIFETIME RISKS; ASSOCIATIONS; POPULATION; COHORT; CARE	Introduction To evaluate unmet clinical need in unselected hypertrophic cardiomyopathy (HCM) patients to determine the risk of a wide range of subsequent cardiovascular disease endpoints and safety endpoints relevant for trial design. Methods Population based cohort (CALIBER, linked primary care, hospital and mortality records in England, period 1997-2010), all people diagnosed with HCM were identified and matched by age, sex and general practice with ten randomly selected people without HCM. Random-effects Poisson models were used to assess the associations between HCM and cardiovascular diseases and bleeding. Results Among 3,290,455 eligible people a diagnosis of hypertrophic cardiomyopathy was found in 4 per 10,000. Forty-one percent of the 1,160 individuals with hypertrophic cardiomyopathy were women and the median age was 57 years. The median follow-up was 4.0 years. Compared to general population controls, people with HCM had higher risk of ventricular arrhythmia (incidence rate ratio = 23.53, [95% confidence interval 12.67-43.72]), cardiac arrest or sudden cardiac death (6.33 [3.69-10.85]), heart failure (4.31, [3.30-5.62]), and atrial fibrillation (3.80 [3.04-4.75]). HCM was also associated with a higher incidence of myocardial infarction ([MI] 1.90 [1.27-2.84]) and coronary revascularisation (2.32 [1.46-3.69]). The absolute Kaplan-Meier risks at 3 years were 8.8% for the composite endpoint of cardiovascular death or heart failure, 8.4% for the composite of cardiovascular death, stroke or myocardial infarction, and 1.5% for major bleeding. Conclusions Our study identified major unmet need in HCM and highlighted the importance of implementing improved cardiovascular prevention strategies to increase life-expectancy of the contemporary HCM population. They also show that national electronic health records provide an effective method for identifying outcomes and clinically relevant estimates of composite efficacy and safety endpoints essential for trial design in rare diseases.	[Pujades-Rodriguez, Mar] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Pujades-Rodriguez, Mar; Gonzalez-Izquierdo, Arturo; Duyx, Bram; Hemingway, Harry] UCL, Farr Inst Hlth Informat Res, Inst Hlth Informat, London, England; [Guttmann, Oliver P.; O'Mahony, Constantinos; Elliott, Perry] UCL, Inst Cardiovasc Sci, London, England; [Guttmann, Oliver P.; O'Mahony, Constantinos; Elliott, Perry] St Bartholomews Hosp, Barts Heart Ctr, London, England; [Duyx, Bram] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands	University of Leeds; University of London; University College London; University of London; University College London; University of London; Queen Mary University London; Maastricht University	Pujades-Rodriguez, M (corresponding author), Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England.; Pujades-Rodriguez, M (corresponding author), UCL, Farr Inst Hlth Informat Res, Inst Hlth Informat, London, England.	M.D.M.PujadesRodriguez@leeds.ac.uk	Elliott, Perry/AAR-3430-2020; Duyx, Bram/W-8668-2019; Pujades-Rodriguez, Mar/T-1129-2018; Hemingway, Harry/C-1219-2009	Elliott, Perry/0000-0003-3383-3984; Duyx, Bram/0000-0002-8879-5391; Pujades-Rodriguez, Mar/0000-0002-1375-1028; Hemingway, Harry/0000-0003-2279-0624; O'Mahony, Constantinos/0000-0001-6931-4647; Gonzalez-Izquierdo, Arturo/0000-0002-0984-5830	UK National Institute for Health Research [RP-PG-0407-10314]; Farr Institute of Health Informatics Research from the Medical Research Council [MR/K006584/1]; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute of Health Research; National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientific Office (Scottish Government Health Directorates); Wellcome Trust; University Academic Fellowship of the University of Leeds; National Institute for Health Research, University College London Hospitals Biomedical Research Centre; Medical Research Council [HDR-9003, HDR-9002, MR/K006584/1, HDR-9006] Funding Source: researchfish; National Institute for Health Research [RP-PG-0407-10314] Funding Source: researchfish	UK National Institute for Health Research(National Institute for Health Research (NIHR)); Farr Institute of Health Informatics Research from the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientific Office (Scottish Government Health Directorates); Wellcome Trust(Wellcome TrustEuropean Commission); University Academic Fellowship of the University of Leeds; National Institute for Health Research, University College London Hospitals Biomedical Research Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a grant from the UK National Institute for Health Research (RP-PG-0407-10314), and by awards establishing the Farr Institute of Health Informatics Research from the Medical Research Council (MR/K006584/1), in partnership with Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientific Office (Scottish Government Health Directorates), and the Wellcome Trust. MPR was funded by a University Academic Fellowship of the University of Leeds. OG was funded by the British Heart Foundation and by the National Institute for Health Research, University College London Hospitals Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR PHR Programme or the Department of Health.	CANNAN CR, 1995, CIRCULATION, V92, P2488, DOI 10.1161/01.CIR.92.9.2488; Cecchi F, 2005, AM HEART J, V150, P947, DOI 10.1016/j.ahj.2005.01.005; Clinical Practice Research Datalink, CLIN TRIALS RAND POI; Denaxas SC, 2012, INT J EPIDEMIOL, V41, P1625, DOI 10.1093/ije/dys188; Dhombres F, 2016, J BIOMED SEMANT, V7, DOI 10.1186/s13326-016-0047-3; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Elliott PM, 2000, J AM COLL CARDIOL, V36, P2212, DOI 10.1016/S0735-1097(00)01003-2; Gallagher AM, 2011, PHARMACOEPIDEM DR S, V20, pS230; George J, 2015, CIRCULATION, V132, P1320, DOI 10.1161/CIRCULATIONAHA.114.013797; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Hughes SE, 2004, HISTOPATHOLOGY, V44, P412, DOI 10.1111/j.1365-2559.2004.01835.x; Koudstaal S, 2017, EUR J HEART FAIL, V19, P1119, DOI 10.1002/ejhf.709; Kubo T, 2013, J AM COLL CARDIOL, V62, P1252, DOI 10.1016/j.jacc.2013.03.055; Maron BJ, 2016, JAMA CARDIOL, V1, P98, DOI 10.1001/jamacardio.2015.0354; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Mathur R, 2014, J PUBLIC HEALTH-UK, V36, P684, DOI 10.1093/pubmed/fdt116; Morley KI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110900; Pasea L, 2017, EUR HEART J; Pujades-Rodriguez M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151245; Pujades-Rodriguez M, 2016, HEART, V102, P383, DOI 10.1136/heartjnl-2015-308514; Pujades-Rodriguez M, 2015, INT J EPIDEMIOL, V44, P129, DOI 10.1093/ije/dyu218; Pujades-Rodriguez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104671; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Shah AD, 2015, LANCET DIABETES ENDO, V3, P105, DOI 10.1016/S2213-8587(14)70219-0; Siontis KC, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001002; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7	28	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191214	10.1371/journal.pone.0191214	http://dx.doi.org/10.1371/journal.pone.0191214			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324812	Green Published, gold			2022-12-26	WOS:000419952400132
J	Showalter, MR; Nonnecke, EB; Linderholm, AL; Cajka, T; Sa, MR; Lonnerdai, B; Kenyon, NJ; Fiehn, O				Showalter, Megan R.; Nonnecke, Eric B.; Linderholm, A. L.; Cajka, Tomas; Sa, Michael R.; Lonnerdai, Bo; Kenyon, Nicholas J.; Fiehn, Oliver			Obesogenic diets alter metabolism in mice	PLOS ONE			English	Article							PLASMA ACYLCARNITINES; BETA-HYDROXYBUTYRATE; LUNG; METABOLOMICS; OBESITY; MARKER	Obesity and accompanying metabolic disease is negatively correlated with lung health yet the exact mechanisms by which obesity affects the lung are not well characterized. Since obesity is associated with lung diseases as chronic bronchitis and asthma, we designed a series of experiments to measure changes in lung metabolism in mice fed obesogenic diets. Mice were fed either control or high fat/sugar diet (45%kcalfat/17% kcal sucrose), or very high fat diet (60%kcalfat/7%sucrose) for 150 days. We performed untargeted metabolomics by GC-TOFMS and HILIC-QTOFMS and lipidomics by RPLC-QTOFMS to reveal global changes in lung metabolism resulting from obesity and diet composition. From a total of 447 detected metabolites, we found 91 metabolite and lipid species significantly altered in mouse lung tissues upon dietary treatments. Significantly altered metabolites included complex lipids, free fatty acids, energy metabolites, amino acids and adenosine and NAD pathway members. While some metabolites were altered in both obese groups compared to control, others were different between obesogenic diet groups. Furthermore, a comparison of changes between lung, kidney and liver tissues indicated few metabolic changes were shared across organs, suggesting the lung is an independent metabolic organ. These results indicate obesity and diet composition have direct mechanistic effects on composition of the lung metabolome, which may contribute to disease progression by lung-specific pathways.	[Showalter, Megan R.; Cajka, Tomas; Sa, Michael R.; Fiehn, Oliver] Univ Calif Davis, NIH West Coast Metabol Ctr, Davis, CA 95616 USA; [Nonnecke, Eric B.; Lonnerdai, Bo] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Linderholm, A. L.; Kenyon, Nicholas J.] Univ Calif Davis, Dept Internal Med, Div Pulm & Crit Care, Davis, CA 95616 USA; [Fiehn, Oliver] King Abdulaziz Univ, Fac Sci, Biochem Dept, Jeddah, Saudi Arabia	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; King Abdulaziz University	Fiehn, O (corresponding author), Univ Calif Davis, NIH West Coast Metabol Ctr, Davis, CA 95616 USA.; Fiehn, O (corresponding author), King Abdulaziz Univ, Fac Sci, Biochem Dept, Jeddah, Saudi Arabia.	ofiehn@ucdavis.edu	Cajka, Tomas/A-8914-2008	Cajka, Tomas/0000-0002-9728-3355; Nonnecke, Eric/0000-0001-5345-2009; Fiehn, Oliver/0000-0002-6261-8928	NIH [U24 DK097154, S10 RR031630]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded as pilot project by NIH U24 DK097154 and by the instrument grant NIH S10 RR031630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2013, J ALLERGY CLIN IMMUN, V131, P636, DOI 10.1016/j.jaci.2012.12.1564; Barupal DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15231-w; Beermann C, 2016, NUTRITION, V32, P1165, DOI 10.1016/j.nut.2016.04.004; Cajka T, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1075-9; Cui L, 2016, SCI REP-UK, V6, DOI 10.1038/srep26076; Diaz J, 2015, IMMUNOL RES, V63, P197, DOI 10.1007/s12026-015-8717-2; Dinger K, 2016, SCI REP-UK, V6, DOI 10.1038/srep24168; Dungan KM, 2008, EXPERT REV MOL DIAGN, V8, P9, DOI 10.1586/14737159.8.1.9; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Grapov D, 2015, BIOINFORMATICS, V31, P2757, DOI 10.1093/bioinformatics/btv194; Kallsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050000; Kim JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116540; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; Leishangthem Geeta Devi, 2013, ISRN Allergy, V2013, P261297, DOI 10.1155/2013/261297; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Matsuda M, 2013, OBES RES CLIN PRACT, V7, pE330, DOI 10.1016/j.orcp.2013.05.004; McCoin CS, 2015, NAT REV ENDOCRINOL, V11, P617, DOI 10.1038/nrendo.2015.129; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Otsubo C, 2015, J BIOL CHEM, V290, P23897, DOI 10.1074/jbc.M115.655837; Ramana KV, 2010, INT J BIOCHEM CELL B, V42, P17, DOI 10.1016/j.biocel.2009.09.009; Rojas-Morales P, 2016, CELL SIGNAL, V28, P917, DOI 10.1016/j.cellsig.2016.04.005; Schooneman MG, 2014, BBA-MOL CELL BIOL L, V1841, P987, DOI 10.1016/j.bbalip.2014.04.001; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Showalter MR, 2017, CURR OPIN CHEM BIOL, V36, P70, DOI 10.1016/j.cbpa.2017.01.012; Singh VP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129850; Skogerson K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-321; SOUBA WW, 1990, JPEN-PARENTER ENTER, V14, pS68, DOI 10.1177/014860719001400407; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Suratt BT, 2016, AM J RESP CELL MOL, V55, P153, DOI 10.1165/rcmb.2016-0063PS; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; Uhlig S, 2008, AM J RESP CRIT CARE, V178, P1100, DOI 10.1164/rccm.200804-595SO; Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/NCHEMBIO.1204, 10.1038/nchembio.1204]; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; Vigetti D, 2002, FEBS LETT, V512, P323, DOI 10.1016/S0014-5793(02)02264-0; Woods PS, 2016, AM J PHYSIOL-LUNG C, V311, pL1160, DOI 10.1152/ajplung.00339.2016; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Zhou Y, 2009, PHARMACOL THERAPEUT, V123, P105, DOI 10.1016/j.pharmthera.2009.04.003	40	44	44	7	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190632	10.1371/journal.pone.0190632	http://dx.doi.org/10.1371/journal.pone.0190632			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324762	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400043
J	Skeate, JG; Da Silva, DM; Chavez-Juan, E; Anand, S; Nuccitelli, R; Kast, WM				Skeate, Joseph G.; Da Silva, Diane M.; Chavez-Juan, Elena; Anand, Snjezana; Nuccitelli, Richard; Kast, W. Martin			Nano-Pulse Stimulation induces immunogenic cell death in human papillomavirus-transformed tumors and initiates an adaptive immune response	PLOS ONE			English	Article							NANOSECOND ELECTRIC PULSES; MEMBRANE PERMEABILIZATION; HEPATOCELLULAR-CARCINOMA; SELF-DESTRUCT; FIELD THERAPY; CANCER; MELANOMAS; IMMUNOTHERAPY; INFECTION; EFFICACY	Nano-Pulse Stimulation (NPS) is a non-thermal pulsed electric field modality that has been shown to have cancer therapeutic effects. Here we applied NPS treatment to the human papillomavirus type 16 (HPV 16)-transformed C3.43 mouse tumor cell model and showed that it is effective at eliminating primary tumors through the induction of immunogenic cell death while subsequently increasing the number of tumor-infiltrating lymphocytes within the tumor microenvironment. In vitro NPS treatment of C3.43 cells resulted in a doubling of activated caspase 3/ 7 along with the translocation of phosphatidylserine (PS) to the outer leaflet of the plasma membrane, indicating programmed cell death activity. Tumor-bearing mice receiving standard NPS treatment showed an initial decrease in tumor volume followed by clearing of tumors in most mice, and a significant increase in overall survival. Intra-tumor analysis of mice that were unable to clear tumors showed an inverse correlation between the number of tumor infiltrating lymphocytes and the size of the tumor. Approximately half of the mice that cleared established tumors were protected against tumor re-challenge on the opposite flank. Selective depletion of CD8(+) T cells eliminated this protection, suggesting that NPS treatment induces an adaptive immune response generating CD8(+) T cells that recognize tumor antigen (s) associated with the C3.43 tumor model. This method may be utilized in the future to not only ablate primary tumors, but also to induce an anti-tumor response driven by effector CD8(+) T cells capable of protecting individuals from disease recurrence.	[Skeate, Joseph G.; Kast, W. Martin] Univ Southern Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA; [Da Silva, Diane M.; Kast, W. Martin] Univ Southern Calif, Dept Obstet & Gynecol, Los Angeles, CA 90089 USA; [Da Silva, Diane M.; Chavez-Juan, Elena; Kast, W. Martin] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; [Anand, Snjezana; Nuccitelli, Richard] Pulse Biosci Inc, Hayward, CA USA	University of Southern California; University of Southern California; University of Southern California	Kast, WM (corresponding author), Univ Southern Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA.; Kast, WM (corresponding author), Univ Southern Calif, Dept Obstet & Gynecol, Los Angeles, CA 90089 USA.; Kast, WM (corresponding author), Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA.	Martin.Kast@med.usc.edu	Ebersole, Joseph L/A-8371-2009; Teske, Tyler/W-9241-2018	Skeate, Joseph/0000-0002-1765-5949; Kast, W Martin/0000-0003-2321-3159	Pulse Biosciences; National Cancer Institute Cancer Center [P30CA014089]; National Institutes of Health [R01 CA074397]; Keck School of Medicine/USC Graduate School PhD Fellowship; Connie de Rosa; USC Norris Comprehensive Cancer Center Auxiliary Women; NATIONAL CANCER INSTITUTE [R01CA074397, P30CA014089] Funding Source: NIH RePORTER	Pulse Biosciences; National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck School of Medicine/USC Graduate School PhD Fellowship; Connie de Rosa; USC Norris Comprehensive Cancer Center Auxiliary Women; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by Pulse Biosciences (http://www.pulsebiosciences.com/). The in vitro experiments outlined in this manuscript were done at Pulse Biosciences. Employees of Pulse Biosciences were also involved in editing and providing input on the manuscript. Immuno-assays within this manuscript were performed in-part by the USC Immune Monitoring Core Facility that is supported in part by the National Cancer Institute Cancer Center Shared Grant award P30CA014089 (https://www.cancer.gov/). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The C3.43 cell line was created through support of the National Institutes of Health R01 CA074397 to W. Martin Kast (https://www.nih.gov/). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was partly funded by Pulse Biosciences. The funder provided support in the form of salaries for authors RN and SA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. Additional support from The Keck School of Medicine/USC Graduate School PhD Fellowship (to J.G.S.), Connie de Rosa, and the USC Norris Comprehensive Cancer Center Auxiliary Women is acknowledged.	Arbyn M, 2011, ANN ONCOL, V22, P2675, DOI 10.1093/annonc/mdr015; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; Bertolotti A, 2017, J AM ACAD DERMATOL, V77, P518, DOI 10.1016/j.jaad.2017.04.012; Cassetti MC, 2004, VACCINE, V22, P520, DOI 10.1016/j.vaccine.2003.07.003; Chen R, 2014, EUR J CANCER, V50, P2705, DOI 10.1016/j.ejca.2014.07.006; Chen XH, 2017, ONCOTARGET, V8, P44032, DOI 10.18632/oncotarget.17178; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Frega A, 2017, EUR REV MED PHARMACO, V21, P2504; Garg AD, 2012, EMBO J, V31, P1062, DOI 10.1038/emboj.2011.497; Guo S, 2017, INT J CANC; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Juhl ME, 2016, INT J STD AIDS, V27, P1071, DOI 10.1177/0956462415607375; Langendijk JA, 2017, RECENT RESULTS CANC, V206, P161, DOI 10.1007/978-3-319-43580-0_12; Marchionne E, 2017, AN BRAS DERMATOL, V92, P95, DOI 10.1590/abd1806-4841.20175009; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0234-5; Nuccitelli R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134364; Nuccitelli R, 2013, BIOCHEM BIOPH RES CO, V435, P580, DOI 10.1016/j.bbrc.2013.05.014; Nuccitelli R, 2012, PIGM CELL MELANOMA R, V25, P618, DOI 10.1111/j.1755-148X.2012.01027.x; Nuccitelli R, 2010, INT J CANCER, V127, P1727, DOI 10.1002/ijc.25364; Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Piersma SJ, 2007, CANCER RES, V67, P354, DOI 10.1158/0008-5472.CAN-06-3388; Reagan-Steiner S, 2015, MMWR-MORBID MORTAL W, V64, P784, DOI 10.15585/mmwr.mm6429a3; Serrano B., 2021, HUMAN PAPILLOMAVIRUS; Shah W, 2011, CELL MOL IMMUNOL, V8, P59, DOI 10.1038/cmi.2010.56; Smith KA, 2009, CLIN CANCER RES, V15, P6167, DOI 10.1158/1078-0432.CCR-09-0645; Stevanovic S, 2017, SCIENCE, V356, P200, DOI 10.1126/science.aak9510; Stewart TJ, 2003, CANCER RES, V63, P3058; van Hall T, 1998, CANCER RES, V58, P3087; Vandenberk L, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00663; Vernier PT, 2011, IEEE ENG MED BIO, P743, DOI 10.1109/IEMBS.2011.6090169; Vernier PT, 2003, BIOCHEM BIOPH RES CO, V310, P286, DOI 10.1016/j.bbrc.2003.08.140; Villa L, 2007, LANCET, V369, P1861, DOI 10.1016/S0140-6736(07)60852-6; Yin SY, 2014, CANCER LETT, V346, P285, DOI 10.1016/j.canlet.2014.01.009	37	30	30	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191311	10.1371/journal.pone.0191311	http://dx.doi.org/10.1371/journal.pone.0191311			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324830	gold, Green Submitted, Green Published			2022-12-26	WOS:000419952400138
J	Wheeler, KC; Jena, MK; Pradhan, BS; Nayak, N; Das, S; Hsu, CD; Wheeler, DS; Chen, K; Nayak, NR				Wheeler, Karen C.; Jena, Manoj K.; Pradhan, Bhola S.; Nayak, Neha; Das, Subhendu; Hsu, Chaur-Dong; Wheeler, David S.; Chen, Kang; Nayak, Nihar R.			VEGF may contribute to macrophage recruitment and M2 polarization in the decidua	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FETAL-MATERNAL INTERFACE; RECURRENT PREGNANCY LOSS; GENE-EXPRESSION; ALTERNATIVE ACTIVATION; HUMAN MONOCYTES; MESSENGER-RNA; THP-1 CELLS; IN-VITRO; M-CSF	It is increasingly evident that cytokines and growth factors produced in the decidua play a pivotal role in the regulation of the local immune microenvironment and the establishment of pregnancy. One of the major growth factors produced in the decidua is vascular endothelial growth factor (VEGF), which acts not only on endothelial cells, but also on multiple other cell types, including macrophages. We sought to determine whether decidua-derived VEGF affects macrophage recruitment and polarization using human endometrial/decidual tissue samples, primary human endometrial stromal cells (ESCs), and the human monocyte cell line THP1. In situ hybridization was used for assessment of local VEGF expression and immunohistochemistry was used for identification and localization of CD68-positive endometrial macrophages. Macrophage migration in culture was assessed using a transwell migration assay, and the various M1/M2 phenotypic markers and VEGF expression were assessed using quantitative real-time PCR (qRT-PCR). We found dramatic increases in both VEGF levels and macrophage numbers in the decidua during early pregnancy compared to the secretory phase endometrium (non-pregnant), with a significant increase in M2 macrophage markers, suggesting that M2 is the predominant macrophage phenotype in the decidua. However, decidual samples from preeclamptic pregnancies showed a significant shift in macrophage phenotype markers, with upregulation of M1 and downregulation of M2 markers. In THP1 cultures, VEGF treatment significantly enhanced macrophage migration and induced M1 macrophages to shift to an M2 phenotype. Moreover, treatment with conditioned media from decidualized ESCs induced changes in macrophage migration and polarization similar to that of VEGF treatment. These effects were abrogated by the addition of a potent VEGF inhibitor. Together these results suggest that decidual VEGF plays a significant role in macrophage recruitment and M2 polarization, and that inhibition of VEGF signaling may contribute to the shift in macrophage polarity observed in different pregnancy disorders, including preeclampsia.	[Wheeler, Karen C.; Jena, Manoj K.; Pradhan, Bhola S.; Nayak, Neha; Das, Subhendu; Hsu, Chaur-Dong; Chen, Kang; Nayak, Nihar R.] Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA; [Jena, Manoj K.] LPU, Dept Biotechnol, Sch Bioengn & Biosci, Phagwara, Punjab, India; [Wheeler, David S.] Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Ann Arbor, MI USA	Wayne State University; Lovely Professional University; University of Michigan System; University of Michigan	Nayak, NR (corresponding author), Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48202 USA.	nnayak@med.wayne.edu	Jena, M/AGM-1989-2022	PRADHAN, BHOLA/0000-0002-6346-2523	Wayne State University Perinatal Initiative; March of Dimes Foundation; National Institute of Child Health and Human Development [HD088549-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD088549] Funding Source: NIH RePORTER	Wayne State University Perinatal Initiative; March of Dimes Foundation(March of Dimes); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Wayne State University Perinatal Initiative, March of Dimes Foundation, and was partly supported by the National Institute of Child Health and Human Development (grant no. HD088549-01) all to NRN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akercan F, 2008, ARCH GYNECOL OBSTET, V277, P109, DOI 10.1007/s00404-007-0430-5; Al-Ofi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042217; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Brown MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00606; Celletti FL, 2001, NAT MED, V7, P425, DOI 10.1038/86490; Chanput W, 2014, INT IMMUNOPHARMACOL, V23, P37, DOI 10.1016/j.intimp.2014.08.002; Christiansen OB, 2006, SEMIN FETAL NEONAT M, V11, P302, DOI 10.1016/j.siny.2006.03.001; Czepluch FS, 2011, ATHEROSCLEROSIS, V215, P331, DOI 10.1016/j.atherosclerosis.2011.01.004; Douglas NC, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-16; Eubank TD, 2003, J IMMUNOL, V171, P2637, DOI 10.4049/jimmunol.171.5.2637; Faas MM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00298; Fan XJ, 2008, FASEB J, V22, P3571, DOI 10.1096/fj.08-111401; Fan XJ, 2014, J CLIN INVEST, V124, P4941, DOI 10.1172/JCI76864; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Genin M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1546-9; Germeyer A, 2005, J CLIN ENDOCR METAB, V90, P1783, DOI 10.1210/jc.2004-1769; Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078; Hannan NJ, 2011, ENDOCRINOLOGY, V152, P4948, DOI 10.1210/en.2011-1248; Hess AP, 2007, BIOL REPROD, V76, P102, DOI 10.1095/biolreprod.106.054791; Houser BL, 2011, J IMMUNOL, V186, P2633, DOI 10.4049/jimmunol.1003153; Hunt JS, 2000, SEMIN CELL DEV BIOL, V11, P127, DOI 10.1006/scdb.2000.0158; IRWIN JC, 1994, ANN NY ACAD SCI, V734, P7, DOI 10.1111/j.1749-6632.1994.tb21730.x; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kloepper J, 2016, P NATL ACAD SCI USA, V113, P4476, DOI 10.1073/pnas.1525360113; Krieg SA, 2012, MOL HUM REPROD, V18, P442, DOI 10.1093/molehr/gas017; Krussel JS, 2000, FERTIL STERIL, V74, P1220, DOI 10.1016/S0015-0282(00)01581-8; Kurtagic E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145115; Kwak-Kim J, 2010, AM J REPROD IMMUNOL, V63, P611, DOI 10.1111/j.1600-0897.2010.00847.x; Lala N, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.097881; Laresgoiti-Servitje E, 2013, J LEUKOCYTE BIOL, V94, P247, DOI 10.1189/jlb.1112603; Larrivee B, 2005, J IMMUNOL, V175, P3015, DOI 10.4049/jimmunol.175.5.3015; Lathi RB, 2005, J CLIN ENDOCR METAB, V90, P1599, DOI 10.1210/jc.2004-1676; Lee HW, 2013, BBA-REV CANCER, V1835, P170, DOI 10.1016/j.bbcan.2012.12.007; Li CH, 2011, CANCER BIOL THER, V12, P872, DOI 10.4161/cbt.12.10.17672; Li N, 2015, CANCER BIOL THER, V16, P297, DOI 10.1080/15384047.2014.1002353; Lidstrom C, 2003, AM J REPROD IMMUNOL, V50, P444, DOI 10.1046/j.8755-8920.2003.00112.x; Linde N, 2012, J PATHOL, V227, P17, DOI 10.1002/path.3989; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maharaj ASR, 2007, MICROVASC RES, V74, P100, DOI 10.1016/j.mvr.2007.03.004; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; McLaren J, 1996, J CLIN INVEST, V98, P482, DOI 10.1172/JCI118815; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; Medeiros LTL, 2014, AM J REPROD IMMUNOL, V72, P5, DOI 10.1111/aji.12222; Melgert BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045229; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nagamatsu T, 2010, REPROD SCI, V17, P209, DOI 10.1177/1933719109349962; Ning F, 2016, AM J REPROD IMMUNOL, V75, P298, DOI 10.1111/aji.12477; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Ou YQ, 2009, ACTA PHARMACOL SIN, V30, P435, DOI 10.1038/aps.2009.21; Outtz HH, 2010, J IMMUNOL, V185, P4363, DOI 10.4049/jimmunol.1000720; Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420; Perfetto CO, 2015, J ASSIST REPROD GEN, V32, P977, DOI 10.1007/s10815-015-0481-7; Saryeddine L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165876; Schonkeren D, 2011, AM J PATHOL, V178, P709, DOI 10.1016/j.ajpath.2010.10.011; Sharma S, 2016, AM J REPROD IMMUNOL, V75, P341, DOI 10.1111/aji.12466; Spiekermann K, 2002, EXP HEMATOL, V30, P767, DOI 10.1016/S0301-472X(02)00837-8; Sung JF, 2011, J CLIN ENDOCR METAB, V96, pE1148, DOI 10.1210/jc.2011-0063; Svensson J, 2011, J IMMUNOL, V187, P3671, DOI 10.4049/jimmunol.1100130; Svensson-Arvelund J, 2015, AM J REPROD IMMUNOL, V74, P100, DOI 10.1111/aji.12357; Svensson-Arvelund J, 2015, J IMMUNOL, V194, P1534, DOI 10.4049/jimmunol.1401536; TISDALL DJ, 1994, J MOL ENDOCRINOL, V12, P181, DOI 10.1677/jme.0.0120181; Tripathi C, 2014, ONCOTARGET, V5, P5350, DOI 10.18632/oncotarget.2110; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Wang N, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00614; Woolard J, 2009, MICROCIRCULATION, V16, P572, DOI 10.1080/10739680902997333; Xu Y, 2016, J IMMUNOL, V196, P2476, DOI 10.4049/jimmunol.1502055; Zhang YH, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00120; Zhao QW, 2002, CIRCULATION, V105, P1110, DOI 10.1161/hc0902.104718	74	100	107	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191040	10.1371/journal.pone.0191040	http://dx.doi.org/10.1371/journal.pone.0191040			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324807	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400099
J	Gao, P; Qin, JX; Li, DL; Zhou, SY				Gao, Pan; Qin, Jiaxing; Li, Delong; Zhou, Shanyue			Inhibitory effect and possible mechanism of a Pseudomonas strain QBA5 against gray mold on tomato leaves and fruits caused by Botrytis cinerea	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; DICARBOXIMIDE FUNGICIDES; BACILLUS-LICHENIFORMIS; POSTHARVEST DISEASES; GLIOCLADIUM-ROSEUM; NATURAL FUNCTIONS; BIOCONTROL; RESISTANCE; LIPOPEPTIDES; PATHOGENS	The fungal pathogen Botrytis cinerea causes gray mold disease on various hosts, which results in serious economic losses. Over the past several decades, many kinds of fungicides have been used to successfully control the disease. Meanwhile, the uses of fungicides lead to environmental pollution as well as a potential threat to the human health by the chemical residues in tomato fruit. Also, the gray mold disease is difficult to control with fungicides. Therefore, exploring alternative measures such as biological controls could be the best choice to control the disease and alleviate damages caused by fungicides. In this study, we isolated and identified a novel Pseudomonas strain termed as QBA5 from healthy tomato plant based on the morphological, biochemical characteristics and molecular detection. The antifungal activity assays revealed that, in the presence of QBA5, conidia germination, germ tube elongation and mycelial growth of B. cinerea were significantly inhibited. Most importantly, QBA5 exerted a significant preventive effectiveness against gray mold on tomato fruits and plants. The possible mechanism of QBA5 involved in the inhibition of B. cinerea was investigated. It revealed that the conidia plasma membrane of B. cinerea was severely damaged by QBA5. Further, four different antifungal compounds in the supernatant of QBA5 were separated by preparative high performance liquid chromatography (PHPLC). Overall, the data indicate that there is a considerable potential for QBA5 to reduce the damage caused by gray mold disease on tomato.	[Gao, Pan; Qin, Jiaxing; Li, Delong; Zhou, Shanyue] Qingdao Agr Univ, Coll Plant Hlth & Med, Qingdao, Peoples R China; [Li, Delong; Zhou, Shanyue] Qingdao Agr Univ, Key Lab Integrated Crop Pests Management Shandong, Qingdao, Peoples R China	Qingdao Agricultural University; Qingdao Agricultural University	Zhou, SY (corresponding author), Qingdao Agr Univ, Coll Plant Hlth & Med, Qingdao, Peoples R China.; Zhou, SY (corresponding author), Qingdao Agr Univ, Key Lab Integrated Crop Pests Management Shandong, Qingdao, Peoples R China.	zhoushanyao@126.com			National Key R&D Program of China [2017YFD0201104]; Key R&D Program of Shandong Province [2016GNC111014]; National Key R&D Program of China; Key R&D Program of Shandong Province	National Key R&D Program of China; Key R&D Program of Shandong Province; National Key R&D Program of China; Key R&D Program of Shandong Province	This study was supported by the National Key R&D Program of China (2017YFD0201104) and the Key R&D Program of Shandong Province (2016GNC111014).	[Anonymous], PLANT PATHOLOGY; [陈志谊 Chen Zhiyi], 2015, [中国生物防治学报, Chinese Journal of Biological Control], V31, P723; Di Francesco A, 2016, EUR J PLANT PATHOL, V145, P711, DOI 10.1007/s10658-016-0867-0; Di Francesco A, 2015, BIOL CONTROL, V81, P8, DOI 10.1016/j.biocontrol.2014.10.004; Diallo S, 2011, FEMS MICROBIOL ECOL, V75, P351, DOI 10.1111/j.1574-6941.2010.01023.x; Dianez F, 2002, PHYTOPARASITICA, V30, P529, DOI 10.1007/BF02979759; Dimkic I, 2013, BIOL CONTROL, V65, P312, DOI 10.1016/j.biocontrol.2013.03.012; Dinesh R, 2015, MICROBIOL RES, V173, P34, DOI 10.1016/j.micres.2015.01.014; Dong X.Z., 2001, COMMON BACTERIAL SYS; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; Fernandez-Ortuno D, 2012, PLANT DIS, V96, P1198, DOI 10.1094/PDIS-12-11-1049-RE; Frey-Klett P, 2011, MICROBIOL MOL BIOL R, V75, P583, DOI 10.1128/MMBR.00020-11; Gomaa EZ, 2012, J MICROBIOL, V50, P103, DOI 10.1007/s12275-012-1343-y; Huang R, 2012, BIOL CONTROL, V62, P53, DOI 10.1016/j.biocontrol.2012.02.010; Huang R, 2011, PHYTOPATHOLOGY, V101, P859, DOI 10.1094/PHYTO-09-10-0255; Gutierrez-Roman MI, 2012, WORLD J MICROB BIOT, V28, P145, DOI 10.1007/s11274-011-0803-6; Kefi A, 2015, WORLD J MICROB BIOT, V31, P1967, DOI 10.1007/s11274-015-1943-x; Kilian M, 2000, FZB24 BACILLUS SUBTI; Lee JP, 2006, BIOL CONTROL, V37, P329, DOI 10.1016/j.biocontrol.2006.01.001; Li GQ, 2002, BOT BULL ACAD SINICA, V43, P211; Liu J, 2007, POSTHARVEST BIOL TEC, V44, P300, DOI 10.1016/j.postharvbio.2006.12.019; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Mela F, 2011, ISME J, V5, P1494, DOI 10.1038/ismej.2011.29; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Montesinos E, 2007, FEMS MICROBIOL LETT, V270, P1, DOI 10.1111/j.1574-6968.2007.00683.x; Mouekouba LDOngouya, 2013, INT C AGR BIOT; Muller T, 2014, FEMS MICROBIOL ECOL, V87, P2, DOI 10.1111/1574-6941.12198; Myresiotis CK, 2007, PLANT DIS, V91, P407, DOI 10.1094/PDIS-91-4-0407; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Pal KK, 2006, PLANT HLTH INSTRUCTO, V202, P147; Pieterse CMJ, 2012, PLANT PHYSIOL, V158, P545, DOI 10.1104/pp.112.900430; Pretorius D, 2015, NEW BIOTECHNOL, V32, P243, DOI 10.1016/j.nbt.2014.12.003; Qin GZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021945; Raaijmakers JM, 2012, ANNU REV PHYTOPATHOL, V50, P403, DOI 10.1146/annurev-phyto-081211-172908; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Schenk ST, 2012, PLANT SIGNAL BEHAV, V7, P178, DOI 10.4161/psb.18789; Shim CK, 2014, PLANT PATHOLOGY J, V30, P90, DOI 10.5423/PPJ.NT.07.2013.0064; Soylu EM, 2010, INT J FOOD MICROBIOL, V143, P183, DOI 10.1016/j.ijfoodmicro.2010.08.015; Sutton JC, 1997, PLANT DIS, V81, P316, DOI 10.1094/PDIS.1997.81.4.316; Vicedo B, 2006, ARCH MICROBIOL, V184, P316, DOI 10.1007/s00203-005-0048-6; Wang J, 2013, INT J FOOD MICROBIOL, V161, P151, DOI 10.1016/j.ijfoodmicro.2012.11.025; Wang ST, 2005, ACTA PHYTOPATHOLOGIC, V35, P91; Weller DM, 2007, PHYTOPATHOLOGY, V97, P250, DOI 10.1094/PHYTO-97-2-0250; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI [10.1111/j.1364-3703.2007.00417.x, 10.1111/J.1364-3703.2007.00417.X]; Yang J, 2009, TRENDS PLANT SCI, V14, P1, DOI 10.1016/j.tplants.2008.10.004; Yourman LF, 1999, PLANT DIS, V83, P569, DOI 10.1094/PDIS.1999.83.6.569; Zhang QH, 2014, BIOL CONTROL, V72, P98, DOI 10.1016/j.biocontrol.2014.02.018	47	23	27	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190932	10.1371/journal.pone.0190932	http://dx.doi.org/10.1371/journal.pone.0190932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320571	gold, Green Published, Green Submitted			2022-12-26	WOS:000419689600073
J	Guo, CH; Wei, MZ; Liu, H				Guo, Chaohua; Wei, Mingzhen; Liu, Hong			Study of gas production from shale reservoirs with multi-stage hydraulic fracturing horizontal well considering multiple transport mechanisms	PLOS ONE			English	Article							POROUS-MEDIA; FLOW; PERMEABILITY; SIMULATION; PERFORMANCE; DESORPTION; MODEL	Development of unconventional shale gas reservoirs (SGRs) has been boosted by the advancements in two key technologies: horizontal drilling and multi-stage hydraulic fracturing. A large number of multi-stage fractured horizontal wells (MsFHW) have been drilled to enhance reservoir production performance. Gas flow in SGRs is a multi-mechanism process, including: desorption, diffusion, and non-Darcy flow. The productivity of the SGRs with MsFHW is influenced by both reservoir conditions and hydraulic fracture properties. However, rare simulation work has been conducted for multi-stage hydraulic fractured SGRs. Most of them use well testing methods, which have too many unrealistic simplifications and assumptions. Also, no systematical work has been conducted considering all reasonable transport mechanisms. And there are very few works on sensitivity studies of uncertain parameters using real parameter ranges. Hence, a detailed and systematic study of reservoir simulation with MsFHW is still necessary. In this paper, a dual porosity model was constructed to estimate the effect of parameters on shale gas production with MsFHW. The simulation model was verified with the available field data from the Barnett Shale. The following mechanisms have been considered in this model: viscous flow, slip flow, Knudsen diffusion, and gas desorption. Langmuir isotherm was used to simulate the gas desorption process. Sensitivity analysis on SGRs' production performance with MsFHW has been conducted. Parameters influencing shale gas production were classified into two categories: reservoir parameters including matrix permeability, matrix porosity; and hydraulic fracture parameters including hydraulic fracture spacing, and fracture half-length. Typical ranges of matrix parameters have been reviewed. Sensitivity analysis have been conducted to analyze the effect of the above factors on the production performance of SGRs. Through comparison, it can be found that hydraulic fracture parameters are more sensitive compared with reservoir parameters. And reservoirs parameters mainly affect the later production period. However, the hydraulic fracture parameters have a significant effect on gas production from the early period. The results of this study can be used to improve the efficiency of history matching process. Also, it can contribute to the design and optimization of hydraulic fracture treatment design in unconventional SGRs.	[Guo, Chaohua] China Univ Geosci, Minist Educ, Key Lab Tecton & Petr Resources, Wuhan, Hubei, Peoples R China; [Wei, Mingzhen] Missouri Univ Sci & Technol, Dept Geol & Petr Engn, Rolla, MO USA; [Liu, Hong] Chongqing Univ Sci & Technol, Dept Petr & Nat Gas Engn, Chongqing, Peoples R China	China University of Geosciences; University of Missouri System; Missouri University of Science & Technology; Chongqing University of Science & Technology	Guo, CH (corresponding author), China Univ Geosci, Minist Educ, Key Lab Tecton & Petr Resources, Wuhan, Hubei, Peoples R China.	chaohua.guo@cug.edu.cn			National Natural Science Foundation of China "Study on Two Component Gas Diffusion and Transport Mechanisms in Organic-rich Shale Nano Matrix and Mathematical Model Construction" [51704265]; Outstanding Talent Development Project of China University of Geosciences [CUG20170614]	National Natural Science Foundation of China "Study on Two Component Gas Diffusion and Transport Mechanisms in Organic-rich Shale Nano Matrix and Mathematical Model Construction"; Outstanding Talent Development Project of China University of Geosciences	The authors want to thank the fund of National Natural Science Foundation of China Study on Two Component Gas Diffusion and Transport Mechanisms in Organic-rich Shale Nano Matrix and Mathematical Model Construction (Project leader: Chaohua Guo; Project No: 51704265); and the Outstanding Talent Development Project of China University of Geosciences (Project leader: Chaohua Guo; Project No:CUG20170614).	Al-Ghamdi A, 1996, SPE J, V1, P93, DOI 10.2118/26959-PA; Alahmadi A.H., 2010, THESIS; Alnoaimi K, 2013, SPE ANN TECHNICAL C; Beskok A, 1999, MICROSCALE THERM ENG, V3, P43; Bustin R.M., 2008, P SPE SHAL GAS PROD; Cheng Y, 2012, J CAN PETROL TECHNOL, V51, P143, DOI 10.2118/127863-PA; Cipolla C.L., 2010, SPE RESERV EVAL ENG, V13, P848; Cipolla CL, 2009, SPE EAGE RES CHAR SI; Cipolla CL, 2009, SPE HYDR FRACT TECHN, DOI [10.2118/119366-MS.SPE-119366-MS, DOI 10.2118/119366-MS.SPE-119366-MS]; Civan F, 2011, TRANSPORT POROUS MED, V86, P925, DOI 10.1007/s11242-010-9665-x; Dehghanpour H., 2011, CAN UNC RES C 15 17; DESWAANO A, 1976, SOC PETROL ENG J, V16, P117, DOI 10.2118/5346-PA; Faybishenko B., 2013, AGU GEOPHYS MONOGRAP, V122, P299; Fazelipour W., 2011, SPE MIDDL E UNC GAS; Florence F.A., 2007, SOC PET ENG ROCK MT; Freeman CM, 2013, J PETROL SCI ENG, V108, P22, DOI 10.1016/j.petrol.2013.05.007; Gong B., 2011, SPE MIDDL E UNC GAS; Grieser W. V., 2009, SPE PROD OP S 4 8 AP; Guo CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143649; Guo CH, 2015, FUEL, V143, P107, DOI 10.1016/j.fuel.2014.11.032; Jahandideh A, 2016, J PETROL SCI ENG, V138, P174, DOI 10.1016/j.petrol.2015.11.032; Javadpour F, 2007, J CAN PETROL TECHNOL, V46, P55, DOI 10.2118/07-10-06; Javadpour F, 2009, J CAN PETROL TECHNOL, V48, P16, DOI 10.2118/09-08-16-DA; Kast W, 2000, INT J HEAT MASS TRAN, V43, P807, DOI 10.1016/S0017-9310(99)00158-1; KAZEMI H, 1969, SOC PETROL ENG J, V9, P451; Klinkenberg L.J., 1941, SOCAR PROC, V41, P200; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Leahy D.A., 2011, SPE ANN TECHN C EXH; Mayerhofer MJ, 2006, SPE ANN TECHNICAL C; Moridis G. J., 2010, SPE LAT AM CAR PETR; Ozkan E., 2010, SPE ANN TECHN C EXH SPE ANN TECHN C EXH; PEACEMAN DW, 1983, SOC PETROL ENG J, V23, P531, DOI 10.2118/10528-PA; PRUESS K, 1985, SOC PETROL ENG J, V25, P14, DOI 10.2118/10509-PA; Rubin B., 2010, SPE W REGIONAL M; Sakhaee-Pour A, 2012, SPE RESERV EVAL ENG, V15, P401, DOI 10.2118/146944-PA; Sepehrnoori K., 2015, J CANADIAN PETROLEUM, V53, P109; Shabro V., 2009, WORLD J ENG, V6, P7; Shi JQ, 2003, FUEL, V82, P1219, DOI 10.1016/S0016-2361(03)00010-3; Snow D.T., 1965, THESIS; WARREN JE, 1963, SOC PETROL ENG J, V3, P245, DOI 10.2118/426-PA; Watson A. T., 1990, SPE RES ENG, V5, P384, DOI [DOI 10.2118/18856-PA, 10.2118/18856-PA]; Wu Y.-S., 2009, SPE HYDR FRACT TECHN; Wu YS, 1998, TRANSPORT POROUS MED, V32, P117, DOI 10.1023/A:1006535211684; Xiong X., 2012, SPE ANN TECHN C EXH; Yan BC, 2016, COMPUTAT GEOSCI, V20, P69, DOI 10.1007/s10596-015-9548-x; Yu W, 2014, J PETROL SCI ENG, V113, P1, DOI 10.1016/j.petrol.2013.12.005; Yu W., 2013, J PETROLEUM ENG, V2013; Yu W, 2014, FUEL, V116, P455, DOI 10.1016/j.fuel.2013.08.032	48	16	16	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0188480	10.1371/journal.pone.0188480	http://dx.doi.org/10.1371/journal.pone.0188480			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320489	gold, Green Submitted, Green Published			2022-12-26	WOS:000419689600002
J	Guo, WL; Chen, BH; Chen, XJ; Guo, YY; Yang, HL; Li, XZ; Wang, GY				Guo, Wei-Li; Chen, Bi-Hua; Chen, Xue-Jin; Guo, Yan-Yan; Yang, He-Lian; Li, Xin-Zheng; Wang, Guang-Yin			Transcriptome profiling of pumpkin (Cucurbita moschata Duch.) leaves infected with powdery mildew	PLOS ONE			English	Article							ABSCISIC-ACID; VITIS-PSEUDORETICULATA; ARABIDOPSIS-THALIANA; EXPRESSION ANALYSIS; ABIOTIC STRESSES; BASAL DEFENSE; IDENTIFICATION; RESISTANCE; CUCUMBER; GENOME	Cucurbit powdery mildew (PM) is one of the most severe fungal diseases, but the molecular mechanisms underlying PM resistance remain largely unknown, especially in pumpkin (Cucurbita moschata Duch.). The goal of this study was to identify gene expression differences in PM-treated plants (harvested at 24 h and 48 h after inoculation) and untreated (control) plants of inbred line (feminine ordinal indicator "112-2" using RNA sequencing (RNA-Seq). The inbred line "112-2" has been purified over 8 consecutive generations of self-pollination and shows high resistance to PM. More than 7600 transcripts were examined in pumpkin leaves, and 3129 and 3080 differentially expressed genes (DEGs) were identified in inbred line "112-2" at 24 and 48 hours post inoculation (hpi), respectively. Based on the KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway database and GO (Gene Ontology) database, a complex regulatory network for PM resistance that may involve hormone signal transduction pathways, transcription factors and defense responses was revealed at the transcription level. In addition, the expression profiles of 16 selected genes were analyzed using quantitative RTPCR. Among these genes, the transcript levels of 6 DEGs, including bHLH87 (Basic Helix-loop-helix transcription factor), ERF014 (Ethylene response factor), WRKY21 (WRKY domain), HSF (heat stress transcription factor A), MLO3 (Mildew Locus O), and SGT1 (Suppressor of G-Two Allele of Skp1), in PM-resistant "112-2" were found to be significantly up-or down-regulated both before 9 hpi and at 24 hpi or 48 hpi; this behavior differed from that observed in the PM-susceptible material (cultivar "Jiujiangjiaoding"). The transcriptome data provide novel insights into the response of Cucurbita moschata to PM stress and are expected to be highly useful for dissecting PM defense mechanisms in this major vegetable and for improving pumpkin breeding with enhanced resistance to PM.	[Guo, Wei-Li; Chen, Bi-Hua; Chen, Xue-Jin; Guo, Yan-Yan; Yang, He-Lian; Li, Xin-Zheng; Wang, Guang-Yin] Henan Inst Sci & Technol, Sch Hort Landscape Architecture, Xin Xiang, Peoples R China	Henan Institute of Science & Technology	Li, XZ (corresponding author), Henan Inst Sci & Technol, Sch Hort Landscape Architecture, Xin Xiang, Peoples R China.	lxz2283@126.com			National Natural Science Foundation of China [31401876]; Henan National Natural Science Foundation [132300410357, 105020216019/004]; Henan Provincial commodity vegetable industry technology system [S2010-3-G06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Henan National Natural Science Foundation; Henan Provincial commodity vegetable industry technology system	The following organizations are acknowledged for their financial support: National Natural Science Foundation of China (No. 31401876), Henan National Natural Science Foundation (No. 132300410357; 105020216019/004) and the Henan Provincial commodity vegetable industry technology system (No. S2010-3-G06).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ando K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-518; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Barilli E, 2014, EUPHYTICA, V198, P13, DOI 10.1007/s10681-014-1062-z; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg JA, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0635-x; Blanca J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-280; Blanca J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-104; Buscaill P, 2014, CURR OPIN PLANT BIOL, V20, P35, DOI 10.1016/j.pbi.2014.04.004; Cheng H, 2013, MOL BIOL REP, V40, P2609, DOI 10.1007/s11033-012-2347-8; Curto M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00517; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Fondevilla S, 2012, AGRON SUSTAIN DEV, V32, P401, DOI 10.1007/s13593-011-0033-1; Fukino N, 2013, MOL BREEDING, V32, P267, DOI 10.1007/s11032-013-9867-3; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grant M, 2006, CURR OPIN PLANT BIOL, V9, P414, DOI 10.1016/j.pbi.2006.05.013; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Guo WL, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00755; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Hyun TK, 2012, PLANT MOL BIOL, V79, P413, DOI 10.1007/s11103-012-9919-9; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Isutsa D. K., 2013, Journal of Agricultural and Biological Science, V8, P610; Jensen MK, 2008, PLANT J, V56, P867, DOI 10.1111/j.1365-313X.2008.03646.x; Jiang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071054; Koga H, 2004, PHYSIOL MOL PLANT P, V65, P3, DOI 10.1016/j.pmpp.2004.11.002; Kumar M, 2009, MOL PLANT, V2, P152, DOI 10.1093/mp/ssn095; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li J, 2017, PLANT PHYSIOL BIOCH, V111, P234, DOI 10.1016/j.plaphy.2016.12.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Peng SB, 2013, PLANT MOL BIOL REP, V31, P240, DOI 10.1007/s11105-012-0463-1; Perez-Garcia A, 2009, MOL PLANT PATHOL, V10, P153, DOI 10.1111/j.1364-3703.2008.00527.x; Rubiales D, 2015, CRIT REV PLANT SCI, V34, P195, DOI 10.1080/07352689.2014.898445; Schouten HJ, 2014, EUPHYTICA, V200, P475, DOI 10.1007/s10681-014-1216-z; Sun HH, 2017, MOL PLANT, V10, P1293, DOI 10.1016/j.molp.2017.09.003; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Wang FT, 2015, PHYSIOL MOL PLANT P, V90, P123, DOI 10.1016/j.pmpp.2015.04.007; [王萍 Wang Ping], 2002, [内蒙古农业大学学报. 自然科学版, Journal of Inner Mongolia Agicultural University], V23, P52; Wei W, 2016, PLANT PHYSIOL BIOCH, V105, P129, DOI 10.1016/j.plaphy.2016.04.014; Wu T, 2010, MOL BIOL REP, V37, P649, DOI 10.1007/s11033-009-9505-7; Wu TQ, 2014, MOL BREEDING, V34, P1437, DOI 10.1007/s11032-014-0128-x; Wyatt LE, 2015, HORTIC RES-ENGLAND, V2, DOI 10.1038/hortres.2014.70; Xing DH, 2008, MOL PLANT, V1, P459, DOI 10.1093/mp/ssn020; Xing LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072571; Xu Q, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3438-z; Xu XM, 2015, CAN J PLANT SCI, V95, P1121, DOI 10.4141/CJPS-2014-403; Yadav M, 2010, NUTR RES REV, V23, P184, DOI 10.1017/S0954422410000107; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang F, 2000, SCI TECHNOL FOOD IND, V21, P62, DOI DOI 10.3969/j.issn.1002-0306.2000.06.020; [张云 Zhang Yun], 2003, [水文地质工程地质, Hydrogeology & Engineering Geology], V30, P6; Zhou JG, 2010, ACTA HORTIC, V871, P141; Zhu XL, 2014, PLANT PHYSIOL, V164, P1499, DOI 10.1104/pp.113.229575; Zhu ZG, 2013, J PLANT PHYSIOL, V170, P923, DOI 10.1016/j.jplph.2013.01.017	59	30	31	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190175	10.1371/journal.pone.0190175	http://dx.doi.org/10.1371/journal.pone.0190175			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320569	Green Published, gold, Green Submitted			2022-12-26	WOS:000419689600037
J	Wekesa, E; Askew, I; Abuya, T				Wekesa, Eliud; Askew, Ian; Abuya, Timothy			Ambivalence in pregnancy intentions: The effect of quality of care and context among a cohort of women attending family planning clinics in Kenya	PLOS ONE			English	Article							CONTRACEPTIVE USE; REPRODUCTIVE INTENTIONS; UNPLANNED PREGNANCY; FERTILITY; HIV; MEN; ABORTION	Context Ambivalence in pregnancy intentions is well-documented in sub-Saharan African (SSA) settings and has been associated with inconsistent use of contraception, thereby exposing women using contraception to the possibility of unintended pregnancies. A better understanding of the potential role for client counseling interventions in enabling women to achieve their pregnancy intentions is essential for aiding program efforts to reduce unintended pregnancies. Objective To measure ambivalence in pregnancy intentions longitudinally and determine its association with the quality of care received, controlling for demographic, socio-economic and contextual factors among a cohort of family planning (FP) clients in Kenya. Methods This paper uses data drawn from a prospective cohort study of FP clients to investigate the relationship between the quality of care received during FP service delivery and the decisiveness of their pregnancy intentions over time. The study tests the hypothesis that higher quality of care enables women to be less ambivalent about their pregnancy intentions. Binary logistic regression with random effects and multinomial logistic regression were used to assess the predictive effect of the quality of care received by a woman on the decisiveness or ambivalence of her pregnancy intentions, and on any shifts in ambivalence over time, controlling for background characteristics. The study recruited 1,957 women aged 15-49 years attending twelve family planning clinics in four counties in Central Kenya; of these, 1,053 women were observed for four rounds of data collection over a period of 24 months and form the sample for analysis. Findings A substantial proportion (43%) of women expressed ambivalence about their intentions to become pregnant at some point during the study period, while over half (57%) remained unequivocal throughout the study. Almost one third of women (31%) shifted from being unequivocal to ambivalent and 12% shifted from ambivalence to being unequivocal. Women experiencing higher quality of care have lower odds of ever expressing ambivalence and higher odds of remaining unequivocal over time, net of other factors. Quality of care was not associated with a shift in ambivalence over time. Conclusion FP programs offering higher quality of care are likely to support women to be more decisive in their pregnancy intentions. Improving the quality of care can contribute to reduced ambivalence and consequently reduced likelihood of unintended pregnancy among contraceptive users. This study provides further evidence of the benefits gained through providing high quality services.	[Wekesa, Eliud] South Eastern Kenya Univ, Sch Humanities & Social Sci, Kitui, Kenya; [Wekesa, Eliud; Askew, Ian; Abuya, Timothy] Populat Council, Dept Reprod Hlth, Nairobi, Kenya; [Askew, Ian] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland	World Health Organization	Wekesa, E (corresponding author), South Eastern Kenya Univ, Sch Humanities & Social Sci, Kitui, Kenya.; Wekesa, E (corresponding author), Populat Council, Dept Reprod Hlth, Nairobi, Kenya.	ewekesa@seku.ac.ke	Abuya, Timothy/AAH-5479-2020		Bill and Melinda Gates; Fred H. Bixby Fellowship	Bill and Melinda Gates(CGIAR); Fred H. Bixby Fellowship	The authors are grateful to Bill and Melinda Gates for funding the research on which this paper is based. A Fred H. Bixby Fellowship funded EW's time to write this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agadjanian V, 2005, POPUL RES POLICY REV, V24, P617, DOI 10.1007/s11113-005-5096-8; Barrett G, 2004, J EPIDEMIOL COMMUN H, V58, P426, DOI 10.1136/jech.2003.014787; Bruce L, 2008, BALANCED COUNSELING; Bruckner H, 2004, PERSPECT SEX REPRO H, V36, P248, DOI 10.1363/3624804; Casterline JB, 2007, DEMOGRAPHY, V44, P729, DOI 10.1353/dem.2007.0043; Chen JL, 2001, FAM PLANN PERSPECT, V33, P144, DOI 10.2307/2673717; Cooper D, 2007, SOC SCI MED, V65, P274, DOI 10.1016/j.socscimed.2007.03.019; Delvaux T, 2007, REPROD HEALTH MATTER, V15, P46, DOI 10.1016/S0968-8080(07)29031-7; Frost JJ, 2007, PERSPECT SEX REPRO H, V39, P90, DOI 10.1363/3909007; Glynn JR, 2000, J ACQ IMMUN DEF SYND, V25, P345, DOI 10.1097/00126334-200012010-00008; Higgins JA, 2012, PERSPECT SEX REPRO H, V44, P236, DOI 10.1363/4423612; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Lewis JJ, 2004, AIDS, V18; Miller WB, 2004, POP STUD-J DEMOG, V58, P193, DOI 10.1080/0032472042000213712; Miller WB, 2010, FERTILITY DESIRES IN; MoH, 2011, MAT NEWB HLTH GUID; Moreau C, 2013, HUM REPROD, V28, P642, DOI 10.1093/humrep/des421; Morof D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035381; Rocca CH, 2010, DEMOGR RES, V23, P293, DOI 10.4054/DemRes.2010.23.11; Santelli J, 2003, PERSPECT SEX REPRO H, V35, P94, DOI 10.1111/j.1931-2393.2003.tb00111.x; Schunmann C, 2006, CONTRACEPTION, V73, P520, DOI 10.1016/j.contraception.2005.12.009; Schwarz EB, 2007, CONTRACEPTION, V75, P305, DOI 10.1016/j.contraception.2006.12.002; Speizer IS, 2006, INT FAM PLAN PERSPEC, V32, P185, DOI 10.1363/3218506; Speizer IS, 2009, REPROD HLTH, V6, P19, DOI [10.1186/1742-4755-6-19, DOI 10.1186/1742-4755-6-19]; Trussell J, 1999, FAM PLANN PERSPECT, V31, P64, DOI 10.2307/2991641; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Univesity of Makere Uganda MoH Population Council, 2003, IMPR QUAL CAR FAM PL; Warren CE, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-973; Wekesa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106292	29	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190473	10.1371/journal.pone.0190473	http://dx.doi.org/10.1371/journal.pone.0190473			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS3CC	29315327	Green Published, Green Submitted, gold			2022-12-26	WOS:000419655900013
J	Kobayashi, M; Jitoku, D; Iwayama, Y; Yamamoto, N; Toyota, T; Suzuki, K; Kikuchi, M; Hashimoto, T; Kanahara, N; Kurumaji, A; Yoshikawa, T; Nishikawa, T				Kobayashi, Momoko; Jitoku, Daisuke; Iwayama, Yoshimi; Yamamoto, Naoki; Toyota, Tomoko; Suzuki, Katsuaki; Kikuchi, Mitsuru; Hashimoto, Tasuku; Kanahara, Nobuhisa; Kurumaji, Akeo; Yoshikawa, Takeo; Nishikawa, Toru			Association studies of WD repeat domain 3 and chitobiosyldiphosphodolichol beta-mannosyltransferase genes with schizophrenia in a Japanese population	PLOS ONE			English	Article							MULTIFACTOR DIMENSIONALITY REDUCTION; BEHAVIORAL SENSITIZATION; HAPLOTYPE BLOCKS; EXPRESSION; GENOME; PHENCYCLIDINE; LINKAGE; CTCF; GLYCOSYLATION; METAANALYSIS	Schizophrenia and schizophrenia-like symptoms induced by the dopamine agonists and N-methyl-D aspartate type glutamate receptor antagonists occur only after the adolescent period. Similarly, animal models of schizophrenia by these drugs are also induced after the critical period around postnatal week three. Based upon the development-dependent onsets of these psychotomimetic effects, by using a DNA microarray technique, we identified the WD repeat domain 3 (WDR3) and chitobiosyldiphosphodolichol beta-mannosyltransferase (ALG1) genes as novel candidates for schizophrenia-related molecules, whose mRNAs were up-regulated in the adult (postnatal week seven), but not in the infant (postnatal week one) rats by an indirect dopamine agonist, and phencyclidine, an antagonist of the NMDA receptor. WDR3 and other related proteins are the nuclear proteins presumably involved in various cellular activities, such as cell cycle progression, signal transduction, apoptosis, and gene regulation. ALG1 is presumed to be involved in the regulation of the protein N-glycosylation. To further elucidate the molecular pathophysiology of schizophrenia, we have evaluated the genetic association of WDR3 and ALG1 in schizophrenia. We examined 21 single nucleotide polymorphisms [SNPs; W1 (rs1812607)-W16 (rs6656360), A1 (rs8053916)-A10 (rs9673733)] from these genes using the Japanese case-control sample (1,808 schizophrenics and 2,170 matched controls). No significant genetic associations of these SNPs were identified. However, we detected a significant association of W4 (rs319471) in the female schizophrenics (allelic P = 0.003, genotypic P = 0.008). Based on a haplotype analysis, the observed haplotypes consisting of W4 (rs319471)-W5 (rs379058) also displayed a significant association in the female schizophrenics (P = 0.016). Even after correction for multiple testing, these associations remained significant. Our findings suggest that the WDR3 gene may likely be a sensitive factor in female patients with schizophrenia, and that modification of the WDR3 signaling pathway warrants further investigation as to the pathophysiology of schizophrenia.	[Kobayashi, Momoko; Jitoku, Daisuke; Yamamoto, Naoki; Kurumaji, Akeo; Nishikawa, Toru] Tokyo Med & Dent Univ, Grad Sch, Dept Psychiat & Behav Sci, Bunkyo Ku, Tokyo, Japan; [Iwayama, Yoshimi; Toyota, Tomoko; Yoshikawa, Takeo] RIKEN Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama, Japan; [Suzuki, Katsuaki] Hamamatsu Univ Sch Med, Dept Psychiat, Hamamatsu, Shizuoka, Japan; [Kikuchi, Mitsuru] Kanazawa Univ, Grad Sch Med Sci, Dept Psychiat & Neurobiol, Kanazawa, Ishikawa, Japan; [Hashimoto, Tasuku; Kanahara, Nobuhisa] Chiba Univ, Grad Sch Med, Dept Psychiat, Chiba, Chiba, Japan	Tokyo Medical & Dental University (TMDU); RIKEN; Hamamatsu University School of Medicine; Kanazawa University; Chiba University	Nishikawa, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Psychiat & Behav Sci, Bunkyo Ku, Tokyo, Japan.	tnis.psyc@tmd.ac.jp	Yoshikawa, Takeo/F-9599-2019	Kobayashi-Tanabe, Momoko/0000-0001-8535-6935	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24791202]; Grants-in-Aid for Scientific Research [26461713, 16K10245] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Toru Nishikawa received the grant entitled Strategic Research Program for Brain Sciences funded by the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and Daisuke Jitoku received the grant named Grant-in-Aid for Scientific Research (C) (No. 24791202) funded by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070302; Bao L, 2008, NUCLEIC ACIDS RES, V36, pD83, DOI 10.1093/nar/gkm875; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bauer D, 2010, SCHIZOPHR RES, V117, P92, DOI 10.1016/j.schres.2009.07.025; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Claudio JO, 1999, GENOMICS, V59, P85, DOI 10.1006/geno.1999.5858; Clemmensen L, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-150; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fujita Y, 2017, J EXP MED, V214, P1431, DOI 10.1084/jem.20161517; FUJIWARA Y, 1987, PSYCHOPHARMACOLOGY, V91, P316, DOI 10.1007/BF00518183; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grubenmann CE, 2004, HUM MOL GENET, V13, P535, DOI 10.1093/hmg/ddh050; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hattori E, 2009, AM J MED GENET B, V150B, P1110, DOI 10.1002/ajmg.b.30941; Hennah W, 2003, HUM MOL GENET, V12, P3151, DOI 10.1093/hmg/ddg341; Hirayama T, 2012, CELL REP, V2, P345, DOI 10.1016/j.celrep.2012.06.014; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; Kim B, 2010, PSYCHIAT RES, V179, P121, DOI 10.1016/j.psychres.2008.08.009; Leung A, 2000, ACTA PSYCHIAT SCAND, V101, P3; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; MacDonald AW, 2009, SCHIZOPHRENIA BULL, V35, P493, DOI 10.1093/schbul/sbp017; McMahon M, 2010, J BIOL CHEM, V285, P18309, DOI 10.1074/jbc.M110.108555; Mendrek A, 2016, NEUROSCI BIOBEHAV R, V67, P57, DOI 10.1016/j.neubiorev.2015.10.013; Moore JH, 2015, METHODS MOL BIOL, V1253, P301, DOI 10.1007/978-1-4939-2155-3_16; Ng MYM, 2009, MOL PSYCHIATR, V14, P774, DOI 10.1038/mp.2008.135; NISHIKAWA T, 1993, INT CONGR SER, V1061, P53; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; REICH DL, 1989, CAN J ANAESTH, V36, P186, DOI 10.1007/BF03011442; Sato D, 1997, NEUROSCI LETT, V239, P21, DOI 10.1016/S0304-3940(97)00879-3; SCALZO FM, 1994, NEUROTOXICOLOGY, V15, P191; SCALZO FM, 1992, NEUROTOXICOL TERATOL, V14, P7, DOI 10.1016/0892-0362(92)90023-4; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Uezato A, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-2; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; WHITE PF, 1982, ANESTHESIOLOGY, V56, P119, DOI 10.1097/00000542-198202000-00007; Yamada K, 2004, BIOL PSYCHIAT, V56, P683, DOI 10.1016/j.biopsych.2004.08.015; Yamada K, 2006, BIOL PSYCHIAT, V60, P192, DOI 10.1016/j.biopsych.2005.11.008; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Yui K, 1999, MOL PSYCHIATR, V4, P512, DOI 10.1038/sj.mp.4000575; Zhang CW, 2014, IEEE INT CONF CLOUD, P9, DOI 10.1109/CLOUD.2014.12; Ziebarth JD, 2013, NUCLEIC ACIDS RES, V41, pD188, DOI 10.1093/nar/gks1165	44	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2018	13	1							e0190991	10.1371/journal.pone.0190991	http://dx.doi.org/10.1371/journal.pone.0190991			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS0GW	29309433	gold, Green Submitted, Green Published			2022-12-26	WOS:000419453100022
J	Kortemeier, E; Ramos, PS; Hunt, KJ; Kim, HJ; Hardiman, G; Chung, DJ				Kortemeier, Emma; Ramos, Paula S.; Hunt, Kelly J.; Kim, Hang J.; Hardiman, Gary; Chung, Dongjun			ShinyGPA: An interactive visualization toolkit for investigating pleiotropic architecture using GWAS datasets	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; GENOME-WIDE ASSOCIATION; DISEASE RISK-FACTORS; INSULIN-RESISTANCE; HEART-DISEASE; LOCI; DIAGNOSIS; VARIANTS; INSIGHTS; NUMBER	In spite of accumulating evidence suggesting that different complex traits share a common risk basis, namely pleiotropy, effective investigation of pleiotropic architecture still remains challenging. In order to address this challenge, we developed ShinyGPA, an interactive and dynamic visualization toolkit to investigate pleiotropic structure. ShinyGPA requires only the summary statistics from genome-wide association studies (GWAS), which reduces the burden on researchers using this tool. ShinyGPA allows users to effectively investigate genetic relationships among phenotypes using a flexible low-dimensional visualization and an intuitive user interface. In addition, ShinyGPA provides joint association mapping functionality that can facilitate biological understanding of the pleiotropic architecture. We analyzed GWAS summary statistics for 12 phenotypes using ShinyGPA and obtained visualization results and joint association mapping results that are well supported by the literature. The visualization produced by ShinyGPA can also be used as a hypothesis generating tool for relationships between phenotypes, which might also be used to improve the design of future genetic studies.	[Kortemeier, Emma; Ramos, Paula S.; Hunt, Kelly J.; Hardiman, Gary; Chung, Dongjun] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Ramos, Paula S.; Hardiman, Gary] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA; [Kim, Hang J.] Univ Cincinnati, Dept Math Sci, Cincinnati, OH 45221 USA	Medical University of South Carolina; Medical University of South Carolina; University System of Ohio; University of Cincinnati	Chung, DJ (corresponding author), Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA.	chungd@musc.edu	Chung, Dongjun/AAI-6032-2020	Chung, Dongjun/0000-0002-8072-5671; Hardiman, Gary/0000-0003-4558-0400; Ramos, Paula/0000-0002-9433-6634	National Institutes of Health [R01 GM122078, R21 CA209848, K01 AR067280]; NATIONAL CANCER INSTITUTE [R21CA209848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR067280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant (R01 GM122078 and R21 CA209848 to D.C.; K01 AR067280 to P.S.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Andreassen OA, 2013, AM J HUM GENET, V92, P197, DOI 10.1016/j.ajhg.2013.01.001; Chung DJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004787; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Esper RJ, 2008, ADV CARDIOL, V45, P17, DOI 10.1159/000115120; FagotCampagna A, 1997, ATHEROSCLEROSIS, V128, P113, DOI 10.1016/S0021-9150(96)05978-3; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Hu FB, 2002, DIABETES CARE, V25, P1129, DOI 10.2337/diacare.25.7.1129; Hunt KJ, 2003, ARTERIOSCL THROM VAS, V23, P1845, DOI 10.1161/01.ATV.0000093471.58663.ED; Lebovitz HE, 2006, DIABETES OBES METAB, V8, P237, DOI 10.1111/j.1463-1326.2005.00521.x; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; MCPHILLIPS JB, 1990, AM J EPIDEMIOL, V131, P443, DOI 10.1093/oxfordjournals.aje.a115519; MEDALIE JH, 1975, ARCH INTERN MED, V135, P811, DOI 10.1001/archinte.135.6.811; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; MYKKANEN L, 1993, DIABETOLOGIA, V36, P553, DOI 10.1007/BF02743273; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ramos PS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002406; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wannamethee SG, 2007, INT J OBESITY, V31, P1089, DOI 10.1038/sj.ijo.0803544; Wei W, 2016, INT J GENOMICS, V2016, DOI 10.1155/2016/6589843	30	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2018	13	1							e0190949	10.1371/journal.pone.0190949	http://dx.doi.org/10.1371/journal.pone.0190949			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS0GW	29309429	Green Submitted, Green Published, gold			2022-12-26	WOS:000419453100021
J	McDonald, JS; McDonald, RJ; Ekins, JB; Tin, AS; Costes, S; Hudson, TM; Schroeder, DJ; Kallmes, K; Kaufmann, SH; Young, PM; Lu, AM; Kadirvel, R; Kallmes, DF				McDonald, Jennifer S.; McDonald, Robert J.; Ekins, Jacob B.; Tin, Anthony S.; Costes, Sylvain; Hudson, Tamara M.; Schroeder, Dana J.; Kallmes, Kevin; Kaufmann, Scott H.; Young, Philip M.; Lu, Aiming; Kadirvel, Ramanathan; Kallmes, David F.			Gadolinium-enhanced cardiac MR exams of human subjects are associated with significant increases in the DNA repair marker 53BP1, but not the damage marker gamma H2AX	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HUMAN BLOOD-LYMPHOCYTES; GENOMIC INSTABILITY; HUMAN-POPULATION; HISTONE H2AX; IMPACT; RADIATION; INTEGRITY	Magnetic resonance imaging is considered low risk, yet recent studies have raised a concern of potential damage to DNA in peripheral blood leukocytes. This prospective Institutional Review Board-approved study examined potential double-strand DNA damage by analyzing changes in the DNA damage and repair markers gamma H2AX and 53BP1 in patients who underwent a 1.5 T gadolinium-enhanced cardiac magnetic resonance (MR) exam. Sixty patients were enrolled (median age 55 years, 39 males). Patients with history of malignancy or who were receiving chemotherapy, radiation therapy, or steroids were excluded. MR sequence data were recorded and blood samples obtained immediately before and after MR exposure. An automated immunofluorescence assay quantified gamma H2AX or 53BP1 foci number in isolated peripheral blood mononuclear cells. Changes in foci number were analyzed using the Wilcoxon signed-rank test. Clinical and MR procedural characteristics were compared between patients who had a > 10% increase in gamma H2AX or 53BP1 foci numbers and patients who did not. The number of gamma H2AX foci did not significantly change following cardiac MR (median foci per cell pre-MR = 0.11, post-MR = 0.11, p =.90), but the number of 53BP1 foci significantly increased following MR (median foci per cell pre-MR = 0.46, post-MR = 0.54, p =.0140). Clinical and MR characteristics did not differ significantly between patients who had at least a 10% increase in foci per cell and those who did not. We conclude that MR exposure leads to a small (median 25%) increase in 53BP1 foci, however the clinical relevance of this increase is unknown and may be attributable to normal variation instead of MR exposure.	[McDonald, Jennifer S.; McDonald, Robert J.; Ekins, Jacob B.; Hudson, Tamara M.; Schroeder, Dana J.; Kallmes, Kevin; Young, Philip M.; Lu, Aiming; Kadirvel, Ramanathan; Kallmes, David F.] Mayo Clin, Dept Radiol, Coll Med, Rochester, MN 55905 USA; [Tin, Anthony S.; Costes, Sylvain] Exogen Biotechnol Inc, Berkeley, CA USA; [Kaufmann, Scott H.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Coll Med, Rochester, MN USA; [Kaufmann, Scott H.] Mayo Clin, Coll Med, Dept Oncol, Rochester, MN USA; [Kallmes, David F.] Mayo Clin, Dept Neurosci, Coll Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	McDonald, JS (corresponding author), Mayo Clin, Dept Radiol, Coll Med, Rochester, MN 55905 USA.	mcdonald.jennifer@mayo.edu	; Costes, Sylvain/D-2522-2013	McDonald, Jennifer/0000-0001-8142-8233; Costes, Sylvain/0000-0002-8542-2389; Kallmes, Kevin/0000-0001-5439-4074	Exogen Biotechnology Inc.	Exogen Biotechnology Inc.	No external funding was used for this study. Exogen Biotechnology Inc. provided support in the form of salaries for authors Anthony S. Tin and Sylvain Costes, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Brand M, 2015, RADIOLOGY, V277, P406, DOI 10.1148/radiol.2015150555; Costes SV, 2006, RADIAT RES, V165, P505, DOI 10.1667/RR3538.1; Fatahi M, 2016, NEUROIMAGE, V133, P288, DOI 10.1016/j.neuroimage.2016.03.023; Fiechter M, 2013, EUR HEART J, V34, P2340, DOI 10.1093/eurheartj/eht184; Greulich S, 2016, F1000RES, V5; Hill MA, 2016, EUR HEART J-CARD IMG, V17, P1230, DOI 10.1093/ehjci/jew163; Kuefner MA, 2015, ROFO-FORTSCHR RONTG, V187, P872, DOI 10.1055/s-0035-1553209; Lancellotti P, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.115.003697; Lee J, 2011, BIOELECTROMAGNETICS, V32, P535, DOI 10.1002/bem.20664; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; Rasche L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147968; Reddig A, 2017, RADIOLOGY, V282, P782, DOI 10.1148/radiol.2016160794; Reddig A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132702; Sanchez-Flores M, 2015, TOXICOL SCI, V144, P406, DOI 10.1093/toxsci/kfv011; Schwenzer NF, 2007, J MAGN RESON IMAGING, V26, P1308, DOI 10.1002/jmri.21138; Scully R, 2013, MUTAT RES-FUND MOL M, V750, P5, DOI 10.1016/j.mrfmmm.2013.07.007; Simi S, 2008, MUTAT RES-FUND MOL M, V645, P39, DOI 10.1016/j.mrfmmm.2008.08.011; Szerencsi A, 2013, INT J RADIAT BIOL, V89, P870, DOI 10.3109/09553002.2013.804962; Valdiglesias V, 2013, MUTAT RES-REV MUTAT, V753, P24, DOI 10.1016/j.mrrev.2013.02.001; Vijayalaxmi, 2015, MUTAT RES-REV MUTAT, V764, P51, DOI 10.1016/j.mrrev.2015.02.002; Watts FZ, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6040047; Yildiz S, 2011, CLIN BIOCHEM, V44, P975, DOI 10.1016/j.clinbiochem.2011.05.005; Yu T, 2006, DNA REPAIR, V5, P935, DOI 10.1016/j.dnarep.2006.05.040; Yuan JS, 2010, FEBS LETT, V584, P3717, DOI 10.1016/j.febslet.2010.05.021	25	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2018	13	1							e0190890	10.1371/journal.pone.0190890	http://dx.doi.org/10.1371/journal.pone.0190890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS0GW	29309426	Green Submitted, gold, Green Published			2022-12-26	WOS:000419453100018
J	Mackie, TD; Kim, BY; Subramanya, AR; Bain, DJ; O'Donnell, AF; Welling, PA; Brodsky, JL				Mackie, Timothy D.; Kim, Bo-Young; Subramanya, Arohan R.; Bain, Daniel J.; O'Donnell, Allyson F.; Welling, Paul A.; Brodsky, Jeffrey L.			The endosomal trafficking factors CORVET and ESCRT suppress plasma membrane residence of the renal outer medullary potassium channel (ROMK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC-RETICULUM; K+ CHANNEL; QUALITY-CONTROL; CYSTIC-FIBROSIS; SURFACE EXPRESSION; SECRETORY PATHWAY; UBIQUITIN LIGASE; WILD-TYPE	Protein trafficking can act as the primary regulatory mechanism for ion channels with high open probabilities, such as the renal outer medullary (ROMK) channel. ROMK, also known as Kir1.1 (KCNJ1), is the major route for potassium secretion into the pro-urine and plays an indispensable role in regulating serum potassium and urinary concentrations. However, the cellular machinery that regulates ROMK trafficking has not been fully defined. To identify regulators of the cell-surface population of ROMK, we expressed a pH-insensitive version of the channel in the budding yeast Saccharomyces cerevisiae. We determined that ROMK primarily resides in the endoplasmic reticulum (ER), as it does in mammalian cells, and is subject to ER-associated degradation (ERAD). However, sufficient ROMK levels on the plasma membrane rescued growth on low-potassium medium of yeast cells lacking endogenous potassium channels. Next, we aimed to identify the biological pathways most important for ROMK regulation. Therefore, we used a synthetic genetic array to identify non-essential genes that reduce the plasma membrane pool of ROMK in potassium-sensitive yeast cells. Genes identified in this screen included several members of the endosomal complexes required for transport (ESCRT) and the class-C core vacuole/endosome tethering (CORVET) complexes. Mass spectroscopy analysis confirmed that yeast cells lacking an ESCRT component accumulate higher potassium concentrations. Moreover, silencing of ESCRT and CORVET components increased ROMK levels at the plasma membrane in HEK293 cells. Our results indicate that components of the post-endocytic pathway influence the cell-surface density of ROMK and establish that components in this pathway modulate channel activity.	[Mackie, Timothy D.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Bain, Daniel J.] Univ Pittsburgh, Dept Geol & Environm Sci, Pittsburgh, PA 15260 USA; [Kim, Bo-Young; Welling, Paul A.] Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA; [Subramanya, Arohan R.] Univ Pittsburgh, Dept Med, 930 Scaife Hall, Pittsburgh, PA 15261 USA; [Subramanya, Arohan R.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Subramanya, Arohan R.] Vet Affairs Pittsburgh Healthcare Syst, Med Serv, Pittsburgh, PA 15240 USA; [Subramanya, Arohan R.] Vet Affairs Pittsburgh Healthcare Syst, Res Serv, Pittsburgh, PA 15240 USA; [O'Donnell, Allyson F.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Duquesne University	Brodsky, JL (corresponding author), A320 Langley Hall,4249 Fifth Ave, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu	Bain, Daniel J/G-3055-2013; Subramanya, Arohan R./AAN-5217-2020	Subramanya, Arohan R./0000-0002-2609-7643; Bain, Daniel/0000-0003-1979-7016; O'Donnell, Allyson/0000-0003-0966-288X	National Institutes of Health [GM75061, DK79307, R01DK098145, DK054231]; National Science Foundation MCB CAREER [1553143]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, R01DK098145, R01DK054231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation MCB CAREER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM75061 cystic fibrosis transmembrane conductance regulator (CFTR) and DK79307 (University of Pittsburgh George O'Brien Kidney Research Center) (to J.L.B.), R01DK098145 (to A.R.S.), and DK054231 (to P.A.W.) and by National Science Foundation MCB CAREER Grant 1553143 (to A.F.O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Qusairi L, 2017, J AM SOC NEPHROL, V28, P2431, DOI 10.1681/ASN.2016070732; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Apaja PM, 2014, PHYSIOLOGY, V29, P265, DOI 10.1152/physiol.00058.2013; Apaja PM, 2013, MOL BIOL CELL, V24, P3787, DOI 10.1091/mbc.E13-07-0417; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Balderhaar HJK, 2013, P NATL ACAD SCI USA, V110, P3823, DOI 10.1073/pnas.1221785110; Balut CM, 2012, CHEMMEDCHEM, V7, P1741, DOI 10.1002/cmdc.201200226; Barreto L, 2011, EUKARYOT CELL, V10, P1241, DOI 10.1128/EC.05029-11; Becuwe M, 2014, ELIFE, V3, DOI 10.7554/eLife.03307; Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; Brocker C, 2012, P NATL ACAD SCI USA, V109, P1991, DOI 10.1073/pnas.1117797109; Buck TM, 2013, J BIOL CHEM, V288, P18366, DOI 10.1074/jbc.M113.469882; Bundis F, 2006, CELL PHYSIOL BIOCHEM, V17, P1, DOI 10.1159/000091454; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Choe H, 1999, BIOPHYS J, V76, P1988, DOI 10.1016/S0006-3495(99)77357-1; Chou HT, 2016, NAT STRUCT MOL BIOL, V23, P761, DOI 10.1038/nsmb.3264; Choy RWY, 2014, NEURON, V82, P55, DOI 10.1016/j.neuron.2014.02.018; Dang HP, 2011, TRAFFIC, V12, P1417, DOI 10.1111/j.1600-0854.2011.01243.x; Donnelly BF, 2013, J BIOL CHEM, V288, P13124, DOI 10.1074/jbc.M113.455394; Ellgaard L, 2016, TRAFFIC, V17, P615, DOI 10.1111/tra.12392; Erpapazoglou Z, 2012, MOL BIOL CELL, V23, P2170, DOI 10.1091/mbc.E11-10-0891; Fallen K, 2009, CHANNELS, V3, P57, DOI 10.4161/chan.3.1.7817; Fang L, 2009, J CLIN INVEST, V119, P3278, DOI 10.1172/JCI37950; Frindt G, 2009, AM J PHYSIOL-RENAL, V296, pF347, DOI 10.1152/ajprenal.90527.2008; Gajewski C, 2011, P NATL ACAD SCI USA, V108, P3240, DOI 10.1073/pnas.1017097108; Galmes R, 2015, TRAFFIC, V16, P1288, DOI 10.1111/tra.12334; Gao YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044150; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057282; Geva Y, 2014, CURR BIOL, V24, pR130, DOI 10.1016/j.cub.2013.12.008; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gong QM, 2005, J BIOL CHEM, V280, P19419, DOI 10.1074/jbc.M502327200; Gottschling DE, 2017, CELL, V169, P24, DOI 10.1016/j.cell.2017.02.030; Grishin A, 2006, J BIOL CHEM, V281, P30104, DOI 10.1074/jbc.M602439200; Guiney EL, 2016, MOL BIOL CELL, V27, P4043, DOI 10.1091/mbc.E16-08-0570; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Haass FA, 2007, P NATL ACAD SCI USA, V104, P18079, DOI 10.1073/pnas.0708765104; Henne WM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016766; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hirota Y, 2008, BIOCHEM BIOPH RES CO, V372, P469, DOI 10.1016/j.bbrc.2008.05.068; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Horazdovsky BF, 1996, J BIOL CHEM, V271, P33607, DOI 10.1074/jbc.271.52.33607; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iwai C, 2013, CARDIOVASC RES, V100, P520, DOI 10.1093/cvr/cvt200; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Kampmeyer C, 2017, J BIOL CHEM, V292, P15240, DOI 10.1074/jbc.M117.789867; Kingsbury JM, 2014, GENETICS, V196, P1077, DOI 10.1534/genetics.114.161646; Kojima A, 2012, BBA-MOL CELL RES, V1823, P534, DOI 10.1016/j.bbamcr.2011.12.004; Kolb AR, 2014, MOL BIOL CELL, V25, P276, DOI 10.1091/mbc.E13-07-0394; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Lachmann J., 2014, CELL LOGIST, V4, DOI DOI 10.4161/21592780.2014.970840; Leung YM, 2000, J BIOL CHEM, V275, P10182, DOI 10.1074/jbc.275.14.10182; Li K., 2016, MOL CELL, V65, P1; Lin DH, 2009, J BIOL CHEM, V284, P29614, DOI 10.1074/jbc.M109.041582; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x; Luo WJ, 2000, MOL BIOL CELL, V11, P579, DOI 10.1091/mbc.11.2.579; MacDonald C, 2016, BIOCHEM SOC T, V44, P474, DOI 10.1042/BST20150263; MacGurn JA, 2014, CURR OPIN CELL BIOL, V29, P92, DOI 10.1016/j.ceb.2014.05.001; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Murray DH, 2016, NATURE, V537, P107, DOI 10.1038/nature19326; Nakamura RL, 1998, METHOD ENZYMOL, V293, P89; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; O'Donnell BM, 2017, J BIOL CHEM, V292, P12813, DOI 10.1074/jbc.M117.786376; Paynter JJ, 2010, CHANNELS, V4, P390, DOI 10.4161/chan.4.5.13006; Perini ED, 2014, TRAFFIC, V15, P1366, DOI 10.1111/tra.12232; Peters M, 2003, KIDNEY INT, V64, P923, DOI 10.1046/j.1523-1755.2003.00153.x; Plemel RL, 2011, MOL BIOL CELL, V22, P1353, DOI 10.1091/mbc.E10-03-0260; Pols MS, 2013, TRAFFIC, V14, P219, DOI 10.1111/tra.12027; Preston GM, 2017, BIOCHEM J, V474, P445, DOI 10.1042/BCJ20160582; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Rapedius M, 2007, NEURON, V55, P602, DOI 10.1016/j.neuron.2007.07.026; Raphemot R, 2013, JOVE-J VIS EXP, V71, P4209; Renigunta A, 2011, CELL PHYSIOL BIOCHEM, V28, P663, DOI 10.1159/000335761; Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469; Ronzaud C, 2013, J CLIN INVEST, V123, P657, DOI 10.1172/JCI61110; Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012; Seaayfan E, 2016, J BIOL CHEM, V291, P4487, DOI 10.1074/jbc.M115.702514; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Shin ME, 2001, J BIOL CHEM, V276, P41388, DOI 10.1074/jbc.M105665200; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Stringer DK, 2011, J CELL BIOL, V192, P229, DOI 10.1083/jcb.201008121; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; van Weering JRT, 2014, SEMIN CELL DEV BIOL, V31, P40, DOI 10.1016/j.semcdb.2014.03.015; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wade JB, 2011, AM J PHYSIOL-RENAL, V300, pF1385, DOI 10.1152/ajprenal.00592.2010; WANG WH, 1990, AM J PHYSIOL, V259, pF494, DOI 10.1152/ajprenal.1990.259.3.F494; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029885; WARD CL, 1994, J BIOL CHEM, V269, P25710; Welling PA, 2009, AM J PHYSIOL-RENAL, V297, pF849, DOI 10.1152/ajprenal.00181.2009; Wiederkehr A, 2000, J CELL BIOL, V149, P397, DOI 10.1083/jcb.149.2.397; Wiederkehr A, 2001, YEAST, V18, P759, DOI 10.1002/yea.726; WOOLFORD CA, 1986, MOL CELL BIOL, V6, P2500, DOI 10.1128/MCB.6.7.2500; Xia WF, 2013, J CELL BIOL, V200, P821, DOI 10.1083/jcb.201207154; Yoo D, 2005, J BIOL CHEM, V280, P35281, DOI 10.1074/jbc.M504836200; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Young JC, 2014, DIS MODEL MECH, V7, P319, DOI 10.1242/dmm.014001; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V283, pF630, DOI 10.1152/ajprenal.00378.2001; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303; Zhou CK, 2014, CELL, V159, P530, DOI 10.1016/j.cell.2014.09.026; ZHOU H, 1994, AM J PHYSIOL, V266, pC809, DOI 10.1152/ajpcell.1994.266.3.C809	106	8	8	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3201	3217		10.1074/jbc.M117.819086	http://dx.doi.org/10.1074/jbc.M117.819086			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29311259	Green Published, hybrid			2022-12-26	WOS:000426562800014
J	Tumelty, KE; Higginson-Scott, N; Fan, XP; Bajaj, P; Knowlton, KM; Shamashkin, M; Coyle, AJ; Lu, W; Berasi, SP				Tumelty, Kathleen E.; Higginson-Scott, Nathan; Fan, Xueping; Bajaj, Piyush; Knowlton, Kelly M.; Shamashkin, Michael; Coyle, Anthony J.; Lu, Weining; Berasi, Stephen P.			Identification of direct negative cross-talk between the SLIT2 and bone morphogenetic protein-Gremlin signaling pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-MESENCHYMAL TRANSITION; PLURIPOTENT STEM-CELLS; URETERAL BUD OUTGROWTH; CONGENITAL-ANOMALIES; NEUROTROPHIC FACTOR; IN-VIVO; EXTRACELLULAR PROTEIN; NEURONAL MIGRATION; SECRETED PROTEINS; VERTEBRATE SLIT	Slit guidance ligand 2 (SLIT2) is a large, secreted protein that binds roundabout (ROBO) receptors on multiple cell types, including neurons and kidney podocytes. S LIT2-ROBO mediated signaling regulates neuronal migration and ureteric bud (UB) outgrowth during kidney development as well as glomerular filtration in adult kidneys. Additionally, SLIT2 binds Gremlin, an antagonist of bone morphogenetic proteins (BMPs), and BMP Gremlin signaling also regulates UB formation. However, direct cross-talk between the ROBO2-SLIT2 and BMP Gremlin signaling pathways has not been established. Here, we report the discovery of negative feedback between the SLIT2 and BMP Gremlin signaling pathways. We found that the SLIT2 Gremlin interaction inhibited both SLIT2-ROBO2 signaling in neurons and Gremlin antagonism of BMP activity in myoblasts and fibroblasts. Furthermore, BMP2 down-regulated SLIT2 expression and promoter activity through canonical BMP signaling. Gremlin treatment, BMP receptor inhibition, and SMAD family member 4 (SMAD4) knockdown rescued BMPmediated repression of SLIT2. BMP2 treatment of nephron progenitor cells derived from human embryonic stem cells decreased SLIT2 expression, further suggesting an interaction between the BMP2 Gremlin and SLIT2 pathways in human kidney cells. In conclusion, our study has revealed direct negative cross-talk between two pathways, previously thought to be unassociated, that may regulate both kidney development and adult tissue maintenance.	[Tumelty, Kathleen E.; Higginson-Scott, Nathan; Knowlton, Kelly M.; Shamashkin, Michael; Coyle, Anthony J.; Berasi, Stephen P.] Pfizer Inc, Ctr Therapeut Innovat, 610 Main St, Cambridge, MA 02139 USA; [Fan, Xueping; Lu, Weining] Boston Univ, Med Ctr, Dept Med, Renal Sect, Boston, MA 02118 USA; [Bajaj, Piyush] Pfizer Inc, Drug Safety Res & Dev, Groton, CT 06340 USA	Pfizer; Boston University; Pfizer	Berasi, SP (corresponding author), Pfizer Inc, Ctr Therapeut Innovat, 610 Main St, Cambridge, MA 02139 USA.	stephen.berasi@pfizer.com	Higginson-Scott, Nathan/GZA-4941-2022	Lu, Weining/0000-0002-6570-3044	Pfizer Worldwide Research and Development; National Institutes of Health [R01DK078226]; Pfizer Centers for Therapeutic Innovation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078226] Funding Source: NIH RePORTER	Pfizer Worldwide Research and Development; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Centers for Therapeutic Innovation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Pfizer Worldwide Research and Development and in part by National Institutes of Health Grant R01DK078226 (to W.L.) and a research grant from the Pfizer Centers for Therapeutic Innovation (to W.L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avsian-Kretchmer O, 2004, MOL ENDOCRINOL, V18, P1, DOI 10.1210/me.2003-0227; Ba-Charvet KTN, 2001, J NEUROSCI, V21, P4281; Bertoli-Avella AM, 2008, J AM SOC NEPHROL, V19, P825, DOI 10.1681/ASN.2007060692; Brazil DP, 2015, TRENDS CELL BIOL, V25, P249, DOI 10.1016/j.tcb.2014.12.004; Bridgewater D, 2009, PEDIATR NEPHROL, V24, P1611, DOI 10.1007/s00467-008-1048-y; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Brugger SM, 2004, DEVELOPMENT, V131, P5153, DOI 10.1242/dev.01390; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Chang JL, 2015, J HEPATOL, V63, P1413, DOI 10.1016/j.jhep.2015.07.033; Chen B, 2004, J IMMUNOL, V173, P5914, DOI 10.4049/jimmunol.173.10.5914; Ciampi O, 2016, STEM CELL RES, V17, P130, DOI 10.1016/j.scr.2016.06.001; Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357; Costantini F, 2012, WIRES DEV BIOL, V1, P693, DOI 10.1002/wdev.52; Delloye-Bourgeois C, 2015, NAT NEUROSCI, V18, P36, DOI 10.1038/nn.3893; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Fan XP, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86934; Fan XP, 2012, CELL REPORTS, V2, P52, DOI 10.1016/j.celrep.2012.06.002; Feng YY, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0469-x; Glister C, 2005, ENDOCRINOLOGY, V146, P1883, DOI 10.1210/en.2004-1303; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Gu F, 2015, FRONT MED-PRC, V9, P431, DOI 10.1007/s11684-015-0416-9; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Hellmich HL, 1996, MECH DEVELOP, V54, P95, DOI 10.1016/0925-4773(95)00464-5; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Hwang DY, 2015, HUM GENET, V134, P905, DOI 10.1007/s00439-015-1570-5; Hwang DY, 2014, KIDNEY INT, V85, P1429, DOI 10.1038/ki.2013.508; Ishida W, 2000, J BIOL CHEM, V275, P6075, DOI 10.1074/jbc.275.9.6075; Izumi N, 2006, AM J PHYSIOL-LUNG C, V290, pL120, DOI 10.1152/ajplung.00171.2005; Johnson K, 1999, J BIOL CHEM, V274, P20709, DOI 10.1074/jbc.274.29.20709; Katagiri T, 2016, COLD SPRING HARB PER, V8; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kinameri E, 2003, MOL BRAIN RES, V117, P221, DOI 10.1016/S0169-328X(03)00326-7; Kohl S, 2014, J AM SOC NEPHROL, V25, P1917, DOI 10.1681/ASN.2013101103; Koli K, 2006, AM J PATHOL, V169, P61, DOI 10.2353/ajpath.2006.051263; Kong RR, 2015, J CLIN INVEST, V125, P4407, DOI 10.1172/JCI81673; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Lam AQ, 2014, J AM SOC NEPHROL, V25, P1211, DOI 10.1681/ASN.2013080831; Lewis TC, 2013, BBA-GENE REGUL MECH, V1829, P1147, DOI 10.1016/j.bbagrm.2013.08.002; Li GY, 2013, J CELL BIOCHEM, V114, P2101, DOI 10.1002/jcb.24559; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Li SS, 2015, INVEST OPHTH VIS SCI, V56, P5210, DOI 10.1167/iovs-14-16184; Liang Y, 1999, J BIOL CHEM, V274, P17885, DOI 10.1074/jbc.274.25.17885; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Lu WN, 2007, AM J HUM GENET, V80, P616, DOI 10.1086/512735; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Morin-Poulard I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11634; Morizane R, 2017, TRENDS MOL MED, V23, P246, DOI 10.1016/j.molmed.2017.01.001; Morizane R, 2015, NAT BIOTECHNOL, V33, P1193, DOI 10.1038/nbt.3392; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Myllarniemi M, 2008, AM J RESP CRIT CARE, V177, P321, DOI 10.1164/rccm.200706-945OC; Nguyen-Ba-Charvet KT, 2004, J NEUROSCI, V24, P1497, DOI 10.1523/JNEUROSCI.4729-03.2004; Nie XG, 2011, DEV BIOL, V352, P141, DOI 10.1016/j.ydbio.2011.01.027; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Pilling D, 2014, P NATL ACAD SCI USA, V111, P18291, DOI 10.1073/pnas.1417426112; Piper M, 2000, MECH DEVELOP, V94, P213, DOI 10.1016/S0925-4773(00)00313-0; Piper M, 2002, INT J DEV BIOL, V46, P545; Raatikainen-Ahokas A, 2000, DEV DYNAM, V217, P146, DOI 10.1002/(SICI)1097-0177(200002)217:2<146::AID-DVDY2>3.3.CO;2-9; Rama N, 2015, NAT MED, V21, P483, DOI 10.1038/nm.3849; Ronca F, 2001, J BIOL CHEM, V276, P29141, DOI 10.1074/jbc.M100240200; ROTHBERG JM, 1992, J MOL BIOL, V227, P367, DOI 10.1016/0022-2836(92)90891-M; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Sainio K, 1997, DEVELOPMENT, V124, P4077; Saunders J, 2016, CELL MOL NEUROBIOL, V36, P955, DOI 10.1007/s10571-015-0281-8; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Towers PR, 1998, EXP NEPHROL, V6, P337; Wainwright EN, 2015, DEV BIOL, V404, P88, DOI 10.1016/j.ydbio.2015.05.023; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wang ZH, 2010, TOXICOL LETT, V198, P348, DOI 10.1016/j.toxlet.2010.07.018; Ward Michael E., 2004, V294, P137; Weber S, 2008, J AM SOC NEPHROL, V19, P891, DOI 10.1681/ASN.2006111282; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872; Xu YF, 2009, J NEPHROL, V22, P403; Yuen DA, 2016, J AM SOC NEPHROL, V27, P2609, DOI 10.1681/ASN.2015040356; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhou XJ, 2017, EXP CELL RES, V352, P123, DOI 10.1016/j.yexcr.2017.02.001; Zilberberg L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-41; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	87	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3039	3055		10.1074/jbc.M117.804021	http://dx.doi.org/10.1074/jbc.M117.804021			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29317497	Green Published, hybrid			2022-12-26	WOS:000426562800002
J	Akerman, L; Casas, R; Ludvigsson, J; Tavira, B; Skoglund, C				Akerman, Linda; Casas, Rosaura; Ludvigsson, Johnny; Tavira, Beatriz; Skoglund, Camilla			Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; MICRORNAS; EXPRESSION; DYSFUNCTION; BIOMARKERS; FAMILY; TARGET	Micro RNAs (miRNAs) are promising disease biomarkers due to their high stability. Their expression in serum is altered in type 1 diabetes, but whether deviations exist in individuals with high risk for type 1 diabetes remains unexplored. We therefore assessed serum miRNAs in high-risk individuals (n = 21) positive for multiple islet autoantibodies, age-matched healthy children (n = 17) and recent-onset type 1 diabetes patients (n = 8), using Serum/Plasma Focus microRNA PCR Panels from Exiqon. The miRNA levels in the high-risk group were similar to healthy controls, and no specific miRNA profile was identified for the high-risk group. However, serum miRNAs appeared to reflect glycemic status and ongoing islet auto-immunity in high-risk individuals, since several miRNAs were associated to glucose homeostasis and autoantibody titers. High-risk individuals progressing to clinical disease after the sampling could not be clearly distinguished from non-progressors, while miRNA expression in the type 1 diabetes group deviated significantly from high-risk individuals and healthy controls, perhaps explained by major metabolic disturbances around the time of diagnosis.	[Akerman, Linda; Casas, Rosaura; Ludvigsson, Johnny; Tavira, Beatriz] Linkoping Univ, Fac Med & Hlth Sci, Dept Clin & Expt Med, Div Pediat, Linkoping, Sweden; [Ludvigsson, Johnny] Univ Hosp, Crown Princess Victoria Childrens Hosp, Linkoping, Region Ostergot, Sweden; [Skoglund, Camilla] Linkoping Univ, Fac Med & Hlth Sci, Dept Med & Hlth Sci, Div Drug Res, Linkoping, Sweden	Linkoping University; Linkoping University	Skoglund, C (corresponding author), Linkoping Univ, Fac Med & Hlth Sci, Dept Med & Hlth Sci, Div Drug Res, Linkoping, Sweden.	camilla.skoglund@liu.se	TAVIRA, BEATRIZ/G-6744-2017; Ludvigsson, Johnny/AAI-2051-2020	TAVIRA, BEATRIZ/0000-0002-5986-6998; Ludvigsson, Johnny/0000-0003-1695-5234; Skoglund, Camilla/0000-0003-4770-8594; Tavira, Beatriz/0000-0001-5578-9756	Swedish Child Diabetes Foundation (Barndiabetesfonden); Swedish Research Council (Vetenskapsradet); Medical Research Council of Southeast Sweden (Forskningsradet i sydostra sverige, FORSS); Novo Nordisk Foundation; ALF/County Council of Ostergotland	Swedish Child Diabetes Foundation (Barndiabetesfonden); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Medical Research Council of Southeast Sweden (Forskningsradet i sydostra sverige, FORSS); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); ALF/County Council of Ostergotland	This research was supported by the Swedish Child Diabetes Foundation (Barndiabetesfonden, http://www.bamdiabetesfonden.se, CS, RC), the Swedish Research Council (Vetenskapsradet, https://www.vr.se, JL, RC), the Medical Research Council of Southeast Sweden (Forskningsradet i sydostra sverige, FORSS, http://www.fou.nu/ls/forss, JL, RC), the Novo Nordisk Foundation (http://novonordiskfonden.dk, JL) and ALF/County Council of Ostergotland (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuhatzira L, 2015, FASEB J, V29, P4374, DOI 10.1096/fj.15-273649; Akerman L, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2900; BJORK E, 1992, J CLIN ENDOCR METAB, V75, P1574, DOI 10.1210/jc.75.6.1574; Brorsson C, 2011, AUTOIMMUNITY, V44, P107, DOI 10.3109/08916934.2010.509120; Carrer M, 2012, P NATL ACAD SCI USA, V109, P15330, DOI 10.1073/pnas.1207605109; Collares Cristhianna V A, 2013, BMC Res Notes, V6, P491, DOI 10.1186/1756-0500-6-491; Dooley J, 2016, DIABETES, V65, P53, DOI 10.2337/db15-0770; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hezova R, 2010, CELL IMMUNOL, V260, P70, DOI 10.1016/j.cellimm.2009.10.012; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Krist B, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/281756; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Ludvigsson J, 2001, Pediatr Diabetes, V2, P170, DOI 10.1034/j.1399-5448.2001.20405.x; Mandemakers W, 2013, DIABETOLOGIA, V56, P1547, DOI 10.1007/s00125-013-2901-5; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Mo MH, 2012, J CANCER, V3, P432, DOI 10.7150/jca.4919; Nagy Zn, 2015, CIRCULATING MICRORNA; Nielsen Lotte B, 2012, Exp Diabetes Res, V2012, P896362, DOI 10.1155/2012/896362; Nielsen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087308; Roggli E, 2012, DIABETES, V61, P1742, DOI 10.2337/db11-1086; Roggli E, 2010, DIABETES, V59, P978, DOI 10.2337/db09-0881; Salas-Perez F, 2013, IMMUNOBIOLOGY, V218, P733, DOI 10.1016/j.imbio.2012.08.276; Samandari N, 2017, DIABETOLOGIA, V60, P354, DOI 10.1007/s00125-016-4156-4; Sebastiani G, 2012, DIABETOLOGIA, V55, pS48; Sebastiani G, 2011, DIABETES-METAB RES, V27, P862, DOI 10.1002/dmrr.1262; Takahashi P, 2014, GENE, V539, P213, DOI 10.1016/j.gene.2014.01.075; Yang ML, 2015, J DIABETES, V7, P158, DOI 10.1111/1753-0407.12163; Zhang Y, 2013, MOL CELL ENDOCRINOL, V381, P230, DOI 10.1016/j.mce.2013.08.004; Zhang Y, 2016, J AUTOIMMUN, V68, P52, DOI 10.1016/j.jaut.2015.12.006; Zhou R, 2015, SCI REP-UK, V5, DOI 10.1038/srep17743	35	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191067	10.1371/journal.pone.0191067	http://dx.doi.org/10.1371/journal.pone.0191067			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346396	Green Submitted, gold, Green Published			2022-12-26	WOS:000422749500025
J	Higgins, R; Kabbaj, MH; Hatcher, A; Wang, YC				Higgins, Ryan; Kabbaj, Marie-Helene; Hatcher, Alexa; Wang, Yanchang			The absence of specific yeast heat-shock proteins leads to abnormal aggregation and compromised autophagic clearance of mutant Huntingtin proteins	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; UBIQUITIN-PROTEASOME SYSTEM; INCLUSION-BODY FORMATION; QUALITY-CONTROL; MOLECULAR CHAPERONES; MISFOLDED PROTEINS; FACTOR FES1; HSP70; DEGRADATION; HSP104	The functionality of a protein depends on its correct folding, but newly synthesized proteins are susceptible to aberrant folding and aggregation. Heat shock proteins (HSPs) function as molecular chaperones that aid in protein folding and the degradation of misfolded proteins. Trinucleotide (CAG) repeat expansion in the Huntingtin gene (HTT) results in the expression of misfolded Huntingtin protein (Htt), which contributes to the development of Huntington's disease. We previously found that the degradation of mutated Htt with polyQ expansion (Htt103QP) depends on both ubiquitin proteasome system and autophagy. However, the role of heat shock proteins in the clearance of mutated Htt remains poorly understood. Here, we report that cytosolic Hsp70 (Ssa family), its nucleotide exchange factors (Sse1 and Fes1), and a Hsp40 co-chaperone (Ydj1) are required for inclusion body formation of Htt103QP proteins and their clearance via autophagy. Extended induction of Htt103QPGFP leads to the formation of a single inclusion body in wild-type yeast cells, but mutant cells lacking these HSPs exhibit increased number of Htt103QP aggregates. Most notably, we detected more aggregated forms of Htt103QP in sse1 Delta. mutant cells using an agarose gel assay. Increased protein aggregates are also observed in these HSP mutants even in the absence Htt103QP overexpression. Importantly, these HSPs are required for autophagy- mediated Htt103QP clearance, but are less critical for proteasome-dependent degradation. These findings suggest a chaperone network that facilitates inclusion body formation of misfolded proteins and the subsequent autophagic clearance.	[Higgins, Ryan; Kabbaj, Marie-Helene; Wang, Yanchang] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Hatcher, Alexa] Florida State Univ, Coll Nursing, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Wang, YC (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.	yanchang.wang@med.fsu.edu		Wang, Yanchang/0000-0001-6782-0570	National Institutes of Health [R01GM102115]; FSU CRC planning grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102115] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FSU CRC planning grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by R01GM102115, National Institutes of Health to YW, https://www.nih.gov/. This work is also supported by a FSU CRC planning grant to YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich H, 2003, MOL BIOL CELL, V14, P477, DOI 10.1091/mbc.E02-07-0413; Abrams JL, 2014, J BIOL CHEM, V289, P13155, DOI 10.1074/jbc.M113.530014; Bauerlein FJB, 2017, CELL, V171, P179, DOI 10.1016/j.cell.2017.08.009; Bersuker K, 2013, J BIOL CHEM, V288, P23633, DOI 10.1074/jbc.C113.481945; Bhat KP, 2014, P NATL ACAD SCI USA, V111, P5706, DOI 10.1073/pnas.1402215111; Bracher A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00010; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Chuang KH, 2016, MOL BIOL CELL, V27, P2025, DOI 10.1091/mbc.E16-01-0026; Ciechanover A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00185; Cyr Douglas M, 2015, Subcell Biochem, V78, P91, DOI 10.1007/978-3-319-11731-7_4; de Oliveira GAP, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00097; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2011, PRION, V5, P285, DOI [10.4161/pri.5.4.18071, 10.4161/pri.18071]; Eroglu B, 2010, MOL CELL BIOL, V30, P4626, DOI 10.1128/MCB.01493-09; Gallagher PS, 2014, J CELL SCI, V127, P1980, DOI 10.1242/jcs.141838; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gong B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041450; Gong YC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.26; Gowda NKC, 2016, MOL BIOL CELL, V27, P1210, DOI 10.1091/mbc.E15-10-0697; Gowda NKC, 2013, P NATL ACAD SCI USA, V110, P5975, DOI 10.1073/pnas.1216778110; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hwang JS, 2007, J GERONTOL A-BIOL, V62, P490, DOI 10.1093/gerona/62.5.490; Kabani M, 2002, MOL CELL BIOL, V22, P4677, DOI 10.1128/MCB.22.13.4677-4689.2002; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kaimal JM, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00027-17; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Kempf C, 2017, MICROBIOL RES, V200, P53, DOI 10.1016/j.micres.2017.03.009; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Leitman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3753; Li XJ, 2010, AUTOPHAGY, V6, P663, DOI 10.4161/auto.6.5.12336; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Mayer MP, 2013, TRENDS BIOCHEM SCI, V38, P507, DOI 10.1016/j.tibs.2013.08.001; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Mukherjee A, 2015, TRENDS MOL MED, V21, P439, DOI 10.1016/j.molmed.2015.04.005; Nagy M, 2016, P NATL ACAD SCI USA, V113, P5424, DOI 10.1073/pnas.1604885113; Nair U, 2011, AUTOPHAGY, V7, P1546, DOI 10.4161/auto.7.12.18424; Needham PG, 2015, J MOL BIOL, V427, P2948, DOI 10.1016/j.jmb.2015.04.010; Nillegoda NB, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00057; O'Driscoll J, 2015, J CELL BIOL, V211, P145, DOI 10.1083/jcb.201505104; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Peter L, 2011, GEN COMP ENDOCR, V172, P39, DOI 10.1016/j.ygcen.2011.02.005; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Qi L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046834, 10.1371/journal.pone.0029572]; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Shahmoradian SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00710; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; Shen K, 2016, ELIFE, V5, DOI 10.7554/eLife.18065; Shiber A, 2013, MOL BIOL CELL, V24, P2076, DOI 10.1091/mbc.E13-01-0010; Sondheimer N, 2001, EMBO J, V20, P2435, DOI 10.1093/emboj/20.10.2435; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Tkach JM, 2008, TRAFFIC, V9, P39, DOI 10.1111/j.1600-0854.2007.00666.x; Torrente MP, 2013, PRION, V7, P457, DOI 10.4161/pri.27531; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; Varshavsky A, 2012, ANNU REV BIOCHEM, V81, P167, DOI 10.1146/annurev-biochem-051910-094049; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Wolfe KJ, 2013, MOL BIOL CELL, V24, P3588, DOI 10.1091/mbc.E13-06-0315; Xu Z, 2013, J CELL SCI, V126, P4173, DOI 10.1242/jcs.126102; Yang J, 2016, ELIFE, V5; Zaffagnini G, 2016, J MOL BIOL, V428, P1714, DOI 10.1016/j.jmb.2016.02.004	73	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191490	10.1371/journal.pone.0191490	http://dx.doi.org/10.1371/journal.pone.0191490			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346421	gold, Green Published, Green Submitted			2022-12-26	WOS:000422749500056
J	Alvarado-Sizzo, H; Casas, A; Parra, F; Arreola-Nava, HJ; Terrazas, T; Sanchez, C				Alvarado-Sizzo, Hernan; Casas, Alejandro; Parra, Fabiola; Julieta Arreola-Nava, Hilda; Terrazas, Teresa; Sanchez, Cristian			Species delimitation in the Stenocereus griseus (Cactaceae) species complex reveals a new species, S-huastecorum	PLOS ONE			English	Article							POPULATION-STRUCTURE; POLASKIA-CHICHIPE; GENETIC-STRUCTURE; TEHUACAN VALLEY; EVOLUTION; CACTUS; DOMESTICATION; PHYLOGENY; SOFTWARE; PHYLOGEOGRAPHY	The Stenocereus griseus species complex (SGSC) has long been considered taxonomically challenging because the number of taxa belonging to the complex and their geographical boundaries remain poorly understood. Bayesian clustering and genetic distance-based methods were used based on nine microsatellite loci in 377 individuals of three main putative species of the complex. The resulting genetic clusters were assessed for ecological niche divergence and areolar morphology, particularly spination patterns. We based our species boundaries on concordance between genetic, ecological, and morphological data, and were able to resolve four species, three of them corresponding to S. pruinosus from central Mexico, S. laevigatus from southern Mexico, and S. griseus from northern South America. A fourth species, previously considered to be S. griseus and commonly misidentified as S. pruinosus in northern Mexico showed significant genetic, ecological, and morphological differentiation suggesting that it should be considered a new species, S. huastecorum, which we describe here. We show that population genetic analyses, ecological niche modeling, and morphological studies are complementary approaches for delimiting species in taxonomically challenging plant groups such as the SGSC.	[Alvarado-Sizzo, Hernan; Casas, Alejandro] Univ Nacl Autonoma Mexico, IIES, Morelia, Michoacan, Mexico; [Parra, Fabiola] Univ Nacl Agraria La Molina, CIZA, Lima, Peru; [Julieta Arreola-Nava, Hilda] Univ Guadalajara, CUCBA, Zapopan, Jalisco, Mexico; [Terrazas, Teresa] Univ Nacl Autonoma Mexico, Inst Biol IB, Mexico City, DF, Mexico; [Sanchez, Cristian] Herbario Univ La Guajira, Riohacha, La Guajira, Colombia; [Sanchez, Cristian] Nucl Univ Pedro Rincon Gutierrez, Univ Los Andes, Fac Ciencias, Posgrad Botan Taxonom Neotrop, Merida, Venezuela	Universidad Nacional Autonoma de Mexico; University Nacional Agraria La Molina; Universidad de Guadalajara; Universidad Nacional Autonoma de Mexico; University of Los Andes Venezuela	Casas, A (corresponding author), Univ Nacl Autonoma Mexico, IIES, Morelia, Michoacan, Mexico.	acasas@iies.unam.mx		Casas, Alejandro/0000-0002-8181-5118; Alvarado-Sizzo, Hernan/0000-0001-7291-0917; Parra, Fabiola/0000-0001-6612-5250	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [CB-2013-01-221800, 298299]; Program of Support to Research and Technological Innovation (PAPIIT), UNAM, Mexico [IN209214, IN206217]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Program of Support to Research and Technological Innovation (PAPIIT), UNAM, Mexico	This study was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACYT), which funded the Research project CB-2013-01-221800 and provided a grant (298299) for Hernan Alvarado-Sizzo (URL: http://www.conacyt.gob.mx/) and the Program of Support to Research and Technological Innovation (PAPIIT), UNAM, Mexico (research projects IN209214 and IN206217). http://dgapa.unam.mx/index.php/impulso-a-la-investigacion/papiit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Garcia-Rubio LA, 2015, BOT SCI, V93, P921, DOI 10.17129/botsci.282; Arakaki M, 2011, P NATL ACAD SCI USA, V108, P8379, DOI 10.1073/pnas.1100628108; Arreola-Nava HJ., 2006, THESIS, P71; Bautista F, 2011, GEOMORPHOLOGY, V135, P308, DOI 10.1016/j.geomorph.2011.02.014; Bonatelli IAS, 2014, MOL ECOL, V23, P3044, DOI 10.1111/mec.12780; Bravo-Hollis H, 1978, CACTACEAS MEXICO, V1, P352; Britton N.L., 1920, CACTACEAE, V2; Brunet J., 1967, PREHISTORY TEHUACAN, P66; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Copetti D, 2017, P NATL ACAD SCI USA, V114, P12003, DOI 10.1073/pnas.1706367114; Cruse-Sanders JM, 2013, ECOL EVOL, V3, P1340, DOI 10.1002/ece3.524; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Duminil J, 2009, PLANT BIOSYST, V143, P528, DOI 10.1080/11263500902722964; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Espinosa D, 2016, BIODIVERSIDAD SIERRA, P21; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ornelas JF, 2015, J HERED, V106, P196, DOI 10.1093/jhered/esu113; Ornelas JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056283; Franck AR, 2013, SYST BOT, V38, P210, DOI 10.1600/036364413X662105; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Gibson A. C., 1991, Cactus and Succulent Journal, V63, P92; GIBSON AC, 1978, ANN MO BOT GARD, V65, P999, DOI 10.2307/2398781; Gibson AC, 1990, AREOLES SPINES CACTU, P94; Gomez-Tuena A, 2007, GEOL SOC AM SPEC PAP, V422, P129, DOI 10.1130/2007.2422(05); Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Hernandez HM, 2011, SUCCULENT PLANT RES, V7, P1; Hernandez-Hernandez T, 2014, NEW PHYTOL, V202, P1382, DOI 10.1111/nph.12752; Hernandez-Hernandez T, 2011, AM J BOT, V98, P44, DOI 10.3732/ajb.1000129; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hippolyte JC, 2011, MAR PETROL GEOL, V28, P259, DOI 10.1016/j.marpetgeo.2009.06.010; Iturralde-Vinent MA, 2006, INT GEOL REV, V48, P791, DOI 10.2747/0020-6814.48.9.791; Moran-Zenteno DJ, 2007, GEOL SOC AM SPEC PAP, V422, P71, DOI 10.1130/2007.2422(03); Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Leinfellner W., 1961, ENTWICKLUNGSLINIEN T; Lozano G., 2015, OPEN J GEN, V5, P1, DOI DOI 10.4236/0JGEN.2015.51001; Luna-Morales C., 2007, Agrociencia (Montevideo), V11, P10; Manea VC, 2006, GEOL SOC AM SPEC PAP, V412, P27, DOI 10.1130/2006.2412(02); Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; MOLINAGARZA RS, 1994, TECTONOPHYSICS, V235, P339, DOI 10.1016/0040-1951(94)90193-7; Mutke J, 2015, SCHUMANNIA, V7, P30; Nassar JM, 2003, AM J BOT, V90, P1628, DOI 10.3732/ajb.90.11.1628; NEI M, 1974, GENETICS, V76, P379; Nyffeler R, 2002, AM J BOT, V89, P312, DOI 10.3732/ajb.89.2.312; Otero-Arnaiz A, 2005, MOL ECOL, V14, P1603, DOI 10.1111/j.1365-294X.2005.02494.x; Otero-Arnaiz A, 2004, MOL ECOL NOTES, V4, P265, DOI 10.1111/j.1471-8286.2004.00642.x; Parra F, 2015, GENET RESOUR CROP EV, V62, P893, DOI 10.1007/s10722-014-0199-x; Parra F, 2010, ANN BOT-LONDON, V106, P483, DOI 10.1093/aob/mcq143; Pennington RT, 2000, J BIOGEOGR, V27, P261, DOI 10.1046/j.1365-2699.2000.00397.x; Perez MF, 2016, MOL PHYLOGENET EVOL, V95, P11, DOI 10.1016/j.ympev.2015.11.005; Phillips SJ, 2011, MAXENT SOFTWARE SPEC; Pritchard JK, 2000, GENETICS, V155, P945; Ramirez-Barahona S, 2013, ECOL EVOL, V3, P725, DOI 10.1002/ece3.483; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rowley GD, 1999, BRADLEYA, V17, P1, DOI DOI 10.25223/BRAD.N17.1999.A1; Ruiz A, 2002, COLUMNAR CACTI THEIR, P324; SAS Institute Inc, 2007, JMP VERS 7, P1989; Sneath PHA., 1973, NUMERICAL TAXONOMY, P230, DOI DOI 10.1111/J.1523-1739.2007.00775.X; Stafleu FA, 1985, REGNUM VEGETABILE; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tapia HJ, 2016, REV MEX BIODIVERS, V87, P288, DOI 10.1016/j.rmb.2016.04.006; Terrazas T, 2002, BOT REV, V68, P444, DOI 10.1663/0006-8101(2002)068[0444:CSAITS]2.0.CO;2; THIERS B, 2017, INDEX HERBARIORUM GL; Valiente-Banuet A, 2000, BOT SCI, V67, P25, DOI 10.17129/botsci.1625; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vazquez-Sanchez M, 2013, SYST BIODIVERS, V11, P103, DOI 10.1080/14772000.2013.775191; Wallace R. S., 2002, CACTI BIOL USES, P1	69	19	19	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190385	10.1371/journal.pone.0190385	http://dx.doi.org/10.1371/journal.pone.0190385			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342184	Green Published, gold, Green Submitted			2022-12-26	WOS:000422653800020
J	De Samber, B; Meul, E; Laforce, B; De Paepe, B; Smet, J; De Bruyne, M; De Rycke, R; Bohic, S; Cloetens, P; Van Coster, R; Vandenabeele, P; Vanden Berghe, T				De Samber, Bjorn; Meul, Eline; Laforce, Brecht; De Paepe, Boel; Smet, Joel; De Bruyne, Michiel; De Rycke, Riet; Bohic, Sylvain; Cloetens, Peter; Van Coster, Rudy; Vandenabeele, Peter; Vanden Berghe, Tom			Nanoscopic X-ray fluorescence imaging and quantification of intracellular key-elements in cryofrozen Friedreich's ataxia fibroblasts	PLOS ONE			English	Article							YEAST FRATAXIN; OXIDATIVE STRESS; IRON; ZINC; CARDIOMYOPATHY; REDISTRIBUTION; DEFICIENCY; LIBRARY; PROTEIN; COPPER	Synchrotron radiation based nanoscopic X-ray fluorescence (SR nano-XRF) analysis can visualize trace level elemental distribution in a fully quantitative manner within single cells. However, in-air XRF analysis requires chemical fixation modifying the cell's chemical composition. Here, we describe first nanoscopic XRF analysis upon cryogenically frozen (-150 degrees C) fibroblasts at the ID16A-NI 'Nano-imaging' end-station located at the European Synchrotron Radiation Facility (ESRF) in Grenoble (France). Fibroblast cells were obtained from skin biopsies from control and Friedreich's ataxia (FRDA) patients. FRDA is an autosomal recessive disorder with dysregulation of iron metabolism as a key feature. By means of the X-ray Fundamental Parameter (FP) method, including absorption correction of the ice layer deposited onto the fibroblasts, background-corrected mass fraction elemental maps of P, S, Cl, K, Ca, Fe and Zn of entire cryofrozen human fibroblasts were obtained. Despite the presence of diffracting microcrystals in the vitreous ice matrix and minor sample radiation damage effects, clusters of iron-rich hot-spots with similar mass fractions were found in the cytoplasm of both control and FRDA fibroblasts. Interestingly, no significant difference in the mean iron concentration was found in the cytoplasm of FRDA fibroblasts, but a significant decrease in zinc concentration. This finding might underscore metal dysregulation, beyond iron, in cells derived from FRDA patients. In conclusion, although currently having slightly increased limits of detection (LODs) compared to non-cryogenic mode, SR based nanoscopic XRF under cryogenic sample conditions largely obliterates the debate on chemical sample preservation and provides a unique tool for trace level elemental imaging in single cells close to their native state with a superior spatial resolution of 20 nm.	[De Samber, Bjorn; Laforce, Brecht] Univ Ghent, Dept Analyt Chem, Ghent, Belgium; [Meul, Eline; De Bruyne, Michiel; De Rycke, Riet; Vandenabeele, Peter; Vanden Berghe, Tom] VIB Ctr Inflammat Res, Ghent, Belgium; [Meul, Eline; De Bruyne, Michiel; De Rycke, Riet; Vandenabeele, Peter; Vanden Berghe, Tom] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [De Paepe, Boel; Smet, Joel] Ghent Univ Hosp, Dept Pediat, Div Pediat Neurol & Metab, Ghent, Belgium; [Bohic, Sylvain] INSERM, Grenoble, France; [Cloetens, Peter] European Synchrotron Radiat Facil, Grenoble, France	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University; Ghent University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); European Synchrotron Radiation Facility (ESRF)	De Samber, B (corresponding author), Univ Ghent, Dept Analyt Chem, Ghent, Belgium.	bjorn.desamber@ugent.be	De Paepe, Boel/B-7548-2013; NanoImaging, ID16A/AAJ-7861-2020; Cloetens, Peter/AAJ-6131-2020; Vanden Berghe, Tom/C-4916-2009; BOHIC, Sylvain/F-6464-2013; Berghe, Tom Vanden/N-2902-2019; Laforce, Brecht/GPX-2175-2022; Vandenabeele, Peter/C-8597-2009; Laforce, Brecht/AAF-9215-2021; De Samber, Bjorn/K-9636-2015	De Paepe, Boel/0000-0001-9403-4401; Cloetens, Peter/0000-0002-4129-9091; Vanden Berghe, Tom/0000-0002-1633-0974; BOHIC, Sylvain/0000-0001-6355-7592; Berghe, Tom Vanden/0000-0002-1633-0974; Vandenabeele, Peter/0000-0002-6669-8822; De Samber, Bjorn/0000-0002-6759-4195	FWO Vlaanderen [12B3313N]; Flemish Institute for the Promotion of Scientific and Technological Research in Industry (IWT Flanders, Belgium); Vlaams Instituut voor Biotechnologie (VIB); Ghent University (MRP, GROUP-ID consortium); Foundation against Cancer [2012-188, FAF-F/2016/865]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO) [FWO G.0875.11, FWO G.0A45.12N, FWO G.0787.13N, FWO G.0C37.14N, FWO G.0E04.16N]; Flemish Government [BOF09/01M00709, BOF16/MET_V/007]; Belgian science policy office (BELSPO) [IAP 7/32]	FWO Vlaanderen(FWO); Flemish Institute for the Promotion of Scientific and Technological Research in Industry (IWT Flanders, Belgium); Vlaams Instituut voor Biotechnologie (VIB); Ghent University (MRP, GROUP-ID consortium); Foundation against Cancer; Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Flemish Government(European Commission); Belgian science policy office (BELSPO)(Belgian Federal Science Policy Office)	Bjorn De Samber acknowledges his postdoctoral research grant from FWO Vlaanderen (www.fwo.be, application no. 12B3313N) and Brecht Laforce was funded by a PhD grant from the Flemish Institute for the Promotion of Scientific and Technological Research in Industry (IWT Flanders, Belgium). Research in the Vandenabeele lab is supported by grants from the Vlaams Instituut voor Biotechnologie (VIB), from Ghent University (MRP, GROUP-ID consortium), grants from the 'Foundation against Cancer' (2012-188 and FAF-F/2016/865), grants from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO) (FWO G.0875.11, FWO G.0A45.12N, FWO G.0787.13N, FWO G.0C37.14N, FWO G.0E04.16N), grants from the Flemish Government (Methusalem BOF09/01M00709 and BOF16/MET_V/007), a grant from the Belgian science policy office (BELSPO)(IAP 7/32). Tom Vanden Berghe has an assistant academic staff position at Ghent University.	Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; Bencze KZ, 2007, CHEM COMMUN, P1798, DOI 10.1039/b703195e; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Brunetti A, 2004, SPECTROCHIM ACTA B, V59, P1725, DOI 10.1016/j.sab.2004.03.014; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Cook JD, 2006, BIOCHEMISTRY-US, V45, P7767, DOI 10.1021/bi060424r; Da Silva JC, 2017, OPTICA, V4, P492, DOI 10.1364/OPTICA.4.000492; De Samber B, 2013, ANAL BIOANAL CHEM, V405, P6061, DOI 10.1007/s00216-013-7019-6; De Samber B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165604; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; Kempenaers L, 2000, SPECTROCHIM ACTA B, V55, P651, DOI 10.1016/S0584-8547(00)00207-X; Koeppen A, 2013, J NEUROPATH EXP NEUR, V72, P554; Koeppen AH, 2012, CEREBELLUM, V11, P845, DOI 10.1007/s12311-012-0383-5; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Kruger PC, 2016, AM J CARDIOL, V118, P127, DOI 10.1016/j.amjcard.2016.04.024; Kurz T, 2008, BBA-GEN SUBJECTS, V1780, P1291, DOI 10.1016/j.bbagen.2008.01.009; LAMARCHE JB, 1980, CAN J NEUROL SCI, V7, P389, DOI 10.1017/S0317167100022927; Le Gros M. A., 2014, J SYNCHROTRON RADIAT, V21, P1; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Longo DL, 2005, NEW ENGL J MED, V372, P1832; Martelli A, 2015, CELL METAB, V21, P311, DOI 10.1016/j.cmet.2015.01.010; Martelli A, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00130; Oteiza PI, 2000, FREE RADICAL BIO MED, V28, P1091, DOI 10.1016/S0891-5849(00)00200-8; Ramirez RL, 2012, AM J CARDIOL, V110, P1820, DOI 10.1016/j.amjcard.2012.08.018; Rouault TA, 2013, NAT REV NEUROSCI, V14, P551, DOI 10.1038/nrn3453; Schoonjans T, 2011, SPECTROCHIM ACTA B, V66, P776, DOI 10.1016/j.sab.2011.09.011; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; Tsou AY, 2011, J NEUROL SCI, V307, P46, DOI 10.1016/j.jns.2011.05.023; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; VEKEMANS B, 1994, X-RAY SPECTROM, V23, P278, DOI 10.1002/xrs.1300230609; Weidemann F, 2012, CIRCULATION, V125, P1626, DOI 10.1161/CIRCULATIONAHA.111.059477	32	12	12	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190495	10.1371/journal.pone.0190495	http://dx.doi.org/10.1371/journal.pone.0190495			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342155	Green Submitted, gold, Green Published			2022-12-26	WOS:000422653800024
J	Tanida-Miyake, E; Koike, M; Uchiyama, Y; Tanida, I				Tanida-Miyake, Emiko; Koike, Masato; Uchiyama, Yasuo; Tanida, Isei			Optimization of mNeonGreen for Homo sapiens increases its fluorescent intensity in mammalian cells	PLOS ONE			English	Article							IN-VIVO; PROTEINS; EXPRESSION; LOCALIZATION; GFPS	Green fluorescent protein (GFP) is tremendously useful for investigating many cellular and intracellular events. The monomeric GFP mNeonGreen is about 3-to 5-times brighter than GFP and monomeric enhanced GFP and shows high photostability. The maturation halftime of mNeonGreen is about 3-fold faster than that of monomeric enhanced GFP. However, the cDNA sequence encoding mNeonGreen contains some codons that are rarely used in Homo sapiens. For better expression of mNeonGreen in human cells, we synthesized a human-optimized cDNA encoding mNeonGreen and generated an expression plasmid for humanized mNeonGreen under the control of the cytomegalovirus promoter. The resultant plasmid was introduced into HEK293 cells. The fluorescent intensity of humanized mNeonGreen was about 1.4-fold higher than that of the original mNeonGreen. The humanized mNeonGreen with a mitochondria-targeting signal showed mitochondrial distribution of mNeonGreen. We further generated an expression vector of humanized mNeonGreen with 3xFLAG tags at its carboxyl terminus as these tags are useful for immunological analyses. The 3xFLAG-tagged mNeonGreen was recognized well with an anti-FLAG-M2 antibody. These plasmids for the expression of humanized mNeonGreen and mNeonGreen-3xFLAG are useful tools for biological studies in mammalian cells using mNeonGreen.	[Tanida-Miyake, Emiko; Koike, Masato; Tanida, Isei] Juntendo Univ, Sch Med, Dept Cell Biol & Neurosci, Tokyo, Japan; [Tanida-Miyake, Emiko] Machida Municipal Hosp, Dept Gastroenterol, Tokyo, Japan; [Uchiyama, Yasuo] Juntendo Univ, Dept Cellular & Mol Neuropathol, Sch Med, Tokyo, Japan	Juntendo University; Juntendo University	Tanida, I (corresponding author), Juntendo Univ, Sch Med, Dept Cell Biol & Neurosci, Tokyo, Japan.	tanida@juntendo.ac.jp	Koike, Masato/F-9584-2010	Koike, Masato/0000-0002-3174-5684; Tanida, Isei/0000-0001-8999-3990	Japan Society for the Promotion of Science (JSPS KAKENHI) [15K12749]; Institute for Environmental & Gender-Specific Medicine at Juntendo University; Research Institute for Diseases of Old Age at the Juntendo University School of Medicine	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Institute for Environmental & Gender-Specific Medicine at Juntendo University; Research Institute for Diseases of Old Age at the Juntendo University School of Medicine	This work was supported by a grant from the Japan Society for the Promotion of Science (JSPS KAKENHI 15K12749)(https://www.jsps.go.jp/j-grantsinaid/) to Isei Tanida, a grant from the Institute for Environmental & Gender-Specific Medicine at Juntendo University (http://www.juntendo.ac.jp/english/department/gra/gender_specific_medicine/) to Isei Tanida, and the Research Institute for Diseases of Old Age at the Juntendo University School of Medicine (http://www.juntendo.ac.jp/english/department/gra/diseases_old_age/) to Isei Tanida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs. Michael Davidson and Brian Kuhlman for providing respective mCherry2-C1 and pLL7.0: Venus-iLID-Mito (From ActA). This work was supported by a grant from the Japan Society for the Promotion of Science (JSPS KAKENHI 15K12749), a grant from the Institute for Environmental & Gender-Specific Medicine at Juntendo University (Tokyo, Japan), and the Research Institute for Diseases of Old Age at the Juntendo University School of Medicine to I.T.	Bach JN, 2017, METHODS MOL BIOL, V1563, P129, DOI 10.1007/978-1-4939-6810-7_9; Barykina NV, 2016, SCI REP-UK, V6, DOI 10.1038/srep34447; Bonnefois T, 2016, J BIOTECHNOL, V236, P35, DOI 10.1016/j.jbiotec.2016.08.006; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cranfill PJ, 2016, NAT METHODS, V13, P557, DOI [10.1038/nmeth.3891, 10.1038/NMETH.3891]; Guntas G, 2015, P NATL ACAD SCI USA, V112, P112, DOI 10.1073/pnas.1417910112; Heppert JK, 2016, MOL BIOL CELL, V27, P3385, DOI 10.1091/mbc.E16-01-0063; Hernan R, 2000, BIOTECHNIQUES, V28, P789, DOI 10.2144/00284pf01; Hostettler L, 2017, G3-GENES GENOM GENET, V7, P607, DOI 10.1534/g3.116.038133; Kaishima M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35932; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	12	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191108	10.1371/journal.pone.0191108	http://dx.doi.org/10.1371/journal.pone.0191108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342181	Green Submitted, gold, Green Published			2022-12-26	WOS:000422653800045
J	Ye, BH; Zhang, YB; Shu, JP; Wu, H; Wang, HJ				Ye, Bi-huan; Zhang, Ya-bo; Shu, Jin-ping; Wu, Hong; Wang, Hao-jie			RNA-sequencing analysis of fungi-induced transcripts from the bamboo wireworm Melanotus cribricollis (Coleoptera: Elateridae) larvae	PLOS ONE			English	Article							BETA-1,3-GLUCAN RECOGNITION PROTEIN; SHORT-CHAIN DEHYDROGENASE/REDUCTASE; IMMUNITY-RELATED GENES; METARHIZIUM-ANISOPLIAE; PATHOGEN RECOGNITION; INSECT; BEETLE; LYSOZYME; MOSQUITO; BACTERIA	Larvae of Melanotus cribricollis, feed on bamboo shoots and roots, causing serious damage to bamboo in Southern China. However, there is currently no effective control measure to limit the population of this underground pest. Previously, a new entomopathogenic fungal strain isolated from M. cribricollis larvae cadavers named Metarhizium pingshaense WP08 showed high pathogenic efficacy indoors, indicated that the fungus could be used as a bio-control measure. So far, the genetic backgrounds of both M. cribricollis and M. pingshaense WP08 were blank. Here, we analyzed the whole transcriptome of M. cribricollis larvae, infected with M. pingshaenseWP08 or not, using high-throughput next generation sequencing technology. In addition, the transcriptome sequencing of M. pingshaense WP08 was also performed for data separation of those two non-model species. The reliability of the RNA-Seq data was also validated through qRT-PCR experiment. The de novo assembly, functional annotation, sequence comparison of four insect species, and analysis of DEGs, enriched pathways, GO terms and immune related candidate genes were operated. The results indicated that, multiple defense mechanisms of M. cribricollis larvae are initiated to protect against the more serious negative effects caused by fungal infection. To our knowledge, this was the first report of transcriptome analysis of Melanotus spp. infected with a fungus, and it could provide insights to further explore insect-fungi interaction mechanisms.	[Ye, Bi-huan; Zhang, Ya-bo; Shu, Jin-ping; Wu, Hong; Wang, Hao-jie] Chinese Acad Forestry, Res Inst Subtrop Forestry, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Shu, JP; Wu, H (corresponding author), Chinese Acad Forestry, Res Inst Subtrop Forestry, Hangzhou, Zhejiang, Peoples R China.	shu_jinping001@163.com; wh931908@sohu.com		Shu, Jinping/0000-0002-3685-9349	Fundamental Research Funds for the Central Non profit Research Institution of CAF [CAFYBB2016SY012]; Special Fund for Forestry Scientific Research [201304403]	Fundamental Research Funds for the Central Non profit Research Institution of CAF; Special Fund for Forestry Scientific Research	This work was supported by "The Fundamental Research Funds for the Central Non profit Research Institution of CAF (CAFYBB2016SY012)" and "The Special Fund for Forestry Scientific Research in the Public Interest (201304403)."	Altincicek B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052004; Amiteye S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-500; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Bajwa R, 2015, ARCH PHARM, V348, P635; Berende A, 2010, EUR CYTOKINE NETW, V21, P7, DOI 10.1684/ecn.2009.0179; Cherry R., 2016, FLORIDA ENTOMOLOGIST, V90, P426; Dai HE, 2013, BIOCHEMISTRY-US, V52, P161, DOI 10.1021/bi301440p; Das Suchismita, 2009, P69; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Deng S, 2012, CHINESE BULL ENTOMOL, V47, P983; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Feyereisen R, 2005, COMPREHENSIVE MOL IN, V4, P1; Hou Cheng-Xiang, 2014, Acta Entomologica Sinica, V57, P13; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jantana W, 2015, BIOSCIENCE REP, V35; Javar S, 2015, INVERTEBR REPROD DEV, V59, P230, DOI 10.1080/07924259.2015.1108934; Jiang H, 2004, INSECT BIOCH MOL BIO; Kabaluk JT, 2007, AGRON J, V99, P1377, DOI 10.2134/agronj2007.0017N; Kabaluk T, 2014, BIOCONTROL, V59, P607, DOI 10.1007/s10526-014-9603-x; Kallberg Y, 2002, PROTEIN SCI, V11, P636, DOI 10.1110/ps.26902; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lemaitre B, 2007, IMMUNOLOGY, V25; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Lopera D, 2008, REV INST MED TROP SP, V50, P169, DOI 10.1590/S0036-46652008000300008; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; OCHIAI M, 1992, CELL TISSUE RES, V268, P431, DOI 10.1007/BF00319149; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Reddy GVP, 2014, J INVERTEBR PATHOL, V120, P43, DOI 10.1016/j.jip.2014.05.005; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; ROBERTSON LN, 1993, AUST J EXP AGR, V33, P953, DOI 10.1071/EA9930953; Saurabh S, 2008, AQUAC RES, V39, P223, DOI 10.1111/j.1365-2109.2007.01883.x; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shu Jin-ping, 2012, Forest Research, V25, P620; Sowa-Jasilek A, 2014, PEPTIDES, V53, P194, DOI 10.1016/j.peptides.2014.01.012; Stambergova H, 2014, CHEM-BIOL INTERACT, V207, P52, DOI 10.1016/j.cbi.2013.11.003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vogel H, 2014, INSECT MOL BIOL, V23, P98, DOI 10.1111/imb.12067; Vogel H, 2011, INSECT MOL BIOL, V20, P787, DOI 10.1111/j.1365-2583.2011.01109.x; Wang HongMin, 2013, Mycosystema, V32, P269; Wang XG, 2005, MOL BIOCHEM PARASIT, V139, P65, DOI 10.1016/j.molbiopara.2004.09.009; Wang XG, 2006, CELL MICROBIOL, V8, P1581, DOI 10.1111/j.1462-5822.2006.00732.x; Werck-Reichhart D, 2000, GENOME BIOL, V6, P1, DOI [10.1186/GB-2000-1-6-REVIEWS3003, DOI 10.1186/GB-2000-1-6-REVIEWS3003]; Xu TS, 2004, MAIN PESTS BAMBOO CH, P27; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang Yabo, 2012, Scientia Silvae Sinicae, V48, P134; Zhang Y, 2009, ARCH INSECT BIOCHEM, V70, P18, DOI 10.1002/arch.20258; Zheng XL, 2012, DEV COMP IMMUNOL, V36, P602, DOI 10.1016/j.dci.2011.10.010; Zhong DB, 2013, EXP PARASITOL, V134, P61, DOI 10.1016/j.exppara.2013.01.014; [周云娥 ZHOU Yun'e], 2008, [浙江林业科技, Journal of Zhejiang Forestry Science and Technology], V28, P28; ZIMMERMANN G, 1993, PESTIC SCI, V37, P375, DOI 10.1002/ps.2780370410	56	5	6	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191187	10.1371/journal.pone.0191187	http://dx.doi.org/10.1371/journal.pone.0191187			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338057	Green Published, gold, Green Submitted			2022-12-26	WOS:000422652700039
J	Han, YL; Clement, TP				Han, Yuling; Clement, T. Prabhakar			Development of a field testing protocol for identifying Deepwater Horizon oil spill residues trapped near Gulf of Mexico beaches	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; TAR BALLS; PETROLEUM BIOMARKERS; CRUDE-OIL; IDENTIFICATION; FATE; INDIA; COAST	The Deepwater Horizon (DWH) accident, one of the largest oil spills in U.S. history, contaminated several beaches located along the Gulf of Mexico (GOM) shoreline. The residues from the spill still continue to be deposited on some of these beaches. Methods to track and monitor the fate of these residues require approaches that can differentiate the DWH residues from other types of petroleum residues. This is because, historically, the crude oil released from sources such as natural seeps and anthropogenic discharges have also deposited other types of petroleum residues on GOM beaches. Therefore, identifying the origin of these residues is critical for developing effective management strategies for monitoring the long-term environmental impacts of the DWH oil spill. Advanced fingerprinting methods that are currently used for identifying the source of oil spill residues require detailed laboratory studies, which can be cost-prohibitive. Also, most agencies typically use untrained workers or volunteers to conduct shoreline monitoring surveys and these worker will not have access to advanced laboratory facilities. Furthermore, it is impractical to routinely fingerprint large volumes of samples that are collected after a major oil spill event, such as the DWH spill. In this study, we propose a simple field testing protocol that can identify DWH oil spill residues based on their unique physical characteristics. The robustness of the method is demonstrated by testing a variety of oil spill samples, and the results are verified by characterizing the samples using advanced chemical fingerprinting methods. The verification data show that the method yields results that are consistent with the results derived from advanced fingerprinting methods. The proposed protocol is a reliable, cost-effective, practical field approach for differentiating DWH residues from other types of petroleum residues.	[Han, Yuling] Auburn Univ, Dept Civil Engn, Environm Engn Program, Auburn, AL 36849 USA; [Clement, T. Prabhakar] Univ Alabama, Dept Civil Construct & Environm Engn, Tuscaloosa, AL 35487 USA	Auburn University System; Auburn University; University of Alabama System; University of Alabama Tuscaloosa	Clement, TP (corresponding author), Univ Alabama, Dept Civil Construct & Environm Engn, Tuscaloosa, AL 35487 USA.	pclement@ua.edu		Clement, Prabhakar/0000-0002-7878-8139	Alabama Emergency Management Agency [G00008967]	Alabama Emergency Management Agency	This work was funded by the Alabama Emergency Management Agency (Grant number: G00008967) to TPC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeppli C, 2014, ENVIRON SCI TECHNOL, V48, P6726, DOI 10.1021/es500825q; [Anonymous], 2010, OIL SPILL ENV FORENS; BALKAS TI, 1982, MAR POLLUT BULL, V13, P202, DOI 10.1016/0025-326X(82)90171-0; Clement TP, 2017, OIL SPILL SCIENCE AND TECHNOLOGY, 2ND EDITION, P851, DOI 10.1016/B978-0-12-809413-6.00016-3; Clement T.P., 2015, PLOS ONE, V10; Fingas M, 2004, J HAZARD MATER, V107, P37, DOI 10.1016/j.jhazmat.2003.11.008; Fingas M., 2016, OIL SPILL SCI TECHNO; Goodman R, 2003, SPILL SCI TECHNOL B, V8, P117, DOI 10.1016/S1353-2561(03)00045-8; Gustitus SA, 2018, REV GEOPHYS; Hayworth JS, 2015, MAR POLLUT BULL, V90, P95, DOI 10.1016/j.marpolbul.2014.11.016; Hostettler FD, 2013, ENVIRON FORENSICS, V14, P262, DOI 10.1080/15275922.2013.843611; John GF, 2016, SCI TOTAL ENVIRON, V573, P189, DOI 10.1016/j.scitotenv.2016.08.059; Kennicutt M. C., 2017, OIL GAS SEEPS GULF M, P275; Liu ZF, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035302; MacDonald IR, 2015, J GEOPHYS RES-OCEANS, V120, P8364, DOI 10.1002/2015JC011062; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20260, DOI 10.1073/pnas.1112139108; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; Mulabagal V, 2013, MAR POLLUT BULL, V70, P147, DOI 10.1016/j.marpolbul.2013.02.026; NRC (National Research Council), 2003, OIL SEA; OSAT-2, 2011, SUMM REP FAT EFF REM; Peters E.K., 2005, BIOMARKER GUIDE BIOM, Vsecond, P471; Plant N. G., 2013, APPL HYDRODYNAMIC SE; SHEN J, 1984, ANAL CHEM, V56, P214, DOI 10.1021/ac00266a021; Stout SA, 2016, ENVIRON FORENSICS, V17, P218, DOI 10.1080/15275922.2016.1177759; Suneel V, 2014, ENVIRON SCI TECHNOL, V48, P11343, DOI 10.1021/es5032213; Suneel V, 2013, MAR POLLUT BULL, V70, P81, DOI 10.1016/j.marpolbul.2013.02.015; Urbano M, 2013, MAR POLLUT BULL, V77, P183, DOI 10.1016/j.marpolbul.2013.10.006; USEPA, 1993, EPA600R693089; WANG ZD, 1994, ENVIRON SCI TECHNOL, V28, P1733, DOI 10.1021/es00058a027; WANG ZD, 1995, ENVIRON SCI TECHNOL, V29, P2622, DOI 10.1021/es00010a025; Wang ZD, 2003, ENERG SOURCE, V25, P491, DOI 10.1080/00908310390195570; WANG ZD, 1994, J CHROMATOGR SCI, V32, P367, DOI 10.1093/chromsci/32.9.367; Wang ZD, 1999, J CHROMATOGR A, V843, P369, DOI 10.1016/S0021-9673(99)00120-X; Wang ZD, 2006, ENVIRON FORENSICS, V7, P105, DOI 10.1080/15275920600667104; Yin F, 2015, SCI TOTAL ENVIRON, V508, P46, DOI 10.1016/j.scitotenv.2014.10.105; Zakaria MP, 2000, ENVIRON SCI TECHNOL, V34, P1189, DOI 10.1021/es990950o	36	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190508	10.1371/journal.pone.0190508	http://dx.doi.org/10.1371/journal.pone.0190508			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329313	Green Published, Green Submitted, gold			2022-12-26	WOS:000419954100015
J	Chauvigne, LAS; Belyk, M; Brown, S				Chauvigne, Lea A. S.; Belyk, Michel; Brown, Steven			Taking two to tango: fMRI analysis of improvised joint action with physical contact	PLOS ONE			English	Article							MIRROR NEURON SYSTEM; BASAL GANGLIA; EFFECTIVE CONNECTIVITY; CORTICAL ACTIVATIONS; PREFRONTAL CORTEX; PREMOTOR CORTEX; MOTOR TASK; PERCEPTION; FOLLOWER; MOTION	Many forms of joint action involve physical coupling between the participants, such as when moving a sofa together or dancing a tango. We report the results of a novel two-person functional MRI study in which trained couple dancers engaged in bimanual contact with an experimenter standing next to the bore of the magnet, and in which the two alternated between being the leader and the follower of joint improvised movements. Leading showed a general pattern of self-orientation, being associated with brain areas involved in motor planning, navigation, sequencing, action monitoring, and error correction. In contrast, following showed a far more sensory, externally-oriented pattern, revealing areas involved in somatosensation, proprioception, motion tracking, social cognition, and outcome monitoring. We also had participants perform a "mutual" condition in which the movement patterns were pre-learned and the roles were symmetric, thereby minimizing any tendency toward either leading or following. The mutual condition showed greater activity in brain areas involved in mentalizing and social reward than did leading or following. Finally, the analysis of improvisation revealed the dual importance of motor-planning and working-memory areas. We discuss these results in terms of theories of both joint action and improvisation.	[Chauvigne, Lea A. S.; Belyk, Michel; Brown, Steven] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	McMaster University	Chauvigne, LAS (corresponding author), McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada.	chauvila@mcmaster.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada [371336]	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant to S. B. from the Natural Sciences and Engineering Research Council (NSERC, grant number 371336) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2003, ANN NY ACAD SCI, V985, P326; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Beaty RE, 2015, NEUROSCI BIOBEHAV R, V51, P108, DOI 10.1016/j.neubiorev.2015.01.004; Beauchamp MS, 2008, NEUROIMAGE, V41, P1011, DOI 10.1016/j.neuroimage.2008.03.015; Begliomini C, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00167; Behrens TEJ, 2009, SCIENCE, V324, P1160, DOI 10.1126/science.1169694; Bengtsson SL, 2007, J COGNITIVE NEUROSCI, V19, P830, DOI 10.1162/jocn.2007.19.5.830; Berkowitz AL, 2008, NEUROIMAGE, V41, P535, DOI 10.1016/j.neuroimage.2008.02.028; Bernstein M, 2015, NEUROSCI BIOBEHAV R, V55, P536, DOI 10.1016/j.neubiorev.2015.06.010; Berridge KC, 2013, CURR OPIN NEUROBIOL, V23, P294, DOI 10.1016/j.conb.2013.01.017; Bickart KC, 2014, NEUROPSYCHOLOGIA, V63, P235, DOI 10.1016/j.neuropsychologia.2014.08.013; Boccia M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01195; Boecker H, 1998, J NEUROPHYSIOL, V79, P1070, DOI 10.1152/jn.1998.79.2.1070; Breman H., 2009, NEUROIMAGE, V47; Brown S, 2006, CEREB CORTEX, V16, P1157, DOI 10.1093/cercor/bhj057; Brown S, 2011, NEUROIMAGE, V58, P250, DOI 10.1016/j.neuroimage.2011.06.012; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Carter RM, 2013, TRENDS COGN SCI, V17, P328, DOI 10.1016/j.tics.2013.05.007; Chaminade T, 2002, NEUROREPORT, V13, P1975, DOI 10.1097/00001756-200210280-00029; Chang SW, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00064; Chauvigne LAS, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00776; Chen JL, 2009, ANN NY ACAD SCI, V1169, P15, DOI 10.1111/j.1749-6632.2009.04556.x; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Davis KD, 1998, J NEUROPHYSIOL, V80, P1533, DOI 10.1152/jn.1998.80.3.1533; de Manzano O, 2012, NEUROIMAGE, V63, P272, DOI 10.1016/j.neuroimage.2012.06.024; de Manzano O, 2012, NEUROIMAGE, V59, P772, DOI 10.1016/j.neuroimage.2011.07.016; Debaere F, 2004, NEUROIMAGE, V21, P1416, DOI 10.1016/j.neuroimage.2003.12.011; Decety J, 2002, NEUROIMAGE, V15, P265, DOI 10.1006/nimg.2001.0938; Donnay GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088665; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Ebisch SJH, 2014, J COGNITIVE NEUROSCI, V26, P2171, DOI 10.1162/jocn_a_00610; Ebisch SJH, 2011, J COGNITIVE NEUROSCI, V23, P1808, DOI 10.1162/jocn.2010.21551; Ehrenreich B., 2007, DANCING STREETS HIST; ELRAWAS R, 2012, FRONT BEHAV NEUROSCI, V6, P1, DOI DOI 10.3389/FNBEH.2012.00063; Eskenazi T, 2015, CORTEX, V70, P90, DOI 10.1016/j.cortex.2015.05.027; Ethofer T, 2011, NEUROIMAGE, V55, P411, DOI 10.1016/j.neuroimage.2010.11.033; Fairhurst MT, 2014, NEUROIMAGE, V84, P688, DOI 10.1016/j.neuroimage.2013.09.027; Floresco SB, 2015, ANNU REV PSYCHOL, V66, P25, DOI 10.1146/annurev-psych-010213-115159; Frith C, 2000, CONTROL OF COGNITIVE PROCESSES: ATTENTION AND PERFORMANCE XVIII, P549; Giordano M, 2015, P SOUND MUS COMP C M; Glover S, 2004, BEHAV BRAIN SCI, V27, P3; Goebl W, 2009, MUSIC PERCEPT, V26, P427, DOI 10.1525/MP.2009.26.5.427; Gonen-Yaacovi G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00465; Grossman ED, 2005, VISION RES, V45, P2847, DOI 10.1016/j.visres.2005.05.027; Guionnet S, 2012, CEREB CORTEX, V22, P971, DOI 10.1093/cercor/bhr177; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Haas BW, 2015, NEUROIMAGE, V107, P175, DOI 10.1016/j.neuroimage.2014.11.060; Hanson JVM, 2009, NEUROREPORT, V20, P1392, DOI 10.1097/WNR.0b013e3283319e25; Harrison SJ, 2009, J MOTOR BEHAV, V41, P519, DOI 10.3200/35-08-014; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hickok G, 2003, J COGNITIVE NEUROSCI, V15, P673, DOI 10.1162/089892903322307393; Hillebrandt H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06240; Hinkley LB, 2007, J NEUROPHYSIOL, V97, P1288, DOI 10.1152/jn.00733.2006; JAHANSHAHI M, 1995, BRAIN, V118, P913, DOI 10.1093/brain/118.4.913; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P51, DOI 10.1016/S0926-6410(00)00022-7; Jantzen KJ, 2007, NEUROPSYCHOLOGIA, V45, P673, DOI 10.1016/j.neuropsychologia.2006.07.020; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Kermadi I, 2000, SOMATOSENS MOT RES, V17, P255; Kitada R, 2010, NEUROIMAGE, V49, P1677, DOI 10.1016/j.neuroimage.2009.09.014; Kokal I, 2009, NEUROIMAGE, V47, P2046, DOI 10.1016/j.neuroimage.2009.06.010; Konvalinka I, 2014, NEUROIMAGE, V94, P79, DOI 10.1016/j.neuroimage.2014.03.003; Krall SC, 2015, BRAIN STRUCT FUNCT, V220, P587, DOI 10.1007/s00429-014-0803-z; Larsson J, 1996, NEUROREPORT, V7, P463, DOI 10.1097/00001756-199601310-00021; Lau HC, 2004, NEUROIMAGE, V21, P1407, DOI 10.1016/j.neuroimage.2003.10.034; Leech R, 2014, BRAIN, V137, P12, DOI 10.1093/brain/awt162; Lehericy S, 2006, CEREB CORTEX, V16, P149, DOI 10.1093/cercor/bhi089; Limb CJ, 2008, PLOS ONE, P3; Malinen S, 2014, EUR J NEUROSCI, V39, P738, DOI 10.1111/ejn.12493; Masumoto J, 2014, EXP BRAIN RES, V232, P3525, DOI 10.1007/s00221-014-4041-7; Matteau I, 2010, BRAIN RES BULL, V82, P264, DOI 10.1016/j.brainresbull.2010.05.001; Mayville JM, 2002, HUM BRAIN MAPP, V17, P214, DOI 10.1002/hbm.10065; McNeill W.H., 1997, KEEPING TOGETHER TIM; Meister IG, 2009, EUR J NEUROSCI, V29, P2074, DOI 10.1111/j.1460-9568.2009.06729.x; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mima T, 1999, BRAIN, V122, P1989, DOI 10.1093/brain/122.10.1989; Mima T, 1998, J NEUROPHYSIOL, V80, P2215, DOI 10.1152/jn.1998.80.4.2215; Molenberghs P, 2009, NEUROSCI BIOBEHAV R, V33, P975, DOI 10.1016/j.neubiorev.2009.03.010; Newman-Norlund RD, 2007, SOC NEUROSCI-UK, V2, P48, DOI 10.1080/17470910701224623; Newman-Norlund RD, 2008, NEUROIMAGE, V41, P169, DOI 10.1016/j.neuroimage.2008.02.026; Newman-Norlund RD, 2007, NAT NEUROSCI, V10, P817, DOI 10.1038/nn1911; Ng AWY, 2012, LECT NOTES ENG COMP, P1449; Noy L, 2011, P NATL ACAD SCI USA, V108, P20947, DOI 10.1073/pnas.1108155108; Pelphrey KA, 2005, CEREB CORTEX, V15, P1866, DOI 10.1093/cercor/bhi064; PETERSEN SE, 1994, CAN J EXP PSYCHOL, V48, P319, DOI 10.1037/1196-1961.48.2.319; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Prescott TJ, 2006, NEURAL NETWORKS, V19, P31, DOI 10.1016/j.neunet.2005.06.049; Price ME, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00363; Radke S, 2011, EXP BRAIN RES, V211, P405, DOI 10.1007/s00221-011-2677-0; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Renier LA, 2009, J NEUROSCI, V29, P10950, DOI 10.1523/JNEUROSCI.0910-09.2009; Richardson MJ, 2008, NEUROSCI LETT, V438, P340, DOI 10.1016/j.neulet.2008.04.083; Richardson MJ, 2007, HUM MOVEMENT SCI, V26, P867, DOI 10.1016/j.humov.2007.07.002; Rowe JB, 2005, CEREB CORTEX, V15, P85, DOI 10.1093/cercor/bhh111; Sacheli LM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01034; Sacheli LM, 2013, EXP BRAIN RES, V226, P473, DOI 10.1007/s00221-013-3459-7; Sanger J, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00312; Schubotz RI, 2007, TRENDS COGN SCI, V11, P211, DOI 10.1016/j.tics.2007.02.006; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Shmuelof L, 2011, NEURON, V72, P469, DOI 10.1016/j.neuron.2011.10.017; Siegel JS, 2014, HUM BRAIN MAPP, V35, P1981, DOI 10.1002/hbm.22307; Skakoon-Sparling SP, 2011, BRAIN COGNITION, V76, P341, DOI 10.1016/j.bandc.2011.04.008; Smiley JF, 2007, J COMP NEUROL, V502, P894, DOI 10.1002/cne.21325; Sofianidis G., 2015, POST BAL BRAIN INT W, P34; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; van der Wel RPRD, 2011, J EXP PSYCHOL HUMAN, V37, P1420, DOI 10.1037/a0022337; van Kemenade BM, 2014, NEUROIMAGE, V84, P420, DOI 10.1016/j.neuroimage.2013.09.004; Vesper C, 2014, EXP BRAIN RES, V232, P2945, DOI 10.1007/s00221-014-3982-1; Vingerhoets G, 2015, HUM BRAIN MAPP, V36, P3426, DOI 10.1002/hbm.22853; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Walter H, 2005, BRAIN RES BULL, V67, P368, DOI 10.1016/j.brainresbull.2005.06.016; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339; Wing AM, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1125; Winstein CJ, 1997, J NEUROPHYSIOL, V77, P1581, DOI 10.1152/jn.1997.77.3.1581; Yang DYJ, 2015, NEUROSCI BIOBEHAV R, V51, P263, DOI 10.1016/j.neubiorev.2015.01.020; Zhou GY, 2016, NEUROIMAGE, V125, P731, DOI 10.1016/j.neuroimage.2015.11.002	116	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191098	10.1371/journal.pone.0191098	http://dx.doi.org/10.1371/journal.pone.0191098			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324862	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400114
J	Cuadros, A; Basterretxea, G; Cardona, L; Cheminee, A; Hidalgo, M; Moranta, J				Cuadros, Amalia; Basterretxea, Gotzon; Cardona, Luis; Cheminee, Adrien; Hidalgo, Manuel; Moranta, Joan			Settlement and post-settlement survival rates of the white seabream (Diplodus sargus) in the western Mediterranean Sea	PLOS ONE			English	Article							GENUS DIPLODUS; TEMPORAL PATTERNS; JUVENILE FISHES; REPRODUCTIVE-BIOLOGY; RECRUITMENT SUCCESS; MARINE RESERVES; SPARID FISHES; HABITAT USE; MORTALITY; GROWTH	Survival during the settlement window is a limiting variable for recruitment. The survival is believed to be strongly determined by biological interactions and sea conditions, however it has been poorly investigated. We examined the settlement patterns related to relevant biotic and abiotic factors (i.e. Density-dependence, wind stress, wave height and coastal current velocity) potentially determining post-settler survival rates of a coastal necto-benthic fish of wide distribution in the Mediterranean and eastern Atlantic, the white seabream (Diplodus sargus). An observational study of the demography of juveniles of this species was carried out at six coves in Menorca Island (Balearic Islands, western Mediterranean). Three of the coves were located in the northern and wind exposed coast, at the Northeast (NE) side; while the other three were found along the southern and sheltered coast, at the Southwest (SW) side of the island. The settlement period extended from early May to late June and maximum juvenile densities at the sampling sites varied between 5 and 11 ind. m(-1) with maximum values observed in late May simultaneously occurring in the two coasts. Our analysis of juvenile survival, based on the interpretation of the observed patters using an individual based model (IBM), revealed two stages in the size-mortality relationships. An initial density-dependent stage was observed for juveniles up to 20 mm TL, followed by a density independent stage when other factors dominated the survival at sizes >20 mm TL. No significant environmental effects were observed for the small size class (<20mm TL). Different significant environmental effects affecting NE and SW coves were observed for the medium (20-30mm TL) and large (>30mm TL) size class. In the NE, the wind stress consistently affected the density of fish of 20 +/- 30 mm and >30 mm TL with a dome-shape effect with higher densities at intermediate values of wind stress and negative effect at the extremes. The best models applied in the SW coves showed a significant non-linear negative effect on fish density that was also consistent for both groups 20 +/- 30 mm and >30 mm TL. Higher densities were observed at low values of wave height in the two groups. Because of these variations, the number of juveniles present at the end of the period was unrelated to their initial density and average survival varied among locations. In consequence, recruitment was (1) primarily limited by denso-dependient procedures at settlement stage, and (2) by sea conditions at post-settlement, where extreme wave conditions depleted juveniles. Accordingly, regional hydrodynamic conditions during the settlement season produced significant impacts on the juvenile densities depending on their size and with contrasted effects in respectto cove orientation. The similar strength in larval supply between coves, in addition to the similar mean phenology for settlers in the north and south of the Island, suggests that all fish may come from the same parental reproductive pool. These factors should be taken into account when assessing relationships between settlers, recruits and adults of white seabream.	[Cuadros, Amalia] IEO, Estacio Invest Jaume Ferrer, Mao, Spain; [Cuadros, Amalia; Cheminee, Adrien] Univ Perpignan, CNRS, Ctr Format Rech Environm Mediterraneens CEFREM, UMR 5110, Via Domitia,Avenue P Alduy, Perpignan, France; [Cuadros, Amalia] Univ Murcia, Dept Ecol & Hydrol, Marine Ecol & Conservat Res Grp, Campus Espinardo, Murcia, Spain; [Basterretxea, Gotzon] Inst Mediterraneo Estudios Avanzados IMEDEA, Miguel Marques 21, Esporles, Mallorca, Spain; [Basterretxea, Gotzon] UIB CSIC, Miguel Marques 21, Esporles, Mallorca, Spain; [Cardona, Luis] Univ Barcelona, Fac Biol, Dept Anim Biol, IRBio, Avinguda Diagonal, Barcelona, Spain; [Cheminee, Adrien] Septentrion Environm, Marseille, France; [Hidalgo, Manuel; Moranta, Joan] IEO, COB, Ecosyst Oceanog Grp GRECO, Moll Ponent S-N, Palma De Mallorca, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite Perpignan Via Domitia; University of Murcia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; University of Barcelona	Moranta, J (corresponding author), IEO, COB, Ecosyst Oceanog Grp GRECO, Moll Ponent S-N, Palma De Mallorca, Spain.	joan.moranta@ieo.es	Cardona, Luis/AAL-1354-2021; Moranta, Joan/B-5522-2008; Cheminée, Adrien/K-5846-2017; Cardona, Luis/L-1680-2014; Cuadros, Amalia/R-9853-2019	Cardona, Luis/0000-0002-7892-1323; Moranta, Joan/0000-0002-9814-0735; Cheminée, Adrien/0000-0002-2982-2142; Cardona, Luis/0000-0002-7892-1323; Cuadros, Amalia/0000-0002-7070-5634	Spanish Institute of Oceanography; postdoctoral contract of the Direccion General d'Educacio, Personal Docent, Universitats i Recerca - European Social Fund; Direccion General de Innovacion e Investigacion, Govern de les IIles Balears	Spanish Institute of Oceanography; postdoctoral contract of the Direccion General d'Educacio, Personal Docent, Universitats i Recerca - European Social Fund; Direccion General de Innovacion e Investigacion, Govern de les IIles Balears	ACu was funded by a PhD studentship from the Spanish Institute of Oceanography. MH was supported by a postdoctoral contract of the Direccion General d'Educacio, Personal Docent, Universitats i Recerca (http://dguni.caib.es/) funded by the European Social Fund 2014-2020. JM was funded by the Direccion General de Innovacion e Investigacion, Govern de les IIles Balears. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis D, 2013, ESTUAR COAST SHELF S, V118, P80, DOI 10.1016/j.ecss.2012.12.014; Arceo H, 2012, P 12 INT COR REEF S, P9; Basterretxea G, 2013, FISH OCEANOGR, V22, P477, DOI 10.1111/fog.12035; Bastrikin DK, 2014, ICES J MAR SCI, V71, P2101, DOI 10.1093/icesjms/fsu029; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Benchalel W, 2013, J APPL ICHTHYOL, V29, P64, DOI 10.1111/j.1439-0426.2012.02057.x; Biagi F, 1998, ITAL J ZOOL, V65, P269, DOI 10.1080/11250009809386831; Bussotti S, 2011, ITAL J ZOOL, V78, P243, DOI 10.1080/11250001003774652; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Cardona L, 2007, ESTUAR COAST SHELF S, V72, P273, DOI 10.1016/j.ecss.2006.10.023; Cardona L, 2007, SCI MAR, V71, P811, DOI 10.3989/scimar.2007.71n4811; Cheminee A, 2011, SCI MAR, V75, P181, DOI 10.3989/scimar.2011.75n1181; Coll J, 2012, SCI MAR, V76, P809, DOI 10.3989/scimar.03531.02H; CONNELL JH, 1985, J EXP MAR BIOL ECOL, V93, P11, DOI 10.1016/0022-0981(85)90146-7; Cote J, 2010, PHILOS T R SOC B, V365, P4065, DOI 10.1098/rstb.2010.0176; COWEN RK, 1985, J MAR RES, V43, P719, DOI 10.1357/002224085788440376; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Cuadros A, 2017, ESTUAR COAST SHELF S, V185, P120, DOI 10.1016/j.ecss.2016.12.014; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670, DOI 10.1139/f89-086; CUSHING DH, 1969, J CONSEIL, V33, P81; Dahlgren CP, 2000, ECOLOGY, V81, P2227; Di Franco A, 2013, J SEA RES, V76, P73, DOI 10.1016/j.seares.2012.11.006; Di Franco A., 2015, ACTA ICHTHYOL PISCAT, P45; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052108; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031681; Di Franco A, 2011, BIOL LETTERS, V7, P454, DOI 10.1098/rsbl.2010.1149; DOHERTY PJ, 1988, OCEANOGR MAR BIOL, V26, P487; Eggleston DB, 2010, FISH OCEANOGR, V19, P89, DOI 10.1111/j.1365-2419.2009.00530.x; Felix-Hackradt FC, 2013, MAR BIOL, V160, P2337, DOI 10.1007/s00227-013-2228-2; Felix-Hackradt FC, 2013, ESTUAR COAST SHELF S, V129, P59, DOI 10.1016/j.ecss.2013.05.029; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; GARCIARUBIES A, 1995, MAR BIOL, V124, P35, DOI 10.1007/BF00349144; Garvey JE, 2003, ECOLOGY, V84, P3339, DOI 10.1890/02-0444; Gomez-Pujol L, 2013, GEO-MAR LETT, V33, P195, DOI 10.1007/s00367-012-0314-y; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Hamilton SL, 2008, P NATL ACAD SCI USA, V105, P1561, DOI 10.1073/pnas.0707676105; HARMELIN-VIVIEN M L, 1985, Revue d'Ecologie la Terre et la Vie, V40, P467; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; HOLM ER, 1990, MAR ECOL PROG SER, V60, P141, DOI 10.3354/meps060141; Jenkins GP, 1996, CAN J FISH AQUAT SCI, V53, P350, DOI 10.1139/cjfas-53-2-350; Jordi A, 2011, J MARINE SYST, V88, P312, DOI 10.1016/j.jmarsys.2011.05.007; Leitao F, 2016, REG ENVIRON CHANGE, V16, P163, DOI 10.1007/s10113-014-0726-5; LEVIN PS, 1994, OECOLOGIA, V97, P124, DOI 10.1007/BF00317916; Lloret J, 2003, MAR ECOL PROG SER, V248, P197, DOI 10.3354/meps248197; Macpherson E, 1997, MAR ECOL PROG SER, V160, P135, DOI 10.3354/meps160135; Macpherson E, 2006, MAR ECOL PROG SER, V327, P257, DOI 10.3354/meps327257; MacPherson E, 1998, J EXP MAR BIOL ECOL, V220, P127, DOI 10.1016/S0022-0981(97)00086-5; Marshall DJ, 2010, ECOL LETT, V13, P128, DOI 10.1111/j.1461-0248.2009.01408.x; Morato T, 2003, J FISH BIOL, V63, P59, DOI 10.1046/j.1095-8649.2003.00129.x; Mouine N, 2012, J MAR BIOL ASSOC UK, V92, P623, DOI 10.1017/S0025315411000798; NORCROSS BL, 1984, T AM FISH SOC, V113, P153, DOI 10.1577/1548-8659(1984)113<153:OAETOF>2.0.CO;2; Pastor J, 2013, FISH RES, V148, P74, DOI 10.1016/j.fishres.2013.08.014; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Pineda J, 2010, J EXP MAR BIOL ECOL, V392, P9, DOI 10.1016/j.jembe.2010.04.008; Planes S, 1998, OIKOS, V83, P293, DOI 10.2307/3546840; Planes S, 1999, J MAR BIOL ASSOC UK, V79, P137, DOI 10.1017/S0025315498000150; Planes S, 2009, AQUAT BIOL, V6, P153, DOI 10.3354/ab00178; POTVIN C, 1990, ECOLOGY, V71, P1389, DOI 10.2307/1938276; Pujolar JM, 2013, DIVERS DISTRIB, V19, P1531, DOI 10.1111/ddi.12114; Ranzi S., 1933, FAUNA FLORA GOLFO NA, V38, P374; Raventos N, 2005, ESTUAR COAST SHELF S, V63, P479, DOI 10.1016/j.ecss.2004.11.018; Roessig JM, 2004, REV FISH BIOL FISHER, V14, P251, DOI 10.1007/s11160-004-6749-0; Sala E, 1997, MAR ECOL PROG SER, V152, P273, DOI 10.3354/meps152273; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Sponaugle S, 2006, MAR ECOL PROG SER, V308, P1, DOI 10.3354/meps308001; Stanley R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046266; Sullivan MC, 2005, FISH OCEANOGR, V14, P386, DOI 10.1111/j.1365-2419.2005.00343.x; THRESHER RE, 1989, COPEIA, P420; TUPPER M, 1995, CAN J FISH AQUAT SCI, V52, P1834, DOI 10.1139/f95-176; Vasconcelos RP, 2014, ICES J MAR SCI, V71, P638, DOI 10.1093/icesjms/fst136; Ventura D, 2015, MAR ECOL-EVOL PERSP, V36, P1013, DOI 10.1111/maec.12198; VICTOR BC, 1986, ECOL MONOGR, V56, P145, DOI 10.2307/1942506; Vigliola L, 1998, MAR ECOL PROG SER, V168, P45, DOI 10.3354/meps168045; Vigliola L., 1998, THESIS CTR OCEANOLOG; WARE DM, 1975, J FISH RES BOARD CAN, V32, P2503, DOI 10.1139/f75-288; Wilkinson DM, 1999, OIKOS, V84, P145, DOI 10.2307/3546874	76	7	7	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190278	10.1371/journal.pone.0190278	http://dx.doi.org/10.1371/journal.pone.0190278			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324758	Green Submitted, Green Published, gold			2022-12-26	WOS:000419952400027
J	Fukui, H; Runker, A; Fabel, K; Buchholz, F; Kempermann, G				Fukui, Hirokazu; Ruenker, Annette; Fabel, Klaus; Buchholz, Frank; Kempermann, Gerd			Transcription factor Runx1 is pro-neurogenic in adult hippocampal precursor cells	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; MOUSE DENTATE GYRUS; NEURONAL DIFFERENTIATION; SKELETAL-MUSCLE; NERVOUS-SYSTEM; PROLIFERATION; GENES; EXPRESSION; MATURATION; GENETICS	Transcription factor Runx1 (Runt Related Transcription Factor 1), plays an important role in the differentiation of hematopoetic stem cells, angiogenesis and the development of nociceptive neurons. These known functions have in common that they relate to lineage decisions. We thus asked whether such role might also be found for Runx1 in adult hippocampal neurogenesis as a process, in which such decisions have to be regulated lifelong. Runx1 shows a widespread low expression in the adult mouse brain, not particularly prominent in the hippocampus and the resident neural precursor cells. Isoforms 1 and 2 of Runx1 (but not 3 to 5) driven by the proximal promoter were expressed in hippocampal precursor cells ex vivo, albeit again at very low levels, and were markedly increased after stimulation with TGF-beta 1. Under differentiation conditions (withdrawal of growth factors) Runx1 became down-regulated. Overexpression of Runx1 in vitro reduced proliferation, increased survival of precursor cells by reducing apoptosis, and increased neuronal differentiation, while slightly reducing dendritic morphology and complexity. Transfection with dominant-negative Runx1 in hippocampal precursor cells in vitro did not result in differences in neurogenesis. Hippocampal expression of Runx1 correlated with adult neurogenesis (precursor cell proliferation) across BXD recombinant strains of mice and covarying transcripts enriched in the GO categories "neural precursor cell proliferation" and "neuron differentiation". Runx1 is thus a plausible candidate gene to be involved in regulating initial differentiation-related steps of adult neurogenesis. It seems, however, that the relative contribution of Runx1 to such effect is complementary and will explain only small parts of the cell-autonomous pro-differentiation effect.	[Fukui, Hirokazu; Ruenker, Annette; Fabel, Klaus; Kempermann, Gerd] German Ctr Neurodegenerat Dis DZNE Dresden, Dresden, Germany; [Fukui, Hirokazu; Ruenker, Annette; Fabel, Klaus; Kempermann, Gerd] Tech Univ Dresden, CRTD, Dresden, Germany; [Buchholz, Frank] Tech Univ Dresden, Med Syst Biol, Dresden, Germany; [Fukui, Hirokazu] Evotec AG, Hamburg, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Evotec	Kempermann, G (corresponding author), German Ctr Neurodegenerat Dis DZNE Dresden, Dresden, Germany.; Kempermann, G (corresponding author), Tech Univ Dresden, CRTD, Dresden, Germany.	gerd.kempermann@tu-dresden.de	Rünker, Annette/AAB-9179-2021; Buchholz, Frank/B-4700-2017; Kempermann, Gerd/F-5416-2010	Rünker, Annette/0000-0002-2524-1041; Buchholz, Frank/0000-0002-4577-3344; Kempermann, Gerd/0000-0002-5304-4061				Appleford PJ, 2009, J CELL BIOCHEM, V108, P14, DOI 10.1002/jcb.22249; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Babu H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00089; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Cameron ER, 2004, ONCOGENE, V23, P4308, DOI 10.1038/sj.onc.1207130; Coffman JA, 2003, CELL BIOL INT, V27, P315, DOI 10.1016/S1065-6995(03)00018-0; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Ito Y, 2003, CURR OPIN GENET DEV, V13, P43, DOI 10.1016/S0959-437X(03)00007-8; Jo M, 2006, MOL ENDOCRINOL, V20, P2156, DOI 10.1210/me.2005-0512; Kagoshima H, 2007, DEVELOPMENT, V134, P3905, DOI 10.1242/dev.008276; Kannan S, 2016, STEM CELLS, V34, P674, DOI 10.1002/stem.2313; Keller P, 2011, J APPL PHYSIOL, V110, P46, DOI 10.1152/japplphysiol.00634.2010; Kempermann G, 2006, P NATL ACAD SCI USA, V103, P780, DOI 10.1073/pnas.0510291103; Kempermann G., 2011, ADULT NEUROGENESIS, V2nd ed.; Kempermann G, 2011, EUR J NEUROSCI, V33, P1018, DOI 10.1111/j.1460-9568.2011.07599.x; Kobayashi A, 2012, MOL CELL NEUROSCI, V49, P23, DOI 10.1016/j.mcn.2011.08.009; Kumano K, 2010, J CELL PHYSL, V22; Kumano K, 2010, J CELL PHYSIOL, V222, P282, DOI 10.1002/jcp.21953; Levanon D, 2001, GENE, V262, P23, DOI 10.1016/S0378-1119(00)00532-1; Logan TT, 2015, STEM CELL RES, V15, P554, DOI 10.1016/j.scr.2015.09.014; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Meier-Stiegen F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011481; Murthy M, 2014, GENE, V540, P191, DOI 10.1016/j.gene.2014.02.038; Overall RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083797; Overall RW, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.15.003.2009; Sroczynska P, 2009, BLOOD, V114, P5279, DOI 10.1182/blood-2009-05-222307; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Vilardell M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-229; Vladimirova V, 2008, J NEUROSCI RES, V86, P2450, DOI 10.1002/jnr.21686; Wang JW, 2017, ADV EXP MED BIOL, V962, P103, DOI 10.1007/978-981-10-3233-2_8; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Wildey GM, 2009, J BIOL CHEM, V284, P20227, DOI 10.1074/jbc.M109.027201; Yokomizo T, 2001, GENES CELLS, V6, P13, DOI 10.1046/j.1365-2443.2001.00393.x; Yoshikawa M, 2007, DEV BIOL, V303, P663, DOI 10.1016/j.ydbio.2006.12.007; Yoshikawa M, 2016, MOL CELL NEUROSCI, V72, P114, DOI 10.1016/j.mcn.2016.02.001	36	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190789	10.1371/journal.pone.0190789	http://dx.doi.org/10.1371/journal.pone.0190789			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324888	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400057
J	Khromov, P; Malliaris, CD; Morozov, AV				Khromov, Pavel; Malliaris, Constantin D.; Morozov, Alexandre V.			Generalization of the Ewens sampling formula to arbitrary fitness landscapes	PLOS ONE			English	Article							GENETIC-VARIABILITY; NATURAL-SELECTION; DELETERIOUS MUTATIONS; MAINTENANCE; FREQUENCIES; ROBUSTNESS; DIVERSITY; EPISTASIS; EVOLUTION; FIXATION	In considering evolution of transcribed regions, regulatory sequences, and other genomic loci, we are often faced with a situation in which the number of allelic states greatly exceeds the size of the population. In this limit, the population eventually adopts a steady state characterized by mutation-selection-drift balance. Although new alleles continue to be explored through mutation, the statistics of the population, and in particular the probabilities of seeing specific allelic configurations in samples taken from the population, do not change with time. In the absence of selection, the probabilities of allelic configurations are given by the Ewens sampling formula, widely used in population genetics to detect deviations from neutrality. Here we develop an extension of this formula to arbitrary fitness distributions. Although our approach is general, we focus on the class of fitness landscapes, inspired by recent high-throughput genotype-phenotype maps, in which alleles can be in several distinct phenotypic states. This class of landscapes yields sampling probabilities that are computationally more tractable and can form a basis for inference of selection signatures from genomic data. Using an efficient numerical implementation of the sampling probabilities, we demonstrate that, for a sizable range of mutation rates and selection coefficients, the steady-state allelic diversity is not neutral. Therefore, it may be used to infer selection coefficients, as well as other evolutionary parameters from population data. We also carry out numerical simulations to challenge various approximations involved in deriving our sampling formulas, such as the infinite-allele limit and the full connectivity assumption inherent in the Ewens theory, in which each allele can mutate into any other allele. We find that, at least for the specific numerical examples studied, our theory remains sufficiently accurate even if these assumptions are relaxed. Thus our framework establishes both theoretical and practical foundations for inferring selection signatures from population-level genomic sequence samples.	[Morozov, Alexandre V.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; Rutgers State Univ, Ctr Quantitat Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Morozov, AV (corresponding author), Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA.	morozov@physics.rutgers.edu	Morozov, Alexandre/E-1984-2016	Morozov, Alexandre/0000-0003-2598-7000	Peter Lindenfeld fellowship - Department of Physics and Astronomy, Rutgers University; Los Alamos National Lab [LANL-DOE 20150236ER]	Peter Lindenfeld fellowship - Department of Physics and Astronomy, Rutgers University; Los Alamos National Lab	PK acknowledges financial support from a Peter Lindenfeld fellowship awarded by the Department of Physics and Astronomy, Rutgers University. AVM was supported in part through a collaboration with Los Alamos National Lab (LANL-DOE 20150236ER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PK acknowledges financial support from a Peter Lindenfeld fellowship awarded by the Department of Physics and Astronomy, Rutgers University. AVM was supported in part through a collaboration with Los Alamos National Lab (LANL-DOE 20150236ER).	Breen MS, 2012, NATURE, V490, P535, DOI 10.1038/nature11510; Chan YH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14614; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Crane H, 2016, STAT SCI, V31, P1, DOI 10.1214/15-STS529; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Desai MM, 2012, THEOR POPUL BIOL, V81, P144, DOI 10.1016/j.tpb.2011.12.002; Ethier S. N., 1987, Stochastic methods in biology. Proceedings of a workshop held in Nagoya, Japan, July 8-12, 1985., P72; ETHIER SN, 1994, STOCH PROC APPL, V54, P1, DOI 10.1016/0304-4149(94)00006-9; Ewens W.J., 2004, MATH POPULATION GENE, DOI [DOI 10.1007/978-0-387-21822-9, 10.1007/978-0-387-21822-9]; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; EWENS WJ, 1980, J MATH BIOL, V10, P155, DOI 10.1007/BF00275839; Eyre-Walker A, 2007, NAT REV GENET, V8, P610, DOI 10.1038/nrg2146; Feder AF, 2014, GENETICS, V196, P509, DOI 10.1534/genetics.113.158220; Feng S, 2016, STAT SCI, V31, P20, DOI 10.1214/15-STS535; Gillespie J. H., 2004, POPULATION GENETICS; GRIFFITHS RC, 1983, J MATH BIOL, V17, P1, DOI 10.1007/BF00276111; Grote MN, 2002, ANN APPL PROBAB, V12, P637; Haddrill PR, 2010, GENETICS, V185, P1381, DOI 10.1534/genetics.110.117614; Handa K, 2005, ELECTRON COMMUN PROB, V10, P223, DOI 10.1214/ECP.v10-1159; Hietpas RT, 2011, P NATL ACAD SCI USA, V108, P7896, DOI 10.1073/pnas.1016024108; Hudson Richard R., 1994, P140; Huillet T, 2007, J COMPUT APPL MATH, V206, P755, DOI 10.1016/j.cam.2006.08.022; Johnson N., 1997, DISCRETE MULTIVARIAT; JOYCE P, 1995, J APPL PROBAB, V32, P609, DOI 10.2307/3215116; Joyce P, 2003, ANN APPL PROBAB, V13, P181; JOYCE P, 1995, J MATH BIOL, V33, P602, DOI 10.1007/BF00298645; Joyce P., 2003, COMPUT SCI STAT, V35, P181; Joyce P, 2012, J COMPUT BIOL, V19, P650, DOI 10.1089/cmb.2012.0033; KIMURA M, 1969, GENETICS, V61, P763; KIMURA M, 1962, GENETICS, V47, P713; KIMURA M, 1955, COLD SPRING HARB SYM, V20, P33, DOI 10.1101/SQB.1955.020.01.006; KINGMAN JFC, 1977, THEOR POPUL BIOL, V11, P274, DOI 10.1016/0040-5809(77)90029-6; KINGMAN JFC, 1975, J ROY STAT SOC B MET, V37, P1; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Li C, 2016, SCIENCE, V352, P837, DOI 10.1126/science.aae0568; LI WH, 1978, GENETICS, V90, P349; LI WH, 1979, GENETICS, V92, P647; LI WH, 1977, P NATL ACAD SCI USA, V74, P2509, DOI 10.1073/pnas.74.6.2509; Lind PA, 2010, SCIENCE, V330, P825, DOI 10.1126/science.1194617; Lunzer M, 2005, SCIENCE, V310, P499, DOI 10.1126/science.1115649; Lunzer M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001162; Martin SH, 2016, GENETICS, V203, P525, DOI 10.1534/genetics.115.183285; Moran P., 1958, MATH P CAMBRIDGE PHI, V54, P60, DOI DOI 10.1017/S0305004100033193; Podgornaia AI, 2015, SCIENCE, V347, P673, DOI 10.1126/science.1257360; Puchta O, 2016, SCIENCE, V352, P840, DOI 10.1126/science.aaf0965; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Ronen R, 2013, GENETICS, V195, P181, DOI 10.1534/genetics.113.152587; Rouzine IM, 2001, MICROBIOL MOL BIOL R, V65, P151, DOI 10.1128/MMBR.65.1.151-185.2001; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Sarkisyan KS, 2016, NATURE, V533, P397, DOI 10.1038/nature17995; SAWYER SA, 1992, GENETICS, V132, P1161; Schraiber JG, 2016, GENETICS, V203, P493, DOI 10.1534/genetics.116.187278; Sella G, 2005, P NATL ACAD SCI USA, V102, P9541, DOI 10.1073/pnas.0501865102; Sella G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000495; Sella G, 2009, THEOR POPUL BIOL, V75, P30, DOI 10.1016/j.tpb.2008.10.001; SLATKIN M, 1994, GENET RES, V64, P71, DOI 10.1017/S0016672300032560; Vitalis R, 2014, GENETICS, V196, P799, DOI 10.1534/genetics.113.152991; WATTERSON GA, 1978, GENETICS, V88, P405; WATTERSON GA, 1977, GENETICS, V85, P789; Wright S, 1937, P NATL ACAD SCI USA, V23, P307, DOI 10.1073/pnas.23.6.307; Wright S, 1931, GENETICS, V16, P0097	61	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190186	10.1371/journal.pone.0190186	http://dx.doi.org/10.1371/journal.pone.0190186			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324850	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400023
J	Tsai, HP; Huang, SF; Li, CF; Chien, HT; Chen, SC				Tsai, Hsiu-Pei; Huang, Shiang-Fu; Li, Chien-Fan; Chien, Huei-Tzu; Chen, Shin-Cheh			Differential microRNA expression in breast cancer with different onset age	PLOS ONE			English	Article							YOUNG-WOMEN; GENE-EXPRESSION; CELLS; METASTASIS; SURVIVAL; TARGETS; TAIWAN; PROLIFERATION; PROFILES; INVASION	Purpose The lower breast cancer incidence in Asian populations compared with Western populations has been speculated to be caused by environmental and genetic variation. Early-onset breast cancer occupies a considerable proportion of breast cancers in Asian populations, but the reason for this is unclear. We aimed to examine miRNA expression profiles in different age-onset groups and pathological subtypes in Asian breast cancer. Methods At the first stage, 10 samples (tumor: n = 6, normal tissue: n = 4) were analyzed with an Agilent microRNA 470 probe microarray. Candidate miRNAs with expression levels that were significantly altered in breast cancer samples or selected from a literature review were further validated by quantitative real-time PCR (qPCR) of 145 breast cancer samples at the second stage of the process. Correlations between clinicopathological parameters of breast cancer patients from different age groups and candidate miRNA expression were elucidated. Results In the present study, the tumor subtypes were significantly different in each age group, and an onset age below 40 had poor disease-free and overall survival rates. For all breast cancer patients, miR-335 and miR-145 were down-regulated, and miR-21, miR-200a, miR200c, and miR-141 were up-regulated. In very young patients (age < 35 y/o), the expression of 3 and 8 specific miRNAs were up-and down-regulated, respectively. In young patients (36-40 y/o), 3 and 3 specific miRNAs were up-and down-regulated, respectively. miR-5325p was up-regulated in triple-negative breast cancer. Conclusions Differential miRNA expressions between normal and tumor tissues were observed in different age groups and tumor subtypes. Evolutionarily conserved miRNA clusters, which initiate malignancy transformation, were up-regulated in the breast cancers of very young patients. None of the significantly altered miRNAs were observed in postmenopausal patients.	[Tsai, Hsiu-Pei; Huang, Shiang-Fu] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Tsai, Hsiu-Pei; Chen, Shin-Cheh] Chang Gung Mem Hosp, Dept Gen Surg, Taoyuan, Taiwan; [Huang, Shiang-Fu; Li, Chien-Fan; Chien, Huei-Tzu] Chang Gung Univ, Dept Publ Hlth, Taoyuan, Taiwan; [Huang, Shiang-Fu] Chang Gung Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Chen, SC (corresponding author), Chang Gung Mem Hosp, Dept Gen Surg, Taoyuan, Taiwan.; Chien, HT (corresponding author), Chang Gung Univ, Dept Publ Hlth, Taoyuan, Taiwan.	kathy.htchien@gmail.com; chensc@cgmh.org.tw	Chien, Huei-Tzu/G-1337-2018	Chien, Huei-Tzu/0000-0002-4120-7070	Chang Gung Memorial Hospital [CMRPG180011]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by Grants CMRPG180011 from Chang Gung Memorial Hospital to SCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Castilla MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047709; Azim HA, 2012, CLIN CANCER RES, V18, P1341, DOI 10.1158/1078-0432.CCR-11-2599; Bastos EP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101656; Bockhorn J, 2013, BREAST CANCER RES TR, V137, P373, DOI 10.1007/s10549-012-2346-4; Chan SH, 2014, ONCOGENE, V33, P4496, DOI 10.1038/onc.2014.10; Chang YY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0301-9; Chen HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165409; Chen J, 2014, CLIN TRANSL ONCOL, V16, P225, DOI 10.1007/s12094-013-1132-z; Chen ST, 2003, BREAST CANCER RES TR, V77, P133, DOI 10.1023/A:1021386026051; de Rinaldis E, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-643; Del Vescovo V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078870; Dijkstra JR, 2012, J CELL MOL MED, V16, P683, DOI 10.1111/j.1582-4934.2011.01467.x; ELSTON CW, 1993, J CLIN PATHOL, V46, P189; Fredholm H, 2009, PLOS ONE, V4, pA38, DOI 10.1371/journal.pone.0007695; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Gotte M, 2010, ONCOGENE, V29, P6569, DOI 10.1038/onc.2010.386; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Huang AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035252; Huang HJ, 2005, J CLIN PATHOL, V58, P611, DOI 10.1136/jcp.2004.022772; Huang S, 2011, BRIT J CANCER, V104, P235, DOI 10.1038/sj.bjc.6606010; Huang Y, 2012, NUCLEIC ACIDS RES, V40, P10478, DOI 10.1093/nar/gks789; Jang K, 2014, TRANSL RES, V163, P242, DOI 10.1016/j.trsl.2013.11.005; Kitago M, 2009, CLIN CANCER RES, V15, P2988, DOI 10.1158/1078-0432.CCR-08-3172; Kuo WH, 2009, BRIT J CANCER, V100, P563, DOI 10.1038/sj.bjc.6604898; Leong SPL, 2010, WORLD J SURG, V34, P2308, DOI 10.1007/s00268-010-0683-1; Li D, 2011, OMICS, V15, P673, DOI 10.1089/omi.2011.0064; Li JY, 2013, ASIAN PAC J CANCER P, V14, P3197, DOI 10.7314/APJCP.2013.14.5.3197; Li SSL, 1999, HUM GENET, V104, P201, DOI 10.1007/s004390050936; Lin CH, 2009, CANCER EPIDEM BIOMAR, V18, P1807, DOI 10.1158/1055-9965.EPI-09-0096; Lohrisch C, 2006, J CLIN ONCOL, V24, P4888, DOI 10.1200/JCO.2005.01.6089; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Luo ZH, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-3; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Niu JX, 2012, J BIOL CHEM, V287, P21783, DOI 10.1074/jbc.M112.355495; Pena-Chilet M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-529; Perez-Rivas LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091884; Png KJ, 2011, GENE DEV, V25, P226, DOI 10.1101/gad.1974211; Rodriguez-Gonzalez FG, 2011, BREAST CANCER RES TR, V127, P43, DOI 10.1007/s10549-010-0940-x; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Shen YC, 2005, CANCER EPIDEM BIOMAR, V14, P1986, DOI 10.1158/1055-9965.EPI-04-0932; Shi M, 2009, CANCER TREAT REV, V35, P328, DOI 10.1016/j.ctrv.2008.12.002; Silveri L, 2006, REPROD NUTR DEV, V46, P549, DOI 10.1051/rnd:2006026; Song XF, 2015, AM J TRANSL RES, V7, P2254; Sung HN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv107; Tan YL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-12; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wang L, 2012, ONCOGENE, V31, P2499, DOI 10.1038/onc.2011.444; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041693; Xu X, 2016, J CELL MOL MED, V20, P95, DOI 10.1111/jcmm.12706; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	53	40	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191195	10.1371/journal.pone.0191195	http://dx.doi.org/10.1371/journal.pone.0191195			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324832	Green Submitted, Green Published, gold			2022-12-26	WOS:000419952400131
J	Yerabham, ASK; Muller-Schiffmann, A; Ziehm, T; Stadler, A; Kober, S; Indurkhya, X; Marreiros, R; Trossbach, SV; Bradshaw, NJ; Prikulis, I; Willbold, D; Weiergraber, OH; Korth, C				Yerabham, Antony S. K.; Mueller-Schiffmann, Andreas; Ziehm, Tamar; Stadler, Andreas; Koeber, Sabrina; Indurkhya, Xela; Marreiros, Rita; Trossbach, Svenja V.; Bradshaw, Nicholas J.; Prikulis, Ingrid; Willbold, Dieter; Weiergraeber, Oliver H.; Korth, Carsten			Biophysical insights from a single chain camelid antibody directed against the Disrupted-in-Schizophrenia 1 protein	PLOS ONE			English	Article							RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; DOMAIN ANTIBODIES; DISRUPTED-IN-SCHIZOPHRENIA-1 DISC1; PROGENITOR PROLIFERATION; RISK; NANOBODIES; MODELS; IMPACT; GENES	Accumulating evidence suggests an important role for the Disrupted-in-Schizophrenia 1 (DISC1) protein in neurodevelopment and chronic mental illness. In particular, the C-terminal 300 amino acids of DISC1 have been found to mediate important protein-protein interactions and to harbor functionally important phosphorylation sites and disease-associated polymorphisms. However, long disordered regions and oligomer-forming subdomains have so far impeded structural analysis. VHH domains derived from camelid heavy chain only antibodies are minimal antigen binding modules with appreciable solubility and stability, which makes them well suited for the stabilizing proteins prior to structural investigation. Here, we report on the generation of a VHH domain derived from an immunized Lama glama, displaying high affinity for the human DISC1 C region (aa 691 +/- 836), and its characterization by surface plasmon resonance, size exclusion chromatography and immunological techniques. The VHH-DISC1 (C region) complex was also used for structural investigation by small angle X-ray scattering analysis. In combination with molecular modeling, these data support predictions regarding the three-dimensional fold of this DISC1 segment as well as its steric arrangement in complex with our VHH antibody.	[Yerabham, Antony S. K.; Mueller-Schiffmann, Andreas; Koeber, Sabrina; Indurkhya, Xela; Marreiros, Rita; Trossbach, Svenja V.; Bradshaw, Nicholas J.; Prikulis, Ingrid; Korth, Carsten] Heinrich Heine Univ Dusseldorf, Dept Neuropathol, Dusseldorf, Germany; [Ziehm, Tamar; Willbold, Dieter; Weiergraeber, Oliver H.] Forschungszentrum Julich, Inst Complex Syst ICS Struct Biochem 6, Julich, Germany; [Stadler, Andreas] Forschungszentrum Julich, JCNS, Julich, Germany; [Stadler, Andreas] Forschungszentrum Julich, ICS, Julich, Germany; [Willbold, Dieter] Heinrich Heine Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Willbold, Dieter] Heinrich Heine Univ Dusseldorf, BMFZ, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Korth, C (corresponding author), Heinrich Heine Univ Dusseldorf, Dept Neuropathol, Dusseldorf, Germany.	ckorth@hhu.de	Weiergräber, Oliver H./G-8940-2013; Bradshaw, Nicholas J./A-5625-2009; Stadler, Andreas/B-2735-2009	Weiergräber, Oliver H./0000-0002-2410-3691; Bradshaw, Nicholas J./0000-0001-5581-8828; Stadler, Andreas/0000-0003-2272-5232; Yerabham, Antony Sravan Kumar/0000-0003-4194-8386	NRW Graduate School BioStruct; HHU Graduate School iBRAIN; Fritz-Thyssen Foundation [10.14.2.140]; EU-FP7 MC-ITN IN-SENS [60761]	NRW Graduate School BioStruct; HHU Graduate School iBRAIN; Fritz-Thyssen Foundation; EU-FP7 MC-ITN IN-SENS	This work was supported by NRW Graduate School BioStruct (http://www.biostruct.uni-duesseldorf.de/startseite-biostruct.html) to CK; HHU Graduate School iBRAIN (http://www.ibrain-duesseldorf.de) to CK; Fritz-Thyssen Foundation (http://www.fritz-thyssen-stiftung.de/?L=1) (#10.14.2.140) to NJB; and EU-FP7 MC-ITN IN-SENS (#60761) to CK.	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Alvarez-Rueda N, 2007, MOL IMMUNOL, V44, P1680, DOI 10.1016/j.molimm.2006.08.007; Bader V, 2012, JOVE-J VIS EXP, DOI 10.3791/4132; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Bever CS, 2016, ANAL BIOANAL CHEM, V408, P5985, DOI 10.1007/s00216-016-9585-x; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; Brenke R, 2012, BIOINFORMATICS, V28, P2608, DOI 10.1093/bioinformatics/bts493; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Dahoun T, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.282; Doyle PJ, 2008, MOL IMMUNOL, V45, P3703, DOI 10.1016/j.molimm.2008.06.005; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fenn TD, 2003, BIOCHEMISTRY-US, V42, P5775, DOI 10.1021/bi027022d; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; Hashimoto R, 2006, HUM MOL GENET, V15, P3024, DOI 10.1093/hmg/ddl244; Hassanzadeh-Ghassabeh G, 2013, NANOMEDICINE-UK, V8, P1013, DOI [10.2217/nnm.13.86, 10.2217/NNM.13.86]; Ishizuka K, 2011, NATURE, V473, P92, DOI 10.1038/nature09859; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Leliveld SR, 2009, BIOCHEMISTRY-US, V48, P7746, DOI 10.1021/bi900901e; Li TF, 2016, J CONTROL RELEASE, V243, P1, DOI 10.1016/j.jconrel.2016.09.019; Lipina TV, 2014, NEUROSCI BIOBEHAV R, V45, P271, DOI 10.1016/j.neubiorev.2014.07.001; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Narayanan S, 2011, J BIOL CHEM, V286, P44266, DOI 10.1074/jbc.M111.271593; Niethammer M, 2000, NEURON, V28, P697, DOI 10.1016/S0896-6273(00)00147-1; Ottis P, 2011, BIOL PSYCHIAT, V70, P604, DOI 10.1016/j.biopsych.2011.03.027; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Rudolph MJ, 2017, J BIOL CHEM, V292, P872, DOI 10.1074/jbc.M116.758102; Sachs NA, 2005, MOL PSYCHIATR, V10, P758, DOI 10.1038/sj.mp.4001667; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santuccione A, 2005, J CELL BIOL, V169, P341, DOI 10.1083/jcb.200409127; Schotte L, 2014, J VIROL, V88, P4403, DOI 10.1128/JVI.03402-13; Shinoda T, 2007, J NEUROSCI, V27, P4, DOI 10.1523/JNEUROSCI.3825-06.2007; Strauss M, 2017, J VIROL, V91, DOI 10.1128/JVI.01443-16; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thys B, 2011, J VIROL METHODS, V173, P300, DOI 10.1016/j.jviromet.2011.02.023; Trossbach SV, 2016, MOL PSYCHIATR, V21, P1561, DOI 10.1038/mp.2015.194; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wahle M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004516; Wang Q, 2011, MOL PSYCHIATR, V16, P1006, DOI 10.1038/mp.2010.87; Wang Y, 2012, TOXICON, V60, P1290, DOI 10.1016/j.toxicon.2012.08.014; Wriggers W, 2012, ACTA CRYSTALLOGR D, V68, P344, DOI 10.1107/S0907444911049791; Wu MT, 2011, J STRUCT BIOL, V174, P124, DOI 10.1016/j.jsb.2010.10.007; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Ye F, 2017, NEURON; Yerabham ASK, 2017, J BIOL CHEM, V292, P6468, DOI 10.1074/jbc.M116.773903; Yerabham ASK, 2013, BIOL CHEM, V394, P1425, DOI 10.1515/hsz-2013-0178; Zhang Yang, 2014, Proteins, V82 Suppl 2, P175, DOI 10.1002/prot.24341	63	3	3	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191162	10.1371/journal.pone.0191162	http://dx.doi.org/10.1371/journal.pone.0191162			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324815	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400125
J	Graspeuntner, S; Bohlmann, MK; Gillmann, K; Speer, R; Kuenzel, S; Mark, H; Hoellen, F; Lettau, R; Griesinger, G; Konig, IR; Baines, JF; Rupp, J				Graspeuntner, Simon; Bohlmann, Michael K.; Gillmann, Kathrin; Speer, Runa; Kuenzel, Sven; Mark, Heike; Hoellen, Friederike; Lettau, Reinhard; Griesinger, Georg; Koenig, Inke R.; Baines, John F.; Rupp, Jan			Microbiota-based analysis reveals specific bacterial traits and a novel strategy for the diagnosis of infectious infertility	PLOS ONE			English	Article							LACTOBACILLUS-CRISPATUS; CHLAMYDIAL HSP60; SEQUENCE DATA; VAGINOSIS; CLASSIFIER; VAGINALIS; RESPONSES; ANTIBODY; HEALTH; WOMEN	Tubal factor infertility (TFI) accounts for more than 30% of the cases of female infertility and mostly resides from an inflammatory process triggered by an infection. Clinical appearances largely differ, and very often infections are not recognized or remain completely asymptomatic over time. Here, we characterized the microbial pattern in females diagnosed with infectious infertility (ININF) in comparison to females with non-infectious infertility (nININF), female sex workers (FSW) and healthy controls (fertile). Females diagnosed with infectious infertility differed significantly in the seroprevalence of IgG antibodies against the C. trachomatis proteins MOMP, OMP2, CPAF and HSP60 when compared to fertile females. Microbiota analysis using 16S amplicon sequencing of cervical swabs revealed significant differences between ININF and fertile controls in the relative read count of Gardnerella (10.08% vs. 5.43%). Alpha diversity varies among groups, which are characterized by community state types including Lactobacillus-dominated communities in fertile females, an increase in diversity in all the other groups and Gardnerella-dominated communities occurring more often in ININF. While all single parameters did not allow predicting infections as the cause of infertility, including C. trachomatis IgG/IgA status together with 16S rRNA gene analysis of the ten most frequent taxa a total of 93.8% of the females were correctly classified. Further studies are needed to unravel the impact of the cervical microbiota in the pathogenesis of infectious infertility and its potential for identifying females at risk earlier in life.	[Graspeuntner, Simon; Gillmann, Kathrin; Rupp, Jan] Univ Lubeck, Dept Infect Dis & Microbiol, Schleswig Holstein, Germany; [Bohlmann, Michael K.; Hoellen, Friederike] Univ Hosp Schleswig Holstein, Dept Obstet & Gynecol, Schleswig Holstein, Germany; [Bohlmann, Michael K.] Univ Hosp Mannheim, Dept Obstet & Gynecol, Baden Wuertemberg, Germany; [Speer, Runa; Mark, Heike] Ctr Sexual Hlth, Berlin Dept Publ Hlth, Berlin, Germany; [Kuenzel, Sven; Baines, John F.] Max Planck Inst Evolutionary Biol, Schleswig Holstein, Germany; [Lettau, Reinhard] Outpatient Med Care Gynecol, Schleswig Holstein, Germany; [Griesinger, Georg] Univ Hosp Schleswig Holstein, Dept Reprod Med & Gynecol Endocrinol, Schleswig Holstein, Germany; [Koenig, Inke R.] Univ Lubeck, Inst Med Biometry & Stat, Schleswig Holstein, Germany; [Baines, John F.] Christian Albrechts Univ Kiel, Inst Expt Med, Schleswig Holstein, Germany	University of Lubeck; University of Kiel; Schleswig Holstein University Hospital; Max Planck Society; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; University of Kiel	Rupp, J (corresponding author), Univ Lubeck, Dept Infect Dis & Microbiol, Schleswig Holstein, Germany.	jan.rupp@uksh.de	König, Inke R/A-4544-2009; Graspeuntner, Simon/B-2176-2013; Baines, John F/B-3580-2010; Rupp, Jan/C-8794-2011; Graspeuntner, Simon/S-2036-2019	König, Inke R/0000-0003-0504-6465; Graspeuntner, Simon/0000-0002-2546-2223; Baines, John F/0000-0002-8132-4909; Rupp, Jan/0000-0001-8722-1233; Graspeuntner, Simon/0000-0002-2546-2223; Griesinger, Georg/0000-0002-0606-5804	German Research Foundation (DFG) [1743, 306]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation (DFG) within the Research Training Group 1743, "Genes, Environment and Inflammation" and the Excellence Cluster 306, "Inflammation at Interfaces". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth JE, 2008, SEX TRANSM DIS, V35, P791, DOI 10.1097/OLQ.0b013e3181788301; Boutros P. C, 2015, BOUTROSLAB PLOTTING; Control ECfDPa, 2008, CHLAM CONTR EUR LIT; Cox C, 2016, EUR J CLIN MICROBIOL, V35, P481, DOI 10.1007/s10096-015-2564-x; Dielissen PW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-534; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Fettweis JM, 2012, BMC GENOMICS, V13; Forsbach-Birk V, 2010, CLIN MICROBIOL INFEC, V16, P1237, DOI 10.1111/j.1469-0691.2009.03041.x; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; Ghartey JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096659; Jespers V, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0825-z; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Muzny CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080254; Nardini P, 2016, SCI REP-UK, V6, DOI 10.1038/srep29024; National Institute for Health and Care Excellence, 2013, FERT ASS TREATM PEOP; Nelson TM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00253; Nunn KL, 2015, MBIO, V6, DOI 10.1128/mBio.01084-15; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Onderdonk AB, 2016, CLIN MICROBIOL REV, V29, P223, DOI 10.1128/CMR.00075-15; Peeling RW, 1997, J INFECT DIS, V175, P1153, DOI 10.1086/516454; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sauerbrei W, 2006, COMPUT STAT DATA AN, V50, P3464, DOI 10.1016/j.csda.2005.07.015; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharma J, 2004, INFECT IMMUN, V72, P7164, DOI 10.1128/IAI.72.12.7164-7171.2004; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Skwor T, 2010, INVEST OPHTH VIS SCI, V51, P5128, DOI 10.1167/iovs.09-5113; Spiegel CA, 2002, REV MED MICROBIOL, V13, P43; Team RC, 2015, R LANG ENV STAT COMP; van der Veer C, 2016, CLIN INFECT DIS; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Witkin SS, 2017, CLIN VACCINE IMMUNOL, V24, DOI [10.1128/CVI.00203-17, 10.1128/cvi.00203-17]; Ziklo N, 2016, TRENDS MICROBIOL, V24, P750, DOI 10.1016/j.tim.2016.05.007	39	29	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0191047	10.1371/journal.pone.0191047	http://dx.doi.org/10.1371/journal.pone.0191047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315330	gold, Green Published, Green Submitted			2022-12-26	WOS:000419655900038
J	Loskutov, YV; Griffin, CL; Marinak, KM; Bobko, A; Margaryan, NV; Geldenhuys, WJ; Sarkaria, JN; Pugacheva, EN				Loskutov, Yuriy V.; Griffin, Caryn L.; Marinak, Kristina M.; Bobko, Andrey; Margaryan, Naira V.; Geldenhuys, Werner J.; Sarkaria, Jann N.; Pugacheva, Elena N.			LPA signaling is regulated through the primary cilium: a novel target in glioblastoma	ONCOGENE			English	Article							LYSOPHOSPHATIDIC ACID; BREAST-CANCER; CELL-PROLIFERATION; PROTEIN; RECEPTORS; GROWTH; DIFFERENTIATION; SENSITIVITY; METASTASIS; ACTIVATION	The primary cilium is a ubiquitous organelle presented on most human cells. It is a crucial signaling hub for multiple pathways including growth factor and G-protein coupled receptors. Loss of primary cilia, observed in various cancers, has been shown to affect cell proliferation. Primary cilia formation is drastically decreased in glioblastoma (GBM), however, the role of cilia in normal astrocyte or glioblastoma proliferation has not been explored. Here, we report that loss of primary cilia in human astrocytes stimulates growth rate in a lysophosphatidic acid (LPA)-dependent manner. We show that lysophosphatidic acid receptor 1 (LPAR1) is accumulated in primary cilia. LPAR1 signaling through G alpha 12/G alpha q was previously reported to be responsible for cancer cell proliferation. We found that in ciliated cells, G alpha 12 and G alpha q are excluded from the cilium, creating a barrier against unlimited proliferation, one of the hallmarks of cancer. Upon loss of primary cilia, LPAR1 redistributes to the plasma membrane with a concomitant increase in LPAR1 association with G alpha 12 and G alpha q. Inhibition of LPA signaling with the small molecule compound Ki16425 in deciliated highly proliferative astrocytes or glioblastoma patient-derived cells/xenografts drastically suppresses their growth both in vitro and in vivo. Moreover, Ki16425 brain delivery via PEG-PLGA nanoparticles inhibited tumor progression in an intracranial glioblastoma PDX model. Overall, our findings establish a novel mechanism by which primary cilium restricts proliferation and indicate that loss of primary cilia is sufficient to increase mitogenic signaling, and is important for the maintenance of a highly proliferative phenotype. Clinical application of LPA inhibitors may prove beneficial to restrict glioblastoma growth and ensure local control of disease.	[Loskutov, Yuriy V.; Griffin, Caryn L.; Marinak, Kristina M.; Pugacheva, Elena N.] West Virginia Univ, Sch Med, WVU Canc Inst, Morgantown, WV 26506 USA; [Bobko, Andrey; Margaryan, Naira V.; Pugacheva, Elena N.] West Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26506 USA; [Geldenhuys, Werner J.] West Virginia Univ, Sch Med, Dept Pharmaceut Sci, Morgantown, WV USA; [Sarkaria, Jann N.] Mayo Clin, Rochester, MN USA; [Pugacheva, Elena N.] West Virginia Univ, Sch Med, Dept Radiat Oncol, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University; Mayo Clinic; West Virginia University	Pugacheva, EN (corresponding author), West Virginia Univ, Sch Med, WVU Canc Inst, Morgantown, WV 26506 USA.; Pugacheva, EN (corresponding author), West Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26506 USA.; Pugacheva, EN (corresponding author), West Virginia Univ, Sch Med, Dept Radiat Oncol, Morgantown, WV 26506 USA.	epugacheva@hsc.wvu.edu		Loskutov, Juergen/0000-0003-3472-4093; Whately, Kristina/0000-0002-5908-8145	NIH/NCI [R21CA208875, R01CA148671]; NIGMS/NIH [U54GM104942]; WVU Cancer Institute Undergraduate Research Fellowship; "Let the Journey Begin" fund; WVCTSI [U54GM104942]; WVU Cancer Institute; NIH [P20RR016440, P20 RR016477, P30RR032138/P30GM103488]; NATIONAL CANCER INSTITUTE [R21CA208875, R01CA148671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); WVU Cancer Institute Undergraduate Research Fellowship; "Let the Journey Begin" fund; WVCTSI; WVU Cancer Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants R21CA208875 (E.N. P), R01CA148671 (E.N. P) from the NIH/NCI, U54GM104942 (W.J. G) from the NIGMS/NIH, WVU Cancer Institute Undergraduate Research Fellowship (C.L.G), and "Let the Journey Begin" fund established by Erin Dunmire, WVU Cancer Institute. Andrey Bobko is supported by startup funding from WVCTSI. Naira V. Margaryan is supported by U54GM104942 from WVCTSI. West Virginia University Microscope Imaging Facility is supported by the WVU Cancer Institute and NIH grants P20RR016440, P20 RR016477 and P30RR032138/P30GM103488.	Barzi M, 2011, J BIOL CHEM, V286, P8067, DOI 10.1074/jbc.M110.178772; Barzi M, 2010, J CELL SCI, V123, P62, DOI 10.1242/jcs.060020; Basten Sander G, 2013, Cilia, V2, P6, DOI 10.1186/2046-2530-2-6; Basten Sander G, 2013, Cilia, V2, P2, DOI 10.1186/2046-2530-2-2; Butowski N. A., 2016, CNS ONCOL, V6, P61; Cao ZM, 2009, ENDOCR RES, V34, P101, DOI 10.3109/07435800903204082; Carlson BL, 2011, CURR PROTOC PHARM, V14, P14; Carlson BL, 2009, INT J RADIAT ONCOL, V75, P212, DOI 10.1016/j.ijrobp.2009.04.026; Christensen ST, 2012, J PATHOL, V226, P172, DOI 10.1002/path.3004; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gan CP, 2014, ONCOTARGET, V5, P9626, DOI 10.18632/oncotarget.2437; Gastrointestinal Complications (PDQ(R)), 2002, HLTH PROF VERS; Geldenhuys W, 2015, PHARM DEV TECHNOL, V20, P497, DOI 10.3109/10837450.2014.892130; Goldsmith Zachariah G, 2011, Genes Cancer, V2, P563, DOI 10.1177/1947601911419362; Gonzalez-Gil I, 2015, MEDCHEMCOMM, V6, P13, DOI 10.1039/c4md00333k; Gradilone SA, 2013, CANCER RES, V73, P2259, DOI 10.1158/0008-5472.CAN-12-2938; Gschwind A, 2002, CANCER RES, V62, P6329; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Hassounah NB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068521; Hoang-Minh LB, 2016, ONCOTARGET, V7, P7029, DOI 10.18632/oncotarget.6854; Hoelzinger DB, 2008, J NEURO-ONCOL, V86, P297, DOI 10.1007/s11060-007-9480-6; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; Kasaharaa K, 2014, ACTA MED OKAYAMA, V68, P317; Kim S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9087; Koutcher JA, 2002, NEOPLASIA, V4, P480, DOI 10.1038/sj.neo.7900269; Kozyreva VK, 2016, MOL CANCER THER, V15, P1809, DOI 10.1158/1535-7163.MCT-15-0688; Li L, 2016, NAT CELL BIOL, V18, P418, DOI 10.1038/ncb3327; Loskutov YV, 2015, ONCOGENE, V34, P3662, DOI 10.1038/onc.2014.297; Manning TJ, 2000, CELL MOTIL CYTOSKEL, V45, P185, DOI 10.1002/(SICI)1097-0169(200003)45:3<185::AID-CM2>3.0.CO;2-G; Marley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070857; McDowell KA, 2011, CURR PHARM DESIGN, V17, P2411; Moser JJ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-448; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Pal K, 2015, METHOD CELL BIOL, V127, P303, DOI 10.1016/bs.mcb.2014.12.003; Patel BR, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.45; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Portnoy S., 2008, P INT SOC MAG RESON, P3206; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Ries LAG., 2007, NIH PUB; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Sarkaria JN, 2007, MOL CANCER THER, V6, P1167, DOI 10.1158/1535-7163.MCT-06-0691; Sarkisian MR, 2014, J NEURO-ONCOL, V117, P15, DOI 10.1007/s11060-013-1340-y; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Schou KB, 2015, EMBO REP, V16, P1099, DOI 10.15252/embr.201540530; SCHUERMANN M, 1990, NUCLEIC ACIDS RES, V18, P4945, DOI 10.1093/nar/18.16.4945; Shano S, 2008, NEUROCHEM INT, V52, P216, DOI 10.1016/j.neuint.2007.07.004; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Wang G, 2013, J CELL SCI, V126, P1355, DOI 10.1242/jcs.114918; Yang Y, 2013, EMBO REP, V14, P741, DOI 10.1038/embor.2013.80; Yoshimura K, 2011, GLIA, V59, P333, DOI 10.1002/glia.21105; Yuan K, 2010, J HISTOCHEM CYTOCHEM, V58, P857, DOI 10.1369/jhc.2010.955856; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276	56	28	28	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2018	37	11					1457	1471		10.1038/s41388-017-0049-3	http://dx.doi.org/10.1038/s41388-017-0049-3			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FZ3AZ	29321663	Green Accepted, Green Submitted			2022-12-26	WOS:000427459500005
J	Mapes, J; Anandan, L; Li, QX; Neff, A; Clevenger, CV; Bagchi, IC; Bagchi, MK				Mapes, Janelle; Anandan, Lavanya; Li, Quanxi; Neff, Alison; Clevenger, Charles V.; Bagchi, Indrani C.; Bagchi, Milan K.			Aberrantly high expression of the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) in mammary epithelium leads to breast tumorigenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLAND DEVELOPMENT; TYROSINE PHOSPHORYLATION; CELL-PROLIFERATION; SIGNAL TRANSDUCER; CROHNS-DISEASE; PROLACTIN GENE; ERBB RECEPTORS; CANCER; STAT5; MOUSE	The peptide hormone prolactin (PRL) and certain members of the epidermal growth factor (EGF) family play central roles in mammary gland development and physiology, and their dysregulation has been implicated in mammary tumorigenesis. Our recent studies have revealed that the CUB and zona pellucida-like domain-containing protein 1 (CUZD1) is a critical factor for PRL-mediated activation of the transcription factor STAT5 in mouse mammary epithelium. Of note, CUZD1 controls production of a specific subset of the EGF family growth factors and consequent activation of their receptors. Here, we found that consistent with this finding, CUZD1 overexpression in non-transformed mammary epithelial HC11 cells increases their proliferation and induces tumorigenic characteristics in these cells. When introduced orthotopically in mouse mammary glands, these cells formed adenocarcinomas, exhibiting elevated levels of STAT5 phosphorylation and activation of the EGF signaling pathway. Selective blockade of STAT5 phosphorylation by pimozide, a small-molecule inhibitor, markedly reduced the production of the EGF family growth factors and inhibited PRL-induced tumor cell proliferation in vitro. Pimozide administration to mice also suppressed CUZD1-driven mammary tumorigenesis in vivo. Analysis of human MCF7 breast cancer cells indicated that CUZD1 controls the production of the same subset of EGF family members in these cells as in the mouse. Moreover, pimozide treatment reduced the proliferation of these cancer cells. Collectively, these findings indicate that overexpression of CUZD1, a regulator of growth factor pathways controlled by PRL and STAT5, promotes mammary tumorigenesis. Blockade of the STAT5 signaling pathway downstream of CUZD1 may offer a therapeutic strategy for managing these breast tumors.	[Mapes, Janelle; Anandan, Lavanya; Neff, Alison; Bagchi, Milan K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [Li, Quanxi; Bagchi, Indrani C.] Univ Illinois, Dept Comparat Biosci, Urbana, IL 61801 USA; [Clevenger, Charles V.] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA 23284 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Virginia Commonwealth University	Bagchi, MK (corresponding author), Univ Illinois, Sch Mol & Cellular Biol, 534 Burrill Hall,407 S Goodwin, Urbana, IL 61801 USA.	mbagchi@life.illinois.edu		Mapes, Janelle/0000-0002-9609-1255	Eunice Kennedy Shriver NICHD/National Institutes of Health as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research [U54 HD055787]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD055787] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD/National Institutes of Health as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Eunice Kennedy Shriver NICHD/National Institutes of Health through cooperative agreement U54 HD055787 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali S, 1998, J BIOL CHEM, V273, P7709, DOI 10.1074/jbc.273.13.7709; Arendt LM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2819; Atalay G, 2003, ANN ONCOL, V14, P1346, DOI 10.1093/annonc/mdg365; Bar-Natan M, 2012, LEUKEMIA, V26, P1407, DOI 10.1038/leu.2011.338; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; BenJonathan N, 1996, ENDOCR REV, V17, P639, DOI 10.1210/er.17.6.639; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Brink TC, 2008, CELLS TISSUES ORGANS, V188, P9, DOI 10.1159/000112843; Brisken C, 1999, DEV BIOL, V210, P96, DOI 10.1006/dbio.1999.9271; Brisken C, 2015, ENDOCRINOLOGY, V156, P3442, DOI 10.1210/en.2015-1392; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Carver KC, 2009, MOL CELL ENDOCRINOL, V307, P1, DOI 10.1016/j.mce.2009.03.014; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen DH, 1999, J BIOL CHEM, V274, P32215, DOI 10.1074/jbc.274.45.32215; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clarkson RWE, 2006, MOL ENDOCRINOL, V20, P675, DOI 10.1210/me.2005-0392; Clevenger CV, 2008, J MAMMARY GLAND BIOL, V13, P147, DOI 10.1007/s10911-008-9074-8; Clevenger CV, 1997, J MAMMARY GLAND BIOL, V2, P59, DOI 10.1023/A:1026325630359; Clevenger CV, 2009, TRENDS ENDOCRIN MET, V20, P223, DOI 10.1016/j.tem.2009.03.001; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; Creamer BA, 2010, MOL CELL BIOL, V30, P2957, DOI 10.1128/MCB.00851-09; Cui QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013180; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; DANIELSON KG, 1989, IN VITRO CELL DEV B, V25, P535; DASILVA L, 1994, J BIOL CHEM, V269, P18267; FUH G, 1995, J BIOL CHEM, V270, P13133, DOI 10.1074/jbc.270.22.13133; Gao J, 1996, MOL ENDOCRINOL, V10, P847, DOI 10.1210/me.10.7.847; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hennighausen L, 1997, J BIOL CHEM, V272, P7567, DOI 10.1074/jbc.272.12.7567; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Howell SJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2129; Huynh H, 2001, ENDOCRINOLOGY, V142, P3607, DOI 10.1210/en.142.8.3607; Hynes NE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003186; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Iavnilovitch E, 2004, INT J CANCER, V112, P607, DOI 10.1002/ijc.20484; Iavnilovitch E, 2002, MOL CANCER RES, V1, P32; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Imamura T, 2002, J BIOL CHEM, V277, P50725, DOI 10.1074/jbc.M204159200; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Kasik JW, 1998, BIOCHEM J, V330, P947; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Komorowski L, 2013, J CROHNS COLITIS, V7, P780, DOI 10.1016/j.crohns.2012.10.011; Leong CTC, 2007, ONCOGENE, V26, P870, DOI 10.1038/sj.onc.1209836; Leong CTC, 2004, ONCOGENE, V23, P5707, DOI 10.1038/sj.onc.1207754; Leung F, 2012, CLIN BIOCHEM, V45, P1543, DOI 10.1016/j.clinbiochem.2012.08.011; Li QX, 2004, J BIOL CHEM, V279, P11570, DOI 10.1074/jbc.M311773200; Liaskos C., 2013, CLIN DEV IMMUNOL, V2013; Liu XW, 1996, MOL ENDOCRINOL, V10, P1496, DOI 10.1210/me.10.12.1496; Liu XW, 1997, GENE DEV, V11, P179, DOI 10.1101/gad.11.2.179; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; Mapes J, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006654; Maskery SM, 2006, IEEE T INF TECHNOL B, V10, P497, DOI 10.1109/TITB.2005.863863; Masuda H, 2012, BREAST CANCER RES TR, V136, P331, DOI 10.1007/s10549-012-2289-9; Michaels MA, 2015, INFLAMM BOWEL DIS, V21, P2864, DOI 10.1097/MIB.0000000000000564; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Nevalainen MT, 2002, MOL ENDOCRINOL, V16, P1108, DOI 10.1210/mend.16.5.0839; Papp M, 2015, J CROHNS COLITIS, V9, P659, DOI 10.1093/ecco-jcc/jjv087; Pavlidis P, 2016, CLIN CHEM LAB MED, V54, P249, DOI 10.1515/cclm-2015-0376; Prassas I, 2014, CLIN CHEM, V60, P381, DOI 10.1373/clinchem.2013.215236; RILLEMA JA, 1994, TRENDS ENDOCRIN MET, V5, P149, DOI 10.1016/1043-2760(94)90011-6; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Rose-Hellekant TA, 2003, ONCOGENE, V22, P4664, DOI 10.1038/sj.onc.1206619; SAINSBURY JRC, 1987, LANCET, V1, P1398; Sakamoto K, 2007, MOL ENDOCRINOL, V21, P1877, DOI 10.1210/me.2006-0316; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Sato T, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-59; SCHMITT-NEY M, 1991, MOL CELL BIOL, V11, P3745, DOI 10.1128/MCB.11.7.3745; Schroeder JA, 1998, CELL GROWTH DIFFER, V9, P451; Scotti ML, 2008, BREAST CANCER RES TR, V111, P241, DOI 10.1007/s10549-007-9789-z; ShawBruha CM, 1997, BREAST CANCER RES TR, V44, P243, DOI 10.1023/A:1005879103367; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Stern DF, 2003, EXP CELL RES, V284, P89, DOI 10.1016/S0014-4827(02)00103-9; STROBL JS, 1990, CANCER RES, V50, P5399; Troyer KL, 2001, J MAMMARY GLAND BIOL, V6, P7, DOI 10.1023/A:1009560330359; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Visvader JE, 2003, INT J BIOCHEM CELL B, V35, P1034, DOI 10.1016/S1357-2725(03)00030-X; Vomachka AJ, 2000, ONCOGENE, V19, P1077, DOI 10.1038/sj.onc.1203348; Wagner KU, 2008, J MAMMARY GLAND BIOL, V13, P93, DOI 10.1007/s10911-008-9062-z; Wagner Kay-Uwe, 2011, J Carcinog, V10, P32, DOI 10.4103/1477-3163.90677; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Wiklund ED, 2010, INT J CANCER, V126, P28, DOI 10.1002/ijc.24813; Yamaji D, 2013, NUCLEIC ACIDS RES, V41, P1622, DOI 10.1093/nar/gks1310; Yamazaki K, 2006, BIOL REPROD, V75, P462, DOI 10.1095/biolreprod.105.048058; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhu BM, 2012, NUCLEIC ACIDS RES, V40, P4461, DOI 10.1093/nar/gks056	88	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 23	2018	293	8					2850	2864		10.1074/jbc.RA117.000162	http://dx.doi.org/10.1074/jbc.RA117.000162			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FX4ML	29321207	hybrid, Green Published			2022-12-26	WOS:000426051900020
J	Collaco, JM; Appel, LJ; McGready, J; Cutting, GR				Collaco, Joseph M.; Appel, Lawrence J.; McGready, John; Cutting, Garry R.			The relationship of lung function with ambient temperature	PLOS ONE			English	Article							AIR-POLLUTION; PULMONARY-FUNCTION; PHYSICAL-ACTIVITY; UNITED-STATES; EXPOSURE; HERITABILITY; POPULATION; PREVALENCE; MORTALITY; CHILDREN	Background Lung function is complex trait with both genetic and environmental factors contributing to variation. It is unknown how geographic factors such as climate affect population respiratory health. Objective To determine whether ambient air temperature is associated with lung function (FEV1) in the general population. Design/Setting Associations between spirometry data from two National Health and Nutrition Examination Survey (NHANES) periods representative of the U.S. non-institutionalized population and mean annual ambient temperature were assessed using survey-weighted multivariate regression. Participants/Measurements The NHANES III (1988-94) cohort included 14,088 individuals (55.6% female) and the NHANES 2007-12 cohort included 14,036 individuals (52.3% female), with mean ages of 37.4 +/- 23.4 and 34.4 +/- 21.8 years old and FEV1 percent predicted values of 99.8 +/- 15.8% and 99.2 +/- 14.5%, respectively. Results After adjustment for confounders, warmer ambient temperatures were associated with lower lung function in both cohorts (NHANES III p = 0.020; NHANES 2007-2012 p = 0.014). The effect was similar in both cohorts with a 0.71% and 0.59% predicted FEV1 decrease for every 10'F increase in mean temperature in the NHANES III and NHANES 2007-2012 cohorts, respectively. This corresponds to similar to 2 percent predicted difference in FEV1 between the warmest and coldest regions in the continental United States. Conclusions In the general U.S. population, residing in regions with warmer ambient air temperatures was associated with lower lung function with an effect size similar to that of traffic pollution. Rising temperatures associated with climate change could have effects on pulmonary function in the general population.	[Collaco, Joseph M.; Appel, Lawrence J.; Cutting, Garry R.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Appel, Lawrence J.; McGready, John] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Collaco, JM (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	mcollac1@jhmi.edu	Appel, Larry/GLT-2608-2022		National Institutes of Health [R01HL128475, R01DK044003]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Institutes of Health (https://projectreporter.nih.gov/ reporter.cfm) (R01HL128475 [JMC] and R01DK044003 [GRC]), which did not have any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Adam M, 2015, EUR RESPIR J, V45, P38, DOI 10.1183/09031936.00130014; Adjemian J, 2014, AM J RESP CRIT CARE, V190, P581, DOI 10.1164/rccm.201405-0884OC; [Anonymous], 1987, Am Rev Respir Dis, V136, P1285; Barone-Adesi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142565; BERKEY CS, 1986, AM J EPIDEMIOL, V123, P250, DOI 10.1093/oxfordjournals.aje.a114233; Bernstein AS, 2013, CHEST, V143, P1455, DOI 10.1378/chest.12-2384; Bowatte G, 2016, J ALLERGY CLIN IMMUN; Carlsen HK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007624; Collaco JM, 2016, J CYST FIBROS; Collaco JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027784; Czogala J, 2014, NICOTINE TOB RES, V16, P655, DOI 10.1093/ntr/ntt203; D'Amato G, 2015, MULTIDISCIP RESP MED, V10, DOI 10.1186/s40248-015-0036-x; ESCHENBACHER WL, 1992, LUNG, V170, P51, DOI 10.1007/BF00164755; Fatima SS, 2013, J PAK MED ASSOC, V63, P310; Gauderman WJ, 2007, LANCET, V369, P571, DOI 10.1016/S0140-6736(07)60037-3; GHIO AJ, 1989, CHEST, V96, P743, DOI 10.1378/chest.96.4.743; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hansel NN, 2015, CMA EVOLUTION STRATE, P1; Harris RJ, 2008, STATA J, V8, P3, DOI 10.1177/1536867X0800800102; Hukkinen M, 2011, TWIN RES HUM GENET, V14, P401, DOI 10.1375/twin.14.5.401; Kan HD, 2007, THORAX, V62, P873, DOI 10.1136/thx.2006.073015; Kosacz Nicole M., 2012, Morbidity and Mortality Weekly Report, V61, P938; Li SS, 2014, EUR RESPIR J, V43, P1059, DOI 10.1183/09031936.00079313; Li SS, 2014, ANN ALLERG ASTHMA IM, V112, P348, DOI 10.1016/j.anai.2014.01.007; Martin SL, 2005, J RURAL HEALTH, V21, P239, DOI 10.1111/j.1748-0361.2005.tb00089.x; MCCLEARN GE, 1994, J GERONTOL, V49, pM264, DOI 10.1093/geronj/49.6.M264; Miller MR, 2009, RESP MED, V103, P442, DOI 10.1016/j.rmed.2008.09.016; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mireku N, 2009, ANN ALLERG ASTHMA IM, V103, P220, DOI 10.1016/S1081-1206(10)60185-8; Moritsugu KP, 2007, AM J PREV MED, V32, P542, DOI 10.1016/j.amepre.2007.02.026; National Center for Health Statistics, SPEC WEIGHT PAR; Rice MB, 2015, AM J RESP CRIT CARE, V191, P656, DOI 10.1164/rccm.201410-1875OC; Rice MB, 2015, AM J RESP CRIT CARE; Schultzl ES, 2016, AM J RESP CRIT CARE, V193, P171, DOI 10.1164/rccm.201505-0928OC; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Shi LH, 2015, NAT CLIM CHANGE, V5, P988, DOI 10.1038/NCLIMATE2704; Singh GK, 2009, J PHYS ACT HEALTH, V6, P73, DOI 10.1123/jpah.6.1.73; Stocker T F, 2013, CLIM CHANG 2013 PHYS; von Glasow R, 2013, AMBIO, V42, P13, DOI 10.1007/s13280-012-0343-9; Voss JD, 2013, INT J OBESITY, V37, P1407, DOI 10.1038/ijo.2013.5; WANG XB, 1993, PEDIATR PULM, V15, P75, DOI 10.1002/ppul.1950150204; WHO, 2014, WHO GUID IND AIR QUA; XU XP, 1991, ARCH ENVIRON HEALTH, V46, P198, DOI 10.1080/00039896.1991.9937448; Zhai GJ, 2007, CHEST, V132, P1772, DOI 10.1378/chest.07-1438	44	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191409	10.1371/journal.pone.0191409	http://dx.doi.org/10.1371/journal.pone.0191409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346418	Green Submitted, gold, Green Published			2022-12-26	WOS:000422749500047
J	Hollingsworth, LR; Brown, AM; Gandour, RD; Bevan, DR				Hollingsworth, Louis R.; Brown, Anne M.; Gandour, Richard D.; Bevan, David R.			Computational study of HIV gp120 as a target for polyanionic entry inhibitors: Exploiting the V3 loop region	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PARTICLE MESH EWALD; PROTEIN FORCE-FIELD; CRYO-EM STRUCTURE; MOLECULAR-DYNAMICS; ENVELOPE GLYCOPROTEINS; STRUCTURAL DYNAMICS; ENV TRIMER; ANTIBODY; RECEPTOR	Multiple approaches are being utilized to develop therapeutics to treat HIV infection. One approach is designed to inhibit entry of HIV into host cells, with a target being the viral envelope glycoprotein, gp120. Polyanionic compounds have been shown to be effective in inhibiting HIV entry, with a mechanism involving electrostatic interactions with the V3 loop of gp120 being proposed. In this study, we applied computational methods to elucidate molecular interactions between the repeat unit of the precisely alternating polyanion, Poly(4,4'-stil-benedicarboxylate-alt-maleic acid) (DCSti-alt-MA) and the V3 loop of gp120 from strains of HIV against which these polyanions were previously tested (IIIb, BaL, 92UG037, JR-CSF) as well as two strains for which gp120 crystal structures are available (YU2, 2B4C). Homology modeling was used to create models of the gp120 proteins. Using monomers of the gp120 protein, we applied extensive molecular dynamics simulations to obtain dominant morphologies that represent a variety of open-closed states of the V3 loop to examine the interaction of 112 ligands of the repeating units of DCSti-alt-MA docked to the V3 loop and surrounding residues. Using the distance between the V1/V2 and V3 loops of gp120 as a metric, we revealed through MD simulations that gp120 from the lab-adapted strains (BaL and IIIb), which are more susceptible to inhibition by DCSti-alt-MA, clearly transitioned to the closed state in one replicate of each simulation set, whereas none of the replicates from the Tier II strains (92UG037 and JR-CSF) did so. Docking repeat unit microspecies to the gp120 protein before and after MD simulation enabled identification of residues that were key for binding. Notably, only a few residues were found to be important for docking both before and after MD simulation as a result of the conformational heterogeneity provided by the simulations. Consideration of the residues that were consistently involved in interactions with the ligand revealed the importance of both hydrophilic and hydrophobic moieties of the ligand for effective binding. The results also suggest that polymers of DCSti-alt-MA with repeating units of different configurations may have advantages for therapeutic efficacy.	[Hollingsworth, Louis R.] Virginia Tech, Dept Chem Engn, Blacksburg, VA USA; [Hollingsworth, Louis R.; Brown, Anne M.; Bevan, David R.] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Hollingsworth, Louis R.; Gandour, Richard D.; Bevan, David R.] Virginia Tech, Dept Chem, Blacksburg, VA USA; [Brown, Anne M.] Virginia Tech, Res & Informat, Univ Lib, Blacksburg, VA USA; [Gandour, Richard D.; Bevan, David R.] Virginia Tech, Ctr Drug Discovery, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Bevan, DR (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.; Bevan, DR (corresponding author), Virginia Tech, Ctr Drug Discovery, Blacksburg, VA USA.	drbevan@vt.edu	Gandour, Richard D./AAN-8407-2020	Gandour, Richard D./0000-0001-5941-9517; Brown, Anne M./0000-0001-6951-8228; Hollingsworth, Louis/0000-0002-4130-3580	Virginia Tech University Libraries Open Access Subvention Fund	Virginia Tech University Libraries Open Access Subvention Fund	The authors thank the Virginia Tech University Libraries Open Access Subvention Fund for supporting us to publish open access. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Advanced Research Computing and the Department of Chemistry at Virginia Tech for computing time on the BlueRidge and Cerebro computing clusters, respectively. We also thank Robert L. Fuchs (B.S.) for his contribution of coordinate files for all 112 ligands of the repeating units of DCSti-alt-MA that were used in the docking protocol. The authors thank the Virginia Tech University Libraries Open Access Subvention Fund for supporting us to publish open access. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Andrianov AM, 2017, J MOL MODEL, V23, DOI 10.1007/s00894-016-3189-4; Andrianov AM, 2015, J BIOMOL STRUCT DYN, V33, P1051, DOI 10.1080/07391102.2014.926832; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BATINIC D, 1992, J BIOL CHEM, V267, P6664; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; CALLAHAN LN, 1991, J VIROL, V65, P1543, DOI 10.1128/JVI.65.3.1543-1550.1991; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chandramouli B, 2014, J STRUCT BIOL, V186, P132, DOI 10.1016/j.jsb.2014.02.014; Chandramouli B, 2013, J BIOMOL STRUCT DYN, V31, P403, DOI 10.1080/07391102.2012.703068; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Danial M, 2015, MACROMOL BIOSCI, V15, P9, DOI 10.1002/mabi.201400298; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Deng Z, 2004, J MED CHEM, V47, P337, DOI 10.1021/jm030331x; DEVICTORIA AL, 2012, PLOS ONE, V0007; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Ellingson SR, 2015, J PHYS CHEM B, V119, P1026, DOI 10.1021/jp506511p; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Este JA, 1997, MOL PHARMACOL, V52, P98, DOI 10.1124/mol.52.1.98; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; FIESER TM, 1987, P NATL ACAD SCI USA, V84, P8568, DOI 10.1073/pnas.84.23.8568; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Gordts SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131219; Guttman M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7144; Guttman M, 2014, STRUCTURE, V22, P974, DOI 10.1016/j.str.2014.05.001; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Herschhorn A, 2016, MBIO, V7, DOI 10.1128/mBio.01598-16; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Karim SSA, 2011, AIDS, V25, P957, DOI 10.1097/QAD.0b013e32834541d9; Kolchinsky P, 2001, J VIROL, V75, P2041, DOI 10.1128/JVI.75.5.2041-2050.2001; Kong L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12040; Kong R, 2016, SCIENCE, V352, P828, DOI 10.1126/science.aae0474; LaLonde JM, 2013, ACS MED CHEM LETT, V4, P338, DOI 10.1021/ml300407y; Lee JH, 2016, SCIENCE, V351, P1043, DOI 10.1126/science.aad2450; Li L, 2013, J MOL MODEL, V19, P905, DOI 10.1007/s00894-012-1619-5; Li Y, 2013, J POLYM SCI POL PHYS, V51, P1565, DOI 10.1002/polb.23370; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu QB, 2017, NAT STRUCT MOL BIOL, V24, P370, DOI 10.1038/nsmb.3382; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; McCormack S, 2010, LANCET, V376, P1329, DOI 10.1016/S0140-6736(10)61086-0; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Meyerson JR, 2013, P NATL ACAD SCI USA, V110, P513, DOI 10.1073/pnas.1214810110; MIERTUS S, 1981, CHEM PHYS, V55, P117, DOI 10.1016/0301-0104(81)85090-2; Molecular Operating Environment (MOE), 2016, 1010 SHERB W SUIT 91; Moraca F, 2016, J CHEM INF MODEL, V56, P2069, DOI 10.1021/acs.jcim.6b00393; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Munro JB, 2015, J VIROL, V89, P5752, DOI 10.1128/JVI.03187-14; Munro JB, 2014, SCIENCE, V346, P759, DOI 10.1126/science.1254426; Neurath AR, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-17; Ozorowski G, 2017, NATURE, V547, P360, DOI 10.1038/nature23010; Pall S., 2014, SOLVING SOFTWARE CHA, P3; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pirrone V, 2011, ANTIVIR RES, V90, P168, DOI 10.1016/j.antiviral.2011.03.176; Prevost J, 2017, J VIROLOGY, V91; Pugach P, 2015, J VIROL, V89, P3380, DOI 10.1128/JVI.03473-14; Rasheed M, 2015, STRUCTURE, V23, P1138, DOI 10.1016/j.str.2015.03.026; Resch W, 2001, VIROLOGY, V288, P51, DOI 10.1006/viro.2001.1087; Rohan LC, 2007, J INFECT DIS, V196, P1285, DOI 10.1086/522610; Sabbagh R, 2016, SEP PURIF TECHNOL, V163, P341, DOI 10.1016/j.seppur.2016.03.009; Sang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104714; SATTENTAU QJ, 1993, J VIROL, V67, P7383, DOI 10.1128/JVI.67.12.7383-7393.1993; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; Savage AM, 2014, J MED CHEM, V57, P6354, DOI 10.1021/jm401913w; Schmidt JRP, 2013, W F WEBMO ENTERPRISE; Schrodinger, 2017, REL 2017 1; Schrodinger LLC, 2015, JYMOL MOL GRAPH DEV; SHIODA T, 1992, P NATL ACAD SCI USA, V89, P9434, DOI 10.1073/pnas.89.20.9434; Shrivastava IH, 2012, BIOCHEMISTRY-US, V51, P7783, DOI 10.1021/bi300878d; Singh J, 2006, CHEM BIOL DRUG DES, V67, P5, DOI 10.1111/j.1747-0285.2005.00323.x; Spyrakis F, 2015, J CHEM INF MODEL, V55, P2256, DOI 10.1021/acs.jcim.5b00169; STAMATATOS L, 1993, J VIROL, V67, P5635, DOI 10.1128/JVI.67.9.5635-5639.1993; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Veillette M, 2015, J VIROL, V89, P545, DOI 10.1128/JVI.02868-14; Wang HQ, 2016, P NATL ACAD SCI USA, V113, pE7151, DOI 10.1073/pnas.1615939113; Wood NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080301; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yokoyama M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037530; Yuan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069789; Yuan Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065115; Zhao Q, 2005, VIROLOGY, V339, P213, DOI 10.1016/j.virol.2005.06.008	99	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190658	10.1371/journal.pone.0190658	http://dx.doi.org/10.1371/journal.pone.0190658			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346393	Green Submitted, Green Published, gold			2022-12-26	WOS:000422749500017
J	Radovich, E; el-Shitany, A; Sholkamy, H; Benova, L				Radovich, Emma; el-Shitany, Atef; Sholkamy, Hania; Benova, Lenka			Rising up: Fertility trends in Egypt before and after the revolution	PLOS ONE			English	Article							REPLACEMENT FERTILITY; TRANSITION; WORLD	In 2014, Egypt's Demographic and Health Survey (EDHS) documented an increase in the total fertility rate (TFR) to 3.5, up from a low of 3.0 recorded by the 2008 EDHS. The increase has been anecdotally attributed to the social upheaval following Egypt's January 2011 revolution, but little is known about when fertility first began to increase and among which sub-groups of women. Using birth histories from seven rounds of EDHS (1992-2014), this study reconstructed fertility rates for single years from 1990-2013 and examined patterns of childbearing in five-year birth cohorts of women. We found that the decline in fertility reversed in 2007, earlier than postulated, plateaued and then increased again in 2013. The increase in TFR coincided with a convergence of fertility rates across education levels, and there is evidence of a shift toward childbearing at younger ages among more educated women, which may be inflating period measures of fertility.	[Radovich, Emma; Benova, Lenka] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [el-Shitany, Atef] Minist Hlth & Populat, Populat & Family Planning Div, Cairo, Egypt; [Sholkamy, Hania] Amer Univ Cairo, Social Res Ctr, Cairo, Egypt	University of London; London School of Hygiene & Tropical Medicine; Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Egyptian Knowledge Bank (EKB); American University Cairo	Radovich, E (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England.	emma.radovich@lshtm.ac.uk	sholkamy, hania/F-5423-2019	Radovich, Emma/0000-0002-8975-8015				[Anonymous], 2006, DEMOGRAPHIC REVOLUTI; [Anonymous], 2015, ECONOMIST; [Anonymous], 2017, WORLD POPULATION PRO; [Anonymous], 2014, GUARDIAN; Baschieri A, 2007, DEMOGR RES, V16, P59, DOI 10.4054/DemRes.2007.16.3; Bongaarts J, 2003, POP STUD-J DEMOG, V57, P321, DOI 10.1080/0032472032000137835; Bongaarts J, 1998, POPUL DEV REV, V24, P271, DOI 10.2307/2807974; Bongaarts J, 2002, POPUL DEV REV, V28, P419, DOI 10.1111/j.1728-4457.2002.00419.x; Cetorelli V, 2014, POPUL DEV REV, V40, P581, DOI 10.1111/j.1728-4457.2014.00001.x; Courbage Y., 2015, DIFI FAM RES P; El-Zanaty F, 1993, EGYPT DEMOGRAPHIC HL; El-Zanaty F., 2001, EGYPT DEMOGRAPHIC HL; El-Zanaty F. H., 2004, EGYPT INTERIM DEMOGR; El-Zeini LO, 2008, STUD FAMILY PLANN, V39, P161, DOI 10.1111/j.1728-4465.2008.164.x; Eltigani EE, 2001, STUD FAMILY PLANN, V32, P17, DOI 10.1111/j.1728-4465.2001.00017.x; Eltigani EE, 2009, STUD FAMILY PLANN, V40, P215, DOI 10.1111/j.1728-4465.2009.00204.x; Fahim Kareem, 2013, NY TIMES; Hendy R., 2015, WORKING PAPERS, V907; Krafft C., 2016, WHY IS FERTILITY RIS; Krafft C, 2015, BEWARE ECHO IMPENDIN; LaGraffe D., 2012, J STRATEGIC SECURITY, V5, P65, DOI [10.5038/1944-0472.5.2.4, DOI 10.5038/1944-0472.5.2.4]; Pullum T. W., 2006, ASSESSMENT AGE DATE; Ren R., NOTE DHS STANDARD WE; Riggs-Perla J, 2011, EGYPT HLTH POPULATIO, V1; Roudi-Fahimi Farzaneh, 2005, MARRIAGE ARAB WORLD; Rutstein SO, 2006, GUIDE DHS STAT; Salem R., 2015, CHANGES I MARRIAGE E; Schoumaker B., 2014, QUALITY CONSISTENCY, V12; Schoumaker B, 2013, DEMOGR RES, V28, P1093, DOI 10.4054/DemRes.2013.28.38; The World Bank, 2010, MIDDL E N AFR WOM WO; United Nations, 2013, WORLD POP AG 2013; Vignoli D., 2006, DEMOGR RES, P15; Youssef H, 2014, RESPONDING RAPID POP; Zaky, 2013, COMP ANAL FERTILITY	34	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190148	10.1371/journal.pone.0190148	http://dx.doi.org/10.1371/journal.pone.0190148			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS9PC	29346389	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000422749500008
J	Hassan, MK; Kumar, D; Naik, M; Dixit, M				Hassan, Md. Khurshidul; Kumar, Dinesh; Naik, Monali; Dixit, Manjusha			The expression profile and prognostic significance of eukaryotic translation elongation factors in different cancers	PLOS ONE			English	Article							TRANSFER-RNA-SYNTHETASE; GAMMA-RELATED SEQUENCE; FACTOR 1 ALPHA-2; FACTOR EEF1A2; FACTOR-I; PROTEIN-SYNTHESIS; DOWN-REGULATION; UP-REGULATION; FACTOR EEF2; OVEREXPRESSION	Eukaryotic translation factors, especially initiation factors have garnered much attention with regards to their role in the onset and progression of different cancers. However, the expression levels and prognostic significance of translation elongation factors remain poorly explored in different cancers. In this study, we have investigated the mRNA transcript levels of seven translation elongation factors in different cancer types using Oncomine and TCGA databases. Furthermore, we have identified the prognostic significance of these factors using Kaplan-Meier Plotter and SurvExpress databases. We observed altered expression levels of all the elongation factors in different cancers. Higher expression of EEF1A2, EEF1 B2, EEF1G, EEF1 D, EEF1 El and EEF2 was observed in most of the cancer types, whereas reverse trend was observed for EEF1A1. Overexpression of many factors predicted poor prognosis in breast (EEF1 D, EEF1 El, EEF2) and lung cancer (EEF1A2, EEF1 B2, EEF1G, EEF1 El). However, we didn't see any common correlation of expression levels of elongation factors with survival outcomes across cancer types. Cancer subtype stratification showed association of survival outcomes and expression levels of elongation factors in specific sub-types of breast, lung and gastric cancer. Most interestingly, we observed a reciprocal relationship between the expression levels of the two EEF1A isoforms viz. EEF1A1 and EEF1A2, in most of the cancer types. Our results suggest that translation elongation factors can have a role in tumorigenesis and affect survival in cancer specific manner. Elongation factors have potential to serve as biomarkers and therapeutic drug targets, yet further study is required. Reciprocal relationship of differential expression between EEF1A isoforms observed in multiple cancer types indicates opposing roles in cancer and needs further investigation.	[Hassan, Md. Khurshidul; Kumar, Dinesh; Naik, Monali; Dixit, Manjusha] HBNI, Sch Biol Sci, Natl Inst Sci Educ & Res, Khurja, Odisha, India	Homi Bhabha National Institute; National Institute of Science Education & Research (NISER)	Dixit, M (corresponding author), HBNI, Sch Biol Sci, Natl Inst Sci Educ & Res, Khurja, Odisha, India.	manjusha@niser.ac.in	Kalra, D/H-6661-2019; Dixit, Manjusha/Y-9892-2019	Kalra, D/0000-0001-5254-4067; Dixit, Manjusha/0000-0002-6997-1054; Hassan, Mohammed Khurshidul/0000-0002-4526-4849; Kumar, Dinesh/0000-0002-3890-326X				Abba MC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-37; Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Anand N, 2002, NAT GENET, V31, P301, DOI 10.1038/ng904; Borradaile NM, 2006, MOL BIOL CELL, V17, P770, DOI 10.1091/mbc.E05-08-0742; Byun HO, 2009, CANCER RES, V69, P4638, DOI 10.1158/0008-5472.CAN-08-4042; Chang YWE, 1997, J BIOL CHEM, V272, P28252, DOI 10.1074/jbc.272.45.28252; Chen E, 2000, EXP CELL RES, V259, P140, DOI 10.1006/excr.2000.4952; CHI KF, 1992, GASTROENTEROLOGY, V103, P98, DOI 10.1016/0016-5085(92)91101-9; De Bortoli M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-223; Dreos R, NUCL ACIDS RES, V41, pD157; Duanmin H, HEPATOGASTROENTEROLO, V60, P870; Duttaroy A, 1998, EXP CELL RES, V238, P168, DOI 10.1006/excr.1997.3819; Flores IL, 2016, CLIN SCI, V130, P785, DOI 10.1042/CS20150646; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; HASSELL JA, 1976, BIOCHEMISTRY-US, V15, P1375, DOI 10.1021/bi00652a004; Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528; Iadevaia V, 2008, RNA, V14, P1730, DOI 10.1261/rna.1037108; Johnsson A, 2000, BRIT J CANCER, V83, P1047, DOI 10.1054/bjoc.2000.1420; Joseph P, 2004, MOL CARCINOGEN, V40, P171, DOI 10.1002/mc.20033; Kawamura M, 2014, ANTICANCER RES, V34, P651; Kim SS, 2011, TUMORI, V97, P380, DOI 10.1700/912.10038; Kobayashi Y, 2009, CELL DEATH DIFFER, V16, P139, DOI 10.1038/cdd.2008.136; Kulkarni G, 2007, BREAST CANCER RES TR, V102, P31, DOI 10.1007/s10549-006-9315-8; Lamberti A, 2007, CELL DEATH DIFFER, V14, P952, DOI 10.1038/sj.cdd.4402102; Lee Jonathan M, 2003, Reprod Biol Endocrinol, V1, P69, DOI 10.1186/1477-7827-1-69; LEW Y, 1992, PANCREAS, V7, P144, DOI 10.1097/00006676-199203000-00003; LI ZB, 2010, PLOS ONE, P1, DOI DOI 10.1371/J0URNAL.P0NE.0010755; Madhavan S, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0150-9; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MIMORI K, 1995, CANCER, V75, P1446, DOI 10.1002/1097-0142(19950315)75:6+<1446::AID-CNCR2820751509>3.0.CO;2-P; Nakamura J, 2009, INT J ONCOL, V34, P1181, DOI 10.3892/ijo_00000246; Newbery HJ, 2007, J BIOL CHEM, V282, P28951, DOI 10.1074/jbc.M703962200; Newbery HJ, 2011, BIOCHEM BIOPH RES CO, V411, P19, DOI 10.1016/j.bbrc.2011.06.062; Oji Y, 2014, INT J ONCOL, V44, P1461, DOI 10.3892/ijo.2014.2318; Pain VM, 1996, EUR J BIOCHEM, V236, P747, DOI 10.1111/j.1432-1033.1996.00747.x; Pan J, 2004, DEV BRAIN RES, V149, P1, DOI 10.1016/j.devbrainres.2003.10.011; Pinke DE, 2008, GYNECOL ONCOL, V108, P561, DOI 10.1016/j.ygyno.2007.11.019; Pott LL, 2017, ONCOTARGET, V8, P11950, DOI 10.18632/oncotarget.14447; Qiu FN, 2016, WORLD J GASTROENTERO, V22, P4226, DOI 10.3748/wjg.v22.i16.4226; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ruest LB, 2002, J BIOL CHEM, V277, P5418, DOI 10.1074/jbc.M110685200; Scaggiante B, 2012, BRIT J CANCER, V106, P166, DOI 10.1038/bjc.2011.500; Spilka R, 2013, CANCER LETT, V340, P9, DOI 10.1016/j.canlet.2013.06.019; Sun HG, 2013, ASIAN PAC J CANCER P, V14, P6533, DOI 10.7314/APJCP.2013.14.11.6533; Sun Y, 2014, BIOCHEM BIOPH RES CO, V450, P1, DOI 10.1016/j.bbrc.2014.05.045; Talapatra S, 2002, CELL DEATH DIFFER, V9, P856, DOI 10.1038/sj.cdd.4401078; Talukder AH, 2001, J BIOL CHEM, V276, P5636, DOI 10.1074/jbc.M006824200; Thornton S, 2003, J MOL MED, V81, P536, DOI 10.1007/s00109-003-0461-8; VENEMA RC, 1991, J BIOL CHEM, V266, P11993; Xu C, 2013, CLIN EXP METASTAS, V30, P933, DOI 10.1007/s10585-013-9593-6; Yang S, 2015, J CANCER RES CLIN, V141, P1265, DOI 10.1007/s00432-014-1897-7; Zang WQ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0315-3	52	52	55	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191377	10.1371/journal.pone.0191377	http://dx.doi.org/10.1371/journal.pone.0191377			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342219	Green Published, Green Submitted, gold			2022-12-26	WOS:000422653800068
J	Nycz, BT; Dominguez, SR; Friedman, D; Hilden, JM; Ir, D; Robertson, CE; Frank, DN				Nycz, Bryan T.; Dominguez, Samuel R.; Friedman, Deborah; Hilden, Joanne M.; Ir, Diana; Robertson, Charles E.; Frank, Daniel N.			Evaluation of bloodstream infections, Clostridium difficile infections, and gut microbiota in pediatric oncology patients	PLOS ONE			English	Article							RISK-FACTORS; BURDEN; EPIDEMIOLOGY; HOSPITALS; SOFTWARE; CHILDREN; HEALTH	Bloodstream infections (BSI) and Clostridium difficile infections (CDI) in pediatric oncology/hematology/bone marrow transplant (BMT) populations are associated with significant morbidity and mortality. The objective of this study was to explore possible associations between altered microbiome composition and the occurrence of BSI and CDI in a cohort of pediatric oncology patients. Stool samples were collected from all patients admitted to the pediatric oncology floor from Oct.-Dec. 2012. Bacterial profiles from patient stools were determined by bacterial 16S rRNA gene profiling. Differences in overall microbiome composition were assessed by a permutation-based multivariate analysis of variance test, while differences in the relative abundances of specific taxa were assessed by Kruskal-Wallis tests. At admission, 9 of 42 patients (21%) were colonized with C. difficile, while 6 of 42 (14%) subsequently developed a CDI. Furthermore, 3 patients (7%) previously had a BSI and 6 patients (14%) subsequently developed a BSI. Differences in overall microbiome composition were significantly associated with disease type (p = 0.0086), chemotherapy treatment (p = 0.018), BSI following admission from any cause (p < 0.0001) or suspected gastrointestinal organisms (p = 0.00043). No differences in baseline microbiota were observed between individuals who did or did not subsequently develop C. difficile infection. Additionally, multiple bacterial groups varied significantly between subjects with post-admission BSI compared with no BSI. Our results suggest that differences in gut microbiota not only are associated with type of cancer and chemotherapy, but may also be predictive of subsequent bloodstream infection.	[Nycz, Bryan T.; Ir, Diana; Robertson, Charles E.; Frank, Daniel N.] Univ Colorado, Div Adult Infect Dis, Sch Med, Aurora, CO 80045 USA; [Dominguez, Samuel R.] Univ Colorado, Div Pediat Infect Dis, Sch Med, Aurora, CO 80045 USA; [Friedman, Deborah] Childrens Hosp Colorado, Dept Epidemiol, Aurora, CO USA; [Hilden, Joanne M.] Childrens Hosp Colorado, Ctr Blood & Canc Disorders, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Children's Hospital Colorado	Frank, DN (corresponding author), Univ Colorado, Div Adult Infect Dis, Sch Med, Aurora, CO 80045 USA.; Dominguez, SR (corresponding author), Univ Colorado, Div Pediat Infect Dis, Sch Med, Aurora, CO 80045 USA.	Samuel.Dominguez@childrenscolorado.org; daniel.frank@ucdenver.edu		ROBERTSON, CHARLES/0000-0002-4136-4121	American Medical Association (AMA) Foundation; Seed Grant Research Program; Infectious Disease Society of America (IDSA) Education and Research Foundation; Medical Scholar program; University of Colorado School of Medicine Medical Student Research Track; University of Colorado School of Medicine Department of Medicine Research and Equity in Academic Medicine (DREAM) Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	American Medical Association (AMA) Foundation; Seed Grant Research Program; Infectious Disease Society of America (IDSA) Education and Research Foundation; Medical Scholar program; University of Colorado School of Medicine Medical Student Research Track; University of Colorado School of Medicine Department of Medicine Research and Equity in Academic Medicine (DREAM) Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Bryan T. Nycz received funding from the following: 1. American Medical Association (AMA) Foundation. 2016 Seed Grant Research Program (no grant number). https://www.ama.-assn.org/2. Infectious Disease Society of America (IDSA) Education and Research Foundation. 2015 Medical Scholar program (no grant number). http://www.Idsociety.org/Medical_Scholors_Program/3. University of Colorado School of Medicine Medical Student Research Track (no grant number), http://www.ucdenver.edu/academics/colleges/medicalschool/education/degree_programs/MDProgram/longitudinal/tracks/researchtrack/Pages/default.aspx 4. University of Colorado School of Medicine Department of Medicine Research and Equity in Academic Medicine (DREAM) Program (no grant number). http://www.ucdenver.edu/academics/colleges/medicalschool/departments/medicine/pages/DREAM-Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano M, 2016, NAT REV UROL, V13, P77, DOI 10.1038/nrurol.2015.292; Brumbaugh DE, 2016, J PEDIATR GASTR NUTR, V63, P320, DOI 10.1097/MPG.0000000000001124; Bultman SJ, 2014, CARCINOGENESIS, V35, P249, DOI 10.1093/carcin/bgt392; Bultman SJ., 2016, SEMINARS ONCOLOGY; Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743; Dantes R, 2016, AM J INFECT CONTROL, V44, P138, DOI 10.1016/j.ajic.2015.09.004; de Blank P, 2013, J PEDIATR-US, V163, P699, DOI 10.1016/j.jpeds.2013.01.062; Dinh DM, 2015, J INFECT DIS, V211, P19, DOI 10.1093/infdis/jiu409; Dominguez SR, 2014, CLIN INFECT DIS, V59, P401, DOI 10.1093/cid/ciu302; Dominguez SR, 2015, J PEDIAT INFECT DIS; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; El Feghaly RE, 2013, J PEDIATR GASTR NUTR, V57, P813, DOI 10.1097/MPG.0b013e3182a3202f; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Frank DN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131944; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Galloway-Pena J, 2017, TRENDS MICROBIOL, V25, P992, DOI 10.1016/j.tim.2017.06.006; Gaur AH, 2015, INFECT CONT HOSP EP, V34, P315; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kelly DL, 2016, CANCER NURS, V39, pE56, DOI 10.1097/NCC.0000000000000286; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Kim J, 2012, PEDIATR INFECT DIS J, V31, P134, DOI 10.1097/INF.0b013e3182352e2c; Kim J, 2008, PEDIATRICS, V122, P1266, DOI 10.1542/peds.2008-0469; Kwa M, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw029; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Magurran AE, 2013, MEASURING BIOL DIVER; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; McDonald L. Clifford, 2012, Morbidity and Mortality Weekly Report, V61, P157; Montassier E, 2015, ALIMENT PHARM THER, V42, P515, DOI 10.1111/apt.13302; Needell JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183786; Needell JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173968; Ohtani N, 2015, MICROBIOME CANC SEMI; Price V, 2013, PEDIATR INFECT DIS J, V32, P610, DOI 10.1097/INF.0b013e31828690a4; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Development Core Team, 2014, R LANG ENV STAT COMP; Rajagopala SV, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2965-y; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Rogers AEJ, 2016, PEDIAT BLOOD CANC; Rogers AEJ, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26254; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Schloss PD, 2007, ANNU REV MICROBIOL, V61, P23, DOI 10.1146/annurev.micro.61.011507.151712; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Seekatz AM, 2014, J CLIN INVEST, V124, P4182, DOI 10.1172/JCI72336; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shah DN, 2016, J HOSP INFECT, V93, P286, DOI 10.1016/j.jhin.2016.04.004; Simon A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-70; Son JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127985; Tai E, 2011, PEDIATR INFECT DIS J, V30, P610, DOI 10.1097/INF.0b013e31820970d1; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; van Vliet MJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000879; Vogtmann E, 2016, BRIT J CANC; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102116; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yang L, 2015, ENCY METAGENOMICS EN, P379	62	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0191232	10.1371/journal.pone.0191232	http://dx.doi.org/10.1371/journal.pone.0191232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329346	Green Published, Green Submitted, gold			2022-12-26	WOS:000419954100053
J	Zhu, HH; Zhang, SL; Sha, QY				Zhu, Huanhuan; Zhang, Shuanglin; Sha, Qiuying			A novel method to test associations between a weighted combination of phenotypes and genetic variants	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OBSTRUCTIVE PULMONARY-DISEASE; POPULATION STRATIFICATION; MULTIPLE PHENOTYPES; CORRELATED TRAITS; MULTIVARIATE PHENOTYPES; STRUCTURED POPULATIONS; PRINCIPAL-COMPONENTS; SEMIPARAMETRIC TEST; JOINT ANALYSIS	Many complex diseases like diabetes, hypertension, metabolic syndrome, et cetera, are measured by multiple correlated phenotypes. However, most genome-wide association studies (GWAS) focus on one phenotype of interest or study multiple phenotypes separately for identifying genetic variants associated with complex diseases. Analyzing one phenotype or the related phenotypes separately may lose power due to ignoring the information obtained by combining phenotypes, such as the correlation between phenotypes. In order to increase statistical power to detect genetic variants associated with complex diseases, we develop a novel method to test a weighted combination of multiple phenotypes (WCmulP). We perform extensive simulation studies as well as real data (COPDGene) analysis to evaluate the performance of the proposed method. Our simulation results show that WCmulP has correct type I error rates and is either the most powerful test or comparable to the most powerful test among the methods we compared. WCmulP also has an outstanding performance for identifying single-nucleotide polymorphisms (SNPs) associated with COPD-related phenotypes.	[Zhu, Huanhuan; Zhang, Shuanglin; Sha, Qiuying] Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA	Michigan Technological University	Sha, QY (corresponding author), Michigan Technol Univ, Dept Math Sci, Houghton, MI 49931 USA.	qsha@mtu.edu			National Human Genome Research Institute of the National Institutes of Health [R15HG008209]; NIH [U01HL089856, U01HL089897]; COPD Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL089856, U01HL089897] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R15HG008209] Funding Source: NIH RePORTER	National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COPD Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by the National Human Genome Research Institute of the National Institutes of Health under Award Number R15HG008209 to QS and SZ. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research used data generated by the COPDGene study, which was supported by NIH grants U01HL089856 and U01HL089897. The COPDGene project is also supported by the COPD Foundation through contributions made by an Industry Advisory Board comprised of Pfizer, AstraZeneca, Boehringer Ingelheim, Novartis, and Sunovion.	Ali AMG, 2011, BRIT J CANCER, V104, P693, DOI 10.1038/sj.bjc.6606078; Aschard H, 2014, AM J HUM GENET, V94, P662, DOI 10.1016/j.ajhg.2014.03.016; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Carlin J, 2015, HANDBOOK OF MISSING; Carpenter J., 2012, MULTIPLE IMPUTATION, DOI DOI 10.1002/9781119942283; Casale FP, 2015, NAT METHODS, V12, P755, DOI [10.1038/nmeth.3439, 10.1038/NMETH.3439]; Chen HS, 2003, ANN HUM GENET, V67, P250, DOI 10.1046/j.1469-1809.2003.00036.x; Cho MH, 2014, LANCET RESP MED, V2, P214, DOI 10.1016/S2213-2600(14)70002-5; Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Cui K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102324; Dahl A, 2016, NAT GENET, V48, P466, DOI 10.1038/ng.3513; De Silva AP, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0372-y; Ferreira MAR, 2009, BIOINFORMATICS, V25, P132, DOI 10.1093/bioinformatics/btn563; Gavish B, 2008, J HYPERTENS, V26, P199, DOI 10.1097/HJH.0b013e3282f25b5a; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hoffman GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075707; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Klei L, 2008, GENET EPIDEMIOL, V32, P9, DOI 10.1002/gepi.20257; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lee JH, 2015, AM J RESP CELL MOL, V52, P365, DOI 10.1165/rcmb.2014-0210OC; Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296; Li XN, 2011, J ALLERGY CLIN IMMUN, V127, P1457, DOI 10.1016/j.jaci.2011.01.056; Liang XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34323; Liu L, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-132; Lutz SM, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0299-4; Majumdar A, 2015, GENET EPIDEMIOL, V39, P635, DOI 10.1002/gepi.21930; O'Reilly PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034861; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Yang Q, 2012, J PROBAB STAT, V2012, DOI 10.1155/2012/652569; Raghunathan TE, 2001, SURV METHODOL, V27, P85; Ray D, 2016, GENET EPIDEMIOL, V40, P20, DOI 10.1002/gepi.21937; Regan EA, 2010, COPD, V7, P32, DOI 10.3109/15412550903499522; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Sha QY, 2012, GENET EPIDEMIOL, V36, P561, DOI 10.1002/gepi.21649; Sha QY, 2011, GENET EPIDEMIOL, V35, P350, DOI 10.1002/gepi.20583; Sun JP, 2016, EUR J HUM GENET, V24, P1344, DOI 10.1038/ejhg.2016.8; Teer JK, 2010, HUM MOL GENET, V19, pR145, DOI 10.1093/hmg/ddq333; Van Buuren S, 2006, J STAT COMPUT SIM, V76, P1049, DOI 10.1080/10629360600810434; van der Sluis S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003235; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Wang ZC, 2016, ANN HUM GENET, V80, P162, DOI 10.1111/ahg.12149; Wang ZC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150975; Wilk JB, 2012, AM J RESP CRIT CARE, V186, P622, DOI 10.1164/rccm.201202-0366OC; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Yan T, 2013, GENET EPIDEMIOL, V37, P571, DOI 10.1002/gepi.21738; Yang JJ, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0868-6; Yang QO, 2010, GENET EPIDEMIOL, V34, P444, DOI 10.1002/gepi.20497; Young RP, 2010, EUR RESPIR J, V36, P1375, DOI 10.1183/09031936.00033310; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zhang J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-158; Zhang SL, 2003, GENET EPIDEMIOL, V24, P44, DOI 10.1002/gepi.10196; Zhang YW, 2014, NEUROIMAGE, V96, P309, DOI 10.1016/j.neuroimage.2014.03.061; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/nmeth.2848, 10.1038/NMETH.2848]; Zhu AZX, 2014, CLIN PHARMACOL THER, V96, P256, DOI 10.1038/clpt.2014.88; Zhu HH, 2015, HUM HERED, V80, P144, DOI 10.1159/000446239; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210; Zhu XF, 2015, AM J HUM GENET, V96, P21, DOI 10.1016/j.ajhg.2014.11.011	66	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 12	2018	13	1							e0190788	10.1371/journal.pone.0190788	http://dx.doi.org/10.1371/journal.pone.0190788			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BY	29329304	Green Submitted, Green Published, gold			2022-12-26	WOS:000419954100022
J	Choi, HMC; Cheing, AKK; Ng, GYF; Cheing, GLY				Choi, Harry M. C.; Cheing, Alex K. K.; Ng, Gabriel Y. F.; Cheing, Gladys L. Y.			Effects of pulsed electromagnetic field (PEMF) on the tensile biomechanical properties of diabetic wounds at different phases of healing	PLOS ONE			English	Article							CELL-PROLIFERATION; MAGNETIC-FIELDS; GENE-EXPRESSION; FOOT ULCERS; IN-VITRO; RATS; SKIN; TISSUE; FGF-2; REGENERATION	The present study investigated the effects of pulsed electromagnetic field (PEMF) on the tensile biomechanical properties of diabetic wounds at different phases of healing. Two intensities of PEMF were adopted for comparison. We randomly assigned 111 10-week-old male streptozotocin-induced diabetic Sprague-Dawley rats to two PEMF groups and a sham control group. Six-millimetre biopsy punched full thickness wounds were made on the lateral side of their hindlimbs. The PEMF groups received active PEMF delivered at 25 Hz with intensity of either 2 mT or 10 mT daily, while the sham group was handled in a similar way except they were not exposed to PEMF. Wound tissues were harvested for tensile testing on post-wounding days 3, 5, 7, 10, 14 and 21. Maximum load, maximum stress, energy absorption capacity, Young's modulus and thickness of wound tissue were measured. On post-wounding day 5, the PEMF group that received 10-mT intensity had significantly increased energy absorption capacity and showed an apparent increase in the maximum load. However, the 10-mT PEMF group demonstrated a decrease in Young's modulus on day 14. The 10-mT PEMF groups showed a significant increase in the overall thickness of wound tissue whereas the 2-mT group showed a significant decrease in the overall maximum stress of the wounds tissue. The present findings demonstrated that the PEMF delivered at 10 mT can improve energy absorption capacity of diabetic wounds in the early healing phase. However, PEMF (both 2-mT and 10-mT) seemed to impair the material properties (maximum stress and Young's modulus) in the remodelling phase. PEMF may be a useful treatment for promoting the recovery of structural properties (maximum load and energy absorption capacity), but it might not be applied at the remodelling phase to avoid impairing the recovery of material properties.	[Choi, Harry M. C.; Cheing, Alex K. K.; Ng, Gabriel Y. F.; Cheing, Gladys L. Y.] Hong Kong Polytech Univ, Fac Hlth & Social Sci, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University	Cheing, GLY (corresponding author), Hong Kong Polytech Univ, Fac Hlth & Social Sci, Dept Rehabil Sci, Kowloon, Hong Kong, Peoples R China.	Gladys.cheing@polyu.edu.hk		CHEING, Gladys/0000-0001-9975-8193; Cheung, Kwok Kuen/0000-0001-7367-9171; Choi, Harry/0000-0002-6113-9773; Cheing, Gladys/0000-0001-7615-8590	General Research Fund, Research Grants Council, Hong Kong [PolyU 5602/13M, PolyU 151003/14M]	General Research Fund, Research Grants Council, Hong Kong	The study was funded by General Research Fund, Research Grants Council, Hong Kong (PolyU 5602/13M and PolyU 151003/14M), which was received by GLYC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athanasiou A, 2007, BIOELECTROMAGNETICS, V28, P362, DOI 10.1002/bem.20303; Baptista AF, 2009, J PERIPHER NERV SYST, V14, P285, DOI 10.1111/j.1529-8027.2009.00240.x; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Callaghan MJ, 2008, PLAST RECONSTR SURG, V121, P130, DOI 10.1097/01.prs.0000293761.27219.84; Cheing GLY, 2014, BIOELECTROMAGNETICS, V35, P161, DOI 10.1002/bem.21832; Choi MC, 2016, ARCH DERMATOL RES, V308, P21, DOI 10.1007/s00403-015-1604-9; Ding S, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-215; GLASSMAN LS, 1986, ANN PLAS SURG, V16, P287, DOI 10.1097/00000637-198604000-00004; Goudarzi I, 2010, BIOELECTROMAGNETICS, V31, P318, DOI 10.1002/bem.20567; He ZM, 2018, BONE, V106, P194, DOI 10.1016/j.bone.2017.09.020; Jasti A C, 2001, Biomed Sci Instrum, V37, P209; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Kwan RLC, 2015, ADV SKIN WOUND CARE, V28, P212, DOI 10.1097/01.ASW.0000462012.58911.53; Madry H, 2013, AM J SPORT MED, V41, P194, DOI 10.1177/0363546512465840; Matic M, 2009, LASER MED SCI, V24, P321, DOI 10.1007/s10103-008-0564-0; McGaughey H, 2009, PHYS THER REV, V14, P132, DOI 10.1179/174328809X435231; Nassar D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037084; Ng GYF, 2011, CONNECT TISSUE RES, V52, P466, DOI 10.3109/03008207.2011.562334; Ng GYF, 2004, ULTRASOUND MED BIOL, V30, P1539, DOI 10.1016/j.ultrasmedbio.2004.08.030; OTTANI V, 1988, BIOELECTROMAGNETICS, V9, P53, DOI 10.1002/bem.2250090105; Patino Osvaldo, 1996, Journal of Burn Care and Rehabilitation, V17, P528, DOI 10.1097/00004630-199611000-00009; Pilla A, 2011, BBA-GEN SUBJECTS, V1810, P1236, DOI 10.1016/j.bbagen.2011.10.001; Sarma G R, 1997, Indian J Lepr, V69, P241; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; STILLER MJ, 1992, BRIT J DERMATOL, V127, P147, DOI 10.1111/j.1365-2133.1992.tb08047.x; Strauch B, 2007, PLAST RECONSTR SURG, V120, P425, DOI 10.1097/01.prs.0000267700.15452.d0; SUSSMAN MD, 1973, AM J PHYSIOL, V224, P1167, DOI 10.1152/ajplegacy.1973.224.5.1167; Tang JB, 2003, J HAND SURG-AM, V28A, P215, DOI 10.1053/jhsu.2003.50052; Tepper OM, 2004, FASEB J, V18, P1231, DOI 10.1096/fj.03-0847fje; TODD DJ, 1991, IRISH MED J, V84, P54; WILLIAMS DF, 1977, J BIOMECH, V10, P633, DOI 10.1016/0021-9290(77)90063-X; Wu J, 2016, BIOMACROMOLECULES, V17, P2168, DOI 10.1021/acs.biomac.6b00398; Wu M, 2015, BIOMECH MODEL MECHAN, V14, P357, DOI 10.1007/s10237-014-0609-1	33	8	8	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191074	10.1371/journal.pone.0191074	http://dx.doi.org/10.1371/journal.pone.0191074			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324868	Green Submitted, gold, Green Published			2022-12-26	WOS:000419952400104
J	Mwau, M; Syeunda, CA; Adhiambo, M; Bwana, P; Kithinji, L; Mwende, J; Oyiengo, L; Sirengo, M; Boeke, CE				Mwau, Matilu; Syeunda, Catherine Akinyi; Adhiambo, Maureen; Bwana, Priska; Kithinji, Lucy; Mwende, Joy; Oyiengo, Laura; Sirengo, Martin; Boeke, Caroline E.			Scale-up of Kenya's national HIV viral load program: Findings and lessons learned	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; ANTIRETROVIRAL THERAPY; CHILDREN; SUPPRESSION; ADHERENCE; ADOLESCENTS; INFANTS; COHORT; ASSAY	Objectives Kenya is one of the first African countries to scale up a national HIV viral load monitoring program. We sought to assess program scale up using the national database and identify areas for systems strengthening. Methods Data from January 2012 to March 2016 were extracted from Kenya's national viral load database. Characteristics of 1,108,356 tests were assessed over time, including reason for testing, turnaround times, test results, treatment regimens, and socio-demographic information. Results The number of facilities offering viral load testing increased to similar to 2,000 with >40,000 tests being conducted per month by 2016. By March 2016, most (84.2%) tests were conducted for routine monitoring purposes and the turnaround time from facility-level sample collection to result dispatch from the lab was 21(24) [median (IQR)] days. Although the proportions of repeat viral load tests increased over time, the volumes were lower than expected. Elevated viral load was much more common in pediatric and adolescent patients (0-<3 years: 43.1%, 3-<10 years: 34.5%, 10-<20 years: 36.6%) than in adults (30-<60 years: 13.3%; p<0.001). Conclusions Coverage of viral load testing dramatically increased in Kenya to >50% of patients on antiretroviral therapy (ART) by early 2016 and represents a relatively efficient laboratory system. However, strengthening of patient tracking mechanisms and viral load result utilization may be necessary to further improve the system. Additional focus is needed on paediatric/adolescent patients to improve viral suppression in these groups. Kenya's national viral load database has demonstrated its usefulness in assessing laboratory programs, tracking trends in patient characteristics, monitoring scale-up of new policies and programs, and identifying problem areas for further investigation.	[Mwau, Matilu; Syeunda, Catherine Akinyi; Adhiambo, Maureen; Bwana, Priska; Kithinji, Lucy; Mwende, Joy] Kenya Govt Med Res Ctr, Nairobi, Kenya; [Oyiengo, Laura; Sirengo, Martin] Minist Hlth, Natl AIDS & STIs Control Program, Nairobi, Kenya	Kenya Medical Research Institute		caroline.boeke@mail.harvard.edu			Hewlett-Packard	Hewlett-Packard	The information technology for Kenya's national viral load database was funded by Hewlett-Packard.	Adejumo OA, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20049; [Anonymous], KEN NAT VIR LOAD DAS; [Anonymous], 2014, NAT AIDS STI CONTR P; [Anonymous], 2012, PROGRAMME NASC; [Anonymous], CHILDRENS REPRESENTA, DOI DOI 10.1186/1471-2458-14-402; [Anonymous], 2011, GUID ANT THER KEN; Asbjornsdottir KH, 2016, AIDS, V30, P2835, DOI 10.1097/QAD.0000000000001244; Bulage L, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2428-3; Campbell C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146322; Cherutich P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154318; Fatti G, 2014, AIDS CARE, V26, P448, DOI 10.1080/09540121.2013.855699; Foissac F, 2013, BRIT J CLIN PHARMACO, V76, P137, DOI 10.1111/bcp.12069; Garcia-Diaz A, 2006, J CLIN MICROBIOL, V44, P1788, DOI 10.1128/JCM.44.5.1788-1791.2006; Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801; Hudelson C, 2015, AIDS CARE, V27, P805, DOI 10.1080/09540121.2015.1011073; Jobanputra K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116144; Lall P, 2015, J INT AIDS SOC, V18, P41, DOI 10.7448/IAS.18.2.19393; LeRoux-Rutledge E, 2015, AIDS CARE, V27, P1367, DOI 10.1080/09540121.2015.1093592; McMahon JH, 2013, B WORLD HEALTH ORGAN, V91, P377, DOI 10.2471/BLT.12.112946; Menson EN, 2006, BMJ-BRIT MED J, V332, P1183, DOI 10.1136/bmj.332.7551.1183; Minchella PA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173009; Muenchhoff M, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00391; Mujugira A, 2016, J ACQUIR IMMUNE DEFI; Mulu A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-28; NASCOP, 2016, MONTHL COMM STOCK ST; National AIDS and STI Control Programme (NASCOP), 2015, KEN HIV TEST SERV GU; Penazzato M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004772.pub4; Prevention CfDCa, 2013, MORBIDITY MORTALITY, V62; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Shearer WT, 1997, NEW ENGL J MED, V336, P1337, DOI 10.1056/NEJM199705083361901; Taylor N, 2009, ANTIVIR THER, V14, P1189, DOI 10.3851/IMP1427; UNAIDS, 2021, YOUNG PEOPL HIV; WHO, 2016, CONS GUID US ANT DUR, VSecond; Zwahlen M, 2009, INT J EPIDEMIOL, V38, P1624, DOI 10.1093/ije/dyp306	34	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190659	10.1371/journal.pone.0190659	http://dx.doi.org/10.1371/journal.pone.0190659			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS7BJ	29324811	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400045
J	Saracino, A; Cozzi-Lepri, A; Shanyinde, M; Silberstein, FC; Nozza, S; Di Biagio, A; Cassola, G; Bruno, G; Capobianchi, M; Puoti, M; Monno, L; Monforte, AD				Saracino, Annalisa; Cozzi-Lepri, Alessandro; Shanyinde, Milensu; Silberstein, Francesca Ceccherini; Nozza, Silvia; Di Biagio, Antonio; Cassola, Giovanni; Bruno, Giuseppe; Capobianchi, Maria; Puoti, Massimo; Monno, Laura; Monforte, Antonella d'Arminio		ICONA Fdn Study	HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients	PLOS ONE			English	Article							IMMUNE ACTIVATION; ANTIRETROVIRAL THERAPY; IMMUNODEFICIENCY; FIBROGENESIS; INDIVIDUALS; COHORT; SCORES; INDEX	Background In vitro, gp120 of both X4 and R5 HIV-1 strains activates human hepatic stellate cells, but if it can promote liver fibrosis in vivo is unknown. We aimed to evaluate if patients carrying X4 or R5 strains have a different liver fibrosis (LF) progression over time. Methods A total of 1,137 HIV-infected patients in ICONA cohort (21% females, 7% HCV co-infected) with an available determination of HIV-1 co-receptor tropism (CRT), a Fibrosis-4 Index for Liver Fibrosis (FIB-4) <3.25 and at least one-year follow-up were included. CRT was assessed by gp120 sequencing on plasma RNA and geno2pheno algorithm (10% false positive rate) or by Trofile. LF was assessed by means of FIB-4. LF progression was defined as an absolute score increase or a transition to higher fibrosis stratum and/or occurrence of liver-related clinical events. Results A total of 249 (22%) patients carried X4 strains, which were associated with older age, lower CD4 count, lower nadir CD4, and intravenous drug use. Overall, X4 and R5 patients had similar baseline FIB-4 scores and similar mean FIB-4 slope after a median follow-up of 35 months. There was no difference between X4 and R5 for time to LF progression (p = 0.925). Estimated risk of LF at 24 months (95% CI) after baseline in X4 and R5 was 10.6% (8.3 +/- 12.9) and 9.9% (5.9 +/- 14.0), respectively. Age, HCV co-infection, diabetes, HIV-duration, HIV-RNA> 100.000 cp/mL, antiretroviral therapy exposure were associated with LF progression at multivariate analysis. Conclusions A slight LF progression over time was observed in HIV-infected patients. No difference was demonstrated for X4 and R5 HIV-1 strains in accelerating LF evolution.	[Saracino, Annalisa; Bruno, Giuseppe; Monno, Laura] Univ Bari, Clin Infect Dis, Bari, Italy; [Cozzi-Lepri, Alessandro; Shanyinde, Milensu] UCL, Dept Infect & Populat Hlth, Med Sch, Royal Free Campus, London, England; [Silberstein, Francesca Ceccherini] Univ Tor Vergata, Dept Expt Med, Rome, Italy; [Nozza, Silvia] Ist Sci San Raffaele, Infect Dis Dept, Milan, Italy; [Di Biagio, Antonio] IRCCS San Martino Hosp, Infect Dis Dept, Genoa, Italy; [Cassola, Giovanni] Galliera Hosp, Div Infect Dis, Genoa, Italy; [Capobianchi, Maria] Natl Inst Infect Dis L Spallanzani, Lab Virol, Rome, Italy; [Puoti, Massimo] AO Niguarda Ca Granda, Dept Infect Dis, Milan, Italy; [Monforte, Antonella d'Arminio] San Paolo H Univ Milan, Dept Hlth Sci, Clin Infect & Trop Dis, Milan, Italy	Universita degli Studi di Bari Aldo Moro; University of London; University College London; University of Rome Tor Vergata; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Genoa; IRCCS AOU San Martino IST; Ente Ospedaliero Ospedali Galliera; IRCCS Lazzaro Spallanzani	Saracino, A (corresponding author), Univ Bari, Clin Infect Dis, Bari, Italy.	annalisa.saracino@uniba.it	PELLICANO', GIOVANNI FRANCESCO/W-4077-2019; Di Maio, Velia Chiara/AGH-2628-2022; Ceccherini-Silberstein, Francesca/K-4762-2016; Di Biagio, Antonio/J-4901-2019; NOZZA, SILVIA/AAC-5445-2022; Puoti, Massimo/AAA-6580-2020; Saracino, Annalisa/F-5084-2017	PELLICANO', GIOVANNI FRANCESCO/0000-0002-9640-8742; Di Biagio, Antonio/0000-0003-1436-5089; MONNO, Laura/0000-0002-2713-4258; Puoti, Massimo/0000-0003-3278-7138; Segala, Daniela/0000-0001-6133-0386; Saracino, Annalisa/0000-0001-9558-208X	Abbvie; BMS; Gilead; Jannsen; MSD; ViiV, Italy	Abbvie(AbbVie); BMS(Bristol-Myers Squibb); Gilead(Gilead Sciences); Jannsen; MSD; ViiV, Italy	The authors received no specific funding for this work. ICONA Foundation is sponsored by unrestricted educational grants of Abbvie, BMS, Gilead, Jannsen, MSD, ViiV, Italy.	Abravanel F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050289; Blackard JT, 2011, CLIN INFECT DIS, V52, P674, DOI 10.1093/cid/ciq199; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Bruno R, 2010, GUT, V59, P513, DOI 10.1136/gut.2008.163287; Crane M, 2012, WORLD J HEPATOL, V4, P91, DOI 10.4254/wjh.v4.i3.91; DallaPiazza M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-116; Gupta D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091569; Hong F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033659; Kooij KW, 2016, AIDS, V30, P1771, DOI 10.1097/QAD.0000000000001119; Li YJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002660; Lin W, 2008, GASTROENTEROLOGY, V134, P803, DOI 10.1053/j.gastro.2008.01.005; Marchetti G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-79; Mendeni M, 2011, CLIN INFECT DIS, V52, P1164, DOI 10.1093/cid/cir071; Nunes D, 2010, AM J GASTROENTEROL, V105, P1346, DOI 10.1038/ajg.2009.746; Price JC, 2012, J INFECT DIS, V205, P1005, DOI 10.1093/infdis/jir885; Rasmussen AL, 2012, VIROLOGY, V430, P43, DOI 10.1016/j.virol.2012.04.011; Saracino A, 2014, J CLIN VIROL, V59, P167, DOI 10.1016/j.jcv.2013.12.009; Saracino A, 2009, J MED VIROL, V81, P2036, DOI 10.1002/jmv.21598; Schuitemaker H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S5; Svicher V, 2010, NEW MICROBIOL, V33, P195; Vallet-Pichard A, 2012, SEMIN LIVER DIS, V32, P158, DOI 10.1055/s-0032-1316471; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Vlahakis SR, 2003, J INFECT DIS, V188, P1455, DOI 10.1086/379738	23	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190302	10.1371/journal.pone.0190302	http://dx.doi.org/10.1371/journal.pone.0190302			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324755	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400028
J	Tsuchiaka, S; Naoi, Y; Imai, R; Masuda, T; Ito, M; Akagami, M; Ouchi, Y; Ishii, K; Sakaguchi, S; Omatsu, T; Katayama, Y; Oba, M; Shirai, J; Satani, Y; Takashima, Y; Taniguchi, Y; Takasu, M; Madarame, H; Sunaga, F; Aoki, H; Makino, S; Mizutani, T; Nagai, M				Tsuchiaka, Shinobu; Naoi, Yuki; Imai, Ryo; Masuda, Tsuneyuki; Ito, Mika; Akagami, Masataka; Ouchi, Yoshinao; Ishii, Kazuo; Sakaguchi, Shoichi; Omatsu, Tsutomu; Katayama, Yukie; Oba, Mami; Shirai, Junsuke; Satani, Yuki; Takashima, Yasuhiro; Taniguchi, Yuji; Takasu, Masaki; Madarame, Hiroo; Sunaga, Fujiko; Aoki, Hiroshi; Makino, Shinji; Mizutani, Tetsuya; Nagai, Makoto			Genetic diversity and recombination of enterovirus G strains in Japanese pigs: High prevalence of strains carrying a papain-like cysteine protease sequence in the enterovirus G population	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; PORCINE ENTEROVIRUS; TESCHOVIRUS; EVOLUTION; POLIOENCEPHALOMYELITIS; SAPELOVIRUS; MECHANISMS; STRATEGIES; FREQUENCY; DYNAMICS	To study the genetic diversity of enterovirus G (EV-G) among Japanese pigs, metagenomics sequencing was performed on fecal samples from pigs with or without diarrhea, collected between 2014 and 2016. Fifty-nine EV-G sequences, which were >5,000 nucleotides long, were obtained. By complete VP1 sequence analysis, Japanese EV-G isolates were classified into G1 (17 strains), G2 (four strains), G3 (22 strains), G4 (two strains), G6 (two strains), G9 (six strains), G10 (five strains), and a new genotype (one strain). Remarkably, 16 G1 and one G2 strain identified in diarrheic (23.5%; four strains) or normal (76.5%; 13 strains) fecal samples possessed a papain-like cysteine protease (PL-CP) sequence, which was recently found in the USA and Belgium in the EV-G genome, at the 2C +/- 3A junction site. This paper presents the first report of the high prevalence of viruses carrying PL-CP in the EV-G population. Furthermore, possible inter-and intragenotype recombination events were found among EV-G strains, including G1-PL-CP strains. Our findings may advance the understanding of the molecular epidemiology and genetic evolution of EV-Gs.	[Tsuchiaka, Shinobu; Naoi, Yuki; Imai, Ryo; Ishii, Kazuo; Sakaguchi, Shoichi; Omatsu, Tsutomu; Katayama, Yukie; Oba, Mami; Shirai, Junsuke; Mizutani, Tetsuya; Nagai, Makoto] Tokyo Univ Agr & Technol, Res & Educ Ctr Prevent Global Infect Dis Anim, Fuchu, Tokyo, Japan; [Masuda, Tsuneyuki] Kurayoshi Livestock Hyg Serv Ctr, Kurayoshi, Tottori, Japan; [Ito, Mika] Ishikawa Nanbu Livestock Hyg Serv Ctr, Kanazawa, Ishikawa, Japan; [Akagami, Masataka; Ouchi, Yoshinao] Kenpoku Livestock Hyg Serv Ctr, Mito, Ibaraki, Japan; [Satani, Yuki; Takashima, Yasuhiro; Taniguchi, Yuji; Takasu, Masaki] Gifu Univ, Fac Appl Biol Sci, Dept Vet Med, Yanagi, Gifu, Japan; [Takashima, Yasuhiro] Gifu Univ GeFAH, Educ & Res Ctr Food Anim Hlth, Gifu, Japan; [Takashima, Yasuhiro] Gifu Univ G CHAIN, Ctr Highly Adv Integrat Nano & Life Sci, Gifu, Japan; [Madarame, Hiroo] Azabu Univ, Sch Vet Med, Lab Small Anim Clin, Sagamihara, Kanagawa, Japan; [Sunaga, Fujiko] Azabu Univ, Sch Vet Med, Dept Vet Med, Sagamihara, Kanagawa, Japan; [Aoki, Hiroshi] Nippon Vet & Life Sci Univ, Fac Vet Sci, Musashino, Tokyo, Japan; [Makino, Shinji] Univ Texas Med Branch Galveston, Dept Microbiol & Immunol, Galveston, TX USA; [Nagai, Makoto] Ishikawa Prefectural Univ, Dept Bioprod Sci, Nonoichi, Ishikawa, Japan	Tokyo University of Agriculture & Technology; Gifu University; Azabu University; Azabu University; Nippon Veterinary & Life Science University; University of Texas System; University of Texas Medical Branch Galveston; Ishikawa Prefecture University	Mizutani, T; Nagai, M (corresponding author), Tokyo Univ Agr & Technol, Res & Educ Ctr Prevent Global Infect Dis Anim, Fuchu, Tokyo, Japan.; Nagai, M (corresponding author), Ishikawa Prefectural Univ, Dept Bioprod Sci, Nonoichi, Ishikawa, Japan.	tmizutan@cc.tuat.ac.jp; m-nagai@ishikawa-pu.ac.jp	Sakaguchi, Shoichi/AAN-1335-2020; Oba, Mami/AFN-3478-2022; MIZUTANI, Tetsuya/G-1086-2013; Ishii, Kazuo/N-9946-2019; Omatsu, Tsutomu/C-8344-2013	Sakaguchi, Shoichi/0000-0003-3650-1221; Oba, Mami/0000-0002-4187-3217; MIZUTANI, Tetsuya/0000-0003-2570-0452; Omatsu, Tsutomu/0000-0001-7860-7409; Ishii, Kazuo/0000-0002-8363-8266	Ministry of Agriculture, Forestry and Fisheries of Japan [716057223]; JSPS KAKENHI [15K07718]; Global Innovation Research of Tokyo University of Agriculture and Technology; Research Project for Improving Food Safety and Animal Health of the Ministry of Agriculture, Forestry and Fisheries of Japan; Grants-in-Aid for Scientific Research [15K07718] Funding Source: KAKEN	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global Innovation Research of Tokyo University of Agriculture and Technology; Research Project for Improving Food Safety and Animal Health of the Ministry of Agriculture, Forestry and Fisheries of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by The Ministry of Agriculture, Forestry and Fisheries of Japan, Award Number: the Research Project for Improving Food Safety and Animal Health of the Ministry of Agriculture, Forestry and Fisheries of Japan (716057223), Grant Recipient: Tetsuya Mizutani. We received three funding including JSPS KAKENHI 15K07718 to Makoto Nagai, Global Innovation Research of Tokyo University of Agriculture and Technology to Tetsuya Mizutani, and the Research Project for Improving Food Safety and Animal Health of the Ministry of Agriculture, Forestry and Fisheries of Japan.	Anbalagan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097517; Arruda PHE, 2017, TRANSBOUND EMERG DIS, V64, P311, DOI 10.1111/tbed.12621; AUERBACH J, 1994, J VET MED B, V41, P277, DOI 10.1111/j.1439-0450.1994.tb00228.x; Austermann-Busch S, 2012, J VIROL, V86, P7393, DOI 10.1128/JVI.00864-12; Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005; Boros A, 2012, J GEN VIROL, V93, P1941, DOI 10.1099/vir.0.041335-0; Boros A, 2012, ARCH VIROL, V157, P981, DOI 10.1007/s00705-012-1255-5; Boros A, 2011, INFECT GENET EVOL, V11, P1096, DOI 10.1016/j.meegid.2011.04.003; Chiu SC, 2014, VET MICROBIOL, V168, P69, DOI 10.1016/j.vetmic.2013.10.019; Chiu SC, 2012, VET MICROBIOL, V161, P88, DOI 10.1016/j.vetmic.2012.07.031; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferreyra FM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070179; Holmblat B, 2014, MBIO, V5, DOI 10.1128/mBio.01119-14; Kaku Y, 2001, J GEN VIROL, V82, P417, DOI 10.1099/0022-1317-82-2-417; Knowles N.J., 2006, DIS SWINE, P337; KNOWLES NJ, 1988, VET REC, V122, P441, DOI 10.1136/vr.122.18.441; KNOWLES NJ, 1979, ARCH VIROL, V62, P201, DOI 10.1007/BF01317552; Knutson TP, 2017, J GEN VIROL, V98, P1305, DOI 10.1099/jgv.0.000799; Krumbholz A, 2002, J VIROL, V76, P5813, DOI 10.1128/JVI.76.11.5813-5821.2002; Lin WC, 2012, ARCH VIROL, V157, P1387, DOI 10.1007/s00705-012-1315-x; Lindner HA, 2005, J VIROL, V79, P15199, DOI 10.1128/JVI.79.24.15199-15208.2005; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lukashev AN, 2010, REV MED VIROL, V20, P327, DOI 10.1002/rmv.660; Lukashev AN, 2008, J CLIN MICROBIOL, V46, P665, DOI 10.1128/JCM.02386-06; Lukashev AN, 2014, J GEN VIROL, V95, P868, DOI 10.1099/vir.0.060004-0; Lukashev AN, 2005, J GEN VIROL, V86, P3281, DOI 10.1099/vir.0.81264-0; Lukashev AN, 2005, REV MED VIROL, V15, P157, DOI 10.1002/rmv.457; Lukashev AN, 2004, J GEN VIROL, V85, P463, DOI 10.1099/vir.0.19469-0; Lukashev AN, 2003, J VIROL, V77, P10423, DOI 10.1128/JVI.77.19.10423-10431.2003; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Mielech AM, 2014, VIRUS RES, V194, P184, DOI 10.1016/j.virusres.2014.01.025; Nagai M, 2015, ARCH VIROL, V160, P2491, DOI 10.1007/s00705-015-2543-7; Neto N, 2016, INFECT GENET EVOL, V43, P135; Neto N, 2017, VIRUS EVOL, V3; Dung NV, 2016, J GEN VIROL, V97, P378, DOI 10.1099/jgv.0.000366; Dung NV, 2014, J GEN VIROL, V95, P549, DOI 10.1099/vir.0.061978-0; Perez-Losada M, 2015, INFECT GENET EVOL, V30, P296, DOI 10.1016/j.meegid.2014.12.022; Prodelalova J, 2012, INFECT GENET EVOL, V12, P1447, DOI 10.1016/j.meegid.2012.04.025; Salles MWS, 2011, J VET DIAGN INVEST, V23, P367, DOI 10.1177/104063871102300231; Savolainen-Kopra C, 2010, REV MED VIROL, V20, P358, DOI 10.1002/rmv.663; Shang PC, 2017, J VIROL, V91, DOI 10.1128/JVI.00450-17; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Skaug B, 2010, CELL, V143, P187, DOI 10.1016/j.cell.2010.09.033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapparel C, 2013, INFECT GENET EVOL, V14, P282, DOI 10.1016/j.meegid.2012.10.016; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vilar MJ, 2016, VIRUS RES, V215, P42, DOI 10.1016/j.virusres.2016.01.019; Wang MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174600; Yamada M, 2014, J COMP PATHOL, V150, P276, DOI 10.1016/j.jcpa.2013.08.004; Yang SX, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-99; Zell R, 2001, J VIROL, V75, P1620, DOI 10.1128/JVI.75.4.1620-1631.2001; Zhang W, 2012, J VIROL, V86, P7008, DOI 10.1128/JVI.00711-12; Zhao C, 2013, TRENDS MICROBIOL, V21, P181, DOI 10.1016/j.tim.2013.01.005	55	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190819	10.1371/journal.pone.0190819	http://dx.doi.org/10.1371/journal.pone.0190819			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324778	Green Submitted, Green Published, gold			2022-12-26	WOS:000419952400060
J	Yan, GX; Xiao, X; Wang, NA; Zhang, FG; Gao, GZ; Xu, K; Chen, BY; Qiao, JW; Wu, XM				Yan, Guixin; Xiao, Xin; Wang, Nian; Zhang, Fugui; Gao, Guizhen; Xu, Kun; Chen, Biyun; Qiao, Jiangwei; Wu, Xiaoming			Genome-wide analysis and expression profiles of glyoxalase gene families in Chinese cabbage (Brassica rapa L)	PLOS ONE			English	Article							ACTING REGULATORY ELEMENTS; CELL-PROLIFERATION; I GENE; MOLECULAR CHARACTERIZATION; COMPREHENSIVE ANALYSIS; STRESS TOLERANCE; SALT TOLERANCE; METHYLGLYOXAL; PLANT; OVEREXPRESSION	The glyoxalase pathway is composed of glyoxalase I (GLYI) and glyoxalase II (GLYII) and is responsible for the detoxification of a cytotoxic metabolite methylglyoxal (MG) into the nontoxic S-D-lactoylglutathione. The two glyoxalase enzymes play a crucial role in stress tolerance in various plant species. Recently, the GLY gene families have well been analyzed in Arabidopsis, rice and soybean, however, little is known about them in Chinese cabbage (Brassica rapa). Here, 16 BrGLYI and 15 BrGLYII genes were identified in the B. rapa genome, and the BrGLYI and BrGLYII proteins were both clustered into five subfamilies. The classifications, chromosomal distributions, gene duplications, exon +/- intron structures, localizations, conserved motifs and promoter cis-elements were also predicted and analyzed. In addition, the expression pattern of these genes in different tissues and their response to biotic and abiotic stresses were analyzed using publicly available data and a quantitative real-time PCR analysis (RT-qPCR). The results indicated that the expression profiles of BrGLY genes varied among different tissues. Notably, a number of BrGLY genes showed responses to biotic and abiotic stress treatments, including Plasmodiophora brassicae infection and various heavy metal stresses. Taken together, this study identifies BrGLYI and BrGLYII gene families in B. rapa and offers insight into their roles in plant development and stress resistance, especially in heavy metal stress tolerance and pathogen resistance.	[Yan, Guixin; Xiao, Xin; Wang, Nian; Zhang, Fugui; Gao, Guizhen; Xu, Kun; Chen, Biyun; Qiao, Jiangwei; Wu, Xiaoming] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Wu, XM (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Oil Crops, Minist Agr, Oil Crops Res Inst, Wuhan, Hubei, Peoples R China.	wuxm@oilcrops.cn	Zhang, Fugui/GNW-2998-2022	Zhang, Fugui/0000-0001-9172-8475	National Key Program for Research and Development [2016YFD0100202]; Chinese Academy of agricultural sciences special Project for basic research [Y2016PT35]; National Infrastructure for Crop Germplasm Resources [NICGR2017-014]	National Key Program for Research and Development; Chinese Academy of agricultural sciences special Project for basic research; National Infrastructure for Crop Germplasm Resources	This work was supported by the National Key Program for Research and Development (2016YFD0100202), Chinese Academy of agricultural sciences special Project for basic research (Y2016PT35), and National Infrastructure for Crop Germplasm Resources (NICGR2017-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank American Journal Experts for language editing. This work was supported by the National Key Program for Research and Development (2016YFD0100202), Chinese Academy of agricultural sciences special Project for basic research (Y2016PT35), and National Infrastructure for Crop Germplasm Resources (NICGR2017-014).	AHMAD Z, 1974, E AFR MED J, V51, P725; Ali B, 2014, BIOL PLANTARUM, V58, P131, DOI 10.1007/s10535-013-0358-5; Viveros MFA, 2013, MOL BIOL REP, V40, P3281, DOI 10.1007/s11033-012-2403-4; Alvarez-Gerding X, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/827951; Bhomkar P, 2008, MOL BREEDING, V22, P169, DOI 10.1007/s11032-008-9164-8; Cardoza V, 2004, IN VITRO CELL DEV-PL, V40, P542, DOI 10.1079/IVP2004568; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Chen ZY, 2004, PHYTOPATHOLOGY, V94, P938, DOI 10.1094/PHYTO.2004.94.9.938; Clugston SL, 1998, J MOL EVOL, V47, P230, DOI 10.1007/PL00006380; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; DESWAL R, 1993, BIOCHEM SOC T, V21, P527, DOI 10.1042/bst0210527; Devanathan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095971; EGYUD LG, 1966, P NATL ACAD SCI USA, V56, P203, DOI 10.1073/pnas.56.1.203; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Espartero J, 1995, PLANT MOL BIOL, V29, P1223, DOI 10.1007/BF00020464; Ghosh A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0773-9; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hossain M. A., 2011, Frontiers of Agriculture in China, V5, P1, DOI 10.1007/s11703-010-1070-2; Hossain MA, 2009, BIOSCI BIOTECH BIOCH, V73, P2007, DOI 10.1271/bbb.90194; Hossain MA, 2009, AUST J CROP SCI, V3, P53; Jain M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159348; Kaur C, 2014, CRIT REV PLANT SCI, V33, P429, DOI 10.1080/07352689.2014.904147; Kaur C, 2014, BIOCHEM SOC T, V42, P485, DOI 10.1042/BST20130242; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li JM, 2014, NEW PHYTOL, V203, P182, DOI 10.1111/nph.12803; Li J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0090225, 10.1371/journal.pone.0105508]; Lin FY, 2010, MOL BIOL REP, V37, P729, DOI 10.1007/s11033-009-9578-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maiti MK, 1997, PLANT MOL BIOL, V35, P471, DOI 10.1023/A:1005891123344; Mukesh Saxena, 2011, Open Plant Science Journal, V5, P23, DOI 10.2174/1874294701105010023; Mustafiz A, 2014, PLANT J, V78, P951, DOI 10.1111/tpj.12521; Mustafiz A, 2011, FUNCT INTEGR GENOMIC, V11, P293, DOI 10.1007/s10142-010-0203-2; NORTON SJ, 1990, BIOCHEM INT, V22, P411; NYANDIEKA HS, 1978, CLIN BIOCHEM, V11, P150, DOI 10.1016/S0009-9120(78)90349-1; PAULUS C, 1993, PLANTA, V189, P561, DOI 10.1007/BF00198220; RAMASWAMY O, 1984, PLANT CELL REP, V3, P121, DOI 10.1007/BF02441015; Roy SD, 2008, PLANT CELL TISS ORG, V95, P1, DOI 10.1007/s11240-008-9402-0; Saxena M, 2005, BIOCHEM BIOPH RES CO, V336, P813, DOI 10.1016/j.bbrc.2005.08.178; SETHI U, 1988, PLANT SCI, V56, P167, DOI 10.1016/0168-9452(88)90031-3; Shamsi FA, 2000, EXP EYE RES, V70, P369, DOI 10.1006/exer.1999.0800; Singla-Pareek SL, 2006, PLANT PHYSIOL, V140, P613, DOI 10.1104/pp.105.073734; Singla-Pareek SL, 2003, P NATL ACAD SCI USA, V100, P14672, DOI 10.1073/pnas.2034667100; Singla-Pareek SL, 2008, TRANSGENIC RES, V17, P171, DOI 10.1007/s11248-007-9082-2; Skipsey M, 2000, ARCH BIOCHEM BIOPHYS, V374, P261, DOI 10.1006/abbi.1999.1596; TALESA V, 1990, BIOCHEM INT, V22, P1115; THORNALLEY PJ, 1990, BIOCHEM J, V269, P1; Tong CB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-689; Tuomainen M, 2011, PLANTA, V233, P1173, DOI 10.1007/s00425-011-1370-7; U. N., 1935, Japanese Journal of Botany, V7, P389; Veena, 1999, PLANT J, V17, P385, DOI 10.1046/j.1365-313X.1999.00390.x; Wang F, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01181; Wang N, 2013, PLANT CELL REP, V32, P61, DOI 10.1007/s00299-012-1340-y; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wu C, 2013, J PLANT RES, V126, P415, DOI 10.1007/s10265-012-0532-4; Wu R., 2005, NEWS LETT, V22, P58; Yadav SK, 2005, BIOCHEM BIOPH RES CO, V337, P61, DOI 10.1016/j.bbrc.2005.08.263; Yadav SK, 2007, PROTEIN EXPRES PURIF, V51, P126, DOI 10.1016/j.pep.2006.07.007; Yadav Sudesh Kumar, 2005, Physiology and Molecular Biology of Plants, V11, P1; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012; Yan GX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00150; Yang B, 2007, PLANT SCI, V173, P156, DOI 10.1016/j.plantsci.2007.04.012; Zeng ZM, 2016, PLANT PHYSIOL BIOCH, V109, P62, DOI 10.1016/j.plaphy.2016.09.006; Zimaro T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/354801	64	10	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191159	10.1371/journal.pone.0191159	http://dx.doi.org/10.1371/journal.pone.0191159			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324881	gold, Green Submitted, Green Published			2022-12-26	WOS:000419952400124
J	Zhao, K; Zheng, WW; Dong, XM; Yin, RH; Gao, R; Li, X; Liu, JF; Zhan, YQ; Yu, M; Chen, H; Ge, CH; Ning, HM; Yang, XM; Li, CY				Zhao, Ke; Zheng, Wei-Wei; Dong, Xiao-Ming; Yin, Rong-Hua; Gao, Rui; Li, Xiu; Liu, Jin-Fang; Zhan, Yi-Qun; Yu, Miao; Chen, Hui; Ge, Chang-Hui; Ning, Hong-Mei; Yang, Xiao-Ming; Li, Chang-Yan			EDAG promotes the expansion and survival of human CD34(+) cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; EX-VIVO EXPANSION; BONE-MARROW-CELLS; HUMAN CYCLIN-A; PROGENITOR CELLS; ERYTHROID-DIFFERENTIATION; OSTEOBLAST RECRUITMENT; EXPRESSION; PHASE; HOXB4	EDAG is multifunctional transcriptional regulator primarily expressed in the lin(lo)c(-)kit(+) Sca-1(+) hematopoietic stem cells (HSC) and CD34(+) progenitor cells. Previous studies indicate that EDAG is required for maintaining hematopoietic lineage commitment balance. Here using ex vivo culture and HSC transplantation models, we report that EDAG enhances the proliferative potential of human cord blood CD34(+) cells, increases survival, prevents cell apoptosis and promotes their repopulating capacity. Moreover, EDAG overexpression induces rapid entry of CD34(+) cells into the cell cycle. Gene expression profile analysis indicate that EDAG knockdown leads to down-regulation of various positive cell cycle regulators including cyclin A, B, D, and E. Together these data provides novel insights into EDAG in regulation of expansion and survival of human hematopoietic stem/progenitor cells.	[Zhao, Ke; Zheng, Wei-Wei; Yin, Rong-Hua; Gao, Rui; Zhan, Yi-Qun; Yu, Miao; Chen, Hui; Ge, Chang-Hui; Yang, Xiao-Ming; Li, Chang-Yan] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China; [Dong, Xiao-Ming; Yang, Xiao-Ming] Tianjin Univ, Sch Chem Engn & Technol, Dept Pharmaceut Engn, Tianjin, Peoples R China; [Li, Xiu] An Hui Med Univ, Hefei, Anhui, Peoples R China; [Liu, Jin-Fang; Li, Chang-Yan] Guang Dong Pharmaceut Univ, Sch Pharm, Guangzhou, Guangdong, Peoples R China; [Ning, Hong-Mei] Acad Mil Med Sci, Affiliated Hosp, Dept Hematopoiet Stem Cell Transplantat, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Tianjin University; Anhui Medical University; Academy of Military Medical Sciences - China	Yang, XM; Li, CY (corresponding author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China.; Yang, XM (corresponding author), Tianjin Univ, Sch Chem Engn & Technol, Dept Pharmaceut Engn, Tianjin, Peoples R China.; Li, CY (corresponding author), Guang Dong Pharmaceut Univ, Sch Pharm, Guangzhou, Guangdong, Peoples R China.; Ning, HM (corresponding author), Acad Mil Med Sci, Affiliated Hosp, Dept Hematopoiet Stem Cell Transplantat, Beijing, Peoples R China.	ninghongmei72@sina.com; xiaomingyang@sina.com; fmmli@163.com		Dong, xiao-ming/0000-0003-2413-8541	Chinese National Natural Science Foundation [81222005, 81070435]; Major State Basic Research of China [2014CBA02001, 2013CB910800]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Major State Basic Research of China	This work was supported by Chinese National Natural Science Foundation Projects (81222005, 81070435); and Major State Basic Research of China (2014CBA02001, 2013CB910800).; This study is partly supported by Chinese National Natural Science Foundation Projects (81222005, 81070435); Major State Basic Research of China (2014CBA02001, 2013CB910800).	Amsellem S, 2003, NAT MED, V9, P1423, DOI 10.1038/nm953; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Ballen KK, 2013, BLOOD, V122, P491, DOI 10.1182/blood-2013-02-453175; Caldon CE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-2; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; Dai MS, 2000, BLOOD, V96, P3985, DOI 10.1182/blood.V96.12.3985.h8003985_3985_3987; DellaRagione F, 1997, BIOCHEM BIOPH RES CO, V231, P73, DOI 10.1006/bbrc.1997.5938; Ding YL, 2010, J CELL BIOCHEM, V110, P866, DOI 10.1002/jcb.22597; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; Huang X, 2016, LEUKEMIA, V30, P144, DOI 10.1038/leu.2015.189; Jiang J, 2010, BLOOD, V116, P711, DOI 10.1182/blood-2009-07-235341; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; KATO JY, 1993, P NATL ACAD SCI USA, V90, P11513, DOI 10.1073/pnas.90.24.11513; Kluger R, 2010, CURR OPIN CHEM BIOL, V14, P538, DOI 10.1016/j.cbpa.2010.03.021; Kruger A, 2002, DEV DYNAM, V223, P414, DOI 10.1002/dvdy.10067; Lauper N, 1998, ONCOGENE, V17, P2637, DOI 10.1038/sj.onc.1202477; Laurenti E, 2015, CELL STEM CELL, V16, P302, DOI 10.1016/j.stem.2015.01.017; Li CY, 2007, LEUKEMIA, V21, P2277, DOI 10.1038/sj.leu.2404901; Li CY, 2008, BBA-GENE REGUL MECH, V1779, P606, DOI 10.1016/j.bbagrm.2008.06.004; Li CY, 2004, CELL DEATH DIFFER, V11, P1299, DOI 10.1038/sj.cdd.4401490; Lu J, 2001, ACTA BIOCH BIOPH SIN, V33, P641; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Povinelli BJ, 2014, STEM CELLS, V32, P105, DOI 10.1002/stem.1513; Rizo A, 2008, BLOOD, V111, P2621, DOI 10.1182/blood-2007-08-106666; ROSENBERG AR, 1995, ONCOGENE, V10, P1501; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; SAUVAGEAU G, 1994, P NATL ACAD SCI USA, V91, P12223, DOI 10.1073/pnas.91.25.12223; Stanevsky A, 2011, STEM CELL REV REP, V7, P425, DOI 10.1007/s12015-010-9183-9; Stanevsky A, 2009, BLOOD REV, V23, P199, DOI 10.1016/j.blre.2009.02.001; SWENSON KI, 1986, CELL, V47, P861, DOI 10.1016/0092-8674(86)90801-9; TRAYCOFF CM, 1994, EXP HEMATOL, V22, P1264; Wurtz T, 2001, EXP CELL RES, V263, P236, DOI 10.1006/excr.2000.5114; Xu W X, 2001, Zhongguo Ying Yong Sheng Li Xue Za Zhi, V17, P192; Yang LV, 2001, MECH DEVELOP, V104, P105, DOI 10.1016/S0925-4773(01)00376-8; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang MJ, 2012, FEBS J, V279, P2848, DOI 10.1111/j.1742-4658.2012.08663.x; Zheng WW, 2014, STEM CELLS, V32, P2278, DOI 10.1002/stem.1723; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	39	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190794	10.1371/journal.pone.0190794	http://dx.doi.org/10.1371/journal.pone.0190794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324880	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400058
J	Dessery, Y; Pallari, J				Dessery, Yoann; Pallari, Jari			Measurements agreement between low-cost and high-level handheld 3D scanners to scan the knee for designing a 3D printed knee brace	PLOS ONE			English	Article							PERSONALIZED INSOLES; FOOT ORTHOSES; OSTEOARTHRITIS; CUSTOM; TRIAL	Use of additive manufacturing is growing rapidly in the orthotics field. This technology allows orthotics to be designed directly on digital scans of limbs. However, little information is available about scanners and 3D scans. The aim of this study is to look at the agreement between manual measurements, high-level and low-cost handheld 3D scanners. We took two manual measurements and three 3D scans with each scanner from 14 lower limbs. The lower limbs were divided into 17 sections of 30mm each from 180mm above the mid-patella to 300mm below. Time to record and to process the three 3D scans for scanners methods were compared with Student t-test while Bland-Altman plots were used to study agreement between circumferences of each section from the three methods. The record time was 97s shorter with high-level scanner than with the low-cost (p = .02) while the process time was nine times quicker with the low-cost scanner (p < .01). An overestimation of 2.5mm was found in high-level scanner compared to manual measurement, but with a better repeatability between measurements. The low-cost scanner tended to overestimate the circumferences from 0.1% to 1.5%, overestimation being greater for smaller circumferences. In conclusion, 3D scanners provide more information about the shape of the lower limb, but the reliability depends on the 3D scanner and the size of the scanned segment. Low-cost scanners could be useful for clinicians because of the simple and fast process, but attention should be focused on accuracy, which depends on the scanned body segment.	[Dessery, Yoann] Peacocks Med Grp, Res & Dev Dept, Newcastle Upon Tyne, Tyne & Wear, England; [Pallari, Jari] PODFO, Res & Dev Dept, Newcastle Upon Tyne, Tyne & Wear, England; [Dessery, Yoann] Moveck Solut, Res & Dev Dept, Quebec City, PQ, Canada		Dessery, Y (corresponding author), Peacocks Med Grp, Res & Dev Dept, Newcastle Upon Tyne, Tyne & Wear, England.; Dessery, Y (corresponding author), Moveck Solut, Res & Dev Dept, Quebec City, PQ, Canada.	ydessery@gmail.com		Dessery, Yoann/0000-0001-5198-356X	European Union Seventh Framework Program (FP7-PEOPLE-ITN) [607510]; A commercial company, Peacocks Medical Group; PODFO	European Union Seventh Framework Program (FP7-PEOPLE-ITN); A commercial company, Peacocks Medical Group; PODFO	This research has received funding from the European Union Seventh Framework Program (FP7-PEOPLE-2013-ITN; KNEEMO) under grant agreement no 607510. A commercial company, Peacocks Medical Group, provided support in the form of salary for author YD, and PODFO provided support in the form of salary for author JP. These funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. Author's commercial affiliation did not play any role in our study.	Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bland JM, 1999, STAT METHODS MED; Bland JM, 2006, HOW SHOULD I CALCULA; Brouwer RW, 2006, OSTEOARTHR CARTILAGE, V14, P777, DOI 10.1016/j.joca.2006.02.004; Cau N, 2016, J NOV PHYSIOTHER; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Dombroski Colin E, 2014, BMC Res Notes, V7, P443, DOI 10.1186/1756-0500-7-443; Draganich L, 2006, J BONE JOINT SURG AM, V88A, P2645, DOI 10.2106/JBJS.D.02787; Giavarina D, 2015, BIOCHEM MEDICA, V25, P141, DOI 10.11613/BM.2015.015; Ifflaender S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061274; Jaeschke L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119430; Jin YA, 2015, PROC CIRP, V36, P199, DOI 10.1016/j.procir.2015.02.125; Koepke N, 2017, PEERJ, V5, DOI 10.7717/peerj.2980; Kuehnapfel A, 2016, SCI REP-UK, V6, DOI 10.1038/srep26672; Laughton C, 2002, J AM PODIAT MED ASSN, V92, P261, DOI 10.7547/87507315-92-5-261; Lunsford C, 2016, PM&R, V8, P1201, DOI 10.1016/j.pmrj.2016.07.003; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; McGraw KO, 1996, PSYCHOL METHODS; Pallari JH, 2010, 21 ANN INT SOLID FRE, P834; Pierrat B, 2012, ASME 2012 11 BIENN C, P1; Pierrat B, 2014, EFFICIENCY COMFORT K, P1; Pierrat B, 2015, COMPUT METHOD BIOMEC, V18, P646, DOI 10.1080/10255842.2013.832227; POLLOCK MA, 1992, ANN CLIN BIOCHEM, V29, P556, DOI 10.1177/000456329202900512; Salles AS, 2013, INT J COMPUT INTEG M, V26, P386, DOI 10.1080/0951192X.2012.717721; Salles AS, 2013, J SPORT SCI, V31, P442, DOI 10.1080/02640414.2012.736629; Salles AS, 2012, WORK, V41, P1771, DOI 10.3233/WOR-2012-0383-1771; Schrank ES, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4024825; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Simenko J, 2016, INT J MORPHOL; Sims RE, 2012, INT J; Spahiu T., 2014, 6 INT C TEXTILE; Squyer E, 2013, CLIN ORTHOP RELAT R, V471, P1982, DOI 10.1007/s11999-013-2814-0; Taha Z, 2013, APPL MECH; Tan CW, 2013, PHYSIOTHERAPY, V99, P247, DOI 10.1016/j.physio.2012.12.004; Telfer S, 2012, ARCH PHYS MED REHAB, V93, P863, DOI 10.1016/j.apmr.2011.12.019; Telfer S, 2010, J FOOT ANKLE RES, V3, DOI 10.1186/1757-1146-3-19; Toth T, 2014, PROCEDIA ENGINEER, V69, P393, DOI 10.1016/j.proeng.2014.03.004; Treleaven P, 2004, IEEE SPECTRUM, V41, P29; Troynikov O, 2011, HFESA 47 ANN C; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Woodburn J, 2002, J RHEUMATOL, V29, P1377; Yu SP, 2016, INT J RHEUM DIS, V19, P279, DOI 10.1111/1756-185X.12796	43	13	14	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190585	10.1371/journal.pone.0190585	http://dx.doi.org/10.1371/journal.pone.0190585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320560	Green Submitted, Green Published, gold			2022-12-26	WOS:000419689600057
J	Krasikova, YS; Rechkunova, NI; Maltseva, EA; Lavrik, OI				Krasikova, Yuliya S.; Rechkunova, Nadejda I.; Maltseva, Ekaterina A.; Lavrik, Olga I.			RPA and XPA interaction with DNA structures mimicking intermediates of the late stages in nucleotide excision repair	PLOS ONE			English	Article							REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; DAMAGED DNA; MOLECULAR-MECHANISMS; BINDING PROTEIN; DUAL INCISION; RECOGNITION; COMPLEX; OLIGONUCLEOTIDES; TFIIH	Replication protein A (RPA) and the xeroderma pigmentosum group A (XPA) protein are indispensable for both pathways of nucleotide excision repair (NER). Here we analyze the interaction of RPA and XPA with DNA containing a flap and different size gaps that imitate intermediates of the late NER stages. Using gel mobility shift assays, we found that RPA affinity for DNA decreased when DNA contained both extended gap and similar sized flap in comparison with gapped-DNA structure. Moreover, crosslinking experiments with the flap-gap DNA revealed that RPA interacts mainly with the ssDNA platform within the long gap and contacts flap in DNA with a short gap. XPA exhibits higher affinity for bubble-DNA structures than to flap-gap-containing DNA. Protein titration analysis showed that formation of the RPA-XPA-DNA ternary complex depends on the protein concentration ratio and these proteins can function as independent players or in tandem. Using fluorescently-labelled RPA, direct interaction of this protein with XPA was detected and characterized quantitatively. The data obtained allow us to suggest that XPA can be involved in the post-incision NER stages via its interaction with RPA.	[Krasikova, Yuliya S.; Rechkunova, Nadejda I.; Maltseva, Ekaterina A.; Lavrik, Olga I.] Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Rechkunova, Nadejda I.; Lavrik, Olga I.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Novosibirsk State University	Lavrik, OI (corresponding author), Inst Chem Biol & Fundamental Med, Novosibirsk, Russia.; Lavrik, OI (corresponding author), Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia.	lavrik@niboch.nsc.ru	Maltseva, Ekaterina/ABE-2612-2021; Rechkunova, Nadezda I/G-5093-2013; Lavrik, Olga I/G-4641-2013	Maltseva, Ekaterina/0000-0002-6800-5989; 	Russian Scientific Foundation [14-24-00038]; Russian Science Foundation [17-24-00011] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Scientific Foundation 14-24-00038 to OIL, www.rscf.ru. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah UB, 2017, EMBO J, V36, P2047, DOI 10.15252/embj.201796664; ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Araujo SJ, 2001, MOL CELL BIOL, V21, P2281, DOI 10.1128/MCB.21.7.2281-2291.2001; Brosey CA, 2013, NUCLEIC ACIDS RES, V41, P2313, DOI 10.1093/nar/gks1332; Burns JL, 1996, J BIOL CHEM, V271, P11607, DOI 10.1074/jbc.271.20.11607; Camenisch U, 2006, NAT STRUCT MOL BIOL, V13, P278, DOI 10.1038/nsmb1061; Chen R, 2016, NUCLEIC ACIDS RES, V44, P5758, DOI 10.1093/nar/gkw339; Chen R, 2014, BIOESSAYS, V36, P1156, DOI 10.1002/bies.201400107; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; Fadda E, 2016, COMPUT STRUCT BIOTEC, V14, P78, DOI 10.1016/j.csbj.2015.11.007; Fagbemi AF, 2011, DNA REPAIR, V10, P722, DOI 10.1016/j.dnarep.2011.04.022; Fan J, 2012, GENE DEV, V26, P2337, DOI 10.1101/gad.194787.112; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Gilljam KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049199; Hanawalt PC, 2000, COLD SPRING HARB SYM, V65, P183, DOI 10.1101/sqb.2000.65.183; Hass CS, 2012, J BIOL CHEM, V287, P3908, DOI 10.1074/jbc.M111.287441; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Kemp MG, 2014, J BIOL CHEM, V289, P26574, DOI 10.1074/jbc.M114.597088; Kemp MG, 2012, J BIOL CHEM, V287, P22889, DOI 10.1074/jbc.M112.374447; KIM CS, 1994, BIOCHEMISTRY-US, V33, P14197, DOI 10.1021/bi00251a031; Kolpashchikov DM, 2001, NUCLEIC ACIDS RES, V29, P373, DOI 10.1093/nar/29.2.373; Krasikova YS, 2016, MOL BIOL+, V50, P649, DOI 10.1134/S0026893316030080; Krasikova YS, 2012, BIOCHEMISTRY-MOSCOW+, V77, P346, DOI 10.1134/S0006297912040050; Krasikova YS, 2008, BIOCHEMISTRY-MOSCOW+, V73, P886, DOI 10.1134/S0006297908080063; Krasikova YS, 2013, J BIOL CHEM, V288, P10936, DOI 10.1074/jbc.M112.444026; Krasikova YS, 2010, NUCLEIC ACIDS RES, V38, P8083, DOI 10.1093/nar/gkq649; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagerwerf S, 2011, DNA REPAIR, V10, P743, DOI 10.1016/j.dnarep.2011.04.024; Lao Y, 2000, BIOCHEMISTRY-US, V39, P850, DOI 10.1021/bi991704s; Lavrik OI, 1999, NUCLEIC ACIDS RES, V27, P4235, DOI 10.1093/nar/27.21.4235; Lavrik OI, 1998, NUCLEIC ACIDS RES, V26, P602, DOI 10.1093/nar/26.2.602; Li CL, 2015, MOL CELL, V59, P1025, DOI 10.1016/j.molcel.2015.08.012; LI L, 1995, MOL CELL BIOL, V15, P5396; Liu Y, 2005, BIOCHEMISTRY-US, V44, P7361, DOI 10.1021/bi047598y; Matsumoto S, 2015, NUCLEIC ACIDS RES, V43, P1700, DOI 10.1093/nar/gkv038; Mocquet V, 2008, EMBO J, V27, P155, DOI 10.1038/sj.emboj.7601948; Moor NA, 2015, NUCLEIC ACIDS RES, V43, P6009, DOI 10.1093/nar/gkv569; Overmeer RM, 2011, J CELL BIOL, V192, P401, DOI 10.1083/jcb.201006011; Patrick SM, 1999, J BIOL CHEM, V274, P14972, DOI 10.1074/jbc.274.21.14972; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Saijo M, 1996, NUCLEIC ACIDS RES, V24, P4719, DOI 10.1093/nar/24.23.4719; Saijo M, 2011, J BIOL CHEM, V286, P5476, DOI 10.1074/jbc.M110.172916; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; SHIVJI MKK, 1995, BIOCHEMISTRY-US, V34, P5011, DOI 10.1021/bi00015a012; Staresincic L, 2009, EMBO J, V28, P1111, DOI 10.1038/emboj.2009.49; Sugasawa K, 2016, DNA REPAIR, V44, P110, DOI 10.1016/j.dnarep.2016.05.015; Sugitani N, 2016, DNA REPAIR, V44, P123, DOI 10.1016/j.dnarep.2016.05.018; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; Van Houten B, 2016, DNA REPAIR, V44, P136, DOI 10.1016/j.dnarep.2016.05.019; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yang ZG, 2002, BIOCHEMISTRY-US, V41, P13012, DOI 10.1021/bi026064z; Yu SL, 2014, DNA REPAIR, V16, P1, DOI 10.1016/j.dnarep.2014.01.005	57	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190782	10.1371/journal.pone.0190782	http://dx.doi.org/10.1371/journal.pone.0190782			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320546	Green Published, gold, Green Submitted			2022-12-26	WOS:000419689600065
J	Morrison, R; Reiss, D				Morrison, Rachel; Reiss, Diana			Precocious development of self-awareness in dolphins	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; CHIMPANZEES PAN-TROGLODYTES; TURSIOPS-TRUNCATUS; RECOGNITION; MIRROR; IMITATION; EMERGENCE; NEWBORNS; PRIMATES; PLAY	Mirror-self recognition (MSR) is a behavioral indicator of self-awareness in young children and only a few other species, including the great apes, dolphins, elephants and magpies. The emergence of self-awareness in children typically occurs during the second year and has been correlated with sensorimotor development and growing social and self-awareness. Comparative studies of MSR in chimpanzees report that the onset of this ability occurs between 2 years 4 months and 3 years 9 months of age. Studies of wild and captive bottle-nose dolphins (Tursiops truncatus) have reported precocious sensorimotor and social awareness during the first weeks of life, but no comparative MSR research has been conducted with this species. We exposed two young bottlenose dolphins to an underwater mirror and analyzed video recordings of their behavioral responses over a 3-year period. Here we report that both dolphins exhibited MSR, indicated by self-directed behavior at the mirror, at ages earlier than generally reported for children and at ages much earlier than reported for chimpanzees. The early onset of MSR in young dolphins occurs in parallel with their advanced sensorimotor development, complex and reciprocal social interactions, and growing social awareness. Both dolphins passed subsequent mark tests at ages comparable with children. Thus, our findings indicate that dolphins exhibit self-awareness at a mirror at a younger age than previously reported for children or other species tested.	[Morrison, Rachel; Reiss, Diana] CUNY, Grad Ctr, Dept Psychol, New York, NY 10016 USA; [Reiss, Diana] CUNY, Hunter Coll, Dept Psychol, New York, NY 10021 USA; [Morrison, Rachel] Univ North Carolina Pembroke, Dept Psychol, Pembroke, NC USA	City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY); University of North Carolina	Reiss, D (corresponding author), CUNY, Grad Ctr, Dept Psychol, New York, NY 10016 USA.; Reiss, D (corresponding author), CUNY, Hunter Coll, Dept Psychol, New York, NY 10021 USA.	dlr28@columbia.edu			Research Foundation of CUNY (PSC-CUNY) [62796-00 40]	Research Foundation of CUNY (PSC-CUNY)	This research was funded by the Research Foundation of CUNY (PSC-CUNY grant # 62796-00 40) to DR. The URL for the funding agency is https://www.rfcuny.org/rfwebsite/research/content.aspx?catID=1190. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; ANDERSON JR, 1984, DEV PSYCHOBIOL, V17, P35, DOI 10.1002/dev.420170104; Asendorpf JB, 1996, DEV PSYCHOL, V32, P313, DOI 10.1037/0012-1649.32.2.313; Bard KA, 2006, INFANCY, V9, P191, DOI 10.1207/s15327078in0902_6; Bischof-Kohler D, 2012, EMOT REV, V4, P40, DOI 10.1177/1754073911421377; BUTTERWORTH G, 1992, PSYCHOL INQ, V3, P103, DOI DOI 10.1207/S15327965PLI0302_1; Chechina ON, 2009, BIOL BULL+, V36, P489, DOI 10.1134/S1062359009050094; de Veer M, 2002, NEUROPSYCHOLOGIA, V1493, P1; Dearolf JL, 2000, J MORPHOL, V244, P203, DOI 10.1002/(SICI)1097-4687(200006)244:3<203::AID-JMOR5>3.0.CO;2-V; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; GALLUP GG, 1982, AM J PRIMATOL, V2, P237, DOI 10.1002/ajp.1350020302; Gallup GG, 1995, ANIM BEHAV, V50, P1525, DOI 10.1016/0003-3472(95)80008-5; Gallup Gordon G. Jr, 1994, P35, DOI 10.1017/CBO9780511565526.005; Gibson QA, 2008, ANIM BEHAV, V76, P375, DOI 10.1016/j.anbehav.2008.01.021; Gubbins C, 1999, MAR MAMMAL SCI, V15, P751, DOI 10.1111/j.1748-7692.1999.tb00841.x; LIN AC, 1992, J COMP PSYCHOL, V106, P120, DOI 10.1037/0735-7036.106.2.120; Mann J, 1999, BEHAVIOUR, V136, P529, DOI 10.1163/156853999501469; Marino Lori, 1994, P380, DOI 10.1017/CBO9780511565526.027; Marten K, 1996, SCI AM, V275, P82, DOI 10.1038/scientificamerican0896-82; McCowan B, 2000, J COMP PSYCHOL, V114, P98, DOI 10.1037//0735-7036.114.1.98; Nielsen M, 2004, INFANT BEHAV DEV, V27, P342, DOI 10.1016/j.infbeh.2003.12.006; Pace Daniela S., 2000, Aquatic Mammals, V26, P57; Paulos R.D., 2010, INT J COMP PSYCHOL, V23, P701, DOI DOI 10.1016/J.SOCSCIMED.2010.01.002; Plotnik JM, 2006, P NATL ACAD SCI USA, V103, P17053, DOI 10.1073/pnas.0608062103; Posada S, 2007, AM J PRIMATOL, V69, P576, DOI 10.1002/ajp.20355; POVINELLI DJ, 1993, J COMP PSYCHOL, V107, P347, DOI 10.1037/0735-7036.107.4.347; Prior H, 2008, PLOS BIOL, V6, P1642, DOI 10.1371/journal.pbio.0060202; Reiss D, 2001, P NATL ACAD SCI USA, V98, P5937, DOI 10.1073/pnas.101086398; REISS D, 1993, J COMP PSYCHOL, V107, P301, DOI 10.1037/0735-7036.107.3.301; Reiss D, 1988, ANIMAL SONAR SYSTEMS, P115; Rochat P, 2003, CONSCIOUS COGN, V12, P717, DOI 10.1016/S1053-8100(03)00081-3; Sarko D., 2002, INT J COMP PSYCHOL, V15, P69; SUAREZ SD, 1981, J HUM EVOL, V10, P175, DOI 10.1016/S0047-2484(81)80016-4; Westergaard G.C., 1994, Human Evolution, V9, P273, DOI 10.1007/BF02435514	34	27	27	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0189813	10.1371/journal.pone.0189813	http://dx.doi.org/10.1371/journal.pone.0189813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS3NS	29320499	Green Published, gold			2022-12-26	WOS:000419689600018
J	Vacher, S; Castagnet, P; Chemlali, W; Lallemand, F; Meseure, D; Pocard, M; Bieche, I; Perrot-Applanat, M				Vacher, Sophie; Castagnet, Patrice; Chemlali, Walid; Lallemand, Francois; Meseure, Didier; Pocard, Marc; Bieche, Ivan; Perrot-Applanat, Martine			High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; MAMMARY EPITHELIAL-CELLS; DIOXIN RECEPTOR; BRCA-1 PROMOTER; CANCER-CELLS; ESTROGEN; ACTIVATION; EXPOSURE; RISK; OVEREXPRESSION	Increasing epidemiological and animal experimental data provide substantial support for the role of aryl hydrocarbon receptor (AhR) in mammary tumorigenesis. The effects of AhR have been clearly demonstrated in rodent models of breast carcinogenesis and in several established human breast cancer cell lines following exposure to AhR ligands or AhR overexpression. However, relatively little is known about the role of AhR in human breast cancers. AhR has always been considered to be a regulator of toxic and carcinogenic responses to environmental contaminants such as TCDD (dioxin) and benzo[ a] pyrene (BaP). The aim of this study was to identify the type of breast tumors (ER alpha-positive or ER alpha-negative) that express AHR and how AhR affects human tumorigenesis. The levels of AHR, AHR nuclear translocator (ARNT) and AHR repressor (AHRR) mRNA expression were analyzed in a cohort of 439 breast tumors, demonstrating a weak association between high AHR expression and age greater than fifty years and ERa-negative status, and HR-/ERBB2 breast cancer subtypes. AHRR mRNA expression was associated with metastasis-free survival, while AHR mRNA expression was not. Immunohistochemistry revealed the presence of AhR protein in both tumor cells (nucleus and/or cytoplasm) and the tumor microenvironment (including endothelial cells and lymphocytes). High AHR expression was correlated with high expression of several genes involved in signaling pathways related to inflammation (IL1B, IL6, TNF, IL8 and CXCR4), metabolism (IDO1 and TDO2 from the kynurenine pathway), invasion (MMP1, MMP2 and PLAU), and IGF signaling (IGF2R, IGF1R and TGFB1). Two well-known ligands for AHR (TCDD and BaP) induced mRNA expression of IL1B and IL6 in an ERa-negative breast tumor cell line. The breast cancer ER status likely influences AhR activity involved in these signaling pathways. The mechanisms involved in AhR activation and target gene expression in breast cancers are also discussed.	[Vacher, Sophie; Chemlali, Walid; Lallemand, Francois; Bieche, Ivan] Inst Curie, Pharmacogen Unit, Dept Genet, Paris, France; [Castagnet, Patrice] Lariboisiere St Louis Hosp, Dept Pathol, Paris, France; [Meseure, Didier] Inst Curie, Dept Pathol, Paris, France; [Pocard, Marc; Perrot-Applanat, Martine] Lariboisiere St Louis Hosp, INSERM, U965, Paris, France; [Pocard, Marc; Perrot-Applanat, Martine] Univ Paris Diderot Paris 7, Paris, France; [Bieche, Ivan] Univ Paris 05, EA7331, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Vacher, S (corresponding author), Inst Curie, Pharmacogen Unit, Dept Genet, Paris, France.		Bièche, Ivan/O-7399-2017	Bièche, Ivan/0000-0002-2430-5429; VACHER, Sophie/0000-0002-0042-6023	Comite Departemental des Hauts-de-Seine de la Ligue Nationale Contre le Cancer; Association pour la Recherche en Cancerologie de Saint-Cloud (ARCS); INSERM (Institut National de Ia Sante et de Ia Recherche Medicale); CNRS (Centre National de la Recherche Scientifique)	Comite Departemental des Hauts-de-Seine de la Ligue Nationale Contre le Cancer; Association pour la Recherche en Cancerologie de Saint-Cloud (ARCS); INSERM (Institut National de Ia Sante et de Ia Recherche Medicale); CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Comite Departemental des Hauts-de-Seine de la Ligue Nationale Contre le Cancer and the Association pour la Recherche en Cancerologie de Saint-Cloud (ARCS) (16). This work was also supported by INSERM (Institut National de Ia Sante et de Ia Recherche Medicale), and CNRS (Centre National de la Recherche Scientifique)(MP-A).; This work was supported by the Comite Departemental des Hauts-de-Seine de la Ligue Nationale Contre le Cancer and the Association pour la Recherche en Cancerologie de Saint-Cloud (ARCS). This work was also supported by INSERM (Institut National de la Sante et de la Recherche Medicale), and CNRS (Centre National de la Recherche Scientifique). We thank Dr JP Brouland (Department of Pathology, Lariboisiere, Paris) for his assistance in micrographs and reading the manuscript. We also thank P Balaguer (INSERM U1194, Montpellier), C Pimkie (INSERM U965, Paris) and C Marty (Lariboisiere, Paris) for their technical help.	Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Bertazzi PA, 1997, EPIDEMIOLOGY, V8, P646, DOI 10.1097/00001648-199710000-00006; Birnbaum LS, 2003, ENVIRON HEALTH PERSP, V111, P389, DOI 10.1289/ehp.5686; Brody JG, 2007, CANCER-AM CANCER SOC, V109, P2667, DOI 10.1002/cncr.22655; Brooks J, 2011, CURR CANCER DRUG TAR, V11, P654, DOI 10.2174/156800911795655967; Brown NM, 1998, CARCINOGENESIS, V19, P1623, DOI 10.1093/carcin/19.9.1623; Roman AC, 2009, J BIOL CHEM, V284, P25135, DOI 10.1074/jbc.M109.013292; COX DR, 1972, J R STAT SOC B, V34, P187; D'Amato NC, 2015, CANCER RES, V75, P4651, DOI 10.1158/0008-5472.CAN-15-2011; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Dere E, 2011, CHEM RES TOXICOL, V24, P494, DOI 10.1021/tx100328r; DOHR O, 1995, ARCH BIOCHEM BIOPHYS, V321, P405, DOI 10.1006/abbi.1995.1411; Feng SL, 2013, BBA-REV CANCER, V1836, P197, DOI 10.1016/j.bbcan.2013.05.001; Fenton SE, 2012, ANNU REV PHARMACOL, V52, P455, DOI 10.1146/annurev-pharmtox-010611-134659; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Go RE, 2015, J STEROID BIOCHEM, V147, P24, DOI 10.1016/j.jsbmb.2014.11.003; Goode GD, 2013, INT J CANCER, V133, P2769, DOI 10.1002/ijc.28297; Guyot E, 2013, DRUG DISCOV TODAY, V18, P479, DOI 10.1016/j.drudis.2012.11.014; Hahn ME, 2009, BIOCHEM PHARMACOL, V77, P485, DOI 10.1016/j.bcp.2008.09.016; Hall JM, 2010, MOL ENDOCRINOL, V24, P359, DOI 10.1210/me.2009-0346; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hockings JK, 2006, CANCER RES, V66, P2224, DOI 10.1158/0008-5472.CAN-05-1619; Hollingshead BD, 2008, CANCER RES, V68, P3609, DOI 10.1158/0008-5472.CAN-07-6168; Jeffy BD, 2005, NEOPLASIA, V7, P873, DOI 10.1593/neo.05256; Jin UH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-498; Knerr S, 2006, MOL NUTR FOOD RES, V50, P897, DOI 10.1002/mnfr.200600006; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; KOCIBA RJ, 1978, TOXICOL APPL PHARM, V46, P279, DOI 10.1016/0041-008X(78)90075-3; Larsen MC, 1998, CANCER RES, V58, P2366; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Litzenburger UM, 2014, ONCOTARGET, V5, P1038, DOI 10.18632/oncotarget.1637; MADIGAN MP, 1995, J NATL CANCER I, V87, P1681, DOI 10.1093/jnci/87.22.1681; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Mountzios G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091407; Mulero-Navarro S, 2005, J BIOL CHEM, V280, P28731, DOI 10.1074/jbc.M504538200; Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846; Murray IA, 2010, CHEM RES TOXICOL, V23, P955, DOI 10.1021/tx100045h; Ohtake F, 2003, NATURE, V423, P545, DOI 10.1038/nature01606; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pellikainen JM, 2004, CLIN CANCER RES, V10, P7621, DOI 10.1158/1078-0432.CCR-04-1061; PERROTAPPLANAT M, 1987, CANCER RES, V47, P2652; Pesatori AC, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-39; Phrakonkham P, 2015, REPROD TOXICOL, V54, P101, DOI 10.1016/j.reprotox.2014.05.016; Platten M, 2012, CANCER RES, V72, P5435, DOI 10.1158/0008-5472.CAN-12-0569; Powell Joann B, 2013, J Cancer Ther, V4, P1177; Puccetti P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122046; Quintana FJ, 2013, PHARMACOL REV, V65, P1148, DOI 10.1124/pr.113.007823; Romagnolo DF, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-2044-9; Safe S, 1999, Expert Opin Investig Drugs, V8, P1385, DOI 10.1517/13543784.8.9.1385; Safe S, 2013, TOXICOL SCI, V135, P1, DOI 10.1093/toxsci/kft128; Saito R, 2014, HORM CANCER-US, V5, P11, DOI 10.1007/s12672-013-0160-z; Salisbury TB, 2014, BIOCHEM PHARMACOL, V91, P390, DOI 10.1016/j.bcp.2014.06.015; Schlezinger JJ, 2006, BIOL CHEM, V387, P1175, DOI 10.1515/BC.2006.145; Stark K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074525; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Tian Y, 1999, J BIOL CHEM, V274, P510, DOI 10.1074/jbc.274.1.510; Vogel CFA, 2007, BIOCHEM BIOPH RES CO, V363, P722, DOI 10.1016/j.bbrc.2007.09.032; Vogel CFA, 2011, ARCH BIOCHEM BIOPHYS, V512, P78, DOI 10.1016/j.abb.2011.05.011; Warner M, 2011, ENVIRON HEALTH PERSP, V119, P1700, DOI 10.1289/ehp.1103720; Wong PS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-234; Wormke M, 2000, FEBS LETT, V478, P109, DOI 10.1016/S0014-5793(00)01830-5; Zhang S, 2009, ENDOCR-RELAT CANCER, V16, P835, DOI 10.1677/ERC-09-0054; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	65	49	52	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190619	10.1371/journal.pone.0190619	http://dx.doi.org/10.1371/journal.pone.0190619			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320557	Green Submitted, Green Published, gold			2022-12-26	WOS:000419689600058
J	Pritzkow, S; Morales, R; Lyon, A; Concha-Marambio, L; Urayama, A; Soto, C				Pritzkow, Sandra; Morales, Rodrigo; Lyon, Adam; Concha-Marambio, Luis; Urayama, Akihiko; Soto, Claudio			Efficient prion disease transmission through common environmental materials	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISFOLDING CYCLIC AMPLIFICATION; CREUTZFELDT-JAKOB-DISEASE; INFECTIOUS PRIONS; SCRAPIE PRIONS; STEEL-SURFACE; PROTEIN; BARRIER; SOIL; FATE	Prion diseases are a group of fatal neurodegenerative diseases associated with a protein-based infectious agent, termed prion. Compelling evidence suggests that natural transmission of prion diseases is mediated by environmental contamination with infectious prions. We hypothesized that several natural and man-made materials, commonly found in the environments of wild and captive animals, can bind prions and may act as vectors for disease transmission. To test our hypothesis, we exposed surfaces composed of various common environmental materials (i.e. wood, rocks, plastic, glass, cement, stainless steel, aluminum, and brass) to hamster-adapted 263K scrapie prions and studied their attachment and retention of infectivity in vitro and in vivo. Our results indicated that these surfaces, with the sole exception of brass, efficiently bind, retain, and release prions. Prion replication was studied in vitro using the protein mis-folding cyclic amplification technology, and infectivity of surface-bound prions was analyzed by intracerebrally challenging hamsters with contaminated implants. Our results revealed that virtually all prion-contaminated materials transmitted the disease at high rates. To investigate a more natural form of exposure to environmental contamination, we simply housed animals with large contaminated spheres made of the different materials under study. Strikingly, most of the hamsters developed classical clinical signs of prion disease and typical disease-associated brain changes. Our findings suggest that prion contamination of surfaces commonly present in the environment can be a source of disease transmission, thus expanding our understanding of the mechanisms for prion spreading in nature.	[Pritzkow, Sandra; Morales, Rodrigo; Lyon, Adam; Concha-Marambio, Luis; Urayama, Akihiko; Soto, Claudio] Univ Texas Houston, Sch Med, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Dept Neurol, Houston, TX 77030 USA; [Concha-Marambio, Luis; Soto, Claudio] Univ Los Andes, Fac Med, Ave San Carlos de Apoquindo 2200, Santiago 2, Chile	University of Texas System; University of Texas Health Science Center Houston; Universidad de los Andes - Chile	Soto, C (corresponding author), Univ Texas Med Sch, Dept Neurol, 6431 Fannin St,MSE R422, Houston, TX 77030 USA.	Claudio.Soto@uth.tmc.edu	Morales, Rodrigo/K-7173-2015; Concha-Marambio, Luis/V-3247-2019	Concha-Marambio, Luis/0000-0002-9454-8389	National Institutes of Health [P01 AI07774, R01 AI132695]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI132695, P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants P01 AI07774 (to C. S.) and R01 AI132695 (to R. M.). Dr. Soto is inventor on several patents related to the PMCA technology and is currently founder, chief scientific officer, and vice president of Amprion Inc., a biotech company focusing on the commercial utilization of PMCA for diagnosis of various neurodegenerative diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Banks WA, 2009, EXP NEUROL, V218, P162, DOI 10.1016/j.expneurol.2009.04.025; Banks WA, 2004, BIOCHEM BIOPH RES CO, V318, P125, DOI 10.1016/j.bbrc.2004.04.009; Barria MA, 2011, J BIOL CHEM, V286, P7490, DOI 10.1074/jbc.M110.198465; Bartelt-Hunt SL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003113; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; BERNOULLI C, 1977, LANCET, V1, P478; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Cassard H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6821; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; David Walter W, 2011, Nat Commun, V2, P200, DOI 10.1038/ncomms1203; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Georgsson G, 2006, J GEN VIROL, V87, P3737, DOI 10.1099/vir.0.82011-0; GIBBS CJ, 1994, J NEUROL NEUROSUR PS, V57, P757, DOI 10.1136/jnnp.57.6.757; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; Hawkins SAC, 2015, VET REC, V176, DOI 10.1136/vr.102743; Hetz C, 2003, TRENDS MOL MED, V9, P237, DOI 10.1016/S1471-4914(03)00069-8; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Konold T, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00032; Maddison BC, 2010, J VIROL, V84, P11560, DOI 10.1128/JVI.01133-10; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; Melchior MB, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-24; Morales R, 2012, NAT PROTOC, V7, P1397, DOI 10.1038/nprot.2012.067; Nichols TA, 2009, PRION, V3, P171, DOI 10.4161/pri.3.3.9819; Pritzkow S, 2015, CELL REP, V11, P1168, DOI 10.1016/j.celrep.2015.04.036; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa P, 2015, VIRUS RES, V207, P47, DOI 10.1016/j.virusres.2014.11.007; Safar JG, 2008, J INFECT DIS, V198, P81, DOI 10.1086/588193; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; Smith CB, 2011, J ENVIRON QUAL, V40, P449, DOI 10.2134/jeq2010.0412; Soto C, 2012, CELL, V149, P968, DOI 10.1016/j.cell.2012.05.007; Uehlinger FD, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0804-7; Urayama A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32338; Urayama A, 2011, FASEB J, V25, P2792, DOI 10.1096/fj.11-180729; VerCauteren KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045774; Wisniewski HM, 1996, LANCET, V347, P1114, DOI 10.1016/S0140-6736(96)90310-4; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	39	27	27	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3363	3373		10.1074/jbc.M117.810747	http://dx.doi.org/10.1074/jbc.M117.810747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29330304	hybrid, Green Published			2022-12-26	WOS:000426562800027
J	Furukawa, K; Ishida, F; Tsuji, M; Miura, Y; Kishimoto, T; Shiba, M; Tanemura, H; Umeda, Y; Sano, T; Yasuda, R; Shimosaka, S; Suzuki, H				Furukawa, Kazuhiro; Ishida, Fujimaro; Tsuji, Masanori; Miura, Yoichi; Kishimoto, Tomoyuki; Shiba, Masato; Tanemura, Hiroshi; Umeda, Yasuyuki; Sano, Takanori; Yasuda, Ryuta; Shimosaka, Shinichi; Suzuki, Hidenori			Hemodynamic characteristics of hyperplastic remodeling lesions in cerebral aneurysms	PLOS ONE			English	Article							HUMAN CAROTID BIFURCATION; WALL SHEAR-STRESS; PULSATILE FLOW; TIME	Background & purpose Hyperplastic remodeling (HR) lesions are sometimes found on cerebral aneurysm walls. Atherosclerosis is the results of HR, which may cause an adverse effect on surgical treatment for cerebral aneurysms. Previous studies have demonstrated that atherosclerotic changes had a correlation with certain hemodynamic characteristics. Therefore, we investigated local hemodynamic characteristics of HR lesions of cerebral aneurysms using computational fluid dynamics (CFD). Methods Twenty-four cerebral aneurysms were investigated using CFD and intraoperative video recordings. HR lesions and red walls were confirmed on the intraoperative images, and the qualification points were determined on the center of the HR lesions and the red walls. The qualification points were set on the virtual operative images for evaluation of wall shear stress (WSS), normalized WSS (NWSS), oscillatory shear index (OSI), relative residence time (RRT), and aneurysm formation indicator (AFI). These hemodynamic parameters at the qualification points were compared between HR lesions and red walls. Results HR lesions had lower NWSS, lower AFI, higher OSI and prolonged RRT compared with red walls. From analysis of the receiver-operating characteristic curve for hemodynamic parameters, OSI was the most optimal hemodynamic parameter to predict HR lesions (area under the curve, 0.745; 95% confidence interval, 0.603-0.887; cutoff value, 0.00917; sensitivity, 0.643; specificity, 0.893; P<0.01). With multivariate logistic regression analyses using stepwise method, NWSS was significantly associated with the HR lesions. Conclusions Although low NWSS was independently associated with HR lesions, OSI is the most valuable hemodynamic parameter to distinguish HR lesions from red walls.	[Furukawa, Kazuhiro; Tsuji, Masanori; Shiba, Masato; Umeda, Yasuyuki; Yasuda, Ryuta; Suzuki, Hidenori] Mie Univ, Grad Sch Med, Dept Neurosurg, Tsu, Mie, Japan; [Ishida, Fujimaro; Kishimoto, Tomoyuki; Shimosaka, Shinichi] Natl Hosp Org, Mie Chuo Med Ctr, Dept Neurosurg, Tsu, Mie, Japan; [Miura, Yoichi] Suzuka Kaisei Hosp, Dept Neurosurg, Suzuka, Mie, Japan; [Tanemura, Hiroshi; Sano, Takanori] Ise Red Cross Hosp, Dept Neurosurg, Ise, Mie, Japan	Mie University	Furukawa, K (corresponding author), Mie Univ, Grad Sch Med, Dept Neurosurg, Tsu, Mie, Japan.	k.furukawa0328@me.com		Furukawa, Kazuhiro/0000-0001-5744-8306	Grants-in-Aid for Scientific Research [17K10825] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Amaya R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166569; Arzani A, 2017, BIOMECH MODEL MECHAN, V16, P787, DOI 10.1007/s10237-016-0853-7; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094; Fukazawa K, 2015, WORLD NEUROSURG, V83, P80, DOI 10.1016/j.wneu.2013.02.012; Furukawa K, 2015, PROGR COMPUTED IMAGI, V36, P73; Himburg HA, 2004, AM J PHYSIOL-HEART C, V286, pH1916, DOI 10.1152/ajpheart.00897.2003; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Lu X, 2004, J PHYSIOL-LONDON, V561, P575, DOI 10.1113/jphysiol.2004.075218; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Mantha A, 2006, AM J NEURORADIOL, V27, P1113; Miura Y, 2013, STROKE, V44, P519, DOI 10.1161/STROKEAHA.112.675306; Papaharilaou Y, 2013, MED BIOL ENG COMPUT, V51, P207, DOI 10.1007/s11517-012-0985-6; Park Chang Kyu, 2014, J Cerebrovasc Endovasc Neurosurg, V16, P247, DOI 10.7461/jcen.2014.16.3.247; Sakarunchai I, 2015, J STROKE CEREBROVASC, V24, P2497, DOI 10.1016/j.jstrokecerebrovasdis.2015.06.032; Soulis JV, 2016, CARDIOL RES, V7, P66, DOI 10.14740/cr467w; Sugiyama S, 2013, NEUROSURGERY, V73, P767, DOI 10.1227/NEU.0000000000000096; Szelenyi A, 2011, CLIN NEUROL NEUROSUR, V113, P129, DOI 10.1016/j.clineuro.2010.10.012; Taylor CA, 1998, ANN BIOMED ENG, V26, P975, DOI 10.1114/1.140; Tsuji M, 2016, J NEUROSURG, V3, P1	20	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191287	10.1371/journal.pone.0191287	http://dx.doi.org/10.1371/journal.pone.0191287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338059	Green Published, Green Submitted, gold			2022-12-26	WOS:000422652700047
J	Schreiber, PW; Bischoff-Ferrari, HA; Boggian, K; Bonani, M; van Delden, C; Enriquez, N; Fehr, T; Garzoni, C; Hirsch, HH; Hirzel, C; Manuel, O; Meylan, P; Saleh, L; Weisser, M; Mueller, NJ				Schreiber, Peter W.; Bischoff-Ferrari, Heike A.; Boggian, Katia; Bonani, Marco; van Delden, Christian; Enriquez, Natalia; Fehr, Thomas; Garzoni, Christian; Hirsch, Hans H.; Hirzel, Cedric; Manuel, Oriol; Meylan, Pascal; Saleh, Lanja; Weisser, Maja; Mueller, Nicolas J.		STCS	Bone metabolism dynamics in the early post transplant period following kidney and liver transplantation	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; FRACTURE RISK; BIOCHEMICAL MARKERS; TURNOVER MARKERS; MINERAL DENSITY; DISEASE; OSTEOPOROSIS; RECIPIENTS; CYCLOSPORINE; IMMUNOSUPPRESSION	Bone disease contributes to relevant morbidity after solid organ transplantation. Vitamin D has a crucial role for bone metabolism. Activation of vitamin D depends on the endocrine function of both, liver and kidney. Our study assessed key markers of bone metabolism at time of transplantation and 6 months after transplantation among 70 kidney and 70 liver recipients. In 70 kidney recipients 25-OH vitamin D levels did not differ significantly between peri-transplant (median 32.5nmol/l) and 6 months post-transplant (median 41.9nmol/l; P = 0.272). Six months post-transplant median 1, 25-(OH)(2) vitamin D levels increased by >300% (from 9.1 to 36.5ng/l; P<0.001) and median intact parathyroid hormone levels decreased by 68.4% (from 208.7 to 66.0 ng/l; P<0.001). Median 6-Crosslaps (CTx) and total procollagen type 1 amino-terminal propeptide (P1NP) decreased by 65.1% (from 1.32 to 0.46ng/ml; P<0.001) and 60.6% (from 158.2 to 62.3ng/ml; P<0.001), respectively. Kidney recipients with incident fractures had significantly lower levels of 1, 25-(OH)(2) vitamin D at time of transplantation and of intact parathyroid hormone 6 months post-transplant. Among 70 liver recipients, 25-OH vitamin D, 1, 25-(OH)(2) vitamin D and intact parathyroid hormone levels were not significantly altered between peri-transplant and 6 months post-transplant. Contrary to kidney recipients, median CTx increased by 60.0% (from 0.45 to 0.72 ng/ml; P = 0.002) and P1NP by 49.3% (from 84.0 to 125.4ng/ml; P = 0.001) in the longitudinal course. Assessed biomarkers didn't differ between liver recipients with and without fractures. To conclude, the assessed panel of biomarkers proved highly dynamic after liver as well as kidney transplantation in the early post-transplant period. After kidney transplantation a significant gain in 1, 25-(OH)(2) vitamin D combined with a decline in iPTH, CTx and P1 NP, whereas after liver transplantation an increase in CTx and P1 NP were characteristic.	[Schreiber, Peter W.; Bischoff-Ferrari, Heike A.; Mueller, Nicolas J.] Univ Hosp Zurich, Zurich, Switzerland; [Schreiber, Peter W.; Mueller, Nicolas J.] Univ Zurich, Div Infect Dis, Zurich, Switzerland; [Schreiber, Peter W.; Mueller, Nicolas J.] Hosp Epidemiol, Zurich, Switzerland; [Bischoff-Ferrari, Heike A.] Univ Zurich, Dept Geriatr & Aging Res, Zurich, Switzerland; [Boggian, Katia] Cantonal Hosp St Gallen, Div Infect Dis, St Gallen, Switzerland; [Boggian, Katia] Hosp Hyg, St Gallen, Switzerland; [Bonani, Marco] Univ Zurich, Dept Nephrol, Zurich, Switzerland; [van Delden, Christian; Enriquez, Natalia] Univ Hosp Geneva, Geneva, Switzerland; [van Delden, Christian; Enriquez, Natalia] Univ Geneva, Dept Surg, Serv Transplantat, Geneva, Switzerland; [Fehr, Thomas] Cantonal Hosp Chur, Internal Med, Chur, Switzerland; [Garzoni, Christian; Hirzel, Cedric] Univ Bern, Bern Univ Hosp, Inselspital, Dept Infect Dis, Bern, Switzerland; [Hirsch, Hans H.; Weisser, Maja] Univ Hosp Basel, Div Infect Dis, Basel, Switzerland; [Hirsch, Hans H.; Weisser, Maja] Hosp Epidemiol, Basel, Switzerland; [Manuel, Oriol; Meylan, Pascal] Univ Hosp CHUV, Lausanne, Switzerland; [Manuel, Oriol; Meylan, Pascal] Univ Lausanne, Infect Dis Serv, Lausanne, Switzerland; [Saleh, Lanja] Univ Hosp Zurich, Inst Clin Chem, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Kantonsspital St. Gallen; University of Zurich; University of Geneva; University of Geneva; University of Bern; University Hospital of Bern; University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Zurich; University Zurich Hospital	Mueller, NJ (corresponding author), Univ Hosp Zurich, Zurich, Switzerland.	nicolas.mueller@usz.ch	Fehr, Thomas/AFQ-9308-2022; Mueller, Nicolas J./B-6864-2013; Study, STCS Swiss Transplant Cohort/G-8344-2017; cavassini, matthias/F-8987-2017	Fehr, Thomas/0000-0003-1668-1800; Mueller, Nicolas J./0000-0002-1059-3191; Study, STCS Swiss Transplant Cohort/0000-0002-6369-819X; cavassini, matthias/0000-0003-0933-7833; Bischoff-Ferrari, Heike/0000-0002-4554-658X; Weisser, Maja/0000-0002-0134-1929	Swiss National Science Foundation; Swiss University Hospitals and transplant centers [33CS30_148512 / 2]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss University Hospitals and transplant centers	This study has been conducted in the framework of the Swiss Transplant Cohort Study, supported by the Swiss National Science Foundation, the Swiss University Hospitals and transplant centers (funding received by NM, PS), http://www.snf.ch/en/Pages/default.aspx, Longitudinal studies: 33CS30_148512 / 2.	Aroldi A, 1997, TRANSPLANTATION, V63, P380, DOI 10.1097/00007890-199702150-00009; Bang UC, 2014, CLIN GASTROENTEROL H, V12, P320, DOI 10.1016/j.cgh.2013.04.031; Bia Margaret, 2008, Transplant Rev (Orlando), V22, P52, DOI 10.1016/j.trre.2007.09.001; Bringhurstea FR, 2011, HARRISONS PRINCIPL E, V18E; Brown JE, 2010, NEOPLASIA, V12, P685, DOI 10.1593/neo.10610; Cavalier E, 2013, CLIN CHIM ACTA, V425, P117, DOI 10.1016/j.cca.2013.07.016; Chavassieux P, 2015, J CLIN ENDOCR METAB, V100, P4662, DOI 10.1210/jc.2015-2957; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; Cohen AJ, 2002, LIVER TRANSPLANT, V8, P916, DOI 10.1053/jlts.2002.35668; Cueto-Manzano AM, 2003, TRANSPLANTATION, V75, P2053, DOI 10.1097/01.TP.0000068869.21770.F6; Dizdar O, 2007, AM J HEMATOL, V82, P185, DOI 10.1002/ajh.20794; Drueke TB, 2016, KIDNEY INT, V89, P289, DOI 10.1016/j.kint.2015.12.004; El Haggan W, 2002, TRANSPLANT P, V34, P1817, DOI 10.1016/S0041-1345(02)03094-4; Floreani A, 2001, OSTEOPOROSIS INT, V12, P749, DOI 10.1007/s001980170051; Gal-Moscovici A, 2007, SEMIN DIALYSIS, V20, P423, DOI 10.1111/j.1525-139X.2007.00319.x; Gallego-Rojo FJ, 1998, HEPATOLOGY, V28, P695, DOI 10.1002/hep.510280315; Garnero P, 2008, MOL DIAGN THER, V12, P157, DOI 10.1007/BF03256280; Hardinger KL, 2003, LIVER TRANSPLANT, V9, P857, DOI 10.1053/jlts.2003.50135; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; HRUSKA KA, 1995, NEW ENGL J MED, V333, P166, DOI 10.1056/NEJM199507203330307; KATZ I, 1994, J BONE MINER RES, V9, P59; Koller MT, 2013, EUR J EPIDEMIOL, V28, P347, DOI 10.1007/s10654-012-9754-y; Krol CG, 2014, J BONE MINER RES, V29, P1763, DOI 10.1002/jbmr.2214; Kumar R, 2011, J AM SOC NEPHROL, V22, P216, DOI 10.1681/ASN.2010020186; Leidig-Bruckner G, 2001, LANCET, V357, P342, DOI 10.1016/S0140-6736(00)03641-2; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; MCDONALD JA, 1991, HEPATOLOGY, V14, P613, DOI 10.1002/hep.1840140407; Monegal A, 2001, OSTEOPOROSIS INT, V12, P484, DOI 10.1007/s001980170094; Monegal A, 2013, CALCIFIED TISSUE INT, V93, P571, DOI 10.1007/s00223-013-9797-4; Morris HA, 2016, CLIN CHIMICA ACTA; Naylor K, 2012, NAT REV RHEUMATOL, V8, P379, DOI 10.1038/nrrheum.2012.86; Naylor KL, 2015, TRANSPLANTATION; Naylor KL, 2013, TRANSPLANTATION, V95, P1461, DOI 10.1097/TP.0b013e31828eead8; Nikkel LE, 2009, TRANSPLANTATION, V87, P1846, DOI 10.1097/TP.0b013e3181a6bbda; Ninkovic M, 2000, EUR J GASTROEN HEPAT, V12, P931, DOI 10.1097/00042737-200012080-00013; Ninkovic M, 2001, CALCIFIED TISSUE INT, V69, P321, DOI 10.1007/s00223-001-2028-4; Phipps AI, 2010, MATURITAS, V67, P60, DOI 10.1016/j.maturitas.2010.04.015; Premaor MO, 2011, QJM-INT J MED, V104, P599, DOI 10.1093/qjmed/hcr025; Rizzari MD, 2012, CLIN J AM SOC NEPHRO, V7, P494, DOI 10.2215/CJN.08630811; Ruiz-Gaspa S, 2011, HEPATOLOGY, V54, P2104, DOI 10.1002/hep.24605; Ueda M, 2002, AM J KIDNEY DIS, V40, P802, DOI 10.1053/ajkd.2002.35692; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; Vasikaran S, 2011, CLIN CHEM LAB MED, V49, P1271, DOI 10.1515/CCLM.2011.602; Wheater G, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-201; Zitta S, 2015, TRANSPLANTATION, V99, P1250, DOI 10.1097/TP.0000000000000521	46	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191167	10.1371/journal.pone.0191167	http://dx.doi.org/10.1371/journal.pone.0191167			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338022	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000422652700035
J	Tien, CF; Huang, LQ; Watanabe, SM; Speidel, JT; Carter, CA; Chen, CP				Tien, ChihFeng; Huang, Liangqun; Watanabe, Susan M.; Speidel, Jordan T.; Carter, Carol A.; Chen, Chaoping			Context-dependent autoprocessing of human immunodeficiency virus type 1 protease precursors	PLOS ONE			English	Article							MALTOSE-BINDING PROTEIN; HIV-1 PROTEASE; ESCHERICHIA-COLI; CLEAVAGE; MODULATION; VARIANTS; UPSTREAM; RESIDUE; MUTANT; SITES	HIV-1 protease autoprocessing is responsible for liberation of free mature protease (PR) from the Gag-Pol polyprotein precursor. A cell-based model system was previously developed to examine the autoprocessing mechanism of fusion precursors carrying the p6*-PR miniprecursor sandwiched between various proteins or epitopes. We here report that precursor autoprocessing is context-dependent as its activity and outcomes can be modulated by sequences upstream of p6*-PR. This was exemplified by the 26aa maltose binding protein (MBP) signal peptide (SigP) when placed at the N-terminus of a fusion precursor. The mature PRs released from SigP-carrying precursors are resistant to self-degradation whereas those released from SigP-lacking fusion precursors are prone to self-degradation. A H69D mutation in PR abolished autoprocessing of SigP-containing fusion precursors whereas it only partially suppressed autoprocessing of fusion precursors lacking SigP. An autoprocessing deficient GFP fusion precursor with SigP exhibited a subcellular distribution pattern distinct from the one without it in transfected HeLa cells. Furthermore, a SigP fusion precursor carrying a substitution at the P1 position released the mature PR and PR-containing fragments that were different from those released from the precursor carrying the same mutation but lacking SigP. We also examined autoprocessing outcomes in viral particles produced by a NL4-3 derived proviral construct and demonstrated the existence of several PR-containing fragments along with the mature PR. Some of these resembled the SigP precursor autoprocessing outcomes. This finding of context-dependent modulation reveals the complexity of precursor autoprocessing regulation that most likely accompanies sequence variation imposed by the evolution of the upstream Gag moiety.	[Tien, ChihFeng; Huang, Liangqun; Speidel, Jordan T.; Chen, Chaoping] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Watanabe, Susan M.; Carter, Carol A.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [Speidel, Jordan T.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	Colorado State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Texas System; University of Texas Medical Branch Galveston	Chen, CP (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	Chaoping.Chen@colostate.edu		Chen, Chaoping/0000-0001-9387-6252	NIH [R03A1108392, R01A1120365, R01GM111028]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120365] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was in part supported by NIH R03A1108392 & R01A1120365 to CC, and R01GM111028 to CAC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cherry E, 1998, J MOL BIOL, V284, P43, DOI 10.1006/jmbi.1998.1968; Counts CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123561; FIKES JD, 1990, J BIOL CHEM, V265, P3417; FIKES JD, 1987, J BACTERIOL, V169, P2345, DOI 10.1128/jb.169.6.2345-2351.1987; Huang LQ, 2013, FUTURE MED CHEM, V5, P1215, DOI 10.4155/fmc.13.89; Huang LQ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-79; Huang LQ, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-27; Huang LQ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-24; Huang LQ, 2009, J VIROL, V83, P7789, DOI 10.1128/JVI.00473-09; Kemal KS, 2007, J INFECT DIS, V195, P535, DOI 10.1086/510855; Louis J M, 2000, Adv Pharmacol, V49, P111; LOUIS JM, 1991, EUR J BIOCHEM, V199, P361, DOI 10.1111/j.1432-1033.1991.tb16132.x; Louis JM, 1999, NAT STRUCT BIOL, V6, P868; Louis JM, 2007, ADV PHARMACOL, V55, P261, DOI 10.1016/S1054-3589(07)55008-8; Louis JM, 2011, P NATL ACAD SCI USA, V108, P9072, DOI 10.1073/pnas.1102278108; Ludwig C, 2008, J VIROL, V82, P4573, DOI 10.1128/JVI.02353-07; MILDNER AM, 1994, BIOCHEMISTRY-US, V33, P9405, DOI 10.1021/bi00198a005; Park JH, 2016, BIOCHEMISTRY-US, V55, P2390, DOI 10.1021/acs.biochem.6b00012; PARTIN K, 1991, P NATL ACAD SCI USA, V88, P4776, DOI 10.1073/pnas.88.11.4776; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Raran-Kurussi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049589; Reuten R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152386; ROSE JR, 1993, J BIOL CHEM, V268, P11939; Sun P, 2011, METHODS MOL BIOL, V705, P259, DOI 10.1007/978-1-61737-967-3_16; TOOHEY K, 1995, VIROLOGY, V213, P70, DOI 10.1006/viro.1995.1547; Watanabe SM, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0298-1; Watanabe SM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-143; Waugh DS, 2016, PROTEIN SCI, V25, P559, DOI 10.1002/pro.2863; Wehrly K, 1997, METHODS, V12, P288, DOI 10.1006/meth.1997.0481; Yu FH, 2017, J VIROL; ZYBARTH G, 1995, J VIROL, V69, P3878, DOI 10.1128/JVI.69.6.3878-3884.1995	31	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e019137	10.1371/journal.pone.0191372	http://dx.doi.org/10.1371/journal.pone.0191372			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338056	Green Published, Green Submitted, gold			2022-12-26	WOS:000422652700052
J	Kisidayova, S; Pristas, P; Zimovcakova, M; Wencelova, MB; Homol'ova, L; Mihalikova, K; Cobanova, K; Gresakova, L; Varadyova, Z				Kisidayova, Svetlana; Pristas, Peter; Zimovcakova, Michaela; Wencelova, Monika Blanar; Homol'ova, Lucia; Mihalikova, Katarina; Cobanova, Klaudia; Gresakova, L'ubomira; Varadyova, Zora			The effects of high dose of two manganese supplements (organic and inorganic) on the rumen microbial ecosystem	PLOS ONE			English	Article							IN-VITRO; CELLULOSE DIGESTION; CILIATE-FREE; SHEEP; PROTOZOA; ENZYMES; CATTLE; ZINC; FERMENTATION; RUMINANTS	Little is known about the effects of the high dose and types of manganese supplements on rumen environment at manganese intake level close above the limit of 150 mg/kg of dry feed matter. The effects of high dose of two manganese supplements (organic and inorganic) on rumen microbial ecosystem after four months of treatment of 18 lambs divided into three treatment groups were studied. We examined the enzyme activities (alpha-amylase, xylanase, and carboxymethyl cellulase), total and differential microscopic counts of rumen ciliates, total microscopic counts of bacteria, and fingerprinting pattern of the eubacterial and ciliates population analyzed by PCR-DGGE. Lambs were fed a basal diet with a basal Mn content (34.3 mg/kg dry matter; control) and supplemented either with inorganic manganous sulfate or organic Mn-chelate hydrate (daily 182.7, 184 mg/kg dry matter of feed, respectively). Basal diet, offered twice daily, consisted of ground barley and hay (268 and 732 g/kg dry matter per animal and day). The rumens of the lambs harbored ciliates of the genera of Entodinium, Epidinium, Diplodinium, Eudiplodinium, Dasytricha, and Isotricha. No significant differences between treatment groups were observed in the total ciliate number, the number of ciliates at the genus level, as well as the total number of bacteria. Organic Mn did decrease the species richness and diversity of the eubacterial population examined by PCR-DGGE. No effects of type of Mn supplement on the enzyme activities were observed. In comparison to the control, a-amylase specific activities were decreased and carboxymethyl-cellulase specific activities were increased by the Mn supplements. Xylanase activities were not influenced. In conclusion, our results suggested that the intake of tested inorganic and organic manganese supplements in excess may affect the specific groups of eubacteria. More studies on intake of Mn supplements at a level close to the limit can reveal if the changes in microbial population impact remarkably the other rumen enzymatic activities.	[Kisidayova, Svetlana; Pristas, Peter; Wencelova, Monika Blanar; Homol'ova, Lucia; Mihalikova, Katarina; Cobanova, Klaudia; Gresakova, L'ubomira; Varadyova, Zora] Slovak Acad Sci, Inst Anim Physiol, Kosice, Slovakia; [Zimovcakova, Michaela] Univ PJ Safarik, Inst Biol & Ecol, Kosice, Slovakia	Slovak Academy of Sciences; University of Pavol Jozef Safarik Kosice	Kisidayova, S (corresponding author), Slovak Acad Sci, Inst Anim Physiol, Kosice, Slovakia.	kisiday@saske.sk	Cobanova Boldizarova, Klaudia/GZG-8733-2022; Pristas, Peter/K-7512-2016; Kišidayová, Svetlana/B-7652-2008; Varadyova, Zora/P-2806-2016; Gresakova, Lubomira/ABB-1687-2021	Cobanova Boldizarova, Klaudia/0000-0001-5842-1965; Pristas, Peter/0000-0002-7948-2617; Kišidayová, Svetlana/0000-0001-6608-4903; Varadyova, Zora/0000-0003-3675-8641; Gresakova, Lubomira/0000-0002-2982-5298	Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic; Slovak Academy of Sciences [VEGA 2/0069/17]	Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic; Slovak Academy of Sciences(Slovak Academy of Sciences)	This study was funded by the Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and the Slovak Academy of Sciences VEGA 2/0069/17 to LG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agarwal N., 2015, RUMEN MICROBIOLOGY E, P17; ARAKAKI C, 1994, J GEN APPL MICROBIOL, V40, P215, DOI 10.2323/jgam.40.215; Arelovich HM, 2000, J ANIM SCI, V78, P2972; BAILEY MJ, 1992, J BIOTECHNOL, V23, P257, DOI 10.1016/0168-1656(92)90074-J; Bao YM, 2007, J APPL POULTRY RES, V16, P448, DOI 10.1093/japr/16.3.448; Belzecki G, 2005, J ANIM FEED SCI, V14, P215; Bird S., 1998, Animal Production in Australia. Proceedings of the Australian Society of Animal Production, V22, P391; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAMBERLAIN CC, 1962, J ANIM SCI, V21, P428, DOI 10.2527/jas1962.213428x; Choudhry P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148469; Crowley JD, 2000, MET IONS BIOL SYST, V37, P209; Damisa D, 2008, INT J BIOL CHEM SCI, V2, P368; Dehority B.A, 2004, RUMEN MICROBIOLOGY; DEMEYER DI, 1981, AGR ENVIRON, V6, P295, DOI 10.1016/0304-1131(81)90020-5; Eugene M, 2004, LIVEST PROD SCI, V85, P81, DOI 10.1016/S0301-6226(03)00117-9; FONTY G, 1988, CAN J MICROBIOL, V34, P235, DOI 10.1139/m88-044; Formigoni A, 2011, ANIM FEED SCI TECH, V164, P191, DOI 10.1016/j.anifeedsci.2011.01.010; Gresakova L, 2016, J TRACE ELEM MED BIO, V38, P138, DOI 10.1016/j.jtemb.2016.05.003; HENRY PR, 1992, J DAIRY SCI, V75, P3473, DOI 10.3168/jds.S0022-0302(92)78123-5; HIDIROGLOU M, 1979, CAN J ANIM SCI, V59, P217, DOI 10.4141/cjas79-028; Hook SE, 2011, MICROB ECOL, V62, P94, DOI 10.1007/s00248-011-9881-0; Horakova K., 1988, MIKROBIOLOGICKE LABO, P173; Jouany J. P., 1991, Rumen microbial metabolism and ruminant digestion., P239; Jouany JP, 1996, J NUTR, V126, pS1335, DOI 10.1093/jn/126.suppl_4.1335S; Kinal S, 2007, CZECH J ANIM SCI, V52, P423, DOI 10.17221/2338-CJAS; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Laho T, 2013, J EQUINE VET SCI, V33, P143, DOI 10.1016/j.jevs.2012.05.064; LENG RA, 1982, BRIT J NUTR, V48, P399, DOI 10.1079/BJN19820123; Loisel P, 2006, ENVIRON MICROBIOL, V8, P720, DOI 10.1111/j.1462-2920.2005.00950.x; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MARTINEZ A, 1970, J ANIM SCI, V31, P982, DOI 10.2527/jas1970.315982x; Martinez A., 1971, EFFECT SOME MAJOR TR; MASTERS DG, 1988, AUST J AGR RES, V39, P517, DOI 10.1071/AR9880517; Michalowski T, 2005, J ANIM FEED SCI, V14, P287; MILLER GL, 1960, ANAL BIOCHEM, V1, P127, DOI 10.1016/0003-2697(60)90004-X; Nubel U, 1996, J BACTERIOL, V178, P5636; Pitropovska E, 2014, ACTA VET BRNO, V83, P219, DOI [10.2754/avb201483030219, 10.2754/av]; Regensbogenova M, 2004, LETT APPL MICROBIOL, V39, P144, DOI 10.1111/j.1472-765X.2004.01542.x; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; Siritantikorn S, 2012, T ROY SOC TROP MED H, V106, P632, DOI 10.1016/j.trstmh.2012.05.004; Spears JW, 2003, J NUTR, P133; Suttle N, 2010, MINERAL NUTRITION OF LIVESTOCK, 4TH EDITION, P355, DOI 10.1079/9781845934729.0355; Tomczuk K, 2005, B VET I PULAWY, V49, P29; Van F, 2006, INT J POULT SCI, V5, P708; WALLACE RJ, 1987, BRIT J NUTR, V58, P87, DOI 10.1079/BJN19870072; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Williams A.G., 1992, RUMEN PROTOZOA	48	4	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191158	10.1371/journal.pone.0191158	http://dx.doi.org/10.1371/journal.pone.0191158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324899	gold, Green Published, Green Submitted			2022-12-26	WOS:000419952400123
J	Meers, GK; Bohnenberger, H; Reichardt, HM; Luhder, F; Reichardt, SD				Meers, Garrit K.; Bohnenberger, Hanibal; Reichardt, Holger M.; Luehder, Fred; Reichardt, Sybille D.			Impaired resolution of DSS-induced colitis in mice lacking the glucocorticoid receptor in myeloid cells	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ULCERATIVE-COLITIS; MACROPHAGES; MODEL; IBD; SUPPRESSION; ACTIVATION; THERAPIES	Inflammatory bowel disease (IBD) is a highly prevalent intestinal disorder for which no cure exists. Currently, the standard first-line treatment of IBD consists of systemic glucocorticoid (GC) application, even though therapy can be complicated by unresponsiveness or adverse effects. In view of the importance of macrophages and neutrophils for the pathogenesis of IBD we set out to define the relevance of these cell types as targets of GC using the mouse model of DSS-induced colitis. We found that the disease did not resolve in GR(lysM) mice lacking the GC receptor (GR) in myeloid cells after removal of the chemical insult. While clinical symptoms and tissue damage in the colon ameliorated again in GR(flox) mice, the disease further aggravated in GR(lysM) littermates. The observed difference coincided with an increased abundance of macrophages in inflammatory infiltrates in the colon of mutant mice whereas neutrophil and T cell numbers were similar. Concomitantly, systemic IL-6 secretion and mRNA levels of pro-inflammatory cytokines in the colon were elevated in GR(lysM) mice and gene expression of scavenger receptors and IL-10 was diminished. Taken together, our results reveal an important role of myeloid cells as targets of GC in DSS-induced colitis and probably in IBD in humans as well.	[Meers, Garrit K.; Reichardt, Holger M.; Reichardt, Sybille D.] Univ Med Ctr Goettingen, Inst Cellular & Mol Immunol, Gottingen, Germany; [Bohnenberger, Hanibal] Univ Med Ctr Goettingen, Inst Pathol, Gottingen, Germany; [Luehder, Fred] Univ Med Ctr Goettingen, Inst Multiple Sclerosis Res & Neuroimmunol, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Reichardt, SD (corresponding author), Univ Med Ctr Goettingen, Inst Cellular & Mol Immunol, Gottingen, Germany.	subille.reichardt@med.uni-goettingen.de	Bohnenberger, Hanibal/F-2317-2013; Reichardt, Holger/AAF-3048-2020	Reichardt, Holger/0000-0003-4647-057X				AlSharari SD, 2013, J PHARMACOL EXP THER, V344, P207, DOI 10.1124/jpet.112.198796; Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Bouguen G, 2015, GUT, V64, P901, DOI 10.1136/gutjnl-2014-307618; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Crielaard BJ, 2011, INT J PHARMACEUT, V416, P499, DOI 10.1016/j.ijpharm.2010.12.045; Danese S, 2011, NEW ENGL J MED, V365, P1713, DOI 10.1056/NEJMra1102942; Do A, 2017, J PHARMACOL EXP THER, V360, P140, DOI 10.1124/jpet.116.236711; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Graversen JH, 2012, MOL THER, V20, P1550, DOI 10.1038/mt.2012.103; Heinsbroek SEM, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001069; Kerr TA, 2012, INFLAMM BOWEL DIS, V18, P344, DOI 10.1002/ibd.21763; Kersting S, 2013, J INFLAMM RES, V6, P71, DOI 10.2147/JIR.S40092; Kleiman A, 2012, FASEB J, V26, P722, DOI 10.1096/fj.11-192112; Kojouharoff G, 1997, CLIN EXP IMMUNOL, V107, P353, DOI 10.1111/j.1365-2249.1997.291-ce1184.x; Lim HY, 2007, IMMUNOLOGY, V122, P47, DOI 10.1111/j.1365-2567.2007.02611.x; Luhder F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091836; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Montes-Cobos E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01319; Montes-Cobos E, 2017, J CONTROL RELEASE, V245, P157, DOI 10.1016/j.jconrel.2016.12.003; Perez-Lopez A, 2016, NAT REV IMMUNOL, V16, P135, DOI 10.1038/nri.2015.17; Pithadia AB, 2011, PHARMACOL REP, V63, P629, DOI 10.1016/S1734-1140(11)70575-8; Platt AM, 2008, IMMUNOL LETT, V119, P22, DOI 10.1016/j.imlet.2008.05.009; Platt AM, 2010, J IMMUNOL, V184, P6843, DOI 10.4049/jimmunol.0903987; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Reber SO, 2006, ENDOCRINOLOGY, V147, P4968, DOI 10.1210/en.2006-0347; Reichardt SD, 2014, ENDOCRINOLOGY, V155, P3899, DOI 10.1210/en.2014-1246; Ren K, 2015, CLIN IMMUNOL, V160, P71, DOI 10.1016/j.clim.2015.03.027; Ren K, 2014, J CONTROL RELEASE, V175, P1, DOI 10.1016/j.jconrel.2013.11.024; Ricart E, 2013, CURR DRUG TARGETS, V14, P1453, DOI 10.2174/13894501113146660234; Schweingruber N, 2011, J IMMUNOL, V187, P4310, DOI 10.4049/jimmunol.1101604; Shah B, 2010, EXPERT REV CLIN IMMU, V6, P607, DOI [10.1586/eci.10.45, 10.1586/ECI.10.45]; Stevceva Liljana, 2001, BMC Clin Pathol, V1, P3, DOI 10.1186/1472-6890-1-3; Svendsen P, 2017, MOL THER-METH CLIN D, V4, P50, DOI 10.1016/j.omtm.2016.11.004; Taves MD, 2011, AM J PHYSIOL-ENDOC M, V301, pE11, DOI 10.1152/ajpendo.00100.2011; Tuckermann JP, 2007, J CLIN INVEST, V117, P1381, DOI 10.1172/JCI28034; Tuckermann JP, 2005, CRIT REV CL LAB SCI, V42, P71, DOI 10.1080/10408360590888983; Uhmann A, 2011, J IMMUNOL, V186, P3383, DOI 10.4049/jimmunol.1001939; Vettorazzi S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8796; Whittem C.G., 2010, J VIS EXP; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wust S, 2008, J IMMUNOL, V180, P8434, DOI 10.4049/jimmunol.180.12.8434; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073	43	32	32	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190846	10.1371/journal.pone.0190846	http://dx.doi.org/10.1371/journal.pone.0190846			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324769	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400062
J	Wong, MYZ; Man, REK; Fenwick, EK; Gupta, P; Li, LJ; van Dam, RM; Chong, MF; Lamoureux, EL				Wong, Mark Y. Z.; Man, Ryan E. K.; Fenwick, Eva K.; Gupta, Preeti; Li, Ling-Jun; van Dam, Rob M.; Chong, Mary F.; Lamoureux, Ecosse L.			Dietary intake and diabetic retinopathy: A systematic review	PLOS ONE			English	Review							POLYUNSATURATED FATTY-ACIDS; ALCOHOL-CONSUMPTION; MEDITERRANEAN DIET; ATHEROSCLEROSIS RISK; CALORIC RESTRICTION; JAPANESE PATIENTS; OXIDATIVE STRESS; GLYCEMIC INDEX; MACULAR EDEMA; REDUCED ODDS	Introduction The evidence linking dietary intake with diabetic retinopathy (DR) is growing but unclear. We conducted a systematic review of the association between dietary intake and DR. Methods We systematically searched PubMed, Embase, Medline, and the Cochrane Central register of controlled trials, for publications between January 1967 and January 2017 using standardized criteria for diet and DR. Interventional and observational studies investigating micro- and macro-nutrient intakes; food and beverage consumptions; and dietary patterns were included. Study quality was evaluated using a modified Newcastle-Ottawa scale for observational studies, and the Cochrane collaboration tool for interventional studies. Results Of 4265 titles initially identified, 31 studies (3 interventional, 28 Observational) were retained. Higher intakes of dietary fibre, oily fish, and greater adherence to a Mediterranean diet were protective of DR. Conversely, high total caloric intake was associated with higher risk of DR. No significant associations of carbohydrate, vitamin D, and sodium intake with DR were found. Associations of antioxidants, fatty acids, proteins and alcohol with DR remain equivocal. Conclusions Dietary fibre, oily fish, a Mediterranean diet and a reduced caloric intake are associated with lower risk of DR. Longitudinal data and interventional models are warranted to confirm our findings and better inform clinical guidelines.	[Wong, Mark Y. Z.; Man, Ryan E. K.; Fenwick, Eva K.; Gupta, Preeti; Li, Ling-Jun; Lamoureux, Ecosse L.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Fenwick, Eva K.; Li, Ling-Jun; Lamoureux, Ecosse L.] Off Clin Sci, Duke NUS Med Sch, Singapore, Singapore; [van Dam, Rob M.; Chong, Mary F.] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [van Dam, Rob M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Chong, Mary F.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; National University of Singapore	Lamoureux, EL (corresponding author), Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore.; Lamoureux, EL (corresponding author), Off Clin Sci, Duke NUS Med Sch, Singapore, Singapore.	ecosse.lamoureux@duke-nus.edu.sg	van Dam, Rob M/F-9674-2010; Lamoureux, Ecosse/Z-5482-2019	van Dam, Rob M/0000-0002-7354-8734; Lamoureux, Ecosse/0000-0001-8674-5705; Man, Ryan/0000-0001-5028-605X				Alcubierre N, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0099-5; Alcubierre N, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/374178; Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS23, DOI 10.2337/dc16-S006; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; [Anonymous], 1991, Ophthalmology, V98, P786; Archer DB, 1999, EYE, V13, P497, DOI 10.1038/eye.1999.130; Beulens JWJ, 2008, DIABETOLOGIA, V51, P1631, DOI 10.1007/s00125-008-1091-z; Blackwood AD, 2000, J R SOC PROMO HEALTH, V120, P242, DOI 10.1177/146642400012000412; Burrows T, 2017, J HUM NUTR DIET, V30, P117, DOI 10.1111/jhn.12407; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Chiu CJ, 2011, PROG RETIN EYE RES, V30, P18, DOI 10.1016/j.preteyeres.2010.09.001; Chmielowska M, 2017, SOCIAL PSYCHIAT PSYC, P1; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Cundiff DK, 2005, MEDGENMED MEDSCAPE G, V7; Das UN, 2013, NUTRITION, V29, P1, DOI 10.1016/j.nut.2012.02.003; Deeks J J, 2003, Health Technol Assess, V7, piii; Diaz-Lopez A, 2015, DIABETES CARE, V38, P2134, DOI 10.2337/dc15-1117; Engelen L, 2014, DIABETOLOGIA, V57, P2315, DOI 10.1007/s00125-014-3367-9; Evert AB, 2013, DIABETES CARE, V36, P3821, DOI 10.2337/dc13-2042; Fenwick EK, 2015, J DIABETES COMPLICAT, V29, P1009, DOI 10.1016/j.jdiacomp.2015.09.001; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Franz MJ, 2007, DIABETES SPECTRUM; Funnell M.M., 2004, CLIN DIABETES, V22, P123, DOI [10.2337/diaclin.22.3.123, DOI 10.2337/DIACLIN.22.3.123]; Ganesan S, 2012, CLIN EXP OPHTHALMOL, V40, P288, DOI 10.1111/j.1442-9071.2011.02594.x; Giuffre G, 2004, GRAEF ARCH CLIN EXP, V242, P535, DOI 10.1007/s00417-004-0880-4; Greenfield JR, 2003, DIABETES CARE, V26, P2734, DOI 10.2337/diacare.26.10.2734; Harjutsalo V, 2014, DIABETIC MED, V31, P156, DOI 10.1111/dme.12307; Herzog R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-154; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Horikawa C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020113; Horikawa C, 2014, J CLIN ENDOCR METAB, V99, P3635, DOI 10.1210/jc.2013-4315; HOUTSMULLER AJ, 1980, DOC OPHTHALMOL, V48, P363, DOI 10.1007/BF00141465; HOWARDWILLIAMS J, 1985, BRIT J OPHTHALMOL, V69, P15, DOI 10.1136/bjo.69.1.15; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Kowluru R. A., 2005, Current Topics in Nutraceutical Research, V3, P209; Kowluru RA, 2008, INVEST OPHTH VIS SCI, V49, P1645, DOI 10.1167/iovs.07-0764; Kumari N., 2014, ALL RES J BIOL, V5; Lee C, 2009, DIABETES, V58; Lee CTC, 2010, OPHTHALMOLOGY, V117, P71, DOI 10.1016/j.ophtha.2009.06.040; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lo CKL, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-45; Lopez JMS, 2016, BMC ENDOCR DISORD, V16, DOI 10.1186/s12902-016-0122-x; Lottenberg AM, 2012, J NUTR BIOCHEM, V23, P1027, DOI 10.1016/j.jnutbio.2012.03.004; Lugo-Radillo A, 2015, INT J DIABETES DEV C, V35, pS375, DOI 10.1007/s13410-015-0360-x; Ma Q, 2014, CRIT REV FOOD SCI, V54, P1, DOI 10.1080/10408398.2011.565523; Ma QH, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/231570; Madsen-Bouterse SA, 2008, REV ENDOCR METAB DIS, V9, P315, DOI 10.1007/s11154-008-9090-4; Mahoney SE, 2014, J DIABETES COMPLICAT, V28, P767, DOI 10.1016/j.jdiacomp.2014.06.011; Martinez-Gonzalez MA, 2015, PROG CARDIOVASC DIS, V58, P50, DOI 10.1016/j.pcad.2015.04.003; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Mayer-Davis EJ, 1998, OPHTHALMOLOGY, V105, P2264, DOI 10.1016/S0161-6420(98)91227-1; McPheeters Melissa L, 2012, Evid Rep Technol Assess (Full Rep), P1; Millen AE, 2004, AM J CLIN NUTR, V79, P865; Millen AE, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0434-1; Moeller S. M., 2007, Journal of the American Dietetic Association, V107, P1233, DOI 10.1016/j.jada.2007.03.014; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; MOSS SE, 1992, OPHTHALMOLOGY, V99, P926; MOSS SE, 1994, OPHTHALMOLOGY, V101, P1962; Murakami K, 2010, MOL NUTR FOOD RES, V54, P471, DOI 10.1002/mnfr.200900157; O'Neil A, 2014, AM J PUBLIC HEALTH, V104, pE31, DOI 10.2105/AJPH.2014.302110; Ros E, 2014, ADV NUTR, V5, p330S, DOI 10.3945/an.113.005389; Roy MS, 2010, ARCH OPHTHALMOL-CHIC, V128, P33, DOI 10.1001/archophthalmol.2009.358; ROY MS, 1989, AM J CLIN NUTR, V50, P728, DOI 10.1093/ajcn/50.4.728; Safi SZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/801269; Sahli MW, 2016, OPHTHAL EPIDEMIOL, V23, P99, DOI 10.3109/09286586.2015.1129426; Sala-Vila A, 2016, JAMA OPHTHALMOL, V134, P1142, DOI 10.1001/jamaophthalmol.2016.2906; Salas-Salvado J, 2014, ANN INTERN MED, V160, P1, DOI 10.7326/M13-1725; Sanhueza C, 2013, J HUM NUTR DIET, V26, P56, DOI 10.1111/j.1365-277X.2012.01283.x; Sapieha P, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.10; Sasaki M, 2015, INVEST OPHTH VIS SCI, V56, P7473, DOI 10.1167/iovs.15-17485; Sharma Y, 2017, EUROPEAN J NUTR; Shim JS, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014009; Skrha J, 2005, PHYSIOL RES, V54, P33, DOI 10.33549/physiolres.930584; Tanaka S, 2012, DIABETES, V61, pA77; Thomas D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006296.pub2; Tikhonenko M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055177; Toledo E, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-207; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wang SQ, 2008, SURV OPHTHALMOL, V53, P512, DOI 10.1016/j.survophthal.2008.06.003; Weindruch R, 2001, J GERONTOL A-BIOL, V56, P20, DOI 10.1093/gerona/56.suppl_1.20; Wells GA, 2011, NEWCASTLE OTTAWA SCA; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Williams M, 2013, CURR DIABETES REP, V13, P481, DOI 10.1007/s11892-013-0384-x; Wong TY, 2016, DIABETIC RETINOPATHY, V2, P16012; YOUNG RJ, 1984, BRIT MED J, V288, P1035, DOI 10.1136/bmj.288.6423.1035; Zhu W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00034-w	88	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0186582	10.1371/journal.pone.0186582	http://dx.doi.org/10.1371/journal.pone.0186582			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324740	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400002
J	Hatazawa, Y; Qian, K; Gong, DW; Kamei, Y				Hatazawa, Yukino; Qian, Kun; Gong, Da-Wei; Kamei, Yasutomi			PGC-1 alpha regulates alanine metabolism in muscle cells	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; RECEPTOR; ALPHA	The skeletal muscle is the largest organ in the human body, depositing energy as protein/amino acids, which are degraded in catabolic conditions such as fasting. Alanine is synthesized and secreted from the skeletal muscle that is used as substrates of gluconeogenesis in the liver. During fasting, the expression of PGC-1 alpha, a transcriptional coactivator of nuclear receptors, is increased in the liver and regulates gluconeogenesis. In the present study, we observed increased mRNA expression of PGC-1 alpha and alanine aminotransferase 2 (ALT2) in the skeletal muscle during fasting. In C2C12 myoblast cells overexpressing PGC-1 alpha, ALT2 expression was increased concomitant with an increased alanine level in the cells and medium. In addition, PGC-1 alpha, along with nuclear receptor ERR, dose-dependently enhanced the ALT2 promoter activity in reporter assay using C2C12 cells. In the absence of glucose in the culture medium, mRNA levels of PGC-1 alpha and ALT2 increased. Endogenous PGC-1 alpha knockdown in C2C12 cells reduced ALT2 gene expression level, induced by the no-glucose medium. Taken together, in the skeletal muscle, PGC-1 alpha activates ALT2 gene expression, and alanine production may play roles in adaptation to fasting.	[Hatazawa, Yukino; Kamei, Yasutomi] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Lab Mol Nutr, Kyoto, Japan; [Hatazawa, Yukino] Japan Soc Promot Sci, Tokyo, Japan; [Qian, Kun] Chongqing Med Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Chongqing, Peoples R China; [Gong, Da-Wei] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA	Kyoto Prefectural University; Japan Society for the Promotion of Science; Chongqing Medical University; University System of Maryland; University of Maryland Baltimore	Kamei, Y (corresponding author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Lab Mol Nutr, Kyoto, Japan.	kamei@kpu.ac.jp	Gong, Dawei/AAB-4283-2020		Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT, Tokyo); Council for Science, Technology, and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP); Technologies for creating next-generation agriculture, forestry and fisheries (funding agency: Bio-oriented Technology Research Advancement Institution, NARO); Grants-in-Aid for Scientific Research [16H04926] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT, Tokyo)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Council for Science, Technology, and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP); Technologies for creating next-generation agriculture, forestry and fisheries (funding agency: Bio-oriented Technology Research Advancement Institution, NARO); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is supported by grants-in-aid for scientific research (KAKENHI) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT, Tokyo). This study is also supported by the Council for Science, Technology, and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP), and Technologies for creating next-generation agriculture, forestry and fisheries (funding agency: Bio-oriented Technology Research Advancement Institution, NARO). The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.; Microarray data analysis was, in part, performed at the Medical Research Support Center, Graduate School of Medicine, Kyoto University. This study is supported by grants-in-aid for scientific research (KAKENHI) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (MEXT, Tokyo). This study is also supported by the Council for Science, Technology, and Innovation (CSTI), Cross-ministerial Strategic Innovation Promotion Program (SIP), and "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO). The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bonnelye E, 1997, MOL ENDOCRINOL, V11, P905, DOI 10.1210/me.11.7.905; FELIG P, 1973, METABOLISM, V22, P179, DOI 10.1016/0026-0495(73)90269-2; Hatazawa Y, 2016, BIOCHEM BIOPH RES CO, V481, P251, DOI 10.1016/j.bbrc.2016.10.133; Hatazawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129084; Hatazawa Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091006; Jadaho SB, 2004, HEPATOLOGY, V39, P1297, DOI 10.1002/hep.20182; Jeyaraj D, 2012, CELL METAB, V15, P311, DOI 10.1016/j.cmet.2012.01.020; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kamei Y, 2014, AM J PHYSIOL-ENDOC M, V307, pE485, DOI 10.1152/ajpendo.00177.2014; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Qian K, 2015, DIABETES-METAB RES, V31, P562, DOI 10.1002/dmrr.2655; Reagan WJ, 2012, TOXICOL PATHOL, V40, P1117, DOI 10.1177/0192623312447550; Shimizu N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7693; Thulin P, 2008, TOXICOL APPL PHARM, V231, P1, DOI 10.1016/j.taap.2008.03.007; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200	18	13	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190904	10.1371/journal.pone.0190904	http://dx.doi.org/10.1371/journal.pone.0190904			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315328	Green Published, gold, Green Submitted			2022-12-26	WOS:000419655900031
J	Lopes, F; Keita, AV; Saxena, A; Reyes, JL; Mancini, NL; Al Rajabi, A; Wang, A; Baggio, CH; Dicay, M; van Dalen, R; Ahn, Y; Carneiro, MBH; Peters, NC; Rho, JM; MacNaughton, WK; Girardin, SE; Jijon, H; Philpott, DJ; Soderholm, JD; McKay, DM				Lopes, Fernando; Keita, Asa V.; Saxena, Alpana; Reyes, Jose Luis; Mancini, Nicole L.; Al Rajabi, Ala; Wang, Arthur; Baggio, Cristiane H.; Dicay, Michael; van Dalen, Rob; Ahn, Younghee; Carneiro, Matheus B. H.; Peters, Nathan C.; Rho, Jong M.; MacNaughton, Wallace K.; Girardin, Stephen E.; Jijon, Humberto; Philpott, Dana J.; Soderholm, Johan D.; McKay, Derek M.			ER-stress mobilization of death-associated protein kinase-1-dependent xenophagy counteracts mitochondria stress-induced epithelial barrier dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; FOLLICLE-ASSOCIATED EPITHELIUM; CROHNS-DISEASE; ANTIINFLAMMATORY DRUGS; ESCHERICHIA-COLI; DAP-KINASE; ACTIVATION; EXPRESSION; AUTOPHAGY; BACTERIA	The gut microbiome contributes to inflammatory bowel disease (IBD), in which bacteria can be present within the epithelium. Epithelial barrier function is decreased in IBD, and dysfunctional epithelial mitochondria and endoplasmic reticulum (ER) stress have been individually associated with IBD. We therefore hypothesized that the combination of ER and mitochondrial stresses significantly disrupt epithelial barrier function. Here, we treated human colonic biopsies, epithelial colonoids, and epithelial cells with an uncoupler of oxidative phosphorylation, dinitrophenol (DNP), with or without the ER stressor tunicamycin and assessed epithelial barrier function by monitoring internalization and translocation of commensal bacteria. We also examined barrier function and colitis in mice exposed to dextran sodium sulfate (DSS) or DNP and co-treated with DAPK6, an inhibitor of death-associated protein kinase 1 (DAPK1). Contrary to our hypothesis, induction of ER stress (i.e. the unfolded protein response) protected against decreased barrier function caused by the disruption of mitochondrial function. ER stress did not prevent DNP-driven uptake of bacteria; rather, specific mobilization of the ATF6 arm of ER stress and recruitment of DAP K1 resulted in enhanced autophagic killing (xenophagy) of bacteria. Of note, epithelia with a Crohn's disease susceptibility mutation in the autophagy gene ATG16L.1 exhibited less xenophagy. Systemic delivery of the DAPK1 inhibitor DAPK6 increased bacterial translocation in DSS- or DNP-treated mice. We conclude that promoting ER stress ATF6 DAPK1 signaling in transporting enterocytes counters the transcellular passage of bacteria evoked by dysfunctional mitochondria, thereby reducing the potential for metabolic stress to reactivate or perpetuate inflammation.	[Lopes, Fernando; Saxena, Alpana; Reyes, Jose Luis; Mancini, Nicole L.; Al Rajabi, Ala; Wang, Arthur; Baggio, Cristiane H.; Dicay, Michael; MacNaughton, Wallace K.; McKay, Derek M.] Univ Calgary, Calvin Joan & Phoebe Snyder Inst Chron Dis, Gastrointestinal Res Grp, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Jijon, Humberto] Univ Calgary, Calvin Joan & Phoebe Snyder Inst Chron Dis, Gastrointestinal Res Grp, Dept Med, Calgary, AB T2N 4N1, Canada; [Ahn, Younghee; Rho, Jong M.] Univ Calgary, Cumming Sch Med, Dept Pediat, Calgary, AB T2N 4N1, Canada; [Ahn, Younghee; Rho, Jong M.] Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB T2N 4N1, Canada; [Ahn, Younghee; Rho, Jong M.] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; [Carneiro, Matheus B. H.; Peters, Nathan C.] Univ Calgary, Cumming Sch Med, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 4N1, Canada; [Keita, Asa V.; Soderholm, Johan D.] Linkoping Univ, Dept Clin & Expt Med, Div Surg, S-58183 Linkoping, Sweden; [van Dalen, Rob; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada; [Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A1, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; Linkoping University; University of Toronto; University of Toronto	Lopes, F; McKay, DM (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Hsc 1877,3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	flopes77@gmail.com; dmckay@ucalgary.ca	van Dalen, Rob/ABA-8185-2020; Mir, Rashid/GOV-3522-2022; McKay, Derek/HCH-3240-2022; Mir, Rashid/AAH-1895-2019; Rajabi, Ala/AAX-7743-2020; Wang, Arthur/AAE-3368-2019; Baggio, Cristiane H/C-5633-2013; Peters, Nathan/AAW-8289-2020; van Dalen, Rob/HHM-8915-2022; Reyes, Jose Luis/D-8322-2018	Rajabi, Ala/0000-0003-2426-6279; Baggio, Cristiane H/0000-0001-5536-7561; Peters, Nathan/0000-0002-2548-9581; van Dalen, Rob/0000-0002-0436-6048; Reyes, Jose Luis/0000-0003-0089-0261; Keita, Asa/0000-0002-6820-0215	Canadian Institutes for Health Research Operating Grant [MPO-126005]; Canadian Institutes for Health Research/Canadian Association of Gastroenterology/Allergan, Inc.; Alberta Innovates-Health Solutions post-doctoral fellowships; Alberta Innovates [201500767] Funding Source: researchfish	Canadian Institutes for Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Canadian Institutes for Health Research/Canadian Association of Gastroenterology/Allergan, Inc.(Canadian Institutes of Health Research (CIHR)); Alberta Innovates-Health Solutions post-doctoral fellowships; Alberta Innovates	This work was supported in part by Canadian Institutes for Health Research Operating Grant MPO-126005 (to D.M.M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Canadian Institutes for Health Research/Canadian Association of Gastroenterology/Allergan, Inc., and Alberta Innovates-Health Solutions post-doctoral fellowships.	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Begun J, 2015, CELL REP, V11, P1905, DOI 10.1016/j.celrep.2015.05.045; Bogaert S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025589; Brandl K, 2009, P NATL ACAD SCI USA, V106, P3300, DOI 10.1073/pnas.0813036106; Cao SS, 2013, GASTROENTEROLOGY, V144, P989, DOI 10.1053/j.gastro.2013.01.023; Chu HT, 2016, SCIENCE, V352, P1116, DOI 10.1126/science.aad9948; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Diamanti MA, 2017, J EXP MED, V214, P423, DOI 10.1084/jem.20161867; Drion CM, 2016, EPILEPSIA, V57, P688, DOI 10.1111/epi.13345; Elliott TR, 2013, INFLAMM BOWEL DIS, V19, P2326, DOI 10.1097/MIB.0b013e3182a38a92; Fernando EH, 2017, AM J PHYSIOL-GASTR L, V313, pG467, DOI 10.1152/ajpgi.00152.2017; Gade P, 2016, J BIOL CHEM, V291, P22030, DOI 10.1074/jbc.M116.725796; Gade P, 2012, P NATL ACAD SCI USA, V109, P10316, DOI 10.1073/pnas.1119273109; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Grootjans J, 2016, NAT REV IMMUNOL, V16, P469, DOI 10.1038/nri.2016.62; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Inoue Y, 2017, FEBS LETT, V591, P3682, DOI 10.1002/1873-3468.12869; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaur M, 2016, INFLAMM BOWEL DIS, V22, P862, DOI 10.1097/MIB.0000000000000705; Keestra-Gounder AM, 2016, NATURE, V532, P394, DOI 10.1038/nature17631; Keita AC, 2008, J PATHOL, V215, P135, DOI 10.1002/path.2337; Keita AV, 2006, LAB INVEST, V86, P504, DOI 10.1038/labinvest.3700397; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Klein A, 2010, PHARMACEUTICALS, V3, P1084, DOI 10.3390/ph3041084; Kuoa SY, 2015, P NATL ACAD SCI USA, V112, pE4281, DOI 10.1073/pnas.1512289112; Kvasnovsky CL, 2015, SCAND J GASTROENTERO, V50, P255, DOI 10.3109/00365521.2014.966753; Lassen KG, 2014, P NATL ACAD SCI USA, V111, P7741, DOI 10.1073/pnas.1407001111; Lewis K, 2010, INFLAMM BOWEL DIS, V16, P1138, DOI 10.1002/ibd.21177; Ling YH, 2009, CANCER CHEMOTH PHARM, V64, P539, DOI 10.1007/s00280-008-0902-8; Marchi S, 2014, BBA-BIOENERGETICS, V1837, P461, DOI 10.1016/j.bbabio.2013.10.015; Matsuzawa-Ishimoto Y, 2017, J EXP MED, V214, P3687, DOI 10.1084/jem.20170558; Merrill NM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184909; Mitsui Y, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1951-0; Moussata D, 2011, GUT, V60, P26, DOI 10.1136/gut.2010.213264; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Nazli A, 2004, AM J PATHOL, V164, P947, DOI 10.1016/S0002-9440(10)63182-3; Oancea I, 2017, GUT, V66, P59, DOI 10.1136/gutjnl-2015-310874; Odenwald MA, 2017, NAT REV GASTRO HEPAT, V14, P9, DOI 10.1038/nrgastro.2016.169; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rath E, 2012, INFLAMM BOWEL DIS, V18, P1364, DOI 10.1002/ibd.21944; Ravindran R, 2016, NATURE, V531, P523, DOI 10.1038/nature17186; Russell RK, 2006, GUT, V55, P1114, DOI 10.1136/gut.2005.082107; Sadabad MS, 2015, GUT, V64, P1546, DOI 10.1136/gutjnl-2014-307289; Saxena A, 2017, AM J PHYSIOL-GASTR L, V313, pG26, DOI 10.1152/ajpgi.00070.2017; Schoultz I, 2012, AM J PHYSIOL-GASTR L, V303, pG536, DOI 10.1152/ajpgi.00125.2012; Schoultz I, 2011, INFLAMM BOWEL DIS, V17, P2008, DOI 10.1002/ibd.21556; Shen T, 2017, INT J BIOCHEM CELL B, V89, P207, DOI 10.1016/j.biocel.2017.06.012; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Somasundaram S, 2000, ALIMENT PHARM THER, V14, P639; Tang HW, 2013, DEV CELL, V27, P489, DOI 10.1016/j.devcel.2013.10.017; Tschurtschenthaler M, 2017, J EXP MED, V214, P401, DOI 10.1084/jem.20160791; van de Beek MC, 2017, BBA-MOL BASIS DIS, V1863, P2255, DOI 10.1016/j.bbadis.2017.06.003; Wallon C, 2005, SCAND J GASTROENTERO, V40, P586, DOI 10.1080/00365520510012235; Wang A, 2014, AM J PATHOL, V184, P2516, DOI 10.1016/j.ajpath.2014.05.019; Wang Z, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00358; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yui SR, 2012, NAT MED, V18, P618, DOI 10.1038/nm.2695; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zhang CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179042; Zhang HS, 2015, J BIOL CHEM, V290, P15327, DOI 10.1074/jbc.M114.633560; Zhang QW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02142	61	21	21	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3073	3087		10.1074/jbc.RA117.000809	http://dx.doi.org/10.1074/jbc.RA117.000809			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29317503	Green Published, hybrid			2022-12-26	WOS:000426562800004
J	Martin, B; Gabris-Weber, BA; Reddy, R; Romero, G; Chattopadhyay, A; Salama, G				Martin, Brian; Gabris-Weber, Beth Ann; Reddy, Rajiv; Romero, Guillermo; Chattopadhyay, Ansuman; Salama, Guy			Relaxin reverses inflammatory and immune signals in aged hearts	PLOS ONE			English	Article							DIFFERENTIATION FACTOR 15; ATRIAL-FIBRILLATION; FAILURE; EXPRESSION; FIBROSIS; SERELAXIN; ARTERIAL; INSIGHTS; DEATH; CELLS	Background 'Healthy' aging drives structural and functional changes in the heart including maladaptive electrical remodeling, fibrosis and inflammation, which lower the threshold for cardiovascular diseases such as heart failure (HF) and atrial fibrillation (AF). Despite mixed results in recent clinical trials, Relaxin-therapy for 2-days could reduce mortality by 37% at 180-days post-treatment, in patients with acute decompensated HF. Relaxin's short life-span (hours) but long-lasting protective actions led us to test the hypothesis that relaxin acts at a genomic level to reverse maladaptive remodeling in aging and HF. Methods and results Young (9-month) and aged (24-month), male and female F-344/Brown Norway rats were treated with relaxin (0.4 mg/kg/day) for 2-weeks delivered by subcutaneous osmotic mini-pumps or with sodium acetate (controls). The genomic effects of aging and relaxin were evaluated by extracting RNA from the left ventricles and analyzing genomic changes by RNA-sequencing, Ingenuity Pathway Analysis, MetaCore and tissue immunohistochemistry. We found that aging promotes a native inflammatory response with distinct sex-differences and relaxin suppresses transcription of multiple genes and signaling pathways associated with inflammation and HF in both genders. In addition, aging significantly increased: macrophage infiltration and atrial natriuretic peptide levels in female ventricles, and activation of the complement cascade, whereas relaxin reversed these age-related effects. Conclusion These data support the hypothesis that relaxin alters gene transcription and suppresses inflammatory pathways and genes associated with HF and aging. Relaxin's suppression of inflammation and fibrosis supports its potential as a therapy for cardiovascular and inflammation-related diseases, such as HF, AF and diabetes.	[Martin, Brian; Salama, Guy] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Martin, Brian; Gabris-Weber, Beth Ann; Reddy, Rajiv; Salama, Guy] Univ Pittsburgh, Sch Med, Heart & Vasc Inst, Pittsburgh, PA 15260 USA; [Romero, Guillermo] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Chattopadhyay, Ansuman] Univ Pittsburgh, Mol Biol Informat Serv, Hlth Sci Lib Syst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Salama, G (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.; Salama, G (corresponding author), Univ Pittsburgh, Sch Med, Heart & Vasc Inst, Pittsburgh, PA 15260 USA.	gsalama@pitt.edu	Salama, Guy/GWQ-9862-2022	Chattopadhyay, Ansuman/0000-0002-5412-3749; Salama, Guy/0000-0002-5306-8178	Samuel and Emma Winters Foundation; University of Pittsburgh School of Medicine Bridge Funds; Vascular Medicine Institute/Heart and Vascular Institute of the University of Pittsburgh	Samuel and Emma Winters Foundation; University of Pittsburgh School of Medicine Bridge Funds; Vascular Medicine Institute/Heart and Vascular Institute of the University of Pittsburgh	This work was supported by Samuel and Emma Winters Foundation (GS), the University of Pittsburgh School of Medicine Bridge Funds (GS), and the Innovator Award from the Vascular Medicine Institute/Heart and Vascular Institute of the University of Pittsburgh (GS).	Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bacchiega BC, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005038; Berger A, 2000, BRIT MED J, V321, P424, DOI 10.1136/bmj.321.7258.424; Boluyt MO, 2004, J APPL PHYSIOL, V96, P822, DOI 10.1152/japplphysiol.01026.2003; BRANDT RR, 1993, J AM COLL CARDIOL, V22, pA86, DOI 10.1016/0735-1097(93)90468-G; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; Chan MMY, 2016, EUR J HEART FAIL, V18, P81, DOI 10.1002/ejhf.431; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Debrah DO, 2005, HYPERTENSION, V46, P745, DOI 10.1161/01.HYP.0000184230.52059.33; Du XJ, 2010, NAT REV CARDIOL, V7, P48, DOI 10.1038/nrcardio.2009.198; Duncan Bruce B, DIABETES, V52, P1799; Felker GM, 2014, J AM COLL CARDIOL, V64, P1591, DOI 10.1016/j.jacc.2014.05.071; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Freeley M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00227; Fric J, 2012, BLOOD, V120, P1380, DOI 10.1182/blood-2012-02-404475; Gaggin HK, 2013, BBA-MOL BASIS DIS, V1832, P2442, DOI 10.1016/j.bbadis.2012.12.014; Ghosh RK, 2016, CARDIOVASC THER; Hayashi H, 2002, J CARDIOVASC ELECTR, V13, P801, DOI 10.1046/j.1540-8167.2002.00801.x; Henry BL, 2016, HEART RHYTHM, V13, P983, DOI 10.1016/j.hrthm.2015.12.030; Himes BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099625; Hofmann U, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0356-y; Hohensinner PJ, 2011, CURR OPIN INFECT DIS, V24, P259, DOI 10.1097/QCO.0b013e328344f50f; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Huerta A, 2016, J HYPERTENS, V34, P130, DOI 10.1097/HJH.0000000000000757; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kraakman MJ, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.31; Lakatta EG, 2015, J MOL CELL CARDIOL, V83, P1, DOI 10.1016/j.yjmcc.2015.04.005; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Lekgabe ED, 2005, HYPERTENSION, V46, P412, DOI 10.1161/01.HYP.0000171930.00697.2f; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Licastro Federico, 2005, Immun Ageing, V2, P8; Lin Q, 2011, J IMMUNOL, V186, P3710, DOI 10.4049/jimmunol.1003007; Lind L, 2016, HEART; Liu JQ, 2016, CLIN MED INSIGHTS-CA, V10, P79, DOI 10.4137/CMC.S33164; Lohning M, 2003, J EXP MED, V197, P181, DOI 10.1084/jem.20020632; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Muehlschlegel JD, 2015, ANESTHESIOLOGY, V122, P537, DOI 10.1097/ALN.0000000000000582; Parikh A, 2013, CIRC RES, V113, P313, DOI 10.1161/CIRCRESAHA.113.301646; Parini P, 1999, ARTERIOSCL THROM VAS, V19, P832, DOI 10.1161/01.ATV.19.4.832; Platonov PG, 2011, J AM COLL CARDIOL, V58, P2225, DOI 10.1016/j.jacc.2011.05.061; Samuel CS, 2004, ENDOCRINOLOGY, V145, P4125, DOI 10.1210/en.2004-0209; Sangaralingham SJ, 2011, HYPERTENSION, V57, P201, DOI 10.1161/HYPERTENSIONAHA.110.160796; Savio-Galimberti Eleonora, 2014, Card Electrophysiol Clin, V6, P741; Schmied M, 1993, AM J PATHOLOGY, V143; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Teichman Sam L, 2010, Curr Heart Fail Rep, V7, P75, DOI 10.1007/s11897-010-0010-z; Thaker Youg R, 2015, INFLAMMATION CELL SI, V2, pe613; Wallentin L, 2014, CIRCULATION, V130, P1847, DOI 10.1161/CIRCULATIONAHA.114.011204; Yang Jialiang, 2015, NATURE, V5; Zahn JM, 2007, PLOS GENET, V3, P2326, DOI 10.1371/journal.pgen.0030201	58	19	19	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190935	10.1371/journal.pone.0190935	http://dx.doi.org/10.1371/journal.pone.0190935			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346407	Green Published, gold, Green Submitted			2022-12-26	WOS:000422749500021
J	Palanisamy, A; Kannappan, R; Xu, ZQ; Martino, A; Friese, MB; Boyd, JD; Crosby, G; Culley, DJ				Palanisamy, Arvind; Kannappan, Ramaswamy; Xu, Zhiqiang; Martino, Audrey; Friese, Matthew B.; Boyd, Justin D.; Crosby, Gregory; Culley, Deborah J.			Oxytocin alters cell fate selection of rat neural progenitor cells in vitro	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; STEM-CELLS; BRAIN-DEVELOPMENT; PLASMA OXYTOCIN; FETAL-BRAIN; DIFFERENTIATION; PROLIFERATION; EXPRESSION; LABOR; MANIPULATIONS	Synthetic oxytocin (sOT) is widely used during labor, yet little is known about its effects on fetal brain development despite evidence that it reaches the fetal circulation. Here, we tested the hypothesis that sOT would affect early neurodevelopment by investigating its effects on neural progenitor cells (NPC) from embryonic day 14 rat pups. NPCs expressed the oxytocin receptor (OXTR), which was downregulated by 45% upon prolonged treatment with sOT. Next, we examined the effects of sOT on NPC death, apoptosis, proliferation, and differentiation using antibodies to NeuN (neurons), Olig2 (oligodendrocytes), and GFAP (astrocytes). Treated NPCs were analysed with unbiased high-throughput immunocytochemistry. Neither 6 nor 24 h exposure to 100 pM or 100 nM sOT had an effect on viability as assessed by PI or CC-3 immunocytochemistry. Similarly, sOT had negligible effect on NPC proliferation, except that the overall rate of NPC proliferation was higher in the 24 h compared to the 6 h group regardless of sOT exposure. The most significant finding was that sOT exposure caused NPCs to select a predominantly neuronal lineage, along with a concomitant decrease in glial cells. Collectively, our data suggest that perinatal exposure to sOT can have neurodevelopmental consequences for the fetus, and support the need for in vivo anatomical and behavioral studies in offspring exposed to sOT in utero.	[Palanisamy, Arvind; Kannappan, Ramaswamy; Martino, Audrey; Friese, Matthew B.; Crosby, Gregory; Culley, Deborah J.] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA; [Palanisamy, Arvind; Xu, Zhiqiang] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Boyd, Justin D.] Beryllium Discovery, Biol, Bedford, MA USA; [Kannappan, Ramaswamy] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Washington University (WUSTL); University of Alabama System; University of Alabama Birmingham	Palanisamy, A (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	arvind.palanisamy@wustl.edu	Crosby, Gregory/N-6578-2019	Friese, Matthew/0000-0001-7410-285X; Boyd, Justin/0000-0002-5197-4724; Palanisamy, Arvind/0000-0001-8460-1759	Foundation for Anesthesia Education and Research; NIH [R01GM088817]	Foundation for Anesthesia Education and Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Foundation for Anesthesia Education and Research, to AP, https://asahq.org/faer/researchaudeducation; and NIH R01GM088817, to GC.	Altemus M, 2004, BIOL PSYCHIAT, V56, P386, DOI 10.1016/j.biopsych.2004.06.002; [Anonymous], 2009, Obstet Gynecol, V114, P386, DOI 10.1097/AOG.0b013e3181b48ef5; ARNAUDEAU S, 1994, PFLUG ARCH EUR J PHY, V428, P51, DOI 10.1007/BF00374751; Bales KL, 2007, NEUROSCIENCE, V144, P38, DOI 10.1016/j.neuroscience.2006.09.009; Bales KL, 2004, PHYSIOL BEHAV, V81, P519, DOI 10.1016/j.physbeh.2004.02.016; Bales KL, 2004, DEV PSYCHOBIOL, V44, P123, DOI 10.1002/dev.10165; Billeci L, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-148; Butron A M, 1974, J Endocrinol, V60, P499; Cassoni P, 2006, MOL CANCER RES, V4, P351, DOI 10.1158/1541-7786.MCR-06-0024; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Culley DJ, 2011, ANESTHESIOLOGY, V115, P754, DOI 10.1097/ALN.0b013e318223b78b; Dahlen HG, 2013, MED HYPOTHESES, V80, P656, DOI 10.1016/j.mehy.2013.01.017; DAWOOD MY, 1979, ACTA ENDOCRINOL-COP, V91, P704, DOI 10.1530/acta.0.0910704; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Dilworth MR, 2013, PLACENTA, V34, pS34, DOI 10.1016/j.placenta.2012.10.011; DISCALAGUENOT D, 1992, BIOCHEM J, V284, P491, DOI 10.1042/bj2840491; Eckertova M, 2011, BRIT J PHARMACOL, V162, P452, DOI 10.1111/j.1476-5381.2010.01037.x; Elabd C, 2008, STEM CELLS, V26, P2399, DOI 10.1634/stemcells.2008-0127; Ernst C, 2016, TRENDS NEUROSCI, V39, P290, DOI 10.1016/j.tins.2016.03.001; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Fathi F, 2009, INT J CARDIOL, V134, P75, DOI 10.1016/j.ijcard.2008.01.046; Forostyak O, 2016, CELL CALCIUM, V59, P57, DOI 10.1016/j.ceca.2016.02.001; Friedlander E, 2017, EARLY HUM DEV, V106, P13, DOI 10.1016/j.earlhumdev.2017.01.008; FUCHS AR, 1991, AM J OBSTET GYNECOL, V165, P1515; Furukawa S, 2014, J TOXICOL PATHOL, V27, P11, DOI 10.1293/tox.2013-0060; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; GLATZ TH, 1980, ENDOCRINOLOGY, V106, P1006, DOI 10.1210/endo-106-3-1006; Gregory SG, 2013, JAMA PEDIATR, V167, P959, DOI 10.1001/jamapediatrics.2013.2904; Grigsby PL, 2016, SEMIN REPROD MED, V34, P11, DOI 10.1055/s-0035-1570031; Grinevich V, 2015, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00164; Grotegut CA, 2011, AM J PHYSIOL-ENDOC M, V300, pE468, DOI 10.1152/ajpendo.00390.2010; Guillemot F, 2007, PROG NEUROBIOL, V83, P37, DOI 10.1016/j.pneurobio.2007.02.009; Gutkowska J, 2012, J NEUROENDOCRINOL, V24, P599, DOI 10.1111/j.1365-2826.2011.02235.x; Hammock EAD, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00195; Harris VM, 2015, METHODS MOL BIOL, V1312, P465, DOI 10.1007/978-1-4939-2694-7_47; Jafarzadeh N, 2014, NEUROSCI LETT, V564, P105, DOI 10.1016/j.neulet.2014.02.012; Jankowski M, 2004, P NATL ACAD SCI USA, V101, P13074, DOI 10.1073/pnas.0405324101; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kenkel WM, 2014, J NEUROENDOCRINOL, V26, P739, DOI 10.1111/jne.12186; Khazipov R, 2008, PROG BRAIN RES, V170, P243, DOI 10.1016/S0079-6123(08)00421-4; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kurth L, 2011, J ATTEN DISORD, V15, P423, DOI 10.1177/1087054710397800; Lee M. R., 2017, MOL PSYCHIAT; Lestanova Z, 2016, J MOL NEUROSCI, V59, P184, DOI 10.1007/s12031-015-0664-9; Malek A, 1996, J Matern Fetal Med, V5, P245, DOI 10.1002/(SICI)1520-6661(199609/10)5:5<245::AID-MFM3>3.3.CO;2-L; MENS WBJ, 1983, BRAIN RES, V262, P143, DOI 10.1016/0006-8993(83)90478-X; Meziane H, 2015, BIOL PSYCHIAT, V78, P85, DOI 10.1016/j.biopsych.2014.11.010; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Miller TV, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00076; MITCHELL MD, 1982, EUR J OBSTET GYN R B, V14, P115, DOI 10.1016/0028-2243(82)90045-4; Mogi K, 2014, PHYSIOL BEHAV, V133, P68, DOI 10.1016/j.physbeh.2014.05.010; Neumann ID, 2013, PSYCHONEUROENDOCRINO, V38, P1985, DOI 10.1016/j.psyneuen.2013.03.003; Palanisamy A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158058; Paquin J, 2002, P NATL ACAD SCI USA, V99, P9550, DOI 10.1073/pnas.152302499; Paridaen JTML, 2014, EMBO REP, V15, P351, DOI 10.1002/embr.201438447; Patient C, 1999, BRIT J OBSTET GYNAEC, V106, P1311, DOI 10.1111/j.1471-0528.1999.tb08188.x; Phaneuf S, 2000, J REPROD FERTIL, V120, P91, DOI 10.1530/reprod/120.1.91; Prevost M, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00001; Robinson C, 2003, AM J OBSTET GYNECOL, V188, P497, DOI 10.1067/mob.2003.22; SAPINO A, 1993, ENDOCRINOLOGY, V133, P838, DOI 10.1210/en.133.2.838; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Smallwood M, 2016, ASN NEURO, V8, DOI 10.1177/1759091416659742; SMOAK IW, 1993, TERATOLOGY, V47, P203, DOI 10.1002/tera.1420470304; TAKAGI T, 1985, HORM METAB RES, V17, P308, DOI 10.1055/s-2007-1013526; TAKEDA S, 1985, ENDOCRINOL JAPON, V32, P875; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; TRIBOLLET E, 1989, J NEUROSCI, V9, P1764; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212; Veening JG, 2010, PHYSIOL BEHAV, V101, P193, DOI 10.1016/j.physbeh.2010.05.004; Weisman O, 2015, BEHAV BRAIN RES, V284, P207, DOI 10.1016/j.bbr.2015.02.028; Yoshimura R, 1996, NEUROSCI RES, V24, P291, DOI 10.1016/0168-0102(95)01003-3	72	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191160	10.1371/journal.pone.0191160	http://dx.doi.org/10.1371/journal.pone.0191160			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346405	gold, Green Published			2022-12-26	WOS:000422749500032
J	Ponert, JM; Schwarz, S; Haschemi, R; Muller, J; Potzsch, B; Bendas, G; Schlesinger, M				Ponert, Jan Moritz; Schwarz, Svenja; Haschemi, Reza; Mueller, Jens; Poetzsch, Bernd; Bendas, Gerd; Schlesinger, Martin			The mechanisms how heparin affects the tumor cell induced VEGF and chemokine release from platelets to attenuate the early metastatic niche formation	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; BREAST-CANCER; FLOW CONDITIONS; CARCINOMA-CELLS; TISSUE FACTOR; P-SELECTIN; GPIIB-IIIA; ADHESION; ANGIOGENESIS; MACROPHAGES	Metastasis is responsible for the majority of cancer associated fatalities. Tumor cells leaving the primary tumor and entering the blood flow immediately interact with platelets. Activated platelets contribute in different ways to cancer cell survival and proliferation, e.g. in formation of the early metastatic niche by release of different growth factors and chemokines. Here we show that a direct interaction between platelets and MV3 melanoma or MCF7 breast cancer cells induces platelet activation and a VEGF release in citrated plasma that cannot be further elevated by the coagulation cascade and generated thrombin. In contrast, the release of platelet-derived chemokines CXCL5 and CXCL7 depends on both, a thrombin-mediated platelet activation and a direct interaction between tumor cells and platelets. Preincubation of platelets with therapeutic concentrations of unfractionated heparin reduces the tumor cell initiated VEGF release from platelets. In contrast, tumor cell induced CXCL5 and CXCL7 release from platelets was not impacted by heparin pretreatment in citrated plasma. In defibrinated, recalcified plasma, on the contrary, heparin is able to reduce CXCL5 and CXCL7 release from platelets by thrombin inhibition. Our data indicate that different chemokines and growth factors in diverse platelet granules are released in tightly regulated processes by various trigger mechanisms. We show for the first time that heparin is able to reduce the mediator release induced by different tumor cells both in a contact and coagulation dependent manner.	[Ponert, Jan Moritz; Schwarz, Svenja; Haschemi, Reza; Bendas, Gerd; Schlesinger, Martin] Rheinische Friedrich Wilhelms Univ Bonn, Dept Pharm, Bonn, Germany; [Mueller, Jens; Poetzsch, Bernd] Univ Bonn, Med Ctr, Inst Expt Hematol & Transfus Med, Bonn, Germany	University of Bonn; University of Bonn	Schlesinger, M (corresponding author), Rheinische Friedrich Wilhelms Univ Bonn, Dept Pharm, Bonn, Germany.	martin.schlesinger@uni-bonn.de	Müller, Jens/A-8264-2012	Müller, Jens/0000-0001-7713-9631	Pharmaceutical Institute of University of Bonn; Kirstin Diehl Stiftung, Neuwied, Germany	Pharmaceutical Institute of University of Bonn; Kirstin Diehl Stiftung, Neuwied, Germany	Experiments were primarily financed by budget resources of the Pharmaceutical Institute of University of Bonn. Experiments were partially supported by the Kirstin Diehl Stiftung, Neuwied, Germany. The funders (Kirstin Diehl Stiftung) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study, except Kirstin Diehl Stiftung.	Agnelli G, 2012, NEW ENGL J MED, V366, P601, DOI 10.1056/NEJMoa1108898; Battinelli EM, 2014, BLOOD, V123, P101, DOI 10.1182/blood-2013-02-485011; Bonde AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-35; Borsig L, 2010, PROG MOL BIOL TRANSL, V93, P335, DOI 10.1016/S1877-1173(10)93014-7; Borsig L, 2010, THROMB RES, V125, pS66, DOI 10.1016/S0049-3848(10)70017-7; Chatterjee M, 2011, BLOOD, V117, P3907, DOI 10.1182/blood-2010-12-327007; Chen Q, 2011, CANCER CELL, V20, P538, DOI 10.1016/j.ccr.2011.08.025; Dardik R, 1997, INT J CANCER, V70, P201, DOI 10.1002/(SICI)1097-0215(19970117)70:2<201::AID-IJC11>3.0.CO;2-L; Dardik R, 1998, BRIT J CANCER, V77, P2069, DOI 10.1038/bjc.1998.349; FeldingHabermann B, 1996, J BIOL CHEM, V271, P5892, DOI 10.1074/jbc.271.10.5892; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Gay LJ, 2011, CANCER CELL, V20, P553, DOI 10.1016/j.ccr.2011.11.001; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Ho-Tin-Noe B, 2008, CANCER RES, V68, P6851, DOI 10.1158/0008-5472.CAN-08-0718; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Jain S, 2009, J THROMB HAEMOST, V7, P1713, DOI 10.1111/j.1538-7836.2009.03559.x; Kakkar AK, 2004, J CLIN ONCOL, V22, P1944, DOI 10.1200/JCO.2004.10.002; Kasthuri RS, 2009, J CLIN ONCOL, V27, P4834, DOI 10.1200/JCO.2009.22.6324; Kisucka J, 2006, P NATL ACAD SCI USA, V103, P855, DOI 10.1073/pnas.0510412103; Kitamura T, 2015, J EXP MED, V212, P1043, DOI 10.1084/jem.20141836; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Klement GL, 2009, BLOOD, V113, P2835, DOI 10.1182/blood-2008-06-159541; Kuznetsov HS, 2012, CANCER DISCOV, V2, P1150, DOI 10.1158/2159-8290.CD-12-0216; Labelle M, 2014, P NATL ACAD SCI USA, V111, pE3053, DOI 10.1073/pnas.1411082111; Labelle M, 2012, CANCER DISCOV, V2, P1091, DOI 10.1158/2159-8290.CD-12-0329; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Laubli H, 2009, BLOOD, V114, P4583, DOI 10.1182/blood-2008-10-186585; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lee AYY, 2005, J CLIN ONCOL, V23, P2123, DOI 10.1200/JCO.2005.03.133; Lu HH, 2014, NAT CELL BIOL, V16, P1105, DOI 10.1038/ncb3041; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Ma L, 2005, P NATL ACAD SCI USA, V102, P216, DOI 10.1073/pnas.0406682102; MADSEN PS, 1986, ACTA PATH MICRO IM C, V94, P193; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; McCarty OJT, 2000, BLOOD, V96, P1789, DOI 10.1182/blood.V96.5.1789.h8001789_1789_1797; Menter DG, 2014, CANCER METAST REV, V33, P231, DOI 10.1007/s10555-014-9498-0; Mitrugno A., 2015, BLOOD REV; Nieswandt B, 1999, CANCER RES, V59, P1295; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Palumbo JS, 2007, BLOOD, V110, P133, DOI 10.1182/blood-2007-01-065995; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Placke T, 2011, J INNATE IMMUN, V3, P374, DOI 10.1159/000323936; POGGI A, 1993, BAILLIERE CLIN HAEM, V6, P731, DOI 10.1016/S0950-3536(05)80196-9; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; RUSSO J, 1976, J NATL CANCER I, V56, P279, DOI 10.1093/jnci/56.2.279; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Spiegel A, 2016, CANCER DISCOV, V6, P630, DOI 10.1158/2159-8290.CD-15-1157; Stevenson JL, 2007, THROMB RES, V120, pS107, DOI 10.1016/S0049-3848(07)70138-X; VANMUIJEN GNP, 1991, INT J CANCER, V48, P85; VANOOST BA, 1986, BIOCHEM CELL BIOL, V64, P699, DOI 10.1139/o86-096; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012	55	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0191303	10.1371/journal.pone.0191303	http://dx.doi.org/10.1371/journal.pone.0191303			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346400	Green Published, Green Submitted, gold			2022-12-26	WOS:000422749500040
J	van Puijvelde, GHM; Foks, AC; van Bochove, RE; Bot, I; Habets, KLL; de Jager, SC; ter Borg, MND; van Osch, P; Boon, L; Vos, M; de Waard, V; Kuiper, J				van Puijvelde, Gijs H. M.; Foks, Amanda C.; van Bochove, Rosemarie E.; Bot, Ilze; Habets, Kim L. L.; de Jager, Saskia C.; ter Borg, Mariette N. D.; van Osch, Puck; Boon, Louis; Vos, Mariska; de Waard, Vivian; Kuiper, Johan			CD1d deficiency inhibits the development of abdominal aortic aneurysms in LDL receptor deficient mice	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; KILLER T-CELLS; ANGIOTENSIN-II; NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; ATHEROSCLEROTIC LESIONS; ALTERNATIVE ACTIVATION; IMMUNE-RESPONSES; DENDRITIC CELLS; MURINE MODEL	An abdominal aortic aneurysm (AAA) is a dilatation of the abdominal aorta leading to serious complications and mostly to death. AAA development is associated with an accumulation of inflammatory cells in the aorta including NKT cells. An important factor in promoting the recruitment of these inflammatory cells into tissues and thereby contributing to the development of AAA is angiotensin II (Ang II). We demonstrate that a deficiency in CD1d dependent NKT cells under hyperlipidemic conditions (LDLr-/- CD1d(-/-) mice) results in a strong decline in the severity of angiotensin II induced aneurysm formation when compared with LDLr-/- mice. In addition, we show that Ang II amplifies the activation of NKT cells both in vivo and in vitro. We also provide evidence that type I NKT cells contribute to AAA development by inducing the expression of matrix degrading enzymes in vSMCs and macrophages, and by cytokine dependently decreasing vSMC viability. Altogether, these data prove that CD1d dependent NKT cells contribute to AAA development in the Ang II-mediated aneurysm model by enhancing aortic degradation, establishing that therapeutic applications which target NKT cells can be a successful way to prevent AAA development.	[van Puijvelde, Gijs H. M.; Foks, Amanda C.; van Bochove, Rosemarie E.; Bot, Ilze; Habets, Kim L. L.; de Jager, Saskia C.; ter Borg, Mariette N. D.; van Osch, Puck; Kuiper, Johan] Leiden Univ, Leiden Acad, Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Vos, Mariska; de Waard, Vivian] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Bioceros B.V.; University of Amsterdam; Academic Medical Center Amsterdam	van Puijvelde, GHM (corresponding author), Leiden Univ, Leiden Acad, Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands.	puijvelde@lacdr.leidenuniv.nl	van Puijvelde, Gijs/AAM-9889-2020; de+Jager, Saskia/ABC-4264-2020; de+Jager, Saskia/AAE-1132-2022; Boon, Laurence/HCI-3629-2022	Foks, Amanda/0000-0002-9747-3458; Bot, Ilze/0000-0002-1242-1959; de Jager, Saskia/0000-0002-5233-0066; Boon, Louis/0000-0002-0937-9171	Hartstichting [2007T039, 2008B048, 2012T083]	Hartstichting	This study was funded by Hartstichting, with the following grants: 2007T039 (Dr. Gijs H.M. van Puijvelde); 2008B048 (Ph.D. Amanda C. Foks); 2012T083 (Ph.D. Ilze Bot). Louis Boon, employed by Bioceros BV, Utrecht, The Netherlands, supported this study in the form of providing us with neutralizing alpha-IFN gamma, alpha-IL4 and alpha-IL10 antibodies and did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslanian AM, 2005, ARTERIOSCL THROM VAS, V25, P628, DOI 10.1161/01.ATV.0000153046.59370.13; Balce DR, 2011, BLOOD, V118, P4199, DOI 10.1182/blood-2011-01-328906; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Bown MJ, 2007, J VASC SURG, V46, P687, DOI 10.1016/j.jvs.2007.06.025; Burdin N, 1998, J IMMUNOL, V161, P3271; Cao RY, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00009; Chan WL, 2005, CIRC RES, V96, P675, DOI 10.1161/01.RES.0000160543.84254.f1; Chan WL, 2005, CELL IMMUNOL, V233, P109, DOI 10.1016/j.cellimm.2005.04.020; Chiba A, 2004, ARTHRITIS RHEUM, V50, P305, DOI 10.1002/art.11489; Chizzolini C, 2000, J IMMUNOL, V164, P5952, DOI 10.4049/jimmunol.164.11.5952; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2011, J ZHEJIANG UNIV-SC B, V12, P624, DOI 10.1631/jzus.B1101002; de Waard V, 2010, ATHEROSCLEROSIS, V211, P84, DOI 10.1016/j.atherosclerosis.2010.01.042; Galle C, 2005, CLIN EXP IMMUNOL, V142, P519, DOI 10.1111/j.1365-2249.2005.02938.x; Geng YJ, 1996, ARTERIOSCL THROM VAS, V16, P19, DOI 10.1161/01.ATV.16.1.19; Golledge ALV, 2009, DIS MARKERS, V26, P181, DOI [10.1155/2009/352319, 10.3233/DMA-2009-0629]; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Golledge J, 2010, AM J PATHOL, V176, P2098, DOI 10.2353/ajpath.2010.090416; Golledge J, 2010, ARTERIOSCL THROM VAS, V30, P1075, DOI 10.1161/ATVBAHA.110.206573; Harrison SC, 2012, EUR HEART J; Hoch NE, 2009, AM J PHYSIOL-REG I, V296, pR208, DOI 10.1152/ajpregu.90521.2008; Johnsen SH, 2010, ARTERIOSCL THROM VAS, V30, P1263, DOI 10.1161/ATVBAHA.110.203588; Johnston WF, 2013, ARTERIOSCL THROM VAS, V33, P294, DOI 10.1161/ATVBAHA.112.300432; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Li Y, 2016, CARDIOVASC RES, V109, P305, DOI 10.1093/cvr/cvv259; Liu J, 2015, ARTERIOSCL THROM VAS, V35, P1826, DOI 10.1161/ATVBAHA.115.305482; Lombardi V, 2010, J IMMUNOL, V184, P2107, DOI 10.4049/jimmunol.0901208; Manning MW, 2002, VASC MED, V7, P45, DOI 10.1191/1358863x02vm413ra; Michon IN, 2002, BBA-MOL CELL RES, V1591, P87, DOI 10.1016/S0167-4889(02)00254-9; Middleton RK, 2007, J VASC SURG, V45, P574, DOI 10.1016/j.jvs.2006.11.020; Moehle CW, 2011, J THORAC CARDIOV SUR, V142, P1567, DOI 10.1016/j.jtcvs.2011.07.053; Nahmod KA, 2003, FASEB J, V17, P491, DOI 10.1096/fj.02-0755fje; Nahmod K, 2010, J PHARMACOL EXP THER, V334, P854, DOI 10.1124/jpet.109.161760; Nakai Y, 2004, BLOOD, V104, P2051, DOI 10.1182/blood-2003-10-3485; Nambiar J, 2015, MABS-AUSTIN, V7, P638, DOI 10.1080/19420862.2015.1016693; Ocana E, 2008, ATHEROSCLEROSIS, V200, P264, DOI 10.1016/j.atherosclerosis.2007.12.043; Oki S, 2005, INT IMMUNOL, V17, P1619, DOI 10.1093/intimm/dxh342; Owens AP, 2011, ARTERIOSCL THROM VAS, V31, P2813, DOI 10.1161/ATVBAHA.111.238642; Sasaguri T, 1998, ATHEROSCLEROSIS, V138, P247, DOI 10.1016/S0021-9150(97)00296-7; Schonbeck U, 2002, AM J PATHOL, V161, P499, DOI 10.1016/S0002-9440(10)64206-X; Shimizu K, 2004, J CLIN INVEST, V114, P300, DOI 10.1172/JCI200419855; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Silverstein Marc D, 2005, Proc (Bayl Univ Med Cent), V18, P345; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Tazawa H, 2013, BLOOD, V122, P2582, DOI 10.1182/blood-2012-02-407452; Tupin E, 2004, J EXP MED, V199, P417, DOI 10.1084/jem.20030997; Upchurch GR, 2006, AM FAM PHYSICIAN, V73, P1198; van Puijvelde GHM, 2017, EUR J PHARMACOL, V816, P47, DOI 10.1016/j.ejphar.2017.03.052; Wang Y. X., 2006, HDB MOUSE MODELS CAR, V125; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Xiong WF, 2009, J IMMUNOL, V183, P2741, DOI 10.4049/jimmunol.0803164; Xiong WF, 2004, J IMMUNOL, V172, P2607, DOI 10.4049/jimmunol.172.4.2607; Xu J, 2012, J SURG RES, V178, P512, DOI 10.1016/j.jss.2011.12.016; Yodoi K, 2015, HYPERTENSION, V65, P889, DOI 10.1161/HYPERTENSIONAHA.114.04934; Zhang JD, 2012, CIRC RES, V110, P1604, DOI 10.1161/CIRCRESAHA.111.261768	56	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2018	13	1							e0190962	10.1371/journal.pone.0190962	http://dx.doi.org/10.1371/journal.pone.0190962			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS9PC	29346401	Green Published, gold, Green Submitted			2022-12-26	WOS:000422749500023
J	Talukder, SK; Azhaguvel, P; Chekhovskiy, K; Saha, MC				Talukder, Shyamal K.; Azhaguvel, Perumal; Chekhovskiy, Konstantin; Saha, Malay C.			Molecular discrimination of tall fescue morphotypes in association with Festuca relatives	PLOS ONE			English	Article							SUMMER DORMANCY; PHYLOGENETIC-RELATIONSHIPS; ARUNDINACEA SCHREB.; CHLOROPLAST GENOME; GENETIC DIVERSITY; UNIVERSAL PRIMERS; DNA VARIATION; GRASSES; POACEAE; EVOLUTION	Tall fescue (Festuca arundinacea Schreb.) is an important cool-season perennial grass species used as forage and turf, and in conservation plantings. There are three morphotypes in hexaploid tall fescue: Continental, Mediterranean and Rhizomatous. This study was conducted to develop morphotype-specific molecular markers to distinguish Continental and Mediterranean tall fescues, and establish their relationships with other species of the Festuca genus for genomic inference. Chloroplast sequence variation and simple sequence repeat (SSR) polymorphism were explored in 12 genotypes of three tall fescue morphotypes and four Festuca species. Hypervariable chloroplast regions were retrieved by using 33 specifically designed primers followed by sequencing the PCR products. SSR polymorphism was studied using 144 tall fescue SSR primers. Four chloroplast (NFTCHL17, NFTCHL43, NFTCHL45 and NFTCHL48) and three SSR (nffa090, nffa204 and nffa338) markers were identified which can distinctly differentiate Continental and Mediterranean morphotypes. A primer pair, NFTCHL45, amplified a 47 bp deletion between the two morphotypes is being routinely used in the Noble Research Institute's core facility for morphotype discrimination. Both chloroplast sequence variation and SSR diversity showed a close association between Rhizomatous and Continental morphotypes, while the Mediterranean morphotype was in a distant Glade. F. pratensis and F. arundinacea var. glaucescens, the P and G1G2 genome donors, respectively, were grouped with the Continental Glade, and F. mairei (M1 M2 genome) grouped with the Mediterranean Glade in chloroplast sequence variation, while both F. pratensis and F. maireiformed independent Glade in SSR analysis. Age estimation based on chloroplast sequence variation indicated that the Continental and Mediterranean clades might have been colonized independently during 0.65 +/- 0.06 and 0.96 +/- 0.1 million years ago (Mya) respectively. The findings of the study will enhance tall fescue breeding for persistence and productivity.	[Talukder, Shyamal K.; Azhaguvel, Perumal; Chekhovskiy, Konstantin; Saha, Malay C.] Noble Res Inst LLC, Ardmore, OK USA; [Azhaguvel, Perumal] Syngenta, Slater, IA USA	Noble Research Institute; Syngenta	Saha, MC (corresponding author), Noble Res Inst LLC, Ardmore, OK USA.	mcsaha@noble.org	Talukder, Shyamal/AAW-6614-2021	Chekhovskiy, Konstantin/0000-0002-6149-2366				BORRILL M, 1971, CYTOLOGIA, V36, P1, DOI 10.1508/cytologia.36.1; BORRILL M, 1977, NEW PHYTOL, V78, P661, DOI 10.1111/j.1469-8137.1977.tb02171.x; BORRILL M, 1972, NEW PHYTOL, V71, P523, DOI 10.1111/j.1469-8137.1972.tb01953.x; Cahoon AB, 2010, AM J BOT, V97, P49, DOI 10.3732/ajb.0900008; Cao M, 2003, CROP SCI, V43, P1659, DOI 10.2135/cropsci2003.1659; Cao M, 2001, THEOR APPL GENET, V103, P248, DOI 10.1007/s001220100564; CHANDRASEKHARAN P, 1971, Z PFLANZENZUCHTUNG, V65, P345; Charmet G, 1997, THEOR APPL GENET, V94, P1038, DOI 10.1007/s001220050512; Charrier S, 2006, 13 AUSTR PLANT BREED; Chen FC, 2001, J HERED, V92, P481, DOI 10.1093/jhered/92.6.481; Cheng YJ, 2005, TREE PHYSIOL, V25, P661, DOI 10.1093/treephys/25.6.661; Clayton W. D., 1986, Kew Bulletin Additional Series, V13; Clement SL, 2001, CROP SCI, V41, P570, DOI 10.2135/cropsci2001.412570x; De Bruijn J, 2004, Barenbrug USA, Inc (Tanget, OR) United States, Patent No. [6677507, 20046677507]; Dierking R, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.07.0032; Drummond JB., 2006, THESIS; Duchene D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-65; EVANS GM, 1973, CROP SCI, V13, P376, DOI 10.2135/cropsci1973.0011183X001300030026x; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Gaut BS, 2000, PLANT SYST EVOL, V224, P33, DOI 10.1007/BF00985265; Graham SW, 2000, INT J PLANT SCI, V161, pS83, DOI 10.1086/317583; Greiner S, 2011, MOL ECOL, V20, P671, DOI 10.1111/j.1365-294X.2010.04984.x; Hand ML, 2012, THEOR APPL GENET, V124, P1127, DOI 10.1007/s00122-011-1774-6; Hand ML, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-303; HUMPHREYS MW, 1995, HEREDITY, V75, P171, DOI 10.1038/hdy.1995.120; HUNT KL, 1981, CROP SCI, V21, P400, DOI 10.2135/cropsci1981.0011183X002100030012x; Inda LA, 2008, MOL PHYLOGENET EVOL, V46, P932, DOI 10.1016/j.ympev.2007.11.022; Ingvarsson PK, 2003, MOL BIOL EVOL, V20, P1737, DOI 10.1093/molbev/msg163; JADASHECART J, 1973, M FODD CROPS SECT EU; JAUHAR PP, 1975, CHROMOSOMA, V52, P363, DOI 10.1007/BF00364020; JERNSTEDT JA, 1985, CROP SCI, V25, P539, DOI 10.2135/cropsci1985.0011183X002500030026x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kopecky D, 2016, FRONT ENV SCI-SWITZ, V4, DOI 10.3389/fenvs.2016.00066; Lewis E, 1963, RESP WELSH PL BREED, P26; MALIK CP, 1967, CARYOLOGIA, V20, P1; Mathews DJ, 2001, GENOME RES, V11, P1382; Mian MAR, 2005, GENOME, V48, P637, DOI [10.1139/g05-029, 10.1139/G05-029]; Moriyama EN, 1996, MOL BIOL EVOL, V13, P261, DOI 10.1093/oxfordjournals.molbev.a025563; Nie ZN, 2009, CROP SCI, V49, P2405, DOI 10.2135/cropsci2009.06.0320; Norton MR, 2006, AUST J AGR RES, V57, P1267, DOI 10.1071/AR06082; Pasakinskiene I, 1998, HEREDITY, V81, P659, DOI 10.1046/j.1365-2540.1998.00446.x; Provan J, 2004, MOL ECOL NOTES, V4, P262, DOI 10.1111/j.1471-8286.2004.00636.x; Reed KFM, 2004, AUST J EXP AGR, V44, P873, DOI 10.1071/EA03173; Schardl C, 2007, ENDOPHYTES TALL FESC; SEAL AG, 1983, HEREDITY, V50, P225, DOI 10.1038/hdy.1983.26; Sleper D. A., 1990, Biotechnology in tall fescue improvement., P167; STAMMERS M, 1995, HEREDITY, V74, P19, DOI 10.1038/hdy.1995.3; Stewart A, 1997, 8 INT TURFGR RES C S; STEWART AV, 1995, NZ TURF MANAGEMENT J, V9, P32; Subramanian S, 2003, GENOME RES, V13, P838, DOI 10.1101/gr.1152803; Tabbasam N, 2014, PLANT SYST EVOL, V300, P559, DOI 10.1007/s00606-013-0891-x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Takach JE, 2012, APPL ENVIRON MICROB, V78, P5501, DOI 10.1128/AEM.01084-12; TZVELEV NN, 1989, BOT REV, V55, P141, DOI 10.1007/BF02858328; Volaire F, 2006, ANN BOT-LONDON, V98, P927, DOI 10.1093/aob/mcl195; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; XU WW, 1994, THEOR APPL GENET, V88, P685, DOI 10.1007/BF01253971; Zwick ME, 2000, ANNU REV GENOM HUM G, V1, P387, DOI 10.1146/annurev.genom.1.1.387	58	3	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191343	10.1371/journal.pone.0191343	http://dx.doi.org/10.1371/journal.pone.0191343			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342197	gold, Green Submitted, Green Published			2022-12-26	WOS:000422653800065
J	Andley, UP; Tycksen, E; McGlasson-Naumann, BN; Hamilton, PD				Andley, Usha P.; Tycksen, Eric; McGlasson-Naumann, Brittney N.; Hamilton, Paul D.			Probing the changes in gene expression due to alpha-crystallin mutations in mouse models of hereditary human cataract	PLOS ONE			English	Article							LENS EPITHELIAL-CELLS; A-CRYSTALLIN; B-CRYSTALLIN; DIFFERENTIAL EXPRESSION; CHAPERONE; PROTEIN; CHROMATIN; MECHANISM; STRESS; GROWTH	The mammalian eye lens expresses a high concentration of crystallins (alpha, beta and gamma-crystallins) to maintain the refractive index essential for lens transparency. Crystallins are long-lived proteins that do not turnover throughout life. The structural destabilization of crystallins by UV exposure, glycation, oxidative stress and mutations in crystallin genes leads to protein aggregation and development of cataracts. Several destabilizing mutations in crystallin genes are linked with human autosomal dominant hereditary cataracts. To investigate the mechanism by which the alpha-crystallin mutations Cryaa-R49C and Cryab-R120G lead to cataract formation, we determined whether these mutations cause an altered expression of specific transcripts in the lens at an early postnatal age by RNA-seq analysis. Using knock-in mouse models previously generated in our laboratory, in the present work, we identified genes that exhibited altered abundance in the mutant lenses, including decreased transcripts for Clic5, an intracellular water channel in Cryaa-R49C heterozygous mutant lenses, and increased transcripts for Eno1b in Cryab-R120G heterozygous mutant lenses. In addition, RNA-seq analysis revealed increased histones H2B, H2A, and H4 gene expression in Cryaa-R49C mutant lenses, suggesting that the alpha A-crystallin mutation regulates histone expression via a transcriptional mechanism. Additionally, these studies confirmed the increased expression of histones H2B, H2A, and H4 by proteomic analysis of Cryaa-R49C knock-in and Cryaa; Cryab gene knockout lenses reported previously. Taken together, these findings offer additional insight into the early transcriptional changes caused by Cryaa and Cryab mutations associated with autosomal dominant human cataracts, and indicate that the transcript levels of certain genes are affected by the expression of mutant alpha-crystallin in vivo.	[Andley, Usha P.; McGlasson-Naumann, Brittney N.; Hamilton, Paul D.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63130 USA; [Tycksen, Eric] Washington Univ St Louis, Genome Technol Access Ctr, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Andley, UP (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63130 USA.	andley@vision.wustl.edu		Hamilton, Paul/0000-0001-7187-706X; Tycksen, Eric/0000-0001-6362-0141	NEI [EY05681, EY02687]; Research to Prevent Blindness Unrestricted Grant; National Cancer Institute (NCI) Cancer Center [P30 CA91842]; National Center for Research Resources (NCRR) [UL1TR000448]; component of NIH and NIH Roadmap for Medical Research; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002345, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002687, R01EY005681] Funding Source: NIH RePORTER	NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Unrestricted Grant(Research to Prevent Blindness (RPB)); National Cancer Institute (NCI) Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); component of NIH and NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NEI EY05681 (Dr. Usha P. Andley), NEI EY02687, and Research to Prevent Blindness Unrestricted Grant to The Department of Ophthalmology and Visual Sciences. We would like to thank the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine for help with the genomic analyses. The Center is partially supported by a National Cancer Institute (NCI) Cancer Center Support Grant (#P30 CA91842) to the Siteman Cancer Center and by an Institute for Clinical and Translational Science (ICTS)/Clinical and Translational Science Awards (CTSA) Grant (#UL1TR000448) from the National Center for Research Resources (NCRR), a component of NIH and NIH Roadmap for Medical Research. This publication is solely the responsibility of the authors and does not necessarily represent the official view of NCRR or NIH.	Alfano G, 2005, HUM MOL GENET, V14, P913, DOI 10.1093/hmg/ddi084; Andley UP, 1998, J BIOL CHEM, V273, P31252, DOI 10.1074/jbc.273.47.31252; Andley UP, 2002, J BIOL CHEM, V277, P10178, DOI 10.1074/jbc.M109211200; Andley UP, 2008, BIOCHEMISTRY-US, V47, P9697, DOI 10.1021/bi800594t; Andley Usha P., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000111; Andley UP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095507; Andley UP, 2013, BIOCHEMISTRY-US, V52, P2933, DOI 10.1021/bi400180d; Andley UP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017671; Audette DS, 2016, DEVELOPMENT, V143, P318, DOI 10.1242/dev.127860; Bai F, 2004, EXP EYE RES, V79, P795, DOI 10.1016/j.exer.2004.05.006; Bai F, 2004, MOL CELL BIOCHEM, V265, P115, DOI 10.1023/B:MCBI.0000044365.48900.82; Bai F, 2003, J BIOL CHEM, V278, P36876, DOI 10.1074/jbc.M304010200; Biswas A, 2006, BIOCHEMISTRY-US, V45, P4569, DOI 10.1021/bi052574s; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Cimen MYB, 2008, CLIN CHIM ACTA, V390, P1, DOI 10.1016/j.cca.2007.12.025; Cook AJL, 2011, MOL CELL, V44, P918, DOI 10.1016/j.molcel.2011.11.021; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DWORK AJ, 1990, INVEST OPHTH VIS SCI, V31, P489; Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015; Francis PJ, 2000, J MED GENET, V37, P481, DOI 10.1136/jmg.37.7.481; Gangalum RK, 2004, J BIOL CHEM, V279, P43374, DOI 10.1074/jbc.C400371200; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Gunesdogan U, 2014, ELIFE, V3, DOI 10.7554/eLife.02443; Hegde SM, 2014, INVEST OPHTH VIS SCI, V55, P6398, DOI 10.1167/iovs.14-14623; Hoang TV, 2014, MOL VIS, V20, P1491; Hubner MR, 2013, CURR OPIN GENET DEV, V23, P89, DOI 10.1016/j.gde.2012.11.006; Khan SY, 2015, INVEST OPHTH VIS SCI, V56, P4919, DOI 10.1167/iovs.14-16253; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li XY, 2013, J NEUROSCI, V33, P19423, DOI 10.1523/JNEUROSCI.2561-13.2013; Li ZG, 2016, SCI REP-UK, V6, DOI 10.1038/srep27105; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Mackay DS, 2003, EUR J HUM GENET, V11, P784, DOI 10.1038/sj.ejhg.5201046; MacRae TH, 2000, CELL MOL LIFE SCI, V57, P899, DOI 10.1007/PL00000733; Maki N, 2010, MOL VIS, V16, P1893; Makley LN, 2015, SCIENCE, V350, P674, DOI 10.1126/science.aac9145; Martino VB, 2016, DIS MODEL MECH, V9, P849, DOI 10.1242/dmm.025262; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Nishida H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-108; Oh-hashi K, 2013, MOL CELL BIOCHEM, V380, P97, DOI 10.1007/s11010-013-1663-1; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Pietrowski D, 1997, BIOL CHEM, V378, P1183; PIETROWSKI D, 1994, GENE, V144, P171, DOI 10.1016/0378-1119(94)90375-1; Pineau P, 2005, MOL BIOL EVOL, V22, P582, DOI 10.1093/molbev/msi053; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Rein DB, 2006, ARCH OPHTHALMOL-CHIC, V124, P1754, DOI 10.1001/archopht.124.12.1754; Resnikoff S, 2012, INDIAN J OPHTHALMOL, V60, P387, DOI 10.4103/0301-4738.100532; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson ML, 1996, INVEST OPHTH VIS SCI, V37, P2276; Salles FT, 2014, CYTOSKELETON, V71, P61, DOI 10.1002/cm.21159; Schlessinger A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388157; Sidjanin D, 1996, PHOTOCHEM PHOTOBIOL, V63, P79, DOI 10.1111/j.1751-1097.1996.tb02995.x; Stanger SJ, 2016, FASEB J, V30, P2777, DOI 10.1096/fj.201500136R; Tumelty KE, 2014, J BIOL CHEM, V289, P2526, DOI 10.1074/jbc.M113.502617; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Watson GW, 2010, BIOCHEM BIOPH RES CO, V401, P192, DOI 10.1016/j.bbrc.2010.09.023; Wolf L, 2013, NUCLEIC ACIDS RES, V41, P10199, DOI 10.1093/nar/gkt824; Wride MA, 2003, MOL VIS, V9, P360; Xi JH, 2003, J CELL SCI, V116, P1073, DOI 10.1242/jcs.00325; Xi JH, 2008, J BIOL CHEM, V283, P5801, DOI 10.1074/jbc.M708704200; Yang Y, 2007, J MOL BIOL, V369, P917, DOI 10.1016/j.jmb.2007.04.004; Yoshida N, 2015, CANCER SCI, V106, P1455, DOI 10.1111/cas.12742; ZHAO SL, 2014, BIOMED RES INT, DOI DOI 10.1155/2014/986048; Zhou YF, 2016, BBA-MOL BASIS DIS, V1862, P1433, DOI 10.1016/j.bbadis.2016.05.003	69	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190817	10.1371/journal.pone.0190817	http://dx.doi.org/10.1371/journal.pone.0190817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338044	Green Published, gold, Green Submitted			2022-12-26	WOS:000422652700019
J	Grottoli, AG; Martins, PD; Wilkins, MJ; Johnston, MD; Warner, ME; Cai, WJ; Melman, TF; Hoadley, KD; Pettay, DT; Levas, S; Schoepf, V				Grottoli, Andrea G.; Martins, Paula Dalcin; Wilkins, Michael J.; Johnston, Michael D.; Warner, Mark E.; Cai, Wei-Jun; Melman, Todd F.; Hoadley, Kenneth D.; Pettay, D. Tye; Levas, Stephen; Schoepf, Verena			Coral physiology and microbiome dynamics under combined warming and ocean acidification	PLOS ONE			English	Article							NATURAL PH GRADIENT; BACTERIAL COMMUNITIES; CLIMATE-CHANGE; SCLERACTINIAN CORALS; PARTIAL-PRESSURE; HEAT-STRESS; CO2; HOST; TEMPERATURE; HYPOTHESIS	Rising seawater temperature and ocean acidification threaten the survival of coral reefs. The relationship between coral physiology and its microbiome may reveal why some corals are more resilient to these global change conditions. Here, we conducted the first experiment to simultaneously investigate changes in the coral microbiome and coral physiology in response to the dual stress of elevated seawater temperature and ocean acidification expected by the end of this century. Two species of corals, Acropora millepora containing the thermally sensitive endosymbiont C21a and Turbinaria reniformis containing the thermally tolerant endosymbiont Symbiodinium trenchi, were exposed to control (26.5 degrees C and pCO(2) of 364 mu atm) and treatment (29.0 degrees C and pCO(2) of 750 mu atm) conditions for 24 days, after which we measured the microbial community composition. These microbial findings were interpreted within the context of previously published physiological measurements from the exact same corals in this study (calcification, organic carbon flux, ratio of photosynthesis to respiration, photosystem II maximal efficiency, total lipids, soluble animal protein, soluble animal carbohydrates, soluble algal protein, soluble algal carbohydrate, biomass, endosymbiotic algal density, and chlorophyll a). Overall, dually stressed A. millepora had reduced microbial diversity, experienced large changes in microbial community composition, and experienced dramatic physiological declines in calcification, photosystem II maximal efficiency, and algal carbohydrates. In contrast, the dually stressed coral T. reniformis experienced a stable and more diverse microbiome community with minimal physiological decline, coupled with very high total energy reserves and particulate organic carbon release rates. Thus, the microbiome changed and microbial diversity decreased in the physiologically sensitive coral with the thermally sensitive endosymbiotic algae but not in the physiologically tolerant coral with the thermally tolerant endosymbiont. Our results confirm recent findings that temperature-stress tolerant corals have a more stable microbiome, and demonstrate for the first time that this is also the case under the dual stresses of ocean warming and acidification. We propose that coral with a stable microbiome are also more physiologically resilient and thus more likely to persist in the future, and shape the coral species diversity of future reef ecosystems.	[Grottoli, Andrea G.; Wilkins, Michael J.; Johnston, Michael D.; Levas, Stephen; Schoepf, Verena] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Martins, Paula Dalcin; Wilkins, Michael J.] Ohio State Univ, Dept Microbiol, Columbus, OH USA; [Warner, Mark E.; Cai, Wei-Jun; Hoadley, Kenneth D.; Pettay, D. Tye] Univ Delaware, Sch Marine Sci & Policy, Lewes, DE 19958 USA; [Melman, Todd F.] Reef Syst Coral Farm, New Albany, OH USA; [Levas, Stephen] Univ Wisconsin, Dept Geol & Geog, Whitewater, WI 53190 USA; [Schoepf, Verena] Univ Western Australia, ARC Ctr Excellence Coral Reef Studies, UWA Oceans Inst, Crawley, WA, Australia; [Schoepf, Verena] Univ Western Australia, Sch Earth Sci, Crawley, WA, Australia	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Delaware; University of Wisconsin System; University of Western Australia; University of Western Australia	Grottoli, AG (corresponding author), Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA.	grottoli.1@osu.edu	Schoepf, Verena/H-5786-2014; Martins, Paula Dalcin/AAZ-1698-2020; Cai, Wei-Jun/C-1361-2013; Levas, Stephen/AAA-6774-2020; Warner, Mark E/J-6241-2013	Schoepf, Verena/0000-0002-9467-1088; Martins, Paula Dalcin/0000-0003-1242-0267; Cai, Wei-Jun/0000-0003-3606-8325; Warner, Mark/0000-0003-1015-9413; Hoadley, Kenneth/0000-0002-9287-181X; Wilkins, Michael/0000-0002-3595-0853	U.S. National Science Foundation [NSF-EF-1041124, 1040940, 1041070]; Ohio State University; Division Of Ocean Sciences [1459536] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Ohio State University(Ohio State University); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding by the U.S. National Science Foundation (NSF-EF-1041124, 1040940, 1041070 to AGG, MEW, and WJC, respectively) and from The Ohio State University (start-up funds to MJW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Reef Systems Coral Farm funder provided space for the experiment and contributed to the physical construction and maintenance of the experimental setup, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank the staff at Reef Systems Coral Farm, E. Zebrowski, M. Berzelis, M. Ringwald, S. Blackhurst, K. Dobson, C. Saup, and Y. Matsui for their assistance with the experiment. This work was supported by funding from the U.S. National Science Foundation (NSF-EF-1041124, 1040940, 1041070 to AGG, MEW, and WJC, respectively) and from The Ohio State University (start-up funds to MJW). Sequences have been deposited in NCBI's Sequence Read Archive under accession number PRJNA344759. The physiological data are archived at www.bco-dmo.org/project/528004.	Ainsworth TD, 2010, TRENDS ECOL EVOL, V25, P233, DOI 10.1016/j.tree.2009.11.001; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Anthony KRN, 2009, FUNCT ECOL, V23, P539, DOI 10.1111/j.1365-2435.2008.01531.x; Banin F, 2000, WATER AIR SOIL POLL, V123, P337, DOI 10.1023/A:1005274331988; Barott KL, 2011, ENVIRON MICROBIOL, V13, P1192, DOI 10.1111/j.1462-2920.2010.02419.x; Ben-Haim Y, 2003, INT J SYST EVOL MICR, P309; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Ceh J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036920; Chen CP, 2011, ISME J, V5, P728, DOI 10.1038/ismej.2010.151; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Comeau S, 2013, MAR BIOL, V160, P1127, DOI 10.1007/s00227-012-2165-5; Dove SG, 2013, P NATL ACAD SCI USA, V110, P15342, DOI 10.1073/pnas.1302701110; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edmunds PJ, 2012, GLOBAL CHANGE BIOL, V18, P2173, DOI 10.1111/j.1365-2486.2012.02695.x; Gorley C.K., 2006, GETTING STARTED PRIM; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Grottoli AG, 2014, GLOBAL CHANGE BIOL, V20, P3823, DOI 10.1111/gcb.12658; Hadaidi G, 2017, SCI REP-UK, V7, DOI 10.1038/srep45362; Hernandez-Agreda A, TRENDS MICR IN PRESS, V16; Hoadley KD, 2015, SCI REP-UK, V5, DOI 10.1038/srep18371; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; IPCC, 2013, SUMM POL; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Jokiel P.L., 1978, Monographs on Oceanographic Methodology, P529; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Koren O, 2006, APPL ENVIRON MICROB, V72, P5254, DOI 10.1128/AEM.00554-06; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; Kvennefors ECE, 2012, MICROB ECOL, V63, P605, DOI 10.1007/s00248-011-9946-0; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Levas S, 2015, MAR ECOL PROG SER, V519, P153, DOI 10.3354/meps11072; Levas SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063267; Littman R, 2011, ENV MICROBIOL REP, V3, P651, DOI 10.1111/j.1758-2229.2010.00234.x; Littman RA, 2010, MOL ECOL, V19, P1978, DOI 10.1111/j.1365-294X.2010.04620.x; Littman RA, 2009, FEMS MICROBIOL ECOL, V68, P152, DOI 10.1111/j.1574-6941.2009.00666.x; MARSH JA, 1970, ECOLOGY, V51, P254; Meron D, 2013, MICROB ECOL, V65, P269, DOI 10.1007/s00248-012-0127-6; Meron D, 2012, ISME J, V6, P1775, DOI 10.1038/ismej.2012.19; Meron D, 2011, ISME J, V5, P51, DOI 10.1038/ismej.2010.102; Miller J, 2003, REV BIOL TROP, V51, P47; Morrow KM, 2015, ISME J, V9, P894, DOI 10.1038/ismej.2014.188; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Noonan SHC, 2016, ICES J MAR SCI, V73, P715, DOI 10.1093/icesjms/fsv127; Pogoreutz C, 2017, GLOBAL CHANGE BIOL, V23, P3838, DOI 10.1111/gcb.13695; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Radecker N, 2014, MAR ECOL PROG SER, V511, P297, DOI 10.3354/meps10912; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Ritchie KB, 1995, MOL MAR BIOL BIOTECH, V4, P345; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2004, BACTERIAL DIS HYPOTH; Santos HF, 2014, ISME J, V8, P2272, DOI 10.1038/ismej.2014.70; SASIKALA K, 1990, FEMS MICROBIOL LETT, V72, P23, DOI 10.1016/0378-1097(90)90338-Q; Schoepf V, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1887; Schoepf V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075049; Sharp KH, 2012, BIOL BULL-US, V223, P66, DOI 10.1086/BBLv223n1p66; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Thompson JR, 2015, FRONTIERS CELLULAR I, P4; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Tremblay P, 2016, SCI REP-UK, V6, DOI 10.1038/srep38112; Veal CJ, 2010, CORAL REEFS, V29, P893, DOI 10.1007/s00338-010-0647-9; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Warner ME., 2010, CHLOROPHYLL FLUORESC; Webster NS, 2016, SCI REP-UK, V6, DOI 10.1038/srep19324; Webster NS, 2013, ENV MICROBIOL REP, V5, P243, DOI 10.1111/1758-2229.12006; Winer BJ, 1971, STAT PRINCIPLES EXPT; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zhou GW, 2016, SCI REP-UK, V6, DOI 10.1038/srep35971; Ziegler M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14213; Ziegler M, 2016, MAR POLLUT BULL, V105, P629, DOI 10.1016/j.marpolbul.2015.12.045	83	82	82	4	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191156	10.1371/journal.pone.0191156	http://dx.doi.org/10.1371/journal.pone.0191156			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338021	gold, Green Published, Green Submitted			2022-12-26	WOS:000422652700033
J	Horak, M; Zlamal, F; Iliev, R; Kucera, J; Cacek, J; Svobodova, L; Hlavonova, Z; Kalina, T; Slaby, O; Bienertova-Vasku, J				Horak, Martin; Zlamal, Filip; Iliev, Robert; Kucera, Jan; Cacek, Jan; Svobodova, Lenka; Hlavonova, Zuzana; Kalina, Tomas; Slaby, Ondrej; Bienertova-Vasku, Julie			Exercise-induced circulating microRNA changes in athletes in various training scenarios	PLOS ONE			English	Article							GROWTH	Background The aim of the study was to compare selected extracellular miRNA levels (miR-16, miR-21, miR-93 and miR-222 with the response to 8-week-long explosive strength training (EXPL), hypertrophic strength training (HYP) and high-intensity interval training (HIIT). Methods 30 young male athletes of white European origin (mean age: 22.5 +/- 4.06 years) recruited at the Faculty of Sports Studies of Masaryk University were enrolled in this study. The study participants were randomly assigned to three possible training scenarios: EXPL, HYP or HITT and participated in 8-week-long program in given arm. Blood plasma samples were collected at the baseline and at week 5 and 8 and anthropometric and physical activity parameters were measured. Pre- and post-intervention characteristics were compared and participants were further evaluated as responders (RES) or non-responders (NRES). RES/NRES status was established for the following characteristics: 300 degrees/s right leg extension (t300), 60 degrees/s right leg extension (t60), isometric extension (IE), vertical jump, isometric extension of the right leg and body fat percentage (BFP). Results No differences in miRNA levels were apparent between the intervention groups at baseline. No statistically significant prediction role was observed using crude univariate stepwise regression model analysis where RES/NRES status for t300, t60, IE, vertical jump and pFM was used as a dependent variable and miR-21, miR-222, miR-16 and miR-93 levels at baseline were used as independent variables. The baseline levels of miR-93 expressed an independent prediction role for responder status based on isometric extension of the right leg (beta estimate 0.76, 95% CI: -0.01; 1.53, p = 0.052). Discussion The results of the study indicate that 8-week-long explosive strength training, hypertrophic strength training and high-intensity interval training regimens are associated with significant changes in miR-16, mir-21, miR-222 and miR-93 levels compared to a baseline in athletic young men.	[Horak, Martin; Zlamal, Filip; Bienertova-Vasku, Julie] Masaryk Univ, Fac Med, Dept Pathol Physiol, Kamenice 5, Brno, Czech Republic; [Horak, Martin; Zlamal, Filip; Bienertova-Vasku, Julie] Masaryk Univ, Res Ctr Tox Cpds Environm, Kamenice 5, Brno, Czech Republic; [Iliev, Robert; Slaby, Ondrej] Masaryk Univ, Fac Sports Studies, Dept Athlet Swimming & Outdoor Sports, Kamenice 5, Brno, Czech Republic; [Cacek, Jan; Svobodova, Lenka; Hlavonova, Zuzana; Kalina, Tomas] Masaryk Univ, Cent European Inst Technol, Kamenice 5, Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno; Masaryk University Brno; Masaryk University Brno	Bienertova-Vasku, J (corresponding author), Masaryk Univ, Fac Med, Dept Pathol Physiol, Kamenice 5, Brno, Czech Republic.; Bienertova-Vasku, J (corresponding author), Masaryk Univ, Res Ctr Tox Cpds Environm, Kamenice 5, Brno, Czech Republic.	vasku.julie@seznam.cz	Horak, Martin/V-8484-2018; Kalina, Tomáš/AAH-4261-2021; Vasku, Julie Bienertova/AAV-6821-2020; Cacek, Jan/AAQ-6694-2021; Svobodová, Lenka/AAL-4356-2021	Horak, Martin/0000-0003-3928-2685; Kalina, Tomáš/0000-0003-0414-2922; Vasku, Julie Bienertova/0000-0001-5327-808X; Cacek, Jan/0000-0003-4277-8438; Svobodová, Lenka/0000-0003-1624-2859; Hlavonova, Zuzana/0000-0001-6872-1275	CETOCOEN PLUS project [CZ.02.1.01/0.0/0.0/15_003/0000469]	CETOCOEN PLUS project	The presented paper was supported from the CETOCOEN PLUS project CZ.02.1.01/0.0/0.0/15_003/0000469.	Altana Valentina, 2015, Microrna, V4, P74; Badal SS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12076; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057496; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cui S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00351-0; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Febbraio MA, 2017, NAT REV ENDOCRINOL, V13, P72, DOI 10.1038/nrendo.2016.218; Fernandes T, 2012, HYPERTENSION, V59, P513, DOI 10.1161/HYPERTENSIONAHA.111.185801; Ihle MA, 2015, MOL ONCOL, V9, P1421, DOI 10.1016/j.molonc.2015.03.013; Kilian Y, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00092; Liu XJ, 2015, CELL METAB, V21, P584, DOI 10.1016/j.cmet.2015.02.014; Lombardi G, 2016, CLIN BIOCHEM; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Missiaglia E, 2016, CANC LETT; Polakovicova M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101553; Roncarati R, 2014, J AM COLL CARDIOL, V63, P920, DOI 10.1016/j.jacc.2013.09.041; Russell AP, 2015, PROG MOL BIOL TRANSL, V135, P471, DOI 10.1016/bs.pmbts.2015.07.018; Sapp RM, 2017, J APPL PHYSIOL, V122, P702, DOI 10.1152/japplphysiol.00982.2016; Sheedy FJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00019; Viereck J, 2017, CIRC RES, V120, P381, DOI 10.1161/CIRCRESAHA.116.308434; Wahl P, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00643; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wardle SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122107; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405	28	28	29	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191060	10.1371/journal.pone.0191060	http://dx.doi.org/10.1371/journal.pone.0191060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338015	gold, Green Published, Green Submitted			2022-12-26	WOS:000422652700028
J	Yamanouchi, M; Hoshino, J; Ubara, Y; Takaichi, K; Kinowaki, K; Fujii, T; Ohashi, K; Mise, K; Toyama, T; Hara, A; Kitagawa, K; Shimizu, M; Furuichi, K; Wada, T				Yamanouchi, Masayuki; Hoshino, Junichi; Ubara, Yoshifumi; Takaichi, Kenmei; Kinowaki, Keiichi; Fujii, Takeshi; Ohashi, Kenichi; Mise, Koki; Toyama, Tadashi; Hara, Akinori; Kitagawa, Kiyoki; Shimizu, Miho; Furuichi, Kengo; Wada, Takashi			Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; JAPANESE PATIENTS; DISEASE; BIOPSY; PROGNOSIS; MELLITUS; SYSTEM	Background There have been a limited number of biopsy-based studies on diabetic nephropathy, and therefore the clinical importance of renal biopsy in patients with diabetes in late-stage chronic kidney disease (CKD) is still debated. We aimed to clarify the renal prognostic value of pathological information to clinical information in patients with diabetes and advanced CKD. Methods We retrospectively assessed 493 type 2 diabetics with biopsy-proven diabetic nephropathy in four centers in Japan. 296 patients with stage 3-5 CKD at the time of biopsy were identified and assigned two risk prediction scores for end-stage renal disease (ESRD): the Kidney Failure Risk Equation (KFRE, a score composed of clinical parameters) and the Diabetic Nephropathy Score (D-score, a score integrated pathological parameters of the Diabetic Nephropathy Classification by the Renal Pathology Society (RPS DN Classification)). They were randomized 2:1 to development and validation cohort. Hazard Ratios (HR) of incident ESRD were reported with 95% confidence interval (CI) of the KFRE, D-score and KFRE+D-score in Cox regression model. Improvement of risk prediction with the addition of D-score to the KFRE was assessed using c-statistics, continuous net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Results During median follow-up of 1.9 years, 194 patients developed ESRD. The cox regression analysis showed that the KFRE,D-score and KFRE+D-score were significant predictors of ESRD both in the development cohort and in the validation cohort. The c-statistics of the D-score was 0.67. The c-statistics of the KFRE was good, but its predictive value was weaker than that in the miscellaneous CKD cohort originally reported (c-statistics, 0.78 vs. 0.90) and was not significantly improved by adding the D-score (0.78 vs. 0.79, p = 0.83). Only continuous NRI was positive after adding the D-score to the KFRE (0.4%; CI: 0.0-0.8%). Conclusions We found that the predict values of the KFRE and the D-score were not as good as reported, and combining the D-score with the KFRE did not significantly improve prediction of the risk of ESRD in advanced diabetic nephropathy. To improve prediction of renal prognosis for advanced diabetic nephropathy may require different approaches with combining clinical and pathological parameters that were not measured in the KFRE and the RPS DN Classification.	[Yamanouchi, Masayuki; Wada, Takashi] Kanazawa Univ, Grad Sch Med Sci, Fac Med, Inst Pharmaceut & Hlth Sci,Dept Nephrol & Lab Med, Kanazawa, Ishikawa, Japan; [Yamanouchi, Masayuki; Hoshino, Junichi; Ubara, Yoshifumi; Takaichi, Kenmei] Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan; [Yamanouchi, Masayuki; Hoshino, Junichi; Ubara, Yoshifumi; Takaichi, Kenmei] Toranomon Hosp Kajigaya, Nephrol Ctr, Kawasaki, Kanagawa, Japan; [Yamanouchi, Masayuki; Hoshino, Junichi; Ubara, Yoshifumi; Takaichi, Kenmei] Okinaka Mem Inst Med Res, Tokyo, Japan; [Kinowaki, Keiichi; Fujii, Takeshi; Ohashi, Kenichi] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan; [Ohashi, Kenichi] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa, Japan; [Mise, Koki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan; [Toyama, Tadashi; Hara, Akinori; Shimizu, Miho; Furuichi, Kengo; Wada, Takashi] Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan; [Kitagawa, Kiyoki] Natl Hosp Org, Kanazawa Med Ctr, Div Internal Med, Kanazawa, Ishikawa, Japan	Kanazawa University; Toranomon Hospital; Toranomon Hospital; Yokohama City University; Okayama University; Kanazawa University	Yamanouchi, M; Wada, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Fac Med, Inst Pharmaceut & Hlth Sci,Dept Nephrol & Lab Med, Kanazawa, Ishikawa, Japan.; Yamanouchi, M (corresponding author), Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan.; Yamanouchi, M (corresponding author), Toranomon Hosp Kajigaya, Nephrol Ctr, Kawasaki, Kanagawa, Japan.; Yamanouchi, M (corresponding author), Okinaka Mem Inst Med Res, Tokyo, Japan.; Wada, T (corresponding author), Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan.	m.yamanouchi@toranomon.gr.jp; twada@m-kanazawa.jp	FURUICHI, Kengo/AAA-5685-2019; Fujii, Takeshi/D-5877-2014; Hara, Akinori/W-8522-2019	Fujii, Takeshi/0000-0001-7237-1183; Mise, Koki/0000-0003-0296-7429; Yamanouchi, Masayuki/0000-0003-3264-9691	Japan Agency for Medical Research and Development [15ek0310003h0001]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was partly supported by a Grant-in-Aid for Practical Research Projects for Renal Diseases from the Japan Agency for Medical Research and Development (grant no: 15ek0310003h0001). The funding source had no role in study design or execution, data analysis, manuscript writing, or manuscript submission.	Chang TI, 2011, DIABETES RES CLIN PR, V92, P198, DOI 10.1016/j.diabres.2011.01.017; Chen PM, 2017, CLIN EXP NEPHROL, V21, P307, DOI 10.1007/s10157-016-1290-8; Drawz PE, 2013, J AM GERIATR SOC, V61, P762, DOI 10.1111/jgs.12223; Fiorentino M, 2017, NEPHROL DIAL TRANSPL, V32, P97, DOI 10.1093/ndt/gfw070; Furuichi K, 2018, NEPHROL DIAL TRANSPL, V33, P138, DOI 10.1093/ndt/gfw417; Goto M, 2009, NEPHROL DIAL TRANSPL, V24, P3068, DOI 10.1093/ndt/gfp273; Hoshino J, 2015, AM J NEPHROL, V41, P337, DOI 10.1159/000431333; Imai Enyu, 2007, Clin Exp Nephrol, V11, P41, DOI 10.1007/s10157-006-0453-4; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Keane WF, 2006, CLIN J AM SOC NEPHRO, V1, P761, DOI 10.2215/CJN.01381005; Kerr KF, 2014, CLIN J AM SOC NEPHRO, V9, P1488, DOI 10.2215/CJN.10351013; Klessens CQF, 2016, KIDNEY INT, V90, P149, DOI 10.1016/j.kint.2016.01.023; Lennartz CS, 2016, CLIN J AM SOC NEPHRO, V11, P609, DOI 10.2215/CJN.08110715; Mise K, 2014, NEPHROL DIAL TRANSPL, V29, P109, DOI 10.1093/ndt/gft349; Oh SW, 2012, DIABETES RES CLIN PR, V97, P418, DOI 10.1016/j.diabres.2012.03.016; Okada T, 2012, NEPHROLOGY, V17, P68, DOI 10.1111/j.1440-1797.2011.01525.x; Schroeder EB, 2017, CLIN J AM SOC NEPHRO, V12, P87, DOI 10.2215/CJN.01290216; Sharma SG, 2013, CLIN J AM SOC NEPHRO, V8, P1718, DOI 10.2215/CJN.02510213; Tangri N, 2016, JAMA-J AM MED ASSOC, V315, P164, DOI 10.1001/jama.2015.18202; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wada T, 2014, CLIN EXP NEPHROL, V18, P613, DOI 10.1007/s10157-013-0879-4; Wong TYH, 2002, DIABETES CARE, V25, P900, DOI 10.2337/diacare.25.5.900; Yamamoto K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091067	25	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0190930	10.1371/journal.pone.0190930	http://dx.doi.org/10.1371/journal.pone.0190930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338014	gold, Green Published, Green Submitted			2022-12-26	WOS:000422652700023
J	Constantinides, C; Maguire, M; McNeill, E; Carnicer, R; Swider, E; Srinivas, M; Carr, CA; Schneider, JE				Constantinides, Christakis; Maguire, Mahon; McNeill, Eileen; Carnicer, Ricardo; Swider, Edyta; Srinivas, Mangala; Carr, Carolyn A.; Schneider, Jurgen E.			Fast, quantitative, murine cardiac F-19 MRI/MRS of PFCE-labeled progenitor stem cells and macrophages at 9.4T	PLOS ONE			English	Article							CARDIOSPHERE-DERIVED CELLS; IN-VIVO; PERFLUOROCARBON NANOPARTICLES; MRI; TRACKING; VISUALIZATION; MIGRATION; INFILTRATION; INFLAMMATION; MYOCARDITIS	Purpose To a) achieve cardiac F-19-Magnetic Resonance Imaging (MRI) of perfluoro-crown-ether (PFCE) labeled cardiac progenitor stem cells (CPCs) and bone-derived bone marrow macrophages, b) determine label concentration and cellular load limits, and c) achieve spectroscopic and image-based quantification. Methods Theoretical simulations and experimental comparisons of spoiled-gradient echo (SPGR), rapid acquisition with relaxation enhancement (RARE), and steady state at free precession (SSFP) pulse sequences, and phantom validations, were conducted using F-19 MRI/Magnetic Resonance Spectroscopy (MRS) at 9.4 T. Successful cell labeling was confirmed using flow cytometry and confocal microscopy. For CPC and macrophage concentration quantification, in vitro and post-mortem cardiac validations were pursued with the use of the transfection agent FuGENE. Feasibility of fast imaging is demonstrated in murine cardiac acquisitions in vivo, and in post-mortem murine skeletal and cardiac applications. Results SPGR/SSFP proved favorable imaging sequences yielding good signal-to-noise ratio values. Confocal microscopy confirmed heterogeneity of cellular label uptake in CPCs. F-19 MRI indicated lack of additional benefits upon label concentrations above 7.5 +/- 10 mg/ml/million cells. The minimum detectable CPC load was similar to 500k (similar to 10k/voxel) in two-dimensional (2D) acquisitions (3 +/- 5 min) using the butterfly coil. Additionally, absolute F-19 based concentration and intensity estimates (trifluoroacetic-acid solutions, macrophages, and labeled CPCs in vitro and post-CPC injections in the post-mortem state) scaled linearly with fluorine concentrations. Fast, quantitative cardiac F-19-MRI was demonstrated with SPGR/SSFP and MRS acquisitions spanning 3 +/- 5 min, using a butterfly coil. Conclusion The developed methodologies achieved in vivo cardiac F-19 of exogenously injected labeled CPCs for the first time, accelerating imaging to a total acquisition of a few minutes, providing evidence for their potential for possible translational work.	[Constantinides, Christakis; Maguire, Mahon; McNeill, Eileen; Carnicer, Ricardo; Schneider, Jurgen E.] Univ Oxford, Radcliffe Dept Med, Dept Cardiovasc Med, Oxford, England; [Swider, Edyta; Srinivas, Mangala] Radboud Univ Nijmegen, Med Ctr, Dept Tumor Immunol, Nijmegen, Netherlands; [Carr, Carolyn A.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Constantinides, Christakis] Chi Biomed Ltd, Nicosia, Cyprus; [Schneider, Jurgen E.] Univ Leeds, Fac Med & Hlth, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England	University of Oxford; Radboud University Nijmegen; University of Oxford; University of Leeds	Constantinides, C (corresponding author), Univ Oxford, Radcliffe Dept Med, Dept Cardiovasc Med, Oxford, England.; Constantinides, C (corresponding author), Chi Biomed Ltd, Nicosia, Cyprus.	Christakis.Constantinides@gmail.com	Srinivas, Mangala/A-2167-2014	Srinivas, Mangala/0000-0002-3835-1995; McNeill, Eileen/0000-0003-0971-9858; Constantinides, Christakis/0000-0001-9225-7572	European Union's Horizon 2020 research and innovation programme under Marie Sklodowska-Curie [652986]; European Research Council [ERC-2013-StG-336454, ERC-PoC-713524]; Radboud Universiteit SWT [14716]; Wellcome Trust Core [090532/Z/09/Z]; British Heart Foundation (BHF) [FS/11/50/29038]; British Heart Foundation [FS/15/15/31364, FS/11/50/29038] Funding Source: researchfish; Rosetrees Trust [M315] Funding Source: researchfish	European Union's Horizon 2020 research and innovation programme under Marie Sklodowska-Curie; European Research Council(European Research Council (ERC)European Commission); Radboud Universiteit SWT; Wellcome Trust Core; British Heart Foundation (BHF)(British Heart Foundation); British Heart Foundation(British Heart Foundation); Rosetrees Trust(Rosetrees Trust)	The project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 652986 to Christakis Constantinides, European Research Council grants ERC-2013-StG-336454 and ERC-PoC-713524, Radboud Universiteit SWT grant 14716 (MS), Wellcome Trust Core Award (grant 090532/Z/09/Z), and British Heart Foundation (BHF) grant FS/11/50/29038 (JS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday S, 2014, RSC ADV, V4, P31706, DOI 10.1039/c4ra04041d; Ahrens ET, 2014, MAGN RESON MED, V72, P1696, DOI 10.1002/mrm.25454; Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Boehm-Sturm P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029040; Bonetto F, 2012, NMR BIOMED, V25, P1095, DOI 10.1002/nbm.2774; Chalmers KH, 2011, MAGN RESON MED, V66, P931, DOI 10.1002/mrm.22881; Chen IY, 2011, CIRCULATION, V123, P425, DOI 10.1161/CIRCULATIONAHA.109.916338; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Colotti R, 2016, MAGNETIC RESONANCE M; Constantinides C, 2016, ISMRM WORKSH MOL CEL; Constantinides C, 2016, ESMRMB 2016; de Vries A, 2014, CONTRAST MEDIA MOL I, V9, P83, DOI 10.1002/cmmi.1541; Faber C., 2016, FLUORINE MAGNETIC RE, P1; Feyen DAM, 2016, ADV DRUG DELIVER REV, V106, P104, DOI 10.1016/j.addr.2016.04.023; Flogel U, 2008, CIRCULATION, V118, P140, DOI 10.1161/CIRCULATIONAHA.107.737890; Gaudet JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118544; Giraudeau C, 2010, MAGN RESON MED, V63, P1119, DOI 10.1002/mrm.22269; Goette MJ, 2015, MAGN RESON MED, V74, P537, DOI 10.1002/mrm.25437; Gomes RSM, 2013, ACS NANO, V7, P3362, DOI 10.1021/nn400171w; Hanicke W, 2003, MAGN RESON MED, V49, P771, DOI 10.1002/mrm.10410; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Jacoby C, 2014, MAGN RESON MATER PHY, V27, P101, DOI 10.1007/s10334-013-0391-6; Jacoby C, 2014, NMR BIOMED, V27, P261, DOI 10.1002/nbm.3059; Kadayakkara DK, 2014, J MAGN RESON, V242, P18, DOI 10.1016/j.jmr.2014.01.014; Kampf T, 2010, J MAGN RESON, V207, P262, DOI 10.1016/j.jmr.2010.09.006; Kislukhin AA, 2016, NAT MATER, V15, P662, DOI [10.1038/nmat4585, 10.1038/NMAT4585]; Lee D, 2010, MAGN RESON MED, V63, P570, DOI 10.1002/mrm.22298; Malandraki-Miller S, 2014, HEART, V100, DOI 10.1136/heartjnl-2014-306916.41; Mastropietro A, 2014, J MAGN RESON IMAGING, V40, P162, DOI 10.1002/jmri.24347; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Neubauer AM, 2008, MAGN RESON MED, V60, P1066, DOI 10.1002/mrm.21750; Partlow KC, 2007, FASEB J, V21, P1647, DOI 10.1096/fj.06-6505com; Ribot EJ, 2014, INT J NANOMED, V9, P1731, DOI 10.2147/IJN.S59127; Ruiz-Cabello J, 2008, MAGN RESON MED, V60, P1506, DOI 10.1002/mrm.21783; Schmid F, 2013, MAGN RESON MED, V69, P1056, DOI 10.1002/mrm.24341; SILVER MS, 1984, J MAGN RESON, V59, P347, DOI 10.1016/0022-2364(84)90181-1; Srinivas M, 2007, MAGN RESON MED, V58, P725, DOI 10.1002/mrm.21352; Srinivas M, 2012, BIOMATERIALS, V33, P8830, DOI 10.1016/j.biomaterials.2012.08.048; Srinivas M, 2010, TRENDS BIOTECHNOL, V28, P363, DOI 10.1016/j.tibtech.2010.04.002; Srinivas M, 2010, BIOMATERIALS, V31, P7070, DOI 10.1016/j.biomaterials.2010.05.069; Stuckey DJ, 2006, STEM CELLS, V24, P1968, DOI 10.1634/stemcells.2006-0074; Tan SC, 2016, CELL TRANSPLANT, V25, P35, DOI 10.3727/096368915X687697; van Heeswijk RB, 2013, CIRC-CARDIOVASC IMAG, V6, P277, DOI 10.1161/CIRCIMAGING.112.000125; van Heeswijk RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042236; Waiczies H, 2013, JOVE-J VIS EXP, V20; Waiczies H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021981; Ye YX, 2013, CIRCULATION, V128, P1878, DOI 10.1161/CIRCULATIONAHA.113.000731; Zhong J, 2013, MAGN RESON MED, V69, P1683, DOI 10.1002/mrm.24414	48	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190558	10.1371/journal.pone.0190558	http://dx.doi.org/10.1371/journal.pone.0190558			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324754	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400038
J	Fujii, N; Miyabayashi, S; Sugita, T; Kobayashi, A; Yamazaki, C; Miyazawa, Y; Kamada, M; Kasahara, H; Osada, I; Shimazu, T; Fusejima, Y; Higashibata, A; Yamazaki, T; Ishioka, N; Takahashi, H				Fujii, Nobuharu; Miyabayashi, Sachiko; Sugita, Tomoki; Kobayashi, Akie; Yamazaki, Chiaki; Miyazawa, Yutaka; Kamada, Motoshi; Kasahara, Haruo; Osada, Ikuko; Shimazu, Toru; Fusejima, Yasuo; Higashibata, Akira; Yamazaki, Takashi; Ishioka, Noriaki; Takahashi, Hideyuki			Root-tip-mediated inhibition of hydrotropism is accompanied with the suppression of asymmetric expression of auxin-inducible genes in response to moisture gradients in cucumber roots	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; CELL EXPANSION; GRAVITROPISM; TRANSPORT; CAP; TRAFFICKING; GRAVITY; PROTEIN; GENOME; PEA	In cucumber seedlings, gravitropism interferes with hydrotropism, which results in the nearly complete inhibition of hydrotropism under stationary conditions. However, hydrotropic responses are induced when the gravitropic response in the root is nullified by clinorotation. Columella cells in the root cap sense gravity, which induces the gravitropic response. In this study, we found that removing the root tip induced hydrotropism in cucumber roots under stationary conditions. The application of auxin transport inhibitors to cucumber seedlings under stationary conditions suppressed the hydrotropic response induced by the removal of the root tip. To investigate the expression of genes related to hydrotropism in de-tipped cucumber roots, we conducted transcriptome analysis of gene expression by RNA-Seq using seedlings exhibiting hydrotropic and gravitropic responses. Of the 21 and 45 genes asymmetrically expressed during hydrotropic and gravitropic responses, respectively, five genes were identical. Gene ontology (GO) analysis indicated that the category auxin-inducible genes was significantly enriched among genes that were more highly expressed in the concave side of the root than the convex side during hydrotropic or gravitropic responses. Reverse transcription followed by quantitative polymerase chain reaction (RT-qPCR) analysis revealed that root hydrotropism induced under stationary conditions (by removing the root tip) was accompanied by the asymmetric expression of several auxin-inducible genes. However, intact roots did not exhibit the asymmetric expression patterns of auxin-inducible genes under stationary conditions, even in the presence of a moisture gradient. These results suggest that the root tip inhibits hydrotropism by suppressing the induction of asymmetric auxin distribution. Auxin transport and distribution not mediated by the root tip might play a role in hydrotropism in cucumber roots.	[Fujii, Nobuharu; Miyabayashi, Sachiko; Sugita, Tomoki; Kobayashi, Akie; Takahashi, Hideyuki] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi, Japan; [Yamazaki, Chiaki; Shimazu, Toru; Fusejima, Yasuo] Japan Space Forum, Chiyoda Ku, Tokyo, Japan; [Miyazawa, Yutaka] Yamagata Univ, Fac Sci, Kojirakawa Machi, Yamagata, Japan; [Kamada, Motoshi] Adv Engn Serv Co Ltd, Takezono, Tsukuba, Japan; [Kasahara, Haruo; Higashibata, Akira] Japan Aerosp Explorat Agcy, JEM Utilizat Ctr, Sengen, Tsukuba, Japan; [Osada, Ikuko] Japan Manned Space Syst Co Ltd, Chiyoda Ku, Otemachi, Tokyo, Japan; [Yamazaki, Takashi] Teikyo Univ, Grad Sch Med, Itabashi Ku, Tokyo, Japan; [Ishioka, Noriaki] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa, Japan	Tohoku University; Yamagata University; Advanced Engineering Services Co., Ltd. (A.E.S.); Japan Aerospace Exploration Agency (JAXA); Teikyo University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS)	Fujii, N (corresponding author), Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi, Japan.	nobuharu@ige.tohoku.ac.jp	Fujii, Nobuharu/AAH-7402-2019; shimazu, Toru/AAA-5311-2020; Miyazawa, Yutaka/AAQ-8594-2020	shimazu, Toru/0000-0003-0343-8035; Miyazawa, Yutaka/0000-0002-4491-6112	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [24620002]; Japan Society for the Promotion of Science (JSPS) [16K07955]; JSPS [26870057, K15K119130]; Council for Science and Technology Policy [GS002]; Cabinet Office; JSPS; MEXT KAKENHI [221S0002]; Grants-in-Aid for Scientific Research [17K07433] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy(Council for Science and Technology Policy (CSTP)); Cabinet Office; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was conducted by the Ground-Based Research Announcement for Space Utilization program promoted by the Japan Space Forum. This work also was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (no. 24620002) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan to H.T., by a Grant-in-Aid for Scientific Research (C) (no. 16K07955) from the Japan Society for the Promotion of Science (JSPS) to H.T., by a Grant-in-Aid for Young Scientists (B) (no. 26870057) from the JSPS to A.K., by the Funding Program for Next-Generation World-Leading Researchers (GS002) from the Council for Science and Technology Policy, Cabinet Office, and JSPS to Y.M., and by a Grant-in-Aid for Scientific Research (C) (K15K119130) from the JSPS to N.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Motoshi Kamada is employed by Advanced Engineering Services Co., Ltd. Ikuko Osada is employed by Japan Manned Space Systems Co., Ltd. Advanced Engineering Services Co., Ltd. and Japan Manned Space Systems Co., Ltd. provided support in the form of salaries for authors M.K. and I.O., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; We are grateful to MEXT KAKENHI (no. 221S0002) for supporting the RNA-Seq analysis of cucumber root gravitropism in this work.	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Baster P, 2013, EMBO J, V32, P260, DOI 10.1038/emboj.2012.310; Benjamins R, 2001, DEVELOPMENT, V128, P4057; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; Blancaflor EB, 1998, PLANT PHYSIOL, V116, P213, DOI 10.1104/pp.116.1.213; Dietrich D, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.57; Esmon CA, 2006, P NATL ACAD SCI USA, V103, P236, DOI 10.1073/pnas.0507127103; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Guo FQ, 2002, J EXP BOT, V53, P835, DOI 10.1093/jexbot/53.370.835; HAGEN G, 1984, PLANTA, V162, P147, DOI 10.1007/BF00410211; Herranz R, 2013, ASTROBIOLOGY, V13, P1, DOI 10.1089/ast.2012.0876; Hoson T, 1997, PLANTA, V203, pS187, DOI 10.1007/PL00008108; Hu LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074646; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; JAFFE MJ, 1985, SCIENCE, V230, P445, DOI 10.1126/science.230.4724.445; JUNIPER BE, 1966, NATURE, V209, P93, DOI 10.1038/209093a0; Kaneyasu T, 2007, J EXP BOT, V58, P1143, DOI 10.1093/jxb/erl274; Kaufman Peter B., 1995, P547; KISS JZ, 1989, PLANTA, V177, P198, DOI 10.1007/BF00392808; Kleine-Vehn J, 2010, P NATL ACAD SCI USA, V107, P22344, DOI 10.1073/pnas.1013145107; Kobayashi A, 2007, P NATL ACAD SCI USA, V104, P4724, DOI 10.1073/pnas.0609929104; Kraft TFB, 2000, PLANTA, V211, P415, DOI 10.1007/s004250000302; Li Z, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-540; Mazur E, 2016, SCI REP-UK, V6, DOI 10.1038/srep33754; MCCLURE BA, 1989, SCIENCE, V243, P91, DOI 10.1126/science.11540631; Miyazawa Y, 2009, PLANT PHYSIOL, V149, P835, DOI 10.1104/pp.108.131003; Mizuno H, 2002, PLANT CELL PHYSIOL, V43, P793, DOI 10.1093/pcp/pcf093; Molisch H., 1883, SITZUNGSBERICHTE AKA, V88, P897; Morohashi K, 2017, NEW PHYTOL, V215, P1476, DOI 10.1111/nph.14689; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Murray J, 1880, POWER MOVEMENT PLANT, P129, DOI [10.5962/bhl.title.102319, DOI 10.5962/BHL.TITLE.102319]; Nakajima Y, 2017, J EXP BOT, V68, P3441, DOI 10.1093/jxb/erx193; PILET PE, 1971, NATURE-NEW BIOL, V233, P115, DOI 10.1038/newbio233115b0; Sachs JV, 1872, ARB BOT I WURZBURG, V1, P209; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; SHEVELL DE, 1994, CELL, V77, P1051, DOI 10.1016/0092-8674(94)90444-8; Spartz AK, 2014, PLANT CELL, V26, P2129, DOI 10.1105/tpc.114.126037; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Takahashi H, 1996, J PLANT RES, V109, P335, DOI 10.1007/BF02344481; Takahashi H, 1999, J PLANT RES, V112, P497, DOI 10.1007/PL00013906; Takahashi H, 2009, PLANT MOL BIOL, V69, P489, DOI 10.1007/s11103-008-9438-x; Takahashi N, 2002, PLANTA, V216, P203, DOI 10.1007/s00425-002-0840-3; Taniguchi M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29570; THEOLOGIS A, 1985, J MOL BIOL, V183, P53, DOI 10.1016/0022-2836(85)90280-3; Went FW., 1937, PHYTOHORMONES; Wu Jian, 2014, BMC Res Notes, V7, P218, DOI 10.1186/1756-0500-7-218	46	7	7	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0189827	10.1371/journal.pone.0189827	http://dx.doi.org/10.1371/journal.pone.0189827			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324818	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400012
J	Leary, CJ; Ralicki, HF; Laurencio, D; Crocker-Buta, S; Malone, JH				Leary, Christopher J.; Ralicki, Hannah F.; Laurencio, David; Crocker-Buta, Sarah; Malone, John H.			Assessing the links among environmental contaminants, endocrinology, and parasites to understand amphibian declines in montane regions of Costa Rica	PLOS ONE			English	Article							DEPOSITED ORGANIC CONTAMINANTS; SIERRA-NEVADA MOUNTAINS; CALLING MATING TACTICS; STEROID-HORMONE LEVELS; CURRENT-USE PESTICIDES; DISRUPTING CHEMICALS; POPULATION DECLINES; STRESS HORMONE; PLASMA GONADOTROPINS; MULTIPLE STRESSORS	Amphibians inhabiting montane riparian zones in the Neotropics are particularly vulnerable to decline, but the reasons are poorly understood. Because environmental contaminants, endocrine disruption, and pathogens often figure prominently in amphibian declines it is imperative that we understand how these factors are potentially interrelated to affect montane populations. One possibility is that increased precipitation associated with global warming promotes the deposition of contaminants in montane regions. Increased exposure to contaminants, in turn, potentially elicits chronic elevations in circulating stress hormones that could contribute to montane population declines by compromising resistance to pathogens and/ or production of sex steroids regulating reproduction. Here, we test this hypothesis by examining contaminant levels, stress and sex steroid levels, and nematode abundances in male drab treefrogs, Smilisca sordida, from lowland and montane populations in Costa Rica. We found no evidence that montane populations were more likely to possess contaminants (i.e., organochlorine, organophosphate and carbamate pesticides or benzidine and chlorophenoxy herbicides) than lowland populations. We also found no evidence of elevational differences in circulating levels of the stress hormone corticosterone, estradiol or progesterone. However, montane populations possessed lower androgen levels, hosted more nematode species, and had higher nematode abundances than lowland populations. Although these results suggested that nematodes contributed to lower androgens in montane populations, we were unable to detect a significant inverse relationship between nematode abundance and androgen level. Our results suggest that montane populations of this species are not at greater risk of exposure to contaminants or chronic stress, but implicate nematodes and compromised sex steroid levels as potential threats to montane populations.	[Leary, Christopher J.; Crocker-Buta, Sarah] Univ Mississippi, Dept Biol, University, MS 38677 USA; [Ralicki, Hannah F.] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Laurencio, David] Auburn Univ, Museum Nat Hist, Dept Biol Sci, Auburn, AL 36849 USA; [Malone, John H.] Univ Connecticut, Inst Syst Genom, Storrs, CT USA; [Malone, John H.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA	University of Mississippi; University of Connecticut; Auburn University System; Auburn University; University of Connecticut; University of Connecticut	Leary, CJ (corresponding author), Univ Mississippi, Dept Biol, University, MS 38677 USA.	cjleary@olemiss.edu		Leary, Christopher/0000-0001-6257-3339	Global Wildlife Conservation [5007-0000]; University of Connecticut startup funds	Global Wildlife Conservation; University of Connecticut startup funds	Funding was provided through Global Wildlife Conservation grant #5007-0000 to CJL and the University of Connecticut startup funds to JHM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E., 2005, HORMONES ANIMAL SOCI; Alford RA, ECOTOXICOLOGY AMPHIB, DOI [10.1016/j.mce.2010.04.005, DOI 10.1016/J.MCE.2010.04.005]; Allen MR, 2002, NATURE, V419, P224, DOI 10.1038/nature01092; Angermann JE, 2002, ENVIRON TOXICOL CHEM, V21, P2209, DOI [10.1897/1551-5028(2002)021<2209:PBATIP>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;2209:PBATIP&gt;2.0.CO;2]; Araya K, 2014, PESTICIDES POLLUTION; BATEMAN A, 1989, ENDOCR REV, V10, P92, DOI 10.1210/edrv-10-1-92; Belden LK, 2005, J PARASITOL, V91, P686, DOI 10.1645/GE-397R; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blais JM, 1998, NATURE, V395, P585, DOI 10.1038/26944; Boone MD, 2007, ECOL APPL, V17, P291, DOI 10.1890/1051-0761(2007)017[0291:MSIACE]2.0.CO;2; Bradford DF, 2013, ENVIRON TOXICOL CHEM, V32, P517, DOI 10.1002/etc.2094; Bradford DF, 2010, ENVIRON TOXICOL CHEM, V29, P1056, DOI 10.1002/etc.139; BREUSCH TS, 1979, ECONOMETRICA, V47, P1287, DOI 10.2307/1911963; Bursey CR, 2010, COMP PARASITOL, V77, P221, DOI 10.1654/4418.1; CAREY C, 1995, ENVIRON HEALTH PERSP, V103, P13, DOI 10.2307/3432406; Carey C, 1999, DEV COMP IMMUNOL, V23, P459, DOI 10.1016/S0145-305X(99)00028-2; Christin MS, 2003, ENVIRON TOXICOL CHEM, V22, P1127, DOI [10.1897/1551-5028(2003)022&lt;1127:EOAPOT&gt;2.0.CO;2, 10.1002/etc.5620220522]; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Daly GL, 2007, ENVIRON SCI TECHNOL, V41, P1118, DOI 10.1021/es0622709; Daly GL, 2005, ENVIRON SCI TECHNOL, V39, P385, DOI 10.1021/es048859u; Davidson C, 2004, ECOL APPL, V14, P1892, DOI 10.1890/03-5224; Davidson C, 2001, ECOL APPL, V11, P464, DOI 10.1890/1051-0761(2001)011[0464:DOTCRL]2.0.CO;2; Davidson C, 2007, ECOL APPL, V17, P587, DOI 10.1890/06-0181; Davidson C, 2012, ENVIRON TOXICOL CHEM, V31, P1895, DOI 10.1002/etc.1902; Davis AG, 2015, HORM BEHAV, V69, P119, DOI 10.1016/j.yhbeh.2015.01.005; Donat MG, 2016, NAT CLIM CHANGE, V6, P508, DOI [10.1038/nclimate2941, 10.1038/NCLIMATE2941]; Egea-Serrano A, 2012, ECOL EVOL, V2, P1382, DOI 10.1002/ece3.249; Eikenaar C, 2012, AM NAT, V180, P642, DOI 10.1086/667891; Emerson Sharon B., 2001, P36; Fellers GM, 2004, ENVIRON TOXICOL CHEM, V23, P2170, DOI 10.1897/03-491; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Floyd RM, 2005, MOL ECOL NOTES, V5, P611, DOI 10.1111/j.1471-8286.2005.01009.x; Fonner CW, 2017, DIS AQUAT ORGAN, V123, P159, DOI 10.3354/dao03089; Fuxjager MJ, 2011, FUNCT ECOL, V25, P132, DOI 10.1111/j.1365-2435.2010.01784.x; Galloway T, 2003, ECOTOXICOLOGY, V12, P345, DOI 10.1023/A:1022579416322; Gascon Claude, 2012, Alytes (Paris), V29, P15; George D., 2010, SPSS WINDOWS STEP ST, V10; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Goodman BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020193; Goymann W, 2004, AM NAT, V164, P327, DOI 10.1086/422856; Greenberg N., 1987, P461; GUYER C., 2005, AMPHIBIANS REPTILES; Hayes TB, 2010, J EXP BIOL, V213, P921, DOI 10.1242/jeb.040865; Hayes TB, 2002, P NATL ACAD SCI USA, V99, P5476, DOI 10.1073/pnas.082121499; Hayes TB, 2005, INTEGR COMP BIOL, V45, P321, DOI 10.1093/icb/45.2.321; Hayes TB, 2006, ENVIRON HEALTH PERSP, V114, P40, DOI 10.1289/ehp.8051; Heil M, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00080; Holdridge LR, 1967, LIFE ZONE ECOLOGY; Hopkins WA, 2007, ILAR J, V48, P270, DOI 10.1093/ilar.48.3.270; ITOH M, 1990, GEN COMP ENDOCR, V78, P242, DOI 10.1016/0016-6480(90)90011-A; Johnson PTJ, 2003, CONSERV BIOL, V17, P1724, DOI 10.1111/j.1523-1739.2003.00217.x; Joshi AM, 2017, GEN COMP ENDOCR, V246, P142, DOI 10.1016/j.ygcen.2016.12.003; Kallenborn R, 2006, ECOTOX ENVIRON SAFE, V63, P100, DOI 10.1016/j.ecoenv.2005.02.016; Klein SL, 2000, NEUROSCI BIOBEHAV R, V24, P627, DOI 10.1016/S0149-7634(00)00027-0; Koprivnikar J, 2012, ECOHEALTH, V9, P342, DOI 10.1007/s10393-012-0785-3; Lacher TE, 2010, WILDLIFE TOXICOLOGY, P111; Leary CJ, 2008, BEHAV ECOL, V19, P1103, DOI 10.1093/beheco/arn102; Leary CJ, 2008, ANIM BEHAV, V76, P175, DOI 10.1016/j.anbehav.2007.12.020; Leary CJ, 2006, AM NAT, V168, P431, DOI 10.1086/506975; Leary CJ, 2015, GEN COMP ENDOCR, V213, P32, DOI 10.1016/j.ygcen.2014.12.017; Leary CJ, 2013, HORM BEHAV, V63, P20, DOI 10.1016/j.yhbeh.2012.11.006; Leary CJ, 2006, HORM BEHAV, V49, P425, DOI 10.1016/j.yhbeh.2005.09.004; Leary CJ, 2004, BEHAV ECOL, V15, P313, DOI 10.1093/beheco/arh015; LeNoir JS, 1999, ENVIRON TOXICOL CHEM, V18, P2715, DOI [10.1002/etc.5620181210, 10.1897/1551-5028(1999)018&lt;2715:STOCUP&gt;2.3.CO;2]; LICHT P, 1983, GEN COMP ENDOCR, V50, P124, DOI 10.1016/0016-6480(83)90249-6; Madelaire CB, 2016, GEN COMP ENDOCR, V228, P9, DOI 10.1016/j.ygcen.2016.01.011; Malone JH, 2004, J HERPETOL, V38, P27, DOI 10.1670/32-03A; Malone JH, 2006, J HERPETOL, V40, P230, DOI 10.1670/140-05A.1; Mann RM, 2009, ENVIRON POLLUT, V157, P2903, DOI 10.1016/j.envpol.2009.05.015; MARDIA KV, 1970, BIOMETRIKA, V57, P519, DOI 10.1093/biomet/57.3.519; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; Mason R.L., 2003, STAT DESIGN ANAL EXP; McConnell LL, 1998, ENVIRON TOXICOL CHEM, V17, P1908, DOI 10.1897/1551-5028(1998)017&lt;1908:WDOCUP&gt;2.3.CO;2; Mendelson JR, 2006, SCIENCE, V313, P48, DOI 10.1126/science.1128396; Mendelson JR, 2004, REV BIOL TROP, V52, P991; Moore Frank L., 2002, P515; Muller CJ, 2011, J CLIMATE, V24, P2784, DOI 10.1175/2011JCLI3876.1; Navas Carlos A., 2016, P155; Navas Carlos A., 2012, Alytes (Paris), V29, P119; Navas Carlos A., 2007, PHYLLOMEDUSA, V6, P83; Pottinger TG, 2003, PURE APPL CHEM, V75, P2321, DOI 10.1351/pac200375112321; Powers T, 2004, ANNU REV PHYTOPATHOL, V42, P367, DOI 10.1146/annurev.phyto.42.040803.140348; Presley SM, 2010, WILDLIFE TOXICOLOGY, P73; Rahimi R, 2007, PESTIC BIOCHEM PHYS, V88, P115, DOI 10.1016/j.pestbp.2006.10.003; Reeves RA, 2017, HERPETOL CONSERV BIO, V12, P68; Rohr JR, 2008, NATURE, V455, P1235, DOI 10.1038/nature07281; Romero LM, 2002, GEN COMP ENDOCR, V128, P1; Ruggeri J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130554; SAPOLSKY R M, 1992, P287; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Saradha B, 2006, ENVIRON TOXICOL PHAR, V21, P34, DOI 10.1016/j.etap.2005.06.004; Savage J.M., 2002, AMPHIBIANS REPTILES; Smalling KL, 2013, ENVIRON TOXICOL CHEM, V32, P2026, DOI 10.1002/etc.2308; Sparling D, 2010, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, SECOND EDITION, pXXV; Sparling DW, 2015, ECOTOXICOLOGY, V24, P262, DOI 10.1007/s10646-014-1375-7; Sparling DW, 2001, ENVIRON TOXICOL CHEM, V20, P1591, DOI [10.1002/etc.5620200725, 10.1897/1551-5028(2001)020&lt;1591:PAAPDI&gt;2.0.CO;2]; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tabachnick B.G., 2014, USING MULTIVARIATE S, VSixth; Tyler CR, 1998, CRIT REV TOXICOL, V28, P319, DOI 10.1080/10408449891344236; Van Rooij P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0266-0; von Duszeln Jurgen, 1991, P410; Vos JG, 2000, CRIT REV TOXICOL, V30, P71, DOI 10.1080/10408440091159176; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Waye A, 2011, J TOXICOL ENV HEAL B, V14, P270, DOI 10.1080/10937404.2011.578273; Whitfield SM, 2016, COPEIA, V104, P351, DOI 10.1643/CH-15-300; WINGFIELD JC, 1990, AM NAT, V136, P829, DOI 10.1086/285134; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191	111	5	6	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0191183	10.1371/journal.pone.0191183	http://dx.doi.org/10.1371/journal.pone.0191183			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324824	Green Published, Green Submitted, gold			2022-12-26	WOS:000419952400129
J	Teng, WC; Kang, YC; Hou, WJ; Hu, HZ; Luo, WJ; Wei, J; Wang, LH; Zhang, BY				Teng, Weichao; Kang, Yachao; Hou, Wenjuan; Hu, Houzhen; Luo, Wenji; Wei, Jie; Wang, Linghui; Zhang, Boyu			Phosphorus application reduces aluminum toxicity in two Eucalyptus clones by increasing its accumulation in roots and decreasing its content in leaves	PLOS ONE			English	Article							ORGANIC-ACID EXUDATION; LIPID-PEROXIDATION; FRUIT-DEVELOPMENT; CITRATE SYNTHASE; LOW-P; AL; TOLERANCE; GROWTH; RESISTANCE; INHIBITION	Under acidic conditions, aluminum (Al) toxicity is an important factor limiting plant productivity; however, the application of phosphorus (P) might alleviate the toxic effects of Al. In this study, seedlings of two vegetatively propagated Eucalyptus clones, E. grandis x E. urophylla 'G9' and E. grandis x E. urophylla 'DH32-29' were subjected to six treatments (two levels of Al stress and three levels of P). Under excessive Al stress, root Al content was higher, whereas shoot and leaf Al contents were lower with P application than those without P application. Further, Al accumulation was higher in the roots, but lower in the shoots and leaves of G9 than in those of DH32-29. The secretion of organic acids was higher under Al stress than under no Al stress. Further, under Al stress, the roots of G9 secreted more organic acids than those of DH32-29. With an increase in P supply, Al-induced secretion of organic acids from roots decreased. Under Al stress, some enzymes, including PEPC, CS, and IDH, played important roles in organic acid biosynthesis and degradation. Thus, our results indicate that P can reduce Al toxicity via the fixation of elemental Al in roots and restriction of its transport to stems and leaves, although P application cannot promote the secretion of organic acid anions. Further, the higher Al-resistance of G9 might be attributed to the higher Al accumulation in and organic acid anion secretion from roots and the lower levels of Al in leaves.	[Teng, Weichao; Kang, Yachao; Hou, Wenjuan; Hu, Houzhen; Luo, Wenji; Wang, Linghui; Zhang, Boyu] Guangxi Univ, Forestry Coll, Nanning, Guangxi, Peoples R China; [Teng, Weichao; Wang, Linghui] Guangxi Univ, Key Lab Natl Forestry Bur Fast Growing Wood Breedi, Nanning, Guangxi, Peoples R China; [Teng, Weichao; Wang, Linghui] Guangxi Coll & Univ Key Lab Forestry Sci & Engn, Nanning, Guangxi, Peoples R China; [Wei, Jie] Nanning Dawangtan Reservoir Management, Nanning, Guangxi, Peoples R China	Guangxi University; Guangxi University	Wang, LH (corresponding author), Guangxi Univ, Forestry Coll, Nanning, Guangxi, Peoples R China.; Wang, LH (corresponding author), Guangxi Univ, Key Lab Natl Forestry Bur Fast Growing Wood Breedi, Nanning, Guangxi, Peoples R China.; Wang, LH (corresponding author), Guangxi Coll & Univ Key Lab Forestry Sci & Engn, Nanning, Guangxi, Peoples R China.	vincentt@yeah.net			National Natural Science Foundation [31360174]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation, grant number 31360174, https://isisn.nsfc.gov.cn/egrantweb/project/rptprogress/index?datetimestamp=1494235819311.	ALVA AK, 1986, SOIL SCI SOC AM J, V50, P133, DOI 10.2136/sssaj1986.03615995005000010026x; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Bose J, 2013, PLANT PHYSIOL, V161, P1347; Chao LU, 2009, ACTA AGR JIANGXI; Chen FX, 2009, FOOD CHEM, V114, P657, DOI 10.1016/j.foodchem.2008.10.003; delaFuente JM, 1997, SCIENCE, V276, P1566, DOI 10.1126/science.276.5318.1566; DELHAIZE E, 1995, PLANT PHYSIOL, V107, P315, DOI 10.1104/pp.107.2.315; Delhaize E, 2001, PLANT PHYSIOL, V125, P2059, DOI 10.1104/pp.125.4.2059; Dong DF, 2004, PHYSIOL PLANTARUM, V122, P190, DOI 10.1111/j.1399-3054.2004.00373.x; Fukuda T, 2007, PLANT SCI, V172, P1157, DOI 10.1016/j.plantsci.2007.02.020; Gaume A, 2001, PLANT SOIL, V228, P253, DOI 10.1023/A:1004824019289; Gaume A, 2001, PLANT SOIL, V234, P73, DOI 10.1023/A:1010535132296; Giannakoula A, 2008, J PLANT PHYSIOL, V165, P385, DOI 10.1016/j.jplph.2007.01.014; Haynes RJ, 2001, NUTR CYCL AGROECOSYS, V59, P47, DOI 10.1023/A:1009823600950; HIRAI M, 1977, PLANT CELL PHYSIOL, V18, P791; Hubbard RM, 2010, FOREST ECOL MANAG, V259, P1714, DOI 10.1016/j.foreco.2009.10.028; Ikka T, 2013, PHYTOCHEMISTRY, V94, P142, DOI 10.1016/j.phytochem.2013.06.016; Iqbal M. T., 2013, South African Journal of Plant and Soil, V30, P13, DOI 10.1080/02571862.2013.770929; Ishikawa S, 2000, SOIL SCI PLANT NUTR, V46, P751, DOI 10.1080/00380768.2000.10409141; JANSEN S, 2004, EVOLUTION PLANT PHYS, P467; Jemo M, 2007, J PLANT PHYSIOL, V164, P442, DOI 10.1016/j.jplph.2005.12.010; Jiang HX, 2009, PHYSIOL PLANTARUM, V137, P298, DOI 10.1111/j.1399-3054.2009.01288.x; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Koyama H, 2000, PLANT CELL PHYSIOL, V41, P1030, DOI 10.1093/pcp/pcd029; LeNoble ME, 1996, PLANT CELL ENVIRON, V19, P1132, DOI 10.1111/j.1365-3040.1996.tb00428.x; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Ma JF, 1997, PLANT CELL PHYSIOL, V38, P1019, DOI 10.1093/oxfordjournals.pcp.a029266; Ma JF, 2010, FUNCT PLANT BIOL, V37, pIII, DOI 10.1071/FPv37n4_FO; Mariano ED, 2005, J PLANT NUTR, V28, P323, DOI 10.1081/PLN-200047625; Mariano Jorge ED, 2005, BRAZ J PLANT PHYSIOL, V17, P157; Martins N, 2013, PLANT SCI, V198, P1, DOI 10.1016/j.plantsci.2012.09.001; MIYASAKA SC, 1991, PLANT PHYSIOL, V96, P737, DOI 10.1104/pp.96.3.737; Moreno-Alvarado M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00073; MULLETTE KJ, 1975, PLANT SOIL, V42, P495, DOI 10.1007/BF00010026; MULLETTE KJ, 1974, PLANT SOIL, V41, P199, DOI 10.1007/BF00017956; Nakagawa T, 2003, J PLANT NUTR, V26, P619, DOI 10.1081/PLN-120017669; Nguyen NT, 2003, PLANT SCI, V165, P147, DOI 10.1016/S0168-9452(03)00153-5; Osaki M, 1997, SOIL SCI PLANT NUTR, V43, P551, DOI 10.1080/00380768.1997.10414782; PELLET DM, 1995, PLANTA, V196, P788, DOI 10.1007/BF01106775; Pilon-Smits EAH, 2009, CURR OPIN PLANT BIOL, V12, P267, DOI 10.1016/j.pbi.2009.04.009; Pineros MA, 2002, PLANT PHYSIOL, V129, P1194, DOI 10.1104/pp.002295; R'bia O., 2011, International Journal of Agricultural Research, V6, P194, DOI 10.3923/ijar.2011.194.208; RYAN PR, 1995, PLANTA, V196, P103, DOI 10.1007/BF00193223; Sasaki M, 1988, JAPANESE J SOIL SCI, V59, P601; Shi H.M., 2009, THESIS; Silva IR, 2004, TREE PHYSIOL, V24, P1267, DOI 10.1093/treephys/24.11.1267; Sun QB, 2008, ANN BOT-LONDON, V102, P795, DOI 10.1093/aob/mcn166; Tahara K, 2008, PLANT SOIL, V302, P175, DOI 10.1007/s11104-007-9464-5; TAN KZ, 1990, PLANT SOIL, V124, P15, DOI [10.1007/BF00010926, 10.1007/BF00010927]; Trejo-Tellez LI, 2010, PLANT SOIL, V326, P187, DOI 10.1007/s11104-009-9994-0; Wu DM, 2013, ACTA PHYSIOL PLANT, V35, P223, DOI 10.1007/s11738-012-1067-y; Yamamoto Y, 2001, PLANT PHYSIOL, V125, P199, DOI 10.1104/pp.125.1.199; Yang LT, 2011, PLANT SCI, V180, P521, DOI 10.1016/j.plantsci.2010.11.011; Yang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130963; Yang ZM, 2004, PLANT SCI, V166, P1589, DOI 10.1016/j.plantsci.2004.02.012; Ye S., 2007, THESIS; Zhang LW, 2005, IEEE-ASME T MECH, V10, P297, DOI 10.1109/TMECH.2005.848298	57	14	17	9	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2018	13	1							e0190900	10.1371/journal.pone.0190900	http://dx.doi.org/10.1371/journal.pone.0190900			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS7BJ	29324770	Green Published, gold, Green Submitted			2022-12-26	WOS:000419952400070
J	Patch, AM; Nones, K; Kazakoff, SH; Newell, F; Wood, S; Leonard, C; Holmes, O; Xu, QY; Addala, V; Creaney, J; Robinson, BW; Fu, SJ; Geng, CY; Li, T; Zhang, WW; Liang, XM; Rao, JH; Wang, JH; Tian, MY; Zhao, YG; Teng, F; Gou, HL; Yang, BC; Jiang, H; Mu, F; Supsup, JVP; Waddell, N				Patch, Ann-Marie; Nones, Katia; Kazakoff, Stephen H.; Newell, Felicity; Wood, Scott; Leonard, Conrad; Holmes, Oliver; Xu, Qinying; Addala, Venkateswar; Creaney, Jenette; Robinson, Bruce W.; Fu, Shujin; Geng, Chunyu; Li, Tong; Zhang, Wenwei; Liang, Xinming; Rao, Junhua; Wang, Jiahao; Tian, Mingyu; Zhao, Yonggang; Teng, Fei; Gou, Honglan; Yang, Bicheng; Jiang, Hui; Mu, Feng; Supsup, John V. Pearson; Waddell, Nicola			Germline and somatic variant identification using BGISEQ-500 and HiSeq X Ten whole genome sequencing	PLOS ONE			English	Article							MUTATIONAL PROCESSES; HUMAN CANCER; SIGNATURES	Technological innovation and increased affordability have contributed to the widespread adoption of genome sequencing technologies in biomedical research. In particular large cancer research consortia have embraced next generation sequencing, and have used the technology to define the somatic mutation landscape of multiple cancer types. These studies have primarily utilised the Illumina HiSeq platforms. In this study we performed whole genome sequencing of three malignant pleural mesothelioma and matched normal samples using a new platform, the BGISEQ-500, and compared the results obtained with Illumina HiSeq X Ten. Germline and somatic, single nucleotide variants and small insertions or deletions were independently identified from data aligned human genome reference. The BGISEQ-500 and HiSeq X Ten platforms showed high concordance for germline calls with genotypes from SNP arrays (> 99%). The germline and somatic single nucleotide variants identified in both sequencing platforms were highly concordant (86% and 72% respectively). These results indicate the potential applicability of the BGISEQ-500 platform for the identification of somatic and germline single nucleotide variants by whole genome sequencing. The BGISEQ-500 datasets described here represent the first publicly-available cancer genome sequencing performed using this platform.	[Patch, Ann-Marie; Nones, Katia; Kazakoff, Stephen H.; Newell, Felicity; Wood, Scott; Leonard, Conrad; Holmes, Oliver; Xu, Qinying; Addala, Venkateswar; Supsup, John V. Pearson; Waddell, Nicola] QIMR Berghofer Med Res Inst, Dept Genet & Computat Biol, Brisbane, Qld, Australia; [Creaney, Jenette; Robinson, Bruce W.] Univ Western Australia, Sch Med & Pharmacol, Natl Ctr Asbestos Related Dis, Nedlands, WA, Australia; [Creaney, Jenette; Robinson, Bruce W.] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA, Australia; [Fu, Shujin; Geng, Chunyu; Li, Tong; Zhang, Wenwei; Liang, Xinming; Rao, Junhua; Wang, Jiahao; Tian, Mingyu; Zhao, Yonggang; Teng, Fei; Gou, Honglan; Yang, Bicheng; Jiang, Hui; Mu, Feng] BGI Shenzhen, BGI, Shenzhen, Peoples R China	QIMR Berghofer Medical Research Institute; University of Western Australia; University of Western Australia; Beijing Genomics Institute (BGI)	Waddell, N (corresponding author), QIMR Berghofer Med Res Inst, Dept Genet & Computat Biol, Brisbane, Qld, Australia.	nic.waddell@qimrberghofer.edu.au	Pearson, John/AAT-4211-2020; Waddell, Nicola/H-4929-2015; Leonard, Conrad/AAD-2587-2020; Addala, Venkateswar/ABB-8071-2020; Patch, Ann-Marie/C-4201-2018; Nones, Katia/AAX-6453-2021; Newell, Felicity/AAN-1253-2020	Waddell, Nicola/0000-0002-3950-2476; Leonard, Conrad/0000-0002-4131-2065; Addala, Venkateswar/0000-0002-3569-2065; Patch, Ann-Marie/0000-0001-6121-4019; Nones, Katia/0000-0003-1925-5196; Zhao, Yonggang/0000-0002-0295-3062; Pearson, John/0000-0003-0904-4598	Australian National Health and Medical Research Council (NHMRC) [APP1089404, APP1108638, APP1112113]; Keith Boden fellowship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Keith Boden fellowship	This work was supported by the Australian National Health and Medical Research Council (NHMRC) (grant number APP1089404, and APP1108638 to BR, APP1112113 and APP1089404 to NW). The BGISEQ-500 sequencing was provided by BGI.; We are grateful to the Keith Boden estate that supports KN with the Keith Boden fellowship. The BGISEQ-500 sequencing was provided by BGI. The authors would like to thank the Genome Aggregation Database (gnomAD) and the groups that provided exome and genome variant data to this resource. A full list of contributing groups can be found at http://gnomad.broadinstitute.org/about	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Alioto TS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10001; Bueno R, 2016, NAT GENET, V48, P407, DOI 10.1038/ng.3520; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Fehlmann T, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0287-1; Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49; Huang J, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix024; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kassahn KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074380; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mak SST, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/gix049; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nones K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6224; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Zhang B, 2016, INSECT BIOCHEM MOLEC, V79, P108, DOI 10.1016/j.ibmb.2016.11.001	22	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190264	10.1371/journal.pone.0190264	http://dx.doi.org/10.1371/journal.pone.0190264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320538	Green Published, gold, Green Submitted			2022-12-26	WOS:000419689600041
J	Citron, YR; Fagerstrom, CJ; Keszthelyi, B; Huang, B; Rusan, NM; Kelly, MJS; Agard, DA				Citron, Y. Rose; Fagerstrom, Carey J.; Keszthelyi, Bettina; Huang, Bo; Rusan, Nasser M.; Kelly, Mark J. S.; Agard, David A.			The centrosomin CM2 domain is a multifunctional binding domain with distinct cell cycle roles	PLOS ONE			English	Article							MICROTUBULE NUCLEATION; PROTEIN; PERICENTRIN; MATURATION; MAINTAIN; REVEALS; CNN	The centrosome serves as the main microtubule-organizing center in metazoan cells, yet despite its functional importance, little is known mechanistically about the structure and organizational principles that dictate protein organization in the centrosome. In particular, the protein-protein interactions that allow for the massive structural transition between the tightly organized interphase centrosome and the highly expanded matrix-like arrangement of the mitotic centrosome have been largely uncharacterized. Among the proteins that undergo a major transition is the Drosophila melanogaster protein centrosomin that contains a conserved carboxyl terminus motif, CM2. Recent crystal structures have shown this motif to be dimeric and capable of forming an intramolecular interaction with a central region of centrosomin. Here we use a combination of in-cell microscopy and in vitro oligomer assessment to show that dimerization is not necessary for CM2 recruitment to the centrosome and that CM2 alone undergoes significant cell cycle dependent rearrangement. We use NMR binding assays to confirm this intramolecular interaction and show that residues involved in solution are consistent with the published crystal structure and identify L1137 as critical for binding. Additionally, we show for the first time an in vitro interaction of CM2 with the Drosophila pericentrin-like-protein that exploits the same set of residues as the intramolecular interaction. Furthermore, NMR experiments reveal a calcium sensitive interaction between CM2 and calmodulin. Although unexpected because of sequence divergence, this suggests that centrosomin-mediated assemblies, like the mammalian pericentrin, may be calcium regulated. From these results, we suggest an expanded model where during interphase CM2 interacts with pericentrin-like-protein to form a layer of centrosomin around the centriole wall and that at the onset of mitosis this population acts as a nucleation site of intramolecular centrosomin interactions that support the expansion into the metaphase matrix.	[Citron, Y. Rose; Keszthelyi, Bettina; Huang, Bo; Kelly, Mark J. S.; Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Citron, Y. Rose; Keszthelyi, Bettina; Agard, David A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Fagerstrom, Carey J.; Rusan, Nasser M.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Huang, Bo; Kelly, Mark J. S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of California System; University of California San Francisco	Agard, DA (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.; Agard, DA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	agard@msg.ucsf.edu			National Institutes of Health [DP20D008479, GM031627, R35GM118099]; Packard Fellow for Science and Engineering, Chan Zuckerberg Biohub Investigator; Division of Intramural Research at the National Heart, Lung, and Blood Institute, National Institutes of Health [1ZIAHL006104]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284, R35GM118099] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008479] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellow for Science and Engineering, Chan Zuckerberg Biohub Investigator; Division of Intramural Research at the National Heart, Lung, and Blood Institute, National Institutes of Health; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	B.H. is supported by the following sources: National Institutes of Health, Director's New Innovator Award (DP20D008479), Packard Fellow for Science and Engineering, Chan Zuckerberg Biohub Investigator. N.M.R. is supported by the Division of Intramural Research at the National Heart, Lung, and Blood Institute, National Institutes of Health Project (1ZIAHL006104). D.A.A is supported by the National Institutes of Health (GM031627 and R35GM118099) and the Howard Hughes Medical Institute.	Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Ball G, 2015, SIMCHECK TOOLBOX SUC, P1; Brownlee CW, 2011, J CELL BIOL, V195, P231, DOI 10.1083/jcb.201107086; Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036; Choi YK, 2010, J CELL BIOL, V191, P1089, DOI 10.1083/jcb.201007030; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Feng Z, 2017, CELL, V169, P1078, DOI 10.1016/j.cell.2017.05.030; Fu JY, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120104; Galletta BJ, 2016, NATURE COMMUNICATION, V7, P1; Hajduk PJ, 1997, J MED CHEM, V40, P3144, DOI 10.1021/jm9703404; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Lerit DA, 2015, J CELL BIOL, V210, P79, DOI 10.1083/jcb.201503117; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Richens JH, 2015, BIOL OPEN, V4, P1052, DOI 10.1242/bio.012914; Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049; Samejima I, 2008, J CELL SCI, V121, P3971, DOI 10.1242/jcs.038414; Schubert M, 1999, J MAGN RESON, V141, P34, DOI 10.1006/jmre.1999.1881; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang Z, 2010, J BIOL CHEM, V285, P22658, DOI 10.1074/jbc.M110.105965; Woodruff JB, 2017, CELL, V169, P1066, DOI 10.1016/j.cell.2017.05.028; Zhang J., 2007, MOL BIOL CELL, P1	26	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2018	13	1							e0190530	10.1371/journal.pone.0190530	http://dx.doi.org/10.1371/journal.pone.0190530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3CC	29315319	Green Published, Green Submitted, gold			2022-12-26	WOS:000419655900014
J	Chandrannowlishwaran, P; Sun, M; Casey, KL; Romanyuk, AV; Grizel, AV; Sopova, JV; Rubel, AA; Nussbaum-Krammer, C; Vorberg, IM; Chernoff, YO				Chandrannowlishwaran, Pavithra; Sun, Meng; Casey, Kristin L.; Romanyuk, Andrey V.; Grizel, Anastasiya V.; Sopova, Julia V.; Rubel, Aleksandr A.; Nussbaum-Krammer, Carmen; Vorberg, Ina M.; Chernoff, Yury O.			Mammalian amyloidogenic proteins promote prion nucleation in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-RESOLUTION STRUCTURE; DE-NOVO APPEARANCE; ALZHEIMERS-DISEASE; SACCHAROMYCES-CEREVISIAE; TRANSGENIC MICE; PSI+ PRION; TRANSLATION TERMINATION; SECONDARY STRUCTURE; ACTIN CYTOSKELETON; BETA-PROTEIN	Fibrous cross-beta aggregates (amyloids) and their transmissible forms (prions) cause diseases in mammals (including humans) and control heritable traits in yeast. Initial nucleation of a yeast prion by transiently overproduced prion-forming protein or its (typically, QN-rich) prion domain is efficient only in the presence of another aggregated (in most cases, QN-rich) protein. Here, we demonstrate that a fusion of the prion domain of yeast protein Sup35 to some non-QN-rich mammalian proteins, associated with amyloid diseases, promotes nucleation of Sup35 prions in the absence of pre-existing aggregates. In contrast, both a fusion of the Sup35 prion domain to a multimeric non-amyloidogenic protein and the expression of a mammalian amyloidogenic protein that is not fused to the Sup35 prion domain failed to promote prion nucleation, further indicating that physical linkage of a mammalian amyloidogenic protein to the prion domain of a yeast protein is required for the nucleation of a yeast prion. Biochemical and cytological approaches confirmed the nucleation of protein aggregates in the yeast cell. Sequence alterations antagonizing or enhancing amyloidogenicity of human amyloid-beta (associated with Alzheimer's disease) and mouse prion protein (associated with prion diseases), respectively, antagonized or enhanced nucleation of a yeast prion by these proteins. The yeast-based prion nucleation assay, developed in our work, can be employed for mutational dissection of amyloidogenic proteins. We anticipate that it will aid in the identification of chemicals that influence initial amyloid nucleation and in searching for new amyloidogenic proteins in a variety of proteomes.	[Chandrannowlishwaran, Pavithra; Sun, Meng; Casey, Kristin L.; Romanyuk, Andrey V.; Chernoff, Yury O.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Grizel, Anastasiya V.; Sopova, Julia V.; Rubel, Aleksandr A.; Chernoff, Yury O.] St Petersburg State Univ, Lab Amyloid Biol, St Petersburg 199034, Russia; [Grizel, Anastasiya V.; Rubel, Aleksandr A.; Chernoff, Yury O.] St Petersburg State Univ, Inst Translat Biomed, St Petersburg 199034, Russia; [Sopova, Julia V.; Rubel, Aleksandr A.] St Petersburg State Univ, Dept Genet & Biotechnol, St Petersburg 199034, Russia; [Sopova, Julia V.] Russian Acad Sci, St Petersburg Branch, NI Vavilov Inst Gen Genet, St Petersburg 199034, Russia; [Nussbaum-Krammer, Carmen] Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Vorberg, Ina M.] Deutsch Zentrum Neurodegenerat Erkrankungen, D-53175 Bonn, Germany; [Sun, Meng] Antise Biotech Co Ltd, Bldg A, Beijing 101318, Peoples R China; [Romanyuk, Andrey V.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; Saint Petersburg State University; Saint Petersburg State University; Saint Petersburg State University; Russian Academy of Sciences; Vavilov Institute of General Genetics; Ruprecht Karls University Heidelberg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University System of Georgia; Georgia Institute of Technology	Chernoff, YO (corresponding author), Georgia Inst Technol, 950 Atlantic Dr, Atlanta, GA 30332 USA.	yury.chernoff@biology.gatech.edu	Sopova, Julia/N-5112-2015; Chernoff, Yury O/J-2833-2014; Rubel, Aleksandr A/D-2903-2013; Nussbaum-Krammer, Carmen/AAY-3081-2020; Sopova, Julia/AAE-8214-2021; Grizel, Anastasia V/A-4415-2015	Sopova, Julia/0000-0002-7825-273X; Rubel, Aleksandr A/0000-0001-6203-2006; Nussbaum-Krammer, Carmen/0000-0002-8689-1363; Sopova, Julia/0000-0002-7825-273X; Grizel, Anastasia V/0000-0003-4875-8171; Chernoff, Yury/0000-0002-8934-9051	Emory Alzheimer's Disease Research Center from the National Institutes of Health [P50AG025688]; Creutzfeldt-Jakob Disease Family Foundation (CJD Foundation); Russian Science Foundation (RSF) [14-50-00069]; Russian Foundation for Basic Research (RFBR) [15-04-08159]; Scheller College of Business, Georgia Institute of Technology; Institute for Bioengineering and Bioscience, Georgia Institute of Technology; St. Petersburg State University Postdoctoral Fellowship [1.50.1038.2014]; St. Petersburg State University [15.61.2218.2013]; Russian Science Foundation [14-50-00069] Funding Source: Russian Science Foundation; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	Emory Alzheimer's Disease Research Center from the National Institutes of Health; Creutzfeldt-Jakob Disease Family Foundation (CJD Foundation); Russian Science Foundation (RSF)(Russian Science Foundation (RSF)); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Scheller College of Business, Georgia Institute of Technology; Institute for Bioengineering and Bioscience, Georgia Institute of Technology; St. Petersburg State University Postdoctoral Fellowship; St. Petersburg State University; Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Emory Alzheimer's Disease Research Center Grant P50AG025688 from the National Institutes of Health, a Creutzfeldt-Jakob Disease Family Foundation (CJD Foundation) grant (to Y. O. C.), Russian Science Foundation (RSF) Grant 14-50-00069 (to Y. O. C.), and Russian Foundation for Basic Research (RFBR) Grant 15-04-08159 (to A. A. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, CJD Foundation, RSF, or RFBR.; 'Recipient of a Ti:GER Fellowship from Scheller College of Business, Georgia Institute of Technology.; 'Recipient of a Parker H. Petit Scholarship from the Institute for Bioengineering and Bioscience, Georgia Institute of Technology.; Recipient of St. Petersburg State University Postdoctoral Fellowship 1.50.1038.2014.; Supported in part by St. Petersburg State University (Project 15.61.2218.2013).	Alzheimer's Association, 2017, ALZHEIMERS DEMENT, V13, P325, DOI [DOI 10.1016/J.JALZ.2017.02.001, 10.1016/j.jalz.2017.02.001]; Bagriantsev S, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-32; Bartz JC, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a024349; Benetti F, 2015, PRION, V9, P119, DOI 10.1080/19336896.2015.1022023; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Chernova TA, 2017, CELL REP, V18, P751, DOI 10.1016/j.celrep.2016.12.082; Chernova TA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a023663; Chernova TA, 2011, MOL CELL, V43, P242, DOI 10.1016/j.molcel.2011.07.001; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Choe YJ, 2009, EUKARYOT CELL, V8, P968, DOI 10.1128/EC.00353-08; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Cohen M, 2016, PRION, V10, P9, DOI 10.1080/19336896.2015.1123371; Colvin MT, 2016, J AM CHEM SOC, V138, P9663, DOI 10.1021/jacs.6b05129; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 1996, GENETICS, V144, P1375; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Diaz-Espinoza R, 2012, NAT STRUCT MOL BIOL, V19, P370, DOI 10.1038/nsmb.2266; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Flechsig E, 2004, CURR MOL MED, V4, P337, DOI 10.2174/1566524043360645; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Ghaemmaghami S., 2016, COLD SPRING HARB PER, V6; Ghahramani S., 2005, FUNDAMENTALS PROBABI; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; Goehler H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009642; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Groveman BR, 2015, J BIOL CHEM, V290, P1119, DOI 10.1074/jbc.M114.619627; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; Irvine GB, 2008, MOL MED, V14, P451, DOI 10.2119/2007-00100.Irvine; James BD, 2014, NEUROLOGY, V82, P1045, DOI 10.1212/WNL.0000000000000240; Jansen C, 2010, ACTA NEUROPATHOL, V119, P189, DOI 10.1007/s00401-009-0609-x; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jones RW, 2015, ALZHEIMERS DEMENT, V11, P280, DOI 10.1016/j.jalz.2014.03.001; Kahn SE, 1999, DIABETES, V48, P241, DOI 10.2337/diabetes.48.2.241; Kaiser C., 1994, METHODS YEAST GENETI; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V192, P525, DOI 10.1006/bbrc.1993.1447; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kochneva-Pervukhova NV, 1998, CURR GENET, V34, P146, DOI 10.1007/s002940050379; Kovac V, 2016, BIOCHEM BIOPH RES CO, V481, P1, DOI 10.1016/j.bbrc.2016.11.036; Krammer C, 2008, FASEB J, V22, P762, DOI 10.1096/fj.07-8733com; KUSHNIROV VV, 1990, YEAST, V6, P461, DOI 10.1002/yea.320060603; Kutzler MA, 2006, VACCINE, V24, P4630, DOI 10.1016/j.vaccine.2005.08.036; Li SX, 2007, J MOL BIOL, V366, P1603, DOI 10.1016/j.jmb.2006.12.027; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Lorenz H, 2002, J BIOL CHEM, V277, P8508, DOI 10.1074/jbc.M110197200; Makarava N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003759; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; MORI H, 1992, J BIOL CHEM, V267, P17082; Morimoto A, 2004, J BIOL CHEM, V279, P52781, DOI 10.1074/jbc.M406262200; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Newby GA, 2017, CELL, V171, P966, DOI 10.1016/j.cell.2017.09.041; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Nizhnikov AA, 2016, PRION, V10, P182, DOI 10.1080/19336896.2016.1181253; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; PARSELL DA, 1991, NATURE, V353, P270, DOI 10.1038/353270a0; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; Porzoor A, 2016, METHODS MOL BIOL, V1303, P217, DOI 10.1007/978-1-4939-2627-5_12; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Prusiner SB, 1997, ANNU REV GENET, V31, P139, DOI 10.1146/annurev.genet.31.1.139; PRUSINER SB, 1993, ARCH NEUROL-CHICAGO, V50, P1129, DOI 10.1001/archneur.1993.00540110011002; Requena JR, 2014, PRION, V8, P60, DOI 10.4161/pri.28368; Rubel' A A, 2008, Mol Biol (Mosk), V42, P123; Rubel AA, 2013, PRION, V7, P469, DOI 10.4161/pri.26867; Saijo E, 2016, J VIROL, V90, P4905, DOI 10.1128/JVI.00088-16; Sambrook J., 2001, MOL CLONING LAB MANU; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Stefanis L., 2014, COLD SPRING HARB PER, V2; Suzuki G, 2012, SCIENCE, V336, P355, DOI 10.1126/science.1219491; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Theint T, 2017, BIOMOL NMR ASSIGN, V11, P75, DOI 10.1007/s12104-016-9723-6; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Van Nostrand WE, 2001, J BIOL CHEM, V276, P32860, DOI 10.1074/jbc.M104135200; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; WESTERMARK P, 1994, AMYLOID, V1, P47, DOI 10.3109/13506129409148624; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2013, BIOCHEMISTRY-US, V52, P1514, DOI 10.1021/bi301686a; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Zhou P, 2001, MOL MICROBIOL, V39, P37, DOI 10.1046/j.1365-2958.2001.02224.x; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	94	13	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3436	3450		10.1074/jbc.M117.809004	http://dx.doi.org/10.1074/jbc.M117.809004			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29330303	Green Published, hybrid			2022-12-26	WOS:000426562800033
J	Graf, L; Dick, A; Sendker, F; Barth, E; Marz, M; Daumke, O; Kochs, G				Graf, Laura; Dick, Alexej; Sendker, Franziska; Barth, Emanuel; Marz, Manja; Daumke, Oliver; Kochs, Georg			Effects of allelic variations in the human myxovirus resistance protein A on its antiviral activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MXA PROTEIN; DYNAMIN-LIKE MXA; INNATE IMMUNITY; DOMAIN DIMERIZATION; VIRAL NUCLEOPROTEIN; GTPASE ACTIVATION; VIRUS-REPLICATION; GENETIC-VARIATION; INFLUENZA; INHIBIT	Only a minority of patients infected with seasonal influenza A viruses exhibit a severe or fatal outcome of infection, but the reasons for this inter-individual variability in influenza susceptibility are unclear. To gain further insights into the molecular mechanisms underlying this variability, we investigated naturally occurring allelic variations of the myxovirus resistance 1 (MX1) gene coding for the influenza restriction factor MxA. The interferon-induced dynamin-like GTPase consists of an N-terminal GTPase domain, a bundle signaling element, and a C-terminal stalk responsible for oligomerization and viral target recognition. We used online databases to search for variations in the MX1 gene. Deploying in vitro approaches, we found that non-synonymous variations in the GTPase domain cause the loss of antiviral and enzymatic activities. Furthermore, we showed that these amino acid substitutions disrupt the interface for GTPase domain dimerization required for the stimulation of GTP hydrolysis. Variations in the stalk were neutral or slightly enhanced or abolished MxA antiviral function. Remarkably, two other stalk variants altered MxA's antiviral specificity. Variations causing the loss of antiviral activity were found only in heterozygous carriers. Interestingly, the inactive stalk variants blocked the antiviral activity of WT MxA in a dominant-negative way, suggesting that heterozygotes are phenotypically MxA-negative. In contrast, the GTPase-deficient variants showed no dominant-negative effect, indicating that heterozygous carriers should remain unaffected. Our results demonstrate that naturally occurring mutations in the human MX1 gene can influence MxA function, which may explain individual variations in influenza virus susceptibility in the human population.	[Graf, Laura; Sendker, Franziska; Kochs, Georg] Univ Freiburg, Med Ctr, Inst Virol, Hermann Herder Str 11, D-79104 Freiburg, Germany; [Graf, Laura; Kochs, Georg] Univ Freiburg, Spemann Grad Sch Biol & Med, Albertstr 19a, D-79104 Freiburg, Germany; [Dick, Alexej; Daumke, Oliver] Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany; [Dick, Alexej; Daumke, Oliver] Free Univ Berlin, Inst Chem & Biochem, Takustr 6, D-14195 Berlin, Germany; [Barth, Emanuel; Marz, Manja] Friedrich Schiller Univ Jena, Bioinformat High Throughput Anal, Leutragraben 1, D-07743 Jena, Germany; [Marz, Manja] Fritz Lipmann Inst, Leibniz Inst Age Res, Beutenbergstr 11, D-07745 Jena, Germany; [Marz, Manja] European Virus Bioinformat Ctr, Leutragraben 1, D-07743 Jena, Germany; [Kochs, Georg] Univ Freiburg, Fac Med, D-79085 Freiburg, Germany; [Graf, Laura] Univ Freiburg, Fac Biol, Spemann Grad Sch Biol & Med, Freiburg, Germany	University of Freiburg; University of Freiburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Freiburg; University of Freiburg	Kochs, G (corresponding author), Univ Freiburg, Med Ctr, Inst Virol, Hermann Herder Str 11, D-79104 Freiburg, Germany.; Daumke, O (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	oliver.daumke@mdc-berlin.de; georg.kochs@uniklinik-freiburg.de		Marz, Manja/0000-0003-4783-8823; Barth, Emanuel/0000-0003-0803-8858; Dick, Alexej/0000-0003-0580-1897	Deutsche Forschungsgemeinschaft [KO 1579/8-2, DA 1127/1, MA 5082/7-1]; Thuringian country programme ProExzellenz of the Thuringian Ministry for Research (TMWWDG) [RegenerAging-FSU-I-03/14]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Thuringian country programme ProExzellenz of the Thuringian Ministry for Research (TMWWDG)	This work was supported by Deutsche Forschungsgemeinschaft Grants KO 1579/8-2 (to G.K.), DA 1127/1 (to O.D.), and MA 5082/7-1 (to M.M.) and the Thuringian country programme ProExzellenz of the Thuringian Ministry for Research (TMWWDG; RegenerAging-FSU-I-03/14) (to E.B.).The authors declare that they have no conflicts of interest with the contents of this article.	Abel L, 2014, CURR OPIN IMMUNOL, V30, P72, DOI 10.1016/j.coi.2014.07.002; AEBI M, 1989, MOL CELL BIOL, V9, P5062, DOI 10.1128/MCB.9.11.5062; Casanova JL, 2015, P NATL ACAD SCI USA, V112, pE7118, DOI 10.1073/pnas.1521644112; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chen Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15744; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; Ciencewicki JM, 2014, FASEB J, V28, P1947, DOI 10.1096/fj.13-239855; Deeg CM, 2017, J EXP MED, V214, P1239, DOI 10.1084/jem.20161033; Dick A, 2015, J BIOL CHEM, V290, P12779, DOI 10.1074/jbc.M115.650325; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Flohr F, 1999, FEBS LETT, V463, P24, DOI 10.1016/S0014-5793(99)01598-7; Gao S, 2011, IMMUNITY, V35, P514, DOI 10.1016/j.immuni.2011.07.012; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Habjan M, 2009, VIROLOGY, V385, P400, DOI 10.1016/j.virol.2008.12.011; Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003; Kochs G, 1999, J BIOL CHEM, V274, P4370, DOI 10.1074/jbc.274.7.4370; Kochs G, 2002, P NATL ACAD SCI USA, V99, P3153, DOI 10.1073/pnas.052430399; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Matzinger SR, 2013, J VIROL, V87, P1150, DOI 10.1128/JVI.02271-12; Mitchell PS, 2012, CELL HOST MICROBE, V12, P598, DOI 10.1016/j.chom.2012.09.005; Nigg PE, 2015, J BIOL CHEM, V290, P29893, DOI 10.1074/jbc.M115.681494; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Patzina C, 2014, J BIOL CHEM, V289, P6020, DOI 10.1074/jbc.M113.543892; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; PITOSSI F, 1993, J VIROL, V67, P6726, DOI 10.1128/JVI.67.11.6726-6732.1993; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; Reichelt M, 2004, TRAFFIC, V5, P772, DOI 10.1111/j.1600-0854.2004.00219.x; Rennie ML, 2014, STRUCTURE, V22, P1433, DOI 10.1016/j.str.2014.08.015; Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858; Reuther P, 2015, SCI REP-UK, V5, DOI 10.1038/srep11346; SCHWEMMLE M, 1995, VIROLOGY, V206, P545, DOI 10.1016/S0042-6822(95)80071-9; Shendure J, 2016, NATURE, V536, P277, DOI 10.1038/536277a; STAEHELI P, 1991, J VIROL, V65, P4498, DOI 10.1128/JVI.65.8.4498-4501.1991; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Tam TTD, 2012, MOL BIOL REP, V39, P8533, DOI 10.1007/s11033-012-1708-7; To KKW, 2015, CURR OPIN VIROL, V14, P7, DOI 10.1016/j.coviro.2015.04.010; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; World Health Organization, 2010, WHO PUBL HLTH RES AG; Xiao H, 2013, J VIROL, V87, P13053, DOI 10.1128/JVI.02220-13; Yu ZJ, 2008, ARCH VIROL, V153, P1677, DOI 10.1007/s00705-008-0168-9; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11	46	10	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 2	2018	293	9					3056	3072		10.1074/jbc.M117.812784	http://dx.doi.org/10.1074/jbc.M117.812784			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FY1HO	29330299	Green Published, hybrid			2022-12-26	WOS:000426562800003
J	Lindegaard, B; Hvid, T; Mygind, HW; Hartvig-Mortensen, O; Grondal, T; Abildgaard, J; Gerstoft, J; Pedersen, BK; Baranowski, M				Lindegaard, Birgitte; Hvid, Thine; Mygind, Helene Wolsk; Hartvig-Mortensen, Ole; Grondal, Thomas; Abildgaard, Julie; Gerstoft, Jan; Pedersen, Bente Klarlund; Baranowski, Marcin			Low expression of IL-18 and IL-18 receptor in human skeletal muscle is associated with systemic and intramuscular lipid metabolism-Role of HIV lipodystrophy	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; IFN-GAMMA PRODUCTION; INSULIN-RESISTANCE; INFECTED PATIENTS; TNF-ALPHA; GENE-EXPRESSION; ELEVATED LEVELS; INTERLEUKIN-18; PLASMA; FAT	Introduction Interleukin (IL)-18 is involved in regulation of lipid and glucose metabolism. Mice lacking whole-body IL-18 signalling are prone to develop weight gain and insulin resistance, a phenotype which is associated with impaired fat oxidation and ectopic skeletal muscle lipid deposition. IL-18 mRNA is expressed in human skeletal muscle but a role for IL-18 in muscle has not been identified. Patients with HIV-infection and lipodystrophy (LD) are characterized by lipid and glucose disturbances and increased levels of circulating IL-18. We hypothesized that skeletal muscle IL-18 and IL-18 receptor (R) expression would be altered in patients with HIV-lipodystrophy. Design and methods Twenty-three HIV-infected patients with LD and 15 age-matched healthy controls were included in a cross-sectional study. Biopsies from the vastus lateralis muscle were obtained and IL-18 and IL-18R mRNA expression were measured by real-time PCR and sphingolipids (ceramides, sphingosine, sphingosine-1-Phosphate, sphinganine) were measured by HPLC. Insulin resistance was assessed by HOMA and the insulin response during an OGTT. Results Patients with HIV-LD had a 60% and 54% lower level of muscular IL-18 and IL-18R mRNA expression, respectively, compared to age-matched healthy controls. Patients with HIV-LD had a trend towards increased levels of ceramide (18.3 +/- 4.7 versus 14.8 +/- 3.0,p = 0.06) and sphingosine (0.41 +/- 0.13 versus 0.32 +/- 0.07, and lower level of sphinganine (p = 0.06). Low levels of muscle IL-18 mRNA correlated to high levels of ceramides (r = -0.31, p = 0.038) and sphingosine-1P (r = -0.29, p = 0.046) in skeletal muscle, whereas such a correlation was not found in healthy controls. Low expression of IL-18 mRNA in skeletal muscle correlated to elevated concentration of circulating triglycerides (R-p = -0.73, p<0.0001). Neither muscle expression of IL-18 mRNA or ceramide correlated to parameters of insulin resistance. Conclusion IL-18 (mRNA) in skeletal muscle appears to be involved in the regulation of intramuscular lipid metabolism and hypertriglyceridemia.	[Lindegaard, Birgitte; Hvid, Thine; Mygind, Helene Wolsk; Grondal, Thomas; Abildgaard, Julie; Pedersen, Bente Klarlund] Rigshosp, Ctr Inflammat & Metab, Copenhagen, Denmark; [Lindegaard, Birgitte; Hvid, Thine; Mygind, Helene Wolsk; Grondal, Thomas; Abildgaard, Julie; Pedersen, Bente Klarlund] Rigshosp, Ctr Phys Act Res, Copenhagen, Denmark; [Lindegaard, Birgitte; Gerstoft, Jan] Rigshosp, Dept Infect Dis, Copenhagen, Denmark; [Lindegaard, Birgitte] Nordsjaellands Hosp, Dept Lung & Infect Dis, Hillerod, Denmark; [Hartvig-Mortensen, Ole] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Baranowski, Marcin] Med Univ Bialystok, Dept Physiol, Bialystok, Poland	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Medical University of Bialystok	Lindegaard, B (corresponding author), Rigshosp, Ctr Inflammat & Metab, Copenhagen, Denmark.; Lindegaard, B (corresponding author), Rigshosp, Ctr Phys Act Res, Copenhagen, Denmark.; Lindegaard, B (corresponding author), Rigshosp, Dept Infect Dis, Copenhagen, Denmark.; Lindegaard, B (corresponding author), Nordsjaellands Hosp, Dept Lung & Infect Dis, Hillerod, Denmark.	birgitte.lindegaard.madsen@regionh.dk	Pedersen, Bente Klarlund/AGR-3217-2022; Abildgaard, Julie/ABB-2325-2020; Baranowski, Marcin/F-6718-2011; Lindegaard, Birgitte/AGY-9629-2022	Pedersen, Bente Klarlund/0000-0001-6508-6288; Abildgaard, Julie/0000-0003-1317-7051; Baranowski, Marcin/0000-0002-3714-5815; Lindegaard, Birgitte/0000-0002-5236-8427; Mortensen, Ole Hartvig/0000-0003-1118-6317	Danish National Research Foundation [DNRF55]; TrygFonden; Lundbeck foundation; Danish AIDS Foundation; Novo Nordisk Foundation; Direktor Emil Hertz og Hustru Inger Hertz Fond; Direktor Jacob Madsen og Hustru Olga Madsens Fond; Fonden for Laegevidenskabens Fremme; Danish Council for Strategic Research [09-067009, 09-075724]	Danish National Research Foundation(Danmarks Grundforskningsfond); TrygFonden; Lundbeck foundation(Lundbeckfonden); Danish AIDS Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Direktor Emil Hertz og Hustru Inger Hertz Fond; Direktor Jacob Madsen og Hustru Olga Madsens Fond; Fonden for Laegevidenskabens Fremme; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by the Danish National Research Foundation (DNRF55). The Centre for Physical Activity Research (CFAS) is supported by a grant from TrygFonden. This study was further supported by grants from the Lundbeck foundation, the Danish AIDS Foundation, the Novo Nordisk Foundation, Direktor Emil Hertz og Hustru Inger Hertz Fond, Direktor Jacob Madsen og Hustru Olga Madsens Fond, Fonden for Laegevidenskabens Fremme. CIM/CFAS is a member of DD2 - the Danish Center for Strategic Research in Type 2 Diabetes (the Danish Council for Strategic Research, grant no. 09-067009 and 09-075724). The funders had a no role in study design, data collection adn analysis, decision to publish, or prepation of the manuscript.	Adams JM, 2004, DIABETES, V53, P25, DOI 10.2337/diabetes.53.1.25; Alboni S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-9; Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; Aso Y, 2003, DIABETES CARE, V26, P2622, DOI 10.2337/diacare.26.9.2622; Benetti E, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/678627; Bergman BC, 2016, DIABETOLOGIA, V59, P785, DOI 10.1007/s00125-015-3850-y; Boden G, 2008, ENDOCRIN METAB CLIN, V37, P635, DOI 10.1016/j.ecl.2008.06.007; Bruun JM, 2007, EUR J ENDOCRINOL, V157, P465, DOI 10.1530/EJE-07-0206; BUCHFUHRER MJ, 1983, J APPL PHYSIOL, V55, P1558, DOI 10.1152/jappl.1983.55.5.1558; Capeau J, 2007, CURR OPIN HIV AIDS, V2, P247, DOI 10.1097/COH.0b013e3281e66919; Carr A, 2003, LANCET, V361, P726, DOI 10.1016/S0140-6736(03)12656-6; Chandrasekar B, 2005, J BIOL CHEM, V280, P26263, DOI 10.1074/jbc.M502586200; Coen PM, 2010, DIABETES, V59, P80, DOI 10.2337/db09-0988; de WR, 2013, PLOS ONE, V8; Ebbert JO, 2013, NUTRIENTS, V5, P498, DOI 10.3390/nu5020498; Esposito K, 2002, J CLIN ENDOCR METAB, V87, P3864, DOI 10.1210/jc.2002-????; Fain JN, 2006, METABOLISM, V55, P1113, DOI 10.1016/j.metabol.2006.04.008; Falasca K, 2007, INT J IMMUNOPATH PH, V20, P519, DOI 10.1177/039463200702000310; Fukami T, 2001, CLIN IMMUNOL, V101, P12, DOI 10.1006/clim.2001.5080; Gallego-Escuredo JM, 2013, JAIDS-J ACQ IMM DEF, V64, P142, DOI 10.1097/QAI.0b013e31829bdb67; Gan SK, 2002, DIABETES, V51, P3163, DOI 10.2337/diabetes.51.11.3163; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Haughey NJ, 2004, ANN NEUROL, V55, P257, DOI 10.1002/ana.10828; Hoshino K, 1999, J IMMUNOL, V162, P5041; Kalina U, 2000, J IMMUNOL, V165, P1307, DOI 10.4049/jimmunol.165.3.1307; Kitessa SM, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080466; Knapp M, 2013, PROSTAG OTH LIPID M, V106, P53, DOI 10.1016/j.prostaglandins.2013.10.001; Koenen TB, 2011, ENDOCRINOLOGY, V152, P3769, DOI 10.1210/en.2010-1480; Krogh-Madsen R, 2006, AM J PHYSIOL-ENDOC M, V291, pE108, DOI 10.1152/ajpendo.00471.2005; Lech M, 2010, INT IMMUNOL, V22, P717, DOI 10.1093/intimm/dxq058; Lee MKS, 2016, SEMIN IMMUNOL, V28, P441, DOI 10.1016/j.smim.2016.10.001; Lindegaard B, 2008, J CLIN ENDOCR METAB, V93, P3860, DOI 10.1210/jc.2007-2733; Lindegaard B, 2004, JAIDS-J ACQ IMM DEF, V36, P588, DOI 10.1097/00126334-200405010-00006; Lindegaard B, 2004, AIDS, V18, P1956, DOI 10.1097/00002030-200409240-00013; Lindegaard B, 2013, DIABETES, V62, P3064, DOI 10.2337/db12-1095; Lindegaard B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055632; Luzi L, 2003, AM J PHYSIOL-ENDOC M, V284, pE274, DOI 10.1152/ajpendo.00391.2001; Maagaard A, 2006, ANTIVIR THER, V11, P601; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moriwaki Y, 2003, METABOLISM, V52, P605, DOI 10.1053/meta.2003.50096; Murphy AJ, 2016, CELL METAB, V23, P155, DOI 10.1016/j.cmet.2015.09.024; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Novick D, 2013, SEMIN IMMUNOL, V25, P439, DOI 10.1016/j.smim.2013.10.014; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Ortmeyer HK, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12794; Park M, 2016, J BIOL CHEM, V291, P23978, DOI 10.1074/jbc.M116.737684; Payne BAI, 2011, NAT GENET, V43, P806, DOI 10.1038/ng.863; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Petersen AMW, 2007, LUNG, V185, P161, DOI 10.1007/s00408-007-9000-7; Plomgaard P, 2005, EXERC IMMUNOL REV, V11, P53; Scheele C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039657; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Sievers M, 2009, J INFECT DIS, V200, P252, DOI 10.1086/599986; Smart MC, 2011, NUTR METAB CARDIOVAS, V21, P476, DOI 10.1016/j.numecd.2009.12.004; Spoto B, 2014, NUTR METAB CARDIOVAS, V24, P1137, DOI 10.1016/j.numecd.2014.04.017; Straczkowski M, 2007, DIABETOLOGIA, V50, P2366, DOI 10.1007/s00125-007-0781-2; Torriani M, 2003, J APPL PHYSIOL, V95, P1005, DOI 10.1152/japplphysiol.00366.2003; Tucci M, 2006, CLIN EXP IMMUNOL, V146, P21, DOI 10.1111/j.1365-2249.2006.03180.x; Vassimon HS, 2012, NUTRITION, V28, P912, DOI 10.1016/j.nut.2011.12.010; Villarroya F, 2007, CURR OPIN HIV AIDS, V2, P261, DOI 10.1097/COH.0b013e32810fd785; Villarroya F, 2010, BBA-MOL CELL BIOL L, V1801, P392, DOI 10.1016/j.bbalip.2009.09.018; Wicks SE, 2015, P NATL ACAD SCI USA, V112, pE3300, DOI 10.1073/pnas.1418560112; Wood IS, 2005, BIOCHEM BIOPH RES CO, V337, P422, DOI 10.1016/j.bbrc.2005.09.068; Yoo JK, 2005, J IMMUNOL, V175, P8280, DOI 10.4049/jimmunol.175.12.8280; Zilverschoon GR, 2008, INT J OBES LOND; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	66	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0186755	10.1371/journal.pone.0186755	http://dx.doi.org/10.1371/journal.pone.0186755			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342149	Green Submitted, Green Published, gold			2022-12-26	WOS:000422653800001
J	Papackova, Z; Heczkova, M; Dankova, H; Sticova, E; Lodererova, A; Bartonova, L; Poruba, M; Cahova, M				Papackova, Zuzana; Heczkova, Marie; Dankova, Helena; Sticova, Eva; Lodererova, Alena; Bartonova, Lenka; Poruba, Martin; Cahova, Monika			Silymarin prevents acetaminophen-induced hepatotoxicity in mice	PLOS ONE			English	Article							INDUCED LIVER-INJURY; NITRIC-OXIDE SYNTHASE; CELL-DEATH; HEPATOPROTECTIVE ACTIVITY; OXIDATIVE STRESS; APOPTOSIS; ANTIOXIDANT; NECROSIS; CYTOCHROME-P450; RIP3	Acetaminophen or paracetamol (APAP) overdose is a common cause of liver injury. Silymarin (SLM) is a hepatoprotective agent widely used for treating liver injury of different origin. In order to evaluate the possible beneficial effects of SLM, Balb/c mice were pretreated with SLM (100 mg/kg b.wt. per os) once daily for three days. Two hours after the last SLM dose, the mice were administered APAP (300 mg/kg b.wt. i.p.) and killed 6 (T-6), 12 (T-12) and 24 (T-24) hours later. SLM-treated mice exhibited a significant reduction in APAP-induced liver injury, assessed according to AST and ALT release and histological examination. SLM treatment significantly reduced superoxide production, as indicated by lower GSSG content, lower HO-1 induction, alleviated nitrosative stress, decreased p-JNK activation and direct measurement of mitochondrial superoxide production in vitro. SLM did not affect the APAPinduced decrease in CYP2E1 activity and expression during the first 12 hrs. Neutrophil infiltration and enhanced expression of inflammatory markers were first detected at T-12 in both groups. Inflammation progressed in the APAP group at T-24 but became attenuated in SLMtreated animals. Histological examination suggests that necrosis the dominant cell death pathway in APAP intoxication, which is partially preventable by SLM pretreatment. We demonstrate that SLM significantly protects against APAP-induced liver damage through the scavenger activity of SLM and the reduction of superoxide and peroxynitrite content. Neutrophil-induced damage is probably secondary to necrosis development.	[Papackova, Zuzana; Heczkova, Marie; Dankova, Helena; Cahova, Monika] Inst Clin & Expt Med, Dept Metab & Diabet, Prague, Czech Republic; [Papackova, Zuzana] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Vet Sci, Prague, Czech Republic; [Sticova, Eva; Lodererova, Alena; Bartonova, Lenka] Inst Clin & Expt Med, Clin & Transplant Pathol Dept, Prague, Czech Republic; [Poruba, Martin] Palacky Univ Olomouc, Fac Med & Dent, Dept Pharmacol, Olomouc, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM); Czech University of Life Sciences Prague; Institute for Clinical & Experimental Medicine (IKEM); Palacky University Olomouc	Papackova, Z (corresponding author), Inst Clin & Expt Med, Dept Metab & Diabet, Prague, Czech Republic.; Papackova, Z (corresponding author), Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Vet Sci, Prague, Czech Republic.	zuzana.papackova@ikem.cz	Cahova, Monika/Z-1568-2018	Cahova, Monika/0000-0003-2640-5084; Sticova, Eva/0000-0003-2486-6266; Poruba, Martin/0000-0003-1252-4971	Czech Science Foundation [17-08888S]; Czech Republic; MH CZ DRO "Institute for Clinical and Experimental Medicine IKEM" [IN 00023001]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Republic(Czech Republic Government); MH CZ DRO "Institute for Clinical and Experimental Medicine IKEM"	This study was supported by grant 17-08888S from the Czech Science Foundation (http://gacr.cz/), Czech Republic to MP and by MH CZ DRO "Institute for Clinical and Experimental Medicine IKEM, IN 00023001" to MC. (http://www.mzcr.cz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rasheed N, 2016, PHARMACOGN MAG, V12, pS337, DOI 10.4103/0973-1296.185765; Bajt ML, 2011, TOXICOL SCI, V122, P598, DOI 10.1093/toxsci/kfr116; Bajt ML, 2001, AM J PHYSIOL-GASTR L, V281, pG1188, DOI 10.1152/ajpgi.2001.281.5.G1188; Bunchorntavakul C, 2013, CLIN LIVER DIS, V17, P587, DOI 10.1016/j.cld.2013.07.005; BUSTAMANTE E, 1977, ANAL BIOCHEM, V80, P401, DOI 10.1016/0003-2697(77)90661-3; Cederbaum AI, 2006, J GASTROEN HEPATOL, V21, pS22, DOI 10.1111/j.1440-1746.2006.04595.x; Chen Xingmiao, 2014, Biomed J, V37, P120, DOI 10.4103/2319-4170.134084; Cheung C, 2005, DRUG METAB DISPOS, V33, P449, DOI 10.1124/dmd.104.002402; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Comelli MC, 2007, INTEGR CANCER THER, V6, P120, DOI 10.1177/1534735407302349; Dambach DM, 2002, HEPATOLOGY, V35, P1093, DOI 10.1053/jhep.2002.33162; Dara L, 2015, HEPATOLOGY, V62, P1847, DOI 10.1002/hep.27939; Du K, 2016, REDOX BIOL, V10, P148, DOI 10.1016/j.redox.2016.10.001; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Gardner CR, 1998, HEPATOLOGY, V27, P748, DOI 10.1002/hep.510270316; Guengerich FP, 2009, NAT PROTOC, V4, P1245, DOI 10.1038/nprot.2009.121; Gujral JS, 2002, TOXICOL SCI, V67, P322, DOI 10.1093/toxsci/67.2.322; Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hinson JA, 2002, NITRIC OXIDE-BIOL CH, V6, P160, DOI 10.1006/niox.2001.0404; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Jaeschke H, 2003, GASTROENTEROLOGY, V125, P1246, DOI 10.1016/S0016-5085(03)01209-5; JAESCHKE H, 1993, HEPATOLOGY, V17, P915, DOI 10.1016/0270-9139(93)90169-N; Jaeschke H, 2008, HEPATOLOGY, V48, P699, DOI 10.1002/hep.22556; Jaeschke H, 2014, J CLIN TRANSL HEPATO, V2, P153, DOI 10.14218/JCTH.2014.00014; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Jaeschke H, 2011, LIFE SCI, V88, P737, DOI 10.1016/j.lfs.2011.01.025; Jain NK, 2011, ASIAN PAC J TROP MED, V4, P470, DOI 10.1016/S1995-7645(11)60128-4; Knight T. R., 2004, COMP HEPATOL, V3, P1; Knight TR, 2002, J PHARMACOL EXP THER, V303, P468, DOI 10.1124/jpet.102.038968; Koksal E, 2009, J ENZYM INHIB MED CH, V24, P395, DOI [10.1080/14756360802188081, 10.1080/14756360802188081 ]; Kuriakose GC, 2010, INDIAN J EXP BIOL, V48, P1123; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Manov I, 2006, ACTA PHARMACOL SIN, V27, P259, DOI 10.1111/j.1745-7254.2006.00278.x; Masubuchi Y, 2005, J HEPATOL, V42, P110, DOI 10.1016/j.jhep.2004.09.015; McGill MR, 2013, PHARM RES-DORDR, V30, P2174, DOI 10.1007/s11095-013-1007-6; Michael SL, 2001, NITRIC OXIDE-BIOL CH, V5, P432, DOI 10.1006/niox.2001.0385; MIGUEZ MP, 1994, CHEM-BIOL INTERACT, V91, P51, DOI 10.1016/0009-2797(94)90006-X; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Nayak SS, 2011, PHARM BIOL, V49, P111, DOI 10.3109/13880209.2010.501084; Patel N, 2010, TOXICOL APPL PHARM, V245, P143, DOI 10.1016/j.taap.2010.02.002; PRESCOTT LF, 1980, BRIT J CLIN PHARMACO, V10, pS373, DOI 10.1111/j.1365-2125.1980.tb01825.x; Ramachandran A, 2013, HEPATOLOGY, V58, P2099, DOI 10.1002/hep.26547; Rumack BH, 2004, HEPATOLOGY, V40, P10, DOI 10.1002/hep.20300; Sabina Evan Prince, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P1264, DOI 10.3736/jcim20111116; Serviddio G, 2014, FREE RADICAL BIO MED, V73, P117, DOI 10.1016/j.freeradbiomed.2014.05.002; Serviddio G, 2010, J PHARMACOL EXP THER, V332, P922, DOI 10.1124/jpet.109.161612; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; WAGNER H, 1974, ARZNEIMITTEL-FORSCH, V24, P466; Wardman P, 2007, FREE RADICAL BIO MED, V43, P995, DOI 10.1016/j.freeradbiomed.2007.06.026; Wu MZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006430; Xie WY, 2016, LIFE SCI, V152, P180, DOI 10.1016/j.lfs.2016.04.002; Xie YC, 2013, TOXICOL SCI, V131, P325, DOI 10.1093/toxsci/kfs283; Yang X, 2016, HEPATOLOGY, V64, P311, DOI 10.1002/hep.28263; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	57	52	55	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0191353	10.1371/journal.pone.0191353	http://dx.doi.org/10.1371/journal.pone.0191353			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342206	Green Published, Green Submitted, gold			2022-12-26	WOS:000422653800066
J	Petrick, JL; Falk, RT; Hyland, PL; Caron, P; Pfeiffer, RM; Wood, SN; Dawsey, SM; Abnet, CC; Taylor, PR; Guillemette, C; Murray, LJ; Anderson, LA; Cook, MB				Petrick, Jessica L.; Falk, Roni T.; Hyland, Paula L.; Caron, Patrick; Pfeiffer, Ruth M.; Wood, Shannon N.; Dawsey, Sanford M.; Abnet, Christian C.; Taylor, Philip R.; Guillemette, Chantal; Murray, Liam J.; Anderson, Lesley A.; Cook, Michael B.			Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR Study	PLOS ONE			English	Article							BREAST-CANCER RISK; LONG-TERM STORAGE; BARRETTS-ESOPHAGUS; REFLUX ESOPHAGITIS; PROSTATE-CANCER; SERUM; TESTOSTERONE; MEN; INFLAMMATION; ESTROGEN	Background Esophageal adenocarcinoma (EA) is characterized by a strong male predominance. Sex steroid hormones have been hypothesized to underlie this sex disparity, but no population-based study to date has examined this potential association. Methods Using mass spectrometry and ELISA, we quantitated sex steroid hormones and sex hormone binding globulin, respectively, in plasma from males- 172 EA cases and 185 controls-within the Factors Influencing the Barrett/Adenocarcinoma Relationship (FINBAR) Study, a case-control investigation conducted in Northern Ireland and Ireland. Multivariable adjusted logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for associations between circulating hormones and EA. Results Higher androgen: estrogen ratio metrics were associated with increased odds of EA (e.g., testosterone: estradiol ratio ORQ4v.Q1 = 2.58, 95% CI = 1.23-5.43; P-trend = 0.009). All estrogens and androgens were associated with significant decreased odds of EA. When restricted to individuals with minimal to no decrease in body mass index, the size of association for the androgen: estrogen ratio was not greatly altered. Conclusions This first study of sex steroid hormones and EA provides tentative evidence that androgen: estrogen balance may be a factor related to EA. Replication of these findings in prospective studies is needed to enhance confidence in the causality of this effect.	[Petrick, Jessica L.; Falk, Roni T.; Hyland, Paula L.; Pfeiffer, Ruth M.; Wood, Shannon N.; Dawsey, Sanford M.; Abnet, Christian C.; Taylor, Philip R.; Cook, Michael B.] NIH, Natl Canc Inst, DHHS, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Caron, Patrick; Guillemette, Chantal] Laval Univ, Ctr Hosp Univ Laval Quebec CHU Quebec, Res Ctr, Quebec City, PQ, Canada; [Caron, Patrick; Guillemette, Chantal] Laval Univ, Fac Pharm, Pharmacogen Lab, Quebec City, PQ, Canada; [Murray, Liam J.; Anderson, Lesley A.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Publ Hlth, Belfast, Antrim, North Ireland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Laval University; Laval University; Queens University Belfast	Petrick, JL (corresponding author), NIH, Natl Canc Inst, DHHS, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	jessica.petrick@nih.gov	Abnet, Christian C/C-4111-2015; Petrick, Jessica/P-1678-2017; Cook, Michael B/A-5641-2009; Guillemette, Chantal/AAT-6246-2020; Guillemette, Chantal/J-6463-2012; Petrick, Jessica/AAA-9079-2020	Abnet, Christian C/0000-0002-3008-7843; Petrick, Jessica/0000-0001-6580-450X; Cook, Michael B/0000-0002-0533-7302; Guillemette, Chantal/0000-0002-1113-1212; Anderson, Lesley/0000-0002-1000-3649; Wood, Shannon/0000-0003-4389-3526	NIH Intramural Research Program, National Cancer Institute; Cancer Focus Northern Ireland (formerly the Ulster Cancer Foundation); Northern Ireland RD office; Health Research Board, Ireland; NATIONAL CANCER INSTITUTE [ZIACP010220] Funding Source: NIH RePORTER	NIH Intramural Research Program, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Focus Northern Ireland (formerly the Ulster Cancer Foundation); Northern Ireland RD office; Health Research Board, Ireland; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by NIH Intramural Research Program, National Cancer Institute; Cancer Focus Northern Ireland (formerly the Ulster Cancer Foundation); the Northern Ireland R&D office; and the Health Research Board, Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 2008, GUT, V57, P734, DOI 10.1136/gut.2007.132662; Anderson LA, 2007, WORLD J GASTROENTERO, V13, P1585, DOI 10.3748/wjg.v13.i10.1585; Anderson LA, 2006, CANCER RES, V66, P4975, DOI 10.1158/0008-5472.CAN-05-4253; Anderson LA, 2009, GASTROENTEROLOGY, V136, P799, DOI 10.1053/j.gastro.2008.12.005; Arnold M, 2015, GUT, V64, P381, DOI 10.1136/gutjnl-2014-308124; Asanuma K, 2016, WORLD J GASTROENTERO, V22, P1800, DOI 10.3748/wjg.v22.i5.1800; Awan AK, 2007, EJSO-EUR J SURG ONC, V33, P561, DOI 10.1016/j.ejso.2006.12.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burney BO, 2012, J CACHEXIA SARCOPENI, V3, P149, DOI 10.1007/s13539-012-0065-7; Burney BO, 2012, J CLIN ENDOCR METAB, V97, pE700, DOI 10.1210/jc.2011-2387; Caron P, 2015, STEROIDS, V104, P16, DOI 10.1016/j.steroids.2015.07.009; Cook MB, 2017, ANDROLOGY-US, V5, P240, DOI 10.1111/andr.12314; Cook MB, 2017, ANDROLOGY IN PRESS; Cook MB, 2015, CLIN GASTROENTEROL H, V13, P673, DOI 10.1016/j.cgh.2014.08.027; Cooper SC, 2012, CANCER CAUSE CONTROL, V23, P819, DOI 10.1007/s10552-012-9950-9; Cooper SC, 2009, CANCER CAUSE CONTROL, V20, P1363, DOI 10.1007/s10552-009-9359-2; Dai Q, 2016, BRIT J NUTR, V115, P342, DOI 10.1017/S0007114515004444; Denver P, 2013, WORLD J GASTROENTERO, V19, P1770, DOI 10.3748/wjg.v19.i11.1770; Ferguson HR, 2008, CANCER EPIDEM BIOMAR, V17, P727, DOI 10.1158/1055-9965.EPI-07-2570; Ferguson HR, 2008, CANCER EPIDEM BIOMAR, V17, P736, DOI 10.1158/1055-9965.EPI-07-2832; Freedman ND, 2010, EUR J CANCER, V46, P2473, DOI 10.1016/j.ejca.2010.05.005; Garcia JM, 2006, CANCER-AM CANCER SOC, V106, P2583, DOI 10.1002/cncr.21889; Gislefoss RE, 2009, CLIN CHEM LAB MED, V47, P596, DOI 10.1515/CCLM.2009.121; Holl K, 2008, ACTA ONCOL, V47, P406, DOI 10.1080/02841860701592400; Kupelian V, 2010, CLIN ENDOCRINOL, V72, P527, DOI 10.1111/j.1365-2265.2009.03713.x; Ladanchuk TC, 2010, SCAND J GASTROENTERO, V45, P1397, DOI 10.3109/00365521.2010.503968; Lagergren J, 1998, CANCER EPIDEM BIOMAR, V7, P913; LEYMARIE P, 1974, J STEROID BIOCHEM, V5, P167, DOI 10.1016/0022-4731(74)90124-1; Liao CH, 2012, CLIN CHIM ACTA, V413, P803, DOI 10.1016/j.cca.2012.01.021; Maggio M, 2005, J Endocrinol Invest, V28, P116; Mathieu LN, 2014, DIS ESOPHAGUS, V27, P757, DOI 10.1111/dote.12147; McGlynn KA, 2005, CANCER EPIDEM BIOMAR, V14, P1732, DOI 10.1158/1055-9965.EPI-05-0128; Mulholland HG, 2011, BRIT J NUTR, V106, P732, DOI 10.1017/S0007114511000742; Mulholland HG, 2009, CANCER CAUSE CONTROL, V20, P279, DOI 10.1007/s10552-008-9242-6; Muller M, 2003, EUR J ENDOCRINOL, V149, P583, DOI 10.1530/eje.0.1490583; Murphy SJ, 2007, CARCINOGENESIS, V28, P1323, DOI 10.1093/carcin/bgm007; Murphy SJ, 2005, WORLD J GASTROENTERO, V11, P7290, DOI 10.3748/wjg.v11.i46.7290; Murphy SJ, 2010, J NUTR, V140, P1757, DOI 10.3945/jn.110.124362; O'Doherty MG, 2011, INT J CANCER, V129, P1493, DOI 10.1002/ijc.26108; O'Doherty MG, 2010, CANCER CAUSE CONTROL, V21, P2269, DOI 10.1007/s10552-010-9652-0; O'Rorke MA, 2012, INT J CANCER, V131, P1882, DOI 10.1002/ijc.27434; Rashid F, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-9; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Rutegard M, 2010, BRIT J CANCER, V103, P735, DOI 10.1038/sj.bjc.6605804; Schmidt M, 2006, ANN NY ACAD SCI, V1069, P236, DOI 10.1196/annals.1351.021; Sharp L, 2013, J NUTR, V143, P1966, DOI 10.3945/jn.113.174664; Shivappa N, 2017, BRIT J NUTR, V117, P1323, DOI 10.1017/S0007114517001131; SODERGARD R, 1982, J STEROID BIOCHEM, V16, P801, DOI 10.1016/0022-4731(82)90038-3; Starka L, 2009, J STEROID BIOCHEM, V116, P118, DOI 10.1016/j.jsbmb.2009.05.008; Stroud LR, 2007, PSYCHONEUROENDOCRINO, V32, P140, DOI 10.1016/j.psyneuen.2006.11.008; Sukocheva OA, 2013, DIS ESOPHAGUS, V26, P628, DOI 10.1111/dote.12000; Thomas HV, 1997, BRIT J CANCER, V75, P1075, DOI 10.1038/bjc.1997.183; Thomas HV, 1997, BRIT J CANCER, V76, P401, DOI 10.1038/bjc.1997.398; UEO H, 1990, CANCER RES, V50, P7212; Vatten LJ, 1997, CANCER EPIDEM BIOMAR, V6, P967; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Yang HQ, 2012, WORLD J GASTROENTERO, V18, P393, DOI 10.3748/wjg.v18.i5.393	57	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2018	13	1							e0190325	10.1371/journal.pone.0190325	http://dx.doi.org/10.1371/journal.pone.0190325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8II	29342161	Green Published, gold, Green Submitted			2022-12-26	WOS:000422653800018
J	Chowdhury, AI; Haider, R; Abdullah, AM; Christou, A; Ali, NA; Rahman, AE; Iqbal, A; Bari, S; Hoque, DME; El Arifeen, S; Kissoon, N; Larson, CP				Chowdhury, Atique Iqbal; Haider, Rafiqul; Abdullah, Abu Yousuf Md; Christou, Aliki; Ali, Nabeel Ashraf; Rahman, Ahmed Ehsnaur; Iqbal, Afrin; Bari, Sanwarul; Hoque, D. M. Emdadul; El Arifeen, Shams; Kissoon, Niranjan; Larson, Charles P.			Using geospatial techniques to develop an emergency referral transport system for suspected sepsis patients in Bangladesh	PLOS ONE			English	Article							HEALTH-CARE; DEVELOPING-COUNTRIES; INFORMATION-SYSTEMS; SERVICES; ACCESS; ACCESSIBILITY; INTERVENTION; AFRICA; EQUITY; MALAWI	Background A geographic information system (GIS)-based transport network within an emergency referral system can be the key to reducing health system delays and increasing the chances of survival, especially during an emergency. We employed a GIS to design an emergency transport system for the rapid transfer of pregnant or early post-partum women, newborns, and children under 5 years of age with suspected sepsis under the Interrupting Pathways to Sepsis Initiative (IPSI) project. Methods A GIS database was developed by mapping the villages, roads, and relevant physical features of the study area. A travel-time algorithm was developed to incorporate the time taken by different modes of local transport to reach the health complexes. These were used in a network analysis to identify the shortest routes to the hospitals from the villages, which were categorized into green, yellow, and red zones based on their proximity to the nearest hospitals to provide transport facilities. An emergency call-in centre established for the project managed the transport system, and its data was used to assess the uptake of this transport system amongst distant communities. Results Fifteen pre-existing and two new routes were identified as the shortest routes to the health complexes. The call-in centre personnel used this route information to direct both patients and transport drivers to the nearest transport hubs or pick-up points. Adherence with referral advice was high in areas where the IPSI transport operated. Over the study period, the utilisation of the project's transport doubled and referral compliance from distant zones similarly increased. Conclusions The GIS system created for this study facilitated rapid referral of patients in emergency from distant zones, using locally available transport and resources. The methodology described in this study to develop and implement an emergency transport system can be applied in similar, rural, low-income country settings.	[Chowdhury, Atique Iqbal; Haider, Rafiqul; Abdullah, Abu Yousuf Md; Ali, Nabeel Ashraf; Rahman, Ahmed Ehsnaur; Iqbal, Afrin; Bari, Sanwarul; Hoque, D. M. Emdadul; El Arifeen, Shams] Int Ctr Diarrhoeal Dis Res Icddr B, Maternal & Child Hlth Div, Dhaka, Bangladesh; [Christou, Aliki] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Kissoon, Niranjan; Larson, Charles P.] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada	International Centre for Diarrhoeal Disease Research (ICDDR); University of Sydney; University of British Columbia	Chowdhury, AI (corresponding author), Int Ctr Diarrhoeal Dis Res Icddr B, Maternal & Child Hlth Div, Dhaka, Bangladesh.	atiquei@icddrb.org	Christou, Aliki/D-1249-2018; Hoque, Dewan/O-3606-2015; Kissoon, Niranjan/AAC-6140-2021; Hoque, Dewan Md. Emdadul/J-1999-2019; Chowdhury, Atique Iqbal/A-6046-2016; Abdullah, Abu Yousuf Md/AAX-7051-2021; Haider, Rafiqul/A-4236-2016	Christou, Aliki/0000-0001-9525-8255; Hoque, Dewan/0000-0001-8219-9196; Hoque, Dewan Md. Emdadul/0000-0001-8219-9196; Chowdhury, Atique Iqbal/0000-0001-9140-5983; Abdullah, Abu Yousuf Md/0000-0001-8641-990X; Arifeen, Shams/0000-0002-5372-5932; Haider, Rafiqul/0000-0002-7864-3319; Kissoon, Niranjan/0000-0001-8847-9973	Global Affairs Canada Trade and Developments MUSKOKA Initiative on Maternal, Newborn and Child Health (MNCH) [S065353001]	Global Affairs Canada Trade and Developments MUSKOKA Initiative on Maternal, Newborn and Child Health (MNCH)	This study was a component of the project titled "Interrupting Pathways to Maternal, Newborn and Early Childhood Sepsis Initiative" (IPSI) (project number S065353001) that was funded by Global Affairs Canada Trade and Developments MUSKOKA Initiative on Maternal, Newborn and Child Health (MNCH), received by Dr. Charles Larson, url http://www.internatonal.gc.ca/. The funders had no role in study design, data collection, analysis and writing the manuscript.	Abdullah AYM, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0054-9; Al-Taiar A, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-38; [Anonymous], 2017, INDEPENDENT; [Anonymous], 2016, DAILY STAR; [Anonymous], 2012, GOOGL EARTH 6 2; Bailey P., 2009, MON EM OBST CAR HDB; Bailey PE, 2011, INT J GYNECOL OBSTET, V115, P300, DOI 10.1016/j.ijgo.2011.09.004; Banu M, 2014, PUBLIC HEALTH, V128, P332, DOI 10.1016/j.puhe.2014.01.009; Banu M, 2010, MANOSHI WORKING PAPE, P1; BBS (Bangladesh Bureau of Statistics), POP HOUS CENS 2011 C; Bishop ID, 2000, CITIES, V17, P85, DOI 10.1016/S0264-2751(00)00004-4; Bossyns P, 2005, TROP MED INT HEALTH, V10, P879, DOI 10.1111/j.1365-3156.2005.01459.x; Brammer H, 1993, GEOGRAPHICAL COMPLEX, P246; Children St, 2013, MAMONI INTEGRATED SA; Dewan A, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0069-2; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Global Health Hub @ UBC, INT PATHW SEPS IN IP; Hofman JJ, 2008, INT J GYNECOL OBSTET, V102, P191, DOI 10.1016/j.ijgo.2008.04.001; Kim D, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0045-1; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Machira K, 2017, AFR HEALTH SCI, V17, P400, DOI 10.4314/ahs.v17i2.14; Makanga PT, 2017, INT J HEALTH GEOGR, V16, DOI 10.1186/s12942-016-0074-4; Murray M, 2003, JAMA-J AM MED ASSOC, V289, P1035, DOI 10.1001/jama.289.8.1035; Murray SF, 2006, SOC SCI MED, V62, P2205, DOI 10.1016/j.socscimed.2005.10.025; Neutens T, 2015, J TRANSP GEOGR, V43, P14, DOI 10.1016/j.jtrangeo.2014.12.006; Noor AM, 2006, TROP MED INT HEALTH, V11, P188, DOI 10.1111/j.1365-3156.2005.01555.x; Noor AM, 2003, TROP MED INT HEALTH, V8, P917, DOI 10.1046/j.1365-3156.2003.01112.x; Paul BK, 2009, NAT HAZARDS, V50, P289, DOI 10.1007/s11069-008-9340-5; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Rahman AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170267; Sabde Y, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-57; Schuurman Nadine, 2006, Int J Health Geogr, V5, P43, DOI 10.1186/1476-072X-5-43; STORY M, 1986, PHOTOGRAMM ENG REM S, V52, P397; Sudhof L, 2013, TROP MED INT HEALTH, V18, P18, DOI 10.1111/tmi.12016; Tanser F, 2006, SOC SCI MED, V63, P691, DOI 10.1016/j.socscimed.2006.01.015; Tayler-Smith K, 2013, TROP MED INT HEALTH, V18, P166, DOI 10.1111/tmi.12022; Terkelsen CJ, 2011, ANN INTERN MED, V155, P361, DOI 10.7326/0003-4819-155-6-201109200-00004; United Nations Children's Fund (UNICEF), 2010, OP PER REF TRANSP SE; Zinszer K, 2014, B WORLD HEALTH ORGAN, V92, P178, DOI 10.2471/BLT.13.125260	39	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191054	10.1371/journal.pone.0191054	http://dx.doi.org/10.1371/journal.pone.0191054			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS8HZ	29338012	gold, Green Published, Green Submitted			2022-12-26	WOS:000422652700027
J	Kim, AR; Lee, DH; Lee, SH; Rubino, I; Choi, HJ; Quan, FS				Kim, Ah-Ra; Lee, Dong-Hun; Lee, Su-Hwa; Rubino, Ilaria; Choi, Hyo-Jick; Quan, Fu-Shi			Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein	PLOS ONE			English	Article							IMMUNE-RESPONSES; INFECTION; RSV; INFLUENZA; MICE; DISEASE; RISK; EOSINOPHILIA; INFANTS; CELLS	Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract illness in infants, young children and the elderly. However, there is no licensed vaccine available against RSV infection. In this study, we generated virus-like particle (VLP) vaccine and investigated the vaccine efficacy in a mouse model. For VLP vaccines, tandem gene (1-780 bp) for V1 VLPs and tandem repeat gene (repeated 450-780 bp) for V5 VLPs were constructed in pFastBacTM vectors, respectively. Influenza matrix protein 1 (M1) was used as a core protein in the VLPs. Notably, upon challenge infection, significantly lower virus loads were measured in the lung of mice immunized with V1 or V5 VLPs compared to those of naive mice and formalin-inactivated RSV immunized control mice. In particular, V5 VLPs immunization showed significantly lower virus titers than V1 VLPs immunization. Furthermore, V5 VLPs immunization elicited increased memory B cells responses in the spleen. These results indicated that V5 VLP vaccine containing tandem repeat gene protein provided better protection than V1 VLPs with significantly decreased inflammation in the lungs. Thus, V5 VLPs could be a potential vaccine candidate against RSV.	[Kim, Ah-Ra; Lee, Dong-Hun; Lee, Su-Hwa] Kyung Hee Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Kim, Ah-Ra; Lee, Dong-Hun; Lee, Su-Hwa; Quan, Fu-Shi] Kyung Hee Univ, Sch Med, Dept Med Zool, Seoul, South Korea; [Rubino, Ilaria; Choi, Hyo-Jick] Univ Alberta, Dept Chem & Mat Engn, Edmonton, AB T6G 1H9, Canada	Kyung Hee University; Kyung Hee University; University of Alberta	Quan, FS (corresponding author), Kyung Hee Univ, Sch Med, Dept Med Zool, Seoul, South Korea.	fsquan@khu.ac.kr	Quan, Fu-Shi/V-1826-2019	Choi, Hyo-Jick/0000-0001-8233-5864; Lee, Darrall/0000-0002-6990-4441; Rubino, Ilaria/0000-0003-1589-1566	National Research Foundation of Korea (NRF) [NRF-2014R1A2A2A01004899]; Agri-Bio Industry Technology Development Program [315030-03-1-HD020]; Ministry of Health and Welfare, Republic of Korea [HI15C2928]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Agri-Bio Industry Technology Development Program; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the National Research Foundation of Korea (NRF) (NRF-2014R1A2A2A01004899), and a grant from the Agri-Bio Industry Technology Development Program (315030-03-1-HD020), and a grant from the Ministry of Health and Welfare, Republic of Korea (HI15C2928).	Acosta PL, 2016, CLIN VACCINE IMMUNOL, V23, P189, DOI 10.1128/CVI.00609-15; Airoldi I, 2004, CLIN CANCER RES, V10, P144, DOI 10.1158/1078-0432.CCR-1026-3; Castilow EM, 2008, J IMMUNOL, V180, P2376, DOI 10.4049/jimmunol.180.4.2376; Choi HJ, 2012, BIOMATERIALS, V33, P3756, DOI 10.1016/j.biomaterials.2012.01.054; Feldman SA, 1999, J VIROL, V73, P6610, DOI 10.1128/JVI.73.8.6610-6617.1999; Flegr J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090203; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; GLEZEN WP, 1981, J PEDIATR-US, V98, P708, DOI 10.1016/S0022-3476(81)80829-3; HOLBERG CJ, 1991, AM J EPIDEMIOL, V133, P1135, DOI 10.1093/oxfordjournals.aje.a115826; Jorquera PA, 2015, VACCINES-BASEL, V3, P829, DOI 10.3390/vaccines3040829; Kafuye-Mlwilo MY, 2012, INFECT IMMUN, V80, P633, DOI 10.1128/IAI.05188-11; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Kato Masahiko, 2004, Allergology International, V53, P301, DOI 10.1111/j.1440-1592.2004.00352.x; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Lang ML, 2009, EXPERT REV VACCINES, V8, P1109, DOI [10.1586/erv.09.56, 10.1586/ERV.09.56]; Lee YS, 2015, J INSTRUM, V10, DOI 10.1088/1748-0221/10/07/P07001; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Openshaw PJM, 2001, VACCINE, V20, pS27, DOI 10.1016/S0264-410X(01)00301-2; Openshaw PJM, 2001, AM J RESP CRIT CARE, V163, pS10, DOI 10.1164/ajrccm.163.supplement_1.2011111; Peebles RS, 2000, J INFECT DIS, V182, P671; Qi FF, 2015, INT IMMUNOPHARMACOL, V29, P408, DOI 10.1016/j.intimp.2015.10.022; Quan FS, 2016, EXPERT REV VACCINES, V15, P1281, DOI 10.1080/14760584.2016.1175942; Quan FS, 2011, J INFECT DIS, V204, P987, DOI 10.1093/infdis/jir474; Sharma A, 2016, J VIROL, V90, P5068, DOI 10.1128/JVI.00259-16; Singh SR, 2007, VACCINE, V25, P6211, DOI 10.1016/j.vaccine.2007.05.068; Sparer TE, 1998, J EXP MED, V187, P1921, DOI 10.1084/jem.187.11.1921; Tebbey PW, 1998, J EXP MED, V188, P1967, DOI 10.1084/jem.188.10.1967; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Wang BZ, 2008, J VIROL, V82, P11813, DOI 10.1128/JVI.01076-08	29	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2018	13	1							e0191277	10.1371/journal.pone.0191277	http://dx.doi.org/10.1371/journal.pone.0191277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS8HZ	29338045	Green Published, Green Submitted, gold			2022-12-26	WOS:000422652700043
J	Balic, I; Vizoso, P; Nilo-Poyanco, R; Sanhueza, D; Olmedo, P; Sepulveda, P; Arriagada, C; Defilippi, BG; Meneses, C; Campos-Vargas, R				Balic, Ivan; Vizoso, Paula; Nilo-Poyanco, Ricardo; Sanhueza, Dayan; Olmedo, Patricio; Sepulveda, Pablo; Arriagada, Cesar; Defilippi, Bruno G.; Meneses, Claudio; Campos-Vargas, Reinaldo			Transcriptome analysis during ripening of table grape berry cv. Thompson Seedless	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; HIGHER-PLANTS; LEAF SENESCENCE; VITIS-VINIFERA; RNA-SEQ; COLD-STORAGE; ARABIDOPSIS; FRUIT; ETHYLENE	Ripening is one of the key processes associated with the development of major organoleptic characteristics of the fruit. This process has been extensively characterized in climacteric fruit, in contrast with non-climacteric fruit such as grape, where the process is less understood. With the aim of studying changes in gene expression during ripening of non-climacteric fruit, an Illumina based RNA-Seq transcriptome analysis was performed on four developmental stages, between veraison and harvest, on table grapes berries cv Thompson Seedless. Functional analysis showed a transcriptional increase in genes related with degradation processes of chlorophyll, lipids, macromolecules recycling and nucleosomes organization; accompanied by a decrease in genes related with chloroplasts integrity and amino acid synthesis pathways. It was possible to identify several processes described during leaf senescence, particularly close to harvest. Before this point, the results suggest a high transcriptional activity associated with the regulation of gene expression, cytoskeletal organization and cell wall metabolism, which can be related to growth of berries and firmness loss characteristic to this stage of development. This high metabolic activity could be associated with an increase in the transcription of genes related with glycolysis and respiration, unexpected for a non-climacteric fruit ripening.	[Balic, Ivan; Sanhueza, Dayan; Olmedo, Patricio; Sepulveda, Pablo; Meneses, Claudio; Campos-Vargas, Reinaldo] Univ Andres Bello, Fac Ciencias Biol, Ctr Biotecnol Vegetal, Santiago, Chile; [Balic, Ivan] Univ Los Lagos, Dept Acuicultura & Recursos Agroalimentarios, Osorno, Chile; [Vizoso, Paula] Univ Mayor, Fac Sci, Ctr Plant Propagat & Conservat CEPROVEG, Santiago, Chile; [Nilo-Poyanco, Ricardo; Meneses, Claudio] FONDAP Ctr Genome Regulat, Santiago, Chile; [Arriagada, Cesar] Univ La Frontera, Fac Ciencias Agr & Forest, Dept Ciencias Forestales, Lab Biorremediac, Temuco, Chile; [Defilippi, Bruno G.] INIA La Platina, Inst Invest Agr, Santiago, Chile	Universidad Andres Bello; Universidad de Los Lagos; Universidad Mayor; Universidad de La Frontera	Campos-Vargas, R (corresponding author), Univ Andres Bello, Fac Ciencias Biol, Ctr Biotecnol Vegetal, Santiago, Chile.	reinaldocampos@unab.cl	Campos-Vargas, Reinaldo/M-4021-2016; Sepúlveda, Pablo Espicel/HCI-5123-2022; Poyanco, Ricardo Nilo/AAJ-8006-2021	Campos-Vargas, Reinaldo/0000-0003-1987-4130; Poyanco, Ricardo Nilo/0000-0003-3041-7539; Arriagada, Cesar/0000-0002-8549-6302; Olmedo, Patricio/0000-0001-8152-8381; Meneses, Claudio/0000-0002-6452-8950	Fondecyt [1150492, 3150538]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by projects Fondecyt 1150492 (RC) and Fondecyt 3150538 (16). Both authors contributed in the conceptualization, formulations, leadership and preparation of the manuscript of this work.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Balic I, 2014, POSTHARVEST BIOL TEC, V93, P15, DOI 10.1016/j.postharvbio.2014.02.001; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; BuchananWollaston V, 1997, J EXP BOT, V48, P181, DOI 10.1093/jxb/48.2.181; BURG SP, 1962, PLANT PHYSIOL, V37, P179, DOI 10.1104/pp.37.2.179; Chae L, 2014, SCIENCE, V344, P510, DOI 10.1126/science.1252076; Chervin C, 2004, PLANT SCI, V167, P1301, DOI 10.1016/j.plantsci.2004.06.026; Chervin C, 2010, VITIS, V49, P129; Chervin C, 2008, PHYSIOL PLANTARUM, V134, P534, DOI 10.1111/j.1399-3054.2008.01158.x; COOMBE BG, 1992, AM J ENOL VITICULT, V43, P101; DALSANTO S, 2016, FRONT PLANT SCI, V7; Deak M, 1999, FEBS LETT, V451, P220, DOI 10.1016/S0014-5793(99)00556-6; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; Dokoozlian NK., 2000, RAISIN PRODUCTION MA, V3393, P30; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ejsmentewicz T, 2015, MOLECULES, V20, P3667, DOI 10.3390/molecules20033667; Espinoza C, 2014, BMC PLANT BIOL BIOME, V14, P1; Fan L, 1997, PLANT CELL, V9, P2183, DOI 10.1105/tpc.9.12.2183; FELLER U, 1994, CRIT REV PLANT SCI, V13, P241, DOI 10.1080/713608059; FERGUSON IB, 1984, PLANT CELL ENVIRON, V7, P477, DOI 10.1111/j.1365-3040.1984.tb01438.x; Ferrero S, 2015, PLANT PHYSL AM SOC P, P00597; Gapper NE, 2013, PLANT MOL BIOL, V82, P575, DOI 10.1007/s11103-013-0050-3; Graham IA, 2002, PROG LIPID RES, V41, P156, DOI 10.1016/S0163-7827(01)00022-4; Grimplet J, 2005, PHYSIOL PLANTARUM, V125, P281, DOI 10.1111/j.1399-3054.2005.00563.x; Gudenschwager O, 2012, S AFR J BOT, V83, P186, DOI 10.1016/j.sajb.2012.08.004; GUT H, 1988, PLANTA, V176, P548, DOI 10.1007/BF00397663; He YH, 2002, PLANT CELL, V14, P805, DOI 10.1105/tpc.010422; Hiroyuki K, 2008, PLANT CELL REP, V27, P1521, DOI 10.1007/s00299-008-0536-7; Hortensteiner S, 1998, J BIOL CHEM, V273, P15335, DOI 10.1074/jbc.273.25.15335; Jia YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065687; Kimbrough JM, 2004, PLANT PHYSIOL, V136, P2790, DOI 10.1104/pp.104.044594; Kirby J, 2009, ANNU REV PLANT BIOL, V60, P335, DOI 10.1146/annurev.arplant.043008.091955; Kost B, 1999, J CELL BIOL, V145, P317, DOI 10.1083/jcb.145.2.317; Kuang JF, 2012, J EXP BOT, V63, P441, DOI 10.1093/jxb/err290; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Liu J, 2010, J EXP BOT SOC EXPT B; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; Mach JM, 2001, P NATL ACAD SCI USA, V98, P771, DOI 10.1073/pnas.021465298; MAKRIDES SC, 1981, J EXP BOT, V32, P725, DOI 10.1093/jxb/32.4.725; Meijer HJG, 2003, ANNU REV PLANT BIOL, V54, P265, DOI 10.1146/annurev.arplant.54.031902.134748; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munoz-Robredo P, 2013, POSTHARVEST BIOL TEC, V76, P163, DOI 10.1016/j.postharvbio.2012.10.006; NITSCH JP, 1960, AM J BOT, V47, P566, DOI 10.2307/2439435; Ortega-Regules A, 2008, EUR FOOD RES TECHNOL, V227, P223, DOI 10.1007/s00217-007-0714-9; Osorio S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00198; Osorio S, 2012, PLANT PHYSIOL, V159, P1713, DOI 10.1104/pp.112.199711; Palliotti A, 2010, AM J ENOL VITICULT, V61, P74; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PIECHULLA B, 1987, PLANT PHYSIOL, V84, P911, DOI 10.1104/pp.84.3.911; Raghothama KG, 1997, PLANT MOL BIOL, V34, P393, DOI 10.1023/A:1005812217945; Rayon C, 1998, J EXP BOT, V49, P1463, DOI 10.1093/jexbot/49.326.1463; RAZUNGLES A, 1988, AM J ENOL VITICULT, V39, P44; Razungles AJ, 1996, J AGR FOOD CHEM, V44, P3821, DOI 10.1021/jf960260t; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson S. P., 2000, Australian Journal of Grape and Wine Research, V6, P175, DOI 10.1111/j.1755-0238.2000.tb00177.x; RUFFNER HP, 1977, PHYTOCHEMISTRY, V16, P1171, DOI 10.1016/S0031-9422(00)94354-1; Schlapfer P, 2017, PLANT PHYSIOL, V173, P2041, DOI 10.1104/pp.16.01942; Schwender J, 2004, NATURE, V432, P779, DOI 10.1038/nature03145; Seymour G. B., 2012, BIOCH FRUIT RIPENING; Shultz RW, 2007, PLANT PHYSIOL, V144, P1697, DOI 10.1104/pp.107.101105; Soukas A, 2000, GENE DEV, V14, P963; Sun RZ, 2015, J PLANT PHYSIOL, V178, P43, DOI 10.1016/j.jplph.2015.01.012; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Suzuki M, 2004, PLANT J, V37, P750, DOI 10.1111/j.1365-313X.2004.02003.x; Sweetman C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-691; TAIZ L, 1984, ANNU REV PLANT PHYS, V35, P585, DOI 10.1146/annurev.pp.35.060184.003101; Thomas H, 2005, S SOC EXPT BIOL, P149; Thompson JE, 1998, PROG LIPID RES, V37, P119, DOI 10.1016/S0163-7827(98)00006-X; Trainotti L, 2006, PLANT SCI, V170, P606, DOI 10.1016/j.plantsci.2005.10.015; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; VERVERIDIS P, 1991, PHYTOCHEMISTRY, V30, P725, DOI 10.1016/0031-9422(91)85241-Q; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Woo HR, 2001, PLANT CELL, V13, P1779, DOI 10.1105/tpc.13.8.1779; Yeung KY, 2001, BIOINFORMATICS, V17, P309, DOI 10.1093/bioinformatics/17.4.309; YOUNG AJ, 1991, PHYSIOL PLANTARUM, V83, P702; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang PF, 2005, PLANT PHYSIOL, V138, P27, DOI 10.1104/pp.105.060376; Zhong SL, 2008, PLANT CELL, V20, P1278, DOI 10.1105/tpc.108.058883; Zoffoli JP, 2009, POSTHARVEST BIOL TEC, V51, P183, DOI 10.1016/j.postharvbio.2008.06.013; Zouid I, 2010, J INT SCI VIGNE VIN, V44, P87	83	21	23	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0190087	10.1371/journal.pone.0190087	http://dx.doi.org/10.1371/journal.pone.0190087			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320527	Green Submitted, Green Published, gold			2022-12-26	WOS:000419689600031
J	Grossman, D; Baum, SE; Andjelic, D; Tatum, C; Torres, G; Fuentes, L; Friedman, J				Grossman, Daniel; Baum, Sarah E.; Andjelic, Denitza; Tatum, Carrie; Torres, Guadalupe; Fuentes, Liza; Friedman, Jennifer			A harm-reduction model of abortion counseling about misoprostol use in Peru with telephone and in-person follow-up: A cohort study	PLOS ONE			English	Article							MEDICAL ABORTION; PREGNANCY; TERMINATION; EFFICACY; IMPLEMENTATION; COMPLICATIONS; OPINIONS; STRATEGY; IMPACT; MEXICO	Background In Peru, abortion is legal only to preserve the life and health of the woman. A non-profit clinic system in Peru implemented a harm-reduction model for women with unwanted pregnancy that included pre-abortion care with instructions about misoprostol use and post-abortion care; they started offering telephone follow-up for clients in 2011. This study aimed to evaluate the effectiveness and safety of the harm-reduction model, and to compare outcomes by type of follow-up obtained. Methods Between January 2012 and March 2013, 500 adult women seeking harm-reduction services were recruited into the study. Telephone surveys were conducted approximately four weeks after their initial harm-reduction counseling session with 262 women (response rate 52%); 9 participants were excluded. The survey focused on whether women pursued an abortion, and if so, what their experience was. Demographic and clinical data were also extracted from clinic records. Results Eighty-six percent of participants took misoprostol; among those taking misoprostol, 89% reported a complete abortion at the time of the survey. Twenty-two percent obtained an aspiration after taking misoprostol and 8% self-reported adverse events including hemor-rhage without transfusion, infection, or severe pain. Among women who took misoprostol, 46% reported receiving in-person follow-up (in some cases both telephone and in-person), 34% received telephone only, and 20% did not report receiving any form of follow-up. Those who had in-person follow-up with the counselor were most likely to report a complete abortion (< 0.001). Satisfaction with both types of follow-up was very high, with 81%-89% reporting being very satisfied. Conclusions Liberalization of restrictive abortion laws is associated with improvements in health outcomes, but the process of legal reform is often lengthy. In the interim, giving women information about evidence-based regimens of misoprostol, as well as offering a range of follow-up options to ensure high quality post-abortion care, may reduce the risks associated with unsafe abortion.	[Grossman, Daniel; Fuentes, Liza] Univ Calif San Francisco, Bixby Ctr Global Reprod Hlth, Dept Obstet Gynecol & Reprod Sci, Adv New Stand Reprod Hlth ANSIRH, Oakland, CA 94143 USA; [Grossman, Daniel; Baum, Sarah E.] Ibis Reprod Hlth, Oakland, CA 94612 USA; [Andjelic, Denitza; Tatum, Carrie; Friedman, Jennifer] Int Planned Parenthood Federat Western Hemisphere, New York, NY USA; [Torres, Guadalupe] Inst Peruano Paternidad Responsable INPPARES, Lima, Peru	University of California System; University of California San Francisco	Grossman, D (corresponding author), Univ Calif San Francisco, Bixby Ctr Global Reprod Hlth, Dept Obstet Gynecol & Reprod Sci, Adv New Stand Reprod Hlth ANSIRH, Oakland, CA 94143 USA.; Grossman, D (corresponding author), Ibis Reprod Hlth, Oakland, CA 94612 USA.	Daniel.Grossman@UCSF.edu		Fuentes, Liza/0000-0003-2990-6933	tobacco company	tobacco company	The study was supported by an anonymous foundation that had no competing interests in relation to this work. The foundation had no role in the study design; in the collection, analysis, and interpretation of the data; in the writing of the report; or in the decision to submit the paper for publication. None of the research costs or authors' salaries were funded by a tobacco company. We do not believe that the identity of the funder would be relevant. Further, the funder requested upon receipt of the grant that they remain anonymous. The authors are not aware of any competing interests.	BARBOSA RM, 1993, STUD FAMILY PLANN, V24, P236, DOI 10.2307/2939191; Bernabe-Ortiz A, 2009, CAN MED ASSOC J, V180, P541, DOI 10.1503/cmaj.090188; Billings DL, 2009, CONTRACEPTION, V79, P445, DOI 10.1016/j.contraception.2008.12.011; Blum J, 2016, CONTRACEPTION, V94, P115, DOI 10.1016/j.contraception.2016.04.001; Briozzo L, 2006, INT J GYNECOL OBSTET, V95, P221, DOI 10.1016/j.ijgo.2006.07.013; Espinoza H, 2004, CONTRACEPTION, V70, P127, DOI 10.1016/j.contraception.2004.03.011; Faundes A, 1996, ADV CONTRACEPT, V12, P1, DOI 10.1007/BF01849540; Gomperts R, 2012, ACTA OBSTET GYN SCAN, V91, P226, DOI 10.1111/j.1600-0412.2011.01285.x; Velez ACG, 2012, REPROD HEALTH MATTER, V20, P22, DOI 10.1016/S0968-8080(12)40668-1; Harper CC, 2007, INT J GYNECOL OBSTET, V98, P66, DOI 10.1016/j.ijgo.2007.03.009; Hu D, 2009, BJOG-INT J OBSTET GY, V116, P768, DOI 10.1111/j.1471-0528.2009.02142.x; Jewkes R, 2005, BJOG-INT J OBSTET GY, V112, P355, DOI 10.1111/j.1471-0528.2004.00422.x; Johnson BR, 2004, REPROD HEALTH MATTER, V12, P184, DOI 10.1016/S0968-8080(04)24023-X; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Labandera A, 2016, INT J GYNECOL OBSTET, V134, pS7, DOI 10.1016/j.ijgo.2016.06.007; Lafaurie MM, 2005, REPROD HEALTH MATTER, V13, P75, DOI 10.1016/S0968-8080(05)26199-2; Lara D, 2011, INT PERSPECT SEX R H, V37, P75, DOI 10.1363/3707511; Perriera LK, 2010, CONTRACEPTION, V81, P143, DOI 10.1016/j.contraception.2009.08.008; Platais I, 2015, CONTRACEPTION, V91, P178, DOI 10.1016/j.contraception.2014.11.004; Ramos S, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-72; Raymond EG, 2016, OBSTET GYNECOL, V128, P739, DOI 10.1097/AOG.0000000000001627; Raymond EG, 2016, OBSTET GYNECOL, V127, P306, DOI 10.1097/AOG.0000000000001274; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sedgh G, 2016, LANCET, V388, P258, DOI 10.1016/S0140-6736(16)30380-4; Singh S, 2016, BJOG-INT J OBSTET GY, V123, P1489, DOI 10.1111/1471-0528.13552; Tavara L, 2004, REV PERU GINECOL OBS, V50, P176; Tavara-Orozco L, 2009, REV PERUANA GINECOLO, V54, P253; Upadhyay UD, 2015, OBSTET GYNECOL, V125, P175, DOI 10.1097/AOG.0000000000000603; von Hertzen H, 2007, LANCET, V369, P1938, DOI 10.1016/S0140-6736(07)60914-3; World Health Organization, 2014, CLIN PRACT HDB SAF A	30	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0189195	10.1371/journal.pone.0189195	http://dx.doi.org/10.1371/journal.pone.0189195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320513	gold, Green Published, Green Submitted			2022-12-26	WOS:000419689600005
J	Jarosz-Biej, M; Kaminska, N; Matuszczak, S; Cichon, T; Pamula-Pilat, J; Czapla, J; Smolarczyk, R; Skwarzynska, D; Kulik, K; Szala, S				Jarosz-Biej, Magdalena; Kaminska, Natalia; Matuszczak, Sybilla; Cichon, Tomasz; Pamula-Pilat, Jolanta; Czapla, Justyna; Smolarczyk, Ryszard; Skwarzynska, Daria; Kulik, Klaudia; Szala, Stanislaw			M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma	PLOS ONE			English	Article							VASCULAR NORMALIZATION; B16-F10 MELANOMA; T-CELLS; CANCER; ANGIOGENESIS; POLARIZATION; PROGRESSION; IL-10; INTERLEUKIN-12; ACTIVATION	Tumor-associated macrophages (TAMs) play a significant role in at least two key processes underlying neoplastic progression: angiogenesis and immune surveillance. TAMs pheno-typic changes play important role in tumor vessel abnormalization/normalization. M2-like TAMs stimulate immunosuppression and formation of defective tumor blood vessels leading to tumor progression. In contrast M1-like TAMs trigger immune response and normalize irregular tumor vascular network which should sensitize cancer cells to chemo-and radiotherapy and lead to tumor growth regression. Here, we demonstrated that combination of endoglin-based DNA vaccine with interleukin 12 repolarizes TAMs from tumor growth-promoting M2-like phenotype to tumor growth-inhibiting M1-like phenotype. Combined therapy enhances tumor infiltration by CD4(+), CD8(+) lymphocytes and NK cells. Depletion of TAMs as well as CD8(+) lymphocytes and NK cells, but not CD4(+) lymphocytes, reduces the effect of combined therapy. Furthermore, combined therapy improves tumor vessel maturation, perfusion and reduces hypoxia. It caused that suboptimal doses of doxorubicin reduced the growth of tumors in mice treated with combined therapy. To summarize, combination of anti-angiogenic drug and immunostimulatory agent repolarizes TAMs phenotype from M2-like (pro-tumor) into M1-like (anti-tumor) which affects the structure of tumor blood vessels, improves the effect of chemotherapy and leads to tumor growth regression.	[Jarosz-Biej, Magdalena] Maria Sklodowska Curie Mem Canc Ctr, Ctr Translat Res & Mol Biol Canc, Gliwice, Poland; Inst Oncol, Gliwice Branch, Gliwice, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Jarosz-Biej, M (corresponding author), Maria Sklodowska Curie Mem Canc Ctr, Ctr Translat Res & Mol Biol Canc, Gliwice, Poland.	Magdalena.Jarosz-Biej@io.gliwice.pl	Smolarczyk, Ryszard/AAL-8683-2021; Jarosz-Biej, Magdalena/AAR-2783-2021	Jarosz-Biej, Magdalena/0000-0003-4023-6782; Pamula-Pilat, Jolanta/0000-0002-6289-2329; Cichon, Tomasz/0000-0002-3009-7080; Czapla, Justyna/0000-0001-5402-8461; Smolarczyk, Ryszard/0000-0002-1131-289X; Matuszczak, Sybilla/0000-0001-6359-2582	National Science Centre (Poland) [UMO-2013/11/B/NZ4/04468, UMO-2014/15/B/NZ4/00696]; Silesian BIO-FARMA. Center for Biotechnology, Bioengineering, and Bioinformatics [POIG.02.01.00-00-166/08]; European Regional Development Fund	National Science Centre (Poland)(National Science Centre, Poland); Silesian BIO-FARMA. Center for Biotechnology, Bioengineering, and Bioinformatics; European Regional Development Fund(European Commission)	This work was performed within the framework of the project no. UMO-2013/11/B/NZ4/04468 financed by the National Science Centre (Poland). This work was supported by the project no. UMO-2014/15/B/NZ4/00696 financed by the National Science Centre (Poland). This work was supported by equipment bought for the purposes of the project no. POIG.02.01.00-00-166/08: "Silesian BIO-FARMA. Center for Biotechnology, Bioengineering, and Bioinformatics" co-financed by European Regional Development Fund within the framework of Innovative Economy Operational Programme 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodduluru LN, 2015, CANCER LETT, V357, P454, DOI 10.1016/j.canlet.2014.12.020; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Casey SC, 2015, SEMIN CANCER BIOL, V35, pS199, DOI 10.1016/j.semcancer.2015.02.007; Chanmee T, 2014, CANCERS, V6, P1670, DOI 10.3390/cancers6031670; Chen PW, 2013, INT REV CEL MOL BIO, V301, P1, DOI 10.1016/B978-0-12-407704-1.00001-4; Cichon T, 2012, ACTA BIOCHIM POL, V59, P377; Czapla J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158745; De Bock K, 2011, NAT REV CLIN ONCOL, V8, P393, DOI 10.1038/nrclinonc.2011.83; De Bock K, 2011, CURR OPIN GENET DEV, V21, P73, DOI 10.1016/j.gde.2010.10.008; Dehnel N, 2017, CURR OPIN PHARMACOL, V35, P12, DOI 10.1016/j.coph.2017.04.007; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Falleni M, 2017, MELANOMA RES, V27, P200, DOI 10.1097/CMR.0000000000000352; Fang ZX, 2017, ONCOTARGET, V8, P54173, DOI 10.18632/oncotarget.17013; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fonsatti E, 2010, CARDIOVASC RES, V86, P12, DOI 10.1093/cvr/cvp332; Fridlender ZG, 2013, BRIT J CANCER, V108, P1288, DOI 10.1038/bjc.2013.93; Gacche RN, 2014, BBA-REV CANCER, V1846, P161, DOI 10.1016/j.bbcan.2014.05.002; George DD, 2017, CANCER GENE THER, V24, P141, DOI 10.1038/cgt.2016.56; Giavina-Bianchi MH, 2017, AN BRAS DERMATOL, V92, P156, DOI 10.1590/abd1806-4841.20176183; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; Gonzalez-Gugel E, 2016, CANCER IMMUNOL IMMUN, V65, P1261, DOI 10.1007/s00262-016-1859-9; Goswami KK, 2017, CELL IMMUNOL, V316, P1, DOI 10.1016/j.cellimm.2017.04.005; Guo CQ, 2013, VASC CELL, V5, DOI 10.1186/2045-824X-5-20; Guo QJ, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/9720912; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu W, 2016, CLIN TRANSL ONCOL, V18, P251, DOI 10.1007/s12094-015-1373-0; Huang YH, 2013, CANCER RES, V73, P2943, DOI 10.1158/0008-5472.CAN-12-4354; Huang YH, 2012, P NATL ACAD SCI USA, V109, P17561, DOI 10.1073/pnas.1215397109; Hui LL, 2015, CANCER LETT, V368, P7, DOI 10.1016/j.canlet.2015.07.039; Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; Jarosz M, 2013, GENE THER, V20, P262, DOI 10.1038/gt.2012.28; Jarosz-Biej M, 2015, ARCH IMMUNOL THER EX, V63, P451, DOI 10.1007/s00005-015-0337-y; Kilinc MO, 2006, J IMMUNOL, V177, P6962, DOI 10.4049/jimmunol.177.10.6962; Kubota K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01661-z; Kuol N, 2017, MATURITAS, V105, P8, DOI 10.1016/j.maturitas.2017.04.014; Lasek W, 2014, CANCER IMMUNOL IMMUN, V63, P419, DOI 10.1007/s00262-014-1523-1; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Mantovani A, 2015, J EXP MED, V212, P435, DOI 10.1084/jem.20150295; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Marelli G, 2017, CURR OPIN PHARMACOL, V35, P57, DOI 10.1016/j.coph.2017.05.007; Martin JD, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a027094; Mattiola I, 2015, J IMMUNOL, V195, P2818, DOI 10.4049/jimmunol.1500325; Mignogna C, 2017, CLIN EXP DERMATOL, V42, P243, DOI 10.1111/ced.13023; Mills CD, 2016, CANCER RES, V76, P513, DOI 10.1158/0008-5472.CAN-15-1737; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Nassiri F, 2011, ANTICANCER RES, V31, P2283; Ngambenjawong C, 2017, ADV DRUG DELIVER REV, V114, P206, DOI 10.1016/j.addr.2017.04.010; O'Neill CF, 2007, AM J PATHOL, V171, P1023, DOI 10.2353/ajpath.2007.061029; Oft M, 2014, CANCER IMMUNOL RES, V2, P194, DOI 10.1158/2326-6066.CIR-13-0214; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Paauwe M, 2016, ONCOGENE, V35, P4069, DOI 10.1038/onc.2015.509; Petty AJ, 2017, IMMUNOTHERAPY-UK, V9, P289, DOI 10.2217/imt-2016-0135; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qin T, 2015, TOXICOL APPL PHARM, V286, P112, DOI 10.1016/j.taap.2015.03.021; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Ramjiawan RR, 2017, ANGIOGENESIS, V20, P185, DOI 10.1007/s10456-017-9552-y; Rhee I, 2016, ARCH PHARM RES, V39, P1588, DOI 10.1007/s12272-016-0820-y; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Rosen LS, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-013-0365-x; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Siemann DW, 2015, PHARMACOL THERAPEUT, V153, P107, DOI 10.1016/j.pharmthera.2015.06.006; Singh S, 2017, LIFE SCI, V174, P50, DOI 10.1016/j.lfs.2017.02.011; Spaw M, 2017, MOL CARCINOGEN, V56, P1199, DOI 10.1002/mc.22583; Szala S., 2015, CANCER IMMUNOLOGY, P401; Szala S, 2010, CANCER IMMUNOL IMMUN, V59, P1449, DOI 10.1007/s00262-010-0873-6; Tartour E, 2011, CANCER METAST REV, V30, P83, DOI 10.1007/s10555-011-9281-4; Teng MWL, 2011, CANCER CELL, V20, P691, DOI 10.1016/j.ccr.2011.11.020; Terme M, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/492920; Tian HY, 2017, ARTERIOSCL THROM VAS, V37, P1115, DOI 10.1161/ATVBAHA.116.308859; Tolaney SM, 2015, P NATL ACAD SCI USA, V112, P14325, DOI 10.1073/pnas.1518808112; Vandereyken M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185786; Viallard C, 2017, ANGIOGENESIS, V20, P409, DOI 10.1007/s10456-017-9562-9; Vitale M, 2014, EUR J IMMUNOL, V44, P1582, DOI 10.1002/eji.201344272; Wallerius M, 2016, CANCER RES, V76, P3166, DOI 10.1158/0008-5472.CAN-15-2596; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Wilke CM, 2011, CANCER IMMUNOL IMMUN, V60, P1529, DOI 10.1007/s00262-011-1104-5; Xu DP, 2004, INT J CANCER, V109, P499, DOI 10.1002/ijc.11696; Yang SX, 2016, BIOMED PHARMACOTHER, V84, P1466, DOI 10.1016/j.biopha.2016.10.046; Zhang H, 2016, J CLIN ONCOL, V34, P3576, DOI 10.1200/JCO.2016.69.6435	84	52	54	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e0191012	10.1371/journal.pone.0191012	http://dx.doi.org/10.1371/journal.pone.0191012			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320562	gold, Green Published, Green Submitted			2022-12-26	WOS:000419689600080
J	Lian, W; Liu, H; Song, QQ; Liu, YQ; Sun, LY; Deng, Q; Wang, SP; Cao, YH; Zhang, XY; Jiang, YY; Lv, HY; Duan, LB; Yu, J				Lian, Wei; Liu, Hui; Song, QuanQuan; Liu, Yun Qi; Sun, Li Yan; Deng, Qing; Wang, Shao Ping; Cao, Yan Hong; Zhang, Xue Ying; Jiang, Yuan Yuan; Lv, Hong Yan; Duan, Li Bin; Yu, Jun			Prevalence of hand osteoarthritis and knee osteoarthritis in Kashin-Beck disease endemic areas and non Kashin-Beck disease endemic areas: A status survey	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; RISK; OBESITY; WOMEN	Osteoarthritis (OA) is a considerable health problem worldwide, and the prevalence of OA varies in different regions. In this study, the prevalence of OA in Kashin-Beck disease (KBD) and non-KBD endemic areas was examined, respectively. According to monitoring data, 4 types of regions (including none, mild, moderate and high KBD endemic areas) in Heilong-jiang and Jilin provinces were selected. All local residents were eligible for inclusion criteria have undergone X-ray images of hands and anteroposterior image of knees. A total of 1673 cases were collected, 1446 cases were analyzed after removing the KBD patients (227). The overall hand OA and knee OA detection rates were 33.3% (481/1446) and 56.6% (818/1446), respectively. After being standardized by age, the detection rate of hand OA in the KBD endemic areas was significantly higher than that in the non-endemic endemic areas. Differently, there was no significant difference in the detection rates of knee OA between the KBD endemic areas and the non-endemic area. The correlation coefficient between the severity of OA and the severity of knee OA was 0.358 and 0.197 in the KBD and non-KBD endemic areas, respectively. Where the KBD historical prevalence level was higher, the severity of the residents' hand OA was more serious. The detection rates of hand OA and knee OA increased with age. The detection rate of knee OA increased with the increase in body mass index. The prevalence of hand OA was closely related to the pathogenic factors of Kashin-Beck disease, and the prevalence of knee OA had no significant correlation with KBD pathogenic factors.	[Lian, Wei; Liu, Hui; Song, QuanQuan; Liu, Yun Qi; Sun, Li Yan; Deng, Qing; Wang, Shao Ping; Cao, Yan Hong; Yu, Jun] Harbin Med Univ, Inst Kashin Beck Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Harbin, Heilongjiang, Peoples R China; [Lian, Wei; Liu, Hui; Song, QuanQuan; Liu, Yun Qi; Sun, Li Yan; Deng, Qing; Wang, Shao Ping; Cao, Yan Hong; Yu, Jun] Natl Hlth & Family Planning Commiss, Key Lab Etiol & Epidemiol, Harbin, Heilongjiang, Peoples R China; [Zhang, Xue Ying; Jiang, Yuan Yuan; Lv, Hong Yan; Duan, Li Bin] Jilin Inst Endem Dis Prevent Second, Changchun, Jilin, Peoples R China	Chinese Center for Disease Control & Prevention; Harbin Medical University	Yu, J (corresponding author), Harbin Med Univ, Inst Kashin Beck Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Harbin, Heilongjiang, Peoples R China.; Yu, J (corresponding author), Natl Hlth & Family Planning Commiss, Key Lab Etiol & Epidemiol, Harbin, Heilongjiang, Peoples R China.	6yujun@126.com	jiang, anyi/GPT-0379-2022		National Natural Science Foundation of China [81472931]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Natural Science Foundation of China (no. 81472931, http://www.nsfc.gov.cn/). JY received the funding. JY provided guidance and analysis in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by grants from the National Natural Science Foundation of China (No. 81472931). For sample collection, the authors acknowledge help from the Centers for Disease Control and Prevention of Heigang, Jiaohe, Songyuan, and Huinan counties. We also thank the patients and controls for participating in this study.	Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487; Christensen R, 2007, ANN RHEUM DIS, V66, P433, DOI 10.1136/ard.2006.065904; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; FELSON DT, 1988, ANN INTERN MED, V109, P18, DOI 10.7326/0003-4819-109-1-18; FELSON DT, 1992, ANN INTERN MED, V116, P535, DOI 10.7326/0003-4819-116-7-535; Gu MS, 2013, SHANGHAI MED, P57; Li CX., 2006, CHINESE J MISDIAGNOS, V6, P3962; Li NH, 2008, CHINESE J TISSUE ENG, V12, P6546; Li QW, 2004, CHINESE CLIN REHABIL, V35, P7918; Lin L, 2007, CHINESE MED, P552; Liu Ning, 2004, Chinese Journal of Endemiology, V23, P237; LIU Y Q, 2011, CHINESE J CONTROL EN, V26, P259; Martin JA, 2002, BIOGERONTOLOGY, V3, P257, DOI 10.1023/A:1020185404126; Neogi T, 2013, OSTEOARTHR CARTILAGE, V21, P1145, DOI 10.1016/j.joca.2013.03.018; Niu J, 2009, ARTHRIT RHEUM-ARTHR, V61, P329, DOI 10.1002/art.24337; Parazzini F, 2003, MATURITAS, V46, P207, DOI 10.1016/S0378-5122(03)00193-2; [荣杰生 RONG Jiesheng], 2007, [中国骨质疏松杂志, Chinese Journal of Osteoporosis], V13, P723; Rossignol M, 2003, OCCUP ENVIRON MED, V60, P882, DOI 10.1136/oem.60.11.882; [王永斌 WANG Yongbin], 2008, [中国全科医学, Chinese General Practice], V11, P785; Wen ST, 2004, DERMATOLOGY VENEREOL, P37; Wills AK, 2012, ANN RHEUM DIS, V71, P655, DOI 10.1136/ard.2011.154021; Wu YJ, 2011, COMPREHENSIVE SEMICO, V04, P299; [杨建伯 Yang Jianbo], 2002, [中国地方病学杂志, Chinese Journal of Endemiology], V21, P459; Zang CH, 2006, SHANXI MED J, V35, P767; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P1, DOI 10.1016/j.joca.2009.07.013; [余卫 Yu Wei], 2005, [中华放射学杂志, Chinese Journal of Radiology], V39, P67	28	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2018	13	1							e190505	10.1371/journal.pone.0190505	http://dx.doi.org/10.1371/journal.pone.0190505			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS3NS	29320581	Green Submitted, Green Published, gold			2022-12-26	WOS:000419689600054
